Psyllid ID: psy17532

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-
Protein Sequence
MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALLDSTGNSLPPAAQQQNRFSESTM
Secondary Structure (PSIPRED)
ccccccccEEEccccccccEEEEEcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccEEEEEEEccccEEEEEEEcccEEEEEEEEcccHHHHHHHHHHHHccccccccccEEEEEEEEcccccEEEEEEEcccccccHHHHHHcccccHHHHHHHHHHHHHHHHHHcccccccccccccccEEEcccccccEEEcccccEEEEEcccEEEEcccccccccccccccccccHHHHccccccccccccccHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHccccccccccEEEEcccccccccccccccccccHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccHHHccccccccccEEEEcccccccccccccccccccccccccccccccccHEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHccccHHHcccccccccEEEEEccccEEEEEEEccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccHHHHEEEEEEEcccccHHHHHccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccEEEEEcccHccEEcccccccHHcHccHHEEcccccccccccEEEEccccccHHHHHccEccccccEEHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccHEEEccccccccccccccHHHHHHHHHHHHHHccccHHHcccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mecydkpkcvekrpeskknlnfcccegdmcnkdfawepaplpppinsttpikteshplIIFLYTMLPIFALIIPIFLCYWYYRQRklgsyfnpvptlephptsppspqqgcrsiQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQeifklphmehdNILRYIgaekrgesihTEFWLITAYHErgslcdflkcniVTWEQLCRIALSMSKGLMHLHEeilpnkadsykpavahrdfksnnvllkSDLTAAIADFGLALlfepgkpcgdthgqvgtrrymapevLEGAINFSRDAFLRIDMYACALVLWELAsrcssvspppgeyrlpfsaevgdhpsleDMQEAVVhkklrptlpetWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALLdstgnslppaaqqqnrfsestm
Flexible Loop (DISEMBL)
mecydkpkcvekrpeskknlnFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALldstgnslppaaqqqnrfsestm
Low Complexity Region (SEG)
MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFLYTMlpifaliipiflCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALLDSTGNSLPPAAQQQNRFSESTM
Disordered region (IsUnstruct)
******************NLNFCCCEGDMCNKDFAWEPAPL*********IKTESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPV*****************RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC*******************************VHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALL**********************
Disordered Region (DISOPRED)
MECYDKPKC**********LNFCCCEGDMCNKDFAWEP*****************HPLIIFLYTMLPIFALIIPIFLCYWYY******************************SIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM**********************************************************
Disordered Region (DISEMBL)
MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTL*************CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALLDSTGNS****************
Disordered Region (DISPRO)
MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPL************ESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKL****NPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL*******************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVERVAWQSRALLDSTGNSLPPAAQQQNRFSESTM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	461	2.2.26 [Sep-21-2011]
Q90669	513	Activin receptor type-2A	yes	N/A	0.852	0.766	0.599	1e-135
P27041	511	Activin receptor type-2B	N/A	N/A	0.841	0.759	0.564	1e-132
Q90670	512	Activin receptor type-2B	no	N/A	0.859	0.773	0.583	1e-132
P27039	514	Activin receptor type-2A	N/A	N/A	0.859	0.770	0.598	1e-131
Q13705	512	Activin receptor type-2B	yes	N/A	0.859	0.773	0.573	1e-131
P27037	513	Activin receptor type-2A	no	N/A	0.845	0.760	0.592	1e-130
P27038	513	Activin receptor type-2A	yes	N/A	0.856	0.769	0.592	1e-130
P38445	513	Activin receptor type-2B	yes	N/A	0.859	0.771	0.574	1e-130
Q28043	513	Activin receptor type-2A	yes	N/A	0.856	0.769	0.592	1e-130
P27040	536	Activin receptor type-2B	no	N/A	0.861	0.740	0.547	1e-130

>sp|Q90669|AVR2A_CHICK Activin receptor type-2A OS=Gallus gallus GN=ACVR2A PE=2 SV=1

 Score =  480 bits (1236), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 242/404 (59%), Positives = 295/404 (73%), Gaps = 11/404 (2%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPA--PLPPPINSTTPIKTESHPL 58
           + CYD+  C+EK+   +  + FCCCEG+MCN+ F + P      P  N  TP      PL
Sbjct: 83  INCYDRNDCIEKKDSPE--VFFCCCEGNMCNERFFYFPEMEVTQPTSNPVTP----KPPL 136

Query: 59  I-IFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLV 117
               LY+++PI  + + +   +W YR  KL      VPT +     PPSP  G + +QL+
Sbjct: 137 FNTLLYSLVPIMGIAVIVLFSFWMYRHHKLAYPPVLVPT-QDPGPPPPSPLMGLKPLQLL 195

Query: 118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           E+KA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E EI+ LP M+HDNIL++IGAEKR
Sbjct: 196 EIKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEIYSLPGMKHDNILQFIGAEKR 255

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G SI  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D +
Sbjct: 256 GTSIDVDLWLITAFHEKGSLTDFLKANVVSWNELCHIAQTMARGLAYLHEDI-PGLKDGH 314

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
           KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEGA
Sbjct: 315 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 374

Query: 298 INFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVH 357
           INF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VVH
Sbjct: 375 INFQRDAFLRIDMYAMGLVLWELASRCTASDGPVDEYMLPFEEEIGQHPSLEDMQEVVVH 434

Query: 358 KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           KK RP L E W++H+GM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 435 KKKRPVLRECWQKHSGMAMLCETIEECWDHDAEARLSAGCVEER 478

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A. May modulate neuropeptide expression in dorsal root ganglia (DRG) neurons and ovarian follicle development.
Gallus gallus (taxid: 9031)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 3EC: 0

>sp|P27041|AVR2B_XENLA Activin receptor type-2B OS=Xenopus laevis GN=acvr2b PE=2 SV=1

 Score =  471 bits (1213), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/406 (56%), Positives = 286/406 (70%), Gaps = 18/406 (4%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPA-----PLPPPINSTTPIKTES 55
             CYD+ +C+ K  E    + FCCCEG+ CNK F   P      P P P  S        
Sbjct: 84  FNCYDRQECIAK--EENPQVFFCCCEGNYCNKKFTHLPEVETFDPKPQPSASV------- 134

Query: 56  HPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQ 115
             L I +Y++LPI  L + I L +W YR RK    +  V   E     PPSP  G + +Q
Sbjct: 135 --LNILIYSLLPIVGLSMAILLAFWMYRHRK--PSYGHVEINEDPGLPPPSPLVGLKPLQ 190

Query: 116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           L+++KA+GRFG VWKA+  NE VAVKIF +QDKQSWQ E+EIF  P M+H+N+L +I AE
Sbjct: 191 LLDIKARGRFGCVWKARLLNEYVAVKIFPVQDKQSWQCEKEIFTTPGMKHENLLEFIAAE 250

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
           KRG ++  E WLITA+H++GSL D+LK N+V+W +LC I  +M++GL +LHE++   K +
Sbjct: 251 KRGSNLEMELWLITAFHDKGSLTDYLKGNLVSWNELCHITETMARGLAYLHEDVPRCKGE 310

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLE 295
            +KPA+AHRDFKS NVLL++DLTA +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLE
Sbjct: 311 GHKPAIAHRDFKSKNVLLRNDLTAILADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 370

Query: 296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV 355
           GAINF RD+FLRIDMYA  LVLWE+ SRC++   P  EY LPF  E+G HPSLED+QE V
Sbjct: 371 GAINFQRDSFLRIDMYAMGLVLWEIVSRCTAADGPVDEYLLPFEEEIGQHPSLEDLQEVV 430

Query: 356 VHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           VHKK+RP   + W +H G+  LC T+EECWDHDAEARLSA CV ER
Sbjct: 431 VHKKIRPVFKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER 476

Receptor for activin A, activin B and inhibin A. Involved in transmembrane signaling.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|Q90670|AVR2B_CHICK Activin receptor type-2B OS=Gallus gallus GN=ACVR2B PE=2 SV=1

 Score =  471 bits (1211), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/401 (58%), Positives = 290/401 (72%), Gaps = 5/401 (1%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
             CYD+ +CV    E    + FCCCEG+ CN+ F   P    P +    P  T S  L I
Sbjct: 82  FNCYDRQECVAT--EENPQVFFCCCEGNYCNEKFTHLPEVTGPEVIYEPPPPTPS-LLNI 138

Query: 61  FLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVK 120
            +Y++LPI  L + I L +W YR RK    +  V   E     PPSP  G + +QL+E+K
Sbjct: 139 LVYSLLPIAVLSVAILLAFWMYRHRK--PPYGHVDINEDPGPPPPSPLVGLKPLQLLEIK 196

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES 180
           A+GRFG VWKA+  N+ VAVKIF +QDKQSWQSE+EIF  P M+H+N+L++I AEKRG +
Sbjct: 197 ARGRFGCVWKAQLMNDYVAVKIFPIQDKQSWQSEREIFNTPGMKHENLLQFIAAEKRGTN 256

Query: 181 IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA 240
           + TE WLITA+H++GSL D+LK NI++W +LC +A +M++GL +LHE++   K + +KPA
Sbjct: 257 LETELWLITAFHDKGSLTDYLKGNIISWNELCHVAETMARGLSYLHEDVPWCKGEGHKPA 316

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           +AHRDFKS NVLLK+DLTA +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLEGAINF
Sbjct: 317 IAHRDFKSKNVLLKNDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 376

Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL 360
            RDAFLRIDMYA  LVLWEL SRC +V  P  EY LPF  E+G HPSLED+QE VVHKK+
Sbjct: 377 QRDAFLRIDMYAMGLVLWELVSRCRAVDGPVDEYMLPFEEEIGQHPSLEDLQEVVVHKKM 436

Query: 361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           RP   + W +H G+  LC T+EECWDHDAEARLSA CV ER
Sbjct: 437 RPVFKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER 477

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A. May modulate neuropeptide expression in dorsal root ganglia (DRG) neurons and ovarian follicle development.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|P27039|AVR2A_XENLA Activin receptor type-2A OS=Xenopus laevis GN=acvr2a PE=2 SV=1

 Score =  469 bits (1207), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 240/401 (59%), Positives = 293/401 (73%), Gaps = 5/401 (1%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
           + CY+K KC EK+     ++ FCCCEG+ CN+ F   P  +     ++ P+ T+      
Sbjct: 84  INCYNKSKCTEKK--DSPDVFFCCCEGNYCNEKFYHSP-EMEVTQPTSNPVTTKPPLFNT 140

Query: 61  FLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVK 120
            LY+++PI  + + +   +W YR  KL      VPT +     PPSP  G + +QL+EVK
Sbjct: 141 LLYSLVPIMVVAVIVLFSFWMYRHHKLAYPPVLVPT-QDPGPPPPSPLLGLKPLQLLEVK 199

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES 180
           A+GRFG VWKA+  NE VAVKIF +QDK SWQ+E EI+ LP M+H+NIL +IGAEKRG +
Sbjct: 200 ARGRFGCVWKAQLLNETVAVKIFPVQDKLSWQNEYEIYSLPGMKHENILYFIGAEKRGTN 259

Query: 181 IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA 240
           + T+ WLITA+HE+GSL D+LK N+V+W +LC IA +M++GL HLHE+I P   D +KPA
Sbjct: 260 LDTDLWLITAFHEKGSLTDYLKANVVSWNELCLIAETMARGLSHLHEDI-PGLKDGHKPA 318

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           VAHRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEGAINF
Sbjct: 319 VAHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 378

Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL 360
            RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  EVG HPSLEDMQE VVHKK 
Sbjct: 379 QRDAFLRIDMYAFGLVLWELASRCTASDGPVDEYMLPFEEEVGQHPSLEDMQEVVVHKKK 438

Query: 361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           RP L E W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 439 RPILRECWQKHAGMAMLCETIEECWDHDAEARLSAGCVEER 479

Receptor for activin A, activin B and inhibin A. Involved in transmembrane signaling.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|Q13705|AVR2B_HUMAN Activin receptor type-2B OS=Homo sapiens GN=ACVR2B PE=1 SV=3

 Score =  468 bits (1203), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 230/401 (57%), Positives = 288/401 (71%), Gaps = 5/401 (1%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
             CYD+ +CV    E    + FCCCEG+ CN+ F   P    P +    P  T    L +
Sbjct: 82  FNCYDRQECVAT--EENPQVYFCCCEGNFCNERFTHLPEAGGPEVTYEPP-PTAPTLLTV 138

Query: 61  FLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVK 120
             Y++LPI  L + + L +W YR RK    +  V   E     PPSP  G + +QL+E+K
Sbjct: 139 LAYSLLPIGGLSLIVLLAFWMYRHRK--PPYGHVDIHEDPGPPPPSPLVGLKPLQLLEIK 196

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES 180
           A+GRFG VWKA+  N+ VAVKIF +QDKQSWQSE+EIF  P M+H+N+L++I AEKRG +
Sbjct: 197 ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 256

Query: 181 IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA 240
           +  E WLITA+H++GSL D+LK NI+TW +LC +A +MS+GL +LHE++   + + +KP+
Sbjct: 257 LEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 316

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           +AHRDFKS NVLLKSDLTA +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLEGAINF
Sbjct: 317 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 376

Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL 360
            RDAFLRIDMYA  LVLWEL SRC +   P  EY LPF  E+G HPSLE++QE VVHKK+
Sbjct: 377 QRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKM 436

Query: 361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           RPT+ + W +H G+  LC T+EECWDHDAEARLSA CV ER
Sbjct: 437 RPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER 477

Transmembrane serine/threonine kinase activin type-2 receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|P27037|AVR2A_HUMAN Activin receptor type-2A OS=Homo sapiens GN=ACVR2A PE=1 SV=1

 Score =  466 bits (1200), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 241/407 (59%), Positives = 297/407 (72%), Gaps = 17/407 (4%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEP-----APLPPPINSTTPIKTES 55
           + CYD+  CVEK+   +  + FCCCEG+MCN+ F++ P      P   P+    P     
Sbjct: 83  INCYDRTDCVEKKDSPE--VYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTPKPPYYN-- 138

Query: 56  HPLIIFLYTMLPIFALIIPIFLC-YWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSI 114
               I LY+++P+  LI  I +C +W YR  K+      VPT +     PPSP  G + +
Sbjct: 139 ----ILLYSLVPLM-LIAGIVICAFWVYRHHKMAYPPVLVPT-QDPGPPPPSPLLGLKPL 192

Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           QL+EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGA
Sbjct: 193 QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 252

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           EKRG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   
Sbjct: 253 EKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLK 311

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           D +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVL
Sbjct: 312 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 371

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
           EGAINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE 
Sbjct: 372 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEV 431

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           VVHKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 432 VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|P27038|AVR2A_MOUSE Activin receptor type-2A OS=Mus musculus GN=Acvr2a PE=1 SV=1

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 238/402 (59%), Positives = 299/402 (74%), Gaps = 7/402 (1%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
           + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P  +     ++ P+  +     I
Sbjct: 83  INCYDRTDCIEKKDSPE--VYFCCCEGNMCNEKFSYFPE-MEVTQPTSNPVTPKPPYYNI 139

Query: 61  FLYTMLPIFALIIPIFLC-YWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEV 119
            LY+++P+  LI  I +C +W YR  K+      VPT +     PPSP  G + +QL+EV
Sbjct: 140 LLYSLVPLM-LIAGIVICAFWVYRHHKMAYPPVLVPT-QDPGPPPPSPLLGLKPLQLLEV 197

Query: 120 KAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
           KA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEKRG 
Sbjct: 198 KARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 257

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
           S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D +KP
Sbjct: 258 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDGHKP 316

Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
           A++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEGAIN
Sbjct: 317 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 376

Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK 359
           F RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VVHKK
Sbjct: 377 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 436

Query: 360 LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 437 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|P38445|AVR2B_RAT Activin receptor type-2B OS=Rattus norvegicus GN=Acvr2b PE=1 SV=3

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 231/402 (57%), Positives = 289/402 (71%), Gaps = 6/402 (1%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
             CYD+ +CV    E    + FCCCEG+ CN+ F   P P  P +    P  T    L +
Sbjct: 82  FNCYDRQECVAT--EENPQVYFCCCEGNFCNERFTHLPEPGGPEVTYEPP-PTAPTLLTV 138

Query: 61  FLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVK 120
             Y++LPI  L + + L +W YR RK    +  V   E     PPSP  G + +QL+E+K
Sbjct: 139 LAYSLLPIGGLSLIVLLAFWMYRHRK--PPYGHVDIHEDPGPPPPSPLVGLKPLQLLEIK 196

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG-E 179
           A+GRFG VWKA+  N+ VAVKIF +QDKQSWQSE+EIF  P M+H+N+L++I AEKRG  
Sbjct: 197 ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGCS 256

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
           ++  E WLITA+H++GSL D+LK NI+TW +LC +A +MS+GL +LHE++   + + +KP
Sbjct: 257 NLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 316

Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
           ++AHRDFKS NVLLKSDLTA +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLEGAIN
Sbjct: 317 SIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAIN 376

Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK 359
           F RDAFLRIDMYA  LVLWEL SRC +   P  EY LPF  E+G HPSLE++QE VVHKK
Sbjct: 377 FQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKK 436

Query: 360 LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           +RPT+ + W +H G+  LC T+EECWDHDAEARLSA CV ER
Sbjct: 437 MRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER 478

Transmembrane serine/threonine kinase activin type-2 receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|Q28043|AVR2A_BOVIN Activin receptor type-2A OS=Bos taurus GN=ACVR2A PE=2 SV=1

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 238/402 (59%), Positives = 299/402 (74%), Gaps = 7/402 (1%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
           + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P  +     ++ P+  +     I
Sbjct: 83  INCYDRTDCIEKKDSPE--VYFCCCEGNMCNERFSYFP-EMEVTQPTSNPVTPKPPYYNI 139

Query: 61  FLYTMLPIFALIIPIFLC-YWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEV 119
            LY+++P+  LI  I +C +W YR  K+      VPT +     PPSP  G + +QL+EV
Sbjct: 140 LLYSLVPLM-LIAGIVICAFWVYRHHKMAYPPVLVPT-QDPGPPPPSPLLGLKPLQLLEV 197

Query: 120 KAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
           KA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEKRG 
Sbjct: 198 KARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 257

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
           S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D +KP
Sbjct: 258 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDGHKP 316

Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
           A++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEGAIN
Sbjct: 317 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 376

Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK 359
           F RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VVHKK
Sbjct: 377 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 436

Query: 360 LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 437 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

>sp|P27040|AVR2B_MOUSE Activin receptor type-2B OS=Mus musculus GN=Acvr2b PE=1 SV=1

 Score =  464 bits (1194), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 232/424 (54%), Positives = 291/424 (68%), Gaps = 27/424 (6%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
             CYD+ +CV    E    + FCCCEG+ CN+ F   P P  P +    P  T    L +
Sbjct: 82  FNCYDRQECVAT--EENPQVYFCCCEGNFCNERFTHLPEPGGPEVTYEPP-PTAPTLLTV 138

Query: 61  FLYTMLPIFALIIPIFLCYWYYRQRK-----------------------LGSYFNPVPTL 97
             Y++LPI  L + + L +W YR RK                           F P+P  
Sbjct: 139 LAYSLLPIGGLSLIVLLAFWMYRHRKPPYGHVDIHEVRQCQRWAGRRDGCADSFKPLP-F 197

Query: 98  EPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEI 157
           +     PPSP  G + +QL+E+KA+GRFG VWKA+  N+ VAVKIF +QDKQSWQSE+EI
Sbjct: 198 QDPGPPPPSPLVGLKPLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREI 257

Query: 158 FKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS 217
           F  P M+H+N+L++I AEKRG ++  E WLITA+H++GSL D+LK NI+TW +LC +A +
Sbjct: 258 FSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAET 317

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           MS+GL +LHE++   + + +KP++AHRDFKS NVLLKSDLTA +ADFGLA+ FEPGKP G
Sbjct: 318 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 377

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
           DTHGQVGTRRYMAPEVLEGAINF RDAFLRIDMYA  LVLWEL SRC +   P  EY LP
Sbjct: 378 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLP 437

Query: 338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
           F  E+G HPSLE++QE VVHKK+RPT+ + W +H G+  LC T+EECWDHDAEARLSA C
Sbjct: 438 FEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGC 497

Query: 398 VVER 401
           V ER
Sbjct: 498 VEER 501

Transmembrane serine/threonine kinase activin type-2 receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 3

EC: 0

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	461
383856912	522	PREDICTED: activin receptor type-2B-like	0.865	0.764	0.678	1e-164
156550957	522	PREDICTED: activin receptor type-2B-like	0.865	0.764	0.669	1e-164
380015509	526	PREDICTED: activin receptor type-2B-like	0.865	0.758	0.669	1e-164
328777564	525	PREDICTED: activin receptor type-2B [Api	0.865	0.76	0.668	1e-164
332023028	511	Activin receptor type-2B [Acromyrmex ech	0.863	0.778	0.674	1e-162
350417059	526	PREDICTED: activin receptor type-2B-like	0.865	0.758	0.671	1e-161
340713124	526	PREDICTED: activin receptor type-2B-like	0.865	0.758	0.674	1e-160
307206391	527	Activin receptor type-2A [Harpegnathos s	0.861	0.753	0.658	1e-158
193631849	516	PREDICTED: activin receptor type-2B-like	0.867	0.775	0.626	1e-147
189241613	539	PREDICTED: similar to Activin receptor t	0.861	0.736	0.639	1e-143

>gi|383856912|ref|XP_003703950.1| PREDICTED: activin receptor type-2B-like [Megachile rotundata]

 Score =  585 bits (1508), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 274/404 (67%), Positives = 328/404 (81%), Gaps = 5/404 (1%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLP---PPINSTTPI-KTESHP 57
           +CYD+P C+E   E KK L FCCC+G+MCN++F W+P P     P ++   P+  TE   
Sbjct: 88  DCYDRPHCIENSAERKKELFFCCCDGNMCNQNFTWDPHPTSSSKPILHDPEPVPNTEQQI 147

Query: 58  LIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLV 117
           + + L   +P+  L I +   YW YR+RKL  YFN VPTLEP P   PSP  G R IQL+
Sbjct: 148 ITLVLSISIPMLLLAIVLPFLYWCYRRRKL-RYFNEVPTLEPLPLPQPSPNLGLRPIQLL 206

Query: 118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           E+KA+GRFGAVWKA+ KNE VAVK+F +QDKQSWQ+EQEIFKL HM+H++ILR+IG EKR
Sbjct: 207 EIKARGRFGAVWKAQLKNEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILRFIGVEKR 266

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+++ TEFWLITAYHE+GSLCD+LK N+VTW ++CRIA SM++GLMHLHEEI  NKAD Y
Sbjct: 267 GDNLQTEFWLITAYHEKGSLCDYLKANVVTWPEMCRIAESMARGLMHLHEEIPANKADGY 326

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
           KPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEVLEGA
Sbjct: 327 KPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEVLEGA 386

Query: 298 INFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVH 357
           INF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE+VVH
Sbjct: 387 INFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEDEVGLHPTLEDMQESVVH 446

Query: 358 KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           KK RP + ETW++H G+ ++CDTMEECWDHDAEARLSASCV+ER
Sbjct: 447 KKERPVILETWRKHPGLQSICDTMEECWDHDAEARLSASCVMER 490

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156550957|ref|XP_001603863.1| PREDICTED: activin receptor type-2B-like [Nasonia vitripennis]

 Score =  585 bits (1508), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 270/403 (66%), Positives = 329/403 (81%), Gaps = 4/403 (0%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPP--INSTTPI-KTESHPL 58
           ECYDK  CVEK  + KK   FCCC+G+MCNK+F+W+P P  PP  +    P+  TE   +
Sbjct: 89  ECYDKQHCVEKNADRKKQHFFCCCDGNMCNKNFSWDPQPTQPPRVVQQLEPVPNTEQQVI 148

Query: 59  IIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVE 118
            + L   +P+  + + I   +++YR+RKLG YFN +PT+EP P   PSP  G R IQL+E
Sbjct: 149 TLVLSISIPMLVIFVFISGIFYFYRRRKLG-YFNEIPTIEPGPLPQPSPNLGNRPIQLLE 207

Query: 119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
           +KA+GRFGAVWKA+ + E VAVK+F +QD+QSWQSEQEIFKL HM+H++ILR+IG EKRG
Sbjct: 208 IKARGRFGAVWKAQLRAEVVAVKVFPIQDRQSWQSEQEIFKLAHMDHEDILRFIGVEKRG 267

Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK 238
           +++  EFWLITAYHE+GSLCD+LK N+V+W ++CRIA SM++GLMHLHEEI  NKAD YK
Sbjct: 268 DNLQAEFWLITAYHEKGSLCDYLKANVVSWPEMCRIAESMARGLMHLHEEIPANKADGYK 327

Query: 239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAI 298
           PAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEVLEGAI
Sbjct: 328 PAVAHRDFKSKNVLLKNDMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEVLEGAI 387

Query: 299 NFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHK 358
           NF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE+VVHK
Sbjct: 388 NFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEEEVGLHPTLEDMQESVVHK 447

Query: 359 KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           K RP + +TW++H G+LA+CDTMEECWDHDAEARLSASCV+ER
Sbjct: 448 KERPLILDTWRKHPGLLAICDTMEECWDHDAEARLSASCVMER 490

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380015509|ref|XP_003691743.1| PREDICTED: activin receptor type-2B-like [Apis florea]

 Score =  584 bits (1505), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 273/408 (66%), Positives = 328/408 (80%), Gaps = 9/408 (2%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPL-------PPPINSTTPI-KT 53
           +CYD+P C+E   E KK L FCCC+G+MCN++F W+P P        P  I+ + P+  T
Sbjct: 88  DCYDRPHCIENSAERKKELFFCCCDGNMCNQNFTWDPHPTSSSKPIQPSDIHDSEPVPNT 147

Query: 54  ESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRS 113
           E   + + L   +P+  L I +   YW YR+RK G YFN VPTLEP P   PSP  G R 
Sbjct: 148 EQQIITLVLSISIPMLLLAIILPFLYWCYRRRKSG-YFNEVPTLEPLPLPQPSPNLGLRP 206

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           IQL+E+KA+GRFGAVWKA+ KNE VAVK+F +QDKQSWQ+EQEIFKL HM+H++ILR+IG
Sbjct: 207 IQLLEIKARGRFGAVWKAQLKNEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILRFIG 266

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            EKRG+++  EFWLIT+YHE+GSLCD+LK N+VTW ++CRIA SM++GLMHLHEEI  NK
Sbjct: 267 VEKRGDNLQAEFWLITSYHEKGSLCDYLKANVVTWPEMCRIAESMARGLMHLHEEIPANK 326

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
           AD YKPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEV
Sbjct: 327 ADGYKPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEV 386

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQE 353
           LEGAINF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE
Sbjct: 387 LEGAINFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEDEVGLHPTLEDMQE 446

Query: 354 AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           +VVHKK RP + ETW++H G+ ++CDTMEECWDHDAEARLSASCV+ER
Sbjct: 447 SVVHKKERPIILETWRKHPGLQSICDTMEECWDHDAEARLSASCVMER 494

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328777564|ref|XP_395928.4| PREDICTED: activin receptor type-2B [Apis mellifera]

 Score =  583 bits (1503), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 272/407 (66%), Positives = 328/407 (80%), Gaps = 8/407 (1%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEP------APLPPPINSTTPI-KTE 54
           +CYD+P C+E   E KK L FCCC+G+MCN++F W+P       P+ P I+   P+  TE
Sbjct: 88  DCYDRPHCIENSAERKKELFFCCCDGNMCNQNFTWDPHPTSSSKPIQPDIHDLEPVPNTE 147

Query: 55  SHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSI 114
              + + L   +P+  L I +   YW YR+RK G YFN VPTLEP P   PSP  G R I
Sbjct: 148 QQIITLVLSISIPMLLLAIILPFLYWCYRRRKSG-YFNEVPTLEPLPLPQPSPNLGLRPI 206

Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           QL+E+KA+GRFGAVWKA+ KNE VAVK+F +QDKQSWQ+EQEIFKL HM+H++ILR+IG 
Sbjct: 207 QLLEIKARGRFGAVWKAQLKNEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILRFIGV 266

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           EKRG+++  EFWLIT+YHE+GSLCD+LK N+VTW ++C+IA SM++GLMHLHEEI  NKA
Sbjct: 267 EKRGDNLQAEFWLITSYHEKGSLCDYLKANVVTWPEMCKIAESMARGLMHLHEEIPANKA 326

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           D YKPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEVL
Sbjct: 327 DGYKPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEVL 386

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
           EGAINF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE+
Sbjct: 387 EGAINFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEDEVGLHPTLEDMQES 446

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           VVHKK RP + ETW++H G+ ++CDTMEECWDHDAEARLSASCV+ER
Sbjct: 447 VVHKKERPIILETWRKHPGLQSICDTMEECWDHDAEARLSASCVMER 493

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332023028|gb|EGI63293.1| Activin receptor type-2B [Acromyrmex echinatior]

 Score =  578 bits (1491), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 274/406 (67%), Positives = 324/406 (79%), Gaps = 8/406 (1%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHP---- 57
           +CY KP CVE   E K    FCCCEG+MCN++F+W P     P   +   + E  P    
Sbjct: 76  DCYGKPLCVENNMERKNEFFFCCCEGNMCNQNFSWVPQSTTKPTEPSVIHELEPMPNAKQ 135

Query: 58  --LIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQ 115
             + + L   +PI  L I +F  +W YR+RKLG YFN +PTLEP P   PSP  G R IQ
Sbjct: 136 QAITLALLIAIPIL-LTISLFSFWWLYRRRKLG-YFNEIPTLEPVPLPQPSPNLGLRPIQ 193

Query: 116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           L+E+KA+GRFGAVWKA+FKNE VAVK+F +QDKQSWQ+EQEIFKL HM+H++IL +IG E
Sbjct: 194 LLEIKARGRFGAVWKAQFKNEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILHFIGVE 253

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
           KRG+++  EFWLITAYHE+GSLCD+LK NIVTW ++CRIA SM++GLMHLHEEI  NKAD
Sbjct: 254 KRGDNLQAEFWLITAYHEKGSLCDYLKANIVTWPEMCRIAESMARGLMHLHEEIPANKAD 313

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLE 295
            YKPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEVLE
Sbjct: 314 GYKPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEVLE 373

Query: 296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV 355
           GAINF+RD+FLRIDMYAC LVLWELASRC+  + P GEYRLPF  EVG HP+LEDMQE+V
Sbjct: 374 GAINFTRDSFLRIDMYACGLVLWELASRCTVQNGPIGEYRLPFEDEVGLHPTLEDMQESV 433

Query: 356 VHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           VHKK RP + ETW++H G+ ++CDTMEECWDHDAEARLSASCVVER
Sbjct: 434 VHKKERPLILETWRKHPGLSSICDTMEECWDHDAEARLSASCVVER 479

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350417059|ref|XP_003491236.1| PREDICTED: activin receptor type-2B-like [Bombus impatiens]

 Score =  575 bits (1483), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 274/408 (67%), Positives = 328/408 (80%), Gaps = 9/408 (2%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPL-------PPPINSTTPI-KT 53
           +CYD+P C+E   E KK L FCCC+G+MCN++F W+P P        P   + + P+  T
Sbjct: 88  DCYDRPHCIENSAERKKELFFCCCDGNMCNQNFTWDPHPTSSSKPIQPSVFHESEPVPNT 147

Query: 54  ESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRS 113
           E   +I+ L  ++P+    I   L YW YR+RK G YFN VPTLEP P   PSP  G R 
Sbjct: 148 EQQIIILVLSILIPMLLFAIVSPLLYWCYRRRKSG-YFNEVPTLEPLPLPQPSPNLGLRP 206

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           IQL+E+KA+GRFGAVWKA+ KNE VAVK+F +QDKQSWQ+EQEIFKL HM+H++ILR+IG
Sbjct: 207 IQLLEIKARGRFGAVWKAQLKNEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILRFIG 266

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            EKRG+++  EFWLITAYHE+GSLCD+LK N+VTW ++CRIA SM++GLMHLHEEI  NK
Sbjct: 267 VEKRGDNLQAEFWLITAYHEKGSLCDYLKANVVTWPEMCRIAESMARGLMHLHEEIPANK 326

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
           AD YKPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEV
Sbjct: 327 ADGYKPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEV 386

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQE 353
           LEGAINF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE
Sbjct: 387 LEGAINFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEDEVGLHPTLEDMQE 446

Query: 354 AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           +VVHKK RP + ETW++H G+ ++CDTMEECWDHDAEARLSASCV+ER
Sbjct: 447 SVVHKKERPIILETWRKHPGLQSICDTMEECWDHDAEARLSASCVMER 494

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340713124|ref|XP_003395098.1| PREDICTED: activin receptor type-2B-like [Bombus terrestris]

 Score =  572 bits (1475), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 275/408 (67%), Positives = 329/408 (80%), Gaps = 9/408 (2%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPL-------PPPINSTTPI-KT 53
           +CYD+P C+E   E KK L FCCC+G+MCN++F W+P P        P   + + P+  T
Sbjct: 88  DCYDRPHCIENSAERKKELFFCCCDGNMCNQNFTWDPHPTSSSKPIQPSVFHESEPVPNT 147

Query: 54  ESHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRS 113
           E   +I+ L   +P+  L I + L YW YR+RK G YFN VPTLEP P   PSP  G R 
Sbjct: 148 EQQIIILVLSISIPMLLLAIILPLLYWCYRRRKSG-YFNEVPTLEPLPLPQPSPNLGLRP 206

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           IQL+E+KA+GRFGAVWKA+ KNE VAVK+F +QDKQSWQ+EQEIFKL HM+H++ILR+IG
Sbjct: 207 IQLLEIKARGRFGAVWKAQLKNEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILRFIG 266

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            EKRG+++  EFWLITAYHE+GSLCD+LK N+VTW ++CRIA SM++GLMHLHEEI  NK
Sbjct: 267 VEKRGDNLQAEFWLITAYHEKGSLCDYLKANVVTWPEMCRIAESMARGLMHLHEEIPANK 326

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
           AD YKPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEV
Sbjct: 327 ADGYKPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEV 386

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQE 353
           LEGAINF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE
Sbjct: 387 LEGAINFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEDEVGLHPTLEDMQE 446

Query: 354 AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           +VVHKK RP + ETW++H G+ ++CDTMEECWDHDAEARLSASCV+ER
Sbjct: 447 SVVHKKERPIILETWRKHPGLQSICDTMEECWDHDAEARLSASCVMER 494

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307206391|gb|EFN84433.1| Activin receptor type-2A [Harpegnathos saltator]

 Score =  565 bits (1456), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 268/407 (65%), Positives = 329/407 (80%), Gaps = 10/407 (2%)

Query: 2   ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPL-------PPPINSTTPIKTE 54
           +CYDKPKC+E   E +K+L FCCC+G+MCN+DF++EP P        P  I+ + P+  E
Sbjct: 92  DCYDKPKCIEN-TERRKDLFFCCCDGNMCNEDFSFEPLPTLPSKPTQPSVIHESEPVPDE 150

Query: 55  SHPLIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSI 114
             P+ I +  ++    + I +    WYYR++K G  FN +PT EP P    SP  G R I
Sbjct: 151 KQPITILISILITTLFISIIVLFSLWYYRRQKSGD-FNELPTGEP-PLPESSPNLGLRPI 208

Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           QL+E+KA+GRFGAVWKA+ K+E VAVK+F +QDKQSWQ+EQEIFKL HM+H++ILR+IG 
Sbjct: 209 QLLEIKARGRFGAVWKAQLKHEIVAVKVFPIQDKQSWQTEQEIFKLAHMDHEDILRFIGV 268

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           EKRG+++  EFWLITA+HE+GSLCD+LK N+VTW ++CRIA SM++GLMHLHEEI  NKA
Sbjct: 269 EKRGDNLQAEFWLITAFHEKGSLCDYLKANVVTWPEMCRIAESMARGLMHLHEEIPANKA 328

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           D YKPAVAHRDFKS NVLLK+D++A IADFGLAL+F PGKPCGDTHGQVGTRRYMAPEVL
Sbjct: 329 DGYKPAVAHRDFKSKNVLLKADMSACIADFGLALIFHPGKPCGDTHGQVGTRRYMAPEVL 388

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
           EGAINF+RD+FLRIDMYAC LVLWELASRC+    P GEYRLPF  EVG HP+LEDMQE+
Sbjct: 389 EGAINFTRDSFLRIDMYACGLVLWELASRCTVQDGPIGEYRLPFEDEVGLHPTLEDMQES 448

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           VVHKK RP + ETW++H+G+L++CDTMEECWDHDAEARLSASCV+ER
Sbjct: 449 VVHKKERPLILETWRKHSGLLSICDTMEECWDHDAEARLSASCVMER 495

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|193631849|ref|XP_001943451.1| PREDICTED: activin receptor type-2B-like [Acyrthosiphon pisum]

 Score =  527 bits (1358), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 255/407 (62%), Positives = 308/407 (75%), Gaps = 7/407 (1%)

Query: 1   MECYDKPKCVEKRPESKKN-LNFCCCEGDMCNKDFAWEPAPLPPPINSTT--PIKTESHP 57
           +EC  + +C +K+ E K N L FCCCEGD CN +  W+P P  P I +T+  P++ E+  
Sbjct: 93  VECQGQKQCKDKKEEMKPNGLMFCCCEGDFCNSEIMWDPIPTTPRIETTSAKPLRDENEL 152

Query: 58  LIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLV 117
           +   +++ +P+ A+       YW Y++RK+   F+ VP+ +       SP    R IQLV
Sbjct: 153 IHTIVFSTIPLVAVASMFLFVYWVYKRRKIPQ-FSHVPSSDSSHLGNCSPILSNRPIQLV 211

Query: 118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           EVKA+GR+GAVWKA  K + VAVKIF  QDK SW  EQ+I++LPHM+HDN+L +IGAEK 
Sbjct: 212 EVKARGRYGAVWKALHKKDTVAVKIFPPQDKNSWLVEQDIYQLPHMQHDNMLSFIGAEKH 271

Query: 178 G---ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
               E    E+WLITAYH+ GSLCDFLK NI+TW+QLC IA SM++GLMHLHEEI   +A
Sbjct: 272 ASVIEGAKNEYWLITAYHDYGSLCDFLKSNILTWDQLCHIAQSMARGLMHLHEEIPSERA 331

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           D YKPA+AHRDFKSNNVLLK DLTA IADFGLAL+F+PGK CGDTHGQVGTRRYMAPEVL
Sbjct: 332 DQYKPAIAHRDFKSNNVLLKHDLTACIADFGLALVFQPGKSCGDTHGQVGTRRYMAPEVL 391

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
           EGAINFSRDAFLRIDMYAC LVLWELA+RC++      +YRLPF  EVG HPSLEDMQE 
Sbjct: 392 EGAINFSRDAFLRIDMYACGLVLWELATRCTAQQGAIPDYRLPFEEEVGQHPSLEDMQEC 451

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           VVHKKLRP   ++WK H G++ALCDTMEECWDHDAEARLSASCV+ER
Sbjct: 452 VVHKKLRPAFKDSWKSHPGLIALCDTMEECWDHDAEARLSASCVMER 498

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189241613|ref|XP_966360.2| PREDICTED: similar to Activin receptor type-2A precursor (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA) [Tribolium castaneum]

 Score =  514 bits (1323), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 262/410 (63%), Positives = 321/410 (78%), Gaps = 13/410 (3%)

Query: 2   ECYDKPKCVEKRPESKKNLN-FCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLII 60
           +CYDK +CVE+ P+S+K  + FCCCEG+MCN++F WEPAP      S+TPI    +P  I
Sbjct: 92  QCYDKSECVERSPKSQKPKHMFCCCEGNMCNQNFTWEPAPPTEAPPSSTPIPVVYNPHFI 151

Query: 61  FLY---TMLPIFALIIPIFLCYWY-YRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQL 116
           +       +    L  PI    WY +R+RK   YFN +PT EP+P  PPSP    R IQL
Sbjct: 152 YYIAPAVFMGFLVLSAPIL---WYCWRKRKF--YFNELPTSEPNPLPPPSPFLDTRPIQL 206

Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +E+KA+GRFGAVWKA+FK+E VAVKIF +QDKQSW +EQEIFKLPHM H NIL++IG EK
Sbjct: 207 IEIKARGRFGAVWKAQFKSEEVAVKIFPIQDKQSWLTEQEIFKLPHMSHPNILQFIGVEK 266

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA-- 234
           RG+++  EFWLITAYHE+GSLCD+LK + +TW +LC +A +M++GLMHLHE I P K+  
Sbjct: 267 RGDNLKAEFWLITAYHEKGSLCDYLKAHTLTWNELCSVAETMARGLMHLHEAI-PGKSPS 325

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           D  KPA+AHRDFKS NVLLKS++TA IADFGLAL+FE GK CGDTHGQVGTRRYMAPEVL
Sbjct: 326 DPVKPAIAHRDFKSKNVLLKSNMTACIADFGLALVFEFGKSCGDTHGQVGTRRYMAPEVL 385

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
           EGAI+F+ DAF RIDMYAC LVLWEL SRC++   P G+YRLPF  EVG HP+LEDMQE+
Sbjct: 386 EGAIDFNPDAFQRIDMYACGLVLWELVSRCTAQDGPIGDYRLPFEEEVGQHPTLEDMQES 445

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML 404
           VV +K+RP + E W+QH+G+ A+CDT+EECWDHDAEARLSASCV+ER ML
Sbjct: 446 VVQRKVRPVIQEHWRQHSGLAAMCDTIEECWDHDAEARLSASCVMERVML 495

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	461
UNIPROTKB|P27037	513	ACVR2A "Activin receptor type-	0.850	0.764	0.592	3.1e-140
MGI|MGI:102806	513	Acvr2a "activin receptor IIA"	0.850	0.764	0.590	3.9e-140
UNIPROTKB|Q28043	513	ACVR2A "Activin receptor type-	0.850	0.764	0.590	5e-140
UNIPROTKB|F1PKQ5	513	ACVR2A "Uncharacterized protei	0.850	0.764	0.590	5e-140
UNIPROTKB|F1S0H6	513	ACVR2A "Uncharacterized protei	0.850	0.764	0.590	6.3e-140
MGI|MGI:87912	536	Acvr2b "activin receptor IIB"	0.696	0.598	0.633	5.6e-139
RGD|70911	513	Acvr2a "activin A receptor, ty	0.850	0.764	0.585	1.5e-138
UNIPROTKB|P38444	513	Acvr2a "Activin receptor type-	0.850	0.764	0.585	1.5e-138
ZFIN|ZDB-GENE-980526-549	509	acvr2b "activin receptor IIb"	0.850	0.770	0.576	2.5e-136
UNIPROTKB|F1N8I2	515	ACVR2B "Activin receptor type-	0.854	0.765	0.573	3.2e-136

UNIPROTKB|P27037 ACVR2A "Activin receptor type-2A" [Homo sapiens (taxid:9606)]

 Score = 1257 (447.5 bits), Expect = 3.1e-140, Sum P(2) = 3.1e-140
 Identities = 240/405 (59%), Positives = 296/405 (73%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  CVEK+   +  + FCCCEG+MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCVEKKDSPE--VYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR  K+   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHKMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0001702 "gastrulation with mouth forming second" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0007368 "determination of left/right symmetry" evidence=IEA

GO:0007498 "mesoderm development" evidence=IEA

GO:0009952 "anterior/posterior pattern specification" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0019838 "growth factor binding" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0030510 "regulation of BMP signaling pathway" evidence=IEA

GO:0034711 "inhibin binding" evidence=IEA

GO:0042713 "sperm ejaculation" evidence=IEA

GO:0043084 "penile erection" evidence=IEA

GO:0043621 "protein self-association" evidence=IEA

GO:0048706 "embryonic skeletal system development" evidence=IEA

GO:0050999 "regulation of nitric-oxide synthase activity" evidence=IEA

GO:0060011 "Sertoli cell proliferation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=TAS

GO:0005887 "integral to plasma membrane" evidence=TAS

GO:0007178 "transmembrane receptor protein serine/threonine kinase signaling pathway" evidence=TAS

GO:0001934 "positive regulation of protein phosphorylation" evidence=IMP

GO:0030509 "BMP signaling pathway" evidence=IDA;IMP;TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0017002 "activin-activated receptor activity" evidence=IDA

GO:0048185 "activin binding" evidence=IPI

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=IDA

GO:0032927 "positive regulation of activin receptor signaling pathway" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=EXP

GO:0005886 "plasma membrane" evidence=TAS

GO:0030501 "positive regulation of bone mineralization" evidence=IMP

GO:0045669 "positive regulation of osteoblast differentiation" evidence=IMP

GO:0015026 "coreceptor activity" evidence=IDA

GO:0034673 "inhibin-betaglycan-ActRII complex" evidence=IDA

GO:0010862 "positive regulation of pathway-restricted SMAD protein phosphorylation" evidence=IMP

MGI|MGI:102806 Acvr2a "activin receptor IIA" [Mus musculus (taxid:10090)]

 Score = 1256 (447.2 bits), Expect = 3.9e-140, Sum P(2) = 3.9e-140
 Identities = 239/405 (59%), Positives = 296/405 (73%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCIEKKDSPE--VYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR  K+   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHKMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001702 "gastrulation with mouth forming second" evidence=IGI

GO:0001934 "positive regulation of protein phosphorylation" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IEA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007178 "transmembrane receptor protein serine/threonine kinase signaling pathway" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IGI

GO:0007368 "determination of left/right symmetry" evidence=IGI

GO:0007498 "mesoderm development" evidence=IMP

GO:0008584 "male gonad development" evidence=IMP

GO:0009952 "anterior/posterior pattern specification" evidence=IGI

GO:0009966 "regulation of signal transduction" evidence=IDA

GO:0009986 "cell surface" evidence=IDA

GO:0010862 "positive regulation of pathway-restricted SMAD protein phosphorylation" evidence=ISO

GO:0015026 "coreceptor activity" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016362 "activin receptor activity, type II" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0019838 "growth factor binding" evidence=IMP;IPI

GO:0023014 "signal transduction by phosphorylation" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IPI

GO:0030501 "positive regulation of bone mineralization" evidence=ISO

GO:0030509 "BMP signaling pathway" evidence=ISO;IMP

GO:0030510 "regulation of BMP signaling pathway" evidence=IMP

GO:0032924 "activin receptor signaling pathway" evidence=IEA

GO:0032927 "positive regulation of activin receptor signaling pathway" evidence=ISO

GO:0034673 "inhibin-betaglycan-ActRII complex" evidence=ISO

GO:0034711 "inhibin binding" evidence=ISO;IPI

GO:0042713 "sperm ejaculation" evidence=IMP

GO:0043084 "penile erection" evidence=IMP

GO:0043621 "protein self-association" evidence=IPI

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=ISO

GO:0045669 "positive regulation of osteoblast differentiation" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0046881 "positive regulation of follicle-stimulating hormone secretion" evidence=ISO

GO:0048185 "activin binding" evidence=ISO;IPI

GO:0048706 "embryonic skeletal system development" evidence=IMP

GO:0050999 "regulation of nitric-oxide synthase activity" evidence=IMP

GO:0060011 "Sertoli cell proliferation" evidence=IMP

UNIPROTKB|Q28043 ACVR2A "Activin receptor type-2A" [Bos taurus (taxid:9913)]

 Score = 1255 (446.8 bits), Expect = 5.0e-140, Sum P(2) = 5.0e-140
 Identities = 239/405 (59%), Positives = 296/405 (73%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCIEKKDSPE--VYFCCCEGNMCNERFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR  K+   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHKMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

GO:0060011 "Sertoli cell proliferation" evidence=IEA

GO:0050999 "regulation of nitric-oxide synthase activity" evidence=IEA

GO:0048706 "embryonic skeletal system development" evidence=IEA

GO:0048185 "activin binding" evidence=IEA

GO:0045669 "positive regulation of osteoblast differentiation" evidence=IEA

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=IEA

GO:0043621 "protein self-association" evidence=IEA

GO:0043084 "penile erection" evidence=IEA

GO:0042713 "sperm ejaculation" evidence=IEA

GO:0034711 "inhibin binding" evidence=IEA

GO:0034673 "inhibin-betaglycan-ActRII complex" evidence=IEA

GO:0032927 "positive regulation of activin receptor signaling pathway" evidence=IEA

GO:0030510 "regulation of BMP signaling pathway" evidence=IEA

GO:0030509 "BMP signaling pathway" evidence=IEA

GO:0030501 "positive regulation of bone mineralization" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0019838 "growth factor binding" evidence=IEA

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0015026 "coreceptor activity" evidence=IEA

GO:0010862 "positive regulation of pathway-restricted SMAD protein phosphorylation" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0009952 "anterior/posterior pattern specification" evidence=IEA

GO:0007498 "mesoderm development" evidence=IEA

GO:0007368 "determination of left/right symmetry" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0001702 "gastrulation with mouth forming second" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1PKQ5 ACVR2A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1255 (446.8 bits), Expect = 5.0e-140, Sum P(2) = 5.0e-140
 Identities = 239/405 (59%), Positives = 296/405 (73%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCIEKKDSPE--VYFCCCEGNMCNERFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR  K+   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHKMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1S0H6 ACVR2A "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1254 (446.5 bits), Expect = 6.3e-140, Sum P(2) = 6.3e-140
 Identities = 239/405 (59%), Positives = 295/405 (72%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  C+EK+   +  + FCCCEG MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCIEKKDSPE--VYFCCCEGSMCNERFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR  K+   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHKMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 478

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:87912 Acvr2b "activin receptor IIB" [Mus musculus (taxid:10090)]

 Score = 1129 (402.5 bits), Expect = 5.6e-139, Sum P(3) = 5.6e-139
 Identities = 204/322 (63%), Positives = 252/322 (78%)

Query:    80 WYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVA 139
             W  R+      F P+P  +P P  PPSP  G + +QL+E+KA+GRFG VWKA+  N+ VA
Sbjct:   181 WAGRRDGCADSFKPLPFQDPGPP-PPSPLVGLKPLQLLEIKARGRFGCVWKAQLMNDFVA 239

Query:   140 VKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD 199
             VKIF +QDKQSWQSE+EIF  P M+H+N+L++I AEKRG ++  E WLITA+H++GSL D
Sbjct:   240 VKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTD 299

Query:   200 FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA 259
             +LK NI+TW +LC +A +MS+GL +LHE++   + + +KP++AHRDFKS NVLLKSDLTA
Sbjct:   300 YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTA 359

Query:   260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
              +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLEGAINF RDAFLRIDMYA  LVLWE
Sbjct:   360 VLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 419

Query:   320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCD 379
             L SRC +   P  EY LPF  E+G HPSLE++QE VVHKK+RPT+ + W +H G+  LC 
Sbjct:   420 LVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCV 479

Query:   380 TMEECWDHDAEARLSASCVVER 401
             T+EECWDHDAEARLSA CV ER
Sbjct:   480 TIEECWDHDAEARLSAGCVEER 501

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001501 "skeletal system development" evidence=IGI;IMP

GO:0001702 "gastrulation with mouth forming second" evidence=IGI

GO:0001822 "kidney development" evidence=IGI;IMP

GO:0001946 "lymphangiogenesis" evidence=IMP

GO:0001974 "blood vessel remodeling" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IEA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IDA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005886 "plasma membrane" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007165 "signal transduction" evidence=ISO

GO:0007178 "transmembrane receptor protein serine/threonine kinase signaling pathway" evidence=IEA

GO:0007368 "determination of left/right symmetry" evidence=IGI;IMP

GO:0007389 "pattern specification process" evidence=IGI

GO:0007498 "mesoderm development" evidence=IGI

GO:0007507 "heart development" evidence=IGI;IMP

GO:0009749 "response to glucose stimulus" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI;IMP

GO:0009952 "anterior/posterior pattern specification" evidence=ISO;IGI;IMP

GO:0009966 "regulation of signal transduction" evidence=IDA

GO:0009986 "cell surface" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0019838 "growth factor binding" evidence=ISO;IMP;IPI

GO:0023014 "signal transduction by phosphorylation" evidence=IEA

GO:0030073 "insulin secretion" evidence=IGI

GO:0030324 "lung development" evidence=IGI

GO:0030501 "positive regulation of bone mineralization" evidence=ISO

GO:0030509 "BMP signaling pathway" evidence=ISO

GO:0031016 "pancreas development" evidence=IGI

GO:0032147 "activation of protein kinase activity" evidence=IDA

GO:0032924 "activin receptor signaling pathway" evidence=IEA

GO:0032927 "positive regulation of activin receptor signaling pathway" evidence=ISO

GO:0034711 "inhibin binding" evidence=ISO

GO:0035265 "organ growth" evidence=IGI

GO:0042475 "odontogenesis of dentin-containing tooth" evidence=IGI;IMP

GO:0045669 "positive regulation of osteoblast differentiation" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0048185 "activin binding" evidence=ISO;IDA;IPI

GO:0048617 "embryonic foregut morphogenesis" evidence=IMP

GO:0048705 "skeletal system morphogenesis" evidence=IGI;IMP

GO:0050431 "transforming growth factor beta binding" evidence=IDA

GO:0060021 "palate development" evidence=IGI;IMP

GO:0060836 "lymphatic endothelial cell differentiation" evidence=IMP

GO:0060840 "artery development" evidence=IMP

GO:0060841 "venous blood vessel development" evidence=IMP

GO:0061298 "retina vasculature development in camera-type eye" evidence=IMP

RGD|70911 Acvr2a "activin A receptor, type IIA" [Rattus norvegicus (taxid:10116)]

 Score = 1244 (443.0 bits), Expect = 1.5e-138, Sum P(2) = 1.5e-138
 Identities = 237/405 (58%), Positives = 295/405 (72%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCIEKKDSPE--VYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR   +   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHMMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSGGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA C+ ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCLGER 478

GO:0001702 "gastrulation with mouth forming second" evidence=ISO

GO:0001934 "positive regulation of protein phosphorylation" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=TAS

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0007283 "spermatogenesis" evidence=ISO

GO:0007368 "determination of left/right symmetry" evidence=ISO

GO:0007498 "mesoderm development" evidence=ISO

GO:0008584 "male gonad development" evidence=ISO

GO:0009952 "anterior/posterior pattern specification" evidence=ISO

GO:0009966 "regulation of signal transduction" evidence=ISO

GO:0009986 "cell surface" evidence=ISO

GO:0010033 "response to organic substance" evidence=IEP

GO:0010862 "positive regulation of pathway-restricted SMAD protein phosphorylation" evidence=ISO

GO:0015026 "coreceptor activity" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016362 "activin receptor activity, type II" evidence=IDA

GO:0017002 "activin-activated receptor activity" evidence=IEA;ISO

GO:0019838 "growth factor binding" evidence=ISO

GO:0030165 "PDZ domain binding" evidence=ISO

GO:0030501 "positive regulation of bone mineralization" evidence=ISO

GO:0030509 "BMP signaling pathway" evidence=ISO

GO:0030510 "regulation of BMP signaling pathway" evidence=ISO

GO:0032927 "positive regulation of activin receptor signaling pathway" evidence=ISO

GO:0034673 "inhibin-betaglycan-ActRII complex" evidence=ISO

GO:0034711 "inhibin binding" evidence=ISO;IDA

GO:0042713 "sperm ejaculation" evidence=ISO

GO:0043084 "penile erection" evidence=ISO

GO:0043621 "protein self-association" evidence=ISO

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=ISO

GO:0045669 "positive regulation of osteoblast differentiation" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0046881 "positive regulation of follicle-stimulating hormone secretion" evidence=IMP

GO:0048179 "activin receptor complex" evidence=TAS

GO:0048185 "activin binding" evidence=ISO;IDA;TAS

GO:0048706 "embryonic skeletal system development" evidence=ISO

GO:0050999 "regulation of nitric-oxide synthase activity" evidence=ISO

GO:0060011 "Sertoli cell proliferation" evidence=ISO

UNIPROTKB|P38444 Acvr2a "Activin receptor type-2A" [Rattus norvegicus (taxid:10116)]

 Score = 1244 (443.0 bits), Expect = 1.5e-138, Sum P(2) = 1.5e-138
 Identities = 237/405 (58%), Positives = 295/405 (72%)

Query:     1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAP--LPPPINSTTPIKTESHPL 58
             + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P      P  N  TP K   + +
Sbjct:    83 INCYDRTDCIEKKDSPE--VYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTP-KPPYYNI 139

Query:    59 IIFLYTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPV--PTLEPHPTSPPSPQQGCRSIQL 116
             +  LY++             +W YR   +   + PV  PT +P P  PPSP  G + +QL
Sbjct:   140 L--LYSLVPLMLIAGIVICAFWVYRHHMMA--YPPVLVPTQDPGPP-PPSPLLGLKPLQL 194

Query:   117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
             +EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IGAEK
Sbjct:   195 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 254

Query:   177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             RG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P   D 
Sbjct:   255 RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDG 313

Query:   237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
             +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEVLEG
Sbjct:   314 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSGGDTHGQVGTRRYMAPEVLEG 373

Query:   297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
             AINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE VV
Sbjct:   374 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 433

Query:   357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             HKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA C+ ER
Sbjct:   434 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCLGER 478

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

ZFIN|ZDB-GENE-980526-549 acvr2b "activin receptor IIb" [Danio rerio (taxid:7955)]

 Score = 1212 (431.7 bits), Expect = 2.5e-136, Sum P(2) = 2.5e-136
 Identities = 230/399 (57%), Positives = 282/399 (70%)

Query:     3 CYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFL 62
             CYD+ +CV    E    + FCCCEG+ CN+ F   P  +  P+ S  P+      L + +
Sbjct:    84 CYDRQECVAT--EENPQVFFCCCEGNFCNERFTHLP-DISGPVISPPPVSPSL--LNVLV 138

Query:    63 YTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQ 122
             Y++             +W YR RK   Y +     +P P SPPSP  G + +QL+EVKA+
Sbjct:   139 YSLLPLSMLSMAVLLAFWMYRHRK-PPYGHVDVNEDPGP-SPPSPLVGLKPLQLLEVKAR 196

Query:   123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH 182
             GRFG VWKA+  NE VAVKIF +QDK SWQ+E+E+F  P M+HDN+LR+I AEKRG ++ 
Sbjct:   197 GRFGCVWKAQMINEYVAVKIFPIQDKLSWQNEREMFSTPGMKHDNLLRFIAAEKRGSNLE 256

Query:   183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
              EFWLIT +HERGSL D+LK N V+W  LC IA SM+ GL +LHE++  +K +  KPA+A
Sbjct:   257 MEFWLITEFHERGSLTDYLKGNAVSWADLCVIAESMACGLAYLHEDVPRSKGEGPKPAIA 316

Query:   243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSR 302
             HRDFKS NV+LK DLTA I DFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLEGAINF R
Sbjct:   317 HRDFKSKNVMLKMDLTAVIGDFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQR 376

Query:   303 DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRP 362
             D+FLRIDMYA  LVLWEL SRC +   P  EY LPF  E+G HPSLED+Q+AVVHKKLRP
Sbjct:   377 DSFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEDLQDAVVHKKLRP 436

Query:   363 TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                + W +H+G+  +C+TMEECWDHDAEARLSA CV ER
Sbjct:   437 AFKDCWLKHSGLCQMCETMEECWDHDAEARLSAGCVQER 475

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0007178 "transmembrane receptor protein serine/threonine kinase signaling pathway" evidence=IEA

GO:0032924 "activin receptor signaling pathway" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IEA

GO:0030902 "hindbrain development" evidence=IMP

GO:0051216 "cartilage development" evidence=IMP

GO:0001501 "skeletal system development" evidence=IMP

GO:0001755 "neural crest cell migration" evidence=IMP

UNIPROTKB|F1N8I2 ACVR2B "Activin receptor type-2B" [Gallus gallus (taxid:9031)]

 Score = 1218 (433.8 bits), Expect = 3.2e-136, Sum P(2) = 3.2e-136
 Identities = 229/399 (57%), Positives = 285/399 (71%)

Query:     3 CYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFL 62
             CYD+ +CV    E    + FCCCEG+ CN+ F   P    P +    P  T S  L I +
Sbjct:    87 CYDRQECVAT--EENPQVFFCCCEGNYCNEKFTHLPEVTGPEVIYEPPPPTPSL-LNILV 143

Query:    63 YTMXXXXXXXXXXXXCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQ 122
             Y++             +W YR RK   Y +     +P P  PPSP  G + +QL+E+KA+
Sbjct:   144 YSLLPIAVLSVAILLAFWMYRHRK-PPYGHVDINEDPGPP-PPSPLVGLKPLQLLEIKAR 201

Query:   123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH 182
             GRFG VWKA+  N+ VAVKIF +QDKQSWQSE+EIF  P M+H+N+L++I AEKRG ++ 
Sbjct:   202 GRFGCVWKAQLMNDYVAVKIFPIQDKQSWQSEREIFNTPGMKHENLLQFIAAEKRGTNLE 261

Query:   183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
             TE WLITA+H++GSL D+LK NI++W +LC +A +M++GL +LHE++   K + +KPA+A
Sbjct:   262 TELWLITAFHDKGSLTDYLKGNIISWNELCHVAETMARGLSYLHEDVPWCKGEGHKPAIA 321

Query:   243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSR 302
             HRDFKS NVLLK+DLTA +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPEVLEGAINF R
Sbjct:   322 HRDFKSKNVLLKNDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQR 381

Query:   303 DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRP 362
             DAFLRIDMYA  LVLWEL SRC +V  P  EY LPF  E+G HPSLED+QE VVHKK+RP
Sbjct:   382 DAFLRIDMYAMGLVLWELVSRCRAVDGPVDEYMLPFEEEIGQHPSLEDLQEVVVHKKMRP 441

Query:   363 TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                + W +H G+  LC T+EECWDHDAEARLSA CV ER
Sbjct:   442 VFKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER 480

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=IEA

GO:0005024 "transforming growth factor beta-activated receptor activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0017002 "activin-activated receptor activity" evidence=IEA

GO:0001702 "gastrulation with mouth forming second" evidence=IEA

GO:0001822 "kidney development" evidence=IEA

GO:0001946 "lymphangiogenesis" evidence=IEA

GO:0001974 "blood vessel remodeling" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0007368 "determination of left/right symmetry" evidence=IEA

GO:0007498 "mesoderm development" evidence=IEA

GO:0007507 "heart development" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=IEA

GO:0009791 "post-embryonic development" evidence=IEA

GO:0009952 "anterior/posterior pattern specification" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0019838 "growth factor binding" evidence=IEA

GO:0030073 "insulin secretion" evidence=IEA

GO:0030324 "lung development" evidence=IEA

GO:0030501 "positive regulation of bone mineralization" evidence=IEA

GO:0030509 "BMP signaling pathway" evidence=IEA

GO:0031016 "pancreas development" evidence=IEA

GO:0032147 "activation of protein kinase activity" evidence=IEA

GO:0032927 "positive regulation of activin receptor signaling pathway" evidence=IEA

GO:0035265 "organ growth" evidence=IEA

GO:0042475 "odontogenesis of dentin-containing tooth" evidence=IEA

GO:0045669 "positive regulation of osteoblast differentiation" evidence=IEA

GO:0048185 "activin binding" evidence=IEA

GO:0048617 "embryonic foregut morphogenesis" evidence=IEA

GO:0048705 "skeletal system morphogenesis" evidence=IEA

GO:0060021 "palate development" evidence=IEA

GO:0060836 "lymphatic endothelial cell differentiation" evidence=IEA

GO:0060840 "artery development" evidence=IEA

GO:0060841 "venous blood vessel development" evidence=IEA

GO:0061298 "retina vasculature development in camera-type eye" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q28043	AVR2A_BOVIN	2, ., 7, ., 1, 1, ., 3, 0	0.5920	0.8568	0.7699	yes	N/A
Q13705	AVR2B_HUMAN	2, ., 7, ., 1, 1, ., 3, 0	0.5735	0.8590	0.7734	yes	N/A
P38445	AVR2B_RAT	2, ., 7, ., 1, 1, ., 3, 0	0.5746	0.8590	0.7719	yes	N/A
Q90669	AVR2A_CHICK	2, ., 7, ., 1, 1, ., 3, 0	0.5990	0.8524	0.7660	yes	N/A
Q66T47	AVR2B_PIG	2, ., 7, ., 1, 1, ., 3, 0	0.5685	0.8590	0.7734	yes	N/A
P27038	AVR2A_MOUSE	2, ., 7, ., 1, 1, ., 3, 0	0.5920	0.8568	0.7699	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11.30	0.914
3rd Layer	2.7.11	0.921

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	461
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-17
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-12
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-05
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.001
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.001
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.001
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.002
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.002
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	0.002
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.002
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.003
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	0.003
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	0.004
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.004
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.004
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  185 bits (473), Expect = 9e-56
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 43/293 (14%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNI 168
            +L+     G FG V+KAK K     VAVKI   + ++S + +    EI  L  + H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHE 227
           +R I A +  + +    +L+  Y E G L D+L +   ++ ++  +IAL + +GL +LH 
Sbjct: 61  VRLIDAFEDKDHL----YLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K  N+LL  +    IADFGLA      K        VGT  
Sbjct: 117 N-----------GIIHRDLKPENILLDENGVVKIADFGLAKKLL--KSSSSLTTFVGTPW 163

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           YMAPEVL G   +      ++D+++  ++L+EL +            + PFS       +
Sbjct: 164 YMAPEVLLGGNGYGP----KVDVWSLGVILYELLTG-----------KPPFS-----GEN 203

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
           + D  + +      P   +  K  +G     D +++C + D   R +A  +++
Sbjct: 204 ILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  142 bits (361), Expect = 4e-40
 Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 122 QGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKR 177
           +G FG V+ A+ K     VA+KI   +D  S   E  +EI  L  + H NI++  G  + 
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE- 61

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
                   +L+  Y E GSL D LK N   ++ +++ RI L + +GL +LH         
Sbjct: 62  ---DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN------- 111

Query: 236 SYKPAVAHRDFKSNNVLLKSD-LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                + HRD K  N+LL SD     +ADFGL+ L    K        VGT  YMAPEVL
Sbjct: 112 ----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL 165

Query: 295 EGAINFSRDAFLRIDMYACALVLWELAS 322
            G   +S     + D+++  ++L+EL  
Sbjct: 166 LGKGYYSE----KSDIWSLGVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  126 bits (319), Expect = 2e-33
 Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 53/282 (18%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI----FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G FG V+ A+ K   + VA+K+     + +D++    E +I K   ++H NI+R     
Sbjct: 9   EGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILK--KLKHPNIVRLYDVF 66

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           +       + +L+  Y E G L D LK    ++ ++       +   L +LH        
Sbjct: 67  ED----EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS----KG- 117

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + HRD K  N+LL  D    +ADFGLA   +PG         VGT  YMAPEVL
Sbjct: 118 ------IVHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPEVL 168

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
            G   + +     +D+++  ++L+EL +            + PF           D Q  
Sbjct: 169 LG-KGYGK----AVDIWSLGVILYELLTG-----------KPPFPG---------DDQLL 203

Query: 355 VVHKKLRPTLPETWKQHAGM-LALCDTMEECWDHDAEARLSA 395
            + KK+    P        +     D + +    D E RL+A
Sbjct: 204 ELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTA 245

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (278), Expect = 9e-28
 Identities = 71/305 (23%), Positives = 120/305 (39%), Gaps = 65/305 (21%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKN------ENVAVKIFL----MQDKQSWQSEQEIFKLPHM 163
           + L +   +G FG V+K   K         VAVK        Q  + +  E  I +   +
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMR--KL 58

Query: 164 EHDNILRYIGAEKRGESIHTE-FWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMS 219
           +H NI++ +G          E   ++  Y   G L D+L+      ++   L   AL ++
Sbjct: 59  DHPNIVKLLGV-----CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           +G+ +L            K  + HRD  + N L+  +L   I+DFGL+          D 
Sbjct: 114 RGMEYLES----------KNFI-HRDLAARNCLVGENLVVKISDFGLSRD----LYDDDY 158

Query: 280 HGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL 336
           +   G +   R+MAPE L+    F+  +    D+++  ++LWE+ +      P PG    
Sbjct: 159 YKVKGGKLPIRWMAPESLKEGK-FTSKS----DVWSFGVLLWEIFTLGE--EPYPG---- 207

Query: 337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                     S  ++ E +      P  P        +  L   M +CW  D E R + S
Sbjct: 208 ---------MSNAEVLEYLKKGYRLPKPPNC---PPELYKL---MLQCWAEDPEDRPTFS 252

Query: 397 CVVER 401
            +VE 
Sbjct: 253 ELVEI 257

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  109 bits (276), Expect = 2e-27
 Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 64/304 (21%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKN------ENVAVKIFL----MQDKQSWQSEQEIFKLPHM 163
           + L +   +G FG V+K K K         VAVK        Q  + +  E  I +   +
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMR--KL 58

Query: 164 EHDNILRYIGAEKRGESIHTE-FWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSK 220
           +H N+++ +G          E  +++  Y E G L  +L+ N   ++   L   AL +++
Sbjct: 59  DHPNVVKLLGV-----CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +L            K  + HRD  + N L+  +L   I+DFGL+          D +
Sbjct: 114 GMEYLES----------KNFI-HRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYY 158

Query: 281 GQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
            + G +   R+MAPE L+    F+  +    D+++  ++LWE+ +      P PG     
Sbjct: 159 RKRGGKLPIRWMAPESLKEGK-FTSKS----DVWSFGVLLWEIFTLGE--QPYPGM---- 207

Query: 338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                    S E++ E + +    P  P        +  L   M +CW  D E R + S 
Sbjct: 208 ---------SNEEVLEYLKNGYRLPQPPNC---PPELYDL---MLQCWAEDPEDRPTFSE 252

Query: 398 VVER 401
           +VE 
Sbjct: 253 LVEI 256

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  104 bits (263), Expect = 1e-25
 Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 61/303 (20%)

Query: 114 IQLVEVKAQGRFGAVWKAK------FKNENVAVKIFLM----QDKQSWQSEQEIFKLPHM 163
           ++L +   +G FG V+K             VAVK        ++++ +  E  I K   +
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMK--KL 58

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKG 221
            H NI+R +G   +GE +    +++T Y   G L DFL+ +   +T + L ++AL ++KG
Sbjct: 59  SHPNIVRLLGVCTQGEPL----YIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           + +L            K  V HRD  + N L+  +L   I+DFGL+              
Sbjct: 115 MEYLES----------KNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYED---DYYRK 160

Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MAPE L+    F+  +    D+++  ++LWE+ +              P+
Sbjct: 161 RGGGKLPIKWMAPESLKDGK-FTSKS----DVWSFGVLLWEIFTLGEQ----------PY 205

Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV 398
                   S E++ E  +    R   PE          L + M +CW +D E R + S +
Sbjct: 206 PG-----MSNEEVLEL-LEDGYRLPRPENCPDE-----LYELMLQCWAYDPEDRPTFSEL 254

Query: 399 VER 401
           VE 
Sbjct: 255 VED 257

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  101 bits (254), Expect = 2e-24
 Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 23/187 (12%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
           +++E   +G FG V+KA+ K     VA+K+  ++ K+  +    EI  L   +H NI++Y
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEI 229
            G+  + + +    W++  +   GSL D LK     +T  Q+  +   + KGL +LH   
Sbjct: 63  YGSYLKKDEL----WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + HRD K+ N+LL SD    + DFGL+      K     +  VGT  +M
Sbjct: 118 ----------GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWM 164

Query: 290 APEVLEG 296
           APEV+ G
Sbjct: 165 APEVING 171

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =   99 bits (250), Expect = 8e-24
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 74/305 (24%)

Query: 122 QGRFGAVWKAKFKNEN-----VAVK----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           +G FG V+K K K ++     VAVK        ++++ +  E  + K   + H N++R +
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMK--KLGHPNVVRLL 62

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLK----------CNIVTWEQLCRIALSMSKGL 222
           G     E +    +L+  Y E G L D+L+           + ++ + L   A+ ++KG+
Sbjct: 63  GVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHG 281
            +L            K  V HRD  + N L+  DL   I+DFGL+  +++       T G
Sbjct: 119 EYLAS----------KKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
           ++   R+MAPE L+  I F+     + D+++  ++LWE+ +  ++          P+   
Sbjct: 168 KLPI-RWMAPESLKDGI-FT----SKSDVWSFGVLLWEIFTLGAT----------PYP-G 210

Query: 342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALC-----DTMEECWDHDAEARLSAS 396
           +    S E++ E  + K  R   PE           C     + M  CW  D E R + S
Sbjct: 211 L----SNEEVLEY-LRKGYRLPKPE----------YCPDELYELMLSCWQLDPEDRPTFS 255

Query: 397 CVVER 401
            +VER
Sbjct: 256 ELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 60/192 (31%), Positives = 90/192 (46%), Gaps = 31/192 (16%)

Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNIL 169
           QL ++  +G FG V+K       + VA+K I L + K+       QEI  L +++H NI+
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLK----CNIVTWEQLCRIALS-MSKGLMH 224
           +YIG+ +         ++I  Y E GSL   +K          E L  + +  + +GL +
Sbjct: 63  KYIGSIE----TSDSLYIILEYAENGSLRQIIKKFGPFP----ESLVAVYVYQVLQGLAY 114

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           LHE+            V HRD K+ N+L   D    +ADFG+A          D    VG
Sbjct: 115 LHEQ-----------GVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVG 161

Query: 285 TRRYMAPEVLEG 296
           T  +MAPEV+E 
Sbjct: 162 TPYWMAPEVIEM 173

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 19/190 (10%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDN 167
                E+  +G FG+V+ A  K+  E +AVK   +     ++    E+EI  L  ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLH 226
           I+RY G+E+  +       +   Y   GSL   LK      E + R     + +GL +LH
Sbjct: 61  IVRYYGSER--DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                         + HRD K  N+L+ SD    +ADFG A      +    T    GT 
Sbjct: 119 SN-----------GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 287 RYMAPEVLEG 296
            +MAPEV+ G
Sbjct: 168 YWMAPEVIRG 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILRYIGAEK 176
           +G  G V+KAK +   E VA+K   ++  +     Q   EI  L   +H  +++ +    
Sbjct: 10  EGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP 69

Query: 177 RGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
            G         +        L + L+     +   Q+      + KG+ ++H        
Sbjct: 70  HGSGFVLVMEYMP-----SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN------ 118

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + HRD K  N+L+ +D    IADFGLA LF   +P   +H QV TR Y APE+L
Sbjct: 119 -----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-QVATRWYRAPELL 172

Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            GA    R     +D++A   +  EL
Sbjct: 173 YGA----RKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 26/204 (12%)

Query: 122 QGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
           +G  G V+KA  +   + VA+K   ++ +       EI  +   +H NI+ Y  +   G+
Sbjct: 29  EGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD 88

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
            +    W++  Y + GSL D +  N V     Q+  +   + +GL +LH           
Sbjct: 89  EL----WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----------- 133

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  +ADFG A      K     +  VGT  +MAPEV++  
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRK 191

Query: 298 INFSRDAFLRIDMYACALVLWELA 321
            ++      ++D+++  ++  E+A
Sbjct: 192 -DYGP----KVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 50/302 (16%)

Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIF--LMQDKQSWQSEQEIFKLPH 162
            R ++ ++   +G FG V   ++          VAVK      +++     E+EI  L  
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT 62

Query: 163 MEHDNILRYIG-AEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMS 219
           ++H+NI++Y G  EK G        LI  Y   GSL D+L+   + +  ++L   +  + 
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC--G 277
           KG+ +L  +              HRD  + N+L++S+    I+DFGLA +    K     
Sbjct: 120 KGMDYLGSQ-----------RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
              G+     Y APE L  +  FS  +    D+++  + L+EL +       PP E+   
Sbjct: 169 KEPGESPIFWY-APECLRTSK-FSSAS----DVWSFGVTLYELFTYGDPSQSPPAEFLRM 222

Query: 338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALC-----DTMEECWDHDAEAR 392
                G    +  + E +   K    LP            C     D M+ CW+ + + R
Sbjct: 223 IGIAQG-QMIVTRLLELL---KEGERLPRP--------PSCPDEVYDLMKLCWEAEPQDR 270

Query: 393 LS 394
            S
Sbjct: 271 PS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.3 bits (217), Expect = 5e-19
 Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 35/245 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----DKQSWQSEQEIFKLPHM-EHDNIL 169
           +++    +G FG V+ A+   + VA+K+   +     K+  +  +EI  L  +    NI+
Sbjct: 3   RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLK----CNIVTWEQLCRIALSMSKGLMHL 225
           +     +   S     +L+  Y + GSL D LK       ++  +   I   +   L +L
Sbjct: 62  KLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA-IADFGLALLF----EPGKPCGDTH 280
           H +            + HRD K  N+LL  D     + DFGLA L               
Sbjct: 118 HSK-----------GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
             VGT  YMAPEVL G       A    D+++  + L+EL    + + P  GE     ++
Sbjct: 167 TSVGTPGYMAPEVLLG--LSLAYASSSSDIWSLGITLYEL---LTGLPPFEGEKNSSATS 221

Query: 341 EVGDH 345
           +    
Sbjct: 222 QTLKI 226

Length = 384

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 46/223 (20%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
           +L++    G +G V+KA+     E VA+K+  ++    ++  +QEI  L    H NI+ Y
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL--------CRIALSMSKGLM 223
            G+  R +    + W++  Y   GSL D  +   VT   L        CR  L   KGL 
Sbjct: 66  FGSYLRRD----KLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCRETL---KGLA 115

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL-ALLFEPGKPCGDTHGQ 282
           +LHE               HRD K  N+LL  D    +ADFG+ A L         T  +
Sbjct: 116 YLHET-----------GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-------TIAK 157

Query: 283 ----VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
               +GT  +MAPEV   A+        + D++A  +   ELA
Sbjct: 158 RKSFIGTPYWMAPEVA--AVERKGGYDGKCDIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 85.3 bits (212), Expect = 9e-19
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 46/289 (15%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKI--FLMQDKQSWQSEQEIFKLPHMEHDNI 168
            ++ V+V  QG  G V+K + K   +  A+K       ++   Q  +E+  L   E   +
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHE 227
           ++  GA  +   I     ++  Y + GSL D LK    +    L  IA  + KGL +LH 
Sbjct: 62  VKCYGAFYKEGEIS----IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH- 116

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                     K  + HRD K +N+L+ S     IADFG++ + E      +T   VGT  
Sbjct: 117 ---------TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVT 165

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           YM+PE ++G  ++S  A    D+++  L L E A          G++  PF       PS
Sbjct: 166 YMSPERIQGE-SYSYAA----DIWSLGLTLLECAL---------GKF--PFLP--PGQPS 207

Query: 348 LEDMQEAVVHKKLRPTLPET-WKQHAGMLALCDTMEECWDHDAEARLSA 395
             ++ +A+      P+LP   +          D +  C   D + R SA
Sbjct: 208 FFELMQAICDGPP-PSLPAEEFSPE-----FRDFISACLQKDPKKRPSA 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 34/191 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
            ++E   +G +G+V+KA  K     VA+K+  + ++   +  +EI  L   +   I++Y 
Sbjct: 6   DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-EEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 173 GAEKRGESIH--TEFWLITAYHERGSLCDFLK-CNIV-TWEQLCRIALSMSKGLMHLHEE 228
           G      S    T+ W++  Y   GS+ D +K  N   T E++  I     KGL +LH  
Sbjct: 65  G------SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VG 284
              NK         HRD K+ N+LL  +  A +ADFG++          DT  +    +G
Sbjct: 118 ---NK-------KIHRDIKAGNILLNEEGQAKLADFGVSGQLT------DTMAKRNTVIG 161

Query: 285 TRRYMAPEVLE 295
           T  +MAPEV++
Sbjct: 162 TPFWMAPEVIQ 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 67/293 (22%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDN 167
           + ++L     +G FG V    ++ + VAVK   ++D     Q++ +E  +  +  + H N
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYRGQKVAVKC--LKDDSTAAQAFLAEASV--MTTLRHPN 61

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMH 224
           +++ +G   +G  +    +++T Y  +GSL D+L+     ++T  Q    AL + +G+ +
Sbjct: 62  LVQLLGVVLQGNPL----YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L E+              HRD  + NVL+  DL A ++DFGLA           + GQ  
Sbjct: 118 LEEK-----------NFVHRDLAARNVLVSEDLVAKVSDFGLAK--------EASQGQDS 158

Query: 285 TR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS--RCSSVSPPPGEYRLPFS 339
            +   ++ APE L     FS  +    D+++  ++LWE+ S  R     P P   R+P  
Sbjct: 159 GKLPVKWTAPEALREKK-FSTKS----DVWSFGILLWEIYSFGR----VPYP---RIPLK 206

Query: 340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            +V  H          V K  R   PE          +   M++CW+ D   R
Sbjct: 207 -DVVPH----------VEKGYRMEAPEGCPPE-----VYKVMKDCWELDPAKR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILRYIGAEK 176
           +G +G V+KA+ K   E VA+K   ++ +     +    EI  L  + H NI++ +   +
Sbjct: 9   EGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR 68

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
               ++  F  +        L   +K     +    +      + +GL   H        
Sbjct: 69  HKGDLYLVFEFMDT-----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-------- 115

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + HRD K  N+L+ ++    +ADFGLA  F        TH  V TR Y APE+L
Sbjct: 116 ---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTH-YVVTRWYRAPELL 170

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASR 323
            G   +S      +D+++   +  EL SR
Sbjct: 171 LGDKGYSTP----VDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 80.2 bits (199), Expect = 5e-17
 Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 36/219 (16%)

Query: 116 LVEVKAQGRFGAVWKAKFK--NENVAVK---IFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
           +++   +G FG V+  + K   +   +K   +  M +K+   +  E+  L  + H NI++
Sbjct: 4   IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLK----CNI-VTWEQLCRIALSMSKGLMHL 225
           Y  + +    +     ++  Y + G L   +K           EQ+    + +   L +L
Sbjct: 64  YYESFEEKGKLC----IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 226 HEE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           H   IL            HRD K  N+ L S+    + DFG++ +         T   VG
Sbjct: 120 HSRKIL------------HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVG 165

Query: 285 TRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELAS 322
           T  Y++PE+ +    N+      + D+++   VL+EL +
Sbjct: 166 TPYYLSPELCQNKPYNY------KSDIWSLGCVLYELCT 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 60/202 (29%), Positives = 83/202 (41%), Gaps = 59/202 (29%)

Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVK----------IFLMQDKQSWQSEQEIFKLPH 162
            L+E   +G FG V+KA  K  N+ VA+K          I  +Q        QEI  L  
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--------QEIQFLSQ 55

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGL 222
                I +Y G+  +G    ++ W+I  Y   GS  D LK   +    +  I   +  GL
Sbjct: 56  CRSPYITKYYGSFLKG----SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGL 111

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +LHEE    K         HRD K+ N+LL  +    +ADFG++             GQ
Sbjct: 112 EYLHEE---GKI--------HRDIKAANILLSEEGDVKLADFGVS-------------GQ 147

Query: 283 -----------VGTRRYMAPEV 293
                      VGT  +MAPEV
Sbjct: 148 LTSTMSKRNTFVGTPFWMAPEV 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 85/306 (27%), Positives = 123/306 (40%), Gaps = 79/306 (25%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIF-------KLPHMEH 165
           +LVEV  +G +G V+KA+ K   + VA+KI           E+EI        K  +  H
Sbjct: 9   ELVEVIGEGTYGKVYKARHKKTGQLVAIKIM----DIIEDEEEEIKEEYNILRKYSN--H 62

Query: 166 DNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL--------CRIA 215
            NI  + GA  +K       + WL+      GS+ D +K      ++L         R  
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
           L   +GL +LHE    NK       V HRD K  N+LL  +    + DFG++   +    
Sbjct: 123 L---RGLAYLHE----NK-------VIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDST 166

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFL--RIDMYACALVLWELASRCSSVSPPPGE 333
            G  +  +GT  +MAPEV+  A +   DA    R D+++  +   ELA            
Sbjct: 167 LGRRNTFIGTPYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADG---------- 214

Query: 334 YRLPFSAEVGDHPSLEDMQ--EAVVHKKLR---PTL--PETWKQHAGMLALCDTMEECWD 386
                       P L DM    A + K  R   PTL  PE W +        D + EC  
Sbjct: 215 -----------KPPLCDMHPMRA-LFKIPRNPPPTLKSPENWSK-----KFNDFISECLI 257

Query: 387 HDAEAR 392
            + E R
Sbjct: 258 KNYEQR 263

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 34/222 (15%)

Query: 111 CRSIQLVE---VKAQGRFGAVWKAKFK--NENVAVKIFLM---QDKQSWQSEQEIFKLPH 162
           CRS+   E      +G +G V++A+     E VA+K   M   +D     S +EI  L +
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62

Query: 163 MEHDNI--LRYIGAEKRGESIHTEFWLITAY--HERGSLCDFLKCNIVTWEQLCRIALSM 218
           + H NI  L+ +   K  +SI    +L+  Y   +  SL D +       +  C + L +
Sbjct: 63  LRHPNIVELKEVVVGKHLDSI----FLVMEYCEQDLASLLDNMPTPFSESQVKC-LMLQL 117

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            +GL +LHE             + HRD K +N+LL       IADFGLA  +    P   
Sbjct: 118 LRGLQYLHENF-----------IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL--PAKP 164

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              +V T  Y APE+L G   ++      IDM+A   +L EL
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTT----AIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 79/284 (27%), Positives = 121/284 (42%), Gaps = 46/284 (16%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           SI+LV+    G+FG VW   + N   VAVK         Q++  E  + K   ++HD ++
Sbjct: 7   SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKT--LQHDKLV 64

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R      + E I    ++IT Y  +GSL DFLK +      L +        L+    +I
Sbjct: 65  RLYAVVTKEEPI----YIITEYMAKGSLLDFLKSDEGGKVLLPK--------LIDFSAQI 112

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
               A   +    HRD ++ NVL+   L   IADFGLA + E  +      G     ++ 
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWT 171

Query: 290 APEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APE    AINF   +F ++ D+++  ++L+E+ +      P PG              S 
Sbjct: 172 APE----AINFG--SFTIKSDVWSFGILLYEIVT--YGKIPYPGM-------------SN 210

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D+  A + +  R    E          L D M+ CW   AE R
Sbjct: 211 SDVMSA-LQRGYRMPRMENCPDE-----LYDIMKTCWKEKAEER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 62/293 (21%)

Query: 121 AQGRFGAVWKAKFKNEN--VAVKIFLMQDKQ-----SWQSEQEIFKLPHMEHDNILRYIG 173
             G FG V+ A   +    +AVK   +QD           E ++ +L  ++H N+++Y G
Sbjct: 9   GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL--LKHPNLVKYYG 66

Query: 174 AEKRGESIHTEFWLI-TAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEILP 231
            E     +H E   I   Y   G+L + L+   +  E + R+  L + +GL +LH     
Sbjct: 67  VE-----VHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDT-HGQVGTRRYM 289
                    + HRD K  N+ L  +    + DFG A+ L       G+      GT  YM
Sbjct: 119 --------GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 290 APEVLEGAINFSRDAFLR-IDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP-S 347
           APEV+ G          R  D+++   V+ E+A+                    G  P S
Sbjct: 171 APEVITGG---KGKGHGRAADIWSLGCVVLEMAT--------------------GKRPWS 207

Query: 348 LEDMQEAVVHK---KLRPTLPETWKQHAGMLALC-DTMEECWDHDAEARLSAS 396
             D +  ++       +P +P        +     D ++ C + D + R +AS
Sbjct: 208 ELDNEFQIMFHVGAGHKPPIP----DSLQLSPEGKDFLDRCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 115 QLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLP-HMEHDNILRY 171
           +LVE+   G +G V+K +     +  A+K+  +   +  + +QEI  L  +  H NI  Y
Sbjct: 9   ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 68

Query: 172 IGA--EKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLH 226
            GA  +K    +  + WL+  +   GS+ D +K    N +  E +  I   + +GL HLH
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           +             V HRD K  NVLL  +    + DFG++   +  +  G  +  +GT 
Sbjct: 129 QH-----------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTP 175

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
            +MAPEV+    N       + D+++  +   E+A
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 21/215 (9%)

Query: 115 QLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLP-HMEHDNILRY 171
           +LVEV   G +G V+K +     +  A+K+  + + +  + + EI  L  +  H NI  Y
Sbjct: 19  ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78

Query: 172 IGA--EKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLH 226
            GA  +K       + WL+  +   GS+ D +K    N +  + +  I   + +GL HLH
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                         V HRD K  NVLL  +    + DFG++   +  +  G  +  +GT 
Sbjct: 139 AH-----------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTP 185

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
            +MAPEV+    N       R D+++  +   E+A
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 53/215 (24%), Positives = 105/215 (48%), Gaps = 36/215 (16%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           + L E+  +G FGAV + ++  + VAVK  +  D  +    +E   +  + H N++R +G
Sbjct: 8   LTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEIL 230
                  +H   +++     +G+L +FL+     +V+  QL + +L +++G+ +L  + L
Sbjct: 67  V-----ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---R 287
                       HRD  + N+L+  D  A ++DFGLA +         + G   ++   +
Sbjct: 122 -----------VHRDLAARNILVSEDGVAKVSDFGLARV--------GSMGVDNSKLPVK 162

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           + APE L+    FS  +    D+++  ++LWE+ S
Sbjct: 163 WTAPEALKHK-KFSSKS----DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 64/294 (21%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDN 167
            S++L      G+FG VW   +     VAVK      M   +++  E +I K   + HD 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKK--LRHDK 62

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMH 224
           +++        E I    +++T Y  +GSL DFLK      +   QL  +A  +++G+ +
Sbjct: 63  LVQLYAVCSEEEPI----YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L                 HRD  + N+L+  +L   IADFGLA L E  +       + G
Sbjct: 119 LESR-----------NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT----AREG 163

Query: 285 TR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELAS--RCSSVSPPPGEYRLPF 338
            +   ++ APE    A N+ R  F ++ D+++  ++L E+ +  R     P PG      
Sbjct: 164 AKFPIKWTAPE----AANYGR--FTIKSDVWSFGILLTEIVTYGRV----PYPGMT---- 209

Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           + EV +           V +  R   P    +      L D M +CWD D E R
Sbjct: 210 NREVLEQ----------VERGYRMPRPPNCPE-----ELYDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 78/268 (29%), Positives = 116/268 (43%), Gaps = 45/268 (16%)

Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAEK 176
            +G FG V+K       E VA+KI  +++ +      +QEI  L   +   I RY G+  
Sbjct: 13  GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL 72

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
           +G    T+ W+I  Y   GS  D LK   +    +  I   + KGL +LH E        
Sbjct: 73  KG----TKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE-------- 120

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL-E 295
                 HRD K+ NVLL       +ADFG+A      +   +T   VGT  +MAPEV+ +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQ 175

Query: 296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---YRLPFSAEVGDHPSLE--- 349
            A +F      + D+++  +   ELA       PP  +    R+ F       P+LE   
Sbjct: 176 SAYDF------KADIWSLGITAIELAKG----EPPNSDLHPMRVLFLIPKNSPPTLEGQY 225

Query: 350 -----DMQEAVVHK--KLRPTLPETWKQ 370
                +  EA ++K  + RPT  E  K 
Sbjct: 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 58/283 (20%)

Query: 121 AQGRFGAVWKAKFKNENVA-----VKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V+K   K +        + +  M  ++  ++  E   L  ++   I+RY  + 
Sbjct: 9   GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPN 232
                ++    ++  Y E G L   LK      +  +Q+ R  + +  GL HLH      
Sbjct: 69  LDKGKLN----IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH------ 118

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   + HRD KS N+ L +     I D G+A L        +T   VGT  Y++PE
Sbjct: 119 -----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ 352
           + E      +    + D++A  +VL+E    C+                 G HP   + Q
Sbjct: 172 LCE-----DKPYNEKSDVWALGVVLYEC---CT-----------------GKHPFDANNQ 206

Query: 353 EAVVHKKLR---PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            A++ K +R   P + + + Q      L   +++C   D   R
Sbjct: 207 GALILKIIRGVFPPVSQMYSQ-----QLAQLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 59/258 (22%)

Query: 123 GRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRG 178
           G  G V K   +     +AVK   ++  ++ Q +  +E+  L       I+ + GA    
Sbjct: 12  GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN- 70

Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEEILPNKAD 235
              + +  +   Y + GSL   LK  +        L +IA+++ KGL +LHE        
Sbjct: 71  ---NGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHE-------- 118

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFG--------LALLFEPGKPCGDTHGQVGTRR 287
             K  + HRD K +N+L+ S     + DFG        LA  F            VGT  
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------------VGTSS 164

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           YMAPE ++G      D  ++ D+++  L L ELA+            R P+  E      
Sbjct: 165 YMAPERIQGN-----DYSVKSDIWSLGLSLIELATG-----------RFPYPPENDPPDG 208

Query: 348 LEDMQEAVVHKKLRPTLP 365
           + ++ + +V++   P LP
Sbjct: 209 IFELLQYIVNEP-PPRLP 225

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 29/219 (13%)

Query: 113 SIQLVEVKAQGRFGAV----WKAKFKNE-NVAVKIFL--MQDKQSWQSEQEIFKLPHMEH 165
            + + +V   G FG V     K   K E +VA+K       DKQ      E   +   +H
Sbjct: 5   YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH 64

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLM 223
            NI+R  G   +         +IT Y E GSL  FL+ N    T  QL  +   ++ G+ 
Sbjct: 65  PNIIRLEGVVTKSRP----VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           +L E        +Y     HRD  + N+L+ S+L   ++DFGL+   E  +    T G  
Sbjct: 121 YLSEM-------NY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              R+ APE    AI + R      D+++  +V+WE+ S
Sbjct: 170 IPIRWTAPE----AIAY-RKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 62/286 (21%), Positives = 119/286 (41%), Gaps = 52/286 (18%)

Query: 117 VEVKAQGRFGAVWKAKFKNEN------VAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNI 168
           ++V   G FG V+K  +  E       VA+K+   +       E   E + +  ++H ++
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW--EQLCRIALSMSKGLMHLH 226
           +R +G       + ++  LIT     G L D+++ +      + L    + ++KG+ +L 
Sbjct: 72  VRLLGI-----CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E+ L            HRD  + NVL+K+     I DFGLA L +  +      G     
Sbjct: 127 EKRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++MA E +   I ++  +    D+++  + +WEL               + F A+  +  
Sbjct: 176 KWMALESILHRI-YTHKS----DVWSYGVTVWEL---------------MTFGAKPYEGI 215

Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
              ++ + ++ K  R   P        M+     + +CW  DAE+R
Sbjct: 216 PAVEIPD-LLEKGERLPQPPICTIDVYMV-----LVKCWMIDAESR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 76/308 (24%), Positives = 127/308 (41%), Gaps = 54/308 (17%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIFL----MQDKQSWQSEQEIFKLP 161
           R ++ + V  +G FG V    +   N      VAVK        Q+   W+ E  I K  
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK-- 61

Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            + H+NI++Y G   ++G        LI  Y   GSL D+L  + +   QL   A  + +
Sbjct: 62  TLYHENIVKYKGCCSEQGGKG---LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICE 118

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +LH       +  Y     HRD  + NVLL +D    I DFGLA       P G  +
Sbjct: 119 GMAYLH-------SQHY----IHRDLAARNVLLDNDRLVKIGDFGLA----KAVPEGHEY 163

Query: 281 GQVGTRR-----YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
            +V         + A E L+             D+++  + L+EL + C S   PP ++ 
Sbjct: 164 YRVREDGDSPVFWYAVECLK-----ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218

Query: 336 L---PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
               P   ++     +E     ++ + +R   P+   Q   +L     M+ CW+ +A+ R
Sbjct: 219 EMIGPKQGQMTVVRLIE-----LLERGMRLPCPKNCPQEVYIL-----MKNCWETEAKFR 268

Query: 393 LSASCVVE 400
            +   ++ 
Sbjct: 269 PTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.7 bits (169), Expect = 6e-13
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 36/214 (16%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIG--- 173
           +G +G V+KA+ K   E VA+K   M++++      + +EI  L  + H NI+R      
Sbjct: 9   EGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVT 68

Query: 174 AEKRGESIHTEFWLITAY--HERGSLCDFLKCNIV--TWEQLCRIALSMSKGLMHLHEEI 229
           ++ +G       +++  Y  H+   L   L    V  T  Q+      + +GL +LH   
Sbjct: 69  SKGKGS-----IYMVFEYMDHD---LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-- 118

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
             N        + HRD K +N+L+ +D    +ADFGLA  +        T+  V T  Y 
Sbjct: 119 --NG-------ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR-VITLWYR 168

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            PE+L GA  +  +    +DM++   +L EL   
Sbjct: 169 PPELLLGATRYGPE----VDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 31/194 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILR 170
           +L+EV   G    V+ A     NE VA+K   ++  Q+   E  +E+  +    H N+++
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQL-CRIALSMSKGLMHLH 226
           Y  +   G+ +    WL+  Y   GSL D +K +       E +   +   + KGL +LH
Sbjct: 64  YYTSFVVGDEL----WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL-ALLFEPGKPCGDTHGQ--- 282
                           HRD K+ N+LL  D +  IADFG+ A L + G     T      
Sbjct: 120 -----------SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG---DRTRKVRKT 165

Query: 283 -VGTRRYMAPEVLE 295
            VGT  +MAPEV+E
Sbjct: 166 FVGTPCWMAPEVME 179

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 39/231 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFL--------MQDKQSWQSEQEIFKLPHMEHD 166
           +++E   +G FG V K + K++    KI +        M +K+  Q   E+  L  ++H 
Sbjct: 3   EVLETIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP 59

Query: 167 NILRYIGAE--KRGESIHTEFWLITAYHERGSLCDFL-KC----NIVTWEQLCRIALSMS 219
           NI+RY      +  ++++    ++  Y E G L   + KC      +  E + RI   + 
Sbjct: 60  NIVRYYDRIIDRSNQTLY----IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
             L   H    P         V HRD K  N+ L ++    + DFGLA +         T
Sbjct: 116 LALYECHNRSDP------GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
           +  VGT  YM+PE L      S D   + D+++   +++EL +     SPP
Sbjct: 170 Y--VGTPYYMSPEQLNHM---SYDE--KSDIWSLGCLIYELCAL----SPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 49/289 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKF--KNENVAVKIFLM---QDKQS--WQSEQEIFKLPHMEHDN 167
           Q +E+  +G +GAV++ K       VA+KI  +    D  S   +    + +L   +  N
Sbjct: 4   QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I +Y G+  +G       W+I  Y E GS+   +K   +  + +  I   +   L ++H 
Sbjct: 64  ITKYYGSYLKG----PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH- 118

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                     K  V HRD K+ N+L+ +     + DFG+A L         T   VGT  
Sbjct: 119 ----------KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGTPY 166

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           +MAPEV+     +   A    D+++  + ++E+A+     +PP             D  +
Sbjct: 167 WMAPEVITEGKYYDTKA----DIWSLGITIYEMATG----NPP-----------YSDVDA 207

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
              M   ++ K   P L +    +     L + +  C D + + RLSA 
Sbjct: 208 FRAMM--LIPKSKPPRLED----NGYSKLLREFVAACLDEEPKERLSAE 250

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 64/228 (28%)

Query: 122 QGRFGAVWKAKFKNEN--VAVK-IFLMQDKQSWQSEQ---------EIFKLPHMEHDNIL 169
           +G +  V+KA+ K     VA+K I L       +  +         EI  L  ++H NI+
Sbjct: 10  EGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLC---DFL----------KCNIVTWEQLCRIAL 216
                            L+  +  + ++    +F+          K  ++T   +    L
Sbjct: 66  G----------------LLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYML 109

Query: 217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF-EPGKP 275
              +GL +LH         ++   + HRD K NN+L+ SD    +ADFGLA  F  P + 
Sbjct: 110 MTLRGLEYLH--------SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
              TH QV TR Y APE+L GA ++     + +DM++   +  EL  R
Sbjct: 159 M--TH-QVVTRWYRAPELLFGARHYG----VGVDMWSVGCIFAELLLR 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 53/260 (20%)

Query: 122 QGRFGAVWKAKFKNENVA-----VKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +G +G+V+K K  ++N       V +  M  K+   +  EI  L  + H NI+ Y  A  
Sbjct: 10  KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL 69

Query: 177 RGESIHTEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHE-EIL 230
            G  +      +  Y   G L   +        ++  +++ RI + + +GL  LHE +IL
Sbjct: 70  DGNKLCI----VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                       HRD KS N+LL ++    I D G++ + +          Q+GT  YMA
Sbjct: 126 ------------HRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMA 169

Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED 350
           PEV +G     R    + D+++   +L+E+A+           +  PF A      S++D
Sbjct: 170 PEVWKG-----RPYSYKSDIWSLGCLLYEMAT-----------FAPPFEAR-----SMQD 208

Query: 351 MQEAVVHKKLRPTLPETWKQ 370
           ++  V   K  P +P  + Q
Sbjct: 209 LRYKVQRGKY-PPIPPIYSQ 227

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 72/219 (32%), Positives = 96/219 (43%), Gaps = 42/219 (19%)

Query: 123 GRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGAEK 176
           G FGAV+ A     NE VA+K      KQS +  Q+I K    L  + H N + Y G   
Sbjct: 26  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNI-----VTWEQLCRIALSMSKGLMHLHEEILP 231
           R    HT  WL+  Y   GS  D L+ +      V    +C  AL    GL +LH     
Sbjct: 86  RE---HTA-WLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQ---GLAYLH----- 132

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
               S++    HRD K+ N+LL    T  +ADFG A L  P          VGT  +MAP
Sbjct: 133 ----SHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF------VGTPYWMAP 180

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
           EV+        D   ++D+++  +   ELA R     PP
Sbjct: 181 EVILAMDEGQYDG--KVDVWSLGITCIELAER----KPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 65.2 bits (160), Expect = 6e-12
 Identities = 63/263 (23%), Positives = 103/263 (39%), Gaps = 57/263 (21%)

Query: 122 QGRFGAVWKAKFKNENV--AVKI----FLMQDKQSWQSEQEIFKLPHMEHDNI--LRYIG 173
           +G FG V   + K+     A+K+     +++ K+   +  E   L  + H  I  L Y  
Sbjct: 3   KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY-- 60

Query: 174 AEKRGESIHTE--FWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
                 +  TE   +L+  Y   G L   L K    + E+    A  +   L +LH    
Sbjct: 61  ------AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL-- 112

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + +RD K  N+LL +D    + DFGLA           T+   GT  Y+A
Sbjct: 113 ---------GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLA 161

Query: 291 PEVLEGA-INFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           PEVL G     +      +D ++  ++L+E+ +         G  + PF AE       +
Sbjct: 162 PEVLLGKGYGKA------VDWWSLGVLLYEMLT---------G--KPPFYAE-----DRK 199

Query: 350 DMQEAVVHKKLRPTLPETWKQHA 372
           ++ E ++   LR   PE     A
Sbjct: 200 EIYEKILKDPLR--FPEFLSPEA 220

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 56/227 (24%)

Query: 117 VEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDN 167
           + V  +G +G V K + K     VA+K F    K+S   E       +E+  L  + H+N
Sbjct: 6   LGVVGEGAYGVVLKCRNKATGEIVAIKKF----KESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----------IVTWEQLCRIALS 217
           I+    A +R   ++    L+  Y ER +L + L+ +             W QL      
Sbjct: 62  IVNLKEAFRRKGRLY----LVFEYVER-TLLELLEASPGGLPPDAVRSYIW-QLL----- 110

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKP 275
             + + + H              + HRD K  N+L+       + DFG A  L   P  P
Sbjct: 111 --QAIAYCH-----------SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
             D    V TR Y APE+L G  N+ +     +D++A   ++ EL  
Sbjct: 158 LTD---YVATRWYRAPELLVGDTNYGKP----VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 65/283 (22%), Positives = 119/283 (42%), Gaps = 47/283 (16%)

Query: 103 SPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFK 159
           SP  P++   S   +    +G  G V  A  K+    V +  M  ++  + E    E+  
Sbjct: 16  SPGDPREYLDSFIKI---GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVI 72

Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS 219
           +    H+N++    +   G+    E W++  + E G+L D +    +  EQ+  + LS+ 
Sbjct: 73  MRDYHHENVVDMYNSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVL 128

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           + L +LH +            V HRD KS+++LL SD    ++DFG     +  K     
Sbjct: 129 RALSYLHNQ-----------GVIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKR 175

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
              VGT  +MAPEV+      SR  +   +D+++  +++ E+         PP       
Sbjct: 176 KSLVGTPYWMAPEVI------SRLPYGTEVDIWSLGIMVIEMID-----GEPP------- 217

Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTM 381
                + P L+ M+   +   L P + ++ K  + +    D M
Sbjct: 218 ---YFNEPPLQAMRR--IRDNLPPRVKDSHKVSSVLRGFLDLM 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 33/217 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNE-NVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILR 170
            L      G FG VW+  +KN   VA+KI    D    Q +Q E +  K   + H +++ 
Sbjct: 9   TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALK--RLRHKHLIS 66

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHE 227
                  GE      ++IT   E+GSL  FL+     ++    L  +A  +++G+ +L E
Sbjct: 67  LFAVCSVGEP----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTR 286
           +              HRD  + N+L+  DL   +ADFGLA L+ E      D        
Sbjct: 123 Q-----------NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY--- 168

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           ++ APE    A +    +  + D+++  ++L+E+ + 
Sbjct: 169 KWTAPE----AASHGTFS-TKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 69/288 (23%), Positives = 130/288 (45%), Gaps = 53/288 (18%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + ++L++   +G FG V    ++   VAVK  +  D  +     E   +  + H N+++ 
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 172 IGA--EKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLH 226
           +G   E++G       +++T Y  +GSL D+L+    +++  + L + +L + + + +L 
Sbjct: 65  LGVIVEEKGG-----LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 118

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                 +A+++     HRD  + NVL+  D  A ++DFGL    +      DT G++   
Sbjct: 119 ------EANNF----VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDT-GKLPV- 163

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++ APE L     FS  +    D+++  ++LWE+ S      P     R+P    V   P
Sbjct: 164 KWTAPEALREK-KFSTKS----DVWSFGILLWEIYSFGRVPYP-----RIPLKDVV---P 210

Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS 394
            +E        K  +   P+          + D M++CW  DA  R S
Sbjct: 211 RVE--------KGYKMDAPDGCPP-----VVYDVMKQCWHLDAATRPS 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 36/218 (16%)

Query: 121 AQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGA 174
             G FGAV+ A+    NE VA+K      KQS +  Q+I K    L  ++H N + Y G 
Sbjct: 34  GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS--KGLMHLHEEILPN 232
             R    HT  WL+  Y   GS  D L+ +    +++   A++    +GL +LH   +  
Sbjct: 94  YLRE---HTA-WLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM-- 146

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD K+ N+LL       +ADFG A +  P       +  VGT  +MAPE
Sbjct: 147 ---------IHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPE 191

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
           V+        D   ++D+++  +   ELA R     PP
Sbjct: 192 VILAMDEGQYDG--KVDVWSLGITCIELAER----KPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.0 bits (157), Expect = 2e-11
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 53/227 (23%)

Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLM-QDKQSWQSE--QEIFKLPHMEHDNILRY 171
           +E   +G +G V+KA  K   E VA+K   +  +++   S   +EI  L  ++H NI++ 
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVK- 62

Query: 172 IGAEKRGESIHTEFWLITAYHERGSL---CDFLKCNIVTWEQLCRIALSMS--------- 219
                          L+   H    L    ++   ++  +       LS +         
Sbjct: 63  ---------------LLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQL 107

Query: 220 -KGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
            +GL + H   IL            HRD K  N+L+  D    +ADFGLA  F       
Sbjct: 108 LRGLAYCHSHRIL------------HRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC 324
            TH +V T  Y APE+L G+ ++S      +D+++   +  E+ +  
Sbjct: 155 YTH-EVVTLWYRAPEILLGSKHYS----TAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGA 174
             G FGAV+ A     NE VAVK      KQ+ +  Q+I K    L  ++H N + Y G 
Sbjct: 30  GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGC 89

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS--KGLMHLHEEILPN 232
             +    HT  WL+  Y   GS  D L+ +    +++   A++    +GL +LH      
Sbjct: 90  YLKE---HTA-WLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---- 140

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   + HRD K+ N+LL       +ADFG A    P       +  VGT  +MAPE
Sbjct: 141 -------NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPE 187

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASR 323
           V+        D   ++D+++  +   ELA R
Sbjct: 188 VILAMDEGQYDG--KVDVWSLGITCIELAER 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 63/296 (21%), Positives = 109/296 (36%), Gaps = 64/296 (21%)

Query: 122 QGRFGAVWKAKFKNE-----NVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGA 174
            G FG V + ++         VAVK            +  +E   +  ++H+N++R  G 
Sbjct: 5   DGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV 64

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILP 231
                 +     ++T     GSL D L+ +         LC  A+ ++ G+ +L  +   
Sbjct: 65  -----VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF- 118

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKPCGDTHGQVGTRR-- 287
                      HRD  + N+LL SD    I DFGL  AL      P  + H  +      
Sbjct: 119 ----------IHRDLAARNILLASDDKVKIGDFGLMRAL------PQNEDHYVMEEHLKV 162

Query: 288 ---YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
              + APE L     FS  +    D++   + LWE+ +              P++   G 
Sbjct: 163 PFAWCAPESLR-TRTFSHAS----DVWMFGVTLWEMFTYG----------EEPWAGLSG- 206

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
                 + + +  +  R   PE   Q      + + M +CW H+   R + + + E
Sbjct: 207 ----SQILKKIDKEGERLERPEACPQD-----IYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 35/197 (17%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           +++LV+    G+FG VW   +     VA+K         +++ +E  + K   ++H  ++
Sbjct: 7   TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMK--QLQHPRLV 64

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLH 226
           R      + E I    ++IT Y E GSL DFLK      +T  +L  +A  +++G+  + 
Sbjct: 65  RLYAVVTQ-EPI----YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
            +       +Y     HRD ++ N+L+   L   IADFGLA L E      +   + G +
Sbjct: 120 RK-------NY----IHRDLRAANILVSETLCCKIADFGLARLIED----NEYTAREGAK 164

Query: 287 ---RYMAPEVLEGAINF 300
              ++ APE    AIN+
Sbjct: 165 FPIKWTAPE----AINY 177

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 68/267 (25%), Positives = 111/267 (41%), Gaps = 43/267 (16%)

Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAEK 176
            +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y G+  
Sbjct: 13  GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 72

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
           +G    T+ W+I  Y   GS  D L+       Q+  +   + KGL +LH E        
Sbjct: 73  KG----TKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE-------- 120

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
                 HRD K+ NVLL       +ADFG+A      +   +T   VGT  +MAPEV++ 
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQQ 175

Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY----------RLPFSAEVGDHP 346
           +   S     + D+++  +   ELA       PP  +           +       G+  
Sbjct: 176 SAYDS-----KADIWSLGITAIELAKG----EPPNSDMHPMRVLFLIPKNNPPTLTGEFS 226

Query: 347 -SLEDMQEAVVHK--KLRPTLPETWKQ 370
              ++  +A ++K    RPT  E  K 
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 51/286 (17%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           S+QL++    G+FG VW   +  N  VAVK         +S+  E +I K   + HD ++
Sbjct: 7   SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMK--KLRHDKLV 64

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLH 226
           +        E I    +++T Y  +GSL DFLK      +    L  +A  ++ G+ ++ 
Sbjct: 65  QLYAVVSE-EPI----YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                      +    HRD +S N+L+   L   IADFGLA L E  +      G     
Sbjct: 120 -----------RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPI 167

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++ APE    A  + R   ++ D+++  ++L EL ++           R+P+   + +  
Sbjct: 168 KWTAPE----AALYGRFT-IKSDVWSFGILLTELVTKG----------RVPYPG-MNNRE 211

Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            LE      V +  R   P+        ++L + M +CW  D E R
Sbjct: 212 VLEQ-----VERGYRMPCPQDCP-----ISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 36/218 (16%)

Query: 121 AQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGA 174
             G FGAV+ A+    +E VA+K      KQS +  Q+I K    L  + H N ++Y G 
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS--KGLMHLHEEILPN 232
             R    HT  WL+  Y   GS  D L+ +    +++   A++    +GL +LH      
Sbjct: 84  YLRE---HTA-WLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---- 134

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   + HRD K+ N+LL       + DFG A +  P       +  VGT  +MAPE
Sbjct: 135 -------NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPE 181

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
           V+        D   ++D+++  +   ELA R     PP
Sbjct: 182 VILAMDEGQYDG--KVDVWSLGITCIELAER----KPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.5 bits (153), Expect = 1e-10
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 32/222 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQD-----KQSWQSEQEIFKLPHMEHD 166
           +L++    G +G V  A  K     VA+K I  + D     K+  +   EI  L H+ H+
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHE 59

Query: 167 NI--LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-TWEQLCRIALSMSKGLM 223
           NI  L  I      E  + + +++T   E   L   +K     T + +      + +GL 
Sbjct: 60  NIIGLLDILRPPSPEDFN-DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQ 282
           +LH       A+     V HRD K +N+L+ S+    I DFGLA  +       G     
Sbjct: 118 YLHS------AN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC 324
           V TR Y APE+L  +  +++     ID+++   +  EL +R 
Sbjct: 167 VVTRWYRAPELLLSSSRYTKA----IDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 80/315 (25%), Positives = 135/315 (42%), Gaps = 76/315 (24%)

Query: 122 QGRFGAVWKAKFKN--ENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEK 176
           QG FG V+KA+ K   + VA+K  LM++++      + +EI  L  ++H+N++  I    
Sbjct: 22  QGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI---- 77

Query: 177 RGESIHTE----------FWLITAYHERGSLCDFLKCNIVTW--EQLCRIALSMSKGLMH 224
             E   T+          F+L+  + E   L   L    V +   ++ ++   +  GL +
Sbjct: 78  --EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF---EPGKPCGDTHG 281
           +H     NK       + HRD K+ N+L+  D    +ADFGLA  F   +  KP   T  
Sbjct: 135 IHR----NK-------ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT-N 182

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR------------------ 323
           +V T  Y  PE+L G     RD    IDM+    ++ E+ +R                  
Sbjct: 183 RVVTLWYRPPELLLG----ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238

Query: 324 -CSSVSPP--PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT 380
            C S++P   PG  +L    ++     L   Q+  V ++L+P + +    HA      D 
Sbjct: 239 LCGSITPEVWPGVDKLELFKKM----ELPQGQKRKVKERLKPYVKD---PHA-----LDL 286

Query: 381 MEECWDHDAEARLSA 395
           +++    D   R+ A
Sbjct: 287 IDKLLVLDPAKRIDA 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 46/211 (21%)

Query: 122 QGRFGAVWKAKFKNEN--VAVKI----FLMQDK--QSWQSEQEI-FKLPHMEHDNILRYI 172
           +G F  V  AK K  N   A+KI     L+++K  +  + E+E+  +L    H  I++  
Sbjct: 11  EGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG--HPGIIKLY 68

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILP 231
              +  E++    + +  Y   G L  +++      E+  R  A  +   L +LH     
Sbjct: 69  YTFQDEENL----YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH----- 119

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--------- 282
           +K       + HRD K  N+LL  D+   I DFG A + +P        G          
Sbjct: 120 SKG------IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 283 ---------VGTRRYMAPEVL-EGAINFSRD 303
                    VGT  Y++PE+L E     S D
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSD 204

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 31/138 (22%)

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM 223
           +H NI+    +   G+    E W++  + E G+L D +    +  EQ+  + L++ K L 
Sbjct: 74  QHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALS 129

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ- 282
            LH +            V HRD KS+++LL SD    ++DFG          C     + 
Sbjct: 130 FLHAQ-----------GVIHRDIKSDSILLTSDGRVKLSDFGF---------CAQVSKEV 169

Query: 283 ------VGTRRYMAPEVL 294
                 VGT  +MAPEV+
Sbjct: 170 PRRKSLVGTPYWMAPEVI 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 58/291 (19%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNI 168
            SIQL+     G+FG VW+  + N   VAVK       D + + +E +I K   + H  +
Sbjct: 6   TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMK--KLRHPKL 63

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHL 225
           ++        E I    +++T   + GSL ++L+      +   QL  +A  ++ G+ +L
Sbjct: 64  IQLYAVCTLEEPI----YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                  +A +Y     HRD  + NVL+  +    +ADFGLA + +          + G 
Sbjct: 120 -------EAQNY----IHRDLAARNVLVGENNICKVADFGLARVIKE----DIYEAREGA 164

Query: 286 R---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-RLPFSAE 341
           +   ++ APE    A  ++R + ++ D+++  ++L E+ +           Y R+P+   
Sbjct: 165 KFPIKWTAPE----AALYNRFS-IKSDVWSFGILLTEIVT-----------YGRMPYPG- 207

Query: 342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                + E +Q+  V +  R   P    +      L D M +CW  D + R
Sbjct: 208 ---MTNAEVLQQ--VDQGYRMPCPPGCPK-----ELYDIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 36/217 (16%)

Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFLM-------QDKQSWQSEQEIFKLPHMEHDNIL 169
           + V  +G FG V   + K +   V I  +        ++ + Q+E ++ KL  + H NI+
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL--LSHPNII 62

Query: 170 RYIGAEKRGESIHTEFWLITA--YHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
            Y       E+   +  L+    Y   G+L +++       ++ C  +L     ++H   
Sbjct: 63  EYY------ENFLEDKALMIVMEYAPGGTLAEYI-------QKRCN-SLLDEDTILHFFV 108

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGT 285
           +IL      +   + HRD K+ N+LL K  +   I DFG++ +L    K     +  VGT
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGT 164

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
             Y++PE+ EG     +    + D++A   VL+ELAS
Sbjct: 165 PCYISPELCEG-----KPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 28/224 (12%)

Query: 113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           S++L +    G+FG VW A + K+  VAVK              E   +  ++HD +++ 
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEE 228
                + E I    ++IT +  +GSL DFLK    +     +L   +  +++G+  +   
Sbjct: 67  HAVVTK-EPI----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 119

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+ + L   IADFGLA + E  +      G     ++
Sbjct: 120 ---------QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKW 169

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            APE    AINF     ++ D+++  ++L E+ +      P PG
Sbjct: 170 TAPE----AINFGSFT-IKSDVWSFGILLMEIVT--YGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 34/86 (39%), Positives = 44/86 (51%), Gaps = 15/86 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL HLH+             + +RD K  NVLL       I+D GLA+  + GK      
Sbjct: 107 GLEHLHQR-----------RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152

Query: 281 GQVGTRRYMAPEVLEGAI-NFSRDAF 305
           G+ GT  YMAPEVL+G + +FS D F
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWF 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 54/303 (17%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDKQSWQS--EQEIFKLPHM 163
           R ++ ++   +G FG+V   ++        E VAVK  L           E+EI  L  +
Sbjct: 4   RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK-LQHSTAEHLRDFEREIEILKSL 62

Query: 164 EHDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALS 217
           +HDNI++Y G    A +R         L+  Y   GSL D+L+ +   +   +L   A  
Sbjct: 63  QHDNIVKYKGVCYSAGRRN------LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ 116

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           + KG+ +L  +              HRD  + N+L++S+    I DFGL  +     P  
Sbjct: 117 ICKGMEYLGSK-----------RYVHRDLATRNILVESENRVKIGDFGLTKVL----PQD 161

Query: 278 DTH------GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
             +      G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP
Sbjct: 162 KEYYKVREPGESPIFWY-APESLTESK-FSVAS----DVWSFGVVLYELFTYSDKSCSPP 215

Query: 332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA 391
            E+      +      +  + E + +    P  P         +     M+ECW++D   
Sbjct: 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA-PPGCPAEIYAI-----MKECWNNDPSQ 269

Query: 392 RLS 394
           R S
Sbjct: 270 RPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 71/326 (21%), Positives = 122/326 (37%), Gaps = 89/326 (27%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKL 160
            +I L     +G FG V+  +  +       E VAVK          ++ ++ E E+  L
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL--L 62

Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---------------KCNI 205
            + +H+NI+++ G    G+       ++  Y E G L  FL                   
Sbjct: 63  TNFQHENIVKFYGVCTEGDP----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118

Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           +T  QL +IA+ ++ G+++L  +              HRD  + N L+  DL   I DFG
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQ-----------HFVHRDLATRNCLVGYDLVVKIGDFG 167

Query: 266 LALLFEPGKPCGDTHGQVGTR----RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWEL 320
           ++          D +   G      R+M PE    +I + +  F    D+++  +VLWE+
Sbjct: 168 MSRDVY----TTDYYRVGGHTMLPIRWMPPE----SIMYRK--FTTESDVWSFGVVLWEI 217

Query: 321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVH-----KKLRPTLPETWKQHAGML 375
            +                    G  P      E V+      + L+   P T        
Sbjct: 218 FT-------------------YGKQPWYGLSNEEVIECITQGRLLQR--PRTCPSE---- 252

Query: 376 ALCDTMEECWDHDAEARLSASCVVER 401
            + D M  CW  D + R++   + ER
Sbjct: 253 -VYDIMLGCWKRDPQQRINIKDIHER 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 78/305 (25%), Positives = 131/305 (42%), Gaps = 62/305 (20%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN--VAVKIF--LMQDKQSWQSEQEIFK-LPHMEHDNIL 169
           +++E   +G +G V+K   K +    AVKI   +    +  ++E  I + LP+  H N++
Sbjct: 25  EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN--HPNVV 82

Query: 170 RYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLM 223
           ++ G   K  + +  + WL+      GS+ + +K  ++  ++L       I      GL 
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           HLH              + HRD K NN+LL ++    + DFG++      +   +T   V
Sbjct: 143 HLHNN-----------RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT--SV 189

Query: 284 GTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
           GT  +MAPEV+  E   ++S DA  R D+++  +   EL                     
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDA--RCDVWSLGITAIELGD------------------- 228

Query: 342 VGDHPSLEDMQEAVVHKKL----RPTL--PETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            GD P L DM       K+     PTL  PE W +     +    + +C   D EAR S 
Sbjct: 229 -GD-PPLFDMHPVKTLFKIPRNPPPTLLHPEKWCR-----SFNHFISQCLIKDFEARPSV 281

Query: 396 SCVVE 400
           + ++E
Sbjct: 282 THLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 51/247 (20%)

Query: 114 IQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLM----QDKQSWQSEQEIFKLPH 162
           + L +   +G FG V KA+        +   VAVK+       +D     SE E+ K+  
Sbjct: 14  LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR-IALSMSKG 221
            +H NI+  +G   +   +    +++  Y   G+L DFL+          R      S  
Sbjct: 74  -KHKNIINLLGVCTQEGPL----YVVVEYAAHGNLRDFLRAR--------RPPGEYASPD 120

Query: 222 LMHLHEEILPNKA-DSYKPAVA------------HRDFKSNNVLLKSDLTAAIADFGLAL 268
                EE L  K   S+   VA            HRD  + NVL+  D    IADFGLA 
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Query: 269 ---LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
                +  +   +    V   ++MAPE L     F R    + D+++  ++LWE+ +   
Sbjct: 181 DIHHIDYYRKTTNGRLPV---KWMAPEAL-----FDRVYTHQSDVWSFGVLLWEIFTLGG 232

Query: 326 SVSPPPG 332
             SP PG
Sbjct: 233 --SPYPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 75/275 (27%), Positives = 118/275 (42%), Gaps = 51/275 (18%)

Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYI 172
           +E   +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
           G+  +     T+ W+I  Y   GS  D L+   +   Q+  I   + KGL +LH E    
Sbjct: 69  GSYLK----DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---- 120

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VGTRRY 288
                     HRD K+ NVLL       +ADFG+A          DT  +    VGT  +
Sbjct: 121 -------KKIHRDIKAANVLLSEHGEVKLADFGVA------GQLTDTQIKRNTFVGTPFW 167

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---YRLPFSAEVGDH 345
           MAPEV++ +   S     + D+++  +   ELA       PP  E    ++ F     + 
Sbjct: 168 MAPEVIKQSAYDS-----KADIWSLGITAIELAKG----EPPHSELHPMKVLFLIPKNNP 218

Query: 346 PSLE--------DMQEAVVHKK--LRPTLPETWKQ 370
           P+LE        +  EA ++K+   RPT  E  K 
Sbjct: 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 53/236 (22%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNE----NVAVKIF----LMQDKQSWQSEQEIF-KLPHME 164
           I+  +V  +G FG V +A  K +    N A+K+        D + +  E E+  KL H  
Sbjct: 4   IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH-- 61

Query: 165 HDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLK-----------------CNIV 206
           H NI+  +GA E RG       ++   Y   G+L DFL+                  + +
Sbjct: 62  HPNIINLLGACENRGY-----LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 207 TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL 266
           T +QL + A  ++ G+ +L E+              HRD  + NVL+  +L + IADFGL
Sbjct: 117 TSQQLLQFASDVATGMQYLSEK-----------QFIHRDLAARNVLVGENLASKIADFGL 165

Query: 267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   E       T G++   R+MA E L  ++  ++      D+++  ++LWE+ S
Sbjct: 166 SRGEE--VYVKKTMGRLPV-RWMAIESLNYSVYTTKS-----DVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 51/228 (22%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQ--------EIFKLPHMEHDNI--LR 170
            +G +G V+KAK KN     +  + + K   +           EI  L  ++H+N+  L 
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE---QLCRIALSMSKGLMH--- 224
            +  E   +S+    +L+  Y E     D  +  I+ +    +   I  SM K L+    
Sbjct: 69  EVFLEHADKSV----YLLFDYAEH----DLWQ--IIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 225 -----LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL----TAAIADFGLALLF-EPGK 274
                LH              V HRD K  N+L+  +        I D GLA LF  P K
Sbjct: 119 NGVHYLHSNW-----------VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           P  D    V T  Y APE+L GA ++++     ID++A   +  EL +
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTK----AIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 32/184 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDNILRYI 172
            G +G V  A        VA+K       + +QS        +E+  L HM+H+N++  +
Sbjct: 25  SGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 173 GAEKRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
                  S+    + +L+T       L + +KC  ++ + +  +   + +GL ++H    
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS--- 136

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
              A      + HRD K +N+ +  D    I DFGLA   +      +  G V TR Y A
Sbjct: 137 ---AG-----IIHRDLKPSNIAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRA 183

Query: 291 PEVL 294
           PE++
Sbjct: 184 PEIM 187

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 42/243 (17%)

Query: 122 QGRFGAVWKA--KFKNENVA---VKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRYIGAE 175
           +G+F  V+KA        VA   V+IF M D ++ Q   +EI  L  ++H N+++Y+ + 
Sbjct: 12  KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF 71

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEIL 230
                 + E  ++    + G L   +K       ++    + +  + +   L H+H +  
Sbjct: 72  IE----NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-- 125

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  NV + +     + D GL   F         H  VGT  YM+
Sbjct: 126 ---------RIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMS 174

Query: 291 PEVLEGA-INFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE----YRLPFSAEVGDH 345
           PE +     NF      + D+++   +L+E+A+     SP  G+    Y L    E  D+
Sbjct: 175 PERIHENGYNF------KSDIWSLGCLLYEMAAL---QSPFYGDKMNLYSLCKKIEKCDY 225

Query: 346 PSL 348
           P L
Sbjct: 226 PPL 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 51/227 (22%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN---VAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           ++++   +G FG ++ AK K+++   V  +I L  M  K+   S++E+  L  M+H NI+
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCD---------FLKCNIVTWEQLCRIALSMSK 220
            +  + +     +   +++  Y + G L           F +  I++W    +I+L    
Sbjct: 63  TFFASFQE----NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL---- 112

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLALLF----EPGKP 275
           GL H+H+             + HRD KS N+ L K+ + A + DFG+A       E    
Sbjct: 113 GLKHIHDR-----------KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           C      VGT  Y++PE+ +     +R    + D+++   VL+EL +
Sbjct: 162 C------VGTPYYLSPEICQ-----NRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 54/288 (18%)

Query: 122 QGRFGAVWKAKFK-NENVAVKIFLM----QDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +G FG V+K   K N  VAVK          K+ +  E EI K    +H NI++ IG   
Sbjct: 5   KGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILK--QYDHPNIVKLIGVCV 62

Query: 177 RGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           + + I    +++      GSL  FL  K N +T ++L +++L  + G+ +L  +      
Sbjct: 63  QKQPI----YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK------ 112

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK-PCGDTHGQVGTRRYMAPEV 293
                   HRD  + N L+  +    I+DFG++   E G     D   Q+   ++ APE 
Sbjct: 113 -----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI-KWTAPE- 165

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ- 352
              A+N+ R      D+++  ++LWE                  FS     +P + + Q 
Sbjct: 166 ---ALNYGRYTSES-DVWSYGILLWET-----------------FSLGDTPYPGMSNQQT 204

Query: 353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
              +    R   P+   +      +   M +CW +D E R S S +  
Sbjct: 205 RERIESGYRMPAPQLCPE-----EIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 40/224 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRYIGA-- 174
           +G FG V+KA+       VA+K  LM +++      + +EI  L  ++H N++  I    
Sbjct: 18  EGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77

Query: 175 EKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK---GLMHLHEE- 228
           E+  +S       +++T Y +   L   L+   V   +  +I   M +   G+ +LHE  
Sbjct: 78  ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTE-SQIKCYMLQLLEGINYLHENH 135

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE------PGKPCGDTH-- 280
           IL            HRD K+ N+L+ +     IADFGLA  ++       G   G T   
Sbjct: 136 IL------------HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 281 -GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
              V TR Y  PE+L G   ++      +D++    V  E+ +R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTA----VDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 26/216 (12%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNI 168
           + + +E   +G +  V+K + +   E VA+K   +  ++   S   +EI  +  ++H+NI
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 169 LRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           +R        + IHTE    L+  Y ++      LK  + T      +  +  K   +  
Sbjct: 61  VRL------HDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTY-- 107

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
            ++L   A  ++  V HRD K  N+L+       +ADFGLA  F  G P      +V T 
Sbjct: 108 -QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTL 164

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            Y AP+VL G    SR     ID+++   ++ E+ +
Sbjct: 165 WYRAPDVLLG----SRTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 37/196 (18%)

Query: 123 GRFGAVWKAKFKNEN---VAVK-IFLMQDKQSWQS-----EQEIFKLPHMEHDNILRYIG 173
           G FG+V++     ++    AVK + L  D Q+ Q      EQEI  L  ++H NI++Y+G
Sbjct: 11  GSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG 69

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
            E+  ++++    L+      GSL   L K        +      +  GL +LH+     
Sbjct: 70  TEREEDNLYIFLELVPG----GSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---- 121

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA---LLFEPGKPCGDTHGQVGTRRYM 289
                     HRD K  N+L+ ++    +ADFG+A   + F   K         G+  +M
Sbjct: 122 -------NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF------KGSPYWM 168

Query: 290 APEVL--EGAINFSRD 303
           APEV+  +G    + D
Sbjct: 169 APEVIAQQGGYGLAAD 184

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 31/236 (13%)

Query: 123 GRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSEQ-EIFKLPHMEHDNILRYIGAEKRGE 179
           G FG V+KA+ K   +  A KI  ++ ++  +    EI  L   +H NI+    A     
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY---- 71

Query: 180 SIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               + W++  + + G+L   +      +T  Q+  +   M + L  LH           
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK-------- 123

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD K+ N+LL  D    +ADFG++   +      DT   +GT  +MAPEV+   
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPEVVACE 178

Query: 298 INFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE---YRLPFSAEVGDHPSLE 349
             F  + +  + D+++  + L ELA       PP  E    R+       + P+L+
Sbjct: 179 -TFKDNPYDYKADIWSLGITLIELAQM----EPPHHELNPMRVLLKILKSEPPTLD 229

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 33/217 (15%)

Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           +++   G FG V K  +  E  ++KI +    +QD+   Q+ QEI      +  ++H  I
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           +R +G    G S+     L+T     GSL D ++ +   +  ++L    + ++KG+ +L 
Sbjct: 72  VRLLGICP-GASLQ----LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             + HR+  + N+LLKSD    IADFG+A L  P       + +  T 
Sbjct: 127 EH-----------RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTP 174

Query: 287 -RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            ++MA E    +I F R    + D+++  + +WE+ S
Sbjct: 175 IKWMALE----SILFGRYTH-QSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 39/212 (18%)

Query: 122 QGRFGAVWKAKFKN--ENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEK 176
           +G +G V+KAK +   E VA+K + L  D +   S   +EI  L  ++H NI+R      
Sbjct: 10  EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY---- 65

Query: 177 RGESIHTEFWLITAYHERGSLCD------FLKCNIVTWEQLCR-IALSMSKGLMHLHEEI 229
             + +H++  L   +      CD      F  CN     ++ +     + KGL   H   
Sbjct: 66  --DVLHSDKKLTLVFE----YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      V HRD K  N+L+  +    +ADFGLA  F  G P      +V T  Y 
Sbjct: 119 ----------NVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWYR 166

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELA 321
            P+VL GA  +S      IDM++   +  ELA
Sbjct: 167 PPDVLFGAKLYSTS----IDMWSAGCIFAELA 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 36/223 (16%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK----NEN-VAVKI----FLMQDKQSWQSEQEIFKLPHME 164
           +++ EV   G FG V + + K     E  VA+K     +  + ++ + SE  I  +   +
Sbjct: 6   VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI--MGQFD 63

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGL 222
           H NI+   G   +   +     +IT + E G+L  FL+ N    T  QL  +   ++ G+
Sbjct: 64  HPNIIHLEGVVTKSRPV----MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +L E        +Y     HRD  + N+L+ S+L   ++DFGL+   E           
Sbjct: 120 KYLSEM-------NY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168

Query: 283 VGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +G +   R+ APE    AI + R      D+++  +V+WE+ S
Sbjct: 169 LGGKIPIRWTAPE----AIAY-RKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 42/235 (17%)

Query: 106 SPQQGCRSIQLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQ-SEQEIFKLPH 162
           +PQ     IQ V     G +G V+KA+     E  AVKI  ++    +   +QEIF +  
Sbjct: 6   NPQHDYELIQRV---GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE 62

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-------KCNIVTWEQLCRIA 215
            +H NI+ Y G+    E +    W+   Y   GSL D         +  I     +CR  
Sbjct: 63  CKHCNIVAYFGSYLSREKL----WICMEYCGGGSLQDIYHVTGPLSELQIA---YVCRET 115

Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
           L   +GL +LH +              HRD K  N+LL  +    +ADFG+A        
Sbjct: 116 L---QGLAYLHSK-----------GKMHRDIKGANILLTDNGDVKLADFGVAAKIT--AT 159

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                  +GT  +MAPEV     N   +     D++A  +   ELA     + PP
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQL--CDIWAVGITAIELA----ELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 28/219 (12%)

Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVKIF--LMQDKQSWQSEQEIFKLPHMEHDNILR 170
           +++E   +G +G V+K   K      AVKI   +    +  ++E  I K    +H N+++
Sbjct: 21  EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK-ALSDHPNVVK 79

Query: 171 YIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLM---H 224
           + G   K+      + WL+      GS+ D +K  +   E++    IA  + + LM   H
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           LH     NK         HRD K NN+LL ++    + DFG++      +   +T   VG
Sbjct: 140 LHV----NKT-------IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT--SVG 186

Query: 285 TRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           T  +MAPEV+  E  ++ + DA  R D+++  +   EL 
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDA--RCDVWSLGITAIELG 223

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 54/284 (19%)

Query: 117 VEVK-AQGRFGAVWKAKFK-NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 10  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 70  VSEEP--------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 119

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 120 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 169

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 170 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 212

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  + E R
Sbjct: 213 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 52/181 (28%), Positives = 75/181 (41%), Gaps = 20/181 (11%)

Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIG 173
            E   QG  G V+ A        V I  M  +Q  + E    EI  +   +H NI+ Y+ 
Sbjct: 24  FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
           +   G+    E W++  Y   GSL D +    +   Q+  +     + L  LH       
Sbjct: 84  SYLVGD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN----- 134

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD KS+N+LL  D +  + DFG      P +    T   VGT  +MAPEV
Sbjct: 135 ------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186

Query: 294 L 294
           +
Sbjct: 187 V 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 76/304 (25%), Positives = 129/304 (42%), Gaps = 68/304 (22%)

Query: 119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAE 175
           V  +G +G V+ A+  +  V + I  + ++ S   +   +EI    +++H NI++Y+G++
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 176 KRGESIHTEFWLITAYHER---GSLCDFLKCNIVTWEQLCRIALSMS-------KGLMHL 225
                    F+ I  + E+   GSL   L+     W  L     ++        +GL +L
Sbjct: 75  SENG-----FFKI--FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           H+             + HRD K +NVL+ +      I+DFG +       PC +T    G
Sbjct: 125 HDN-----------QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TG 171

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           T +YMAPEV+        D   R   Y     +W L   C+ V    G  + PF  E+G+
Sbjct: 172 TLQYMAPEVI--------DKGPR--GYGAPADIWSLG--CTIVEMATG--KPPF-IELGE 216

Query: 345 HPSLEDMQEAVVHK----KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
                   +A + K    K+ P +PE+    A    L      C++ D + R SA  +++
Sbjct: 217 -------PQAAMFKVGMFKIHPEIPESLSAEAKNFIL-----RCFEPDPDKRASAHDLLQ 264

Query: 401 RGML 404
              L
Sbjct: 265 DPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 44/223 (19%)

Query: 123 GRFGAVWKAKFKNEN--VAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           G++G V++  +K  +  VAVK  L +D    + +  E  + K   ++H N+++ +G   R
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMK--EIKHPNLVQLLGVCTR 73

Query: 178 GESIHTEFWLITAYHERGSLCDFLK-CN--IVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
                  F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L         
Sbjct: 74  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-------- 121

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMA 290
              K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ A
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTA 173

Query: 291 PEVLEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           PE L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 174 PESL--AYNKFS----IKSDVWAFGVLLWEIAT--YGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 67/298 (22%), Positives = 120/298 (40%), Gaps = 50/298 (16%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A+ K+    V + +M  ++  + E    E+  +   +H N++    +   
Sbjct: 30  GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV 89

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           GE    E W++  + + G+L D +    +  EQ+  +  S+ + L +LH +         
Sbjct: 90  GE----ELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ--------- 136

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+++LL  D    ++DFG         P       VGT  +MAPEV+   
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVI--- 189

Query: 298 INFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
              SR  +   +D+++  +++ E+         PP     P  A                
Sbjct: 190 ---SRTPYGTEVDIWSLGIMVIEMVD-----GEPPYFSDSPVQA---------------- 225

Query: 357 HKKLRPTLPETWKQ-HAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEEC 413
            K+LR + P   K  H     L D +E     + + R +A  +++   L     + EC
Sbjct: 226 MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT-GLPEC 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA+ K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  +      L  I L + K  +  
Sbjct: 61  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDAS-----PLSGIPLPLIKSYLF- 107

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 108 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 163

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             Y APE+L G              Y+ A+ +W L
Sbjct: 164 LWYRAPEILLGC-----------KYYSTAVDIWSL 187

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 58/221 (26%)

Query: 122 QGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA-E 175
           +G FG     K K +        + I  M  K+  +S +E+  L +M+H NI++Y  + E
Sbjct: 10  EGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE 69

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN-----------IVTW-EQLCRIALSMSKGLM 223
           + G       +++  Y E G L  + K N           I+ W  Q+C         L 
Sbjct: 70  ENGN-----LYIVMDYCEGGDL--YKKINAQRGVLFPEDQILDWFVQICL-------ALK 115

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF----EPGKPCGDT 279
           H+H+             + HRD KS N+ L  D T  + DFG+A +     E  + C   
Sbjct: 116 HVHDR-----------KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--- 161

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              +GT  Y++PE+ E     +R    + D++A   VL+E+
Sbjct: 162 ---IGTPYYLSPEICE-----NRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 70/297 (23%), Positives = 113/297 (38%), Gaps = 67/297 (22%)

Query: 122 QGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYI 172
            G FG+V K  +  ++     VAVK   ++ +     ++E  +    +  ++H  I+R I
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILP 231
           G  K GE       L+      G L  +LK    +    L  +A  ++ G+ +L  +   
Sbjct: 63  GVCK-GEP----LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK--- 114

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC--GDTHGQVGTRRYM 289
                      HRD  + NVLL +   A I+DFG++     G       T G+   + Y 
Sbjct: 115 --------HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY- 165

Query: 290 APEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APE     IN+ +  F  + D+++  + LWE  S                    G  P  
Sbjct: 166 APE----CINYGK--FSSKSDVWSYGVTLWEAFSY-------------------GAKP-Y 199

Query: 349 EDMQEAVVHKKL----RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            +M+ A V   L    R   PE   Q      +   M  CW +  E R + S +   
Sbjct: 200 GEMKGAEVIAMLESGERLPRPEECPQE-----IYSIMLSCWKYRPEDRPTFSELEST 251

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 67/306 (21%), Positives = 124/306 (40%), Gaps = 58/306 (18%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSEQEIF-----KLPHM 163
           ++L ++  +G FG+V + +   ++     VAVK   M+      SE E F      +   
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVK--TMKLDIHTYSEIEEFLSEAACMKDF 58

Query: 164 EHDNILRYIGAEKRGESIHT--EFWLITAYHERGSLCDFL-------KCNIVTWEQLCRI 214
           +H N+++ IG      S+    +  +I  + + G L  FL           +  + L + 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK 274
            + ++ G+     E L N+         HRD  + N +L+ D+T  +ADFGL+     G 
Sbjct: 119 MVDIALGM-----EYLSNRN------FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
                       +++A E L   +  S+      D++A  + +WE+A+R    +P PG  
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKS-----DVWAFGVTMWEIATR--GQTPYPG-- 218

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS 394
                  V +H   + ++     K+    L E +          D M  CW  D + R +
Sbjct: 219 -------VENHEIYDYLRHGNRLKQPEDCLDELY----------DLMYSCWRADPKDRPT 261

Query: 395 ASCVVE 400
            + + E
Sbjct: 262 FTKLRE 267

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 32/220 (14%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHD 166
           I++ +V   G FG V   + K      + V I  ++    +KQ      E   +   +H 
Sbjct: 6   IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMH 224
           NI+   G   + + +     ++T Y E GSL  FL+ +    T  QL  +   ++ G+ +
Sbjct: 66  NIIHLEGVVTKSKPV----MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE--PGKPCGDTHGQ 282
           L +               HRD  + N+L+ S+L   ++DFGL+ + E  P        G+
Sbjct: 122 LSDM-----------GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   R+ APE    AI + R      D+++  +V+WE+ S
Sbjct: 171 IPI-RWTAPE----AIAY-RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 42/222 (18%)

Query: 118 EVKAQGRFGAVWKAKFKN--ENVAVKIFLM------QDKQSWQS-----EQEIFKLPHME 164
           E+  +G +G V+ A      E +AVK   +      +     +        EI  L  ++
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
           H NI++Y+G E   E +     +   Y   GS+   L+      EQL R           
Sbjct: 67  HLNIVQYLGFETTEEYLS----IFLEYVPGGSIGSCLRTYGRFEEQLVR----------F 112

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV- 283
             E++L   A  +   + HRD K++N+L+ +D    I+DFG++      K   D +    
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS------KKSDDIYDNDQ 166

Query: 284 -----GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
                G+  +MAPEV+    ++S+    ++D+++   V+ E+
Sbjct: 167 NMSMQGSVFWMAPEVIH---SYSQGYSAKVDIWSLGCVVLEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 30/229 (13%)

Query: 106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQSWQS-EQEIFKLPH 162
           +PQ+     +L++    G +G V+KA+  N  E  A+K+  ++  + +   +QEI  +  
Sbjct: 6   NPQE---DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKD 62

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKG 221
            +H NI+ Y G+  R + +    W+   +   GSL D       ++  Q+  ++    +G
Sbjct: 63  CKHSNIVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L +LH +              HRD K  N+LL  +    +ADFG++   +          
Sbjct: 119 LYYLHSK-----------GKMHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKS 165

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
            +GT  +MAPEV   A+          D++A  +   ELA     + PP
Sbjct: 166 FIGTPYWMAPEV--AAVERKGGYNQLCDIWAVGITAIELA----ELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)

Query: 117 VEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNILRY 171
           VE   +G +G V+KA+ +  NE +A+K I L Q+ +   S   +EI  L  M+H NI+R 
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 172 ---IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
              + +EKR        +L+  Y +       LK ++ +     +    + K  ++   +
Sbjct: 67  QDVVHSEKR-------LYLVFEYLDLD-----LKKHMDSSPDFAK-NPRLIKTYLY---Q 110

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           IL   A  +   V HRD K  N+L+ +      +ADFGLA  F  G P      +V T  
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLW 168

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           Y APE+L G+ ++S      +D+++   +  E+ ++
Sbjct: 169 YRAPEILLGSRHYSTP----VDIWSVGCIFAEMVNQ 200

Length = 294

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)

Query: 122 QGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEK 176
           +G +G V K K K     VA+K FL  +      +   +EI  L  + H+N++  I   +
Sbjct: 11  EGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR 70

Query: 177 RGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
           R + ++    L+  + +   L D  K  N +   ++ +    + +G+   H         
Sbjct: 71  RKKRLY----LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH------- 119

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                + HRD K  N+L+       + DFG A  L  PG+   D    V TR Y APE+L
Sbjct: 120 ----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELL 172

Query: 295 EGAINFSRDAFLRIDMYACALVLWELAS 322
            G   + R     +D++A   ++ E+ +
Sbjct: 173 VGDTKYGRA----VDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNE----NVAVKIFL----MQDKQSWQSEQEIF-KLPHME 164
           I+  +V  +G FG V KA+ K +    + A+K         D + +  E E+  KL H  
Sbjct: 9   IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-- 66

Query: 165 HDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSM---- 218
           H NI+  +GA E RG       +L   Y   G+L DFL K  ++  +    IA S     
Sbjct: 67  HPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 219 -SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
            S+ L+H   ++        +    HRD  + N+L+  +  A IADFGL+   E      
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVK 179

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            T G++   R+MA E L  ++  +       D+++  ++LWE+ S
Sbjct: 180 KTMGRLPV-RWMAIESLNYSVYTTNS-----DVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.6 bits (140), Expect = 5e-09
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 41/215 (19%)

Query: 122 QGRFGAVWKA--KFKNENVAVK-IF-LMQDKQSWQ-SEQEIFKLPHM-EHDNI---LRYI 172
           +G +G VWKA  +   E VA+K IF   ++    Q + +EI  L  + +H NI   L  I
Sbjct: 17  KGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVI 76

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE-EILP 231
            AE        + +L+  Y E   L   ++ NI+       I   + K L ++H   ++ 
Sbjct: 77  KAEN-----DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVI- 129

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ------VGT 285
                      HRD K +N+LL SD    +ADFGLA          +          V T
Sbjct: 130 -----------HRDLKPSNILLNSDCRVKLADFGLARSLSEL---EENPENPVLTDYVAT 175

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           R Y APE+L G+  +++     +DM++   +L E+
Sbjct: 176 RWYRAPEILLGSTRYTKG----VDMWSVGCILGEM 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 35/160 (21%), Positives = 56/160 (35%), Gaps = 42/160 (26%)

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           +C I L     L +LH +            + HRD K +N+LL       I DF +A   
Sbjct: 106 ICEIVL----ALEYLHSK-----------GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
            P      T    GT  YMAPEVL       +   + +D ++  +  +E           
Sbjct: 151 TPDT---LTTSTSGTPGYMAPEVL-----CRQGYSVAVDWWSLGVTAYECLRG------- 195

Query: 331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTLPETW 368
               + P+            +++ +  K+       P TW
Sbjct: 196 ----KRPY------RGHSRTIRDQIRAKQETADVLYPATW 225

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 53/229 (23%)

Query: 121 AQGRFGAVWKAKFKNE----NVAVKIFLM----QDKQSWQSEQEIF-KLPHMEHDNILRY 171
            +G FG V KA+ K +    + A+K         D + +  E E+  KL H  H NI+  
Sbjct: 4   GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIINL 61

Query: 172 IGA-EKRGESIHTEFWLITAYHERGSLCDFLK-----------------CNIVTWEQLCR 213
           +GA E RG       +L   Y   G+L DFL+                  + ++ +QL  
Sbjct: 62  LGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
            A  +++G+ +L ++              HRD  + N+L+  +  A IADFGL+   E  
Sbjct: 117 FAADVARGMDYLSQK-----------QFIHRDLAARNILVGENYVAKIADFGLSRGQE-- 163

Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                T G++   R+MA E L  ++  +       D+++  ++LWE+ S
Sbjct: 164 VYVKKTMGRLPV-RWMAIESLNYSVYTTNS-----DVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 6e-09
 Identities = 59/235 (25%), Positives = 87/235 (37%), Gaps = 85/235 (36%)

Query: 123 GRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSEQE---------IFKLPHMEHDNILRY 171
           G FG+V+ A  K   E VA+K      K+ + S +E         + KL    H NI++ 
Sbjct: 10  GTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNE--HPNIVK- 62

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLC---DFLKCNIVTWEQLCR--------------I 214
                          L   + E   L    ++++ N+    QL +              I
Sbjct: 63  ---------------LKEVFRENDELYFVFEYMEGNLY---QLMKDRKGKPFSESVIRSI 104

Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK 274
              + +GL H+H           K    HRD K  N+L+       IADFGLA       
Sbjct: 105 IYQILQGLAHIH-----------KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153

Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR-------IDMYACALVLWELAS 322
           P  D    V TR Y APE+L           LR       +D++A   ++ EL +
Sbjct: 154 PYTD---YVSTRWYRAPEIL-----------LRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 56.7 bits (136), Expect = 7e-09
 Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 47/290 (16%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 89  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------- 135

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  + DFG      P +        VGT  +MAPEV+   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVV--- 188

Query: 298 INFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
              +R A+  ++D+++  ++  E+                      G+ P L +     +
Sbjct: 189 ---TRKAYGPKVDIWSLGIMAIEMIE--------------------GEPPYLNENPLRAL 225

Query: 357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL 406
           +       PE            D +  C D D E R SA  +++   L +
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 48/221 (21%)

Query: 117 VEVKAQGRFG-------------AVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM 163
           + V  +G FG              VWK         V +  + +K+   +  EI  L  +
Sbjct: 5   IRVLGKGAFGEATLYRRTEDDSLVVWKE--------VNLTRLSEKERRDALNEIVILSLL 56

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSK 220
           +H NI+ Y        ++  E      Y   G+L D +   K  +   E +      +  
Sbjct: 57  QHPNIIAYYNHFMDDNTLLIEM----EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            + ++H+             + HRD K+ N+ L       + DFG++ +        +T 
Sbjct: 113 AVSYIHKA-----------GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET- 160

Query: 281 GQVGTRRYMAPEVLEGA-INFSRDAFLRIDMYACALVLWEL 320
             VGT  YM+PE+ +G   NF      + D++A   VL+EL
Sbjct: 161 -VVGTPYYMSPELCQGVKYNF------KSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 56.3 bits (135), Expect = 9e-09
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 88  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN--------- 134

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  + DFG      P +    T   VGT  +MAPEV+   
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV--- 187

Query: 298 INFSRDAF-LRIDMYACALVLWEL 320
              +R A+  ++D+++  ++  E+
Sbjct: 188 ---TRKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 20/177 (11%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  K+    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 29  GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 88

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ K L  LH +         
Sbjct: 89  GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ--------- 135

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNIL 169
           Q VE   +G +G V+KA+ K   E VA+K I L  + +   S   +EI  L  + H NI+
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI------VTWEQLCRIALSMSKGLM 223
           R +      + +H+E  L   +       +FL  ++           L      + K  +
Sbjct: 62  RLL------DVVHSENKLYLVF-------EFLDLDLKKYMDSSPLTGLDP---PLIKSYL 105

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC-GDTHGQ 282
           +   ++L   A  +   V HRD K  N+L+  +    +ADFGLA  F  G P    TH +
Sbjct: 106 Y---QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTH-E 159

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           V T  Y APE+L G+  +S      +D+++   +  E+ +R
Sbjct: 160 VVTLWYRAPEILLGSRQYSTP----VDIWSIGCIFAEMVNR 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 36/226 (15%)

Query: 111 CRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS---WQSEQEIFKLPH 162
           CRS+   + +    +G +G V++A+ K   E VA+K   M+ ++      S +EI  L  
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK 60

Query: 163 MEHDNIL--RYIGAEKRGESIHTEFWLITAY--HERGSLCDFLKCNIVTWEQLCRIALSM 218
           ++H NI+  + +      + I    +++  Y  H+  SL + +K   +  E  C + L +
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKI----YMVMEYVEHDLKSLMETMKQPFLQSEVKC-LMLQL 115

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF-EPGKPCG 277
             G+ HLH+    N        + HRD K++N+LL +     I DFGLA  +  P KP  
Sbjct: 116 LSGVAHLHD----NW-------ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY- 163

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            T   V T  Y APE+L GA  +S      IDM++   +  EL ++
Sbjct: 164 -TQLVV-TLWYRAPELLLGAKEYST----AIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 28/164 (17%)

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIV---TWEQLCRIALSMSKGLMHLH------ 226
           K+GE++     ++ +    G  C F+ C      T ++LC I   M+ G +H H      
Sbjct: 35  KQGETLALNERIMLSLVSTGD-CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV 93

Query: 227 ----------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                      EI+      +   V +RD K  N+LL       I+D GLA  F   KP 
Sbjct: 94  FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152

Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              H  VGT  YMAPEVL+    +   A    D ++   +L++L
Sbjct: 153 ---HASVGTHGYMAPEVLQKGTAYDSSA----DWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 42/142 (29%), Positives = 60/142 (42%), Gaps = 27/142 (19%)

Query: 198 CDFLKC---NIVTWEQLCRIALSMSKGLMHLH----------------EEILPNKADSYK 238
           C F+ C      T ++L  I   M+ G +H H                 EI+      + 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAI 298
             V +RD K  N+LL       I+D GLA  F   KP    H  VGT  YMAPEVL+  +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV 171

Query: 299 NFSRDAFLRIDMYACALVLWEL 320
            +   A    D ++   +L++L
Sbjct: 172 AYDSSA----DWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 5/81 (6%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSR 302
           HRD K  N+L+ S+    I DFGLA + EP +    T  +V T+ Y APE+L G+ +++ 
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ-EVVTQYYRAPEILMGSRHYTS 184

Query: 303 DAFLRIDMYACALVLWELASR 323
                +D+++   +  EL  R
Sbjct: 185 ----AVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 58/244 (23%)

Query: 114 IQLVEVKAQGRFGAVWKAK----FKNEN---VAVKIFLMQDKQSWQSEQEIFK----LPH 162
           I+ V    QG FG V++A+       E    VAVK+  ++++ S   + +  +    +  
Sbjct: 7   IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAE 64

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--------------------- 201
            +H NI++ +G    G+ +     L+  Y   G L +FL                     
Sbjct: 65  FDHPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 202 ---KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT 258
                 +   EQLC IA  ++ G+ +L E               HRD  + N L+  ++ 
Sbjct: 121 GLNPLPLSCTEQLC-IAKQVAAGMAYLSER-----------KFVHRDLATRNCLVGENMV 168

Query: 259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW 318
             IADFGL+           +       R+M PE    +I ++R      D++A  +VLW
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPE----SIFYNRYT-TESDVWAYGVVLW 223

Query: 319 ELAS 322
           E+ S
Sbjct: 224 EIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 58/302 (19%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIFLMQDKQSWQSE--QEIFKLPHM 163
           ++Q +    +G FG V+ AK K          V VK       ++ QSE  +E+     +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM 223
            H N++R +G  +  E      ++I  Y + G L  FL+      E+L    LS +K  +
Sbjct: 66  SHKNVVRLLGLCREAEP----HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS-TKQKV 120

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ- 282
            L  +I             HRD  + N L+ S     ++   L           D +   
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL---------SKDVYNSE 171

Query: 283 -------VGTRRYMAPE-VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
                  +   R++APE V E   +FS     + D+++  +++WE+ ++        GE 
Sbjct: 172 YYKLRNALIPLRWLAPEAVQED--DFS----TKSDVWSFGVLMWEVFTQ--------GE- 216

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS 394
            LPF   + D   L  +Q      KL   +PE          L   M  CW  + + R S
Sbjct: 217 -LPFY-GLSDEEVLNRLQA----GKLELPVPEGCPS-----RLYKLMTRCWAVNPKDRPS 265

Query: 395 AS 396
            S
Sbjct: 266 FS 267

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 38/219 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVK-IFLMQDKQSW--QSEQEIFKLPHMEHDNILRY----- 171
           +G +G V+KA+ K   E VA+K + L  +K+ +   + +EI  L  + H NI+       
Sbjct: 17  EGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT 76

Query: 172 -----IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW--EQLCRIALSMSKGLMH 224
                +  +K   +    F+L+  Y +   L   L+  +V +  + +      + +GL +
Sbjct: 77  DKQDALDFKKDKGA----FYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
            H           K    HRD K +N+LL +     +ADFGLA L+   +    T+ +V 
Sbjct: 132 CH-----------KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN-KVI 179

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           T  Y  PE+L G   +       ID+++C  +L EL ++
Sbjct: 180 TLWYRPPELLLGEERYGP----AIDVWSCGCILGELFTK 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 36/218 (16%)

Query: 118 EVKAQGRFGAVWKAKFK---NENVAVKI------FLMQDKQSWQSEQEIFKLPHMEHDNI 168
           +V   G FG V++   K    + VAV I      +  + +Q + SE  I  +    H NI
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASI--MGQFSHHNI 68

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLH 226
           +R  G   +         +IT Y E G+L  +L+ +   +   QL  +   ++ G+ +L 
Sbjct: 69  IRLEGVVTK----FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE--PGKPCGDTHGQVG 284
           +        +Y     HRD  + N+L+ S+L   ++DFGL+ + E  P      + G++ 
Sbjct: 125 DM-------NY----VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
             R+ APE    AI + +      D+++  +V+WE+ S
Sbjct: 174 I-RWTAPE----AIAYRKFTSAS-DVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 53/283 (18%)

Query: 118 EVKAQGRFGAVWKAKFKNEN-VAVKIF---LMQD-KQSWQSEQEIFKLPHMEHDNILRYI 172
           E+  +G FG V+K   K++  VAVK     L Q+ K  + SE  I K    +H NI++ I
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILK--QYDHPNIVKLI 58

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           G   + + I+    L+      G    FL  K + +  +QL + AL  + G+ +L  +  
Sbjct: 59  GVCTQRQPIYIVMELVPG----GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK-- 112

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                       HRD  + N L+  +    I+DFG++   + G        Q+   ++ A
Sbjct: 113 ---------NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI-KWTA 162

Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED 350
           PE    A+N+ R +    D+++  ++LWE                  FS  V  +P + +
Sbjct: 163 PE----ALNYGRYSS-ESDVWSYGILLWE-----------------TFSLGVCPYPGMTN 200

Query: 351 MQ-EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            Q    V K  R + P+          +   M+ CWD+  E R
Sbjct: 201 QQAREQVEKGYRMSCPQKCPDD-----VYKVMQRCWDYKPENR 238

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 117 VEVKAQGRFGAVWKAKFKNENVAV---KIFLMQDKQSWQSE--QEIFKLPHMEHDNILRY 171
           +E   +G +G V+K + K     V   KI L  +++   S   +EI  L  ++H NI+  
Sbjct: 5   IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM--HLHEEI 229
                  + +  E  L   +       +FL  ++  +         M   L+  +L++ I
Sbjct: 65  Q------DVLMQESRLYLIF-------EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ-I 110

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
           L      +   V HRD K  N+L+ +     +ADFGLA  F  G P      +V T  Y 
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYR 168

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           APEVL G+  +S      +D+++   +  E+A++
Sbjct: 169 APEVLLGSPRYS----TPVDIWSIGTIFAEMATK 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 40/286 (13%)

Query: 122 QGRFGAVWKAKF------KNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIG 173
           +G FG V   ++        E VAVK    +   +  ++  +EI  L ++ H+NI++Y G
Sbjct: 14  EGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG 73

Query: 174 --AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEI 229
              E  G  I     LI  +   GSL ++L  N   +  +Q  + A+ + KG+ +L    
Sbjct: 74  ICTEDGGNGIK----LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR- 128

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY- 288
                        HRD  + NVL++S+    I DFGL    E  K        + +  + 
Sbjct: 129 ----------QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE L          ++  D+++  + L+EL + C S S P   + L          ++
Sbjct: 179 YAPECL-----IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKMIGPTHGQMTV 232

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS 394
             +   +   K  P  P   ++      +   M +CW+     R +
Sbjct: 233 TRLVRVLEEGKRLPRPPNCPEE------VYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 54/180 (30%), Positives = 77/180 (42%), Gaps = 40/180 (22%)

Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHT-EFWLITAYHERGSLCDFLK--------CNI 205
           +EI  +  + H +I+R +GA     +     F L   +   GS+   L           I
Sbjct: 52  KEIRLMARLNHPHIIRMLGA-----TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII 106

Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIADF 264
              EQL R       GL +LHE             + HRD K  N+L+ S      IADF
Sbjct: 107 NYTEQLLR-------GLSYLHEN-----------QIIHRDVKGANLLIDSTGQRLRIADF 148

Query: 265 GLAL-LFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           G A  L   G   G+  GQ +GT  +MAPEVL G   + R      D+++   V+ E+A+
Sbjct: 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSC----DVWSVGCVIIEMAT 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 53/188 (28%), Positives = 75/188 (39%), Gaps = 48/188 (25%)

Query: 165 HDNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALS 217
              I++Y GA  ++   SI     +   Y E GSL    K        +  + L +IA S
Sbjct: 58  SPYIVKYYGAFLDESSSSIG----IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES 113

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG--------LALL 269
           + KGL +LH              + HRD K +N+LL       + DFG        LA  
Sbjct: 114 VLKGLSYLHSR-----------KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162

Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
           F             GT  YMAPE ++G   +S    +  D+++  L L E+A       P
Sbjct: 163 F------------TGTSFYMAPERIQGK-PYS----ITSDVWSLGLTLLEVAQNRFPF-P 204

Query: 330 PPGEYRLP 337
           P GE  L 
Sbjct: 205 PEGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 59/258 (22%), Positives = 95/258 (36%), Gaps = 59/258 (22%)

Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK----------C 203
            +E+  L  +   NI R +G       +     +I  Y E G L  FL+          C
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPL----CMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 204 NI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           N   +++  L  +A  ++ G+ +L                 HRD  + N L+  + T  I
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNF-----------VHRDLATRNCLVGKNYTIKI 171

Query: 262 ADFGLAL-LFEPGKPCGDTHGQVGTR-----RYMAPE-VLEGAINFSRDAFLRIDMYACA 314
           ADFG++  L+       D + +V  R     R+MA E VL G      D       +A  
Sbjct: 172 ADFGMSRNLYS-----SDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDV------WAFG 219

Query: 315 LVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGM 374
           + LWE+ + C            P+   + D   +E+          +  LP   +     
Sbjct: 220 VTLWEILTLCR---------EQPYE-HLTDQQVIENAGHFFRDDGRQIYLP---RPPNCP 266

Query: 375 LALCDTMEECWDHDAEAR 392
             + + M ECW  D E R
Sbjct: 267 KDIYELMLECWRRDEEDR 284

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 64/307 (20%), Positives = 121/307 (39%), Gaps = 75/307 (24%)

Query: 122 QGRFGAVWKAKFKN-------ENVAVKIFL----MQDKQSWQSEQEIFKLPHMEHDNILR 170
           QG FG V++   K          VA+K       M+++  + +E  + K  +  H  ++R
Sbjct: 16  QGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH--VVR 73

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLK--------CN---IVTWEQLCRIALSMS 219
            +G    G+   T   ++     +G L  +L+               T ++  ++A  ++
Sbjct: 74  LLGVVSTGQ--PT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGD 278
            G+ +L  +              HRD  + N ++  DLT  I DFG+   ++E      D
Sbjct: 130 DGMAYLAAK-----------KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET-----D 173

Query: 279 THGQVGTR----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
            + + G      R+MAPE L+  +  ++      D+++  +VLWE+A+      P  G  
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKS-----DVWSFGVVLWEMATLAE--QPYQGL- 225

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS 394
                       S E++ + V+       LPE          L + M  CW ++ + R +
Sbjct: 226 ------------SNEEVLKFVIDGGHLD-LPENCPDK-----LLELMRMCWQYNPKMRPT 267

Query: 395 ASCVVER 401
              +V  
Sbjct: 268 FLEIVSS 274

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 15/93 (16%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL HLH+             + +RD K  NVLL +D    I+D GLA+  + G+    T 
Sbjct: 109 GLEHLHQR-----------RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155

Query: 281 GQVGTRRYMAPEVLEG-AINFSRDAF-LRIDMY 311
           G  GT  +MAPE+L+G   +FS D F L + +Y
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLY 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 52/231 (22%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSEQ--------EIF---KLP 161
           + +    +G +G V+KA+  N    VA+K   +       SE+        EI    +L 
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPL-----SEEGIPLSTLREIALLKQLE 56

Query: 162 HMEHDNI--LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KC--NIVTWEQLCRIAL 216
             EH NI  L  +    R +    +  L+  + ++  L  +L KC    +  E +  +  
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRE-LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114

Query: 217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE---PG 273
            + +G+  LH              + HRD K  N+L+ SD    IADFGLA ++      
Sbjct: 115 QLLRGVDFLHSH-----------RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL 163

Query: 274 KPCGDTHGQVGTRRYMAPEVLEGA-INFSRDAFLRIDMYACALVLWELASR 323
                    V T  Y APEVL  +           +DM++   +  EL  R
Sbjct: 164 TSV------VVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFRR 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 60/294 (20%), Positives = 119/294 (40%), Gaps = 61/294 (20%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           + LV+    G+FG VW   +  +  VA+K      ++   SE++  +    +  + H  +
Sbjct: 6   LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKL 61

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           ++  G       I     L+  + E G L D+L+      + E L  + L + +G+ +L 
Sbjct: 62  VQLYGVCTERSPI----CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                         V HRD  + N L+  +    ++DFG+   F        + G     
Sbjct: 118 SS-----------NVIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPV 165

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF----SAEV 342
           ++ +PEV     +FS+ +  + D+++  +++WE+ S          E + P+    ++EV
Sbjct: 166 KWSSPEV----FSFSKYS-SKSDVWSFGVLMWEVFS----------EGKTPYENRSNSEV 210

Query: 343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                +E +      +  +P L           ++ + M+ CW    E R S S
Sbjct: 211 -----VETINAG--FRLYKPRLASQ--------SVYELMQHCWKERPEDRPSFS 249

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 33/220 (15%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN------VAVKIF--LMQDKQSWQSEQEIFKLPHMEH 165
           ++ V+V   G FG V+K  +  E       VA+KI       K + +   E   +  M+H
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGL 222
            +++R +G       +     L+T     G L D++   K NI + + L    + ++KG+
Sbjct: 69  PHLVRLLGV-----CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGS-QLLLNWCVQIAKGM 122

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
           M+L E  L            HRD  + NVL+KS     I DFGLA L E  +   +  G 
Sbjct: 123 MYLEERRL-----------VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               ++MA E +       R    + D+++  + +WEL +
Sbjct: 172 KMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 8/86 (9%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAI 298
           V HRD K +N+L+  D    I DFG+A  L   P +        V TR Y APE+L    
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL---- 183

Query: 299 NFSRDAFLR-IDMYACALVLWELASR 323
             S   +   IDM++   +  E+  R
Sbjct: 184 -LSLPEYTTAIDMWSVGCIFAEMLGR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 36/220 (16%)

Query: 116 LVEVK-AQGRFGAVWKAK--FKNENVAVK---IFLMQDKQSWQS-EQEIFKLPHMEHDNI 168
            +E K  +G+F  V++A      + VA+K   IF M D ++ Q   +EI  L  + H N+
Sbjct: 5   QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLM 223
           ++Y+ +      ++    L  A    G L   +K       ++    + +  + +   + 
Sbjct: 65  IKYLDSFIEDNELNIVLELADA----GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           H+H              V HRD K  NV + +     + D GL   F         H  V
Sbjct: 121 HMHSR-----------RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLV 167

Query: 284 GTRRYMAPE-VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           GT  YM+PE + E   NF      + D+++   +L+E+A+
Sbjct: 168 GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 34/181 (18%)

Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWE 209
           Q E EI  L  + H+NIL      K  E + +E   ++IT  ++   L  F+      W+
Sbjct: 209 QLENEILALGRLNHENIL------KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWK 261

Query: 210 ------QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
                 Q   I   +   + ++H++ L            HRD K  N+ L  D    + D
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKL-----------IHRDIKLENIFLNCDGKIVLGD 310

Query: 264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRI-DMYACALVLWELAS 322
           FG A+ FE  +   D +G VGT    +PE+L      + D +  I D+++C L+L ++ S
Sbjct: 311 FGTAMPFEKEREAFD-YGWVGTVATNSPEIL------AGDGYCEITDIWSCGLILLDMLS 363

Query: 323 R 323
            
Sbjct: 364 H 364

Length = 501

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 32/220 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILR 170
           Q +    +G +G V  A  K     VA+K     + Q++  ++ +EI  L   +H+NI+ 
Sbjct: 8   QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIG 67

Query: 171 YIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
            I    R  S  +  + +++    E   L   +K   ++ + +      + +GL ++H  
Sbjct: 68  -ILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH-- 123

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-----V 283
                A+     V HRD K +N+LL ++    I DFGLA + +P       H       V
Sbjct: 124 ----SAN-----VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD----HTGFLTEYV 170

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            TR Y APE++  +  +++     ID+++   +L E+ S 
Sbjct: 171 ATRWYRAPEIMLNSKGYTKA----IDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 68/299 (22%), Positives = 127/299 (42%), Gaps = 49/299 (16%)

Query: 123 GRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDNILRYIG 173
           G +G+V  A  K   E VA+K       + +QSE       +E+  L HM+H+N++  + 
Sbjct: 26  GAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 174 AEKRGESIHT--EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEI 229
                 S     +F+L+  Y +     D  K   + ++ +++  +   M  GL ++H   
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + HRD K  N+ +  D    I DFGLA   +      +  G V TR Y 
Sbjct: 135 --------SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYR 181

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APEV+   +++++     +D+++   ++ E+ +  +         +L    +V   P  E
Sbjct: 182 APEVILNWMHYNQT----VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237

Query: 350 DMQ--EAVVHKKLRPTLPETWKQHAGML------ALCDTMEECWDHDAEARLSASCVVE 400
            +Q  E    K    +LP+  ++    L         D +E+  + D + RL+A+  +E
Sbjct: 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 55/294 (18%)

Query: 121 AQGRFGAVWKAK--FKNENVAVK-IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A      + VA+K I L +  +      EI  +  +++ NI+ ++ +   
Sbjct: 28  GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV 87

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E +++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 88  GD----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN--------- 134

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+NVLL  D +  + DFG      P +    T   VGT  +MAPEV+   
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV--- 187

Query: 298 INFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA----EVGDHPSLEDMQ 352
              +R A+  ++D+++  ++  E+         PP     P  A         P L++ +
Sbjct: 188 ---TRKAYGPKVDIWSLGIMAIEMVE-----GEPPYLNENPLRALYLIATNGTPELQNPE 239

Query: 353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL 406
                 KL P                D +  C + D E R SA  +++   L L
Sbjct: 240 ------KLSPIFR-------------DFLNRCLEMDVEKRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 6/85 (7%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH--GQVGTRRYMAPEVLEGAI 298
           V HRD K  N+L+ +D    I DFGLA  F              V TR Y APE++    
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185

Query: 299 NFSRDAFLRIDMYACALVLWELASR 323
           ++++     ID+++   +L EL  R
Sbjct: 186 SYTKA----IDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 42/168 (25%), Positives = 79/168 (47%), Gaps = 23/168 (13%)

Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLC 212
           +E+  L HM+H+N++  +       SI    E +L+T       L + +KC  ++ E + 
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQ 121

Query: 213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP 272
            +   + +GL ++H              + HRD K +NV +  D    I DFGLA   + 
Sbjct: 122 FLIYQLLRGLKYIHS-----------AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170

Query: 273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
                +  G V TR Y APE++   +++++     +D+++   ++ EL
Sbjct: 171 -----EMTGYVATRWYRAPEIMLNWMHYNQT----VDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 57/228 (25%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQ-------EIFKLPHMEH 165
           +++ V  +G +G V K + K   E VA+K F    K S ++E+       E+  L  ++ 
Sbjct: 4   EVLGVVGEGAYGVVLKCRHKETKEIVAIKKF----KDSEENEEVKETTLRELKMLRTLKQ 59

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           +NI+    A +R      + +L+  Y E+                      +M + L  +
Sbjct: 60  ENIVELKEAFRR----RGKLYLVFEYVEK----------------------NMLELLEEM 93

Query: 226 HEEILPNKADSY------------KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
              + P K  SY            K  + HRD K  N+L+  +    + DFG A     G
Sbjct: 94  PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153

Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
                T   V TR Y +PE+L GA  + +     +DM++   +L EL+
Sbjct: 154 SNANYTE-YVATRWYRSPELLLGA-PYGKA----VDMWSVGCILGELS 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 27/178 (15%)

Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH 182
           GR  AV +  F  ++   K      K+    E EI  L +++H+ I++Y G  +  E++ 
Sbjct: 27  GRELAVKQVPFDPDSPETK------KEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80

Query: 183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAV 241
               +   Y   GS+ D LK      E + R     + +G+ +LH  +           +
Sbjct: 81  ----IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM-----------I 125

Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPEVLEG 296
            HRD K  N+L  S     + DFG +   +    C    G     GT  +M+PEV+ G
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQ--TICSSGTGMKSVTGTPYWMSPEVISG 181

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 65/297 (21%)

Query: 118 EVKAQGRFGAVWKA-KFKNENVAVKIF-------LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           EV  +G +G V+     + + +AVK         L  +K+  + ++E+  L  ++H NI+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 170 RYIGA--EKRGESIHTEF----WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM 223
           +Y+G   +    SI  EF     + +  +  G L + +          C+    +  G+ 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV---------FCKYTKQILDGVA 116

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           +LH              V HRD K NNV+L  +    + DFG A         G TH  +
Sbjct: 117 YLHNN-----------CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNM 164

Query: 284 -----GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
                GT  +MAPEV+  +  + R +    D+++    ++E+A+       PP       
Sbjct: 165 LKSMHGTPYWMAPEVINES-GYGRKS----DIWSIGCTVFEMAT-----GKPP------- 207

Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
              +     L  M     H+ L P LP+++   A      D +  C   D   R SA
Sbjct: 208 ---LASMDRLAAMFYIGAHRGLMPRLPDSFSAAA-----IDFVTSCLTRDQHERPSA 256

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 20/132 (15%)

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLE 295
           ++  + +RD K  N+LL S+    + DFGL+  F   +   +  +   GT  YMAPEV+ 
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIR 179

Query: 296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV 355
           G       A   +D ++  ++ +EL +  S           PF+ + G+  S  ++   +
Sbjct: 180 GGSGGHDKA---VDWWSLGVLTFELLTGAS-----------PFTVD-GEQNSQSEISRRI 224

Query: 356 VHKKLRPTLPET 367
           +  K  P  P+T
Sbjct: 225 LKSK--PPFPKT 234

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 58/285 (20%), Positives = 115/285 (40%), Gaps = 69/285 (24%)

Query: 123 GRFGAVWKAKFKNE-NVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGAEKR 177
           G+FG V   K++ + +VA+K+     ++   SE +  +    +  + H N+++  G   +
Sbjct: 15  GQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
                   +++T Y   G L ++L+     +  E L  +   + + + +L          
Sbjct: 71  ----QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN------- 119

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAP 291
                  HRD  + N L+  D    ++DFGLA          D +    GT+   ++  P
Sbjct: 120 ----GFIHRDLAARNCLVGEDNVVKVSDFGLARYV-----LDDQYTSSQGTKFPVKWAPP 170

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF----SAEVGDHPS 347
           EV     ++SR +  + D+++  +++WE+ S          E ++P+    ++EV     
Sbjct: 171 EVF----DYSRFSS-KSDVWSFGVLMWEVFS----------EGKMPYERFSNSEV----- 210

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           +E +      +  RP L  T         +   M  CW    E R
Sbjct: 211 VESVSAGY--RLYRPKLAPT--------EVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 37/222 (16%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNE-----NVAVKIFLMQDKQSWQSE--QEIFKLPHMEHD 166
           I L     +G+FG V++  + +       VAVK        S + +  QE + +   +H 
Sbjct: 8   ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHP 67

Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGL 222
           +I++ IG       + TE   W++      G L  +L+ N   +    L   +  +S  L
Sbjct: 68  HIVKLIG-------VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +L  +              HRD  + NVL+ S     + DFGL+   E       + G+
Sbjct: 121 AYLESK-----------RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK 169

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRI-DMYACALVLWELASR 323
           +   ++MAPE    +INF R  F    D++   + +WE+   
Sbjct: 170 LPI-KWMAPE----SINFRR--FTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 59/256 (23%), Positives = 107/256 (41%), Gaps = 46/256 (17%)

Query: 122 QGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKR 177
            G  G+V K K        A K+  +  K S + +  +E+  +       I+ + GA   
Sbjct: 15  AGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74

Query: 178 GESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             +I     +   + + GSL    K    +  E L +IA+++ +GL +L+          
Sbjct: 75  ENNIC----MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY---------- 120

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
               + HRD K +N+L+ S     + DFG++   E      DT   VGT  YM+PE ++G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTF--VGTSTYMSPERIQG 176

Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD-----HP-SLED 350
              ++    ++ D+++  + + ELA             + PF+    D      P  + D
Sbjct: 177 G-KYT----VKSDVWSLGISIIELALG-----------KFPFAFSNIDDDGQDDPMGILD 220

Query: 351 MQEAVVHKKLRPTLPE 366
           + + +V +   P LP 
Sbjct: 221 LLQQIVQEP-PPRLPS 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 43/169 (25%), Positives = 84/169 (49%), Gaps = 25/169 (14%)

Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTWEQL 211
           +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T + +
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTDDHV 122

Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
             +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA   +
Sbjct: 123 QFLIYQILRGLKYIHS------AD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171

Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
                 +  G V TR Y APE++   +++++     +D+++   ++ EL
Sbjct: 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQT----VDIWSVGCIMAEL 211

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 50/287 (17%)

Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILRYIGAEKRGE 179
           G FG V+KA+ K   V     ++  K   + E    EI  L   +H NI++ + A     
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF---- 71

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
                 W++  +   G++ D +   +   +T  Q+  +     + L +LHE    NK   
Sbjct: 72  YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHE----NK--- 123

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
               + HRD K+ N+L   D    +ADFG++   +  +        +GT  +MAPEV+  
Sbjct: 124 ----IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV- 355
             +  R    + D+++  + L E+A     + PP              H  L  M+  + 
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMA----QIEPP--------------HHELNPMRVLLK 219

Query: 356 VHKKLRPTL--PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
           + K   PTL  P  W          D +++C + + +AR + + +++
Sbjct: 220 IAKSEPPTLAQPSRWSSE-----FKDFLKKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 27/195 (13%)

Query: 138 VAVKIFLMQDKQSWQSE-QEIFKLPHMEHDNILRYI-----GAEKRGESIHTEFWLITAY 191
           VAVK  ++ D QS +   +EI  +  ++HDNI++             E + +   L + Y
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 192 ----HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK 247
               +    L + L+   ++ E        + +GL ++H              V HRD K
Sbjct: 93  IVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS-----------ANVLHRDLK 141

Query: 248 SNNVLLKS-DLTAAIADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAF 305
             NV + + DL   I DFGLA + +P     G     + T+ Y +P +L    N+++   
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK--- 198

Query: 306 LRIDMYACALVLWEL 320
             IDM+A   +  E+
Sbjct: 199 -AIDMWAAGCIFAEM 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 52/283 (18%)

Query: 117 VEVK-AQGRFGAVWKAKFK-NENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           ++VK  QG FG VW   +     VA+K         +++  E +I K   + HD ++  +
Sbjct: 10  LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMK--KLRHDKLVP-L 66

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEEI 229
            A    E I    +++T +  +GSL DFLK      +   QL  +A  ++ G+ ++    
Sbjct: 67  YAVVSEEPI----YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--- 119

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   +    HRD ++ N+L+  +L   IADFGLA L E  +      G     ++ 
Sbjct: 120 --------RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWT 170

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APE    A  + R   ++ D+++  ++L EL ++           R+P+   V +   LE
Sbjct: 171 APE----AALYGRFT-IKSDVWSFGILLTELVTKG----------RVPYPGMV-NREVLE 214

Query: 350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                 V +  R   P+   +     +L + M+ CW  D + R
Sbjct: 215 Q-----VERGYRMPCPQGCPE-----SLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 38/142 (26%)

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L +I++++ +GL +L E+            + HRD K +N+L+ S     + DFG++   
Sbjct: 101 LGKISIAVLRGLTYLREKH----------KIMHRDVKPSNILVNSRGEIKLCDFGVS--- 147

Query: 271 EPGKPCGDTHGQ---------VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
                     GQ         VGTR YM+PE L+G    +       D+++  L L E+A
Sbjct: 148 ----------GQLIDSMANSFVGTRSYMSPERLQG----THYTVQS-DIWSLGLSLVEMA 192

Query: 322 SRCSSVSPP-PGEYRLPFSAEV 342
                + PP   E    F   V
Sbjct: 193 IGRYPIPPPDAKELEAMFGRPV 214

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 66/259 (25%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNE--------NVAVKIFLMQDKQSWQSE-----QEIFK 159
           ++ L +   +G FG V KA              VAVK   M  + +  SE      E   
Sbjct: 1   NLVLGKTLGEGEFGKVVKA-TAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNL 56

Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--------------- 204
           L  + H ++++  GA  +   +     LI  Y + GSL  FL+ +               
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 205 ----------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK 254
                      +T   L   A  +S+G+ +L E  L            HRD  + NVL+ 
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL-----------VHRDLAARNVLVA 161

Query: 255 SDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
                 I+DFGL+  ++E       + G++   ++MA E L   I  ++      D+++ 
Sbjct: 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV-KWMAIESLFDHIYTTQS-----DVWSF 215

Query: 314 ALVLWELASRCSSVSPPPG 332
            ++LWE+ +     +P PG
Sbjct: 216 GVLLWEIVTL--GGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 32/207 (15%)

Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDNILRYIGAE 175
           G +G V  A   +     K+ + +  + +QSE       +E+  L HM+H+N++  +   
Sbjct: 26  GAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83

Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
               S+    +F+L+  +     L   +K   ++ +++  +   M KGL ++H       
Sbjct: 84  TPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH------- 135

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  + HRD K  N+ +  D    I DFGLA   +      +  G V TR Y APEV
Sbjct: 136 ----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVTRWYRAPEV 186

Query: 294 LEGAINFSRDAFLRIDMYACALVLWEL 320
           +   +++++     +D+++   ++ E+
Sbjct: 187 ILNWMHYTQT----VDIWSVGCIMAEM 209

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 24/210 (11%)

Query: 117 VEVKAQGRFGAVWKAKFK-NEN-VAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYI 172
           +E   +G +  V+K + K  EN VA+K   ++ ++     + +E+  L  ++H NI+   
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL- 69

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
                 + +HT+  L   +       ++L  ++  +   C   +SM    + L++ IL  
Sbjct: 70  -----HDIVHTDKSLTLVF-------EYLDKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRG 116

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
            A  ++  V HRD K  N+L+       +ADFGLA       P      +V T  Y  P+
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPD 174

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           VL G+  +S     +IDM+    + +E+AS
Sbjct: 175 VLLGSSEYST----QIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 70/291 (24%), Positives = 114/291 (39%), Gaps = 65/291 (22%)

Query: 123 GRFGAVWKAKFKNEN---VAVK-IFLM-----QDKQSWQ-------SEQEIFKLPHMEHD 166
           G FG V+K + KN     +A+K I +      +DK+          SE  I K   + H 
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK-EQLRHP 69

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-----KCNIVTWEQLCRIALSMSKG 221
           NI+RY       + ++    LI    E   L +       K    T E++  I + M   
Sbjct: 70  NIVRYYKTFLENDRLYIVMDLI----EGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L +LH+E            + HRD   NN++L  D    I DFGLA   +  +P      
Sbjct: 126 LRYLHKE----------KRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTS 172

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
            VGT  Y  PE+++    +   A    D++A   +L+++     ++ PP       +S  
Sbjct: 173 VVGTILYSCPEIVKN-EPYGEKA----DVWAFGCILYQMC----TLQPP------FYST- 216

Query: 342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                ++  +   +V     P     + +      + D +  C   DAEAR
Sbjct: 217 -----NMLSLATKIVEAVYEPLPEGMYSED-----VTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 68/267 (25%), Positives = 112/267 (41%), Gaps = 58/267 (21%)

Query: 138 VAVKIFL----MQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYH 192
           VAVK+        ++++  SE +I  + H+  H+NI+  +GA   G  I     +IT Y 
Sbjct: 68  VAVKMLKPTAHSSEREALMSELKI--MSHLGNHENIVNLLGACTIGGPI----LVITEYC 121

Query: 193 ERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN 249
             G L +FL+      +T E L   +  ++KG+       L +K         HRD  + 
Sbjct: 122 CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM-----AFLASKN------CIHRDLAAR 170

Query: 250 NVLLKSDLTAAIADFGLA--LLFEPGKPC-GDTHGQVGTRRYMAPE-VLEGAINFSRDAF 305
           NVLL       I DFGLA  ++ +      G+    V   ++MAPE +      F     
Sbjct: 171 NVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES--- 224

Query: 306 LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLP 365
              D+++  ++LWE+ S     +P PG   +P  ++               +K ++    
Sbjct: 225 ---DVWSYGILLWEIFSL--GSNPYPG---MPVDSK--------------FYKLIKEGYR 262

Query: 366 ETWKQHAGMLALCDTMEECWDHDAEAR 392
               +HA    + D M+ CWD D   R
Sbjct: 263 MAQPEHAPA-EIYDIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 42/244 (17%)

Query: 121 AQGRFGAVWKAKFKNENVAV-----KIF-LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+F  V++A    + V V     +IF LM  K      +EI  L  + H N+++Y  +
Sbjct: 11  GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEI 229
                    E  ++    + G L   +K       ++  + + +  + +   L H+H   
Sbjct: 71  FIE----DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR- 125

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      V HRD K  NV + +     + D GL   F         H  VGT  YM
Sbjct: 126 ----------RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYM 173

Query: 290 APE-VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE----YRLPFSAEVGD 344
           +PE + E   NF      + D+++   +L+E+A+     SP  G+    Y L    E  D
Sbjct: 174 SPERIHENGYNF------KSDIWSLGCLLYEMAAL---QSPFYGDKMNLYSLCKKIEQCD 224

Query: 345 HPSL 348
           +P L
Sbjct: 225 YPPL 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 48/222 (21%), Positives = 98/222 (44%), Gaps = 40/222 (18%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIFLMQDKQSWQSEQEIFK----LPHMEHD 166
           + +  ++    G+FG V   K++ + +VA+K+     K+   SE E  +    +  + H+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMKLSHE 59

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMH 224
            +++  G   +   I    +++T Y   G L ++L+ +       QL  +   + +G+ +
Sbjct: 60  KLVQLYGVCTKQRPI----YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQV 283
           L  +              HRD  + N L+       ++DFGL+          D +   V
Sbjct: 116 LESK-----------QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-----LDDEYTSSV 159

Query: 284 GTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           G++   R+  PEVL  +  FS  +    D++A  +++WE+ S
Sbjct: 160 GSKFPVRWSPPEVLLYS-KFSSKS----DVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKR 177
            +G +G V+KAK K+     +  L Q +    S  + +EI  L  ++H N++    A ++
Sbjct: 10  GRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI----ALQK 65

Query: 178 GESIHTE--FWLITAY--HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
               H++   WL+  Y  H+   +  F + +    + + ++  SM K L++   +IL   
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPM-QLPRSMVKSLLY---QILDGI 121

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLT----AAIADFGLALLF-EPGKPCGDTHGQVGTRRY 288
              +   V HRD K  N+L+  +        IAD G A LF  P KP  D    V T  Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            APE+L GA ++++     ID++A   +  EL
Sbjct: 182 RAPELLLGARHYTK----AIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 23/160 (14%)

Query: 195 GSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL 253
           GSL   LK      EQ L ++++++ KGL +L E          K  + HRD K +N+L+
Sbjct: 88  GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIMHRDVKPSNILV 137

Query: 254 KSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYA 312
            S     + DFG++     G+         VGTR YM+PE L+G  ++S    ++ D+++
Sbjct: 138 NSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS----VQSDIWS 187

Query: 313 CALVLWELASRCSSVSPPPG-EYRLPFSAEVGDHPSLEDM 351
             L L E+A     + PP   E  L F   V   P+  + 
Sbjct: 188 MGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 39/211 (18%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94

Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA------LLFEPGKPCGDTHGQVGTRRYM 289
                + HRD K +N+++KSD T  I DFGLA       +  P          V TR Y 
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---------YVVTRYYR 192

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           APEV+ G + +  +    +D+++   ++ E+
Sbjct: 193 APEVILG-MGYKEN----VDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 29/76 (38%), Positives = 36/76 (47%), Gaps = 16/76 (21%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT- 279
           GL  LH E              +RD K  N+LL       I+D GLA+      P G++ 
Sbjct: 114 GLEDLHRE-----------NTVYRDLKPENILLDDYGHIRISDLGLAVKI----PEGESI 158

Query: 280 HGQVGTRRYMAPEVLE 295
            G+VGT  YMAPEVL 
Sbjct: 159 RGRVGTVGYMAPEVLN 174

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 122 QGRFGAVWKAKFK-NEN-VAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYIGAEKR 177
           +G +  V+K + K  EN VA+K   ++ ++     + +E+  L +++H NI+        
Sbjct: 15  EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL------ 68

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
            + IHTE  L   +       ++L  ++  +   C   +SM    + + + +L   +  +
Sbjct: 69  HDIIHTERCLTLVF-------EYLDSDLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCH 120

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
           K  + HRD K  N+L+       +ADFGLA       P      +V T  Y  P+VL G+
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 298 INFSRDAFLRIDMYACALVLWELAS 322
             +S      IDM+    +L+E+A+
Sbjct: 179 TEYSTP----IDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 61/261 (23%), Positives = 102/261 (39%), Gaps = 37/261 (14%)

Query: 38  PAPLPPPINSTTPIKTESHP-LIIFLYTMLPIFALIIPIFLCYWYYRQRKLGSYFNPVPT 96
             PLP     TT  +    P L + L    P  A+ +P+             S  +   +
Sbjct: 9   GVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPL----------PPPSSSSSSSS 58

Query: 97  LEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN--VAVKIFL--MQDKQSWQ 152
                 S PS  +    ++ V     G  G V+K   +      A+K+     +D    Q
Sbjct: 59  SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118

Query: 153 SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC 212
             +EI  L  + H N+++          I     ++  + + GSL      +I   + L 
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQ----VLLEFMDGGSL---EGTHIADEQFLA 171

Query: 213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFE 271
            +A  +  G+ +LH           +  + HRD K +N+L+ S     IADFG++ +L +
Sbjct: 172 DVARQILSGIAYLH-----------RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220

Query: 272 PGKPCGDTHGQVGTRRYMAPE 292
              PC  +   VGT  YM+PE
Sbjct: 221 TMDPCNSS---VGTIAYMSPE 238

Length = 353

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 29/82 (35%), Positives = 37/82 (45%), Gaps = 26/82 (31%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA------LLFEPGK 274
           G+ HLH              + HRD K +N+++KSD T  I DFGLA       +  P  
Sbjct: 130 GIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-- 176

Query: 275 PCGDTHGQVGTRRYMAPEVLEG 296
                   V TR Y APEV+ G
Sbjct: 177 -------YVVTRYYRAPEVILG 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 22/138 (15%)

Query: 195 GSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL 253
           GSL   LK    +  E L ++++++ +GL +L E          K  + HRD K +N+L+
Sbjct: 88  GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE----------KHQIMHRDVKPSNILV 137

Query: 254 KSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYA 312
            S     + DFG++     G+         VGTR YM+PE L+G  ++S    ++ D+++
Sbjct: 138 NSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS----VQSDIWS 187

Query: 313 CALVLWELASRCSSVSPP 330
             L L ELA     + PP
Sbjct: 188 MGLSLVELAIGRYPIPPP 205

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 48/216 (22%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 116 LVEVKAQGRFGAVWKAKFKNE--NVAVKIFLMQDKQSWQ---SEQEIFKLPHMEHDNILR 170
            V V  +G +G V   + + +     +K   +++    +   +EQE   L  ++H NI+ 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHE 227
           Y  + +  + +    +++  + E G L   LK     ++   Q+    + ++  L +LHE
Sbjct: 64  YRESWEGEDGL---LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           +            + HRD K+ NV L       + D G+A + E    C      +GT  
Sbjct: 121 K-----------HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPY 167

Query: 288 YMAPEVLEGAINFSRDAF-LRIDMYACALVLWELAS 322
           YM+PE+      FS   +  + D++A    ++E+A+
Sbjct: 168 YMSPEL------FSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 14/77 (18%)

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           ++ G++HLH              + +RD K  NVLL       ++D GLA+  + GK   
Sbjct: 104 ITCGILHLHSM-----------DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-- 150

Query: 278 DTHGQVGTRRYMAPEVL 294
               + GT  YMAPE+L
Sbjct: 151 -ITQRAGTNGYMAPEIL 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 33/171 (19%)

Query: 137 NVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAY 191
           NVAVK           + ++ +E+  L  + H NI+  +      +S+    + +L+   
Sbjct: 48  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
            +  +LC  +   +   E++  +   M  G+ HLH              + HRD K +N+
Sbjct: 108 MD-ANLCQVIHMEL-DHERMSYLLYQMLCGIKHLHS-----------AGIIHRDLKPSNI 154

Query: 252 LLKSDLTAAIADFGLA------LLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++KSD T  I DFGLA       +  P          V TR Y APEV+ G
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTP---------YVVTRYYRAPEVILG 196

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 46/221 (20%)

Query: 134 KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT 189
           K   VAVK+       +D     SE E+ K+   +H NI+  +GA  +   +    +++ 
Sbjct: 43  KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPL----YVLV 97

Query: 190 AYHERGSLCDFLK-------------CNI----VTWEQLCRIALSMSKGLMHLHEEILPN 232
            Y  +G+L ++L+             C +    +T++ L   A  +++G+ +L  +    
Sbjct: 98  EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---- 153

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRYMAP 291
                     HRD  + NVL+  D    IADFGLA  +         T+G++   ++MAP
Sbjct: 154 -------KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV-KWMAP 205

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           E L     F R    + D+++  ++LWE+ +     SP PG
Sbjct: 206 EAL-----FDRVYTHQSDVWSFGVLLWEIFT--LGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 24/214 (11%)

Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 15  GQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 72

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E     A    K ++ +  EI
Sbjct: 73  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 187

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  + F+  +    D+++  +VLWE+A+
Sbjct: 188 MSPESLKDGV-FTTYS----DVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 27/74 (36%), Positives = 35/74 (47%), Gaps = 14/74 (18%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL  LH E            + +RD K  N+LL       I+D GLA+    G+      
Sbjct: 114 GLEDLHRE-----------RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IR 159

Query: 281 GQVGTRRYMAPEVL 294
           G+VGT  YMAPEV+
Sbjct: 160 GRVGTVGYMAPEVV 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 25/177 (14%)

Query: 123 GRFGAVWKAK--FKNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           G FG V  A+     +NVA+K  +        + ++ +E+  L H+ H+NI   I     
Sbjct: 21  GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI---ISLSDI 77

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
             S   + + +T       L   L    +  + +      + +GL ++H           
Sbjct: 78  FISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS---------- 126

Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD K +N+L+  +    I DFGLA + +P        G V TR Y APE++
Sbjct: 127 -AGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIM 177

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 33/115 (28%), Positives = 49/115 (42%), Gaps = 25/115 (21%)

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLAL 268
           QL        KG+ H H           K  V HRD K  N+L+ K      IAD GL  
Sbjct: 118 QLL-------KGVAHCH-----------KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            F    P      ++ T  Y APEVL G+ ++S      +D+++   +  E++ +
Sbjct: 160 AFS--IPVKSYTHEIVTLWYRAPEVLLGSTHYSTP----VDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 28/184 (15%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 29  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87

Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 88  QKSLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 137

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 188

Query: 293 VLEG 296
           V+ G
Sbjct: 189 VILG 192

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 49/194 (25%), Positives = 73/194 (37%), Gaps = 49/194 (25%)

Query: 122 QGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE----------QEIFKLPHMEHDNIL 169
           +G +G V+K + +     VA+K F+       +SE          +EI  L  ++H N++
Sbjct: 11  EGSYGVVFKCRNRETGQIVAIKKFV-------ESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 170 RYIGAEKRGESIHTEFWLI--TAYHE-----RGSLCDFLKCNIVTWEQLCRIALSMSKGL 222
             I   +R   +H  F     T  +E     RG          + W+ L  +        
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFC----- 116

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            H H  I             HRD K  N+L+       + DFG A +     P  D    
Sbjct: 117 -HKHNCI-------------HRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDY 160

Query: 283 VGTRRYMAPEVLEG 296
           V TR Y APE+L G
Sbjct: 161 VATRWYRAPELLVG 174

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 20/147 (13%)

Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
            +EI  L  ++H+NI++Y+G+    +  H   +L   Y   GS+   L       E L R
Sbjct: 54  AREIALLKELQHENIVQYLGSSLDAD--HLNIFL--EYVPGGSVAALLNNYGAFEETLVR 109

Query: 214 -IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP 272
                + KGL +LH              + HRD K  N+L+ +     I+DFG++   E 
Sbjct: 110 NFVRQILKGLNYLHNR-----------GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158

Query: 273 GKPCGDTHGQ----VGTRRYMAPEVLE 295
                 T+G      G+  +MAPEV++
Sbjct: 159 NSLSTKTNGARPSLQGSVFWMAPEVVK 185

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILR----YIG 173
            +G +G V+KAK K+        L Q +    S  + +EI  L  ++H N++     ++ 
Sbjct: 10  GRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS 69

Query: 174 AEKRGESIHTEFWLITAY--HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
              R      + WL+  Y  H+   +  F + +    ++  ++   M K L++   +IL 
Sbjct: 70  HADR------KVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLY---QILD 119

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLT----AAIADFGLALLF-EPGKPCGDTHGQVGTR 286
                +   V HRD K  N+L+  +        IAD G A LF  P KP  D    V T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE+L GA ++++     ID++A   +  EL
Sbjct: 180 WYRAPELLLGARHYTK----AIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 58/240 (24%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD-----KQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N     + + V +  +++     +Q +Q E E+  + 
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV- 63

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK----------------CNI 205
            ++H +I+R+ G    G  +   F     Y   G L  FL+                   
Sbjct: 64  -LQHQHIVRFYGVCTEGRPLLMVF----EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118

Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           +T  Q+  IA  ++ G+++L                 HRD  + N L+   L   I DFG
Sbjct: 119 LTLGQMLAIASQIASGMVYLA-----------SLHFVHRDLATRNCLVGQGLVVKIGDFG 167

Query: 266 LALLFEPGKPCGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           ++            + +VG R     R+M PE +       R      D+++  +VLWE+
Sbjct: 168 MSRDIY-----STDYYRVGGRTMLPIRWMPPESI-----LYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 45/239 (18%)

Query: 154 EQEIFKLPHMEHDNILRYIGA----EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE 209
           E EI  L ++ HD I++Y G     E++  SI  E      Y   GS+ D LK      E
Sbjct: 52  ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE------YMPGGSIKDQLKAYGALTE 105

Query: 210 QLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
            + R     + +G+ +LH  +           + HRD K  N+L  S     + DFG + 
Sbjct: 106 NVTRRYTRQILQGVSYLHSNM-----------IVHRDIKGANILRDSAGNVKLGDFGASK 154

Query: 269 LFEPGKPCGDTHGQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV 327
             +     G     V GT  +M+PEV+ G   + R A    D+++ A  + E+ +     
Sbjct: 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKA----DVWSVACTVVEMLTE---- 205

Query: 328 SPPPGEYRLPFS----AEVGDHPSLED---------MQEAVVHKKLRPTLPETWKQHAG 373
            PP  EY    +    A     P L D         +++  V +K RPT     +    
Sbjct: 206 KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 32/114 (28%), Positives = 57/114 (50%), Gaps = 20/114 (17%)

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--L 268
           L +IA+S+ K L +LH ++          +V HRD K +NVL+  +    + DFG++  L
Sbjct: 105 LGKIAVSIVKALEYLHSKL----------SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154

Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELA 321
           +    K         G + YMAPE +   +N     + ++ D+++  + + ELA
Sbjct: 155 VDSVAKTI-----DAGCKPYMAPERINPELNQK--GYDVKSDVWSLGITMIELA 201

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 36/212 (16%)

Query: 123 GRFGAVWKAKFK----NENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGA 174
           G FG V K  +K     + VAVKI L  D      + E+ +    +  +++  I+R IG 
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKI-LKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64

Query: 175 EKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPN 232
                    E W L+    E G L  FL+ N  VT + +  +   +S G+ +L E     
Sbjct: 65  ------CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---- 114

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKPCGDTHGQVGTRRYMA 290
                     HRD  + NVLL +   A I+DFGL  AL  +       THG+   + Y A
Sbjct: 115 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-A 166

Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           PE +     FS  +    D+++  +++WE  S
Sbjct: 167 PECMN-YYKFSSKS----DVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 40/135 (29%), Positives = 63/135 (46%), Gaps = 20/135 (14%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           + HRD K+ NVL+       + DFG A            +G  GT    APEVL G    
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG---- 336

Query: 301 SRDAFLR-IDMYACALVLWELASRCSSV-SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHK 358
             D +   +D+++  LV++E A   +S+ S   G+ R P+ A++     L  +++A VH 
Sbjct: 337 --DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI-----LRIIRQAQVH- 388

Query: 359 KLRPTLPETWKQHAG 373
                  + + QHAG
Sbjct: 389 ------VDEFPQHAG 397

Length = 461

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 35/193 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQSWQ--------SEQEIFKLPHME 164
           Q++    QG +G V+ AK K+  E VA+K   M+    ++        +E++I  L   +
Sbjct: 4   QILTQVGQGGYGQVFLAKKKDTGEIVALKR--MKKSLLFKLNEVRHVLTERDI--LTTTK 59

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS-MSKGLM 223
            + +++ + A +  E +    +L   Y   G     L    V  E   R  ++ M + + 
Sbjct: 60  SEWLVKLLYAFQDDEYL----YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
            LHE               HRD K  N L+ +     + DFGL+            +  V
Sbjct: 116 ALHEL-----------GYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVV 159

Query: 284 GTRRYMAPEVLEG 296
           G+  YMAPEVL G
Sbjct: 160 GSPDYMAPEVLRG 172

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 121 AQGRFGAVWKAKFK-NEN-VAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYIGAEK 176
            +G +  V+K + K  +N VA+K   ++ ++     + +E+  L  ++H NI+       
Sbjct: 15  GEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL----- 69

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
             + IHTE  L   +       ++L  ++  +   C  +++M    + L + +L      
Sbjct: 70  -HDIIHTEKSLTLVF-------EYLDKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYC 120

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++  V HRD K  N+L+       +ADFGLA       P      +V T  Y  P++L G
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 297 AINFSRDAFLRIDMYACALVLWELAS 322
           + ++S     +IDM+    + +E+++
Sbjct: 179 STDYST----QIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 56/241 (23%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSEQEIFK----LPHM 163
           +++ +E   +G FG V+K +    N      +V I  +++    + +QE  +    +  +
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IV 206
           +H NI+  +G   + +     F     Y   G L +FL  N                  +
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLF----EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 207 TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL 266
                  IA+ ++ G+ +L                 HRD  + N L+   LT  I+DFGL
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSH-----------HFVHRDLAARNCLVGEGLTVKISDFGL 170

Query: 267 ALLFEPGKPCGDTHGQVGTR----RYMAPE-VLEGAINFSRDAFLRIDMYACALVLWELA 321
           +          D +          R+M PE +L G   F+ ++    D+++  +VLWE+ 
Sbjct: 171 SRDIYS----ADYYRVQSKSLLPVRWMPPEAILYG--KFTTES----DIWSFGVVLWEIF 220

Query: 322 S 322
           S
Sbjct: 221 S 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 31/214 (14%)

Query: 117 VEVKAQGRFGAV----WKAKFKNENVAVKIFLMQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V    W  + +   + V I  +++  S ++ +EI    + +  +++ ++
Sbjct: 12  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLH 226
            R +G       + +   LIT     G L D+++ +   +  + L    + ++KG+ +L 
Sbjct: 72  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E  L            HRD  + NVL+K+     I DFGLA L    +      G     
Sbjct: 127 ERRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           ++MA E +       R    + D+++  + +WEL
Sbjct: 176 KWMALESI-----LHRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 73/308 (23%), Positives = 123/308 (39%), Gaps = 50/308 (16%)

Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILRYIGAEKRGE 179
           G FG V+KAK K         +++ K   + E    EI  L    H  I++ +GA     
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF---- 78

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
               + W++  +   G++ D +   +   +T  Q+  I   M + L +LH          
Sbjct: 79  YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM-------- 129

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
               + HRD K+ NVLL  D    +ADFG++   +  K        +GT  +MAPEV+  
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV- 355
                     + D+++  + L E+A     + PP              H  L  M+  + 
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMA----QIEPP--------------HHELNPMRVLLK 226

Query: 356 VHKKLRPTL--PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEEC 413
           + K   PTL  P  W      +   D ++   D   E R SA+ ++E   ++   +    
Sbjct: 227 IAKSEPPTLSQPSKWS-----MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281

Query: 414 WDHDAEAR 421
            +  AEA+
Sbjct: 282 RELVAEAK 289

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 53/286 (18%)

Query: 122 QGRFGAVWKAKFKNENVAVKIFLMQD------KQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G FG V+  + + +N  V +   ++      K  +  E  I K     H NI+R IG  
Sbjct: 5   RGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILK--QYSHPNIVRLIGVC 62

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            + + I+    L+    + G    FL+     +  ++L ++  + + G+ +L  +     
Sbjct: 63  TQKQPIYIVMELV----QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK----- 113

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                    HRD  + N L+       I+DFG++   E G        +    ++ APE 
Sbjct: 114 ------HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE- 166

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ- 352
              A+N+ R +    D+++  ++LWE                  FS     + +L + Q 
Sbjct: 167 ---ALNYGRYSS-ESDVWSFGILLWE-----------------AFSLGAVPYANLSNQQT 205

Query: 353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV 398
              + + +R   PE        L     ME CW++D   R S S V
Sbjct: 206 REAIEQGVRLPCPELCPDAVYRL-----MERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 42/222 (18%)

Query: 122 QGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD----NILR------- 170
           +G FG V++ + K+     +I+ M+      S++EI     + H     NIL        
Sbjct: 3   KGTFGQVYQVRKKDTR---RIYAMKV----LSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 171 -YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS-MSKGLMHLHEE 228
            +I   K      ++ +L+T Y   G L   L+      E   +  ++ +   L HLH+ 
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRR 287
                       + +RD K  N+LL +    A+ DFGL+   +       T     GT  
Sbjct: 116 -----------DIVYRDLKPENILLDATGHIALCDFGLS---KANLTDNKTTNTFCGTTE 161

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
           Y+APEVL     +++     +D ++  ++++E+   C   SP
Sbjct: 162 YLAPEVLLDEKGYTK----HVDFWSLGVLVFEM---CCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 26/184 (14%)

Query: 154 EQEIFKLPHMEHDNILRYIGAEK-RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC 212
           E EI  L +++H+ I++Y G  + R E   T F     Y   GS+ D LK      E + 
Sbjct: 52  ECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF---MEYMPGGSVKDQLKAYGALTESVT 108

Query: 213 R-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
           R     + +G+ +LH  +           + HRD K  N+L  S     + DFG +   +
Sbjct: 109 RKYTRQILEGMSYLHSNM-----------IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157

Query: 272 PGKPCGDTHGQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                G     V GT  +M+PEV+ G   + R A    D+++    + E+ +      PP
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKA----DVWSLGCTVVEMLTE----KPP 208

Query: 331 PGEY 334
             EY
Sbjct: 209 WAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 44.1 bits (105), Expect = 6e-05
 Identities = 55/241 (22%), Positives = 87/241 (36%), Gaps = 65/241 (26%)

Query: 123 GRFGAVWKAKFKNENV--AVKIF-------LMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           G FG V   K K++N   A+K           Q +  +  E+EI +     H  I++   
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEE--CNHPFIVKLYR 60

Query: 174 AEKRGESIH--------TEFWLITAYHERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMH 224
             K  + I+         E W  T   +RG             E   R     +     +
Sbjct: 61  TFKDKKYIYMLMEYCLGGELW--TILRDRGLFD----------EYTARFYIACVVLAFEY 108

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           LH              + +RD K  N+LL S+    + DFG A   + G+    T    G
Sbjct: 109 LHNR-----------GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154

Query: 285 TRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           T  Y+APE++     +FS      +D ++  ++L+EL              R PF  +  
Sbjct: 155 TPEYVAPEIILNKGYDFS------VDYWSLGILLYELL--TG---------RPPFGEDDE 197

Query: 344 D 344
           D
Sbjct: 198 D 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 29/175 (16%)

Query: 153 SEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN---IVT 207
           S +E   L  M+H NI+ +       ES   +   +++  Y + G L   +K     +  
Sbjct: 45  SRKEAVLLAKMKHPNIVAF------KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98

Query: 208 WEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA 267
            + + +  + M  G+ H+HE+            V HRD KS N+ L  +    + DFG A
Sbjct: 99  EDTILQWFVQMCLGVQHIHEK-----------RVLHRDIKSKNIFLTQNGKVKLGDFGSA 147

Query: 268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            L     P       VGT  Y+ PE+ E   N   +   + D+++   +L+EL +
Sbjct: 148 RLL--TSPGAYACTYVGTPYYVPPEIWE---NMPYNN--KSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 6/60 (10%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALL------FEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           HRD K +N+L+ S+    + DFGL+ +              +    VGT  Y+APEV+ G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 14/87 (16%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VGTRRYMAPEVLEG 296
           V HRD K +N+LL ++    I DFGLA      +   +        V TR Y APE+L  
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLA------RTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 297 AINFSRDAFLRIDMYACALVLWELASR 323
              ++      ID+++   +  EL  R
Sbjct: 183 CSEYTT----AIDVWSVGCIFAELLGR 205

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 14/75 (18%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL  LH+E            + +RD K  N+LL       I+D GLA+    G+      
Sbjct: 114 GLEDLHQE-----------RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIK 159

Query: 281 GQVGTRRYMAPEVLE 295
           G+VGT  YMAPEV++
Sbjct: 160 GRVGTVGYMAPEVVK 174

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 72/265 (27%), Positives = 109/265 (41%), Gaps = 59/265 (22%)

Query: 114 IQLVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQ----SEQEIFKLPHMEHDN 167
           IQ  E+   G  G V+KA        +AVK+  +      Q    SE EI  L   +   
Sbjct: 3   IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEI--LYKCDSPY 60

Query: 168 ILRYIGA---EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
           I+ + GA   E R  SI TEF       + GSL  + K   +    L RIA+++ KGL +
Sbjct: 61  IIGFYGAFFVENR-ISICTEFM------DGGSLDVYRK---IPEHVLGRIAVAVVKGLTY 110

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKPCGDTHGQ 282
           L           +   + HRD K +N+L+ +     + DFG++  L+    K        
Sbjct: 111 L-----------WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT------Y 153

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           VGT  YMAPE + G         +  D+++  +   ELA             R P+    
Sbjct: 154 VGTNAYMAPERISG-----EQYGIHSDVWSLGISFMELALG-----------RFPYPQIQ 197

Query: 343 GDHPSLEDMQ--EAVVHKKLRPTLP 365
            +  SL  +Q  + +V +   P LP
Sbjct: 198 KNQGSLMPLQLLQCIVDED-PPVLP 221

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 40/241 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL 169
           ++++    GRFG V+  K K         A+    +++++  Q   E+  +  ++H NI+
Sbjct: 16  EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
           RYI  ++     + + +++  + + G L  +  KC  +  +      + +++ L+H    
Sbjct: 76  RYI--DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDL-----------------TAAIADFGLALLFE 271
               K       V HRD K  N+ L + +                  A I DFGL+    
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS---- 189

Query: 272 PGKPCG---DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVS 328
             K  G     H  VGT  Y +PE+L        D   + DM+A   +++EL   CS  +
Sbjct: 190 --KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD---KSDMWALGCIIYEL---CSGKT 241

Query: 329 P 329
           P
Sbjct: 242 P 242

Length = 1021

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 21/146 (14%)

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL 269
            L RI  ++ KGL  L EE            + HRD K  NVL+  +    + DFG++  
Sbjct: 103 VLRRITYAVVKGLKFLKEEH----------NIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152

Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVS 328
                    T+  +G + YMAPE ++         + ++ D+++  L + E+A       
Sbjct: 153 LV--ASLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY- 207

Query: 329 PPPGEYRLPF---SAEV-GDHPSLED 350
            PP  Y   F   SA V GD P+L  
Sbjct: 208 -PPETYANIFAQLSAIVDGDPPTLPS 232

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 30/144 (20%)

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L HLH           K  + +RD K  N+LL S+    + DFGL+  F   +    T+ 
Sbjct: 118 LEHLH-----------KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYS 165

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
             GT  YMAPE++ G     +     +D ++  ++++EL +  S           PF+ E
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGK----AVDWWSLGILIFELLTGAS-----------PFTLE 210

Query: 342 VGDHPSLEDMQEAVVHKKLRPTLP 365
            G+  +  ++   ++  K  P  P
Sbjct: 211 -GERNTQSEVSRRIL--KCDPPFP 231

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 46/220 (20%)

Query: 136 ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT 189
           E V V + +++D  + +      SE E+ K+   +H NI+  +GA  +   +    ++I 
Sbjct: 46  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPL----YVIV 100

Query: 190 AYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPN 232
            Y  +G+L ++L+                    +T++ L      +++G+ +L  +    
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---- 156

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD  + NVL+  +    IADFGLA           T       ++MAPE
Sbjct: 157 -------KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            L     F R    + D+++  +++WE+ +     SP PG
Sbjct: 210 AL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 31/113 (27%), Positives = 50/113 (44%), Gaps = 21/113 (18%)

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           +GL +LH +            + HRD K+ N+ +       I D G A  F    P    
Sbjct: 168 EGLRYLHAQ-----------RIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAP--AF 213

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPP 331
            G  GT    APEVL      +RD +  + D+++  +VL+E+ +  S++   P
Sbjct: 214 LGLAGTVETNAPEVL------ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260

Length = 357

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 27/202 (13%)

Query: 119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
           V ++G+ GA +K K     +   +  + D  S     EI  +  ++H NI++ IG  +  
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-PSSEIADMGKLQHPNIVKLIGLCRS- 754

Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK 238
                  +LI  Y E  +L + L    ++WE+  +IA+ ++K L  LH            
Sbjct: 755 ---EKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIGIAKALRFLHCRC--------S 801

Query: 239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAI 298
           PAV   +     +++         D     L  PG  C DT   + +  Y+APE  E   
Sbjct: 802 PAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISS-AYVAPETRE--- 851

Query: 299 NFSRDAFLRIDMYACALVLWEL 320
             ++D   + D+Y   L+L EL
Sbjct: 852 --TKDITEKSDIYGFGLILIEL 871

Length = 968

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 35/146 (23%), Positives = 63/146 (43%), Gaps = 29/146 (19%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L HLH           K  + +RD K  N+LL S+    + DFGL+  F   +     +
Sbjct: 117 ALEHLH-----------KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAY 164

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
              GT  YMAP+++ G       A   +D ++  ++++EL +  S           PF+ 
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKA---VDWWSMGVLMYELLTGAS-----------PFTV 210

Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPE 366
           + G+  S  ++   ++  +  P  P+
Sbjct: 211 D-GEKNSQAEISRRILKSE--PPYPQ 233

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 71/327 (21%), Positives = 115/327 (35%), Gaps = 85/327 (25%)

Query: 107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDKQSWQSEQEIFK-- 159
           P+    SI L+     G FG V++  ++        + V +  + +  S Q E +     
Sbjct: 1   PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60

Query: 160 --LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--------IVTWE 209
             +    H NI+R IG            +++      G L  FL+ N         +T +
Sbjct: 61  LIMSKFNHQNIVRLIGVSFE----RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            L   A  ++KG  +L E               HRD  + N LL        A IADFG+
Sbjct: 117 DLLFCARDVAKGCKYLEEN-----------HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165

Query: 267 ALLFEPGKPCGDTHGQVGTRR---------YMAPEV-LEGAINFSRDAFLRIDMYACALV 316
           A          D +     R+         +M PE  L+G          + D+++  ++
Sbjct: 166 A---------RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT------SKTDVWSFGVL 210

Query: 317 LWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRP--TLPETWKQHAGM 374
           LWE+ S      P PG              + E M+      +L P    P         
Sbjct: 211 LWEIFSL--GYMPYPGR------------TNQEVMEFVTGGGRLDPPKGCPG-------- 248

Query: 375 LALCDTMEECWDHDAEARLSASCVVER 401
             +   M +CW H  E R + + ++ER
Sbjct: 249 -PVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 24/190 (12%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           ++++V  +G FG V   K KN   A K+F M+    W+  +        E  ++L   G 
Sbjct: 4   EILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVL-VNGD 59

Query: 175 EKRGESIHTEF------WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
            +   ++H  F      +L+  Y+  G L   L      +E   R+   M++   +L E 
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLS----KFED--RLPEDMAR--FYLAEM 111

Query: 229 ILPNKADS-YKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTR 286
           ++    DS ++    HRD K +N+L+  +    +ADFG  L L E G     +   VGT 
Sbjct: 112 VI--AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVAVGTP 167

Query: 287 RYMAPEVLEG 296
            Y++PE+L+ 
Sbjct: 168 DYISPEILQA 177

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 18/105 (17%)

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           +S  L +LHE             + +RD K +NVLL S+    + D+G+    E  +P  
Sbjct: 105 ISLALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGD 151

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            T    GT  Y+APE+L G      D    +D +A  ++++E+ +
Sbjct: 152 TTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMA 191

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 36/212 (16%)

Query: 122 QGRFGAVW-----KAKFKNENVAVK---IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           +G FG V+     KA  +     +K   +  +   ++ Q+ QE   L  ++H  I+++  
Sbjct: 10  KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHA 69

Query: 174 AEKRGESIHTEFWLITAYHERGSL-CDFLKCN----IVTWEQLCRIALSMSKGLMHLHEE 228
           +    ++    F +IT Y E   L C   +       ++  Q+C   + +  G+ ++H+ 
Sbjct: 70  SFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K+ N+ LK++L   I DFG++ L      C       GT  Y
Sbjct: 126 -----------RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM--GSCDLATTFTGTPYY 171

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           M+PE L+     S+      D+++   +L+E+
Sbjct: 172 MSPEALKHQGYDSKS-----DIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 51/235 (21%)

Query: 154 EQEIFKLPHMEHDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE 209
           E EI  L ++ H+ I++Y G      +R  SI  E      +   GS+ D LK      E
Sbjct: 52  ECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME------HMPGGSIKDQLKSYGALTE 105

Query: 210 QLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
            + R     + +G+ +LH  +           + HRD K  N+L  S     + DFG + 
Sbjct: 106 NVTRKYTRQILEGVSYLHSNM-----------IVHRDIKGANILRDSVGNVKLGDFGASK 154

Query: 269 LFEPGKPCGDTHGQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV 327
             +     G     V GT  +M+PEV+ G   + R A    D+++    + E+ +     
Sbjct: 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKA----DIWSVGCTVVEMLTE---- 205

Query: 328 SPPPGEY----------------RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPE 366
            PP  E+                 LP    V DH   + ++   V  KLRP+  E
Sbjct: 206 KPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDH-CRDFLKRIFVEAKLRPSADE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 47/219 (21%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query: 121 AQGRFGAVWKAKFKN-----ENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEHDNILR 170
            +G FG V+ A+  N     + + V +  ++D     ++ +  E E+  L +++H++I++
Sbjct: 14  GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL--LTNLQHEHIVK 71

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLH 226
           + G    G+ +     ++  Y + G L  FL+ +    ++  E      L+ S+ ++H+ 
Sbjct: 72  FYGVCVEGDPL----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ-MLHIA 126

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           ++I             HRD  + N L+  +L   I DFG++            + +VG  
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGH 181

Query: 287 -----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
                R+M PE +       R      D+++  +VLWE+
Sbjct: 182 TMLPIRWMPPESI-----MYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 40/211 (18%)

Query: 122 QGRFGAVWK--AKFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNI--LRYIGAE 175
           +G +  V+K  ++   + VA+K+  M+ ++   + + +E   L  ++H NI  L  I   
Sbjct: 15  EGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74

Query: 176 KRG-----ESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEI 229
           K       E +HT+       H  G        N+  +  QL R       GL ++H + 
Sbjct: 75  KETLTFVFEYMHTDLAQYMIQHPGG----LHPYNVRLFMFQLLR-------GLAYIHGQ- 122

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + HRD K  N+L+       +ADFGLA       P      +V T  Y 
Sbjct: 123 ----------HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYR 170

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            P+VL GA ++S      +D++    +  E+
Sbjct: 171 PPDVLLGATDYSSA----LDIWGAGCIFIEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 33/120 (27%)

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI--ADFGLAL 268
           L +IA++  K L +L EE+           + HRD K +N+LL  D    I   DFG+  
Sbjct: 109 LGKIAVATVKALNYLKEEL----------KIIHRDVKPSNILL--DRNGNIKLCDFGI-- 154

Query: 269 LFEPGKPCG---DTHGQ---VGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELA 321
                   G   D+  +    G R YMAPE ++     +RD + +R D+++  + L+E+A
Sbjct: 155 -------SGQLVDSIAKTRDAGCRPYMAPERID---PSARDGYDVRSDVWSLGITLYEVA 204

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 28/71 (39%), Positives = 37/71 (52%), Gaps = 6/71 (8%)

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT-HGQVGTRRYMAPEV 293
           D  +  + +RD K  N+LL       I+D GLA+      P G+T  G+VGT  YMAPEV
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEV 172

Query: 294 LEG-AINFSRD 303
           +      FS D
Sbjct: 173 INNEKYTFSPD 183

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 51/225 (22%)

Query: 189 TAYHERGSLCDF---------LKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
           + + E  SL D          L   ++T E L   +  ++KG+     E L ++      
Sbjct: 150 SGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM-----EFLASRK----- 199

Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGK-PCGDTHGQVGTRRYMAPEVLEG 296
              HRD  + N+LL  +    I DFGLA  +  +P     GD    +   ++MAPE +  
Sbjct: 200 -CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL---KWMAPETI-- 253

Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
              F R   ++ D+++  ++LWE+ S     SP PG           D      ++E   
Sbjct: 254 ---FDRVYTIQSDVWSFGVLLWEIFSL--GASPYPGVKI--------DEEFCRRLKEGTR 300

Query: 357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            +    T PE ++          TM +CW  +   R + S +VE 
Sbjct: 301 MRAPDYTTPEMYQ----------TMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 37/230 (16%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIF---LMQDKQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N +       VAVK      +  ++ +Q E E+  L 
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL--LT 62

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG 221
           +++H++I+++ G    G+ +   F     Y + G L  FL+ +      L       +KG
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVF----EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118

Query: 222 ------LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
                 ++H+  +I             HRD  + N L+ ++L   I DFG++        
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DV 173

Query: 276 CGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
               + +VG       R+M PE +       R      D+++  ++LWE+
Sbjct: 174 YSTDYYRVGGHTMLPIRWMPPESI-----MYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 29/83 (34%), Positives = 38/83 (45%), Gaps = 15/83 (18%)

Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK 274
           A  +  GL  LHE             + +RD K +NVLL S+    IADFG+    + G 
Sbjct: 102 AAEIVLGLQFLHER-----------GIIYRDLKLDNVLLDSEGHIKIADFGMC---KEGI 147

Query: 275 PCGDTHGQ-VGTRRYMAPEVLEG 296
             G T     GT  Y+APE+L  
Sbjct: 148 LGGVTTSTFCGTPDYIAPEILSY 170

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 42/136 (30%), Positives = 60/136 (44%), Gaps = 27/136 (19%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAIN 299
           V +RD K  N++L  D    I DFGL    + G   G T     GT  Y+APEVLE    
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLE---- 168

Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK 359
              D    +D +   +V++E+   C          RLPF  +  DH   E + E ++ ++
Sbjct: 169 -DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH---ERLFELILMEE 211

Query: 360 LRPTLPETWKQHAGML 375
           +R   P T    A  L
Sbjct: 212 IR--FPRTLSPEAKSL 225

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 3/68 (4%)

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           +K  + +RD K +NVLL  D    IADFG+      G+    T    GT  Y+APE+L+G
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--CGTPDYIAPEILKG 170

Query: 297 AI-NFSRD 303
              N S D
Sbjct: 171 QKYNESVD 178

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 35/184 (19%)

Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-----------C 203
           +EI  +  +++ NI+R +G     + +     +IT Y E G L  FL             
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHAN 121

Query: 204 NI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           NI  V+   L  +A+ ++ G+ +L                 HRD  + N L+ +  T  I
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASL-----------NFVHRDLATRNCLVGNHYTIKI 170

Query: 262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPE-VLEGAINFSRDAFLRIDMYACALVLWEL 320
           ADFG++     G         V   R+MA E +L G    + D       +A  + LWE+
Sbjct: 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV------WAFGVTLWEM 224

Query: 321 ASRC 324
            + C
Sbjct: 225 FTLC 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 41/234 (17%)

Query: 108 QQGCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDKQSWQSE--QEIFK 159
               R + L ++  +G FG ++          K E V VK       +   +   QE   
Sbjct: 3   ISRDR-VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61

Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNI--------VTWEQ 210
           L  + H NIL  +             +++  Y   G+L  FL +C +        ++ +Q
Sbjct: 62  LYGLSHQNILPILHVCIED---GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L  +A+ ++ G+ +LH           K  V H+D  + N ++  +L   I D  L+  L
Sbjct: 119 LVHMAIQIACGMSYLH-----------KRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 270 FEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           F     C GD   +    ++MA E L     +S  +    D+++  ++LWEL +
Sbjct: 168 FPMDYHCLGDNENR--PVKWMALESLVNKE-YSSAS----DVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 69/274 (25%), Positives = 106/274 (38%), Gaps = 41/274 (14%)

Query: 138 VAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERG 195
           VAVKI      ++ +++  +E+  L  ++  NI+R +G     + +     +IT Y E G
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL----CMITEYMENG 104

Query: 196 SLCDFLKC----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRD 245
            L  FL            N       C  A+S S  L+H+  +I             HRD
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS-SLLHVALQIASGMKYLSSLNFVHRD 163

Query: 246 FKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE-VLEGAINFSRDA 304
             + N L+  +LT  IADFG++     G         V   R+MA E +L G    + D 
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223

Query: 305 FLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL 364
                 +A  + LWE+   C            P+  E+ D   +E+  E    +  +  L
Sbjct: 224 ------WAFGVTLWEILMLCKE---------QPYG-ELTDEQVIENAGEFFRDQGRQVYL 267

Query: 365 --PETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
             P    Q      L + M +CW  D   R S S
Sbjct: 268 FRPPPCPQ-----GLYELMLQCWSRDCRERPSFS 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 36/158 (22%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           + +RD K  N+LL S     + DFGL    E  +P   T    GT  Y+APEVL      
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLR----- 169

Query: 301 SRDAFLR-IDMYACALVLWELASRCSSVSPPPGEYRLP--FSAEVGDHPSLEDMQEAVVH 357
            ++ + R +D +    VL+E+             Y LP  +S +V        M + ++H
Sbjct: 170 -KEPYDRTVDWWCLGAVLYEML------------YGLPPFYSRDVS------QMYDNILH 210

Query: 358 KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           K L+    +T       +A CD +      D   RL A
Sbjct: 211 KPLQLPGGKT-------VAACDLLVGLLHKDQRRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 42/198 (21%)

Query: 153 SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--------- 203
           SE E+ K+   +H NI+  +GA  +   +    ++I  Y  +G+L ++L+          
Sbjct: 72  SEMEMMKMIG-KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYC 126

Query: 204 --------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
                     ++++ L   A  +++G+ +L  +              HRD  + NVL+  
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTE 175

Query: 256 DLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACA 314
           D    IADFGLA  +         T+G++   ++MAPE L     F R    + D+++  
Sbjct: 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFG 229

Query: 315 LVLWELASRCSSVSPPPG 332
           ++LWE+ +     SP PG
Sbjct: 230 VLLWEIFTLGG--SPYPG 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 23/212 (10%)

Query: 117 VEVKAQGRFGAVWKAKF----KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           V+V   G FG V+K  +    +N  + V I ++++  S ++ +EI    ++       Y+
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEIL 230
                G  + +   L+T     G L D+++ N   +  + L    + ++KG+ +L E  L
Sbjct: 72  -CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                       HRD  + NVL+KS     I DFGLA L +  +      G     ++MA
Sbjct: 131 -----------VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            E +       R    + D+++  + +WEL +
Sbjct: 180 LESI-----LHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 37/147 (25%), Positives = 57/147 (38%), Gaps = 42/147 (28%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFE-----------------------PGKPCG 277
           V HRD K +N+LL       I D+G A+  +                       PGK   
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK--- 190

Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
                VGT  YMAPE L G       A    D+YA  ++L+++     ++S P   YR  
Sbjct: 191 ----IVGTPDYMAPERLLGV-----PASESTDIYALGVILYQML----TLSFP---YRRK 234

Query: 338 FSAEVGDHPSLEDMQEAVVHKKLRPTL 364
              ++     +    E   ++++ P L
Sbjct: 235 KGRKISYRDVILSPIEVAPYREIPPFL 261

Length = 932

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 38/219 (17%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNI 168
           S + +E   +G +  V+K K K   + VA+K+  +Q+++   + + +E   L  ++H NI
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 169 --LRYIGAEKRG-----ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG 221
             L  I   K       E +HT+       H  G   + +K  +    QL R       G
Sbjct: 66  VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLF---QLLR-------G 115

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L ++H+             + HRD K  N+L+       +ADFGLA       P      
Sbjct: 116 LSYIHQRY-----------ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSN 162

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           +V T  Y  P+VL G+  +S      +DM+    +  E+
Sbjct: 163 EVVTLWYRPPDVLLGSTEYST----CLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 41.3 bits (97), Expect = 7e-04
 Identities = 36/109 (33%), Positives = 48/109 (44%), Gaps = 22/109 (20%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAIN 299
           V +RD K  N++L  D    I DFGL    + G   G T     GT  Y+APEVLE    
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLE---- 168

Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
              D    +D +   +V++E+   C          RLPF  +  DH  L
Sbjct: 169 -DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 23/166 (13%)

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ------LCRIAL 216
           + H N+L+ +G  +  ESI   + L+  +   G L ++L+ N     Q      L R+A 
Sbjct: 52  LNHPNVLQCLG--QCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC 107

Query: 217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
            ++ GL+ LH           +    H D    N  L +DL+  I D+GLAL   P    
Sbjct: 108 EVASGLLWLH-----------QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156

Query: 277 GDTHGQVGTRRYMAPEVLE--GAINFSRDAFLRIDMYACALVLWEL 320
                     R++APE++E  G     +D   + ++++  + +WEL
Sbjct: 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 9/87 (10%)

Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLE 295
           ++  + +RD K +NVLL +D    + D+G+    + G   GDT     GT  Y+APE+L 
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMC---KEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 296 GAINFSRDAFLRIDMYACALVLWELAS 322
           G      +    +D +A  ++++E+ +
Sbjct: 170 G-----EEYGFSVDWWALGVLMFEMMA 191

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 40.7 bits (95), Expect = 9e-04
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 32/165 (19%)

Query: 122 QGRFGAVWKAKFKNEN-----VAVK-----IFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +G FG+V +A+ K+E+     VAVK     IF   D + +  E    K    +H N+++ 
Sbjct: 9   KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMK--EFDHPNVIKL 66

Query: 172 IGA--EKRGESIHTEFWLITAYHERGSLCDFLKCN-------IVTWEQLCRIALSMSKGL 222
           IG     R +       +I  + + G L  FL  +        +  + L R  + ++ G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA 267
                E L +K         HRD  + N +L  ++T  +ADFGL+
Sbjct: 127 -----EYLSSKN------FIHRDLAARNCMLNENMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 36/120 (30%), Positives = 57/120 (47%), Gaps = 29/120 (24%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV--GTRRYMAPEVLEGAINF 300
           HRD KS N+LL S+    + DFG + ++       D  G+   GT  Y+APE+      +
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMY--AATVSDDVGRTFCGTPYYVAPEIWRRK-PY 222

Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL 360
           S+ A    DM++  ++L+EL +            + PF          E+M+E V+HK L
Sbjct: 223 SKKA----DMFSLGVLLYELLT-----------LKRPFDG--------ENMEE-VMHKTL 258

Length = 496

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 36/193 (18%)

Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQ------------DKQSWQSEQEIFKLPHME 164
           ++V  +G +G V++ +        KIF M+            D    ++E+ I  L  ++
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVK 58

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS-MSKGLM 223
           H  I+  I A + G     + +LI  Y   G L   L+   +  E      LS +S  L 
Sbjct: 59  HPFIVDLIYAFQTG----GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE 114

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL--LFEPGKPCGDTHG 281
           HLH           +  + +RD K  N+LL +     + DFGL    + E       TH 
Sbjct: 115 HLH-----------QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV----THT 159

Query: 282 QVGTRRYMAPEVL 294
             GT  YMAPE+L
Sbjct: 160 FCGTIEYMAPEIL 172

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 25/81 (30%), Positives = 32/81 (39%), Gaps = 27/81 (33%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLA-------------------LLFEPGKPCGDTHGQ- 282
           HRD K +N+L+ +D    +ADFGL                    L  +        H Q 
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183

Query: 283 -------VGTRRYMAPEVLEG 296
                  VGT  Y+APEVL G
Sbjct: 184 RVRANSTVGTPDYIAPEVLRG 204

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 26/87 (29%), Positives = 40/87 (45%), Gaps = 17/87 (19%)

Query: 222 LMHLHEEILPNKADSYKPA-------------VAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           +MH+H ++       +  A             + +RD K +N+LL ++    IADFGL  
Sbjct: 90  MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC- 148

Query: 269 LFEPGKPCGDTHGQ-VGTRRYMAPEVL 294
             + G   GD      GT  ++APEVL
Sbjct: 149 --KEGMGFGDRTSTFCGTPEFLAPEVL 173

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 50/229 (21%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL 169
           +S +L  +   G FG V++A     +E VA+K  L QD Q     +E+  + ++ H NI+
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QDPQ--YKNRELLIMKNLNHINII 122

Query: 170 -----RYIGAEKRGE-----SIHTEFWLITA-----YHERG--SLCDFLKCNIVTWEQLC 212
                 Y    K+ E     ++  EF   T      ++ R   +L  FL   + ++ QLC
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-VKLYSY-QLC 180

Query: 213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIADFGLALLFE 271
           R        L ++H +            + HRD K  N+L+  +  T  + DFG A    
Sbjct: 181 R-------ALAYIHSKF-----------ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222

Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            G+    +   + +R Y APE++ GA N++      ID+++   ++ E+
Sbjct: 223 AGQ---RSVSYICSRFYRAPELMLGATNYTT----HIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 42/136 (30%), Positives = 60/136 (44%), Gaps = 27/136 (19%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAIN 299
           V +RD K  N++L  D    I DFGL    + G   G T     GT  Y+APEVLE    
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPEVLE---- 169

Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK 359
              D    +D +   +V++E+   C          RLPF  +  DH   E + E ++ ++
Sbjct: 170 -DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH---EKLFELILMEE 212

Query: 360 LRPTLPETWKQHAGML 375
           +R   P T    A  L
Sbjct: 213 IR--FPRTLSPEAKSL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 53/241 (21%)

Query: 122 QGRFGAVWKAK-------FKNENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDNI 168
           +G FG V +A+         ++ V V + +++D  + +      SE E+ KL   +H NI
Sbjct: 22  EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-KHKNI 80

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQL 211
           +  +G   +        ++I  Y  +G+L +FL+                    ++++ L
Sbjct: 81  INLLGVCTQ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
              A  +++G+ +L                 HRD  + NVL+  D    IADFGLA    
Sbjct: 137 VSCAYQVARGMEYLESR-----------RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
                  T       ++MAPE L     F R    + D+++  +++WE+ +     SP P
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGILMWEIFTLGG--SPYP 238

Query: 332 G 332
           G
Sbjct: 239 G 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 32/121 (26%), Positives = 48/121 (39%), Gaps = 42/121 (34%)

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL 269
           QL        K L H+H           +  + HRD K  N+L+K D    +ADFG    
Sbjct: 108 QLL-------KSLDHMH-----------RNGIFHRDIKPENILIKDD-ILKLADFG---- 144

Query: 270 FEPGKPCGDTHGQ------VGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
                 C   + +      + TR Y APE L  +G          ++D++A   V +E+ 
Sbjct: 145 -----SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP------KMDIWAVGCVFFEIL 193

Query: 322 S 322
           S
Sbjct: 194 S 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 40/229 (17%)

Query: 118 EVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHMEHDNI 168
            V  +G FG V+         +  + AVK    I  +++ + +  E  I K     H N+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMK--DFSHPNV 58

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLH 226
           L  +G     E       ++  Y + G L +F++   +  T + L    L ++KG+ +L 
Sbjct: 59  LSLLGICLPSEGSPL---VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGT 285
            +              HRD  + N +L    T  +ADFGLA  +++  K     H   G 
Sbjct: 116 SK-----------KFVHRDLAARNCMLDESFTVKVADFGLARDIYD--KEYYSVHNHTGA 162

Query: 286 R---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
           +   ++MA E L+     ++    + D+++  ++LWEL +R     P P
Sbjct: 163 KLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTR--GAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 54/212 (25%), Positives = 83/212 (39%), Gaps = 32/212 (15%)

Query: 118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPH-MEHDNILRYIGAEK 176
           +V  +G FG V  A+ K E     + ++Q K   + ++E     H M   N+L       
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE----KHIMSERNVLLKNVKHP 56

Query: 177 RGESIHTEF------WLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
               +H  F      + +  Y   G L   L+      E   R  A  ++  L +LH   
Sbjct: 57  FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL- 115

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + +RD K  N+LL S     + DFGL    E  +  G T    GT  Y+
Sbjct: 116 ----------NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYL 163

Query: 290 APEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
           APEVL       +  + R +D +    VL+E+
Sbjct: 164 APEVLH------KQPYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 123 GRFGAVWKAKFKNE----NVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEK 176
           G FG V K  +K      +VA+K+   ++++S + E  +E   +  +++  I+R IG  +
Sbjct: 6   GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE 65

Query: 177 RGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
             E++     L+      G L  FL  K + +T   +  +   +S G+ +L  +      
Sbjct: 66  -AEAL----MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK------ 114

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   HRD  + NVLL +   A I+DFGL  AL  +       + G+   + Y APE
Sbjct: 115 -----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY-APE 168

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
                INF R    R D+++  + +WE  S
Sbjct: 169 ----CINF-RKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 8/84 (9%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           + +RD K +NVLL ++    + D+G+    E  +P   T    GT  Y+APE+L G    
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRG---- 170

Query: 301 SRDAFLRIDMYACALVLWE-LASR 323
             D    +D +A  ++++E +A R
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 39.5 bits (93), Expect = 0.003
 Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 39/196 (19%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQD----KQSWQSEQEIFKLPHMEH 165
              + ++    G FG V   + K   +  A+KI         KQ      E   L  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCR-----IALSMS 219
             ++   G+ +   ++    +L+  Y   G L   L K      E + R     + L   
Sbjct: 61  PFLVNLYGSFQDDSNL----YLVMEYVPGGELFSHLRKSGRFP-EPVARFYAAQVVL--- 112

Query: 220 KGLMHLH-EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
             L +LH  +I+            +RD K  N+LL SD    I DFG A   +     G 
Sbjct: 113 -ALEYLHSLDIV------------YRDLKPENLLLDSDGYIKITDFGFAKRVK-----GR 154

Query: 279 THGQVGTRRYMAPEVL 294
           T+   GT  Y+APE++
Sbjct: 155 TYTLCGTPEYLAPEII 170

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 52/228 (22%)

Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
            E     D L    +T E L   +  +++G+     E L ++         HRD  + N+
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGM-----EFLASRK------CIHRDLAARNI 204

Query: 252 LLKSDLTAAIADFGLA--LLFEPGKPCGDTHGQVGTRR----YMAPEVLEGAINFSRDAF 305
           LL  +    I DFGLA  +  +P       + + G  R    +MAPE +     F +   
Sbjct: 205 LLSENNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPESI-----FDKVYT 253

Query: 306 LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLP 365
            + D+++  ++LWE+ S     SP PG           D      ++E    +      P
Sbjct: 254 TQSDVWSFGVLLWEIFSL--GASPYPGVQI--------DEEFCRRLKEGTRMRAPEYATP 303

Query: 366 ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEEC 413
           E +            M +CW ++ E R + S +VE     L D ++E 
Sbjct: 304 EIYS----------IMLDCWHNNPEDRPTFSELVEI----LGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 37/165 (22%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRR----YMAPE-VLEG 296
           HRD  + N+LL       I DFGLA          D++  V G  R    +MAPE +   
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-----NDSNYVVKGNARLPVKWMAPESIFNC 291

Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
              F        D+++  ++LWE+ S  S  SP PG   +P  ++             ++
Sbjct: 292 VYTFES------DVWSYGILLWEIFSLGS--SPYPG---MPVDSKF----------YKMI 330

Query: 357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            +  R   PE          + D M+ CWD D   R +   +V+ 
Sbjct: 331 KEGYRMLSPE-----CAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 10/82 (12%)

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLT--AAIADFGLALLFEPGKPCGD-- 278
            L  ++L   A ++   + HRD K  N+++ ++ +   A + DFG+  L  PG    D  
Sbjct: 83  RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVA 141

Query: 279 ----THGQVGTRRYMAPEVLEG 296
               T   +GT  Y APE L G
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRG 163

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 24/221 (10%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 8   ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 67

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGL 222
             H  ++R +G   +G+       L+      G L  +L+      E          + +
Sbjct: 68  CHH--VVRLLGVVSKGQPTLVVMELMA----HGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
           + +  EI    A        HRD  + N ++  D T  I DFG+   ++E         G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 182 LLPV-RWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 34/134 (25%), Positives = 58/134 (43%), Gaps = 35/134 (26%)

Query: 146 QDKQSWQSEQEIFKLPHMEHDNILRYIG--AEKRGESIHTEFWLITAYHERGSL------ 197
           Q++  +  E + ++   ++H N+L+ +G   E       T + L+  +   G L      
Sbjct: 37  QEQMKFLEEAQPYR--SLQHSNLLQCLGQCTEV------TPYLLVMEFCPLGDLKGYLRS 88

Query: 198 ---CDFLKCNIVTWEQL-CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL 253
               + +  +  T +++ C IAL    GL+HLH           K    H D    N LL
Sbjct: 89  CRKAELMTPDPTTLQRMACEIAL----GLLHLH-----------KNNFIHSDLALRNCLL 133

Query: 254 KSDLTAAIADFGLA 267
            +DLT  I D+GL+
Sbjct: 134 TADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 22/54 (40%), Positives = 26/54 (48%), Gaps = 1/54 (1%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEV 293
           V HRD K  N+L  +D    I DFGLA + F            V TR Y APE+
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	461
KOG3653|consensus	534		100.0
KOG2052|consensus	513		100.0
KOG0192|consensus	362		100.0
KOG0197|consensus	468		100.0
KOG0581|consensus	364		100.0
KOG1026|consensus	774		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0595|consensus	429		100.0
KOG1187|consensus	361		100.0
KOG0591|consensus	375		100.0
KOG1095|consensus	1025		100.0
KOG0598|consensus	357		100.0
KOG0196|consensus	996		100.0
KOG0198|consensus	313		100.0
KOG0582|consensus	516		100.0
KOG4721|consensus	904		100.0
KOG0592|consensus	604		100.0
KOG1094|consensus	807		100.0
KOG0661|consensus	538		100.0
KOG0578|consensus	550		100.0
KOG0600|consensus	560		100.0
KOG0616|consensus	355		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193|consensus	678		100.0
KOG0194|consensus	474		100.0
KOG0659|consensus	318		100.0
KOG0583|consensus	370		100.0
KOG0658|consensus	364		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0585|consensus	576		100.0
KOG0593|consensus	396		100.0
KOG0588|consensus	786		100.0
KOG0663|consensus	419		100.0
KOG0605|consensus	550		100.0
KOG0201|consensus	467		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0660|consensus	359		100.0
KOG0694|consensus	694		100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597|consensus	808		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG4257|consensus	974		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0033|consensus	355		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0611|consensus	668		100.0
KOG1025|consensus	1177		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0580|consensus	281		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG4278|consensus	1157		100.0
KOG0594|consensus	323		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0599|consensus	411		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0589|consensus	426		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG1989|consensus	738		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0610|consensus	459		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0199|consensus	1039		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577|consensus	948		100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0667|consensus	586		100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0032|consensus	382		100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0574|consensus	502		100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0579|consensus	1187		100.0
KOG4279|consensus	1226		100.0
KOG2345|consensus	302		100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0584|consensus	632		100.0
KOG4717|consensus	864		100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0200|consensus	609		100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0586|consensus	596		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4645|consensus	1509		100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0596|consensus	677		100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1035|consensus	1351		100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0604|consensus	400		100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0666|consensus	438		100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983|consensus	391		100.0
KOG0986|consensus	591		100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0587|consensus	953		100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0690|consensus	516		100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0669|consensus	376		100.0
KOG0612|consensus	1317		100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0607|consensus	463		100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1024|consensus	563		100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4250|consensus	732		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006|consensus	361		100.0
KOG4236|consensus	888		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696|consensus	683		100.0
KOG0603|consensus	612		100.0
KOG0662|consensus	292		100.0
KOG1151|consensus	775		100.0
KOG0671|consensus	415		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984|consensus	282		100.0
KOG0614|consensus	732		100.0
KOG1027|consensus	903		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0664|consensus	449		100.0
KOG0668|consensus	338		100.0
KOG0695|consensus	593		100.0
KOG0608|consensus	1034		100.0
KOG0576|consensus	829		99.97
KOG0665|consensus	369		99.97
KOG1290|consensus	590		99.97
KOG1152|consensus	772		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0670|consensus	752		99.96
KOG1345|consensus	378		99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195|consensus	448		99.95
KOG1167|consensus	418		99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1023|consensus	484		99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590|consensus	601		99.9
KOG1164|consensus	322		99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4158|consensus	598		99.86
KOG1163|consensus	341		99.86
KOG1165|consensus	449		99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1240|consensus	1431		99.85
KOG0603|consensus	612		99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG1033|consensus	516		99.79
KOG1166|consensus	974		99.79
smart00090	237	RIO RIO-like kinase.	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0606|consensus	1205		99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG0590|consensus	601		99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG1266|consensus	458		99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG0601|consensus	524		99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG0601|consensus	524		99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG0606|consensus	1205		99.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
KOG1243|consensus	690		99.12
KOG3087|consensus	229		99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
KOG3741|consensus	655		98.79
COG4248	637	Uncharacterized protein with protein kinase and he	98.68
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.65
PRK09902	216	hypothetical protein; Provisional	98.63
KOG2137|consensus	700		98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.46
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.31
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.24
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.22
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.2
KOG1035|consensus	1351		98.19
KOG0576|consensus	829		98.19
KOG1235|consensus	538		98.12
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.01
PRK10593	297	hypothetical protein; Provisional	97.97
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.96
PLN02876	822	acyl-CoA dehydrogenase	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.78
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.45
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.35
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.23
PLN02236	344	choline kinase	97.12
KOG1826|consensus	2724		97.1
PRK05231	319	homoserine kinase; Provisional	96.94
PLN02756	418	S-methyl-5-thioribose kinase	96.92
KOG2270|consensus	520		96.87
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.81
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.61
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.53
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.52
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.32
KOG2268|consensus	465		96.15
PRK12396	409	5-methylribose kinase; Reviewed	96.07
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.8
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.6
PTZ00384	383	choline kinase; Provisional	95.57
KOG1093|consensus	725		95.0
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.94
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.77
COG2334	331	Putative homoserine kinase type II (protein kinase	94.67
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.42
KOG1236|consensus	565		94.33
PTZ00296	442	choline kinase; Provisional	94.29
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	93.47

>KOG3653|consensus

Probab=100.00  E-value=2.2e-73  Score=544.94  Aligned_cols=404  Identities=54%  Similarity=0.955  Sum_probs=341.5

Q ss_pred             CCCCCCccccccccc-cCCCceEEecCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CceeeehhhHHHHHHHHHHHHHH
Q psy17532          1 MECYDKPKCVEKRPE-SKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTES-HPLIIFLYTMLPIFALIIPIFLC   78 (461)
Q Consensus         1 ~~~~~~~~c~~~~~~-~~~~~~~c~~~~~~C~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~   78 (461)
                      |+|+|.++||.+++. ..++.++|||.||.||.++...+.+.+++.+++.+..+.. ...+++++..+++.+++++++.+
T Consensus        95 ~~c~~~~eCv~s~~~~~g~t~~~CcCs~~~CN~n~s~~~~~~~~~t~~~~~~~~~~~~~~~~al~~~~~v~~l~~lvi~~  174 (534)
T KOG3653|consen   95 INCEDSSECVVSAEPPPGQTLYFCCCSTDFCNANFSHLPPPGPEGTPSSPDLATNDGEVLIYALIPLLLVSLLAALVILA  174 (534)
T ss_pred             cccccccccccCCCCCCCCeEEEEecCCCcccCCccccCCCCCCCCCCCCCcccccCceehhhHHHHHHHHHHHHHHHHH
Confidence            689999999999775 4446999999999999999876655433333333222222 23333333434455555556666


Q ss_pred             HhhhhhccCCCC---CCCCCCCCCCCCCCCCCccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHH
Q psy17532         79 YWYYRQRKLGSY---FNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQ  155 (461)
Q Consensus        79 ~~~~~~r~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~  155 (461)
                      |+.+|++|..+.   ....+.. ...+..+++......+++.++||+|+||.||+|+++++.||||++...+.+.++.|+
T Consensus       175 ~~~~r~~k~~~~~~e~~~~p~~-d~~~~~sspl~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek  253 (534)
T KOG3653|consen  175 FLGYRQRKNAREEIEPVLIPLE-DSGPAPSSPLLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEK  253 (534)
T ss_pred             HHHHHHhhcccccCccCcccCC-CCCCCCCcccccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHH
Confidence            666666655432   2222222 223344556677889999999999999999999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcC
Q psy17532        156 EIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD  235 (461)
Q Consensus       156 ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~  235 (461)
                      +|..+-.++|+||++|+++...+.....++|||+||.+.|+|.+||+.+.++|....+++..+++||+|||+.+-  ...
T Consensus       254 ~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p--~~d  331 (534)
T KOG3653|consen  254 NIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELP--RGD  331 (534)
T ss_pred             HHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCC--cCC
Confidence            999999999999999999988776666789999999999999999999999999999999999999999999854  668


Q ss_pred             CCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccccc-CCCCCccchHHHH
Q psy17532        236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS-RDAFLRIDMYACA  314 (461)
Q Consensus       236 ~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~k~DVwS~G  314 (461)
                      .++|+|+|||||++||||.+|+++.|+|||||..+..+.....+.+.+||.+|||||++.|..++. .....+.||||+|
T Consensus       332 ~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg  411 (534)
T KOG3653|consen  332 HHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG  411 (534)
T ss_pred             CCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence            899999999999999999999999999999999999888777788899999999999999987776 4455779999999


Q ss_pred             HHHHHHHcCCCCCC-CCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc
Q psy17532        315 LVLWELASRCSSVS-PPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       315 vil~el~tg~~~~~-~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      .+||||++++..+. ++.++|+.||..+.+.+|+.+++++.+++++.||.+|+.|..+.....+++.++.||+.||+.|.
T Consensus       412 LVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL  491 (534)
T KOG3653|consen  412 LVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL  491 (534)
T ss_pred             HHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence            99999999998776 78889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhcHHHhh
Q psy17532        394 SASCVVERGMLALC  407 (461)
Q Consensus       394 s~~evl~~l~~~~~  407 (461)
                      ||..+.+++.++..
T Consensus       492 TA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  492 TAGCVEERMAELMM  505 (534)
T ss_pred             hhHHHHHHHHHHhc
Confidence            99999999887775

>KOG2052|consensus

Probab=100.00  E-value=5.9e-59  Score=442.75  Aligned_cols=292  Identities=43%  Similarity=0.767  Sum_probs=260.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      .+.+++.+.||+|+||.||+|+|+|+.||||+|...+...+..|.||..-..|+|+||+.|++....++...+++|||++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            46789999999999999999999999999999999999999999999998889999999999998888888899999999


Q ss_pred             hccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        191 YHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       191 ~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      |.++|||+|||....++.+..++++..+|.||+|||..+++++   .+|.|.|||||+.||||++++++.|+|+|||...
T Consensus       290 YHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTq---gKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  290 YHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQ---GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             cccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCC---CCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            9999999999999999999999999999999999999998776   6999999999999999999999999999999776


Q ss_pred             CCCCCC--CCCCCCcCCCcccccccccccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        271 EPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       271 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~-~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ......  ...+..+||.+|||||++....+... +....+||||||.++||++-++.. .+-..+++.||++....+|+
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~-ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES-GGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc-CCEehhhcCCcccCCCCCCC
Confidence            654321  23456799999999999987655442 223568999999999999876543 34556789999999999999


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ++++.+.+...++||.+|..|...+....+..||+.||..+|..|.||--+-+.+.++.
T Consensus       446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999999999999999999999987766665443

>KOG0192|consensus

Probab=100.00  E-value=3.8e-53  Score=415.15  Aligned_cols=261  Identities=33%  Similarity=0.486  Sum_probs=223.8

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECCCc-EEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~-vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ......+.+.+.+|+|+||+||+|.++|+. ||||++......   ...+.+|+.+|.+++|||||+|+|++.....   
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---  113 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---  113 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence            344556677778999999999999999998 999999754432   3467899999999999999999999988652   


Q ss_pred             eeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC-eecccCCCCcEEEcCCC-c
Q psy17532        184 EFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA-VAHRDFKSNNVLLKSDL-T  258 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~-ivHrDLkp~NILl~~~~-~  258 (461)
                      .+.+||||+++|+|.+++..   ..+++..+++++.|||+||.|||++           + ||||||||+|||++.++ +
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~-----------~~iIHrDLK~~NiLv~~~~~~  182 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE-----------GPIIHRDLKSDNILVDLKGKT  182 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-----------CCeeecccChhhEEEcCCCCE
Confidence            35899999999999999954   5799999999999999999999998           6 99999999999999998 9


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......  .......||+.|||||++.+.   ...++.|+|||||||+||||+||           +.||
T Consensus       183 ~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~-----------~~Pf  246 (362)
T KOG0192|consen  183 LKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTG-----------EIPF  246 (362)
T ss_pred             EEECCCccceeecccc--ccccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHC-----------CCCC
Confidence            9999999998765432  223346899999999999853   35789999999999999999999           7777


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      ...     ........+.....|+.+|..++.     .+..||.+||+.||++||++.+++..+..+...
T Consensus       247 ~~~-----~~~~~~~~v~~~~~Rp~~p~~~~~-----~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  247 EDL-----APVQVASAVVVGGLRPPIPKECPP-----HLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CCC-----CHHHHHHHHHhcCCCCCCCccCCH-----HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            665     345666778888899999987554     899999999999999999999999999877653

>KOG0197|consensus

Probab=100.00  E-value=5.2e-53  Score=413.42  Aligned_cols=258  Identities=26%  Similarity=0.453  Sum_probs=222.9

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECCC-cEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .....+.+++.+.||+|.||.||.|.+++. .||||.++........+.+|+.+|++|+|+|||+++|+|....++    
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi----  276 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI----  276 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce----
Confidence            344566778889999999999999999886 899999987776667788999999999999999999999987654    


Q ss_pred             eeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +||||||+.|+|.+||+.   ..+...+.+.++.|||+||+||+++           ++|||||.++||||+++..+||+
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-----------~~IHRDLAARNiLV~~~~~vKIs  345 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-----------NYIHRDLAARNILVDEDLVVKIS  345 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC-----------CccchhhhhhheeeccCceEEEc
Confidence            999999999999999975   4689999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||||+...++. +....+..-++.|.|||.+..+     .++.|||||||||+||||+|.+          +.||... 
T Consensus       346 DFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~-----~FS~kSDVWSFGVlL~E~fT~G----------~~py~~m-  408 (468)
T KOG0197|consen  346 DFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYG-----KFSSKSDVWSFGVLLWELFTYG----------RVPYPGM-  408 (468)
T ss_pred             ccccccccCCCc-eeecCCCCCCceecCHHHHhhC-----CcccccceeehhhhHHHHhccC----------CCCCCCC-
Confidence            999999655443 3444555678899999999764     7889999999999999999985          7788766 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          +..+..+.+ ..++|.+.|+.++.     +++++|..||+.+|++|||++.+...+..+.
T Consensus       409 ----sn~ev~~~l-e~GyRlp~P~~CP~-----~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  409 ----SNEEVLELL-ERGYRLPRPEGCPD-----EVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             ----CHHHHHHHH-hccCcCCCCCCCCH-----HHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                667777665 45667778887776     8999999999999999999997777665443

>KOG0581|consensus

Probab=100.00  E-value=9.3e-52  Score=387.68  Aligned_cols=261  Identities=27%  Similarity=0.366  Sum_probs=219.0

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecC--ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQ--DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ....+++....||+|..|+||+++++  ++.+|+|.+...  .....+..+|+.++...+||+||++||+|.....   +
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~  152 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---E  152 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---e
Confidence            44567888999999999999999995  678999999433  3445566899999999999999999999988663   4


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +.|+||||++|||.++++. +++++..+.+++.+|++||.|||+..          +||||||||+||||+..|.+||||
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~----------~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER----------KIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc----------CeeeccCCHHHeeeccCCCEEecc
Confidence            6899999999999999964 67999999999999999999999632          999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||.++.+...    ...+.+||..|||||.+.+.     .|+.++||||||++++|+++|           +.||.....
T Consensus       223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~-----~Ys~~sDIWSLGLsllE~a~G-----------rfP~~~~~~  282 (364)
T KOG0581|consen  223 FGVSGILVNS----IANTFVGTSAYMSPERISGE-----SYSVKSDIWSLGLSLLELAIG-----------RFPYPPPNP  282 (364)
T ss_pred             ccccHHhhhh----hcccccccccccChhhhcCC-----cCCcccceecccHHHHHHhhC-----------CCCCCCcCC
Confidence            9999988654    35668999999999999884     788899999999999999999           555544333


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .....-++...+..+. .|.+|..    ..++++++||..||++||.+|||+.|+++|.+....
T Consensus       283 ~~~~~~~Ll~~Iv~~p-pP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  283 PYLDIFELLCAIVDEP-PPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             CCCCHHHHHHHHhcCC-CCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            3345566666666543 3556654    233489999999999999999999999999987653

>KOG1026|consensus

Probab=100.00  E-value=8.5e-51  Score=416.16  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=225.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      ....++++.+.||+|.||+||+|+..+       ..||||.++....  ...++++|+..+..++|||||+|+|+|..++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            355678888999999999999999843       4599999975543  4567899999999999999999999999988


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-----------CC----CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-----------NI----VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR  244 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-----------~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHr  244 (461)
                      +.    ++|+|||..|||.+||+.           ..    |+..+.+.|+.|||.||+||-++           .+|||
T Consensus       563 P~----~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-----------~FVHR  627 (774)
T KOG1026|consen  563 PL----CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-----------HFVHR  627 (774)
T ss_pred             ee----EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------ccccc
Confidence            65    999999999999999942           12    88899999999999999999999           89999


Q ss_pred             cCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCC
Q psy17532        245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC  324 (461)
Q Consensus       245 DLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~  324 (461)
                      ||..+|+||.++..|||+||||++.+...+++.......-+++|||||.+..     .+++++||||||||+|||+++-+
T Consensus       628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-----~kFTteSDVWs~GVvLWEIFsyG  702 (774)
T KOG1026|consen  628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-----GKFTTESDVWSFGVVLWEIFSYG  702 (774)
T ss_pred             chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-----Ccccchhhhhhhhhhhhhhhccc
Confidence            9999999999999999999999999887766555545677899999999875     48899999999999999999975


Q ss_pred             CCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       325 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                                ..||.+.     +.++.++.+..+.. ...|+.++.     ++++||..||+.+|++||+++||-.+|..
T Consensus       703 ----------~QPy~gl-----Sn~EVIe~i~~g~l-L~~Pe~CP~-----~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  703 ----------KQPYYGL-----SNQEVIECIRAGQL-LSCPENCPT-----EVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             ----------cCccccc-----chHHHHHHHHcCCc-ccCCCCCCH-----HHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence                      8888877     77888888888877 677887776     89999999999999999999999999876


Q ss_pred             Hhh
Q psy17532        405 ALC  407 (461)
Q Consensus       405 ~~~  407 (461)
                      ...
T Consensus       762 ~~~  764 (774)
T KOG1026|consen  762 WAQ  764 (774)
T ss_pred             HHh
Confidence            543

>KOG0615|consensus

Probab=100.00  E-value=7.4e-51  Score=384.23  Aligned_cols=261  Identities=25%  Similarity=0.284  Sum_probs=212.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh--------hhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ--------SWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      ...+.|.+.+.||+|+||.|-+|..  +++.||||++..+...        ....++|+.+|++|+|||||++++++...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3456788899999999999999988  5789999999654221        12236899999999999999999999987


Q ss_pred             CccceeeeeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-  256 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-  256 (461)
                      ..    +|+||||++||+|.+++ .++.+.++.-..++.|++.|+.|||++           ||+||||||+|||+..+ 
T Consensus       249 ds----~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~-----------GI~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  249 DS----SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ-----------GIIHRDIKPENILLSNDA  313 (475)
T ss_pred             Cc----eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc-----------CcccccCCcceEEeccCC
Confidence            64    49999999999999988 455688888899999999999999999           99999999999999876 


Q ss_pred             --CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        257 --LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       257 --~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                        ..+||+|||+|+....+   ....+.+||+.|.|||++.+...  ..+..++|+||+||+||-+++|           
T Consensus       314 e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~--~~~~~kVDiWSlGcvLfvcLsG-----------  377 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGV--EYYPSKVDIWSLGCVLFVCLSG-----------  377 (475)
T ss_pred             cceEEEecccchhhccccc---eehhhhcCCccccChhheecCCe--ecccchheeeeccceEEEEecc-----------
Confidence              78999999999988644   34667899999999999976422  2333589999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .+||.+..+..    .+.+.+..+.+ ...|..|..  .+++..+||.+||..||++|||++|+++|.|....
T Consensus       378 ~pPFS~~~~~~----sl~eQI~~G~y-~f~p~~w~~--Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  378 YPPFSEEYTDP----SLKEQILKGRY-AFGPLQWDR--ISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             CCCcccccCCc----cHHHHHhcCcc-cccChhhhh--hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            66776653332    13344555544 334455544  56689999999999999999999999999987653

>KOG0575|consensus

Probab=100.00  E-value=2.2e-49  Score=391.85  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=217.3

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEec----CChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLM----QDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~----~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..|...+.||+|||+.||+++.  .|+.||+|++.+    ...+..+..+||.+.+.|+|||||+++++|++.+.+    
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV----   93 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV----   93 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce----
Confidence            6799999999999999999998  689999999975    344556667899999999999999999999998865    


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |||.|+|++|+|..+++ .+.+++.++..+++||+.||.|||+.           +|+|||||..|+|+++++++||+||
T Consensus        94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~-----------~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL-----------GIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc-----------CceecccchhheeecCcCcEEeccc
Confidence            99999999999999996 45799999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |||..+.....  ...+.+||+.|.|||++..     ..++..+||||+||+||.|+.|           +.||...   
T Consensus       163 GLAt~le~~~E--rk~TlCGTPNYIAPEVl~k-----~gHsfEvDiWSlGcvmYtLL~G-----------~PPFetk---  221 (592)
T KOG0575|consen  163 GLATQLEYDGE--RKKTLCGTPNYIAPEVLNK-----SGHSFEVDIWSLGCVMYTLLVG-----------RPPFETK---  221 (592)
T ss_pred             ceeeeecCccc--ccceecCCCcccChhHhcc-----CCCCCchhhhhhhhHHHhhhhC-----------CCCcccc---
Confidence            99999875532  3445799999999999975     4778899999999999999999           6677655   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                        +.++....+....+.  +|...+     .+..+||.++|+.||.+|||+++|+.|.++
T Consensus       222 --~vkety~~Ik~~~Y~--~P~~ls-----~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  222 --TVKETYNKIKLNEYS--MPSHLS-----AEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             --hHHHHHHHHHhcCcc--cccccC-----HHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence              677777777666543  444333     378899999999999999999999999887

>KOG0595|consensus

Probab=100.00  E-value=6e-49  Score=371.77  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=205.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ....+|.+.+.||+|+||+||+|++  ++..||||.+....   +.....+.||.+|+.++|||||++++++.+++.+  
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i--   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI--   84 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE--
Confidence            3456899999999999999999999  46889999986553   2233347899999999999999999999998754  


Q ss_pred             eeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC------
Q psy17532        184 EFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD------  256 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~------  256 (461)
                        |||||||.+|||.+|++.. .+++..+..++.|+|.||++||++           +||||||||+||||+..      
T Consensus        85 --~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~-----------~IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   85 --YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN-----------NIIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             --EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCCcceEEeccCCCCCCC
Confidence              9999999999999999765 799999999999999999999999           99999999999999875      


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      -.+||+|||+|+.+.++.   .....+|++.|||||++..     .+|+.|+|+||.|+|+|++++|           +.
T Consensus       152 ~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~-----~~YdAKADLWSiG~Ilyq~l~g-----------~~  212 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMS-----QQYDAKADLWSIGTILYQCLTG-----------KP  212 (429)
T ss_pred             ceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHh-----ccccchhhHHHHHHHHHHHHhC-----------CC
Confidence            468999999999998654   3556799999999999965     5888999999999999999999           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCC-CCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPT-LPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ||...     +..++...+.......+ ++.....     .+.+|+...+..+|.+|.+..+-+.+.
T Consensus       213 Pf~a~-----t~~eL~~~~~k~~~~~~~~~~~~s~-----~~~~Ll~~ll~~~~~~~~~~~~~~~~~  269 (429)
T KOG0595|consen  213 PFDAE-----TPKELLLYIKKGNEIVPVLPAELSN-----PLRELLISLLQRNPKDRISFEDFFDHP  269 (429)
T ss_pred             Ccccc-----CHHHHHHHHhccccccCchhhhccC-----chhhhhhHHHhcCccccCchHHhhhhh
Confidence            66554     66677665555443333 3333222     455788888888888888877666654

>KOG1187|consensus

Probab=100.00  E-value=9.4e-49  Score=386.57  Aligned_cols=266  Identities=28%  Similarity=0.416  Sum_probs=202.1

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ...+++|.....||+|+||.||+|...+ +.||||++.....+ ..++..|+.++.+++|||+|+|+|||.+.+.   +.
T Consensus        71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~---~~  147 (361)
T KOG1187|consen   71 RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE---HR  147 (361)
T ss_pred             HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc---eE
Confidence            4466788888999999999999999965 88999988766554 5568899999999999999999999998763   34


Q ss_pred             eeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +||+|||++|+|.++|...   .++|..+++|+.++|+||+|||+.        +.|+||||||||+|||+|+++++||+
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~--------~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEG--------CPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccC--------CCCCEecCCCCHHHeeECCCCCEEcc
Confidence            8999999999999999543   789999999999999999999987        46789999999999999999999999


Q ss_pred             ecCCccccCC-CCCCCCCCCC-cCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        263 DFGLALLFEP-GKPCGDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       263 DFGla~~~~~-~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |||+|+.... ...   .... .||.+|+|||++..     ...+.|+|||||||+|.||+||+.+.......       
T Consensus       220 DFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~-----g~lt~KsDVySFGVvllElitgr~~~d~~~~~-------  284 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYAST-----GKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-------  284 (361)
T ss_pred             CccCcccCCccccc---eeeecCCCCccCChhhhcc-----CCcCcccccccchHHHHHHHhCCcccCCCCCc-------
Confidence            9999976654 221   1112 79999999999865     37788999999999999999997554322110       


Q ss_pred             ccCCCCCHHHHH-HHH----hccCCCCCCC-chhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        341 EVGDHPSLEDMQ-EAV----VHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       341 ~~~~~~~~~~~~-~~~----~~~~~~~~~p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                         ......+.. ..+    ......+.+. ..+........+..+..+|++.+|++||+|.+|++.+
T Consensus       285 ---~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L  349 (361)
T KOG1187|consen  285 ---GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL  349 (361)
T ss_pred             ---ccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence               000111111 111    1112223322 1111113445667777788888888888887776665

>KOG0591|consensus

Probab=100.00  E-value=1.2e-49  Score=359.04  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=212.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEE-EecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGA-EKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~-~~~~~~  180 (461)
                      ......+|++.++||+|.||+||++..  +|..||.|.+....   ........|+.+|++|+|||||++++. +.+...
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            445567899999999999999999987  68899999886433   333445689999999999999999994 444332


Q ss_pred             cceeeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                         .++||||||.+|||...++     ...+++..+++++.|++.||.++|+.+-       +.-|+||||||.||+|+.
T Consensus        94 ---vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-------r~~VmHRDIKPaNIFl~~  163 (375)
T KOG0591|consen   94 ---VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-------RGTVMHRDIKPANIFLTA  163 (375)
T ss_pred             ---hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-------ccceeeccCcchheEEcC
Confidence               2589999999999999984     3469999999999999999999999532       114999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      +|.+||+||||++.+....  ....+.+||+.||+||.+.+     ..|+.||||||+||++|||..-           +
T Consensus       164 ~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~-----~~Y~~kSDiWslGCllyEMcaL-----------~  225 (375)
T KOG0591|consen  164 NGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHE-----SGYNFKSDIWSLGCLLYEMCAL-----------Q  225 (375)
T ss_pred             CCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhc-----CCCCcchhHHHHHHHHHHHHhc-----------C
Confidence            9999999999999998765  34567899999999999987     4888999999999999999998           7


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCC-chhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .||.+.     +.-.+..++..+.+ +++| +.++     ..+..||..|++.||+.||+...++..+.
T Consensus       226 ~PF~g~-----n~~~L~~KI~qgd~-~~~p~~~YS-----~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  226 SPFYGD-----NLLSLCKKIEQGDY-PPLPDEHYS-----TDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             CCcccc-----cHHHHHHHHHcCCC-CCCcHHHhh-----hHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            777765     67777777777654 4455 4433     48999999999999999998655555443

>KOG1095|consensus

Probab=100.00  E-value=5.4e-48  Score=408.89  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=221.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC---CC----cEEEEEEecC--ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK---NE----NVAVKIFLMQ--DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~---~~----~vAvK~~~~~--~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      .......++.+.||+|.||.||+|.+.   +.    .||||.+...  ..+..++.+|..+|++++|||||+++|++.+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            345678899999999999999999994   32    3899988654  33455678999999999999999999999986


Q ss_pred             CccceeeeeeehhccCCChhhhhcCC--------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCc
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKCN--------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN  250 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~N  250 (461)
                      ...    +|++|||++|||..||++.        .++..+++.++.|||+|+.||+++           ++|||||.++|
T Consensus       768 ~~~----~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-----------~fvHRDLAaRN  832 (1025)
T KOG1095|consen  768 GPP----LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-----------HFVHRDLAARN  832 (1025)
T ss_pred             CCc----EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-----------CCcCcchhhhh
Confidence            544    8999999999999999654        489999999999999999999999           89999999999


Q ss_pred             EEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q psy17532        251 VLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP  330 (461)
Q Consensus       251 ILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~  330 (461)
                      |||+....|||+|||+|+.+...+.+.......-+.+|||||.+..     ..++.|+|||||||+|||++|.+      
T Consensus       833 CLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-----~iFtskSDvWsFGVllWEifslG------  901 (1025)
T KOG1095|consen  833 CLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-----GIFTSKSDVWSFGVLLWEIFSLG------  901 (1025)
T ss_pred             eeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-----cccccccchhhhHHHHHHHHhCC------
Confidence            9999999999999999997766655444433456789999999986     37888999999999999999986      


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       331 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                          ..||...     ...++...+..++ |...|..|+.     .++++|..||+.+|++||++..+++++..+...
T Consensus       902 ----~~PY~~~-----~n~~v~~~~~~gg-RL~~P~~CP~-----~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  902 ----ATPYPSR-----SNFEVLLDVLEGG-RLDPPSYCPE-----KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ----CCCCCCc-----chHHHHHHHHhCC-ccCCCCCCCh-----HHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                7788765     5556666666666 7777877776     899999999999999999999999988776654

>KOG0598|consensus

Probab=100.00  E-value=9.9e-48  Score=360.48  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=215.3

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ....++|++.++||+|+||+||.++.+  ++.+|+|.+++..    ........|..+|.+++||.||+++-.|.+.+  
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--   98 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--   98 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--
Confidence            456789999999999999999999984  6779999986432    23344567888899999999999999999876  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+|+|+||+.||.|...|+ ++.++++.+..++..|+.||.|||+.           +||||||||+|||+|.+|+++
T Consensus        99 --kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~-----------gIiyRDlKPENILLd~~GHi~  165 (357)
T KOG0598|consen   99 --KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK-----------GIIYRDLKPENILLDEQGHIK  165 (357)
T ss_pred             --eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC-----------CeeeccCCHHHeeecCCCcEE
Confidence              4599999999999999996 56799999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+||||++......  ..+.+.+||+.|||||++.+     ..|+..+|.||+|+++|||++|           ..||..
T Consensus       166 LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~-----~gy~~~vDWWsLGillYeML~G-----------~pPF~~  227 (357)
T KOG0598|consen  166 LTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLG-----KGYDKAVDWWSLGILLYEMLTG-----------KPPFYA  227 (357)
T ss_pred             EeccccchhcccCC--CccccccCCccccChHHHhc-----CCCCcccchHhHHHHHHHHhhC-----------CCCCcC
Confidence            99999998654433  24556899999999999987     4888999999999999999999           566665


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc----cccchhhhcHHHhhhhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL----SASCVVERGMLALCDTM  410 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~l~~~~~~~~  410 (461)
                      .     +..++.+.+..++. +..|..++.     +.+++++++|..||++|.    .+.++-+|.++....+.
T Consensus       228 ~-----~~~~~~~~I~~~k~-~~~p~~ls~-----~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  228 E-----DVKKMYDKILKGKL-PLPPGYLSE-----EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             c-----cHHHHHHHHhcCcC-CCCCccCCH-----HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence            4     56677777776652 333443443     789999999999999996    46677777766554444

>KOG0196|consensus

Probab=100.00  E-value=5.1e-48  Score=388.74  Aligned_cols=258  Identities=27%  Similarity=0.412  Sum_probs=220.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--C---CcEEEEEEecC--ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--N---ENVAVKIFLMQ--DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~---~~vAvK~~~~~--~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ...+.+.++||.|.||.|++|+++  +   ..||||.++..  .++..++..|+.+|.+++||||++|.|+.....+.  
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv--  705 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV--  705 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee--
Confidence            445678999999999999999984  2   45999999854  45566778999999999999999999999887765  


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                        +||+|||++|+|..||+.  +.+++.++..++++||.||.||-+.           ++|||||.++||||+.+..+|+
T Consensus       706 --MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm-----------~YVHRDLAARNILVNsnLvCKV  772 (996)
T KOG0196|consen  706 --MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM-----------NYVHRDLAARNILVNSNLVCKV  772 (996)
T ss_pred             --EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc-----------CchhhhhhhhheeeccceEEEe
Confidence              899999999999999964  4699999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCC-CCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGK-PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      +||||++.++++. ..+.+.+..-+++|.|||.+.-     ++++.+||||||||+|||.++-+          ..||.+
T Consensus       773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-----RKFTsASDVWSyGIVmWEVmSyG----------ERPYWd  837 (996)
T KOG0196|consen  773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYG----------ERPYWD  837 (996)
T ss_pred             ccccceeecccCCCccccccCCccceeecChhHhhh-----cccCchhhccccceEEEEecccC----------CCcccc
Confidence            9999999987654 2334455566789999999965     58889999999999999988764          788876


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                      +     +..+....+ ..++|.+.|.+++.     .|+.||..||++|-.+||.+.+|+..|..+...-
T Consensus       838 m-----SNQdVIkaI-e~gyRLPpPmDCP~-----aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  838 M-----SNQDVIKAI-EQGYRLPPPMDCPA-----ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             c-----chHHHHHHH-HhccCCCCCCCCcH-----HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            6     666666665 45566676766665     8999999999999999999999999998876543

>KOG0198|consensus

Probab=100.00  E-value=3.1e-47  Score=362.73  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=207.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..++...+.||+|+||.||++...  |+..|||.....+.. ....++|+.+|.+++|||||+++|.......  ..+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEe
Confidence            456888999999999999999995  689999998765322 2346899999999999999999997544432  35799


Q ss_pred             eehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~DF  264 (461)
                      +|||+++|+|.+++...  .+++..+.++++||++||+|||++           +||||||||+|||++. ++.+||+||
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~-----------g~vH~DiK~~NiLl~~~~~~~KlaDF  162 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK-----------GIVHCDIKPANILLDPSNGDVKLADF  162 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeccCcccceEEEeCCCCeEEeccC
Confidence            99999999999999654  599999999999999999999999           9999999999999999 799999999


Q ss_pred             CCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++....... ........||+.|||||++.++    .....++|||||||++.||+||           ..||...  
T Consensus       163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g----~~~~~~sDiWSlGCtVvEM~Tg-----------~~PW~~~--  225 (313)
T KOG0198|consen  163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG----EVARRESDIWSLGCTVVEMLTG-----------KPPWSEF--  225 (313)
T ss_pred             ccccccccccccccccccccCCccccCchhhcCC----CcCCccchhhhcCCEEEeccCC-----------CCcchhh--
Confidence            99988764111 1224457899999999999852    1222579999999999999999           5555432  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       . ......-.+......|.+|...+.     +.++++.+|+..||++||||+++++|++...
T Consensus       226 -~-~~~~~~~~ig~~~~~P~ip~~ls~-----~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  226 -F-EEAEALLLIGREDSLPEIPDSLSD-----EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             -c-chHHHHHHHhccCCCCCCCcccCH-----HHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence             0 112222233334455677766443     8899999999999999999999999987654

>KOG0582|consensus

Probab=100.00  E-value=8.2e-46  Score=353.23  Aligned_cols=297  Identities=22%  Similarity=0.281  Sum_probs=225.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh--hHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ......|++.++||.|.-++||+|+.  .++.||||++..+....  ....+|+..|+.++||||++++..|..+.    
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~----   97 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS----   97 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc----
Confidence            34567999999999999999999998  57899999998654433  34578999999999999999999998865    


Q ss_pred             eeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        184 EFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++|+||.||.+||+.+.++.   ..+.+..+..|.+++++||.|||.+           |.||||||+.||||+++|.+|
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-----------G~IHRdvKAgnILi~~dG~Vk  166 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-----------GHIHRDVKAGNILIDSDGTVK  166 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-----------CceecccccccEEEcCCCcEE
Confidence            56999999999999999964   3589999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCC-CCCC-CCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKP-CGDT-HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       261 i~DFGla~~~~~~~~-~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      |+|||.+..+..... .... ...+||+.|||||++...   ...|+.|+||||||++..||++|           +.||
T Consensus       167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~---~~GYdfKaDIwSfGITA~ELA~G-----------~aPf  232 (516)
T KOG0582|consen  167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ---LHGYDFKADIWSFGITACELAHG-----------HAPF  232 (516)
T ss_pred             EcCceeeeeecccCceeeEeeccccCcccccChHHhhhc---ccCccchhhhhhhhHHHHHHhcC-----------CCCc
Confidence            999999866644331 1112 567899999999997654   26899999999999999999999           5555


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCC--CCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhhhhccCCC
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPT--LPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTMEECWDH  416 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~c~~~  416 (461)
                      ...    +..+-+...+......+.  ..+.-........+++++..||.+||.+||||+++++|.++..++........
T Consensus       233 ~k~----pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~  308 (516)
T KOG0582|consen  233 SKY----PPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKK  308 (516)
T ss_pred             ccC----ChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchh
Confidence            432    122222222211111111  00111111234589999999999999999999999999998776544322222


Q ss_pred             ChhhhhhhhHHHHHHHHHHHh
Q psy17532        417 DAEARLSASCVVERVAWQSRA  437 (461)
Q Consensus       417 ~~~~r~~~~~~~~~~~~~~~~  437 (461)
                      --..-|+..+.+....|....
T Consensus       309 ~l~~l~~l~~r~~~~q~~~~~  329 (516)
T KOG0582|consen  309 LLQSLPPLGTRFKKSQSKEES  329 (516)
T ss_pred             hhccCCcHHHHHHHHHhhhcc
Confidence            222335556666666666543

>KOG4721|consensus

Probab=100.00  E-value=1.2e-47  Score=373.87  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=213.6

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..+...++.+..++-||.|+-|.||+|++.++.||||+++      ...|.+|.-|++|+|+||+.|.|+|....    -
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsP----c  186 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSP----C  186 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCc----e
Confidence            3455566777788899999999999999999999999863      24467788899999999999999998865    5


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      |+||||||..|-|+..|+. +.++...+..+..+||.||.|||.+           .|||||||.-||||..+..+||+|
T Consensus       187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h-----------KIIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH-----------KIIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh-----------hHhhhccCCCceEeeccceEEecc
Confidence            6999999999999999975 4689999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||-++......   ..-.+.||..|||||++..     ...+.|+|||||||+||||+||           ..||.....
T Consensus       256 FGTS~e~~~~S---TkMSFaGTVaWMAPEvIrn-----ePcsEKVDIwSfGVVLWEmLT~-----------EiPYkdVds  316 (904)
T KOG4721|consen  256 FGTSKELSDKS---TKMSFAGTVAWMAPEVIRN-----EPCSEKVDIWSFGVVLWEMLTG-----------EIPYKDVDS  316 (904)
T ss_pred             ccchHhhhhhh---hhhhhhhhHhhhCHHHhhc-----CCcccccceehhHHHHHHHHhc-----------CCCccccch
Confidence            99998876542   2345789999999999987     4788999999999999999999           788865421


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                           ..++-.|-...+..++|..+++     .++-||+.||+..|.+||++.+++.|+...
T Consensus       317 -----sAIIwGVGsNsL~LpvPstcP~-----GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  317 -----SAIIWGVGSNSLHLPVPSTCPD-----GFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             -----heeEEeccCCcccccCcccCch-----HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence                 2222233445566777877665     788999999999999999999999998653

>KOG0592|consensus

Probab=100.00  E-value=2.1e-46  Score=364.95  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=211.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~  180 (461)
                      .....+|.+++.||+|+|++|++|+.  .++.+|||++.+.-    .......+|-..|.+| .||.|++|+-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45667999999999999999999998  47889999985421    1111222344445566 89999999999999775


Q ss_pred             cceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                      +    |+|+||+++|+|.++|+ -+.+++.....++.+|+.||+|||+.           |||||||||+|||+|+||++
T Consensus       149 L----YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~-----------GIIHRDlKPENILLd~dmhi  213 (604)
T KOG0592|consen  149 L----YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN-----------GIIHRDLKPENILLDKDGHI  213 (604)
T ss_pred             e----EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc-----------CceeccCChhheeEcCCCcE
Confidence            4    99999999999999995 46799999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCC---------CC--CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPC---------GD--THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVS  328 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~  328 (461)
                      ||+|||.|+.+.+....         ..  ....+||..|.+||+|.++     ..+..+|||+||||||.|+.|     
T Consensus       214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-----~~~~~sDiWAlGCilyQmlaG-----  283 (604)
T KOG0592|consen  214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-----PAGPSSDLWALGCILYQMLAG-----  283 (604)
T ss_pred             EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-----CCCcccchHHHHHHHHHHhcC-----
Confidence            99999999998653221         11  1458999999999999874     677889999999999999999     


Q ss_pred             CCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        329 PPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       329 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                            ..||.+.     +.-.+.++++.-.  -.+|+.++.     .+.+||++.|..||.+|+|+++|-+|.++-...
T Consensus       284 ------~PPFra~-----NeyliFqkI~~l~--y~fp~~fp~-----~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  284 ------QPPFRAA-----NEYLIFQKIQALD--YEFPEGFPE-----DARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             ------CCCCccc-----cHHHHHHHHHHhc--ccCCCCCCH-----HHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                  5566544     2223334444332  345665553     789999999999999999999999999987776


Q ss_pred             hhh
Q psy17532        409 TME  411 (461)
Q Consensus       409 ~~~  411 (461)
                      +..
T Consensus       346 w~n  348 (604)
T KOG0592|consen  346 WEN  348 (604)
T ss_pred             hhh
Confidence            653

>KOG1094|consensus

Probab=100.00  E-value=8.2e-46  Score=362.26  Aligned_cols=254  Identities=25%  Similarity=0.355  Sum_probs=208.7

Q ss_pred             cceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ..+.+.+.||+|.||.|.+++..+ ..||||+++.....  ...+.+||.+|.+++|||||+++|+|..++++    ++|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi----cmI  613 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL----CMI  613 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch----HHH
Confidence            456678999999999999999976 89999999765433  35678999999999999999999999998866    899


Q ss_pred             ehhccCCChhhhhcCCC---CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +|||++|+|.+|+..+.   +.-....+|+.|||.||+||.+.           ++|||||.++|||++.++++||+|||
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~-----------nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL-----------NFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh-----------chhhccccccceeecCcccEEecCcc
Confidence            99999999999996652   24456788999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.+..+..+......+-+++|||+|.+..+     +++++||||+||+++||+++-+.         ..||...    
T Consensus       683 msR~lysg~yy~vqgr~vlpiRwmawEsillg-----kFttaSDvWafgvTlwE~~~~C~---------e~Py~~l----  744 (807)
T KOG1094|consen  683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLG-----KFTTASDVWAFGVTLWEVFMLCR---------EQPYSQL----  744 (807)
T ss_pred             cccccccCCceeeecceeeeeeehhHHHHHhc-----cccchhhhhhhHHHHHHHHHHHh---------hCchhhh----
Confidence            99988887766555566788999999988653     78899999999999999987653         5677654    


Q ss_pred             CCHHHHHHHH---hc-cC--CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        346 PSLEDMQEAV---VH-KK--LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~~~---~~-~~--~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                       +.++..+..   .. +.  .-+..|..++.     .++++|.+||..|-++||+++++...+..
T Consensus       745 -t~e~vven~~~~~~~~~~~~~l~~P~~cp~-----~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  745 -TDEQVVENAGEFFRDQGRQVVLSRPPACPQ-----GLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             -hHHHHHHhhhhhcCCCCcceeccCCCcCcH-----HHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence             333333221   11 11  12234444444     89999999999999999999999887754

>KOG0661|consensus

Probab=100.00  E-value=1.2e-47  Score=368.32  Aligned_cols=273  Identities=23%  Similarity=0.313  Sum_probs=209.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|.+++.||.|.||.||+|+.  .++.||||+++..-.  ++-...+|+..|++|+ |||||++.+++.+.+.   .+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~---~L   85 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR---IL   85 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc---eE
Confidence            46899999999999999999998  578899999865432  2334468999999998 9999999999988763   56


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++|||||+. +|+++++.  ..+++..+..|+.||++||+|+|.+           |+.||||||+|||+..+..+||+|
T Consensus        86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~-----------GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH-----------GFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc-----------CcccccCChhheEecccceeEecc
Confidence            999999986 99999954  4699999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+||.+.+...   .+..+.|..|+|||++...    ..|+.+.||||+|||++|+.+-++.|.+..+..++---..+.
T Consensus       154 FGLARev~SkpP---YTeYVSTRWYRAPEvLLrs----~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL  226 (538)
T KOG0661|consen  154 FGLAREVRSKPP---YTEYVSTRWYRAPEVLLRS----GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL  226 (538)
T ss_pred             cccccccccCCC---cchhhhcccccchHHhhhc----cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence            999999876654   3346889999999999864    467788999999999999999988775543221110000011


Q ss_pred             CCCCHHHHH---HHHhccCCC-C-----CCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQ---EAVVHKKLR-P-----TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~---~~~~~~~~~-~-----~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      +.|..+...   +....-+++ |     .+....+.  .+.+..+||.+|+.+||++||||++++++.++...
T Consensus       227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~--~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN--ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc--cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            111111111   111111111 1     11111111  45688899999999999999999999999987654

>KOG0578|consensus

Probab=100.00  E-value=4.3e-46  Score=365.71  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=211.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh-hHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS-WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ....|...+.||+|..|.||.|+.  +++.||||++....... ....+|+.+|+..+|+|||++++.+...+    ++|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d----eLW  346 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD----ELW  346 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc----eeE
Confidence            345678888999999999999988  56789999997655433 33468999999999999999999887654    669


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +|||||++|+|.|.+....+++.++..|+++++.||+|||.+           +|+|||||.+|||++.+|.+||+|||+
T Consensus       347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~-----------gIiHrDIKSDnILL~~~g~vKltDFGF  415 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR-----------GIIHRDIKSDNILLTMDGSVKLTDFGF  415 (550)
T ss_pred             EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc-----------ceeeeccccceeEeccCCcEEEeeeee
Confidence            999999999999999998999999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +..+.....  .....+||++|||||++..     +.|+.|+||||||++++||+-|           ..||..+   . 
T Consensus       416 caqi~~~~~--KR~TmVGTPYWMAPEVvtr-----k~YG~KVDIWSLGIMaIEMveG-----------EPPYlnE---~-  473 (550)
T KOG0578|consen  416 CAQISEEQS--KRSTMVGTPYWMAPEVVTR-----KPYGPKVDIWSLGIMAIEMVEG-----------EPPYLNE---N-  473 (550)
T ss_pred             eeccccccC--ccccccCCCCccchhhhhh-----cccCccccchhhhhHHHHHhcC-----------CCCccCC---C-
Confidence            988876543  4566899999999999976     5889999999999999999999           5555432   1 


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ....+......+......++.     .+..+++|+.+||..|+++|++|.|+|+|.+..++
T Consensus       474 PlrAlyLIa~ng~P~lk~~~k-----lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  474 PLRALYLIATNGTPKLKNPEK-----LSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             hHHHHHHHhhcCCCCcCCccc-----cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            222222222223333333443     34489999999999999999999999999987443

>KOG0600|consensus

Probab=100.00  E-value=8.8e-46  Score=357.92  Aligned_cols=261  Identities=25%  Similarity=0.330  Sum_probs=207.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .+.|+.++.||+|.||.||+|+.  +|+.||+|++..+...   .....+||.+|++|+||||++|.+......  ...+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~--~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL--SGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC--CceE
Confidence            46788999999999999999998  5788999999765532   233479999999999999999999987762  3467


Q ss_pred             eeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      |||+|||++ ||.-++...  .+++.++..++.|++.||+|+|++           +|+|||||.+|||||.+|.+||+|
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~-----------gvlHRDIK~SNiLidn~G~LKiaD  261 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR-----------GVLHRDIKGSNILIDNNGVLKIAD  261 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc-----------CeeeccccccceEEcCCCCEEecc
Confidence            999999998 999999765  599999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC----------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE----------  333 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~----------  333 (461)
                      ||||+++..... ...+..+-|..|.|||+|.|.    ..|+..+|+||.||||.||++|+++|.+..+.          
T Consensus       262 FGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~----t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc  336 (560)
T KOG0600|consen  262 FGLARFYTPSGS-APYTSRVVTLWYRPPELLLGA----TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC  336 (560)
T ss_pred             ccceeeccCCCC-cccccceEEeeccChHHhcCC----cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence            999998776543 234557889999999999986    57889999999999999999998887553211          


Q ss_pred             ----------CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        334 ----------YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       334 ----------~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                .++|+.........            +...+.+.+.  ..+....+|+..+|..||.+|.||.+++++-+
T Consensus       337 GSP~e~~W~~~kLP~~~~~kp~~~------------y~r~l~E~~~--~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey  402 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPHATIFKPQQP------------YKRRLRETFK--DFPASALDLLEKLLSLDPDKRGTASSALQSEY  402 (560)
T ss_pred             CCCChhccccccCCcccccCCCCc------------ccchHHHHhc--cCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence                      11221111000000            0111111111  12346789999999999999999999999877


Q ss_pred             H
Q psy17532        404 L  404 (461)
Q Consensus       404 ~  404 (461)
                      +
T Consensus       403 F  403 (560)
T KOG0600|consen  403 F  403 (560)
T ss_pred             c
Confidence            6

>KOG0616|consensus

Probab=100.00  E-value=2.8e-45  Score=333.09  Aligned_cols=254  Identities=20%  Similarity=0.312  Sum_probs=216.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|+.++.||.|+||.|.+++.  +|.-+|+|++....    ++.....+|..+|+.+.||+++++++.+.+...  
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~--  118 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN--  118 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe--
Confidence            5678999999999999999999998  46789999997543    233444678899999999999999999998764  


Q ss_pred             eeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                        +++||||.+||.|.++|+ .+++++..+..++.||+.||+|||+.           +|++|||||+|||+|++|.+||
T Consensus       119 --lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~-----------~iiYRDLKPENiLlD~~G~iKi  185 (355)
T KOG0616|consen  119 --LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL-----------DIIYRDLKPENLLLDQNGHIKI  185 (355)
T ss_pred             --EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc-----------CeeeccCChHHeeeccCCcEEE
Confidence              499999999999999996 46899999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|+.+..     .+.+.+||+.|+|||++..     +.+...+|.|||||++|||+.|           ..||...
T Consensus       186 tDFGFAK~v~~-----rT~TlCGTPeYLAPEii~s-----k~ynkavDWWalGVLIYEMlaG-----------~pPF~~~  244 (355)
T KOG0616|consen  186 TDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQS-----KGYNKAVDWWALGVLIYEMLAG-----------YPPFYDD  244 (355)
T ss_pred             EeccceEEecC-----cEEEecCCccccChHHhhc-----CCCCcchhHHHHHHHHHHHHcC-----------CCCCcCC
Confidence            99999998764     3556899999999999976     5888899999999999999999           6677655


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHhhhhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLALCDTM  410 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~~~~~  410 (461)
                           +...+.+++..++++  +|..+..     ++++|++++|+.|-.+|.     ...+|-.|.|+....+.
T Consensus       245 -----~~~~iY~KI~~~~v~--fP~~fs~-----~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  245 -----NPIQIYEKILEGKVK--FPSYFSS-----DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             -----ChHHHHHHHHhCccc--CCcccCH-----HHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence                 446777888887654  5555444     799999999999999993     45678888777655444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.5e-45  Score=360.80  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~  178 (461)
                      ...++|++.+.||+|+||.||+|.+.       ++.||||++.....  ......+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34568999999999999999999752       35799999864322  223456789989898 899999999988754


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-------------------------------------------------------
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-------------------------------------------------------  203 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------------------------------------  203 (461)
                      +.   .+++||||+++|+|.+++..                                                       
T Consensus        84 ~~---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 NG---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             CC---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            32   45899999999999999853                                                       


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCC
Q psy17532        204 --------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP  275 (461)
Q Consensus       204 --------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~  275 (461)
                              ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++.......
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~  229 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR-----------KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD  229 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEECCCCccceEEEcCCCcEEEeecccccccccCcc
Confidence                    2377888999999999999999998           999999999999999999999999999987644332


Q ss_pred             CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHH
Q psy17532        276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA  354 (461)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~  354 (461)
                      ........++..|+|||++.+     ..++.++|||||||++|||++ |           ..||.....    .+.+...
T Consensus       230 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~el~~~g-----------~~pf~~~~~----~~~~~~~  289 (338)
T cd05102         230 YVRKGSARLPLKWMAPESIFD-----KVYTTQSDVWSFGVLLWEIFSLG-----------ASPYPGVQI----NEEFCQR  289 (338)
T ss_pred             hhcccCCCCCccccCcHHhhc-----CCCCcccCHHHHHHHHHHHHhCC-----------CCCCCCCCc----cHHHHHH
Confidence            222333456788999999865     367789999999999999997 7           556644311    1222222


Q ss_pred             HhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       355 ~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      + ........+..     .+..+.+|+.+||+.||++|||+.++++.|..+.
T Consensus       290 ~-~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         290 L-KDGTRMRAPEN-----ATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             H-hcCCCCCCCCC-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2 22222333332     2347999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193|consensus

Probab=100.00  E-value=7.2e-46  Score=365.31  Aligned_cols=262  Identities=28%  Similarity=0.392  Sum_probs=209.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ...+.+.+.+.||+|+||+||+|+|.| .||||++.....   +...+++|+..+++-+|.||+-|.|+|..+.     +
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-----~  462 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-----L  462 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----e
Confidence            344567788999999999999999976 489999986543   3455689999999999999999999998765     2


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .||+.+|+|-+|+.+|+.  ..+.....+.|+.|||+||.|||.+           +|||||||..||++.++++|||+|
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK-----------~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK-----------NIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh-----------hhhhhhccccceEEccCCcEEEec
Confidence            799999999999999964  4588899999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |||+..-..-..........|...|||||+++..  ....|+..+||||||+++|||++|           .+||...  
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmq--d~nPfS~qSDVYaFGiV~YELltg-----------~lPysi~--  596 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ--DDNPFSFQSDVYAFGIVWYELLTG-----------ELPYSIQ--  596 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhc--ccCCCCcccchhhhhHHHHHHHhC-----------cCCcCCC--
Confidence            9998543221111123345688999999999753  356889999999999999999999           6777633  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                         ..++++-.+-++.+.+......  ..+..++++|+..||..++++||.+.+|+..|..+.-
T Consensus       597 ---~~dqIifmVGrG~l~pd~s~~~--s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  597 ---NRDQIIFMVGRGYLMPDLSKIR--SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---ChhheEEEecccccCccchhhh--ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               3333333344443444333221  2245589999999999999999999999998876654

>KOG0194|consensus

Probab=100.00  E-value=1.5e-45  Score=366.44  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=217.2

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEEC--C---Cc-EEEEEEecC----ChhhhHHHHHHHHcCCCCCCCeeEEEEE
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--N---EN-VAVKIFLMQ----DKQSWQSEQEIFKLPHMEHDNILRYIGA  174 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~---~~-vAvK~~~~~----~~~~~~~~~ei~~l~~l~H~nIv~l~g~  174 (461)
                      ..++..-++..+.+.||+|+||.||+|+++  +   .. ||||..+..    ..+...+..|+++|.+++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345556677888899999999999999983  1   23 899988742    2334456789999999999999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEE
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVL  252 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NIL  252 (461)
                      .....++    ++|||+|.||+|.+||+...  ++..+.+.++.++|.||+|||++           +++||||.++|||
T Consensus       230 a~~~~Pl----~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k-----------~~IHRDIAARNcL  294 (474)
T KOG0194|consen  230 AVLEEPL----MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK-----------NCIHRDIAARNCL  294 (474)
T ss_pred             EcCCCcc----EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC-----------CCcchhHhHHHhe
Confidence            9988766    99999999999999997654  99999999999999999999999           9999999999999


Q ss_pred             EcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q psy17532        253 LKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG  332 (461)
Q Consensus       253 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~  332 (461)
                      ++.++.+||+|||+++.-....  .......-+.+|+|||.+...     .++.++|||||||++||+++.+        
T Consensus       295 ~~~~~~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~-----~~s~kTDV~sfGV~~~Eif~~g--------  359 (474)
T KOG0194|consen  295 YSKKGVVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTG-----IFSFKTDVWSFGVLLWEIFENG--------  359 (474)
T ss_pred             ecCCCeEEeCccccccCCccee--eccccccCcceecChhhhccC-----ccccccchhheeeeEEeeeccC--------
Confidence            9999999999999997654111  111122467899999999763     7789999999999999999943        


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                        ..||.+.     ...++...+...+++...|...+     ..+..++.+||..||++||+|.++.+.+..+..
T Consensus       360 --~~Py~g~-----~~~~v~~kI~~~~~r~~~~~~~p-----~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  360 --AEPYPGM-----KNYEVKAKIVKNGYRMPIPSKTP-----KELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             --CCCCCCC-----CHHHHHHHHHhcCccCCCCCCCH-----HHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence              4578766     66678888878888888777433     488999999999999999999999999877664

>KOG0659|consensus

Probab=100.00  E-value=2.3e-45  Score=329.10  Aligned_cols=268  Identities=26%  Similarity=0.339  Sum_probs=207.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .+|...+.||+|.||.||+|++  +|+.||||+++..+..   .....+||..|+.++|+||+.++++|......    .
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l----~   77 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL----S   77 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce----E
Confidence            4678889999999999999998  5789999999765433   34567999999999999999999999887655    7


Q ss_pred             eeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||+|||+. +|...++..  .++..++..++.++++||+|||++           .|+||||||.|+||+.+|.+||+||
T Consensus        78 lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~-----------~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   78 LVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK-----------WILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             EEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh-----------hhhcccCCccceEEcCCCcEEeecc
Confidence            99999997 999999754  589999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------C
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------R  335 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------~  335 (461)
                      |+|+.+.+...  .....+-|..|+|||.+.|.    +.|+..+||||.|||+.||+.|.+.|.+..+-.         .
T Consensus       146 GLAr~f~~p~~--~~~~~V~TRWYRAPELLfGs----r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG  219 (318)
T KOG0659|consen  146 GLARFFGSPNR--IQTHQVVTRWYRAPELLFGS----RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG  219 (318)
T ss_pred             cchhccCCCCc--ccccceeeeeccChHHhccc----hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence            99999876542  22334789999999999886    688889999999999999999977665544311         1


Q ss_pred             CCCccccCCCCCHHHHHHHHhccC-CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKK-LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .|-...   .|....+-+.+.... ..+.....++  .++.+..+|+.++|..||.+|+|++|+++|..+..
T Consensus       220 TP~~~~---WP~~~~lpdY~~~~~~P~~~~~~lf~--aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  220 TPTPDQ---WPEMTSLPDYVKIQQFPKPPLNNLFP--AASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             CCCccc---CccccccccHHHHhcCCCCccccccc--cccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            111111   011111111111110 0011111121  23446789999999999999999999999976643

>KOG0583|consensus

Probab=100.00  E-value=1.1e-44  Score=358.32  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=212.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC----Ch--hhhHHHHHHHHcCCCC-CCCeeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ----DK--QSWQSEQEIFKLPHME-HDNILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~----~~--~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~  179 (461)
                      ...+.|.+.+.||+|+||+|++|.+  +++.||||++...    ..  ......+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999988  5789999976543    11  2334457999999998 999999999998866


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-C
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-L  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~  257 (461)
                      .    +++||||+.+|+|.+++.. +++.+..+.+++.|++.|++|+|+.           +|+||||||+|||++.+ +
T Consensus        94 ~----~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~-----------gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   94 K----IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR-----------GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             e----EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-----------CEeeCCCCHHHEEecCCCC
Confidence            3    6999999999999999965 7899999999999999999999999           99999999999999999 9


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDA-FLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      .+||+|||++......  .......+||+.|+|||++.+...    | +.++||||+||+||.|++|           ..
T Consensus       159 ~~Kl~DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~----Y~g~~aDvWS~GViLy~ml~G-----------~~  221 (370)
T KOG0583|consen  159 NLKLSDFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGT----YSGKAADVWSLGVILYVLLCG-----------RL  221 (370)
T ss_pred             CEEEeccccccccCCC--CCcccCCCCCcccCCHHHhCCCCC----cCCchhhhhhhHHHHHHHHhC-----------CC
Confidence            9999999999887411  134566899999999999987531    3 3779999999999999999           78


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ||...     ....+...+..+.  ..+|....    +.++.+|+.+||..||.+|+|+.++++|.|...
T Consensus       222 PF~d~-----~~~~l~~ki~~~~--~~~p~~~~----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  222 PFDDS-----NVPNLYRKIRKGE--FKIPSYLL----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCc-----cHHHHHHHHhcCC--ccCCCCcC----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            88663     5555555554443  34555431    348899999999999999999999999998876

>KOG0658|consensus

Probab=100.00  E-value=8.4e-46  Score=346.80  Aligned_cols=275  Identities=22%  Similarity=0.288  Sum_probs=209.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc-ceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI-HTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~-~~~~~l  187 (461)
                      .-+|.-.+++|+|+||.||+|..  .++.||||+.-.+.+   ..-+|+.+|..++|||||+++-+|...... .-...+
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            34688889999999999999998  457899998754433   223577788899999999999988765443 123458


Q ss_pred             eehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceEE
Q psy17532        188 ITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAI  261 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~ki  261 (461)
                      ||||||. +|.++++     +..++...+.-+..||.+||+|||+.           +|+||||||.|+|+|.+ |.+||
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-----------~IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-----------GICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-----------CcccCCCChheEEEcCCCCeEEe
Confidence            9999998 9999997     46788888999999999999999998           99999999999999976 99999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      ||||.|+.+..++.   ......|..|+|||.+.|.    ..|+.+.||||.||++.||+-|++.|.+..+..++--...
T Consensus       168 cDFGSAK~L~~~ep---niSYicSRyYRaPELifga----~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik  240 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK  240 (364)
T ss_pred             ccCCcceeeccCCC---ceeEEEeccccCHHHHcCc----cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence            99999999987764   3446778999999999886    6888999999999999999999888776554322222222


Q ss_pred             cCCCCCHHHHHHHHhc------cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVH------KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~------~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .-+.|+.+++......      ................+.+..+|+.++|.++|.+|.++.|++.|.++-..
T Consensus       241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence            2233344443322111      11111111111112344588999999999999999999999999876543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-44  Score=349.28  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=203.7

Q ss_pred             eEeecCCceEEEEEEECCCcEEEEEEecCChhh----hHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQS----WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~----~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ..||+|++|.||+|+++|+.||||.+.......    ..+.+|+.++.+++|||||+++|++.+.......+++||||++
T Consensus        26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            578999999999999999999999987543322    3456899999999999999999998762211235689999999


Q ss_pred             CCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        194 RGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       194 ~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      +|+|.+++.. ..+++.....++.|++.||.|||+..          +++||||||+|||+++++.+||+|||+++.+..
T Consensus       106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----------~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT----------NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC----------CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            9999999964 46899999999999999999999731          788999999999999999999999999986543


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      .     .....|+..|+|||++.+.   ...++.++|||||||++|||++|           ..||...     ...++.
T Consensus       176 ~-----~~~~~~~~~y~aPE~~~~~---~~~~~~k~Di~SlGvil~el~~g-----------~~Pf~~~-----~~~~~~  231 (283)
T PHA02988        176 P-----PFKNVNFMVYFSYKMLNDI---FSEYTIKDDIYSLGVVLWEIFTG-----------KIPFENL-----TTKEIY  231 (283)
T ss_pred             c-----cccccCcccccCHHHhhhc---cccccchhhhhHHHHHHHHHHHC-----------CCCCCCC-----CHHHHH
Confidence            2     1234688999999998652   13678899999999999999999           6677543     445555


Q ss_pred             HHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..+.....++.+|..+     +..+.+||.+||+.||++|||++++++.+..+.
T Consensus       232 ~~i~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        232 DLIINKNNSLKLPLDC-----PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHhcCCCCCCCCcC-----cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            5665555555655433     348999999999999999999999999887654

>KOG0585|consensus

Probab=100.00  E-value=6e-45  Score=349.37  Aligned_cols=265  Identities=24%  Similarity=0.340  Sum_probs=213.6

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---------------hhHHHHHHHHcCCCCCCCeeE
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---------------SWQSEQEIFKLPHMEHDNILR  170 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---------------~~~~~~ei~~l~~l~H~nIv~  170 (461)
                      ....+.|++++.||+|.||.|-+|+.  .++.||||++.+....               ..+..+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            44578999999999999999999998  5788999999543211               124468999999999999999


Q ss_pred             EEEEEecCCccceeeeeeehhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCC
Q psy17532        171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN  249 (461)
Q Consensus       171 l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~  249 (461)
                      |+.+..+..  ...+|||+|||..|.+...-.... +++.++.++++++..||+|||.+           +||||||||+
T Consensus       173 LiEvLDDP~--s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q-----------giiHRDIKPs  239 (576)
T KOG0585|consen  173 LIEVLDDPE--SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ-----------GIIHRDIKPS  239 (576)
T ss_pred             EEEeecCcc--cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc-----------Ceeccccchh
Confidence            999988766  457899999999998877665555 99999999999999999999999           9999999999


Q ss_pred             cEEEcCCCceEEEecCCccccCCCCCC---CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCC
Q psy17532        250 NVLLKSDLTAAIADFGLALLFEPGKPC---GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS  326 (461)
Q Consensus       250 NILl~~~~~~ki~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~  326 (461)
                      |+||+++|++||+|||.+..+..+...   ......+||+.|||||.+.++... ...+.+.||||+||+||-|+.|   
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~-~~~g~a~DiWalGVTLYCllfG---  315 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSF-SYSGFALDIWALGVTLYCLLFG---  315 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCc-cccchhhhhhhhhhhHHHhhhc---
Confidence            999999999999999999877443211   123346899999999998774221 1234678999999999999999   


Q ss_pred             CCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                              +.||.+.     ..-++..++....+.  +|..   ....+.+++||.++|.+||+.|.+..+|..|+|...
T Consensus       316 --------~~PF~~~-----~~~~l~~KIvn~pL~--fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  316 --------QLPFFDD-----FELELFDKIVNDPLE--FPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             --------cCCcccc-----hHHHHHHHHhcCccc--CCCc---ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                    7888665     445566666665442  3322   123458999999999999999999999999998655


Q ss_pred             h
Q psy17532        407 C  407 (461)
Q Consensus       407 ~  407 (461)
                      -
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            4

>KOG0593|consensus

Probab=100.00  E-value=8e-46  Score=337.36  Aligned_cols=266  Identities=23%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      +.|+.+.++|+|+||.||++++  +|+.||||++.....+   .....+||..|++++|+|+|.++.+|....    .++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr----klh   77 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR----KLH   77 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc----eeE
Confidence            4678888999999999999998  4788999999754432   234579999999999999999999998866    458


Q ss_pred             eeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||+|||+. ++.+-|.  .+.++.+.+.+++.|++.|+.|+|++           ++|||||||+||||+.++.+|||||
T Consensus        78 LVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~-----------n~IHRDIKPENILit~~gvvKLCDF  145 (396)
T KOG0593|consen   78 LVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN-----------NCIHRDIKPENILITQNGVVKLCDF  145 (396)
T ss_pred             EEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc-----------CeecccCChhheEEecCCcEEeccc
Confidence            99999998 5555553  34589999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCC-CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc-c
Q psy17532        265 GLALLFEP-GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE-V  342 (461)
Q Consensus       265 Gla~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~-~  342 (461)
                      |+|+.+.. +..   .+..+.|..|+|||.+.|.    .+|+..+||||.||++.||++|.+.|.+.++-.++---.. .
T Consensus       146 GFAR~L~~pgd~---YTDYVATRWYRaPELLvGD----tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL  218 (396)
T KOG0593|consen  146 GFARTLSAPGDN---YTDYVATRWYRAPELLVGD----TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL  218 (396)
T ss_pred             hhhHhhcCCcch---hhhhhhhhhccChhhhccc----CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence            99999873 332   2345789999999999884    5788889999999999999999766544332110000000 0


Q ss_pred             CCCCCHHHHHHHHh----ccCCCCCCC-------chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        343 GDHPSLEDMQEAVV----HKKLRPTLP-------ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       343 ~~~~~~~~~~~~~~----~~~~~~~~p-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |+  .....+....    ..+.+.+-|       ..++.  .+..+.+|++.||..||++|++.+++++|..+
T Consensus       219 G~--L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~--~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  219 GN--LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK--ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             cc--cCHHHHHHhccCCceeeeecCCCCCccchhhhccc--chHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence            00  0000000000    011111111       11221  34478899999999999999999999999876

>KOG0588|consensus

Probab=100.00  E-value=9.4e-45  Score=360.29  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=220.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC----ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~----~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....-|++++.||+|+-|.|-+|++  +|+.+|||++...    .......|+||.+|+-+.||||+++|+++.+..   
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~---   85 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ---   85 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc---
Confidence            3456789999999999999999999  6899999999654    233455689999999999999999999998865   


Q ss_pred             eeeeeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       ++|+|.||+++|.|++++ +.+++++.++.+++.||+.|+.|+|..           +|+||||||+|+|+|.++.+||
T Consensus        86 -~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~-----------~icHRDLKpENlLLd~~~nIKI  153 (786)
T KOG0588|consen   86 -HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF-----------NICHRDLKPENLLLDVKNNIKI  153 (786)
T ss_pred             -eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh-----------cceeccCCchhhhhhcccCEee
Confidence             569999999999999988 667899999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|..-..+.   ...+.+|++.|.|||++.|..|.    +.++||||.|||||.|+||           ++||.+.
T Consensus       154 ADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYd----G~~sDVWSCGVILfALLtG-----------~LPFdDd  215 (786)
T KOG0588|consen  154 ADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYD----GRPSDVWSCGVILFALLTG-----------KLPFDDD  215 (786)
T ss_pred             eccceeecccCCc---cccccCCCcccCCchhhcCCCCC----CCccccchhHHHHHHHHhC-----------CCCCCCc
Confidence            9999997655443   34567999999999999986332    3679999999999999999           8999755


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                           +...+..+|..+.+.  +|...+     .+..+|+.+|+..||++|.|.+||++|++.....
T Consensus       216 -----Nir~LLlKV~~G~f~--MPs~Is-----~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  216 -----NIRVLLLKVQRGVFE--MPSNIS-----SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             -----cHHHHHHHHHcCccc--CCCcCC-----HHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence                 788888888887653  444333     3789999999999999999999999999876654

>KOG0663|consensus

Probab=100.00  E-value=7.6e-45  Score=335.05  Aligned_cols=270  Identities=23%  Similarity=0.291  Sum_probs=209.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhh---hHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~---~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..+.|+.+..|++|.||.||+|+++  ++.||+|+++......   ....+||.+|.+++|||||.+-.+....+  ...
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--~d~  151 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--MDK  151 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--cce
Confidence            4567899999999999999999994  6789999998654321   23468999999999999999999887655  346


Q ss_pred             eeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +|+|||||+. ||..++..  +++...+...++.|+++||+|||.+           .|+|||||++|+|++..|.+||+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~-----------wilHRDLK~SNLLm~~~G~lKia  219 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN-----------WILHRDLKTSNLLLSHKGILKIA  219 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc-----------eeEecccchhheeeccCCcEEec
Confidence            8999999998 99999953  5799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC--------
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY--------  334 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~--------  334 (461)
                      |||+|+.+....  ...+..+-|..|+|||++.|.    +.|++..|+||+|||+.|++++++.|.+.....        
T Consensus       220 DFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~----~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l  293 (419)
T KOG0663|consen  220 DFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGA----KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL  293 (419)
T ss_pred             ccchhhhhcCCc--ccCcceEEEeeecCHHHhcCC----cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence            999999886543  334556889999999999986    678899999999999999999988886643211        


Q ss_pred             -CCCCccccCCCCCHHHHH--H-----HHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        335 -RLPFSAEVGDHPSLEDMQ--E-----AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       335 -~~pf~~~~~~~~~~~~~~--~-----~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ..|-...   .+.+..+-  .     ......++..++.    ...++.-.+|+..+|.+||.+|.||++.|+|-++..
T Consensus       294 lGtPte~i---wpg~~~lp~~k~~~f~~~pyn~lr~kF~~----~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  294 LGTPSEAI---WPGYSELPAVKKMTFSEHPYNNLRKKFGA----LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             hCCCcccc---CCCccccchhhccccCCCCchhhhhhccc----cccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence             1111000   00000000  0     0001111222221    112346789999999999999999999999987765

>KOG0605|consensus

Probab=100.00  E-value=3.9e-44  Score=349.34  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=214.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ....++|+++.+||+|+||.||+|+-  +|+.+|+|++++....    ......|-.+|...++|+||+|+-.|.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            56788999999999999999999987  5788999999765432    22334566778889999999999999998755


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                          ||||||++|||+..+|. ...|+++.+..++.+++.|++.||+.           |+|||||||+|+|||..|++|
T Consensus       217 ----YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~-----------gyIHRDIKPdNlLiD~~GHiK  281 (550)
T KOG0605|consen  217 ----YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL-----------GYIHRDIKPDNLLIDAKGHIK  281 (550)
T ss_pred             ----EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc-----------CcccccCChhheeecCCCCEe
Confidence                99999999999999984 56799999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCC---------------------CCCC------------------------CCCCCcCCCccccccccc
Q psy17532        261 IADFGLALLFEPG---------------------KPCG------------------------DTHGQVGTRRYMAPEVLE  295 (461)
Q Consensus       261 i~DFGla~~~~~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~l~  295 (461)
                      |+||||+..+...                     ....                        .....+||+-|||||++.
T Consensus       282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll  361 (550)
T KOG0605|consen  282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL  361 (550)
T ss_pred             eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence            9999999544210                     0000                        011347999999999998


Q ss_pred             ccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHH
Q psy17532        296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGML  375 (461)
Q Consensus       296 ~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  375 (461)
                      +     +.|+..+|+||||||+|||+.|           -.||.+.     +..+....+........+|....   .+.
T Consensus       362 ~-----kgY~~~cDwWSLG~ImyEmLvG-----------yPPF~s~-----tp~~T~rkI~nwr~~l~fP~~~~---~s~  417 (550)
T KOG0605|consen  362 G-----KGYGKECDWWSLGCIMYEMLVG-----------YPPFCSE-----TPQETYRKIVNWRETLKFPEEVD---LSD  417 (550)
T ss_pred             c-----CCCCccccHHHHHHHHHHHHhC-----------CCCCCCC-----CHHHHHHHHHHHhhhccCCCcCc---ccH
Confidence            8     4788899999999999999999           6666655     55666666666655555555432   335


Q ss_pred             HHHHHHHHHccccHhhhcc---ccchhhhcHHHhhhhh
Q psy17532        376 ALCDTMEECWDHDAEARLS---ASCVVERGMLALCDTM  410 (461)
Q Consensus       376 ~l~~li~~cl~~dP~~Rps---~~evl~~l~~~~~~~~  410 (461)
                      +..+||.+|+. ||++|..   ++||-+|+++....+.
T Consensus       418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            88999999999 9999985   7888899988766554

>KOG0201|consensus

Probab=100.00  E-value=4.5e-45  Score=347.97  Aligned_cols=250  Identities=29%  Similarity=0.391  Sum_probs=204.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..|+..+.||+|.||.||+|..  .++.||+|++.....  .....++|+..+..++++||.++||.+..+..+    |+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L----wi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL----WI   88 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH----HH
Confidence            3577779999999999999998  468899999976543  334567899999999999999999999887654    99


Q ss_pred             eehhccCCChhhhhcCCCC-CHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCNIV-TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||||.+|++.+.|+.+.+ .+..+.-+++++..||.|||.+           +.+|||||+.|||+..+|.+|++|||.
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~-----------~kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE-----------KKIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc-----------ceecccccccceeEeccCcEEEEecce
Confidence            9999999999999987665 8888899999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +..+.....  .....+||+.|||||++.+     ..|+.|+||||||++.+||++|.+|+..-.+ ++.-|        
T Consensus       158 a~ql~~~~~--rr~tfvGTPfwMAPEVI~~-----~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlf--------  221 (467)
T KOG0201|consen  158 AGQLTNTVK--RRKTFVGTPFWMAPEVIKQ-----SGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLF--------  221 (467)
T ss_pred             eeeeechhh--ccccccccccccchhhhcc-----ccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEE--------
Confidence            988776542  3467899999999999986     4788999999999999999999555432211 01111        


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                              .+.+...|.+...     .+..+++||..||++||+.||+|.++++|-+..
T Consensus       222 --------lIpk~~PP~L~~~-----~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk  267 (467)
T KOG0201|consen  222 --------LIPKSAPPRLDGD-----FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIK  267 (467)
T ss_pred             --------eccCCCCCccccc-----cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHH
Confidence                    1112222233333     344799999999999999999999999996543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-43  Score=350.05  Aligned_cols=250  Identities=21%  Similarity=0.273  Sum_probs=203.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....+|++.+.||+|+||.||+|+.+  ++.||||.+....    .......+|+.++.+++||||+++++++.+.+   
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---   91 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN---   91 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC---
Confidence            34678999999999999999999984  6789999986432    12234567888999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||
T Consensus        92 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~dlkp~NIll~~~~~~kl  159 (329)
T PTZ00263         92 -RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK-----------DIIYRDLKPENLLLDNKGHVKV  159 (329)
T ss_pred             -EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCHHHEEECCCCCEEE
Confidence             45999999999999999854 4689999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++.....     .....||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...
T Consensus       160 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg-----------~~pf~~~  218 (329)
T PTZ00263        160 TDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSK-----GHGKAVDWWTMGVLLYEFIAG-----------YPPFFDD  218 (329)
T ss_pred             eeccCceEcCCC-----cceecCChhhcCHHHHcCC-----CCCCcceeechHHHHHHHHcC-----------CCCCCCC
Confidence            999999876432     2235789999999999763     567889999999999999999           5566432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~  406 (461)
                           ...+..+.+....  ..+|...+     ..+.+||.+||+.||++||+     +++++.|.+...
T Consensus       219 -----~~~~~~~~i~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        219 -----TPFRIYEKILAGR--LKFPNWFD-----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             -----CHHHHHHHHhcCC--cCCCCCCC-----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence                 3334444444432  23443322     37899999999999999997     588998887644

>KOG0660|consensus

Probab=100.00  E-value=1.4e-44  Score=337.91  Aligned_cols=278  Identities=25%  Similarity=0.317  Sum_probs=211.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEec--C-ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecC-Cccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLM--Q-DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG-ESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~--~-~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~-~~~~~~~  185 (461)
                      ..|...+.||+|+||.|..+..  +|+.||||++..  + .....+..+|+..|+.++|+||+.+++++..+ ......+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4555678999999999999998  578999999862  2 22334557899999999999999999998762 2224578


Q ss_pred             eeeehhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |+|+|+|+. +|...++.+. ++.+....++.|+++||.|+|+.           +|+||||||+|+|++.+..+||+||
T Consensus       102 YiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA-----------nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen  102 YLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA-----------NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             EEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc-----------cccccccchhheeeccCCCEEeccc
Confidence            999999965 9999998877 99999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+|+...........+..+.|..|.|||++...    ..|+...||||.|||+.||++|++.|.+...-.++--......
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~----~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNS----SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG  245 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhcc----ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence            999988654222334667889999999999764    6888999999999999999999888865432111100001111


Q ss_pred             CCCHHH--------HHHHHhccCCCCCCC--chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        345 HPSLED--------MQEAVVHKKLRPTLP--ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       345 ~~~~~~--------~~~~~~~~~~~~~~p--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .|..+.        ....+.+....+..|  ..++  .......+|+++||..||.+|+|++|+++|+....-
T Consensus       246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp--~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP--NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC--CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            122221        122222222233322  2233  234577899999999999999999999999975543

>KOG0694|consensus

Probab=100.00  E-value=3e-43  Score=352.03  Aligned_cols=273  Identities=23%  Similarity=0.328  Sum_probs=219.8

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----h--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----K--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....+|.++++||+|+||+|+++.++  ++.+|||.+++..    .  .....|+.|..+.. +||.+++++.+|.+.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTKE  442 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccCC
Confidence            567789999999999999999999995  5679999997543    2  22233444555555 8999999999999876


Q ss_pred             ccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                          ++|+||||+.||++..+.+...+++..+..++..|+.||.|||++           +|||||||.+|||+|.+|++
T Consensus       443 ----~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~-----------~IIYRDlKLdNiLLD~eGh~  507 (694)
T KOG0694|consen  443 ----HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN-----------GIIYRDLKLDNLLLDTEGHV  507 (694)
T ss_pred             ----eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc-----------CceeeecchhheEEcccCcE
Confidence                459999999999987777888999999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++......  ..+.+.+||+.|||||++.+     ..|+..+|.|||||+||||+.|           +.||.
T Consensus       508 kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e-----~~Yt~aVDWW~lGVLlyeML~G-----------q~PF~  569 (694)
T KOG0694|consen  508 KIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTE-----QSYTRAVDWWGLGVLLYEMLVG-----------ESPFP  569 (694)
T ss_pred             EecccccccccCCCC--CccccccCChhhcChhhhcc-----CcccchhhHHHHHHHHHHHHcC-----------CCCCC
Confidence            999999998755322  35677999999999999987     4888899999999999999999           77777


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHHhhhhh-hcc
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLALCDTM-EEC  413 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~~~~~~-~~c  413 (461)
                      ++     +.+++.+.+.....  .+|...+     .+..++|+++|..||++|..+     .+|..|.++....+. +.-
T Consensus       570 gd-----dEee~FdsI~~d~~--~yP~~ls-----~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  570 GD-----DEEEVFDSIVNDEV--RYPRFLS-----KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             CC-----CHHHHHHHHhcCCC--CCCCccc-----HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence            65     66777777766543  3443333     378899999999999999965     677788877655444 333


Q ss_pred             CCCChhhhhhhhH
Q psy17532        414 WDHDAEARLSASC  426 (461)
Q Consensus       414 ~~~~~~~r~~~~~  426 (461)
                      -+..|.-+|+...
T Consensus       638 r~i~PPf~P~i~~  650 (694)
T KOG0694|consen  638 RRIKPPFVPTIKG  650 (694)
T ss_pred             ccCCCCCCcccCC
Confidence            3334545555543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.8e-43  Score=351.67  Aligned_cols=257  Identities=24%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|++       .+..||||+++....  ......+|+.++..+ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            44556899999999999999999975       235799999864322  223456799999989 89999999999988


Q ss_pred             CCccceeeeeeehhccCCChhhhhcCC-----------------------------------------------------
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKCN-----------------------------------------------------  204 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------  204 (461)
                      ...    .++||||+++|+|.++++..                                                     
T Consensus       111 ~~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         111 GGP----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             CCc----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            664    48999999999999988431                                                     


Q ss_pred             -----------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        205 -----------------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       205 -----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                                             .+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dlkp~Nill~~~~~~kl  255 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-----------NCIHRDLAARNILLTHGRITKI  255 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCchhhEEEECCCcEEE
Confidence                                   367888999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++...............++..|+|||++.+     ..++.++|||||||++|||++++          ..||...
T Consensus       256 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDi~slG~~l~ellt~g----------~~p~~~~  320 (375)
T cd05104         256 CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGILLWEIFSLG----------SSPYPGM  320 (375)
T ss_pred             ecCccceeccCcccccccCCCCCCcceeChhHhcC-----CCCCCCCCHHHHHHHHHHHHhcC----------CCCCCCC
Confidence            99999987654332222223345678999999876     36778999999999999999832          4555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .    ....... ......++..+...     +.++.+|+.+||+.||++|||+.++++.+..
T Consensus       321 ~----~~~~~~~-~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         321 P----VDSKFYK-MIKEGYRMLSPECA-----PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             C----chHHHHH-HHHhCccCCCCCCC-----CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            1    1112222 22333333333322     2379999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597|consensus

Probab=100.00  E-value=2e-44  Score=351.50  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=211.9

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhh---hHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~---~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|.+.+.||+|+||.||+|+.+  .+.||+|.+.+..+..   ....+|+.+++.++|||||.++++|....    ++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~----~~~   77 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA----HLW   77 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc----eEE
Confidence            46788899999999999999985  4679999987654433   33468999999999999999999998865    569


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +|+||+.+ +|..+|. .+.++++.+..++.++..||.|||+.           +|+|||+||+|||++..+++|++|||
T Consensus        78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~-----------rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN-----------RILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc-----------CcccccCCcceeeecCCCceeechhh
Confidence            99999986 9999995 45799999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +|+....+.  .......||+.|||||++.+     ..|+..+|.||+|||+||+++|           +.||...    
T Consensus       146 ~Ar~m~~~t--~vltsikGtPlYmAPElv~e-----~pyd~~sDlWslGcilYE~~~G-----------~PPF~a~----  203 (808)
T KOG0597|consen  146 LARAMSTNT--SVLTSIKGTPLYMAPELVEE-----QPYDHTSDLWSLGCILYELYVG-----------QPPFYAR----  203 (808)
T ss_pred             hhhhcccCc--eeeeeccCcccccCHHHHcC-----CCccchhhHHHHHHHHHHHhcC-----------CCCchHH----
Confidence            999876544  23456789999999999987     4788889999999999999999           6677654    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                       +..++.+.+.....+++.       ..+..+..+++..|.+||.+|.|..+++.|.+-.....
T Consensus       204 -si~~Lv~~I~~d~v~~p~-------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  204 -SITQLVKSILKDPVKPPS-------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             -HHHHHHHHHhcCCCCCcc-------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence             556666666655443332       23448899999999999999999999999987554433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=341.68  Aligned_cols=247  Identities=22%  Similarity=0.316  Sum_probs=200.7

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|..+  ++.||||.+.....    ......+|+.++++++||||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~   76 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR----FL   76 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC----eE
Confidence            36899999999999999999985  78899999864322    2234567889999999999999999887754    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK-----------EIVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCHHHeEECCCCCEEEEec
Confidence            899999999999999854 4689999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.....     .....||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...   
T Consensus       146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~l~~g-----------~~pf~~~---  201 (291)
T cd05612         146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQS-----KGHNKAVDWWALGILIYEMLVG-----------YPPFFDD---  201 (291)
T ss_pred             CcchhccCC-----cccccCChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC---
Confidence            999876432     223568999999999876     3567889999999999999999           5555433   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~  406 (461)
                        ........+....  ..+|...     +..+.+||++||+.||++||+     ++++++|.|...
T Consensus       202 --~~~~~~~~i~~~~--~~~~~~~-----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         202 --NPFGIYEKILAGK--LEFPRHL-----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             --CHHHHHHHHHhCC--cCCCccC-----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence              3334444444433  2334332     237899999999999999995     888888877543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-43  Score=338.27  Aligned_cols=248  Identities=29%  Similarity=0.495  Sum_probs=194.4

Q ss_pred             eeEEeEeecCCceEEEEEEEC------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +++.+.||.|.||.||+|.+.      +..|+||.++....  ....+.+|+..+.+++||||++++|++...+.    +
T Consensus         1 ~~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~   76 (259)
T PF07714_consen    1 IKLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----L   76 (259)
T ss_dssp             EEEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----E
T ss_pred             CEEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----c
Confidence            357889999999999999997      56799999965332  24556788999999999999999999995543    5


Q ss_pred             eeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ++|+||+++|+|.++|...   .+++..+..++.||+.||.|||+.           +|+|+||+++|||+++++.+||+
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----------~iiH~~l~~~nill~~~~~~Kl~  145 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN-----------NIIHGNLSPSNILLDSNGQVKLS  145 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-----------TEEEST-SGGGEEEETTTEEEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-----------ccccccccccccccccccccccc
Confidence            8999999999999999654   799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++................+...|+|||.+.+.     .++.++||||||+++|||++++          ..||... 
T Consensus       146 ~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~ksDVysfG~~l~ei~~~~----------~~p~~~~-  209 (259)
T PF07714_consen  146 DFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG-----EYTKKSDVYSFGMLLYEILTLG----------KFPFSDY-  209 (259)
T ss_dssp             STTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS-----EESHHHHHHHHHHHHHHHHTTS----------SGTTTTS-
T ss_pred             ccccccccccccccccccccccccccccccccccc-----cccccccccccccccccccccc----------ccccccc-
Confidence            99999877433222223345677899999998764     4778999999999999999943          5666443 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                          ...++...+ ....++..+..++.     .+.++|.+||+.||++|||+.++++.|
T Consensus       210 ----~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  210 ----DNEEIIEKL-KQGQRLPIPDNCPK-----DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----CHHHHHHHH-HTTEETTSBTTSBH-----HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccccccccc-cccccceeccchhH-----HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                445555555 33344455555443     799999999999999999999998864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4257|consensus

Probab=100.00  E-value=8.9e-44  Score=349.99  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=208.8

Q ss_pred             eeEEeEeecCCceEEEEEEEC----CC--cEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK----NE--NVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~----~~--~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +.+.+.||.|.||.||+|.+.    |+  .||||..+.+.  .....+..|..+|++++|||||+++|+|.+..     .
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----~  465 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----M  465 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----e
Confidence            445578999999999999984    32  48999887533  33456778999999999999999999998753     4


Q ss_pred             eeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      |||||.++.|.|..||+.+  .++...+..++.||+.||+|||+.           ++|||||..+|||+.+...+||+|
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk-----------rfVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK-----------RFVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh-----------chhhhhhhhhheeecCcceeeecc
Confidence            9999999999999999654  588889999999999999999999           899999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.++.+..+ ..+...-++.|||||.+.-     +.++.+||||-|||.+||+++-+          ..||.+...
T Consensus       535 FGLSR~~ed~~yY-kaS~~kLPIKWmaPESINf-----RrFTtASDVWMFgVCmWEIl~lG----------vkPfqgvkN  598 (974)
T KOG4257|consen  535 FGLSRYLEDDAYY-KASRGKLPIKWMAPESINF-----RRFTTASDVWMFGVCMWEILSLG----------VKPFQGVKN  598 (974)
T ss_pred             cchhhhccccchh-hccccccceeecCccccch-----hcccchhhHHHHHHHHHHHHHhc----------CCccccccc
Confidence            9999999876654 3445667899999998864     57889999999999999998754          566665422


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .     +.. ..+.++.|++.|+.|+.     .++.||.+||++||.+||.+.++...|..+..
T Consensus       599 s-----DVI-~~iEnGeRlP~P~nCPp-----~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  599 S-----DVI-GHIENGERLPCPPNCPP-----ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             c-----ceE-EEecCCCCCCCCCCCCh-----HHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            1     111 12456678888888776     89999999999999999999999998877664

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.3e-43  Score=344.52  Aligned_cols=244  Identities=23%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      +.||+|+||.||+++.  +++.||||++....    .......+|+.++.+++||||+++++++....    .+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----RLCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----EEEEEEeC
Confidence            4799999999999988  47889999987432    12234467888999999999999999988765    45999999


Q ss_pred             ccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        192 HERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       192 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      +++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC-----------DVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999999998854 5689999999999999999999999           9999999999999999999999999999754


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      ....  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     ....
T Consensus       146 ~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg-----------~~Pf~~~-----~~~~  202 (323)
T cd05571         146 ISDG--ATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ-----DHEK  202 (323)
T ss_pred             ccCC--CcccceecCccccChhhhcC-----CCCCccccCcccchhhhhhhcC-----------CCCCCCC-----CHHH
Confidence            3221  12334579999999999876     3677899999999999999999           5666433     3344


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      +...+....  ..+|..++     .++.+||.+||+.||++||     ++.++++|.+...
T Consensus       203 ~~~~~~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         203 LFELILMEE--IRFPRTLS-----PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HHHHHHcCC--CCCCCCCC-----HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            444444332  23444333     3789999999999999999     7999999887643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9e-43  Score=349.48  Aligned_cols=257  Identities=24%  Similarity=0.327  Sum_probs=199.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|+..       +..||||.+.....  ......+|+.+++.+ +|+|||++++++..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            455678999999999999999999862       24699999865432  223456789999998 89999999999987


Q ss_pred             CCccceeeeeeehhccCCChhhhhcC------------------------------------------------------
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKC------------------------------------------------------  203 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~------------------------------------------------------  203 (461)
                      ...    +++||||+++|+|.+++..                                                      
T Consensus       114 ~~~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         114 GGP----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             CCC----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            653    4899999999999998842                                                      


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        204 -----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       204 -----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                                       .++++..+.+++.||+.||.|||+.           +|+||||||+|||+++++.+||+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----------giiHrDLkp~Nil~~~~~~~kL~DfGl  258 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-----------NCIHRDVAARNVLLTDGRVAKICDFGL  258 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-----------CEEeccCchheEEEeCCCeEEEeecee
Confidence                             1367888999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++...............++..|||||++.+     ..++.++|||||||++|||++ |           ..||.....  
T Consensus       259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ellt~G-----------~~Pf~~~~~--  320 (374)
T cd05106         259 ARDIMNDSNYVVKGNARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEIFSLG-----------KSPYPGILV--  320 (374)
T ss_pred             eeeccCCcceeeccCCCCccceeCHHHhcC-----CCCCccccHHHHHHHHHHHHhCC-----------CCCCccccc--
Confidence            987654332222223345678999999865     367789999999999999997 8           556654311  


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                         .............+..+...     +.++.+++.+||+.||++|||+.++++.+..+
T Consensus       321 ---~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         321 ---NSKFYKMVKRGYQMSRPDFA-----PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---cHHHHHHHHcccCccCCCCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               11122222333333333322     24799999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0033|consensus

Probab=100.00  E-value=5.4e-45  Score=322.81  Aligned_cols=257  Identities=21%  Similarity=0.317  Sum_probs=214.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .+.|++.++||+|.|+.||++.+  +|+.+|+|++...   .....+.++|+.+...|+|||||++.+........    
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~----   85 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH----   85 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee----
Confidence            35788899999999999999987  5788999987532   33445668999999999999999999987765543    


Q ss_pred             eeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC---CceEE
Q psy17532        186 WLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD---LTAAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~---~~~ki  261 (461)
                      |+|+|+|.||+|..-+ ++..+++..+..+++||+++|.|+|.+           +|||||+||+|+|+.+.   --+||
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n-----------~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN-----------GIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-----------CceeccCChhheeeeeccCCCceee
Confidence            8999999999997654 555678899999999999999999999           99999999999999643   46899


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|..+..+   ....+.+||+.|||||++..     ..|+..+|||+.|||||-|+.|           .+||.++
T Consensus       155 ~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrk-----dpy~kpvDiW~cGViLfiLL~G-----------~~PF~~~  215 (355)
T KOG0033|consen  155 ADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVG-----------YPPFWDE  215 (355)
T ss_pred             cccceEEEeCCc---cccccccCCCcccCHHHhhc-----CCCCCcchhhhhhHHHHHHHhC-----------CCCCCCc
Confidence            999999998843   34667899999999999976     4788899999999999999999           7777765


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                           +..++.+.+..+.+..+-| .|+.  .+++.++|+++||..||.+|.|+.|+|+|.|.....+
T Consensus       216 -----~~~rlye~I~~g~yd~~~~-~w~~--is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~  275 (355)
T KOG0033|consen  216 -----DQHRLYEQIKAGAYDYPSP-EWDT--VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER  275 (355)
T ss_pred             -----cHHHHHHHHhccccCCCCc-ccCc--CCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence                 6678888888877654433 3544  4458899999999999999999999999998655433

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-42  Score=333.70  Aligned_cols=252  Identities=20%  Similarity=0.255  Sum_probs=196.2

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .|+..+.||+|+||.||+|..  +++.||||.+......    .....+|+.++..++|+||+++++++.+.+    .++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~----~~~   76 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC----eEE
Confidence            478899999999999999987  5789999998643221    223457899999999999999999988765    458


Q ss_pred             eeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +||||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+|||+++++.+||+|
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~iiH~dikp~Nill~~~~~~kl~D  145 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-----------RIVYRDLKPENILLDDRGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEeCCCCHHHEEECCCCCEEEee
Confidence            99999999999988742   3589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++........   .....||..|+|||++.+     ..++.++|||||||++|||++|           +.||.....
T Consensus       146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g-----------~~pf~~~~~  206 (285)
T cd05631         146 LGLAVQIPEGET---VRGRVGTVGYMAPEVINN-----EKYTFSPDWWGLGCLIYEMIQG-----------QSPFRKRKE  206 (285)
T ss_pred             CCCcEEcCCCCe---ecCCCCCCCccCHhhhcC-----CCCCcccCchhHHHHHHHHHhC-----------CCCCCCCCc
Confidence            999987643321   234578999999999976     3677889999999999999999           555543211


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~  406 (461)
                      . ...+.+...+..  ....++..+     +..+.+|+++||+.||++||+     ++++++|.+...
T Consensus       207 ~-~~~~~~~~~~~~--~~~~~~~~~-----s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         207 R-VKREEVDRRVKE--DQEEYSEKF-----SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             c-hhHHHHHHHhhc--ccccCCccC-----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            1 011222222211  111233322     347899999999999999997     788888876533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=345.57  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ....+|+..+.||+|+||.||+|++.  ++.||||++......  .....+|+.++..++|+||+++++++....    .
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  146 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG----E  146 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC----e
Confidence            34678899999999999999999984  788999998644322  334568999999999999999999987755    4


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +++||||+++|+|.+..   ...+..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus       147 ~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~~~~kL~Df  212 (353)
T PLN00034        147 IQVLLEFMDGGSLEGTH---IADEQFLADVARQILSGIAYLHRR-----------HIVHRDIKPSNLLINSAKNVKIADF  212 (353)
T ss_pred             EEEEEecCCCCcccccc---cCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecCCCHHHEEEcCCCCEEEccc
Confidence            58999999999987643   356778889999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.+....  .......||..|+|||++..........+.++|||||||++|||++|           +.||...  .
T Consensus       213 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g-----------~~pf~~~--~  277 (353)
T PLN00034        213 GVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG-----------RFPFGVG--R  277 (353)
T ss_pred             ccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhC-----------CCCCCCC--C
Confidence            9998765332  12234578999999999865322223345689999999999999999           5555421  1


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..........+.. ...+..+..     .+.++.+||.+||+.||++|||+.|+++|.+....
T Consensus       278 ~~~~~~~~~~~~~-~~~~~~~~~-----~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        278 QGDWASLMCAICM-SQPPEAPAT-----ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CccHHHHHHHHhc-cCCCCCCCc-----cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            1122222222221 122233332     23479999999999999999999999999876654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-42  Score=338.27  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=193.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC------------------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK------------------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNIL  169 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv  169 (461)
                      ..++|++.+.||+|+||.||+|.++                  +..||||.+.....  ....+.+|+.++.+++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            3468999999999999999999852                  23599999865432  233456899999999999999


Q ss_pred             EEEEEEecCCccceeeeeeehhccCCChhhhhcCC--------------------CCCHHHHHHHHHHHHHHHHHHhhcc
Q psy17532        170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--------------------IVTWEQLCRIALSMSKGLMHLHEEI  229 (461)
Q Consensus       170 ~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------~l~~~~~~~i~~~ia~gL~yLH~~~  229 (461)
                      ++++++.+.+.    .++||||+++|+|.+++...                    .+++..+.+++.||+.||.|||+. 
T Consensus        83 ~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          83 RLLGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99999987653    49999999999999988432                    357788999999999999999998 


Q ss_pred             cCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccc
Q psy17532        230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRID  309 (461)
Q Consensus       230 ~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~D  309 (461)
                                +|+||||||+|||++.++.+||+|||+++.+.............++..|+|||++.++     .++.++|
T Consensus       158 ----------~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~D  222 (304)
T cd05096         158 ----------NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-----KFTTASD  222 (304)
T ss_pred             ----------CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-----CCCchhh
Confidence                      9999999999999999999999999999876543322223334568899999998653     5778999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHH---hccC---CCCCCCchhccchhHHHHHHHHHH
Q psy17532        310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV---VHKK---LRPTLPETWKQHAGMLALCDTMEE  383 (461)
Q Consensus       310 VwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~---~~~~---~~~~~p~~~~~~~~~~~l~~li~~  383 (461)
                      |||||+++|||+++..         ..||...     ...+....+   ....   .....+..     .+..+.+||.+
T Consensus       223 v~slG~~l~el~~~~~---------~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~  283 (304)
T cd05096         223 VWAFGVTLWEILMLCK---------EQPYGEL-----TDEQVIENAGEFFRDQGRQVYLFRPPP-----CPQGLYELMLQ  283 (304)
T ss_pred             hHHHHHHHHHHHHccC---------CCCCCcC-----CHHHHHHHHHHHhhhccccccccCCCC-----CCHHHHHHHHH
Confidence            9999999999997521         3455433     112222111   1111   11111222     23479999999


Q ss_pred             HccccHhhhccccchhhhc
Q psy17532        384 CWDHDAEARLSASCVVERG  402 (461)
Q Consensus       384 cl~~dP~~Rps~~evl~~l  402 (461)
                      ||+.||++|||+.++.+.|
T Consensus       284 cl~~~p~~RPs~~~i~~~l  302 (304)
T cd05096         284 CWSRDCRERPSFSDIHAFL  302 (304)
T ss_pred             HccCCchhCcCHHHHHHHH
Confidence            9999999999999997765

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0611|consensus

Probab=100.00  E-value=5.7e-44  Score=336.06  Aligned_cols=255  Identities=19%  Similarity=0.270  Sum_probs=216.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|.||.|-+|..  .|+.||||.+.++.-.    .-...+||.+|+.|+||||+.++.+|.+.+.+  
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI--  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI--  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE--
Confidence            346899999999999999999986  5899999988654322    23357899999999999999999999987654  


Q ss_pred             eeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                        .|||||..+|.|++|+. ++.|++.++..+++||..|+.|+|.+           +++|||||.+|||+|.++++||+
T Consensus       129 --vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn-----------rVvHRDLKLENILLD~N~NiKIA  195 (668)
T KOG0611|consen  129 --VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN-----------RVVHRDLKLENILLDQNNNIKIA  195 (668)
T ss_pred             --EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc-----------cceecccchhheeecCCCCeeee
Confidence              89999999999999995 56799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||||+..+..+.   ....++|++.|.+||++.|..+.    +..+|-|||||+||.|+.|           .+||.+. 
T Consensus       196 DFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~----GPEVDsWsLGvLLYtLVyG-----------tMPFDG~-  256 (668)
T KOG0611|consen  196 DFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYK----GPEVDSWSLGVLLYTLVYG-----------TMPFDGR-  256 (668)
T ss_pred             ccchhhhhcccc---HHHHhcCCcccCCccccCCCCCC----CCccchhhHHHHHHHHhhc-----------ccccCCc-
Confidence            999998776543   35568999999999999986332    3568999999999999999           8888776 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTM  410 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~  410 (461)
                          ....+...+..+.++.+-.+.        ...-||+.||..||++|-|..+|..|.|.-.-..+
T Consensus       257 ----Dhk~lvrQIs~GaYrEP~~PS--------dA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~  312 (668)
T KOG0611|consen  257 ----DHKRLVRQISRGAYREPETPS--------DASGLIRWMLMVNPERRATIEDIASHWWVNWGYNM  312 (668)
T ss_pred             ----hHHHHHHHhhcccccCCCCCc--------hHHHHHHHHHhcCcccchhHHHHhhhheeeccccc
Confidence                677788888877766543221        56789999999999999999999999876444333

>KOG1025|consensus

Probab=100.00  E-value=1.2e-42  Score=351.19  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=212.0

Q ss_pred             eeEEeEeecCCceEEEEEEE--CC----CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KN----ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~----~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++..++||+|+||+||+|.+  ++    .+||||++.....  .......|+..|.+++|||+++++|+|..+.     +
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----~  772 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----L  772 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----H
Confidence            44567999999999999998  33    4699998864433  3455678999999999999999999998764     3


Q ss_pred             eeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .||++||+.|+|.+|++.+  .+.....+.|..|||+||.|||++           ++|||||..+||||.+...+||.|
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q-----------rlVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ-----------RLVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc-----------chhhhhhhhhheeecCCCeEEEEe
Confidence            7999999999999999654  588899999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+.+..+..........-.+.|||-|.+..     +.++.++|||||||++||++|-+          ..||.+.  
T Consensus       842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~-----~~~thqSDVWsfGVtiWElmTFG----------a~Py~gi--  904 (1177)
T KOG1025|consen  842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-----RKYTHQSDVWSFGVTIWELMTFG----------AKPYDGI--  904 (1177)
T ss_pred             cchhhccCcccccccccccccCcHHHHHHHhhc-----cCCCchhhhhhhhhhHHHHHhcC----------CCccCCC--
Confidence            999999988766555666677889999999875     58889999999999999999964          6677655  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                         ..+++-..+ ..+.|..-|+.++.     +++-+|.+||..|++.||+++++..++.++....
T Consensus       905 ---~~~eI~dll-e~geRLsqPpiCti-----DVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  905 ---PAEEIPDLL-EKGERLSQPPICTI-----DVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             ---CHHHhhHHH-hccccCCCCCCccH-----HHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence               555554444 44445666666554     8999999999999999999999999887766543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-42  Score=342.63  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=202.7

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC---CcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN---ENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|+||.||+|++++   ..||+|.+....    .......+|+.++..++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            34567789999999999999999998743   479999986432    22234467888999999999999999998765


Q ss_pred             ccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .+++||||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.
T Consensus       105 ----~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDLkp~NILl~~~~~  169 (340)
T PTZ00426        105 ----YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL-----------NIVYRDLKPENLLLDKDGF  169 (340)
T ss_pred             ----EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEccCCCHHHEEECCCCC
Confidence                4599999999999999995 45689999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++.....     .....||+.|||||++.+.     .++.++|||||||++|||++|           ..||
T Consensus       170 ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell~G-----------~~Pf  228 (340)
T PTZ00426        170 IKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNV-----GHGKAADWWTLGIFIYEILVG-----------CPPF  228 (340)
T ss_pred             EEEecCCCCeecCCC-----cceecCChhhcCHHHHhCC-----CCCccccccchhhHHHHHhcC-----------CCCC
Confidence            999999999876432     2345789999999999763     567889999999999999999           5566


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHH
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLA  405 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~  405 (461)
                      ...     ........+.....  .+|..++     ..+.++|++||+.||++|+     +++++++|.+..
T Consensus       229 ~~~-----~~~~~~~~i~~~~~--~~p~~~~-----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        229 YAN-----EPLLIYQKILEGII--YFPKFLD-----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             CCC-----CHHHHHHHHhcCCC--CCCCCCC-----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence            433     23333444444332  2333332     3688999999999999995     899999998764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.7e-42  Score=342.20  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             ceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCC-----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQD-----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      +|++.+.||+|+||.||+++.     .++.||+|++....     ........|+.++..+ +|+||+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence            488999999999999999886     46789999986422     1123345788888888 5999999999987755  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+|
T Consensus        79 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivHrDlkp~Nili~~~~~~k  145 (332)
T cd05614          79 --KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL-----------GIVYRDIKLENILLDSEGHVV  145 (332)
T ss_pred             --EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcEecCCCHHHeEECCCCCEE
Confidence              4589999999999999985 45689999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++....... .......||..|+|||++.+.    ..++.++|||||||++|||++|           ..||..
T Consensus       146 l~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg-----------~~pf~~  209 (332)
T cd05614         146 LTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGK----GGHGKAVDWWSLGILIFELLTG-----------ASPFTL  209 (332)
T ss_pred             EeeCcCCccccccCC-CccccccCCccccCHHHhcCC----CCCCCccccccchhhhhhhhcC-----------CCCCCC
Confidence            999999986543321 123345799999999998753    2456789999999999999999           455533


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      ... ......+...+..  ..+.++...+     ..+.+++.+||+.||++||     +++++++|.+...
T Consensus       210 ~~~-~~~~~~~~~~~~~--~~~~~~~~~~-----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         210 EGE-RNTQSEVSRRILK--CDPPFPSFIG-----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCC-CCCHHHHHHHHhc--CCCCCCCCCC-----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            211 1123333333332  2234444333     3789999999999999999     6779999887543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-42  Score=340.15  Aligned_cols=246  Identities=22%  Similarity=0.302  Sum_probs=194.2

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHH---HHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEI---FKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei---~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      |++.+.||+|+||.||+|..  +++.||||.+....    ........|+   ..+..++||||+++++++....    .
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----~   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----H   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC----E
Confidence            67899999999999999998  46889999987432    1112223333   3456789999999999998765    4


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +++||||+++|+|..+++.+.+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~-----------~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN-----------KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEecCCCHHHeEECCCCcEEeCcc
Confidence            59999999999999999888899999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......|++.|||||++.+     ..++.++|||||||++|||++|           ..||...   
T Consensus       146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~G-----------~~pf~~~---  204 (324)
T cd05589         146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIYEMLVG-----------ESPFPGD---  204 (324)
T ss_pred             cCCccCCCCC--CcccccccCccccCHhHhcC-----CCCCcccchhhHHHHHHHHHhC-----------CCCCCCC---
Confidence            9987543222  12334578999999999876     3667889999999999999999           5666433   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGML  404 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~  404 (461)
                        ...+....+....  ..+|...+     ..+.++|.+||..||++||     ++.+++++.+.
T Consensus       205 --~~~~~~~~i~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f  260 (324)
T cd05589         205 --DEEEVFDSIVNDE--VRYPRFLS-----REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF  260 (324)
T ss_pred             --CHHHHHHHHHhCC--CCCCCCCC-----HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence              3344444444332  22333332     3788999999999999999     46677777654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=337.99  Aligned_cols=242  Identities=22%  Similarity=0.306  Sum_probs=193.7

Q ss_pred             eecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||+|+||.||+|+..  ++.||+|.+....    .......+|+.++.+++||||+++++++...+    .+++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEEEEEcCCC
Confidence            699999999999984  6789999986432    22234457888899999999999999988765    4599999999


Q ss_pred             CCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        194 RGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       194 ~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      +|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKF-----------NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            999999985 45689999999999999999999998           999999999999999999999999999976433


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      ..  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...++.
T Consensus       146 ~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg-----------~~pf~~~-----~~~~~~  202 (312)
T cd05585         146 DD--DKTNTFCGTPEYLAPELLLG-----HGYTKAVDWWTLGVLLYEMLTG-----------LPPFYDE-----NVNEMY  202 (312)
T ss_pred             CC--CccccccCCcccCCHHHHcC-----CCCCCccceechhHHHHHHHhC-----------CCCcCCC-----CHHHHH
Confidence            22  12334579999999999976     3677899999999999999999           5666543     334444


Q ss_pred             HHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc---ccchhhhcHHHh
Q psy17532        353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS---ASCVVERGMLAL  406 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~l~~~~  406 (461)
                      ..+....  ..++..++     ..+.++|.+||..||++||+   +.+++.|.+...
T Consensus       203 ~~~~~~~--~~~~~~~~-----~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         203 RKILQEP--LRFPDGFD-----RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHHHcCC--CCCCCcCC-----HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence            4444332  23343333     37899999999999999985   678888877554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-42  Score=340.25  Aligned_cols=244  Identities=24%  Similarity=0.307  Sum_probs=195.0

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      +.||+|+||.||+++.  +++.||+|.+....    .......+|+.++..++||||+++++++....    .+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----EEEEEEeC
Confidence            4799999999999997  47889999986432    12233457888999999999999999988765    45999999


Q ss_pred             ccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        192 HERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       192 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      +++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-----------DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            999999998854 4689999999999999999999999           9999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      ....  .......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...     ....
T Consensus       146 ~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell~g-----------~~Pf~~~-----~~~~  202 (323)
T cd05595         146 ISDG--ATMKTFCGTPEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ-----DHER  202 (323)
T ss_pred             cCCC--CccccccCCcCcCCcccccCC-----CCCchhchhhhHHHHHHHHhC-----------CCCCCCC-----CHHH
Confidence            3221  122345789999999998763     667889999999999999999           5666433     3334


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      ....+.....  .+|..++     ..+.++|.+||+.||++||     ++.++++|.+...
T Consensus       203 ~~~~~~~~~~--~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         203 LFELILMEEI--RFPRTLS-----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             HHHHHhcCCC--CCCCCCC-----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            4444433322  3343333     3789999999999999998     8899998876643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-42  Score=338.17  Aligned_cols=259  Identities=21%  Similarity=0.319  Sum_probs=196.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++.....  ......+|+.+++.++||||+++++++.+..    ..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE----TLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC----eEE
Confidence            46899999999999999999998  478899999864432  2334567899999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+. |+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-----------YILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCCEEECCC
Confidence            9999996 688888854  4589999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......+|+.|+|||++.+.    ..++.++|||||||++|||++|..||.....            
T Consensus       148 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------------  209 (303)
T cd07869         148 GLARAKSVPS--HTYSNEVVTLWYRPPDVLLGS----TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD------------  209 (303)
T ss_pred             CcceeccCCC--ccCCCCcccCCCCChHHHcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc------------
Confidence            9997653322  122345689999999998653    3567789999999999999999555532111            


Q ss_pred             CCCHHHHHHHHhc---------------------cCCC----CCCCchhccchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        345 HPSLEDMQEAVVH---------------------KKLR----PTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       345 ~~~~~~~~~~~~~---------------------~~~~----~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                         ..+....+..                     ....    ..+...+.....+..+.+|+.+||+.||++|||+.+++
T Consensus       210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l  286 (303)
T cd07869         210 ---IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL  286 (303)
T ss_pred             ---HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence               1111111000                     0000    00011111111234688999999999999999999999


Q ss_pred             hhcHHHh
Q psy17532        400 ERGMLAL  406 (461)
Q Consensus       400 ~~l~~~~  406 (461)
                      +|.++..
T Consensus       287 ~h~~f~~  293 (303)
T cd07869         287 SHEYFSD  293 (303)
T ss_pred             cCccccc
Confidence            9987644

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-42  Score=345.41  Aligned_cols=262  Identities=19%  Similarity=0.229  Sum_probs=207.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....+|++.+.||+|+||.||+++..  ++.||+|.+....    ........|+.+++.++||||+++++++.+..   
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~---  116 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK---  116 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC---
Confidence            34678999999999999999999984  6789999986422    12223457888899999999999999988765   


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                       .+++||||+++|+|.+++....+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus       117 -~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         117 -YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM-----------GFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             -EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHEEEcCCCCEEEE
Confidence             459999999999999999888899999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++....... .......||+.|+|||++.+... ...++.++|||||||++|||++|           ..||... 
T Consensus       185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~DiwSlGvilyelltG-----------~~Pf~~~-  250 (370)
T cd05596         185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVG-----------DTPFYAD-  250 (370)
T ss_pred             eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCC-CCCCCCceeeeehhHHHHHHHhC-----------CCCcCCC-
Confidence            9999987653321 12234579999999999865311 13467899999999999999999           5666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~~  406 (461)
                          ........+........+|...   ..+.++.+||.+||..+|++  |+|+.++++|.+...
T Consensus       251 ----~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         251 ----SLVGTYSKIMDHKNSLTFPDDI---EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             ----CHHHHHHHHHcCCCcCCCCCcC---CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence                2333444444433333344321   13358899999999999998  999999999987643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.1e-42  Score=328.66  Aligned_cols=252  Identities=24%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...+|++.+.||+|+||.||+|.++     +..||+|.+.....  ....+++|+..+.+++||||++++|++....   
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   79 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN---   79 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC---
Confidence            3567999999999999999999863     45799999875432  2334678999999999999999999988755   


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       ..++||||+++|+|.+++..  ..+++..++.++.|++.||+|||+.           +++||||||+|||++.++.+|
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~-----------~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          80 -TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM-----------GYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             -CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeeccccHhhEEEcCCCcEE
Confidence             45999999999999999964  3689999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~  339 (461)
                      ++|||.+........ .......++..|+|||++.+     ..++.++|||||||++||+++ |           ..||.
T Consensus       148 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~ell~~g-----------~~p~~  210 (266)
T cd05064         148 ISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQY-----HHFSSASDVWSFGIVMWEVMSYG-----------ERPYW  210 (266)
T ss_pred             ECCCcccccccccch-hcccCCCCceeecCHHHHhh-----CCccchhHHHHHHHHHHHHhcCC-----------CCCcC
Confidence            999998765432211 11223345678999999865     367789999999999999876 7           56665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ..     ...++...+... .....+..++     ..+.+++.+||+.+|++||++.++++.+..
T Consensus       211 ~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         211 DM-----SGQDVIKAVEDG-FRLPAPRNCP-----NLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             cC-----CHHHHHHHHHCC-CCCCCCCCCC-----HHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            43     333444444332 3334444433     378999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=340.02  Aligned_cols=254  Identities=22%  Similarity=0.238  Sum_probs=200.8

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||||++.....    .......|+.++..++||||+++++++....    .+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~----~~   76 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE----YL   76 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC----EE
Confidence            36899999999999999999984  68899999875321    2233457888899999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL-----------GYIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999954 5689999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++....     ......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...   
T Consensus       146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g-----------~~pf~~~---  201 (333)
T cd05600         146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGK-----GYDFTVDYWSLGCMLYEFLCG-----------FPPFSGS---  201 (333)
T ss_pred             cCCccccc-----ccCCcccCccccChhHhcCC-----CCCCccceecchHHHhhhhhC-----------CCCCCCC---
Confidence            99976543     23345789999999999763     677899999999999999999           5566433   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchh-ccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETW-KQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ...+....+.........|... +....+.++.+||.+||..+|++||++.++++|.+...
T Consensus       202 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         202 --TPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             --CHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence              2333333332211111111110 00112457899999999999999999999999987653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.4e-42  Score=333.25  Aligned_cols=269  Identities=20%  Similarity=0.268  Sum_probs=193.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||+|.+.....  ......+|+.++++++||||+++++++.+..    .++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER----CLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC----eEE
Confidence            46799999999999999999988  467899999864332  2234567899999999999999999987754    458


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++ +|.+++..  ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-----------KILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEECCCCCEEECcC
Confidence            99999985 99998853  3478999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------C
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------R  335 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------~  335 (461)
                      |+++......  .......++..|+|||++.+.    ..++.++|||||||++|||++|..||.......         .
T Consensus       148 G~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (288)
T cd07871         148 GLARAKSVPT--KTYSNEVVTLWYRPPDVLLGS----TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG  221 (288)
T ss_pred             cceeeccCCC--ccccCceecccccChHHhcCC----cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9997654322  122345789999999998653    356788999999999999999965553221100         0


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .|...........++..... ....+.. +..-.....+.++.+|+.+||..||.+|||++|+++|.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYL-FPQYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             CCChHHhhccccchhhhccc-cCccCCC-chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence            00000000000000000000 0000000 000000112357889999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0580|consensus

Probab=100.00  E-value=3.8e-43  Score=310.55  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=211.3

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....++|++.+.||+|.||.||+|+.+  +-.||+|++.+..-    -..+..+|+.+.+.|+||||+++|++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            3456789999999999999999999995  45799999865432    23455688999999999999999999999775


Q ss_pred             cceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      +    ||++||.++|+|+..|..   ..+++.....++.|+|.||.|+|..           +++||||||+|+|++..+
T Consensus        97 i----yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-----------~VIhRdiKpenlLlg~~~  161 (281)
T KOG0580|consen   97 I----YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-----------RVIHRDIKPENLLLGSAG  161 (281)
T ss_pred             e----EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-----------CcccCCCCHHHhccCCCC
Confidence            5    999999999999999973   3588999999999999999999988           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      ..||+|||-+..-+.    ......+||.-|.+||+..+     ..++..+|+|++|++.||++.|           ..|
T Consensus       162 ~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~-----~~hd~~Vd~w~lgvl~yeflvg-----------~pp  221 (281)
T KOG0580|consen  162 ELKIADFGWSVHAPS----NKRKTLCGTLDYLPPEMVEG-----RGHDKFVDLWSLGVLCYEFLVG-----------LPP  221 (281)
T ss_pred             CeeccCCCceeecCC----CCceeeecccccCCHhhcCC-----CCccchhhHHHHHHHHHHHHhc-----------CCc
Confidence            999999999976543    34566899999999999987     4777889999999999999999           566


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      |...     +..+....+..-.  ..+|...+.     ...++|.+|+.++|.+|.+..|+++|.|...
T Consensus       222 Fes~-----~~~etYkrI~k~~--~~~p~~is~-----~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  222 FESQ-----SHSETYKRIRKVD--LKFPSTISG-----GAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             hhhh-----hhHHHHHHHHHcc--ccCCcccCh-----hHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            6654     3344455544432  344544333     7889999999999999999999999988654

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.5e-42  Score=338.60  Aligned_cols=243  Identities=22%  Similarity=0.291  Sum_probs=194.9

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      +.||+|+||.||+++.  +++.||||++....    .......+|+.++..++||||+++++++...+    .+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----RLCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----EEEEEEeC
Confidence            4689999999999988  47889999986432    22234567888999999999999999988765    45999999


Q ss_pred             ccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        192 HERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       192 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      +++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG-----------KIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999999998854 4689999999999999999999998           9999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      ....  .......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...     ...+
T Consensus       146 ~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGvil~elltG-----------~~Pf~~~-----~~~~  202 (328)
T cd05593         146 ITDA--ATMKTFCGTPEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ-----DHEK  202 (328)
T ss_pred             CCcc--cccccccCCcCccChhhhcCC-----CCCccCCccccchHHHHHhhC-----------CCCCCCC-----CHHH
Confidence            3221  122345799999999998763     567889999999999999999           5666433     3334


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHH
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLA  405 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~  405 (461)
                      ....+....  ..+|..++     ..+.+||.+||..||++|+     ++.++++|.+..
T Consensus       203 ~~~~~~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  255 (328)
T cd05593         203 LFELILMED--IKFPRTLS-----ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT  255 (328)
T ss_pred             HHHHhccCC--ccCCCCCC-----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            444443322  23444333     3789999999999999997     899999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG4278|consensus

Probab=100.00  E-value=5e-43  Score=344.26  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=219.3

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEECC--CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ..+.....++.+..+||.|.||.||.|.|+.  -.||||.++.+......+.+|+.+|+.++|||+|+|+|+|....+  
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP--  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP--  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--
Confidence            3444556778889999999999999999975  569999999888888889999999999999999999999987654  


Q ss_pred             eeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        183 TEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        +|||+|||..|+|.+||++   ..++.-.++.++.||+.||+||..+           ++|||||.++|+|+.++..+
T Consensus       338 --FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-----------nFIHRDLAARNCLVgEnhiV  404 (1157)
T KOG4278|consen  338 --FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-----------NFIHRDLAARNCLVGENHIV  404 (1157)
T ss_pred             --eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-----------hhhhhhhhhhhccccccceE
Confidence              4999999999999999964   3467777889999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+||||++.+..+. +....+..-++.|.|||.+.-+     .++.|+|||+|||+||||.|-+          -.||.
T Consensus       405 KvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyN-----tFSiKSDVWAFGVLLWEIATYG----------MsPYP  468 (1157)
T KOG4278|consen  405 KVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN-----TFSIKSDVWAFGVLLWEIATYG----------MSPYP  468 (1157)
T ss_pred             EeeccchhhhhcCCc-eecccCccCcccccCccccccc-----ccccchhhHHHHHHHHHHHhcC----------CCCCC
Confidence            999999999887554 3334445567899999988643     6778999999999999999965          56776


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      +.     ...++. .++..++|..-|+.|+.     .+++||+.||++.|.+||++.|+.+.++.+
T Consensus       469 Gi-----dlSqVY-~LLEkgyRM~~PeGCPp-----kVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  469 GI-----DLSQVY-GLLEKGYRMDGPEGCPP-----KVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             Cc-----cHHHHH-HHHhccccccCCCCCCH-----HHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            65     444443 34567788888888765     899999999999999999999998876554

>KOG0594|consensus

Probab=100.00  E-value=2.8e-43  Score=330.23  Aligned_cols=276  Identities=21%  Similarity=0.273  Sum_probs=203.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCC-eeEEEEEEecCCc--cc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDN-ILRYIGAEKRGES--IH  182 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~n-Iv~l~g~~~~~~~--~~  182 (461)
                      ...|+..++||+|.||+||+|+.  +|+.||+|.+.....   ......+|+.++++++|+| ||++++++.+.+.  ..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45678888999999999999998  578899999976544   2344579999999999999 9999999887652  12


Q ss_pred             eeeeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      ..+++|+||+.. +|..|+..     ..++...+..+++||+.||+|||++           +|+||||||+||||+++|
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-----------~IlHRDLKPQNlLi~~~G  157 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-----------GILHRDLKPQNLLISSSG  157 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecccCCcceEEECCCC
Confidence            356899999987 99999954     2477788999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC-
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL-  336 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~-  336 (461)
                      .+||+|||+|+...-..  ......++|..|.|||++.|.    ..|+...||||+|||+.||+++++.|.+..+..+. 
T Consensus       158 ~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs----~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~  231 (323)
T KOG0594|consen  158 VLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGS----TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF  231 (323)
T ss_pred             cEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCC----CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            99999999999765332  224457899999999999986    46778899999999999999998877654321000 


Q ss_pred             -CCccccCCCCCHHHHHHHHhccCCCCCCCc-----hhcc--chhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        337 -PFSAEVGDHPSLEDMQEAVVHKKLRPTLPE-----TWKQ--HAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       337 -pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~-----~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       -|.  ..+.|+.+..-.......+.+.++.     .+..  ........+++.+||..+|.+|.||+.+++|..+..
T Consensus       232 ~If~--~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~  307 (323)
T KOG0594|consen  232 RIFR--LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE  307 (323)
T ss_pred             HHHH--HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence             000  0000000000000000011111111     0100  001136789999999999999999999999976544

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-41  Score=336.17  Aligned_cols=270  Identities=22%  Similarity=0.298  Sum_probs=203.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..++|++.+.||+|+||.||+++..  +..||+|.+.....  ......+|+.++.+++||||+++++++...+    .+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~   78 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----EI   78 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----EE
Confidence            3568999999999999999999984  67899999865432  2345678999999999999999999988765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+..          +|+||||||+|||++.++.+||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------~ivH~dlkp~Nil~~~~~~~kl~Df  148 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH----------QIMHRDVKPSNILVNSRGEIKLCDF  148 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC----------CEEcCCCChhhEEEcCCCcEEEccC
Confidence            899999999999999964 45899999999999999999999851          6999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC-C----CC-CC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE-Y----RL-PF  338 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~-~----~~-pf  338 (461)
                      |+++.+....    .....||..|+|||++.+.     .++.++|||||||++|||++|+.||...... .    .. .+
T Consensus       149 g~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  219 (331)
T cd06649         149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV  219 (331)
T ss_pred             cccccccccc----cccCCCCcCcCCHhHhcCC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence            9997664322    2345789999999998763     5778999999999999999998777432110 0    00 00


Q ss_pred             cc---------------------c---cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc
Q psy17532        339 SA---------------------E---VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS  394 (461)
Q Consensus       339 ~~---------------------~---~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps  394 (461)
                      ..                     .   ........+....+... .++..+.    ...+.++.+||.+||..||++|||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~l~~li~~~L~~~P~~Rpt  294 (331)
T cd06649         220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKLPN----GVFTPDFQEFVNKCLIKNPAERAD  294 (331)
T ss_pred             ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhC-CCcCCCC----ccccHHHHHHHHHHccCCcccCCC
Confidence            00                     0   00000011111222111 1122221    123357999999999999999999


Q ss_pred             ccchhhhcHHHhh
Q psy17532        395 ASCVVERGMLALC  407 (461)
Q Consensus       395 ~~evl~~l~~~~~  407 (461)
                      +.++++|.+....
T Consensus       295 ~~ell~h~~~~~~  307 (331)
T cd06649         295 LKMLMNHTFIKRS  307 (331)
T ss_pred             HHHHhcChHHhhc
Confidence            9999999886543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=352.35  Aligned_cols=258  Identities=21%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--  181 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--  181 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||.+.....   .....++|+..+..++|+||+++++.+......  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3456999999999999999999987  578999999865432   233456788889999999999998876543221  


Q ss_pred             --ceeeeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        182 --HTEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       182 --~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                        ...+++||||+++|+|.++++.     ..+++..+..++.|++.||.|||+.           +|+||||||+|||++
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-----------~IiHrDLKP~NILl~  177 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-----------HMIHRDIKSANILLC  177 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEEe
Confidence              1235799999999999999853     3588999999999999999999998           999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        255 SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      .++.+||+|||+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++|           
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~k~DVwSlGvilyeLltG-----------  241 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-----KPYSKKADMFSLGVLLYELLTL-----------  241 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHC-----------
Confidence            999999999999987654322222344679999999999976     3677899999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ..||...     ...+....+...... .++...+     .++.+++.+||+.||++||++.+++++.+.
T Consensus       242 ~~Pf~~~-----~~~~~~~~~~~~~~~-~~~~~~~-----~~l~~li~~~L~~dP~~RPs~~ell~~p~~  300 (496)
T PTZ00283        242 KRPFDGE-----NMEEVMHKTLAGRYD-PLPPSIS-----PEMQEIVTALLSSDPKRRPSSSKLLNMPIC  300 (496)
T ss_pred             CCCCCCC-----CHHHHHHHHhcCCCC-CCCCCCC-----HHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence            5566443     344444544443332 3343332     379999999999999999999999998654

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.1e-42  Score=344.92  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=198.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCCC-CCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHME-HDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~  178 (461)
                      ...+.|++.+.||+|+||.||+|++.+       ..||||++.....  ......+|+.++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            446789999999999999999998732       3599999864432  2334568999999996 99999999999876


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-------------------------------------------------------
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-------------------------------------------------------  203 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------------------------------------  203 (461)
                      .    ..++||||+++|+|.+++..                                                       
T Consensus       114 ~----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         114 G----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             C----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            5    34999999999999988742                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCe
Q psy17532        204 ------------------------------------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV  241 (461)
Q Consensus       204 ------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~i  241 (461)
                                                                ..+++..++.++.|++.||+|||+.           +|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~i  258 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-----------NC  258 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-----------Ce
Confidence                                                      1367788899999999999999998           99


Q ss_pred             ecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       242 vHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      +||||||+|||++.++.+||+|||+++...............++..|+|||++.+.     .++.++|||||||++|||+
T Consensus       259 vH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell  333 (400)
T cd05105         259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-----LYTTLSDVWSYGILLWEIF  333 (400)
T ss_pred             eCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-----CCCchhhHHHHHHHHHHHH
Confidence            99999999999999999999999999876543322223334577889999998763     5678999999999999999


Q ss_pred             c-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        322 S-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       322 t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                      + |           ..||.....    ....... .....++..+..+     +..+.++|.+||+.||++||++.++.+
T Consensus       334 t~g-----------~~P~~~~~~----~~~~~~~-~~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         334 SLG-----------GTPYPGMIV----DSTFYNK-IKSGYRMAKPDHA-----TQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HCC-----------CCCCcccch----hHHHHHH-HhcCCCCCCCccC-----CHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            7 6           556543311    1122222 2233333444333     347899999999999999999999999


Q ss_pred             hcHHH
Q psy17532        401 RGMLA  405 (461)
Q Consensus       401 ~l~~~  405 (461)
                      .+..+
T Consensus       393 ~l~~l  397 (400)
T cd05105         393 IVESL  397 (400)
T ss_pred             HHHHH
Confidence            87654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.7e-42  Score=330.88  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=201.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...+|++.+.||+|+||.||+|...+       ..||+|.+......  ...+.+|+..+..++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            34689999999999999999998743       45999988644322  2345688999999999999999999887653


Q ss_pred             cceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeec
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAH  243 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivH  243 (461)
                          .+++|||+++|+|.+++..                 ..+++..+..++.|++.||.|||+.           +++|
T Consensus        83 ----~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-----------~i~H  147 (283)
T cd05048          83 ----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-----------HFVH  147 (283)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-----------Ceec
Confidence                4899999999999999853                 3478889999999999999999999           9999


Q ss_pred             ccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-
Q psy17532        244 RDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-  322 (461)
Q Consensus       244 rDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-  322 (461)
                      |||||+|||+++++.+||+|||+++...............+++.|+|||.+.+.     .++.++|||||||++|||++ 
T Consensus       148 ~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDv~slG~il~el~~~  222 (283)
T cd05048         148 RDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-----KFTTESDIWSFGVVLWEIFSY  222 (283)
T ss_pred             cccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-----cCchhhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999876443322223345678899999988653     56788999999999999998 


Q ss_pred             CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        323 RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       323 g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      |           ..||.+.     ...++...+... ..+..+..++     .++.+|+.+||+.||++||++++++++|
T Consensus       223 g-----------~~p~~~~-----~~~~~~~~i~~~-~~~~~~~~~~-----~~~~~l~~~c~~~~p~~Rp~~~~i~~~l  280 (283)
T cd05048         223 G-----------LQPYYGF-----SNQEVIEMIRSR-QLLPCPEDCP-----ARVYALMIECWNEIPARRPRFKDIHTRL  280 (283)
T ss_pred             C-----------CCCCCCC-----CHHHHHHHHHcC-CcCCCcccCC-----HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            7           5566543     334444444433 2333444333     4899999999999999999999999987


Q ss_pred             H
Q psy17532        403 M  403 (461)
Q Consensus       403 ~  403 (461)
                      .
T Consensus       281 ~  281 (283)
T cd05048         281 R  281 (283)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=342.93  Aligned_cols=255  Identities=19%  Similarity=0.242  Sum_probs=200.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|+.  +++.||||++....    .......+|+.++..++|+||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~~   76 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN----YL   76 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----eE
Confidence            3789999999999999999998  47889999997532    22233457888899999999999999998865    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-----------~ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL-----------GYIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeccCCHHHeEECCCCCEEEeec
Confidence            999999999999999854 5689999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCC------------------------------------CCCCCcCCCcccccccccccccccCCCCCcc
Q psy17532        265 GLALLFEPGKPCG------------------------------------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRI  308 (461)
Q Consensus       265 Gla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~  308 (461)
                      |+++.+.......                                    .....+||+.|+|||++.+     ..++.++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~  220 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-----TGYNKEC  220 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-----CCCCCee
Confidence            9997653221000                                    0112469999999999865     3677899


Q ss_pred             chHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHcccc
Q psy17532        309 DMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHD  388 (461)
Q Consensus       309 DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~d  388 (461)
                      |||||||++|||++|           ..||...     ...+....+........+|...   ..+..+.+||.+|+. +
T Consensus       221 DiwSlG~il~el~~G-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~ll~-~  280 (364)
T cd05599         221 DWWSLGVIMYEMLVG-----------YPPFCSD-----NPQETYRKIINWKETLQFPDEV---PLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             eeecchhHHHHhhcC-----------CCCCCCC-----CHHHHHHHHHcCCCccCCCCCC---CCCHHHHHHHHHHcc-C
Confidence            999999999999999           5666443     2333334443333333333321   123478899999996 9


Q ss_pred             Hhhhcc---ccchhhhcHHHh
Q psy17532        389 AEARLS---ASCVVERGMLAL  406 (461)
Q Consensus       389 P~~Rps---~~evl~~l~~~~  406 (461)
                      |.+|++   +.++++|.+...
T Consensus       281 p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         281 AERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             HhhcCCCCCHHHHhcCCCcCC
Confidence            999998   999999987644

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0599|consensus

Probab=100.00  E-value=3.7e-43  Score=315.61  Aligned_cols=267  Identities=22%  Similarity=0.347  Sum_probs=217.3

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-----h----hhHHHHHHHHcCCC-CCCCeeEEEEE
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-----Q----SWQSEQEIFKLPHM-EHDNILRYIGA  174 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-----~----~~~~~~ei~~l~~l-~H~nIv~l~g~  174 (461)
                      .+.....|.-.++||+|..+.|.++.+  .+..+|+|++.....     .    .....+|+.+|+++ .||||+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            344556788889999999999999887  478899999864321     1    11234788888887 79999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      +..+.+.    ++|+|.|+.|.|.|||... .++++...+|++|+..|++|||..           +||||||||+|||+
T Consensus        92 yes~sF~----FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~-----------~IVHRDLKpENILl  156 (411)
T KOG0599|consen   92 YESDAFV----FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR-----------NIVHRDLKPENILL  156 (411)
T ss_pred             ccCcchh----hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh-----------hhhhcccChhheee
Confidence            9887654    8999999999999999765 489999999999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPG  332 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~  332 (461)
                      |++..+||+|||+|..+.++.   .....+||++|+|||.+..+.+.+ ..|+..+|+||.|||||.|+.|++||     
T Consensus       157 ddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF-----  228 (411)
T KOG0599|consen  157 DDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF-----  228 (411)
T ss_pred             ccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch-----
Confidence            999999999999999998875   355679999999999998765443 56788899999999999999996544     


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhhh
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTM  410 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~  410 (461)
                            ...     ..--+...++.+++...-| .|.+  .+...++||.+||..||.+|.|++|++.|.++.....+
T Consensus       229 ------wHR-----kQmlMLR~ImeGkyqF~sp-eWad--is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  229 ------WHR-----KQMLMLRMIMEGKYQFRSP-EWAD--ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             ------hHH-----HHHHHHHHHHhcccccCCc-chhh--ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence                  322     1223345666666654433 3544  44588999999999999999999999999998665433

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-41  Score=334.27  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=200.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCC----cEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNE----NVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|++.+.||+|+||.||+|++  .++    .||||.+.....  ....+..|+.+++.++||||++++|++....  
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~--   82 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--   82 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC--
Confidence            346799999999999999999987  333    389999864322  2334567888999999999999999987643  


Q ss_pred             ceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .++++||+++|+|.+++...  .+++..++.++.||+.||+|||+.           +|+||||||+|||++.++.+
T Consensus        83 ---~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-----------~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          83 ---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER-----------RLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             ---ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc-----------CeeccccchhheEecCCCcE
Confidence               37999999999999999653  588999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+++.+.............++..|+|||++.+     ..++.++||||||+++|||++ |           ..||
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slGv~l~el~t~g-----------~~p~  212 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFG-----------SKPY  212 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhcc-----CCCCchhhhHHHHHHHHHHHcCC-----------CCCC
Confidence            9999999987764432222233345678999999875     367789999999999999998 7           5566


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ...++.. +.....+...+..++     ..+.+++.+||..||++||++.+++.++..+..
T Consensus       213 ~~~-----~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         213 DGI-----PASEISS-ILEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCC-----CHHHHHH-HHhCCCCCCCCCCCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            432     2233332 233333333333322     378999999999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-41  Score=350.20  Aligned_cols=254  Identities=20%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ....|.+.+.||+|+||.||+|...   ++.||+|.+...... .....+|+.+++.++|||||++++++...+    .+
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~~  140 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD----KL  140 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC----EE
Confidence            3456999999999999999999873   467888876544332 234567999999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++||||+++|+|.++++.     ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+|
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-----------~ivHrDlkp~NIll~~~~~~k  209 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-----------KMMHRDLKSANIFLMPTGIIK  209 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEECCcCHHhEEECCCCcEE
Confidence            999999999999988742     3588999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++|           ..||..
T Consensus       210 L~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg-----------~~Pf~~  273 (478)
T PTZ00267        210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-----KRYSKKADMWSLGVILYELLTL-----------HRPFKG  273 (478)
T ss_pred             EEeCcCceecCCccccccccccCCCccccCHhHhCC-----CCCCcHHhHHHHHHHHHHHHhC-----------CCCCCC
Confidence            999999987654332222344579999999999876     3677899999999999999999           556643


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      .     ...++...+..+... .++..++     ..+.++|.+||..||++||++.+++.+.+..
T Consensus       274 ~-----~~~~~~~~~~~~~~~-~~~~~~s-----~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        274 P-----SQREIMQQVLYGKYD-PFPCPVS-----SGMKALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             C-----CHHHHHHHHHhCCCC-CCCccCC-----HHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence            2     334445555444332 2333222     3799999999999999999999999876543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-42  Score=337.59  Aligned_cols=243  Identities=25%  Similarity=0.364  Sum_probs=193.5

Q ss_pred             eEeecCCceEEEEEEE-----CCCcEEEEEEecCC-----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        118 EVKAQGRFGAVWKAKF-----KNENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +.||+|+||.||+++.     .++.||||++....     ........|+.++..++||||+++++++...+    .+++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~~l   77 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----KLYL   77 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----eEEE
Confidence            6899999999999986     36789999986432     12233467888999999999999999988765    4599


Q ss_pred             eehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||||+++|+|.+++. .+.+.+..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ-----------GIIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence            999999999999985 44578889999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++......  .......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...     
T Consensus       147 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~G-----------~~pf~~~-----  203 (323)
T cd05584         147 CKESIHEG--TVTHTFCGTIEYMAPEILMRS-----GHGKAVDWWSLGALMYDMLTG-----------APPFTAE-----  203 (323)
T ss_pred             CeecccCC--CcccccCCCccccChhhccCC-----CCCCcceecccHHHHHHHhcC-----------CCCCCCC-----
Confidence            97543222  123345789999999998763     567889999999999999999           5566433     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLA  405 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~  405 (461)
                      ........+....  ..+|...+     ..+.++|.+||+.||++||     ++.++++|.+..
T Consensus       204 ~~~~~~~~~~~~~--~~~~~~~~-----~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         204 NRKKTIDKILKGK--LNLPPYLT-----PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             CHHHHHHHHHcCC--CCCCCCCC-----HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence            2233334443332  23343322     3789999999999999999     788998887653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-41  Score=340.16  Aligned_cols=256  Identities=19%  Similarity=0.208  Sum_probs=199.4

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||+||+|+.  .++.||||++.....    .......|+.++..++|+||+++++.+.+..    .+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~----~~   76 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL----NL   76 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----eE
Confidence            3689999999999999999988  467899999864321    2233457888899999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-----------givHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL-----------GFIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEecCCCHHHeEECCCCCEEEeec
Confidence            99999999999999985 45799999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCC---------------------------------CCCCCCcCCCcccccccccccccccCCCCCccchH
Q psy17532        265 GLALLFEPGKPC---------------------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMY  311 (461)
Q Consensus       265 Gla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVw  311 (461)
                      |+++.+......                                 ......+||+.|+|||++.+     ..++.++|||
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~Dvw  220 (363)
T cd05628         146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-----TGYNKLCDWW  220 (363)
T ss_pred             cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-----CCCCCchhhh
Confidence            999765321100                                 00123579999999999976     3677899999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh
Q psy17532        312 ACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA  391 (461)
Q Consensus       312 S~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~  391 (461)
                      ||||++|||++|           ..||...     ...+....+........+|...+   .+.++.+++.+++. +|++
T Consensus       221 SlGvil~ell~G-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~~~---~s~~~~~li~~l~~-~~~~  280 (363)
T cd05628         221 SLGVIMYEMLIG-----------YPPFCSE-----TPQETYKKVMNWKETLIFPPEVP---ISEKAKDLILRFCC-EWEH  280 (363)
T ss_pred             hhHHHHHHHHhC-----------CCCCCCC-----CHHHHHHHHHcCcCcccCCCcCC---CCHHHHHHHHHHcC-Chhh
Confidence            999999999999           6666543     33444455544333333443221   23478889988664 4554


Q ss_pred             ---hccccchhhhcHHHhh
Q psy17532        392 ---RLSASCVVERGMLALC  407 (461)
Q Consensus       392 ---Rps~~evl~~l~~~~~  407 (461)
                         ||+++++++|.+....
T Consensus       281 r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         281 RIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             cCCCCCHHHHhCCCCCCCC
Confidence               5899999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.6e-42  Score=339.08  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~  178 (461)
                      ...++|++.+.||+|+||.||+|...       ++.||+|++.....  .......|+.++.++ +|+||+++++++...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34568999999999999999999753       35799999864322  223345788888888 899999999988754


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-------------------------------------------------------
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-------------------------------------------------------  203 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------------------------------------  203 (461)
                      ..   .++++|||+++|+|.+++..                                                       
T Consensus        84 ~~---~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          84 GG---PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             CC---CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            32   45899999999999998842                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCC
Q psy17532        204 -------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC  276 (461)
Q Consensus       204 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~  276 (461)
                             ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++.+......
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-----------~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~  229 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR-----------KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY  229 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch
Confidence                   2578999999999999999999998           9999999999999999999999999999876543322


Q ss_pred             CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHH
Q psy17532        277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV  355 (461)
Q Consensus       277 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~  355 (461)
                      .......++..|+|||++.+     ..++.++|||||||++|||++ |           ..||.....    .+.+. ..
T Consensus       230 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~SlGv~l~el~t~g-----------~~p~~~~~~----~~~~~-~~  288 (337)
T cd05054         230 VRKGDARLPLKWMAPESIFD-----KVYTTQSDVWSFGVLLWEIFSLG-----------ASPYPGVQI----DEEFC-RR  288 (337)
T ss_pred             hhccCCCCCccccCcHHhcC-----CCCCccccHHHHHHHHHHHHHcC-----------CCCCCCCCc----cHHHH-HH
Confidence            22333456788999999876     367889999999999999998 7           455543211    11122 22


Q ss_pred             hccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        356 VHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       356 ~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .....++..+..+     ..++.+++.+||+.+|++||++.+++++|..+.
T Consensus       289 ~~~~~~~~~~~~~-----~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         289 LKEGTRMRAPEYA-----TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HhccCCCCCCccC-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2233333334332     347899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-42  Score=340.27  Aligned_cols=259  Identities=19%  Similarity=0.221  Sum_probs=203.2

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+++.  +++.||||++.....    .....+.|+.++..++|+||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~----~~   76 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD----NL   76 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----eE
Confidence            3689999999999999999998  478899999975322    2334567888888999999999999988755    45


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+++|+|.++++.  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-----------~i~H~Dlkp~NIll~~~~~~kL~D  145 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM-----------GYVHRDIKPENVLIDRTGHIKLAD  145 (330)
T ss_pred             EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEcccCchHheEECCCCCEEecc
Confidence            999999999999999965  4699999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF-SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||++..+...... ......||+.|+|||++.+.... ...++.++|||||||++|||++|           ..||... 
T Consensus       146 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g-----------~~Pf~~~-  212 (330)
T cd05601         146 FGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG-----------RSPFHEG-  212 (330)
T ss_pred             CCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC-----------CCCCCCC-
Confidence            9999876543321 22334789999999998643221 24567899999999999999999           5566433 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ........+........+|..   ...+..+.+|+.+||. ||++|||+.+++.|.+...
T Consensus       213 ----~~~~~~~~i~~~~~~~~~~~~---~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         213 ----TSAKTYNNIMNFQRFLKFPED---PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             ----CHHHHHHHHHcCCCccCCCCC---CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence                223333344333222223321   1123478999999998 9999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-41  Score=322.62  Aligned_cols=249  Identities=18%  Similarity=0.351  Sum_probs=198.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..+|++.+.||+|+||.||+++++. ..+|+|.+...........+|+.++.+++||||+++++++.....    +++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP----LYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC----EEEEE
Confidence            4578999999999999999999854 579999886554444566789999999999999999999877653    48999


Q ss_pred             hhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+||++++++.+||+|||++
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~ni~i~~~~~~kl~d~g~~  147 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-----------SFIHRDLAARNCLVSSTGVVKVSDFGMT  147 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccccCcceEEEcCCCeEEECCCCCc
Confidence            99999999999854  3589999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +....... .......++..|+|||++.+     ..++.++||||||+++|||++ |           +.||...     
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~~g-----------~~p~~~~-----  205 (256)
T cd05114         148 RYVLDDEY-TSSSGAKFPVKWSPPEVFNF-----SKYSSKSDVWSFGVLMWEVFTEG-----------KMPFEKK-----  205 (256)
T ss_pred             cccCCCce-eccCCCCCchhhCChhhccc-----CccchhhhhHHHHHHHHHHHcCC-----------CCCCCCC-----
Confidence            86543321 11223345678999999875     356788999999999999999 7           5566433     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ...+....+.... ++..|...     +..+.+++.+||+.||++||+++++++.+
T Consensus       206 ~~~~~~~~i~~~~-~~~~~~~~-----~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         206 SNYEVVEMISRGF-RLYRPKLA-----SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CHHHHHHHHHCCC-CCCCCCCC-----CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            3334444443322 22333322     24789999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-41  Score=341.18  Aligned_cols=261  Identities=19%  Similarity=0.208  Sum_probs=205.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+++..  ++.||+|.+....    .......+|+.++..++||||+++++++.+..    
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~----  116 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK----  116 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----
Confidence            3468999999999999999999984  6789999986421    12233457888889999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||+++|+|.+++....+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~-----------~IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM-----------GLIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHEEECCCCCEEEEe
Confidence            459999999999999999888899999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+.+..... .......||+.|||||++.+.. ....++.++|||||||++|||++|           ..||...  
T Consensus       186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~~DiwSlG~ilyell~G-----------~~Pf~~~--  250 (370)
T cd05621         186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLFEMLVG-----------DTPFYAD--  250 (370)
T ss_pred             cccceecccCCc-eecccCCCCcccCCHHHHhccC-CCCCCCcccCEEeehHHHHHHHhC-----------CCCCCCC--
Confidence            999987653321 1223457999999999986531 112367889999999999999999           5666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~~  406 (461)
                         +.......+........+|...   ..+..+.+++.+||..++.+  |+++.++++|.+...
T Consensus       251 ---~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         251 ---SLVGTYSKIMDHKNSLNFPEDV---EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             ---CHHHHHHHHHhCCcccCCCCcc---cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence               3333444444443333444321   12347889999999866554  889999999988643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.3e-42  Score=331.96  Aligned_cols=270  Identities=22%  Similarity=0.287  Sum_probs=193.6

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|+.+  ++.||||++.....   ......+|+.++..++|+||+++++++....    .++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   76 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG----KLY   76 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC----EEE
Confidence            36899999999999999999994  67899999865422   2234567899999999999999999987755    459


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||++++.|..+.. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN-----------DIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999999877765553 34689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc-cCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE-VGD  344 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~-~~~  344 (461)
                      +++.+..... .......|+..|+|||++.+.     .++.++|||||||++|||++|..||........ .+... ...
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~  218 (287)
T cd07848         146 FARNLSEGSN-ANYTEYVATRWYRSPELLLGA-----PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLG  218 (287)
T ss_pred             Cccccccccc-ccccccccccccCCcHHHcCC-----CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhC
Confidence            9987654321 122335689999999998763     567889999999999999999555532211000 00000 000


Q ss_pred             CCCHHHHHHHHhccCC-CCCCC-----chhc---cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKL-RPTLP-----ETWK---QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~-~~~~p-----~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ................ ....+     ..+.   ....+..+.+||++||+.||++|||++++++|.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            0000000000000000 00000     0000   0113357999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-41  Score=333.77  Aligned_cols=243  Identities=25%  Similarity=0.366  Sum_probs=188.8

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcC-CCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLP-HMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~-~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.+  ++.||||.+....    ........|..++. ..+||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e   76 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EEEEEEc
Confidence            47999999999999984  5679999987432    11122233444444 358999999999988755    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-----------~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK-----------GIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            9999999999854 4689999999999999999999998           999999999999999999999999999976


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~G-----------~~Pf~~~-----~~~  202 (316)
T cd05592         146 NMNGE--GKASTFCGTPDYIAPEILKGQ-----KYNESVDWWSFGVLLYEMLIG-----------QSPFHGE-----DED  202 (316)
T ss_pred             CCCCC--CccccccCCccccCHHHHcCC-----CCCCcccchhHHHHHHHHHhC-----------CCCCCCC-----CHH
Confidence            54322  223345799999999998763     577889999999999999999           5666543     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc-chhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS-CVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~l~~~  405 (461)
                      ++...+..  ..+.+|...+     .++.+++.+||+.||++||++. ++++|.+..
T Consensus       203 ~~~~~i~~--~~~~~~~~~~-----~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~  252 (316)
T cd05592         203 ELFDSILN--DRPHFPRWIS-----KEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR  252 (316)
T ss_pred             HHHHHHHc--CCCCCCCCCC-----HHHHHHHHHHccCCHHHcCCChHHHHcCcccC
Confidence            44444432  2334444333     3788999999999999999875 677776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-41  Score=328.81  Aligned_cols=255  Identities=23%  Similarity=0.285  Sum_probs=187.7

Q ss_pred             cceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCChh---hhHHHHHHHH---cCCCCCCCeeEEEEEEecCCc-c
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDKQ---SWQSEQEIFK---LPHMEHDNILRYIGAEKRGES-I  181 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~---~~~~~~ei~~---l~~l~H~nIv~l~g~~~~~~~-~  181 (461)
                      ++|++.+.||+|+||.||+|+..   ++.||||.+......   .....+|+.+   +..++||||+++++++..... .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999872   567999988643221   1223345444   445589999999998864321 1


Q ss_pred             ceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                      ...+++||||++ |+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-----------~iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-----------RVVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCCHHHEEEcCCCC
Confidence            235689999997 599999853   3489999999999999999999998           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......   ......||..|+|||++.+     ..++.++|||||||++|||++|.+||.....      
T Consensus       149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~~f~~~~~------  214 (290)
T cd07862         149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------  214 (290)
T ss_pred             EEEccccceEeccCCc---ccccccccccccChHHHhC-----CCCCCccchHHHHHHHHHHHcCCCCcCCCCH------
Confidence            9999999998764331   2334578999999999865     3567889999999999999999655533211      


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhc---------------------cchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWK---------------------QHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---------------------~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                                .+....+.... ....+..|+                     ....+..+.+|+.+||+.||++|||+.+
T Consensus       215 ----------~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  283 (290)
T cd07862         215 ----------VDQLGKILDVI-GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  283 (290)
T ss_pred             ----------HHHHHHHHHHh-CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence                      11111111100 000000000                     0113357889999999999999999999


Q ss_pred             hhhhcH
Q psy17532        398 VVERGM  403 (461)
Q Consensus       398 vl~~l~  403 (461)
                      +++|.+
T Consensus       284 ~l~hp~  289 (290)
T cd07862         284 ALSHPY  289 (290)
T ss_pred             HhcCCC
Confidence            999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.8e-42  Score=336.94  Aligned_cols=243  Identities=23%  Similarity=0.299  Sum_probs=193.8

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      +.||+|+||.||+++.  +++.||+|++....    ........|+.++..++||||+++++++....    .+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----EEEEEEeC
Confidence            4699999999999987  57889999987432    12233456888889999999999999988765    45999999


Q ss_pred             ccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        192 HERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       192 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      +++|+|.+++.. ..+++..+..++.||+.||.|||+ .           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~-----------~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK-----------NVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            999999998854 468999999999999999999997 6           999999999999999999999999999875


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...     ..+
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tG-----------~~Pf~~~-----~~~  202 (325)
T cd05594         146 GIKDG--ATMKTFCGTPEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ-----DHE  202 (325)
T ss_pred             cCCCC--cccccccCCcccCCHHHHccC-----CCCCccccccccceeeeeccC-----------CCCCCCC-----CHH
Confidence            43222  122345699999999998763     667899999999999999999           5666433     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~  405 (461)
                      .....+....  ..+|...+     .++.+|+.+||+.||++|+     ++.++++|.+..
T Consensus       203 ~~~~~i~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         203 KLFELILMEE--IRFPRTLS-----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             HHHHHHhcCC--CCCCCCCC-----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            4444443332  23343332     3789999999999999997     899999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-42  Score=340.44  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=203.4

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||||++....    ........|+.++..++|+||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~   76 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE----HL   76 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC----eE
Confidence            36899999999999999999985  7899999987432    22334567888899999999999999988765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL-----------GFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHeEECCCCCEEeecC
Confidence            999999999999999954 4799999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCC---------------------------CCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        265 GLALLFEPGK---------------------------PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       265 Gla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                      |+++......                           .........||+.|+|||++.+.     .++.++|||||||++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il  220 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-----PYGLECDWWSLGVIL  220 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-----CCCCceeeEecchhh
Confidence            9998765432                           00112345789999999999763     677899999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-cc
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-AS  396 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~  396 (461)
                      |||++|           ..||...     ........+........+|...   ..+..+.+||.+||. ||++||+ +.
T Consensus       221 ~ell~g-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~~---~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         221 YEMLYG-----------FPPFYSD-----TLQETYNKIINWKESLRFPPDP---PVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             hhhccC-----------CCCCCCC-----CHHHHHHHHhccCCcccCCCCC---CCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            999999           5666543     2333334444322222233221   023478999999997 9999999 99


Q ss_pred             chhhhcHHHhh
Q psy17532        397 CVVERGMLALC  407 (461)
Q Consensus       397 evl~~l~~~~~  407 (461)
                      ++++|.+....
T Consensus       281 ~ll~hp~~~~~  291 (350)
T cd05573         281 EIKSHPFFKGI  291 (350)
T ss_pred             HHhcCCCcCCC
Confidence            99999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0589|consensus

Probab=100.00  E-value=1.2e-42  Score=339.43  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=213.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..+|..++.+|+|+||.++..+++  ++.+++|.+....   ......++|+.++++++|||||.+++.|..++.   -.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~---~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ---LL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc---eE
Confidence            467899999999999999988874  5789999997544   333355789999999999999999999988764   24


Q ss_pred             eeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +|||+||+||+|.+.+++.   .++++.+..++.|++.|+.|||++           +|+|||||+.||+++.+..+||+
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-----------~iLHRDlK~~Nifltk~~~VkLg  148 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-----------RVLHRDLKCANIFLTKDKKVKLG  148 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh-----------hhhcccchhhhhhccccCceeec
Confidence            8999999999999999543   489999999999999999999988           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+.+.+..  ......+||+.||.||++.+     ..|..|+|||||||++|||++-           +.+|... 
T Consensus       149 DfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d-----~pYn~KSDiWsLGC~~yEm~~l-----------k~aF~a~-  209 (426)
T KOG0589|consen  149 DFGLAKILNPED--SLASTVVGTPYYMCPEILSD-----IPYNEKSDIWSLGCCLYEMCTL-----------KPAFKAS-  209 (426)
T ss_pred             chhhhhhcCCch--hhhheecCCCcccCHHHhCC-----CCCCccCcchhhcchHHHHHhc-----------ccccCcc-
Confidence            999999987664  24566899999999999987     5888999999999999999998           5666554 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                          +...+...+..... .++|..+..     ++..+|..|+..+|+.||++.+++.++..
T Consensus       210 ----~m~~Li~ki~~~~~-~Plp~~ys~-----el~~lv~~~l~~~P~~RPsa~~LL~~P~l  261 (426)
T KOG0589|consen  210 ----NMSELILKINRGLY-SPLPSMYSS-----ELRSLVKSMLRKNPEHRPSALELLRRPHL  261 (426)
T ss_pred             ----chHHHHHHHhhccC-CCCCccccH-----HHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence                55666666666553 456665554     89999999999999999999999998543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-41  Score=335.23  Aligned_cols=277  Identities=21%  Similarity=0.199  Sum_probs=197.5

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc-ceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI-HTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~-~~~~~  186 (461)
                      +|++.+.||+|+||.||+|+.  +++.||||++....   .......+|+.+++.++||||+++++++...... ...++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            488999999999999999998  46889999986321   2233456899999999999999999988654321 23469


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dlkp~NIll~~~~~~kL~Dfg  148 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA-----------NVFHRDLKPKNILANADCKLKICDFG  148 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEECCCCcEEEccCc
Confidence            9999996 689998854 4699999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +++........ .......||..|+|||++.+.   ...++.++|||||||++|||++|+.||.................
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cccccccccCccccccCCCCCCCcCCHHHHhcc---ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            99865332211 112345789999999998642   13667899999999999999999655533211000000000000


Q ss_pred             CCCHHH-----------HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        345 HPSLED-----------MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       345 ~~~~~~-----------~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .+....           ..... .......+...++  ..+..+.+++.+||+.||++|||++++++|.+....
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSM-RKKQPVPFSQKFP--NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhh-cccCCCchHHhcC--CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence            000000           00000 0000111111111  123478899999999999999999999999987554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-41  Score=346.83  Aligned_cols=273  Identities=18%  Similarity=0.266  Sum_probs=193.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCC----ccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE----SIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~----~~~~  183 (461)
                      ...+|++.+.||+|+||.||+|..  .++.||||++....   ....+|+.+++.++|+|||++++++....    ....
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            346899999999999999999998  46789999885432   22346888999999999999999875432    1112


Q ss_pred             eeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-
Q psy17532        184 EFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-  257 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-  257 (461)
                      .+++||||+++ +|.+++.     ...+++..+..++.||+.||+|||+.           +|+||||||+|||++.++ 
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-----------~IiHrDLKp~NILl~~~~~  208 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-----------FICHRDLKPQNLLIDPNTH  208 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCcCHHHEEEcCCCC
Confidence            35799999985 7877663     34689999999999999999999999           999999999999999664 


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+|+.+....   ......||+.|+|||++.+.    ..++.++|||||||++|||++|.+||.+........
T Consensus       209 ~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  281 (440)
T PTZ00036        209 TLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGA----TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV  281 (440)
T ss_pred             ceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            79999999998765432   12345789999999998653    357789999999999999999955553321100000


Q ss_pred             CccccCCCCCHHHHHHHHhccCC-CCCCC----chhc---cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKL-RPTLP----ETWK---QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~-~~~~p----~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      -.......+..+.+..  ....+ ...+|    ..+.   ....+.++.+||.+||..||++|||+.+++.|.++..
T Consensus       282 ~i~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        282 RIIQVLGTPTEDQLKE--MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHhCCCCHHHHHH--hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence            0000000001111100  00000 00000    0000   0112347899999999999999999999999998754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-41  Score=332.26  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=190.8

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCC-CCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPH-MEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~-l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+..  ++.||||.+....    ........|..++.. ++||||+++++++.+..    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----~~~lv~e   76 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----NLFFVME   76 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----EEEEEEe
Confidence            46999999999999984  5789999987532    122233445555554 59999999999998765    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~-----------~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-----------GIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            9999999999964 5689999999999999999999998           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G-----------~~pf~~~-----~~~  202 (316)
T cd05619         146 NMLGD--AKTCTFCGTPDYIAPEILLG-----QKYNTSVDWWSFGVLLYEMLIG-----------QSPFHGH-----DEE  202 (316)
T ss_pred             CCCCC--CceeeecCCccccCHHHHcC-----CCCCchhhhhhHHHHHHHHHhC-----------CCCCCCC-----CHH
Confidence            43222  12334578999999999876     3677899999999999999999           5666443     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc-chhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS-CVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~l~~~~  406 (461)
                      ++...+....  +.+|..++     ..+.+++.+||..||++||++. +++.|.+...
T Consensus       203 ~~~~~i~~~~--~~~~~~~~-----~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         203 ELFQSIRMDN--PCYPRWLT-----REAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             HHHHHHHhCC--CCCCccCC-----HHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            4444443322  23333222     3788999999999999999997 7878776544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-41  Score=333.89  Aligned_cols=244  Identities=23%  Similarity=0.292  Sum_probs=192.1

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.+  ++.||||++....    ........|+.++..+ +||||+++++++...+    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----~~~lv~e   76 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----RLFFVME   76 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EEEEEEc
Confidence            47999999999999984  5789999987432    1222334566666655 7999999999988765    4599999


Q ss_pred             hccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++... .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-----------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-----------GIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            99999999988654 799999999999999999999998           999999999999999999999999999875


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+.     .++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslGvil~~l~~G-----------~~pf~~~-----~~~  202 (318)
T cd05570         146 GILGG--VTTSTFCGTPDYIAPEILSYQ-----PYGPAVDWWALGVLLYEMLAG-----------QSPFEGD-----DED  202 (318)
T ss_pred             cCcCC--CcccceecCccccCHHHhcCC-----CCCcchhhhhHHHHHHHHhhC-----------CCCCCCC-----CHH
Confidence            32221  122345689999999999763     677899999999999999999           5666433     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~~  406 (461)
                      .....+....  ..+|...     +..+.+||.+||..||++|||+     .+++++.+...
T Consensus       203 ~~~~~i~~~~--~~~~~~~-----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         203 ELFQSILEDE--VRYPRWL-----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             HHHHHHHcCC--CCCCCcC-----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            4444443332  2333332     2378999999999999999999     88888876544

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.4e-41  Score=324.38  Aligned_cols=252  Identities=21%  Similarity=0.330  Sum_probs=198.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|++.+.||+|+||.||+|..      .+..||+|.+......  ...+++|+.+++.++||||+++++++..... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-   81 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP-   81 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc-
Confidence            356899999999999999999985      3467999998643322  2345678999999999999999999887653 


Q ss_pred             ceeeeeeehhccCCChhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeec
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC------------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAH  243 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivH  243 (461)
                         .++||||+++|+|.+++..                  ..+++..+..++.|++.||.|||++           +|+|
T Consensus        82 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-----------~i~H  147 (283)
T cd05090          82 ---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-----------FFVH  147 (283)
T ss_pred             ---eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-----------Ceeh
Confidence               4899999999999999841                  2378888999999999999999998           9999


Q ss_pred             ccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-
Q psy17532        244 RDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-  322 (461)
Q Consensus       244 rDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-  322 (461)
                      |||||+|||+++++.+||+|||+++...............++..|+|||++.+.     .++.++||||||+++|||++ 
T Consensus       148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~~  222 (283)
T cd05090         148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-----KFSSDSDIWSFGVVLWEIFSF  222 (283)
T ss_pred             hccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-----CCCchhhhHHHHHHHHHHHcC
Confidence            999999999999999999999999876443322223334567789999998753     56788999999999999998 


Q ss_pred             CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        323 RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       323 g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      |           ..||...     ....+.+.+.... .+..+..+     +..+.+++.+||+.||++||++.++++++
T Consensus       223 g-----------~~p~~~~-----~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  280 (283)
T cd05090         223 G-----------LQPYYGF-----SNQEVIEMVRKRQ-LLPCSEDC-----PPRMYSLMTECWQEGPSRRPRFKDIHTRL  280 (283)
T ss_pred             C-----------CCCCCCC-----CHHHHHHHHHcCC-cCCCCCCC-----CHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence            6           5566433     2233344443322 22333332     34789999999999999999999998876


Q ss_pred             H
Q psy17532        403 M  403 (461)
Q Consensus       403 ~  403 (461)
                      .
T Consensus       281 ~  281 (283)
T cd05090         281 R  281 (283)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-41  Score=340.77  Aligned_cols=255  Identities=19%  Similarity=0.240  Sum_probs=195.4

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .|++++.||+|+||.||+|+.  +++.||||++....    ........|+.++..++|+||+++++++.+..    .++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----~~~   77 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD----NLY   77 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC----EEE
Confidence            588999999999999999998  46789999986532    12234567888899999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+||||+.++.+||+|||
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~-----------givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM-----------GFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecCCcHHHEEECCCCCEEEeeCc
Confidence            99999999999999854 5688999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCC---------------------------------------------CCCCCCcCCCcccccccccccccc
Q psy17532        266 LALLFEPGKPC---------------------------------------------GDTHGQVGTRRYMAPEVLEGAINF  300 (461)
Q Consensus       266 la~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~  300 (461)
                      +++.+......                                             .......||+.|+|||++.+    
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----  222 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR----  222 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC----
Confidence            98643210000                                             00123479999999999876    


Q ss_pred             cCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHH
Q psy17532        301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT  380 (461)
Q Consensus       301 ~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~l  380 (461)
                       ..++.++|||||||++|||++|           ..||...     ...+....+........+|...   ..+.++.+|
T Consensus       223 -~~~~~~~DiwSlG~il~elltG-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~dl  282 (381)
T cd05626         223 -KGYTQLCDWWSVGVILFEMLVG-----------QPPFLAP-----TPTETQLKVINWENTLHIPPQV---KLSPEAVDL  282 (381)
T ss_pred             -CCCCCccceeehhhHHHHHHhC-----------CCCCcCC-----CHHHHHHHHHccccccCCCCCC---CCCHHHHHH
Confidence             3677899999999999999999           5566433     2222233333222222333211   123478899


Q ss_pred             HHHHc--cccHhhhccccchhhhcHHHh
Q psy17532        381 MEECW--DHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       381 i~~cl--~~dP~~Rps~~evl~~l~~~~  406 (461)
                      |.+++  ..++..|+++.+++.|.+...
T Consensus       283 i~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         283 ITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHHccCcccccCCCCHHHHhcCcccCC
Confidence            99844  556666999999999987644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG1989|consensus

Probab=100.00  E-value=9e-42  Score=351.43  Aligned_cols=265  Identities=22%  Similarity=0.285  Sum_probs=207.3

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-C-CcEEEEEEecCChhhh-HHHHHHHHcCCCC-CCCeeEEEEE-Eec--CCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-N-ENVAVKIFLMQDKQSW-QSEQEIFKLPHME-HDNILRYIGA-EKR--GES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~-~~vAvK~~~~~~~~~~-~~~~ei~~l~~l~-H~nIv~l~g~-~~~--~~~  180 (461)
                      ..+..++++.++|.+|||+.||+|+.. + ..||+|++...+.... ...+||.+|+.|. |+|||.|++. ...  ++.
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            346678899999999999999999994 3 7899999876554443 3478999999996 9999999993 222  222


Q ss_pred             cceeeeeeehhccCCChhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      ...+++|+||||.+|+|-|++.   ...|++.++++|+.|+++|+++||..         +|+|||||||-+||||+.++
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~---------~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL---------KPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC---------CCccchhhhhhhheEEcCCC
Confidence            2468899999999999999995   34599999999999999999999987         78999999999999999999


Q ss_pred             ceEEEecCCccccCCCC-CCC------CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGK-PCG------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP  330 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~-~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~  330 (461)
                      ..||||||.|...-..- ...      ..-....|+.|+|||++.-  +.....+.|+|||+|||+||-|+..       
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl--ysg~pI~eKsDIWALGclLYkLCy~-------  254 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL--YSGLPIGEKSDIWALGCLLYKLCYF-------  254 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh--hcCCCCcchhHHHHHHHHHHHHHHh-------
Confidence            99999999985432111 000      0112356899999999853  3446889999999999999999998       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       331 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                          ..||+...         .-.++.+.+..+..+.     .+..|.+||+.||+.||++||++-++++++.++...
T Consensus       255 ----t~PFe~sg---------~laIlng~Y~~P~~p~-----ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  255 ----TTPFEESG---------KLAILNGNYSFPPFPN-----YSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----CCCcCcCc---------ceeEEeccccCCCCcc-----HHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                66665431         1123444433222222     334899999999999999999999999999888764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.2e-41  Score=330.49  Aligned_cols=248  Identities=21%  Similarity=0.290  Sum_probs=193.8

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCC-CCeeEEEEEEecCCccceee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEH-DNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +|++.+.||+|+||.||+|+.+  ++.||||++....    ........|+.++..++| ++|+++++++...+    .+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   76 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----RL   76 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----EE
Confidence            4889999999999999999985  5679999986432    222334567777777866 46888888887754    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~dlkp~Nill~~~~~~kL~Df  145 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-----------GIIYRDLKLDNVMLDAEGHIKIADF  145 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHeEEcCCCCEEEeec
Confidence            999999999999999854 4689999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......||..|+|||++.+.     .++.++|||||||++|||++|           +.||...   
T Consensus       146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGvil~elltG-----------~~pf~~~---  204 (324)
T cd05587         146 GMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQ-----PYGKSVDWWAFGVLLYEMLAG-----------QPPFDGE---  204 (324)
T ss_pred             CcceecCCCC--CceeeecCCccccChhhhcCC-----CCCcccchhhhHHHHHHHHhC-----------CCCCCCC---
Confidence            9987532221  122345789999999999763     567889999999999999999           5666433   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLA  405 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~  405 (461)
                        ...+....+....  ..+|...+     ..+.+++.+||..||++|+++     .++++|.+..
T Consensus       205 --~~~~~~~~i~~~~--~~~~~~~~-----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~  261 (324)
T cd05587         205 --DEDELFQSIMEHN--VSYPKSLS-----KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR  261 (324)
T ss_pred             --CHHHHHHHHHcCC--CCCCCCCC-----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence              3344444444332  33443332     378899999999999999987     5777776543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-41  Score=331.89  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=191.1

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.+  ++.||||++....    ........|+.++..+ +||||+++++++...+    .+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~~iv~E   76 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----RLFFVME   76 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----EEEEEEc
Confidence            47999999999999984  6789999986432    1222334566666555 7999999999988765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~-----------~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK-----------GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            999999999885 45699999999999999999999998           999999999999999999999999999876


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g-----------~~Pf~~~-----~~~  202 (320)
T cd05590         146 GIFNG--KTTSTFCGTPDYIAPEILQE-----MLYGPSVDWWAMGVLLYEMLCG-----------HAPFEAE-----NED  202 (320)
T ss_pred             cCcCC--CcccccccCccccCHHHHcC-----CCCCCccchhhhHHHHHHHhhC-----------CCCCCCC-----CHH
Confidence            43221  12334578999999999875     3567889999999999999999           5666543     344


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc------cchhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA------SCVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~~~  405 (461)
                      ++.+.+....  ..+|...     +.++.+++.+||+.||++||++      ++++.|.+..
T Consensus       203 ~~~~~i~~~~--~~~~~~~-----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~  257 (320)
T cd05590         203 DLFEAILNDE--VVYPTWL-----SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK  257 (320)
T ss_pred             HHHHHHhcCC--CCCCCCC-----CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence            4555554432  2233322     2378999999999999999998      6777777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=339.83  Aligned_cols=255  Identities=18%  Similarity=0.224  Sum_probs=196.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+++.  +++.||||.+.....    .....++|+.++..++||||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~   76 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ----YL   76 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----ee
Confidence            3689999999999999999988  578899999864321    2233467888899999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~-----------givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL-----------GFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHEEECCCCCEEEeec
Confidence            999999999999999854 5689999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCC------------CC---------------------------------CCCCCcCCCccccccccccccc
Q psy17532        265 GLALLFEPGKP------------CG---------------------------------DTHGQVGTRRYMAPEVLEGAIN  299 (461)
Q Consensus       265 Gla~~~~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~l~~~~~  299 (461)
                      |+++.+.....            ..                                 ......||+.|+|||++.+   
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---  222 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ---  222 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc---
Confidence            99964321100            00                                 0012469999999999875   


Q ss_pred             ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHH
Q psy17532        300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCD  379 (461)
Q Consensus       300 ~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~  379 (461)
                        ..++.++|||||||++|||++|           ..||...     ...+....+........+|...   ..+.++.+
T Consensus       223 --~~~~~~~DiwSlGvil~elltG-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~d  281 (377)
T cd05629         223 --QGYGQECDWWSLGAIMFECLIG-----------WPPFCSE-----NSHETYRKIINWRETLYFPDDI---HLSVEAED  281 (377)
T ss_pred             --CCCCCceeeEecchhhhhhhcC-----------CCCCCCC-----CHHHHHHHHHccCCccCCCCCC---CCCHHHHH
Confidence              3677899999999999999999           5566433     2223333333322223333321   12347889


Q ss_pred             HHHHHccccHhhh---ccccchhhhcHHHh
Q psy17532        380 TMEECWDHDAEAR---LSASCVVERGMLAL  406 (461)
Q Consensus       380 li~~cl~~dP~~R---ps~~evl~~l~~~~  406 (461)
                      ||.+|+. +|.+|   +++.+++.|.+...
T Consensus       282 li~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         282 LIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             HHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9999997 77776   59999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3e-41  Score=331.00  Aligned_cols=244  Identities=23%  Similarity=0.325  Sum_probs=190.2

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCC-CCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPH-MEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~-l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++||+|+||.||+|+.+  ++.||||.+....    ........|..++.. ++||||+++++++.+.+    .+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----HLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----EEEEEEC
Confidence            47999999999999984  6789999987532    122233455555544 58999999999998765    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK-----------GIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            9999999998854 4689999999999999999999999           999999999999999999999999999875


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+.     .++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGvil~el~~g-----------~~Pf~~~-----~~~  202 (316)
T cd05620         146 NVFGD--NRASTFCGTPDYIAPEILQGL-----KYTFSVDWWSFGVLLYEMLIG-----------QSPFHGD-----DED  202 (316)
T ss_pred             cccCC--CceeccCCCcCccCHHHHcCC-----CCCcccchhhhHHHHHHHHhC-----------CCCCCCC-----CHH
Confidence            43222  123345789999999999763     677889999999999999999           5666433     333


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-cchhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-SCVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~evl~~l~~~~  406 (461)
                      .+.+.+...  .+.+|...     +.++.++|.+||+.||++||++ +++++|.+...
T Consensus       203 ~~~~~~~~~--~~~~~~~~-----~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         203 ELFESIRVD--TPHYPRWI-----TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             HHHHHHHhC--CCCCCCCC-----CHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence            444443322  23344332     2378999999999999999998 47777876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-42  Score=335.42  Aligned_cols=242  Identities=22%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             eEeecCCceEEEEEEE-----CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        118 EVKAQGRFGAVWKAKF-----KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      +.||+|+||.||+++.     .++.||+|++.....   .......|+.++.+++||||+++++++.+..    .+++||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~   77 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KLYLIL   77 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EEEEEE
Confidence            5799999999999875     467899999875322   2234467888899999999999999998765    459999


Q ss_pred             hhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        190 AYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       190 e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||+++
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  146 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL-----------GIIYRDLKPENILLDEEGHIKLTDFGLSK  146 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence            99999999999854 4689999999999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      ......  .......||..|+|||++.+     ..++.++|||||||++|||++|           +.||...     ..
T Consensus       147 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg-----------~~p~~~~-----~~  203 (318)
T cd05582         147 ESIDHE--KKAYSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTG-----------SLPFQGK-----DR  203 (318)
T ss_pred             ccCCCC--CceecccCChhhcCHHHHcC-----CCCCCccceeccceEeeeeccC-----------CCCCCCC-----CH
Confidence            654332  12334578999999999876     3567889999999999999999           5666543     33


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc-----hhhhcHH
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC-----VVERGML  404 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-----vl~~l~~  404 (461)
                      .+....+....  ..+|...+     ..+.+||++||+.||++||++.+     ++.+.+.
T Consensus       204 ~~~~~~i~~~~--~~~p~~~~-----~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~  257 (318)
T cd05582         204 KETMTMILKAK--LGMPQFLS-----PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF  257 (318)
T ss_pred             HHHHHHHHcCC--CCCCCCCC-----HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence            33444443332  23343322     37899999999999999999655     6666543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.9e-41  Score=318.86  Aligned_cols=249  Identities=21%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .++|++.+.||+|+||.||+|++.+ ..+|||.+.........+.+|+.++.+++||||+++++++.....    +++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP----IYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC----cEEEE
Confidence            4579999999999999999999865 469999887554444556789999999999999999999877654    48999


Q ss_pred             hhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++|+|.+++..  ..+++..+..++.||+.||+|||+.           +++|+||||+|||++.++.+||+|||++
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~nili~~~~~~kl~d~g~~  147 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK-----------QFIHRDLAARNCLVDDQGCVKVSDFGLS  147 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccccCcceEEEcCCCCEEECCCccc
Confidence            99999999999954  3589999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +....... .......++..|+|||++.+.     .++.++||||||+++|||++ |           ..||...     
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Di~slG~~l~~l~~~g-----------~~p~~~~-----  205 (256)
T cd05113         148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYS-----KFSSKSDVWAFGVLMWEVYSLG-----------KMPYERF-----  205 (256)
T ss_pred             eecCCCce-eecCCCccChhhCCHHHHhcC-----cccchhHHHHHHHHHHHHhcCC-----------CCCcCcC-----
Confidence            87644321 112233466789999998653     56788999999999999998 7           5566432     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ...+....+... .+...+...     +..+.+++.+||+.||++||++.++++.+
T Consensus       206 ~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         206 NNSETVEKVSQG-LRLYRPHLA-----SEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CHHHHHHHHhcC-CCCCCCCCC-----CHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            233344444332 233333322     34899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.4e-41  Score=339.08  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=200.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCChh--hhHHHHHHHHcCCCC-CCCeeEEEEEEe
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHME-HDNILRYIGAEK  176 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~-H~nIv~l~g~~~  176 (461)
                      .....++|.+.+.||+|+||.||+|++.+       +.||||++......  .....+|+.++.++. |||||++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            44556788999999999999999999743       46999999754322  234567899999997 999999999998


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcCC----------------------------------------------------
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKCN----------------------------------------------------  204 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------  204 (461)
                      ...    ..++||||+++|+|.++++..                                                    
T Consensus       112 ~~~----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         112 KGG----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             cCC----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            765    348999999999999998431                                                    


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        205 -----------------------------------------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       205 -----------------------------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                                                                     .+++..+..++.|++.||+|||+.         
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------  258 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---------  258 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---------
Confidence                                                           256777889999999999999988         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +|+||||||+|||+++++.+||+|||+++...............++..|+|||.+.+.     .++.++||||||+++
T Consensus       259 --~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGvil  331 (401)
T cd05107         259 --NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-----LYTTLSDVWSFGILL  331 (401)
T ss_pred             --CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-----CCCcHhHHHHHHHHH
Confidence              9999999999999999999999999999875433221222234578899999998653     567889999999999


Q ss_pred             HHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        318 WELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       318 ~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      |||++ |           ..||...     ...+..........++..|...     +..+.+|+.+||..||++||+++
T Consensus       332 ~e~l~~g-----------~~P~~~~-----~~~~~~~~~~~~~~~~~~p~~~-----~~~l~~li~~cl~~~P~~RPs~~  390 (401)
T cd05107         332 WEIFTLG-----------GTPYPEL-----PMNEQFYNAIKRGYRMAKPAHA-----SDEIYEIMQKCWEEKFEIRPDFS  390 (401)
T ss_pred             HHHHHcC-----------CCCCCCC-----CchHHHHHHHHcCCCCCCCCCC-----CHHHHHHHHHHcCCChhHCcCHH
Confidence            99998 6           4555432     1122222233334444444433     24899999999999999999999


Q ss_pred             chhhhcHHHh
Q psy17532        397 CVVERGMLAL  406 (461)
Q Consensus       397 evl~~l~~~~  406 (461)
                      ++++.|..+.
T Consensus       391 ell~~L~~~~  400 (401)
T cd05107         391 QLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHHh
Confidence            9999986543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.2e-41  Score=322.13  Aligned_cols=268  Identities=25%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .|++.+.||+|+||+||++.+      .+..||+|.+.....  ....+.+|+..+++++||||+++++++.....  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~   82 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG--KG   82 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--ce
Confidence            348899999999999998764      356799999865432  23445678999999999999999998765432  24


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++++|||+++|+|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-----------~i~H~dlkp~Nili~~~~~~~l~df  151 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ-----------HYIHRDLAARNVLLDNDRLVKIGDF  151 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccccChheEEEcCCCcEEEeec
Confidence            68999999999999999888899999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++......... ......++..|+|||.+.+.     .++.++||||||+++|||++|+.|+...............+
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  226 (283)
T cd05080         152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-----KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG  226 (283)
T ss_pred             ccccccCCcchhhccCCCCCCCceeeCHhHhccc-----CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence            9998765432211 12223456789999988653     56789999999999999999977664332211100000000


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                       .......... .........+..+     +..+.+++.+||+.||++|||++++++.+..+
T Consensus       227 -~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         227 -QMTVVRLIEL-LERGMRLPCPKNC-----PQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             -ccchhhhhhh-hhcCCCCCCCCCC-----CHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence             0011111111 1222223333332     34899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.5e-41  Score=322.82  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=199.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc--ceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI--HTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~--~~~~  185 (461)
                      .+.|++.+.||+|+||.||+|..  .++.||+|.+............|+.++.++ +|+||+++++++......  ...+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            35688889999999999999988  467899999876555445566788888887 799999999998764321  2357


Q ss_pred             eeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +++|||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+||++++++.+||+
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-----------~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-----------KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCccCCCCHHHEEECCCCCEEEc
Confidence            899999999999999864   3589999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++......  .......|+..|+|||++.+.......++.++|||||||++|||++|.           .||... 
T Consensus       154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~-----------~p~~~~-  219 (272)
T cd06637         154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA-----------PPLCDM-  219 (272)
T ss_pred             cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC-----------CCcccc-
Confidence            999998764322  223345789999999998643222345778999999999999999994           444322 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                          ..............+...+..     .+..+.+||.+||..||++|||+.++++|.+
T Consensus       220 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         220 ----HPMRALFLIPRNPAPRLKSKK-----WSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             ----CHHHHHHHHhcCCCCCCCCCC-----cCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence                111111111111111111222     2247899999999999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-41  Score=322.84  Aligned_cols=253  Identities=22%  Similarity=0.340  Sum_probs=196.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..++|++.+.||+|+||.||+|.+.+       +.||||.+.....  ....+.+|+.+++.++|+||+++++++.... 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            45689999999999999999998743       4699998754322  2234567888899999999999999987655 


Q ss_pred             cceeeeeeehhccCCChhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN-----------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN  249 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~  249 (461)
                         ..++||||+++|+|.+++...           .+++..+..++.|++.||+|||+.           +++||||||+
T Consensus        83 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~~vH~dlkp~  148 (277)
T cd05062          83 ---PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-----------KFVHRDLAAR  148 (277)
T ss_pred             ---CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCcchh
Confidence               348999999999999998531           357788999999999999999998           9999999999


Q ss_pred             cEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q psy17532        250 NVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP  329 (461)
Q Consensus       250 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~  329 (461)
                      |||+++++.+||+|||+++...............++..|+|||++.+     ..++.++|||||||++|||++++     
T Consensus       149 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~-----  218 (277)
T cd05062         149 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLA-----  218 (277)
T ss_pred             eEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-----CCcCchhHHHHHHHHHHHHHcCC-----
Confidence            99999999999999999986654332222223355788999999875     35678899999999999999942     


Q ss_pred             CCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        330 PPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       330 ~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                           ..||...     ...+....+..... +..+...     +..+.+++.+||+.||++|||+.++++.+.
T Consensus       219 -----~~p~~~~-----~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         219 -----EQPYQGM-----SNEQVLRFVMEGGL-LDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----CCCCCCC-----CHHHHHHHHHcCCc-CCCCCCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 4555433     33444444433322 2333322     347999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.6e-41  Score=319.53  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...++|++.+.||+|+||.||+|... +..||+|.+...........+|+.+++.++|+||+++++++...+.    .++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   78 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP----IYI   78 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----cEE
Confidence            34578999999999999999999984 5679999887555444566788899999999999999999877653    489


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|||+++|+|.++++.   ..+++..+..++.|++.||+|||+.           +++||||||+||+++.++.+||+||
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-----------~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-----------NYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccccchhhEEecCCCcEEECCC
Confidence            9999999999999853   3588899999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++....... .......++..|+|||++.+.     .++.++||||||+++|||++ |           ..||...  
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~t~g-----------~~p~~~~--  208 (261)
T cd05072         148 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFG-----SFTIKSDVWSFGILLYEIVTYG-----------KIPYPGM--  208 (261)
T ss_pred             ccceecCCCce-eccCCCccceecCCHHHhccC-----CCChhhhhhhhHHHHHHHHccC-----------CCCCCCC--
Confidence            99987654321 112233467789999998653     56778999999999999998 7           5666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ........+... .+.+.+..     .+..+.+++.+||+.||++||+++++.+.+.
T Consensus       209 ---~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         209 ---SNSDVMSALQRG-YRMPRMEN-----CPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             ---CHHHHHHHHHcC-CCCCCCCC-----CCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence               233333333322 22222222     2347899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.1e-41  Score=319.39  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=201.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...+|++.+.||+|+||.||+|.++  ++.||+|.+...........+|+..+..++|+||+++++++.....    +++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC----cEE
Confidence            3467899999999999999999984  6789999987655444556788999999999999999999887653    489


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|||+++|+|.+++..   ..+++..++.++.|++.||+|||+.           +++||||||+|||+++++.+||+||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-----------~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-----------NFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeecccCcceEEEcCCCcEEeCCC
Confidence            9999999999999853   3488999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |++........ .......++..|+|||.+.+     ..++.++||||||+++|||++ |           ..||...  
T Consensus       149 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~t~g-----------~~p~~~~--  209 (263)
T cd05052         149 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYG-----------MSPYPGI--  209 (263)
T ss_pred             cccccccccee-eccCCCCCccccCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCC-----------CCCCCCC--
Confidence            99987654321 11222334678999998865     366788999999999999998 7           5555433  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                         ..++...... ...++..+...+     ..+.+++.+||+.||++|||+.++++.+..
T Consensus       210 ---~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         210 ---DLSQVYELLE-KGYRMERPEGCP-----PKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             ---CHHHHHHHHH-CCCCCCCCCCCC-----HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence               3333333332 233344444333     489999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.1e-41  Score=329.42  Aligned_cols=247  Identities=21%  Similarity=0.274  Sum_probs=193.7

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +|++.+.||+|+||.||+|+..  ++.||||.+.....    .......|..++..+ +|++|+++++++...+    .+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   76 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD----RL   76 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC----EE
Confidence            4789999999999999999984  56899999874321    112234455555555 6899999999987765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~Nill~~~~~~kL~Df  145 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-----------GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEecCCCHHHeEECCCCcEEEccC
Confidence            999999999999998853 5689999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...   
T Consensus       146 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg-----------~~Pf~~~---  204 (323)
T cd05616         146 GMCKENMWDG--VTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAG-----------QAPFEGE---  204 (323)
T ss_pred             CCceecCCCC--CccccCCCChhhcCHHHhcC-----CCCCCccchhchhHHHHHHHhC-----------CCCCCCC---
Confidence            9997643222  12334578999999999976     3677899999999999999999           6666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGML  404 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~  404 (461)
                        ....+...+....  ..+|...     +.++.+++.+||+.||++|+++     .++++|.+.
T Consensus       205 --~~~~~~~~i~~~~--~~~p~~~-----s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~  260 (323)
T cd05616         205 --DEDELFQSIMEHN--VAYPKSM-----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  260 (323)
T ss_pred             --CHHHHHHHHHhCC--CCCCCcC-----CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence              3344455554433  2334332     2478999999999999999985     566666554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0610|consensus

Probab=100.00  E-value=1.8e-41  Score=321.12  Aligned_cols=272  Identities=20%  Similarity=0.261  Sum_probs=217.1

Q ss_pred             CCCCccCCcceeEEeEeecCCceEEEEEEECC--CcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEec
Q psy17532        104 PPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKR  177 (461)
Q Consensus       104 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~  177 (461)
                      ........++|++++.||.|.-|+||+++.++  ..+|+|++.+....    ..+.+.|-.+|+.++||.+..||+.+..
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            34456678899999999999999999999976  67999999654322    2233445556889999999999999998


Q ss_pred             CCccceeeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                      +...    +++||||+||+|...++.+   .+++..+..++..|+.||+|||-.           |||+|||||+||||.
T Consensus       149 ~~~~----cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml-----------GivYRDLKPENILvr  213 (459)
T KOG0610|consen  149 DKYS----CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML-----------GIVYRDLKPENILVR  213 (459)
T ss_pred             ccee----EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh-----------ceeeccCCcceeEEe
Confidence            7754    8999999999999998654   599999999999999999999988           999999999999999


Q ss_pred             CCCceEEEecCCccccCC---------------------------------C-CC--------------------CCCCC
Q psy17532        255 SDLTAAIADFGLALLFEP---------------------------------G-KP--------------------CGDTH  280 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~---------------------------------~-~~--------------------~~~~~  280 (461)
                      ++|++.|+||.|+.....                                 . ..                    .....
T Consensus       214 edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSn  293 (459)
T KOG0610|consen  214 EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSN  293 (459)
T ss_pred             cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccc
Confidence            999999999999754310                                 0 00                    00123


Q ss_pred             CCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCC
Q psy17532        281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL  360 (461)
Q Consensus       281 ~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~  360 (461)
                      ..+||-.|.|||++.|.     ..+.++|+|+|||++|||+.|           ..||.+.     +.++....++.+.+
T Consensus       294 SFVGThEYlAPEvI~G~-----GHgsAVDWWtfGIflYEmLyG-----------~TPFKG~-----~~~~Tl~NIv~~~l  352 (459)
T KOG0610|consen  294 SFVGTHEYLAPEVIRGE-----GHGSAVDWWTFGIFLYEMLYG-----------TTPFKGS-----NNKETLRNIVGQPL  352 (459)
T ss_pred             ccccccccccceeeecC-----CCCchhhHHHHHHHHHHHHhC-----------CCCcCCC-----CchhhHHHHhcCCC
Confidence            45899999999999984     677899999999999999999           7777765     33444444544433


Q ss_pred             CCCCCchhccchhHHHHHHHHHHHccccHhhhcc----ccchhhhcHHHhhhhh-hccCCC
Q psy17532        361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLS----ASCVVERGMLALCDTM-EECWDH  416 (461)
Q Consensus       361 ~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~l~~~~~~~~-~~c~~~  416 (461)
                        .+|+.-   ..+..+++||+++|.+||.+|..    |.||-+|.++....+. ++|..+
T Consensus       353 --~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~P  408 (459)
T KOG0610|consen  353 --KFPEEP---EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARP  408 (459)
T ss_pred             --cCCCCC---cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCC
Confidence              344321   24458999999999999999998    9999999999887777 456544

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-41  Score=338.99  Aligned_cols=270  Identities=20%  Similarity=0.226  Sum_probs=195.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...+|++.+.||+|+||.||++..  .++.||+|....     ....+|+.++++++|||||++++++....    ..++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~l  160 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNK----FTCL  160 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECC----eeEE
Confidence            346799999999999999999998  467899997532     23467889999999999999999987755    3489


Q ss_pred             eehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      |+|++. ++|.+++. ...+++..++.++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~-----------~IvHrDiKP~NIll~~~~~vkL~DFG~  228 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-----------RIIHRDIKAENIFINHPGDVCLGDFGA  228 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCChHhEEEcCCCCEEEEeCCc
Confidence            999985 68988884 34689999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC-----------
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR-----------  335 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~-----------  335 (461)
                      |+....... .......||+.|+|||++.+     ..++.++|||||||++|||++|..|+....+...           
T Consensus       229 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i  302 (391)
T PHA03212        229 ACFPVDINA-NKYYGWAGTIATNAPELLAR-----DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI  302 (391)
T ss_pred             ccccccccc-cccccccCccCCCChhhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence            975432211 12334579999999999876     3677899999999999999999765533211000           


Q ss_pred             ------CCCccccCCCCCHHHHHHHHhcc-CCCCCCCchhcc-chhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        336 ------LPFSAEVGDHPSLEDMQEAVVHK-KLRPTLPETWKQ-HAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       336 ------~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                            .|..................... ...+.....|.. ...+.++.+||.+||+.||++|||+.|+++|.++..
T Consensus       303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             HHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                  00000000000011111011111 111111111111 123457899999999999999999999999987643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-41  Score=331.21  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=190.8

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++||+|+||.||+|+..  ++.||||++....    ........|+.++..+ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----~~~lv~E   76 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----RLFFVME   76 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----eEEEEEe
Confidence            46899999999999985  5789999986432    1122334566666544 8999999999998765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-----------GVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            999999998884 45689999999999999999999999           999999999999999999999999999976


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg-----------~~Pf~~~-----~~~  202 (321)
T cd05591         146 GILNG--VTTTTFCGTPDYIAPEILQE-----LEYGPSVDWWALGVLMYEMMAG-----------QPPFEAD-----NED  202 (321)
T ss_pred             cccCC--ccccccccCccccCHHHHcC-----CCCCCccceechhHHHHHHhcC-----------CCCCCCC-----CHH
Confidence            43222  12334568999999999875     3677889999999999999999           5666543     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-------cccchhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-------SASCVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~~l~~~  405 (461)
                      .....+.....  .+|...     +.++.+++.+||+.||++||       +++++++|.+..
T Consensus       203 ~~~~~i~~~~~--~~p~~~-----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~  258 (321)
T cd05591         203 DLFESILHDDV--LYPVWL-----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK  258 (321)
T ss_pred             HHHHHHHcCCC--CCCCCC-----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence            44455544332  223222     23789999999999999999       778888887653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.9e-41  Score=335.96  Aligned_cols=262  Identities=19%  Similarity=0.208  Sum_probs=203.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ....++|++.+.||+|+||.||+++.+  ++.||+|++....    .......+|+.++..++||||+++++.+.+..  
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--  116 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--  116 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--
Confidence            345679999999999999999999984  6789999986422    12223457788888999999999999998755  


Q ss_pred             ceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                        .+++||||+++|+|.++++...++...+..++.||+.||+|||+.           +|+||||||+|||++.++.+||
T Consensus       117 --~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         117 --YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM-----------GFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             --EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEeCCCCHHHEEECCCCCEEE
Confidence              459999999999999999888899999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++.+..... .......||+.|||||++.+.. ....++.++|||||||++|||++|           ..||...
T Consensus       184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~DiwSlGvilyell~G-----------~~Pf~~~  250 (371)
T cd05622         184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVG-----------DTPFYAD  250 (371)
T ss_pred             EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccC-CCccCCCccceeehhHHHHHHHhC-----------CCCCCCC
Confidence            99999987653321 1223467999999999987531 112367899999999999999999           5666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLA  405 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~  405 (461)
                           ........+........+|..   ...+..+.++|.+|+..++.+  |+++.++++|.+..
T Consensus       251 -----~~~~~~~~i~~~~~~~~~~~~---~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         251 -----SLVGTYSKIMNHKNSLTFPDD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             -----CHHHHHHHHHcCCCcccCCCc---CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence                 333444444443333333321   123347899999999844433  67899999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.1e-41  Score=338.12  Aligned_cols=254  Identities=21%  Similarity=0.268  Sum_probs=195.6

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .|++++.||+|+||.||+|+.  .++.||||++....    .......+|+.++..++|+||+++++.+.+..    .++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~----~~~   77 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD----NLY   77 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC----EEE
Confidence            588999999999999999998  46789999986432    12234567888899999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~-----------~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-----------GFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEECCCCCEEEeECC
Confidence            99999999999999854 4688999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCC---------------------------------------------CCCCCCCcCCCcccccccccccccc
Q psy17532        266 LALLFEPGKP---------------------------------------------CGDTHGQVGTRRYMAPEVLEGAINF  300 (461)
Q Consensus       266 la~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~  300 (461)
                      +++.+.....                                             ........||+.|+|||++.+    
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----  222 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR----  222 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC----
Confidence            9854321000                                             000123469999999999876    


Q ss_pred             cCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHH
Q psy17532        301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT  380 (461)
Q Consensus       301 ~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~l  380 (461)
                       ..++.++|||||||++|||++|           ..||...     ...+....+........+|..   ...+.++.++
T Consensus       223 -~~~~~~~DiwSlGvil~elltG-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~~l  282 (382)
T cd05625         223 -TGYTQLCDWWSVGVILYEMLVG-----------QPPFLAQ-----TPLETQMKVINWQTSLHIPPQ---AKLSPEASDL  282 (382)
T ss_pred             -CCCCCeeeEEechHHHHHHHhC-----------CCCCCCC-----CHHHHHHHHHccCCCcCCCCc---ccCCHHHHHH
Confidence             3677899999999999999999           5566433     222333333332222333321   1123478888


Q ss_pred             HHHHccccHhhhcc---ccchhhhcHHHh
Q psy17532        381 MEECWDHDAEARLS---ASCVVERGMLAL  406 (461)
Q Consensus       381 i~~cl~~dP~~Rps---~~evl~~l~~~~  406 (461)
                      |.+++ .||++|++   +.++++|.+...
T Consensus       283 i~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         283 IIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            98876 59999997   889999987644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-41  Score=318.09  Aligned_cols=251  Identities=23%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ..++|++.+.||+|+||.||+|.++ ++.||||.+...........+|+.++++++|+||+++++++...+.    .+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   79 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP----IYIV   79 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCC----eeee
Confidence            4567999999999999999999984 5679999987655445566788999999999999999999877653    4899


Q ss_pred             ehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+|||
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-----------NYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeccCCcceEEEcCCCCEEECCcc
Confidence            9999999999999543   589999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +++....... ........+..|+|||++.+     ..++.++||||||+++|||++ |           +.||...   
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g-----------~~p~~~~---  208 (261)
T cd05068         149 LARVIKEDIY-EAREGAKFPIKWTAPEAALY-----NRFSIKSDVWSFGILLTEIVTYG-----------RMPYPGM---  208 (261)
T ss_pred             eEEEccCCcc-cccCCCcCceeccCcccccc-----CCCCchhhHHHHHHHHHHHHhcC-----------CCCCCCC---
Confidence            9987753221 11222234568999998865     356788999999999999999 6           6666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ........+.. ......+..     .+..+.+++.+||+.||++||++.++.+.|.
T Consensus       209 --~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         209 --TNAEVLQQVDQ-GYRMPCPPG-----CPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             --CHHHHHHHHHc-CCCCCCCCc-----CCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence              23333333322 222233332     2347999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.2e-41  Score=322.24  Aligned_cols=244  Identities=24%  Similarity=0.331  Sum_probs=188.3

Q ss_pred             eecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||+|+||+||++..  +++.||||.+......    ......|+.++..++|+||+++.+++....    .+++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEEEEEeCCC
Confidence            69999999999988  4678999998643221    123457888899999999999999887754    4589999999


Q ss_pred             CCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        194 RGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       194 ~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      +|+|.+++.     ...+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||++.
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nili~~~~~~~l~dfg~~~  145 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-----------RIIYRDLKPENVLLDNDGNVRISDLGLAV  145 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEEeeCccce
Confidence            999998772     24589999999999999999999998           99999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+.....  ......||+.|+|||++.+.     .++.++||||||+++|||++|           +.||...... ...
T Consensus       146 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g-----------~~pf~~~~~~-~~~  206 (280)
T cd05608         146 ELKDGQS--KTKGYAGTPGFMAPELLQGE-----EYDFSVDYFALGVTLYEMIAA-----------RGPFRARGEK-VEN  206 (280)
T ss_pred             ecCCCCc--cccccCCCcCccCHHHhcCC-----CCCccccHHHHHHHHHHHHhC-----------CCCCCCCCcc-hhH
Confidence            7654332  23345789999999999763     667889999999999999999           5555432111 111


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHH
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGML  404 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~  404 (461)
                      ......+...  ...++..     .+..+.+++.+||+.||++||     +++++++|.+.
T Consensus       207 ~~~~~~~~~~--~~~~~~~-----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         207 KELKQRILND--SVTYPDK-----FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             HHHHHhhccc--CCCCccc-----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            2222222221  1122222     234789999999999999999     56777777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.9e-41  Score=330.58  Aligned_cols=242  Identities=23%  Similarity=0.283  Sum_probs=188.6

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHH-HcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIF-KLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.  +++.||||++.....    .......|.. .++.++||||+++++.+...+    .+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----~~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----KLYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----EEEEEEc
Confidence            4799999999999998  478899999864321    1122223333 457789999999999988765    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL-----------NIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            9999999998854 4689999999999999999999998           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g-----------~~pf~~~-----~~~  202 (323)
T cd05575         146 GIEHS--KTTSTFCGTPEYLAPEVLRK-----QPYDRTVDWWCLGAVLYEMLYG-----------LPPFYSR-----DTA  202 (323)
T ss_pred             cccCC--CccccccCChhhcChhhhcC-----CCCCccccccccchhhhhhhcC-----------CCCCCCC-----CHH
Confidence            43222  12334578999999999876     3677889999999999999999           5666543     344


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc----chhhhcHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS----CVVERGML  404 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----evl~~l~~  404 (461)
                      ++...+.....  .++...     +..+.++|.+||+.||++||++.    ++++|.+.
T Consensus       203 ~~~~~i~~~~~--~~~~~~-----~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~  254 (323)
T cd05575         203 EMYDNILNKPL--RLKPNI-----SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF  254 (323)
T ss_pred             HHHHHHHcCCC--CCCCCC-----CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence            44444444322  222222     23789999999999999999985    66666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.9e-41  Score=331.33  Aligned_cols=268  Identities=24%  Similarity=0.326  Sum_probs=200.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||++...  +..+|+|.+.....  ......+|+.++..++|+||+++++++.+.+    .++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----EIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC----EEE
Confidence            468999999999999999999984  67899998865422  2345678999999999999999999998865    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.++++. ..+++..+..++.|++.||.|||+..          +|+||||||+|||++.++.+||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----------~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH----------KIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC----------CEEecCCChhhEEEcCCCCEEEeeCC
Confidence            99999999999999864 45889999999999999999999741          69999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC----------
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR----------  335 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~----------  335 (461)
                      ++..+....    .....|+..|+|||++.+.     .++.++|||||||++|||++|..||........          
T Consensus       150 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  220 (333)
T cd06650         150 VSGQLIDSM----ANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG  220 (333)
T ss_pred             cchhhhhhc----cccCCCCccccCHHHhcCC-----CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccC
Confidence            997654321    2335689999999998763     567889999999999999999777653221000          


Q ss_pred             CCCcccc----------------CCCC--CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        336 LPFSAEV----------------GDHP--SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       336 ~pf~~~~----------------~~~~--~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                      .+.....                ...+  ....+...+.. ...+.++.    ...+.++.+||.+||+.||++|||+.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~li~~~L~~~P~~Rpt~~e  295 (333)
T cd06650         221 DPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN-EPPPKLPS----GVFGAEFQDFVNKCLIKNPAERADLKQ  295 (333)
T ss_pred             CccccccCcccCCccchhhhhcccccccccHHHHHHHHhc-CCCccCCC----CCcCHHHHHHHHHhccCCcccCcCHHH
Confidence            0000000                0000  00111111111 11122221    112347899999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      ++.|.+...
T Consensus       296 ll~h~~~~~  304 (333)
T cd06650         296 LMVHAFIKR  304 (333)
T ss_pred             HhhCHHHhc
Confidence            999987644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.9e-41  Score=330.33  Aligned_cols=261  Identities=20%  Similarity=0.223  Sum_probs=202.1

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+++.+  ++.||+|++....    ........|+.++..++|+||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~   76 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN----NL   76 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----EE
Confidence            36899999999999999999985  5679999986422    11223456777888899999999999988765    45


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+++|+|.++++.  ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~-----------~iiHrDlkp~Nili~~~~~~kL~D  145 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL-----------HYVHRDIKPDNILMDMNGHIRLAD  145 (332)
T ss_pred             EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHEEECCCCCEEEee
Confidence            999999999999999964  5689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.+..... .......||+.|+|||++.+.......++.++|||||||++|||++|           +.||...  
T Consensus       146 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g-----------~~Pf~~~--  211 (332)
T cd05623         146 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG-----------ETPFYAE--  211 (332)
T ss_pred             cchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC-----------CCCCCCC--
Confidence            999976543321 12233579999999999864221123567899999999999999999           6666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~~  406 (461)
                         ...+....+.....+..+|....  ..+..+.+|+.+|+..++++  |+++.++++|.+...
T Consensus       212 ---~~~~~~~~i~~~~~~~~~p~~~~--~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         212 ---SLVETYGKIMNHKERFQFPAQVT--DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             ---CHHHHHHHHhCCCccccCCCccc--cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence               33444455554444444443321  13457899999999765554  689999999987543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5e-41  Score=331.32  Aligned_cols=253  Identities=18%  Similarity=0.253  Sum_probs=191.5

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++||+|+||.||+|+.  +++.||||+++....    .......|+.++..+ +||||+++++++.+..    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----~~~lv~e   76 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----RLFFVIE   76 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----EEEEEEe
Confidence            4799999999999998  467899999975321    122345677777777 7999999999998765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++. .+.+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER-----------GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            999999999884 45799999999999999999999999           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+     ..++.++|||||||++|||++|..||...... ..|      ......
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~~~------~~~~~~  211 (329)
T cd05588         146 GIRPG--DTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS-DNP------DQNTED  211 (329)
T ss_pred             cccCC--CccccccCCccccCHHHHcC-----CCCCCccceechHHHHHHHHHCCCCccccccc-ccc------cccchH
Confidence            32211  12334578999999999976     36778999999999999999995555311100 000      001112


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc------ccchhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS------ASCVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~l~~~~  406 (461)
                      ...+.+....  ..+|..++     ..+.++|.+||+.||++|++      ++++++|.+...
T Consensus       212 ~~~~~~~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         212 YLFQVILEKQ--IRIPRSLS-----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHHcCC--CCCCCCCC-----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            2233333322  23444332     37899999999999999998      568888877643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.4e-41  Score=338.66  Aligned_cols=256  Identities=21%  Similarity=0.264  Sum_probs=196.6

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++++.||+|+||.||+|+.  .++.||||++....    .......+|+.++..++|+||+++++.+.+.+    .+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~~   76 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD----NL   76 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----EE
Confidence            3689999999999999999998  46889999986432    12234567888999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM-----------GFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999854 4578888999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCC-----------------------------------------CCCCCCCcCCCcccccccccccccccCC
Q psy17532        265 GLALLFEPGKP-----------------------------------------CGDTHGQVGTRRYMAPEVLEGAINFSRD  303 (461)
Q Consensus       265 Gla~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~  303 (461)
                      |+|..+.....                                         ........||+.|||||++.+     ..
T Consensus       146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~  220 (376)
T cd05598         146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-----TG  220 (376)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-----CC
Confidence            99853321000                                         000123479999999999976     36


Q ss_pred             CCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHH
Q psy17532        304 AFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEE  383 (461)
Q Consensus       304 ~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~  383 (461)
                      ++.++|||||||++|||++|           ..||...     ...+....+........++..   ...+..+.++|.+
T Consensus       221 ~~~~~DiwSlGvilyell~G-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~---~~~s~~~~~li~~  281 (376)
T cd05598         221 YTQLCDWWSVGVILYEMLVG-----------QPPFLAD-----TPAETQLKVINWETTLHIPSQ---AKLSREASDLILR  281 (376)
T ss_pred             CCcceeeeeccceeeehhhC-----------CCCCCCC-----CHHHHHHHHhccCccccCCCC---CCCCHHHHHHHHH
Confidence            77899999999999999999           5566443     222333333322222222221   1123478889999


Q ss_pred             HccccHhhhc---cccchhhhcHHHhh
Q psy17532        384 CWDHDAEARL---SASCVVERGMLALC  407 (461)
Q Consensus       384 cl~~dP~~Rp---s~~evl~~l~~~~~  407 (461)
                      |+ .+|++|+   ++.++++|.+....
T Consensus       282 l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         282 LC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             Hh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            76 5999999   89999999886543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-41  Score=330.50  Aligned_cols=261  Identities=20%  Similarity=0.222  Sum_probs=200.3

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+++..  ++.||||++....    .......+|+.++..++|+||+++++++.+..    .+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~   76 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN----NL   76 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC----eE
Confidence            47899999999999999999984  6789999986422    12223456777888899999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+++|+|.+++..  ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nill~~~~~~kl~D  145 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL-----------GYVHRDIKPDNVLLDKNGHIRLAD  145 (331)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEECCCCHHHEEECCCCCEEEEE
Confidence            999999999999999954  4689999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++..+..... .......||+.|||||++.+.......++.++|||||||++|||++|           ..||...  
T Consensus       146 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g-----------~~Pf~~~--  211 (331)
T cd05597         146 FGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG-----------ETPFYAE--  211 (331)
T ss_pred             CCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC-----------CCCCCCC--
Confidence            999977654322 11223468999999999864211123567889999999999999999           5666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~~  406 (461)
                         ...+....+........++.....  .+..+.++|++|+..++++  |+++.++++|.+...
T Consensus       212 ---~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         212 ---SLVETYGKIMNHKEHFQFPPDVTD--VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             ---CHHHHHHHHHcCCCcccCCCccCC--CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence               333344444433333333332211  3457899999988664443  789999999987643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-40  Score=320.61  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=196.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCC----cEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNE----NVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|++.+.||+|+||.||+|.+  .++    .||+|.+......  ......|+..+.+++||||+++++++...   
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~---   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA---   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC---
Confidence            346889999999999999999998  344    3777776533221  23445677788999999999999987543   


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        ..++++||+++|+|.+++..  ..+++..+..++.||+.||.|||+.           +++||||||+|||++.++.+
T Consensus        82 --~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          82 --SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH-----------RMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             --ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeccccCcceEEEcCCCcE
Confidence              24789999999999999953  4689999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+++.+.............++..|+|||.+.+.     .++.++||||||+++||+++ |           ..||
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~el~t~g-----------~~p~  212 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-----RYTHQSDVWSYGVTVWEMMSYG-----------AEPY  212 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-----CcCchhhHHHHHHHHHHHHcCC-----------CCCC
Confidence            99999999876543322223334577899999998753     57789999999999999998 7           5566


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...     ........ .....++..+..+     ...+.+++.+||..||++|||+.++++.+..+.
T Consensus       213 ~~~-----~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         213 AGM-----RPHEVPDL-LEKGERLAQPQIC-----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCC-----CHHHHHHH-HHCCCcCCCCCCC-----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            433     22222222 2333333333332     237889999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.5e-41  Score=332.44  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~  178 (461)
                      ...++|++.+.||+|+||.||+|.+       .++.||||++.....  ......+|+.++.++ +|+||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456899999999999999999974       356799999865332  223456788899999 789999999988654


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-------------------------------------------------------
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-------------------------------------------------------  203 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------------------------------------  203 (461)
                      ..   .++++|||+++|+|.+++..                                                       
T Consensus        84 ~~---~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          84 GG---PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             CC---ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            32   35899999999999998843                                                       


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        204 -------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       204 -------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                                   ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-----------KCIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence                         1367788899999999999999998           9999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .............++..|+|||.+.+     ..++.++||||||+++|||++ |           ..||....    ...
T Consensus       230 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g-----------~~p~~~~~----~~~  289 (343)
T cd05103         230 YKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLG-----------ASPYPGVK----IDE  289 (343)
T ss_pred             ccCcchhhcCCCCCCcceECcHHhcC-----CCCCchhhHHHHHHHHHHHHHCC-----------CCCCCCcc----ccH
Confidence            43322222223345678999999865     366788999999999999997 6           44554321    111


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .... ......+...|...     +..+.+++.+||+.||++|||+.++++++..+.
T Consensus       290 ~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         290 EFCR-RLKEGTRMRAPDYT-----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHH-HHhccCCCCCCCCC-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2222 22233333334322     237899999999999999999999999987665

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.6e-41  Score=320.10  Aligned_cols=254  Identities=20%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             eeEEeEeecCCceEEEEEEECC--C--cEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--ccee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKN--E--NVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTE  184 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~--~--~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~  184 (461)
                      +.+.+.||+|+||.||+|++..  .  .||+|.++...   ........|+.++..++|+||+++++++.....  ....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999843  2  58999886432   223345678888999999999999998754321  1124


Q ss_pred             eeeeehhccCCChhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        185 FWLITAYHERGSLCDFLK-------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      .+++|||+++|+|.+++.       ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~  149 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-----------SFIHRDLAARNCMLNENM  149 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccccchhheEEcCCC
Confidence            589999999999999872       13478999999999999999999998           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++...............++..|+|||.+.+     ..++.++||||||+++|||++++          ..|
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~el~~~g----------~~p  214 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-----RVYTTKSDVWSFGVTMWEIATRG----------QTP  214 (272)
T ss_pred             CEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-----CCcChHHHHHHHHHHHHHHHcCC----------CCC
Confidence            999999999987654332222223346778999999875     35678899999999999999942          556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |...     ...++...+.... ....+..+     +..+.+++.+||+.||++|||+.++++++..
T Consensus       215 ~~~~-----~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         215 YPGV-----ENSEIYDYLRQGN-RLKQPPDC-----LDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC-----CHHHHHHHHHcCC-CCCCCCCC-----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            6432     2334444443332 22233322     3478999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-41  Score=323.03  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=199.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .++|.+.+.||+|+||.||+|+..       ++.||||.+......  ...+.+|+.++..++|+||+++++++....  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence            467899999999999999999863       357999998654332  345678899999999999999999998865  


Q ss_pred             ceeeeeeehhccCCChhhhhcCC---------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccC
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN---------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDF  246 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~---------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDL  246 (461)
                        ..++||||+++|+|.+++...               .+++..+..++.|++.||.|||+.           +++||||
T Consensus        82 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----------~i~h~dl  148 (280)
T cd05049          82 --PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-----------HFVHRDL  148 (280)
T ss_pred             --CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-----------Ceecccc
Confidence              459999999999999998532               378889999999999999999998           9999999


Q ss_pred             CCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCC
Q psy17532        247 KSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCS  325 (461)
Q Consensus       247 kp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~  325 (461)
                      ||+|||++.++.+||+|||+++...............+++.|+|||++.+.     .++.++||||||+++|||++ |  
T Consensus       149 kp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~e~~~~g--  221 (280)
T cd05049         149 ATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSFGVVLWEIFTYG--  221 (280)
T ss_pred             ccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-----CcchhhhHHHHHHHHHHHHhcC--
Confidence            999999999999999999999765433322222334567889999998763     67788999999999999998 7  


Q ss_pred             CCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       326 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                               ..||...     ...+....+..+.. ...+..+     +..+.+++.+||+.||++||++.|+++.+.
T Consensus       222 ---------~~p~~~~-----~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         222 ---------KQPWYGL-----SNEEVIECITQGRL-LQRPRTC-----PSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---------CCCCCCC-----CHHHHHHHHHcCCc-CCCCCCC-----CHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                     5666443     33344444443322 2223322     347999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.5e-41  Score=330.03  Aligned_cols=252  Identities=19%  Similarity=0.277  Sum_probs=189.6

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.+  ++.||+|++....    ........|+.++.++ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~~lv~E   76 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RLFFVIE   76 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----EEEEEEe
Confidence            47999999999999984  6789999987532    1222345666666555 8999999999988765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|..++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            999999998885 45699999999999999999999999           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+     ..++.++|||||||++|||++|..||......       .........
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~~~~~  211 (329)
T cd05618         146 GLRPG--DTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-------DNPDQNTED  211 (329)
T ss_pred             ccCCC--CccccccCCccccCHHHHcC-----CCCCCccceecccHHHHHHhhCCCCCccCCCc-------CCcccccHH
Confidence            43221  12334578999999999976     36678899999999999999995554211000       000011122


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc------cchhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA------SCVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~~~  405 (461)
                      .+...+....  ..+|...+     ..+.++|.+||+.||++||++      .++++|.+..
T Consensus       212 ~~~~~i~~~~--~~~p~~~~-----~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~  266 (329)
T cd05618         212 YLFQVILEKQ--IRIPRSLS-----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  266 (329)
T ss_pred             HHHHHHhcCC--CCCCCCCC-----HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            2233333322  23444332     378899999999999999995      5888887653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=321.55  Aligned_cols=252  Identities=22%  Similarity=0.268  Sum_probs=196.0

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .|++.++||+|+||.||++..  +++.||||.+......    .....+|+.++..++|+||+++++.+...+    .++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   76 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC----eEE
Confidence            478899999999999999998  4788999998643221    223457889999999999999999987765    459


Q ss_pred             eeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||+++++.++|+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~~l~D  145 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-----------RIVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcEecCCCHHHEEECCCCCEEEee
Confidence            99999999999988742   3589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.......   .....|+..|+|||++.+     ..++.++||||||+++|||++|           ..||.....
T Consensus       146 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~Diws~G~~l~el~~g-----------~~pf~~~~~  206 (285)
T cd05605         146 LGLAVEIPEGET---IRGRVGTVGYMAPEVVKN-----ERYTFSPDWWGLGCLIYEMIEG-----------KSPFRQRKE  206 (285)
T ss_pred             CCCceecCCCCc---cccccCCCCccCcHHhcC-----CCCCccccchhHHHHHHHHHHC-----------CCCCCCCch
Confidence            999987643321   234578999999999875     3567889999999999999999           555543211


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                       ....+.+...+..  ....++...     +..+.+||.+||+.||++||     +++++++|.+...
T Consensus       207 -~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         207 -KVKREEVERRVKE--DQEEYSEKF-----SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             -hhHHHHHHHHhhh--cccccCccc-----CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence             0111222222211  112233222     33789999999999999999     7778888876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=319.31  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..++|++.+.||+|+||.||+|..++       ..||+|.+.....  ....+.+|+.++..++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            45689999999999999999998743       5699999864432  22345678888999999999999999887653


Q ss_pred             cceeeeeeehhccCCChhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN-----------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN  249 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~  249 (461)
                          .++||||+++|+|.+++...           .+++..+..++.|++.||.|||+.           +|+||||||+
T Consensus        84 ----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~di~p~  148 (277)
T cd05032          84 ----TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-----------KFVHRDLAAR  148 (277)
T ss_pred             ----cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccccccChh
Confidence                48999999999999998531           367889999999999999999998           9999999999


Q ss_pred             cEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCC
Q psy17532        250 NVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVS  328 (461)
Q Consensus       250 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~  328 (461)
                      |||++.++.+||+|||+++.+.............++..|+|||.+.+     ..++.++|||||||++||+++ |     
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g-----  218 (277)
T cd05032         149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-----GVFTTKSDVWSFGVVLWEMATLA-----  218 (277)
T ss_pred             eEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-----CCCCcccchHHHHHHHHHhhccC-----
Confidence            99999999999999999987654432222334457889999999865     356788999999999999998 6     


Q ss_pred             CCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        329 PPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       329 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                            ..||...     ...+....+. ....+.+|..+     +..+.+++.+||+.+|++|||+.++++.+.
T Consensus       219 ------~~p~~~~-----~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         219 ------EQPYQGL-----SNEEVLKFVI-DGGHLDLPENC-----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ------CCCCccC-----CHHHHHHHHh-cCCCCCCCCCC-----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                  5566433     3344444443 33334445443     348999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-40  Score=317.96  Aligned_cols=254  Identities=21%  Similarity=0.360  Sum_probs=199.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|+.  +++.||||.+....    .....+.+|+.+++.++||||+++++++.+.+    .+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   77 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN----EL   77 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC----eE
Confidence            5799999999999999999998  57889999875422    22234567899999999999999999988754    45


Q ss_pred             eeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++++||+++|+|.+++.     ...++...+..++.|++.||.|||++           +++||||||+|||++.++.++
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~H~dl~~~nil~~~~~~~~  146 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-----------RVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-----------CeeCCCCCHHHEEEcCCCCEE
Confidence            89999999999998873     34578899999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++........  ......|+..|+|||.+.+.     .++.++||||||+++|||++|+           .||..
T Consensus       147 l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~-----------~p~~~  208 (267)
T cd08228         147 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAALQ-----------SPFYG  208 (267)
T ss_pred             ECccccceeccchhH--HHhcCCCCccccChhhhccC-----CCCchhhHHHHHHHHHHHhcCC-----------CCCcc
Confidence            999999987654321  12235688899999998753     5667899999999999999994           44432


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .   ..........+......+..+..     .+..+.++|.+||..||++||++.++++.+..+.
T Consensus       209 ~---~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         209 D---KMNLFSLCQKIEQCDYPPLPTEH-----YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             c---cccHHHHHHHHhcCCCCCCChhh-----cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            2   11222333333332222222222     2347999999999999999999999999886653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-40  Score=321.27  Aligned_cols=255  Identities=22%  Similarity=0.346  Sum_probs=200.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..++|.+.+.||+|+||.||+|+..       +..+|+|.+...... .....+|+..+++++|+||+++++++..... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   81 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP-   81 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc-
Confidence            3467999999999999999999863       245888988654432 2346788999999999999999999987653 


Q ss_pred             ceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecc
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR  244 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHr  244 (461)
                         .++||||+++|+|.+++..+                 .+++..++.++.||+.||+|||++           +|+||
T Consensus        82 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-----------~i~H~  147 (291)
T cd05094          82 ---LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-----------HFVHR  147 (291)
T ss_pred             ---eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-----------Ceeec
Confidence               48999999999999998532                 378899999999999999999999           99999


Q ss_pred             cCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-C
Q psy17532        245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-R  323 (461)
Q Consensus       245 DLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g  323 (461)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++.+     ..++.++||||||+++|||++ |
T Consensus       148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g  222 (291)
T cd05094         148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVILWEIFTYG  222 (291)
T ss_pred             ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-----CCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999976644322122334456789999998876     366788999999999999999 7


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       324 ~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                 ..||...     ...+..+..... ..+..+..     .+..+.+++.+||+.||++|||+.++++.+.
T Consensus       223 -----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         223 -----------KQPWFQL-----SNTEVIECITQG-RVLERPRV-----CPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             -----------CCCCCCC-----CHHHHHHHHhCC-CCCCCCcc-----CCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                       5565433     223333333332 22222322     2347899999999999999999999999987


Q ss_pred             HHh
Q psy17532        404 LAL  406 (461)
Q Consensus       404 ~~~  406 (461)
                      .+.
T Consensus       281 ~~~  283 (291)
T cd05094         281 ALG  283 (291)
T ss_pred             HHH
Confidence            664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0199|consensus

Probab=100.00  E-value=8.8e-42  Score=339.76  Aligned_cols=257  Identities=23%  Similarity=0.323  Sum_probs=214.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC---C--CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK---N--ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ..+.+.+.++||+|.||.|++|.|+   |  -.||||.+.....  ....+.+|+..|.+|+|+|+++|||+..+..   
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp---  184 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP---  184 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch---
Confidence            3456778899999999999999995   3  3599999975433  3556789999999999999999999998732   


Q ss_pred             eeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        183 TEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        ..+|+|+++.|||.+.|+.   ..|....+..++.|||.||.||.++           ++|||||..+|+|+-....+
T Consensus       185 --~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-----------rlvHRDLAARNlllasprtV  251 (1039)
T KOG0199|consen  185 --AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-----------RLVHRDLAARNLLLASPRTV  251 (1039)
T ss_pred             --hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-----------hhhhhhhhhhhheeccccee
Confidence              3799999999999999965   3578889999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCC-CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      ||+||||.+.+..++.++. .....-...|.|||.+..     ..++.+||||+|||++|||+|++          ..||
T Consensus       252 KI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-----~kFShaSDvWmyGVTiWEMFtyG----------EePW  316 (1039)
T KOG0199|consen  252 KICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-----RKFSHASDVWMYGVTIWEMFTYG----------EEPW  316 (1039)
T ss_pred             eeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-----ccccccchhhhhhhhHHhhhccC----------CCCC
Confidence            9999999999987665443 233456788999999986     47888999999999999999986          7788


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      .+.     .-.++.+.+- .+.+...|+.++     +.++++|.+||..+|++|||+..|.+.+...+..
T Consensus       317 ~G~-----~g~qIL~~iD-~~erLpRPk~cs-----edIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  317 VGC-----RGIQILKNID-AGERLPRPKYCS-----EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             CCC-----CHHHHHHhcc-ccccCCCCCCCh-----HHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence            776     4456666655 566666776655     4999999999999999999999998776655543

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-40  Score=320.82  Aligned_cols=256  Identities=23%  Similarity=0.353  Sum_probs=201.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..++|.+.+.||+|+||.||++...       +..+|+|.+..... ......+|+.++.+++|+||+++++++..... 
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   81 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP-   81 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-
Confidence            3568999999999999999999852       24589998864432 23346788899999999999999999987653 


Q ss_pred             ceeeeeeehhccCCChhhhhcCC--------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCC
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN--------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK  247 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~--------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLk  247 (461)
                         +++||||+++|+|.+++...              .+++..+..++.|++.||+|||+.           +++|||||
T Consensus        82 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-----------~i~H~dlk  147 (288)
T cd05093          82 ---LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-----------HFVHRDLA  147 (288)
T ss_pred             ---cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecccC
Confidence               48999999999999998532              389999999999999999999998           99999999


Q ss_pred             CCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCC
Q psy17532        248 SNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSS  326 (461)
Q Consensus       248 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~  326 (461)
                      |+|||+++++.+||+|||+++...............++..|+|||++.+     ..++.++||||||+++|||++ |   
T Consensus       148 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~t~g---  219 (288)
T cd05093         148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFTYG---  219 (288)
T ss_pred             cceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCC---
Confidence            9999999999999999999986644322222233446788999999865     366788999999999999999 6   


Q ss_pred             CCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                              ..||...     ...+....+..... ...+..+     +.++.+|+.+||+.||++|||+.++++.+..+.
T Consensus       220 --------~~p~~~~-----~~~~~~~~i~~~~~-~~~~~~~-----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         220 --------KQPWYQL-----SNNEVIECITQGRV-LQRPRTC-----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             --------CCCCCCC-----CHHHHHHHHHcCCc-CCCCCCC-----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                    5566433     23344444443322 2223222     247999999999999999999999998886655


Q ss_pred             h
Q psy17532        407 C  407 (461)
Q Consensus       407 ~  407 (461)
                      .
T Consensus       281 ~  281 (288)
T cd05093         281 K  281 (288)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-41  Score=323.79  Aligned_cols=252  Identities=21%  Similarity=0.346  Sum_probs=198.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..+|++.+.||+|+||.||+|...       +..||||.+......  ...+..|+.++..++||||+++++++..... 
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-   82 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP-   82 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc-
Confidence            456888899999999999999873       356999998754332  2345678888899999999999999987654 


Q ss_pred             ceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecc
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR  244 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHr  244 (461)
                         .++++||+++++|.+++..                 ..+++..+..++.|++.||.|||+.           +|+||
T Consensus        83 ---~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-----------gi~H~  148 (283)
T cd05091          83 ---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-----------HVVHK  148 (283)
T ss_pred             ---eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-----------Ccccc
Confidence               4899999999999999842                 2478888999999999999999998           99999


Q ss_pred             cCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCC
Q psy17532        245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC  324 (461)
Q Consensus       245 DLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~  324 (461)
                      ||||+|||+++++.+||+|||+++...............+++.|+|||.+.++     .++.++||||||+++|||++++
T Consensus       149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~~~g  223 (283)
T cd05091         149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-----KFSIDSDIWSYGVVLWEVFSYG  223 (283)
T ss_pred             ccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-----CCCcchhHHHHHHHHHHHHcCC
Confidence            99999999999999999999999876543322223344567899999998653     5678899999999999999832


Q ss_pred             CCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       325 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                ..||...     ...+..+.+..... ...+..++     ..+.+|+.+||+.||++||++.+++.+|.
T Consensus       224 ----------~~p~~~~-----~~~~~~~~i~~~~~-~~~~~~~~-----~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         224 ----------LQPYCGY-----SNQDVIEMIRNRQV-LPCPDDCP-----AWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             ----------CCCCCCC-----CHHHHHHHHHcCCc-CCCCCCCC-----HHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence                      4555433     33445555544432 23343333     47899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0577|consensus

Probab=100.00  E-value=4.7e-42  Score=336.08  Aligned_cols=248  Identities=27%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh---h-HHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS---W-QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~-~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      -|.-++.||.|+||.||-|+.  +.+.||||.++...++.   | +..+|+..|.+++|||+|.+.|+|....    ..|
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~----TaW  102 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH----TAW  102 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc----hHH
Confidence            466678999999999999998  46789999997665443   3 3468999999999999999999998754    349


Q ss_pred             eeehhccCCChhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||||- ||-.|+|  +..++.+.++..|+.+.+.||+|||+.           +.||||||+.|||+++.|.|||+||
T Consensus       103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~-----------~~IHRDiKAGNILLse~g~VKLaDF  170 (948)
T KOG0577|consen  103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-----------NRIHRDIKAGNILLSEPGLVKLADF  170 (948)
T ss_pred             HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh-----------hHHhhhccccceEecCCCeeeeccc
Confidence            9999996 5888887  467899999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |.|....+      ...++||++|||||++..-  ....|+-|+||||||++..||.-++           .|+...+  
T Consensus       171 GSAsi~~P------AnsFvGTPywMAPEVILAM--DEGqYdgkvDvWSLGITCIELAERk-----------PPlFnMN--  229 (948)
T KOG0577|consen  171 GSASIMAP------ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERK-----------PPLFNMN--  229 (948)
T ss_pred             cchhhcCc------hhcccCCccccchhHheec--cccccCCccceeeccchhhhhhhcC-----------CCccCch--
Confidence            99976543      4568999999999998643  3368889999999999999999994           4433220  


Q ss_pred             CCCHHHHHHHHhccCCCCCCC-chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ....+ .. +..+..|.++ ..|+     ..++.|+..||.+-|.+|||+++++.|.+...
T Consensus       230 --AMSAL-YH-IAQNesPtLqs~eWS-----~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  230 --AMSAL-YH-IAQNESPTLQSNEWS-----DYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             --HHHHH-HH-HHhcCCCCCCCchhH-----HHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence              11111 12 2233334443 4454     48999999999999999999999999976543

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=317.02  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=196.9

Q ss_pred             eeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      |++.+.||+|+||.||+|...     +..||||++......   ...+..|+..++.++|+||+++++++......  ..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567899999999999999873     256999998754322   23456788889999999999999988664431  12


Q ss_pred             eeeeeehhccCCChhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        184 EFWLITAYHERGSLCDFLKC-------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ..++++||+++|+|.+++..       ..+++..+..++.|++.||.|||+.           +|+||||||+||+++++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-----------~i~H~dlkp~Nil~~~~  149 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-----------NFIHRDLAARNCMLRED  149 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccccchheEEECCC
Confidence            35899999999999998832       2588999999999999999999998           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+++...............++..|+|||.+.+     ..++.++||||||+++|||++++          ..
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~SlG~il~el~~~g----------~~  214 (273)
T cd05035         150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-----RVYTSKSDVWAFGVTMWEIATRG----------QT  214 (273)
T ss_pred             CeEEECCccceeeccccccccccccccCCccccCHhhccc-----CCCCcccchHHHHHHHHHHHhCC----------CC
Confidence            9999999999987654433222223345678999999865     35678899999999999999932          55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...     ...+..+.+... ..+..+..+     +..+.+++.+||+.||++|||+.++++++..+
T Consensus       215 p~~~~-----~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         215 PYPGV-----ENHEIYDYLRHG-NRLKQPEDC-----LDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCC-----CHHHHHHHHHcC-CCCCCCcCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            55432     223334443332 233344333     34899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-40  Score=319.82  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=197.2

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      ...++|++.+.||+|+||.||+|.+.+       ..||+|.+.....  ....+.+|+.+++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            445789999999999999999999854       5688887754322  2234567888999999999999999987765


Q ss_pred             ccceeeeeeehhccCCChhhhhcCC--------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcE
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKCN--------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                      .    .++||||+++|+|.+++...        .+++..++.++.||+.||+|||+.           +++||||||+||
T Consensus        83 ~----~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivH~dlkp~ni  147 (277)
T cd05036          83 P----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-----------HFIHRDIAARNC  147 (277)
T ss_pred             C----cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecccchheE
Confidence            3    48999999999999998543        488999999999999999999998           999999999999


Q ss_pred             EEcCCC---ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCC
Q psy17532        252 LLKSDL---TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSV  327 (461)
Q Consensus       252 Ll~~~~---~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~  327 (461)
                      |++.++   .+||+|||+++.+..............+..|+|||++.+     ..++.++|||||||++|||++ |    
T Consensus       148 l~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~~g----  218 (277)
T cd05036         148 LLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-----GIFTSKTDVWSFGVLLWEIFSLG----  218 (277)
T ss_pred             EEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-----CCcCchhHHHHHHHHHHHHHcCC----
Confidence            998754   699999999987643322111222344578999999865     367889999999999999997 6    


Q ss_pred             CCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        328 SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       328 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                             ..||...     ...+....+.. ..+...+...     +..+.+++.+||+.||++|||+.++++++.
T Consensus       219 -------~~pf~~~-----~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         219 -------YMPYPGR-----TNQEVMEFVTG-GGRLDPPKGC-----PGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -------CCCCCCC-----CHHHHHHHHHc-CCcCCCCCCC-----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                   6666543     33344443332 2223333332     247899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=316.11  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=200.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .++|++.+.||+|+||.||+|++.     ...||||.+.....  ....+..|+..+.+++|+||+++++.+.....   
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP---   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc---
Confidence            457999999999999999999984     24699998864332  23345678889999999999999999877653   


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++|||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||+++++.+||
T Consensus        80 -~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-----------~i~H~di~p~nili~~~~~~~l  147 (266)
T cd05033          80 -VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM-----------NYVHRDLAARNILVNSNLVCKV  147 (266)
T ss_pred             -eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCcceEEEcCCCCEEE
Confidence             4899999999999999854  3689999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++...............++..|+|||.+.+.     .++.++||||||+++|||++ |           ..||..
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~Dv~slG~~l~~l~~~g-----------~~p~~~  211 (266)
T cd05033         148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-----KFTSASDVWSFGIVMWEVMSYG-----------ERPYWD  211 (266)
T ss_pred             CccchhhcccccccceeccCCCCCccccChhhhccC-----CCccccchHHHHHHHHHHHccC-----------CCCCCC
Confidence            999999887532221222234456789999998753     56788999999999999998 7           556643


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      .     ...+....+... .....+..+     +..+.+++.+||+.||++||++.++++++..+
T Consensus       212 ~-----~~~~~~~~~~~~-~~~~~~~~~-----~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         212 M-----SNQDVIKAVEDG-YRLPPPMDC-----PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C-----CHHHHHHHHHcC-CCCCCCCCC-----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3     334444444332 222333322     34789999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-40  Score=321.69  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=201.1

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      .....++|++.+.||+|+||.||+|...+       ..+|+|.+.....  ......+|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            44566789999999999999999998742       4699998864322  223456788888888 8999999999987


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCC
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP  239 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~  239 (461)
                      ...    .++++|||+++|+|.++++.                 ..+++..++.++.|++.||.|||+.           
T Consensus        87 ~~~----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----------  151 (293)
T cd05053          87 QEG----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-----------  151 (293)
T ss_pred             CCC----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-----------
Confidence            765    35999999999999999843                 2478999999999999999999998           


Q ss_pred             CeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHH
Q psy17532        240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE  319 (461)
Q Consensus       240 ~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~e  319 (461)
                      +|+||||||+|||++.++.+||+|||+++.+.............++..|+|||++.+     ..++.++|||||||++||
T Consensus       152 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~e  226 (293)
T cd05053         152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLLWE  226 (293)
T ss_pred             CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-----CCcCcccceeehhhHHHH
Confidence            999999999999999999999999999987654332222233345678999998865     356788999999999999


Q ss_pred             HHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        320 LAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       320 l~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      |++ |           ..||...     ...+....... ...+..+...     +..+.+|+.+||..||++|||+.++
T Consensus       227 l~~~g-----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~ei  284 (293)
T cd05053         227 IFTLG-----------GSPYPGI-----PVEELFKLLKE-GYRMEKPQNC-----TQELYHLMRDCWHEVPSQRPTFKQL  284 (293)
T ss_pred             HhcCC-----------CCCCCCC-----CHHHHHHHHHc-CCcCCCCCCC-----CHHHHHHHHHHcccCcccCcCHHHH
Confidence            998 6           4555432     33344433332 2233333322     3478999999999999999999999


Q ss_pred             hhhcHHH
Q psy17532        399 VERGMLA  405 (461)
Q Consensus       399 l~~l~~~  405 (461)
                      ++++..+
T Consensus       285 l~~l~~~  291 (293)
T cd05053         285 VEDLDRM  291 (293)
T ss_pred             HHHHHHh
Confidence            9998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.9e-40  Score=317.96  Aligned_cols=254  Identities=23%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCC----cEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNE----NVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|++.+.||+|+||.||+|++  +++    .||+|.+.....  ......+|+.++..++|+||+++++++....  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   82 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST--   82 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC--
Confidence            456899999999999999999987  343    489998864432  2334567888899999999999999987532  


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .++++||+++|+|.++++.  ..+++..++.++.|++.||+|||++           +|+||||||+|||+++++.+
T Consensus        83 ---~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          83 ---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV-----------RLVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             ---cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccccccceEEEcCCCcE
Confidence               3799999999999999964  3589999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+++...............++..|+|||.+.+     ..++.++|||||||++|||++ |           ..||
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~t~g-----------~~p~  212 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-----RRFTHQSDVWSYGVTVWELMTFG-----------AKPY  212 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCC-----------CCCC
Confidence            9999999987754332112223345678999999865     357788999999999999998 6           4555


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...     ....+...+ .....+..+..+     +..+.+++.+||+.||++||++.++++.+..+.
T Consensus       213 ~~~-----~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         213 DGI-----PAREIPDLL-EKGERLPQPPIC-----TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CCC-----CHHHHHHHH-HCCCcCCCCccC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            432     222333322 222233333322     347899999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=314.95  Aligned_cols=250  Identities=20%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..+|++.+.||+|+||.||+|.++ +..+|+|.+.........+..|+.++..++|+||+++++++.....    .++||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP----IFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc----eEEEE
Confidence            356889999999999999999985 4579999986544444456678889999999999999999876653    48999


Q ss_pred             hhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++++|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+||+++.++.+||+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dl~p~ni~i~~~~~~kl~dfg~~  147 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-----------GFIHRDLAARNCLVGEDNVVKVSDFGLA  147 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccccccHhhEEECCCCcEEECCcccc
Confidence            99999999999853  3589999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      +....... .......++..|+|||.+.+.     .++.++||||||+++|||++++          ..||...     .
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~Di~slG~il~~l~~~g----------~~p~~~~-----~  206 (256)
T cd05059         148 RYVLDDQY-TSSQGTKFPVKWAPPEVFDYS-----RFSSKSDVWSFGVLMWEVFSEG----------KMPYERF-----S  206 (256)
T ss_pred             eecccccc-cccCCCCCCccccCHHHhccC-----CCCchhhHHHHHHHHHHHhccC----------CCCCCCC-----C
Confidence            76643221 111222345689999998763     5678899999999999999932          5566433     2


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ..+....+. ...+...+..     .+..+.+++.+||..+|++|||+.++++.+
T Consensus       207 ~~~~~~~~~-~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         207 NSEVVESVS-AGYRLYRPKL-----APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHH-cCCcCCCCCC-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            233333332 2233333333     234899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-40  Score=322.80  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=201.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC---------CcEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEE
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN---------ENVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAE  175 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~  175 (461)
                      ....++|.+.+.||+|+||.||+++..+         ..+|+|.+....  ........|+.++..+ +|+||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3345789999999999999999998632         459999987532  2223456788888888 799999999999


Q ss_pred             ecCCccceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCC
Q psy17532        176 KRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK  238 (461)
Q Consensus       176 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~  238 (461)
                      ....    .+++||||+++|+|.+++...                 .+++..++.++.|++.||+|||+.          
T Consensus        94 ~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----------  159 (307)
T cd05098          94 TQDG----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----------  159 (307)
T ss_pred             ecCC----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----------
Confidence            8765    348999999999999999532                 478899999999999999999998          


Q ss_pred             CCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHH
Q psy17532        239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW  318 (461)
Q Consensus       239 ~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~  318 (461)
                       +++||||||+|||++.++.+||+|||+++...............++..|+|||++.+.     .++.++|||||||++|
T Consensus       160 -gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~  233 (307)
T cd05098         160 -KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFGVLLW  233 (307)
T ss_pred             -CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-----CCCcHHHHHHHHHHHH
Confidence             9999999999999999999999999999766432221122223355789999998763     5678899999999999


Q ss_pred             HHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        319 ELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       319 el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      ||++++          ..||...     ..+++...+.. ..+...+...     +.++.+|+.+||..+|++|||+.++
T Consensus       234 el~~~g----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~ev  292 (307)
T cd05098         234 EIFTLG----------GSPYPGV-----PVEELFKLLKE-GHRMDKPSNC-----TNELYMMMRDCWHAVPSQRPTFKQL  292 (307)
T ss_pred             HHHcCC----------CCCCCcC-----CHHHHHHHHHc-CCCCCCCCcC-----CHHHHHHHHHHcccChhhCcCHHHH
Confidence            999832          4555432     33444444332 2333344333     2488999999999999999999999


Q ss_pred             hhhcHHHhh
Q psy17532        399 VERGMLALC  407 (461)
Q Consensus       399 l~~l~~~~~  407 (461)
                      ++.+..+..
T Consensus       293 l~~l~~~~~  301 (307)
T cd05098         293 VEDLDRILA  301 (307)
T ss_pred             HHHHHHHHH
Confidence            999877654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=314.61  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ++|++.+.||+|+||.||+|..  .++.||+|.+.....      .....++|+.++.+++||||+++++++....    
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE----   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence            4688999999999999999987  478899998864321      1234567888999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||+|+||+++.++.++|+
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~i~H~dl~p~nilv~~~~~~~l~  146 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN-----------MIVHRDIKGANILRDSAGNVKLG  146 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEe
Confidence            55999999999999999854 4688999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCC-CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        263 DFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       263 DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |||+++.......... .....++..|+|||++.+.     .++.++||||||+++|||++|           +.||...
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g-----------~~p~~~~  210 (263)
T cd06625         147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-----GYGRKADVWSVGCTVVEMLTE-----------KPPWAEF  210 (263)
T ss_pred             ecccceeccccccccccccCCCcCccccCcceeccC-----CCCchhhhHHHHHHHHHHHhC-----------CCCcccc
Confidence            9999976643221111 1234678899999999763     577889999999999999999           5555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                           ...............+.++...+     ..+.++|.+||..||++|||+.+++++.+
T Consensus       211 -----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         211 -----EAMAAIFKIATQPTNPQLPSHVS-----PDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             -----chHHHHHHHhccCCCCCCCccCC-----HHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence                 11222222333333344444333     37899999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-40  Score=328.39  Aligned_cols=260  Identities=20%  Similarity=0.230  Sum_probs=200.6

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+++.+  ++.||+|.+....    ........|+.++..++|+||+++++++.+.+    ..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~----~~   76 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN----YL   76 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----EE
Confidence            47899999999999999999984  5779999986422    11223456777888899999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      |+||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~-----------~iiHrDlkp~Nill~~~~~~kl~D  145 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL-----------HYVHRDIKPDNVLLDMNGHIRLAD  145 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCchHHEEEcCCCCEEEEe
Confidence            999999999999999964  5689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++....... .......||+.|+|||++.+.......++.++|||||||++|||++|           ..||...  
T Consensus       146 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g-----------~~Pf~~~--  211 (331)
T cd05624         146 FGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG-----------ETPFYAE--  211 (331)
T ss_pred             ccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhC-----------CCCccCC--
Confidence            999987654322 11223569999999999865321113467889999999999999999           5666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLA  405 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~  405 (461)
                         ...+....+.....+..+|..+..  .++.+.+++.+|+..++++  |++++++++|.+..
T Consensus       212 ---~~~~~~~~i~~~~~~~~~p~~~~~--~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~  270 (331)
T cd05624         212 ---SLVETYGKIMNHEERFQFPSHITD--VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE  270 (331)
T ss_pred             ---CHHHHHHHHHcCCCcccCCCcccc--CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence               333444444444444444443322  3458899999999876654  46888999887653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-40  Score=321.87  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=203.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC---------CCcEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEE
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGA  174 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~  174 (461)
                      ......+|++.+.||+|+||.||+|+..         +..||+|.+....  .......+|+..+..+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            4456788999999999999999999752         2369999876432  2234456788888888 89999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      +....    ..++||||+++|+|.+++..                 ..+++..+..++.||+.||.|||+.         
T Consensus        90 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---------  156 (304)
T cd05101          90 CTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---------  156 (304)
T ss_pred             EecCC----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---------
Confidence            88765    34899999999999999853                 2467888999999999999999998         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+     ..++.++||||||+++
T Consensus       157 --givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l  229 (304)
T cd05101         157 --KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLM  229 (304)
T ss_pred             --CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-----CCCCchhhHHHHHHHH
Confidence              999999999999999999999999999987654332222333456788999999865     3577889999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                      |||++++          ..||...     ...++...+... .+...+..     .+..+.+|+.+||..+|++|||+.+
T Consensus       230 ~el~~~g----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~li~~cl~~~p~~Rps~~e  288 (304)
T cd05101         230 WEIFTLG----------GSPYPGI-----PVEELFKLLKEG-HRMDKPAN-----CTNELYMMMRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             HHHHcCC----------CCCcccC-----CHHHHHHHHHcC-CcCCCCCC-----CCHHHHHHHHHHcccChhhCCCHHH
Confidence            9999842          4455432     344554444332 23333333     2348999999999999999999999


Q ss_pred             hhhhcHHHhh
Q psy17532        398 VVERGMLALC  407 (461)
Q Consensus       398 vl~~l~~~~~  407 (461)
                      +++.|..+..
T Consensus       289 ~l~~l~~~~~  298 (304)
T cd05101         289 LVEDLDRILT  298 (304)
T ss_pred             HHHHHHHHHH
Confidence            9999877654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-40  Score=320.79  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=197.8

Q ss_pred             ceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      +|++.+.||+|+||.||+|....       ..+|+|.+.....  ......+|+.++..++||||+++++.+.....   
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP---   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence            47888999999999999998732       4588888764432  22345678999999999999999999877654   


Q ss_pred             eeeeeehhccCCChhhhhcC-------------------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCC
Q psy17532        184 EFWLITAYHERGSLCDFLKC-------------------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK  238 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~  238 (461)
                       .++++||+.+|+|.+++..                         ..+++..++.++.|++.||.|||+.          
T Consensus        78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------  146 (290)
T cd05045          78 -LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----------  146 (290)
T ss_pred             -cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----------
Confidence             4899999999999998742                         2477889999999999999999998          


Q ss_pred             CCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHH
Q psy17532        239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW  318 (461)
Q Consensus       239 ~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~  318 (461)
                       +|+||||||+|||+++++.+||+|||+++...............++..|+|||.+.+     ..++.++||||||+++|
T Consensus       147 -~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~  220 (290)
T cd05045         147 -KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-----HIYTTQSDVWSFGVLLW  220 (290)
T ss_pred             -CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-----CCcchHhHHHHHHHHHH
Confidence             999999999999999999999999999987644332222233456778999998865     35778899999999999


Q ss_pred             HHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        319 ELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       319 el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                      ||++ |           ..||...     ..+++.+.+. ...+...+...     +..+.+++.+||+.||++||++++
T Consensus       221 el~t~g-----------~~p~~~~-----~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         221 EIVTLG-----------GNPYPGI-----APERLFNLLK-TGYRMERPENC-----SEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HHHhcC-----------CCCCCCC-----CHHHHHHHHh-CCCCCCCCCCC-----CHHHHHHHHHHccCCcccCCCHHH
Confidence            9998 7           5555432     3334443332 22333344333     247999999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      +++.+..+.
T Consensus       279 i~~~l~~~~  287 (290)
T cd05045         279 ISKELEKMM  287 (290)
T ss_pred             HHHHHHHHH
Confidence            999987664

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0667|consensus

Probab=100.00  E-value=3e-41  Score=337.57  Aligned_cols=269  Identities=23%  Similarity=0.280  Sum_probs=203.8

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC-C-----CCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME-H-----DNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~~~  184 (461)
                      +|.+.++||+|.||.|.+|..  +++.||||+++....-..+...|+.+|..|+ |     -|+|+++++|...+    +
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~----H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN----H  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----c
Confidence            788999999999999999998  4688999999877776677788999988886 4     38999999998765    5


Q ss_pred             eeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC--Cce
Q psy17532        185 FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD--LTA  259 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~--~~~  259 (461)
                      ++||+|.+.. +|+++|+.+   .++...+..++.||+.||.+||+.           +|||+||||+||||.+-  ..+
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l-----------~IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL-----------GIIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeccCChhheeeccCCcCce
Confidence            5999999976 999999765   488999999999999999999998           99999999999999753  479


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC-----
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-----  334 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~-----  334 (461)
                      ||+|||.|......     ......+..|+|||++.|.     .|+.+.||||||||+.||++|.+.|.+.....     
T Consensus       331 KVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGl-----pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  331 KVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGL-----PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             eEEecccccccCCc-----ceeeeeccccccchhhccC-----CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence            99999999876543     2256788999999999984     88899999999999999999988886542110     


Q ss_pred             ------------------CCCCcc--------ccCC---C---CCHHHHHHHHhccCCCCCCCchhc---cchhHHHHHH
Q psy17532        335 ------------------RLPFSA--------EVGD---H---PSLEDMQEAVVHKKLRPTLPETWK---QHAGMLALCD  379 (461)
Q Consensus       335 ------------------~~pf~~--------~~~~---~---~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~l~~  379 (461)
                                        +.-|..        ....   .   +...............|.-...+.   .......+.+
T Consensus       401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d  480 (586)
T KOG0667|consen  401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID  480 (586)
T ss_pred             HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence                              000111        0000   0   000011111111111110111111   1124467899


Q ss_pred             HHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        380 TMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       380 li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ++.+||.+||.+|+|+.++++|.+.-..
T Consensus       481 flk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  481 FLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             HHHHHhccCchhcCCHHHHhcCcccccc
Confidence            9999999999999999999999987643

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-40  Score=332.87  Aligned_cols=256  Identities=19%  Similarity=0.237  Sum_probs=198.7

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+++.  .++.||||++....    ........|+.++..++|+||+++++.+.+..    .+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----~~   76 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR----NL   76 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----EE
Confidence            3689999999999999999998  46889999986432    12233456888888999999999999988765    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~-----------givHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL-----------GFIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEccCCCHHHEEECCCCCEEEeec
Confidence            99999999999999985 45689999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCC---------------------------------CCCCCCcCCCcccccccccccccccCCCCCccchH
Q psy17532        265 GLALLFEPGKPC---------------------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMY  311 (461)
Q Consensus       265 Gla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVw  311 (461)
                      |+++.+......                                 .......||+.|+|||++.+     ..++.++|||
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~~~Diw  220 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-----TGYNKLCDWW  220 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-----CCCCCcceec
Confidence            998765321100                                 00123579999999999876     3677899999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh
Q psy17532        312 ACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA  391 (461)
Q Consensus       312 S~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~  391 (461)
                      ||||++|||++|           ..||...     ........+........+|...   ..+.++.+||.+++ .||++
T Consensus       221 SlGvilyel~tG-----------~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~l~-~~p~~  280 (360)
T cd05627         221 SLGVIMYEMLIG-----------YPPFCSE-----TPQETYRKVMNWKETLVFPPEV---PISEKAKDLILRFC-TDSEN  280 (360)
T ss_pred             cccceeeecccC-----------CCCCCCC-----CHHHHHHHHHcCCCceecCCCC---CCCHHHHHHHHHhc-cChhh
Confidence            999999999999           5566443     3333444444333223333321   12347889999876 49999


Q ss_pred             hcc---ccchhhhcHHHhh
Q psy17532        392 RLS---ASCVVERGMLALC  407 (461)
Q Consensus       392 Rps---~~evl~~l~~~~~  407 (461)
                      |++   +.++++|.+....
T Consensus       281 R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         281 RIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             cCCCCCHHHHhcCCCCCCC
Confidence            995   6788999876443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-40  Score=322.83  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=198.9

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      .....++|.+.+.||+|+||.||+|...       +..||||.+.....  ......+|+.+++++ +|+||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3455678999999999999999999752       24699998865432  223456789999999 8999999999988


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ..+.    .++||||+++|+|.++++..   .+++.++..++.|++.||.|||++           +|+|+||||+|||+
T Consensus       110 ~~~~----~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----------~ivH~dlkp~Nil~  174 (302)
T cd05055         110 IGGP----ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-----------NCIHRDLAARNVLL  174 (302)
T ss_pred             cCCc----eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeehhhhccceEEE
Confidence            7654    49999999999999999643   289999999999999999999998           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPG  332 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~  332 (461)
                      +.++.+||+|||+++.+.............++..|+|||.+.+.     .++.++|||||||++|||++ |         
T Consensus       175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslGvil~el~t~g---------  240 (302)
T cd05055         175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-----VYTFESDVWSYGILLWEIFSLG---------  240 (302)
T ss_pred             cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-----CCCcHhHHHHHHHHHHHHHhCC---------
Confidence            99999999999999876543221122233567889999998663     56788999999999999998 7         


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                        ..||....    ....... ......++..+..     .+..+.+++.+||+.+|++|||+.++++.+..
T Consensus       241 --~~p~~~~~----~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         241 --SNPYPGMP----VDSKFYK-LIKEGYRMAQPEH-----APAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             --CCCcCCCC----chHHHHH-HHHcCCcCCCCCC-----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence              44554321    1122222 2222233332322     23479999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-40  Score=326.41  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=187.5

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHH-HHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEI-FKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei-~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++||+|+||.||+|+.  .++.||+|++.....    .......|+ .++..++||||+++++++.+.+    .+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----~~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----KLYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----EEEEEEc
Confidence            4799999999999998  467899999864321    112223343 3567889999999999988765    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL-----------NIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999999988854 5688999999999999999999998           999999999999999999999999999875


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g-----------~~pf~~~-----~~~  202 (321)
T cd05603         146 GVEPE--ETTSTFCGTPEYLAPEVLRK-----EPYDRTVDWWCLGAVLYEMLYG-----------LPPFYSR-----DVS  202 (321)
T ss_pred             CCCCC--CccccccCCcccCCHHHhcC-----CCCCCcCcccccchhhhhhhcC-----------CCCCCCC-----CHH
Confidence            42221  12334578999999999875     3577889999999999999999           5666543     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc----chhhhcHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS----CVVERGML  404 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----evl~~l~~  404 (461)
                      .+...+....  ..+|..     ....+.+++.+||+.||++||++.    ++++|.+.
T Consensus       203 ~~~~~i~~~~--~~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~  254 (321)
T cd05603         203 QMYDNILHKP--LQLPGG-----KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF  254 (321)
T ss_pred             HHHHHHhcCC--CCCCCC-----CCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence            4444444432  223322     223789999999999999999875    56566543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0032|consensus

Probab=100.00  E-value=1.6e-40  Score=328.66  Aligned_cols=255  Identities=26%  Similarity=0.366  Sum_probs=211.4

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCcc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHME-HDNILRYIGAEKRGESI  181 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~  181 (461)
                      .....|++.+.||+|.||.||+++.  +|+.+|+|.+.+...    .....++|+.+|.++. |||||.+++++.+..  
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--
Confidence            3456799999999999999999998  478899999975433    2345678999999998 999999999999876  


Q ss_pred             ceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC----C
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD----L  257 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~----~  257 (461)
                        .+++|||++.||.|.+.+....+++.++..++.|++.|+.|||+.           +|+||||||+|+|+...    +
T Consensus       110 --~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~-----------gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  110 --SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL-----------GVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             --eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC-----------CceeccCCHHHeeeccccCCCC
Confidence              559999999999999998543599999999999999999999998           99999999999999653    4


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+|++|||+|.....+   ......+||+.|+|||++.+     ..|+..+||||+||++|.|++|           ..|
T Consensus       177 ~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~-----~~y~~~~DiWS~Gvi~yiLL~G-----------~~P  237 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGG-----RPYGDEVDVWSIGVILYILLSG-----------VPP  237 (382)
T ss_pred             cEEEeeCCCceEccCC---ceEeeecCCccccCchhhcC-----CCCCcccchhHHHHHHHHHhhC-----------CCC
Confidence            7999999999988762   24566899999999999975     4788899999999999999999           566


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      |.+.     +.......+..+.+... .+.|+.  .+..+.++|++++..||.+|+|+.++++|+|..
T Consensus       238 F~~~-----~~~~~~~~i~~~~~~f~-~~~w~~--is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  238 FWGE-----TEFEIFLAILRGDFDFT-SEPWDD--ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             CcCC-----ChhHHHHHHHcCCCCCC-CCCccc--cCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence            6554     33344445666554222 223333  356899999999999999999999999998843

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-40  Score=326.12  Aligned_cols=236  Identities=24%  Similarity=0.296  Sum_probs=182.6

Q ss_pred             eEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHH-HHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEI-FKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei-~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+..  ++.||+|++.....    .......|. ..+..++|+||+++++++...+    .+++|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----~~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KLYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----eEEEEEe
Confidence            47999999999999984  56799999864321    111222333 3467789999999999988765    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++.. ..+.+..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL-----------NIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999999999854 4588888999999999999999999           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g-----------~~pf~~~-----~~~  202 (325)
T cd05602         146 NIEHN--GTTSTFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYG-----------LPPFYSR-----NTA  202 (325)
T ss_pred             cccCC--CCcccccCCccccCHHHHcC-----CCCCCccccccccHHHHHHhcC-----------CCCCCCC-----CHH
Confidence            43222  12334579999999999876     3677889999999999999999           5566433     333


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      ++...+.....  .++..     .+..+.+++.+||+.||.+||++.+.
T Consensus       203 ~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~  244 (325)
T cd05602         203 EMYDNILNKPL--QLKPN-----ITNSARHLLEGLLQKDRTKRLGAKDD  244 (325)
T ss_pred             HHHHHHHhCCc--CCCCC-----CCHHHHHHHHHHcccCHHHCCCCCCC
Confidence            44444433321  12222     22378999999999999999998843

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=313.06  Aligned_cols=247  Identities=27%  Similarity=0.479  Sum_probs=201.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..++|++.+.||+|+||.||+|...++.||||.+........+...|+.++..++|+||+++++++.+..    ..++||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~   79 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN----PLYIVT   79 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC----CeEEEE
Confidence            4568999999999999999999999999999999765544456678999999999999999999988754    348999


Q ss_pred             hhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        190 AYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       190 e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||+++|+|.++++..   .+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+|||+
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-----------~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-----------NFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccchhcccceEEEeCCCCEEEccccc
Confidence            999999999999543   589999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++......     ....++..|+|||.+.+.     .++.++||||||+++||+++ |           ..||...    
T Consensus       149 ~~~~~~~~-----~~~~~~~~~~ape~~~~~-----~~~~~~Di~slG~il~~l~~~g-----------~~p~~~~----  203 (256)
T cd05039         149 AKEASQGQ-----DSGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFG-----------RVPYPRI----  203 (256)
T ss_pred             cccccccc-----ccCCCcccccCchhhcCC-----cCCcHHHHHHHHHHHHHHHhcC-----------CCCCCCC----
Confidence            98764322     123456789999998653     56678999999999999997 7           5555433    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                       ...++...+.. ..+...+..+     +..+.+++.+||..+|++|||+.++++.+.
T Consensus       204 -~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         204 -PLKDVVPHVEK-GYRMEAPEGC-----PPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             -CHHHHHHHHhc-CCCCCCccCC-----CHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence             33444443332 2233334332     348999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-40  Score=317.56  Aligned_cols=270  Identities=25%  Similarity=0.364  Sum_probs=198.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..+|++.+.||+|+||.||+|.+      .+..||||.+...... ...+++|+.++..++||||+++++++...+.  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--R   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC--C
Confidence            35789999999999999999985      3578999998654433 3345789999999999999999998765432  2


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      .+++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~-----------~i~H~dlkp~nili~~~~~~~l  149 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK-----------RYVHRDLATRNILVESENRVKI  149 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC-----------CceeccCCHhhEEECCCCeEEE
Confidence            46899999999999999954  3589999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++.+....... ......++..|+|||++.+.     .++.++||||||+++|||++|..++..+......-...
T Consensus       150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd05081         150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-----KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN  224 (284)
T ss_pred             CCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-----CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc
Confidence            9999998765433211 11222345579999998653     56788999999999999999865543221110000000


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ..........+.+.+ ....+...+..+     +..+.+|+.+||+.+|++|||+.++++.+..
T Consensus       225 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         225 DKQGQMIVYHLIELL-KNNGRLPAPPGC-----PAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             ccccccchHHHHHHH-hcCCcCCCCCCC-----CHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            000001112222222 222222333322     3479999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9e-40  Score=314.70  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=195.0

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.++||+|+||.||+|+.  .++.||+|.+.....  ......+|+.++.+++||||+++++++...+    ..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN----RISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC----EEEE
Confidence            3678899999999999999987  567899999865422  2234567888899999999999999998765    3489


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||||+++|+|..+.   .+++..+..++.|++.||.|||+.           +|+|+||||+|||++.++.+||+|||++
T Consensus        77 v~e~~~~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          77 CTEFMDGGSLDVYR---KIPEHVLGRIAVAVVKGLTYLWSL-----------KILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             EEecCCCCChHHhh---cCCHHHHHHHHHHHHHHHHHHHHC-----------CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            99999999997653   478888999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC--
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH--  345 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~--  345 (461)
                      ..+....    .....|+..|+|||++.+.     .++.++||||||+++|||++|..||           .......  
T Consensus       143 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~~l~~g~~pf-----------~~~~~~~~~  202 (279)
T cd06619         143 TQLVNSI----AKTYVGTNAYMAPERISGE-----QYGIHSDVWSLGISFMELALGRFPY-----------PQIQKNQGS  202 (279)
T ss_pred             eeccccc----ccCCCCChhhcCceeecCC-----CCCCcchHHHHHHHHHHHHhCCCCc-----------hhhcccccc
Confidence            8664322    2345789999999998763     5678999999999999999995444           3211111  


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .............. .+..+.    ...+.++.++|.+||..||++||++++++++.+...
T Consensus       203 ~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         203 LMPLQLLQCIVDED-PPVLPV----GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             cchHHHHHHHhccC-CCCCCC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            01112222222211 111111    112347899999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4e-40  Score=324.04  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=191.8

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +|++.+.||+|+||.||+|+.  +++.||||++....    ........|+.++..+. |++|+++++++.+.+    .+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   76 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD----RL   76 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC----EE
Confidence            478889999999999999998  46789999987432    11223445666666664 677888988887755    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~-----------~ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR-----------GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHeEECCCCCEEEecc
Confidence            999999999999999854 5699999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......||..|+|||++.+     ..++.++|||||||++|||++|           ..||...   
T Consensus       146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG-----------~~pf~~~---  204 (323)
T cd05615         146 GMCKEHMVDG--VTTRTFCGTPDYIAPEIIAY-----QPYGKSVDWWAYGVLLYEMLAG-----------QPPFDGE---  204 (323)
T ss_pred             ccccccCCCC--ccccCccCCccccCHHHHcC-----CCCCCccchhhhHHHHHHHHhC-----------CCCCCCC---
Confidence            9997643322  12334568999999999876     3577899999999999999999           5666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc-----chhhhcHH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS-----CVVERGML  404 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-----evl~~l~~  404 (461)
                        ........+.....  .+|...+     ..+.+++.+||+.||++|++..     ++.+|.+.
T Consensus       205 --~~~~~~~~i~~~~~--~~p~~~~-----~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f  260 (323)
T cd05615         205 --DEDELFQSIMEHNV--SYPKSLS-----KEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF  260 (323)
T ss_pred             --CHHHHHHHHHhCCC--CCCccCC-----HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence              33444444444332  3333332     3788999999999999999863     55566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-40  Score=326.30  Aligned_cols=250  Identities=18%  Similarity=0.259  Sum_probs=189.2

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.  .++.||||++.....    .......|+.++.++ +|+||+++++++.+..    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e   76 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----RLFLVIE   76 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----EEEEEEe
Confidence            4799999999999998  457899999975322    122345677777676 6999999999988765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++. .+.+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~-----------~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER-----------GIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            999999999885 45799999999999999999999999           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||+.|+|||++.+     ..++.++|||||||++|||++|..||......         .......
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~ell~g~~pf~~~~~~---------~~~~~~~  209 (327)
T cd05617         146 GLGPG--DTTSTFCGTPNYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAGRSPFDIITDN---------PDMNTED  209 (327)
T ss_pred             ccCCC--CceecccCCcccCCHHHHCC-----CCCCchheeehhHHHHHHHHhCCCCCCccCCC---------cccccHH
Confidence            32211  12334579999999999876     36678999999999999999995554321110         0011222


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc------chhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS------CVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~------evl~~l~~~  405 (461)
                      .....+....  ..+|...+     ..+.+++.+||+.||++|+++.      ++++|.+..
T Consensus       210 ~~~~~~~~~~--~~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~  264 (327)
T cd05617         210 YLFQVILEKP--IRIPRFLS-----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR  264 (327)
T ss_pred             HHHHHHHhCC--CCCCCCCC-----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence            2333333222  22443322     3788999999999999999864      777776543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-40  Score=318.46  Aligned_cols=263  Identities=23%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc-cce
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES-IHT  183 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~-~~~  183 (461)
                      ....++|++.+.||+|+||.||+++.  .++.+|+|.+............|+.++.++ +|+||+++++++..... ...
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            34567899999999999999999988  467899998865444344556788888888 79999999998754321 123


Q ss_pred             eeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        184 EFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                      .+++||||+++|+|.+++.     ...+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-----------KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-----------CccccCCCHHhEEECCCCC
Confidence            5699999999999999874     24588889999999999999999998           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......  .......|+..|+|||++.........++.++|||||||++|||++|           ..||
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g-----------~~p~  229 (286)
T cd06638         163 VKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DPPL  229 (286)
T ss_pred             EEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC-----------CCCC
Confidence            9999999998765332  12233568999999999865332234577899999999999999999           4454


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ....    ..................+..+     ...+.++|.+||+.||++|||+.+++++++
T Consensus       230 ~~~~----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         230 ADLH----PMRALFKIPRNPPPTLHQPELW-----SNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             CCCc----hhHHHhhccccCCCcccCCCCc-----CHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            3321    1111111100000111112222     237899999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-40  Score=316.89  Aligned_cols=257  Identities=23%  Similarity=0.300  Sum_probs=196.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ...+|++.+.||+|+||.||+|+.  +++.||+|++..... .....++|+.++.+++||||+++++++...+    .++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~----~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE----KLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC----EEE
Confidence            346799999999999999999997  467899999865432 2334567889999999999999999988754    458


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.++++ ...+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+|||
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK-----------GKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEECCCCCEEECcCc
Confidence            9999999999999885 45689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.+....  .......|+..|+|||.+.+.  ....++.++|||||||++|||++|..|           |.....  
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~~Dvws~G~il~el~~g~~p-----------~~~~~~--  214 (267)
T cd06646         152 VAAKITATI--AKRKSFIGTPYWMAPEVAAVE--KNGGYNQLCDIWAVGITAIELAELQPP-----------MFDLHP--  214 (267)
T ss_pred             cceeecccc--cccCccccCccccCHhHcccc--cCCCCcchhhHHHHHHHHHHHHhCCCC-----------ccccch--
Confidence            998764322  122335688999999988532  113466789999999999999999544           422100  


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         .+...........+.....  ....+..+.++|.+||..||++|||+++++++++
T Consensus       215 ---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         215 ---MRALFLMSKSNFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ---hhhheeeecCCCCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence               0000011111111111110  1112348999999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.9e-40  Score=311.69  Aligned_cols=247  Identities=24%  Similarity=0.437  Sum_probs=197.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ...+|++.+.||+|+||.||+|..+++.||+|.+.... ....+..|+.++++++|+||+++++++....   ...+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~lv~   79 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK---GGLYIVT   79 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC---CceEEEE
Confidence            45689999999999999999999999999999986433 2345667888999999999999999865433   2358999


Q ss_pred             hhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        190 AYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       190 e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||+++|+|.++++..   .+++..+..++.|++.||+|||++           +|+||||||+||++++++.+||+|||+
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-----------NFVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeccccchheEEEcCCCcEEecCCcc
Confidence            999999999998543   378999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++......     ....++..|+|||++.+     ..++.++||||||+++|||++ |           ..||...    
T Consensus       149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~~g-----------~~p~~~~----  203 (256)
T cd05082         149 TKEASSTQ-----DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFG-----------RVPYPRI----  203 (256)
T ss_pred             ceeccccC-----CCCccceeecCHHHHcc-----CCCCchhhhHHHHHHHHHHHhCC-----------CCCCCCC----
Confidence            97654322     22345678999998865     356788999999999999998 7           5565432    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                       ...+....+.. ...+..+..+     +..+.+++.+||+.||++|||+.+++++|.
T Consensus       204 -~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         204 -PLKDVVPRVEK-GYKMDAPDGC-----PPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             -CHHHHHHHHhc-CCCCCCCCCC-----CHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence             33444333322 2233333332     347899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.6e-40  Score=327.77  Aligned_cols=276  Identities=23%  Similarity=0.290  Sum_probs=196.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|++.+.||+|+||.||++..  .++.||||.+....   .......+|+.++..++||||+++++++......  .
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999987  47889999986432   2233456788999999999999999998654422  1


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~-----------~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-ELDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEECCCCCEEEe
Confidence            346899999975 67776643 488899999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++......   ......||..|+|||++.+     ..++.++|||||||++|||++|..||..........-....
T Consensus       166 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~  237 (359)
T cd07876         166 DFGLARTACTNF---MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ  237 (359)
T ss_pred             cCCCccccccCc---cCCCCcccCCCCCchhccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999997654322   2334578999999999976     36778899999999999999996555432110000000000


Q ss_pred             CCCCCHH---H----HHHHHhccCCCCCCC--c---hhc-------cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        343 GDHPSLE---D----MQEAVVHKKLRPTLP--E---TWK-------QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       343 ~~~~~~~---~----~~~~~~~~~~~~~~p--~---~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ...+...   .    ...........+...  +   .|.       ....+..+.+||.+||..||++|||+.|+++|.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            0000000   0    000000000000000  0   000       0112347899999999999999999999999997


Q ss_pred             HHh
Q psy17532        404 LAL  406 (461)
Q Consensus       404 ~~~  406 (461)
                      ...
T Consensus       318 ~~~  320 (359)
T cd07876         318 ITV  320 (359)
T ss_pred             hhh
Confidence            653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.4e-40  Score=316.13  Aligned_cols=257  Identities=23%  Similarity=0.284  Sum_probs=200.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC------CCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|++.++||+|+||.||+|.+.      +..||+|++....  .......+|+.++..++|+||+++++++.....
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            34578999999999999999999984      3679999886432  223445678888999999999999998776432


Q ss_pred             cceeeeeeehhccCCChhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcE
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC---------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                         ..++++||+++|+|.+++..         ..+++..+..++.|++.||+|||+.           +++||||||+||
T Consensus        83 ---~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------~i~H~di~p~ni  148 (280)
T cd05043          83 ---PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-----------GVIHKDIAARNC  148 (280)
T ss_pred             ---CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecccCHhhE
Confidence               34899999999999999853         3588999999999999999999998           999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q psy17532        252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPP  330 (461)
Q Consensus       252 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~  330 (461)
                      |+++++.+||+|||+++.+.............++..|+|||++.+     ..++.++||||||+++||+++ |       
T Consensus       149 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~~~g-------  216 (280)
T cd05043         149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-----KEYSSASDVWSFGVLLWELMTLG-------  216 (280)
T ss_pred             EEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-----CCCCchhhHHHhHHHHHHHhcCC-------
Confidence            999999999999999987644332111223456778999999865     356788999999999999999 7       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       331 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ..||...     ...++...+.. ..+...+..     .+..+.+++.+||..||++|||+.++++.|..+.
T Consensus       217 ----~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         217 ----QTPYVEI-----DPFEMAAYLKD-GYRLAQPIN-----CPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             ----CCCcCcC-----CHHHHHHHHHc-CCCCCCCCc-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                5666543     22333333322 222222222     2347899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.6e-40  Score=318.53  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..+|++.+.||+|+||.||+|..  .++.||+|.+...... .....+|+.++..++|+||+++++.+....    ..++
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~----~~~l   94 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELWV   94 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC----EEEE
Confidence            35899999999999999999987  5688999988754332 334567888899999999999999988754    4599


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||||+++|+|.+++....+++.++..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||++
T Consensus        95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~-----------gi~H~dLkp~Nill~~~~~~kl~dfg~~  163 (296)
T cd06654          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-----------QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (296)
T ss_pred             eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEEcCCCCEEECccccc
Confidence            99999999999999888899999999999999999999998           9999999999999999999999999998


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ........  ......++..|+|||.+.+.     .++.++|||||||++|||++|           ..||.....    
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~~l~~g-----------~~pf~~~~~----  221 (296)
T cd06654         164 AQITPEQS--KRSTMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMIEG-----------EPPYLNENP----  221 (296)
T ss_pred             hhcccccc--ccCcccCCccccCHHHHcCC-----CCCccchHHHHHHHHHHHHhC-----------CCCCCCCCH----
Confidence            76543321  12334688999999998753     566889999999999999999           455543211    


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .................+..     ....+.+++.+||..||++|||+.+++++.+...+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         222 LRALYLIATNGTPELQNPEK-----LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHhHHHHhcCCCCCCCCccc-----cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            11111111111111111221     23478999999999999999999999999876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-40  Score=325.64  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=187.4

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHH-HcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIF-KLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|+.  +++.||||++.....    .......|.. +++.++||||+++++++...+    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----~~~lv~e   76 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----KLYFVLD   76 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----EEEEEEc
Confidence            4689999999999998  478899999864321    1122233433 467789999999999988765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|..++. ...+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI-----------NIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            999999998885 45689999999999999999999998           999999999999999999999999999975


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+.     .++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~G-----------~~pf~~~-----~~~  202 (325)
T cd05604         146 GIAQS--DTTTTFCGTPEYLAPEVIRKQ-----PYDNTVDWWCLGAVLYEMLYG-----------LPPFYCR-----DVA  202 (325)
T ss_pred             CCCCC--CCcccccCChhhCCHHHHcCC-----CCCCcCccccccceehhhhcC-----------CCCCCCC-----CHH
Confidence            43222  123345799999999998763     567889999999999999999           5566443     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc----chhhhcHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS----CVVERGML  404 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----evl~~l~~  404 (461)
                      ++...+.....  .++..     .+..+.+++.+||..||++||++.    ++++|.+.
T Consensus       203 ~~~~~~~~~~~--~~~~~-----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f  254 (325)
T cd05604         203 EMYDNILHKPL--VLRPG-----ASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF  254 (325)
T ss_pred             HHHHHHHcCCc--cCCCC-----CCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence            44444444322  12211     223788999999999999999986    56666544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-40  Score=315.10  Aligned_cols=250  Identities=24%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...+|++.+.||+|+||.||+|... +..+|+|.+..... .......|+.++..++|+||+++++++.....    +++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP----VYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC----eEE
Confidence            3467999999999999999999985 57899999875544 34456788999999999999999999887653    489


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||+++|+|.++++.   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-----------~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-----------NSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccccCcceEEEcCCceEEEccc
Confidence            9999999999999964   3589999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |++........  ......++..|+|||.+.+     ..++.++||||||+++|+|++ |           ..||...  
T Consensus       149 g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~~g-----------~~p~~~~--  208 (261)
T cd05148         149 GLARLIKEDVY--LSSDKKIPYKWTAPEAASH-----GTFSTKSDVWSFGILLYEMFTYG-----------QVPYPGM--  208 (261)
T ss_pred             cchhhcCCccc--cccCCCCceEecCHHHHcc-----CCCCchhhHHHHHHHHHHHHcCC-----------CCCCCcC--
Confidence            99987654321  1223456778999998865     356788999999999999998 6           6666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ...+....+. ...+...+...     +..+.++|.+||..||++|||+.++++.|.
T Consensus       209 ---~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         209 ---NNHEVYDQIT-AGYRMPCPAKC-----PQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             ---CHHHHHHHHH-hCCcCCCCCCC-----CHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               2333434333 23333444332     347899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.9e-40  Score=319.86  Aligned_cols=273  Identities=20%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+|++.+.||+|+||.||+|+.  .++.||+|.+.....  ......+|+.++++++|+||+++++++...+    .++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   80 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK----SLT   80 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC----eEE
Confidence            46799999999999999999988  467899999864432  2234567889999999999999999988765    458


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++ +|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-----------~ivH~dlkp~Nill~~~~~~kl~Df  148 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-----------KVLHRDLKPQNLLINERGELKLADF  148 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCCEEECcc
Confidence            99999985 88888843  3488999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------C
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------R  335 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------~  335 (461)
                      |+++......  .......++..|+|||++.+.    ..++.++|||||||++|||++|..||.......         .
T Consensus       149 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  222 (309)
T cd07872         149 GLARAKSVPT--KTYSNEVVTLWYRPPDVLLGS----SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG  222 (309)
T ss_pred             ccceecCCCc--cccccccccccccCCHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9997654322  112334678999999998653    356788999999999999999965553221100         0


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .|............... ........+..... .....+.++.+||.+||..||++|||+.|+++|.+....
T Consensus       223 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         223 TPTEETWPGISSNDEFK-NYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             CCCHHHHhhhcchhhhh-hhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            00000000000000000 00000000000000 001133478899999999999999999999999887543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.8e-40  Score=310.72  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=199.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|..  +++.|++|.+....   ........|+.+++.++||||+++++++....    .+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG----KLNI   76 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC----EEEE
Confidence            478899999999999999998  47889999986432   33344567888899999999999999988764    4599


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||+++++|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-----------~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-----------KILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCcceEEEeCCCCEEEccc
Confidence            9999999999999854   4688999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.+.....  ......|+..|+|||++.+.     .++.++||||||+++|||++|           ..||...   
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~~---  204 (256)
T cd08529         146 GVAKLLSDNTN--FANTIVGTPYYLSPELCEDK-----PYNEKSDVWALGVVLYECCTG-----------KHPFDAN---  204 (256)
T ss_pred             ccceeccCccc--hhhccccCccccCHHHhcCC-----CCCCccchHHHHHHHHHHHhC-----------CCCCCCC---
Confidence            99987654332  22334688999999998763     567889999999999999999           5666433   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ........+... ..+.++...     +..+.+++.+||+.+|++||++.+++++.+
T Consensus       205 --~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         205 --NQGALILKIIRG-VFPPVSQMY-----SQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             --CHHHHHHHHHcC-CCCCCcccc-----CHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence              223333333332 233344322     247899999999999999999999998753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.9e-41  Score=317.36  Aligned_cols=253  Identities=27%  Similarity=0.446  Sum_probs=196.9

Q ss_pred             eeEEeEeecCCceEEEEEEECC--CcEEEEEEecCChhhhHH---HHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQSWQS---EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~---~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |++.+.||+|+||+||+++..+  +.||+|.+..........   .+|+..+.+++|+||+++++++....    ..++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN----YLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS----EEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc----ccccc
Confidence            7899999999999999999954  569999998766544433   34888888999999999999998854    45899


Q ss_pred             ehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        189 TAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       189 ~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |||+++++|.+++. ...+++..+..++.|+++||+|||+.           +|+|+||||+|||++.++.++|+|||.+
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~-----------~i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK-----------GIVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT-----------TEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-----------cccccccccccccccccccccccccccc
Confidence            99999999999997 67899999999999999999999999           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      .......  .......++..|+|||++...    ...+.++||||+|+++|+|++|           ..||...  ....
T Consensus       146 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~~-----------~~p~~~~--~~~~  206 (260)
T PF00069_consen  146 VKLSENN--ENFNPFVGTPEYMAPEVLQQG----KKYTRKSDIWSLGIILYELLTG-----------KLPFEES--NSDD  206 (260)
T ss_dssp             EESTSTT--SEBSSSSSSGGGSCHHHHTTT----SSBSTHHHHHHHHHHHHHHHHS-----------SSSSTTS--SHHH
T ss_pred             ccccccc--ccccccccccccccccccccc----cccccccccccccccccccccc-----------ccccccc--cchh
Confidence            7642111  234456789999999998721    4677899999999999999999           5555432  0001


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ...................   .......+.++|.+||+.||++|||+.+++++.|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  207 QLEIIEKILKRPLPSSSQQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             HHHHHHHHHHTHHHHHTTS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             hhhhhhhcccccccccccc---cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence            1111111111110000000   0111258999999999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.7e-40  Score=310.95  Aligned_cols=243  Identities=26%  Similarity=0.362  Sum_probs=188.9

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      +.||+|+||.||+|+.  +++.||+|.+....  .....+.+|+.+++.++|+||+++++++.....    +++||||++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC----eEEEEeecc
Confidence            4689999999999988  57889999875432  223445778888999999999999999887653    489999999


Q ss_pred             CCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccC
Q psy17532        194 RGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       194 ~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~  271 (461)
                      +|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||++....
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK-----------HCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccccccchheEEEcCCCcEEECccccCcccc
Confidence            9999999954  3589999999999999999999998           99999999999999999999999999997654


Q ss_pred             CCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      ............++..|+|||.+.+.     .++.++||||||+++|||++ |           ..||...     ....
T Consensus       146 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~e~~~~~-----------~~p~~~~-----~~~~  204 (252)
T cd05084         146 DGVYASTGGMKQIPVKWTAPEALNYG-----RYSSESDVWSFGILLWEAFSLG-----------AVPYANL-----SNQQ  204 (252)
T ss_pred             cccccccCCCCCCceeecCchhhcCC-----CCChHHHHHHHHHHHHHHHhCC-----------CCCcccc-----CHHH
Confidence            32211111112335679999998663     56788999999999999998 6           5555432     2223


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ....+. ...+...+..+     +..+.+++.+||+.||++|||+.++++.+
T Consensus       205 ~~~~~~-~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~~~~~l  250 (252)
T cd05084         205 TREAIE-QGVRLPCPELC-----PDAVYRLMERCWEYDPGQRPSFSTVHQEL  250 (252)
T ss_pred             HHHHHH-cCCCCCCcccC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            323222 22333344333     34789999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8e-40  Score=318.02  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=195.1

Q ss_pred             cceeEEeEeecCCceEEEEEEECC--C--cEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFKN--E--NVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~~--~--~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ++|++.++||+|+||.||+|..+.  .  .+|+|.++...  .....+.+|+.++.++ +||||+++++++....    .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----Y   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC----c
Confidence            578999999999999999998843  2  47888876322  2233456788888888 7999999999987755    3


Q ss_pred             eeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCC
Q psy17532        185 FWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK  247 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLk  247 (461)
                      +++++||+++|+|.+++...                 .+++..+..++.|++.||+|||+.           +|+|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-----------~ivH~dlk  146 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-----------QFIHRDLA  146 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCcCC
Confidence            48999999999999998532                 378889999999999999999998           99999999


Q ss_pred             CCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCC
Q psy17532        248 SNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSS  326 (461)
Q Consensus       248 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~  326 (461)
                      |+|||++.++.+||+|||++.......   .......+..|+|||++.+     ..++.++|||||||++|||++ |   
T Consensus       147 p~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~t~g---  215 (297)
T cd05089         147 ARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNY-----SVYTTKSDVWSFGVLLWEIVSLG---  215 (297)
T ss_pred             cceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhcc-----CCCCchhhHHHHHHHHHHHHcCC---
Confidence            999999999999999999986432211   1112233567999998865     356789999999999999998 7   


Q ss_pred             CCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                              ..||...     ...+....+.. ...+..+..++     ..+.+|+.+||+.||.+||+++++++.+..+.
T Consensus       216 --------~~pf~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         216 --------GTPYCGM-----TCAELYEKLPQ-GYRMEKPRNCD-----DEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             --------CCCCCCC-----CHHHHHHHHhc-CCCCCCCCCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    5566443     33344444332 23333443333     37899999999999999999999999987665


Q ss_pred             h
Q psy17532        407 C  407 (461)
Q Consensus       407 ~  407 (461)
                      .
T Consensus       277 ~  277 (297)
T cd05089         277 E  277 (297)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-39  Score=319.82  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=199.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC---------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      ....+|.+.+.||+|+||.||+|+..         ...||+|.+.....  .......|+.++.++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34568999999999999999999752         34599998764322  223456788888888 6999999999987


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCC
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP  239 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~  239 (461)
                      ...    .++++|||+++|+|.+++..                 ..+++..+..++.|++.||.|||+.           
T Consensus        89 ~~~----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-----------  153 (314)
T cd05099          89 QEG----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-----------  153 (314)
T ss_pred             cCC----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-----------
Confidence            654    35899999999999999843                 2478899999999999999999998           


Q ss_pred             CeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHH
Q psy17532        240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE  319 (461)
Q Consensus       240 ~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~e  319 (461)
                      +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+     ..++.++||||||+++||
T Consensus       154 gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~e  228 (314)
T cd05099         154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGILMWE  228 (314)
T ss_pred             CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-----CCcCccchhhHHHHHHHH
Confidence            999999999999999999999999999987654322122222344568999999865     357788999999999999


Q ss_pred             HHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       320 l~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      |++++          ..||...     ...+....+... .....+..+     +.++.+++.+||+.||++|||+.+++
T Consensus       229 l~~~g----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~~-----~~~l~~li~~cl~~~p~~Rps~~~ll  287 (314)
T cd05099         229 IFTLG----------GSPYPGI-----PVEELFKLLREG-HRMDKPSNC-----THELYMLMRECWHAVPTQRPTFKQLV  287 (314)
T ss_pred             HHhCC----------CCCCCCC-----CHHHHHHHHHcC-CCCCCCCCC-----CHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            99932          5566433     334444444332 223333332     23788999999999999999999999


Q ss_pred             hhcHHHhh
Q psy17532        400 ERGMLALC  407 (461)
Q Consensus       400 ~~l~~~~~  407 (461)
                      +.+..+..
T Consensus       288 ~~l~~~~~  295 (314)
T cd05099         288 EALDKVLA  295 (314)
T ss_pred             HHHHHHHH
Confidence            98876653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.6e-40  Score=315.89  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=197.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc--ccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES--IHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~--~~~~  184 (461)
                      ..+.|++.+.||+|+||.||+|+.  .++.||+|.+..........+.|+.++.++ +|+||+++++++.....  ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            446899999999999999999998  467899999876554445567788877777 79999999999864321  1346


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ++++|||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.++|
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-----------~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-----------KVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEE
Confidence            7999999999999999854   3588888999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++.......  .......|+..|+|||++.........++.++|||||||++|||++|.           .||...
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~-----------~p~~~~  229 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA-----------PPLCDM  229 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC-----------CCcccc
Confidence            9999987654321  122345688999999988643222346778899999999999999994           454322


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .    ...... .+..... +.+.    ....+..+.+||.+||..||.+||++.+++++.+
T Consensus       230 ~----~~~~~~-~~~~~~~-~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         230 H----PMRALF-LIPRNPP-PKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             C----HHhhhh-hHhhCCC-CCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            1    111111 1111111 1111    1123348999999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.2e-40  Score=331.12  Aligned_cols=277  Identities=23%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-cceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~~  186 (461)
                      +|++.+.||+|+||.||+|..  +++.||||.+....   .......+|+.++..++|+||+++++++..... .....+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999997  57889999885432   122345678999999999999999999876541 112568


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+. ++|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA-----------GILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCChHHEEECCCCCEEecccc
Confidence            9999997 58888774 45699999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++....... .......++..|+|||++.+.    ..++.++|||||||++|||++|+.||..................
T Consensus       149 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         149 LARVEEPDES-KHMTQEVVTQYYRAPEILMGS----RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             ceeecccCcc-ccCCCCCcCCCcCCHHHHcCC----CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9987543321 122334678999999998763    34678899999999999999996555432210000000000011


Q ss_pred             CCHHHHH-------HHHhccCCCCC-CCchh-ccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQ-------EAVVHKKLRPT-LPETW-KQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~-------~~~~~~~~~~~-~p~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      +..+++.       ..+......+. .+..+ .....++++.+||.+||+.||++|||+.++++|.+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence            1111111       11111111111 10000 00112457899999999999999999999999987654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.4e-40  Score=318.11  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC------------------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN------------------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNIL  169 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------------------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv  169 (461)
                      ...+|++.+.||+|+||.||+|+..+                  ..||+|.+.....  ......+|+.++.+++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            34689999999999999999998742                  3489999865432  234456789999999999999


Q ss_pred             EEEEEEecCCccceeeeeeehhccCCChhhhhcCC------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       170 ~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      ++++++....    .++++|||+++++|.+++...            .+++..+..++.|++.||+|||+.         
T Consensus        83 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---------  149 (296)
T cd05051          83 RLLGVCTVDP----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---------  149 (296)
T ss_pred             EEEEEEecCC----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---------
Confidence            9999998765    348999999999999998543            488999999999999999999998         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +|+||||||+|||++.++.++|+|||+++...............++..|+|||++.+.     .++.++|||||||++
T Consensus       150 --~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l  222 (296)
T cd05051         150 --NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-----KFTTKSDVWAFGVTL  222 (296)
T ss_pred             --CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-----CCCccchhhhhHHHH
Confidence              9999999999999999999999999999876543322223344567899999998653     577889999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhcc----CCCCCCCchhccchhHHHHHHHHHHHccccHhhhc
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHK----KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      |||+++..         ..||...     ...+........    ......+..   ...+.++.+++.+||+.||++||
T Consensus       223 ~el~~~~~---------~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp  285 (296)
T cd05051         223 WEILTLCR---------EQPYEHL-----TDQQVIENAGHFFRDDGRQIYLPRP---PNCPKDIYELMLECWRRDEEDRP  285 (296)
T ss_pred             HHHHhcCC---------CCCCCCc-----ChHHHHHHHHhccccccccccCCCc---cCCCHHHHHHHHHHhccChhcCC
Confidence            99998421         3455332     222222222211    111111110   11234899999999999999999


Q ss_pred             cccchhhhcH
Q psy17532        394 SASCVVERGM  403 (461)
Q Consensus       394 s~~evl~~l~  403 (461)
                      |+.++++.|.
T Consensus       286 t~~el~~~L~  295 (296)
T cd05051         286 TFREIHLFLQ  295 (296)
T ss_pred             CHHHHHHHhc
Confidence            9999988763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-39  Score=314.18  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc-cceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES-IHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~-~~~~~  185 (461)
                      ..++|++.+.||+|+||.||++..  .++.+|+|.+..........+.|+.++.++ +||||+++++++...+. ....+
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            467899999999999999999998  467899999865444444556788888888 89999999999876432 12357


Q ss_pred             eeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++||||+++|+|.++++     ...+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+|
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-----------RIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHEEEcCCCCEE
Confidence            99999999999999874     34689999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++.......  ......|+..|+|||++.........++.++|||||||++|||++|           +.||..
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g-----------~~p~~~  235 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG-----------DPPLFD  235 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC-----------CCCCCC
Confidence            999999987654321  1223468899999999865422223467899999999999999999           455543


Q ss_pred             ccCCCCCHHHHHHHHhccC-CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        341 EVGDHPSLEDMQEAVVHKK-LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .     ........+.... .....++.     ....+.++|.+||+.||++||++.++++|.+
T Consensus       236 ~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         236 M-----HPVKTLFKIPRNPPPTLLHPEK-----WCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             C-----cHHHHHHHHhcCCCCCCCcccc-----cCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence            2     1111111121111 11111222     2237899999999999999999999999865

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.4e-40  Score=326.86  Aligned_cols=274  Identities=21%  Similarity=0.274  Sum_probs=195.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|++.+.||+|+||.||++..  .++.||||.+....   .......+|+.+++.++||||+++++++......  .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999987  47889999986432   2223445788889999999999999988654321  2


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+++||||+++ +|.+++.. .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~-----------givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCChHHEEECCCCCEEEe
Confidence            346899999975 77777753 588899999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC---------
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------  333 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~---------  333 (461)
                      |||+++......   ......||..|+|||++.+     ..++.++|||||||++|||++|..||......         
T Consensus       162 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (355)
T cd07874         162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_pred             eCcccccCCCcc---ccCCccccCCccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999998654322   2234578999999999876     35778899999999999999996555322100         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhcc-C-CCCCCCchhc----------cchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHK-K-LRPTLPETWK----------QHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~-~-~~~~~p~~~~----------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      ...|.......  ........+... . ....++..++          .......+.+||.+||..||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         234 LGTPCPEFMKK--LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hCCCCHHHHHh--hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000000000  000000000000 0 0000010000          01123478999999999999999999999999


Q ss_pred             cHHHh
Q psy17532        402 GMLAL  406 (461)
Q Consensus       402 l~~~~  406 (461)
                      .+...
T Consensus       312 p~~~~  316 (355)
T cd07874         312 PYINV  316 (355)
T ss_pred             cchhc
Confidence            87643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4e-40  Score=340.03  Aligned_cols=272  Identities=19%  Similarity=0.218  Sum_probs=187.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC------CCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM------EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l------~H~nIv~l~g~~~~~~~~  181 (461)
                      ..++|++.+.||+|+||+||+|..  .++.||||++............|+.++..+      +|.+|+++++++....  
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~--  204 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET--  204 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC--
Confidence            346899999999999999999988  467899999864333222333444444333      4667999999887643  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCC--
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDL--  257 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~--  257 (461)
                       ..+++|||++ +++|.+++. ...+++..+..++.||+.||+|||+ .           +||||||||+|||++.++  
T Consensus       205 -~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        205 -GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL-----------HLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             -ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------CeecCCCCHHHEEEecCCcc
Confidence             3568999988 678988884 4579999999999999999999997 5           899999999999998765  


Q ss_pred             --------------ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        258 --------------TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       258 --------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                                    .+||+|||++.....     ......||+.|+|||++.+     ..++.++|||||||++|||++|
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLG-----LGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhc-----CCCCcHHHHHHHHHHHHHHHhC
Confidence                          499999998864321     2334679999999999976     3677899999999999999999


Q ss_pred             CCCCCCCCCCCC--------CCCccccCCCCCHHHHHHHH-hccCCCCCCCch----------hccchhHHHHHHHHHHH
Q psy17532        324 CSSVSPPPGEYR--------LPFSAEVGDHPSLEDMQEAV-VHKKLRPTLPET----------WKQHAGMLALCDTMEEC  384 (461)
Q Consensus       324 ~~~~~~~~~~~~--------~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~p~~----------~~~~~~~~~l~~li~~c  384 (461)
                      +.||........        .++...........+..... ....+++.....          +........+.+||.+|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            666543221000        00000000000000000000 000001100000          00011234678999999


Q ss_pred             ccccHhhhccccchhhhcHHHh
Q psy17532        385 WDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       385 l~~dP~~Rps~~evl~~l~~~~  406 (461)
                      |.+||++|||+.|+++|.+...
T Consensus       422 L~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCcChhhCCCHHHHhcCccccc
Confidence            9999999999999999998765

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-39  Score=314.93  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=194.8

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .|+..+.||+|+||.||++...  ++.||||.+......    ......|+.++.+++|+||+.+++.+.+.+    .++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   76 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC----EEE
Confidence            3778899999999999999984  678999998643221    223456888999999999999999988765    459


Q ss_pred             eeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.++|+|
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~iiH~dikp~Nil~~~~~~~~l~D  145 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-----------RIVYRDLKPENILLDDHGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEeCCCCHHHEEECCCCCEEEee
Confidence            99999999999998842   3589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++........   .....|+..|+|||++.+.     .++.++||||||+++|||++|           ..||.....
T Consensus       146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g-----------~~Pf~~~~~  206 (285)
T cd05630         146 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE-----RYTFSPDWWALGCLLYEMIAG-----------QSPFQQRKK  206 (285)
T ss_pred             ccceeecCCCcc---ccCCCCCccccChHHHcCC-----CCCCccccHHHHHHHHHHHhC-----------CCCCCCCCc
Confidence            999976543321   2235789999999998763     577889999999999999999           455543211


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~  406 (461)
                        ............ .....++..+     +..+.+|+.+||+.||++|||     +.++++|.+...
T Consensus       207 --~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         207 --KIKREEVERLVK-EVQEEYSEKF-----SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             --cchHHHHHhhhh-hhhhhcCccC-----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence              011111111111 1111222222     237899999999999999999     889999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.3e-40  Score=319.28  Aligned_cols=254  Identities=25%  Similarity=0.351  Sum_probs=194.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CC--cEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NE--NVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~--~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      ...++|++.+.||+|+||.||+|.++  +.  .+|+|.+....  .....+.+|+.++.++ +|+||+++++++...+. 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~-   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC-
Confidence            45678999999999999999999974  33  35777765322  2223456788888898 89999999999887653 


Q ss_pred             ceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecc
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR  244 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHr  244 (461)
                         +++||||+++|+|.++++..                 .+++..++.++.|++.||+|||+.           +|+||
T Consensus        83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-----------gi~H~  148 (303)
T cd05088          83 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-----------QFIHR  148 (303)
T ss_pred             ---ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-----------Ccccc
Confidence               49999999999999998532                 478899999999999999999998           99999


Q ss_pred             cCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-C
Q psy17532        245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-R  323 (461)
Q Consensus       245 DLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g  323 (461)
                      ||||+|||++.++.+||+|||+++.....   .......++..|+|||++.+     ..++.++|||||||++|||+| |
T Consensus       149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g  220 (303)
T cd05088         149 DLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLG  220 (303)
T ss_pred             ccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhc-----cCCcccccchhhhhHHHHHHhcC
Confidence            99999999999999999999998643211   11122234678999998865     356788999999999999998 7


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       324 ~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                 ..||...     ...+....+. ...+...+..     .+..+.+|+.+||+.||++||++++++..+.
T Consensus       221 -----------~~p~~~~-----~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         221 -----------GTPYCGM-----TCAELYEKLP-QGYRLEKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             -----------CCCcccC-----ChHHHHHHHh-cCCcCCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                       5565432     2233333332 2222223322     2347899999999999999999999999987


Q ss_pred             HHhh
Q psy17532        404 LALC  407 (461)
Q Consensus       404 ~~~~  407 (461)
                      .+..
T Consensus       279 ~~~~  282 (303)
T cd05088         279 RMLE  282 (303)
T ss_pred             HHHH
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-40  Score=319.15  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=193.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEECC----------------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEE
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKN----------------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYI  172 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~----------------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~  172 (461)
                      .++|++.+.||+|+||.||+++..+                ..||||.+.....  ....+.+|+.++.+++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999987632                2489998864322  223456899999999999999999


Q ss_pred             EEEecCCccceeeeeeehhccCCChhhhhcCC-------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCC
Q psy17532        173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN-------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP  239 (461)
Q Consensus       173 g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~  239 (461)
                      +++.....    .++||||+++++|.+++...             .+++..++.++.|++.||.|||+.           
T Consensus        84 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-----------  148 (295)
T cd05097          84 GVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-----------  148 (295)
T ss_pred             EEEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-----------
Confidence            99987654    48999999999999998532             367888999999999999999998           


Q ss_pred             CeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHH
Q psy17532        240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE  319 (461)
Q Consensus       240 ~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~e  319 (461)
                      +++||||||+|||++.++.+||+|||++..+.............++..|+|||++.+     ..++.++||||||+++||
T Consensus       149 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~~l~e  223 (295)
T cd05097         149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-----GKFTTASDVWAFGVTLWE  223 (295)
T ss_pred             CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-----CCcCchhhHHHHHHHHHH
Confidence            999999999999999999999999999976644332222233456788999998865     357789999999999999


Q ss_pred             HHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHh---ccC---CCCCCCchhccchhHHHHHHHHHHHccccHhhhc
Q psy17532        320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV---HKK---LRPTLPETWKQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       320 l~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~---~~~---~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      |+++..         ..||...     ...+....+.   ...   .....+..     .+..+.+|+.+||+.||++||
T Consensus       224 l~~~~~---------~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~RP  284 (295)
T cd05097         224 MFTLCK---------EQPYSLL-----SDEQVIENTGEFFRNQGRQIYLSQTPL-----CPSPVFKLMMRCWSRDIKDRP  284 (295)
T ss_pred             HHHcCC---------CCCCccc-----ChHHHHHHHHHhhhhccccccCCCCCC-----CCHHHHHHHHHHcCCCchhCc
Confidence            998421         3455432     2222222111   111   11111111     234899999999999999999


Q ss_pred             cccchhhhcH
Q psy17532        394 SASCVVERGM  403 (461)
Q Consensus       394 s~~evl~~l~  403 (461)
                      |++++++.|.
T Consensus       285 s~~~i~~~l~  294 (295)
T cd05097         285 TFNKIHHFLR  294 (295)
T ss_pred             CHHHHHHHHh
Confidence            9999988763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.7e-40  Score=315.35  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=196.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..++|.+.+.||+|+||.||++..       .+..+|+|.+..... ....+.+|+..+..++|+||+++++++..... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   81 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP-   81 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc-
Confidence            456889999999999999999974       245689998764432 23456788999999999999999999887653 


Q ss_pred             ceeeeeeehhccCCChhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeeccc
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRD  245 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrD  245 (461)
                         .+++|||+++|+|.+++...                .+++..+..++.|++.||+|||+.           +|+|||
T Consensus        82 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-----------~i~H~d  147 (280)
T cd05092          82 ---LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-----------HFVHRD  147 (280)
T ss_pred             ---eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-----------Ceeccc
Confidence               48999999999999998542                478899999999999999999998           999999


Q ss_pred             CCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CC
Q psy17532        246 FKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RC  324 (461)
Q Consensus       246 Lkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~  324 (461)
                      |||+|||+++++.+||+|||+++...............+++.|+|||++.+.     .++.++|||||||++|||++ | 
T Consensus       148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g-  221 (280)
T cd05092         148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-----KFTTESDIWSFGVVLWEIFTYG-  221 (280)
T ss_pred             ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-----CcCchhhHHHHHHHHHHHHcCC-
Confidence            9999999999999999999999765433221222233457889999988763     57788999999999999998 6 


Q ss_pred             CCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       325 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                ..||...     ...+....+... .....+...     +..+.+++.+||+.||++||++.++++.+.
T Consensus       222 ----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         222 ----------KQPWYQL-----SNTEAIECITQG-RELERPRTC-----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----------CCCCccC-----CHHHHHHHHHcC-ccCCCCCCC-----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                      5555432     222333333322 222233322     247899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-39  Score=315.25  Aligned_cols=256  Identities=22%  Similarity=0.345  Sum_probs=197.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      ....+|++.+.||+|+||.||+|..+       +..||+|.+.....  ......+|+..++.++|+||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34578999999999999999999763       24699998764332  2233457888899999999999999987765


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      .    .++||||+++|+|.++++.           ..+++..+..++.|++.||.|||+.           +|+||||||
T Consensus        83 ~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~i~H~dikp  147 (288)
T cd05061          83 P----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-----------KFVHRDLAA  147 (288)
T ss_pred             C----cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CCcCCCCCh
Confidence            3    4999999999999999953           2346778899999999999999998           999999999


Q ss_pred             CcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q psy17532        249 NNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVS  328 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~  328 (461)
                      +|||++.++.+||+|||+++...............++..|+|||.+.+.     .++.++|||||||++|||++++    
T Consensus       148 ~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-----~~~~~~DvwslG~~l~el~~~~----  218 (288)
T cd05061         148 RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-----VFTTSSDMWSFGVVLWEITSLA----  218 (288)
T ss_pred             heEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-----CCChHhHHHHHHHHHHHHHhCC----
Confidence            9999999999999999999866443322222223457789999998753     5678899999999999999842    


Q ss_pred             CCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        329 PPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       329 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                            ..||...     ..++....+..... +..+...     +..+.+++.+||+.||++|||+.++++.+...
T Consensus       219 ------~~p~~~~-----~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         219 ------EQPYQGL-----SNEQVLKFVMDGGY-LDQPDNC-----PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ------CCCCCCC-----CHHHHHHHHHcCCC-CCCCCCC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                  4566432     33444444443322 2233322     24799999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.9e-40  Score=310.76  Aligned_cols=242  Identities=24%  Similarity=0.351  Sum_probs=190.0

Q ss_pred             EeecCCceEEEEEEE----CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        119 VKAQGRFGAVWKAKF----KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      .||+|+||.||+|.+    ++..+|+|++......   ......|+.++..++|+||+++++++...     .+++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcEEEEec
Confidence            589999999999976    3577999998644322   23456788889999999999999987543     34899999


Q ss_pred             ccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        192 HERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       192 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      +++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET-----------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            999999999954 4689999999999999999999998           9999999999999999999999999999876


Q ss_pred             CCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        271 EPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       271 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      ....... ......++..|+|||.+.+     ..++.++||||||+++|||++ |           ..||...     ..
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g-----------~~p~~~~-----~~  204 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNY-----YKFSSKSDVWSFGVLMWEAFSYG-----------QKPYKGM-----KG  204 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhcc-----CCcCchhHHHHHHHHHHHHHhCC-----------CCCCCCC-----CH
Confidence            5433211 1222345678999998865     356678999999999999998 7           5666543     22


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ......+.. ...+..|..++     .++.++|.+||+.||++||++++|.+.|.
T Consensus       205 ~~~~~~i~~-~~~~~~~~~~~-----~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         205 NEVTQMIES-GERMECPQRCP-----PEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             HHHHHHHHC-CCCCCCCCCCC-----HHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence            333344333 33344554333     47999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=327.63  Aligned_cols=243  Identities=23%  Similarity=0.306  Sum_probs=186.4

Q ss_pred             eecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCC---CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        120 KAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHM---EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       120 lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l---~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ||+|+||.||+|+.  .++.||||++.....    .......|..++...   +||||+++++++....    .+++|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----~~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----DLYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC----eEEEEEc
Confidence            69999999999998  478899999864321    111222344443333   7999999999988765    4599999


Q ss_pred             hccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++. ...+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~-----------~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY-----------DIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             CCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            999999999885 45689999999999999999999999           999999999999999999999999999976


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      .....  .......||..|+|||++.+.    ..++.++|||||||++|||++|           ..||...     ...
T Consensus       146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~elltG-----------~~Pf~~~-----~~~  203 (330)
T cd05586         146 NLTDN--KTTNTFCGTTEYLAPEVLLDE----KGYTKHVDFWSLGVLVFEMCCG-----------WSPFYAE-----DTQ  203 (330)
T ss_pred             CCCCC--CCccCccCCccccCHHHHcCC----CCCCCccceeccccEEEEeccC-----------CCCCCCC-----CHH
Confidence            43322  123345799999999998653    3467889999999999999999           5566443     334


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc----cccchhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL----SASCVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~l~~~  405 (461)
                      ++...+.....+  ++..    ..+..+.+++.+||+.||++||    ++.++++|.+..
T Consensus       204 ~~~~~i~~~~~~--~~~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         204 QMYRNIAFGKVR--FPKN----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             HHHHHHHcCCCC--CCCc----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence            444444443332  2221    1234788999999999999998    567777777654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0574|consensus

Probab=100.00  E-value=2.1e-42  Score=314.47  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...-|.++++||+|+||.||+|.+  .|+.||||.+.... +.....+||.+|.+.+.+++|++||.+....    .+|+
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s----DLWI  105 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS----DLWI  105 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCC----ceEe
Confidence            345688899999999999999988  58899999986543 3345678999999999999999999776543    5699


Q ss_pred             eehhccCCChhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||||..|++.+.+  ++.++++.++..++++.++||+|||..           .-+|||||+.|||++.+|.+||+|||
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~-----------~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL-----------KKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH-----------HHHHhhcccccEEEcccchhhhhhcc
Confidence            99999999999988  567899999999999999999999998           77999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      .|..+.+..  .......||+.|||||++..-     .|+.++||||||++..||..|++||..-.+ ++.-|..-    
T Consensus       175 VAGQLTDTM--AKRNTVIGTPFWMAPEVI~EI-----GY~~~ADIWSLGITaIEMAEG~PPYsDIHP-MRAIFMIP----  242 (502)
T KOG0574|consen  175 VAGQLTDTM--AKRNTVIGTPFWMAPEVIEEI-----GYDTKADIWSLGITAIEMAEGRPPYSDIHP-MRAIFMIP----  242 (502)
T ss_pred             ccchhhhhH--HhhCccccCcccccHHHHHHh-----ccchhhhHhhhcchhhhhhcCCCCcccccc-cceeEecc----
Confidence            998776433  345667899999999999763     677899999999999999999666543211 11111110    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                                ........-|+.|+.     ++.+++++||.+.|++|-||.++++|.+.
T Consensus       243 ----------T~PPPTF~KPE~WS~-----~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi  286 (502)
T KOG0574|consen  243 ----------TKPPPTFKKPEEWSS-----EFNDFIRSCLIKKPEERKTALRLCEHTFI  286 (502)
T ss_pred             ----------CCCCCCCCChHhhhh-----HHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence                      001111123566665     89999999999999999999999998764

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-40  Score=312.66  Aligned_cols=260  Identities=26%  Similarity=0.370  Sum_probs=202.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc--cceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES--IHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~--~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|..+  ++.+|+|.+.........+.+|+.+++++ +|+||+++++++.....  ....+
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            478999999999999999999984  57899999876665556677889888888 79999999999876552  23457


Q ss_pred             eeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++||||+++++|.+++.     ...+++..+..++.|++.||.|||+.           +++|+||+|+||+++.++.+|
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-----------~i~H~~l~p~ni~~~~~~~~~  153 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-----------KVIHRDIKGQNILLTKNAEVK  153 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----------CcccCCCCHHHEEEccCCeEE
Confidence            99999999999999884     24689999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++.......  .......|+..|+|||++.........++.++||||||+++|||++|           ..||..
T Consensus       154 l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g-----------~~p~~~  220 (275)
T cd06608         154 LVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG-----------KPPLCD  220 (275)
T ss_pred             ECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC-----------CCCccc
Confidence            99999997654332  12234568899999999865433345677899999999999999999           555542


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .     ........+... ..+.+...   ...+..+.+||.+||..||++|||+.+++++.|
T Consensus       221 ~-----~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         221 M-----HPMRALFKIPRN-PPPTLKSP---ENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             c-----chHHHHHHhhcc-CCCCCCch---hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence            2     111111122111 11111110   112347899999999999999999999998864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.4e-40  Score=329.85  Aligned_cols=271  Identities=20%  Similarity=0.241  Sum_probs=199.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC----CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+|++.+.||+|+||.||++...    +..||||.+...    ....+|+.++++++|||||++++++....    .++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKS----TVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCC----EEE
Confidence            457999999999999999999864    356999987542    23457888999999999999999987654    458


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++||++. ++|.+++. ...+++..++.++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~-----------givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR-----------GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEEcCCCCEEEccCc
Confidence            9999996 68999884 45699999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC-----------
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-----------  334 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~-----------  334 (461)
                      +++.+.............||..|+|||++.+.     .++.++|||||||++|||++|+.||.+.....           
T Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        231 AACKLDAHPDTPQCYGWSGTLETNSPELLALD-----PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             cccccCcccccccccccccccCccCHhHhcCC-----CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            99876544322233346799999999998763     67788999999999999999977665432110           


Q ss_pred             --CCCCccccCCCCCHHHHHHHHhccCCCC--CCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 --RLPFSAEVGDHPSLEDMQEAVVHKKLRP--TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                        ..|.................. ....++  .++..........++.++|.+||..||++|||+.+++.|.++...
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hccCccccCCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence              000000000000000000000 011111  112211112234578899999999999999999999999987653

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-39  Score=310.84  Aligned_cols=249  Identities=26%  Similarity=0.425  Sum_probs=197.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .++|++.+.||+|+||.||+|... +..||+|.+...........+|+.++++++|+||+++++++...     ..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE-----PIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCC-----CcEEEE
Confidence            457899999999999999999874 56799999876554445667899999999999999999987542     348999


Q ss_pred             hhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        190 AYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       190 e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+||++++++.+||+|||+
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-----------~i~H~di~p~Nili~~~~~~~l~dfg~  148 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-----------NYIHRDLRSANILVGDGLVCKIADFGL  148 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCccceEEEeCCceEEeCCcee
Confidence            99999999999854   3489999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +..+..... .......++..|+|||.+.+     ..++.++||||||+++|||++ |           ..||...    
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~g-----------~~p~~~~----  207 (260)
T cd05070         149 ARLIEDNEY-TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKG-----------RVPYPGM----  207 (260)
T ss_pred             eeeccCccc-ccccCCCCCccccChHHHhc-----CCCcchhhhHHHHHHHHHHHhcC-----------CCCCCCC----
Confidence            987654321 11223345678999998865     367789999999999999999 6           5566443    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                       ...+....+.. ...+..+..     .+..+.+|+.+||..||++|||+.++.+.|.
T Consensus       208 -~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         208 -NNREVLEQVER-GYRMPCPQD-----CPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             -CHHHHHHHHHc-CCCCCCCCc-----CCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence             23333333332 223333332     2347999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=349.26  Aligned_cols=265  Identities=22%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ......+|++++.||+|+||.||+|+..  +..||+|.+....   .....+..|+.++..++|||||++++++..... 
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~-   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN-   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC-
Confidence            3445678999999999999999999984  5679999886432   223445679999999999999999998865432 


Q ss_pred             ceeeeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-  255 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-  255 (461)
                       ..+||||||+++|+|.++|..     ..+++..++.|+.||+.||.|||+...    .....+||||||||+||||+. 
T Consensus        87 -~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~----~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         87 -QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD----GPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhccc----ccccCCceeccCcHHHeEeecC
Confidence             356999999999999999853     469999999999999999999998510    000126999999999999964 


Q ss_pred             ----------------CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHH
Q psy17532        256 ----------------DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE  319 (461)
Q Consensus       256 ----------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~e  319 (461)
                                      .+.+||+|||+++.+....   ......||+.|+|||++.+.   ...++.++|||||||||||
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge---~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHE---TKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhcc---CCCCCchhHHHHHHHHHHH
Confidence                            3458999999998764332   22345789999999998653   1356789999999999999


Q ss_pred             HHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       320 l~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      |++|           ..||...    .....+...+...   +.++.    ...+..+.+||..||..+|++||++.+++
T Consensus       236 LLTG-----------k~PF~~~----~~~~qli~~lk~~---p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL  293 (1021)
T PTZ00266        236 LCSG-----------KTPFHKA----NNFSQLISELKRG---PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCL  293 (1021)
T ss_pred             HHHC-----------CCCCCcC----CcHHHHHHHHhcC---CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence            9999           5565432    1233333333221   12221    11234799999999999999999999999


Q ss_pred             hhcHHH
Q psy17532        400 ERGMLA  405 (461)
Q Consensus       400 ~~l~~~  405 (461)
                      .+.+..
T Consensus       294 ~h~~ik  299 (1021)
T PTZ00266        294 GYQIIK  299 (1021)
T ss_pred             ccHHHh
Confidence            887654

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-39  Score=333.20  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=193.6

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..|.+.+.||+|+||.||+|.+.  ++.||||....     ....+|+.++++++|+|||++++++....    ..++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~----~~~lv~  239 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGG----LTCLVL  239 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECC----EEEEEE
Confidence            36999999999999999999994  57799996432     22457888999999999999999987765    348999


Q ss_pred             hhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |++. |+|.+++..  ..+++..++.++.|++.||.|||+.           +|+||||||+||||+.++.+||+|||++
T Consensus       240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----------gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE-----------GIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9995 699998854  3699999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC-CCCCCCCCCccccCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP-PPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~-~~~~~~~pf~~~~~~~~  346 (461)
                      +.+.............||..|+|||++.+.     .++.++|||||||++|||++|..++.. .......|+.       
T Consensus       308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~-------  375 (461)
T PHA03211        308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGD-----PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD-------  375 (461)
T ss_pred             eecccccccccccccCCCcCCcCHHHHcCC-----CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcH-------
Confidence            876543221222345799999999999763     677899999999999999998754322 2222222221       


Q ss_pred             CHHHHHHHHhccC-------------------------CCCCC-Cchhcc-chhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        347 SLEDMQEAVVHKK-------------------------LRPTL-PETWKQ-HAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       347 ~~~~~~~~~~~~~-------------------------~~~~~-p~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                        ..+...+....                         .++.. ...|.. ......+.+||.+||..||++|||+.|++
T Consensus       376 --~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL  453 (461)
T PHA03211        376 --AQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL  453 (461)
T ss_pred             --HHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence              11111111100                         01110 011111 01223688999999999999999999999


Q ss_pred             hhcHH
Q psy17532        400 ERGML  404 (461)
Q Consensus       400 ~~l~~  404 (461)
                      +|.++
T Consensus       454 ~hp~f  458 (461)
T PHA03211        454 RLPLF  458 (461)
T ss_pred             hCccc
Confidence            99764

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-39  Score=310.64  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=197.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..+|++.+.||+|+||.||+|+..+ ..||+|.+...........+|+.++..++|+||+++++.+...     ..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----PIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CcEEEE
Confidence            4579999999999999999998844 5799999875444445667889999999999999999987542     248999


Q ss_pred             hhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        190 AYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       190 e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+||++++++.+||+|||+
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-----------~i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-----------NYVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccccCcccEEEcCCCcEEeccCCc
Confidence            99999999999964   3478999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++.+..... .......++..|+|||++.+     ..++.++||||||+++|||++|+          ..||...     
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DvwslG~~l~ellt~g----------~~p~~~~-----  207 (262)
T cd05071         149 ARLIEDNEY-TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKG----------RVPYPGM-----  207 (262)
T ss_pred             eeecccccc-ccccCCcccceecCHhHhcc-----CCCCchhhHHHHHHHHHHHHcCC----------CCCCCCC-----
Confidence            987654322 12223456778999998865     35778899999999999999943          5566433     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ........+... .....+..     .+..+.+++.+||+.||++||+++++++.+..
T Consensus       208 ~~~~~~~~~~~~-~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         208 VNREVLDQVERG-YRMPCPPE-----CPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             ChHHHHHHHhcC-CCCCCccc-----cCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            223333333222 22222222     23478999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.2e-39  Score=361.58  Aligned_cols=256  Identities=24%  Similarity=0.341  Sum_probs=190.4

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..+...++||+|+||.||+|+.  .+..||||.+.....   ..+.|+..+++++|||||+++|++.+...    .++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~----~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKG----AYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCC----CEEEE
Confidence            3566778999999999999997  578899998864322   22356778899999999999999987654    48999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ||+++|+|.++++.  ++|..+.+++.|+|+||+|||..        +.++|+||||||+||+++.++.+++. ||.+..
T Consensus       763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~--------~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCR--------CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccC--------CCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            99999999999964  89999999999999999999954        23499999999999999999988876 666544


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      ...      .....+|..|||||++.+     ..++.++|||||||++|||+||+.||           ....+......
T Consensus       832 ~~~------~~~~~~t~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~el~tg~~p~-----------~~~~~~~~~~~  889 (968)
T PLN00113        832 LCT------DTKCFISSAYVAPETRET-----KDITEKSDIYGFGLILIELLTGKSPA-----------DAEFGVHGSIV  889 (968)
T ss_pred             ccc------CCCccccccccCcccccC-----CCCCcccchhhHHHHHHHHHhCCCCC-----------CcccCCCCcHH
Confidence            321      122368899999999875     36788999999999999999996554           22222222222


Q ss_pred             HHHHHHhc-----cCCCCCCCchhc-cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        350 DMQEAVVH-----KKLRPTLPETWK-QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       350 ~~~~~~~~-----~~~~~~~p~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      +.......     ...++.+..... ......++.+++.+||+.||++|||+.++++.+..+..
T Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            21111110     011111111111 11234578899999999999999999999999876653

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-39  Score=309.17  Aligned_cols=250  Identities=24%  Similarity=0.419  Sum_probs=199.6

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ..++|++.++||+|+||.||+|.. +++.||+|.+...........+|+.++++++|+||+++++++...     .++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE-----PIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccC-----CcEEE
Confidence            346899999999999999999998 467899999876555555677899999999999999999987442     35899


Q ss_pred             ehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +++||||||+||++++++.++|+|||
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-----------~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-----------NYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------CeecccccHHhEEEcCCCCEEEccCc
Confidence            999999999999853   3589999999999999999999988           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      ++........ .......++..|+|||++.+.     .++.++||||||+++|||++ |           ..||...   
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Di~slG~~l~el~~~g-----------~~p~~~~---  207 (260)
T cd05067         148 LARLIEDNEY-TAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSFGILLTEIVTYG-----------RIPYPGM---  207 (260)
T ss_pred             ceeecCCCCc-ccccCCcccccccCHHHhccC-----CcCcccchHHHHHHHHHHHhCC-----------CCCCCCC---
Confidence            9987653221 122234567889999998653     56778999999999999999 7           6666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ...+...... ...+...+...     +.++.+++.+||+.||++||++++++..+.
T Consensus       208 --~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         208 --TNPEVIQNLE-RGYRMPRPDNC-----PEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             --ChHHHHHHHH-cCCCCCCCCCC-----CHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence              2233333332 22333333332     247999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-39  Score=309.12  Aligned_cols=243  Identities=23%  Similarity=0.330  Sum_probs=189.7

Q ss_pred             EeecCCceEEEEEEEC----CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhc
Q psy17532        119 VKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      .||+|+||.||+|.+.    +..||+|++......  .....+|+.++++++|+||+++++++...     .+++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEEEeC
Confidence            4899999999999873    345999988654322  23456888999999999999999987542     358999999


Q ss_pred             cCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        193 ERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       193 ~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      ++|+|.+++.  ...+++..+++++.|++.||.|||++           +++||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK-----------NFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------CeeecccchheEEEcCCCcEEeccCCccccc
Confidence            9999999995  34689999999999999999999998           9999999999999999999999999999866


Q ss_pred             CCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        271 EPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       271 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      ....... ......++..|+|||++.+.     .++.++||||||+++||+++ |           ..||...     ..
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~g-----------~~p~~~~-----~~  204 (257)
T cd05115         146 GADDSYYKARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGITMWEAFSYG-----------QKPYKKM-----KG  204 (257)
T ss_pred             cCCccceeccCCCCCCcccCCHHHHccC-----CCCchhhHHHHHHHHHHHhcCC-----------CCCcCcC-----CH
Confidence            5433211 12222346789999998653     56788999999999999997 7           5666543     22


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .+....+.. ..++..+...     +.++.++|.+||..||++||++.++.+.+..
T Consensus       205 ~~~~~~~~~-~~~~~~~~~~-----~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         205 PEVMSFIEQ-GKRLDCPAEC-----PPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             HHHHHHHHC-CCCCCCCCCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            333333332 3334444332     3489999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-40  Score=324.39  Aligned_cols=275  Identities=24%  Similarity=0.310  Sum_probs=197.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~  183 (461)
                      .++|++.+.||+|+||.||+|..  .++.||||.+.....   ......+|+.+++.++|+||+++++++.....  ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46799999999999999999987  467899999864322   22334578999999999999999998764322  123


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++++|++ +++|.++++...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA-----------GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecccCChhhEEECCCCCEEEcC
Confidence            568999998 67999999888899999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....     .....||..|+|||++.+.    ..++.++|||||||++|||++|..||.........--.....
T Consensus       162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07878         162 FGLARQADDE-----MTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV  232 (343)
T ss_pred             CccceecCCC-----cCCccccccccCchHhcCC----ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            9999875432     2345789999999998753    356788999999999999999955543211000000000000


Q ss_pred             CCCCHHHHHHHHhcc------CCCCCCCch-hcc--chhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHK------KLRPTLPET-WKQ--HAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~------~~~~~~p~~-~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..+.. +....+...      ...+..+.. +..  ......+.+|+.+||..||++|||+.++++|.+....
T Consensus       233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         233 GTPSP-EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             CCCCH-HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            00000 000000000      000111100 000  0122367899999999999999999999999987653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-39  Score=313.21  Aligned_cols=242  Identities=21%  Similarity=0.274  Sum_probs=185.2

Q ss_pred             eecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||+|+||.||+++.  .++.||+|.+.....    .......|+.++.+++||||+++++++....    .+++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEEEEEecCC
Confidence            69999999999987  478899999864221    1223345888899999999999999987754    4599999999


Q ss_pred             CCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        194 RGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       194 ~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      +|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||++...
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~  145 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-----------DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL  145 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence            9999988743   3588999999999999999999998           9999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      .....   .....|+..|+|||++.+.     .++.++|||||||++|||++|           ..||..... .....+
T Consensus       146 ~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~~g-----------~~p~~~~~~-~~~~~~  205 (277)
T cd05607         146 KDGKT---ITQRAGTNGYMAPEILKEE-----PYSYPVDWFAMGCSIYEMVAG-----------RTPFKDHKE-KVAKEE  205 (277)
T ss_pred             CCCce---eeccCCCCCccCHHHHccC-----CCCCchhHHHHHHHHHHHHhC-----------CCCCCCCcc-hhhHHH
Confidence            54321   2234689999999998763     577899999999999999999           455543211 112223


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      +............ ..     ..+.++.+||.+||+.||++||++.|+++++
T Consensus       206 ~~~~~~~~~~~~~-~~-----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         206 LKRRTLEDEVKFE-HQ-----NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHhhccccccc-cc-----cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            3233222221111 01     1234789999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-39  Score=309.25  Aligned_cols=246  Identities=24%  Similarity=0.426  Sum_probs=197.2

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +|++.+.||+|+||.||+++.  .+..+|+|.+....  ........|+.+++.++|+||+++++.+.+..    .++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG----HLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----EEEEE
Confidence            478999999999999999998  46889999886432  22344567888899999999999999998765    45999


Q ss_pred             ehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+++|+|.+++..   ..++...+..++.|++.||.|||+.           +|+|+||||+|||+++++.++|+|||
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-----------~i~H~dl~p~nili~~~~~~~l~dfg  145 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-----------RVLHRDIKSKNIFLTQNGKVKLGDFG  145 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-----------CcccCCCCcceEEECCCCcEEEcccC
Confidence            999999999998843   3588999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++........  ......|+..|+|||++.+.     .++.++||||||+++|+|++|           ..||...    
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~g-----------~~p~~~~----  203 (255)
T cd08219         146 SARLLTSPGA--YACTYVGTPYYVPPEIWENM-----PYNNKSDIWSLGCILYELCTL-----------KHPFQAN----  203 (255)
T ss_pred             cceeeccccc--ccccccCCccccCHHHHccC-----CcCchhhhhhhchhheehhhc-----------cCCCCCC----
Confidence            9977654321  12335688999999998763     567889999999999999999           5566432    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ........+..... ..++..++     ..+.++|.+||+.||++|||+.+++.+.
T Consensus       204 -~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         204 -SWKNLILKVCQGSY-KPLPSHYS-----YELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             -CHHHHHHHHhcCCC-CCCCcccC-----HHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence             33333344433322 23444333     3788999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.8e-40  Score=314.80  Aligned_cols=255  Identities=21%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             eeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      |++.+.||+|+||.||+|...  +..+|+|.+..... ......+|+.+++.++|+||+++++++...+    .+++|+|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----EEEEEEE
Confidence            678889999999999999985  56788888865432 2334567888899999999999999988754    4589999


Q ss_pred             hccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        191 YHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       191 ~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |+++|+|..++.  ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-----------~i~H~dlkp~nili~~~~~~kl~dfg~~~  151 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-----------KIIHRDLKAGNILFTLDGDIKLADFGVSA  151 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCcccEEEccCCCEEEccccccc
Confidence            999999999874  35689999999999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      ......  .......++..|+|||++.........++.++|||||||++|||++|           ..||...     ..
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g-----------~~p~~~~-----~~  213 (282)
T cd06643         152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI-----------EPPHHEL-----NP  213 (282)
T ss_pred             cccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccC-----------CCCcccc-----CH
Confidence            654322  12234568899999999864322234567889999999999999999           4555432     11


Q ss_pred             HHHHHHHhcc-CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        349 EDMQEAVVHK-KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       349 ~~~~~~~~~~-~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+........ ......+..+     +..+.++|.+||+.||++||++.+++++.+...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         214 MRVLLKIAKSEPPTLAQPSRW-----SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             HHHHHHHhhcCCCCCCCcccc-----CHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence            2222222111 1111222222     247899999999999999999999999987544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-39  Score=326.24  Aligned_cols=270  Identities=22%  Similarity=0.284  Sum_probs=195.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|++.+.||+|+||.||++..  .++.||||++....   .......+|+.+++.++||||+++++++......  .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999987  46789999986432   2233456788889999999999999987654321  2


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+++||||+++ +|.+++.. .+++..+..++.|++.||+|||++           +|+||||||+|||++.++.+||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhC-----------CeecCCCCHHHEEECCCCcEEEE
Confidence            346899999975 78887753 588899999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC---------
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------  333 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~---------  333 (461)
                      |||+++......   ......||..|+|||++.+     ..++.++|||||||++|||++|+.||......         
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  240 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  240 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999998654322   2234578999999999976     36778999999999999999996555322100         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCC--------------Cchhc-cchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL--------------PETWK-QHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------p~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      ...|......   ...........  .++.+              +.... .......+.+||.+||..||++|||+.++
T Consensus       241 ~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~  315 (364)
T cd07875         241 LGTPCPEFMK---KLQPTVRTYVE--NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  315 (364)
T ss_pred             cCCCCHHHHH---hhhHHHHHHHh--hCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence            0000000000   00000000000  00000              00000 00123478899999999999999999999


Q ss_pred             hhhcHHH
Q psy17532        399 VERGMLA  405 (461)
Q Consensus       399 l~~l~~~  405 (461)
                      ++|.+..
T Consensus       316 L~hp~~~  322 (364)
T cd07875         316 LQHPYIN  322 (364)
T ss_pred             hcCcccc
Confidence            9998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.9e-39  Score=314.02  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=201.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..+|++.+.||.|+||.||+|..  +++.||+|.+..... ......+|+..++.++|+||+++++++....    .+++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD----ELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc----eEEE
Confidence            35799999999999999999986  578899998865432 2334567888899999999999999988755    4599


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |+||+++|+|.+++....+++.++..++.|++.||+|||+.           +++||||||+||+++.++.+||+|||++
T Consensus        94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-----------~i~H~dL~p~Nili~~~~~~kl~dfg~~  162 (296)
T cd06655          94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN-----------QVIHRDIKSDNVLLGMDGSVKLTDFGFC  162 (296)
T ss_pred             EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999999888899999999999999999999999           9999999999999999999999999998


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ........  ......++..|+|||.+.+     ..++.++|||||||++|||++|           ..||...     .
T Consensus       163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~~lltg-----------~~pf~~~-----~  219 (296)
T cd06655         163 AQITPEQS--KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEG-----------EPPYLNE-----N  219 (296)
T ss_pred             hhcccccc--cCCCcCCCccccCcchhcC-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-----C
Confidence            87654332  1233468889999999865     3567889999999999999999           5555432     1


Q ss_pred             HHHHHHHHhccC-CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        348 LEDMQEAVVHKK-LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       348 ~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .......+.... .....+..     .+..+.++|.+||..||++||++.+++.+.+...+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         220 PLRALYLIATNGTPELQNPEK-----LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHHHhcCCcccCCccc-----CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            111111121111 11111222     23478899999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-39  Score=313.82  Aligned_cols=259  Identities=22%  Similarity=0.270  Sum_probs=187.5

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcC---CCCCCCeeEEEEEEecCCc-cce
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLP---HMEHDNILRYIGAEKRGES-IHT  183 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~---~l~H~nIv~l~g~~~~~~~-~~~  183 (461)
                      +|++.+.||+|+||.||+|+.  +++.||+|.+......   .....+|+.++.   .++||||+++++++..... ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            488999999999999999998  4678999988643221   123334555444   4579999999998865322 123


Q ss_pred             eeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        184 EFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      .++++|||+++ +|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN-----------CIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEECCCCCEE
Confidence            56899999985 89888854   3489999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++......   ......||..|+|||++.+     ..++.++|||||||++|||++|.++|.......      
T Consensus       149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~------  214 (288)
T cd07863         149 LADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD------  214 (288)
T ss_pred             ECccCccccccCcc---cCCCccccccccCchHhhC-----CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH------
Confidence            99999998765332   2233568899999999875     357789999999999999999965553221100      


Q ss_pred             ccCCCCCHHHHHHHHh--------------ccCCCCCCCchhc--cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        341 EVGDHPSLEDMQEAVV--------------HKKLRPTLPETWK--QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~--------------~~~~~~~~p~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                            ....+.....              .....+..+....  ....+..+.+++.+||+.||++|||+.+++.|.+
T Consensus       215 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         215 ------QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             ------HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence                  0001110000              0000000000000  0113347889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-39  Score=308.50  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=196.1

Q ss_pred             cceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      .+|++.+.||+|+||.||+|..++ ..+|+|.+...........+|+.++++++|+||+++++++...     ..+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE-----PIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CcEEEEE
Confidence            578999999999999999999854 5799998765544444567889999999999999999987542     2489999


Q ss_pred             hccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        191 YHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       191 ~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |+++|+|.+++...   .+++..+..++.|++.||+|||+.           +|+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-----------~i~H~dl~~~Nill~~~~~~~l~dfg~~  149 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-----------NYIHRDLRAANILVGDNLVCKIADFGLA  149 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeecccCcceEEEcCCCeEEECCCccc
Confidence            99999999999542   478999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +....... .......++..|+|||.+.+     ..++.++||||||+++|||++ |           ..||...     
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~~l~el~t~g-----------~~p~~~~-----  207 (260)
T cd05069         150 RLIEDNEY-TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKG-----------RVPYPGM-----  207 (260)
T ss_pred             eEccCCcc-cccCCCccchhhCCHHHhcc-----CCcChHHHHHHHHHHHHHHHhCC-----------CCCCCCC-----
Confidence            77643321 11223346778999998865     357788999999999999999 6           5666543     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ...+....... ...+..+..     .+..+.+++.+||+.||++||+++++++.+.
T Consensus       208 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         208 VNREVLEQVER-GYRMPCPQG-----CPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             CHHHHHHHHHc-CCCCCCCcc-----cCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence            22333333322 233333332     2347999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-39  Score=321.13  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=201.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC---------CCcEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEE
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGA  174 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~  174 (461)
                      ......+|++.+.||+|+||.||+|+..         +..||+|.+....  .......+|+.++.++ +|+||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3344567999999999999999999862         1258999876432  2233456788888898 89999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      +.....    .++++||+++|+|.+++..                 ..+++..++.++.|++.||.|||+.         
T Consensus        87 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---------  153 (334)
T cd05100          87 CTQDGP----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---------  153 (334)
T ss_pred             EccCCc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---------
Confidence            987653    4899999999999999853                 2378889999999999999999998         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+     ..++.++||||||+++
T Consensus       154 --givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il  226 (334)
T cd05100         154 --KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLL  226 (334)
T ss_pred             --CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-----CCcCchhhhHHHHHHH
Confidence              999999999999999999999999999987654332222223345678999999865     3567889999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                      |||++++          ..||...     ..++....+... .....+...     +..+.+++.+||+.+|++|||+.+
T Consensus       227 ~el~~~g----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~~-----~~~l~~li~~cl~~~p~~Rps~~e  285 (334)
T cd05100         227 WEIFTLG----------GSPYPGI-----PVEELFKLLKEG-HRMDKPANC-----THELYMIMRECWHAVPSQRPTFKQ  285 (334)
T ss_pred             HHHHhcC----------CCCCCCC-----CHHHHHHHHHcC-CCCCCCCCC-----CHHHHHHHHHHcccChhhCcCHHH
Confidence            9999832          5566443     344444444332 233333322     247899999999999999999999


Q ss_pred             hhhhcHHHhh
Q psy17532        398 VVERGMLALC  407 (461)
Q Consensus       398 vl~~l~~~~~  407 (461)
                      +++++..+..
T Consensus       286 ll~~l~~~~~  295 (334)
T cd05100         286 LVEDLDRVLT  295 (334)
T ss_pred             HHHHHHHHhh
Confidence            9999877764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0579|consensus

Probab=100.00  E-value=1.4e-41  Score=334.69  Aligned_cols=256  Identities=20%  Similarity=0.321  Sum_probs=205.3

Q ss_pred             cceeEEeEeecCCceEEEEEEECCC--cEEEEEEecCC-hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFKNE--NVAVKIFLMQD-KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~~~--~vAvK~~~~~~-~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +.+.++..||.|+||.||+|..+..  ..|.|.+.... ........||.+|+.++||+||+|++.|...+    .+||+
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en----kLwil  107 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN----KLWIL  107 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC----ceEEE
Confidence            4678899999999999999998644  35667765433 33345668999999999999999999876654    45999


Q ss_pred             ehhccCCChhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      .|||.||-....+  -...|++.++.-+++|++.||.|||++           +|||||||+.|||++-+|.++|+|||.
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~-----------~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ-----------NIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc-----------chhhhhccccceEEEecCcEeeecccc
Confidence            9999999998876  346799999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +.......  .....+.||++|||||++....+.+..|+.++||||||++|.||..+.           .|-...     
T Consensus       177 SAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiE-----------PPHhel-----  238 (1187)
T KOG0579|consen  177 SAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIE-----------PPHHEL-----  238 (1187)
T ss_pred             cccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccC-----------CCcccc-----
Confidence            86543322  235568999999999999888777789999999999999999999983           333222     


Q ss_pred             CHHHHHHHH-hccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        347 SLEDMQEAV-VHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       347 ~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      +.-.+.-.+ ........-|..|..     .+.+++.+||.+||..||+++++++|.+.-
T Consensus       239 npMRVllKiaKSePPTLlqPS~Ws~-----~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  239 NPMRVLLKIAKSEPPTLLQPSHWSR-----SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             chHHHHHHHhhcCCCcccCcchhhh-----HHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            222222222 222222334566665     899999999999999999999999998753

>KOG4279|consensus

Probab=100.00  E-value=3.3e-41  Score=335.10  Aligned_cols=248  Identities=26%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             eEeecCCceEEEEEEECCC--cEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        118 EVKAQGRFGAVWKAKFKNE--NVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~--~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      -+||+|.||+||-|++..+  .+|||-+...+. ...-...||..-++++|.|||+++|.+..++    .+-|.||-++|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----f~kIFMEqVPG  656 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG----FFKIFMEQVPG  656 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC----eEEEEeecCCC
Confidence            3799999999999999654  578888764433 3334567899999999999999999987765    34799999999


Q ss_pred             CChhhhhcC--CCC--CHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEEEecCCccc
Q psy17532        195 GSLCDFLKC--NIV--TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALL  269 (461)
Q Consensus       195 gsL~~~l~~--~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~DFGla~~  269 (461)
                      |||.++|+.  +++  .+..+-.+..||++||.|||++           .|||||||-.||||+. .|.+||+|||-++.
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen-----------~IVHRDIKGDNVLvNTySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN-----------KIVHRDIKGDNVLVNTYSGVLKISDFGTSKR  725 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc-----------ceeeccccCCcEEEeeccceEEecccccchh
Confidence            999999975  355  7788889999999999999999           9999999999999985 79999999999998


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      +..-..  .+....||..|||||++..+   .+.|+.++|||||||++.||.||++|           |....    +..
T Consensus       726 LAginP--~TETFTGTLQYMAPEvIDqG---~RGYG~aADIWS~GCT~vEMATGrPP-----------F~Elg----spq  785 (1226)
T KOG4279|consen  726 LAGINP--CTETFTGTLQYMAPEVIDQG---PRGYGKAADIWSFGCTMVEMATGRPP-----------FVELG----SPQ  785 (1226)
T ss_pred             hccCCc--cccccccchhhhChHhhccC---CcCCCchhhhhhccceeEeeccCCCC-----------eeecC----Chh
Confidence            765433  35567899999999999876   36788999999999999999999554           43321    111


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ...-++---+..|++|+..+.     +.+.+|.+|+.+||.+||+|.+++...+..
T Consensus       786 AAMFkVGmyKvHP~iPeelsa-----eak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  786 AAMFKVGMYKVHPPIPEELSA-----EAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             HhhhhhcceecCCCCcHHHHH-----HHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence            112223233456788876544     889999999999999999999999987643

>KOG2345|consensus

Probab=100.00  E-value=7.1e-41  Score=297.41  Aligned_cols=268  Identities=24%  Similarity=0.260  Sum_probs=205.1

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC-hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-cce
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD-KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHT  183 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~  183 (461)
                      ....++|++.+.||+|||+.||+++.  +++.+|+|++.... .+.....+||..-++++||||++++++...+.. ...
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            34567999999999999999999986  67889999987555 445566789999999999999999997654432 235


Q ss_pred             eeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        184 EFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                      +.||++.|...|+|.+.+.     ...+++.+.+.|+.+|++||++||+.         .|+++||||||.|||+.+++.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~---------~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK---------EPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc---------CCcccccCCCcceeEecCCCc
Confidence            6799999999999999883     34689999999999999999999998         457999999999999999999


Q ss_pred             eEEEecCCccccCCCCCC-------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPC-------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      ++|.|||.+....-.-..       ........|..|+|||.+.-.  .....+.++|||||||+||+|+.|.       
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk--~~~ti~ertDIWSLGCtLYa~mf~~-------  238 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK--SHCTITERTDIWSLGCTLYAMMFGE-------  238 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc--cCcccccccchhhhhHHHHHHHHcC-------
Confidence            999999998765321110       011234578999999999653  2346778999999999999999994       


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                          .||....+...+..   -.+....+  .+|..   ...++.+.++|+.|+..||.+||++.+++.++..+
T Consensus       239 ----sPfe~~~~~GgSla---LAv~n~q~--s~P~~---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  239 ----SPFERIYQQGGSLA---LAVQNAQI--SIPNS---SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----CcchHHhhcCCeEE---Eeeecccc--ccCCC---CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                44433221111110   01111111  22322   22456899999999999999999999999987543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-39  Score=311.37  Aligned_cols=251  Identities=22%  Similarity=0.272  Sum_probs=192.6

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .|+..+.||+|+||+||+|..  +++.||+|.+......    .....+|+.++..++|+||+.+++.+...+    ..+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   76 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD----ALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC----EEE
Confidence            367889999999999999998  4678999998643221    223457888999999999999999988765    348


Q ss_pred             eeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||+++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-----------~iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-----------NTVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecCCCHHHEEECCCCCEEEec
Confidence            99999999999988742   3589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++.......   ......|+..|+|||++.+     ..++.++||||||+++|||++|           ..||.....
T Consensus       146 fg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g-----------~~P~~~~~~  206 (285)
T cd05632         146 LGLAVKIPEGE---SIRGRVGTVGYMAPEVLNN-----QRYTLSPDYWGLGCLIYEMIEG-----------QSPFRGRKE  206 (285)
T ss_pred             CCcceecCCCC---cccCCCCCcCccChHHhcC-----CCCCcccchHHHHHHHHHHHhC-----------CCCCCCCCH
Confidence            99997654332   1234578999999999875     3577889999999999999999           555543210


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLA  405 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~  405 (461)
                       ......+...+...  ...++..+     +..+.+|+.+||+.||++||+     +.+++++.+..
T Consensus       207 -~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05632         207 -KVKREEVDRRVLET--EEVYSAKF-----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR  265 (285)
T ss_pred             -HHHHHHHHHhhhcc--ccccCccC-----CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence             00111222222111  11222222     237889999999999999999     56677765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-39  Score=309.50  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=195.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--C---CcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--N---ENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~---~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ...|++.+.||+|+||.||+|+..  +   ..||||.+....  .....+..|+..++.++||||+++++++.++..   
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP---   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc---
Confidence            356899999999999999999984  2   359999986432  223456788999999999999999999877653   


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       +++||||+++|+|.++++.  +.+++..+..++.|++.||.|||+.           +++||||||+|||++.++.+||
T Consensus        80 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~-----------g~~H~dl~p~nili~~~~~~kl  147 (269)
T cd05065          80 -VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM-----------NYVHRDLAARNILVNSNLVCKV  147 (269)
T ss_pred             -eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecccChheEEEcCCCcEEE
Confidence             4899999999999999854  4589999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCC---CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q psy17532        262 ADFGLALLFEPGKPCGD---THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLP  337 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~p  337 (461)
                      +|||+++..........   ......+..|+|||.+.+     ..++.++||||||+++||+++ |           ..|
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DvwslG~~l~e~l~~g-----------~~p  211 (269)
T cd05065         148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYG-----------ERP  211 (269)
T ss_pred             CCCccccccccCccccccccccCCCcceeecCHhHhcc-----CcccchhhhhhhHHHHHHHhcCC-----------CCC
Confidence            99999976644321111   111122457999999875     366788999999999999887 7           556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |...     ...+....+.. ..+.+.+..+     +..+.+++.+||..+|++||++.+++..+..
T Consensus       212 ~~~~-----~~~~~~~~i~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         212 YWDM-----SNQDVINAIEQ-DYRLPPPMDC-----PTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             CCCC-----CHHHHHHHHHc-CCcCCCcccC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            6433     23344444432 2233333332     3478999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=307.34  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=191.2

Q ss_pred             eEeecCCceEEEEEEECC-----CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++||+|+||.||+|++..     ..+|+|.+.....  .......|+.+++.++|+||+++++++...     .+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceEEEEE
Confidence            479999999999998732     5699999875443  334556789999999999999999987543     3489999


Q ss_pred             hccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.+++... .+++..+..++.|++.||+|||+.           +++||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~-----------~i~H~di~p~nili~~~~~~kl~df~~~~~  144 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK-----------HFVHRDLAARNVLLVNRHQAKISDFGMSRA  144 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc-----------CeeccCcccceEEEcCCCcEEeccccccce
Confidence            99999999999654 499999999999999999999998           999999999999999999999999999987


Q ss_pred             cCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        270 FEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       270 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ........ ......++..|+|||.+.+     ..++.++||||||+++|||++ |           ..||...     .
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~~g-----------~~p~~~~-----~  203 (257)
T cd05060         145 LGAGSDYYRATTAGRWPLKWYAPECINY-----GKFSSKSDVWSYGVTLWEAFSYG-----------AKPYGEM-----K  203 (257)
T ss_pred             eecCCcccccccCccccccccCHHHhcC-----CCCCccchHHHHHHHHHHHHcCC-----------CCCcccC-----C
Confidence            65433211 1222234578999998865     357789999999999999998 7           5566433     2


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ..++...+... .....+..+     +..+.++|.+||..||++||++.++++.+..
T Consensus       204 ~~~~~~~~~~~-~~~~~~~~~-----~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         204 GAEVIAMLESG-ERLPRPEEC-----PQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             HHHHHHHHHcC-CcCCCCCCC-----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            23333333332 222333333     2478999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=313.74  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=201.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .++|++.+.||+|+||.||+|...  +..||+|.+...... ...+..|+.++++++|+||+++++.+....    .+++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN----KLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC----eEEE
Confidence            357899999999999999999984  678999998754432 334567888999999999999999988755    4599


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.++|+|||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-----------~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH-----------KVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCChhhEEECCCCCEEEccCc
Confidence            9999999999999854  4689999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.......  .......++..|+|||++.........++.++||||||+++|||++|           ..||...    
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g-----------~~p~~~~----  211 (280)
T cd06611         149 VSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM-----------EPPHHEL----  211 (280)
T ss_pred             cchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhC-----------CCCcccC----
Confidence            987654322  12233568899999999864332234567889999999999999999           5555433    


Q ss_pred             CCHHHHHHHHhccC-CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKK-LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ............. .....+..++     ..+.++|.+||+.||++||++.+++++.+...
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         212 -NPMRVLLKILKSEPPTLDQPSKWS-----SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             -CHHHHHHHHhcCCCCCcCCcccCC-----HHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence             1122222222211 1111222232     37899999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.6e-40  Score=312.64  Aligned_cols=253  Identities=23%  Similarity=0.390  Sum_probs=197.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|..  +++.+|||.+....    .......+|+.+++.++|+||+++++++...+    .+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~   77 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN----EL   77 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC----eE
Confidence            5788899999999999999997  57889999876432    12234567889999999999999999988765    44


Q ss_pred             eeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      +++|||+++++|.++++     ...+++..+..++.|++.||.|||+.           +++|+||||+||+++.++.++
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~H~dl~p~nili~~~~~~~  146 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-----------RVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEEcCCCCEE
Confidence            89999999999999885     34589999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++........  ......|+..|+|||.+.+.     .++.++||||||+++|||++|           ..||..
T Consensus       147 l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~~p~~~  208 (267)
T cd08229         147 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAAL-----------QSPFYG  208 (267)
T ss_pred             ECcchhhhccccCCc--ccccccCCcCccCHHHhcCC-----CccchhhHHHHHHHHHHHHhC-----------CCCccc
Confidence            999999877654321  22345688999999998653     567789999999999999999           445532


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      .   ..........+..... +..+.    ...+..+.+++.+||+.||++|||+.+|++.+..+
T Consensus       209 ~---~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         209 D---KMNLYSLCKKIEQCDY-PPLPS----DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             c---cchHHHHhhhhhcCCC-CCCCc----ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            2   1122222233322222 12221    12345899999999999999999999998877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=307.54  Aligned_cols=244  Identities=29%  Similarity=0.441  Sum_probs=197.8

Q ss_pred             eEeecCCceEEEEEEEC-----CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|...     +..||+|.+......  ......|+..+..++|+||+++++++....    .+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEEEE
Confidence            46899999999999985     678999998755433  345578899999999999999999988744    4599999


Q ss_pred             hccCCChhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        191 YHERGSLCDFLKC----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       191 ~~~~gsL~~~l~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      |+++|+|.+++..          ..+++..+..++.|++.||+|||++           +|+||||||+||+++.++.+|
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-----------~i~H~di~p~nili~~~~~~~  145 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-----------KFVHRDLAARNCLVGEDLVVK  145 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-----------CcccCccCcceEEECCCCcEE
Confidence            9999999999964          5689999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||.+................++..|+|||.+.+.     .++.++||||||+++|||++++          ..||..
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g----------~~p~~~  210 (262)
T cd00192         146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-----IFTSKSDVWSFGVLLWEIFTLG----------ATPYPG  210 (262)
T ss_pred             EcccccccccccccccccccCCCcCccccCHHHhccC-----CcchhhccHHHHHHHHHHHhcC----------CCCCCC
Confidence            9999999887654322233445678899999988763     5678899999999999999942          455544


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      .     ...++.+.+.. ..+...+...     +.++.+++.+||..||++|||+.++++++
T Consensus       211 ~-----~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         211 L-----SNEEVLEYLRK-GYRLPKPEYC-----PDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             C-----CHHHHHHHHHc-CCCCCCCccC-----ChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            3     33444444443 2333444433     34899999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9e-40  Score=320.51  Aligned_cols=268  Identities=23%  Similarity=0.275  Sum_probs=187.1

Q ss_pred             EeEeecCCceEEEEEEEC----CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhc
Q psy17532        117 VEVKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      ...||+|+||.||+|+..    ++.||+|.+..... .....+|+.++++++||||+++++++.....  ..++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHAD--RKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCC--cEEEEEEecc
Confidence            368999999999999963    46799998864332 2345678999999999999999998865432  3568999998


Q ss_pred             cCCChhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE----cCCCc
Q psy17532        193 ERGSLCDFLKC----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL----KSDLT  258 (461)
Q Consensus       193 ~~gsL~~~l~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl----~~~~~  258 (461)
                      .+ +|.+++..          ..+++..+..++.||+.||.|||++           +|+||||||+|||+    +.++.
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----------~ivHrDlkp~Nil~~~~~~~~~~  150 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-----------WVLHRDLKPANILVMGEGPERGR  150 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-----------CEEcCCCCHHHEEEecCCCCcCc
Confidence            64 88887742          2488899999999999999999999           99999999999999    45678


Q ss_pred             eEEEecCCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC--C
Q psy17532        259 AAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY--R  335 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~--~  335 (461)
                      +||+|||+++....... ........||+.|+|||++.+.    ..++.++|||||||++|||++|.+||.......  .
T Consensus       151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~  226 (317)
T cd07868         151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  226 (317)
T ss_pred             EEEeecCceeccCCCCccccccCCccccccccCCHHHcCC----CCcCchhhHHHHHHHHHHHHhCCCCccCCccccccc
Confidence            99999999987654321 1123346789999999998763    356788999999999999999987775432211  1


Q ss_pred             CCCccc-------cCCCCCHHHH------------HHHHhccCCC-CCCCchhc--cchhHHHHHHHHHHHccccHhhhc
Q psy17532        336 LPFSAE-------VGDHPSLEDM------------QEAVVHKKLR-PTLPETWK--QHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       336 ~pf~~~-------~~~~~~~~~~------------~~~~~~~~~~-~~~p~~~~--~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      .|+...       ....+.....            .......... ........  .......+.+||.+||..||++||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  306 (317)
T cd07868         227 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  306 (317)
T ss_pred             ccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC
Confidence            111000       0000000000            0000000000 00000000  001123678999999999999999


Q ss_pred             cccchhhhcH
Q psy17532        394 SASCVVERGM  403 (461)
Q Consensus       394 s~~evl~~l~  403 (461)
                      |++|+++|.+
T Consensus       307 t~~e~l~hp~  316 (317)
T cd07868         307 TSEQAMQDPY  316 (317)
T ss_pred             CHHHHhcCCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-39  Score=306.42  Aligned_cols=249  Identities=21%  Similarity=0.391  Sum_probs=198.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..+|++.+.||+|+||.||+|.+. ++.+|+|.+.........+..|+.++.+++||||+++++++....    .+++||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS----PICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC----ceEEEE
Confidence            457899999999999999999885 778999988765544556778999999999999999999987755    458999


Q ss_pred             hhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++|+|.+++..  ..++++.+..++.|++.||+|||+.           +++||||||+||+++.++.+||+|||++
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~i~h~dl~p~ni~i~~~~~~~l~d~g~~  147 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS-----------NVIHRDLAARNCLVGENQVVKVSDFGMT  147 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccccccceEEEcCCCeEEECCCcce
Confidence            99999999999854  3589999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +....... .......++..|+|||.+.+.     .++.++||||||+++|||++ |           ..||...     
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~-----~~~~~~Dv~slG~~l~el~~~g-----------~~p~~~~-----  205 (256)
T cd05112         148 RFVLDDQY-TSSTGTKFPVKWSSPEVFSFS-----KYSSKSDVWSFGVLMWEVFSEG-----------KTPYENR-----  205 (256)
T ss_pred             eecccCcc-cccCCCccchhhcCHhHhccC-----CcChHHHHHHHHHHHHHHHcCC-----------CCCCCcC-----
Confidence            76543221 112233456789999988753     56778999999999999998 6           5566433     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ....+.+..... .+...+..     .+..+.+|+.+||+.+|++|||+.++++++
T Consensus       206 ~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         206 SNSEVVETINAG-FRLYKPRL-----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CHHHHHHHHhCC-CCCCCCCC-----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            333444433222 22222322     224799999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-39  Score=315.53  Aligned_cols=267  Identities=23%  Similarity=0.310  Sum_probs=198.8

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.+.||+|+||.||+++..  +..+|+|.+......  ..+..+|+.++.+++||||+++++++...+    .+++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG----EISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----EEEE
Confidence            36899999999999999999984  677899987644222  234567899999999999999999998765    4599


Q ss_pred             eehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||||+++|+|.++++. ..+++..+..++.|++.||.|||+..          +++||||||+|||++.++.+||+|||+
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH----------KIMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC----------CEEECCCChHHEEEecCCcEEEccCCC
Confidence            9999999999999954 56899999999999999999999731          899999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC-CCCCcc-----
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-RLPFSA-----  340 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~-~~pf~~-----  340 (461)
                      +.......    .....|+..|+|||++.+.     .++.++||||||+++|||++|..||....... ...+..     
T Consensus       147 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (308)
T cd06615         147 SGQLIDSM----ANSFVGTRSYMSPERLQGT-----HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG  217 (308)
T ss_pred             cccccccc----cccCCCCcCccChhHhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccc
Confidence            87654321    2345788999999998653     56788999999999999999977764221100 000000     


Q ss_pred             --------------ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 --------------EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 --------------~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                                    .........+....... ...+.+|..    ..+.++.++|.+||..||++|||+.+++++.+...
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVN-EPPPKLPSG----AFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             cccCCcccccCCCCCccchhhHHHHHHHHhc-CCCccCcCc----ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                          00000001111111111 112222211    13347899999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-39  Score=314.94  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=191.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC------------------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeE
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK------------------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILR  170 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~  170 (461)
                      .++|++.+.||+|+||.||++...                  +..||+|.+.....  ....+.+|+.++..++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457999999999999999998643                  23589998864322  2335678899999999999999


Q ss_pred             EEEEEecCCccceeeeeeehhccCCChhhhhcCC------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCC
Q psy17532        171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK  238 (461)
Q Consensus       171 l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~  238 (461)
                      +++++.....    .++||||+++|+|.+++...            .+++..+..++.|++.||+|||+.          
T Consensus        84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----------  149 (296)
T cd05095          84 LLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----------  149 (296)
T ss_pred             EEEEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----------
Confidence            9999987654    48999999999999998542            367788999999999999999998          


Q ss_pred             CCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHH
Q psy17532        239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW  318 (461)
Q Consensus       239 ~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~  318 (461)
                       +|+||||||+|||++.++.++|+|||+++.+.............++..|+|||...++     .++.++|||||||++|
T Consensus       150 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~DiwSlG~~l~  223 (296)
T cd05095         150 -NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-----KFTTASDVWAFGVTLW  223 (296)
T ss_pred             -CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-----CccchhhhhHHHHHHH
Confidence             9999999999999999999999999999876443322222223456789999987653     5778999999999999


Q ss_pred             HHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHH----hccCC--CCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        319 ELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV----VHKKL--RPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       319 el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~----~~~~~--~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      ||+++..         ..||...     ...+.....    .....  ....+..     .+..+.+|+.+||+.||++|
T Consensus       224 el~~~~~---------~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~R  284 (296)
T cd05095         224 EILTLCK---------EQPYSQL-----SDEQVIENTGEFFRDQGRQVYLPKPAL-----CPDSLYKLMLSCWRRNAKER  284 (296)
T ss_pred             HHHHhCC---------CCCcccc-----ChHHHHHHHHHHHhhccccccCCCCCC-----CCHHHHHHHHHHcCCCcccC
Confidence            9998411         4455432     111211111    11111  1111222     23478999999999999999


Q ss_pred             ccccchhhhcH
Q psy17532        393 LSASCVVERGM  403 (461)
Q Consensus       393 ps~~evl~~l~  403 (461)
                      |++.++++.|.
T Consensus       285 p~~~~i~~~l~  295 (296)
T cd05095         285 PSFQEIHATLL  295 (296)
T ss_pred             CCHHHHHHHHh
Confidence            99999988763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-39  Score=307.92  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+|+..+.||+|+||.||+|..  .+..||+|.+.....      .....++|+.+++.++|+||+++++++....  ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~   79 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--EK   79 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--CC
Confidence            3688999999999999999987  478899998864321      1234567889999999999999999887543  12


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++++||+++++|.+++.. ..+++.....++.|++.||+|||+.           +|+||||||+||+++.++.+||+
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~-----------~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN-----------MIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCCHHHEEECCCCCEEEc
Confidence            56899999999999999854 4689999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        263 DFGLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       263 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |||+++.+..... ........++..|+|||++.+     ..++.++|||||||++|||++|           ..||...
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~el~~g-----------~~pf~~~  212 (266)
T cd06651         149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-----EGYGRKADVWSLGCTVVEMLTE-----------KPPWAEY  212 (266)
T ss_pred             cCCCccccccccccCCccccCCccccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHHC-----------CCCcccc
Confidence            9999976543211 111223458899999999875     3567889999999999999999           4555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                          ....... ........+.++...     .+.+.+++ +||..||++||+++++++|.+.
T Consensus       213 ----~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~  264 (266)
T cd06651         213 ----EAMAAIF-KIATQPTNPQLPSHI-----SEHARDFL-GCIFVEARHRPSAEELLRHPFA  264 (266)
T ss_pred             ----chHHHHH-HHhcCCCCCCCchhc-----CHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence                1122222 222222334444332     23677888 7888999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-39  Score=314.21  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..++|++.+.||+|+||.||+|...       ++.||+|.+.....  ....+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4568999999999999999999873       46799998865432  23346678999999999999999999887653


Q ss_pred             cceeeeeeehhccCCChhhhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN-----------------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                          ++++|||+++|+|.+++...                       .+++..++.++.|++.||+|||+.         
T Consensus        83 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---------  149 (288)
T cd05050          83 ----MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---------  149 (288)
T ss_pred             ----cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---------
Confidence                48999999999999998531                       367888899999999999999998         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +++||||||+|||++.++.+||+|||++..+..............+..|+|||.+.+     ..++.++|||||||++
T Consensus       150 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il  222 (288)
T cd05050         150 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-----NRYTTESDVWAYGVVL  222 (288)
T ss_pred             --CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-----CCCCchhHHHHHHHHH
Confidence              999999999999999999999999999976644332222233345678999998865     3677889999999999


Q ss_pred             HHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        318 WELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       318 ~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      |||++ |           ..||...     ...+....+..... ...+..     .+.++.+|+.+||+.||++|||+.
T Consensus       223 ~el~~~~-----------~~p~~~~-----~~~~~~~~~~~~~~-~~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~  280 (288)
T cd05050         223 WEIFSYG-----------MQPYYGM-----AHEEVIYYVRDGNV-LSCPDN-----CPLELYNLMRLCWSKLPSDRPSFA  280 (288)
T ss_pred             HHHHhCC-----------CCCCCCC-----CHHHHHHHHhcCCC-CCCCCC-----CCHHHHHHHHHHcccCcccCCCHH
Confidence            99998 5           4555433     33444444433332 222322     234799999999999999999999


Q ss_pred             chhhhcH
Q psy17532        397 CVVERGM  403 (461)
Q Consensus       397 evl~~l~  403 (461)
                      |+++.|.
T Consensus       281 el~~~l~  287 (288)
T cd05050         281 SINRILQ  287 (288)
T ss_pred             HHHHHhh
Confidence            9988764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-39  Score=310.83  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=183.6

Q ss_pred             eEeecCCceEEEEEEEC----CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        118 EVKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      +.||+|+||.||+|...    ...+|+|.+......  ...+.+|+..++.++|+||+++++.+....    .+++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~----~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI----PYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC----ceEEEEEe
Confidence            36899999999999762    245888876543222  234467888888999999999999988765    35999999


Q ss_pred             ccCCChhhhhcCC------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        192 HERGSLCDFLKCN------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       192 ~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +++|+|.+++...      ..++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-----------DFIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-----------CEecccccHhheEecCCCcEEEeccc
Confidence            9999999998543      246778889999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCccccccccccccc--ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN--FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      +++...............++..|+|||++.....  ....++.++|||||||++|||++++          ..||...  
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~----------~~p~~~~--  213 (269)
T cd05042         146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA----------DQPYPDL--  213 (269)
T ss_pred             cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC----------CCCCCcC--
Confidence            9876443322122233456778999999754211  1235678899999999999999943          4555432  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                         ...+.......... ..++........+..+.+++..|| .||++|||+++|++.+
T Consensus       214 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         214 ---SDEQVLKQVVREQD-IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ---CHHHHHHHHhhccC-ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence               22222222222211 111111111123347888999999 5999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-39  Score=313.03  Aligned_cols=266  Identities=22%  Similarity=0.254  Sum_probs=192.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|+.  +++.||||.+.....   ......+|+.++..++||||+++++++.++.    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~   76 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES----RLYL   76 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC----eEEE
Confidence            478999999999999999998  478899999864322   1234567899999999999999999998755    4599


Q ss_pred             eehhccCCChhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        188 ITAYHERGSLCDFLKC----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ||||++ |+|.+++..    ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-----------RVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecCCCHHHEEEcCCCcEEECc
Confidence            999997 689888743    4589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||++.......  .......++..|+|||++.+.    ..++.++||||||+++|||++|++||.......         
T Consensus       145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~  218 (285)
T cd07861         145 FGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGS----PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL  218 (285)
T ss_pred             ccceeecCCCc--ccccCCcccccccChHHhcCC----CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            99997654322  122334678899999988653    345678999999999999999966654321100         


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..+.................. .......+....  ...+.++.++|.+||+.||++|||+.+++++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         219 GTPTEDVWPGVTSLPDYKNTF-PKWKKGSLRSAV--KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             CCCChhhhhcchhhHHHHhhc-cccCcchhHHhc--CCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence            000000000000000000000 000000000000  113347889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-39  Score=325.00  Aligned_cols=266  Identities=20%  Similarity=0.216  Sum_probs=188.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ..+|++.+.||+|+||.||+|+..  ++.||+|+....     ....|+.++.+++|+||+++++++....    ..++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGA----ITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCC----eeEEE
Confidence            457999999999999999999995  467999974322     2345788899999999999999998765    34899


Q ss_pred             ehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||+. |+|.+++..  ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||+
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ-----------RIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCCEEEecCcc
Confidence            99995 689998853  4689999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC-CCCC-------
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-RLPF-------  338 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~-~~pf-------  338 (461)
                      ++......   ......||..|+|||++.+.     .++.++|||||||++|||+++..++....... ..+.       
T Consensus       204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l  275 (357)
T PHA03209        204 AQFPVVAP---AFLGLAGTVETNAPEVLARD-----KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL  275 (357)
T ss_pred             ccccccCc---ccccccccccccCCeecCCC-----CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence            97543221   22345689999999999763     67789999999999999998754432111100 0000       


Q ss_pred             ----------ccccCCCCCHHHHHHHHhcc-CCCCCCC--chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        339 ----------SAEVGDHPSLEDMQEAVVHK-KLRPTLP--ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       339 ----------~~~~~~~~~~~~~~~~~~~~-~~~~~~p--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                                .......+............ ..+....  ........+..+.+||.+||+.||++|||+.|+++|.+..
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             HHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence                      00000000000000000000 0000000  0000111233567899999999999999999999998753

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.4e-39  Score=312.68  Aligned_cols=257  Identities=23%  Similarity=0.288  Sum_probs=198.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+.|++.+.||+|+||.||+|+..  +..||+|.+...... .....+|+.+++.++|+||+++++.+....    .+++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   86 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG----KLWI   86 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC----eEEE
Confidence            367999999999999999999984  678999998755432 334567888899999999999999987654    4599


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||||+++|+|..++.  ...+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+|||
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-----------~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM-----------KIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC-----------CeeecCCCcceEEEcCCCCEEEccCc
Confidence            999999999998874  34689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.......  .......++..|+|||++.+.......++.++|||||||++|||++|           ..||...    
T Consensus       156 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g-----------~~p~~~~----  218 (292)
T cd06644         156 VSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-----------EPPHHEL----  218 (292)
T ss_pred             cceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcC-----------CCCCccc----
Confidence            987643321  12233567889999999865322234567889999999999999999           5555432    


Q ss_pred             CCHHHHHHHHhccCC-CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        346 PSLEDMQEAVVHKKL-RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                       .............. ....+..     .+..+.++|.+||..||++||++.+++++.+..
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  273 (292)
T cd06644         219 -NPMRVLLKIAKSEPPTLSQPSK-----WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS  273 (292)
T ss_pred             -cHHHHHHHHhcCCCccCCCCcc-----cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence             11122222211111 1111222     234789999999999999999999999997643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-39  Score=315.48  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=200.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..+|++.+.||+|+||.||+|..  .++.||+|.+...... ......|+.+++.++|+||+++++++..+.    .+++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~l   93 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELWV   93 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----EEEE
Confidence            36899999999999999999987  5788999998754332 334567888899999999999999998755    4599


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||||+++|+|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.++|+|||++
T Consensus        94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-----------~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN-----------QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEECcCccc
Confidence            99999999999999888899999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ........  ......++..|+|||.+.+     ..++.++|||||||++|++++|..||......              
T Consensus       163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--------------  221 (297)
T cd06656         163 AQITPEQS--KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------------  221 (297)
T ss_pred             eEccCCcc--CcCcccCCccccCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--------------
Confidence            77654321  1233568889999999875     35678899999999999999995544321110              


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ................+..     .+..+.+++.+||..||++||++.+++++.+...+
T Consensus       222 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         222 -RALYLIATNGTPELQNPER-----LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             -hheeeeccCCCCCCCCccc-----cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence             0000000001001111222     22378899999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.6e-39  Score=307.92  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=184.2

Q ss_pred             eEeecCCceEEEEEEECC----CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        118 EVKAQGRFGAVWKAKFKN----ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~----~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      +.||+|+||.||+|...+    ..+|+|.+.....  ....+.+|+.++++++||||+++++++.+...    +++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cEEEEEC
Confidence            368999999999998742    4689998865432  22345678899999999999999999877653    4899999


Q ss_pred             ccCCChhhhhcCC------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        192 HERGSLCDFLKCN------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       192 ~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +++|+|.+++...      ..++..+..++.|++.||+|||+.           +++||||||+||+++.++.+||+|||
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~i~H~dlkp~nil~~~~~~~kL~dfg  145 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-----------NFIHSDLALRNCLLTADLTVKIGDYG  145 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-----------CEeccccCcceEEEcCCCcEEECCcc
Confidence            9999999998532      356677889999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCccccccccccccc--ccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcccc
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN--FSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~  342 (461)
                      +++...............++..|+|||++.+...  ....++.++||||||+++|||++ |           ..||... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g-----------~~p~~~~-  213 (269)
T cd05087         146 LSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG-----------SQPYRHL-  213 (269)
T ss_pred             ccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCC-----------CCCCCCC-
Confidence            9976543322222233567889999999864211  01235678999999999999996 8           5555432 


Q ss_pred             CCCCCHHHHHHH-HhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        343 GDHPSLEDMQEA-VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       343 ~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                          ...+.... +.....+...+.  ........+.++|..|| .+|++|||+++|+..|
T Consensus       214 ----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l  267 (269)
T cd05087         214 ----SDEQVLTYTVREQQLKLPKPR--LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL  267 (269)
T ss_pred             ----ChHHHHHHHhhcccCCCCCCc--cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence                11222222 111111111111  11123347889999999 6899999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-39  Score=314.08  Aligned_cols=259  Identities=23%  Similarity=0.329  Sum_probs=200.5

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.+.||+|+||.||+++..  ++.||+|.+....  .......+|+.++.+++|+||+++++.+...+    .+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG----AVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC----eEEE
Confidence            36889999999999999999985  7889999886532  22345567888899999999999999888754    4589


Q ss_pred             eehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        188 ITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ||||+++++|.+++...    .+++..+..++.|++.||.|||+..          +|+||||||+|||++.++.+||+|
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----------~i~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH----------NIIHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC----------CEeeCCCCHHHEEECCCCCEEEee
Confidence            99999999999998654    7899999999999999999999631          899999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCccccccccccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||++..+....    .....++..|+|||.+.+... ....++.++|||||||++|||++|           ..||....
T Consensus       147 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g-----------~~pf~~~~  211 (286)
T cd06622         147 FGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG-----------RYPYPPET  211 (286)
T ss_pred             cCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhC-----------CCCCCCcc
Confidence            99997654322    233467889999999865422 223457889999999999999999           55554321


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .  .........+.. ...+.++..+     +.++.++|.+||..||++||++.+++++.+....
T Consensus       212 ~--~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         212 Y--ANIFAQLSAIVD-GDPPTLPSGY-----SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             h--hhHHHHHHHHhh-cCCCCCCccc-----CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            0  011111112222 2223344333     3478999999999999999999999999876554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.6e-39  Score=305.66  Aligned_cols=252  Identities=21%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+|++.+.||+|+||.||+|..  +++.||||.+.....      .....++|+.++.+++|+||+++++++.+...  .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~   79 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME--R   79 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC--c
Confidence            4789999999999999999997  467899998853221      12345678999999999999999998866432  2


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .++++|||+++|+|.+++.. ..+++.....++.|++.||+|||+.           +|+|+||||+|||++.++.+||+
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN-----------MIVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEecCCCCEEEC
Confidence            45799999999999999854 4588999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        263 DFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       263 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |||+++.+...... .......|+..|+|||++.+.     .++.++||||||+++|||++|           ..||...
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~g-----------~~p~~~~  212 (265)
T cd06652         149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-----GYGRKADIWSVGCTVVEMLTE-----------KPPWAEF  212 (265)
T ss_pred             cCccccccccccccccccccCCCCccccChhhhcCC-----CCCcchhHHHHHHHHHHHhhC-----------CCCCCcc
Confidence            99999865432111 112234688999999998653     567889999999999999999           5555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                          ...... .........+.+|...     ...+.+++.+||. +|++||++++++++.+
T Consensus       213 ----~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         213 ----EAMAAI-FKIATQPTNPVLPPHV-----SDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             ----chHHHH-HHHhcCCCCCCCchhh-----CHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence                112222 2222222333344332     2378899999995 9999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.9e-39  Score=308.10  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=196.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--C---CcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--N---ENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~---~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..+|++.+.||+|+||.||+|+..  +   ..+|+|.+....  ........|+..+.+++||||+++++++...+.   
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP---   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc---
Confidence            467899999999999999999873  2   369999886432  223455778889999999999999999877653   


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +++||||||+|||++.++.+||
T Consensus        80 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~i~h~dlkp~nili~~~~~~~l  147 (267)
T cd05066          80 -VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILVNSNLVCKV  147 (267)
T ss_pred             -cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeehhhchhcEEECCCCeEEe
Confidence             4899999999999999964  3589999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCc
Q psy17532        262 ADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~  339 (461)
                      +|||+++......... ......++..|+|||++.+     ..++.++||||||+++||+++ |           ..||.
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~ell~~g-----------~~p~~  211 (267)
T cd05066         148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYG-----------ERPYW  211 (267)
T ss_pred             CCCCcccccccccceeeecCCCccceeecCHhHhcc-----CccCchhhhHHHHHHHHHHhcCC-----------CCCcc
Confidence            9999998765432211 1122334568999999875     357788999999999999887 7           56665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ..     ...+....+... .+.+.+..     .+..+.+++.+||+.+|++||++.++++.+..
T Consensus       212 ~~-----~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         212 EM-----SNQDVIKAIEEG-YRLPAPMD-----CPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             cC-----CHHHHHHHHhCC-CcCCCCCC-----CCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            43     223333333332 23333322     23478999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-39  Score=310.88  Aligned_cols=256  Identities=21%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||+|.+...... .....+|+.++..++||||+++++.+...+    .++
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~----~~~   82 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD----KLW   82 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----EEE
Confidence            345889999999999999999998  4688999998755432 233567888899999999999999987765    459


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.+++. .+.+++..+..++.|++.||.|||+.           +|+|+||||+||+++.++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK-----------GKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCCEEECcce
Confidence            9999999999999985 45689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.......  .......|+..|+|||++...  ....++.++|||||||++|||++|.           .||....   
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~DvwSlG~il~~l~~~~-----------~p~~~~~---  213 (267)
T cd06645         152 VSAQITATI--AKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWAVGITAIELAELQ-----------PPMFDLH---  213 (267)
T ss_pred             eeeEccCcc--cccccccCcccccChhhhccc--cCCCCCchhhhHHHHHHHHHHhcCC-----------CCccccc---
Confidence            987664322  223345789999999987421  1135678899999999999999994           4443221   


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ..... .........+.....  ....+..+.+++.+||..||++|||++++++|.
T Consensus       214 -~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~  266 (267)
T cd06645         214 -PMRAL-FLMTKSNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP  266 (267)
T ss_pred             -chhhH-HhhhccCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence             00111 111111111111100  011234788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.1e-39  Score=314.39  Aligned_cols=274  Identities=19%  Similarity=0.273  Sum_probs=195.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..++|++.+.||+|+||.||+|+.+  ++.||+|.+.....  ......+|+.+++.++|+||+++++++....    .+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~~   79 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK----SL   79 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC----eE
Confidence            3568999999999999999999884  67899999864432  2234567899999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||++ ++|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-----------~i~H~dlkp~Nil~~~~~~~kl~d  147 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-----------KVLHRDLKPQNLLINERGELKLAD  147 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCCHHHEEECCCCcEEECc
Confidence            89999997 599998853  4588999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++.......  .......++..|+|||++.+.    ..++.++|||||||++|||++|..||.........-+.....
T Consensus       148 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~  221 (301)
T cd07873         148 FGLARAKSIPT--KTYSNEVVTLWYRPPDILLGS----TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL  221 (301)
T ss_pred             CcchhccCCCC--CcccccceeecccCcHHHhCC----CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99997654322  112334678899999998653    346678999999999999999965553221100000000000


Q ss_pred             CCCCHHHHHHHHhcc-C-CCCCCCc---hh---ccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHK-K-LRPTLPE---TW---KQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~-~-~~~~~p~---~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..+.. ......... . .....+.   .+   .....+..+.+||.+||..||.+|||++++++|.+...
T Consensus       222 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         222 GTPTE-ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             CCCCh-hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            00000 000000000 0 0000110   00   00112347889999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0584|consensus

Probab=100.00  E-value=2.7e-40  Score=327.98  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=207.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEe-----cCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFL-----MQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~-----~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+-.++.++||+|.|-+||+|.+.  |..||=-.++     .......++..|+.+|+.|+|+|||++|.++.+...  .
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~  116 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--K  116 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--c
Confidence            344567789999999999999985  4444432222     222333556789999999999999999999988764  3


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~ki  261 (461)
                      .+-+|+|.+..|+|..|+++ +.++.+.+..|++||++||.|||++         .|+|+|||||-.||+|+.+ |.|||
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~---------~PPIIHRDLKCDNIFinG~~G~VKI  187 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ---------DPPIIHRDLKCDNIFVNGNLGEVKI  187 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC---------CCCccccccccceEEEcCCcCceee
Confidence            56899999999999999965 4699999999999999999999998         8899999999999999975 89999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|+|||.......    .....||+.|||||++..      .|+..+||||||+.|+||+|+           ..||..-
T Consensus       188 GDLGLAtl~r~s~----aksvIGTPEFMAPEmYEE------~YnE~VDVYaFGMCmLEMvT~-----------eYPYsEC  246 (632)
T KOG0584|consen  188 GDLGLATLLRKSH----AKSVIGTPEFMAPEMYEE------NYNELVDVYAFGMCMLEMVTS-----------EYPYSEC  246 (632)
T ss_pred             cchhHHHHhhccc----cceeccCccccChHHHhh------hcchhhhhhhhhHHHHHHHhc-----------cCChhhh
Confidence            9999998876432    344789999999999874      678889999999999999999           7788653


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                          .+..++..+|..+..    |..+... ..+++++||.+|+.. .++|||+.|+|++.++-..
T Consensus       247 ----~n~AQIYKKV~SGiK----P~sl~kV-~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  247 ----TNPAQIYKKVTSGIK----PAALSKV-KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ----CCHHHHHHHHHcCCC----HHHhhcc-CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                356777788877643    3333322 234899999999999 9999999999999877554

>KOG4717|consensus

Probab=100.00  E-value=2.9e-40  Score=319.09  Aligned_cols=249  Identities=23%  Similarity=0.326  Sum_probs=206.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..-|.+.+.||+|.|+.|-+|++  .|+.||||++.+...   ......+|+..|+-++|||||++|.+....    ..+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ----TKl   92 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ----TKL   92 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc----ceE
Confidence            34588889999999999999987  899999999965433   334556899999999999999999998764    456


Q ss_pred             eeeehhccCCChhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc-CCCceEEE
Q psy17532        186 WLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-SDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~-~~~~~ki~  262 (461)
                      |||+|+-.+|+|++|+  +...++++.+.+++.||..|+.|+|..           .+|||||||+||.+- .-|.+||.
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL-----------HVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL-----------HVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh-----------hhhcccCCcceeEEeeecCceEee
Confidence            9999999999999999  455799999999999999999999998           899999999999775 56899999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |||++..+.+++   .....+|+..|-|||++.|.     .|+ .++||||||||||-|+.|           +.||...
T Consensus       162 DFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGD-----sYDAPAVDiWSLGVILyMLVCG-----------q~PFqeA  222 (864)
T KOG4717|consen  162 DFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGD-----SYDAPAVDIWSLGVILYMLVCG-----------QPPFQEA  222 (864)
T ss_pred             eccccccCCCcc---hhhcccchhhccCchhhhcC-----ccCCcchhhhHHHHHHHHHHhC-----------CCccccc
Confidence            999998887765   35567999999999999985     333 578999999999999999           6677655


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                           +..+....++..++  .+|....     .+.++||..||..||.+|-+.++|..+.|..
T Consensus       223 -----NDSETLTmImDCKY--tvPshvS-----~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  223 -----NDSETLTMIMDCKY--TVPSHVS-----KECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             -----cchhhhhhhhcccc--cCchhhh-----HHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence                 33344455555554  3454433     4889999999999999999999999887753

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-39  Score=313.99  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=197.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCC----cEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNE----NVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|+..+.||+|+||.||+|.+  .+.    .||+|.+......  .....+|+.++..++||||++++|++....  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--
Confidence            446788999999999999999987  343    4788887643322  224567888899999999999999986543  


Q ss_pred             ceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .++++||+++|+|.+++...  .+++..+..++.|++.||.|||++           +|+||||||+|||++.++.+
T Consensus        83 ---~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-----------~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          83 ---IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-----------RLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             ---ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc-----------CeeccccccceeeecCCCce
Confidence               36999999999999998643  588999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+++.+.............++..|+|||++.+     ..++.++||||||+++|||++ |           ..||
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~el~t~g-----------~~p~  212 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-----RKFTHQSDVWSYGVTIWELMTFG-----------GKPY  212 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHHHhcc-----CCCChHHHHHHHHHHHHHHHhCC-----------CCCC
Confidence            9999999987654332222333456778999999865     367788999999999999998 6           4555


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ........+ .....+..+..+     +..+.+++.+||..||++||++.++++.+..+..
T Consensus       213 ~~~-----~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         213 DGI-----PTREIPDLL-EKGERLPQPPIC-----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCC-----CHHHHHHHH-HCCCCCCCCCCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            432     223333332 223333333222     2378999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.2e-39  Score=305.62  Aligned_cols=253  Identities=23%  Similarity=0.387  Sum_probs=199.2

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|...  ++.||+|.+....    .......+|+.++.+++|+||+++++++...+    .+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~----~~   77 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN----EL   77 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----eE
Confidence            57999999999999999999984  7889999886322    22344568899999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.           +|+||||+|+||+++.++.++
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~h~dl~p~nil~~~~~~~~  146 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-----------RIMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCcChhhEEECCCCcEE
Confidence            899999999999998842     3488999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++..+.....  ......++..|+|||.+.+     ..++.++||||||+++|||++|.           .||..
T Consensus       147 l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~~l~~g~-----------~p~~~  208 (267)
T cd08224         147 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQ-----------SPFYG  208 (267)
T ss_pred             EeccceeeeccCCCc--ccceecCCccccCHHHhcc-----CCCCchhcHHHHHHHHHHHHHCC-----------CCccc
Confidence            999999977654321  1233468889999999865     35678899999999999999994           45432


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ..   ....+..+..... ..+..+.    ...+..+.++|.+||..+|++|||+.++++.+..+
T Consensus       209 ~~---~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         209 DK---MNLYSLCKKIEKC-DYPPLPA----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC---ccHHHHHhhhhcC-CCCCCCh----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            21   1222333333222 2223332    11234789999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-39  Score=311.71  Aligned_cols=268  Identities=24%  Similarity=0.358  Sum_probs=198.4

Q ss_pred             cceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      +-|++.+.||+|+||.||++++      .+..||+|.+....  .......+|+.+++.++|+||+++++++.....  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG--N   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC--C
Confidence            4578899999999999999985      35679999986443  223456789999999999999999999876532  2


Q ss_pred             eeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      .+++||||+++|+|.+++...  .+++..+..++.|++.||+|||++           +|+||||||+|||++.++.+||
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~-----------gi~H~dlkp~Nil~~~~~~~~l  150 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-----------QYVHRDLAARNVLVESEHQVKI  150 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecccchheEEEcCCCCEEE
Confidence            458999999999999998543  589999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++.+...... .......++..|+|||++.+     ..++.++||||||+++|||++++.++..+......-...
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~  225 (284)
T cd05079         151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-----SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP  225 (284)
T ss_pred             CCCccccccccCccceeecCCCCCCccccCHHHhcc-----CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence            999999876543321 11223456778999998865     356788999999999999999865442221110000000


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      . ............. ....+...+..     .+..+.+|+.+||+.||++|||+.++++.+..
T Consensus       226 ~-~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         226 T-HGQMTVTRLVRVL-EEGKRLPRPPN-----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             c-cccccHHHHHHHH-HcCccCCCCCC-----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            0 0111122222222 22222233332     33489999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6e-39  Score=307.16  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=182.0

Q ss_pred             EeecCCceEEEEEEE-CC---CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhc
Q psy17532        119 VKAQGRFGAVWKAKF-KN---ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~-~~---~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      .||+|+||.||+|+. ++   ..+++|.+.....  ....+.+|+..+..++||||+++++.+.....    +++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~----~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP----YLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc----cEEEEecC
Confidence            689999999999976 33   2456676654332  23345678888889999999999999987653    48999999


Q ss_pred             cCCChhhhhcCC-----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        193 ERGSLCDFLKCN-----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       193 ~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ++|+|.++++..     .+.+..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-----------~i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-----------NFLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCccceEEEcCCccEEecccccc
Confidence            999999999642     356677889999999999999998           9999999999999999999999999998


Q ss_pred             cccCCCCCCCCCCCCcCCCccccccccccccc--ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN--FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ................++..|+|||++.+...  ....++.++||||||+++|||++++          ..||...    
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~----------~~p~~~~----  212 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA----------AQPYSHL----  212 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC----------CCCCCCC----
Confidence            65332221122234568899999999854211  1234567899999999999999863          4455332    


Q ss_pred             CCHHHHHHHHhccC----CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHKK----LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ...+....+..+.    .++.++..     ....+.+++..|| .+|++||+++++++.|
T Consensus       213 -~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         213 -SDREVLNHVIKDQQVKLFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             -CHHHHHHHHHhhcccccCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence             2223333322221    12222222     3347889999999 6799999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.2e-39  Score=306.86  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----------SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      +|.+...||+|+||.||+|..  .++.||+|.+......          ....++|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999987  4688999988543221          1234678889999999999999999887653


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                          .++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.           +++||||+|+||++++++.+
T Consensus        81 ----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~-----------~ivH~di~p~nil~~~~~~~  145 (267)
T cd06628          81 ----LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR-----------GIIHRDIKGANILVDNKGGI  145 (267)
T ss_pred             ----cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc-----------CcccccCCHHHEEEcCCCCE
Confidence                4899999999999999965 4688999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCC----CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCG----DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      ||+|||+++.........    ......|+..|+|||.+.+.     .++.++||||||+++|||++|           .
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~  209 (267)
T cd06628         146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-----SYTRKADIWSLGCLVVEMLTG-----------K  209 (267)
T ss_pred             EecccCCCcccccccccCCccccccccCCCcCccChhHhccC-----CCCchhhhHHHHHHHHHHhhC-----------C
Confidence            999999998775322111    11234578899999998763     566789999999999999999           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .||....    ....+ ..+. ....+.++..++     ..+.++|++||+.||++||++.+++++.+
T Consensus       210 ~p~~~~~----~~~~~-~~~~-~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         210 HPFPDCT----QLQAI-FKIG-ENASPEIPSNIS-----SEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             CCCCCcc----HHHHH-HHHh-ccCCCcCCcccC-----HHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence            5554321    11111 1111 133344444333     47899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.4e-39  Score=306.12  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=197.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CC---cEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NE---NVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~---~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .++|+..+.||+|+||.||+|+..  +.   .+|+|.+....  ........|+.++..++|+||+++++++...+.   
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP---   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC---
Confidence            457899999999999999999983  32   69999886442  223445678888999999999999999987654   


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +++||||||+|||++.++.+||
T Consensus        81 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-----------~i~H~dlkp~Nili~~~~~~kl  148 (268)
T cd05063          81 -AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM-----------NYVHRDLAARNILVNSNLECKV  148 (268)
T ss_pred             -cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccccchhhEEEcCCCcEEE
Confidence             4899999999999999954  4689999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCc
Q psy17532        262 ADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~  339 (461)
                      +|||++.......... .......+..|+|||++.+     ..++.++|||||||++|||++ |           ..||.
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~il~ell~~g-----------~~p~~  212 (268)
T cd05063         149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-----RKFTSASDVWSFGIVMWEVMSFG-----------ERPYW  212 (268)
T ss_pred             CCCccceecccccccceeccCCCcCceecCHHHhhc-----CCcChHhHHHHHHHHHHHHHhCC-----------CCCCC
Confidence            9999998765432111 1112234567999999865     356788999999999999997 7           55664


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ..     ...+....+... .+.+.+..     .+..+.+++.+||..||++||++.++++.+..+
T Consensus       213 ~~-----~~~~~~~~i~~~-~~~~~~~~-----~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         213 DM-----SNHEVMKAINDG-FRLPAPMD-----CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cC-----CHHHHHHHHhcC-CCCCCCCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            33     223344444332 22222222     234789999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-39  Score=307.78  Aligned_cols=255  Identities=22%  Similarity=0.369  Sum_probs=200.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CC----cEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NE----NVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~----~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|++.+.||+|+||.||+|...  ++    .||+|.+.....  ......+|+..+.+++|+||+++++++.. .  
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S--   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C--
Confidence            3467899999999999999999873  32    589998765432  23345678999999999999999999876 2  


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        ..++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+
T Consensus        82 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          82 --QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK-----------RLVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             --ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEecccCcceEEEcCCCeE
Confidence              45899999999999999965  3589999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+++.+.............++..|+|||.+.+     ..++.++||||||+++||+++ |           ..||
T Consensus       149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~~~g-----------~~p~  212 (279)
T cd05057         149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-----RIYTHKSDVWSYGVTVWELMTFG-----------AKPY  212 (279)
T ss_pred             EECCCcccccccCcccceecCCCcccccccCHHHhhc-----CCcCchhhHHHHHHHHHHHhcCC-----------CCCC
Confidence            9999999987764432222222334678999998864     356788999999999999998 7           5566


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ...++...+... .....+..++     ..+.+++.+||..||++||++.++++.+..+..
T Consensus       213 ~~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         213 EGI-----PAVEIPDLLEKG-ERLPQPPICT-----IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCC-----CHHHHHHHHhCC-CCCCCCCCCC-----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            443     334444444332 2233333222     378899999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.7e-39  Score=308.71  Aligned_cols=251  Identities=26%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      .|+..+.||+|+||.||+|..  .++.||+|.+....  .......+|+.+++.++|+||+++++++.+..    .+++|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   80 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT----KLWII   80 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----EEEEE
Confidence            577888999999999999988  46789999987543  22344567888899999999999999998765    45999


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |||+++|+|.+++..+.+++..+..++.|++.||+|||+.           +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~-----------~ivH~dl~p~Nil~~~~~~~~l~dfg~~~  149 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE-----------KKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCcCCChhhEEEcCCCCEEEcccccce
Confidence            9999999999999888899999999999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .......  ......++..|+|||++.+.     ..+.++||||||+++|||++|           ..||...     ..
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~-----~~~~~~Dv~slG~il~el~tg-----------~~p~~~~-----~~  206 (277)
T cd06640         150 QLTDTQI--KRNTFVGTPFWMAPEVIQQS-----AYDSKADIWSLGITAIELAKG-----------EPPNSDM-----HP  206 (277)
T ss_pred             eccCCcc--ccccccCcccccCHhHhccC-----CCccHHHHHHHHHHHHHHHHC-----------CCCCCCc-----Ch
Confidence            7654321  22334678899999998753     567889999999999999999           4455432     11


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ......+ .....+.++..     .+..+.+++.+||+.||++||++.+++.+.+....
T Consensus       207 ~~~~~~~-~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         207 MRVLFLI-PKNNPPTLTGE-----FSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             HhHhhhh-hcCCCCCCchh-----hhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            1111111 12222333322     33478999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.4e-39  Score=303.22  Aligned_cols=248  Identities=22%  Similarity=0.377  Sum_probs=196.5

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+++.  .++.||+|.+.....   .....++|+..+++++|+||+++++.+....   ..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED---GLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC---CEEEE
Confidence            488999999999999999988  467899999864332   2234567888899999999999998875433   24589


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|||+++++|.+++..   ..+++.++..++.|++.||+|||+.           +|+||||||+||+++.++.++|+||
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~-----------~i~H~di~p~nil~~~~~~~~l~df  146 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-----------HILHRDLKTQNVFLTRTNIIKVGDL  146 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCchhEEEecCCcEEEecc
Confidence            9999999999999853   3589999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++.......  .......+++.|+|||++.+     ..++.++||||||+++|||++|           ..||...   
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g-----------~~~~~~~---  205 (257)
T cd08223         147 GIARVLENQC--DMASTLIGTPYYMSPELFSN-----KPYNYKSDVWALGCCVYEMATL-----------KHAFNAK---  205 (257)
T ss_pred             cceEEecccC--CccccccCCcCccChhHhcC-----CCCCchhhhHHHHHHHHHHHcC-----------CCCCCCC---
Confidence            9998764332  12334568899999999876     3567789999999999999999           4555432   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ............. .+..+..     .+..+.+++.+||+.||++|||+.+++++.+
T Consensus       206 --~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         206 --DMNSLVYRIIEGK-LPPMPKD-----YSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             --CHHHHHHHHHhcC-CCCCccc-----cCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence              2233333333322 2233332     2347999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.2e-39  Score=307.34  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=196.2

Q ss_pred             ceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCCh-------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDK-------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      +|+..+.||+|+||.||+|.. +++.+|||.+.....       ......+|+.+++.++|+||+++++++.+..    .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----T   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----e
Confidence            467889999999999999987 577899998864321       1233567888999999999999999998764    4


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++++||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+|+||+|+||++++++.+||+|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN-----------CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCcCHHhEEECCCCeEEecc
Confidence            5899999999999999964 5689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCC----CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        264 FGLALLFEPGKP----CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       264 FGla~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||++........    ........|+..|+|||++.+.     .++.++||||||+++|||++|           ..||.
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g-----------~~p~~  209 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-----GYGRKSDIWSIGCTVFEMATG-----------KPPLA  209 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCC-----CCcchhhHHHHHHHHHHHHhC-----------CCccc
Confidence            999976532111    0112335688999999998753     567889999999999999999           55654


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ...    ...............+.++..+     +..+.++|++||..||++||++.+++++.+
T Consensus       210 ~~~----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         210 SMD----RLAAMFYIGAHRGLMPRLPDSF-----SAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             cCC----hHHHHHHhhhccCCCCCCCCCC-----CHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            320    1122222221222333444433     347899999999999999999999998864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.7e-39  Score=313.11  Aligned_cols=271  Identities=19%  Similarity=0.227  Sum_probs=192.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+|++.+.||+|+||.||+|..  +++.||+|.+......  .....+|+.++..++|+||+++++++....    ..+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE----TLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC----eEE
Confidence            46899999999999999999987  4788999998654322  234567888899999999999999988754    458


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|+||+. ++|.+++..  ..+.+..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ-----------HILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCChHHEEEcCCCcEEEecc
Confidence            9999996 688777643  4578888999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC----------
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY----------  334 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~----------  334 (461)
                      |+++......  .......++..|+|||++.+.    ..++.++||||||+++|||++|..||.......          
T Consensus       148 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  221 (291)
T cd07870         148 GLARAKSIPS--QTYSSEVVTLWYRPPDVLLGA----TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVL  221 (291)
T ss_pred             ccccccCCCC--CCCCCccccccccCCceeecC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHc
Confidence            9997653322  112334578999999998653    245678999999999999999965553221100          


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..|..........................+...+........+.+++.+|+..||++|||+.+++.|.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         222 GVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             CCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence            000000000000000000000000000011111111122357889999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-39  Score=304.32  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=198.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .++|++.+.||+|+||.||+|..  .++.+|+|.+...... .....+|+.++++++||||+++++++....    .+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD----KLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC----EEEE
Confidence            35799999999999999999998  3678999998754432 344578889999999999999999987755    4599


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +|||+++++|.+++..  ..+++..+..++.|++.||.|||+.           +|+|+||||+||+++.++.+||+|||
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-----------~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET-----------GKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-----------CceecCCChhhEEECCCCCEEECccc
Confidence            9999999999999854  4799999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++..+....  .......++..|+|||.+.+..  ...++.++||||||+++|||++|           ..||...    
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~--~~~~~~~~Di~slG~~l~~~~tg-----------~~p~~~~----  207 (262)
T cd06613         147 VSAQLTATI--AKRKSFIGTPYWMAPEVAAVER--KGGYDGKCDIWALGITAIELAEL-----------QPPMFDL----  207 (262)
T ss_pred             cchhhhhhh--hccccccCCccccCchhhcccc--cCCcCchhhhHHHHHHHHHHHhC-----------CCCCCCC----
Confidence            997765422  1223356888999999986531  12566789999999999999999           4555432    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ...............+.....  ....+.++.+++++||..||++|||+++++.+.
T Consensus       208 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         208 -HPMRALFLISKSNFPPPKLKD--KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             -CHHHHHHHHHhccCCCccccc--hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence             111212222222222211111  112345789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.7e-39  Score=305.10  Aligned_cols=244  Identities=26%  Similarity=0.447  Sum_probs=195.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ..+|++.+.||+|+||.||+|...++.||+|.+.... ......+|+.++..++||||+++++++....     .+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~v~e   78 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-----LYIVME   78 (254)
T ss_pred             HHHceeeeeeccCCCCceEecccCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-----cEEEEE
Confidence            4679999999999999999999999999999986433 2335567888899999999999999986533     489999


Q ss_pred             hccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        191 YHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       191 ~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |+++|+|.+++...   .+++..+..++.|++.||.|||+.           +++||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~~~H~dl~p~nili~~~~~~kl~Dfg~~  147 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-----------KLVHRDLAARNILVSEDGVAKVSDFGLA  147 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccccCcceEEEcCCCcEEECCCccc
Confidence            99999999999542   478999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      .......     .....+..|+|||.+.+.     .++.++||||||+++|||++ |           ..||...     
T Consensus       148 ~~~~~~~-----~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~~l~el~~~g-----------~~p~~~~-----  201 (254)
T cd05083         148 RVGSMGV-----DNSKLPVKWTAPEALKHK-----KFSSKSDVWSYGVLLWEVFSYG-----------RAPYPKM-----  201 (254)
T ss_pred             eeccccC-----CCCCCCceecCHHHhccC-----CcCchhhHHHHHHHHHHHHhCC-----------CCCCccC-----
Confidence            7643221     123346789999988653     56788999999999999998 6           5566443     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ...+....+.. ..++..+..     .+..+.+++.+||+.+|++||+++++++.+.
T Consensus       202 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         202 SLKEVKECVEK-GYRMEPPEG-----CPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CHHHHHHHHhC-CCCCCCCCc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            33344443332 233333332     2347899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.9e-39  Score=303.70  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|+..+.||+|+||.||.++.  +++.+++|.+....   .....+.+|+.++++++|+||+++++++.+..    .+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~~   76 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN----TLLI   76 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC----eEEE
Confidence            488999999999999988887  57889999886432   23344568999999999999999999998765    4589


Q ss_pred             eehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +++||||+|+||+++.++.+||+||
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~h~dl~p~ni~~~~~~~~kl~d~  145 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-----------GILHRDIKTLNIFLTKAGLIKLGDF  145 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CccccCCChHhEEEeCCCCEEECcC
Confidence            99999999999999653   589999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++........  ......++..|+|||++.+.     ..+.++||||||+++|||++|           ..||...   
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~-----~~~~~~Dv~slG~i~~~l~~g-----------~~~~~~~---  204 (256)
T cd08221         146 GISKILGSEYS--MAETVVGTPYYMSPELCQGV-----KYNFKSDIWALGCVLYELLTL-----------KRTFDAT---  204 (256)
T ss_pred             cceEEcccccc--cccccCCCccccCHhhcCCC-----CCCCcchhHHHHHHHHHHHHC-----------CCCCCCC---
Confidence            99987654331  23345689999999998763     466789999999999999999           5555432   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ...+....+......+ .+.     ..+..+.+++.+||..||++||++.+++++++
T Consensus       205 --~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         205 --NPLNLVVKIVQGNYTP-VVS-----VYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             --CHHHHHHHHHcCCCCC-Ccc-----ccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence              2333333444433322 222     12347899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.7e-39  Score=309.37  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..+|++.+.||+|+||.||+|+.+       .+.||+|.+......  .....+|+.++.+++|+||+++++++.+... 
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   82 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP-   82 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc-
Confidence            368899999999999999999973       356999988644332  3456788999999999999999999877553 


Q ss_pred             ceeeeeeehhccCCChhhhhcCC----------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN----------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                         .++||||+++|+|.+++...          .+++..+..++.|++.||.|||+.           +|+||||||+||
T Consensus        83 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-----------~i~H~dlkp~Ni  148 (275)
T cd05046          83 ---HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-----------RFVHRDLAARNC  148 (275)
T ss_pred             ---ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-----------CcccCcCccceE
Confidence               48999999999999998532          489999999999999999999998           999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       252 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      |++.++.++|+|||+++....... .......++..|+|||.+.+.     ..+.++||||||+++|||++++       
T Consensus       149 li~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~~~-------  215 (275)
T cd05046         149 LVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED-----DFSTKSDVWSFGVLMWEVFTQG-------  215 (275)
T ss_pred             EEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccC-----CCCchhhHHHHHHHHHHHHhCC-------
Confidence            999999999999999876533221 223344667889999988653     4567899999999999999942       


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ..||...     ..................+..     .+..+.+++.+||..||++|||+.+++..+.
T Consensus       216 ---~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         216 ---ELPFYGL-----SDEEVLNRLQAGKLELPVPEG-----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ---CCCcccc-----chHHHHHHHHcCCcCCCCCCC-----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence               5566432     223333343333332222322     2348999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.6e-39  Score=306.44  Aligned_cols=237  Identities=18%  Similarity=0.286  Sum_probs=179.9

Q ss_pred             eEeecCCceEEEEEEECC--------------CcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        118 EVKAQGRFGAVWKAKFKN--------------ENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~--------------~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      +.||+|+||.||+|+...              ..||+|.+...... ...+..|+.++..++||||+++++++....   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~---   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV---   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            468999999999998632              24888887543332 223456778889999999999999988754   


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc--
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT--  258 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~--  258 (461)
                       ..++||||+++|+|..++..  ..+++..++.++.||+.||+|||+.           +|+||||||+|||++.++.  
T Consensus        78 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~dlkp~Nill~~~~~~~  145 (262)
T cd05077          78 -ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK-----------DLVHGNVCTKNILLAREGIDG  145 (262)
T ss_pred             -CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-----------CeECCCCCcccEEEecCCccC
Confidence             34899999999999998853  4689999999999999999999998           9999999999999987654  


Q ss_pred             -----eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        259 -----AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       259 -----~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                           +|++|||++......      ....++..|+|||.+.+.    ..++.++|||||||++|||++++         
T Consensus       146 ~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~el~~~~---------  206 (262)
T cd05077         146 ECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDS----KNLSIAADKWSFGTTLWEICYNG---------  206 (262)
T ss_pred             CCCceeEeCCCCCCccccCc------ccccccccccChhhhcCC----CCCCchhHHHHHHHHHHHHHhCC---------
Confidence                 899999998765322      234678899999988642    35678899999999999998532         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ..||...     ...+.. ...........+       ...++.+||.+||+.||++||++.++++++
T Consensus       207 -~~p~~~~-----~~~~~~-~~~~~~~~~~~~-------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         207 -EIPLKDK-----TLAEKE-RFYEGQCMLVTP-------SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -CCCCCCc-----chhHHH-HHHhcCccCCCC-------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             4455432     111111 111111111111       234789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-38  Score=308.92  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=198.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||++..  .++.||+|.+....    .......+|+.++++++||||+++++++..+.    .+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   76 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS----NL   76 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----eE
Confidence            4689999999999999999998  46889999986432    22334567888999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||+|+|||++.++.+||+||
T Consensus        77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-----------~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL-----------DIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCCCHHHEEECCCCCEEEeeC
Confidence            89999999999999985 45689999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.....     .....+++.|+|||.+.+.     ..+.++||||||+++|+|++|           ..||...   
T Consensus       146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~~---  201 (290)
T cd05580         146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSK-----GYGKAVDWWALGILIYEMLAG-----------YPPFFDD---  201 (290)
T ss_pred             CCccccCCC-----CCCCCCCccccChhhhcCC-----CCCccccHHHHHHHHHHHHhC-----------CCCCCCC---
Confidence            999876543     2334688999999988653     566789999999999999999           5666433   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGML  404 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~  404 (461)
                        ........+...  ...+|..++     ..+.+++.+||..||++|+     +++++++|.+.
T Consensus       202 --~~~~~~~~~~~~--~~~~~~~~~-----~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         202 --NPIQIYEKILEG--KVRFPSFFS-----PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             --CHHHHHHHHhcC--CccCCccCC-----HHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence              223333333322  233444332     3789999999999999999     67777777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-39  Score=310.24  Aligned_cols=270  Identities=24%  Similarity=0.347  Sum_probs=202.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC------CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      .+.|++.+.||+|+||.||+|+++      ++.||||.+......  ...+++|+.+++.++|+||+++++++....  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG--G   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC--C
Confidence            357888899999999999999974      567999998755443  456678999999999999999999887633  2


Q ss_pred             eeeeeeehhccCCChhhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ...+++|||+++|+|.+++....  +++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+|
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-----------~i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ-----------RYIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHhEEEcCCCCEE
Confidence            24589999999999999996554  99999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      |+|||++......... .......++..|+|||.+.+.     .++.++||||||+++|||++|..|+......... +.
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~  223 (284)
T cd05038         150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-----KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MI  223 (284)
T ss_pred             EcccccccccccCCcceeccCCCCCcccccCcHHHccC-----CCCcccchHHHhhhhheeeccCCCcccccchhcc-cc
Confidence            9999999877633221 112223456679999988653     5678899999999999999997665432221100 00


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ...........+.+... ...+...+..+     +.++.+++.+||+.||++|||+.++++.+..+
T Consensus       224 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         224 GIAQGQMIVTRLLELLK-EGERLPRPPSC-----PDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccccccHHHHHHHHH-cCCcCCCCccC-----CHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00011112333333322 22222333322     24799999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-39  Score=304.68  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...++|++.+.||+|+||.||+|..+ +..||||.+............|+.++++++|+||+++++++....    .+++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~   78 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE----PIYI   78 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC----ceEE
Confidence            34578999999999999999999884 467999998765555556778999999999999999999987654    3499


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||+++++|.+++..   ..+++..+..++.|++.||.|||++           +++|+||||+||++++++.+||+||
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-----------~i~h~di~p~nili~~~~~~~l~d~  147 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-----------NYIHRDLAARNILVGENLVCKIADF  147 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCcchheEEEcCCCCEEECcc
Confidence            9999999999999954   3589999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++.+..... .......++..|+|||.+.+.     .++.++||||||+++||+++ |           +.||...  
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~il~~l~t~g-----------~~p~~~~--  208 (261)
T cd05034         148 GLARLIEDDEY-TAREGAKFPIKWTAPEAANYG-----RFTIKSDVWSFGILLTEIVTYG-----------RVPYPGM--  208 (261)
T ss_pred             ccceeccchhh-hhhhccCCCccccCHHHhccC-----CcCchhHHHHHHHHHHHHHhCC-----------CCCCCCC--
Confidence            99987653221 111223356789999988753     56788999999999999999 7           5666433  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ........+.. ..+...+...     +..+.+++.+||..||++||+++++.+.+.
T Consensus       209 ---~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         209 ---TNREVLEQVER-GYRMPRPPNC-----PEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ---CHHHHHHHHHc-CCCCCCCCCC-----CHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence               22333333332 2233333332     347899999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.3e-39  Score=306.64  Aligned_cols=253  Identities=22%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..+|.+.+.||+|+||.||+|.+..     ..||||......  .......+|+.++++++|+||+++++++.+.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-----   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-----
Confidence            4568899999999999999998732     368999876443  2234567789999999999999999988753     


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ..++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +++||||||+|||++.++.+||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~~~H~dl~p~nili~~~~~~~l  148 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK-----------RFVHRDIAARNVLVSSPDCVKL  148 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccccChheEEEecCCCeEE
Confidence            24799999999999999964  3489999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++......... .....++..|+|||.+.+     ..++.++||||||+++||+++ |           ..||..
T Consensus       149 ~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g-----------~~pf~~  211 (270)
T cd05056         149 GDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMLG-----------VKPFQG  211 (270)
T ss_pred             ccCceeeeccccccee-cCCCCccccccChhhhcc-----CCCCchhhhHHHHHHHHHHHHcC-----------CCCCCC
Confidence            9999998765442211 222345578999998865     356788999999999999986 8           556643


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .     ...+....+.. ..+...+...     +..+.++|.+||..+|++|||+.++++.+..+..
T Consensus       212 ~-----~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         212 V-----KNNDVIGRIEN-GERLPMPPNC-----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             C-----CHHHHHHHHHc-CCcCCCCCCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            3     22222333322 2233344333     2479999999999999999999999999876653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0200|consensus

Probab=100.00  E-value=1.1e-39  Score=344.09  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=212.5

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEEC---------CCcEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEE
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIG  173 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g  173 (461)
                      .......++++.+.||+|.||.|++|...         ...||||.++...  .+......|+.+|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34445556677789999999999999863         2359999986433  3345567888888887 7999999999


Q ss_pred             EEecCCccceeeeeeehhccCCChhhhhcCCC-----------------CCHHHHHHHHHHHHHHHHHHhhcccCCCcCC
Q psy17532        174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNI-----------------VTWEQLCRIALSMSKGLMHLHEEILPNKADS  236 (461)
Q Consensus       174 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~  236 (461)
                      +|.....    +++|+||+..|+|.+||+..+                 ++..+++.++.|||.||+||++.        
T Consensus       370 ~~t~~~~----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~--------  437 (609)
T KOG0200|consen  370 ACTQDGP----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV--------  437 (609)
T ss_pred             eeccCCc----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--------
Confidence            9988543    489999999999999997666                 99999999999999999999999        


Q ss_pred             CCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCC-CCcCCCcccccccccccccccCCCCCccchHHHHH
Q psy17532        237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL  315 (461)
Q Consensus       237 ~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gv  315 (461)
                         ++|||||.++|||+..+..+||+|||+|+.......+.... ...-+..|||||.+..     ..++.|+|||||||
T Consensus       438 ---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-----~~ft~kSDVWSfGI  509 (609)
T KOG0200|consen  438 ---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-----RVFTSKSDVWSFGI  509 (609)
T ss_pred             ---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-----CcccccchhhHHHH
Confidence               99999999999999999999999999999776655433121 1114677999999976     47889999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc
Q psy17532        316 VLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA  395 (461)
Q Consensus       316 il~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  395 (461)
                      +||||+|.+          ..||.+.    +...++.+ ....+.+...|..+..     +++++|+.||+.+|++||++
T Consensus       510 ~L~EifsLG----------~~PYp~~----~~~~~l~~-~l~~G~r~~~P~~c~~-----eiY~iM~~CW~~~p~~RP~F  569 (609)
T KOG0200|consen  510 LLWEIFTLG----------GTPYPGI----PPTEELLE-FLKEGNRMEQPEHCSD-----EIYDLMKSCWNADPEDRPTF  569 (609)
T ss_pred             HHHHHhhCC----------CCCCCCC----CcHHHHHH-HHhcCCCCCCCCCCCH-----HHHHHHHHHhCCCcccCCCH
Confidence            999999986          6677652    12455544 5566778888887654     89999999999999999999


Q ss_pred             cchhhhcHHH
Q psy17532        396 SCVVERGMLA  405 (461)
Q Consensus       396 ~evl~~l~~~  405 (461)
                      .++.+.+...
T Consensus       570 ~~~~~~~~~~  579 (609)
T KOG0200|consen  570 SECVEFFEKH  579 (609)
T ss_pred             HHHHHHHHHH
Confidence            9999988774

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=308.89  Aligned_cols=252  Identities=27%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +|++.+.||.|+||.||+|+.  +++.||+|.+....  .......+|+.+++.++|+||+++++++.+..    .+++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v   77 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS----KLWII   77 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC----eEEEE
Confidence            678889999999999999998  46889999986543  22334567888999999999999999988764    45999


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      +||+++++|.+++....+++..+..++.|++.||.|||+.           +++||||+|+||++++++.++|+|||+++
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-----------~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE-----------GKIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEECCCCCEEEcccccce
Confidence            9999999999999888899999999999999999999998           99999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+....  .......++..|+|||++.+.     .++.++||||||+++|||++|           ..||...     ..
T Consensus       147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~-----~~~~~sDv~slG~il~~l~tg-----------~~p~~~~-----~~  203 (274)
T cd06609         147 QLTSTM--SKRNTFVGTPFWMAPEVIKQS-----GYDEKADIWSLGITAIELAKG-----------EPPLSDL-----HP  203 (274)
T ss_pred             eecccc--cccccccCCccccChhhhccC-----CCCchhhHHHHHHHHHHHHhC-----------CCCcccC-----ch
Confidence            876432  123345688899999999763     477899999999999999999           4555332     11


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ......+. ....+.++..    ..+..+.+++.+||..||++|||+++++++.+....
T Consensus       204 ~~~~~~~~-~~~~~~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         204 MRVLFLIP-KNNPPSLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HHHHHHhh-hcCCCCCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            11222221 1222222221    123478999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.1e-39  Score=305.86  Aligned_cols=243  Identities=23%  Similarity=0.347  Sum_probs=192.4

Q ss_pred             eEeecCCceEEEEEEECC---C--cEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFKN---E--NVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~---~--~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|.+..   +  .||||.+.....  ....+.+|+..+++++|+||+++++.+.. .    .+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEEEEEE
Confidence            468999999999998732   2  589999875544  23456789999999999999999999876 3    4589999


Q ss_pred             hccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        191 YHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       191 ~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |+++|+|.+++...   .+++..+..++.|++.||.|||+.           +++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-----------~i~H~di~p~nil~~~~~~~kl~dfg~~  144 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-----------RFIHRDLAARNILLASDDKVKIGDFGLM  144 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-----------CccccccCcccEEEecCCEEEecccccc
Confidence            99999999999653   589999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCC
Q psy17532        268 LLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       268 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +.+...... .......++..|+|||++.+     ..++.++||||||+++|||++ |           ..||...    
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Di~slG~~l~el~t~g-----------~~p~~~~----  204 (257)
T cd05040         145 RALPQNEDHYVMEEHLKVPFAWCAPESLRT-----RTFSHASDVWMFGVTLWEMFTYG-----------EEPWAGL----  204 (257)
T ss_pred             ccccccccceecccCCCCCceecCHHHhcc-----cCcCchhhhHHHHHHHHHHHhCC-----------CCCCCCC----
Confidence            877543221 11223457789999998865     356788999999999999998 8           5666433    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ...++...+.........+..     .+..+.+++.+||+.+|++|||+.++++.+
T Consensus       205 -~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         205 -SGSQILKKIDKEGERLERPEA-----CPQDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             -CHHHHHHHHHhcCCcCCCCcc-----CCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence             333444433332222333332     234799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.6e-39  Score=304.88  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=189.0

Q ss_pred             eEeecCCceEEEEEEEC-----CCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFK-----NENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|...     +..||+|.+....  ........|+.+++.++||||+++++++...+.   ..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEEEe
Confidence            46899999999999863     2469999875322  223345678888999999999999998765432   3489999


Q ss_pred             hccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        191 YHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       191 ~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |+.+|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||+++++.+||+|||+++
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlk~~nili~~~~~~kl~dfg~~~  146 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-----------KFVHRDLAARNCMLDESFTVKVADFGLAR  146 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccccccCcceEEEcCCCcEEECCccccc
Confidence            9999999999964  3467888899999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        269 LFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       269 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      .+......  .......++..|+|||.+.+     ..++.++||||||+++|||++|+          ..||...     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~----------~~~~~~~-----  206 (262)
T cd05058         147 DIYDKEYYSVHNHTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRG----------APPYPDV-----  206 (262)
T ss_pred             cccCCcceeecccccCcCCccccChhHhcc-----CccchHHHHHHHHHHHHHHHcCC----------CCCCCCC-----
Confidence            65432211  11123456778999998865     35678899999999999999974          3344322     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...++...+... ..+..+...     +..+.+++.+||..+|++||++.++++.+..+.
T Consensus       207 ~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         207 DSFDITVYLLQG-RRLLQPEYC-----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CHHHHHHHHhcC-CCCCCCCcC-----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            223333333332 223333322     237899999999999999999999999886653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-38  Score=301.92  Aligned_cols=242  Identities=24%  Similarity=0.372  Sum_probs=189.5

Q ss_pred             eEeecCCceEEEEEEE-CCCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        118 EVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      ++||+|+||.||+|.. .+..||+|.+......  ...+.+|+.++..++||||+++++++.....    .++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEEEEECCCC
Confidence            4789999999999987 4577999987644322  2345678888999999999999999887653    4899999999


Q ss_pred             CChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        195 GSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       195 gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      |+|.+++..  ..+++..+..++.|++.||.|||+.           +++||||||+||+++.++.+||+|||++.....
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK-----------NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            999999853  3578999999999999999999998           999999999999999999999999999976543


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDM  351 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~  351 (461)
                      ... .......++..|+|||++.+.     .++.++||||||+++||+++ |           ..||...     .....
T Consensus       146 ~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~ll~~~~~~g-----------~~p~~~~-----~~~~~  203 (250)
T cd05085         146 GIY-SSSGLKQIPIKWTAPEALNYG-----RYSSESDVWSYGILLWETFSLG-----------VCPYPGM-----TNQQA  203 (250)
T ss_pred             ccc-ccCCCCCCcccccCHHHhccC-----CCCchhHHHHHHHHHHHHhcCC-----------CCCCCCC-----CHHHH
Confidence            321 111223446789999998653     56788999999999999998 7           5566443     22333


Q ss_pred             HHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        352 QEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       352 ~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ...+. ...+...+...     +..+.+++.+||+.+|++||++.++++.+
T Consensus       204 ~~~~~-~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         204 REQVE-KGYRMSCPQKC-----PDDVYKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             HHHHH-cCCCCCCCCCC-----CHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            33332 23333333332     34799999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-39  Score=312.94  Aligned_cols=251  Identities=28%  Similarity=0.368  Sum_probs=198.0

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      .|+..+.||+|+||.||+|..  .++.||+|.+....  .......+|+.++++++|+||+++++++....    .+++|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   80 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT----KLWII   80 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC----ceEEE
Confidence            466778899999999999987  46789999886433  22334578899999999999999999987755    45999


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |||+++|+|.+++..+.+++..+..++.|++.||.|||++           +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE-----------RKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC-----------CeeccCCChheEEEeCCCCEEEccccccc
Confidence            9999999999999888899999999999999999999998           99999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+.....  ......++..|+|||++.+.     .++.++||||||+++|||++|.           .||....     .
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~-----------~p~~~~~-----~  206 (277)
T cd06642         150 QLTDTQI--KRNTFVGTPFWMAPEVIKQS-----AYDFKADIWSLGITAIELAKGE-----------PPNSDLH-----P  206 (277)
T ss_pred             cccCcch--hhhcccCcccccCHHHhCcC-----CCchhhhHHHHHHHHHHHHhCC-----------CCCcccc-----h
Confidence            7654321  12234678899999998763     5678899999999999999994           4443221     1


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ......+ .....+.++..     .+..+.+++.+||..+|++||++.+++.+.+....
T Consensus       207 ~~~~~~~-~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         207 MRVLFLI-PKNSPPTLEGQ-----YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             hhHHhhh-hcCCCCCCCcc-----cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            1111111 11122222222     23478999999999999999999999999876543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-38  Score=305.86  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=196.4

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-----------hhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-----------SWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-----------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      +|.+.+.||+|+||.||+|..  +++.||||.+......           ......|+..+..++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999987  5788999987532110           123456888899999999999999987755


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .+++||||+++|+|.++++. ..+++..+..++.|++.||.|||+.           +++||||+|+||+++.++.
T Consensus        82 ----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~~~nil~~~~~~  146 (272)
T cd06629          82 ----YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK-----------GILHRDLKADNLLVDADGI  146 (272)
T ss_pred             ----ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC-----------CeeecCCChhhEEEcCCCe
Confidence                45899999999999999965 5689999999999999999999998           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      ++|+|||+++...............|+..|+|||.+.+..   ..++.++||||||+++||+++|           ..||
T Consensus       147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g-----------~~p~  212 (272)
T cd06629         147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS---QGYSAKVDIWSLGCVVLEMFAG-----------RRPW  212 (272)
T ss_pred             EEEeeccccccccccccccccccccCCccccCHHHhcccc---CCCCccchhHHHHHHHHHHHhC-----------CCCC
Confidence            9999999997654322111233456889999999987531   2467889999999999999999           5555


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ...    ....... ........+.++.... ...+..+.++|.+||..||++|||+.+++.|.+
T Consensus       213 ~~~----~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         213 SDE----EAIAAMF-KLGNKRSAPPIPPDVS-MNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             cCc----chHHHHH-HhhccccCCcCCcccc-ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence            322    1111121 1222223333333221 123458999999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-38  Score=306.36  Aligned_cols=261  Identities=23%  Similarity=0.258  Sum_probs=199.3

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|+..+.||.|+||.||++..  .++.+|+|.+.....  ......+|+.++++++||||+++++++....  ...+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES--SSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--CCeEEE
Confidence            3688999999999999999998  467899999875433  2344568899999999999999999986644  235689


Q ss_pred             eehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        188 ITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ||||+++|+|.+++.     ...++...+..++.|++.||+|||+.           +++|+||+|+||+++.++.++|+
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-----------~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-----------KIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEEecCCeEEEe
Confidence            999999999998863     24588999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++.......    .....++..|+|||.+.+     ..++.++||||||+++|||++|..||           ....
T Consensus       148 dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~-----------~~~~  207 (287)
T cd06621         148 DFGVSGELVNSL----AGTFTGTSFYMAPERIQG-----KPYSITSDVWSLGLTLLEVAQNRFPF-----------PPEG  207 (287)
T ss_pred             eccccccccccc----cccccCCccccCHHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCC-----------Cccc
Confidence            999987654322    123457889999999865     35678899999999999999995444           3221


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhc-cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWK-QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .......+....+... ..+.++.... ....+..+.+++.+||..||++|||+.|++++.+...
T Consensus       208 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         208 EPPLGPIELLSYIVNM-PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             CCCCChHHHHHHHhcC-CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence            1111222333333221 1122221111 0113457899999999999999999999999987633

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-39  Score=306.40  Aligned_cols=243  Identities=26%  Similarity=0.361  Sum_probs=186.3

Q ss_pred             eEeecCCceEEEEEEECC--C--cEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKFKN--E--NVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~--~--~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++||+|+||.||+|+..+  .  .+|+|.+....  .......+|+.++.++ +||||+++++++.....    +++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----LYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----ceEEEE
Confidence            468999999999999843  2  46888776322  2233456788888899 89999999999987653    489999


Q ss_pred             hccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        191 YHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       191 ~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      |+++|+|.+++...                 .+++..+..++.|++.||+|||+.           +++||||||+|||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-----------~i~H~dikp~nili  145 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-----------QFIHRDLAARNILV  145 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecccccceEEE
Confidence            99999999998532                 378899999999999999999998           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPG  332 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~  332 (461)
                      +.++.+||+|||++......   ........+..|+|||++.+     ..++.++||||||+++|||++ |         
T Consensus       146 ~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~el~~~g---------  208 (270)
T cd05047         146 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLG---------  208 (270)
T ss_pred             cCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHcc-----CCCCchhhHHHHHHHHHHHHcCC---------
Confidence            99999999999998643211   11112234667999998865     356788999999999999997 7         


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                        ..||...     ...+....+.. ..+...+..     .+..+.+++.+||+.||.+|||+.+++..|..+
T Consensus       209 --~~pf~~~-----~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         209 --GTPYCGM-----TCAELYEKLPQ-GYRLEKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --CCCcccc-----CHHHHHHHHhC-CCCCCCCCc-----CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence              5666433     23333333322 222223322     234789999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4e-39  Score=315.73  Aligned_cols=268  Identities=24%  Similarity=0.291  Sum_probs=186.7

Q ss_pred             EeEeecCCceEEEEEEEC----CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhc
Q psy17532        117 VEVKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      ...||+|+||.||+|+..    +..||+|.+..... .....+|+.+++.++||||+++++++.....  ..+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSD--RKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC--CeEEEEEeee
Confidence            368999999999999974    36799998864432 2345678999999999999999998865432  3568999998


Q ss_pred             cCCChhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE----cCCCc
Q psy17532        193 ERGSLCDFLKC----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL----KSDLT  258 (461)
Q Consensus       193 ~~gsL~~~l~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl----~~~~~  258 (461)
                      .+ +|.+++..          ..+++..+..++.|++.||.|||+.           +|+||||||+|||+    +.++.
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-----------~ivH~Dlkp~Nil~~~~~~~~~~  150 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-----------WVLHRDLKPANILVMGEGPERGR  150 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----------CEEcCCCCHHHEEEccCCCCCCc
Confidence            75 78877631          2478888999999999999999998           99999999999999    55679


Q ss_pred             eEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC--C
Q psy17532        259 AAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY--R  335 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~--~  335 (461)
                      +||+|||+++........ .......||..|+|||++.+.    ..++.++|||||||++|||+||.+||.......  .
T Consensus       151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~  226 (317)
T cd07867         151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  226 (317)
T ss_pred             EEEeeccceeccCCCcccccccCcceecccccCcHHhcCC----CccCcHHHHHhHHHHHHHHHhCCCCccccccccccc
Confidence            999999999876543211 123345789999999998753    356788999999999999999987775432211  1


Q ss_pred             CCCcccc--------C--CCCCHHHH---------HHHHhccCC-CCCCCchh--ccchhHHHHHHHHHHHccccHhhhc
Q psy17532        336 LPFSAEV--------G--DHPSLEDM---------QEAVVHKKL-RPTLPETW--KQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       336 ~pf~~~~--------~--~~~~~~~~---------~~~~~~~~~-~~~~p~~~--~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      .+|....        +  ........         ......... ...+....  ........+.+|+.+||..||++||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~  306 (317)
T cd07867         227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI  306 (317)
T ss_pred             ccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc
Confidence            1111000        0  00000000         000000000 00000000  0001223688999999999999999


Q ss_pred             cccchhhhcH
Q psy17532        394 SASCVVERGM  403 (461)
Q Consensus       394 s~~evl~~l~  403 (461)
                      |+.|+++|.+
T Consensus       307 t~~e~l~hp~  316 (317)
T cd07867         307 TSEQALQDPY  316 (317)
T ss_pred             CHHHHhcCCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-39  Score=304.50  Aligned_cols=248  Identities=26%  Similarity=0.393  Sum_probs=196.1

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ++|++.+.||+|+||.||+|+..  +..+|+|.+..... .....+|+..++.++|+||+++++++....    .+++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNT----DLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCC----cEEEEE
Confidence            57899999999999999999985  57899999875433 456678899999999999999999998764    458999


Q ss_pred             hhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++++|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||+|+||+++.++.+||+|||++
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~-----------~i~H~dl~~~ni~~~~~~~~~l~dfg~~  146 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN-----------KKIHRDIKAGNILLNEEGQAKLADFGVS  146 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCcceEEECCCCcEEEcccccc
Confidence            9999999999985  45689999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ........  ......++..|+|||++.+.     .++.++||||||+++|||++|.           .||...     .
T Consensus       147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~s~G~il~~l~~g~-----------~p~~~~-----~  203 (256)
T cd06612         147 GQLTDTMA--KRNTVIGTPFWMAPEVIQEI-----GYNNKADIWSLGITAIEMAEGK-----------PPYSDI-----H  203 (256)
T ss_pred             hhcccCcc--ccccccCCccccCHHHHhcC-----CCCchhhHHHHHHHHHHHHhCC-----------CCCCCc-----c
Confidence            87654321  22334578899999998763     6678899999999999999994           444322     1


Q ss_pred             HHHHHHHHhcc-CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        348 LEDMQEAVVHK-KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       348 ~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .......+... ......+..     ....+.+++.+||+.||++|||+.+++++.+
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         204 PMRAIFMIPNKPPPTLSDPEK-----WSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             hhhhhhhhccCCCCCCCchhh-----cCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence            11111111110 000111111     2247899999999999999999999998864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-38  Score=302.13  Aligned_cols=247  Identities=22%  Similarity=0.402  Sum_probs=198.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+++.  .++.||+|.+...   ........+|+.++++++|+||+++++++...+    ..++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG----NLYI   76 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC----eEEE
Confidence            488999999999999999988  4688999998643   223345678899999999999999999987755    4599


Q ss_pred             eehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |+||+++++|.+++...   .+++..+..++.|++.||.|||+.           +++|+||+|+|||++.++.++|+||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~h~~l~~~nil~~~~~~~~l~d~  145 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-----------KILHRDIKSQNIFLTKDGTIKLGDF  145 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEEcCCCCEEEeec
Confidence            99999999999998542   578999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++........  ......|+..|+|||++.+.     ..+.++||||||+++|||++|           ..||...   
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~i~~~l~~g-----------~~~~~~~---  204 (256)
T cd08218         146 GIARVLNSTVE--LARTCIGTPYYLSPEICENR-----PYNNKSDIWALGCVLYEMCTL-----------KHAFEAG---  204 (256)
T ss_pred             cceeecCcchh--hhhhccCCccccCHHHhCCC-----CCCCccchhHHHHHHHHHHcC-----------CCCccCC---
Confidence            99977644321  12234578899999998653     566789999999999999999           4555432   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ...+....+..+. .+..+..+     +..+.++|.+||+.+|++||++.++++|.+
T Consensus       205 --~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         205 --NMKNLVLKIIRGS-YPPVSSHY-----SYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             --CHHHHHHHHhcCC-CCCCcccC-----CHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence              3334444443332 23333333     237999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-39  Score=304.90  Aligned_cols=237  Identities=19%  Similarity=0.310  Sum_probs=183.3

Q ss_pred             eEeecCCceEEEEEEECCC------------cEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        118 EVKAQGRFGAVWKAKFKNE------------NVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~------------~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +.||+|+||.||+|...+.            .|++|.+.........+.+|+.+++.++|+||+++++++.. .    ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D----EN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C----Cc
Confidence            4689999999999999543            37888776544334556778888999999999999999876 3    23


Q ss_pred             eeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC------
Q psy17532        186 WLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL------  257 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~------  257 (461)
                      ++||||+++|+|.+++...  .+++..+..++.||+.||+|||+.           +|+||||||+|||++.++      
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK-----------KLVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC-----------CeecccCccceEEEecCccccCCc
Confidence            8999999999999999643  589999999999999999999998           999999999999999887      


Q ss_pred             -ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 -TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 -~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                       .+||+|||++.....      .....++..|+|||++.+..   ..++.++||||||+++|||++|+          ..
T Consensus       145 ~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~~~~~l~~~~----------~~  205 (259)
T cd05037         145 PFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQ---ASLTIAADKWSFGTTLLEICSNG----------EE  205 (259)
T ss_pred             eeEEeCCCCccccccc------ccccccCCCccChhhhcCCC---CCcchhhHHHHHHHHHHHHHhCC----------CC
Confidence             799999999986543      12245677899999987631   35678899999999999999963          44


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ||....     ............ ....+.       ...+.++|.+||..||++|||+.++++.|
T Consensus       206 p~~~~~-----~~~~~~~~~~~~-~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         206 PLSTLS-----SSEKERFYQDQH-RLPMPD-------CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CcccCC-----chhHHHHHhcCC-CCCCCC-------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            554321     111111111111 111111       14789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.1e-39  Score=316.20  Aligned_cols=272  Identities=19%  Similarity=0.247  Sum_probs=189.8

Q ss_pred             EEeEeecC--CceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        116 LVEVKAQG--RFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       116 ~~~~lg~G--~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ++++||+|  +||+||+++.  +++.||||++....   ........|+.+++.++||||+++++++...+    .+++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN----ELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----EEEEE
Confidence            56789999  7899999988  47889999986542   22234457888899999999999999998765    45899


Q ss_pred             ehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.++++|||
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-----------GYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCCChhhEEEecCCcEEEcccc
Confidence            999999999999853   3589999999999999999999998           99999999999999999999999998


Q ss_pred             CccccCCCCC-C----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC------
Q psy17532        266 LALLFEPGKP-C----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY------  334 (461)
Q Consensus       266 la~~~~~~~~-~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~------  334 (461)
                      .+........ .    .......++..|+|||++.+.   ...++.++|||||||++|||++|..||.......      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  223 (327)
T cd08227         147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL  223 (327)
T ss_pred             hhhccccccccccccccccccccceecccChHHhhcc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh
Confidence            7644321110 0    011223567789999998653   1256788999999999999999976664321100      


Q ss_pred             --CCCCccccCCCCCHHHHHHHHhcc-------------CCCCCCCch---hccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        335 --RLPFSAEVGDHPSLEDMQEAVVHK-------------KLRPTLPET---WKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       335 --~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~~p~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                        ..|....... ...++........             ..++.....   -.....+..+.+|+.+||+.||++|||++
T Consensus       224 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  302 (327)
T cd08227         224 NGTVPCLLDTTT-IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS  302 (327)
T ss_pred             cCCccccccccc-hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence              0000000000 0000000000000             000000000   00011235789999999999999999999


Q ss_pred             chhhhcHHHh
Q psy17532        397 CVVERGMLAL  406 (461)
Q Consensus       397 evl~~l~~~~  406 (461)
                      ++++|.+...
T Consensus       303 ell~~p~f~~  312 (327)
T cd08227         303 TLLNHSFFKQ  312 (327)
T ss_pred             HHhcChhhhh
Confidence            9999988754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=308.06  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=197.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCC---CCCeeEEEEEEecCCccceee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHME---HDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .|+..+.||+|+||.||+|..  .++.||+|.+....  ......++|+.+++.++   ||||+++++++....    .+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~----~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP----RL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC----EE
Confidence            477889999999999999998  47889999986432  22344567777777775   999999999987654    45


Q ss_pred             eeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        186 WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++||||+++++|.++++.+.+++..+..++.|++.||.|||+.           +|+|+||+|+||+++.++.++|+|||
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----------~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV-----------GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            8999999999999999888899999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.......  .......|+..|+|||.+.++    ..++.++||||||+++|+|++|.           .||...    
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~ll~g~-----------~p~~~~----  205 (277)
T cd06917         147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEG----KYYDTKADIWSLGITIYEMATGN-----------PPYSDV----  205 (277)
T ss_pred             ceeecCCCc--cccccccCCcceeCHHHhccC----CccccchhHHHHHHHHHHHHhCC-----------CCCCCC----
Confidence            998775443  122334688999999988653    34567899999999999999994           444322    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ......... .....+.++.    ...+.++.++|.+||+.||++||++.+++.+.+...
T Consensus       206 -~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         206 -DAFRAMMLI-PKSKPPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             -Chhhhhhcc-ccCCCCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence             111111111 1111122221    113347999999999999999999999999877643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-38  Score=303.76  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=193.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++.+.....||+|+||.||+|+..  +..||+|.+..... ......+|+.+++.++|+||+++++++...+    .++
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~   81 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG----FFK   81 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC----EEE
Confidence            3445555678999999999999874  56799998865443 3345578899999999999999999988765    458


Q ss_pred             eeehhccCCChhhhhcC--CCC--CHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEE
Q psy17532        187 LITAYHERGSLCDFLKC--NIV--TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAI  261 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki  261 (461)
                      +|+||+++++|.+++..  ..+  ++..+..++.|++.||+|||+.           +|+||||||+||+++. ++.+||
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-----------QIVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC-----------CEeecCCCHHHEEEcCCCCeEEE
Confidence            99999999999999964  345  7888899999999999999998           9999999999999986 679999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++........  ......|+..|+|||++.+.   ...++.++||||||+++|||++|.           .||...
T Consensus       151 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slGvvl~~l~~g~-----------~p~~~~  214 (268)
T cd06624         151 SDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKG---PRGYGAPADIWSLGCTIVEMATGK-----------PPFIEL  214 (268)
T ss_pred             ecchhheecccCCC--ccccCCCCccccChhhhccc---cccCCchhhhHHHHHHHHHHHhCC-----------CCCccc
Confidence            99999976643221  12234578999999998653   124678899999999999999994           454322


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..   ...... ........+.++...     ..++.+++.+||+.+|++|||+.++++|.+
T Consensus       215 ~~---~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         215 GE---PQAAMF-KVGMFKIHPEIPESL-----SAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             cC---hhhhHh-hhhhhccCCCCCccc-----CHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence            10   001111 111112223344332     247899999999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3e-39  Score=311.46  Aligned_cols=254  Identities=26%  Similarity=0.320  Sum_probs=191.6

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|+.  +|+.||+|.+......   .....+|+..+++++|+||+++++++.+..    .+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~----~~~l   76 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK----KLTL   76 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC----ceEE
Confidence            478899999999999999998  4788999998643221   234467888999999999999999987765    4599


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |+||++ |+|.+++.  ...+++..+..++.||++||.|||+.           +|+||||||+||+++.++.+||+|||
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-----------~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          77 VFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-----------NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCCCHHHEEEcCCCcEEECccc
Confidence            999997 58888874  35689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++......  .......++..|+|||++.+.    ..++.++|||||||++|||++|+.|+.....             
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-------------  205 (284)
T cd07839         145 LARAFGIPV--RCYSAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGND-------------  205 (284)
T ss_pred             hhhccCCCC--CCcCCCccccCCcChHHHhCC----cccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-------------
Confidence            998664332  122334678899999998663    3457889999999999999999655422111             


Q ss_pred             CCHHHHHHHHh------------------ccCCCCCCCchh--c--cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVV------------------HKKLRPTLPETW--K--QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~------------------~~~~~~~~p~~~--~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ..+....+.                  .....+..+...  .  ....+.++.++|.+||+.||++|||++++++|.|
T Consensus       206 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         206 --VDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             --HHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence              111111000                  000001111000  0  0113357889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-38  Score=302.17  Aligned_cols=250  Identities=25%  Similarity=0.421  Sum_probs=197.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ...+|++.+.||+|+||.||+|.. .+..+|+|.+...........+|+.+++.++|+||+++++.+.. .    .++++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~----~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E----PIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C----CeEEE
Confidence            356899999999999999999987 45679999887554444566788989999999999999998876 2    34899


Q ss_pred             ehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +++||||||+||+++.++.+||+|||
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-----------~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-----------NYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-----------CccccccCcceEEEcCCCcEEECCCc
Confidence            999999999999954   3478889999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      ++..+..... .......++..|+|||++.+     ..++.++||||||+++||+++ |           ..||...   
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~t~g-----------~~p~~~~---  207 (260)
T cd05073         148 LARVIEDNEY-TAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYG-----------RIPYPGM---  207 (260)
T ss_pred             ceeeccCCCc-ccccCCcccccccCHhHhcc-----CCcCccccchHHHHHHHHHHhcC-----------CCCCCCC---
Confidence            9987654321 12223456678999999865     356778999999999999999 6           5566543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ....+...+.. ......+..     .+.++.+++.+||+.||++||++.++++.|.
T Consensus       208 --~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         208 --SNPEVIRALER-GYRMPRPEN-----CPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             --CHHHHHHHHhC-CCCCCCccc-----CCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence              22333333322 222222222     2347899999999999999999998887764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-39  Score=310.35  Aligned_cols=264  Identities=22%  Similarity=0.261  Sum_probs=199.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..++|++.+.||+|+||+||++...  ++.||+|++.....  ......+|+.++..++||||+++++++....    .+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~   78 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN----NI   78 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC----EE
Confidence            3468899999999999999999984  78899998865432  2345567888899999999999999998764    55


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.+++.. +.+++.....++.+++.||.|||+..          +++||||||+||++++++.++|+||
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----------~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH----------RIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc----------CeeccCCCHHHEEECCCCcEEEccC
Confidence            999999999999998854 46899999999999999999999731          8999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++.......    .....|+..|+|||++.+.     .++.++|||||||++||+++|..||..........     ..
T Consensus       149 gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-----~~  214 (284)
T cd06620         149 GVSGELINSI----ADTFVGTSTYMSPERIQGG-----KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-----DD  214 (284)
T ss_pred             Ccccchhhhc----cCccccCcccCCHHHHccC-----CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-----hh
Confidence            9987653221    2235789999999998653     66788999999999999999955553222110000     00


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .....+......... .+.++.    ...+..+.+|+.+||+.||++|||+.|++++++.+.
T Consensus       215 ~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         215 PMGILDLLQQIVQEP-PPRLPS----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hhHHHHHHHHHhhcc-CCCCCc----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            001111222222211 122221    113347899999999999999999999999976654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.5e-39  Score=307.26  Aligned_cols=235  Identities=17%  Similarity=0.239  Sum_probs=178.2

Q ss_pred             EeecCCceEEEEEEEC--------------------------CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEE
Q psy17532        119 VKAQGRFGAVWKAKFK--------------------------NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRY  171 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~~--------------------------~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l  171 (461)
                      .||+|+||.||+|...                          ...||+|.+...... ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5899999999999751                          124888888643322 2234567778899999999999


Q ss_pred             EEEEecCCccceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCC
Q psy17532        172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN  249 (461)
Q Consensus       172 ~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~  249 (461)
                      ++++.....    .++||||+++|+|..++..  +.+++..+..++.||++||+|||+.           +|+||||||+
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~iiH~dlkp~  146 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK-----------NLVHGNVCAK  146 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-----------CccCCCCCcc
Confidence            999987653    4899999999999999853  4689999999999999999999998           9999999999


Q ss_pred             cEEEcCCC-------ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH-
Q psy17532        250 NVLLKSDL-------TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA-  321 (461)
Q Consensus       250 NILl~~~~-------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~-  321 (461)
                      |||++..+       .+|++|||++......      ....++..|+|||.+.+.    ..++.++||||||+++|||+ 
T Consensus       147 Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~----~~~~~~~Dv~slG~~l~el~~  216 (274)
T cd05076         147 NILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG----NSLSTAADKWSFGTTLLEICF  216 (274)
T ss_pred             cEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCC----CCCCcHHHHHHHHHHHHHHHh
Confidence            99997643       4799999998654321      223577889999988653    35678899999999999995 


Q ss_pred             cCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        322 SRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       322 tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      +|           ..||...     ...+.... ....  ..++...     ...+.++|.+||+.+|++|||+.+++++
T Consensus       217 ~g-----------~~p~~~~-----~~~~~~~~-~~~~--~~~~~~~-----~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         217 DG-----------EVPLKER-----TPSEKERF-YEKK--HRLPEPS-----CKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CC-----------CCCcccc-----ChHHHHHH-HHhc--cCCCCCC-----ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            56           5555432     11111111 1111  1222211     1368899999999999999999999987


Q ss_pred             c
Q psy17532        402 G  402 (461)
Q Consensus       402 l  402 (461)
                      |
T Consensus       273 L  273 (274)
T cd05076         273 L  273 (274)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-38  Score=306.57  Aligned_cols=256  Identities=22%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||+|++.....   .......|+.+++.++|+||+++++++....    .++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~   76 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR----KLH   76 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC----EEE
Confidence            36899999999999999999984  78899998864322   1233567888999999999999999998765    458


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++++|..++.. ..+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+|||
T Consensus        77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-----------~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH-----------NCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCChhhEEEcCCCcEEECccc
Confidence            99999999888887743 4689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++..+.....  ......++..|+|||++.+.    ..++.++||||||+++|||++|..|           |.+..   
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~i~~~l~~g~~p-----------~~~~~---  205 (286)
T cd07847         146 FARILTGPGD--DYTDYVATRWYRAPELLVGD----TQYGPPVDVWAIGCVFAELLTGQPL-----------WPGKS---  205 (286)
T ss_pred             cceecCCCcc--cccCcccccccCCHHHHhCC----CCcCchhhhHHHHHHHHHHHhCCCC-----------CCCCC---
Confidence            9987754331  12234678899999998653    3466789999999999999999544           43221   


Q ss_pred             CCHHHHHHHH--h-----------c-cCC--CCCCCch--h-----ccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAV--V-----------H-KKL--RPTLPET--W-----KQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~--~-----------~-~~~--~~~~p~~--~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ..+......  .           . ...  ....+..  .     .....+..+.+|+.+||+.||++||++.+++.|.
T Consensus       206 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         206 -DVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             -hHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence             001110000  0           0 000  0000000  0     0011235789999999999999999999999986


Q ss_pred             H
Q psy17532        403 M  403 (461)
Q Consensus       403 ~  403 (461)
                      +
T Consensus       285 ~  285 (286)
T cd07847         285 Y  285 (286)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-38  Score=302.12  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=198.9

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||++..  .++.||+|.+.....   .......|+.+++.++|+||+++++++.....  ...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN--QTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC--CEEEE
Confidence            478899999999999999987  467899999864332   23345678889999999999999998765432  35689


Q ss_pred             eehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHh-----hcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        188 ITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLH-----EEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      +|||+++|+|.+++..     ..+++..+..++.|++.||+|||     +.           +|+|+||||+||+++.++
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-----------~i~h~dl~p~nili~~~~  147 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-----------TVLHRDLKPANIFLDANN  147 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-----------cceecCCCHHHEEEecCC
Confidence            9999999999999853     46899999999999999999999     66           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||++........  ......++..|+|||++.+.     .++.++||||||+++|+|++|           ..|
T Consensus       148 ~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~~p  209 (265)
T cd08217         148 NVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHM-----SYDEKSDIWSLGCLIYELCAL-----------SPP  209 (265)
T ss_pred             CEEEecccccccccCCcc--cccccccCCCccChhhhcCC-----CCCchhHHHHHHHHHHHHHHC-----------CCc
Confidence            999999999987764432  12335689999999998763     567889999999999999999           556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      |...     ....+...+.... .+.++..++     ..+.+++.+||+.+|++||++.+++++.+
T Consensus       210 ~~~~-----~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~l~~~~l~~~p~~Rp~~~~il~~~~  264 (265)
T cd08217         210 FTAR-----NQLQLASKIKEGK-FRRIPYRYS-----SELNEVIKSMLNVDPDKRPSTEELLQLPL  264 (265)
T ss_pred             ccCc-----CHHHHHHHHhcCC-CCCCccccC-----HHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence            5433     2334444443332 233444333     37899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.8e-38  Score=307.65  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=194.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...|++.+.||+|+||.||+|+.  .++.||+|.+.....    ......+|+.++..++||||+++++++.+.+.    
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~----   89 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT----   89 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe----
Confidence            35689999999999999999998  478899998864322    12345678888999999999999999987653    


Q ss_pred             eeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .++|+||++ |+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||+|+||+++.++.+||+
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~-----------~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH-----------ERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCCcccEEECCCCCEEEe
Confidence            489999997 57877763  45689999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++......      ....++..|+|||++.+.  ....++.++||||||+++|||++|           ..||... 
T Consensus       158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~s~G~il~el~tg-----------~~p~~~~-  217 (307)
T cd06607         158 DFGSASLVSPA------NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER-----------KPPLFNM-  217 (307)
T ss_pred             ecCcceecCCC------CCccCCccccCceeeecc--CCCCCCcccchHHHHHHHHHHHcC-----------CCCCCCc-
Confidence            99999765432      234678899999988532  123567899999999999999999           4555332 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCC-chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ........+... ..+.++ ..|     +..+.++|.+||..||++||++.+++.+.+...
T Consensus       218 ----~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         218 ----NAMSALYHIAQN-DSPTLSSNDW-----SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             ----cHHHHHHHHhcC-CCCCCCchhh-----CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                111111112111 112221 222     347899999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-38  Score=302.34  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=198.2

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.+.||.|+||.||+|..  ++..+|+|.+.....  ......+|+..++.++|+||+++++.+...+    .+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD----ELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC----EEEE
Confidence            4689999999999999999997  467899999864332  3345578888899999999999999987765    4599


Q ss_pred             eehhccCCChhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        188 ITAYHERGSLCDFLKC----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      |+||+++++|.++++.    ..+++..+..++.|++.||+|||+.           +|+||||+|+||++++++.+||+|
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~-----------~i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-----------GQIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHhEEEcCCCCEEEcc
Confidence            9999999999999954    3589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCC--CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        264 FGLALLFEPGKPCG--DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       264 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      ||++..+.......  ......|+..|+|||++...    ..++.++||||||+++|||++|           ..||...
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~----~~~~~~~Dv~slG~i~~~l~~g-----------~~p~~~~  210 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV----HGYDFKADIWSFGITAIELATG-----------AAPYSKY  210 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccc----cCcCcccchHhHhHHHHHHHhC-----------CCCcccc
Confidence            99997766543221  12334688999999998653    3567889999999999999999           5555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                           ............ ..+.++........+..+.+++.+||..||++||++.++++|.+
T Consensus       211 -----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         211 -----PPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             -----ChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence                 111111122121 11112211111123457899999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-38  Score=304.21  Aligned_cols=251  Identities=27%  Similarity=0.359  Sum_probs=199.4

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      -|++.+.||+|+||.||+|..  +++.||||.+.....  ......+|+..+.+++|+||+++++++..+.    .+++|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT----KLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC----eEEEE
Confidence            467888999999999999987  467899998764332  2234567888999999999999999998765    45899


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |||+++|+|.+++....+++..+..++.|++.||.|||+.           +++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE-----------KKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC-----------CeecCCCCHHhEEECCCCCEEEeecccce
Confidence            9999999999999888899999999999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+.....  ......++..|+|||.+.+.     ..+.++|||||||++|||++|           ..||...     ..
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g-----------~~p~~~~-----~~  206 (277)
T cd06641         150 QLTDTQI--KRNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELAKG-----------EPPHSEL-----HP  206 (277)
T ss_pred             ecccchh--hhccccCCccccChhhhccC-----CCCchhhHHHHHHHHHHHHcC-----------CCCCCcc-----ch
Confidence            7654321  12234678899999998653     566789999999999999999           5555432     11


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ......+ .....+.++..     .+..+.+++.+||..||++||++.+++.|.+....
T Consensus       207 ~~~~~~~-~~~~~~~~~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         207 MKVLFLI-PKNNPPTLEGN-----YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHH-hcCCCCCCCcc-----cCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            2222222 22222233322     23478999999999999999999999999776553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.7e-39  Score=340.83  Aligned_cols=255  Identities=21%  Similarity=0.234  Sum_probs=189.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|+.  .++.||||++.....    ......+|+.++++++||||+++++++.+.+    ..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~----~l   77 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD----PV   77 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC----EE
Confidence            5799999999999999999998  478899999864321    2334567899999999999999999998765    44


Q ss_pred             eeeehhccCCChhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        186 WLITAYHERGSLCDFLKC------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ++||||+++|+|.+++..            ..+++..++.++.||+.||+|||+.           +|+||||||+|||+
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-----------GIIHRDLKPeNILL  146 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-----------GVLHRDLKPDNILL  146 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCchheEEE
Confidence            899999999999998852            2356677899999999999999998           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCC----------------CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        254 KSDLTAAIADFGLALLFEPGKP----------------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                      +.++.+||+|||+++.......                ........||+.|||||++.+.     .++.++|||||||++
T Consensus       147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-----~~S~kSDIWSLGVIL  221 (932)
T PRK13184        147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-----PASESTDIYALGVIL  221 (932)
T ss_pred             cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-----CCCcHhHHHHHHHHH
Confidence            9999999999999987621110                0011234699999999998763     667899999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-cc
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-AS  396 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~  396 (461)
                      |||+||.           .||....+..    ...........  ...   +....+..+.+++.+||+.||++|++ ++
T Consensus       222 yELLTG~-----------~PF~~~~~~k----i~~~~~i~~P~--~~~---p~~~iP~~L~~LI~rcL~~DP~kR~ss~e  281 (932)
T PRK13184        222 YQMLTLS-----------FPYRRKKGRK----ISYRDVILSPI--EVA---PYREIPPFLSQIAMKALAVDPAERYSSVQ  281 (932)
T ss_pred             HHHHHCC-----------CCCCCcchhh----hhhhhhccChh--hcc---ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999995           4443321110    00000000000  000   00112347889999999999999975 45


Q ss_pred             chhhhcHHHh
Q psy17532        397 CVVERGMLAL  406 (461)
Q Consensus       397 evl~~l~~~~  406 (461)
                      ++++.+....
T Consensus       282 eLl~~Le~~l  291 (932)
T PRK13184        282 ELKQDLEPHL  291 (932)
T ss_pred             HHHHHHHHHH
Confidence            5555554443

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=299.01  Aligned_cols=244  Identities=26%  Similarity=0.351  Sum_probs=190.9

Q ss_pred             eEeecCCceEEEEEEEC-CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        118 EVKAQGRFGAVWKAKFK-NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      ++||+|+||.||++... ++.||+|.+.....  ....+.+|+.++++++|+||+++++++.....    .++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eEEEEEcCCC
Confidence            46899999999999985 78899998865433  23456778889999999999999999887653    4899999999


Q ss_pred             CChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        195 GSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       195 gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      ++|.+++..  ..+++..+..++.+++.||.|||++           +++||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~-----------~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  145 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK-----------NCIHRDLAARNCLVGENNVLKISDFGMSREEEG  145 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence            999999853  4588999999999999999999998           999999999999999999999999999986653


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      ...........++..|+|||.+.+.     .++.++||||||+++|||++++          ..||...     ......
T Consensus       146 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~i~~~l~t~~----------~~p~~~~-----~~~~~~  205 (251)
T cd05041         146 GIYTVSDGLKQIPIKWTAPEALNYG-----RYTSESDVWSYGILLWETFSLG----------DTPYPGM-----SNQQTR  205 (251)
T ss_pred             CcceeccccCcceeccCChHhhccC-----CCCcchhHHHHHHHHHHHHhcc----------CCCCccC-----CHHHHH
Confidence            2211111223346679999998653     5678899999999999999942          5566443     222333


Q ss_pred             HHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ..+.. ..+...+..     .+..+.+++.+||..+|++|||+.++++.|
T Consensus       206 ~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~ell~~l  249 (251)
T cd05041         206 ERIES-GYRMPAPQL-----CPEEIYRLMLQCWAYDPENRPSFSEIYNEL  249 (251)
T ss_pred             HHHhc-CCCCCCCcc-----CCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence            33322 223333333     234899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.4e-39  Score=306.63  Aligned_cols=244  Identities=24%  Similarity=0.370  Sum_probs=189.7

Q ss_pred             eEeecCCceEEEEEEECC--------CcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        118 EVKAQGRFGAVWKAKFKN--------ENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~--------~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +.||+|+||.||+|+...        ..+|||.+....  .......+|+.+++.++||||+++++++.....    .++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eEE
Confidence            368999999999998743        469999875433  233456688999999999999999999877653    489


Q ss_pred             eehhccCCChhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC--
Q psy17532        188 ITAYHERGSLCDFLKC--------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL--  257 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~--  257 (461)
                      ||||+++|+|.+++..        ..+++..+..++.|++.||+|||+.           +++|+||||+|||++.++  
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~i~H~dl~p~nil~~~~~~~  145 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-----------HFIHRDLAARNCLVSEKGYD  145 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCChheEEEecCCCC
Confidence            9999999999999853        2378899999999999999999998           999999999999999887  


Q ss_pred             ---ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCC
Q psy17532        258 ---TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGE  333 (461)
Q Consensus       258 ---~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~  333 (461)
                         .+||+|||+++...............++..|+|||++.++     .++.++||||||+++|||++ |          
T Consensus       146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~ellt~g----------  210 (269)
T cd05044         146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-----KFTTQSDVWSFGVLMWEILTLG----------  210 (269)
T ss_pred             CCcceEECCcccccccccccccccCcccCCCccccCHHHHccC-----CcccchhHHHHHHHHHHHHHcC----------
Confidence               8999999999876543322222334567889999998763     56788999999999999998 7          


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                       ..||...     ...+....+.. ..+...+..     .+..+.+++.+||..+|++||++.++++.+.
T Consensus       211 -~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         211 -QQPYPAL-----NNQEVLQHVTA-GGRLQKPEN-----CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -CCCCccc-----CHHHHHHHHhc-CCccCCccc-----chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             5566432     22233333322 222233332     3347899999999999999999999988763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-38  Score=301.52  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      +|+..+.||+|+||.||+|..  +++.||+|.+.....      ......+|+..++.++|+||+++++++....    .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED----N   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC----e
Confidence            367778999999999999998  478899998865431      2234567888999999999999999987764    4


Q ss_pred             eeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++++||+++++|.+++... .+++..+..++.|++.||+|||+.           +|+|+||+|+||+++.++.+||+|
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~~~ni~~~~~~~~kl~d  145 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR-----------NTVHRDIKGANILVDTNGVVKLAD  145 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEEcc
Confidence            58999999999999999654 489999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++.......   ......|+..|+|||.+...    ..++.++|+||||+++|+|++|           ..||...  
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~----~~~~~~~D~~slG~~l~~l~~g-----------~~pf~~~--  205 (258)
T cd06632         146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQ----GGYGLAADIWSLGCTVLEMATG-----------KPPWSQL--  205 (258)
T ss_pred             Cccceeccccc---cccccCCCcceeCHHHhcCC----CCCCchhhhHHHHHHHHHHHhC-----------CCCcccC--
Confidence            99997764432   12345688999999998653    1367889999999999999999           4555432  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ...............+.++...     +..+.+++.+||..||++||++.+++.+.+
T Consensus       206 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         206 ---EGVAAVFKIGRSKELPPIPDHL-----SDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             ---cHHHHHHHHHhcccCCCcCCCc-----CHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence               1111111222212233444332     347899999999999999999999998863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.6e-38  Score=299.86  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=196.5

Q ss_pred             eeEEeEeecCCceEEEEEEECC------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKN------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      +++.+.||+|+||.||+++...      ..||+|.+.....  .......|+..+..++|+||+++++++.+..    .+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE----PL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC----ee
Confidence            4577899999999999999954      7799999865443  3445667888899999999999999988764    45


Q ss_pred             eeeehhccCCChhhhhcCCC---CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +++|||+++++|.+++....   +++..+..++.|++.||+|||+.           +++||||||+||++++++.++|+
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-----------~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-----------NFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-----------CeeecccccceEEEccCCeEEEc
Confidence            89999999999999996433   89999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++........... ...++..|+|||.+.+     ..++.++||||||+++|||++++          ..||... 
T Consensus       146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~i~~~l~~~g----------~~p~~~~-  208 (258)
T smart00219      146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKD-----GKFTSKSDVWSFGVLLWEIFTLG----------ESPYPGM-  208 (258)
T ss_pred             ccCCceecccccccccc-cCCCcccccChHHhcc-----CCCCcchhHHHHHHHHHHHHhCC----------CCCCCCC-
Confidence            99999877654322211 2347789999998854     35678899999999999999842          4555432 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                          ....+.+.+.... ....+..     .+..+.+++.+||..||++|||+.++++.+
T Consensus       209 ----~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      209 ----SNEEVLEYLKKGY-RLPKPEN-----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CHHHHHHHHhcCC-CCCCCCc-----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                3344444443332 2333332     234799999999999999999999988753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0586|consensus

Probab=100.00  E-value=3.9e-39  Score=319.38  Aligned_cols=255  Identities=20%  Similarity=0.340  Sum_probs=217.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .......|.+.+.||+|.|+.|.+|++  ++..||||.+......   ....-+|+.+|+.++|||||+++.+.....  
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~--  128 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA--  128 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc--
Confidence            344567899999999999999999998  6889999998654332   233568999999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+|+||||+.+|.+++|+. .+++.+..+..++.|+..|++|||++           .|||||||++|||++.++++|
T Consensus       129 --~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k-----------~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  129 --TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK-----------NIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             --eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc-----------ceeccccchhhccccccccee
Confidence              4599999999999999995 45677788999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++..+..+.   .....+|++.|.|||++.|.    ...+.++|+||+|+++|-|+.|           .+||.+
T Consensus       196 IaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~----~y~gpe~D~Wslgvvly~LV~G-----------sLPFDG  257 (596)
T KOG0586|consen  196 IADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGK----KYDGPEVDIWSLGVVLYALVEG-----------SLPFDG  257 (596)
T ss_pred             eeccccceeecccc---cccccCCCCCccChHhhcCc----ccCCcceehhhhhhhheeeeec-----------ccccCC
Confidence            99999999887543   35567999999999999885    2334789999999999999999           888876


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .     +...+.+.++.++++-++.-.       .+..++|+++|..+|.+|++.+++.++-|.-.
T Consensus       258 ~-----~lk~Lr~rvl~gk~rIp~~ms-------~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  258 Q-----NLKELRPRVLRGKYRIPFYMS-------CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             c-----ccccccchheeeeecccceee-------chhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence            6     667777888888877665532       26779999999999999999999998876543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-38  Score=308.56  Aligned_cols=272  Identities=25%  Similarity=0.292  Sum_probs=194.5

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      +|++.+.||+|+||.||+|..  .++.||||.+......      ......|+.++..++|+||+++++++.+.+    .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----N   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC----E
Confidence            478899999999999999998  4688999998754322      233457888899999999999999998754    4


Q ss_pred             eeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .++||||+ +|+|.+++...  .+++..+..++.||++||.|||+.           +|+|+||||+|||++.++.+||+
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~i~H~dl~p~nill~~~~~~~l~  144 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN-----------WILHRDLKPNNLLIASDGVLKLA  144 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecCCChhhEEEcCCCCEEEc
Confidence            58999999 89999999664  499999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++.......  ......++..|+|||.+.+.    ..++.++|||||||++|||++|.++|...............
T Consensus       145 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~  218 (298)
T cd07841         145 DFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGA----RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA  218 (298)
T ss_pred             cceeeeeccCCCc--cccccccceeeeCHHHHhCC----CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence            9999987654321  12234567889999988543    35678899999999999999995444322110000000000


Q ss_pred             CCCCCHHHHHH-----HHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQE-----AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~-----~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...+.......     ........+..+..-.....+..+.++|.+||+.||++|||+.+++++.+...
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            00000000000     00000000000000000112457899999999999999999999999976544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.8e-38  Score=302.25  Aligned_cols=257  Identities=22%  Similarity=0.364  Sum_probs=193.7

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHH-cCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFK-LPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||+|++.....  .......|+.. ++.++||||+++++++....    ..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~----~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG----DVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC----cEE
Confidence            46899999999999999999984  78899999865432  22233344443 55679999999999998765    359


Q ss_pred             eeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        187 LITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ++|||++ |+|.+++..     ..+++..+..++.|++.||.|||++.          +++||||||+|||++.++.+||
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~----------~i~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL----------SVIHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------CeecCCCCHHHEEECCCCCEEE
Confidence            9999997 688887742     35899999999999999999999752          7999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++.......   ......++..|+|||++.+... ...++.++||||||+++|||++|           ..||...
T Consensus       146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~~l~~l~~g-----------~~p~~~~  210 (283)
T cd06617         146 CDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATG-----------RFPYDSW  210 (283)
T ss_pred             eeccccccccccc---ccccccCCccccChhhcCCccc-ccccCccccchhhHHHHHHHHhC-----------CCCCCcc
Confidence            9999998654321   1223467889999999875322 13567889999999999999999           4555321


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .   ...+.+.... . ...+.++..    ..+.++.++|.+||..||++||++.+++++.+....
T Consensus       211 ~---~~~~~~~~~~-~-~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         211 K---TPFQQLKQVV-E-EPSPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             c---cCHHHHHHHH-h-cCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            1   1222222222 1 222233321    123479999999999999999999999999877664

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-38  Score=308.56  Aligned_cols=254  Identities=20%  Similarity=0.279  Sum_probs=197.8

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||+|...  ++.||+|.+......    ......|+..+..++|+||+++++.+....    ..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   76 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET----YL   76 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC----EE
Confidence            36899999999999999999984  688999998754322    234567888899999999999999987755    45


Q ss_pred             eeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ++||||+.+++|.+++..   ..+++..+..++.|++.||+|||+.           +++||||||+||+++.++.++|+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nili~~~~~~~l~  145 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL-----------GIVYRDLKPENILLHESGHIMLS  145 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCChHHeEEcCCCCEEEe
Confidence            999999999999999864   4589999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCC---------------------------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHH
Q psy17532        263 DFGLALLFEPGKPC---------------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL  315 (461)
Q Consensus       263 DFGla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gv  315 (461)
                      |||++.........                           .......|+..|+|||++.+.     .++.++||||||+
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~  220 (316)
T cd05574         146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-----GHGSAVDWWTLGI  220 (316)
T ss_pred             ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-----CCCchHHHHHHHH
Confidence            99998765332110                           011234688999999998763     5678899999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-
Q psy17532        316 VLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-  394 (461)
Q Consensus       316 il~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-  394 (461)
                      ++|+|++|           ..||...     ........+.....  .++...   ..+..+.+++.+||..||++||| 
T Consensus       221 ll~~l~~g-----------~~pf~~~-----~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         221 LLYEMLYG-----------TTPFKGS-----NRDETFSNILKKEV--TFPGSP---PVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             HHHHHhhC-----------CCCCCCC-----chHHHHHHHhcCCc--cCCCcc---ccCHHHHHHHHHHccCCHhHCCCc
Confidence            99999999           5565433     12222222222221  222211   13358999999999999999999 


Q ss_pred             ---ccchhhhcHHHh
Q psy17532        395 ---ASCVVERGMLAL  406 (461)
Q Consensus       395 ---~~evl~~l~~~~  406 (461)
                         +.+++.+.+...
T Consensus       280 ~~~~~~ll~~~~~~~  294 (316)
T cd05574         280 KRGAAEIKQHPFFRG  294 (316)
T ss_pred             hhhHHHHHcCchhhc
Confidence               888888866543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=308.65  Aligned_cols=271  Identities=18%  Similarity=0.242  Sum_probs=190.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||+|..  +++.||||.+.....  ......+|+.++++++|+||+++++++.+..    ..+
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK----TLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC----eEE
Confidence            46899999999999999999998  468899999864332  2234457899999999999999999988765    458


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+.+ +|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-----------~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR-----------RVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecccCCHHHEEEcCCCCEEECcc
Confidence            99999985 99998853  3588999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC-CCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR-LPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~-~pf~~~~~  343 (461)
                      |+++......  .......++..|+|||++.+.    ..++.++||||||+++|||++|..||........ ........
T Consensus       148 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  221 (291)
T cd07844         148 GLARAKSVPS--KTYSNEVVTLWYRPPDVLLGS----TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL  221 (291)
T ss_pred             ccccccCCCC--ccccccccccccCCcHHhhcC----cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence            9987543221  111223568899999988653    3466789999999999999999655532210000 00000000


Q ss_pred             CCCCHHHHHHHHhc---cC--CC----CCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVH---KK--LR----PTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~---~~--~~----~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..+...........   ..  ..    ..+............+.+++.+||+.||++|||+.+++.+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             CCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            00000000000000   00  00    000000001111147789999999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.5e-39  Score=304.63  Aligned_cols=237  Identities=21%  Similarity=0.323  Sum_probs=181.4

Q ss_pred             eEeecCCceEEEEEEEC---------CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        118 EVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +.||+|+||.||+|..+         ...||+|.+...... ......|+.++..++||||+++++++..+..    .++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----SIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----cEE
Confidence            46899999999999873         234888887543322 2344667888899999999999999987653    489


Q ss_pred             eehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc-------
Q psy17532        188 ITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT-------  258 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~-------  258 (461)
                      ||||+++|+|.++++..  .+++..++.++.||+.||+|||+.           +|+||||||+|||++.++.       
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~iiH~dlkp~nili~~~~~~~~~~~~  145 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK-----------GLTHGNVCAKNVLLIREEDRKTGNPP  145 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCccceEEEecccccccCCCc
Confidence            99999999999999643  489999999999999999999998           9999999999999987765       


Q ss_pred             -eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        259 -AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 -~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                       ++++|||++......      ....++..|+|||++.+.    ..++.++||||||+++|||++|.          ..|
T Consensus       146 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~----------~~~  205 (258)
T cd05078         146 FIKLSDPGISITVLPK------EILLERIPWVPPECIENP----QNLSLAADKWSFGTTLWEIFSGG----------DKP  205 (258)
T ss_pred             eEEecccccccccCCc------hhccccCCccCchhccCC----CCCCchhhHHHHHHHHHHHHcCC----------CCC
Confidence             699999998654322      224678899999998753    34677899999999999999984          233


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      |...     ....... ....  +..+|...     ..++.+||.+||+.||++|||++++++.|
T Consensus       206 ~~~~-----~~~~~~~-~~~~--~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         206 LSAL-----DSQKKLQ-FYED--RHQLPAPK-----WTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             hhhc-----cHHHHHH-HHHc--cccCCCCC-----cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            3321     1111111 1111  22333221     23789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.5e-38  Score=306.28  Aligned_cols=252  Identities=21%  Similarity=0.262  Sum_probs=192.4

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.+.||+|+||.||++...  ++.||+|.+.....    ......+|+.++..++||||+++++.+....    .+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~   76 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR----HL   76 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC----EE
Confidence            36899999999999999999984  57899998865432    1223457888899999999999999987754    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++|+|.++++. ..+++..+..++.|++.||.|||+.           +++||||||+||+++.++.+||+||
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY-----------GIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCchHHEEECCCCCEEEeeC
Confidence            899999999999999954 5689999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCC-------------CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        265 GLALLFEPGKP-------------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       265 Gla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      |+++.......             ........++..|+|||.+.+     ..++.++||||||+++|||++|        
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~vl~el~~g--------  212 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVG--------  212 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCccccCchhccC-----CCCCchhhHHHHHHHHHHHHhC--------
Confidence            99874211100             001112457889999999865     3567889999999999999999        


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCC-CCCCchhccchhHHHHHHHHHHHccccHhhhccc---cchhhhcHH
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLR-PTLPETWKQHAGMLALCDTMEECWDHDAEARLSA---SCVVERGML  404 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~evl~~l~~  404 (461)
                         ..||.+.     ...++.......... +..+.     ..+..+.++|.+||+.||++||++   .+++++.+.
T Consensus       213 ---~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~  276 (305)
T cd05609         213 ---CVPFFGD-----TPEELFGQVISDDIEWPEGDE-----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF  276 (305)
T ss_pred             ---CCCCCCC-----CHHHHHHHHHhcccCCCCccc-----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence               5565432     333444443333211 11111     123478999999999999999985   455555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-38  Score=303.16  Aligned_cols=248  Identities=22%  Similarity=0.295  Sum_probs=198.7

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      +|++.+.||+|+||.||+|..+  ++.||+|.+....    .......+|+.++++++||||+++++.+..+.    .++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   76 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE----NMY   76 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC----eEE
Confidence            4889999999999999999984  7889999986432    22345567888999999999999999887655    459


Q ss_pred             eeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +|+||+++++|.+++... .+++..+..++.|++.||.|||+.           +++|+||+|+||++++++.++|+|||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----------~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK-----------GIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHeEEcCCCCEEEeecc
Confidence            999999999999999665 799999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.......   ......|+..|+|||.+.+.     .++.++||||||+++|+|++|           ..||...... 
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~g-----------~~p~~~~~~~-  205 (258)
T cd05578         146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQ-----GYSVAVDWWSLGVTAYECLRG-----------KRPYRGHSRT-  205 (258)
T ss_pred             cccccCCCc---cccccCCChhhcCHHHHccc-----CCCCcccchhhHHHHHHHHhC-----------CCCCCCCCcc-
Confidence            997765432   22345688899999998763     467889999999999999999           5555443211 


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc--cchhhhcH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA--SCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl~~l~  403 (461)
                       ....+......  ..+.+|..++     ..+.++|.+||..||.+||++  ++++++.+
T Consensus       206 -~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~  257 (258)
T cd05578         206 -IRDQIRAKQET--ADVLYPATWS-----TEAIDAINKLLERDPQKRLGDNLKDLKNHPY  257 (258)
T ss_pred             -HHHHHHHHhcc--ccccCcccCc-----HHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence             12222222221  3344444443     388999999999999999999  77777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.2e-38  Score=297.77  Aligned_cols=246  Identities=22%  Similarity=0.391  Sum_probs=194.9

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||++..  .++.+|||.+....   ........|+.+++.++|+||+++++.+...+    .+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK----ALMI   76 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC----EEEE
Confidence            488999999999999999987  46789999986532   22344567899999999999999999887654    4589


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceEEEe
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~ki~D  263 (461)
                      ||||+++++|.+++..   ..+++..+..++.|++.||.|||++           +|+||||||+||+++.+ +.+||+|
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-----------~i~h~dl~~~nil~~~~~~~~~l~d  145 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-----------LILHRDLKTQNILLDKHKMVVKIGD  145 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEEcc
Confidence            9999999999999954   3489999999999999999999998           99999999999999865 5689999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++.......   ......++..|+|||.+.+     ...+.++||||||+++|+|++|           ..||...  
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~~-----------~~~~~~~--  204 (256)
T cd08220         146 FGISKILSSKS---KAYTVVGTPCYISPELCEG-----KPYNQKSDIWALGCVLYELASL-----------KRAFEAA--  204 (256)
T ss_pred             CCCceecCCCc---cccccccCCcccCchhccC-----CCCCcccchHHHHHHHHHHHhC-----------CCCcccC--
Confidence            99998765432   1233568899999999875     3567789999999999999999           4555432  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ........+.... ...++..+     +..+.+++.+||..||++|||+.+++.+.+
T Consensus       205 ---~~~~~~~~~~~~~-~~~~~~~~-----~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         205 ---NLPALVLKIMSGT-FAPISDRY-----SPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             ---chHHHHHHHHhcC-CCCCCCCc-----CHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence               2222333333322 22333332     337999999999999999999999998853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.1e-38  Score=301.72  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=193.2

Q ss_pred             eeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      |++.+.||+|+||.||+|.+.     +..||||.+....   ....+..+|+..++.++||||+++++++......  ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999863     4679999986532   2233456789999999999999999988654321  12


Q ss_pred             eeeeeehhccCCChhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        184 EFWLITAYHERGSLCDFLKC-------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ..++++||+++|+|.+++..       ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dikp~nili~~~  149 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-----------NFIHRDLAARNCMLNEN  149 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeecccchhhEEEcCC
Confidence            34688999999999988732       1478889999999999999999998           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+++....+..........++..|++||.+.+.     .++.++||||||+++|||++++          ..
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~sDi~slG~il~el~~~g----------~~  214 (273)
T cd05074         150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-----VYTTHSDVWAFGVTMWEIMTRG----------QT  214 (273)
T ss_pred             CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC-----ccchhhhhHHHHHHHHHHhhCC----------CC
Confidence            99999999999876543322222334566789999988653     5667899999999999999932          45


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...     ...+....+.... ....+..     .+..+.+++.+||+.+|++|||+.+++..+..+
T Consensus       215 p~~~~-----~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         215 PYAGV-----ENSEIYNYLIKGN-RLKQPPD-----CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCC-----CHHHHHHHHHcCC-cCCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            55432     2233333333322 1122222     224799999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.4e-38  Score=299.15  Aligned_cols=244  Identities=22%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             eecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||.|+||.||+|+..  ++.||+|.+.....    ......+|+.++..++|+||+++++.+.++..    +++++||++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY----IYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc----cEEEEecCC
Confidence            699999999999996  78899999864332    22345678888999999999999999887653    489999999


Q ss_pred             CCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        194 RGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       194 ~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      +|+|.+++.. ..+++..+..++.|++.||+|||+.           +++|+||+|+||+++.++.+||+|||+++....
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----------~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR-----------GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-----------CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            9999999965 4589999999999999999999998           999999999999999999999999999987754


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      ..   ......++..|+|||.+.+     ..++.++||||||+++|||++|           ..||.....   ...+..
T Consensus       146 ~~---~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g-----------~~p~~~~~~---~~~~~~  203 (262)
T cd05572         146 GQ---KTWTFCGTPEYVAPEIILN-----KGYDFSVDYWSLGILLYELLTG-----------RPPFGEDDE---DPMEIY  203 (262)
T ss_pred             cc---ccccccCCcCccChhHhcC-----CCCCChhhhhhhHHHHHHHHhC-----------CCCcCCCCC---CHHHHH
Confidence            32   1223467889999999865     3567889999999999999999           555543311   123334


Q ss_pred             HHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHH
Q psy17532        353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLA  405 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~  405 (461)
                      ..+........+|...     +..+.++|.+||..||++||+     +.|+++|.+.-
T Consensus       204 ~~~~~~~~~~~~~~~~-----~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         204 NDILKGNGKLEFPNYI-----DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             HHHhccCCCCCCCccc-----CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            4444333444555443     348999999999999999999     78888887754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-38  Score=310.17  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .|+....||+|+||.||+|..  .++.||+|.+..... ......+|+.++..++||||+++++++..++    .+++|+
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~iv~   97 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----ELWVLM   97 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----eEEEEE
Confidence            444556899999999999987  478899999864332 2334567888899999999999999988765    459999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ||+++++|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||++..
T Consensus        98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-----------~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ-----------GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            999999999999888899999999999999999999998           999999999999999999999999999976


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      +....  .......|+..|+|||++.+.     .++.++||||||+++|||++|           ..||...     ...
T Consensus       167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~g-----------~~p~~~~-----~~~  223 (297)
T cd06659         167 ISKDV--PKRKSLVGTPYWMAPEVISRT-----PYGTEVDIWSLGIMVIEMVDG-----------EPPYFSD-----SPV  223 (297)
T ss_pred             ccccc--ccccceecCccccCHHHHccC-----CCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-----CHH
Confidence            54332  122345688999999998753     567889999999999999999           4555422     111


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      .....+.... .+. ....  ...+..+.++|.+||+.||++||++.+++++.+...+.
T Consensus       224 ~~~~~~~~~~-~~~-~~~~--~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         224 QAMKRLRDSP-PPK-LKNA--HKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHhccC-CCC-cccc--CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            2122221111 111 1111  11234789999999999999999999999998877653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-38  Score=309.43  Aligned_cols=255  Identities=23%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+.|.....||+|+||.||++..  ++..||||.+...... .....+|+..+..++|+||+++++.+..++    ..++
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~~l   96 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----ELWV   96 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----eEEE
Confidence            34556667899999999999987  4788999988654322 334567888999999999999999987765    4599


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||||+++++|.+++....+++..+..++.||+.||+|||+.           +|+||||||+||+++.++.+||+|||++
T Consensus        97 v~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-----------~ivH~dlkp~Nill~~~~~~kL~dfg~~  165 (292)
T cd06658          97 VMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ-----------GVIHRDIKSDSILLTSDGRIKLSDFGFC  165 (292)
T ss_pred             EEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecCCCHHHEEEcCCCCEEEccCcch
Confidence            99999999999999877899999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      .......  .......|+..|+|||++.+     ..++.++||||||+++|||++|           ..||...     .
T Consensus       166 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~el~~g-----------~~p~~~~-----~  222 (292)
T cd06658         166 AQVSKEV--PKRKSLVGTPYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMIDG-----------EPPYFNE-----P  222 (292)
T ss_pred             hhccccc--ccCceeecCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-----C
Confidence            7654322  12233568899999999865     3567889999999999999999           4555432     1


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .......+. ....+.++..   ...+..+.+++.+||..||++|||+.+++++.+....
T Consensus       223 ~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         223 PLQAMRRIR-DNLPPRVKDS---HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHHH-hcCCCccccc---cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            111111111 1111222211   1123478899999999999999999999999776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-38  Score=306.13  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=199.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC-hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD-KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.||+|+||.||+|..  +++.||+|.+.... ........|+.++..++||||+++++++...+    .++
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~   92 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD----ELW   92 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC----cEE
Confidence            347899999999999999999986  56789999986432 22334567888899999999999999988765    348


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +|+||+++|+|.+++....+++..+..++.|++.||.|||+.           +++||||||+||+++.++.+||+|||+
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-----------gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-----------QVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeeccCCHHHEEEcCCCCEEEccCcc
Confidence            999999999999999888899999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +........  ......++..|+|||.+.+.     .++.++||||||+++||+++|.           .||.....   
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~ll~~ll~g~-----------~pf~~~~~---  220 (293)
T cd06647         162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMVEGE-----------PPYLNENP---  220 (293)
T ss_pred             eeccccccc--ccccccCChhhcCchhhccC-----CCCchhhHHHHHHHHHHHHhCC-----------CCCCCCCh---
Confidence            876654332  22334688899999998653     5677899999999999999994           44432210   


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ..... .+.. ...+.++.   ....+..+.++|.+||..||++||++.+++.|.+...+
T Consensus       221 -~~~~~-~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         221 -LRALY-LIAT-NGTPELQN---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             -hhhee-ehhc-CCCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence             01100 0000 11111111   11123478999999999999999999999999876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=311.78  Aligned_cols=280  Identities=21%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-cceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||.+....  ........|+.++++++|+||+++++++..... .....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            36899999999999999999987  57889999986432  223345678999999999999999998765432 12346


Q ss_pred             eeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        186 WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++|+||+.+ +|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        84 ~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-----------~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA-----------NVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHEEECCCCCEEECccc
Confidence            899999975 999999888899999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +++......... ......|+..|+|||.+.+.    ..++.++|||||||++|||++|..||.........-.......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~  227 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNS----KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG  227 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            998764432211 12335688999999987543    3567889999999999999999655532110000000000000


Q ss_pred             CCCHHHHHHH--------HhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEA--------VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~--------~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+..+.....        .......+..+..-.....+..+.++|.+||+.||++|||+.++++|.+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence            0111111000        0000000111100000112347899999999999999999999999976543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.7e-38  Score=306.20  Aligned_cols=278  Identities=24%  Similarity=0.353  Sum_probs=194.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc---
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI---  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~---  181 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||.+......   .....+|+.++++++||||+++++++......   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            456899999999999999999998  4788999988643221   22345788899999999999999988764321   


Q ss_pred             -ceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        182 -HTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       182 -~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                       ....++||||+.+ +|.+++...  .+++..+..++.|++.||.|||+.           +++|+||||+|||++.++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN-----------KILHRDMKAANILITKDGI  157 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHEEECCCCc
Confidence             2356899999975 888888544  689999999999999999999998           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +||+|||++.........  .......++..|+|||.+.+.    ..++.++||||||+++|||++|..+|.........
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~  233 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE----RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL  233 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC----cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999876433211  112234678899999988653    34567899999999999999996655432210000


Q ss_pred             --------CCcccc-CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        337 --------PFSAEV-GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       337 --------pf~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                              .+.... ......................+...........+.++|.+||..||++|||++++++|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence                    000000 0000000000000000000001111111112346789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.6e-39  Score=304.55  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +|+..+.||+|+||.||++..+  ++.||+|.+.....  ...+..+|+..+++++||||+++++.+....    .++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG----DISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC----EEEEE
Confidence            5788899999999999999995  78899999865432  2334567888888999999999999988764    56999


Q ss_pred             ehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||+++++|.+++..  ..+++..+..++.|++.||+|||+ .           +++|+||||+||+++.++.+||+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----------~i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH-----------KIIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC-----------CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999964  568999999999999999999998 7           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      .+.......    .....++..|+|||.+.+.     .++.++||||||+++|+|++|.           .||.......
T Consensus       147 ~~~~~~~~~----~~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~-----------~p~~~~~~~~  206 (265)
T cd06605         147 VSGQLVNSL----AKTFVGTSSYMAPERIQGN-----DYSVKSDIWSLGLSLIELATGR-----------FPYPPENDPP  206 (265)
T ss_pred             cchhhHHHH----hhcccCChhccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhCC-----------CCCCcccccc
Confidence            987654322    1125688899999998763     6778899999999999999994           4443321111


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ....+........ ..+.++..    ..+..+.++|.+||..||++|||+.+++.+.+..
T Consensus       207 ~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         207 DGIFELLQYIVNE-PPPRLPSG----KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             ccHHHHHHHHhcC-CCCCCChh----hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            1222333333222 22333322    1234789999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-39  Score=332.57  Aligned_cols=271  Identities=19%  Similarity=0.245  Sum_probs=186.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEECC---CcEEEE------------------EEecCChhhhHHHHHHHHcCCCCCCCee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKN---ENVAVK------------------IFLMQDKQSWQSEQEIFKLPHMEHDNIL  169 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~---~~vAvK------------------~~~~~~~~~~~~~~ei~~l~~l~H~nIv  169 (461)
                      ..+|++++.||+|+||+||++..+.   ..+++|                  .+..........++|+.++.+++|+|||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4679999999999999999987632   112222                  1111222233457899999999999999


Q ss_pred             EEEEEEecCCccceeeeeeehhccCCChhhhhcCCC------CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeec
Q psy17532        170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI------VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAH  243 (461)
Q Consensus       170 ~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivH  243 (461)
                      ++++++.....    .|+|+|++. ++|.+++....      .....+..++.||+.||.|||+.           +|+|
T Consensus       227 ~l~~~~~~~~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-----------gIiH  290 (501)
T PHA03210        227 KIEEILRSEAN----TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-----------KLIH  290 (501)
T ss_pred             cEeEEEEECCe----eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-----------Ceec
Confidence            99999987653    489999985 58888774432      33566788999999999999998           9999


Q ss_pred             ccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        244 RDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       244 rDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      |||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+     ..++.++|||||||++|||++|
T Consensus       291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~~  364 (501)
T PHA03210        291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAG-----DGYCEITDIWSCGLILLDMLSH  364 (501)
T ss_pred             CCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcC-----CCCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999999999999999987754332 12234579999999999976     3677899999999999999998


Q ss_pred             CCCCCCCCCCC------------CCCCccccCCCCCHHHHHHHHhccC---CCCCCCchhccchhHHHHHHHHHHHcccc
Q psy17532        324 CSSVSPPPGEY------------RLPFSAEVGDHPSLEDMQEAVVHKK---LRPTLPETWKQHAGMLALCDTMEECWDHD  388 (461)
Q Consensus       324 ~~~~~~~~~~~------------~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~~~l~~li~~cl~~d  388 (461)
                      ..++.......            ..+....   ......+...+....   ....++..+........+.+++.+||..|
T Consensus       365 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D  441 (501)
T PHA03210        365 DFCPIGDGGGKPGKQLLKIIDSLSVCDEEF---PDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD  441 (501)
T ss_pred             CCCCccCCCCCHHHHHHHHHHhcccChhhc---CCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence            53221110000            0000000   000001111110000   00011111111122346788999999999


Q ss_pred             HhhhccccchhhhcHHHh
Q psy17532        389 AEARLSASCVVERGMLAL  406 (461)
Q Consensus       389 P~~Rps~~evl~~l~~~~  406 (461)
                      |++|||+.|++.|.++..
T Consensus       442 P~~Rpsa~elL~hp~f~~  459 (501)
T PHA03210        442 WHLRPGAAELLALPLFSA  459 (501)
T ss_pred             cccCcCHHHHhhChhhhc
Confidence            999999999999988644

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.2e-38  Score=301.90  Aligned_cols=255  Identities=26%  Similarity=0.337  Sum_probs=194.5

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|+.  .++.||||++.....   ......+|+.++++++|+||+++++++....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~~   76 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS----GFVL   76 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC----eeEE
Confidence            478999999999999999998  478899999875432   2345678888999999999999999988754    4589


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |+||+ +++|.+++..  ..+++..+..++.||+.||+|||+.           +++|+||||+||+++.++.++|+|||
T Consensus        77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN-----------GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCcCHHHEEEcCCCcEEEeeee
Confidence            99999 9999999843  4689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++........ .......++..|+|||++.+.    ..++.++||||||+++|||++|.++|.....             
T Consensus       145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-------------  206 (286)
T cd07832         145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGA----RKYDPGVDLWAVGCIFAELLNGSPLFPGEND-------------  206 (286)
T ss_pred             ecccccCCCC-CccccccCcccccCceeeecc----ccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-------------
Confidence            9987654321 112345688999999988653    3457889999999999999999544432211             


Q ss_pred             CCHHHHHHHHhcc-------------------C--CCCCCCchhcc--chhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHK-------------------K--LRPTLPETWKQ--HAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~-------------------~--~~~~~p~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                         ......+...                   .  .....+..+..  ......+.+++++||..||++|||++++++|.
T Consensus       207 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         207 ---IEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             ---HHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               0000000000                   0  00000000000  11235889999999999999999999999987


Q ss_pred             HH
Q psy17532        403 ML  404 (461)
Q Consensus       403 ~~  404 (461)
                      +.
T Consensus       284 ~~  285 (286)
T cd07832         284 YF  285 (286)
T ss_pred             Cc
Confidence            53

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=297.86  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=197.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC------hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD------KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+|++.+.||+|+||.||+|+.  +++.||+|.+....      ......++|+..+++++|+||+++++++.+...  .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--~   79 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE--K   79 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC--C
Confidence            4789999999999999999987  47889999875321      122345678999999999999999999876542  3


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++++||+++++|.+++.. ..+++.....++.|++.||.|||+.           +++|+||||+||+++.++.++|+
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-----------~i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN-----------MIVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEEcCCCCEEEC
Confidence            56899999999999999854 5689999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        263 DFGLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       263 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |||+++....... ........++..|+|||++.+.     ..+.++|||||||++|||++|           ..||...
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~~  212 (264)
T cd06653         149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-----GYGRKADVWSVACTVVEMLTE-----------KPPWAEY  212 (264)
T ss_pred             ccccccccccccccCccccccCCcccccCHhhhcCC-----CCCccccHHHHHHHHHHHHhC-----------CCCCCcc
Confidence            9999986543211 0112235688999999998763     567889999999999999999           5555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                          ...... ........++.+|....     ..+.+++.+||. +|.+||++.+++.|++
T Consensus       213 ----~~~~~~-~~~~~~~~~~~~p~~~~-----~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         213 ----EAMAAI-FKIATQPTKPMLPDGVS-----DACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             ----CHHHHH-HHHHcCCCCCCCCcccC-----HHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence                112222 23333334445554433     479999999999 5799999999998863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-37  Score=297.16  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=198.9

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|..  +++.||+|.+.....   .......|+.+++.++|+||+++++.+...+    .+++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l   76 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE----KVYI   76 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC----EEEE
Confidence            478899999999999999987  468899999875544   3345578888999999999999999987654    4589


Q ss_pred             eehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      |+||+++++|.+++..+ .+++..+..++.|++.||.|||+.           +|+|+||+|+||++++++.+||+|||+
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----------~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-----------GIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEEccccc
Confidence            99999999999999654 488999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCC-C-CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        267 ALLFEPGKPCG-D-THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       267 a~~~~~~~~~~-~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +.......... . .....++..|+|||++.+..  ....+.++||||||+++||+++|           ..||....  
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g-----------~~pf~~~~--  210 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATG-----------KRPWSELD--  210 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhC-----------CCCccCCc--
Confidence            98765433211 1 12346788999999987641  12367889999999999999999           55554321  


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                        ........+. ....+.+|...   ..+..+.+++.+||+.||++|||+.+++.+.+
T Consensus       211 --~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         211 --NEFQIMFHVG-AGHKPPIPDSL---QLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             --chHHHHHHHh-cCCCCCCCccc---ccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence              1111111121 23333444321   12347889999999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.1e-38  Score=302.03  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=202.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .....|+..+.||+|+||.||+|.++  +..||+|.+............|+..+..++|+||+++++++....    ..+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD----ELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECC----EEE
Confidence            34567888999999999999999995  788999999765544445678888999999999999999988764    459


Q ss_pred             eeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|+||+++++|.+++...  .+++..+..++.|++.||.|||+.           +|+|+||+|+||+++.++.++|+||
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-----------gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ-----------NVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCChhhEEEcCCCCEEECcc
Confidence            999999999999999765  799999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++........  ......++..|+|||++.+     ..++.++||||||+++|+|++|           ..||...   
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slGvil~~l~~g-----------~~p~~~~---  219 (286)
T cd06614         161 GFAAQLTKEKS--KRNSVVGTPYWMAPEVIKR-----KDYGPKVDIWSLGIMCIEMAEG-----------EPPYLRE---  219 (286)
T ss_pred             chhhhhccchh--hhccccCCcccCCHhHhcC-----CCCCCccccHHHHHHHHHHHhC-----------CCCCCCC---
Confidence            99876543321  1223457889999998865     3567889999999999999999           5555432   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        .............. +..+..   ...+..+.++|.+||+.+|.+||++.+++++.+...
T Consensus       220 --~~~~~~~~~~~~~~-~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         220 --PPLRALFLITTKGI-PPLKNP---EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             --CHHHHHHHHHhcCC-CCCcch---hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence              11122222222211 111111   112347999999999999999999999999987655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.6e-38  Score=300.20  Aligned_cols=246  Identities=24%  Similarity=0.361  Sum_probs=190.7

Q ss_pred             ceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCCh-----------hhhHHHHHHHHcC-CCCCCCeeEEEEEEec
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDK-----------QSWQSEQEIFKLP-HMEHDNILRYIGAEKR  177 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~-----------~~~~~~~ei~~l~-~l~H~nIv~l~g~~~~  177 (461)
                      +|++.+.||+|+||.||+|...   ++.+|||.+.....           ...+...|+..+. .++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4778899999999999999985   47799998753221           1122345676665 4799999999999887


Q ss_pred             CCccceeeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcE
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                      .+    ..+++|||+++++|.+++.     ...+++..+..++.|++.||.|||+ .           +++|+||+|+||
T Consensus        81 ~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----------~i~H~dl~~~ni  145 (269)
T cd08528          81 ND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK-----------RIVHRDLTPNNI  145 (269)
T ss_pred             CC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC-----------ceeecCCCHHHE
Confidence            65    4599999999999998873     3468999999999999999999996 4           899999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       252 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      |++.++.+||+|||++.......   ......|+..|+|||.+.+.     .++.++||||||+++|||++|        
T Consensus       146 l~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Dv~slG~ll~~l~~g--------  209 (269)
T cd08528         146 MLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNE-----PYGEKADVWAFGCILYQMCTL--------  209 (269)
T ss_pred             EECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCC-----CCchHHHHHHHHHHHHHHHhC--------
Confidence            99999999999999998765432   22345688999999998763     567889999999999999999        


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                         ..||...     ........+......+.....     .+..+.++|.+||+.||++||++.|+.+++
T Consensus       210 ---~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         210 ---QPPFYST-----NMLSLATKIVEAVYEPLPEGM-----YSEDVTDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             ---CCccccc-----CHHHHHHHHhhccCCcCCccc-----CCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence               4555332     223333333333332221112     234799999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.3e-38  Score=301.15  Aligned_cols=245  Identities=24%  Similarity=0.306  Sum_probs=185.2

Q ss_pred             EeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHH---HHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        119 VKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEI---FKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei---~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      +||+|+||.||++..  +++.+|+|.+......    ......|.   ..+...+|+||+.+++++...+    .+++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD----KLCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC----eEEEEE
Confidence            489999999999998  4688999988643211    11122222   2344458999999999988755    458999


Q ss_pred             hhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        190 AYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       190 e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||++.
T Consensus        77 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~-----------~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          77 DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR-----------FVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            9999999999885 45699999999999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      ......    .....|+..|+|||.+.++    ..++.++|||||||++|||++|           ..||.....  ...
T Consensus       146 ~~~~~~----~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g-----------~~pf~~~~~--~~~  204 (279)
T cd05633         146 DFSKKK----PHASVGTHGYMAPEVLQKG----TAYDSSADWFSLGCMLFKLLRG-----------HSPFRQHKT--KDK  204 (279)
T ss_pred             eccccC----ccCcCCCcCccCHHHhcCC----CCCCchhhhHHHHHHHHHHHhC-----------CCCcCCCCC--cCH
Confidence            654322    2234689999999988642    3567889999999999999999           555543211  122


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      ........  .....+++.++     ..+.++|.+||..||++||     |++++++|.++..
T Consensus       205 ~~~~~~~~--~~~~~~~~~~~-----~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         205 HEIDRMTL--TVNVELPDSFS-----PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             HHHHHHhh--cCCcCCccccC-----HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            22222211  12233444333     3789999999999999999     5999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-38  Score=303.46  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=190.2

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|+..+.||+|+||.||+|+.  +++.||||.+......   .....+|+..+++++||||+++++++.+..    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~~   76 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN----KLYL   76 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC----cEEE
Confidence            478999999999999999998  4788999988643321   234568999999999999999999987655    4589


Q ss_pred             eehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||+. ++|.+++..   ..+++..+..++.|++.||+|||+.           +++||||+|+||+++.++.+||+||
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----------~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-----------RVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCCEEEeec
Confidence            999996 689988843   4589999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.+....  .......++..|+|||++.+.    ..++.++||||||+++|||+||+.||.....            
T Consensus       145 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~------------  206 (284)
T cd07860         145 GLARAFGVPV--RTYTHEVVTLWYRAPEILLGC----KYYSTAVDIWSLGCIFAEMVTRRALFPGDSE------------  206 (284)
T ss_pred             cchhhcccCc--cccccccccccccCCeEEecC----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------------
Confidence            9997664332  112334578899999988653    3456789999999999999999555432211            


Q ss_pred             CCCHHHHHHHHhccCC---------------CCCCCc----hhc--cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKL---------------RPTLPE----TWK--QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~---------------~~~~p~----~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         .............               ...++.    ...  ....+..+.++|.+||+.||++|||+++++.|.+
T Consensus       207 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         207 ---IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             ---HHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence               0011000000000               000000    000  0112347889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4645|consensus

Probab=100.00  E-value=6.6e-40  Score=345.93  Aligned_cols=253  Identities=28%  Similarity=0.384  Sum_probs=202.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +++-...||.|.||.||.|..  +|+..|||-++.....   .....+|..++..++|||+|+++|+-...+    +.+|
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe----kv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE----KVYI 1311 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH----HHHH
Confidence            445567899999999999998  6788999988655433   223457889999999999999999987755    4489


Q ss_pred             eehhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      .||||++|+|.+.+..++ .++.....+..|++.|++|||++           |||||||||.|||++.+|.+|++|||.
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~-----------gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH-----------GIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc-----------CceecCCCccceeeecCCcEEeecccc
Confidence            999999999999997654 55566677889999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCC--CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        267 ALLFEPGKP--CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       267 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |..+.....  ........||+.|||||++.+.  .++....+.||||+||++.||+||           +.||..... 
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t--~~kG~~~A~DiWslGCVVlEM~tG-----------krPW~~~dn- 1446 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGT--KGKGHGGAADIWSLGCVVLEMATG-----------KRPWAELDN- 1446 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhccc--ccCCCCcchhhhcccceEEEeecC-----------CCchhhccc-
Confidence            988765431  1224466899999999999875  234556789999999999999999           555544311 


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                          +......+..+-.|.+|+..+.     +-.+++.+||..||++|.++.|++++-+
T Consensus      1447 ----e~aIMy~V~~gh~Pq~P~~ls~-----~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1447 ----EWAIMYHVAAGHKPQIPERLSS-----EGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred             ----hhHHHhHHhccCCCCCchhhhH-----hHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence                1112223344556888887443     7789999999999999999999988853

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.8e-38  Score=298.78  Aligned_cols=253  Identities=24%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      +|+..+.||+|+||.||+|..  +++.||+|.+.....       .......|+..+++++|+||+++++++.+.+    
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS----   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence            477889999999999999987  578899999864321       1234568999999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki  261 (461)
                      .+++|+||+++++|.++++. ..+++..+..++.|++.||.|||+.           +++||||||+||+++.++ .+||
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~-----------~i~H~~i~~~nil~~~~~~~~~l  145 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-----------QIIHRDVKGANLLIDSTGQRLRI  145 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEE
Confidence            45899999999999999954 5689999999999999999999999           999999999999998775 6999


Q ss_pred             EecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        262 ADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       262 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      +|||++.........  .......++..|+|||.+.+     ..++.++||||||+++|+|++|           ..||.
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g-----------~~p~~  209 (268)
T cd06630         146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-----EQYGRSCDVWSVGCVIIEMATA-----------KPPWN  209 (268)
T ss_pred             cccccccccccccccCCccccccccccceeCHhHhcc-----CCCCcccchHHHHHHHHHHHhC-----------CCCCC
Confidence            999999776543211  11223468899999999865     3567889999999999999999           44553


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .....  ...............+.++...+     ..+.+++.+||..||++||++.+++++.+
T Consensus       210 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         210 AEKHS--NHLALIFKIASATTAPSIPEHLS-----PGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             CCCCc--chHHHHHHHhccCCCCCCchhhC-----HHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence            22111  11122222222223344444332     37899999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.6e-38  Score=297.25  Aligned_cols=247  Identities=22%  Similarity=0.407  Sum_probs=195.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|..  .+..||+|.+....   .......+|+.+++.++|+||+++++.+....    .+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~----~~~l   76 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG----RLFI   76 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC----eEEE
Confidence            478999999999999999998  46789999986532   23334568899999999999999999987755    4599


Q ss_pred             eehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEEe
Q psy17532        188 ITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~D  263 (461)
                      |+||+++++|.+++...   .+++..+..++.|++.||.|||+.           +++|+||||+||++++++ .+||+|
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~H~dl~~~nil~~~~~~~~~l~d  145 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-----------KILHRDIKSQNIFLSKNGMVAKLGD  145 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccccCCHHHEEEcCCCCeEEecc
Confidence            99999999999998542   478999999999999999999998           999999999999999885 569999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||.+........  ......|+..|+|||++.+.     .++.++||||||+++|||++|           ..||...  
T Consensus       146 ~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~~p~~~~--  205 (257)
T cd08225         146 FGIARQLNDSME--LAYTCVGTPYYLSPEICQNR-----PYNNKTDIWSLGCVLYELCTL-----------KHPFEGN--  205 (257)
T ss_pred             cccchhccCCcc--cccccCCCccccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhC-----------CCCCCCc--
Confidence            999987654321  12234688999999988653     567889999999999999999           5555432  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                         ...+.......... ..++..     .+..+.+++.+||..+|++|||+.+++.+.+
T Consensus       206 ---~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         206 ---NLHQLVLKICQGYF-APISPN-----FSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             ---cHHHHHHHHhcccC-CCCCCC-----CCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence               22333333333222 222222     2347999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=306.98  Aligned_cols=268  Identities=25%  Similarity=0.324  Sum_probs=194.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE----CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF----KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~----~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .|++.+.||+|+||.||+|..    .++.||+|.+....    .......+|+.++..++||||+++++++.+..  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--DKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--Cce
Confidence            478899999999999999998    35789999987532    12234467888899999999999999998763  235


Q ss_pred             eeeeehhccCCChhhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---
Q psy17532        185 FWLITAYHERGSLCDFLKC------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---  255 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---  255 (461)
                      +++||||+++ +|.+++..      ..++...+..++.|++.||.|||+.           +|+||||||+|||++.   
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~h~dlkp~Nil~~~~~~  146 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-----------WVLHRDLKPANILVMGEGP  146 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-----------CEeeCCCCHHHEEEcCCCC
Confidence            7999999975 77776631      2578899999999999999999998           9999999999999999   


Q ss_pred             -CCceEEEecCCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        256 -DLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       256 -~~~~ki~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                       ++.+||+|||+++.+..... ........++..|+|||++.+.    ..++.++||||||+++|||++|..||......
T Consensus       147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         147 ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTLEPIFKGREAK  222 (316)
T ss_pred             ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence             89999999999987644322 1123345678999999988653    35678899999999999999997776543332


Q ss_pred             C--CCCCccccCCCCCHHHHHHHHh--------------------ccCCCCCCCc----hhccc--hhHHHHHHHHHHHc
Q psy17532        334 Y--RLPFSAEVGDHPSLEDMQEAVV--------------------HKKLRPTLPE----TWKQH--AGMLALCDTMEECW  385 (461)
Q Consensus       334 ~--~~pf~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~p~----~~~~~--~~~~~l~~li~~cl  385 (461)
                      .  ..|+...     ....+.+...                    .......++.    .+...  ..+..+.+++.+||
T Consensus       223 ~~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  297 (316)
T cd07842         223 IKKSNPFQRD-----QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL  297 (316)
T ss_pred             ccccchhHHH-----HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence            1  1111100     0000000000                    0000011110    00000  23357899999999


Q ss_pred             cccHhhhccccchhhhcH
Q psy17532        386 DHDAEARLSASCVVERGM  403 (461)
Q Consensus       386 ~~dP~~Rps~~evl~~l~  403 (461)
                      ..||++|||+.++++|.+
T Consensus       298 ~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         298 EYDPTKRITAEEALEHPY  315 (316)
T ss_pred             cCCcccCcCHHHHhcCCC
Confidence            999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-38  Score=305.10  Aligned_cols=270  Identities=21%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|..+  ++.||+|.+.....   ......+|+.++..++||||+++++++....    .++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   76 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK----RLY   76 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC----eEE
Confidence            36889999999999999999984  68899998754322   1234567888899999999999999987654    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +|+||+++++|.++... ..+++..+..++.|++.||+|||+.           +|+||||+|+||++++++.++|+|||
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-----------NIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEECCCCcEEEEeee
Confidence            99999999999887753 3589999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc--cccC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS--AEVG  343 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~--~~~~  343 (461)
                      ++..+.....  ......++..|+|||++.+.    ..++.++||||||+++|||++|.++|....... ....  ....
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~  218 (286)
T cd07846         146 FARTLAAPGE--VYTDYVATRWYRAPELLVGD----TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLG  218 (286)
T ss_pred             eeeeccCCcc--ccCcccceeeccCcHHhccc----cccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhC
Confidence            9987654331  22335678999999998653    345678999999999999999955543221100 0000  0000


Q ss_pred             CC-CCHHHHH--HHHhccCCCCCCCchh----ccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DH-PSLEDMQ--EAVVHKKLRPTLPETW----KQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~-~~~~~~~--~~~~~~~~~~~~p~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .. .......  .........+......    .....+..+.+|+.+||+.||++||++.+++++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence            00 0000000  0000000000000000    00112357899999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-37  Score=295.42  Aligned_cols=253  Identities=28%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||||++.....  .......|+..+.+++|+||+++++++....    .+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG----EISI   76 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC----eEEE
Confidence            36889999999999999999984  78899999876543  3445678888899999999999999988764    4599


Q ss_pred             eehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |+||+++++|.+++.. ..+++..+..++.|+++||.|||+ .           +++||||+|+||+++.++.++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~-----------~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR-----------HIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC-----------CCccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999999964 678999999999999999999999 8           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++........  ......++..|+|||.+.+.     .++.++||||||+++|||++|           ..||.....  
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~tg-----------~~p~~~~~~--  205 (264)
T cd06623         146 ISKVLENTLD--QCNTFVGTVTYMSPERIQGE-----SYSYAADIWSLGLTLLECALG-----------KFPFLPPGQ--  205 (264)
T ss_pred             cceecccCCC--cccceeecccccCHhhhCCC-----CCCchhhHHHHHHHHHHHHhC-----------CCCCccccc--
Confidence            9987654332  12234678899999998653     667889999999999999999           445433211  


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ....+....+.... .+.++..    ..+..+.+++.+||..+|++||++.+++++.+.
T Consensus       206 ~~~~~~~~~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~  259 (264)
T cd06623         206 PSFFELMQAICDGP-PPSLPAE----EFSPEFRDFISACLQKDPKKRPSAAELLQHPFI  259 (264)
T ss_pred             cCHHHHHHHHhcCC-CCCCCcc----cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence            13333444443222 2222222    123489999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-37  Score=308.76  Aligned_cols=273  Identities=21%  Similarity=0.284  Sum_probs=196.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|+..+.||+|+||.||+|..  .++.||||.+....   .......+|+.+++.++|+||+++++++......  .
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            357899999999999999999998  57889999985422   2223445788899999999999999988654321  1


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ...++||||+. |+|.+++... ++...+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~-----------gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCCHHHEEECCCCCEEEc
Confidence            24689999996 5899888654 89999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC---------
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------  333 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~---------  333 (461)
                      |||+++......   ......++..|+|||++.+     ..++.++|||||||++|+|++|..||......         
T Consensus       161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  232 (353)
T cd07850         161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ  232 (353)
T ss_pred             cCccceeCCCCC---CCCCCcccccccCHHHHhC-----CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            999998764432   1233467899999999876     36778899999999999999996555322100         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCC--C-----CC-----CCchhc--cchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKL--R-----PT-----LPETWK--QHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~--~-----~~-----~p~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      ...|......   ..............  .     ..     .+....  ....+..+.++|.+||+.||++|||+.+++
T Consensus       233 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL  309 (353)
T cd07850         233 LGTPSDEFMS---RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL  309 (353)
T ss_pred             cCCCCHHHHH---HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence            0000000000   00000000000000  0     00     000000  112345788999999999999999999999


Q ss_pred             hhcHHHh
Q psy17532        400 ERGMLAL  406 (461)
Q Consensus       400 ~~l~~~~  406 (461)
                      ++.+...
T Consensus       310 ~~~~~~~  316 (353)
T cd07850         310 QHPYINV  316 (353)
T ss_pred             cChhHhh
Confidence            9987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-37  Score=303.44  Aligned_cols=261  Identities=25%  Similarity=0.290  Sum_probs=195.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..++|++.+.||+|+||.||+|..  +++.||+|.+......   .....+|+.++.+++|+||+++++++....  ...
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--LDS   82 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--CCe
Confidence            456899999999999999999998  4788999998644322   223457899999999999999999987643  124


Q ss_pred             eeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +++||||+.+ +|.+++..  ..+++..+..++.|++.||.|||+.           +++||||||+||+++.++.+||+
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN-----------FIIHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEECCCCCEEEC
Confidence            6899999974 88888853  5689999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++........  ......++..|+|||++.+.    ..++.++||||||+++|||++|..||....           
T Consensus       151 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~~~f~~~~-----------  213 (309)
T cd07845         151 DFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGC----TTYTTAIDMWAVGCILAELLAHKPLLPGKS-----------  213 (309)
T ss_pred             ccceeeecCCccC--CCCcccccccccChhhhcCC----CCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----------
Confidence            9999987654321  12233457889999998653    356788999999999999999955543211           


Q ss_pred             CCCCCHHHHHHHHhccC-----------------CCCCCC----chhcc--chhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        343 GDHPSLEDMQEAVVHKK-----------------LRPTLP----ETWKQ--HAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~-----------------~~~~~p----~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                           ..+....+....                 ....++    ..+..  ...+..+.++|.+||..||++|||+.+++
T Consensus       214 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il  288 (309)
T cd07845         214 -----EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL  288 (309)
T ss_pred             -----HHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence                 111111111100                 000000    00000  01245788999999999999999999999


Q ss_pred             hhcHHHh
Q psy17532        400 ERGMLAL  406 (461)
Q Consensus       400 ~~l~~~~  406 (461)
                      .|.+...
T Consensus       289 ~h~~f~~  295 (309)
T cd07845         289 ESSYFKE  295 (309)
T ss_pred             cChhhcc
Confidence            9988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.1e-38  Score=303.49  Aligned_cols=270  Identities=23%  Similarity=0.292  Sum_probs=193.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|+..  ++.+|+|.++.....   .....+|+.++.+++||||+++++++....  ....
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~~   81 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--LDKI   81 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--CCcE
Confidence            457899999999999999999984  678999998654322   223457888899999999999999987653  1356


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+++ +|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~i~H~dl~p~nili~~~~~~~l~d  149 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN-----------WILHRDLKTSNLLLNNRGILKICD  149 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCCHHHEEECCCCcEEEee
Confidence            999999974 99998853  3589999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||+++......  .......++..|+|||.+.+.    ...+.++||||||+++|||++|..||.......         
T Consensus       150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  223 (293)
T cd07843         150 FGLAREYGSPL--KPYTQLVVTLWYRAPELLLGA----KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL  223 (293)
T ss_pred             cCceeeccCCc--cccccccccccccCchhhcCC----ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99998765432  122334678899999998753    245678999999999999999966554221100         


Q ss_pred             CCCCccccCCCCCHHHHHH---HHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        335 RLPFSAEVGDHPSLEDMQE---AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..|+...   .+....+..   ..........+...++.......+.++|++||+.||++|||+.|++++.+
T Consensus       224 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         224 GTPTEKI---WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             CCCchHH---HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence            0000000   000000000   00000000000011111112347899999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-37  Score=299.77  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=196.9

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .|...+.||+|+||.||++..  .++.+|+|.+...... .....+|+.++..++|+||+++++++...+    ..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~----~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD----ELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC----eEEEEE
Confidence            455568999999999999987  4678999988644322 234567888899999999999999987755    459999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ||+++++|.+++....+++..+..++.|++.||+|||+.           +|+||||+|+||+++.++.++|+|||++..
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ-----------GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            999999999999888899999999999999999999998           999999999999999999999999999876


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      ......  ......|+..|+|||.+.+.     .++.++||||||+++|||++|           ..||...     ...
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~ell~g-----------~~p~~~~-----~~~  221 (285)
T cd06648         165 VSKEVP--RRKSLVGTPYWMAPEVISRL-----PYGTEVDIWSLGIMVIEMVDG-----------EPPYFNE-----PPL  221 (285)
T ss_pred             hccCCc--ccccccCCccccCHHHhcCC-----CCCCcccHHHHHHHHHHHHhC-----------CCCCcCC-----CHH
Confidence            543321  22334688999999998653     567889999999999999999           4455432     112


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .....+... ..+.....   ...+..+.++|.+||..||++||++.+++++.+...
T Consensus       222 ~~~~~~~~~-~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         222 QAMKRIRDN-LPPKLKNL---HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             HHHHHHHhc-CCCCCccc---ccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence            222222222 11111111   113347999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-37  Score=301.45  Aligned_cols=257  Identities=15%  Similarity=0.176  Sum_probs=182.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCChhh------------hHHHHHHHHcCCCCCCCeeEEE
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQDKQS------------WQSEQEIFKLPHMEHDNILRYI  172 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~------------~~~~~ei~~l~~l~H~nIv~l~  172 (461)
                      ....|++.++||+|+||.||+|...+     ..+|+|.........            .....+...+..++|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34689999999999999999999853     356777543322111            0112233456678999999999


Q ss_pred             EEEecCCccceeeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcE
Q psy17532        173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       173 g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                      +++..........++++|++.. ++.+.++.. ..++..+..++.|++.||+|||+.           +|+||||||+||
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~iiHrDiKp~Ni  157 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH-----------GISHGDIKPENI  157 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHE
Confidence            9766544322234678887754 676666543 367888999999999999999998           999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCC
Q psy17532        252 LLKSDLTAAIADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS  326 (461)
Q Consensus       252 Ll~~~~~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~  326 (461)
                      |++.++.+||+|||+|+.+......     .......||+.|+|||++.+     ..++.++|||||||++|||++|   
T Consensus       158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-----~~~~~~~DiwSlG~~l~el~~g---  229 (294)
T PHA02882        158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-----ACVTRRGDLESLGYCMLKWAGI---  229 (294)
T ss_pred             EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-----CCCCcHHHHHHHHHHHHHHHhC---
Confidence            9999999999999999876432211     11223469999999999876     3678899999999999999999   


Q ss_pred             CCCCCCCCCCCCccccCCCCCH----HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSL----EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                              ..||..........    .+....+......  ++.      .+..+.++++.||..+|++||++.++++.+
T Consensus       230 --------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        230 --------KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK--IKN------ANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             --------CCCCCccccchHHHHHhHHHHHHHhhhhhhc--cCC------CCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                    56664431111001    1111222222111  111      234799999999999999999999988754

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.5e-37  Score=292.65  Aligned_cols=253  Identities=27%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|+..+.||+|+||.||+|...  ++.|++|.+....   .......+|+..+++++|+||+++++.+....  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--KNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--CCeEEE
Confidence            4778899999999999999985  7889999987554   23445678899999999999999999988762  135689


Q ss_pred             eehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ++||+++++|.+++... .+++..+..++.|++.||+|||+.           +++|+||+|+||+++.++.++|+|||.
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN-----------GIVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEEcCCCCEEEccccc
Confidence            99999999999999654 799999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +................++..|+|||.+.+.     ..+.++||||||+++|+|++|           ..||....    
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~~p~~~~~----  207 (260)
T cd06606         148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-----EYGRAADIWSLGCTVIEMATG-----------KPPWSELG----  207 (260)
T ss_pred             EEecccccccccccCCCCCccccCHhhhcCC-----CCCchhhHHHHHHHHHHHHhC-----------CCCCCCCC----
Confidence            9877654321113345688999999998763     467889999999999999999           45554331    


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ........+......+.++..++     ..+.+++.+||..||++||++.+++.|.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         208 NPMAALYKIGSSGEPPEIPEHLS-----EEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             chHHHHHhccccCCCcCCCcccC-----HHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence            11122222222233444554443     48999999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.4e-38  Score=302.65  Aligned_cols=269  Identities=22%  Similarity=0.299  Sum_probs=191.8

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +|++.+.||+|+||.||+|+.  +++.||||.+......  .....+|+.+++.++|+||+++++++...+.    +++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK----LMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc----EEEE
Confidence            488999999999999999998  4788999998754322  3345678889999999999999999988653    4899


Q ss_pred             ehhccCCChhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        189 TAYHERGSLCDFLKC----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |||+++ +|.+++..    ..+++..+..++.|++.||.|||+.           +++||||||+||++++++.+||+||
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-----------RVLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCCHHHEEECCCCcEEEeec
Confidence            999985 89888853    3589999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......++..|++||++.+.    ..++.++||||||+++|||++|..||.................
T Consensus       145 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07836         145 GLARAFGIPV--NTFSNEVVTLWYRAPDVLLGS----RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG  218 (284)
T ss_pred             chhhhhcCCc--cccccccccccccChHHhcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            9997654322  112334678899999998653    3456789999999999999999555432211000000000000


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhcc------chhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQ------HAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .+.................++.....      ...+..+.+++.+||+.||++||++.+++++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  283 (284)
T cd07836         219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW  283 (284)
T ss_pred             CCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            00000000000000011111110000      012347889999999999999999999998864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0596|consensus

Probab=100.00  E-value=9.1e-39  Score=311.75  Aligned_cols=260  Identities=20%  Similarity=0.250  Sum_probs=198.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChh---hhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQ---SWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .-+.|++++.||+||.+.||++... .+.+|+|++.....+   ..-+..||..|.+| .|.+||++++|...++.    
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~----  434 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY----  434 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce----
Confidence            4567889999999999999999985 467888876533222   23356899999998 59999999999887654    


Q ss_pred             eeeeehhccCCChhhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +|+||||-+. ||..+|+...  +..-.+..+..||+.++.++|..           ||||.||||.|.|+- .|.+||+
T Consensus       435 lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~-----------gIVHSDLKPANFLlV-kG~LKLI  501 (677)
T KOG0596|consen  435 LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH-----------GIVHSDLKPANFLLV-KGRLKLI  501 (677)
T ss_pred             EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh-----------ceeecCCCcccEEEE-eeeEEee
Confidence            4999998765 9999997653  22237888999999999999999           999999999999987 4689999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccc------cCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF------SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~------~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      |||+|..+..+........++||+.||+||.+....+.      .-..+.++||||+|||||+|+.|           +.
T Consensus       502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg-----------kt  570 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG-----------KT  570 (677)
T ss_pred             eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc-----------CC
Confidence            99999999887765566778999999999998654322      12366889999999999999999           55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...    .+...-...+...+-.-.+|+.-    ...++.++|+.||.+||++|||..++|+|.+..
T Consensus       571 Pf~~~----~n~~aKl~aI~~P~~~Iefp~~~----~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~  631 (677)
T KOG0596|consen  571 PFGQI----INQIAKLHAITDPNHEIEFPDIP----ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ  631 (677)
T ss_pred             chHHH----HHHHHHHHhhcCCCccccccCCC----CchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence            55422    01111112222222222333221    222489999999999999999999999998643

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-37  Score=308.39  Aligned_cols=279  Identities=20%  Similarity=0.240  Sum_probs=199.3

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|..  +++.||+|++.....   ......+|+.++..++||||+++++++..........+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6899999999999999999987  478899999865322   22344578899999999999999998765443334679


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+. |+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA-----------NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEEcCCCcEEecccc
Confidence            9999996 69999985 44589999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        266 LALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       266 la~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      +++........  .......|+..|+|||.+.+.    ..++.++||||||+++|||++|..||.......         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~  228 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL----PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL  228 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCC----cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHh
Confidence            99776433211  112245788999999998653    356788999999999999999965553221100         


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..|..... .........+...........+-.......+..+.++|.+||+.||++|||+++++.+.+....
T Consensus       229 g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         229 GSPSEEVL-NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             CCChhHhh-hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence            00000000 0000000011110001111111000001134579999999999999999999999999887554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-37  Score=297.24  Aligned_cols=245  Identities=23%  Similarity=0.290  Sum_probs=185.6

Q ss_pred             EeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHH---HHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        119 VKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSE---QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~---~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      +||+|+||.||+|..  .++.||+|.+......    .....   ..+..+...+||||+++++++...+    .+++||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----KLSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----EEEEEE
Confidence            489999999999987  4678999988643211    11111   2233455568999999999988765    458999


Q ss_pred             hhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        190 AYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       190 e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++
T Consensus        77 e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~-----------~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          77 DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-----------FVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            99999999998854 4689999999999999999999998           99999999999999999999999999997


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+....    .....|+..|+|||++.++    ..++.++||||||+++|||++|.           .||......  ..
T Consensus       146 ~~~~~~----~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~s~G~~l~~l~~g~-----------~p~~~~~~~--~~  204 (278)
T cd05606         146 DFSKKK----PHASVGTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRGH-----------SPFRQHKTK--DK  204 (278)
T ss_pred             ccCccC----CcCcCCCcCCcCcHHhcCC----CCCCcccchHhHHHHHHHHHhCC-----------CCCCCCCcc--ch
Confidence            654322    2234789999999998653    24678899999999999999994           455432111  11


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      .......  ....+.+|..+     +..+.+++.+||..||++||     ++.+++++.+...
T Consensus       205 ~~~~~~~--~~~~~~~~~~~-----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         205 HEIDRMT--LTMAVELPDSF-----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             HHHHHHh--hccCCCCCCcC-----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence            1211111  11223344333     24799999999999999999     8889998876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1035|consensus

Probab=100.00  E-value=1.3e-38  Score=334.79  Aligned_cols=256  Identities=26%  Similarity=0.422  Sum_probs=193.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecC--------
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRG--------  178 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~--------  178 (461)
                      ..+|+.+++||+||||.||+++.  +|+.+|||++....  .......+|+..+++|+|||||+++..+...        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            45788889999999999999998  69999999997653  3334456899999999999999999654320        


Q ss_pred             ----------------------------------------------C---------------------------------
Q psy17532        179 ----------------------------------------------E---------------------------------  179 (461)
Q Consensus       179 ----------------------------------------------~---------------------------------  179 (461)
                                                                    .                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0                                 


Q ss_pred             --------------------ccc--------eeeeeeehhccCCChhhhhcCCCCC--HHHHHHHHHHHHHHHHHHhhcc
Q psy17532        180 --------------------SIH--------TEFWLITAYHERGSLCDFLKCNIVT--WEQLCRIALSMSKGLMHLHEEI  229 (461)
Q Consensus       180 --------------------~~~--------~~~~lv~e~~~~gsL~~~l~~~~l~--~~~~~~i~~~ia~gL~yLH~~~  229 (461)
                                          ...        ..+||-||||+.-.|.++++.+.+.  .....+++++|+.||+|+|+. 
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~-  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ-  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC-
Confidence                                000        2358999999998888888777664  778899999999999999999 


Q ss_pred             cCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccC----------------CCCCCCCCCCCcCCCccccccc
Q psy17532        230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE----------------PGKPCGDTHGQVGTRRYMAPEV  293 (461)
Q Consensus       230 ~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~  293 (461)
                                |||||||||.||++|.+..|||+|||+|+...                .+......++.+||..|+|||+
T Consensus       717 ----------giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  717 ----------GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             ----------ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence                      99999999999999999999999999998722                0111113456789999999999


Q ss_pred             ccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCch--hccc
Q psy17532        294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPET--WKQH  371 (461)
Q Consensus       294 l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~  371 (461)
                      +.+...  ..|+.|+|+||||||++||+.              ||...      .+..  .++..-.++.+|..  +...
T Consensus       787 l~~~~~--~~Yn~KiDmYSLGIVlFEM~y--------------PF~Ts------MERa--~iL~~LR~g~iP~~~~f~~~  842 (1351)
T KOG1035|consen  787 LSDTSS--NKYNSKIDMYSLGIVLFEMLY--------------PFGTS------MERA--SILTNLRKGSIPEPADFFDP  842 (1351)
T ss_pred             hccccc--ccccchhhhHHHHHHHHHHhc--------------cCCch------HHHH--HHHHhcccCCCCCCcccccc
Confidence            987521  368899999999999999974              34321      1111  11111112333332  2222


Q ss_pred             hhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        372 AGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       372 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      . ...-..+|+++++.||.+||||.|+|..-
T Consensus       843 ~-~~~e~slI~~Ll~hdP~kRPtA~eLL~s~  872 (1351)
T KOG1035|consen  843 E-HPEEASLIRWLLSHDPSKRPTATELLNSE  872 (1351)
T ss_pred             c-chHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence            2 23456899999999999999999999753

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.4e-37  Score=294.98  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=185.2

Q ss_pred             cceeEEeEe--ecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVK--AQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~l--g~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +.|++.+.+  |+|+||.||++..  .+..+|+|.+.......  .+.+...+ ..+|+||+++++.+...+    .+++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~~~~~~-~~~h~~iv~~~~~~~~~~----~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQL-MKDNPNFIKLYYSVTTLK----GHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhHHHHHH-hhcCCCEEEEEEEEecCC----eeEE
Confidence            455666555  9999999999997  46789999986543221  12222221 127999999999998765    4599


Q ss_pred             eehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~DFG  265 (461)
                      ||||+++|+|.++++.+ .+++..+..++.|+++||.|||+.           +++||||||+||+++.++ .++|+|||
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH-----------NIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            99999999999999654 799999999999999999999998           999999999999999998 99999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.....      ....++..|+|||++.+.     .++.++||||||+++|||++|.           .||.......
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~-----------~p~~~~~~~~  213 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGH-----NYDVSFDWWAVGVLTYELLTGK-----------HPFKEDEDEE  213 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCC-----CCCchhhHHHHHHHHHHHHHCC-----------CCCCCCCcch
Confidence            99765432      224688999999999763     5678899999999999999994           4554321111


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-ccchhhhcHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-ASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~l~~  404 (461)
                      .....+.... .  .....+..     .+..+.++|.+||+.||++||+ ++++++|.|.
T Consensus       214 ~~~~~~~~~~-~--~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~  265 (267)
T PHA03390        214 LDLESLLKRQ-Q--KKLPFIKN-----VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL  265 (267)
T ss_pred             hhHHHHHHhh-c--ccCCcccc-----cCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence            1222222222 1  11122222     3347999999999999999996 5999998764

>KOG0604|consensus

Probab=100.00  E-value=1.4e-38  Score=289.64  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=203.4

Q ss_pred             CCcceeEE-eEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLV-EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .+++|++. ++||-|-.|.|-.+.+  +++.+|+|++...  ...+.|.|+..+ .-.|||||++++++.+.......+.
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~-~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWM-ASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhh-hcCCCceEEeehhhhhhccCceeeE
Confidence            34566654 6899999999999988  4788999987532  222333333332 2379999999999987665556678


Q ss_pred             eeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCceE
Q psy17532        187 LITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAA  260 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~~k  260 (461)
                      +|||+|+||.|.+.+..   ..+++.++..|+.||+.|+.|||+.           +|.||||||+|+|...   |-.+|
T Consensus       136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~-----------nIAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM-----------NIAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc-----------chhhccCChhheeeecCCCCcceE
Confidence            99999999999999954   3599999999999999999999999           9999999999999975   45789


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+.-...   ....+.+-|++|.|||++-.     ..|+..+|+||+||++|-|+.|-+||++..+.       
T Consensus       205 LtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~-----eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-------  269 (400)
T KOG0604|consen  205 LTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------  269 (400)
T ss_pred             ecccccccccCCC---ccccCCcccccccCHHHhCc-----hhcCCCCCccchhHHHHHhhcCCCcccccCCc-------
Confidence            9999999875532   23455678999999999965     36888899999999999999995555444332       


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           .....+..++..+.+..+- +.|+.  .++..+++|+.+|..+|.+|.|..++++|.|...
T Consensus       270 -----aispgMk~rI~~gqy~FP~-pEWs~--VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  270 -----AISPGMKRRIRTGQYEFPE-PEWSC--VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             -----cCChhHHhHhhccCccCCC-hhHhH--HHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence                 1223456666666654333 34554  6678999999999999999999999999987643

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.2e-37  Score=289.25  Aligned_cols=248  Identities=29%  Similarity=0.459  Sum_probs=197.2

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      +|+..+.||+|+||.||++...  ++.+++|++..... ......+|+..+..++|+||+++++.+....    ..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD----ELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----eEEEEE
Confidence            4788899999999999999985  78899999875543 3455678888999999999999999988764    458999


Q ss_pred             hhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++++|.+++...  .+++..+..++.|++.||.|||+.           +++||||+|+||+++.++.++|+|||.+
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----------~i~h~dl~p~ni~i~~~~~~~l~d~~~~  145 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-----------GIIHRDIKAANILLTSDGEVKLIDFGLS  145 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-----------CEecCCCCHHHEEEccCCeEEEeecccc
Confidence            999999999999654  789999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ........   .....++..|+|||.+.+.     ..+.++||||||+++|+|++|           ..||...     .
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~~p~~~~-----~  201 (253)
T cd05122         146 AQLSDTKA---RNTMVGTPYWMAPEVINGK-----PYDYKADIWSLGITAIELAEG-----------KPPYSEL-----P  201 (253)
T ss_pred             cccccccc---ccceecCCcccCHHHHcCC-----CCCccccHHHHHHHHHHHHhC-----------CCCCCCC-----c
Confidence            87654431   2345688999999998764     467889999999999999999           4555432     1


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .......... ...+.++...   ..+..+.+++.+||..||++|||+.++++|.+
T Consensus       202 ~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         202 PMKALFKIAT-NGPPGLRNPE---KWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             hHHHHHHHHh-cCCCCcCccc---ccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            1111111211 1112222111   11347999999999999999999999998853

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.7e-37  Score=302.16  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=194.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..|+..+.||+|+||.||+|+.  .+..||+|.+......    ......|+.+++.++|+|++++++++....    ..
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~  100 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH----TA  100 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC----eE
Confidence            4578889999999999999998  4678999998643221    234567888999999999999999988765    34


Q ss_pred             eeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||++ |+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||+|+||+++.++.+||+|
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----------~i~H~dL~p~Nil~~~~~~~kl~d  168 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-----------NMIHRDIKAGNILLTEPGQVKLAD  168 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCcccEEECCCCCEEEec
Confidence            89999997 58888773  45689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++.....      .....|+..|+|||++...  ....++.++|||||||++|||++|+           .||...  
T Consensus       169 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~--~~~~~~~~~Dv~slGvil~el~~g~-----------~p~~~~--  227 (317)
T cd06635         169 FGSASIASP------ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERK-----------PPLFNM--  227 (317)
T ss_pred             CCCccccCC------cccccCCccccChhhhhcC--CCCCCCccccHHHHHHHHHHHHhCC-----------CCCCCc--
Confidence            999875432      2234688899999997531  1135678899999999999999994           444332  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                         ........+.........+..     .+..+.+++.+||+.+|++||++.+++++++....
T Consensus       228 ---~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         228 ---NAMSALYHIAQNESPTLQSNE-----WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ---cHHHHHHHHHhccCCCCCCcc-----ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence               222222222222221222222     23478999999999999999999999999887654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-37  Score=297.71  Aligned_cols=267  Identities=20%  Similarity=0.232  Sum_probs=188.7

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |++.+.||+|+||.||+|+.  +++.||+|.+....  .......+|+..+.++. |+||+++++++.+..  ...+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK--TGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC--CCcEEEE
Confidence            57889999999999999998  46889999886432  22223346777788884 999999999998762  1246999


Q ss_pred             ehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      |||++ |+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+||+++. +.+||+|||+
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-----------~i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN-----------GIFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecccCHHHEEEcC-CCeEEEeccc
Confidence            99997 588888854  4689999999999999999999998           9999999999999999 9999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++.+.....   .....++..|+|||++.++    ..++.++|||||||++|||++|..||.................. 
T Consensus       146 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~-  217 (282)
T cd07831         146 CRGIYSKPP---YTEYISTRWYRAPECLLTD----GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT-  217 (282)
T ss_pred             ccccccCCC---cCCCCCCcccCChhHhhcC----CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCC-
Confidence            987654322   1234578899999987543    34567899999999999999995554322110000000000000 


Q ss_pred             CHHHHHHHHhcc-CCCCCCCchhc------cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        347 SLEDMQEAVVHK-KLRPTLPETWK------QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       347 ~~~~~~~~~~~~-~~~~~~p~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ............ .....++....      ....+..+.++|.+||+.||++||++.+++++.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            000111111000 00111111100      0123468999999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.7e-37  Score=299.55  Aligned_cols=258  Identities=21%  Similarity=0.278  Sum_probs=189.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc-ccee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHM-EHDNILRYIGAEKRGES-IHTE  184 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~-~~~~  184 (461)
                      ++|++.+.||+|+||.||+|..  +++.||||.+......   .....+|+.++..+ +|+||+++++++..... ....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3689999999999999999998  4688999987643221   23456788888888 56999999998876543 1223


Q ss_pred             eeeeehhccCCChhhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CC
Q psy17532        185 FWLITAYHERGSLCDFLKC------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DL  257 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~  257 (461)
                      +++||||+++ +|.+++..      ..+++..+..++.||+.||.|||+.           +|+||||||+||+++. ++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-----------~i~H~dl~~~nil~~~~~~  148 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-----------GVMHRDLKPQNLLVDKQKG  148 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCChHHEEEecCCC
Confidence            6899999985 89888732      3579999999999999999999998           9999999999999998 89


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++.+....  .......+++.|+|||++.+.    ..++.++||||||+++|||++|..||.....     
T Consensus       149 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----  217 (295)
T cd07837         149 LLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGS----THYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-----  217 (295)
T ss_pred             eEEEeecccceecCCCc--cccCCcccccCCCChHHhhCC----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----
Confidence            99999999997654322  112234568889999988653    3567889999999999999999555432110     


Q ss_pred             CccccCCCCCHHHHHHHHh---------------------ccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        338 FSAEVGDHPSLEDMQEAVV---------------------HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                                .........                     .....+...... ....+..+.++|.+||..||++||++.
T Consensus       218 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~R~~~~  286 (295)
T cd07837         218 ----------LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRA-VPDLSPEGLDLLQKMLRYDPAKRISAK  286 (295)
T ss_pred             ----------HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHh-ccccCHHHHHHHHHHccCChhhcCCHH
Confidence                      111100000                     000000000000 011335789999999999999999999


Q ss_pred             chhhhcH
Q psy17532        397 CVVERGM  403 (461)
Q Consensus       397 evl~~l~  403 (461)
                      +++.|.|
T Consensus       287 eil~~~~  293 (295)
T cd07837         287 AALTHPY  293 (295)
T ss_pred             HHhcCCC
Confidence            9999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-37  Score=308.33  Aligned_cols=276  Identities=26%  Similarity=0.337  Sum_probs=197.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||.||+|..  .++.+|||.+....   .......+|+.++.++ +|+||+++++++...+.  ..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~--~~   83 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND--KD   83 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC--ce
Confidence            46789999999999999999988  46789999885321   2223345788889999 99999999998865432  24


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +++||||++ ++|.+++..+.+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG-----------NVIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             EEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEEcCCCcEEEeec
Confidence            689999997 5999999877889999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCC---CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        265 GLALLFEPGKPC---GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       265 Gla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |+++.+......   .......|+..|+|||.+.+.    ..++.++||||||+++|||++|..||.........-....
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~  227 (337)
T cd07852         152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGS----TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE  227 (337)
T ss_pred             cchhccccccccccCcchhcccccccccCceeeecc----ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999876543221   122334688999999988653    3566789999999999999999655532211000000000


Q ss_pred             cCCCCCHH-----------HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLE-----------DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~-----------~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ....+..+           .+...+.. .....+....+.  .+..+.++|.+||+.||++|||+.+++++.+....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         228 VIGPPSAEDIESIKSPFAATMLDSLPS-RPRKPLDELLPK--ASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhCCCCHHHHHHHHhhhHHHhhhhccc-ccccchhhhccC--CCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            00000000           00000000 000111111111  23578999999999999999999999999765543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=297.70  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=191.8

Q ss_pred             eeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |++.+.||+|+||.||+|+..  ++.+|+|.+....   ........|+.++..++|+||+++++++....  ....++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CCcEEEE
Confidence            678899999999999999984  5889999997553   22334567888999999999999999988762  1356999


Q ss_pred             ehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||+++ +|.+++...  .+++..+..++.|++.||+|||+.           +++|+||||+|||+++++.+||+|||+
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-----------~~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN-----------GILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceeccCcHHHeEEcCCCCEEEccccc
Confidence            999985 899988554  689999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +........ .......++..|+|||.+.+.    ..++.++||||||+++|||++|..||.....              
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--------------  207 (287)
T cd07840         147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGA----TRYGPEVDMWSVGCILAELFLGKPIFQGSTE--------------  207 (287)
T ss_pred             eeeccCCCc-ccccccccccccCCceeeEcc----ccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--------------
Confidence            987654331 112334568889999987653    2466889999999999999999555432211              


Q ss_pred             CHHHHHHHHhcc-------------------CC--CCCCCch---hccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        347 SLEDMQEAVVHK-------------------KL--RPTLPET---WKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       347 ~~~~~~~~~~~~-------------------~~--~~~~p~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                        ......+...                   ..  ....+..   ......+..+.+++.+||..||++||++.+++++.
T Consensus       208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         208 --LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             --HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence              0111100000                   00  0000000   00011245789999999999999999999999886


Q ss_pred             H
Q psy17532        403 M  403 (461)
Q Consensus       403 ~  403 (461)
                      +
T Consensus       286 ~  286 (287)
T cd07840         286 Y  286 (287)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-37  Score=300.44  Aligned_cols=258  Identities=22%  Similarity=0.319  Sum_probs=192.2

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|+..+.||+|+||.||+++.  .++.||+|.+....  ........|+.++.++. |+||+++++++....    ..+
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~----~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG----DCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC----cEE
Confidence            4677788999999999999998  46889999986443  22334567888888885 999999999987754    348


Q ss_pred             eeehhccCCChhhhh------cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        187 LITAYHERGSLCDFL------KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       187 lv~e~~~~gsL~~~l------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++|||+.. +|.++.      ....+++..+..++.|++.||+|||+..          +|+||||||+|||++.++.+|
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~----------~i~H~dlkp~Nil~~~~~~~k  148 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL----------KIIHRDVKPSNILLDRNGNIK  148 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC----------CeeccCCCHHHEEEccCCcEE
Confidence            99999864 655543      2356899999999999999999999742          899999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++.+....   ......|+..|+|||++.+..  ...++.++||||||+++|||++|           ..||..
T Consensus       149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g-----------~~p~~~  212 (288)
T cd06616         149 LCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATG-----------KFPYPK  212 (288)
T ss_pred             EeecchhHHhccCC---ccccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhC-----------CCCchh
Confidence            99999997664332   122346888999999986531  12567889999999999999999           556543


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..   ...+.+. .+.. ...+.++.... ...+.++.+||.+||+.||++|||+.+++++.+...
T Consensus       213 ~~---~~~~~~~-~~~~-~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         213 WN---SVFDQLT-QVVK-GDPPILSNSEE-REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             cc---hHHHHHh-hhcC-CCCCcCCCcCC-CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            21   1111211 1111 11122221111 123458999999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0666|consensus

Probab=100.00  E-value=4.1e-39  Score=294.37  Aligned_cols=279  Identities=24%  Similarity=0.318  Sum_probs=207.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC------CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ....|+....||+|.||.||+|..+      ...+|+|.++.+..   -+....+|+..++.++||||+.+..++...+ 
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d-  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD-  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC-
Confidence            4567899999999999999999653      23699999875422   2344578999999999999999999887642 


Q ss_pred             cceeeeeeehhccCCChhhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                        ..+|+++||.+. ||.+.++-      ..++...+..|+.||+.|+.|||++           =|+||||||.||||.
T Consensus       101 --~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-----------WvlHRDLKPaNIlvm  166 (438)
T KOG0666|consen  101 --KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-----------WVLHRDLKPANILVM  166 (438)
T ss_pred             --ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-----------heeeccCCcceEEEe
Confidence              356999999998 99998853      2478888999999999999999999           899999999999998


Q ss_pred             CC----CceEEEecCCccccCCCC-CCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q psy17532        255 SD----LTAAIADFGLALLFEPGK-PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP  329 (461)
Q Consensus       255 ~~----~~~ki~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~  329 (461)
                      .+    |.|||+|||+++.+...- ........+-|+.|.|||++.|.    +.||.+.||||.|||+.||+|-.+.|.+
T Consensus       167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa----~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA----RHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc----ccccchhhhHHHHHHHHHHHccCccccc
Confidence            77    999999999999886543 22244566789999999999986    6888999999999999999999998876


Q ss_pred             CCC--CCCCCCccc-------cCCC------------CCHHHHHHHHhccCCCCC-CCchhccc-hhHHHHHHHHHHHcc
Q psy17532        330 PPG--EYRLPFSAE-------VGDH------------PSLEDMQEAVVHKKLRPT-LPETWKQH-AGMLALCDTMEECWD  386 (461)
Q Consensus       330 ~~~--~~~~pf~~~-------~~~~------------~~~~~~~~~~~~~~~~~~-~p~~~~~~-~~~~~l~~li~~cl~  386 (461)
                      ...  ..+.||...       ....            |................. +..-+... ..+....+|+.++|.
T Consensus       243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~  322 (438)
T KOG0666|consen  243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT  322 (438)
T ss_pred             hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence            432  223366322       0000            111111111110111110 11111000 122347899999999


Q ss_pred             ccHhhhccccchhhhcHHHhh
Q psy17532        387 HDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       387 ~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .||.+|.|+++++++..+...
T Consensus       323 yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  323 YDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             cCchhhccHHHHhcccccccC
Confidence            999999999999999887664

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=298.64  Aligned_cols=265  Identities=23%  Similarity=0.280  Sum_probs=189.1

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |++.+.||+|++|.||+|..  +++.||||++......   .....+|+..++.++|+||+++++++.+..    ..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~----~~~iv   76 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN----KLYLV   76 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----eEEEE
Confidence            56788999999999999987  5788999998654322   234567888999999999999999988764    45999


Q ss_pred             ehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||++ ++|.+++...   .+++..+..++.|++.||+|||+.           +++||||+|+||+++.++.++|+|||
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-----------~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-----------RVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeCCCCCHHHEEEcCCCcEEEeecc
Confidence            99995 6999998554   489999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------CC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------RL  336 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------~~  336 (461)
                      +++......  .......++..|+|||++.+.    ..++.++||||||+++|||++|..||.......         ..
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (283)
T cd07835         145 LARAFGVPV--RTYTHEVVTLWYRAPEILLGS----RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT  218 (283)
T ss_pred             cccccCCCc--cccCccccccCCCCCceeecC----cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            997654322  112234568899999988653    345678999999999999999955543211100         00


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      |-...........+...... ..........  ....+..+.+++.+||+.||++|||+.+++++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         219 PDEDVWPGVTSLPDYKPTFP-KWARQDLSKV--VPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             CChHHhhhhhhchhhhhhcc-cccccchhhh--cCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence            00000000000000000000 0000000000  0112347889999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=299.10  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=193.3

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|...  ++.||||.+.....   ......+|+.++++++|+||+++++++...+    .++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   76 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG----RLY   76 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC----EEE
Confidence            36899999999999999999984  67899998864322   2345578899999999999999999998754    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||++++.|..+... ..+++..+..++.|++.||.|||+.           +++||||+|+||++++++.+||+|||
T Consensus        77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-----------NIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEECCCCCEEEEeee
Confidence            99999998777766643 4589999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++........ .......++..|+|||++.+.    ..++.++||||||+++|||++|..+|.....             
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-------------  207 (288)
T cd07833         146 FARALRARPA-SPLTDYVATRWYRAPELLVGD----TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-------------  207 (288)
T ss_pred             cccccCCCcc-ccccCcccccCCcCCchhcCC----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------
Confidence            9987654432 122335678899999998753    2567889999999999999999655432111             


Q ss_pred             CCHHHHHHHH---------------hccCCCC-CC-----Cch---hccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        346 PSLEDMQEAV---------------VHKKLRP-TL-----PET---WKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       346 ~~~~~~~~~~---------------~~~~~~~-~~-----p~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                        .+......               ....... .+     +..   ......+.++.+||++||..||++|||+++++++
T Consensus       208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         208 --IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             --HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              00000000               0000000 00     000   0001124579999999999999999999999987


Q ss_pred             cH
Q psy17532        402 GM  403 (461)
Q Consensus       402 l~  403 (461)
                      .+
T Consensus       286 ~~  287 (288)
T cd07833         286 PY  287 (288)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5e-37  Score=290.66  Aligned_cols=247  Identities=21%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||++...  +..||+|.+.....   .......|+..++.++|+|++++++.+....    ..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----~~~l   76 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG----KLCI   76 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC----EEEE
Confidence            4788999999999999999995  78899999875432   3344567888899999999999999988764    4589


Q ss_pred             eehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        188 ITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      |+||+++++|.+++..     ..+++..+..++.+++.||.|||+.           +++|+||+|+||+++.++.++|+
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----------~~~H~dl~~~nil~~~~~~~~l~  145 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-----------KILHRDIKPQNIFLTSNGLVKLG  145 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-----------CEecccCChHHeEEcCCCcEEEC
Confidence            9999999999999854     5689999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++.......  .......|+..|+|||.+.+.     .++.++||||||+++|+|++|           ..||... 
T Consensus       146 d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g-----------~~p~~~~-  206 (258)
T cd08215         146 DFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNK-----PYNYKSDIWSLGCVLYELCTL-----------KHPFEGE-  206 (258)
T ss_pred             CccceeecccCc--ceecceeeeecccChhHhccC-----CCCccccHHHHHHHHHHHHcC-----------CCCCCCC-
Confidence            999998765433  122335688899999988653     567889999999999999999           5555432 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                          ....+........ .+.++..++     ..+.+++.+||..+|++|||+.+++++.+
T Consensus       207 ----~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         207 ----NLLELALKILKGQ-YPPIPSQYS-----SELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             ----cHHHHHHHHhcCC-CCCCCCCCC-----HHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence                2333444433332 233443333     37899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.3e-37  Score=295.97  Aligned_cols=254  Identities=21%  Similarity=0.346  Sum_probs=194.0

Q ss_pred             ceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCCh-----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQDK-----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      +|++.+.||+|+||.||+++.     +++.||+|++.....     .......|+.++..+ +|+||+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence            478899999999999999986     468899999864321     223456788888888 6999999999887754  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+++||||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +++||||+|+|||++.++.+|
T Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~-----------~i~H~dl~p~nil~~~~~~~k  145 (290)
T cd05613          79 --KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL-----------GIIYRDIKLENILLDSNGHVV  145 (290)
T ss_pred             --eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHeEECCCCCEE
Confidence              4589999999999999985 44688999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++....... .......|+..|+|||.+.+.   ...++.++||||||+++|+|++|           ..||..
T Consensus       146 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~~l~~ll~g-----------~~p~~~  210 (290)
T cd05613         146 LTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGG---DGGHDKAVDWWSMGVLMYELLTG-----------ASPFTV  210 (290)
T ss_pred             EeeCccceecccccc-cccccccCCcccCChhhccCC---CCCCCccccHHHHHHHHHHHhcC-----------CCCCCc
Confidence            999999987644321 122335688999999998653   12456789999999999999999           445432


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGML  404 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~  404 (461)
                      . +......++...+...  .+.++...     ...+.+++.+||..||++||     ++.+++++.+.
T Consensus       211 ~-~~~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~  271 (290)
T cd05613         211 D-GEKNSQAEISRRILKS--EPPYPQEM-----SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF  271 (290)
T ss_pred             C-CccccHHHHHHHhhcc--CCCCCccC-----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence            2 1112333333333222  22333322     23789999999999999997     66777776554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-37  Score=305.11  Aligned_cols=275  Identities=20%  Similarity=0.253  Sum_probs=197.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-ccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~  184 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||.+...   .........|+.++..++|+||+++++++..... ....
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35799999999999999999998  4788999988642   2223345678888999999999999998765432 1134


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+.           +++||||||+|||++.++.+||+|
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA-----------NVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEEcCCCCEEECc
Confidence            699999996 689988854 5689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||+++......  .......++..|+|||.+.+.    ..++.++|||||||++|||++|..||.......         
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         152 FGLARTTSEKG--DFMTEYVVTRWYRAPELLLNC----SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             CccccccCCCc--ccccccccccCccChHHHhcC----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99998765432  112334678899999988653    246788999999999999999966664321100         


Q ss_pred             CCCCccccCCCCCHHHHHHHHhc--cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVH--KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..|..... ...........+..  ...++.+....  ...+..+.++|++||+.||++|||+.++++|.+...
T Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         226 GSPSEEDL-GFIRNEKARRYIRSLPYTPRQSFARLF--PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CCCChHHh-hhcCchhhhHHHHhcCcccccCHHHHc--ccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            00000000 00000000000100  00011111111  123457899999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-37  Score=304.94  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=191.3

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      .+.+.+|.|+++.||+++.+++.||||++...   .......+.|+..++.++|+||+++++++...+    .++++|||
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~----~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS----ELYVVSPL   80 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC----eEEEEEec
Confidence            34555667777777777778999999998754   223345678999999999999999999988765    45999999


Q ss_pred             ccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        192 HERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       192 ~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      +++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||.+.
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-----------~ivH~dlk~~Nili~~~~~~kl~d~~~~~  149 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK-----------GFIHRSVKASHILLSGDGKVVLSGLRYSV  149 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCcceEEEecCCceEEecCccce
Confidence            999999999864   3588999999999999999999999           99999999999999999999999999987


Q ss_pred             ccCCCCC-----CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        269 LFEPGKP-----CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       269 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      .......     ........++..|+|||++.+..   ..++.++|||||||++|||++|..||.....           
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Diws~G~il~el~~g~~pf~~~~~-----------  215 (314)
T cd08216         150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL---QGYNEKSDIYSVGITACELANGHVPFKDMPA-----------  215 (314)
T ss_pred             eeccccccccccccccccccccccccCHHHhcCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-----------
Confidence            6543211     01122345778899999986531   2467889999999999999999655532211           


Q ss_pred             CCCCHHHHHHHHhcc-----------------------CCCCCCC---chhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        344 DHPSLEDMQEAVVHK-----------------------KLRPTLP---ETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~-----------------------~~~~~~p---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                          .....+.....                       ...+...   ...........+.+|+.+||..||++|||+++
T Consensus       216 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         216 ----TQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             ----HHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence                00111110000                       0000000   00000112357889999999999999999999


Q ss_pred             hhhhcHHHhh
Q psy17532        398 VVERGMLALC  407 (461)
Q Consensus       398 vl~~l~~~~~  407 (461)
                      +++|.+...+
T Consensus       292 ll~~p~~~~~  301 (314)
T cd08216         292 LLNHSFFKQC  301 (314)
T ss_pred             HhcCchHhhh
Confidence            9999986544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983|consensus

Probab=100.00  E-value=1.4e-37  Score=279.80  Aligned_cols=259  Identities=20%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhh--hHHHHHHHHcCCC-CCCCeeEEEEEEecCCccce
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS--WQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~--~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+.++++.+..||.|.-|.|++++++  |...|||.+.......  .+....+.++..- +.|.||+.+|+|..+...  
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV--  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV--  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH--
Confidence            45677888899999999999999995  5889999997654332  2334455544333 589999999999987644  


Q ss_pred             eeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                        ++.||.|.. .+..+|+  .+++++.-+-++...+.+||.||.++.          +|+|||+||+|||+|+.|++|+
T Consensus       167 --~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH----------~viHRDvKPSNILlDe~GniKl  233 (391)
T KOG0983|consen  167 --FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH----------GVIHRDVKPSNILLDERGNIKL  233 (391)
T ss_pred             --HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc----------ceeecccCccceEEccCCCEEe
Confidence              899999864 5555654  356888888889999999999998874          9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      ||||++..+-++..   .....|.+.|||||-+.-.  ....|+.++||||||++++||+||           +.||.+.
T Consensus       234 CDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~--~~~kYDiRaDVWSlGITlveLaTg-----------~yPy~~c  297 (391)
T KOG0983|consen  234 CDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPP--DKPKYDIRADVWSLGITLVELATG-----------QYPYKGC  297 (391)
T ss_pred             ecccccceeecccc---cccccCCccccCccccCCC--CCCccchhhhhhhhccchhhhhcc-----------cCCCCCC
Confidence            99999987765542   3345788999999998754  235788999999999999999999           7777653


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         +..++ +...+.+. ..|.+|..-   ..+..+.+++..||.+|+.+||...++++|.+...
T Consensus       298 ---~tdFe-~ltkvln~-ePP~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  298 ---KTDFE-VLTKVLNE-EPPLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             ---CccHH-HHHHHHhc-CCCCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence               22333 33444442 235555431   14568999999999999999999999999986544

>KOG0986|consensus

Probab=100.00  E-value=8.9e-38  Score=298.31  Aligned_cols=254  Identities=23%  Similarity=0.288  Sum_probs=200.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .+.|..-++||+|+||.||-++.  +|+.+|.|.+.+....    .....+|-.+|.+++.+.||.+--+|.+.+.    
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~----  259 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA----  259 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc----
Confidence            45678889999999999998876  6888999987432211    2223567777889999999999888888764    


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +++|+..|.||||.-+|.+   ..+++..++.++.+|+.||++||+.           +||.|||||+|||+|+.|+++|
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-----------~iVYRDLKPeNILLDd~GhvRI  328 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-----------RIVYRDLKPENILLDDHGHVRI  328 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-----------ceeeccCChhheeeccCCCeEe
Confidence            4999999999999988843   3599999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|+|||..+..++.   ..+.+||.+|||||++.+.     .|+...|.|||||+||||+.|           +.||...
T Consensus       329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne-----~Y~~s~Dwf~lGCllYemi~G-----------~sPFr~~  389 (591)
T KOG0986|consen  329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNE-----VYDFSPDWFSLGCLLYEMIAG-----------HSPFRQR  389 (591)
T ss_pred             eccceEEecCCCCc---cccccCcccccCHHHHcCC-----cccCCccHHHHHhHHHHHHcc-----------cCchhhh
Confidence            99999999887653   3445999999999999875     577889999999999999999           5555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~  406 (461)
                       ......+++-..+....  ..+++.+     +++.++|.+..|.+||++|..     ++++-+|..+..
T Consensus       390 -KeKvk~eEvdrr~~~~~--~ey~~kF-----S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  390 -KEKVKREEVDRRTLEDP--EEYSDKF-----SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             -hhhhhHHHHHHHHhcch--hhccccc-----CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence             11112233333333221  2334443     448999999999999999985     567888876644

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=289.29  Aligned_cols=240  Identities=20%  Similarity=0.288  Sum_probs=183.6

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHH-HcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIF-KLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +.||+|+||.||+|..  .++.||||.+......    ......|.. .....+|+||+++++++...+    .+++|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e   77 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----YLYLVME   77 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----eEEEEEe
Confidence            5689999999999998  4688999998643221    111223322 344568999999999998755    4599999


Q ss_pred             hccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        191 YHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       191 ~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      |+++|+|.++++. ..+++..+..++.|++.||.|||+.           +++||||+|+||+++.++.+||+|||+++.
T Consensus        78 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~-----------~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          78 YLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR-----------GIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            9999999999964 5689999999999999999999998           999999999999999999999999999876


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      ...      .....++..|+|||.+.+.     .++.++||||||+++|||++|           ..||...     ...
T Consensus       147 ~~~------~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~il~~l~~g-----------~~p~~~~-----~~~  199 (260)
T cd05611         147 GLE------NKKFVGTPDYLAPETILGV-----GDDKMSDWWSLGCVIFEFLFG-----------YPPFHAE-----TPD  199 (260)
T ss_pred             ccc------cccCCCCcCccChhhhcCC-----CCcchhhhHHHHHHHHHHHHC-----------CCCCCCC-----CHH
Confidence            432      2234678899999998763     467889999999999999999           5555432     223


Q ss_pred             HHHHHHhccCCC--CCCCchhccchhHHHHHHHHHHHccccHhhhccc---cchhhhcHH
Q psy17532        350 DMQEAVVHKKLR--PTLPETWKQHAGMLALCDTMEECWDHDAEARLSA---SCVVERGML  404 (461)
Q Consensus       350 ~~~~~~~~~~~~--~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~evl~~l~~  404 (461)
                      .+..........  ......     .+..+.+++.+||+.||++||++   +|+++|.+.
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         200 AVFDNILSRRINWPEEVKEF-----CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             HHHHHHHhcccCCCCccccc-----CCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            333333222211  111111     23478999999999999999977   477777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-37  Score=292.29  Aligned_cols=244  Identities=23%  Similarity=0.328  Sum_probs=190.9

Q ss_pred             eecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||+|+||.||+++..  ++.+|+|.+.....    ......+|+.++.+++|+||+++++.+....    .+++++||++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEEEecCC
Confidence            689999999999994  78899999865432    2334567888899999999999999887654    4599999999


Q ss_pred             CCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        194 RGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       194 ~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      +|+|.++++. ..+++..+..++.|++.||+|||+.           +++||||+|+||+++.++.+||+|||++.....
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~-----------~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN-----------GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-----------CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9999999964 5689999999999999999999998           999999999999999999999999999876543


Q ss_pred             CCCC------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        273 GKPC------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       273 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ....      .......++..|+|||.+.+.     ..+.++||||||+++|||++|           ..||...     
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g-----------~~p~~~~-----  204 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-----GHSKTVDWWSLGCILYEFLVG-----------IPPFHGE-----  204 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCC-----CCCcchhhHHHHHHHHHHHhC-----------CCCCCCC-----
Confidence            3110      122334678899999998663     467889999999999999999           5555433     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc---cchhhhcHH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA---SCVVERGML  404 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~evl~~l~~  404 (461)
                      ........+..+..  ..+....   .+..+.+++.+||+.+|++|||+   .+++++.+.
T Consensus       205 ~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         205 TPEEIFQNILNGKI--EWPEDVE---VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             CHHHHHHHHhcCCc--CCCcccc---CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence            23344444433222  2222210   23478999999999999999999   777777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0587|consensus

Probab=100.00  E-value=4.9e-37  Score=313.85  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=210.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCC-ccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGE-SIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~-~~~~~~~  186 (461)
                      ...|++.++||+|.+|.||+++.  +++.+|||++..........|.|..+++.. +|||++.++|++.-.. ....++|
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            45789999999999999999887  578899999987776666677777776665 8999999999875433 3457899


Q ss_pred             eeehhccCCChhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ||||||.+||.-|+++   ..++.|..+..|++.++.||.+||.+           .++|||+|-.|||++.++.|||.|
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n-----------kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN-----------KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc-----------ceeeecccCceEEEeccCcEEEee
Confidence            9999999999999985   45799999999999999999999999           899999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||.+..++...  .......||+.|||||++.........|+.++|+||||++..||.-|.+|+....+           
T Consensus       167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------  233 (953)
T KOG0587|consen  167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------  233 (953)
T ss_pred             eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------
Confidence            99998887654  45667899999999999987766667788999999999999999999544422111           


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                         . ..+.........+..-|+.|.+     ++.++|..||.+|.++||+..++++|.+.-
T Consensus       234 ---m-raLF~IpRNPPPkLkrp~kWs~-----~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  234 ---M-RALFLIPRNPPPKLKRPKKWSK-----KFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             ---h-hhhccCCCCCCccccchhhHHH-----HHHHHHHHHHhhccccCcchhhhccCCccc
Confidence               0 0000000111111122455554     899999999999999999999999998654

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.6e-37  Score=293.56  Aligned_cols=244  Identities=26%  Similarity=0.336  Sum_probs=186.5

Q ss_pred             eecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||+|+||+||++..  +++.||+|.+.....    .......|+.++..++||||+++++++...+    .+++||||++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEEEEEecCC
Confidence            68999999999987  478899999864321    1223356888899999999999999987754    4599999999


Q ss_pred             CCChhhhhcC-C--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        194 RGSLCDFLKC-N--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       194 ~gsL~~~l~~-~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      +|+|.+++.. .  .+++..+..++.|++.||.|||+.           +++||||+|+||+++.++.+||+|||++...
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-----------~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~  145 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-----------RIVYRDLKPENVLLDDHGNVRISDLGLAVEL  145 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence            9999999843 2  589999999999999999999998           9999999999999999999999999999766


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      ....   ......++..|+|||++.+.     .++.++||||||+++|+|++|           ..||...... .....
T Consensus       146 ~~~~---~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~~~~~-~~~~~  205 (277)
T cd05577         146 KGGK---KIKGRAGTPGYMAPEVLQGE-----VYDFSVDWFALGCTLYEMIAG-----------RSPFRQRKEK-VEKEE  205 (277)
T ss_pred             ccCC---ccccccCCCCcCCHHHhcCC-----CCCchhhhHHHHHHHHHHhhC-----------CCCCCCCccc-ccHHH
Confidence            4322   22335678899999998763     467889999999999999999           4555332110 11222


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHH
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLA  405 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~  405 (461)
                      +......  .....+..+     +..+.++|.+||+.||++||     ++.+++.|.+..
T Consensus       206 ~~~~~~~--~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~  258 (277)
T cd05577         206 LKRRTLE--MAVEYPDKF-----SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK  258 (277)
T ss_pred             HHhcccc--ccccCCccC-----CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence            2222211  122233332     34789999999999999999     555577776553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-36  Score=295.24  Aligned_cols=260  Identities=20%  Similarity=0.313  Sum_probs=194.4

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....++|++.+.||+|+||.||+|+++  ++.||||.+.....  .......|+..+.+. .|+||+++++++.+..   
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---   87 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS---   87 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC---
Confidence            445678999999999999999999996  78899999875432  222334455544455 5999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        183 TEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                       .++++|||+. ++|.+++.  ...+++..+..++.|++.||+|||+ .           +|+||||+|+||++++++.+
T Consensus        88 -~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----------~i~H~dl~p~nill~~~~~~  154 (296)
T cd06618          88 -DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH-----------GVIHRDVKPSNILLDASGNV  154 (296)
T ss_pred             -eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC-----------CEecCCCcHHHEEEcCCCCE
Confidence             4599999985 47777664  3468999999999999999999997 4           89999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||++..+.....   .....++..|+|||.+.+... ...++.++||||||+++|||++|           ..||.
T Consensus       155 kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g-----------~~p~~  219 (296)
T cd06618         155 KLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATG-----------QFPYK  219 (296)
T ss_pred             EECccccchhccCCCc---ccCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhC-----------CCCCC
Confidence            9999999977643321   223357889999999875321 23467889999999999999999           55554


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...    ...+....+.... .+.++..   ...+.++.+|+.+||..||++||++.+++.+.+...
T Consensus       220 ~~~----~~~~~~~~~~~~~-~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         220 NCK----TEFEVLTKILQEE-PPSLPPN---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             cch----hHHHHHHHHhcCC-CCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            320    1112222332222 1222211   113357999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.3e-37  Score=304.95  Aligned_cols=278  Identities=22%  Similarity=0.266  Sum_probs=195.0

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc-------
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI-------  181 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~-------  181 (461)
                      .+|++.+.||.|+||.||+|..  .++.||+|.+...... .....+|+.++++++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6899999999999999999988  4678999998654432 23456788899999999999999876654321       


Q ss_pred             ---ceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CC
Q psy17532        182 ---HTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DL  257 (461)
Q Consensus       182 ---~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~  257 (461)
                         ....++||||++ ++|.+++..+.+++..+..++.||+.||.|||+.           +|+||||||+||+++. ++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------givH~dikp~Nili~~~~~  152 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA-----------NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEEcCCCc
Confidence               124689999997 5999999888899999999999999999999998           9999999999999984 56


Q ss_pred             ceEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC--
Q psy17532        258 TAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY--  334 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~--  334 (461)
                      .+||+|||+++.+...... .......++..|+|||++.+.    ..++.++|||||||++|||++|..||.......  
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP----NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCc----cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            7899999999776432211 111234578899999987543    356678999999999999999965553221100  


Q ss_pred             -----CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        335 -----RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       335 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                           ..|........................+..+........+.++.+||.+||..||++|||+.+++.|.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence                 00000000000000000000000000111110000011234788999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.5e-37  Score=295.15  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=195.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCcccee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ++|++.+.||+|+||.||+|+.  ++..||+|++....    ........|..++.+++ |+||+++++++....    .
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----~   76 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE----N   76 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc----e
Confidence            4689999999999999999998  57889999986422    22234456777788888 999999999887755    4


Q ss_pred             eeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++||||+++++|.+++... .+++..+..++.|++.||.|||+.           +++|+||+|+||+++.++.++|+|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~-----------~~~H~dl~~~ni~i~~~~~~~l~d  145 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK-----------GIIHRDLKPENILLDKDMHIKITD  145 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCHHHeEECCCCCEEecC
Confidence            58999999999999999654 799999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCC------------------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCC
Q psy17532        264 FGLALLFEPGKPC------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS  325 (461)
Q Consensus       264 FGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~  325 (461)
                      ||++.........                  .......++..|+|||++.+.     ..+.++||||||+++|++++|  
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Di~slG~~l~~l~~g--  218 (280)
T cd05581         146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-----PAGKSSDLWALGCIIYQMLTG--  218 (280)
T ss_pred             CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-----CCChhhhHHHHHHHHHHHHhC--
Confidence            9999876533210                  112234578899999988653     467789999999999999999  


Q ss_pred             CCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc----cchhhh
Q psy17532        326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA----SCVVER  401 (461)
Q Consensus       326 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~  401 (461)
                               ..||...     ........+..  ....++..++     ..+.+++.+||+.||++||++    ++++.|
T Consensus       219 ---------~~p~~~~-----~~~~~~~~~~~--~~~~~~~~~~-----~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         219 ---------KPPFRGS-----NEYLTFQKILK--LEYSFPPNFP-----PDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ---------CCCCCCc-----cHHHHHHHHHh--cCCCCCCccC-----HHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                     5555433     11222222222  2223444332     378999999999999999999    888877


Q ss_pred             cH
Q psy17532        402 GM  403 (461)
Q Consensus       402 l~  403 (461)
                      .+
T Consensus       278 ~~  279 (280)
T cd05581         278 PF  279 (280)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.1e-37  Score=289.44  Aligned_cols=244  Identities=27%  Similarity=0.453  Sum_probs=197.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+++.  +++.+|+|.+....   ........|+..++.++|+||+++++++....    .+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN----KLCI   76 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC----EEEE
Confidence            478999999999999999987  46789999986533   22334457888899999999999999887753    5699


Q ss_pred             eehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        188 ITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      |+||+++++|.+++..     ..+++..+..++.|++.||+|||+.           +++|+||+|.||+++.++.+||+
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-----------~i~h~~l~~~ni~~~~~~~~kl~  145 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-----------KILHRDLKSANILLVANDLVKIG  145 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-----------CcccCCCCcceEEEecCCcEEEe
Confidence            9999999999999854     5689999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++......    .....++..|+|||.+.+     ..++.++|+||||+++|||++|           +.||... 
T Consensus       146 d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g-----------~~p~~~~-  204 (256)
T cd08530         146 DLGISKVLKKNM----AKTQIGTPHYMAPEVWKG-----RPYSYKSDIWSLGCLLYEMATF-----------APPFEAR-  204 (256)
T ss_pred             eccchhhhccCC----cccccCCccccCHHHHCC-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-
Confidence            999998775431    223567889999999865     3566789999999999999999           5565433 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                          ........+.... .+.++..+     +.++.+++.+||..+|++||++.+++.++
T Consensus       205 ----~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         205 ----SMQDLRYKVQRGK-YPPIPPIY-----SQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             ----CHHHHHHHHhcCC-CCCCchhh-----CHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence                3333333333322 23333332     34799999999999999999999999886

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0690|consensus

Probab=100.00  E-value=4.6e-38  Score=288.95  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=205.5

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|..+++||+|.||.|-+++-  .++.+|+|++++.-    ........|-.+|...+||.+..+.-.|...+   
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d---  241 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD---  241 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc---
Confidence            4567899999999999999999987  47889999986432    22233346777888999999999887777755   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||||..||.|.-+|.. ..++++....+...|..||.|||++           +||.||||.+|.|+|.+|++||
T Consensus       242 -rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~-----------~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  242 -RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR-----------NIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             -eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC-----------CeeeeechhhhheeccCCceEe
Confidence             55999999999999999854 4689999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++.--...  ..+...+||+.|+|||++..+     .|+..+|.|.+||++|||+.|           ++||+..
T Consensus       310 tDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDn-----DYgraVDWWG~GVVMYEMmCG-----------RLPFyn~  371 (516)
T KOG0690|consen  310 TDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDN-----DYGRAVDWWGVGVVMYEMMCG-----------RLPFYNK  371 (516)
T ss_pred             eecccchhccccc--ceeccccCChhhcCchhhccc-----cccceeehhhhhHHHHHHHhc-----------cCccccc
Confidence            9999997532221  346678999999999999874     777889999999999999999           8888765


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLA  405 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~  405 (461)
                           ..+.+.+.+.-+.++  +|.....     +.+.|+...|.+||.+|..     |.||.+|-++.
T Consensus       372 -----dh~kLFeLIl~ed~k--FPr~ls~-----eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~  428 (516)
T KOG0690|consen  372 -----DHEKLFELILMEDLK--FPRTLSP-----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA  428 (516)
T ss_pred             -----chhHHHHHHHhhhcc--CCccCCH-----HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence                 556667777666553  4544443     7889999999999999975     44555555443

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-36  Score=293.86  Aligned_cols=270  Identities=23%  Similarity=0.287  Sum_probs=190.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|+.  +++.||+|.+.....   ......+|+.++++++|+||+++++++.+..    .++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   77 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK----RLY   77 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC----eEE
Confidence            5799999999999999999998  467899998854322   1234567888999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEEE
Q psy17532        187 LITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIA  262 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~  262 (461)
                      +||||++ ++|.+++...   .+++..+..++.||+.||+|||++           +++||||+|+||+++. ++.+||+
T Consensus        78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~i~H~dl~p~nill~~~~~~~kl~  145 (294)
T PLN00009         78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-----------RVLHRDLKPQNLLIDRRTNALKLA  145 (294)
T ss_pred             EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCCcceEEEECCCCEEEEc
Confidence            9999996 5888887432   257788889999999999999998           9999999999999985 5679999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC---------
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------  333 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~---------  333 (461)
                      |||++.......  .......++..|+|||++.+.    ..++.++||||||+++|+|+||..||......         
T Consensus       146 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~  219 (294)
T PLN00009        146 DFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGS----RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI  219 (294)
T ss_pred             ccccccccCCCc--cccccCceeecccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999997654322  112334678899999988653    35677899999999999999996555322110         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...|............+....  ........... .....+..+.+++.+||+.||++||++.+++++.+...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        220 LGTPNEETWPGVTSLPDYKSA--FPKWPPKDLAT-VVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hCCCChhhccccccchhhhhh--cccCCCCCHHH-hCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            000000000000000000000  00000000000 00112347889999999999999999999999977644

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-36  Score=296.52  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=192.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc----
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES----  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~----  180 (461)
                      ..++|++.+.||+|+||.||+|..  +++.||||.+.....   .......|+.++..++||||+++++++.+...    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            356899999999999999999998  468899999865432   22344678889999999999999998876541    


Q ss_pred             --cceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        181 --IHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       181 --~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                        ....+++|+||+++ +|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+||+++++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~i~H~dl~p~nili~~~  152 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK-----------NFLHRDIKCSNILLNNK  152 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEECCC
Confidence              11256899999986 77777754  3589999999999999999999998           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||++........ .......++..|+|||.+.+.    ..++.++|||||||++|||++|++||......   
T Consensus       153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---  224 (302)
T cd07864         153 GQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFTKKPIFQANQEL---  224 (302)
T ss_pred             CcEEeCcccccccccCCcc-cccccceeccCccChHHhcCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---
Confidence            9999999999987654332 112223567889999988653    24567899999999999999995554321100   


Q ss_pred             CCccccCCCCCHHHHHHHHhccC--CCC-------------------CCCchhccchhHHHHHHHHHHHccccHhhhccc
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKK--LRP-------------------TLPETWKQHAGMLALCDTMEECWDHDAEARLSA  395 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~--~~~-------------------~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  395 (461)
                               .....+........  ..+                   .....+.  ..+..+.+++.+||..||++|||+
T Consensus       225 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~  293 (302)
T cd07864         225 ---------AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS--FIPTPALDLLDHMLTLDPSKRCTA  293 (302)
T ss_pred             ---------HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcC--CCCHHHHHHHHHHccCChhhCCCH
Confidence                     00000000000000  000                   0000010  123578999999999999999999


Q ss_pred             cchhhhcH
Q psy17532        396 SCVVERGM  403 (461)
Q Consensus       396 ~evl~~l~  403 (461)
                      .+++++.+
T Consensus       294 ~~il~~~~  301 (302)
T cd07864         294 EEALNSPW  301 (302)
T ss_pred             HHHhcCCC
Confidence            99998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.7e-37  Score=298.67  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...|+..+.||+|+||.||+|+.  +++.||+|.+.....    ......+|+.+++.++|+|++++++++....    .
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~   89 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----T   89 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----e
Confidence            34577788999999999999998  467899998864221    2233457888899999999999999988754    4


Q ss_pred             eeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .++||||+. |+|.+++.  ...+++..+..++.|++.||.|||+.           +++||||||+|||++.++.+||+
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-----------~i~H~dl~p~nil~~~~~~~kl~  157 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-----------NMIHRDVKAGNILLSEPGLVKLG  157 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHhEEECCCCcEEEC
Confidence            589999997 68888763  44589999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++......      ....++..|+|||++.+.  ....++.++|||||||++|||++|           ..||... 
T Consensus       158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g-----------~~p~~~~-  217 (308)
T cd06634         158 DFGSASIMAPA------NXFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER-----------KPPLFNM-  217 (308)
T ss_pred             CcccceeecCc------ccccCCccccCHHHHhhc--ccCCCCcccchHHHHHHHHHHHcC-----------CCCCccc-
Confidence            99998765432      234678899999997532  113466789999999999999999           4454332 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                          ........+.... .+..+.    ...+..+.+||.+||..+|++||++.+++++.+....
T Consensus       218 ----~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         218 ----NAMSALYHIAQNE-SPALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ----cHHHHHHHHhhcC-CCCcCc----ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                1112222222221 122111    1123478999999999999999999999999876664

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-36  Score=300.39  Aligned_cols=274  Identities=20%  Similarity=0.258  Sum_probs=197.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      .++|++.+.||+|+||.||+|..  +++.||||++.....   ......+|+.+++.++|+||+++++++......  ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            46799999999999999999987  478899999854321   123345788999999999999999998765432  23


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||+ +++|.+++....+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----------gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA-----------GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEee
Confidence            568999999 67999999888899999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc-c
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE-V  342 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~-~  342 (461)
                      ||++......     .....++..|+|||++.+.    ..++.++||||||+++|++++|..||........  +... .
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~  230 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNW----MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMK  230 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            9999765432     2234678899999998653    2466789999999999999999555432211000  0000 0


Q ss_pred             CCCCCHHHHHHHHhcc-------CCCCCCCchhc--cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHK-------KLRPTLPETWK--QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~-------~~~~~~p~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ............+...       ......+....  ....+..+.++|.+|++.||++|||+.+++.+.+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0000000000000000       00000000000  01123468899999999999999999999999887654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-36  Score=299.83  Aligned_cols=273  Identities=21%  Similarity=0.284  Sum_probs=195.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|++.+.||+|+||.||+|..  +++.||+|++.....   ......+|+.++.+++|+||+++++++......  .
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            347899999999999999999987  478899999864321   223445788899999999999999988654321  1


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..++++++++ +++|.++++...+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-----------DIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCChHHEEEcCCCCEEEe
Confidence            2457888887 77999999888899999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC--------
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY--------  334 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~--------  334 (461)
                      |||+++.....     .....++..|+|||.+.+.    ..++.++|||||||++|||++|..||.......        
T Consensus       163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             ccccccccccc-----ccccccCCCccCHHHHhCc----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999765322     2335678899999988652    346678999999999999999955542211000        


Q ss_pred             -CCCCccccCCCCCHHHHHHHHhccCCCC--CCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        335 -RLPFSAEVGDHPSLEDMQEAVVHKKLRP--TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       335 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ..+-.......+. .........-...+  .+...+  ...+..+.++|.+||+.||++||++.+++.|.+...
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         234 VGTPGAELLKKISS-ESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             hCCCCHHHHhhccc-HhHHHHHHHhcccCCcchhhhc--CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence             0000000000000 00000000000000  000000  012347889999999999999999999999987654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-36  Score=299.59  Aligned_cols=270  Identities=20%  Similarity=0.260  Sum_probs=187.5

Q ss_pred             eEeecC--CceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        118 EVKAQG--RFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       118 ~~lg~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ..||+|  +||+||++++  .++.||||++......   ....++|+.+++.++||||+++++++..+..    +++|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~----~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW----LWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc----eEEEEe
Confidence            456666  9999999998  5789999998654322   2345678888888999999999999988653    489999


Q ss_pred             hccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        191 YHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       191 ~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |+.+|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+|++|||.+
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-----------~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN-----------GYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            9999999999864   3588999999999999999999998           9999999999999999999999999865


Q ss_pred             cccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCC----------
Q psy17532        268 LLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG----------  332 (461)
Q Consensus       268 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~----------  332 (461)
                      .........     .......++..|+|||++.+.   ...++.++|||||||++|||++|..||.....          
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  225 (328)
T cd08226         149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD---LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG  225 (328)
T ss_pred             hhhhccCccccccccccccccCccCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC
Confidence            433211100     001112356679999998753   12467889999999999999999766643211          


Q ss_pred             CCCCCCccccCCCCCHH-HH-----------HHHHhccCCCCCCC-ch--h-ccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        333 EYRLPFSAEVGDHPSLE-DM-----------QEAVVHKKLRPTLP-ET--W-KQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~-~~-----------~~~~~~~~~~~~~p-~~--~-~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      ....|+....  .+... ..           .+.+.......... ..  . .....+..+.+||.+||..||++|||+.
T Consensus       226 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~  303 (328)
T cd08226         226 PPYSPLDITT--FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS  303 (328)
T ss_pred             CCCCCccccc--cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence            0000110000  00000 00           00000000000000 00  0 0112345789999999999999999999


Q ss_pred             chhhhcHHHhh
Q psy17532        397 CVVERGMLALC  407 (461)
Q Consensus       397 evl~~l~~~~~  407 (461)
                      ++++|.+....
T Consensus       304 e~l~~~~~~~~  314 (328)
T cd08226         304 SLLSHAFFKQV  314 (328)
T ss_pred             HHhhCHHHHHH
Confidence            99999987554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=284.23  Aligned_cols=246  Identities=29%  Similarity=0.430  Sum_probs=196.4

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +|++.+.||+|+||.||+|+.  .++.||+|.+.....   ......+|+.++.+++|+|++++++++.+..    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD----SLYI   76 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----EEEE
Confidence            478899999999999999988  467899999875543   3345578888999999999999999987754    4589


Q ss_pred             eehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +|||+++++|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.++|+|||+
T Consensus        77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-----------GVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC-----------CcccCCCCHHHEEECCCCCEEEecccc
Confidence            9999999999999854 5789999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +........  ......++..|+|||.+.+.     ..+.++||||||+++|+|++|           ..||....    
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~~lG~~l~~l~~g-----------~~p~~~~~----  203 (254)
T cd06627         146 ATKLNDVSK--DDASVVGTPYWMAPEVIEMS-----GASTASDIWSLGCTVIELLTG-----------NPPYYDLN----  203 (254)
T ss_pred             ceecCCCcc--cccccccchhhcCHhhhcCC-----CCCcchhHHHHHHHHHHHHhC-----------CCCCCCcc----
Confidence            987765432  12335688899999998653     466789999999999999999           45554321    


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      ....... .. ....+.++...     +..+.+++.+||..+|++|||+.+++.+.
T Consensus       204 ~~~~~~~-~~-~~~~~~~~~~~-----~~~~~~~i~~~l~~~p~~R~~~~~~l~~~  252 (254)
T cd06627         204 PMAALFR-IV-QDDHPPLPEGI-----SPELKDFLMQCFQKDPNLRPTAKQLLKHP  252 (254)
T ss_pred             HHHHHHH-Hh-ccCCCCCCCCC-----CHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence            1111111 11 12223333332     34789999999999999999999998874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.1e-37  Score=295.92  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=196.0

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      |+....||+|+||.||++..  +++.||||.+..... ......+|+.+++.++|+||+++++.+...+    ..++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEEEEEe
Confidence            33346899999999999988  468899998754332 2334567888899999999999999988765    4599999


Q ss_pred             hccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        191 YHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       191 ~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      |+++++|.+++....+++..+..++.|++.||+|||+.           +++||||+|+||+++.++.++|+|||++...
T Consensus        98 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-----------givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ-----------GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            99999999999877899999999999999999999998           9999999999999999999999999998765


Q ss_pred             CCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHH
Q psy17532        271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED  350 (461)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~  350 (461)
                      ....  .......|+..|+|||.+.+.     .++.++||||||+++|||++|           ..||...     ....
T Consensus       167 ~~~~--~~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slGvil~el~tg-----------~~p~~~~-----~~~~  223 (292)
T cd06657         167 SKEV--PRRKSLVGTPYWMAPELISRL-----PYGPEVDIWSLGIMVIEMVDG-----------EPPYFNE-----PPLK  223 (292)
T ss_pred             cccc--ccccccccCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-----CHHH
Confidence            4322  112335688999999988653     566789999999999999999           5555432     1112


Q ss_pred             HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       351 ~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..... .......+...   ...+..+.+++.+||..||.+||++.++++|.+....
T Consensus       224 ~~~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         224 AMKMI-RDNLPPKLKNL---HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             HHHHH-HhhCCcccCCc---ccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence            22221 11111111110   1123478899999999999999999999999877664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-36  Score=299.49  Aligned_cols=274  Identities=22%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      ..+|.+.+.||+|+||.||+|+.  +++.||||.+.....   ......+|+.++..++|+||+++++++......  ..
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            35799999999999999999987  478899998864321   123356788999999999999999998754321  23


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++|+||+.. +|..++. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-----------~i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSA-----------GIIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEEee
Confidence            56899999974 7877663 4689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....     .....++..|+|||++.+.    ..++.++|||||||++|||++|+.||................
T Consensus       161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         161 FGLARHADAE-----MTGYVVTRWYRAPEVILNW----MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             CCCCcCCCCC-----CCCceeeecccChhhhcCc----cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999765321     2234678899999998653    246788999999999999999955553211000000000000


Q ss_pred             CCCCHHHHHHHHhcc------CCCCCCC-chhcc--chhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHK------KLRPTLP-ETWKQ--HAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~------~~~~~~p-~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..+. ..........      ...+..+ ..+..  ...+..+.+||.+||+.||++||++++++.|.+....
T Consensus       232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         232 GVPG-PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             CCCC-HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            0000 0000000000      0000111 00000  0123468899999999999999999999999876554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.3e-36  Score=296.80  Aligned_cols=273  Identities=25%  Similarity=0.327  Sum_probs=191.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc----
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI----  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~----  181 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||.+......   .....+|+..++.++|+||+++++++......    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            57999999999999999999998  4678999988643221   22446788889999999999999987654321    


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                      ...+++|+||+.+ +|..++..  ..+++..+..++.|+++||.|||+.           +|+||||||+|||+++++.+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-----------~i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN-----------HILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEECCCCCE
Confidence            2356899999975 77777643  3699999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCC---------CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCG---------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP  330 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~  330 (461)
                      ||+|||+++.........         ......++..|+|||.+.+.    ..++.++||||||+++|||++|.++|...
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE----RRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC----CccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            999999997654322111         11233568889999988653    35678899999999999999996655322


Q ss_pred             CCCC---------CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhcc--chhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        331 PGEY---------RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQ--HAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       331 ~~~~---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      ....         ..|....   .+....... ..........+.....  ......+.+++.+||..||++|||+.+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         231 SDIDQLHLIFKLCGTPTEET---WPGWRSLPG-CEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             CHHHHHHHHHHHhCCCChhh---chhhhhccc-ccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            1100         0000000   000000000 0000000000100000  01224788999999999999999999999


Q ss_pred             hhcH
Q psy17532        400 ERGM  403 (461)
Q Consensus       400 ~~l~  403 (461)
                      .|.+
T Consensus       307 ~~~~  310 (311)
T cd07866         307 EHPY  310 (311)
T ss_pred             cCCC
Confidence            8865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0669|consensus

Probab=100.00  E-value=7.6e-39  Score=284.87  Aligned_cols=280  Identities=23%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc---
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH---  182 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~---  182 (461)
                      .+.|+-..+||+|.||.||+|+.+  ++.||+|++...+.   -.....+|+.+|..++|+|++.++..|.......   
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            346777789999999999999884  57799987654332   2334578999999999999999999886654333   


Q ss_pred             -eeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        183 -TEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       183 -~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                       ..+|+|+++|+. +|.-+|...  +++..++.+++.++..||.|+|..           .|+|||+|+.|+||+.++.+
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-----------kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN-----------KILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh-----------hHHhhcccHhhEEEcCCceE
Confidence             348999999998 999999654  689999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCC--CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCG--DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      ||+|||+++.+...+...  .....+-|..|.+||.+.|.    +.++.+.|||..|||+.||+||.+.+++.....++-
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~----r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~  239 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD----REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH  239 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcc----cccCCcchhHhHHHHHHHHHccCccccCChHHHHHH
Confidence            999999998876443211  22345679999999999985    688899999999999999999988887654322111


Q ss_pred             Cccc--------cCCCCCHHHHHHHHhc----cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        338 FSAE--------VGDHPSLEDMQEAVVH----KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       338 f~~~--------~~~~~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      +...        ..-....-.+.+.+..    ++....+++....-....+..+|+.+++..||.+|+.++++++|.++.
T Consensus       240 ~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  240 LISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             HHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            1000        0000000011111100    000001111111111123677999999999999999999999998775


Q ss_pred             h
Q psy17532        406 L  406 (461)
Q Consensus       406 ~  406 (461)
                      .
T Consensus       320 k  320 (376)
T KOG0669|consen  320 K  320 (376)
T ss_pred             c
Confidence            5

>KOG0612|consensus

Probab=100.00  E-value=3.4e-38  Score=329.20  Aligned_cols=266  Identities=21%  Similarity=0.242  Sum_probs=219.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecC----ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~----~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .....+|.++++||+|+||.|..++++  ++.+|.|++++.    ......+..|-.+|..-+.+-||++.-.|.+....
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            345679999999999999999999995  678999998642    22233344555556677799999999999987754


Q ss_pred             ceeeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                          |+|||||+||||-.++... +++++.+..++..|..||.-||+-           |+|||||||+|||||..|++|
T Consensus       151 ----YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m-----------gyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  151 ----YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM-----------GYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             ----EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc-----------cceeccCCcceeEecccCcEe
Confidence                9999999999999999654 599999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||.+..+..+.. ......+|||-|.+||++.........|+..+|.||+||++|||+.|           ..||+.
T Consensus       216 LADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG-----------~TPFYa  283 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYG-----------ETPFYA  283 (1317)
T ss_pred             eccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcC-----------CCcchH
Confidence            999999987764433 23455789999999999975433336788999999999999999999           888887


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc---ccchhhhcHHHhhhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS---ASCVVERGMLALCDT  409 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~l~~~~~~~  409 (461)
                      .     +..+...+++..+....+|+..   ..+++.++||.+.+. +|+.|..   .+++-.|+++....+
T Consensus       284 d-----slveTY~KIm~hk~~l~FP~~~---~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  284 D-----SLVETYGKIMNHKESLSFPDET---DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             H-----HHHHHHHHHhchhhhcCCCccc---ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence            6     6777778888877777788432   256789999998776 7899998   999999998876544

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=296.05  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=190.2

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |++.+.||+|+||.||+|+.  .++.||||.+.....  ......+|+..+.+++ |+||+++++++....    ..++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~----~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND----ELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC----cEEEE
Confidence            57889999999999999998  467899998864322  2233456888888998 999999999988754    45999


Q ss_pred             ehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+ +|+|.+++...   .+++..+..++.|++.||.|||++           +++|+||+|+||+++.++.++|+|||
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-----------~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-----------GFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCChhhEEEcCCCCEEEeecc
Confidence            9999 78999988543   689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.......   .....++..|+|||++.+.    ..++.++||||||+++|||++|..+|.........--.......
T Consensus       145 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  217 (283)
T cd07830         145 LAREIRSRPP---YTDYVSTRWYRAPEILLRS----TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT  217 (283)
T ss_pred             cceeccCCCC---cCCCCCcccccCceeeecC----cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCC
Confidence            9987654322   2234678899999988653    35678899999999999999996555332110000000000000


Q ss_pred             CCHHHHHHHH-hccCCCCCCCch----hc--cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAV-VHKKLRPTLPET----WK--QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~-~~~~~~~~~p~~----~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      +......+.. ........++..    ..  .......+.+++++||..||++|||+.|++.+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            0000000000 000000000000    00  0011357899999999999999999999998864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.9e-36  Score=293.10  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=189.6

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      |...+.||+|+||.||+|+.  .++.||+|.+.....    .......|+.++..++|+|++++++++.+..    ..|+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   98 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH----TAWL   98 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC----EEEE
Confidence            56678899999999999987  578899999864322    1223467888899999999999999998765    4489


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||||+. |+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||+|+||+++.++.+||+|||
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~-----------gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-----------NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCChhhEEECCCCCEEEeecC
Confidence            999996 58888774  34689999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.....      .....|+..|+|||++...  ....++.++||||||+++|||++|           ..||...    
T Consensus       167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~slGvil~el~~g-----------~~p~~~~----  223 (313)
T cd06633         167 SASKSSP------ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER-----------KPPLFNM----  223 (313)
T ss_pred             CCcccCC------CCCccccccccChhhcccc--CCCCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC----
Confidence            9864321      2235688999999998531  113567789999999999999999           4555432    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       .....................+     +..+.+|+.+||+.+|++||++.+++.+.+...
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         224 -NAMSALYHIAQNDSPTLQSNEW-----TDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             -ChHHHHHHHHhcCCCCCCcccc-----CHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence             1111111221111111111122     236899999999999999999999999976544

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0607|consensus

Probab=100.00  E-value=2.4e-37  Score=283.64  Aligned_cols=272  Identities=22%  Similarity=0.308  Sum_probs=206.5

Q ss_pred             eEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      +.||+|+|+.|--+..  ++..+|||++.+.... ..+.-+|+.++.+. .|+||++++++|.+..    .+|||||-|.
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~----~FYLVfEKm~  159 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT----RFYLVFEKMR  159 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc----eEEEEEeccc
Confidence            6899999999988765  7899999999765433 33445777777777 6999999999999876    5699999999


Q ss_pred             CCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC---ceEEEecCCccc
Q psy17532        194 RGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL---TAAIADFGLALL  269 (461)
Q Consensus       194 ~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~---~~ki~DFGla~~  269 (461)
                      ||+|...+. ...+++.++.++..+||.||.|||.+           ||.||||||+|||-.+..   -+||+||.|+.-
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k-----------gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK-----------GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc-----------CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            999999885 45699999999999999999999999           999999999999997654   479999988754


Q ss_pred             cCCCCCCC-----CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        270 FEPGKPCG-----DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       270 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +.......     ...+.+|+..|||||+..--......|+.++|.||||||+|-|++|-+||.+..+. ..-|.....-
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~-dCGWdrGe~C  307 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA-DCGWDRGEVC  307 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC-cCCccCCCcc
Confidence            43222221     23356899999999987543223356788999999999999999997777766553 2222211000


Q ss_pred             CCCHHHHHHHHhccCCCCCCC-chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                      ..-...+.+.+..+.+  .+| .+|..  .+.+.++++...+..|+.+|.++.+++.|+|.-.+..
T Consensus       308 r~CQ~~LFesIQEGkY--eFPdkdWah--IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKY--EFPDKDWAH--ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             HHHHHHHHHHHhccCC--cCChhhhHH--hhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            0112234455555544  344 44543  5568899999999999999999999999998776643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-36  Score=289.94  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=189.4

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecC------ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQ------DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~------~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      +|.+.+.||+|+||.||+++..  +..+++|.++..      .....+...|+.+++.++||||+++++++.+..    .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----A   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC----c
Confidence            4788999999999999999885  345666665421      122234556888899999999999999887654    3


Q ss_pred             eeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        185 FWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                      +++|+||+++++|.+++.     ...+++..+..++.|++.||.|||+.           +++|+||||+||++++ +.+
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~i~h~~l~~~nili~~-~~~  144 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-----------RILHRDLKAKNIFLKN-NLL  144 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-----------CccccCCChhheEeec-CCE
Confidence            589999999999998874     34689999999999999999999998           9999999999999986 569


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++.......  ......|+..|+|||.+.+     ..++.++||||||+++|+|++|           ..||.
T Consensus       145 ~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~~-----------~~~~~  206 (260)
T cd08222         145 KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKH-----QGYDSKSDIWSLGCILYEMCCL-----------AHAFE  206 (260)
T ss_pred             eecccCceeecCCCcc--cccCCCCCcCccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCC
Confidence            9999999977644321  2233467889999998865     3566789999999999999999           45553


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..     ........... ...+..+..+     +.++.++|.+||..||++||++.+++++.+
T Consensus       207 ~~-----~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         207 GQ-----NFLSVVLRIVE-GPTPSLPETY-----SRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             Cc-----cHHHHHHHHHc-CCCCCCcchh-----cHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence            22     22222233322 2233334333     247899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.2e-36  Score=296.06  Aligned_cols=270  Identities=23%  Similarity=0.290  Sum_probs=194.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..++|++.+.||+|+||.||+|..  +++.||||++....   ........|+.++..++||||+++++++....   ..
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~   84 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL---ED   84 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC---Cc
Confidence            456899999999999999999987  46789999875322   22334567888999999999999999886533   23


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +++++||+ +++|.++++...+++..+..++.|++.||.|||+.           +|+||||+|+|||+++++.+||+||
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~-----------~iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA-----------GVVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEeECCCCCEEeCcc
Confidence            58999998 56999999888899999999999999999999998           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc--cc
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA--EV  342 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~--~~  342 (461)
                      |++......     .....++..|+|||.+.+.    ..++.++||||||+++|||++|..||.......  .+..  ..
T Consensus       153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~--~~~~~~~~  221 (328)
T cd07856         153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTW----QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN--QFSIITDL  221 (328)
T ss_pred             ccccccCCC-----cCCCcccccccCceeeecc----CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence            999764321     2234678899999987652    356788999999999999999965553211100  0000  00


Q ss_pred             CCCCCHHHHHH---------HHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQE---------AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~---------~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...+. ++..+         ...........+..-.....+..+.++|.+||+.||++|||+++++.+.+...
T Consensus       222 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~  293 (328)
T cd07856         222 LGTPP-DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP  293 (328)
T ss_pred             hCCCC-HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence            00000 00000         00000111111110000112358999999999999999999999999976543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.2e-36  Score=298.89  Aligned_cols=259  Identities=22%  Similarity=0.244  Sum_probs=191.2

Q ss_pred             cee-EEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh---------------hHHHHHHHHcCCCCCCCeeEEEEE
Q psy17532        113 SIQ-LVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS---------------WQSEQEIFKLPHMEHDNILRYIGA  174 (461)
Q Consensus       113 ~~~-~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---------------~~~~~ei~~l~~l~H~nIv~l~g~  174 (461)
                      +|. +.+.||+|+||.||+|..  .++.||||.+.......               ....+|+.++..++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            444 567899999999999987  47889999986432221               134578889999999999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      +...+    ..++||||+. |+|.+++.. ..+++.....++.|++.||.|||+.           +|+||||+|+|||+
T Consensus        89 ~~~~~----~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~-----------~i~H~dl~~~nill  152 (335)
T PTZ00024         89 YVEGD----FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW-----------YFMHRDLSPANIFI  152 (335)
T ss_pred             EecCC----cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecccccHHHeEE
Confidence            88765    4589999997 699999854 4689999999999999999999998           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCC------------CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        254 KSDLTAAIADFGLALLFEPGKP------------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      +.++.+||+|||+++.......            ........++..|+|||++.+.    ..++.++||||||+++|||+
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA----EKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC----CCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999976651110            0112233568889999998753    34578899999999999999


Q ss_pred             cCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhcc-------------------CCCCCCCchhcc--chhHHHHHHH
Q psy17532        322 SRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHK-------------------KLRPTLPETWKQ--HAGMLALCDT  380 (461)
Q Consensus       322 tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~p~~~~~--~~~~~~l~~l  380 (461)
                      +|..||.....                .+....+...                   ......+.....  ...+..+.++
T Consensus       229 tg~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (335)
T PTZ00024        229 TGKPLFPGENE----------------IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL  292 (335)
T ss_pred             hCCCCCCCCCH----------------HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHH
Confidence            99555432211                1111111000                   000000110000  1123578899


Q ss_pred             HHHHccccHhhhccccchhhhcHHHhh
Q psy17532        381 MEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       381 i~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      +.+||+.||++|||+++++.+.+....
T Consensus       293 i~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        293 LQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHcCCCchhccCHHHHhcCcccCCC
Confidence            999999999999999999999876543

>KOG1024|consensus

Probab=100.00  E-value=1.2e-36  Score=285.74  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=206.0

Q ss_pred             cceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      .++++..++-+|.||.||+|.+..       +.|-||.++....+  ......|...+..+.|||+..+.+++.....  
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~--  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA--  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence            456777788999999999997742       45777877543332  2334578888888999999999999876542  


Q ss_pred             eeeeeeehhccCCChhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC---------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                       ..++++.++.-|+|..||..         +.++..++..++.|++.|++|||+.           +|||.||..+|++|
T Consensus       362 -~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-----------~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  362 -TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-----------GVIHKDIAARNCVI  429 (563)
T ss_pred             -cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-----------Ccccchhhhhccee
Confidence             34789999999999999961         2367788999999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      |+...+||+|=.+++.+-+.+..-.......+..||+||.+..+     .|+..+|||||||+||||+|-+         
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-----~yssasDvWsfGVllWELmtlg---------  495 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-----HYSSASDVWSFGVLLWELMTLG---------  495 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-----hhcchhhhHHHHHHHHHHHhcC---------
Confidence            99999999999999998877654444455668899999999874     7778899999999999999975         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                       +.||.+.     ...++.. .+..++|..-|..+++     ++..+|.-||+.+|++||+++++...|.+.
T Consensus       496 -~~PyaeI-----DPfEm~~-ylkdGyRlaQP~NCPD-----eLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  496 -KLPYAEI-----DPFEMEH-YLKDGYRLAQPFNCPD-----ELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -CCCcccc-----CHHHHHH-HHhccceecCCCCCcH-----HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence             7777654     4445544 4455667777777766     899999999999999999999999887654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.8e-36  Score=289.95  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=191.8

Q ss_pred             ceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCCh-----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQDK-----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~-----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      +|++.+.||+|+||.||+++.     +++.||||.+.....     .......|+.++.++ +|+||+++++.+....  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence            478899999999999999985     356799999864321     223456788888899 6999999999887654  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+++||||+++|+|.+++.. ..+++..+..++.|+++||.|||+.           +++||||||+||+++.++.++
T Consensus        79 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-----------~~~H~dl~p~nil~~~~~~~~  145 (288)
T cd05583          79 --KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL-----------GIIYRDIKLENILLDSEGHVV  145 (288)
T ss_pred             --EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHeEECCCCCEE
Confidence              45899999999999999854 5689999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++.+..... .......|+..|+|||.+.+..   ...+.++||||||+++|||++|           ..||..
T Consensus       146 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Dv~slG~il~el~tg-----------~~p~~~  210 (288)
T cd05583         146 LTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGS---GGHDKAVDWWSLGVLTFELLTG-----------ASPFTV  210 (288)
T ss_pred             EEECccccccccccc-cccccccCCccccCHHHhcCCC---CCCcchhhhHHHHHHHHHHHhC-----------CCCccc
Confidence            999999977654322 1222346889999999986531   1356789999999999999999           455532


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccch---hhhcH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV---VERGM  403 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev---l~~l~  403 (461)
                      .. ......++...+...  .+..+...+     ..+.+++.+||+.||++|||+.++   +++.+
T Consensus       211 ~~-~~~~~~~~~~~~~~~--~~~~~~~~~-----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         211 DG-EQNSQSEISRRILKS--KPPFPKTMS-----AEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             Cc-ccchHHHHHHHHHcc--CCCCCcccC-----HHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence            21 111223333333222  123333322     378999999999999999997655   55543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.5e-36  Score=298.19  Aligned_cols=276  Identities=23%  Similarity=0.254  Sum_probs=192.8

Q ss_pred             ceeEEeEeecCCceEEEEEEEC----CCcEEEEEEecCCh---hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK----NENVAVKIFLMQDK---QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      +|++.+.||+|+||.||+++..    +..||||.+.....   ......+|+.++.++ +|+||+++++.+.........
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4789999999999999999985    55799998864221   123445788888888 599999999976543222234


Q ss_pred             eeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++++||+. ++|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------givH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA-----------NVLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHeEEcCCCCEEeCc
Confidence            688999986 58999884 45689999999999999999999998           999999999999999999999999


Q ss_pred             cCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC-------
Q psy17532        264 FGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-------  334 (461)
Q Consensus       264 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~-------  334 (461)
                      ||+++.+......  .......|+..|+|||++.+.    ..++.++||||||+++|+|++|..||.......       
T Consensus       149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~  224 (332)
T cd07857         149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF----QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ  224 (332)
T ss_pred             CCCceecccccccccccccCcccCccccCcHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence            9999876543211  112335789999999987653    356788999999999999999965553211000       


Q ss_pred             --CCCCccccCCCCCHHHHHHHHhc--cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 --RLPFSAEVGDHPSLEDMQEAVVH--KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 --~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                        ..|....... ............  ......++..++  ..+..+.+++.+||+.||++|||+.+++.+.+....
T Consensus       225 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         225 VLGTPDEETLSR-IGSPKAQNYIRSLPNIPKKPFESIFP--NANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HhCCCCHHHHHh-hhhhhHHHHHHhccccCCcchHhhCC--CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence              0000000000 000000000000  000111111111  123478999999999999999999999999876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=292.16  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=190.6

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |+..+.||+|++|.||+|..  +++.+|+|.+......   ......|+..+++++|+||+++++++..+.    .+++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v   76 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG----DLYLV   76 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC----CEEEE
Confidence            56778999999999999998  4788999998654322   344567888899999999999999988764    45899


Q ss_pred             ehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||+++ +|.+++..  ..+++..+..++.|++.||.|||+.           +|+|+||||+||+++.++.+||+|||.
T Consensus        77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~H~dl~p~nili~~~~~~~l~df~~  144 (283)
T cd05118          77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH-----------GILHRDLKPENLLINTEGVLKLADFGL  144 (283)
T ss_pred             EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCcCHHHEEECCCCcEEEeeeee
Confidence            999975 89888855  3789999999999999999999998           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +.......  .......++..|+|||.+.+.    ...+.++||||||+++|+|++|..+|           ....    
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~~~-----------~~~~----  203 (283)
T cd05118         145 ARSFGSPV--RPYTHYVVTRWYRAPELLLGD----KGYSTPVDIWSVGCIFAELLSRRPLF-----------PGKS----  203 (283)
T ss_pred             eEecCCCc--ccccCccCcccccCcHHHhcC----CCCCchhHHHHHHHHHHHHHhCCCCC-----------CCCC----
Confidence            97765432  112234678899999998653    35678899999999999999995444           3221    


Q ss_pred             CHHHHHHHHhcc-------------------------CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        347 SLEDMQEAVVHK-------------------------KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       347 ~~~~~~~~~~~~-------------------------~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                       ..+....+...                         ..........  ...+..+.++|.+||+.||.+||++.+++.+
T Consensus       204 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         204 -EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF--PNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             -HHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhh--hhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence             00100000000                         0000000000  1134589999999999999999999999988


Q ss_pred             cH
Q psy17532        402 GM  403 (461)
Q Consensus       402 l~  403 (461)
                      .+
T Consensus       281 ~~  282 (283)
T cd05118         281 PY  282 (283)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-36  Score=296.86  Aligned_cols=278  Identities=23%  Similarity=0.272  Sum_probs=198.7

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCC-ccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE-SIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~-~~~~~~~  186 (461)
                      +|++.+.||+|+||.||+|+..  ++.||||.+....   ........|+.+++.++|+||+++++++.... .....++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4889999999999999999984  6889999886432   22345567888999999999999999987754 1123569


Q ss_pred             eeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++|||++ ++|.+++... .+++..+..++.|++.||+|||+.           +|+||||||.|||++.++.++|+|||
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-----------gi~H~dlkp~nili~~~~~~~L~dfg  148 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA-----------NVIHRDLKPSNILVNSNCDLKICDFG  148 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEcccC
Confidence            9999998 4899988653 789999999999999999999998           99999999999999999999999999


Q ss_pred             CccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------C
Q psy17532        266 LALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------R  335 (461)
Q Consensus       266 la~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------~  335 (461)
                      ++......... .......++..|+|||++.+.    ..++.++||||||+++|+|++|..||.......         .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  224 (330)
T cd07834         149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS----SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG  224 (330)
T ss_pred             ceEeecccccccccccccccccCcCCceeeecc----cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence            99876543210 112345678899999998763    256788999999999999999966654322100         0


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .|-..... ..........+.........+-.-.....+..+.++|.+||+.||++|||+.+++.+.+....
T Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         225 TPSEEDLK-FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             CCChhHhh-hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            00000000 000000000111000000000000001123578999999999999999999999999877654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-36  Score=287.80  Aligned_cols=254  Identities=23%  Similarity=0.282  Sum_probs=186.5

Q ss_pred             eeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---hhHHHHHHHH---cCCCCCCCeeEEEEEEecCCc-ccee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFK---LPHMEHDNILRYIGAEKRGES-IHTE  184 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~~~~~~ei~~---l~~l~H~nIv~l~g~~~~~~~-~~~~  184 (461)
                      |++.+.||+|+||.||+|+.+  ++.||+|.+......   .....+|+.+   +..++|+||+++++++...+. ....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999984  688999998643221   1223345544   455579999999999887653 1123


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ++++|||+.+ +|.+++..   ..+++..+..++.|++.||.|||+.           +++|+||+|+||+++.++.+||
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-----------~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH-----------RIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCChhhEEEccCCCEEE
Confidence            6899999974 89988854   2589999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++........   .....++..|+|||++.+.     .++.++||||||+++|||++|.++|....          
T Consensus       149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~s~G~~l~~l~~~~~~~~~~~----------  210 (287)
T cd07838         149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQS-----SYATPVDMWSVGCIFAELFRRRPLFRGTS----------  210 (287)
T ss_pred             eccCcceeccCCcc---cccccccccccChHHhccC-----CCCCcchhhhHHHHHHHHHhCCCcccCCC----------
Confidence            99999987654321   2234578899999998763     56788999999999999999954443211          


Q ss_pred             cCCCCCHHHHHHHHhccC------------------CCCCCCchhcc--chhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        342 VGDHPSLEDMQEAVVHKK------------------LRPTLPETWKQ--HAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~------------------~~~~~p~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                            ..+....+....                  .....+.....  ......+.+++.+||+.||++||++.+++.|
T Consensus       211 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         211 ------EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ------hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                  111111111100                  00000000000  1123577899999999999999999999988


Q ss_pred             cH
Q psy17532        402 GM  403 (461)
Q Consensus       402 l~  403 (461)
                      .+
T Consensus       285 ~~  286 (287)
T cd07838         285 PY  286 (287)
T ss_pred             cC
Confidence            54

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-36  Score=282.72  Aligned_cols=239  Identities=25%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             eecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        120 KAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       120 lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      ||+|+||.||++...  ++.+|+|.+.....    .......|+.+++.++|+||+++++.+..+.    ..++||||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEEEecCC
Confidence            699999999999984  68899999865432    2234567888899999999999999887755    4499999999


Q ss_pred             CCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        194 RGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       194 ~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      +++|.+++... .+++..+..++.|++.||.|||+.           +++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~-----------~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL-----------GIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            99999999654 689999999999999999999998           999999999999999999999999999977654


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      ..  .......++..|+|||.+.+.     ..+.++|+||||+++||+++|           ..||...     ......
T Consensus       146 ~~--~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~D~~slG~~~~~l~~g-----------~~p~~~~-----~~~~~~  202 (250)
T cd05123         146 EG--SRTNTFCGTPEYLAPEVLLGK-----GYGKAVDWWSLGVLLYEMLTG-----------KPPFYAE-----DRKEIY  202 (250)
T ss_pred             CC--CcccCCcCCccccChHHhCCC-----CCCchhhHHHHHHHHHHHHHC-----------CCCCCCC-----CHHHHH
Confidence            32  123345678899999998753     466789999999999999999           5666433     223333


Q ss_pred             HHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc---cchhhhcH
Q psy17532        353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA---SCVVERGM  403 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~evl~~l~  403 (461)
                      ..+..  ....++...+     ..+.+++++||..||++||++   .++++|.+
T Consensus       203 ~~~~~--~~~~~~~~~~-----~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         203 EKILK--DPLRFPEFLS-----PEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             HHHhc--CCCCCCCCCC-----HHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence            44433  2233444332     378999999999999999999   67776653

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-36  Score=300.17  Aligned_cols=273  Identities=21%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~  182 (461)
                      ..++|++.+.||+|+||.||+|+..  ++.||||.+....   .......+|+.+++.++|+||+++++++.....  ..
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999984  6789999886432   122334578889999999999999987765432  11


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+++|+||+ +++|.+++....+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.+||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-----------gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA-----------GIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEECCCCCEEEc
Confidence            2368999998 56999999888899999999999999999999998           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||++......     .....++..|+|||.+.+.    ..++.++||||||+++|||++|..||...............
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             ccccccccccc-----ccCCcccccccCHHHHhCC----CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence            99999765432     2334678899999988653    24667899999999999999995544321110000000000


Q ss_pred             CCCCCHHHHHHHH--------hc---cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAV--------VH---KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~--------~~---~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...+. +.+....        ..   ...+..+...+.  ..+..+.++|.+||+.||++|||+.+++.|.+...
T Consensus       232 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         232 VGTPD-EELLQKISSESARNYIQSLPQMPKKDFKEVFS--GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             cCCCC-HHHHhhccchhHHHHHHhccccCCCCHHHHhc--cCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence            00000 0000000        00   000001111111  12457899999999999999999999999987654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4250|consensus

Probab=100.00  E-value=1.2e-36  Score=305.63  Aligned_cols=199  Identities=25%  Similarity=0.345  Sum_probs=166.0

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~  185 (461)
                      ..+...+.||+|+||.||+|++  .|+.||||.+....  ......-+|+.+|++++|+|||+++++-.+...  .....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            4567788999999999999997  58999999986532  223344578999999999999999998765541  12345


Q ss_pred             eeeehhccCCChhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC--CC--
Q psy17532        186 WLITAYHERGSLCDFLKC----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS--DL--  257 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~--~~--  257 (461)
                      .+|||||.+|||..+|..    ..|++.+.+.+..+++.||.|||++           +|+||||||.||++-.  +|  
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-----------~IvHRDlKP~NIvl~~Gedgq~  161 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-----------GIVHRDLKPGNIVLQIGEDGQS  161 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-----------CceeccCCCCcEEEeecCCCce
Confidence            899999999999999964    3599999999999999999999999           9999999999999842  23  


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVS  328 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~  328 (461)
                      ..||+|||.|+.++.+.   .....+||..|.+||++...    +.|+..+|.|||||++||.+||..||-
T Consensus       162 IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q----~~y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  162 IYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQ----KKYTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             EEeeecccccccCCCCC---eeeeecCchhhcChHHHhhc----cCcCceeehhhhhhHHHHHhccCCCCC
Confidence            56999999999998765   35567999999999999852    467778999999999999999966654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=288.57  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=190.7

Q ss_pred             eeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |+..+.||+|+||.||+|+..  ++.||+|.+....   ........|+.+++.++|+||+++++++....    .+++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~~v   76 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER----KLYLV   76 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC----ceEEE
Confidence            567789999999999999994  6889999987543   22234567888899999999999999988764    45899


Q ss_pred             ehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||++ ++|.+++...  .+++..+..++.|++.||.|||+.           +|+||||+|+||++++++.+||+|||+
T Consensus        77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------~i~H~~l~~~ni~~~~~~~~~l~d~g~  144 (282)
T cd07829          77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH-----------RILHRDLKPQNILINRDGVLKLADFGL  144 (282)
T ss_pred             ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCChheEEEcCCCCEEEecCCc
Confidence            99998 5999999664  799999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++.......  ......++..|+|||.+.+.    ..++.++||||||+++|||++|..+|..................+
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07829         145 ARAFGIPLR--TYTHEVVTLWYRAPEILLGS----KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP  218 (282)
T ss_pred             ccccCCCcc--ccCccccCcCcCChHHhcCC----cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC
Confidence            987654321  22234567889999998653    356778999999999999999955443221000000000000000


Q ss_pred             CHHHHHHHHh----ccCCCCCCC-----chhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        347 SLEDMQEAVV----HKKLRPTLP-----ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       347 ~~~~~~~~~~----~~~~~~~~p-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .. .......    .....+...     ..++  ..+..+.+++.+||..||++||++.+++.+.+
T Consensus       219 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         219 TE-ESWPGVTKLPDYKPTFPKFPPKDLEKVLP--RLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             cH-HHHHhhcccccccccccccCccchHHhcc--cccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            00 0000000    000000000     0000  11347999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2e-35  Score=316.07  Aligned_cols=143  Identities=22%  Similarity=0.313  Sum_probs=125.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||.||+|.+.  ++.||||++.....    .......|+.++..++|+||+++++++....    .
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----~   78 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN----N   78 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC----E
Confidence            568999999999999999999995  78899999864322    1234567888888999999999999887755    4


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++||||+++|+|.+++.. +.+++..++.++.||+.||+|||+.           +|+||||||+||||+.++.+||+|
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~-----------gIiHrDLKP~NILl~~~g~vkL~D  147 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH-----------GIIHRDLKPDNMLISNEGHIKLTD  147 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEeCCccHHHEEEcCCCCEEEEe
Confidence            5999999999999999853 4688999999999999999999998           999999999999999999999999


Q ss_pred             cCCcc
Q psy17532        264 FGLAL  268 (461)
Q Consensus       264 FGla~  268 (461)
                      ||+++
T Consensus       148 FGls~  152 (669)
T cd05610         148 FGLSK  152 (669)
T ss_pred             CCCCc
Confidence            99986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-35  Score=308.88  Aligned_cols=309  Identities=17%  Similarity=0.197  Sum_probs=188.1

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC------CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecC--
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG--  178 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~--  178 (461)
                      +....++|++.+.||+|+||.||+|++.      +..||||++.......... .+  .+....+.++..++..+...  
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~-~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM-NE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHH-HH--HHHhhchhhHHHHHHhhhcccc
Confidence            4456789999999999999999999984      5689999875432211111 11  11222233333332221110  


Q ss_pred             CccceeeeeeehhccCCChhhhhcCCCC---------------------CHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKCNIV---------------------TWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~~~l---------------------~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      .....++++|+||+.+|+|.+++....+                     ....+..++.|++.||+|||+.         
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---------  274 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---------  274 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---------
Confidence            0113467999999999999999864321                     1233567899999999999998         


Q ss_pred             CCCeecccCCCCcEEEcC-CCceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccccc---------------
Q psy17532        238 KPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS---------------  301 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---------------  301 (461)
                        +|+||||||+|||++. ++.+||+|||+|+.+..+.. .......+++.|||||.+.......               
T Consensus       275 --gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l  351 (566)
T PLN03225        275 --GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL  351 (566)
T ss_pred             --CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence              9999999999999986 58999999999987654332 2233467899999999764321111               


Q ss_pred             --CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc-------C-CCCCHHHHHHHHhccCCCCCCCchhcc-
Q psy17532        302 --RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV-------G-DHPSLEDMQEAVVHKKLRPTLPETWKQ-  370 (461)
Q Consensus       302 --~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~-------~-~~~~~~~~~~~~~~~~~~~~~p~~~~~-  370 (461)
                        ..++.++|||||||+||||+++.           .++....       . ...........+ .....+.....+.. 
T Consensus       352 ~~~~~~~k~DVwSlGviL~el~~~~-----------~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  419 (566)
T PLN03225        352 WQLNLPDRFDIYSAGLIFLQMAFPN-----------LRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPRASPDLRRGFEVL  419 (566)
T ss_pred             ccccCCCCcccHHHHHHHHHHHhCc-----------CCCchHHHHHHHHHHhcCCcHHHHHHhh-ccccchhhhhhhhhc
Confidence              12445779999999999999873           2221100       0 000001110000 01011111100000 


Q ss_pred             chhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhhh-hccCCC--ChhhhhhhhHHHHHHHHHHHhhhccC
Q psy17532        371 HAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDTM-EECWDH--DAEARLSASCVVERVAWQSRALLDST  442 (461)
Q Consensus       371 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~-~~c~~~--~~~~r~~~~~~~~~~~~~~~~~~~~~  442 (461)
                      ........+||.+||..||++|||+.++++|.+....... ....+.  -...+.+.....+...|....+..+.
T Consensus       420 d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  494 (566)
T PLN03225        420 DLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLLGLSVMQNLRLQLFRATQQDYGEAAAWVVFLMAKSG  494 (566)
T ss_pred             cccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCccccccccccccccchhhHHHHHHHHHHHHHHHHhcC
Confidence            0012245689999999999999999999999987554332 111111  11122333444455666666665543

>KOG1006|consensus

Probab=100.00  E-value=1.2e-37  Score=279.19  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=197.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC--hhhhHHHHHHHH-cCCCCCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD--KQSWQSEQEIFK-LPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...+++-+..||.|.||+|++-.++  |+..|||++....  .++.+...|... ++.-+.||||++||++...+    .
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG----d  137 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG----D  137 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC----c
Confidence            3455666789999999999999884  7889999997543  334445556554 55568999999999876644    4


Q ss_pred             eeeeehhccCCChhhhh------cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        185 FWLITAYHERGSLCDFL------KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                      .|+.||+|.- ||..+.      +...+++.-+-.|..-...||.||-...          .|||||+||+|||+|..|.
T Consensus       138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l----------kiIHRDvKPSNILldr~G~  206 (361)
T KOG1006|consen  138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL----------KIIHRDVKPSNILLDRHGD  206 (361)
T ss_pred             eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh----------hhhhccCChhheEEecCCC
Confidence            5999999975 777654      3456888888888888999999999874          8999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||||||++..+..+-   ..+...|...|||||-+...   ...|+.+|||||||++|+|+.||           ..||
T Consensus       207 vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~---~~gyDiRSDvWSLGITL~EvAtG-----------~fPy  269 (361)
T KOG1006|consen  207 VKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPS---DKGYDIRSDVWSLGITLYEVATG-----------NFPY  269 (361)
T ss_pred             EeeecccchHhHHHHH---HhhhccCCccccChhccCCc---cCCcchhhhhhhhcceEeeeecC-----------CCCc
Confidence            9999999997765432   23345788999999999764   24688999999999999999999           7777


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..+..   .++++. .+..+.. |.+.........+..+..+|..|+.+|-.+||...++.+..+..+
T Consensus       270 r~w~s---vfeql~-~Vv~gdp-p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  270 RKWDS---VFEQLC-QVVIGDP-PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             chHHH---HHHHHH-HHHcCCC-CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            66522   233333 3333321 222211111224458999999999999999999999998876544

>KOG4236|consensus

Probab=100.00  E-value=3.3e-36  Score=291.65  Aligned_cols=244  Identities=23%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             EeEeecCCceEEEEEEE--CCCcEEEEEEec---CChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        117 VEVKAQGRFGAVWKAKF--KNENVAVKIFLM---QDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~---~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      .++||+|.||+||-|++  +|+.||||++.+   ..++..+..+|+.+|.+++||.||.+-..|++.+.+    ++|||-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv----FVVMEK  644 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV----FVVMEK  644 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE----EEEehh
Confidence            37899999999999998  589999999853   234456677899999999999999999999987754    899999


Q ss_pred             ccCCChhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC---CceEEEecC
Q psy17532        192 HERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD---LTAAIADFG  265 (461)
Q Consensus       192 ~~~gsL~~~l---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~---~~~ki~DFG  265 (461)
                      +.| +..+.+   ..+++++.....++.||+.||.|||.+           +|+|+||||+|||+.+.   -.+||+|||
T Consensus       645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-----------nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK-----------NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-----------ceeeccCCchheeeccCCCCCceeecccc
Confidence            964 666655   345799999999999999999999998           99999999999999764   479999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +|+.+....   .....+||+.|+|||++..     +.|...-|+||.|||+|--++|           ..||...    
T Consensus       713 fARiIgEks---FRrsVVGTPAYLaPEVLrn-----kGyNrSLDMWSVGVIiYVsLSG-----------TFPFNEd----  769 (888)
T KOG4236|consen  713 FARIIGEKS---FRRSVVGTPAYLAPEVLRN-----KGYNRSLDMWSVGVIIYVSLSG-----------TFPFNED----  769 (888)
T ss_pred             ceeecchhh---hhhhhcCCccccCHHHHhh-----ccccccccceeeeEEEEEEecc-----------cccCCCc----
Confidence            999987543   3556799999999999986     4677778999999999999999           7777644    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                         +++.+.+....+ ...|.-|..  .+....+||...|+..-.+|.|....+.|.|..
T Consensus       770 ---EdIndQIQNAaF-MyPp~PW~e--is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  770 ---EDINDQIQNAAF-MYPPNPWSE--ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             ---cchhHHhhcccc-ccCCCchhh--cCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence               334444433221 122333443  445788999999999999999999999998864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3e-35  Score=276.47  Aligned_cols=224  Identities=19%  Similarity=0.178  Sum_probs=170.9

Q ss_pred             CCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhh
Q psy17532        123 GRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF  200 (461)
Q Consensus       123 G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~  200 (461)
                      |.||.||+++.  +++.||+|.+.....    ...|...+....||||+++++++....    .+++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCCCCHHHH
Confidence            89999999998  578899999865432    223333344557999999999988754    45999999999999998


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCC
Q psy17532        201 LKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT  279 (461)
Q Consensus       201 l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~  279 (461)
                      +.. ..+++..+..++.|++.||.|||+.           +|+||||||+||+++.++.++++|||++......     .
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~  139 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHRE-----------GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----C  139 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----c
Confidence            843 4689999999999999999999998           9999999999999999999999999988665432     1


Q ss_pred             CCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccC
Q psy17532        280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK  359 (461)
Q Consensus       280 ~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~  359 (461)
                      ....++..|+|||.+.+     ..++.++||||+|+++|||++|..++.....                 .     ....
T Consensus       140 ~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~~~~~~~~-----------------~-----~~~~  192 (237)
T cd05576         140 DGEAVENMYCAPEVGGI-----SEETEACDWWSLGAILFELLTGKTLVECHPS-----------------G-----INTH  192 (237)
T ss_pred             ccCCcCccccCCcccCC-----CCCCchhhHHHHHHHHHHHHHCcchhhcCch-----------------h-----cccc
Confidence            23456778999998865     3567789999999999999999543321100                 0     0001


Q ss_pred             CCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhc
Q psy17532        360 LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERG  402 (461)
Q Consensus       360 ~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l  402 (461)
                      ....+|...     +..+.++|.+||+.||++||++     +++++|.
T Consensus       193 ~~~~~~~~~-----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~  235 (237)
T cd05576         193 TTLNIPEWV-----SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP  235 (237)
T ss_pred             cccCCcccC-----CHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence            111233322     2378999999999999999997     4555543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696|consensus

Probab=100.00  E-value=1.2e-35  Score=280.49  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=205.3

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC--CcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~  180 (461)
                      .....+|.++.+||+|+||.|.+|..+|  +.+|||+++.+-    .+..-...|-.+|+-. +-|.++++..++.+-+ 
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-  423 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-  423 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-
Confidence            4456789999999999999999999976  569999986532    2222233455555444 6789999999888766 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+|+||||+.+|+|--.+++ +.+.+..+..++..||-||-|||++           +|+.||||..|||+|.+|++
T Consensus       424 ---RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k-----------gIiYRDLKLDNvmLd~eGHi  489 (683)
T KOG0696|consen  424 ---RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK-----------GIIYRDLKLDNVMLDSEGHI  489 (683)
T ss_pred             ---heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC-----------CeeeeeccccceEeccCCce
Confidence               45999999999999888754 5788899999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++.---+.  ..+...+||+-|+|||++.-     ..|+..+|.|||||+||||+.|           +.||.
T Consensus       490 Ki~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~Y-----qPYgksvDWWa~GVLLyEmlaG-----------QpPFd  551 (683)
T KOG0696|consen  490 KIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAG-----------QPPFD  551 (683)
T ss_pred             EeeecccccccccCC--cceeeecCCCcccccceEEe-----cccccchhHHHHHHHHHHHHcC-----------CCCCC
Confidence            999999997643222  34567899999999999864     5788899999999999999999           66776


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHHhhhhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLALCDTM  410 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~~~~~~  410 (461)
                      ++     ..+++...+.....  .+|...+.     +..++....|.+.|.+|...     .+|.+|.++....+.
T Consensus       552 Ge-----DE~elF~aI~ehnv--syPKslSk-----EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  552 GE-----DEDELFQAIMEHNV--SYPKSLSK-----EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             CC-----CHHHHHHHHHHccC--cCcccccH-----HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence            65     55666666666543  45655444     77799999999999999864     456677766555544

>KOG0603|consensus

Probab=100.00  E-value=9.9e-36  Score=296.67  Aligned_cols=243  Identities=23%  Similarity=0.284  Sum_probs=194.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcC-CCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLP-HMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~-~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..+|++...+|.|+|+.|-.+..  +++..+||++....   .+..+|+.++. .-+||||+++.+.+.++.    +.|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~----~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGK----EIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCc----eeee
Confidence            56788888999999999999988  57889999997552   22334443333 348999999999998865    4599


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE-cCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl-~~~~~~ki~DFGl  266 (461)
                      |||++.+|-|.+.+...+.....+..|+.+|+.|+.|||++           |+|||||||+|||+ ++.++++|+|||.
T Consensus       394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~-----------gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ-----------GVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             eehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc-----------CeeecCCChhheeecCCCCcEEEEEech
Confidence            99999999888888665544478888999999999999998           99999999999999 5899999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++.+...     ....+-|..|.|||++..     ..++.++||||||++||+|++|           +.||...    |
T Consensus       463 a~~~~~~-----~~tp~~t~~y~APEvl~~-----~~yt~acD~WSLGvlLy~ML~G-----------~tp~~~~----P  517 (612)
T KOG0603|consen  463 WSELERS-----CDTPALTLQYVAPEVLAI-----QEYTEACDWWSLGVLLYEMLTG-----------RTLFAAH----P  517 (612)
T ss_pred             hhhCchh-----hcccchhhcccChhhhcc-----CCCCcchhhHHHHHHHHHHHhC-----------CCccccC----C
Confidence            9887654     223466889999999985     5889999999999999999999           4555433    1


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      .-.++...+....    +.+.     .+...++|++.||+.||.+||+++++..|.|..
T Consensus       518 ~~~ei~~~i~~~~----~s~~-----vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  518 AGIEIHTRIQMPK----FSEC-----VSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             chHHHHHhhcCCc----cccc-----cCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence            2234444443332    2222     345889999999999999999999999999873

>KOG0662|consensus

Probab=100.00  E-value=1.5e-35  Score=251.48  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=194.2

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .|.-.++||+|.||+||+|+..  ++.||+|++..++.+   .....+||-+++.++|.|||+++++.....    .+.+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk----kltl   78 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK----KLTL   78 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc----eeEE
Confidence            4566789999999999999984  678999999765443   234578999999999999999999877655    4489


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |+|||.. +|..|..  ++.++.+....++.|+++||.|+|++           ++.||||||.|.||+.+|++|++|||
T Consensus        79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh-----------nvlhrdlkpqnllin~ngelkladfg  146 (292)
T KOG0662|consen   79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH-----------NVLHRDLKPQNLLINRNGELKLADFG  146 (292)
T ss_pred             eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh-----------hhhhccCCcceEEeccCCcEEecccc
Confidence            9999976 8999884  45689999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +|+.+.-...+  .+..+-|..|.+|.++-|.    +-|++..|+||.|||+.|+...+.|..          .+.    
T Consensus       147 larafgipvrc--ysaevvtlwyrppdvlfga----kly~tsidmwsagcifaelanagrplf----------pg~----  206 (292)
T KOG0662|consen  147 LARAFGIPVRC--YSAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLF----------PGN----  206 (292)
T ss_pred             hhhhcCCceEe--eeceeeeeeccCcceeeee----ehhccchHhhhcchHHHHHhhcCCCCC----------CCC----
Confidence            99987654322  3345779999999999875    567788999999999999987654432          221    


Q ss_pred             CCHHHHHHHHh------------------ccCCCCCCCc--hhccc--hhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVV------------------HKKLRPTLPE--TWKQH--AGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~------------------~~~~~~~~p~--~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                       ...+...++.                  .-..-|.+|.  .|.+.  .-...-++|+++.+.-+|..|.+|+++++|..
T Consensus       207 -dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy  285 (292)
T KOG0662|consen  207 -DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY  285 (292)
T ss_pred             -cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence             1111111110                  0011122221  12110  01124578999999999999999999999875


Q ss_pred             H
Q psy17532        404 L  404 (461)
Q Consensus       404 ~  404 (461)
                      +
T Consensus       286 f  286 (292)
T KOG0662|consen  286 F  286 (292)
T ss_pred             c
Confidence            4

>KOG1151|consensus

Probab=100.00  E-value=8.9e-36  Score=283.54  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=198.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hh------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQ------SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..+|-++.+||+|||+.||+|.+  ..+.||||+-....  .+      .....+|-.+-+.|+||.||++|+++.-+..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35788889999999999999987  56789999874322  11      1223478888999999999999999876542


Q ss_pred             cceeeeeeehhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---C
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---D  256 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~  256 (461)
                         .++-|+|||+|.+|.-||+.+. ++++++..|+.||..||.||.+.         +|+|||-||||.|||+-+   .
T Consensus       542 ---sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi---------kpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  542 ---SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI---------KPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             ---cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc---------CCCeeeeccCCccEEEecCccc
Confidence               4689999999999999997654 89999999999999999999988         789999999999999964   4


Q ss_pred             CceEEEecCCccccCCCCCCC-----CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCG-----DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      |.+||+||||++.++.+....     .+....||..|++||.+.-+. .....+.|+||||.|||+|..+.|        
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-ePPKIsnKVDVWSvGVIFyQClYG--------  680 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-EPPKISNKVDVWSVGVIFYQCLYG--------  680 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC-CCCccccceeeEeeehhhhhhhcc--------
Confidence            789999999999987654321     244568999999999885432 124678999999999999999999        


Q ss_pred             CCCCCCCccccCCCCCHHHHHHH-HhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEA-VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                         +.||...    .+-.++.+. .+-......+|..   ...+.+..++|++||++.-++|....++..+.
T Consensus       681 ---rKPFGhn----qsQQdILqeNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp  742 (775)
T KOG1151|consen  681 ---RKPFGHN----QSQQDILQENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP  742 (775)
T ss_pred             ---CCCCCCc----hhHHHHHhhhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence               4555332    122333221 1111112233322   22334788999999999999998877666554

>KOG0671|consensus

Probab=100.00  E-value=5.3e-36  Score=281.46  Aligned_cols=270  Identities=21%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCC--C----CeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEH--D----NILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H--~----nIv~l~g~~~~~~~~  181 (461)
                      -..+|++...+|+|.||.|-.+...  +..||||+++.-.........|+.++.++.+  |    -+|++.++|.-.+  
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg--  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG--  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC--
Confidence            3678999999999999999999884  5679999998666666667788888888832  2    3667777776544  


Q ss_pred             ceeeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---  255 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---  255 (461)
                        +.+||+|.+ |-|+++||+.+   +++...+..|+.|++++++|||+.           +++|-||||+|||+.+   
T Consensus       165 --hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~-----------kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  165 --HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL-----------KLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             --ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc-----------ceeecCCChheEEEeccce
Confidence              558999988 44999999764   588999999999999999999999           9999999999999842   


Q ss_pred             -----------------CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHH
Q psy17532        256 -----------------DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW  318 (461)
Q Consensus       256 -----------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~  318 (461)
                                       +..+||+|||.|..-...     ....+.|..|.|||++.+-     .++.++||||+||||.
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgL-----GwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGL-----GWSQPCDVWSIGCILV  300 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheecc-----CcCCccCceeeeeEEE
Confidence                             235899999999765432     2456789999999999884     7889999999999999


Q ss_pred             HHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHH-----hc-cCCC---------------CCCC-ch--hccchhH
Q psy17532        319 ELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV-----VH-KKLR---------------PTLP-ET--WKQHAGM  374 (461)
Q Consensus       319 el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~-----~~-~~~~---------------~~~p-~~--~~~~~~~  374 (461)
                      |+.||...|++..+..++.......+ |....+..+.     .. +.+.               +..| ..  .......
T Consensus       301 ElytG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  301 ELYTGETLFQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             EeeccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            99999888877653221111000000 1111111111     00 0000               0111 00  1112344


Q ss_pred             HHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        375 LALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       375 ~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..|.+||++||..||.+|+|+.|++.|.++-.
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALSHPFFAR  411 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence            68999999999999999999999999988754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.2e-34  Score=290.04  Aligned_cols=271  Identities=19%  Similarity=0.199  Sum_probs=182.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE------------------CCCcEEEEEEecCChh---------------hhHHH
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF------------------KNENVAVKIFLMQDKQ---------------SWQSE  154 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------------------~~~~vAvK~~~~~~~~---------------~~~~~  154 (461)
                      ....++|++.++||+|+||.||+|..                  +++.||||++......               .....
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            34678999999999999999999964                  2457999998643221               11123


Q ss_pred             HHHHHcCCCCCCCe-----eEEEEEEecCC----ccceeeeeeehhccCCChhhhhcCC---------------------
Q psy17532        155 QEIFKLPHMEHDNI-----LRYIGAEKRGE----SIHTEFWLITAYHERGSLCDFLKCN---------------------  204 (461)
Q Consensus       155 ~ei~~l~~l~H~nI-----v~l~g~~~~~~----~~~~~~~lv~e~~~~gsL~~~l~~~---------------------  204 (461)
                      .|+..+.+++|.|+     ++++++|....    ......|+||||+++|+|.++++..                     
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46666666666554     67788775421    1123569999999999999988531                     


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCC
Q psy17532        205 ----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH  280 (461)
Q Consensus       205 ----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~  280 (461)
                          .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+++....+... ...
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~-----------~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~  368 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRI-----------GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPL  368 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-Ccc
Confidence                235677888999999999999998           9999999999999999999999999999765443221 122


Q ss_pred             CCcCCCcccccccccccccccC-----------------CCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        281 GQVGTRRYMAPEVLEGAINFSR-----------------DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       281 ~~~gt~~y~aPE~l~~~~~~~~-----------------~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ...+|+.|+|||.+........                 ....+.||||+||+++||++|..          .||.....
T Consensus       369 ~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l----------~p~~~~~~  438 (507)
T PLN03224        369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL----------RPVANIRL  438 (507)
T ss_pred             ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCC----------CCccchhh
Confidence            2345789999998854211100                 11134799999999999999842          13321100


Q ss_pred             CCCC------HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccH---hhhccccchhhhcHHH
Q psy17532        344 DHPS------LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDA---EARLSASCVVERGMLA  405 (461)
Q Consensus       344 ~~~~------~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~l~~~  405 (461)
                      ....      .............  .++. +  ...+....+|+.++|..+|   .+|+|++|+++|.|+.
T Consensus       439 f~~~~~~~~~~~~~~r~~~~~~~--~~~~-~--d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        439 FNTELRQYDNDLNRWRMYKGQKY--DFSL-L--DRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             hhhHHhhccchHHHHHhhcccCC--Cccc-c--cccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            0000      0000111111111  2221 1  1133578999999999866   6899999999998763

>KOG0984|consensus

Probab=100.00  E-value=2.1e-34  Score=249.69  Aligned_cols=193  Identities=23%  Similarity=0.365  Sum_probs=157.9

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC--ChhhhHHHHHHHH-cCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ--DKQSWQSEQEIFK-LPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~--~~~~~~~~~ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      +++.-+..||+|+||.|-+-++  +|+..|||.+...  +....+...|+.+ +.....|.+|.|+|...+..    ..|
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg----dvw  121 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG----DVW  121 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc----cEE
Confidence            4455567899999999866666  7899999998654  3334445567765 44558999999999877654    459


Q ss_pred             eeehhccCCChhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        187 LITAYHERGSLCDFL-----KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       187 lv~e~~~~gsL~~~l-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +.||.|.. ||..|-     +...+++..+-+|+..+..||.|||++.          .++|||+||+||||+.+|++||
T Consensus       122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL----------~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL----------SVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh----------hhhhccCCcceEEEccCCcEEE
Confidence            99999976 888765     3456899999999999999999999985          8999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      ||||.+..+.++-.   .+...|...|||||.+..+.+. +.|+.||||||||+++.||.++
T Consensus       191 CDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~-~gY~vksDvWSLGItmiElA~l  248 (282)
T KOG0984|consen  191 CDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQ-KGYSVKSDVWSLGITMIEMAIL  248 (282)
T ss_pred             cccccceeehhhhH---HHHhcCCCccCChhhcCcccCc-ccceeehhhhhhhhhhhhhhhc
Confidence            99999988765431   2225678899999999876543 3899999999999999999999

>KOG0614|consensus

Probab=100.00  E-value=2.4e-35  Score=284.80  Aligned_cols=261  Identities=19%  Similarity=0.248  Sum_probs=212.5

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECCCc--EEEEEEecC----ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~--vAvK~~~~~----~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      ..+....+++.+..||-|+||.|=+++.+++.  +|+|++++.    ..+....-.|-.+|...+.|.||++|..|.+..
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            34556778889999999999999999987655  899988643    233333345666777889999999999999877


Q ss_pred             ccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                      ..    |++||-|-||.|-..|+ ++.++......++..+.+|++|||++           +||.|||||+|.|+|.+|.
T Consensus       494 yv----YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k-----------~iIYRDLKPENllLd~~Gy  558 (732)
T KOG0614|consen  494 YV----YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK-----------GIIYRDLKPENLLLDNRGY  558 (732)
T ss_pred             hh----hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc-----------CceeccCChhheeeccCCc
Confidence            55    89999999999999995 46799999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||.|||+|+.+..+.   .+.+.+||+.|.|||++.+     +..+..+|.||||+++|||++|.+           ||
T Consensus       559 ~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILn-----KGHD~avDyWaLGIli~ELL~G~p-----------PF  619 (732)
T KOG0614|consen  559 LKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILN-----KGHDRAVDYWALGILIYELLTGSP-----------PF  619 (732)
T ss_pred             eEEeehhhHHHhccCC---ceeeecCCcccccchhhhc-----cCcchhhHHHHHHHHHHHHHcCCC-----------CC
Confidence            9999999999988764   4667899999999999976     477788999999999999999954           45


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHhhhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLALCDTM  410 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~~~~~  410 (461)
                      .+.     ..-...+.++.+.-...+|.....     ...+||++....+|.+|..     ..++-+|-|+.-..+.
T Consensus       620 s~~-----dpmktYn~ILkGid~i~~Pr~I~k-----~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  620 SGV-----DPMKTYNLILKGIDKIEFPRRITK-----TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             CCC-----chHHHHHHHHhhhhhhhcccccch-----hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence            433     223344555555444456655443     6779999999999999997     6688888887665544

>KOG1027|consensus

Probab=100.00  E-value=3.1e-35  Score=299.37  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=186.6

Q ss_pred             EEeEeecCCceE-EEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        116 LVEVKAQGRFGA-VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       116 ~~~~lg~G~fg~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      -.+++|.|+-|+ ||+|.+.++.||||++......  ...+||..|..- +|||||++++...+..+    .||..|.|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~--~A~rEi~lL~eSD~H~NviRyyc~E~d~qF----~YIalELC~  586 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFD--FAQREIQLLQESDEHPNVIRYYCSEQDRQF----LYIALELCA  586 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHH--HHHHHHHHHHhccCCCceEEEEeeccCCce----EEEEehHhh
Confidence            346788998886 6999999999999998643332  346788877665 79999999998877654    499999997


Q ss_pred             CCChhhhhcCCC--C---CHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---C--CceEEEe
Q psy17532        194 RGSLCDFLKCNI--V---TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---D--LTAAIAD  263 (461)
Q Consensus       194 ~gsL~~~l~~~~--l---~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~--~~~ki~D  263 (461)
                      . +|.+++....  +   .......+..|++.||++||+.           +||||||||.||||+.   +  ..++|+|
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-----------~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-----------KIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-----------ccccccCCCceEEEEccCCCcceeEEecc
Confidence            6 9999997631  1   1134567889999999999997           9999999999999976   3  5789999


Q ss_pred             cCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        264 FGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       264 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||+++.+..+... ....+..||-+|+|||++...     .-+..+|||||||++|+.++|+          ..||....
T Consensus       655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~-----~~~~avDiFslGCvfyYvltgG----------~HpFGd~~  719 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED-----RKTQAVDIFSLGCVFYYVLTGG----------SHPFGDSL  719 (903)
T ss_pred             cccccccCCCcchhhcccCCCCcccccCHHHHhcc-----ccCcccchhhcCceEEEEecCC----------ccCCCchH
Confidence            9999999876542 345667899999999999874     3345789999999999999996          67776431


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                            +. ...+..+......-..  ...  .+..+||.+|++.||..||+|.+|+.|+.+.
T Consensus       720 ------~R-~~NIl~~~~~L~~L~~--~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  720 ------ER-QANILTGNYTLVHLEP--LPD--CEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ------Hh-hhhhhcCccceeeecc--Cch--HHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                  11 1122222221111000  000  1678999999999999999999999998654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-32  Score=257.51  Aligned_cols=238  Identities=29%  Similarity=0.411  Sum_probs=186.7

Q ss_pred             CceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhh
Q psy17532        124 RFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD  199 (461)
Q Consensus       124 ~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~  199 (461)
                      +||.||+|+..  ++.+|+|++......  .....+|+..+++++|+||+++++.+....    ..++++||+++++|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCCCCCCHHH
Confidence            58999999995  588999998654432  345678888899999999999999987754    4589999999999999


Q ss_pred             hhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCC
Q psy17532        200 FLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD  278 (461)
Q Consensus       200 ~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~  278 (461)
                      ++.... +++..+..++.+++.||.|||+.           +++|+||+|+||+++.++.++|+|||.+.......   .
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~  142 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSN-----------GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L  142 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHc-----------CeecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence            996544 89999999999999999999998           99999999999999999999999999998765432   2


Q ss_pred             CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhcc
Q psy17532        279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHK  358 (461)
Q Consensus       279 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~  358 (461)
                      .....++..|++||.+.+     ..++.++||||||+++|+|++|           ..||...    .....+.+.....
T Consensus       143 ~~~~~~~~~~~~pE~~~~-----~~~~~~~Di~slG~~l~~l~~~-----------~~p~~~~----~~~~~~~~~~~~~  202 (244)
T smart00220      143 LTTFVGTPEYMAPEVLLG-----KGYGKAVDVWSLGVILYELLTG-----------KPPFPGD----DQLLELFKKIGKP  202 (244)
T ss_pred             cccccCCcCCCCHHHHcc-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC----CcHHHHHHHHhcc
Confidence            334567889999998864     3566789999999999999999           4555431    1223333333222


Q ss_pred             CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        359 KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       359 ~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..... ...   ...+..+.+++.+||..||++||++.+++++.+
T Consensus       203 ~~~~~-~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      203 KPPFP-PPE---WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             CCCCc-ccc---ccCCHHHHHHHHHHccCCchhccCHHHHhhCCC
Confidence            21111 110   002247899999999999999999999998753

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664|consensus

Probab=100.00  E-value=6.1e-35  Score=262.67  Aligned_cols=275  Identities=24%  Similarity=0.333  Sum_probs=205.1

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-cceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~~  186 (461)
                      +++-.+.||-|.||.||..++  +|+.||.|++..-.   ......-+|+..|..++|.|++..++....... ...++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455567899999999999998  68999999885321   223445688999999999999999988765432 123578


Q ss_pred             eeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +++|.|.. +|...+ ..+.++.+.+.-+..||++||.|||+.           +|.||||||.|.|+++|..+||+|||
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA-----------~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA-----------NILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc-----------chhhccCCCccEEeccCceEEecccc
Confidence            99999976 899887 456799999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +|+..+.++. ......+-|.+|.|||++.|.    +.|+...||||.|||+.|++.++-.|+...+..++-...+..+.
T Consensus       202 LARvee~d~~-~hMTqEVVTQYYRAPEiLMGa----RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT  276 (449)
T KOG0664|consen  202 LARTWDQRDR-LNMTHEVVTQYYRAPELLMGA----RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT  276 (449)
T ss_pred             cccccchhhh-hhhHHHHHHHHhccHHHhhcc----hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence            9998765543 223345678999999999986    67888999999999999999886666543332222222233445


Q ss_pred             CCHHHHHH-------HHhccCCC-CCCCchhc---cchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        346 PSLEDMQE-------AVVHKKLR-PTLPETWK---QHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~-------~~~~~~~~-~~~p~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |+.+.+..       .+++...+ |.++..+.   ......+...++..++..||++|.+..+++.++..
T Consensus       277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            56665542       22333322 22222111   11122456688899999999999999999887654

>KOG0668|consensus

Probab=100.00  E-value=1.9e-33  Score=247.18  Aligned_cols=273  Identities=21%  Similarity=0.279  Sum_probs=200.6

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.+|+|.|+.||.|..  +++.++||+++.-  ......+|+.+|..|. ||||+++++...++..  ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S--ktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES--KTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc--cCch
Confidence            467899999999999999999995  6789999999753  3456678999999996 9999999999988663  3557


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~ki~DFG  265 (461)
                      ||+||..+-+...+..  .++..++..++.++++||.|+|+.           ||+|||+||.|++||.. -.++|+|+|
T Consensus       112 LiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~-----------GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSM-----------GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             hHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhc-----------CcccccCCcceeeechhhceeeeeecc
Confidence            9999999877766553  478888999999999999999999           99999999999999964 679999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC-cc----
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF-SA----  340 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf-~~----  340 (461)
                      +|-+..++..+   +..+.+..|.-||.+..-    ..|+..-|+|||||++..|+..+.||....+.+..-- -.    
T Consensus       179 LAEFYHp~~eY---nVRVASRyfKGPELLVdy----~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG  251 (338)
T KOG0668|consen  179 LAEFYHPGKEY---NVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG  251 (338)
T ss_pred             hHhhcCCCcee---eeeeehhhcCCchheeec----hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence            99887766543   234667888999999764    5677888999999999999999777643222110000 00    


Q ss_pred             -----------ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        341 -----------EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       341 -----------~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                                 ...-++.++++.....+......+... .....+.+..+|+.+.|..|-.+|+||.|++.|..+.-.
T Consensus       252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~-n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSE-NQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcc-ccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                       000001111111111111100011111 112234578899999999999999999999999877543

>KOG0695|consensus

Probab=100.00  E-value=2.4e-32  Score=252.16  Aligned_cols=249  Identities=21%  Similarity=0.336  Sum_probs=191.2

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----h-h-hHHHHHHHHcCCCCCCCeeEEEEEEe
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----Q-S-WQSEQEIFKLPHMEHDNILRYIGAEK  176 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~-~-~~~~~ei~~l~~l~H~nIv~l~g~~~  176 (461)
                      .+.....++|.++++||+|+|++|-+++++  .+.+|+|++++.-.    + . -+.++.+.. ..-+||.+|.+..+|.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe-~asn~pflvglhscfq  321 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFE-QASNNPFLVGLHSCFQ  321 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHH-hccCCCeEEehhhhhc
Confidence            455667889999999999999999999985  46799998864311    1 1 122333332 2348999999999988


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                      +..    .+++|.||.++|+|--.+++ ..++++.+..+...|+.||.|||+.           ||+.||||..|+|+|.
T Consensus       322 tes----rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r-----------giiyrdlkldnvllda  386 (593)
T KOG0695|consen  322 TES----RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER-----------GIIYRDLKLDNVLLDA  386 (593)
T ss_pred             ccc----eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc-----------CeeeeeccccceEEcc
Confidence            765    45899999999999877754 5699999999999999999999999           9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      .|++||+|+|+++.--...  ..++..+||+.|.|||++.|.     .|+..+|.|+|||+++||+.|+.|         
T Consensus       387 eghikltdygmcke~l~~g--d~tstfcgtpnyiapeilrge-----eygfsvdwwalgvlmfemmagrsp---------  450 (593)
T KOG0695|consen  387 EGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGE-----EYGFSVDWWALGVLMFEMMAGRSP---------  450 (593)
T ss_pred             CCceeecccchhhcCCCCC--cccccccCCCcccchhhhccc-----ccCceehHHHHHHHHHHHHcCCCC---------
Confidence            9999999999997643222  346678999999999999984     788899999999999999999544         


Q ss_pred             CCCccccCC--CCCHHH-HHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc
Q psy17532        336 LPFSAEVGD--HPSLED-MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS  394 (461)
Q Consensus       336 ~pf~~~~~~--~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps  394 (461)
                        |.....+  ..+.++ +.+.++...+|  +|...+-     ....+++.-|++||.+|..
T Consensus       451 --fdivgm~n~d~ntedylfqvilekqir--iprslsv-----kas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  451 --FDIVGMDNPDMNTEDYLFQVILEKQIR--IPRSLSV-----KASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --cceecCCCcccchhHHHHHHHhhhccc--ccceeeh-----hhHHHHHHhhcCCcHHhcC
Confidence              4332111  123333 33444444443  4443332     4567889999999999975

>KOG0608|consensus

Probab=100.00  E-value=7.9e-33  Score=273.29  Aligned_cols=258  Identities=20%  Similarity=0.240  Sum_probs=188.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      +..-|..++.||-|+||+|.+++.  +...+|.|.+.+.+.-    ....+.|-.+|...+.+-||+||-.|.+.+.+  
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL--  704 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL--  704 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce--
Confidence            445688899999999999999987  3567999998654432    22335677778899999999999999998754  


Q ss_pred             eeeeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                        |+||+|++||++-.+| +-+.+.++.+..++..+..|+++.|..           |+|||||||.|||||.+|++||+
T Consensus       705 --YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm-----------GFIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  705 --YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM-----------GFIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             --EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc-----------cceecccCccceEEccCCceeee
Confidence              9999999999999987 566788888889999999999999988           99999999999999999999999


Q ss_pred             ecCCccccCC---CCCCC-------------------------------------CCCCCcCCCcccccccccccccccC
Q psy17532        263 DFGLALLFEP---GKPCG-------------------------------------DTHGQVGTRRYMAPEVLEGAINFSR  302 (461)
Q Consensus       263 DFGla~~~~~---~~~~~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~  302 (461)
                      ||||+.-+.-   .+.+.                                     .....+||..|+|||++..     .
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-----~  846 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-----T  846 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-----c
Confidence            9999865421   00000                                     0123479999999999976     4


Q ss_pred             CCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHH
Q psy17532        303 DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTME  382 (461)
Q Consensus       303 ~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~  382 (461)
                      .++..+|.||.|||||||+.|++||           ....     ..+.+.++..-.....++..   ...+.+..+||.
T Consensus       847 g~~q~cdwws~gvil~em~~g~~pf-----------~~~t-----p~~tq~kv~nw~~~l~~~~~---~~ls~e~~~li~  907 (1034)
T KOG0608|consen  847 GYTQLCDWWSVGVILYEMLVGQPPF-----------LADT-----PGETQYKVINWRNFLHIPYQ---GNLSKEALDLIQ  907 (1034)
T ss_pred             CccccchhhHhhHHHHHHhhCCCCc-----------cCCC-----CCcceeeeeehhhccccccc---cccCHHHHHHHH
Confidence            7788899999999999999995554           3321     11111122221111223221   112235667776


Q ss_pred             HHccccHhhhcc---ccchhhhcHHHhh
Q psy17532        383 ECWDHDAEARLS---ASCVVERGMLALC  407 (461)
Q Consensus       383 ~cl~~dP~~Rps---~~evl~~l~~~~~  407 (461)
                      ++. .++++|..   +++|-.|.++...
T Consensus       908 kLc-~sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  908 KLC-CSADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             HHh-cChhhhhcccchhhhhcCcccccc
Confidence            643 46778874   5567777766443

>KOG0576|consensus

Probab=99.97  E-value=1.4e-32  Score=273.52  Aligned_cols=290  Identities=21%  Similarity=0.302  Sum_probs=215.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhH-HHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQ-SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~-~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ...+|+++..+|.|.||.||+++.  +++..|||.++......+. ..+||.+++..+|||||.++|.+...+..    |
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl----w   88 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL----W   88 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc----E
Confidence            456899999999999999999998  5789999999876655443 46789999999999999999988776544    9


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++||||.+|+|.+.-+ .+++++.++....+..++||+|||+.           +-+|||||-.|||+++.|.+|++|||
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~-----------gk~hRdiKGanilltd~gDvklaDfg  157 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ-----------GKIHRDIKGANILLTDEGDVKLADFG  157 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC-----------CcccccccccceeecccCceeecccC
Confidence            9999999999999764 56899999999999999999999998           88999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      .+..+...-  .......||++|||||+..-+  ....|..++|||+.|++..|+.--++|           ....    
T Consensus       158 vsaqitati--~KrksfiGtpywmapEvaave--rkggynqlcdiwa~gitAiel~eLqpp-----------lfdl----  218 (829)
T KOG0576|consen  158 VSAQITATI--AKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWALGITAIELGELQPP-----------LFDL----  218 (829)
T ss_pred             chhhhhhhh--hhhhcccCCccccchhHHHHH--hcccccccccccccccchhhhhhcCCc-----------cccc----
Confidence            997665432  345568999999999986322  124677899999999999999776432           2111    


Q ss_pred             CCHHHHHH--HHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh------hhhh-hccCCC
Q psy17532        346 PSLEDMQE--AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL------CDTM-EECWDH  416 (461)
Q Consensus       346 ~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~------~~~~-~~c~~~  416 (461)
                         ..++.  ......+.|+--+  ....-.+.+.+|++.++-++|++||++..++.|.+-..      ...+ ..|-.+
T Consensus       219 ---hpmr~l~LmTkS~~qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P  293 (829)
T KOG0576|consen  219 ---HPMRALFLMTKSGFQPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNP  293 (829)
T ss_pred             ---chHHHHHHhhccCCCCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCC
Confidence               11111  1112222222111  11223348999999999999999999998887653211      1111 245555


Q ss_pred             ChhhhhhhhHHHHHHHHHHHhh
Q psy17532        417 DAEARLSASCVVERVAWQSRAL  438 (461)
Q Consensus       417 ~~~~r~~~~~~~~~~~~~~~~~  438 (461)
                      ++..|-..+.-.+...|..+..
T Consensus       294 ~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  294 NPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             CCcccccccCCcccccchhhhh
Confidence            6555555555555555555443

>KOG0665|consensus

Probab=99.97  E-value=7.1e-32  Score=248.27  Aligned_cols=273  Identities=21%  Similarity=0.252  Sum_probs=193.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      ..+|.-+..+|.|.- .|..+-+  .++.||+|.+...   .....+..+|...+..++|+||++++.++......  ..
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777778888887 5666655  5889999987532   12234456899999999999999999998765432  24


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++|+|||||.. +|...+. ..++.+.+..+..|++.|+.|||+.           +|+||||||+||++..+..+||.|
T Consensus        95 e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~-----------~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhc-----------ceeecccCcccceecchhheeecc
Confidence            57999999975 9999886 4578889999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+.-...   ...+..+.|..|.|||++.+.     .+...+||||.||++.||++|+-.|.+.....+.--.....
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~-----~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l  233 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL  233 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheecc-----CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence            9999765433   234557889999999999874     47788999999999999999976664321100000000001


Q ss_pred             CCCCHH---HHHH---HHhc---c----CCCCCCCch-hc----c-chhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        344 DHPSLE---DMQE---AVVH---K----KLRPTLPET-WK----Q-HAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       344 ~~~~~~---~~~~---~~~~---~----~~~~~~p~~-~~----~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      +++...   ++..   ....   +    .....+|+. |+    . ......+++++.+||..||++|.|++++|.|+..
T Consensus       234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence            111111   1100   0000   0    000111111 11    1 1234578899999999999999999999999865


Q ss_pred             H
Q psy17532        405 A  405 (461)
Q Consensus       405 ~  405 (461)
                      -
T Consensus       314 ~  314 (369)
T KOG0665|consen  314 K  314 (369)
T ss_pred             e
Confidence            4

>KOG1290|consensus

Probab=99.97  E-value=1.6e-30  Score=250.90  Aligned_cols=134  Identities=20%  Similarity=0.235  Sum_probs=114.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCC-----C---CCeeEEEEEEecCC
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHME-----H---DNILRYIGAEKRGE  179 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-----H---~nIv~l~g~~~~~~  179 (461)
                      ...+|-+.++||-|.|++||++.+.  .+-||+|+.+...........||.+|++++     |   ..||+|++.|...+
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3468999999999999999999984  577999998765555556678898887762     3   37999999998887


Q ss_pred             ccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                      ....++++|+|++ |-+|..+++.   +.++...+..|++||+.||.|||..+          +|||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec----------gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC----------GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc----------CccccCCCcceeeee
Confidence            7777899999998 4488888853   45899999999999999999999985          999999999999993

>KOG1152|consensus

Probab=99.97  E-value=1.4e-31  Score=262.42  Aligned_cols=190  Identities=28%  Similarity=0.443  Sum_probs=160.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhh-------HHHHHHHHcCCCC---CCCeeEEEEEEe
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSW-------QSEQEIFKLPHME---HDNILRYIGAEK  176 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~-------~~~~ei~~l~~l~---H~nIv~l~g~~~  176 (461)
                      ..+|..++.+|.|+||.|++|.++  ...|+||.+.+..-  +.|       ..-.||.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            457899999999999999999995  46799998864321  111       1236999999997   999999999999


Q ss_pred             cCCccceeeeeeehhc-cCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        177 RGESIHTEFWLITAYH-ERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~-~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                      +.+    .|||+||-. ++-+|.+|+..+ .+++.++..|+.||+.|+++||++           +|||||||-+|+.++
T Consensus       640 ddd----~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~-----------~ivhrdikdenvivd  704 (772)
T KOG1152|consen  640 DDD----YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ-----------GIVHRDIKDENVIVD  704 (772)
T ss_pred             cCC----eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc-----------CceecccccccEEEe
Confidence            976    458999975 345899999654 599999999999999999999999           999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        255 SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      .+|.+||+|||.|....++-    ....+||..|.|||++.|..+.+    ..-|||++|++||.++..
T Consensus       705 ~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~g----k~qdiwalgillytivyk  765 (772)
T KOG1152|consen  705 SNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLG----KPQDIWALGILLYTIVYK  765 (772)
T ss_pred             cCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCC----CcchhhhhhheeeEEEec
Confidence            99999999999998766542    44578999999999999875444    446999999999999988

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.8e-29  Score=228.88  Aligned_cols=208  Identities=35%  Similarity=0.505  Sum_probs=177.9

Q ss_pred             eecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCC
Q psy17532        120 KAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERG  195 (461)
Q Consensus       120 lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~g  195 (461)
                      ||+|++|.||++...  ++.+++|++......  .....+|+..+..++|++|+++++++....    ..++++||++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEecCCCC
Confidence            689999999999996  889999998765442  345678899999999999999999988753    458999999999


Q ss_pred             ChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEEEecCCccccCC
Q psy17532        196 SLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEP  272 (461)
Q Consensus       196 sL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~DFGla~~~~~  272 (461)
                      +|.+++...  .+++..+..++.+++++|.+||+.           +++|+||+|.||+++. ++.++|+|||.+.....
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN-----------GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            999999765  689999999999999999999998           9999999999999999 89999999999987654


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      ...  ......+...|++||.+...    ...+.++|+|++|+++++|                                
T Consensus       146 ~~~--~~~~~~~~~~~~~pe~~~~~----~~~~~~~D~~~lg~~~~~l--------------------------------  187 (215)
T cd00180         146 DKS--LLKTIVGTPAYMAPEVLLGK----GYYSEKSDIWSLGVILYEL--------------------------------  187 (215)
T ss_pred             Ccc--hhhcccCCCCccChhHhccc----CCCCchhhhHHHHHHHHHH--------------------------------
Confidence            321  12334577889999988653    2566788999999999998                                


Q ss_pred             HHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                                            ..+.+++.+|++.||++||++.++++++
T Consensus       188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                  1678999999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670|consensus

Probab=99.96  E-value=9.2e-31  Score=253.83  Aligned_cols=263  Identities=19%  Similarity=0.230  Sum_probs=193.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC------CCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME------HDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~------H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..|.+....|+|-|++|.+|..  .|..||||++..+..-...-.+|+.+|++|+      --|+++|+..|...+    
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn----  507 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN----  507 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc----
Confidence            4567777889999999999998  4779999999877665666678888888885      247888888777654    


Q ss_pred             eeeeeehhccCCChhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-Cc
Q psy17532        184 EFWLITAYHERGSLCDFLKC----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LT  258 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~  258 (461)
                      +++||+|-+.- +|.++|+.    -.|....+..++.|+..||..|-..           +|+|.||||.|||+++. ..
T Consensus       508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c-----------~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC-----------GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc-----------CeeecccCccceEeccCcce
Confidence            56999998854 99999953    2478888999999999999999987           99999999999999975 67


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC-----
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE-----  333 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~-----  333 (461)
                      +||||||.|.......    .+...-+..|.|||++.|.     .|+...|+||.||+||||.||+-.|.+....     
T Consensus       576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~-----~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGL-----PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             eeeccCcccccccccc----ccHHHHHHhccCcceeecC-----cccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            8999999998765433    3344567789999999984     7778899999999999999997766543221     


Q ss_pred             ---CCCCCccccCCCCCH----------------------------------HHHHHHHhccCCCCCCCchhccchhHHH
Q psy17532        334 ---YRLPFSAEVGDHPSL----------------------------------EDMQEAVVHKKLRPTLPETWKQHAGMLA  376 (461)
Q Consensus       334 ---~~~pf~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~p~~~~~~~~~~~  376 (461)
                         .+.+|.........+                                  .++...+.   -.+.+|..-  ......
T Consensus       647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~---~~q~~~deq--~~~~~~  721 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELI---AVQRLPDEQ--PKIVQQ  721 (752)
T ss_pred             HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHh---ccCCCCchh--HHHHHH
Confidence               111221110000000                                  00000000   001122211  124468


Q ss_pred             HHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        377 LCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       377 l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      +.+|+.+||..||++|.|..++|.|++.
T Consensus       722 ~rdLLdkml~LdP~KRit~nqAL~HpFi  749 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITVNQALKHPFI  749 (752)
T ss_pred             HHHHHHHHhccChhhcCCHHHHhcCCcc
Confidence            9999999999999999999999999864

>KOG1345|consensus

Probab=99.96  E-value=3.1e-30  Score=232.28  Aligned_cols=247  Identities=14%  Similarity=0.222  Sum_probs=189.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEE-EecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGA-EKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~-~~~~~~~~~~~~  186 (461)
                      .+.|.+.+.||+|.||.+-+++++  ++.+++|.+........++.+|..---.| .|.||+.-|++ |...+    .|+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEE
Confidence            467889999999999999999996  46799999876666667777887653333 69999988775 43332    568


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC--CCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS--DLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~--~~~~ki~DF  264 (461)
                      +++||++.|||.+-+....+.+....+++.|++.||.|+|++           ++||||||.+||||-+  ...+||+||
T Consensus        99 F~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk-----------nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK-----------NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             EeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc-----------chhhcccccceEEEecCCccEEEeeec
Confidence            999999999999999888899999999999999999999999           9999999999999943  358999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+.+......     ....-+..|.+||......+..-.....+|||.||++++.++||           ..||......
T Consensus       168 G~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG-----------~~PWQka~~~  231 (378)
T KOG1345|consen  168 GLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTG-----------KFPWQKASIM  231 (378)
T ss_pred             ccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecC-----------CCcchhhhcc
Confidence            9997654321     12234567899998765443344556778999999999999999           5566544444


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      ++.+-+.....  +...+..|..+..  .++.+..+.++-|..++++|
T Consensus       232 d~~Y~~~~~w~--~rk~~~~P~~F~~--fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  232 DKPYWEWEQWL--KRKNPALPKKFNP--FSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             CchHHHHHHHh--cccCccCchhhcc--cCHHHHHHHHHhcCCccccc
Confidence            44444443333  3334566666543  34577788999999999999

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.5e-27  Score=220.86  Aligned_cols=190  Identities=31%  Similarity=0.421  Sum_probs=159.7

Q ss_pred             eeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      |.+.+.||+|++|.||++...  ++.+|+|.+.....  ......+|+..+.+++|+|++++++++....    ..++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE----PLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC----ceEEEE
Confidence            567889999999999999995  58899999875543  3445667888888999999999999987654    458999


Q ss_pred             hhccCCChhhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++++|.+++....  +++..+..++.+++.+|.|||+.           +++|+||+|.||+++.++.++|+|||++
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----------~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL-----------GIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence            9999999999996543  89999999999999999999998           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      ........ .......++..|++||.+.+    ...++.++||||||++++||++|
T Consensus       146 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Dv~~lG~~~~~l~~g  196 (225)
T smart00221      146 RFIHRDLA-ALLKTVKGTPFYLAPEVLLG----GKGYGEAVDIWSLGVILYELLWG  196 (225)
T ss_pred             eEecCccc-ccccceeccCCcCCHhHhcC----CCCCCchhhHHHHHHHHHHHHHC
Confidence            87754320 01233567888999998842    13566789999999999999999

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.3e-28  Score=269.57  Aligned_cols=206  Identities=15%  Similarity=0.121  Sum_probs=142.3

Q ss_pred             cCCCCC-CCeeEEEEEEecCC---ccceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCC
Q psy17532        160 LPHMEH-DNILRYIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNK  233 (461)
Q Consensus       160 l~~l~H-~nIv~l~g~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  233 (461)
                      .+.++| +||+++++++..+.   .....+++++||+ +++|.++|..  ..+++..++.++.||++||+|||++     
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----   99 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ-----   99 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC-----
Confidence            445667 68888998873322   1112457888987 5599999964  3589999999999999999999998     


Q ss_pred             cCCCCCCeecccCCCCcEEEcC-------------------CCceEEEecCCccccCCCCC---------C-----CCCC
Q psy17532        234 ADSYKPAVAHRDFKSNNVLLKS-------------------DLTAAIADFGLALLFEPGKP---------C-----GDTH  280 (461)
Q Consensus       234 ~~~~~~~ivHrDLkp~NILl~~-------------------~~~~ki~DFGla~~~~~~~~---------~-----~~~~  280 (461)
                            +|+||||||+||||+.                   ++.+||+|||+++.......         .     ....
T Consensus       100 ------gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (793)
T PLN00181        100 ------GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI  173 (793)
T ss_pred             ------CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence                  9999999999999954                   44566677777654321000         0     0011


Q ss_pred             CCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCC
Q psy17532        281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL  360 (461)
Q Consensus       281 ~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~  360 (461)
                      ...||+.|||||++.+     ..++.++|||||||+||||++|           ..|+...       ............
T Consensus       174 ~~~gt~~Y~APE~~~~-----~~~~~~sDVwSlGviL~ELl~~-----------~~~~~~~-------~~~~~~~~~~~~  230 (793)
T PLN00181        174 LAMEMSWYTSPEEDNG-----SSSNCASDVYRLGVLLFELFCP-----------VSSREEK-------SRTMSSLRHRVL  230 (793)
T ss_pred             ccCCCcceEChhhhcc-----CCCCchhhhhhHHHHHHHHhhC-----------CCchhhH-------HHHHHHHHHhhc
Confidence            2458889999999876     3678899999999999999998           3343211       111111111111


Q ss_pred             CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       361 ~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+.....      .....+++.+||..||.+||++.++++|.+...
T Consensus       231 ~~~~~~~------~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        231 PPQILLN------WPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             Chhhhhc------CHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            1111111      124568899999999999999999999987643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.5e-27  Score=213.34  Aligned_cols=166  Identities=23%  Similarity=0.311  Sum_probs=123.0

Q ss_pred             CChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        195 GSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       195 gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      |+|.++++  ...+++..+..++.|++.||.|||+.           +      ||+|||++.++.+|+  ||+++....
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-----------~------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ-----------A------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-----------C------CcccEeEcCccceee--ccceEeecc
Confidence            78999996  34699999999999999999999988           5      999999999999999  999987543


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHH
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ  352 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~  352 (461)
                      ..       ..||+.|||||++.+.     .++.++|||||||++|||++|           ..||.....    .....
T Consensus        62 ~~-------~~g~~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg-----------~~p~~~~~~----~~~~~  114 (176)
T smart00750       62 EQ-------SRVDPYFMAPEVIQGQ-----SYTEKADIYSLGITLYEALDY-----------ELPYNEERE----LSAIL  114 (176)
T ss_pred             cc-------CCCcccccChHHhcCC-----CCcchhhHHHHHHHHHHHHhC-----------CCCccccch----hcHHH
Confidence            21       2688999999999763     677899999999999999999           445533211    11112


Q ss_pred             HHHhccCCCCCCCch-hccchhHH--HHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        353 EAVVHKKLRPTLPET-WKQHAGML--ALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       353 ~~~~~~~~~~~~p~~-~~~~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..+..... ...+.. ........  .+.++|.+||+.||++||++.+++++++.+..
T Consensus       115 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      115 EILLNGMP-ADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHhc-cCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22211111 111110 00111222  68999999999999999999999999977653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195|consensus

Probab=99.95  E-value=3.1e-28  Score=219.45  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=199.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..+..++.+..+|.+...|..|+|++.|..+++|++...+   .....+..|.-.|+-+.||||+.++|.|..+..    
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----  261 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----  261 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----
Confidence            3455667778889999999999999999999999987543   334456677777888899999999999988754    


Q ss_pred             eeeeehhccCCChhhhhcCCC---CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +.++..||+.|||+..|+++.   ++..++.+++.+||+|++|||+.         .|-|.---|.+..++||++.+++|
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl---------ep~ipr~~lns~hvmidedltari  332 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL---------EPMIPRFYLNSKHVMIDEDLTARI  332 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc---------chhhhhhhcccceEEecchhhhhe
Confidence            489999999999999998753   67889999999999999999997         445666679999999999999887


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +- +-+++.      ....+..-.+.||+||.+......  .--..+|+|||++++||+.|+           ..||...
T Consensus       333 sm-ad~kfs------fqe~gr~y~pawmspealqrkped--~n~raadmwsfaillwel~tr-----------evpfadl  392 (448)
T KOG0195|consen  333 SM-ADTKFS------FQEVGRAYSPAWMSPEALQRKPED--LNIRAADMWSFAILLWELNTR-----------EVPFADL  392 (448)
T ss_pred             ec-ccceee------eeccccccCcccCCHHHHhcCchh--cchhhhhHHHHHHHHHHhhcc-----------ccccccC
Confidence            52 212111      112234457899999999764211  112468999999999999999           7777654


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                           +.-+.-.++.-+++|+.+|+....     .+..||.-|++.||.+||.++.++--|+.+
T Consensus       393 -----spmecgmkialeglrv~ippgis~-----hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  393 -----SPMECGMKIALEGLRVHIPPGISR-----HMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -----CchhhhhhhhhccccccCCCCccH-----HHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                 333444566678889999977554     788999999999999999999988776544

>KOG1167|consensus

Probab=99.95  E-value=4.1e-28  Score=231.31  Aligned_cols=277  Identities=21%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ....|...++||.|.|++||++..     +++.||+|.+..... ......|+..|..+ -+.||+++.+++...+.   
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~---  109 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ---  109 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCe---
Confidence            345788899999999999999987     346799999865433 22355677777777 69999999999887664   


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~ki~  262 (461)
                       ..+|+||++.-+..++...  ++..++..+++.+..||.++|.+           |||||||||+|+|.+.. +.-.|.
T Consensus       110 -v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~-----------GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  110 -VAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKN-----------GIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             -eEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhcc-----------CccccCCCccccccccccCCceEE
Confidence             4899999999888888865  67889999999999999999999           99999999999999865 567899


Q ss_pred             ecCCccccCCCC-------------------------------C--C---------CCCCCCcCCCcccccccccccccc
Q psy17532        263 DFGLALLFEPGK-------------------------------P--C---------GDTHGQVGTRRYMAPEVLEGAINF  300 (461)
Q Consensus       263 DFGla~~~~~~~-------------------------------~--~---------~~~~~~~gt~~y~aPE~l~~~~~~  300 (461)
                      |||+|...+...                               .  +         .......||++|.|||++..-   
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~---  252 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC---  252 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc---
Confidence            999997211000                               0  0         001134799999999999763   


Q ss_pred             cCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC------C-----------ccc--c---CCCCCHHHHHHHHhc-
Q psy17532        301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP------F-----------SAE--V---GDHPSLEDMQEAVVH-  357 (461)
Q Consensus       301 ~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p------f-----------~~~--~---~~~~~~~~~~~~~~~-  357 (461)
                       ..-++++||||.|||+.-++++..||.........+      |           .+.  .   .+-++..+....... 
T Consensus       253 -~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~  331 (418)
T KOG1167|consen  253 -PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL  331 (418)
T ss_pred             -cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence             355688999999999999999988875433221000      0           000  0   001111111110000 


Q ss_pred             --cCCCC-----CCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        358 --KKLRP-----TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       358 --~~~~~-----~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                        +..++     .....+. ...+..+++|+++|+..||.+|.||+++|+|.++-.+..
T Consensus       332 ~~~~~~~~~q~n~~~~~~~-d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  332 HIESIYKSRQPNTEREIGS-DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             Chhhcccccccceeecccc-ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence              00000     0011111 123347899999999999999999999999998765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.1e-25  Score=219.16  Aligned_cols=161  Identities=20%  Similarity=0.186  Sum_probs=125.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEE---CCCcEEEEEEecC------ChhhhHHHHHHHHcCCCCCCCeeE-EEEEEecCCc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF---KNENVAVKIFLMQ------DKQSWQSEQEIFKLPHMEHDNILR-YIGAEKRGES  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vAvK~~~~~------~~~~~~~~~ei~~l~~l~H~nIv~-l~g~~~~~~~  180 (461)
                      ...|++.+.||+|+||+||+|.+   .++.||||++...      ......+.+|+.+|.+++|+||+. +++.    + 
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~-   91 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G-   91 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C-
Confidence            46799999999999999999987   3566899987532      112334678999999999999985 5432    1 


Q ss_pred             cceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccC-CCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDF-KSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDL-kp~NILl~~~~~~  259 (461)
                         ..++||||+++++|.....   ..   ...++.|+++||.|||+.           +|+|||| ||+|||++.++.+
T Consensus        92 ---~~~LVmE~~~G~~L~~~~~---~~---~~~~~~~i~~aL~~lH~~-----------gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         92 ---KDGLVRGWTEGVPLHLARP---HG---DPAWFRSAHRALRDLHRA-----------GITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             ---CcEEEEEccCCCCHHHhCc---cc---hHHHHHHHHHHHHHHHHC-----------CCeeCCCCCcceEEEcCCCCE
Confidence               3489999999999973211   11   246788999999999998           9999999 9999999999999


Q ss_pred             EEEecCCccccCCCCCCCC------CCCCcCCCcccccccccc
Q psy17532        260 AIADFGLALLFEPGKPCGD------THGQVGTRRYMAPEVLEG  296 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~  296 (461)
                      ||+|||+|+.+........      .....+++.|+|||.+..
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999987754332111      134568889999999864

>KOG1023|consensus

Probab=99.91  E-value=1.6e-24  Score=216.74  Aligned_cols=220  Identities=26%  Similarity=0.362  Sum_probs=163.9

Q ss_pred             cCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       160 l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      |+.+.|.|+.+|+|.+.++.    .+++|.+||..|+|.|.+...  .+++.....++++|+.||.|||+.         
T Consensus         1 l~~l~h~n~~~f~g~~~~~~----~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---------   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP----EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---------   67 (484)
T ss_pred             CcccchhhhhhheeeEecCC----ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---------
Confidence            46789999999999999874    558999999999999999654  477778888999999999999987         


Q ss_pred             CCCe-ecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccC--CCCCccchHHHH
Q psy17532        238 KPAV-AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSR--DAFLRIDMYACA  314 (461)
Q Consensus       238 ~~~i-vHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~~~~k~DVwS~G  314 (461)
                        +| .|+.|+++|+++|..+.+||+|||+.................-...|.|||.+.+......  ..+.+.||||||
T Consensus        68 --~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~  145 (484)
T KOG1023|consen   68 --PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG  145 (484)
T ss_pred             --cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence              44 9999999999999999999999999877643111111222234568999999987532221  256789999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc
Q psy17532        315 LVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS  394 (461)
Q Consensus       315 vil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps  394 (461)
                      ++++|++++           +.||....... ...++...+......+..|..+...+..+.+..++.+||..+|++||+
T Consensus       146 ii~~ei~~r-----------~~~~~~~~~~~-~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs  213 (484)
T KOG1023|consen  146 IIMYEILFR-----------SGPFDLRNLVE-DPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS  213 (484)
T ss_pred             HHHHHHHhc-----------cCccccccccC-ChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence            999999999           55554432222 224455554443333344443333344457999999999999999999


Q ss_pred             ccchhhhcHHHh
Q psy17532        395 ASCVVERGMLAL  406 (461)
Q Consensus       395 ~~evl~~l~~~~  406 (461)
                      ++++...+..+.
T Consensus       214 ~~~i~~~~~~~~  225 (484)
T KOG1023|consen  214 IEQIRSKLLTIN  225 (484)
T ss_pred             HHHHHhhhhhhc
Confidence            998877665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.2e-22  Score=197.29  Aligned_cols=257  Identities=26%  Similarity=0.342  Sum_probs=191.9

Q ss_pred             eeEEeEeecCCceEEEEEEECCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCC-CeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHD-NILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~-nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |.+.+.||.|+||.||++... ..+|+|.+......    ...+.+|+..+..+.|+ ||+++++.+.....    .+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS----LYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE----EEEE
Confidence            678899999999999999998 88899988644322    34556788888899888 79999999955442    5899


Q ss_pred             ehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEEe
Q psy17532        189 TAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIAD  263 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~D  263 (461)
                      ++|+.+++|.+++...    .+.......++.|++.++.|+|+.           +++|||+||+|||++..+ .++++|
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-----------~~~hrd~kp~nil~~~~~~~~~l~d  145 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-----------GIIHRDIKPENILLDRDGRVVKLID  145 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHeeecCCCCeEEEec
Confidence            9999999999888654    689999999999999999999999           999999999999999988 799999


Q ss_pred             cCCccccCCCCCCC----CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        264 FGLALLFEPGKPCG----DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       264 FGla~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+++.+.......    ......|+..|+|||.+.+..  ...+....|+||+|++++++++|.           .||.
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~-----------~p~~  212 (384)
T COG0515         146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGL-----------PPFE  212 (384)
T ss_pred             cCcceecCCCCccccccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCC-----------CCCC
Confidence            99998665433211    235678999999999987621  025567789999999999999994           4433


Q ss_pred             cccCCCCCHHHHHHHHhccCCC---CCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLR---PTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      ..... .........+......   ........ ......+.+++.+++..+|..|.++.+...+
T Consensus       213 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         213 GEKNS-SATSQTLKIILELPTPSLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCCcc-ccHHHHHHHHHhcCCcccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            32110 0122333333222211   11111110 1112468899999999999999998877776

>KOG0590|consensus

Probab=99.90  E-value=2.2e-24  Score=225.43  Aligned_cols=258  Identities=19%  Similarity=0.210  Sum_probs=180.7

Q ss_pred             eEEeEeecCCceEEEEEEEC--CCcEEEEEEec---CChhhhH----HHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLM---QDKQSWQ----SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~---~~~~~~~----~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ....++|.|.+|.|+.....  .+.++.|.+..   ......+    ...|..+-..+.|+|++..+....+....    
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~----  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI----  396 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc----
Confidence            35678999999988877662  33344443321   1111111    23466667788999998877766554322    


Q ss_pred             eeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      .-+||||++ +|..++... .++..++-.++.|+..|+.|+|+.           ||.|||||++|++++.++.+||+||
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~-----------GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM-----------GLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc-----------CceeccCccccEEEecCCceEEeec
Confidence            445999999 999999776 799999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        265 GLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       265 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |.+..+.-....  ....+.+|+-.|+|||++.+..+..    ...||||.|+++..|.+|+.           ||....
T Consensus       465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydp----r~vDiwS~~ii~~~m~~~~~-----------~Wk~a~  529 (601)
T KOG0590|consen  465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDP----RAVDVWSCGIIYICMILGRF-----------PWKVAK  529 (601)
T ss_pred             CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCc----chhhhhhccceEEEEecCCC-----------cccccc
Confidence            999776543322  3456778999999999998753222    34799999999999999944           444332


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .....+.+.   .............--....+..-+.+|.++|+.||.+|.|+++|++.-|...
T Consensus       530 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  530 KSDNSFKTN---NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             ccccchhhh---ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            222211000   0000000000000001112346789999999999999999999999887654

>KOG1164|consensus

Probab=99.88  E-value=8.5e-22  Score=193.45  Aligned_cols=255  Identities=22%  Similarity=0.185  Sum_probs=177.4

Q ss_pred             ceeEEeEeecCCceEEEEEEECCC---cEEEEEEecCChh-hhHHHHHHHHcCCCC----CCCeeEEEEEEe-cCCccce
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKNE---NVAVKIFLMQDKQ-SWQSEQEIFKLPHME----HDNILRYIGAEK-RGESIHT  183 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~~---~vAvK~~~~~~~~-~~~~~~ei~~l~~l~----H~nIv~l~g~~~-~~~~~~~  183 (461)
                      .|++.+.||+|+||.||++.....   .+|+|........ ......|+.++..+.    -.++.++++... ...    
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~----   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED----   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc----
Confidence            899999999999999999998543   5888887643222 114445666555554    257888888774 332    


Q ss_pred             eeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC----
Q psy17532        184 EFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD----  256 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~----  256 (461)
                      ..++||+.+ |.+|.++.+.   +.++....++++.|++.+|++||+.           |++||||||.|+++...    
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-----------G~iHRDiKp~N~~~g~~~~~~  162 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-----------GFIHRDIKPENFVVGQSSRSE  162 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-----------CcccCCcCHHHeeecCCCCcc
Confidence            238999987 5699998742   4699999999999999999999999           99999999999999865    


Q ss_pred             -CceEEEecCCccccC--CCCC-----CCC-CCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q psy17532        257 -LTAAIADFGLALLFE--PGKP-----CGD-THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV  327 (461)
Q Consensus       257 -~~~ki~DFGla~~~~--~~~~-----~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~  327 (461)
                       ..+.|.|||+++...  ....     ... .....||.+|.++.+..+     ...+.+.|+||++-++.|++.|    
T Consensus       163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-----~e~~r~DDles~~Y~l~el~~g----  233 (322)
T KOG1164|consen  163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-----IEQGRRDDLESLFYMLLELLKG----  233 (322)
T ss_pred             cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-----CccCCchhhhhHHHHHHHHhcC----
Confidence             468999999998322  1111     011 234569999999998876     3667788999999999999999    


Q ss_pred             CCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        328 SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       328 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                             .+||....... ....+. .............     ..+..+.+++..+-..+..++|....+...+....
T Consensus       234 -------~LPW~~~~~~~-~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  234 -------SLPWEALEMTD-LKSKFE-KDPRKLLTDRFGD-----LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             -------CCCCccccccc-hHHHHH-HHhhhhccccccC-----CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence                   67775432111 111111 1111111111111     11235666666666688889998887777654443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.1e-22  Score=186.53  Aligned_cols=174  Identities=13%  Similarity=0.085  Sum_probs=132.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhH----------HHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQ----------SEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~----------~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..+|+..+++|+|+||.||+...++..+|||.+.........          .++|+..+.+++|++|....+++.....
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            468999999999999999998878889999999643322221          4788888999999999999988664321


Q ss_pred             c----ceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        181 I----HTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       181 ~----~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      .    ....+++|||++|.+|.++..   ++.    ....+++.+|..+|+.           |++|||+||+||+++.+
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~-----------gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQH-----------GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHc-----------CCccCCCChHHEEEeCC
Confidence            1    234589999999999988742   332    3456999999999999           99999999999999998


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS  322 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t  322 (461)
                      + ++|+|||...........              ..++..     +.+..++||||||+++.-...
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vle-----r~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLE-----RHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHH-----hHhcccccccceeEeehHHHH
Confidence            8 999999988654322110              002222     345578999999998876543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=2.6e-22  Score=181.53  Aligned_cols=136  Identities=17%  Similarity=0.128  Sum_probs=105.7

Q ss_pred             EeEeecCCceEEEEEEE-CCCcEEEEEEecCChh------------h---------------hHHHHHHHHcCCCCCCCe
Q psy17532        117 VEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ------------S---------------WQSEQEIFKLPHMEHDNI  168 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~------------~---------------~~~~~ei~~l~~l~H~nI  168 (461)
                      ...||+|+||.||+|.. +|+.||||++......            .               ...+.|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999998 5889999998643210            0               112348888888877665


Q ss_pred             eEEEEEEecCCccceeeeeeehhccCCChhhh-hcCCCCCHHHHHHHHHHHHHHHHHH-hhcccCCCcCCCCCCeecccC
Q psy17532        169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDF-LKCNIVTWEQLCRIALSMSKGLMHL-HEEILPNKADSYKPAVAHRDF  246 (461)
Q Consensus       169 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~~~~~~~ivHrDL  246 (461)
                      .....+...      ..+|||||++++++... +....++...+..++.|++.+|.|+ |+.           +|+||||
T Consensus        82 ~~p~~~~~~------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~-----------giiHrDl  144 (190)
T cd05147          82 PCPEPILLK------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC-----------RLVHADL  144 (190)
T ss_pred             CCCcEEEec------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC-----------CcccCCC
Confidence            433222211      12799999998877655 4566799999999999999999999 687           9999999


Q ss_pred             CCCcEEEcCCCceEEEecCCcccc
Q psy17532        247 KSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       247 kp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      ||+|||++ ++.++|+|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 478999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=8.9e-22  Score=178.43  Aligned_cols=137  Identities=18%  Similarity=0.141  Sum_probs=108.9

Q ss_pred             EeEeecCCceEEEEEEE-CCCcEEEEEEecCChh---------------------------hhHHHHHHHHcCCCCCCCe
Q psy17532        117 VEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ---------------------------SWQSEQEIFKLPHMEHDNI  168 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---------------------------~~~~~~ei~~l~~l~H~nI  168 (461)
                      ...||+|+||.||+|+. +|+.||||++......                           ....+.|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998 4899999998754211                           0112467778888888887


Q ss_pred             eEEEEEEecCCccceeeeeeehhccCCChhh-hhcCCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccC
Q psy17532        169 LRYIGAEKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDF  246 (461)
Q Consensus       169 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDL  246 (461)
                      .....+....      .++||||++++++.. .+....++......++.|++.+|.++|+ .           ||+||||
T Consensus        82 ~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~-----------givHrDl  144 (190)
T cd05145          82 PVPEPILLKK------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA-----------GLVHGDL  144 (190)
T ss_pred             CCceEEEecC------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC-----------CEecCCC
Confidence            5444433221      279999999885543 4566678888999999999999999999 7           9999999


Q ss_pred             CCCcEEEcCCCceEEEecCCccccC
Q psy17532        247 KSNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       247 kp~NILl~~~~~~ki~DFGla~~~~  271 (461)
                      ||+|||++ ++.++|+|||++..+.
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999 8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158|consensus

Probab=99.86  E-value=6.7e-22  Score=187.25  Aligned_cols=204  Identities=24%  Similarity=0.326  Sum_probs=145.8

Q ss_pred             CCCCeeEEEEEEecCCc-----------------------cceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHH
Q psy17532        164 EHDNILRYIGAEKRGES-----------------------IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK  220 (461)
Q Consensus       164 ~H~nIv~l~g~~~~~~~-----------------------~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~  220 (461)
                      +|||||++.++|.+.-.                       ....+|+||.-.+. +|.+|+-.+..+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence            69999999998876321                       12356899998876 9999998777888888889999999


Q ss_pred             HHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc--CCC--ceEEEecCCccccCCCC---CC-CCCCCCcCCCcccccc
Q psy17532        221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK--SDL--TAAIADFGLALLFEPGK---PC-GDTHGQVGTRRYMAPE  292 (461)
Q Consensus       221 gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~--~~~--~~ki~DFGla~~~~~~~---~~-~~~~~~~gt~~y~aPE  292 (461)
                      |+.|||.+           ||.|||||++||||.  +|+  .+.|+|||.+-.-+...   .+ ...-...|.-.-||||
T Consensus       353 av~hL~~h-----------gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  353 AVTHLHKH-----------GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHc-----------cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence            99999999           999999999999993  443  56899999875432211   01 1122345778899999


Q ss_pred             ccccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccc
Q psy17532        293 VLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQH  371 (461)
Q Consensus       293 ~l~~~~~~~-~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  371 (461)
                      +........ ..-..|+|.|+.|.+.||+++.           ..||+.....  ..+   ....++...|.+|+.++. 
T Consensus       422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~-----------~NPFY~rGem--~L~---~r~Yqe~qLPalp~~vpp-  484 (598)
T KOG4158|consen  422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGR-----------SNPFYKRGEM--LLD---TRTYQESQLPALPSRVPP-  484 (598)
T ss_pred             hhhcCCCCceeeccchhhhhhhhhhHHHHhcc-----------CCcccccchh--eec---hhhhhhhhCCCCcccCCh-
Confidence            985421111 1223688999999999999998           5566542111  110   111334445677776554 


Q ss_pred             hhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        372 AGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       372 ~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                          .+.+++...|+.||.+|++..-+.+
T Consensus       485 ----~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  485 ----VARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             ----HHHHHHHHHhcCCccccCCccHHHh
Confidence                7899999999999999999764444

>KOG1163|consensus

Probab=99.86  E-value=2.2e-21  Score=172.58  Aligned_cols=251  Identities=20%  Similarity=0.179  Sum_probs=178.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCC-CCeeEEEEEEecCCccceee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEH-DNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ....+|.+++.||+|+||.+|.|..  .|+.||||.-+..... .+...|..+...|+| ..|..+..+..+....    
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn----   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN----   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-cchhHHHHHHHHhccCCCCchhhhhccccccc----
Confidence            4567899999999999999999988  7899999986543332 233344444444443 3444444454444332    


Q ss_pred             eeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC---CceE
Q psy17532        186 WLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD---LTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~---~~~k  260 (461)
                      .+||+.. |-||.+++.  ...++.+..+-++-|++.-++|+|.+           +++||||||+|.|..-+   ..+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r-----------~fiHRDIKPdNFLMGlgrh~~kl~  154 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR-----------NFIHRDIKPDNFLMGLGRHCNKLY  154 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh-----------ccccccCCccceeeccccccceEE
Confidence            7999988 669999874  45699999999999999999999999           99999999999998643   5678


Q ss_pred             EEecCCccccCCCCC-----CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKP-----CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       261 i~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      ++|||+|+...+...     +.......||.+|.+--...+.     ..+.+-|+=|+|-+|.+.--|           .
T Consensus       155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-----eqSRRDDmeSvgYvLmYfnrG-----------~  218 (341)
T KOG1163|consen  155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-----EQSRRDDMESVGYVLMYFNRG-----------S  218 (341)
T ss_pred             EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhh-----hhhhhhhhhhhcceeeeeecC-----------C
Confidence            999999987754332     2234456899999987766542     344567999999999988888           7


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      +||.+....  +..+-.+.+...+...++...|..  .+.++.-.+.-|-..--++-|.-.
T Consensus       219 LPWQglka~--tk~QKyEkI~EkK~s~~ie~LC~G--~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  219 LPWQGLKAA--TKKQKYEKISEKKMSTPIEVLCKG--FPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             Ccccccchh--hHHHHHHHHHHhhcCCCHHHHhCC--CcHHHHHHHHHHhhcCCCCCCcHH
Confidence            888765222  334444555555554444333333  334777888888777666666544

>KOG1165|consensus

Probab=99.86  E-value=1.4e-20  Score=174.66  Aligned_cols=215  Identities=22%  Similarity=0.248  Sum_probs=160.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      --.|+++++||+|+||.++.|+.  +++.||||.-..... .-+...|-...+.| ..++|...+-+...+..-    .|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N----iL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN----IL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC-cchHHHHHHHHHHHcCCCCCCceeeeccccchh----hh
Confidence            45799999999999999999987  899999997543322 22333343332223 567888777665554422    69


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-----CceE
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-----LTAA  260 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-----~~~k  260 (461)
                      |+|++ |-||.|+..  ...++.+.+..+|.|++.-++|+|++           .+|.|||||+|.||...     ..+.
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k-----------~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK-----------DLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc-----------ceeecccCccceeecCCCCCCCceEE
Confidence            99998 569999874  45699999999999999999999999           89999999999999753     4688


Q ss_pred             EEecCCccccCCCCC-----CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKP-----CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       261 i~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      |+|||+|+...+...     +.......||.+||+--...|     ++-+.+-|+=|||-++.+.+-|           .
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-----rEQSRRDDLEaLGHvFmYFLRG-----------s  233 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRG-----------S  233 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeecccc-----chhhhhhhHHHhhhhhhhhccC-----------C
Confidence            999999988755432     223445679999999887766     4566778999999999999999           7


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCC
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKL  360 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~  360 (461)
                      +||.+.  ..++..+-.+++-..+.
T Consensus       234 LPWQGL--KA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  234 LPWQGL--KADTNKEKYEKIGETKR  256 (449)
T ss_pred             Cccccc--cCcchHHHHHHhccccc
Confidence            777654  22344444555544433

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=6e-21  Score=174.33  Aligned_cols=139  Identities=14%  Similarity=0.171  Sum_probs=107.2

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCCh-hhhHHHHHHHHcCCC-----CCCCeeEEEEEEecCCccceeeeee
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK-QSWQSEQEIFKLPHM-----EHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l-----~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      .-.+.||+|+||.||.-...+. .+||++..... ......+|+..+..+     +||||++++|++.++......+.+|
T Consensus         5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CCcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            3457899999999996222333 47888765422 334567899988888     6799999999998875443345589


Q ss_pred             ehh--ccCCChhhhhcCCCCCHHHHHHHHHHHHHHH-HHHhhcccCCCcCCCCCCeecccCCCCcEEEcC----CCceEE
Q psy17532        189 TAY--HERGSLCDFLKCNIVTWEQLCRIALSMSKGL-MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS----DLTAAI  261 (461)
Q Consensus       189 ~e~--~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~----~~~~ki  261 (461)
                      +||  +++|+|.+++++..+++.  ..++.+++.++ +|||++           +|+||||||+|||++.    ++.++|
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~-----------~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDN-----------RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHC-----------CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            999  668999999987666655  45678888888 999999           9999999999999974    348999


Q ss_pred             EecCCc
Q psy17532        262 ADFGLA  267 (461)
Q Consensus       262 ~DFGla  267 (461)
                      +||+.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995544

>KOG1240|consensus

Probab=99.85  E-value=6.2e-22  Score=207.53  Aligned_cols=251  Identities=24%  Similarity=0.235  Sum_probs=177.3

Q ss_pred             ceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh-----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK-----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~-----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+...+.||+++|=+|.+|+++...|+||++...+.     ...+..+|+. ...++|||.+.+.-+-.....    -||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA----Ayl   98 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA----AYL   98 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH----HHH
Confidence            678889999999999999999877799999965542     1223344555 556799999998776554432    389


Q ss_pred             eehhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      |=+|..+ +|+|.|...+ +..-+.+.|+.|++.||.-+|..           ||+|+|||.+||||+.=+-+.|+||..
T Consensus        99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~-----------gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL-----------GVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc-----------CccccccccceEEEeeechhhhhcccc
Confidence            9999987 9999998776 56677888999999999999998           999999999999999988899999977


Q ss_pred             ccccC--CCCCCC---CCCCCcCCCcccccccccccc------cccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        267 ALLFE--PGKPCG---DTHGQVGTRRYMAPEVLEGAI------NFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       267 a~~~~--~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      -+...  .+....   ...+...-..|.|||-+....      ......+.+.||||+||++.||++-+          +
T Consensus       167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg----------~  236 (1431)
T KOG1240|consen  167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG----------R  236 (1431)
T ss_pred             cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC----------C
Confidence            65432  111100   000112234799999885421      01112557789999999999999864          3


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      .+|        +..++...-..+   ...++..-.......++.|+..|++.||++|.+|++.|+.
T Consensus       237 PlF--------~LSQL~aYr~~~---~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  237 PLF--------TLSQLLAYRSGN---ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             Ccc--------cHHHHHhHhccC---ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            333        222222211111   1111111111122368899999999999999999999986

>KOG0603|consensus

Probab=99.85  E-value=6.4e-22  Score=198.17  Aligned_cols=222  Identities=23%  Similarity=0.346  Sum_probs=170.2

Q ss_pred             EeecCCceEEEEEEE-----CCCcEEEEEEecCChh---hhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeeee
Q psy17532        119 VKAQGRFGAVWKAKF-----KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ++|+|.||.|++++-     .++.+|.|.+++....   ......|..++...+ ||.+|++.-.+.....    .++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k----l~l~l   76 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK----LYLIL   76 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc----hhHhh
Confidence            479999999987643     4567888877543211   112234445566665 9999999988877654    48999


Q ss_pred             hhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        190 AYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      +|..+|+|...+.... ++......+...++-|++++|+.           +|+|||+|++||+++.+|++++.|||+++
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l-----------~iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL-----------GIAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh-----------HHHHhcccccceeecccCccccCCchhhh
Confidence            9999999999886654 66677778888999999999999           99999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      ..-..+      ..+||..|||||++.+       ....+|.||||++++||+||           ..||..        
T Consensus       146 e~v~~~------~~cgt~eymApEI~~g-------h~~a~D~ws~gvl~felltg-----------~~pf~~--------  193 (612)
T KOG0603|consen  146 EAVKEK------IACGTYEYRAPEIING-------HLSAADWWSFGVLAFELLTG-----------TLPFGG--------  193 (612)
T ss_pred             HhHhhh------hcccchhhhhhHhhhc-------cCCcccchhhhhhHHHHhhC-----------CCCCch--------
Confidence            765433      1289999999999973       23567999999999999999           556543        


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA  395 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  395 (461)
                       +....+...  .+.+|....     ..+.+++..++..+|.+|...
T Consensus       194 -~~~~~Il~~--~~~~p~~l~-----~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  194 -DTMKRILKA--ELEMPRELS-----AEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -HHHHHHhhh--ccCCchhhh-----HHHHHHHHHHHhhCHHHHhcc
Confidence             223333322  234444333     378899999999999999976

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=2.7e-20  Score=167.19  Aligned_cols=181  Identities=18%  Similarity=0.183  Sum_probs=134.3

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCChh-----hhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeee
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ-----SWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~-----~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      .....|++|+||+||.+...+..++.+.+.....-     ...+++|+.+|.+++ |++|.+++++.        ..+++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~lv   76 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHLD   76 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEEE
Confidence            45678999999999988888888988877654331     224678999999995 58899998862        22899


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccC-CCCcEEEcCCCceEEEecCCc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDF-KSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDL-kp~NILl~~~~~~ki~DFGla  267 (461)
                      |||+.|.+|.+.+...      ...++.|++.+|.++|+.           ||+|||| ||.|||++.++.++|+|||+|
T Consensus        77 meyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~-----------GIvHrDL~kp~NILv~~~g~i~LIDFG~A  139 (218)
T PRK12274         77 RSYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRC-----------GVAHNDLAKEANWLVQEDGSPAVIDFQLA  139 (218)
T ss_pred             EeeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHC-----------cCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence            9999999987654221      245778999999999999           9999999 799999999999999999999


Q ss_pred             cccCCCCCC------CC-----CCCCcCCCcccccccccccccccCCCC-CccchHHHHHHHHHHHcCC
Q psy17532        268 LLFEPGKPC------GD-----THGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRC  324 (461)
Q Consensus       268 ~~~~~~~~~------~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~-~k~DVwS~Gvil~el~tg~  324 (461)
                      .........      ..     ......++.|++|+.-.-.    ...+ ...+.++-|.-+|.++||+
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l----~~~~~~~~~w~~~g~~~~~~~~~~  204 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL----KRTSWIRELWFATGKPVYRFVTRR  204 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh----ccchhHHHHHHHhcchHHHHHhcc
Confidence            865432210      00     1112356777777744321    1122 3457789999999999994

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=9.1e-20  Score=172.17  Aligned_cols=239  Identities=18%  Similarity=0.205  Sum_probs=141.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhh----hHHHHHHHHcCCCCC----------CCeeEEEE
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS----WQSEQEIFKLPHMEH----------DNILRYIG  173 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----~~~~~ei~~l~~l~H----------~nIv~l~g  173 (461)
                      ..+.+...+.||.|+|+.||.+++.  ++.+|||++.......    .+.++|......+.+          -.++--++
T Consensus        10 ~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   10 RPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             -EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             CceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            3456788899999999999999994  6899999986443221    222334333222221          11111111


Q ss_pred             EEe-c-------CCccce-----eeeeeehhccCCChhhhhcC-----C---CCCHHHHHHHHHHHHHHHHHHhhcccCC
Q psy17532        174 AEK-R-------GESIHT-----EFWLITAYHERGSLCDFLKC-----N---IVTWEQLCRIALSMSKGLMHLHEEILPN  232 (461)
Q Consensus       174 ~~~-~-------~~~~~~-----~~~lv~e~~~~gsL~~~l~~-----~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~  232 (461)
                      ... .       ......     .++++|+-+. +||.+++.-     .   .+....++.+..|+.+.+++||+.    
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----  164 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----  164 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----
Confidence            111 0       000001     2367777774 589888631     1   133444566778999999999999    


Q ss_pred             CcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccc---ccCCCCCccc
Q psy17532        233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN---FSRDAFLRID  309 (461)
Q Consensus       233 ~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~~~k~D  309 (461)
                             |+||+||+|+|++++.+|.+.|+||+.........    . ....+..|.+||.......   ....++.+.|
T Consensus       165 -------GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D  232 (288)
T PF14531_consen  165 -------GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATD  232 (288)
T ss_dssp             -------TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred             -------ceEecccceeeEEEcCCCCEEEcChHHHeecCcee----e-ccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence                   99999999999999999999999998776543221    1 1344577999997744210   1134677889


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccH
Q psy17532        310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDA  389 (461)
Q Consensus       310 VwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP  389 (461)
                      .|++|+++|.|+++           ..||...........             .+ ..|.  ..++.++.||..+|++||
T Consensus       233 aW~LG~~ly~lWC~-----------~lPf~~~~~~~~~~~-------------~f-~~C~--~~Pe~v~~LI~~lL~~~~  285 (288)
T PF14531_consen  233 AWQLGITLYSLWCG-----------RLPFGLSSPEADPEW-------------DF-SRCR--DMPEPVQFLIRGLLQRNP  285 (288)
T ss_dssp             HHHHHHHHHHHHHS-----------S-STCCCGGGSTSGG-------------GG-TTSS-----HHHHHHHHHHT-SSG
T ss_pred             HHHHHHHHHHHHHc-----------cCCCCCCCccccccc-------------cc-hhcC--CcCHHHHHHHHHHccCCc
Confidence            99999999999999           555543211110000             01 1122  234589999999999999


Q ss_pred             hhh
Q psy17532        390 EAR  392 (461)
Q Consensus       390 ~~R  392 (461)
                      ++|
T Consensus       286 ~~R  288 (288)
T PF14531_consen  286 EDR  288 (288)
T ss_dssp             GGS
T ss_pred             ccC
Confidence            998

>KOG1033|consensus

Probab=99.79  E-value=3.9e-20  Score=182.12  Aligned_cols=244  Identities=20%  Similarity=0.243  Sum_probs=157.7

Q ss_pred             cceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCC-hhhhHHHHHHHHcCCCCCCCeeEEEE-----E-EecCC
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQD-KQSWQSEQEIFKLPHMEHDNILRYIG-----A-EKRGE  179 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~-~~~~~~~~ei~~l~~l~H~nIv~l~g-----~-~~~~~  179 (461)
                      ....+.+..+.+++|.++..+..     .+.++.|...... .......+++-.+....|-|..-+.+     . ....+
T Consensus       244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~  323 (516)
T KOG1033|consen  244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN  323 (516)
T ss_pred             ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence            34445566667777777665441     2234444433333 22222334444444444444333333     0 00111


Q ss_pred             cc--ceeeeeeehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        180 SI--HTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       180 ~~--~~~~~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ..  ...+||.|++|..++|.++|...    ..++...+.++.|++.|++|   +           +.+|||+||.||+.
T Consensus       324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k-----------~~ihrdlkp~nif~  389 (516)
T KOG1033|consen  324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K-----------GLIHRDLKPSNIFF  389 (516)
T ss_pred             ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c-----------cchhhhcccccccc
Confidence            11  11368999999999999999643    35777889999999999999   5           88999999999999


Q ss_pred             cCCCceEEEecCCccccCCCC----CCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGK----PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP  329 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~  329 (461)
                      ..+..+||.|||+........    ........+||..||+||.+.+     ..|+.|+||||||+||+|++.-.     
T Consensus       390 ~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-----~~y~~kvdIyaLGlil~EL~~~f-----  459 (516)
T KOG1033|consen  390 SDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-----QQYSEKVDIYALGLILAELLIQF-----  459 (516)
T ss_pred             ccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-----hhhhhhcchhhHHHHHHHHHHHh-----
Confidence            999999999999987765443    1223456789999999999987     48889999999999999998731     


Q ss_pred             CCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        330 PPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       330 ~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                           ...|...        .....+..+.+.+.+..+.+      .-+.|+.+++...|.+||++.+.
T Consensus       460 -----~T~~er~--------~t~~d~r~g~ip~~~~~d~p------~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  460 -----STQFERI--------ATLTDIRDGIIPPEFLQDYP------EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -----ccHHHHH--------HhhhhhhcCCCChHHhhcCc------HHHHHHHHhcCCCcccCchHHHH
Confidence                 2222111        11112222222222222222      44689999999999999955443

>KOG1166|consensus

Probab=99.79  E-value=5.1e-19  Score=189.01  Aligned_cols=194  Identities=19%  Similarity=0.230  Sum_probs=146.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhHHHHHHHHcCCCC---CCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHME---HDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .....|.+.+.||+|+||+||+|.. +++.||+|.=+....-.+-.-.++  +.+|+   -+-|..+..++.-.+    .
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~--~~RLk~~~~~~~~~~~~a~~~~~----~  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQV--MERLKPQMLPSIMHISSAHVFQN----A  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHH--HHhhchhhhcchHHHHHHHccCC----c
Confidence            4456788999999999999999998 678899998665443222222222  23333   122333333322222    2


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-------C
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-------D  256 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-------~  256 (461)
                      -+||+||.+.|+|.+++.. +.+++.....++.|+++-+++||..           +|||+||||+|.||..       +
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~-----------~IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM-----------GIIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc-----------ceecccCCcceeEeecccCCCCcc
Confidence            2799999999999999964 4589999999999999999999999           9999999999999953       3


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC  324 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~  324 (461)
                      ..++|+|||.|..+..-..........+|-.+-.+|+..|     +.++..+|-|.|+.+++-|+.|+
T Consensus       838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-----rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-----RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-----CCCchhhhhHHHHHHHHHHHHHH
Confidence            4689999999955432222123445678889999999987     58889999999999999999993

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=5.6e-19  Score=165.17  Aligned_cols=138  Identities=18%  Similarity=0.167  Sum_probs=107.8

Q ss_pred             ceeEEeEeecCCceEEEEEE-E--CCCcEEEEEEecCChh-------------------------hhHHHHHHHHcCCCC
Q psy17532        113 SIQLVEVKAQGRFGAVWKAK-F--KNENVAVKIFLMQDKQ-------------------------SWQSEQEIFKLPHME  164 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~-~--~~~~vAvK~~~~~~~~-------------------------~~~~~~ei~~l~~l~  164 (461)
                      .|++.+.||+|+||.||+|. .  +|+.||||++......                         ....+.|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46788999999999999998 3  6899999998643210                         012356888888886


Q ss_pred             CC--CeeEEEEEEecCCccceeeeeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC-
Q psy17532        165 HD--NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA-  240 (461)
Q Consensus       165 H~--nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~-  240 (461)
                      +.  .+.++++.   .     ..++||||+++++|..+. ....+.......++.|++.+|.+||+.           + 
T Consensus       109 ~~~i~~p~~~~~---~-----~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------g~  169 (237)
T smart00090      109 EAGVPVPKPIAW---R-----RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE-----------GE  169 (237)
T ss_pred             hcCCCCCeeeEe---c-----CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc-----------CC
Confidence            53  23444442   1     127999999998887765 444566667789999999999999999           8 


Q ss_pred             eecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        241 VAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       241 ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      |+||||||+|||++ ++.++|+|||.+...
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999999999 889999999998754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.3e-18  Score=180.41  Aligned_cols=135  Identities=15%  Similarity=0.170  Sum_probs=110.1

Q ss_pred             ceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh---------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK---------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~---------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .|...+.||+|+||.||+|.+.+..+++|+......         ......+|+.++..++|+||+....++.+...   
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~---  410 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE---  410 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC---
Confidence            445678999999999999999887777775432110         11234678999999999999887777665443   


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                       .++||||+++++|.+++.       ....++.+++.+|.|||+.           +|+||||||+|||+ +++.++|+|
T Consensus       411 -~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~-----------giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        411 -KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKA-----------GIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             -CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhC-----------CCccCCCChHHEEE-ECCcEEEEe
Confidence             389999999999999885       4577899999999999998           99999999999999 677999999


Q ss_pred             cCCcccc
Q psy17532        264 FGLALLF  270 (461)
Q Consensus       264 FGla~~~  270 (461)
                      ||+++..
T Consensus       471 FGla~~~  477 (535)
T PRK09605        471 FGLGKYS  477 (535)
T ss_pred             CcccccC
Confidence            9999753

>KOG0606|consensus

Probab=99.78  E-value=3.8e-19  Score=186.71  Aligned_cols=210  Identities=26%  Similarity=0.398  Sum_probs=144.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...+|..++.|..|+||.||..+++  .+.+|.|+ ..++.          +++     ||..+.|    ..      +.
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------ilR-----nilt~a~----np------fv  134 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------ILR-----NILTFAG----NP------FV  134 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----------hhh-----ccccccC----Cc------ce
Confidence            3468999999999999999999886  67788854 22111          111     2333222    11      22


Q ss_pred             eehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      |      ||-...++.- .++.+        ++.+++|||+.           +|+|||+||+|.||+.-|++|+.|||+
T Consensus       135 v------gDc~tllk~~g~lPvd--------mvla~Eylh~y-----------givhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  135 V------GDCATLLKNIGPLPVD--------MVLAVEYLHSY-----------GIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             e------chhhhhcccCCCCcch--------hhHHhHhhccC-----------CeecCCCCCCcceeeecccccccchhh
Confidence            3      4555555432 23322        27789999998           999999999999999999999999999


Q ss_pred             ccccCCCCC-------------CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        267 ALLFEPGKP-------------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       267 a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      ++..-....             .......+||+.|.|||++..     +.|++.+|+|++|+|+||.+-|+         
T Consensus       190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-----qgygkpvdwwamGiIlyeFLVgc---------  255 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGC---------  255 (1205)
T ss_pred             hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-----hccCCCccHHHHHHHHHHHheee---------
Confidence            876421100             001234589999999999875     47888999999999999999995         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA  395 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  395 (461)
                        .||.++     +.+++...++....  ..|+.  ..+...+..+++.++|..+|..|.-.
T Consensus       256 --vpffGd-----tpeelfg~visd~i--~wpE~--dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  256 --VPFFGD-----TPEELFGQVISDDI--EWPEE--DEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             --eeccCC-----CHHHHHhhhhhhhc--ccccc--CcCCCHHHHHHHHHHHHhChHhhccc
Confidence              455444     55666655554322  12222  12233488999999999999999743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=7.9e-19  Score=161.77  Aligned_cols=133  Identities=17%  Similarity=0.229  Sum_probs=108.9

Q ss_pred             eEeecCCceEEEEEEECCCcEEEEEEecCChh---------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ---------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +.||+|++|.||+|.+.+..|+||........         ....++|+.++..++|+||.....++.+..    ..+++
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~----~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE----NFIIV   77 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC----CCEEE
Confidence            57899999999999999999999986532211         123457888888889998876666655443    33899


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |||+++++|.+++....  . ....++.+++.+|.++|+.           +++|||++|.|||++ ++.++|+|||+++
T Consensus        78 ~e~~~G~~L~~~~~~~~--~-~~~~i~~~i~~~l~~lH~~-----------~i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         78 MEYIEGEPLKDLINSNG--M-EELELSREIGRLVGKLHSA-----------GIIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             EEEeCCcCHHHHHHhcc--H-HHHHHHHHHHHHHHHHHhC-----------CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence            99999999999986532  2 7889999999999999998           999999999999999 7899999999885


Q ss_pred             c
Q psy17532        269 L  269 (461)
Q Consensus       269 ~  269 (461)
                      .
T Consensus       143 ~  143 (211)
T PRK14879        143 F  143 (211)
T ss_pred             C
Confidence            4

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=1.6e-18  Score=158.29  Aligned_cols=129  Identities=16%  Similarity=0.227  Sum_probs=101.5

Q ss_pred             EeecCCceEEEEEEECCCcEEEEEEecCChh---------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ---------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .||+|+||.||+|.+.+..|++|........         .....+|+.++..++|+++.....++....    ..++||
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~----~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD----NKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC----CCEEEE
Confidence            4799999999999999999999986532210         123357888888888876544333333332    238999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ||+++++|.+++.....      .++.+++.+|.+||+.           +++|||++|.|||++ ++.+++.|||+++.
T Consensus        77 e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~-----------gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKA-----------GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHC-----------CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999998754321      7899999999999998           999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=2.3e-18  Score=157.13  Aligned_cols=134  Identities=15%  Similarity=0.157  Sum_probs=104.7

Q ss_pred             eeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChh-----------------------hhHHHHHHHHcCCCCCC--C
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ-----------------------SWQSEQEIFKLPHMEHD--N  167 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~-----------------------~~~~~~ei~~l~~l~H~--n  167 (461)
                      |.+.+.||+|+||.||++.. +++.||||++......                       ......|+..+..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            66778999999999999988 5889999987543210                       01235677777777777  4


Q ss_pred             eeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCC
Q psy17532        168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK  247 (461)
Q Consensus       168 Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLk  247 (461)
                      +.+.++.    .    ..++||||+++++|.+....     .....++.+++.++.++|+.           +|+|||||
T Consensus        97 v~~~~~~----~----~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~-----------gi~H~Dl~  152 (198)
T cd05144          97 VPKPIDW----N----RHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKH-----------GIIHGDLS  152 (198)
T ss_pred             CCceeec----C----CceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHC-----------CCCcCCCC
Confidence            4444442    1    23799999999999876431     34567889999999999998           99999999


Q ss_pred             CCcEEEcCCCceEEEecCCccccC
Q psy17532        248 SNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       248 p~NILl~~~~~~ki~DFGla~~~~  271 (461)
                      |+||+++.++.++|+|||++..+.
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=6.2e-17  Score=151.67  Aligned_cols=137  Identities=18%  Similarity=0.194  Sum_probs=108.0

Q ss_pred             eEee-cCCceEEEEEEECCCcEEEEEEecCC--------------hhhhHHHHHHHHcCCCCCCCe--eEEEEEEecCCc
Q psy17532        118 EVKA-QGRFGAVWKAKFKNENVAVKIFLMQD--------------KQSWQSEQEIFKLPHMEHDNI--LRYIGAEKRGES  180 (461)
Q Consensus       118 ~~lg-~G~fg~Vy~~~~~~~~vAvK~~~~~~--------------~~~~~~~~ei~~l~~l~H~nI--v~l~g~~~~~~~  180 (461)
                      .+|| .||.|+||.+...+..++||++....              .......+|+..+..++|++|  .+.+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            5787 89999999999999999999885321              112344678888999988875  677776544332


Q ss_pred             cceeeeeeehhccC-CChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHER-GSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~-gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                      .....++||||+++ .+|.+++....++...    +.+++.+|.+||+.           ||+||||||.|||++.++.+
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~-----------GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDA-----------GVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHC-----------CCCCCCCCchhEEEcCCCCE
Confidence            22233699999997 6999998776666543    56899999999999           99999999999999998999


Q ss_pred             EEEecCCccc
Q psy17532        260 AIADFGLALL  269 (461)
Q Consensus       260 ki~DFGla~~  269 (461)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998854

>KOG0590|consensus

Probab=99.69  E-value=5.6e-18  Score=177.40  Aligned_cols=258  Identities=22%  Similarity=0.250  Sum_probs=185.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCChh---hhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDKQ---SWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~  183 (461)
                      ...|.+.+.||+|.|+.|-.....   ...+|+|.+......   ......|..+-..+. |.|++++++.......   
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~---   95 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS---   95 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc---
Confidence            456788888999999999887763   345777776544321   122234555555565 9999999998877653   


Q ss_pred             eeeeeehhccCCChhhhh-cCC--CCCHHHHHHHHHHHHHHHHHHh-hcccCCCcCCCCCCeecccCCCCcEEEcCCC-c
Q psy17532        184 EFWLITAYHERGSLCDFL-KCN--IVTWEQLCRIALSMSKGLMHLH-EEILPNKADSYKPAVAHRDFKSNNVLLKSDL-T  258 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l-~~~--~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~  258 (461)
                       ++++++|..+|++.+.+ ...  ..+......++.|+..|+.|+| ..           ++.|||+||+|.+++..+ .
T Consensus        96 -~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-----------~~~h~~ikP~n~~l~~s~~~  163 (601)
T KOG0590|consen   96 -YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN-----------GVTHRDIKPSNSLLDESGSA  163 (601)
T ss_pred             -cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc-----------ccccCCCCCccchhccCCCc
Confidence             48999999999999988 443  4677788899999999999999 77           999999999999999999 9


Q ss_pred             eEEEecCCccccCC-CCCCCCCCCCcC-CCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEP-GKPCGDTHGQVG-TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      .|++|||+|..+.. ...........| ++.|+|||...+.    .......|+||.|+++.-+++|           ..
T Consensus       164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~----~~~~~~~d~~S~g~~l~~~~~g-----------~~  228 (601)
T KOG0590|consen  164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK----AYRGPSVDVWSLGIVLSAMLTG-----------EL  228 (601)
T ss_pred             ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccch----hhcCCCcccccccccccccccC-----------CC
Confidence            99999999987765 333334445677 9999999998763    1233567999999999999999           44


Q ss_pred             CCccccCCCCCHHHHHHHHhccCC-CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKL-RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      |+..............   ..... .......     ......+++.+++..+|+.|.+.+++-...+...
T Consensus       229 p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  229 PWDFPSRKDGRYSSWK---SNKGRFTQLPWNS-----ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             Cccccccccccceeec---ccccccccCcccc-----CChhhhhcccccccCCchhccccccccccccccc
Confidence            4433322221111110   01000 0111111     2236778999999999999999999888766554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=4e-17  Score=147.43  Aligned_cols=134  Identities=19%  Similarity=0.156  Sum_probs=93.8

Q ss_pred             EeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHH-------------------------HHHHHHcCCCCCC--Ce
Q psy17532        117 VEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQS-------------------------EQEIFKLPHMEHD--NI  168 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~-------------------------~~ei~~l~~l~H~--nI  168 (461)
                      .+.||+|+||.||+|... ++.||||++..........                         +.|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999985 8899999986532211111                         1233333333222  23


Q ss_pred             eEEEEEEecCCccceeeeeeehhccCCChhhh-hcCCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccC
Q psy17532        169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDF-LKCNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDF  246 (461)
Q Consensus       169 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDL  246 (461)
                      .+.++..        ..++||||+++|++... +...... .....++.+++.++.++|. .           +|+||||
T Consensus        82 ~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~-----------~ivH~Dl  141 (187)
T cd05119          82 PKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA-----------GLVHGDL  141 (187)
T ss_pred             CceEecC--------CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc-----------CcCcCCC
Confidence            3444321        23899999999654322 2211111 6678899999999999998 7           9999999


Q ss_pred             CCCcEEEcCCCceEEEecCCccccC
Q psy17532        247 KSNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       247 kp~NILl~~~~~~ki~DFGla~~~~  271 (461)
                      ||+||+++ ++.++|+|||.+....
T Consensus       142 ~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         142 SEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             ChhhEEEE-CCcEEEEECccccccc
Confidence            99999999 8999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=4.5e-16  Score=134.52  Aligned_cols=135  Identities=19%  Similarity=0.221  Sum_probs=110.3

Q ss_pred             EEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCC--CCeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEH--DNILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      +.+.||+|.++.||++...+..++||....... ......|+..+..++|  .++.+++++....+    ..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDG----WSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----ccEEEEEecC
Confidence            457899999999999999888999999865433 3455677777778866  58889888776543    3489999999


Q ss_pred             CCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        194 RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       194 ~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ++.+..+      +......++.+++.+|++||...        ..+++|+|++|+|||++..+.+++.|||.++.
T Consensus        77 g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~--------~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV------SEEEKEDIAEQLAELLAKLHQLP--------LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC------CHHHHHHHHHHHHHHHHHHhCCC--------ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8877765      55677888999999999999751        23799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266|consensus

Probab=99.49  E-value=7.4e-15  Score=136.77  Aligned_cols=208  Identities=16%  Similarity=0.206  Sum_probs=140.7

Q ss_pred             HcCCCCCCCeeEEEEEEecCCc-cceeeeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCC
Q psy17532        159 KLPHMEHDNILRYIGAEKRGES-IHTEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPN  232 (461)
Q Consensus       159 ~l~~l~H~nIv~l~g~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  232 (461)
                      .+.++.|.|||++..|+.+... ...+..+++|||..|+|..||++     ..+......+++.||..||.|||+.    
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~----  195 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC----  195 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc----
Confidence            4556789999999999877654 23456899999999999999963     3478888899999999999999976    


Q ss_pred             CcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCC--CCCCCCCcCCCcccccccccccccccCCCCCccch
Q psy17532        233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP--CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDM  310 (461)
Q Consensus       233 ~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DV  310 (461)
                           .|+|+|+++..+-|++..++.+||.--........-..  ........+-++|.|||.=.-     ...+..+||
T Consensus       196 -----~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-----tn~~~a~dI  265 (458)
T KOG1266|consen  196 -----DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-----TNTTGASDI  265 (458)
T ss_pred             -----CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-----cccccchhh
Confidence                 88999999999999999999988853211111100000  011222356788999996432     244567899


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHh
Q psy17532        311 YACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAE  390 (461)
Q Consensus       311 wS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~  390 (461)
                      |+||+...||..+.-          .|-...  .....++....+...     +.+.        .-++++.+|++..|.
T Consensus       266 y~fgmcAlemailEi----------q~tnse--S~~~~ee~ia~~i~~-----len~--------lqr~~i~kcl~~eP~  320 (458)
T KOG1266|consen  266 YKFGMCALEMAILEI----------QSTNSE--SKVEVEENIANVIIG-----LENG--------LQRGSITKCLEGEPN  320 (458)
T ss_pred             hhhhHHHHHHHHhee----------ccCCCc--ceeehhhhhhhheee-----ccCc--------cccCcCcccccCCCC
Confidence            999999999987721          011100  000111111111111     0010        123678999999999


Q ss_pred             hhccccchhhhcHHH
Q psy17532        391 ARLSASCVVERGMLA  405 (461)
Q Consensus       391 ~Rps~~evl~~l~~~  405 (461)
                      .||+|.+++.|+...
T Consensus       321 ~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  321 GRPDARLLLFHPLLF  335 (458)
T ss_pred             CCcchhhhhcCceee
Confidence            999999999877543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=1.6e-13  Score=139.53  Aligned_cols=139  Identities=16%  Similarity=0.163  Sum_probs=94.5

Q ss_pred             eEeecCCceEEEEEEE-CCCcEEEEEEecCChhhh-----------------------------------------HHHH
Q psy17532        118 EVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSW-----------------------------------------QSEQ  155 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~-----------------------------------------~~~~  155 (461)
                      +.||.|++|.||+|+. +|+.||||+....-....                                         .+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999998 689999999854321100                                         0112


Q ss_pred             HHHHcCCC----CCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHH-HHHHHhhccc
Q psy17532        156 EIFKLPHM----EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK-GLMHLHEEIL  230 (461)
Q Consensus       156 ei~~l~~l----~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~  230 (461)
                      |...+.++    +|.+-+.+-.++.+-.   +..+|||||++|++|.++........ ....++..++. .+..+|..  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhC--
Confidence            33333222    3333344433332211   12389999999999998864321111 23456666665 46788888  


Q ss_pred             CCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccC
Q psy17532        231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       231 ~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~  271 (461)
                               |++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 ---------g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---------GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---------CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence                     99999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=1.9e-13  Score=121.22  Aligned_cols=133  Identities=19%  Similarity=0.085  Sum_probs=96.0

Q ss_pred             EeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCee-EEEEEEecCCccceeeeeeehhccCC
Q psy17532        117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL-RYIGAEKRGESIHTEFWLITAYHERG  195 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lv~e~~~~g  195 (461)
                      .+.++.|.++.||+++..+..|++|............+.|+..+..+.+.+++ ++++.....      .++||||+++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~------~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPET------GVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCC------CeEEEEecCCC
Confidence            46789999999999999999999998754432233456777777776554443 555543221      27999999998


Q ss_pred             ChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        196 SLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       196 sL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ++.+..    .   ....++.+++++|+.||+...      ...+++|+|++|.||+++ ++.++++|||.+..
T Consensus        77 ~l~~~~----~---~~~~~~~~l~~~l~~LH~~~~------~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTED----F---SDPENLEKIAKLLKKLHSSPL------PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccccc----c---cCHHHHHHHHHHHHHHhCCCC------CCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            876541    1   113456789999999998711      122469999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.37  E-value=4.7e-13  Score=134.75  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=173.7

Q ss_pred             cceeEEeEeec--CCceEEEEEEE----CCCcEEEEEEec--C-ChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        112 RSIQLVEVKAQ--GRFGAVWKAKF----KNENVAVKIFLM--Q-DKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       112 ~~~~~~~~lg~--G~fg~Vy~~~~----~~~~vAvK~~~~--~-~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      ..+.+.+.+|.  |.+|.||.+..    .+..+|+|.-+.  . ........+|+....++ .|+|.++.+..+..... 
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~-  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI-  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc-
Confidence            45667788999  99999999887    357799987332  1 12233334566655555 59999998888777654 


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHH----HHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSK----GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                         .++-+|++. .+|.++...  ..+....+.....+...    ||.++|+.           +++|-|+||.||++..
T Consensus       193 ---lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-----------~~~~~~~kp~~i~~~~  257 (524)
T KOG0601|consen  193 ---LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-----------NIVHDDLKPANIFTTS  257 (524)
T ss_pred             ---ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC-----------cccccccchhheeccc
Confidence               378888885 588888753  33677777888888888    99999999           9999999999999999


Q ss_pred             C-CceEEEecCCccccCCCCCCC---CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        256 D-LTAAIADFGLALLFEPGKPCG---DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       256 ~-~~~ki~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      + ...+++|||+...+..+....   ......|...|++||++.+      -++...||||+|.++.|..++.....   
T Consensus       258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~------l~~~~~di~sl~ev~l~~~l~~~~~~---  328 (524)
T KOG0601|consen  258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG------LATFASDIFSLGEVILEAILGSHLPS---  328 (524)
T ss_pred             ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc------ccchHhhhcchhhhhHhhHhhccccc---
Confidence            9 889999999998887654211   1112257788999999976      45677899999999999998853321   


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                             .+.   ...+.++.     +   ..+|.++-.. ...++...+..+++.+|-.|++++.+..+-
T Consensus       329 -------~g~---~~~W~~~r-----~---~~ip~e~~~~-~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~  380 (524)
T KOG0601|consen  329 -------VGK---NSSWSQLR-----Q---GYIPLEFCEG-GSSSLRSVTSQMLDEDPRLRLTAQILTALN  380 (524)
T ss_pred             -------CCC---CCCccccc-----c---ccCchhhhcC-cchhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence                   110   00111110     0   1133222211 223566689999999999999998776643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=1.5e-11  Score=126.90  Aligned_cols=144  Identities=15%  Similarity=0.136  Sum_probs=90.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhh--------------------------------------
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS--------------------------------------  150 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~--------------------------------------  150 (461)
                      ..+|+. +.||+|++|.||+|+.+  |+.||||+....-...                                      
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 78999999999999983  7999999986431100                                      


Q ss_pred             ---hHHHHHHHHcCCC----CCCCeeEEEEEEecCCccceeeeeeehhccCCChhhh--hcCCCCCHHHHHHHHHHHHH-
Q psy17532        151 ---WQSEQEIFKLPHM----EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF--LKCNIVTWEQLCRIALSMSK-  220 (461)
Q Consensus       151 ---~~~~~ei~~l~~l----~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~l~~~~~~~i~~~ia~-  220 (461)
                         .+..+|+..+.++    .+.+.+.+-.++.+-   .+..+|||||++|+.|.++  +.....+....   +...+. 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~l---a~~~v~~  271 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLL---AERGVEV  271 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHH---HHHHHHH
Confidence               0012333333322    244444444444321   1233799999999999875  33333322222   111111 


Q ss_pred             HHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC----ceEEEecCCccccCC
Q psy17532        221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL----TAAIADFGLALLFEP  272 (461)
Q Consensus       221 gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~----~~ki~DFGla~~~~~  272 (461)
                      -+.-++..           |++|+|++|.||+++.++    .+++.|||++..++.
T Consensus       272 ~~~Qif~~-----------GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQVFRD-----------GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHhC-----------CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            11223334           999999999999999988    999999999977643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=1.5e-11  Score=110.51  Aligned_cols=133  Identities=17%  Similarity=0.125  Sum_probs=96.0

Q ss_pred             eEeecCCceEEEEEEEC--------CCcEEEEEEecCC------------hh-----------hhH----HHHHHHHcCC
Q psy17532        118 EVKAQGRFGAVWKAKFK--------NENVAVKIFLMQD------------KQ-----------SWQ----SEQEIFKLPH  162 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~--------~~~vAvK~~~~~~------------~~-----------~~~----~~~ei~~l~~  162 (461)
                      ..||.|.=+.||.|...        +..+|||+.+...            ..           ...    .++|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999764        3689999874211            00           001    1378887777


Q ss_pred             CCC--CCeeEEEEEEecCCccceeeeeeehhccCCChh-hhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcccCCCcCCCC
Q psy17532        163 MEH--DNILRYIGAEKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHL-HEEILPNKADSYK  238 (461)
Q Consensus       163 l~H--~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~~~~~  238 (461)
                      +..  -++-+.+++.  .      -+|||||+.++.+. ..++...++..+...+..+++.+|..| |..          
T Consensus        83 l~~~Gv~vP~pi~~~--~------~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~----------  144 (197)
T cd05146          83 MQKAGIPCPEVVVLK--K------HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC----------  144 (197)
T ss_pred             HHHcCCCCCeEEEec--C------CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC----------
Confidence            742  4566666541  1      17999999765442 234444566667778889999999998 777          


Q ss_pred             CCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       239 ~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                       +|||+||++.|||++ ++.+.|+|||.+...
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             999999999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=99.30  E-value=1.8e-12  Score=130.66  Aligned_cols=247  Identities=18%  Similarity=0.146  Sum_probs=169.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCChh---hhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDKQ---SWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...+|.++..||.|.|+.|+....+   +..+++|.+...-..   ......|+.....+ .|.++++++..+...... 
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~-  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG-  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-
Confidence            4567889999999999999998763   567888876533222   11223455544444 588888877766554433 


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~k  260 (461)
                         |+-.|||+++++...... .-+.+...+++..|++.++.++|+.           .++|+|+||+||++..+ +..+
T Consensus       342 ---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~-----------~~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  342 ---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK-----------LFVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             ---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch-----------hhhcccccccceeeccchhhhh
Confidence               799999999988876632 2367788999999999999999988           89999999999999986 7889


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCccc-ccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYM-APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      +.|||.+..+.-..    . ...+.-+++ ..|.+...    ..+..+.|++|||..+.|.+++.          ..+..
T Consensus       408 ~~~~~~~t~~~~~~----~-~~~~~~r~~p~~~~~~e~----~~~~~~~~~~sl~~~~~e~~~~~----------~ls~~  468 (524)
T KOG0601|consen  408 LGDFGCWTRLAFSS----G-VFHHIDRLYPIAEILLED----YPHLSKADIFSLGLSVDEAITGS----------PLSES  468 (524)
T ss_pred             ccccccccccceec----c-cccccccccccchhhccc----cccccccccccccccccccccCc----------ccCcc
Confidence            99999986532211    1 122333444 24544432    35567899999999999999983          12221


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..          .-..+..+..+..+...      ..+..+.+.+...|+..||.+.++..+..+..
T Consensus       469 ~~----------~~~~i~~~~~p~~~~~~------~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  469 GV----------QSLTIRSGDTPNLPGLK------LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             cc----------cceeeecccccCCCchH------HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            11          00111222223333221      36778889999999999999988777765543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=6.2e-11  Score=109.61  Aligned_cols=151  Identities=15%  Similarity=0.132  Sum_probs=111.2

Q ss_pred             eEeecCCceEEEEEEECC-CcEEEEEEecCCh--hhhHHHHHHHHcCCCCC--CCeeEEEEEEecCCccceeeeeeehhc
Q psy17532        118 EVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEH--DNILRYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      +.|+.|.++.||+++..+ +.+++|.......  .....+.|..++..+.+  .++.+++.+..... ..+..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCceEEEEEe
Confidence            578999999999999875 8999998754332  23345667777777754  44566777655432 112348999999


Q ss_pred             cCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCC---------------------------------------
Q psy17532        193 ERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK---------------------------------------  233 (461)
Q Consensus       193 ~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~---------------------------------------  233 (461)
                      +++++.+.+....++..+...++.+++++|..||+......                                       
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            99998887654567888899999999999999997522110                                       


Q ss_pred             ------cCCCCCCeecccCCCCcEEEcC--CCceEEEecCCccc
Q psy17532        234 ------ADSYKPAVAHRDFKSNNVLLKS--DLTAAIADFGLALL  269 (461)
Q Consensus       234 ------~~~~~~~ivHrDLkp~NILl~~--~~~~ki~DFGla~~  269 (461)
                            .......++|+|+.+.|||++.  ++.+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                  0012568999999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606|consensus

Probab=99.24  E-value=8.6e-12  Score=132.11  Aligned_cols=256  Identities=19%  Similarity=0.219  Sum_probs=168.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHH----HHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEI----FKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei----~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ....+.+.+-+-+|.|+.++.++-.  +...++|.......-....-+.+    .++-..+||-+++..-.+....    
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs----  877 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS----  877 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC----
Confidence            4567778888899999999988763  44455554433222111111111    1122235577766554422222    


Q ss_pred             eeeeeehhccCCChhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+|+++|..+|+|...|+... .+.+-....+..+..+++|||+.           .+.|||++|.|+|+..++..+++
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~-----------~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS-----------LRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc-----------hhhcccccccchhhcccCCcccC
Confidence            3489999999999999997654 66566666777888999999987           78999999999999999999999


Q ss_pred             ecCCccccCC---------------------CCC--------CCCCCCCcCCCcccccccccccccccCCCCCccchHHH
Q psy17532        263 DFGLALLFEP---------------------GKP--------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC  313 (461)
Q Consensus       263 DFGla~~~~~---------------------~~~--------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~  313 (461)
                      |||.......                     ...        ........||+.|.+||.+.+.     .....+|+|++
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-----~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-----RHGSAADWWSS 1021 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-----cCCCcchhhhh
Confidence            9984322110                     000        0012234689999999999874     56677899999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc
Q psy17532        314 ALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       314 Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      |++++|.++|.++|           ...     ..+++.+.+.........    ..........+++.+.+..+|.+|.
T Consensus      1022 g~~l~e~l~g~pp~-----------na~-----tpq~~f~ni~~~~~~~p~----g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPF-----------NAE-----TPQQIFENILNRDIPWPE----GPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             hhhhhhhhcCCCCC-----------CCc-----chhhhhhccccCCCCCCC----CccccChhhhhhhhhhhccCchhcc
Confidence            99999999995544           332     333333333332221111    1122345788999999999999999


Q ss_pred             ccc---chhhhcHHH
Q psy17532        394 SAS---CVVERGMLA  405 (461)
Q Consensus       394 s~~---evl~~l~~~  405 (461)
                      .+.   ++-.+....
T Consensus      1082 ~a~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQ 1096 (1205)
T ss_pred             CcccccccccCCccC
Confidence            877   555554443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=2.4e-10  Score=99.62  Aligned_cols=128  Identities=17%  Similarity=0.205  Sum_probs=93.6

Q ss_pred             eEeecCCceEEEEEEECCCcEEEEEEecCCh---------hhhHHHHHHHHcCCCCC--CCeeEEEEEEecCCccceeee
Q psy17532        118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDK---------QSWQSEQEIFKLPHMEH--DNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~---------~~~~~~~ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+++|+=+.+|.+.+.|..+++|.-.....         ...+..+|+.++.++.-  -+...++.+..+.      ..
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~------~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN------GL   75 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC------CE
Confidence            3578999999999999888888886432211         11223467777766643  2344444443332      26


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      |+|||.++-.|.+++...      ...++..+-.-+.-||..           +|+|+||.++||++..+. +.++||||
T Consensus        76 I~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~-----------givHGDLTtsNiIl~~~~-i~~IDfGL  137 (204)
T COG3642          76 IVMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHKA-----------GIVHGDLTTSNIILSGGR-IYFIDFGL  137 (204)
T ss_pred             EEEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhc-----------CeecCCCccceEEEeCCc-EEEEECCc
Confidence            999999998899898665      245666777778889999           999999999999998775 89999999


Q ss_pred             ccc
Q psy17532        267 ALL  269 (461)
Q Consensus       267 a~~  269 (461)
                      +..
T Consensus       138 g~~  140 (204)
T COG3642         138 GEF  140 (204)
T ss_pred             ccc
Confidence            964

>KOG1243|consensus

Probab=99.12  E-value=3.2e-10  Score=115.64  Aligned_cols=163  Identities=16%  Similarity=0.234  Sum_probs=119.0

Q ss_pred             CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHH
Q psy17532        134 KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC  212 (461)
Q Consensus       134 ~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~  212 (461)
                      .+.+|.|...+..... .....+-+..|+.++||||++++..+....    .+|||+|-+.  -|..++++  ++.....
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV~--Pl~~~lk~--l~~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERVR--PLETVLKE--LGKEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeeccc--cHHHHHHH--hHHHHHH
Confidence            4677888877655441 223456677899999999999999988766    4499999874  67777765  3455666


Q ss_pred             HHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccc
Q psy17532        213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE  292 (461)
Q Consensus       213 ~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  292 (461)
                      -.+.||+.||.|||+..          +++|++|.-..|+|+..|.-||++|-++........  ......--..|..|+
T Consensus       108 ~Gl~qIl~AL~FL~~d~----------~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~  175 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDC----------NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPE  175 (690)
T ss_pred             HHHHHHHHHHHHHhccC----------CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChh
Confidence            77889999999999653          899999999999999999999999988754332110  011111223456666


Q ss_pred             cccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        293 VLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       293 ~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      .+..+       ....|.|-||+++||++.|
T Consensus       176 ~~~~s-------~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  176 EIDPS-------EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hcCcc-------ccchhhhhHHHHHHHHhCc
Confidence            55321       1335999999999999998

>KOG3087|consensus

Probab=99.09  E-value=7.3e-10  Score=96.16  Aligned_cols=139  Identities=22%  Similarity=0.221  Sum_probs=97.3

Q ss_pred             EEeEeecCCceEEEEEEECCCcEEEEEEecCC---------hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD---------KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~---------~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ...++-+|+-+.|+++.+.|+...||.-....         ....+..+|+..+.++.--.|.--.-++.+....    .
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~----~   86 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG----Q   86 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC----e
Confidence            56788999999999999999999998542211         1122345788877766433332222223333222    6


Q ss_pred             eeehhccC-CChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC---ce
Q psy17532        187 LITAYHER-GSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL---TA  259 (461)
Q Consensus       187 lv~e~~~~-gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~---~~  259 (461)
                      |+|||.++ -++.+|+...   .........++..|-+.+.-||.+           +|+|+||..+||++..++   .+
T Consensus        87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n-----------diiHGDLTTSNill~~~~~~~~~  155 (229)
T KOG3087|consen   87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN-----------DIIHGDLTTSNILLRSDGNQITP  155 (229)
T ss_pred             EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-----------CeecccccccceEEecCCCcCce
Confidence            99999976 4788887432   223333467888999999999999           999999999999997654   45


Q ss_pred             EEEecCCccc
Q psy17532        260 AIADFGLALL  269 (461)
Q Consensus       260 ki~DFGla~~  269 (461)
                      .++|||++..
T Consensus       156 ~lIdfgls~~  165 (229)
T KOG3087|consen  156 ILIDFGLSSV  165 (229)
T ss_pred             EEEeecchhc
Confidence            8999999853

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=4.3e-09  Score=99.89  Aligned_cols=140  Identities=15%  Similarity=0.113  Sum_probs=94.2

Q ss_pred             EeecCCceEEEEEEECCCcEEEEEEecCChh------------hhHHHHHHHHcCCCC--CCCeeEEEEEEecCC-ccce
Q psy17532        119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ------------SWQSEQEIFKLPHME--HDNILRYIGAEKRGE-SIHT  183 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~------------~~~~~~ei~~l~~l~--H~nIv~l~g~~~~~~-~~~~  183 (461)
                      .+-......|++..+.|+.+.||........            .....+|...+.++.  .-.+...+++..... ....
T Consensus        29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            3333344457788888899999976432211            012445665554442  112233344433221 1122


Q ss_pred             eeeeeehhccCC-Chhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC----
Q psy17532        184 EFWLITAYHERG-SLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS----  255 (461)
Q Consensus       184 ~~~lv~e~~~~g-sL~~~l~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~----  255 (461)
                      .-+||||++++- +|.+++.   ....+......++.+++..+.-||..           ||+|+||++.|||++.    
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~-----------Gi~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA-----------GINHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------cCccCCCChhhEEEeccccC
Confidence            347999999875 7988875   23456667788999999999999999           9999999999999985    


Q ss_pred             ---CCceEEEecCCccc
Q psy17532        256 ---DLTAAIADFGLALL  269 (461)
Q Consensus       256 ---~~~~ki~DFGla~~  269 (461)
                         ++.+.++||+.+..
T Consensus       178 ~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        178 REEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCceEEEEECCcccc
Confidence               46889999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=1.9e-09  Score=96.65  Aligned_cols=123  Identities=21%  Similarity=0.239  Sum_probs=78.8

Q ss_pred             EEEEEEE-CCCcEEEEEEecCCh------------h---------------hhHHHHHHHHcCCCCCC--CeeEEEEEEe
Q psy17532        127 AVWKAKF-KNENVAVKIFLMQDK------------Q---------------SWQSEQEIFKLPHMEHD--NILRYIGAEK  176 (461)
Q Consensus       127 ~Vy~~~~-~~~~vAvK~~~~~~~------------~---------------~~~~~~ei~~l~~l~H~--nIv~l~g~~~  176 (461)
                      .||.|.. ++..+|||+......            .               ....++|...|.++..-  ++.+.+++..
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            4899997 678999998853210            0               01124688888887655  5666665532


Q ss_pred             cCCccceeeeeeehhcc--CCChhhhhcCCCCCHHHHHHHHHHHHHHHHH-HhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        177 RGESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMH-LHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                        +      .|||||++  +..+. .|....++.+....++.+++..+.. +|..           ||+|+||.+.|||+
T Consensus        81 --~------~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~-----------givHGDLs~~NIlv  140 (188)
T PF01163_consen   81 --N------VIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKA-----------GIVHGDLSEYNILV  140 (188)
T ss_dssp             --T------EEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCT-----------TEEESS-STTSEEE
T ss_pred             --C------EEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhc-----------CceecCCChhhEEe
Confidence              1      79999998  54443 3433333345566777788886666 4676           99999999999999


Q ss_pred             cCCCceEEEecCCcccc
Q psy17532        254 KSDLTAAIADFGLALLF  270 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~  270 (461)
                      +++ .+.|+|||.+...
T Consensus       141 ~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  141 DDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             ETT-CEEE--GTTEEET
T ss_pred             ecc-eEEEEecCcceec
Confidence            988 8999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741|consensus

Probab=98.79  E-value=8.3e-08  Score=95.51  Aligned_cols=166  Identities=16%  Similarity=0.160  Sum_probs=122.4

Q ss_pred             CceEEEEEEE--CCCcEEEEEEecCChhhh-HHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccC-CChhh
Q psy17532        124 RFGAVWKAKF--KNENVAVKIFLMQDKQSW-QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHER-GSLCD  199 (461)
Q Consensus       124 ~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~-gsL~~  199 (461)
                      .-.+.|++..  +|..|..|++........ +...-..+++++.|.|||+|..++....+....+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4456788887  688899999832221111 1112244577899999999999988655555678999999986 57777


Q ss_pred             hh-c---------------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        200 FL-K---------------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       200 ~l-~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +- .               ....++..++.++.|+..||.++|+.           |+.-+-|.+.+||++.+..++|+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-----------GLAck~L~~~kIlv~G~~RIriS~  436 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-----------GLACKTLDLKKILVTGKMRIRISG  436 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-----------CceeecccHhHeEeeCcceEEEec
Confidence            54 1               11357788999999999999999999           888899999999999999999988


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC  324 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~  324 (461)
                      .|....+..+.         +       |.+.+.        .+-|.=-||.++.-|.||+
T Consensus       437 C~i~Dvl~~d~---------~-------~~le~~--------Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  437 CGIMDVLQEDP---------T-------EPLESQ--------QQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             ccceeeecCCC---------C-------cchhHH--------hhhhHHHHHHHHHHHhhcc
Confidence            88775554322         0       122221        2348889999999999994

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.68  E-value=6.9e-07  Score=87.02  Aligned_cols=270  Identities=14%  Similarity=0.132  Sum_probs=154.0

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhh-HHHHHHHHcCCCCCCCeeEEEEEE---ecCCccceeeeeeeh
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSW-QSEQEIFKLPHMEHDNILRYIGAE---KRGESIHTEFWLITA  190 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~-~~~~ei~~l~~l~H~nIv~l~g~~---~~~~~~~~~~~lv~e  190 (461)
                      .....||+|+-+.+|-----+..|| |+......... +...|+  ..--.||-+-.-+.+=   ..+.......-++|.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCCccccCCccceeeecchhhchhh-eeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            4557899999999996443333443 66543322221 211222  1222565443311110   001111111345666


Q ss_pred             hccCC-Chhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        191 YHERG-SLCDFLK-------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       191 ~~~~g-sL~~~l~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++. -+..+++       .....|..+++.++.+|.+.+-||..           |.+-+|+.++|+|+.+++.+.|.
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-----------Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-----------GHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-----------CCcccccCccceeeecCceEEEE
Confidence            65543 2333331       12378999999999999999999999           99999999999999999999998


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCC--CCCCCCCc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR-CSSVSPPP--GEYRLPFS  339 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg-~~~~~~~~--~~~~~pf~  339 (461)
                      |-..-.....+.   .....+|...|.+||.-.-..+....-+...|-|.|||++++++.| ..||.+-.  .....|++
T Consensus       160 dsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E  236 (637)
T COG4248         160 DSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE  236 (637)
T ss_pred             cccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence            854333222221   2234578899999997653334445566778999999999999988 44554321  11111221


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHcccc--HhhhccccchhhhcHHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHD--AEARLSASCVVERGMLA  405 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~l~~~  405 (461)
                      ..+... .+..  ......+++ +-|..|+-..-...+..|..+|+..-  +.-|||++.-+..|..+
T Consensus       237 ~~Ia~g-~f~y--a~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         237 TDIAHG-RFAY--ASDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhhhcc-eeee--chhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            100000 0000  000111122 22344443334457888999999753  56899987655554443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.67  E-value=7.9e-08  Score=88.96  Aligned_cols=131  Identities=18%  Similarity=0.195  Sum_probs=90.6

Q ss_pred             eEEeEeecCCceEEEEEEE-CCCcEEEEEEecCCh-----------------------hhhHHHHHHHHcCCCCCC--Ce
Q psy17532        115 QLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDK-----------------------QSWQSEQEIFKLPHMEHD--NI  168 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-----------------------~~~~~~~ei~~l~~l~H~--nI  168 (461)
                      .+...||-|.=+.||.|.. +|.++|||.-.....                       .....++|...|.+|.-.  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            3568999999999999999 589999997532110                       112235788888777543  55


Q ss_pred             eEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       169 v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      .+-+++-        .-.+||||.++-.|...-    ++.+..-.++..|+.-+.-+-..           ||||+|+.+
T Consensus       174 P~P~~~n--------RHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~-----------GiVHGDlSe  230 (304)
T COG0478         174 PKPIAWN--------RHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRR-----------GIVHGDLSE  230 (304)
T ss_pred             CCccccc--------cceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHc-----------CccccCCch
Confidence            5555542        237999999986555432    22333444444444444444455           999999999


Q ss_pred             CcEEEcCCCceEEEecCCcc
Q psy17532        249 NNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~  268 (461)
                      -|||++++|.+.++||--+.
T Consensus       231 fNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         231 FNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             heEEEecCCCEEEEeCcccc
Confidence            99999999999999996553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=1e-07  Score=87.39  Aligned_cols=106  Identities=17%  Similarity=0.193  Sum_probs=77.8

Q ss_pred             HHHHHHHcCCCC--CCCeeEEEEEEecCCccceeeeeeehhccCC-ChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q psy17532        153 SEQEIFKLPHME--HDNILRYIGAEKRGESIHTEFWLITAYHERG-SLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEE  228 (461)
Q Consensus       153 ~~~ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~  228 (461)
                      ..+|...+..+.  .-.+.+.+++...........++|+|++++- +|.+++.. ...+......++.+++..++-||+.
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~  137 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA  137 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC
Confidence            345555443332  2234445555444332224558999999874 79998865 2366677888999999999999999


Q ss_pred             ccCCCcCCCCCCeecccCCCCcEEEcCCC---ceEEEecCCccc
Q psy17532        229 ILPNKADSYKPAVAHRDFKSNNVLLKSDL---TAAIADFGLALL  269 (461)
Q Consensus       229 ~~~~~~~~~~~~ivHrDLkp~NILl~~~~---~~ki~DFGla~~  269 (461)
                                 ||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       138 -----------gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  138 -----------GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             -----------cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence                       999999999999999887   889999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=3.7e-07  Score=82.54  Aligned_cols=138  Identities=12%  Similarity=0.027  Sum_probs=98.2

Q ss_pred             ecCCceEEEEEEECCCcEEEEEEecC-------ChhhhHHHHHHHHcCCCCC--CCeeEEEEEEecCCccceeeeeeehh
Q psy17532        121 AQGRFGAVWKAKFKNENVAVKIFLMQ-------DKQSWQSEQEIFKLPHMEH--DNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       121 g~G~fg~Vy~~~~~~~~vAvK~~~~~-------~~~~~~~~~ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      |+||-+-|++-.+.|..+=+|+-...       ......+.+|+..+.++..  -.+.+.+.......+....-+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            56888999999988888888875311       1122345677776666632  22444442222222223455899997


Q ss_pred             ccC-CChhhhhcCCC---CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc--eEEEecC
Q psy17532        192 HER-GSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT--AAIADFG  265 (461)
Q Consensus       192 ~~~-gsL~~~l~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~--~ki~DFG  265 (461)
                      +++ -||.+++....   .+......+..+++..++-||+.           |+.|+|+.+.|||++.++.  ++++||-
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~-----------Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV-----------NRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC-----------CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            653 48988886543   46777789999999999999999           9999999999999986666  9999997


Q ss_pred             Cccc
Q psy17532        266 LALL  269 (461)
Q Consensus       266 la~~  269 (461)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            6643

>KOG2137|consensus

Probab=98.59  E-value=1.9e-08  Score=103.31  Aligned_cols=154  Identities=12%  Similarity=0.159  Sum_probs=100.2

Q ss_pred             HHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCC-------CCCCcCCCccc
Q psy17532        217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-------THGQVGTRRYM  289 (461)
Q Consensus       217 ~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~-------~~~~~gt~~y~  289 (461)
                      +++.||.|+|...          ++||++|.|++|.++.++..||+.|+++........+..       ..-......|.
T Consensus       107 ~v~dgl~flh~sA----------k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~  176 (700)
T KOG2137|consen  107 NVADGLAFLHRSA----------KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL  176 (700)
T ss_pred             cccchhhhhccCc----------ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence            4558999999873          899999999999999999999999998866554221110       01112456899


Q ss_pred             ccccccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchh
Q psy17532        290 APEVLEGAINFSRDAFLRIDMYACALVLWELASR-CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETW  368 (461)
Q Consensus       290 aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg-~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~  368 (461)
                      |||++.+.     ..+.++|+||+|+++|.+..| ++.+......             ..... .....+-.......  
T Consensus       177 apE~~~~~-----~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-------------~~~~~-~~~~~~~~~~~~s~--  235 (700)
T KOG2137|consen  177 APEYLLGT-----TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-------------LSYSF-SRNLLNAGAFGYSN--  235 (700)
T ss_pred             cchhhccc-----cccccccceeeeeEEEEEecCCcchhhccCCc-------------chhhh-hhcccccccccccc--
Confidence            99999763     556789999999999999944 3332211110             00000 00000000011111  


Q ss_pred             ccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        369 KQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       369 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                         ..+.++++=+.+++..|+..||++.++.....+
T Consensus       236 ---~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff  268 (700)
T KOG2137|consen  236 ---NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFF  268 (700)
T ss_pred             ---cCcHHHHHHHHHHhcCCcccCcchhhhhccccc
Confidence               223378899999999999999987777665443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=1.1e-06  Score=79.86  Aligned_cols=140  Identities=14%  Similarity=0.102  Sum_probs=92.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHH----------HHHHHHcCCC---CCCCeeEEEEEEec
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQS----------EQEIFKLPHM---EHDNILRYIGAEKR  177 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~----------~~ei~~l~~l---~H~nIv~l~g~~~~  177 (461)
                      ...|...+++-......|.+-..+++.+++|.........++.          .+.+..+.++   .--....++.+...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            3578888888888888999999999999999876443222211          1222222222   22223332222211


Q ss_pred             -CCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        178 -GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       178 -~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                       .......++++|||++|-.|.++..   ++.    .++..+.+++.-||+.           |+.|+|..|.|++++.+
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~-----------G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKH-----------GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHc-----------CCccCCCCcCcEEEECC
Confidence             1112245579999999988877643   222    2445677889999999           99999999999999965


Q ss_pred             CceEEEecCCccc
Q psy17532        257 LTAAIADFGLALL  269 (461)
Q Consensus       257 ~~~ki~DFGla~~  269 (461)
                      + +++.||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            4 89999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.46  E-value=1.7e-06  Score=79.36  Aligned_cols=134  Identities=19%  Similarity=0.169  Sum_probs=91.6

Q ss_pred             eEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhH-------------------------HHHHHHHcCCCC--CCCee
Q psy17532        118 EVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQ-------------------------SEQEIFKLPHME--HDNIL  169 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~-------------------------~~~ei~~l~~l~--H~nIv  169 (461)
                      -.|++|.=+.||+|.. ++..+|||++.........                         .++|...|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            4677888889999987 5789999998643221110                         024555555542  33344


Q ss_pred             EEEEEEecCCccceeeeeeehhccCC-ChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        170 RYIGAEKRGESIHTEFWLITAYHERG-SLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       170 ~l~g~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      +-+++...        .|||||+... .-.-.|+.-.+..++...+..++++++.-|-...          ++||+||..
T Consensus       134 ~Pi~~~~n--------VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a----------~LVHgDLSE  195 (268)
T COG1718         134 EPIAFRNN--------VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA----------GLVHGDLSE  195 (268)
T ss_pred             CceeecCC--------eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc----------Ccccccchh
Confidence            44444322        6999999653 2222344444555577788888999988887631          999999999


Q ss_pred             CcEEEcCCCceEEEecCCcccc
Q psy17532        249 NNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~~~  270 (461)
                      =|||+. ++.+.|+|||-|...
T Consensus       196 yNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         196 YNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             hheEEE-CCeEEEEECcccccc
Confidence            999999 889999999988654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.40  E-value=1.1e-06  Score=90.42  Aligned_cols=139  Identities=20%  Similarity=0.195  Sum_probs=89.9

Q ss_pred             eEeecCCceEEEEEEEC-CCcEEEEEEecCChhhh-----------------------------------------HHHH
Q psy17532        118 EVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSW-----------------------------------------QSEQ  155 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~-----------------------------------------~~~~  155 (461)
                      +.|+.++-|.||+|+++ |+.||||+....-....                                         +..+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57889999999999996 89999998753211000                                         0012


Q ss_pred             HHHHcCCC----CCCCeeEEEEEEecCCccceeeeeeehhccCCChhhh--hcCCCCCHHHHHHHHHHHHHHHHHHhhcc
Q psy17532        156 EIFKLPHM----EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF--LKCNIVTWEQLCRIALSMSKGLMHLHEEI  229 (461)
Q Consensus       156 ei~~l~~l----~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~l~~~~~~~i~~~ia~gL~yLH~~~  229 (461)
                      |...+.++    +...=+++=.++.+-.   +.-.|+|||++|-.+.++  ++...++.+.+.....++.--.-+-|   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t---~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d---  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYT---TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD---  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhcc---CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc---
Confidence            33332222    2222333334443211   122799999999999888  45556665544443333322222233   


Q ss_pred             cCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       230 ~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                                |+.|.|..|.||+++.++.+.+.|||+...+++
T Consensus       285 ----------gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 ----------GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ----------CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence                      899999999999999999999999999977654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=2.1e-06  Score=79.77  Aligned_cols=146  Identities=18%  Similarity=0.165  Sum_probs=81.4

Q ss_pred             EeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCC--CeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD--NILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~--nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      ++.++.|..+.||+....+..+++|..... ........|...+..+...  .+.+++........ ....+++|+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~-~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF-NGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE-TSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc-cccceEEEEEecc
Confidence            468999999999999998889999987544 2333445565555555322  35566665433322 2235899999998


Q ss_pred             CChhh----------------hh---cCC-----CCCHHH---------HHHH------------HHHHHH-HHHHHhhc
Q psy17532        195 GSLCD----------------FL---KCN-----IVTWEQ---------LCRI------------ALSMSK-GLMHLHEE  228 (461)
Q Consensus       195 gsL~~----------------~l---~~~-----~l~~~~---------~~~i------------~~~ia~-gL~yLH~~  228 (461)
                      ..+..                .+   +..     ......         ....            ...+.. .+..+++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87777                11   000     001000         0000            111222 23333332


Q ss_pred             ccCCCcCCCCCCeecccCCCCcEEEc-CCCceEEEecCCcc
Q psy17532        229 ILPNKADSYKPAVAHRDFKSNNVLLK-SDLTAAIADFGLAL  268 (461)
Q Consensus       229 ~~~~~~~~~~~~ivHrDLkp~NILl~-~~~~~ki~DFGla~  268 (461)
                      ...    .....++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus       160 ~~~----~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPK----PLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHC----CSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hcc----CCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            110    1345799999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=2.9e-06  Score=73.77  Aligned_cols=130  Identities=15%  Similarity=0.190  Sum_probs=86.0

Q ss_pred             eeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCee-EEEEEEecCCccceeeeeeehhc
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL-RYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      .+..+.|++|.+|.||+|.+.+..+|+|.-.. +......+.|+.+|..++-.++. +++.+..+        ++.|||.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~--------~i~me~i   94 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGED--------FIRMEYI   94 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEechh--------hhhhhhh
Confidence            44567899999999999999999999997543 33344556777777666655554 44544333        5779999


Q ss_pred             cCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCC-CCcEEEcCCCceEEEecCCccc
Q psy17532        193 ERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK-SNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       193 ~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLk-p~NILl~~~~~~ki~DFGla~~  269 (461)
                      .|-.|.+.-...  +-+.+.    .+++. +|.-+..          ||-|..|. |...+|-.+..+.|+||..|+.
T Consensus        95 ~G~~L~~~~~~~--~rk~l~----~vlE~-a~~LD~~----------GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIGG--DRKHLL----RVLEK-AYKLDRL----------GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhcc--cHHHHH----HHHHH-HHHHHHh----------ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            987887765432  223333    33333 3433332          88888885 4444444455899999988863

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.24  E-value=9.4e-06  Score=76.36  Aligned_cols=138  Identities=17%  Similarity=0.188  Sum_probs=83.4

Q ss_pred             eecCCc-eEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeeeehhccCCCh
Q psy17532        120 KAQGRF-GAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLITAYHERGSL  197 (461)
Q Consensus       120 lg~G~f-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL  197 (461)
                      |..|.+ ..||+....+..+.||+.....  .....+|+..+..+. +--+.+++++....+    ..++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~----~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDG----RAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCC----ccEEEEEeeCCccH
Confidence            444544 7899998877788888875432  223455666555542 334556777665542    23799999998777


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHHHHHHhhccc-----------------------------------------------
Q psy17532        198 CDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL-----------------------------------------------  230 (461)
Q Consensus       198 ~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-----------------------------------------------  230 (461)
                      .....     ......++.++++.|.-||+...                                               
T Consensus        80 ~~~~~-----~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          80 AALWE-----ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             hHhhc-----ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            64321     00111233333333333333210                                               


Q ss_pred             CCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       231 ~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ........+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            00001234679999999999999998788999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.22  E-value=3.8e-05  Score=69.06  Aligned_cols=128  Identities=18%  Similarity=0.223  Sum_probs=89.5

Q ss_pred             cceeEEeEeecCCc-eEEEEEEECCCcEEEEEEec---CCh-------------------hhhHHHHHHHHcCCC---CC
Q psy17532        112 RSIQLVEVKAQGRF-GAVWKAKFKNENVAVKIFLM---QDK-------------------QSWQSEQEIFKLPHM---EH  165 (461)
Q Consensus       112 ~~~~~~~~lg~G~f-g~Vy~~~~~~~~vAvK~~~~---~~~-------------------~~~~~~~ei~~l~~l---~H  165 (461)
                      .+++.++.||.|.- |.||+++..|+.+|+|.+..   ...                   ....+..|.....+|   .+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78999999999999 99999999999999999421   100                   011234566655555   55


Q ss_pred             CCe--eEEEEEEecCC--------------ccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcc
Q psy17532        166 DNI--LRYIGAEKRGE--------------SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI  229 (461)
Q Consensus       166 ~nI--v~l~g~~~~~~--------------~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~  229 (461)
                      .++  |+.+|+..-..              .....+.||.||.+...        .++.    .-+.+|.+-|..+|.. 
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k~-  183 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHKL-  183 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHHC-
Confidence            666  99999874431              11123456777766532        1232    3345677778889988 


Q ss_pred             cCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       230 ~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                                ||+-+|+++.|..     .-||+|||.+
T Consensus       184 ----------gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 ----------GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----------CeeeccCcccccc-----CCEEEecccC
Confidence                      9999999999986     4589999864

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.20  E-value=1.8e-05  Score=73.61  Aligned_cols=140  Identities=14%  Similarity=0.056  Sum_probs=84.3

Q ss_pred             eEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCC--eeEEEEEEecCCccceeeeeeehhccCC
Q psy17532        118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN--ILRYIGAEKRGESIHTEFWLITAYHERG  195 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n--Iv~l~g~~~~~~~~~~~~~lv~e~~~~g  195 (461)
                      ..||+|..+.||+.  .+..+++|...... .....++|...+..+..-.  +.+.+++...++.    +.+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----LGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----eeeeeeecCCc
Confidence            57899999999984  35677888875433 2233466777666654322  3455666555432    36899999986


Q ss_pred             C-hhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCC--------------------------------cCCCCCCee
Q psy17532        196 S-LCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK--------------------------------ADSYKPAVA  242 (461)
Q Consensus       196 s-L~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--------------------------------~~~~~~~iv  242 (461)
                      + +...+.   .+......++.++++.+.-||+......                                .....+.++
T Consensus        80 ~~~~~~~~---~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        80 RSFSRIIS---DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             cchhhhhc---CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            3 222221   1222333344444444444443200000                                001244679


Q ss_pred             cccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        243 HRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       243 HrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      |+|+.|.||++++++ +.|+||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035|consensus

Probab=98.19  E-value=4.7e-06  Score=90.60  Aligned_cols=204  Identities=19%  Similarity=0.202  Sum_probs=139.3

Q ss_pred             HHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccC
Q psy17532        153 SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILP  231 (461)
Q Consensus       153 ~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~  231 (461)
                      .+.|+..+.++.|+|++++++|-.......-...+..+++..-++...+.. ..++......+..++..||+|+|+.   
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence            356777788899999999999876654433234566788888888887743 5678888889999999999999988   


Q ss_pred             CCcCCCCCCeecccCCCC---cEEEcCCCceEEE--ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCC
Q psy17532        232 NKADSYKPAVAHRDFKSN---NVLLKSDLTAAIA--DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFL  306 (461)
Q Consensus       232 ~~~~~~~~~ivHrDLkp~---NILl~~~~~~ki~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~  306 (461)
                              ...|.-|..+   +-.++..+.+.++  ||+.++.+....   .......+..|-|+|......   .....
T Consensus       306 --------~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~---~~~~r  371 (1351)
T KOG1035|consen  306 --------SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENT---AKKSR  371 (1351)
T ss_pred             --------ccceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCcccccccccccccc---chhhh
Confidence                    4555555544   4455666777777  999887765432   122334566788888876532   12223


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHcc
Q psy17532        307 RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWD  386 (461)
Q Consensus       307 k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~  386 (461)
                      ..|+|.+|..+..+..|..+.          -.         .....        ..++...     ...+.+...+|+.
T Consensus       372 ~~dL~~lgll~~~~~~~~~i~----------~~---------~~~~~--------~~l~~~~-----~~~~~d~~~~~~~  419 (1351)
T KOG1035|consen  372 LTDLWCLGLLLLQLSQGEDIS----------EK---------SAVPV--------SLLDVLS-----TSELLDALPKCLD  419 (1351)
T ss_pred             hhHHHHHHHHHhhhhhcCccc----------cc---------ccchh--------hhhcccc-----chhhhhhhhhhcc
Confidence            469999999999998873211          00         00000        0111111     1146788999999


Q ss_pred             ccHhhhccccchhhhcHHH
Q psy17532        387 HDAEARLSASCVVERGMLA  405 (461)
Q Consensus       387 ~dP~~Rps~~evl~~l~~~  405 (461)
                      .|+++|+++.+++.+.+..
T Consensus       420 ~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  420 EDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             hhhhhccchhhhhhchhcc
Confidence            9999999999999987643

>KOG0576|consensus

Probab=98.19  E-value=3.2e-07  Score=93.51  Aligned_cols=185  Identities=17%  Similarity=0.155  Sum_probs=125.7

Q ss_pred             ceeEEeEeecCCceEEEEEEECCCc-EEEEEEecCChhhhHHHHHHHHcCCCCCCC-eeEEEEEEecCCccceeeeeeeh
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFKLPHMEHDN-ILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      -+....-.++|++++++|.+-..+. ..++.+...    ....-+++.|.+++||| .+..++-+....    ..+++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~----~~~i~~~  314 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGED----YLWIPMR  314 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCccc----ccchhhh
Confidence            3444556788999999988875433 335544322    23345667788999999 666655544333    3489999


Q ss_pred             hccCC-Chhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        191 YHERG-SLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       191 ~~~~g-sL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ++..| +-.....  ...+...+...+.+.-.++|+++|+.           .=+|||    |||..+ +..|..||+..
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~-----------~~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS-----------YKVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc-----------cccCcc----cccccc-cccccccccCC
Confidence            99887 3222221  11233344555667778899999976           458999    777665 67899999998


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP  329 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~  329 (461)
                      ..+....   ......+++.|+|||+..++     .+..+.|+||+|+--.++.-|-+|-..
T Consensus       379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~-----~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  379 PQLTRTM---KPRTAIGTPEPLAPEVIQEN-----TIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cccCccc---ccccCCCCCCCCCchhhccc-----ccccCCCccCCCcchhhcCCCCCCCCC
Confidence            8776543   34556899999999988764     445667999999877777777555433

>KOG1235|consensus

Probab=98.12  E-value=9.1e-06  Score=83.56  Aligned_cols=136  Identities=15%  Similarity=0.143  Sum_probs=89.4

Q ss_pred             eEeecCCceEEEEEEE-CCCcEEEEEEecCChhh--------------------------------------hHHHHHHH
Q psy17532        118 EVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQS--------------------------------------WQSEQEIF  158 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~--------------------------------------~~~~~ei~  158 (461)
                      +.||.-+.|.||+|+. +|+.||||+-...-...                                      .++.+|+.
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6789999999999999 57889999754321100                                      00112322


Q ss_pred             H----cCCCCCCC------eeEEEEEEecCCccceeeeeeehhccCCChhhh--hcCCCCCHHHHHHHHHHHHHHHHHHh
Q psy17532        159 K----LPHMEHDN------ILRYIGAEKRGESIHTEFWLITAYHERGSLCDF--LKCNIVTWEQLCRIALSMSKGLMHLH  226 (461)
Q Consensus       159 ~----l~~l~H~n------Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~l~~~~~~~i~~~ia~gL~yLH  226 (461)
                      .    ...+.|-+      |-+++-.+..      ...|+||||+|..+.|.  ++...++...+..-+.++..-+-+-|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st------~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLST------KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCc------ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc
Confidence            2    11233444      3333332222      23799999999887764  56667777766655555544444444


Q ss_pred             hcccCCCcCCCCCCeecccCCCCcEEEcC----CCceEEEecCCccccCC
Q psy17532        227 EEILPNKADSYKPAVAHRDFKSNNVLLKS----DLTAAIADFGLALLFEP  272 (461)
Q Consensus       227 ~~~~~~~~~~~~~~ivHrDLkp~NILl~~----~~~~ki~DFGla~~~~~  272 (461)
                                   |++|+|=.|.||++..    ++.+.+-|||+...+..
T Consensus       321 -------------GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 -------------GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             -------------CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence                         8999999999999984    67899999999877653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.01  E-value=1.5e-05  Score=71.68  Aligned_cols=100  Identities=21%  Similarity=0.266  Sum_probs=78.2

Q ss_pred             HHHHHcCCCCC-CCeeEEEEEEecCCccceeeeeeehhccCCChhhh----hcCCCCCHHHHHHHHHHHHHHHHHHhhcc
Q psy17532        155 QEIFKLPHMEH-DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF----LKCNIVTWEQLCRIALSMSKGLMHLHEEI  229 (461)
Q Consensus       155 ~ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~----l~~~~l~~~~~~~i~~~ia~gL~yLH~~~  229 (461)
                      .|..++..+++ +++.+++|+|-.        ++|.||...+++...    .+--.-+|..+.+|+.++++.+.+|+...
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            36666666765 599999999843        689999988766421    11123689999999999999999999862


Q ss_pred             cCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       230 ~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      .       + .+.-.|++++|+-+++++.+|+.|...+...
T Consensus        80 ~-------~-~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   80 L-------G-FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             C-------C-cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            2       1 4677999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.97  E-value=0.00013  Score=70.81  Aligned_cols=84  Identities=15%  Similarity=0.089  Sum_probs=55.3

Q ss_pred             ceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCC---CCeeEEEEEEecCCccceeeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEH---DNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H---~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ...-.+.||.|..+.||+....+..+.+|..+. ......++.|...|+.+.-   -.+.++++++..... .+..+|||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-~g~~~LVm   92 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQGNPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-PGPDVLLL   92 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCCCEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc-CCCeEEEE
Confidence            445567899999999999987666777787543 1122345566666555532   356777777654321 12348999


Q ss_pred             hhccCCChh
Q psy17532        190 AYHERGSLC  198 (461)
Q Consensus       190 e~~~~gsL~  198 (461)
                      |+++++++.
T Consensus        93 E~i~G~~~~  101 (297)
T PRK10593         93 ERLRGVSVE  101 (297)
T ss_pred             eccCCEecC
Confidence            999987764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.96  E-value=7.1e-05  Score=69.91  Aligned_cols=74  Identities=15%  Similarity=0.105  Sum_probs=47.2

Q ss_pred             EeEeecCCceEEEEEEEC---CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeeeehhc
Q psy17532        117 VEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLITAYH  192 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv~e~~  192 (461)
                      ++.|..|-...+|+....   ++.|++|+...........++|+.++..+. +.-..++++...  .      .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~------~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N------GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C------cEEEEee
Confidence            456788888999999875   477889976543322233456776666663 223445554432  1      4899999


Q ss_pred             cCCChh
Q psy17532        193 ERGSLC  198 (461)
Q Consensus       193 ~~gsL~  198 (461)
                      ++.++.
T Consensus        75 ~G~~l~   80 (235)
T cd05157          75 PGRTLE   80 (235)
T ss_pred             CCCcCC
Confidence            987653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PLN02876 acyl-CoA dehydrogenase

Probab=97.93  E-value=9e-05  Score=82.00  Aligned_cols=152  Identities=18%  Similarity=0.169  Sum_probs=92.9

Q ss_pred             EeEeecCCceEEEEEEECC----CcEEEEEEecCC--hhhhHHHHHHHHcCCCC-CCCe--eEEEEEEecCCccceeeee
Q psy17532        117 VEVKAQGRFGAVWKAKFKN----ENVAVKIFLMQD--KQSWQSEQEIFKLPHME-HDNI--LRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~----~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~-H~nI--v~l~g~~~~~~~~~~~~~l  187 (461)
                      .+.++.|.++.+|+....+    ..+++|+.....  ......++|..++..+. |.+|  .++++++.+... .+..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceE
Confidence            5678999999999988754    367777754322  12234568888887774 6654  788888766432 233489


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE----------------------------------------  227 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------  227 (461)
                      ||||+++..+.+-. -..++..++..++.++++.|+.||+                                        
T Consensus       122 VME~v~G~~~~~~~-~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~  200 (822)
T PLN02876        122 IMEYLEGRIFVDPK-LPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR  200 (822)
T ss_pred             EEEecCCcccCCcc-CCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence            99999975443211 0112333444444445555544444                                        


Q ss_pred             -------------cccCCCcCCCCCCeecccCCCCcEEEcCC-C-ceEEEecCCcccc
Q psy17532        228 -------------EILPNKADSYKPAVAHRDFKSNNVLLKSD-L-TAAIADFGLALLF  270 (461)
Q Consensus       228 -------------~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~-~~ki~DFGla~~~  270 (461)
                                   +..........+.+||+|+++.|||++.+ . ..-|.||.++..-
T Consensus       201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence                         21100000013569999999999999853 3 3579999988654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=6.6e-05  Score=70.23  Aligned_cols=140  Identities=18%  Similarity=0.178  Sum_probs=77.1

Q ss_pred             eEeecCCce-EEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCC---CeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        118 EVKAQGRFG-AVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD---NILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       118 ~~lg~G~fg-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      +.++.|+.. .||+.   +..+++|..... ......++|...+..+...   -+.+.++.....+. ....+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~-~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG-YPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC-CCcceEEEEeec
Confidence            456767666 48875   345777865432 2233455666665444311   23333333322211 112378999999


Q ss_pred             CCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCC-----------------------------------------
Q psy17532        194 RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN-----------------------------------------  232 (461)
Q Consensus       194 ~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----------------------------------------  232 (461)
                      |.++.+....      ....++.++++.|.-||+.-...                                         
T Consensus        78 G~~l~~~~~~------~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  151 (235)
T cd05155          78 GETATAAALS------DPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARAL  151 (235)
T ss_pred             CCCCCccccC------CHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHH
Confidence            8777543210      11133444444444444321100                                         


Q ss_pred             ------CcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        233 ------KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       233 ------~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                            ......+.++|+|+.+.|||++++...-|.||+.+.
T Consensus       152 ~~~~~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         152 WEAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             HHHHhcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence                  000134569999999999999977666799999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.78  E-value=0.00015  Score=68.77  Aligned_cols=140  Identities=13%  Similarity=0.150  Sum_probs=75.1

Q ss_pred             eecCCceEEEEEEECCCcEEEEEEecCChhh-hHHHHHHHHcCCCCCCCe-eEEEEEEecCCccceeeeeeehhccCCCh
Q psy17532        120 KAQGRFGAVWKAKFKNENVAVKIFLMQDKQS-WQSEQEIFKLPHMEHDNI-LRYIGAEKRGESIHTEFWLITAYHERGSL  197 (461)
Q Consensus       120 lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~-~~~~~ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~lv~e~~~~gsL  197 (461)
                      +..|-.+.+|+....+..+++|......... ...++|..++..+....+ .++++...  +      ++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~------~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--H------WLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--C------EEEEEeccCccc
Confidence            4567888999998888889998754332221 234566666666643222 23444321  1      689999998665


Q ss_pred             hhh-------h----------cCC-----CCCHHH-HHHHHHHHHH-----HHHHHhhcccCC-CcCCCCCCeecccCCC
Q psy17532        198 CDF-------L----------KCN-----IVTWEQ-LCRIALSMSK-----GLMHLHEEILPN-KADSYKPAVAHRDFKS  248 (461)
Q Consensus       198 ~~~-------l----------~~~-----~l~~~~-~~~i~~~ia~-----gL~yLH~~~~~~-~~~~~~~~ivHrDLkp  248 (461)
                      ..-       +          +..     +++... +..+..++..     .+..++...... ......+.++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            431       0          000     111111 1111111100     011111110000 0011244689999999


Q ss_pred             CcEEEcCCCceEEEecCCcc
Q psy17532        249 NNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~  268 (461)
                      .|||++.++ +.|+||..|.
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC-CEEEeccccC
Confidence            999999877 7899998774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00018  Score=65.08  Aligned_cols=127  Identities=17%  Similarity=0.220  Sum_probs=84.4

Q ss_pred             EeEeecCCceEEEEEEECCCcEEEEEEecCC-----------------hhhhHHHHHHHHcC------CCCCCCeeEEEE
Q psy17532        117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQD-----------------KQSWQSEQEIFKLP------HMEHDNILRYIG  173 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~-----------------~~~~~~~~ei~~l~------~l~H~nIv~l~g  173 (461)
                      ...||+|+.-.||.--. +....||+.....                 ....+..+|+....      ...+.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            46789999999985433 3445678876544                 11233344444322      335889999999


Q ss_pred             EEecCCccceeeeeeehhccC------CChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCC
Q psy17532        174 AEKRGESIHTEFWLITAYHER------GSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK  247 (461)
Q Consensus       174 ~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLk  247 (461)
                      +..++.+.    -+|+|.+..      -+|.++++.+.++. .....+.+.   ..||-+.           .|+.+||+
T Consensus        85 ~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f---~~~l~~~-----------~Iv~~dl~  145 (199)
T PF10707_consen   85 FVETNLGL----GLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEF---KRYLLDH-----------HIVIRDLN  145 (199)
T ss_pred             EEecCCce----EEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHH---HHHHHHc-----------CCeecCCC
Confidence            99988766    466665432      36888888777776 444443333   4566666           89999999


Q ss_pred             CCcEEEcCCC----ceEEEe
Q psy17532        248 SNNVLLKSDL----TAAIAD  263 (461)
Q Consensus       248 p~NILl~~~~----~~ki~D  263 (461)
                      |.||++..+.    .+.|+|
T Consensus       146 ~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  146 PHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cccEEEEecCCCceEEEEEe
Confidence            9999996532    567777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.67  E-value=0.00037  Score=67.77  Aligned_cols=75  Identities=16%  Similarity=0.185  Sum_probs=45.3

Q ss_pred             EeEeecCCceEEEEEEEC--------CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCC-eeEEEEEEecCCccceeeee
Q psy17532        117 VEVKAQGRFGAVWKAKFK--------NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN-ILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~--------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++.+..|-...+|+....        ++.+++|+............+|..++..+.... ..++++++..        .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--------~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN--------GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC--------Cc
Confidence            345666777789988875        368999987554333334455665555543222 2355555432        36


Q ss_pred             eehhccCCChhh
Q psy17532        188 ITAYHERGSLCD  199 (461)
Q Consensus       188 v~e~~~~gsL~~  199 (461)
                      |+||++|..+..
T Consensus        75 v~e~i~G~~l~~   86 (302)
T cd05156          75 IEEFIPSRTLTT   86 (302)
T ss_pred             hhheeCCCcCCH
Confidence            899998876643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.45  E-value=0.00079  Score=65.19  Aligned_cols=146  Identities=15%  Similarity=0.132  Sum_probs=80.8

Q ss_pred             EEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCC--CeeEEEEEEecCC---ccceeeeeeeh
Q psy17532        116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD--NILRYIGAEKRGE---SIHTEFWLITA  190 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~--nIv~l~g~~~~~~---~~~~~~~lv~e  190 (461)
                      -.+.+..|....+|+....+..+++|+....  .....+.|+..+..+.+.  .+.+.+.... +.   ...+..++|++
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~-g~~~~~~~~~~~~l~~   94 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDSGRYVLTLFEKV--SAEELPFFLALLDHLAERGLPVPRPIADRD-GEYLSELAGKPAALVE   94 (296)
T ss_pred             heecccCccccceEEEEeCCCcEEEEEcCCC--ChHhccHHHHHHHHHHHCCCCCCccccCCC-CcEeeeeCCceEEEEE
Confidence            3567777888899998887788999987542  222334455554444322  2444443211 10   01123479999


Q ss_pred             hccCCChhhh----h----------cC--CC----------CCHHHHH----------HHHHHHHHHHHHHhhcccCCCc
Q psy17532        191 YHERGSLCDF----L----------KC--NI----------VTWEQLC----------RIALSMSKGLMHLHEEILPNKA  234 (461)
Q Consensus       191 ~~~~gsL~~~----l----------~~--~~----------l~~~~~~----------~i~~~ia~gL~yLH~~~~~~~~  234 (461)
                      |++|..+...    .          +.  ..          ..|....          .....+...+.++....    .
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~----~  170 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD----P  170 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh----h
Confidence            9998765430    0          00  00          0111100          00111223334443210    0


Q ss_pred             CCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       235 ~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      .....+++|+|+.|.|||++++..+.|.||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            1123479999999999999998778899998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.35  E-value=0.0013  Score=64.14  Aligned_cols=150  Identities=14%  Similarity=0.131  Sum_probs=80.4

Q ss_pred             eeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCC--CCCeeEEEEEEecC--Cccceeeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHME--HDNILRYIGAEKRG--ESIHTEFWLIT  189 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~--H~nIv~l~g~~~~~--~~~~~~~~lv~  189 (461)
                      ...++.++.|.-..+|+...++..+++|+...... ......|+..+..|.  .-.+.+.+......  ....+..++++
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~-~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK-AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ceeccccCCccccceEEEEeCCCcEEEEEecCCCC-HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            34456778888889999887777888997654211 112223333333332  11233443321100  00123458999


Q ss_pred             hhccCCChhhh-----------h---cC--CCC-----------CHHHHH------------HHHHHHHHHHHHHhhccc
Q psy17532        190 AYHERGSLCDF-----------L---KC--NIV-----------TWEQLC------------RIALSMSKGLMHLHEEIL  230 (461)
Q Consensus       190 e~~~~gsL~~~-----------l---~~--~~l-----------~~~~~~------------~i~~~ia~gL~yLH~~~~  230 (461)
                      +|++|..+...           +   +.  ..+           .|....            .....+.+.++++.... 
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~-  181 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW-  181 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh-
Confidence            99988554311           0   10  000           111100            00112334455554321 


Q ss_pred             CCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       231 ~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                         ......+++|+|+.+.||+++.++.+.|.||+.+.
T Consensus       182 ---~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       182 ---PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             ---hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               11224589999999999999998877899998763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.23  E-value=0.0035  Score=62.92  Aligned_cols=74  Identities=12%  Similarity=-0.000  Sum_probs=46.9

Q ss_pred             EeEeecCCceEEEEEEECC--CcEEEEEEecC-----C---hhhhHHHHHHHHcCCC---CCCCeeEEEEEEecCCccce
Q psy17532        117 VEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQ-----D---KQSWQSEQEIFKLPHM---EHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~--~~vAvK~~~~~-----~---~~~~~~~~ei~~l~~l---~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+.||.|.+..||++...+  +.|+||.-...     .   ....+...|...|..+   .-.++.+++.+..+.     
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~-----  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEEL-----  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCC-----
Confidence            4678999999999999864  38999974311     1   1122233444444443   335677888774432     


Q ss_pred             eeeeeehhccCCC
Q psy17532        184 EFWLITAYHERGS  196 (461)
Q Consensus       184 ~~~lv~e~~~~gs  196 (461)
                       .++||||+++..
T Consensus       106 -~~lVME~L~~~~  117 (401)
T PRK09550        106 -AVTVMEDLSDHK  117 (401)
T ss_pred             -CEEEEecCCCcc
Confidence             279999998643

>PLN02236 choline kinase

Probab=97.12  E-value=0.0036  Score=62.07  Aligned_cols=139  Identities=17%  Similarity=0.242  Sum_probs=75.7

Q ss_pred             EeecCCceEEEEEEEC------CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCee-EEEEEEecCCccceeeeeeehh
Q psy17532        119 VKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL-RYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       119 ~lg~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      .+-.|-...+|+....      ++.|++|+...........++|..++..+..-++. ++++.+..        ..|++|
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~ef  114 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVEEF  114 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--------ceEEEe
Confidence            4444777889998753      25788898755433333445666666555333332 45555432        257888


Q ss_pred             ccCCChhhh-h----------------cCCC-------CCHHHHHHHHHH-----------------HHHHHHHHhhccc
Q psy17532        192 HERGSLCDF-L----------------KCNI-------VTWEQLCRIALS-----------------MSKGLMHLHEEIL  230 (461)
Q Consensus       192 ~~~gsL~~~-l----------------~~~~-------l~~~~~~~i~~~-----------------ia~gL~yLH~~~~  230 (461)
                      +++.+|..- +                +...       ..++.+..+..+                 +...+..|.+...
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            876555321 0                1100       112222222211                 1111222222110


Q ss_pred             CCCcCCCCCCeecccCCCCcEEEcC-CCceEEEecCCcc
Q psy17532        231 PNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLAL  268 (461)
Q Consensus       231 ~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~DFGla~  268 (461)
                         .......++|+|+++.|||+++ ++.+.|+||..|.
T Consensus       195 ---~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        195 ---GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ---ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence               0123447899999999999986 4689999998764

>KOG1826|consensus

Probab=97.10  E-value=0.0001  Score=82.31  Aligned_cols=149  Identities=12%  Similarity=0.003  Sum_probs=102.1

Q ss_pred             cCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCC-----CCCHHHHHHHHHHHHHHHHHHhhcccCCCc
Q psy17532        160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----IVTWEQLCRIALSMSKGLMHLHEEILPNKA  234 (461)
Q Consensus       160 l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~  234 (461)
                      ++...|+++.....-.....  ..+-|..++|+..|++.+.+-.+     .+...-......+...+..-+|+.-.    
T Consensus      1283 ~~~~~h~~~~~~p~rI~ps~--s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn---- 1356 (2724)
T KOG1826|consen 1283 LREAKHYLTEVDPLRIPPSE--STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN---- 1356 (2724)
T ss_pred             hhhhhceeeecccccCCCCC--ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc----
Confidence            44568999887766544433  33568999999999999988332     23222222222222444455554411    


Q ss_pred             CCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHH
Q psy17532        235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACA  314 (461)
Q Consensus       235 ~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~G  314 (461)
                        -.---+|++||+-|.+|..+..+|++++|+.+...+..  .......+++.|++|++...-     .++.++|+|+.|
T Consensus      1357 --lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~i-----k~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1357 --LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEI-----KFTKRSDILRRS 1427 (2724)
T ss_pred             --CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHH-----hhhhHHHHHHHH
Confidence              11145899999999999999999999999998443322  223445788899999987653     556669999999


Q ss_pred             HHHHHHHcC
Q psy17532        315 LVLWELASR  323 (461)
Q Consensus       315 vil~el~tg  323 (461)
                      +-+|+.-.|
T Consensus      1428 ~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1428 LSLYLRSDG 1436 (2724)
T ss_pred             HHHHHHhcc
Confidence            999998777

>PRK05231 homoserine kinase; Provisional

Probab=96.94  E-value=0.0053  Score=60.14  Aligned_cols=31  Identities=32%  Similarity=0.440  Sum_probs=26.8

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ..+++|+|+.+.|||++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999977666899998774

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.92  E-value=0.015  Score=58.42  Aligned_cols=80  Identities=14%  Similarity=0.035  Sum_probs=51.6

Q ss_pred             EEeEeecCCceEEEEEEECCCcEEEEEEec-----CC---hhhhHHHHHHHHcCCC---CCCCeeEEEEEEecCCcccee
Q psy17532        116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLM-----QD---KQSWQSEQEIFKLPHM---EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~-----~~---~~~~~~~~ei~~l~~l---~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..+.+|.|....||+....+..++||.-..     ..   ....+...|...|..+   ...++.+++.++.+..     
T Consensus        36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~-----  110 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA-----  110 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC-----
Confidence            467889999999999988777899997541     11   0122222334333332   3357888888887543     


Q ss_pred             eeeeehhccC--CChhhhh
Q psy17532        185 FWLITAYHER--GSLCDFL  201 (461)
Q Consensus       185 ~~lv~e~~~~--gsL~~~l  201 (461)
                       +++|||+++  ..+.+.+
T Consensus       111 -vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        111 -LIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             -EEEEeecCCcceehhhhh
Confidence             789999976  2455544

>KOG2270|consensus

Probab=96.87  E-value=0.0035  Score=61.05  Aligned_cols=136  Identities=17%  Similarity=0.186  Sum_probs=92.5

Q ss_pred             eEeecCCceEEEEEEE-CCCcEEEEEEecC-----Chh-----hh-----------------HHHHHHHHcCCCCCCCee
Q psy17532        118 EVKAQGRFGAVWKAKF-KNENVAVKIFLMQ-----DKQ-----SW-----------------QSEQEIFKLPHMEHDNIL  169 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~-----~~~-----~~-----------------~~~~ei~~l~~l~H~nIv  169 (461)
                      ..|..|.-+.||.+.- +|..+|||+++-.     +..     .+                 =.|+|+..|.+|+...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4577888899999987 6788999987421     100     00                 025677777777544432


Q ss_pred             EEEEEEecCCccceeeeeeehhccCC-ChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        170 RYIGAEKRGESIHTEFWLITAYHERG-SLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       170 ~l~g~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      ----....      .-.|||+|+.+. =-.-.|+.-.++...+..+-.|++.-|.-|-..+          ++||.||.-
T Consensus       230 ~PePIlLk------~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c----------~LVHADLSE  293 (520)
T KOG2270|consen  230 CPEPILLK------NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC----------RLVHADLSE  293 (520)
T ss_pred             CCCceeee------cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh----------ceeccchhh
Confidence            11111111      116999998642 2233456667888888888889998888887664          899999999


Q ss_pred             CcEEEcCCCceEEEecCCcccc
Q psy17532        249 NNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~~~  270 (461)
                      =|+|+- +|.+.|+|.+-+...
T Consensus       294 fN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  294 FNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             hhheEE-CCEEEEEEccccccC
Confidence            999886 468999999877544

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.81  E-value=0.011  Score=56.80  Aligned_cols=76  Identities=16%  Similarity=0.197  Sum_probs=43.3

Q ss_pred             eeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCC---CCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM---EHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l---~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      ++-.+.++.|....+|+...+++.+.||.-......  .++.|..-|+.|   .--.+.+.+++....+..    +||||
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~--~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~----fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGRD--MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA----FLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGCC--HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC----EEEEE
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhhHH--HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc----eEEEE
Confidence            556678899999999999988899999987633333  334444433333   445677888877654432    89999


Q ss_pred             hccCC
Q psy17532        191 YHERG  195 (461)
Q Consensus       191 ~~~~g  195 (461)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.61  E-value=0.018  Score=56.14  Aligned_cols=30  Identities=27%  Similarity=0.456  Sum_probs=25.7

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ..+++|+|+.+.|||++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            458999999999999998 568899998663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.53  E-value=0.021  Score=56.26  Aligned_cols=76  Identities=14%  Similarity=0.240  Sum_probs=45.0

Q ss_pred             ceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCe-eEEEEEEecCCccceeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNI-LRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~  186 (461)
                      .+++..+ ..|-...+|+....+     ..|.+|+...........++|..++..+..-++ .++++++..        .
T Consensus        16 ~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--------G   86 (330)
T PLN02421         16 DFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN--------G   86 (330)
T ss_pred             ceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC--------c
Confidence            4444444 447778899887643     278889875443333345667776666644333 355555422        2


Q ss_pred             eeehhccCCCh
Q psy17532        187 LITAYHERGSL  197 (461)
Q Consensus       187 lv~e~~~~gsL  197 (461)
                      +|.+|+++-.|
T Consensus        87 ~i~~fi~g~~l   97 (330)
T PLN02421         87 MIQSFINARTL   97 (330)
T ss_pred             EeehhhcCCCC
Confidence            58888876544

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.52  E-value=0.027  Score=54.70  Aligned_cols=37  Identities=22%  Similarity=0.419  Sum_probs=31.8

Q ss_pred             CCCCCCeecccCCCCcEEEcCCCceEEEecCCccccC
Q psy17532        235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       235 ~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~  271 (461)
                      ....+.++|+|+.+.|++++...-+-|.||+++..-+
T Consensus       194 ~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         194 WAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            4456789999999999999998889999999986543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.32  E-value=0.045  Score=53.99  Aligned_cols=31  Identities=16%  Similarity=0.323  Sum_probs=25.7

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ...++|+||.+.||+++++. ++++|+.++..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            44789999999999997764 77999987744

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2268|consensus

Probab=96.15  E-value=0.0045  Score=59.36  Aligned_cols=130  Identities=13%  Similarity=0.187  Sum_probs=82.8

Q ss_pred             eeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCC-----------------hhhh------HHHHHHHHcCCCC-CC-C
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQD-----------------KQSW------QSEQEIFKLPHME-HD-N  167 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~-----------------~~~~------~~~~ei~~l~~l~-H~-n  167 (461)
                      +.+++.||-|.-+.||.+-.. |++.++|.-....                 ...|      ...+|..-|+.|. |- -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            457789999999999999984 8888888542110                 0111      1235666666553 21 2


Q ss_pred             eeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCC
Q psy17532        168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFK  247 (461)
Q Consensus       168 Iv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLk  247 (461)
                      +.+.+++.        ..++|||++.+-.|...-+-  .+...+..-+..   -+.-|-.+           |+||+|..
T Consensus       174 VPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v--~d~~~ly~~lm~---~Iv~la~~-----------GlIHgDFN  229 (465)
T KOG2268|consen  174 VPKPIDHN--------RHCVVMELVDGYPLRQVRHV--EDPPTLYDDLMG---LIVRLANH-----------GLIHGDFN  229 (465)
T ss_pred             CCCccccc--------ceeeHHHhhcccceeeeeec--CChHHHHHHHHH---HHHHHHHc-----------Cceecccc
Confidence            23333332        33899999998777765321  223333322222   23334445           99999999


Q ss_pred             CCcEEEcCCCceEEEecCCc
Q psy17532        248 SNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       248 p~NILl~~~~~~ki~DFGla  267 (461)
                      -=||+|++++.++++||--.
T Consensus       230 EFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  230 EFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             hheeEEecCCCEEEeechHh
Confidence            99999999999999999543

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.07  E-value=0.024  Score=56.60  Aligned_cols=79  Identities=14%  Similarity=-0.028  Sum_probs=46.8

Q ss_pred             EeEeecCCceEEEEEEEC--CCcEEEEEEec----CC---hhhhHHHHHHHHcCC---CCCCCeeEEEEEEecCCcccee
Q psy17532        117 VEVKAQGRFGAVWKAKFK--NENVAVKIFLM----QD---KQSWQSEQEIFKLPH---MEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~----~~---~~~~~~~~ei~~l~~---l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .+.||.|.-..||++...  ++.|+||.-..    ..   ....+...|...|..   +--..+.+++.+-.+..     
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~-----  108 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMN-----  108 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHh-----
Confidence            578899999999999974  67899996421    10   111222233333332   22235667776654422     


Q ss_pred             eeeeehhccC-CChhhhh
Q psy17532        185 FWLITAYHER-GSLCDFL  201 (461)
Q Consensus       185 ~~lv~e~~~~-gsL~~~l  201 (461)
                       .+|||+++. ..|.+.|
T Consensus       109 -~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        109 -CCVMEDLSDHTILRTAL  125 (409)
T ss_pred             -hHHHHhCcccHHHHHHH
Confidence             699999864 2345444

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.80  E-value=0.049  Score=52.19  Aligned_cols=32  Identities=19%  Similarity=0.423  Sum_probs=26.5

Q ss_pred             CCCeecccCCCCcEEEcCCCc-eEEEecCCccc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLT-AAIADFGLALL  269 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~-~ki~DFGla~~  269 (461)
                      .+.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            457999999999999997554 56999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.77  E-value=0.02  Score=52.37  Aligned_cols=29  Identities=28%  Similarity=0.469  Sum_probs=20.8

Q ss_pred             CeecccCCCCcEEE-cCCCceEEEecCCcc
Q psy17532        240 AVAHRDFKSNNVLL-KSDLTAAIADFGLAL  268 (461)
Q Consensus       240 ~ivHrDLkp~NILl-~~~~~~ki~DFGla~  268 (461)
                      .+.|.||.+.|||+ +.++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            68999999999999 888999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.60  E-value=0.15  Score=49.64  Aligned_cols=31  Identities=13%  Similarity=0.206  Sum_probs=27.7

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ..+++|+|+.+.|||++.++.+.|+||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4489999999999999999999999998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=95.57  E-value=0.1  Score=52.43  Aligned_cols=77  Identities=14%  Similarity=0.183  Sum_probs=44.2

Q ss_pred             ceeEEeEeecCCceEEEEEEECC---Cc-----EEEEEEecCChhhhHHHHHHHHcCCCCCCCe-eEEEEEEecCCccce
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKN---EN-----VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNI-LRYIGAEKRGESIHT  183 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~---~~-----vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nI-v~l~g~~~~~~~~~~  183 (461)
                      .+++. .+..|-...+|++...+   ..     |.++............++|+.++..+...++ .++++.+..      
T Consensus        52 ~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------  124 (383)
T PTZ00384         52 FIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------  124 (383)
T ss_pred             cEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence            34444 44458888999987642   22     3333322222222344677777777754444 455665532      


Q ss_pred             eeeeeehhccCCChh
Q psy17532        184 EFWLITAYHERGSLC  198 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~  198 (461)
                        ++|+||++|-.|.
T Consensus       125 --g~l~efIeGr~l~  137 (383)
T PTZ00384        125 --FTIQEWVEGNTMG  137 (383)
T ss_pred             --EEEEEEeccccCC
Confidence              6899999886654

>KOG1093|consensus

Probab=95.00  E-value=0.0098  Score=60.36  Aligned_cols=50  Identities=22%  Similarity=0.257  Sum_probs=36.9

Q ss_pred             HHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCC
Q psy17532        152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI  205 (461)
Q Consensus       152 ~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  205 (461)
                      +..-....++.+.|+|.-.++.+.....   ....+|+|++.. ||+++++.+.
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~---~r~IVV~e~~~~-Sled~~~~~~   77 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKH---ERVIVVMEHYTM-SLEDILKTGN   77 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCcc---ceEEEEehhhcc-chHHHHHhcc
Confidence            3334566678889999999988765543   246899999965 9999986544

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.94  E-value=0.018  Score=36.95  Aligned_cols=25  Identities=16%  Similarity=0.255  Sum_probs=13.2

Q ss_pred             CceeeehhhHHHHHHHHHHHHHHHh
Q psy17532         56 HPLIIFLYTMLPIFALIIPIFLCYW   80 (461)
Q Consensus        56 ~~~~~~~~~~~~~~~l~~~~~~~~~   80 (461)
                      ...-+++++++++.+++++++++++
T Consensus         9 ~~vaIa~~VvVPV~vI~~vl~~~l~   33 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVIIIVLGAFLF   33 (40)
T ss_pred             ceEEEEEEEEechHHHHHHHHHHhh
Confidence            3344555566666555555544444

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.77  E-value=0.084  Score=51.69  Aligned_cols=71  Identities=21%  Similarity=0.264  Sum_probs=53.5

Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      .|++|++. +++|. .++  ...+++...++.+.+.-++-+..+.          ..=||||.-.||||+ +|.+.|+||
T Consensus       301 ~yl~~kdh-gt~is-~ik--~~~~~e~lsff~s~~sil~~lekkf----------~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         301 LYLHFKDH-GTPIS-IIK--ADRSEEELSFFWSCISILDILEKKF----------PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             EEEEEecC-Cceee-eee--cccHHHHHHHHHHHHHHHhhhhhcC----------Ccccccccccceeee-cCceEEEEe
Confidence            36677764 33332 222  2467888999998887666666553          789999999999999 999999999


Q ss_pred             CCcccc
Q psy17532        265 GLALLF  270 (461)
Q Consensus       265 Gla~~~  270 (461)
                      -+++.-
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999853

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.67  E-value=0.092  Score=51.49  Aligned_cols=141  Identities=14%  Similarity=0.128  Sum_probs=78.2

Q ss_pred             CceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCC---CCC---eeEEEEEEecCCccc--eeeeeeehhccCC
Q psy17532        124 RFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHME---HDN---ILRYIGAEKRGESIH--TEFWLITAYHERG  195 (461)
Q Consensus       124 ~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~---H~n---Iv~l~g~~~~~~~~~--~~~~lv~e~~~~g  195 (461)
                      .-..||+....+..+++|+.... ....+...|+..+..+.   .+=   |..+=|-....  ..  ...+-+.+|++|.
T Consensus        37 ~eN~~f~~~~~~g~~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~--~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRYILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEA--LSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCeEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhh--ccCCceeEEEEEecCCc
Confidence            34568998887777799988765 33333334444333331   111   22221211100  01  2457788999887


Q ss_pred             Chhh-hh------------------cC----C-----CCCHHH-------------HHHHHHHHHHHHHHHhhcccCCCc
Q psy17532        196 SLCD-FL------------------KC----N-----IVTWEQ-------------LCRIALSMSKGLMHLHEEILPNKA  234 (461)
Q Consensus       196 sL~~-~l------------------~~----~-----~l~~~~-------------~~~i~~~ia~gL~yLH~~~~~~~~  234 (461)
                      .+.. -.                  +.    +     ...|..             ......++...++.+.+...+...
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7772 11                  00    0     123320             111334556666677666433322


Q ss_pred             CCCCCCeecccCCCCcEEEcCCCc-eEEEecCCcc
Q psy17532        235 DSYKPAVAHRDFKSNNVLLKSDLT-AAIADFGLAL  268 (461)
Q Consensus       235 ~~~~~~ivHrDLkp~NILl~~~~~-~ki~DFGla~  268 (461)
                      ... ..+||+|+.|.|||++.+.. +.+.|||-+.
T Consensus       194 ~~~-~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALG-DQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccc-ceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            221 22999999999999999874 8899999763

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.42  E-value=0.14  Score=46.70  Aligned_cols=149  Identities=14%  Similarity=0.043  Sum_probs=83.6

Q ss_pred             CceEEEEEEECCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhh
Q psy17532        124 RFGAVWKAKFKNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL  201 (461)
Q Consensus       124 ~fg~Vy~~~~~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l  201 (461)
                      +.++.-.++-+=.+..+|++.....  ....+..+..++++++  .|+++.   .+ +  ...+-++.|+|-.-.     
T Consensus        74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---ND-n--~~~yGvIlE~Cy~~~-----  140 (308)
T PF07387_consen   74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---ND-N--NYKYGVILERCYKIK-----  140 (308)
T ss_pred             CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cC-C--CceeEEEEeeccCcc-----
Confidence            3334434433323445665532221  1222345566666654  477776   22 2  235678899885311     


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCC
Q psy17532        202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG  281 (461)
Q Consensus       202 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~  281 (461)
                         .+.   . .++.-=+++|.-.|+.         .++.+|+|-.|+||+-|..|.+||.|=+.-..            
T Consensus       141 ---i~~---~-N~i~agi~~L~~fH~~---------~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------------  192 (308)
T PF07387_consen  141 ---INF---S-NFITAGIKDLMDFHSE---------NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------------  192 (308)
T ss_pred             ---cch---h-HHHHHhHHHHHHhhcc---------CCCeecCCCChhheeecCCCCEEecChhhhhh------------
Confidence               011   1 1111124567788866         44899999999999999999999999764311            


Q ss_pred             CcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       282 ~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                        .+.-|.--|+        ...+.++.+=+|=.-++++...
T Consensus       193 --~~V~~vN~~Y--------~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  193 --NQVNMVNIEY--------ESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             --heeeEEeeec--------cccChHHHHHHHHHHHHHHHHH
Confidence              1122333221        2344566777777667777664

The function of this family is unknown.

>KOG1236|consensus

Probab=94.33  E-value=0.071  Score=52.92  Aligned_cols=62  Identities=19%  Similarity=0.304  Sum_probs=46.4

Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHh-hcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH-EEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ...++-+|+.+-++..+++....+++-..+++.-.++||--+- -.           +++|.|+.|.||++.-+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vD-----------NFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVD-----------NFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhh-----------cceecccCCCcEEEEec
Confidence            3467888999999999998777776666667666666654332 22           78999999999999643

>PTZ00296 choline kinase; Provisional

Probab=94.29  E-value=0.32  Score=49.82  Aligned_cols=29  Identities=21%  Similarity=0.415  Sum_probs=24.2

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ...++|.|+-+.|||.++++ ++|+||-.|
T Consensus       283 ~~VfCHNDl~~~NiL~~~~~-l~LIDfEYA  311 (442)
T PTZ00296        283 DIVFCHNDLQENNIINTNKC-LRLIDFEYS  311 (442)
T ss_pred             CeeEEeCCCCccceeecCCC-EEEEeeccc
Confidence            45789999999999887554 999999765

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=93.47  E-value=0.084  Score=44.67  Aligned_cols=32  Identities=16%  Similarity=0.100  Sum_probs=14.5

Q ss_pred             eeeehhhHHHHHHHHHHHHHHHhhhhhccCCC
Q psy17532         58 LIIFLYTMLPIFALIIPIFLCYWYYRQRKLGS   89 (461)
Q Consensus        58 ~~~~~~~~~~~~~l~~~~~~~~~~~~~r~~~~   89 (461)
                      .+|.+++++++.+++++++++|++++|+|+..
T Consensus        50 IVIGvVVGVGg~ill~il~lvf~~c~r~kktd   81 (154)
T PF04478_consen   50 IVIGVVVGVGGPILLGILALVFIFCIRRKKTD   81 (154)
T ss_pred             EEEEEEecccHHHHHHHHHhheeEEEecccCc
Confidence            44444444444444444444444444444443

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	461
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-120
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-118
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-68
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-63
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-63
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-63
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-63
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-63
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-62
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-60
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-57
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-57
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-56
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-55
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-12
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-10
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-05
1lx5_B	102	Crystal Structure Of The Bmp7ACTRII EXTRACELLULAR D		5e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-04

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score =  430 bits (1105), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 200/288 (69%), Positives = 237/288 (82%), Gaps = 1/288 (0%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           +QL+EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP M+H+NIL++IG
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
           AEKRG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL +LHE+I P  
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGL 144
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
            D +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQVGTRRYMAPEV
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQE 353
           LEGAINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+G HPSLEDMQE
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQE 264
Query: 354 AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            VVHKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 265 VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score =  421 bits (1081), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 193/289 (66%), Positives = 237/289 (82%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           S+QL+E+KA+GRFG VWKA+  N+ VAVKIF +QDKQSWQSE+EIF  P M+H+N+L++I
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFI 75
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
            AEKRG ++  E WLITA+H++GSL D+LK NI+TW +LC +A +MS+GL +LHE++   
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
           + + +KP++AHRDFKS NVLLKSDLTA +ADFGLA+ FEPGKP GDTHGQVGTRRYMAPE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ 352
           VLEGAINF RDAFLRIDMYA  LVLWEL SRC +   P  EY LPF  E+G HPSLE++Q
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQ 255
Query: 353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           E VVHKK+RPT+ + W +H G+  LC T+EECWDHDAEARLSA CV ER
Sbjct: 256 EVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER 304

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score =  254 bits (649), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 133/308 (43%), Positives = 194/308 (62%), Gaps = 16/308 (5%)
Query: 107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD 166
           P     +++L+E+  +GR+GAV+K       VAVK+F   ++Q++ +E+ I+++P MEHD
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHD 67
Query: 167 NILRYI-GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           NI R+I G E+       E+ L+  Y+  GSL  +L  +   W   CR+A S+++GL +L
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL------LFEPGKPCGDT 279
           H E LP + D YKPA++HRD  S NVL+K+D T  I+DFGL++      L  PG+     
Sbjct: 128 HTE-LP-RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 280 HGQVGTRRYMAPEVLEGAINFSRD---AFLRIDMYACALVLWELASRCSSVSPPPG--EY 334
             +VGT RYMAPEVLEGA+N  RD   A  ++DMYA  L+ WE+  RC+ + P     EY
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNL-RDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHA-GMLALCDTMEECWDHDAEARL 393
           ++ F  EVG+HP+ EDMQ  V  +K RP  PE WK+++  + +L +T+E+CWD DAEARL
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 394 SASCVVER 401
           +A    ER
Sbjct: 305 TAQXAEER 312

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  238 bits (606), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 178/288 (61%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL 
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RY
Sbjct: 161 GTQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPS 276
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           +E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  238 bits (606), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 178/288 (61%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL 
Sbjct: 28  ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 87
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 147
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RY
Sbjct: 148 GTQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPS 263
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           +E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A
Sbjct: 264 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 311

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  238 bits (606), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 178/288 (61%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL 
Sbjct: 3   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 62
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RY
Sbjct: 123 GTQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPS 238
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           +E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A
Sbjct: 239 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 286

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  237 bits (605), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 178/288 (61%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL 
Sbjct: 8   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 67
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 127
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RY
Sbjct: 128 GTQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPS 243
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           +E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A
Sbjct: 244 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 291

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  237 bits (605), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 178/288 (61%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL 
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RY
Sbjct: 122 GTQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPS 237
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           +E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  237 bits (605), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 178/288 (61%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL 
Sbjct: 5   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 64
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 124
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RY
Sbjct: 125 GTQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPS 240
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           +E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A
Sbjct: 241 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 288

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score =  228 bits (580), Expect = 8e-60,   Method: Compositional matrix adjust.
 Identities = 120/288 (41%), Positives = 172/288 (59%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            + IQ+V+   +GR+G VW  K++ E VAVK+F   ++ SW  E EI++   M H+NIL 
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I A+ +G    T+ +LIT YHE GSL D+LK   +  + + ++A S   GL HLH EI 
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRY 288
             +    KPA+AHRD KS N+L+K + T  IAD GLA+ F       D   + +VGT+RY
Sbjct: 156 STQG---KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 289 MAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           M PEVL+ ++N +   +++  DMY+  L+LWE+A RC S      EY+LP+   V   PS
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-GGIVEEYQLPYHDLVPSDPS 271
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            EDM+E V  KKLRP+ P  W     +  +   M ECW H+  +RL+A
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score =  219 bits (557), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 168/287 (58%), Gaps = 7/287 (2%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           R I L+E   +GR+G VW+  ++ ENVAVKIF  +D++SW  E E++    + H+NIL +
Sbjct: 37  RQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGF 96
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           I ++       T+ WLIT YHE GSL D+L+   +      RI LS++ GL HLH EI  
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG--QVGTRRYM 289
            +    KPA+AHRD KS N+L+K +    IAD GLA++        D     +VGT+RYM
Sbjct: 157 TQG---KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 290 APEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APEVL+  I     D++ R+D++A  LVLWE+A R  S +    +Y+ PF   V + PS 
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPNDPSF 272
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           EDM++ V   + RP +P  W     + +L   M+ECW  +  ARL+A
Sbjct: 273 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 319

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score =  218 bits (556), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 168/287 (58%), Gaps = 7/287 (2%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           R I L+E   +GR+G VW+  ++ ENVAVKIF  +D++SW  E E++    + H+NIL +
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           I ++       T+ WLIT YHE GSL D+L+   +      RI LS++ GL HLH EI  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG--QVGTRRYM 289
            +    KPA+AHRD KS N+L+K +    IAD GLA++        D     +VGT+RYM
Sbjct: 128 TQG---KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 290 APEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APEVL+  I     D++ R+D++A  LVLWE+A R  S +    +Y+ PF   V + PS 
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPNDPSF 243
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           EDM++ V   + RP +P  W     + +L   M+ECW  +  ARL+A
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score =  216 bits (551), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 116/285 (40%), Positives = 167/285 (58%), Gaps = 7/285 (2%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           I L+E   +GR+G VW+  ++ ENVAVKIF  +D++SW  E E++    + H+NIL +I 
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
           ++       T+ WLIT YHE GSL D+L+   +      RI LS++ GL HLH EI   +
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG--QVGTRRYMAP 291
               KPA+AHRD KS N+L+K +    IAD GLA++        D     +VGT+RYMAP
Sbjct: 130 G---KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 292 EVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED 350
           EVL+  I     D++ R+D++A  LVLWE+A R  S +    +Y+ PF   V + PS ED
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPNDPSFED 245
Query: 351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           M++ V   + RP +P  W     + +L   M+ECW  +  ARL+A
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score =  214 bits (544), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 122/288 (42%), Positives = 168/288 (58%), Gaps = 7/288 (2%)
Query: 111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            R + LVE   +GR+G VW+  +  E+VAVKIF  +D+QSW  E EI+    + HDNIL 
Sbjct: 7   ARQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILG 66
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +I ++    +  T+ WLIT YHE GSL DFL+   +      R+A+S + GL HLH EI 
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG--QVGTRRY 288
             +    KPA+AHRDFKS NVL+KS+L   IAD GLA++   G    D     +VGT+RY
Sbjct: 127 GTQG---KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 289 MAPEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           MAPEVL+  I     +++   D++A  LVLWE+A R + V+    +YR PF   V + PS
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARR-TIVNGIVEDYRPPFYDVVPNDPS 242
Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            EDM++ V   +  PT+P        +  L   M ECW  +  ARL+A
Sbjct: 243 FEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTA 290

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVK-----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V+K    N  VAVK     + +  ++   Q +QEI  +   +H+N++  +G  
Sbjct: 40  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 99
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNI----VTWEQLCRIALSMSKGLMHLHEEILP 231
             G+    +  L+  Y   GSL D L C      ++W   C+IA   + G+  LHE    
Sbjct: 100 SDGD----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                      HRD KS N+LL    TA I+DFGLA   E           VGT  YMAP
Sbjct: 153 --------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
           E L G I        + D+Y+  +VL E+ +      P   E+R P
Sbjct: 205 EALRGEIT------PKSDIYSFGVVLLEIITGL----PAVDEHREP 240

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVK-----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V+K    N  VAVK     + +  ++   Q +QEI  +   +H+N++  +G  
Sbjct: 40  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 99
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNI----VTWEQLCRIALSMSKGLMHLHEEILP 231
             G+    +  L+  Y   GSL D L C      ++W   C+IA   + G+  LHE    
Sbjct: 100 SDGD----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                      HRD KS N+LL    TA I+DFGLA   E           VGT  YMAP
Sbjct: 153 --------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
           E L G I        + D+Y+  +VL E+ +      P   E+R P
Sbjct: 205 EALRGEIT------PKSDIYSFGVVLLEIITGL----PAVDEHREP 240

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVK-----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V+K    N  VAVK     + +  ++   Q +QEI  +   +H+N++  +G  
Sbjct: 34  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 93
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNI----VTWEQLCRIALSMSKGLMHLHEEILP 231
             G+    +  L+  Y   GSL D L C      ++W   C+IA   + G+  LHE    
Sbjct: 94  SDGD----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 146
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                      HRD KS N+LL    TA I+DFGLA   E           VGT  YMAP
Sbjct: 147 --------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
           E L G I        + D+Y+  +VL E+ +      P   E+R P
Sbjct: 199 EALRGEIT------PKSDIYSFGVVLLEIITGL----PAVDEHREP 234

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVK-----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V+K    N  VAVK     + +  ++   Q +QEI      +H+N++  +G  
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFS 90
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNI----VTWEQLCRIALSMSKGLMHLHEEILP 231
             G+    +  L+  Y   GSL D L C      ++W   C+IA   + G+  LHE    
Sbjct: 91  SDGD----DLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN--- 143
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                      HRD KS N+LL    TA I+DFGLA   E           VGT  Y AP
Sbjct: 144 --------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
           E L G I        + D+Y+  +VL E+ +      P   E+R P
Sbjct: 196 EALRGEIT------PKSDIYSFGVVLLEIITGL----PAVDEHREP 231

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILR 170
           + + E    G FG V +A++   +VAVKI + QD  + +  +   E+  +  + H NI+ 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHL 225
           ++GA  +  ++     ++T Y  RGSL   L  +    EQL       +A  ++KG+ +L
Sbjct: 99  FMGAVTQPPNLS----IVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYL 153
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H            P + HRD KS N+L+    T  + DFGL+ L         +    GT
Sbjct: 154 HNR---------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGT 202
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
             +MAPEVL    +  +      D+Y+  ++LWELA+
Sbjct: 203 PEWMAPEVLRDEPSNEKS-----DVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILR 170
           + + E    G FG V +A++   +VAVKI + QD  + +  +   E+  +  + H NI+ 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHL 225
           ++GA  +  ++     ++T Y  RGSL   L  +    EQL       +A  ++KG+ +L
Sbjct: 99  FMGAVTQPPNLS----IVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYL 153
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H            P + HR+ KS N+L+    T  + DFGL+ L         +    GT
Sbjct: 154 HNR---------NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGT 202
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
             +MAPEVL    +  +      D+Y+  ++LWELA+
Sbjct: 203 PEWMAPEVLRDEPSNEKS-----DVYSFGVILWELAT 234

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLP-HMEHDNILR 170
            +LVE+   G +G V+K +     +  A+K+  +   +  + +QEI  L  +  H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 171 YIGA--EKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHL 225
           Y GA  +K    +  + WL+  +   GS+ D +K    N +  E +  I   + +GL HL
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H+             V HRD K  NVLL  +    + DFG++   +  +  G  +  +GT
Sbjct: 146 HQH-----------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGT 192
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
             +MAPEV+    N       + D+++  +   E+A
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 52/287 (18%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           SI+LV+    G+FG VW   + N   VAVK         Q++  E  + K   ++HD ++
Sbjct: 14  SIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK--TLQHDKLV 71
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLH 226
           R      R E I+    +IT Y  +GSL DFLK +    V   +L   +  +++G+ ++ 
Sbjct: 72  RLYAVVTREEPIY----IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                      +    HRD ++ NVL+   L   IADFGLA + E  +      G     
Sbjct: 128 -----------RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPI 175
Query: 287 RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
           ++ APE    AINF    F ++ D+++  ++L+E+ +      P PG             
Sbjct: 176 KWTAPE----AINFG--CFTIKSDVWSFGILLYEIVTYGK--IPYPGR------------ 215
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            +  D+  A+      P +     +      L D M+ CW   AE R
Sbjct: 216 -TNADVMTALSQGYRMPRVENCPDE------LYDIMKMCWKEKAEER 255

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 131/297 (44%), Gaps = 56/297 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + I++ EV  +G FG V KAK++ ++VA+K    + ++      E+ +L  + H NI++ 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK-AFIVELRQLSRVNHPNIVKL 67
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHE 227
            GA            L+  Y E GSL + L         T        L  S+G+ +LH 
Sbjct: 68  YGA------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH- 120
Query: 228 EILPNKADSYKP-AVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTH--GQV 283
                   S +P A+ HRD K  N+LL +  T   I DFG A   +       TH     
Sbjct: 121 --------SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNK 165
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G+  +MAPEV EG+ N+S     + D+++  ++LWE+ +R           R PF  E+G
Sbjct: 166 GSAAWMAPEVFEGS-NYSE----KCDVFSWGIILWEVITR-----------RKPFD-EIG 208
Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
             P+   M    VH   RP L +   +    L     M  CW  D   R S   +V+
Sbjct: 209 G-PAFRIMW--AVHNGTRPPLIKNLPKPIESL-----MTRCWSKDPSQRPSMEEIVK 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 131/297 (44%), Gaps = 56/297 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + I++ EV  +G FG V KAK++ ++VA+K    + ++      E+ +L  + H NI++ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK-AFIVELRQLSRVNHPNIVKL 66
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHE 227
            GA            L+  Y E GSL + L         T        L  S+G+ +LH 
Sbjct: 67  YGA------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH- 119
Query: 228 EILPNKADSYKP-AVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTH--GQV 283
                   S +P A+ HRD K  N+LL +  T   I DFG A   +       TH     
Sbjct: 120 --------SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNK 164
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G+  +MAPEV EG+ N+S     + D+++  ++LWE+ +R           R PF  E+G
Sbjct: 165 GSAAWMAPEVFEGS-NYSE----KCDVFSWGIILWEVITR-----------RKPFD-EIG 207
Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
             P+   M    VH   RP L +   +    L     M  CW  D   R S   +V+
Sbjct: 208 G-PAFRIMW--AVHNGTRPPLIKNLPKPIESL-----MTRCWSKDPSQRPSMEEIVK 256

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
             G FG V+K K+  + VAVKI  + D   +Q      E+  L    H NIL ++G   +
Sbjct: 45  GSGSFGTVYKGKWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNKAD 235
                    ++T + E  SL   L      ++  QL  IA   ++G+ +LH +       
Sbjct: 104 -----DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK------- 151
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLE 295
                + HRD KSNN+ L   LT  I DFGLA +              G+  +MAPEV+ 
Sbjct: 152 ----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 296 GAIN--FSRDAFLRIDMYACALVLWELAS 322
              N  FS     + D+Y+  +VL+EL +
Sbjct: 208 MQDNNPFS----FQSDVYSYGIVLYELMT 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 21  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 76
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L  +   +E  +L  IA   ++G+ +LH +     
Sbjct: 77  ----STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  D T  I DFGLA +              G+  +MAPEV
Sbjct: 128 ------SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +  S     + D+YA  +VL+EL +
Sbjct: 182 IR--MQDSNPYSFQSDVYAFGIVLYELMT 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 22  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 77
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 78  ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 128
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 129 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 183 IR--MQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 19  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 74
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 75  ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 125
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 126 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 180 IR--MQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 22  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 77
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 78  ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 128
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 129 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 183 IR--MQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 45  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 100
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 101 ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 151
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 152 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 205
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 206 IR--MQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 50/286 (17%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           SI+LV+    G+FG VW   + N   VAVK         Q++  E  + K   ++HD ++
Sbjct: 13  SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK--TLQHDKLV 70
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLH 226
           R      + E I+    +IT +  +GSL DFLK +    V   +L   +  +++G+ ++ 
Sbjct: 71  RLYAVVTKEEPIY----IITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                      +    HRD ++ NVL+   L   IADFGLA + E  +      G     
Sbjct: 127 -----------RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPI 174
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++ APE    AINF     ++ ++++  ++L+E+ +      P PG              
Sbjct: 175 KWTAPE----AINFGCFT-IKSNVWSFGILLYEIVTYGK--IPYPGR------------- 214
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           +  D+  A+      P +     +      L D M+ CW   AE R
Sbjct: 215 TNADVMSALSQGYRMPRMENCPDE------LYDIMKMCWKEKAEER 254

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 17  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 72
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 73  ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 123
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 124 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 178 IR--MQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 33  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 88
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L  +   +E  +L  IA   ++G+ +LH +     
Sbjct: 89  ----STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK----- 139
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMAP 291
                 ++ HRD KSNN+ L  D T  I DFGLA   E  +  G    +   G+  +MAP
Sbjct: 140 ------SIIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAP 191
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           EV+   +  S     + D+YA  +VL+EL +
Sbjct: 192 EVIR--MQDSNPYSFQSDVYAFGIVLYELMT 220

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 44  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 99
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 100 ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 150
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 151 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 204
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 205 IR--MQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 17  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 72
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 73  ----STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 123
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 ++ HRD KSNN+ L  DLT  I DFGLA +              G+  +MAPEV
Sbjct: 124 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELAS 322
           +   +        + D+YA  +VL+EL +
Sbjct: 178 IR--MQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 33  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 88
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L  +   +E  +L  IA   ++G+ +LH +     
Sbjct: 89  ----STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK----- 139
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMAP 291
                 ++ HRD KSNN+ L  D T  I DFGLA   E  +  G    +   G+  +MAP
Sbjct: 140 ------SIIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAP 191
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           EV+   +  S     + D+YA  +VL+EL +
Sbjct: 192 EVIR--MQDSNPYSFQSDVYAFGIVLYELMT 220

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 17  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 72
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 73  ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 123
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMAP 291
                 ++ HRD KSNN+ L  DLT  I DFGLA   E  +  G    +   G+  +MAP
Sbjct: 124 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAP 175
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           EV+   +        + D+YA  +VL+EL +
Sbjct: 176 EVIR--MQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 37  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 92
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 93  ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 143
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMAP 291
                 ++ HRD KSNN+ L  DLT  I DFGLA   E  +  G    +   G+  +MAP
Sbjct: 144 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAP 195
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           EV+   +        + D+YA  +VL+EL +
Sbjct: 196 EVIR--MQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLM-----QDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
             G FG V+K K+  + VAVK+  +     Q  Q++++E  + +     H NIL ++G  
Sbjct: 45  GSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLR--KTRHVNILLFMGY- 100
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLHEEILPNK 233
               S   +  ++T + E  SL   L      +E  +L  IA   ++G+ +LH +     
Sbjct: 101 ----STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK----- 151
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMAP 291
                 ++ HRD KSNN+ L  DLT  I DFGLA   E  +  G    +   G+  +MAP
Sbjct: 152 ------SIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRWSGSHQFEQLSGSILWMAP 203
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           EV+   +        + D+YA  +VL+EL +
Sbjct: 204 EVIR--MQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 109/246 (44%), Gaps = 51/246 (20%)
Query: 119 VKAQGRFGAVW--KAKFKNENVAVKIF-LMQDKQSWQSE---QEIFKLPHMEHDNILR-Y 171
           V  +G FG V   K K   +  AVK+    Q KQ    E   +E+  L  ++H NI++ Y
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLH 226
              E +G      F+L+   +  G L D     I++ ++       RI   +  G+ ++H
Sbjct: 93  EFFEDKGY-----FYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQV 283
                      K  + HRD K  N+LL+S   D    I DFGL+  FE  K   D   ++
Sbjct: 144 -----------KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KI 189
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSA 340
           GT  Y+APEVL G  +       + D+++  ++L+ L S C    PP     EY +    
Sbjct: 190 GTAYYIAPEVLHGTYD------EKCDVWSTGVILYILLSGC----PPFNGANEYDILKKV 239
Query: 341 EVGDHP 346
           E G + 
Sbjct: 240 EKGKYT 245

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 119/275 (43%), Gaps = 58/275 (21%)
Query: 90  YFNPVPTLEPHPTSPPSPQ-QGCRSIQLVEVKAQGRFGAVW--KAKFKNENVAVKIF-LM 145
           YF        H T+  S + +G R      V  +G FG V   K K   +  AVK+    
Sbjct: 15  YFQGPGMFVQHSTAIFSDRYKGQR------VLGKGSFGEVILCKDKITGQECAVKVISKR 68
Query: 146 QDKQSWQSE---QEIFKLPHMEHDNILR-YIGAEKRGESIHTEFWLITAYHERGSLCDFL 201
           Q KQ    E   +E+  L  ++H NI++ Y   E +G      F+L+   +  G L D  
Sbjct: 69  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-----FYLVGEVYTGGELFD-- 121
Query: 202 KCNIVTWEQL-----CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS- 255
              I++ ++       RI   +  G+ ++H           K  + HRD K  N+LL+S 
Sbjct: 122 --EIISRKRFSEVDAARIIRQVLSGITYMH-----------KNKIVHRDLKPENLLLESK 168
Query: 256 --DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
             D    I DFGL+  FE  K   D   ++GT  Y+APEVL G  +       + D+++ 
Sbjct: 169 SKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAPEVLHGTYD------EKCDVWST 219
Query: 314 ALVLWELASRCSSVSPP---PGEYRLPFSAEVGDH 345
            ++L+ L S C    PP     EY +    E G +
Sbjct: 220 GVILYILLSGC----PPFNGANEYDILKKVEKGKY 250

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 57/285 (20%)
Query: 126 GAVWKAKFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH 182
           G +WK +++  ++ VK+  ++D   ++S    +E  +L    H N+L  +GA +   + H
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 183 TEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
               LIT +   GSL + L      +V   Q  + AL M++G+  LH         + +P
Sbjct: 84  PT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---------TLEP 132
Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
            +      S +V++  D+TA I+   +   F+       + G++    ++APE L+    
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKK-- 183
Query: 300 FSRDAFLR-IDMYACALVLWELASRCSSVSPPPGEYRLPFS----AEVGDHPSLEDMQEA 354
              D   R  DM++ A++LWEL +R            +PF+     E+G   +LE     
Sbjct: 184 -PEDTNRRSADMWSFAVLLWELVTR-----------EVPFADLSNMEIGMKVALEG---- 227
Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV 399
                LRPT+P     H   L     M+ C + D   R     +V
Sbjct: 228 -----LRPTIPPGISPHVSKL-----MKICMNEDPAKRPKFDMIV 262

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 119 VKAQGRFGAVW--KAKFKNENVAVKIF-LMQDKQSWQSE---QEIFKLPHMEHDNILR-Y 171
           V  +G FG V   K K   +  AVK+    Q KQ    E   +E+  L  ++H NI++ Y
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLH 226
              E +G      F+L+   +  G L D     I++ ++       RI   +  G+ ++H
Sbjct: 117 EFFEDKGY-----FYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVLSGITYMH 167
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQV 283
                      K  + HRD K  N+LL+S   D    I DFGL+  FE  K   D   ++
Sbjct: 168 -----------KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KI 213
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSA 340
           GT  Y+APEVL G  +       + D+++  ++L+ L S C    PP     EY +    
Sbjct: 214 GTAYYIAPEVLHGTYD------EKCDVWSTGVILYILLSGC----PPFNGANEYDILKKV 263
Query: 341 EVGDH 345
           E G +
Sbjct: 264 EKGKY 268

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 119 VKAQGRFGAVW--KAKFKNENVAVKIF-LMQDKQSWQSE---QEIFKLPHMEHDNILR-Y 171
           V  +G FG V   K K   +  AVK+    Q KQ    E   +E+  L  ++H NI++ Y
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLH 226
              E +G      F+L+   +  G L D     I++ ++       RI   +  G+ ++H
Sbjct: 116 EFFEDKGY-----FYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVLSGITYMH 166
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQV 283
                      K  + HRD K  N+LL+S   D    I DFGL+  FE  K   D   ++
Sbjct: 167 -----------KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KI 212
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSA 340
           GT  Y+APEVL G  +       + D+++  ++L+ L S C    PP     EY +    
Sbjct: 213 GTAYYIAPEVLHGTYD------EKCDVWSTGVILYILLSGC----PPFNGANEYDILKKV 262
Query: 341 EVGDH 345
           E G +
Sbjct: 263 EKGKY 267

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 117 VEVKAQGRFGAVWKAKFKNEN--VAVKIFLM------QDKQSWQSEQEIFKLPHMEHDNI 168
           ++   +G+F  V+KA+ KN N  VA+K   +      +D  +  + +EI  L  + H NI
Sbjct: 15  LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           +  + A     +I   F  +        L   +K N  ++T   +    L   +GL +LH
Sbjct: 75  IGLLDAFGHKSNISLVFDFMET-----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           +             + HRD K NN+LL  +    +ADFGLA  F  G P      QV TR
Sbjct: 130 QH-----------WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQVVTR 176
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC 324
            Y APE+L GA    R   + +DM+A   +L EL  R 
Sbjct: 177 WYRAPELLFGA----RMYGVGVDMWAVGCILAELLLRV 210

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 118 EVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRYIGA 174
           EV  +G FG   K   +   E + +K  +  D+++ ++  +E+  +  +EH N+L++IG 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPN 232
             + + ++     IT Y + G+L   +K   +   W Q    A  ++ G+ +LH      
Sbjct: 76  LYKDKRLN----FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---- 127
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF--EPGKPCG----------DTH 280
                   + HRD  S+N L++ +    +ADFGLA L   E  +P G            +
Sbjct: 128 -------NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS 326
             VG   +MAPE++ G     R    ++D+++  +VL E+  R ++
Sbjct: 181 TVVGNPYWMAPEMING-----RSYDEKVDVFSFGIVLCEIIGRVNA 221

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 20  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 76
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 77  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 132 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 179
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 180 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 22  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 78
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 79  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 134 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 181
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 182 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 23  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 80  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 134
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 135 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 182
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 183 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 222

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 70
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 71  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 126 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 173
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 174 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 213

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 16  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 72
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 73  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 127
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 128 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 175
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 176 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 70
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 71  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 126 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 173
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 174 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 15  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 71
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 72  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 126
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 127 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA-REGAKFP 174
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 175 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 24  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 80
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 81  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 135
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 136 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 183
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 184 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 223

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 19  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 75
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 76  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 130
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 131 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 178
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 179 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 107/245 (43%), Gaps = 51/245 (20%)
Query: 119 VKAQGRFGAVW--KAKFKNENVAVKIF-LMQDKQSWQSE---QEIFKLPHMEHDNILR-Y 171
           V  +G FG V   K K   +  AVK+    Q KQ    E   +E+  L  ++H NI + Y
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLH 226
              E +G      F+L+   +  G L D     I++ ++       RI   +  G+ + H
Sbjct: 93  EFFEDKGY-----FYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVLSGITYXH 143
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQV 283
                      K  + HRD K  N+LL+S   D    I DFGL+  FE  K   D   ++
Sbjct: 144 -----------KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD---KI 189
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSA 340
           GT  Y+APEVL G  +       + D+++  ++L+ L S C    PP     EY +    
Sbjct: 190 GTAYYIAPEVLHGTYD------EKCDVWSTGVILYILLSGC----PPFNGANEYDILKKV 239
Query: 341 EVGDH 345
           E G +
Sbjct: 240 EKGKY 244

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 20  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 76
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 77  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 132 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 179
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 180 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 9   TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 65
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 66  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 121 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 168
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 169 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMK--QLQHQRL 70
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 71  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 126 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 173
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 174 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 213

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 51/286 (17%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           S+QL++    G+FG VW   +  N  VA+K         +S+  E +I K   ++HD ++
Sbjct: 10  SLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMK--KLKHDKLV 67
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLH 226
           +               +++T Y  +GSL DFLK      +    L  +A  ++ G+ ++ 
Sbjct: 68  QLYAVVS-----EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                      +    HRD +S N+L+ + L   IADFGLA L E  +      G     
Sbjct: 123 -----------RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTA-RQGAKFPI 170
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++ APE    A  + R   ++ D+++  ++L EL ++           R+P+   + +  
Sbjct: 171 KWTAPE----AALYGRFT-IKSDVWSFGILLTELVTKG----------RVPYPG-MNNRE 214
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            LE      V +  R   P+        ++L + M  CW  D E R
Sbjct: 215 VLEQ-----VERGYRMPCPQDCP-----ISLHELMIHCWKKDPEER 250

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 55/295 (18%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIFLMQDKQS--------WQSEQEIFKLPHMEHDNILR 170
            +G FG V K +   +   VA+K  ++ D +          + ++E+F + ++ H NI++
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
             G       +  EF      + R  L D  K + + W    R+ L ++ G+ ++  +  
Sbjct: 88  LYGLMHNPPRMVMEFVPCGDLYHR--LLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ-- 141
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS-----DLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                   P + HRD +S N+ L+S      + A +ADFGL+      +      G +G 
Sbjct: 142 -------NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGN 189
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
            ++MAPE + GA   S     + D Y+ A++L+ + +         GE   PF       
Sbjct: 190 FQWMAPETI-GAEEESYTE--KADTYSFAMILYTILT---------GEG--PFDEYSYGK 235
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
               +M   +  + LRPT+PE          L + +E CW  D + R   S +V+
Sbjct: 236 IKFINM---IREEGLRPTIPEDCPPR-----LRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 115/272 (42%), Gaps = 53/272 (19%)
Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILRYIGAEK 176
            +G FG V+K       E VA+KI  +++ +      +QEI  L   +   I RY G+  
Sbjct: 28  GKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYL 87
Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
           +     T+ W+I  Y   GS  D LK   +    +  I   + KGL +LH E        
Sbjct: 88  KS----TKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE-------- 135
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VGTRRYMAPE 292
                 HRD K+ NVLL       +ADFG+A          DT  +    VGT  +MAPE
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVA------GQLTDTQIKRNXFVGTPFWMAPE 186
Query: 293 VL-EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---RLPFSAEVGDHPSL 348
           V+ + A +F      + D+++  +   ELA       PP  +    R+ F       P+L
Sbjct: 187 VIKQSAYDF------KADIWSLGITAIELAKG----EPPNSDLHPMRVLFLIPKNSPPTL 236
Query: 349 E--------DMQEAVVHK--KLRPTLPETWKQ 370
           E        +  EA ++K  + RPT  E  K 
Sbjct: 237 EGQHSKPFKEFVEACLNKDPRFRPTAKELLKH 268

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 119 VKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYIGAE 175
           +  +G FG V+K +  +   VAVK    +  Q    Q + E+  +    H N+LR     
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRL---- 100
Query: 176 KRGESIH-TEFWLITAYHERGSLCDFLKCNI-----VTWEQLCRIALSMSKGLMHLHEEI 229
            RG  +  TE  L+  Y   GS+   L+        + W +  RIAL  ++GL +LH   
Sbjct: 101 -RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--- 156
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH---GQVGTR 286
                D   P + HRD K+ N+LL  +  A + DFGLA L +      D H      GT 
Sbjct: 157 -----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDXHVXXAVRGTI 207
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            ++APE L    +       + D++   ++L EL +
Sbjct: 208 GHIAPEYLSTGKSSE-----KTDVFGYGVMLLELIT 238

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 123 GRFGAV--WKAKFKNENVAVKIFLMQDKQSW----QSEQEIFKLPHMEHDNILRYIGAEK 176
           G FG V   + +     VAVKI   Q  +S     + ++EI  L    H +I++      
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI- 80
Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
              S  T+F+++  Y   G L D++          C+           L ++IL      
Sbjct: 81  ---STPTDFFMVMEYVSGGELFDYI----------CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++  V HRD K  NVLL + + A IADFGL+ +   G+   D+    G+  Y APEV+ G
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISG 184
Query: 297 AINFSRDAFLRIDMYACALVLWEL 320
            +     A   +D+++C ++L+ L
Sbjct: 185 RLY----AGPEVDIWSCGVILYAL 204

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+FG VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 10  TLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMK--QLQHQRL 66
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 67  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HR+ ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 122 EER-----------NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 169
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 170 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 61/290 (21%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + ++L++   +G FG V    ++   VAVK  +  D  +     E   +  + H N+++ 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 172 IGA---EKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHL 225
           +G    EK G       +++T Y  +GSL D+L+    +++  + L + +L + + + +L
Sbjct: 252 LGVIVEEKGG------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                            HRD  + NVL+  D  A ++DFGL    +      DT G++  
Sbjct: 306 EGN-----------NFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDT-GKLPV 350
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
            ++ APE L     FS  +    D+++  ++LWE+ S      P     R+P        
Sbjct: 351 -KWTAPEALREK-KFSTKS----DVWSFGILLWEIYSFGRVPYP-----RIPL------- 392
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGML---ALCDTMEECWDHDAEAR 392
                       K + P + + +K  A      A+ D M+ CW  DA  R
Sbjct: 393 ------------KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 107 PQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLP 161
           P     + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERG-SLCDFLKCNIVTWEQLCRIALSMSK 220
            + H NI++ +      + IHTE  L   +      L DF+  + +T      I L + K
Sbjct: 61  ELNHPNIVKLL------DVIHTENKLYLVFEFLSMDLKDFMDASALTG-----IPLPLIK 109
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
             +    ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P     
Sbjct: 110 SYLF---QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 164
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            +V T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 165 HEVVTLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 203

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 26/272 (9%)
Query: 115 QLVEVKAQGRFGAVWKAKF---KNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNIL 169
           +L EV   G   AV +A +   K E VA+K   ++  Q+   E  +EI  +    H NI+
Sbjct: 13  ELQEVIGSGA-TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
            Y  +      +  E WL+      GS+ D +K  +   E   +  +     +  +  E+
Sbjct: 72  SYYTSF----VVKDELWLVMKLLSGGSVLDIIKHIVAKGEH--KSGVLDESTIATILREV 125
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTR 286
           L      +K    HRD K+ N+LL  D +  IADFG++     G        +   VGT 
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
            +MAPEV+E    +      + D+++  +   ELA+  +     P    L  + +  D P
Sbjct: 186 CWMAPEVMEQVRGYD----FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-NDPP 240
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALC 378
           SLE     V  K++     +++++   M++LC
Sbjct: 241 SLE---TGVQDKEMLKKYGKSFRK---MISLC 266

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSE-QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  K   + VAVK   ++ +Q  +    E+  +    HDN++    +   
Sbjct: 54  GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLV 113
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + LS+ + L +LH +         
Sbjct: 114 GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ--------- 160
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL SD    ++DFG     +  K        VGT  +MAPEV+
Sbjct: 161 --GVIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVI 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 45/241 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLM----QDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V    +        E VAVK        Q +  W+ E +I +  
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT- 72
Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            + H++I++Y G  E +GE       L+  Y   GSL D+L  + +   QL   A  + +
Sbjct: 73  -LYHEHIIKYKGCCEDQGEK---SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 128
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +LH +              HR+  + NVLL +D    I DFGLA      K   + H
Sbjct: 129 GMAYLHSQ-----------HYIHRNLAARNVLLDNDRLVKIGDFGLA------KAVPEGH 171
Query: 281 GQVGTRR-------YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                R        + APE L+         +   D+++  + L+EL + C S   PP +
Sbjct: 172 EYYRVREDGDSPVFWYAPECLK-----EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 226
Query: 334 Y 334
           +
Sbjct: 227 F 227

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 26/272 (9%)
Query: 115 QLVEVKAQGRFGAVWKAKF---KNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNIL 169
           +L EV   G   AV +A +   K E VA+K   ++  Q+   E  +EI  +    H NI+
Sbjct: 18  ELQEVIGSGA-TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
            Y  +      +  E WL+      GS+ D +K  +   E   +  +     +  +  E+
Sbjct: 77  SYYTSF----VVKDELWLVMKLLSGGSVLDIIKHIVAKGEH--KSGVLDESTIATILREV 130
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTR 286
           L      +K    HRD K+ N+LL  D +  IADFG++     G        +   VGT 
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
            +MAPEV+E    +      + D+++  +   ELA+  +     P    L  + +  D P
Sbjct: 191 CWMAPEVMEQVRGYD----FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-NDPP 245
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALC 378
           SLE     V  K++     +++++   M++LC
Sbjct: 246 SLET---GVQDKEMLKKYGKSFRK---MISLC 271

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 45/241 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLM----QDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V    +        E VAVK        Q +  W+ E +I +  
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT- 72
Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            + H++I++Y G  E +GE       L+  Y   GSL D+L  + +   QL   A  + +
Sbjct: 73  -LYHEHIIKYKGCCEDQGEK---SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 128
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +LH       A  Y     HR+  + NVLL +D    I DFGLA      K   + H
Sbjct: 129 GMAYLH-------AQHY----IHRNLAARNVLLDNDRLVKIGDFGLA------KAVPEGH 171
Query: 281 GQVGTRR-------YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                R        + APE L+         +   D+++  + L+EL + C S   PP +
Sbjct: 172 EYYRVREDGDSPVFWYAPECLK-----EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 226
Query: 334 Y 334
           +
Sbjct: 227 F 227

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILRYI 172
           +E   +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y 
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
           G+  +G    ++ W+I  Y   GS  D L+       Q+  +   + KGL +LH E    
Sbjct: 88  GSYLKG----SKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---- 139
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD K+ NVLL       +ADFG+A      +   +T   VGT  +MAPE
Sbjct: 140 -------KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPE 190
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELA 321
           V++ +   S     + D+++  +   ELA
Sbjct: 191 VIQQSAYDS-----KADIWSLGITAIELA 214

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 55/295 (18%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIFLMQDKQS--------WQSEQEIFKLPHMEHDNILR 170
            +G FG V K +   +   VA+K  ++ D +          + ++E+F + ++ H NI++
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
             G       +  EF      + R  L D  K + + W    R+ L ++ G+ ++  +  
Sbjct: 88  LYGLMHNPPRMVMEFVPCGDLYHR--LLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ-- 141
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS-----DLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                   P + HRD +S N+ L+S      + A +ADFG +      +      G +G 
Sbjct: 142 -------NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLLGN 189
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
            ++MAPE + GA   S     + D Y+ A++L+ + +         GE   PF       
Sbjct: 190 FQWMAPETI-GAEEESYTE--KADTYSFAMILYTILT---------GEG--PFDEYSYGK 235
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
               +M   +  + LRPT+PE          L + +E CW  D + R   S +V+
Sbjct: 236 IKFINM---IREEGLRPTIPEDCPPR-----LRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNI 168
           +++LVE    G+ G VW   +     VAVK  L Q   S   + +E  + K   ++H  +
Sbjct: 14  TLKLVERLGAGQAGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMK--QLQHQRL 70
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHL 225
           +R               ++IT Y E GSL DFLK      +T  +L  +A  +++G+  +
Sbjct: 71  VRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            E               HRD ++ N+L+   L+  IADFGLA L E  +      G    
Sbjct: 126 EER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA-REGAKFP 173
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            ++ APE    AIN+     ++ D+++  ++L E+ +      P PG
Sbjct: 174 IKWTAPE----AINYGTFT-IKSDVWSFGILLTEIVTHGR--IPYPG 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 168 ILRYIGAEKRGESIHTEFWLITAY-HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           I++ +      + IHTE  L   + H    L  F+  + +T      I L + K  +   
Sbjct: 63  IVKLL------DVIHTENKLYLVFEHVHQDLKTFMDASALTG-----IPLPLIKSYLF-- 109
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
            ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T 
Sbjct: 110 -QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 WYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 199

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 39/247 (15%)
Query: 92  NPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----- 146
           NP PT+         P      I+  +V  +G FG V KA+ K + + +   + +     
Sbjct: 3   NPDPTI--------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA 54
Query: 147 ---DKQSWQSEQEIF-KLPHMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFL 201
              D + +  E E+  KL H  H NI+  +GA E RG       +L   Y   G+L DFL
Sbjct: 55  SKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFL 107
Query: 202 -KCNIVTWEQLCRIALSM-----SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
            K  ++  +    IA S      S+ L+H   ++        +    HRD  + N+L+  
Sbjct: 108 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 167
Query: 256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL 315
           +  A IADFGL+   E       T G++   R+MA E L  ++  +       D+++  +
Sbjct: 168 NYVAKIADFGLSRGQEV--YVKKTMGRLPV-RWMAIESLNYSVYTTNS-----DVWSYGV 219
Query: 316 VLWELAS 322
           +LWE+ S
Sbjct: 220 LLWEIVS 226

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKI----FLMQDKQSWQSEQEIFKLPHME 164
           +++ EV   G FG V + + K        VA+K     +  + ++ + SE  I  +   E
Sbjct: 18  VKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI--MGQFE 75
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGL 222
           H NI+R  G       +     ++T + E G+L  FL+ N    T  QL  +   ++ G+
Sbjct: 76  HPNIIRLEGVVTNSMPVM----ILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 131
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +L E        SY     HRD  + N+L+ S+L   ++DFGL+   E           
Sbjct: 132 RYLAEM-------SY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180
Query: 283 VGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +G +   R+ APE    AI F R      D ++  +V+WE+ S
Sbjct: 181 LGGKIPIRWTAPE----AIAF-RKFTSASDAWSYGIVMWEVMS 218

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 168 ILRYIGAEKRGESIHTEFWLITAY-HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           I++ +      + IHTE  L   + H    L  F+  + +T      I L + K  +   
Sbjct: 67  IVKLL------DVIHTENKLYLVFEHVDQDLKKFMDASALTG-----IPLPLIKSYLF-- 113
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
            ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T 
Sbjct: 114 -QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 171 WYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L DF+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKDFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 39/247 (15%)
Query: 92  NPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----- 146
           NP PT+         P      I+  +V  +G FG V KA+ K + + +   + +     
Sbjct: 13  NPDPTI--------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA 64
Query: 147 ---DKQSWQSEQEIF-KLPHMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFL 201
              D + +  E E+  KL H  H NI+  +GA E RG       +L   Y   G+L DFL
Sbjct: 65  SKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFL 117
Query: 202 -KCNIVTWEQLCRIALSM-----SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
            K  ++  +    IA S      S+ L+H   ++        +    HRD  + N+L+  
Sbjct: 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177
Query: 256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL 315
           +  A IADFGL+   E       T G++   R+MA E L  ++  +       D+++  +
Sbjct: 178 NYVAKIADFGLSRGQEV--YVKKTMGRLPV-RWMAIESLNYSVYTTNS-----DVWSYGV 229
Query: 316 VLWELAS 322
           +LWE+ S
Sbjct: 230 LLWEIVS 236

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKI----FLMQDKQSWQSEQEIFKLPHME 164
           +++ EV   G FG V + + K        VA+K     +  + ++ + SE  I  +   E
Sbjct: 16  VKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI--MGQFE 73
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGL 222
           H NI+R  G       +     ++T + E G+L  FL+ N    T  QL  +   ++ G+
Sbjct: 74  HPNIIRLEGVVTNSMPVM----ILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 129
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +L E        SY     HRD  + N+L+ S+L   ++DFGL+   E           
Sbjct: 130 RYLAEM-------SY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 283 VGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +G +   R+ APE    AI F R      D ++  +V+WE+ S
Sbjct: 179 LGGKIPIRWTAPE----AIAF-RKFTSASDAWSYGIVMWEVMS 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 121 AQGRFGAVWKAK--FKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V K K     +  AVK+      ++K +    +E+  L  ++H NI++     
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 176 KRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           +   S    F+++   +  G L D  +K    +     RI   +  G+ ++H        
Sbjct: 91  EDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH-------- 138
Query: 235 DSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
              K  + HRD K  N+LL+S   D    I DFGL+  F+      D   ++GT  Y+AP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAP 192
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSAEVGDH 345
           EVL G  +       + D+++  ++L+ L S     +PP     EY +    E G +
Sbjct: 193 EVLRGTYD------EKCDVWSAGVILYILLSG----TPPFYGKNEYDILKRVETGKY 239

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 55/295 (18%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIFLMQDKQS--------WQSEQEIFKLPHMEHDNILR 170
            +G FG V K +   +   VA+K  ++ D +          + ++E+F + ++ H NI++
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
             G       +  EF      + R  L D  K + + W    R+ L ++ G+ ++  +  
Sbjct: 88  LYGLMHNPPRMVMEFVPCGDLYHR--LLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ-- 141
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS-----DLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                   P + HRD +S N+ L+S      + A +ADF L+      +      G +G 
Sbjct: 142 -------NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLGN 189
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
            ++MAPE + GA   S     + D Y+ A++L+ + +         GE   PF       
Sbjct: 190 FQWMAPETI-GAEEESYTE--KADTYSFAMILYTILT---------GEG--PFDEYSYGK 235
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
               +M   +  + LRPT+PE          L + +E CW  D + R   S +V+
Sbjct: 236 IKFINM---IREEGLRPTIPEDCPPR-----LRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 11  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 71  VSEEP--------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 120
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 121 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 170
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 171 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 213
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 214 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 248

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 119 VKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYIGAE 175
           +  +G FG V+K +  +   VAVK    +  Q    Q + E+  +    H N+LR     
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL---- 92
Query: 176 KRGESIH-TEFWLITAYHERGSLCDFLKCNI-----VTWEQLCRIALSMSKGLMHLHEEI 229
            RG  +  TE  L+  Y   GS+   L+        + W +  RIAL  ++GL +LH   
Sbjct: 93  -RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--- 148
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL--FEPGKPCGDTHGQVGTRR 287
                D   P + HRD K+ N+LL  +  A + DFGLA L  ++         G +G   
Sbjct: 149 -----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIG--- 200
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++APE L    +       + D++   ++L EL +
Sbjct: 201 HIAPEYLSTGKSSE-----KTDVFGYGVMLLELIT 230

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 13  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 73  VSEEP--------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 122
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 123 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 172
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 173 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 215
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 216 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 250

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHME 164
           G  + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + 
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 165 HDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGL 222
           H NI++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  
Sbjct: 61  HPNIVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSY 108
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
           +    ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +
Sbjct: 109 LF---QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHE 163
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           V T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 164 VVTLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 121 AQGRFGAVWKAK--FKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V K K     +  AVK+      ++K +    +E+  L  ++H NI++     
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 176 KRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           +   S    F+++   +  G L D  +K    +     RI   +  G+ ++H        
Sbjct: 91  EDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH-------- 138
Query: 235 DSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
              K  + HRD K  N+LL+S   D    I DFGL+  F+      D   ++GT  Y+AP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAP 192
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSAEVGDH 345
           EVL G  +       + D+++  ++L+ L S     +PP     EY +    E G +
Sbjct: 193 EVLRGTYD------EKCDVWSAGVILYILLSG----TPPFYGKNEYDILKRVETGKY 239

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 121 AQGRFGAVWKAK--FKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            +G FG V K K     +  AVK+      ++K +    +E+  L  ++H NI++     
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 176 KRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           +   S    F+++   +  G L D  +K    +     RI   +  G+ ++H        
Sbjct: 91  EDSSS----FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH-------- 138
Query: 235 DSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
              K  + HRD K  N+LL+S   D    I DFGL+  F+      D   ++GT  Y+AP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAP 192
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP---PGEYRLPFSAEVGDH 345
           EVL G  +       + D+++  ++L+ L S     +PP     EY +    E G +
Sbjct: 193 EVLRGTYD------EKCDVWSAGVILYILLSG----TPPFYGKNEYDILKRVETGKY 239

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 45/241 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLM----QDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V    +        E VAVK        Q +  W+ E +I +  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT- 89
Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            + H++I++Y G  E  G +      L+  Y   GSL D+L  + +   QL   A  + +
Sbjct: 90  -LYHEHIIKYKGCCEDAGAA---SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 145
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +LH       A  Y     HRD  + NVLL +D    I DFGLA      K   + H
Sbjct: 146 GMAYLH-------AQHY----IHRDLAARNVLLDNDRLVKIGDFGLA------KAVPEGH 188
Query: 281 GQVGTRR-------YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                R        + APE L+         +   D+++  + L+EL + C S   PP +
Sbjct: 189 EXYRVREDGDSPVFWYAPECLK-----EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243
Query: 334 Y 334
           +
Sbjct: 244 F 244

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMH 224
           I++ +      + IHTE  L   +       +FL  ++ T+     L  I L + K  + 
Sbjct: 67  IVKLL------DVIHTENKLYLVF-------EFLHQDLKTFMDASALTGIPLPLIKSYLF 113
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
              ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V 
Sbjct: 114 ---QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV 168
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 169 TLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 107 PQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLP 161
           P     + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSM 218
            + H NI++ +      + IHTE  L   +       +FL  ++  +     L  I L +
Sbjct: 61  ELNHPNIVKLL------DVIHTENKLYLVF-------EFLSMDLKKFMDASALTGIPLPL 107
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            K  +    ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P   
Sbjct: 108 IKSYLF---QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRT 162
Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
              +V T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERG-SLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           I++ +      + IHTE  L   +      L DF+  + +T      I L + K  +   
Sbjct: 66  IVKLL------DVIHTENKLYLVFEFLSMDLKDFMDASALTG-----IPLPLIKSYLF-- 112
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
            ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T 
Sbjct: 113 -QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 170 WYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 202

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 107/216 (49%), Gaps = 32/216 (14%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + ++L++   +G FG V    ++   VAVK  +  D  +     E   +  + H N+++ 
Sbjct: 12  KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 172 IGA--EKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLH 226
           +G   E++G       +++T Y  +GSL D+L+    +++  + L + +L + + + +L 
Sbjct: 71  LGVIVEEKGG-----LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 124
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                 + +++     HRD  + NVL+  D  A ++DFGL    +      DT G++   
Sbjct: 125 ------EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDT-GKLPV- 169
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++ APE L  A  FS  +    D+++  ++LWE+ S
Sbjct: 170 KWTAPEALREAA-FSTKS----DVWSFGILLWEIYS 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGA 174
             G FGAV+ A+    +E VA+K      KQS +  Q+I K    L  + H N ++Y G 
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS--KGLMHLHEEILPN 232
             R    HT  WL+  Y   GS  D L+ +    +++   A++    +GL +LH      
Sbjct: 123 YLRE---HTA-WLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---- 173
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   + HRD K+ N+LL       + DFG A +  P          VGT  +MAPE
Sbjct: 174 -------NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPE 220
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASR 323
           V+        D   ++D+++  +   ELA R
Sbjct: 221 VILAMDEGQYDG--KVDVWSLGITCIELAER 249

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + K+ H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 107 PQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLP 161
           P     + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 162 HMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS 219
            + H NI++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + 
Sbjct: 61  ELNHPNIVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLI 108
Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           K  +    ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P    
Sbjct: 109 KSYLF---QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTY 163
Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             +V T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 106 SPQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKL 160
            P     + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L
Sbjct: 1   GPLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 161 PHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSM 218
             + H NI++ +      + IHTE   +L+  +  +  L  F+  + +T      I L +
Sbjct: 61  KELNHPNIVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPL 108
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            K  +    ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P   
Sbjct: 109 IKSYLF---QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRT 163
Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
              +V T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 164 YXHEVVTLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 204

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           S++L +    G+FG VW A + K+  VAVK         +++ +E  + K   ++HD ++
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT--LQHDKLV 73
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           + + A    E I+    +IT +  +GSL DFLK +  + + L +        L+    +I
Sbjct: 74  K-LHAVVTKEPIY----IITEFMAKGSLLDFLKSDEGSKQPLPK--------LIDFSAQI 120
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
               A   +    HRD ++ N+L+ + L   IADFGLA + E  +      G     ++ 
Sbjct: 121 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWT 179
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           APE    AINF     ++ D+++  ++L E+ +
Sbjct: 180 APE----AINFGSFT-IKSDVWSFGILLMEIVT 207

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 27/201 (13%)
Query: 139 AVKIFLMQDKQSWQSEQ-EIFKLPHMEHDNILRYIGAE------KRGESIHTEFWLITAY 191
           AVKI  +    S+ +E+ +  +   ++  +ILR +         K     +T F+L+   
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 192 HERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN 250
            ++G L D+L   +   E+  R I  ++ + +  LH           K  + HRD K  N
Sbjct: 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-----------KLNIVHRDLKPEN 154
Query: 251 VLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR-ID 309
           +LL  D+   + DFG +   +PG+   +     GT  Y+APE++E ++N +   + + +D
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLREV---CGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 310 MYACALVLWELASRCSSVSPP 330
           M++  ++++ L +     SPP
Sbjct: 212 MWSTGVIMYTLLAG----SPP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 27/201 (13%)
Query: 139 AVKIFLMQDKQSWQSEQ-EIFKLPHMEHDNILRYIGAE------KRGESIHTEFWLITAY 191
           AVKI  +    S+ +E+ +  +   ++  +ILR +         K     +T F+L+   
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 192 HERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN 250
            ++G L D+L   +   E+  R I  ++ + +  LH           K  + HRD K  N
Sbjct: 93  MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-----------KLNIVHRDLKPEN 141
Query: 251 VLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR-ID 309
           +LL  D+   + DFG +   +PG+   +     GT  Y+APE++E ++N +   + + +D
Sbjct: 142 ILLDDDMNIKLTDFGFSCQLDPGEKLREV---CGTPSYLAPEIIECSMNDNHPGYGKEVD 198
Query: 310 MYACALVLWELASRCSSVSPP 330
           M++  ++++ L +     SPP
Sbjct: 199 MWSTGVIMYTLLAG----SPP 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           S++L +    G+FG VW A + K+  VAVK         +++ +E  + K   ++HD ++
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT--LQHDKLV 246
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           + + A    E I+    +IT +  +GSL DFLK +  + + L +        L+    +I
Sbjct: 247 K-LHAVVTKEPIY----IITEFMAKGSLLDFLKSDEGSKQPLPK--------LIDFSAQI 293
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
               A   +    HRD ++ N+L+ + L   IADFGLA + E  +      G     ++ 
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWT 352
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           APE    AINF     ++ D+++  ++L E+ +
Sbjct: 353 APE----AINFGSFT-IKSDVWSFGILLMEIVT 380

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 43/271 (15%)
Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILRYI 172
           +E   +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y 
Sbjct: 32  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
           G+  +     T+ W+I  Y   GS  D L+   +   Q+  I   + KGL +LH E    
Sbjct: 92  GSYLK----DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---- 143
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD K+ NVLL       +ADFG+A      +   +T   VGT  +MAPE
Sbjct: 144 -------KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPE 194
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---RLPFSAEVGDHPSLE 349
           V++ +   S     + D+++  +   ELA       PP  E    ++ F     + P+LE
Sbjct: 195 VIKQSAYDS-----KADIWSLGITAIELARG----EPPHSELHPMKVLFLIPKNNPPTLE 245
Query: 350 --------DMQEAVVHKK--LRPTLPETWKQ 370
                   +  EA ++K+   RPT  E  K 
Sbjct: 246 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 276

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 123 GRFGAV--WKAKFKNENVAVKIFLMQDKQSW----QSEQEIFKLPHMEHDNILRYIGAEK 176
           G FG V   + +     VAVKI   Q  +S     + ++EI  L    H +I++      
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI- 80
Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
              S  T+F+++  Y   G L D++          C+           L ++IL      
Sbjct: 81  ---STPTDFFMVMEYVSGGELFDYI----------CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++  V HRD K  NVLL + + A IADFGL+ +   G+    +    G+  Y APEV+ G
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISG 184
Query: 297 AINFSRDAFLRIDMYACALVLWEL 320
            +     A   +D+++C ++L+ L
Sbjct: 185 RLY----AGPEVDIWSCGVILYAL 204

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 61/307 (19%)
Query: 101 PTSPPSPQQGCR--------SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFL---MQDK 148
           PTS P  Q   +        S++L     QG FG VW   +     VA+K      M  +
Sbjct: 166 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE 225
Query: 149 QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW 208
              Q  Q + KL H +   +   +  E          +++T Y  +GSL DFLK  +  +
Sbjct: 226 AFLQEAQVMKKLRHEKLVQLYAVVSEEP--------IYIVTEYMSKGSLLDFLKGEMGKY 277
Query: 209 ---EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
               QL  +A  ++ G+ ++            +    HRD ++ N+L+  +L   +ADFG
Sbjct: 278 LRLPQLVDMAAQIASGMAYVE-----------RMNYVHRDLRAANILVGENLVCKVADFG 326
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           L  L E  +      G     ++ APE    A  + R   ++ D+++  ++L EL ++  
Sbjct: 327 LGRLIEDNEYTA-RQGAKFPIKWTAPE----AALYGRFT-IKSDVWSFGILLTELTTKG- 379
Query: 326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
                    R+P+   V  +  + D  E        P  PE         +L D M +CW
Sbjct: 380 ---------RVPYPGMV--NREVLDQVERGYRMPCPPECPE---------SLHDLMCQCW 419
Query: 386 DHDAEAR 392
             D E R
Sbjct: 420 RKDPEER 426

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD  + N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 134/304 (44%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIF-------LMQDKQSWQSEQEIFKLPHMEHD 166
           + L E+   G FG V++A +  + VAVK         + Q  ++ + E ++F +  ++H 
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM--LKHP 66
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           NI+   G   +         L+  +   G L   L    +  + L   A+ +++G+ +LH
Sbjct: 67  NIIALRGVCLK----EPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH 122
Query: 227 EE-ILPNKADSYKPAVAHRDFKSNNVLL-----KSDLT---AAIADFGLALLFEPGKPCG 277
           +E I+P         + HRD KS+N+L+       DL+     I DFGLA  +       
Sbjct: 123 DEAIVP---------IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM- 172
Query: 278 DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
                 G   +MAPEV+  ++ FS+ +    D+++  ++LWEL +         GE  +P
Sbjct: 173 ---SAAGAYAWMAPEVIRASM-FSKGS----DVWSYGVLLWELLT---------GE--VP 213
Query: 338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
           F    G       +   V   KL   +P T  +          ME+CW+ D  +R S + 
Sbjct: 214 FRGIDG-----LAVAYGVAMNKLALPIPSTCPE-----PFAKLMEDCWNPDPHSRPSFTN 263
Query: 398 VVER 401
           ++++
Sbjct: 264 ILDQ 267

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 121 AQGRFGAVWKAKFKNE--NVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGA-- 174
            +G FG V++AK K +  N A+K   + +++  + +  +E+  L  +EH  I+RY  A  
Sbjct: 14  GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 175 -EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW-EQLCRIALSMSKGLMHLHEEILPN 232
            +   E +      +  Y +   LC   K N+  W    C I        +H+  +I   
Sbjct: 74  EKNTTEKLQPSSPKVYLYIQM-QLCR--KENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA----------LLFEPGKPCGDTHGQ 282
               +   + HRD K +N+    D    + DFGL            +  P        GQ
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           VGT+ YM+PE + G  ++S     ++D+++  L+L+EL
Sbjct: 191 VGTKLYMSPEQIHGN-SYSH----KVDIFSLGLILFEL 223

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 49/294 (16%)
Query: 121 AQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFK-LPHMEHDNILRYIG-AEKR 177
             G FG V+K   ++   VA+K    +  Q  +  +   + L    H +++  IG  ++R
Sbjct: 48  GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCN-----IVTWEQLCRIALSMSKGLMHLHEEILPN 232
            E I     LI  Y E G+L   L  +      ++WEQ   I +  ++GL +LH      
Sbjct: 108 NEMI-----LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---- 158
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV---GTRRYM 289
                  A+ HRD KS N+LL  +    I DFG++   + G   G TH      GT  Y+
Sbjct: 159 -------AIIHRDVKSINILLDENFVPKITDFGIS---KKGTELGQTHLXXVVKGTLGYI 208
Query: 290 APE-VLEGAINFSRDAFLRIDMYACALVLWE-LASRCSSVSPPPGEY--RLPFSAEVGDH 345
            PE  ++G +        + D+Y+  +VL+E L +R + V   P E      ++ E  ++
Sbjct: 209 DPEYFIKGRLT------EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV 399
             LE + +  +  K+R   PE+ ++        DT  +C    +E R S   V+
Sbjct: 263 GQLEQIVDPNLADKIR---PESLRKFG------DTAVKCLALSSEDRPSMGDVL 307

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILRYI 172
           +E   +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
           G+  +     T+ W+I  Y   GS  D L+   +   Q+  I   + KGL +LH E    
Sbjct: 72  GSYLK----DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD K+ NVLL       +ADFG+A      +   +T   VGT  +MAPE
Sbjct: 124 -------KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPE 174
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELA 321
           V++ +   S     + D+++  +   ELA
Sbjct: 175 VIKQSAYDS-----KADIWSLGITAIELA 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 106 SPQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKL 160
            P     + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L
Sbjct: 1   GPLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 161 PHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSM 218
             + H NI++ +      + IHTE   +L+  +  +  L  F+  + +T      I L +
Sbjct: 61  KELNHPNIVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPL 108
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            K  +    ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P   
Sbjct: 109 IKSYLF---QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRT 163
Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
              +V T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 164 YTHEVVTLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 204

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGA 174
             G FGAV+ A+    +E VA+K      KQS +  Q+I K    L  + H N ++Y G 
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS--KGLMHLHEEILPN 232
             R    HT  WL+  Y   GS  D L+ +    +++   A++    +GL +LH      
Sbjct: 84  YLRE---HTA-WLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---- 134
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   + HRD K+ N+LL       + DFG A +  P          VGT  +MAPE
Sbjct: 135 -------NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPE 181
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASR 323
           V+        D   ++D+++  +   ELA R
Sbjct: 182 VILAMDEGQYDG--KVDVWSLGITCIELAER 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 61/307 (19%)
Query: 101 PTSPPSPQQGCR--------SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIF---LMQDK 148
           PTS P  Q   +        S++L     QG FG VW   +     VA+K      M  +
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 307
Query: 149 QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW 208
              Q  Q + KL H +   +   +  E          +++T Y  +GSL DFLK     +
Sbjct: 308 AFLQEAQVMKKLRHEKLVQLYAVVSEEP--------IYIVTEYMSKGSLLDFLKGETGKY 359
Query: 209 ---EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
               QL  +A  ++ G+ ++            +    HRD ++ N+L+  +L   +ADFG
Sbjct: 360 LRLPQLVDMAAQIASGMAYVE-----------RMNYVHRDLRAANILVGENLVCKVADFG 408
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           LA L E  +      G     ++ APE    A  + R   ++ D+++  ++L EL ++  
Sbjct: 409 LARLIEDNEYTA-RQGAKFPIKWTAPE----AALYGRFT-IKSDVWSFGILLTELTTKG- 461
Query: 326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
                    R+P+   V  +  + D  E        P  PE+         L D M +CW
Sbjct: 462 ---------RVPYPGMV--NREVLDQVERGYRMPCPPECPES---------LHDLMCQCW 501
Query: 386 DHDAEAR 392
             + E R
Sbjct: 502 RKEPEER 508

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++  Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 139 AVKIFLMQDKQSWQSEQ-EIFKLPHMEHDNILRYIGAE------KRGESIHTEFWLITAY 191
           AVKI  +    S+ +E+ +  +   ++  +ILR +         K     +T F+L+   
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 192 HERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN 250
            ++G L D+L   +   E+  R I  ++ + +  LH           K  + HRD K  N
Sbjct: 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-----------KLNIVHRDLKPEN 154
Query: 251 VLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR-ID 309
           +LL  D+   + DFG +   +PG+         GT  Y+APE++E ++N +   + + +D
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLRSV---CGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 310 MYACALVLWELASRCSSVSPP 330
           M++  ++++ L +     SPP
Sbjct: 212 MWSTGVIMYTLLAG----SPP 228

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/316 (22%), Positives = 130/316 (41%), Gaps = 64/316 (20%)
Query: 116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE-QEIFKLPHMEHDNILRYIGA 174
           ++E   +G +G+V+KA  K     V I  +  +   Q   +EI  +   +  ++++Y G+
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 175 EKRGESIHTEFWLITAYHERGSLCDF--LKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
             +    +T+ W++  Y   GS+ D   L+   +T +++  I  S  KGL +LH      
Sbjct: 93  YFK----NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH------ 142
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
               +   + HRD K+ N+LL ++  A +ADFG+A   +        +  +GT  +MAPE
Sbjct: 143 ----FMRKI-HRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPE 195
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWEL---ASRCSSVSPPPGEY---RLPFSAEVGDHP 346
           V++               Y C   +W L   A   +   PP  +    R  F       P
Sbjct: 196 VIQEI------------GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP 243
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE------ 400
           +                 PE W  +       D +++C     E R +A+ +++      
Sbjct: 244 TFRK--------------PELWSDN-----FTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
Query: 401 -RGMLALCDTMEECWD 415
            +G+  L D + E  D
Sbjct: 285 AKGVSILRDLINEAMD 300

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 71  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 117
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 118 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 174 LWYRAPEILLGXKYYST----AVDIWSLGCIFAEMVTR 207

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 39/247 (15%)
Query: 92  NPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----- 146
           NP PT+         P      I+  +V  +G FG V KA+ K + + +   + +     
Sbjct: 10  NPDPTI--------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA 61
Query: 147 ---DKQSWQSEQEIF-KLPHMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFL 201
              D + +  E E+  KL H  H NI+  +GA E RG       +L   Y   G+L DFL
Sbjct: 62  SKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFL 114
Query: 202 -KCNIVTWEQLCRIALSM-----SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
            K  ++  +    IA S      S+ L+H   ++        +    HR+  + N+L+  
Sbjct: 115 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGE 174
Query: 256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL 315
           +  A IADFGL+   E       T G++   R+MA E L  ++  +       D+++  +
Sbjct: 175 NYVAKIADFGLSRGQEV--YVKKTMGRLPV-RWMAIESLNYSVYTTNS-----DVWSYGV 226
Query: 316 VLWELAS 322
           +LWE+ S
Sbjct: 227 LLWEIVS 233

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + ++L++   +G FG V    ++   VAVK  +  D  +     E   +  + H N+++ 
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 172 IGA--EKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLH 226
           +G   E++G       +++T Y  +GSL D+L+    +++  + L + +L + + + +L 
Sbjct: 65  LGVIVEEKGG-----LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 118
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                 + +++     HRD  + NVL+  D  A ++DFGL    +      DT G++   
Sbjct: 119 ------EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDT-GKLPV- 163
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++ APE L     FS  +    D+++  ++LWE+ S
Sbjct: 164 KWTAPEALREK-KFSTKS----DVWSFGILLWEIYS 194

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 71  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 117
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 118 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 174 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 207

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + ++L++   +G FG V    ++   VAVK  +  D  +     E   +  + H N+++ 
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 172 IGA---EKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHL 225
           +G    EK G       +++T Y  +GSL D+L+    +++  + L + +L + + + +L
Sbjct: 80  LGVIVEEKGG------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                  + +++     HRD  + NVL+  D  A ++DFGL    +      DT G++  
Sbjct: 134 -------EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDT-GKLPV 178
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            ++ APE L     FS  +    D+++  ++LWE+ S
Sbjct: 179 -KWTAPEALREK-KFSTKS----DVWSFGILLWEIYS 209

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLM--QDKQSWQSEQEIFKLPHMEHD 166
           I +  V   G FG V   + K        VA+K   +   +KQ      E   +   +H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMH 224
           NI+   G   + + +     ++T Y E GSL  FLK N    T  QL  +   +S G+ +
Sbjct: 84  NIIHLEGVVTKSKPVM----IVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG-DTHGQV 283
           L +               HRD  + N+L+ S+L   ++DFGL+ + E        T G  
Sbjct: 140 LSDM-----------GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              R+ APE    AI F R      D+++  +V+WE+ S
Sbjct: 189 IPIRWTAPE----AIAF-RKFTSASDVWSYGIVMWEVVS 222

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMH 224
           I++ +      + IHTE  L   +       +FL  ++  +     L  I L + K  + 
Sbjct: 65  IVKLL------DVIHTENKLYLVF-------EFLSMDLKKFMDASALTGIPLPLIKSYLF 111
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
              ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V 
Sbjct: 112 ---QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV 166
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           T  Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 TLWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 201

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 85
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 86  -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 133
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 188
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 189 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 56/290 (19%)
Query: 119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAE 175
           V  +G +G V+  +  +  V + I  + ++ S  S+   +EI    H++H NI++Y+G+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 176 KRGESIHTEFWLITAYHER---GSLCDFLKCN---IVTWEQLCRI-ALSMSKGLMHLHEE 228
                  +E   I  + E+   GSL   L+     +   EQ        + +GL +LH+ 
Sbjct: 88  ------FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                       + HRD K +NVL+ +      I+DFG +       PC +T    GT +
Sbjct: 142 -----------QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQ 188
Query: 288 YMAPEVLE-GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           YMAPE+++ G   + + A    D+++    + E+A+      PP  E   P +A      
Sbjct: 189 YMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATG----KPPFYELGEPQAAMF---- 236
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                   V   K+ P +PE+    A    L     +C++ D + R  A+
Sbjct: 237 -------KVGMFKVHPEIPESMSAEAKAFIL-----KCFEPDPDKRACAN 274

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V+   +K  ++ V +  +++      E  +E   +  ++H N+++ +G      +
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----T 98
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           +   F+++T Y   G+L D+L+ CN   VT   L  +A  +S  + +L            
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE----------- 147
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 202
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 203 L--AYNTFS----IKSDVWAFGVLLWEIATY--GMSPYPG 234

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 66  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 112
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 113 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 168
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 169 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGXKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 61/307 (19%)
Query: 101 PTSPPSPQQGCR--------SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIF---LMQDK 148
           PTS P  Q   +        S++L     QG FG VW   +     VA+K      M  +
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 224
Query: 149 QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW 208
              Q  Q + KL H +   +   +  E          +++T Y  +GSL DFLK     +
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEP--------IYIVTEYMSKGSLLDFLKGETGKY 276
Query: 209 ---EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
               QL  +A  ++ G+ ++            +    HRD ++ N+L+  +L   +ADFG
Sbjct: 277 LRLPQLVDMAAQIASGMAYVE-----------RMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           LA L E  +      G     ++ APE    A  + R   ++ D+++  ++L EL ++  
Sbjct: 326 LARLIEDNEYTA-RQGAKFPIKWTAPE----AALYGRFT-IKSDVWSFGILLTELTTKG- 378
Query: 326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
                    R+P+   V  +  + D  E        P  PE         +L D M +CW
Sbjct: 379 ---------RVPYPGMV--NREVLDQVERGYRMPCPPECPE---------SLHDLMCQCW 418
Query: 386 DHDAEAR 392
             + E R
Sbjct: 419 RKEPEER 425

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 61/307 (19%)
Query: 101 PTSPPSPQQGCR--------SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIF---LMQDK 148
           PTS P  Q   +        S++L     QG FG VW   +     VA+K      M  +
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 224
Query: 149 QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW 208
              Q  Q + KL H +   +   +  E          +++T Y  +GSL DFLK     +
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEP--------IYIVTEYMSKGSLLDFLKGETGKY 276
Query: 209 ---EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
               QL  +A  ++ G+ ++            +    HRD ++ N+L+  +L   +ADFG
Sbjct: 277 LRLPQLVDMAAQIASGMAYVE-----------RMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           LA L E  +      G     ++ APE    A  + R   ++ D+++  ++L EL ++  
Sbjct: 326 LARLIEDNEYTA-RQGAKFPIKWTAPE----AALYGRFT-IKSDVWSFGILLTELTTKG- 378
Query: 326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
                    R+P+   V  +  + D  E        P  PE         +L D M +CW
Sbjct: 379 ---------RVPYPGMV--NREVLDQVERGYRMPCPPECPE---------SLHDLMCQCW 418
Query: 386 DHDAEAR 392
             + E R
Sbjct: 419 RKEPEER 425

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 67  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 113
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 114 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 169
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 170 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 66  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 112
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 113 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 168
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 169 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 63  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 109
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 110 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 165
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 166 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 199

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++  Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 80
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 81  -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 128
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 184 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 215

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILRYI 172
           +E   +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y 
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
           G+  +     T+ W+I  Y   GS  D L+   +   Q+  I   + KGL +LH E    
Sbjct: 87  GSYLK----DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---- 138
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VGTRRY 288
                     HRD K+ NVLL       +ADFG+A          DT  +    VGT  +
Sbjct: 139 -------KKIHRDIKAANVLLSEHGEVKLADFGVA------GQLTDTQIKRNXFVGTPFW 185
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
           MAPEV++ +   S     + D+++  +   ELA
Sbjct: 186 MAPEVIKQSAYDS-----KADIWSLGITAIELA 213

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 66  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 112
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 113 --QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 168
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 169 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 65  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 111
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 112 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 167
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 168 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 65  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 111
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 112 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 167
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 168 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 201

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +G L DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAV-KIFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+ KI L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAV-KIFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+ KI L  + +   S   +EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 63  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 109
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 110 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 166 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 80
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 81  -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 128
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 184 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 63  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 109
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 110 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 166 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 65  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 111
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 112 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 167
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 168 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 201

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G+FG V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 78
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 79  -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 126
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT     G +   ++ APE 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTXTAHAGAKFPIKWTAPES 181
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 182 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 213

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 63  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 109
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 110 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 165
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 166 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 199

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 15  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++T Y  +GSL DFLK     +    QL  +A  ++ G+ ++   
Sbjct: 75  VSEEP--------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 124
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 125 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 174
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 175 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 217
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  + E R
Sbjct: 218 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEER 252

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGLA + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 65  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 111
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 112 --QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 167
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 168 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 85
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 86  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 133
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 188
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 189 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 220

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 63  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 109
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 110 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 166 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 199

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++  Y  +GSL DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 85
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 86  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 133
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 188
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 189 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 220

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   A  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 118/275 (42%), Gaps = 51/275 (18%)
Query: 117 VEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILRYI 172
           +E   +G FG V+K       + VA+KI  +++ +      +QEI  L   +   + +Y 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
           G+  +     T+ W+I  Y   GS  D L+   +   Q+  I   + KGL +LH E    
Sbjct: 72  GSYLK----DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VGTRRY 288
                     HRD K+ NVLL       +ADFG+A          DT  +    VGT  +
Sbjct: 124 -------KKIHRDIKAANVLLSEHGEVKLADFGVA------GQLTDTQIKRNXFVGTPFW 170
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---RLPFSAEVGDH 345
           MAPEV++ +   S     + D+++  +   ELA       PP  E    ++ F     + 
Sbjct: 171 MAPEVIKQSAYDS-----KADIWSLGITAIELARG----EPPHSELHPMKVLFLIPKNNP 221
Query: 346 PSLE--------DMQEAVVHKK--LRPTLPETWKQ 370
           P+LE        +  EA ++K+   RPT  E  K 
Sbjct: 222 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 256

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 48/281 (17%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 19  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           +  E          +++T Y  +GSL DFLK     + +L +        L+ +  +I  
Sbjct: 79  VSEEP--------IYIVTEYMNKGSLLDFLKGETGKYLRLPQ--------LVDMSAQIAS 122
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
             A   +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++ AP
Sbjct: 123 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAP 181
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDM 351
           E    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  + D 
Sbjct: 182 E----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREVLDQ 224
Query: 352 QEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            E        P  PE+         L D M +CW  + E R
Sbjct: 225 VERGYRMPCPPECPES---------LHDLMCQCWRKEPEER 256

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 111/291 (38%), Gaps = 47/291 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 89  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------- 135
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  + DFG      P +    T   VGT  +MAPEV+   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV--- 188
Query: 298 INFSRDAFL-RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
              +R A+  ++D+++  ++  E+                      G+ P L +     +
Sbjct: 189 ---TRKAYGPKVDIWSLGIMAIEMIE--------------------GEPPYLNENPLRAL 225
Query: 357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC 407
           +       PE            D +  C D D E R SA  +++   L + 
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 84
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 85  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 132
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 187
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 188 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 219

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 82
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 83  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 130
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 185
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 186 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 93
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 94  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 141
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 196
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 197 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 228

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 82
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 83  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 130
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 185
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 186 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 217

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 56/290 (19%)
Query: 119 VKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAE 175
           V  +G +G V+  +  +  V + I  + ++ S  S+   +EI    H++H NI++Y+G+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 176 KRGESIHTEFWLITAYHER---GSLCDFLKCN---IVTWEQLCRI-ALSMSKGLMHLHEE 228
                  +E   I  + E+   GSL   L+     +   EQ        + +GL +LH+ 
Sbjct: 74  ------FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                       + HRD K +NVL+ +      I+DFG +       PC +T    GT +
Sbjct: 128 -----------QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQ 174
Query: 288 YMAPEVLE-GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           YMAPE+++ G   + + A    D+++    + E+A+      PP  E   P +A      
Sbjct: 175 YMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATG----KPPFYELGEPQAAMF---- 222
Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                   V   K+ P +PE+    A    L     +C++ D + R  A+
Sbjct: 223 -------KVGMFKVHPEIPESMSAEAKAFIL-----KCFEPDPDKRACAN 260

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 105/227 (46%), Gaps = 42/227 (18%)
Query: 105 PSPQQGCRSIQLVEVKAQGRFGAV---WKAKFKNENVAVKIF------LMQDKQSWQSEQ 155
           P   QG R +        G +G+V   + A+ + + VAVK        L+  +++++   
Sbjct: 19  PQRLQGLRPV------GSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYR--- 68
Query: 156 EIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+  L H++H+N++  +       SI   +E +L+T       L + +KC  ++ E +  
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQF 127
Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
           +   + +GL ++H              + HRD K +NV +  D    I DFGLA      
Sbjct: 128 LVYQLLRGLKYIH-----------SAGIIHRDLKPSNVAVNEDCELRILDFGLA-----R 171
Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           +   +  G V TR Y APE++   +++++     +D+++   ++ EL
Sbjct: 172 QADEEMTGYVATRWYRAPEIMLNWMHYNQT----VDIWSVGCIMAEL 214

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 80
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 81  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 128
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 184 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 121 AQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRYIGAE 175
            QG FG V+KA+ +   + VA+K  LM++++      + +EI  L  ++H+N++  I   
Sbjct: 27  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 86
Query: 176 KRGESIHTE----FWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLMHLHEEI 229
           +   S +       +L+  + E   L   L   +V  T  ++ R+   +  GL ++H   
Sbjct: 87  RTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 142
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH--GQVGTRR 287
                   +  + HRD K+ NVL+  D    +ADFGLA  F   K         +V T  
Sbjct: 143 --------RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           Y  PE+L G     RD    ID++    ++ E+ +R   +     +++L   +++
Sbjct: 195 YRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 81
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 82  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 129
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH----GQVGTRRYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G     ++ APE 
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAPAGAKFPIKWTAPES 184
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 185 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 105/227 (46%), Gaps = 42/227 (18%)
Query: 105 PSPQQGCRSIQLVEVKAQGRFGAV---WKAKFKNENVAVKIF------LMQDKQSWQSEQ 155
           P   QG R +        G +G+V   + A+ + + VAVK        L+  +++++   
Sbjct: 27  PQRLQGLRPV------GSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYR--- 76
Query: 156 EIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+  L H++H+N++  +       SI   +E +L+T       L + +KC  ++ E +  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQF 135
Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
           +   + +GL ++H              + HRD K +NV +  D    I DFGLA      
Sbjct: 136 LVYQLLRGLKYIH-----------SAGIIHRDLKPSNVAVNEDSELRILDFGLA-----R 179
Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           +   +  G V TR Y APE++   +++++     +D+++   ++ EL
Sbjct: 180 QADEEMTGYVATRWYRAPEIMLNWMHYNQT----VDIWSVGCIMAEL 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 123 GRFGAV--WKAKFKNENVAVKIFLMQDKQSW----QSEQEIFKLPHMEHDNILRYIGAEK 176
           G FG V   K +     VAVKI   Q  +S     +  +EI  L    H +I++      
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI- 85
Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADS 236
              S  ++ +++  Y   G L D++          C+      K    L ++IL      
Sbjct: 86  ---STPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++  V HRD K  NVLL + + A IADFGL+ +   G+    +    G+  Y APEV+ G
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISG 189
Query: 297 AINFSRDAFLRIDMYACALVLWEL 320
            +     A   +D+++  ++L+ L
Sbjct: 190 RLY----AGPEVDIWSSGVILYAL 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 80
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 81  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 128
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 184 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 215

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 121 AQGRFGAVWKAKFK--NENVAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNILRYIGAE 175
            QG FG V+KA+ +   + VA+K  LM++++      + +EI  L  ++H+N++  I   
Sbjct: 26  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85
Query: 176 KRGESIHTE----FWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLMHLHEEI 229
           +   S +       +L+  + E   L   L   +V  T  ++ R+   +  GL ++H   
Sbjct: 86  RTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 141
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC--GDTHGQVGTRR 287
                   +  + HRD K+ NVL+  D    +ADFGLA  F   K         +V T  
Sbjct: 142 --------RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           Y  PE+L G     RD    ID++    ++ E+ +R   +     +++L   +++
Sbjct: 194 YRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 82
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 83  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 130
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH----GQVGTRRYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G     ++ APE 
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAPAGAKFPIKWTAPES 185
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 186 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 217

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 121 AQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRYIGAE 175
            QG FG V+KA+ +   + VA+K  LM++++      + +EI  L  ++H+N++  I   
Sbjct: 27  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 86
Query: 176 KRGESIHTE----FWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLMHLHEEI 229
           +   S +       +L+  + E   L   L   +V  T  ++ R+   +  GL ++H   
Sbjct: 87  RTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 142
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC--GDTHGQVGTRR 287
                   +  + HRD K+ NVL+  D    +ADFGLA  F   K         +V T  
Sbjct: 143 --------RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           Y  PE+L G     RD    ID++    ++ E+ +R   +     +++L   +++
Sbjct: 195 YRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 50/261 (19%)
Query: 82  YRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRS---------IQLVEVKAQGRFGAVWKAK 132
           Y Q KL     P P     P +   P +  RS         I + ++   G  G V   +
Sbjct: 15  YFQGKL-----PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGR 69
Query: 133 FK---NENVAVKI------FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT 183
            +     +V V I      +  + ++ + SE  I  +   +H NI+R  G   RG     
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI--MGQFDHPNIIRLEGVVTRGRLA-- 125
Query: 184 EFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV 241
              ++T Y E GSL  FL+ +    T  QL  +   +  G+ +L +              
Sbjct: 126 --MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-----------LGY 172
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFE--PGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
            HRD  + NVL+ S+L   ++DFGL+ + E  P      T G++   R+ APE    AI 
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPI-RWTAPE----AIA 227
Query: 300 FSRDAFLRIDMYACALVLWEL 320
           F R      D+++  +V+WE+
Sbjct: 228 F-RTFSSASDVWSFGVVMWEV 247

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 50/261 (19%)
Query: 82  YRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRS---------IQLVEVKAQGRFGAVWKAK 132
           Y Q KL     P P     P +   P +  RS         I + ++   G  G V   +
Sbjct: 15  YFQGKL-----PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGR 69
Query: 133 FK---NENVAVKI------FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT 183
            +     +V V I      +  + ++ + SE  I  +   +H NI+R  G   RG     
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI--MGQFDHPNIIRLEGVVTRGRLA-- 125
Query: 184 EFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV 241
              ++T Y E GSL  FL+ +    T  QL  +   +  G+ +L +              
Sbjct: 126 --MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-----------LGY 172
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFE--PGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
            HRD  + NVL+ S+L   ++DFGL+ + E  P      T G++   R+ APE    AI 
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI-RWTAPE----AIA 227
Query: 300 FSRDAFLRIDMYACALVLWEL 320
           F R      D+++  +V+WE+
Sbjct: 228 F-RTFSSASDVWSFGVVMWEV 247

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 121 AQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRYIGAE 175
            QG FG V+KA+ +   + VA+K  LM++++      + +EI  L  ++H+N++  I   
Sbjct: 27  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 86
Query: 176 KRGESIHTE----FWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLMHLHEEI 229
           +   S +       +L+  + E   L   L   +V  T  ++ R+   +  GL ++H   
Sbjct: 87  RTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 142
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC--GDTHGQVGTRR 287
                   +  + HRD K+ NVL+  D    +ADFGLA  F   K         +V T  
Sbjct: 143 --------RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           Y  PE+L G     RD    ID++    ++ E+ +R   +     +++L   +++
Sbjct: 195 YRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GFVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 48/281 (17%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 19  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           +  E          +++T Y  +GSL DFLK     + +L +        L+ +  +I  
Sbjct: 79  VSEEP--------IYIVTEYMNKGSLLDFLKGETGKYLRLPQ--------LVDMSAQIAS 122
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
             A   +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++ AP
Sbjct: 123 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTA-RQGAKFPIKWTAP 181
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDM 351
           E    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  + D 
Sbjct: 182 E----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREVLDQ 224
Query: 352 QEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            E        P  PE+         L D M +CW  + E R
Sbjct: 225 VERGYRMPCPPECPES---------LHDLMCQCWRKEPEER 256

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 21  VDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 80
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 81  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 136
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 137 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 185
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 240
Query: 320 LAS 322
           + S
Sbjct: 241 VMS 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 113 SIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDN 167
           + Q VE   +G +G V+KA  K   E VA+K I L  + +   S   +EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 168 ILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I++ +      + IHTE   +L+  +  +  L  F+  + +T      I L + K  +  
Sbjct: 64  IVKLL------DVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-----IPLPLIKSYLF- 110
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             ++L   +  +   V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T
Sbjct: 111 --QLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y APE+L G   +S      +D+++   +  E+ +R
Sbjct: 167 LWYRAPEILLGCKYYST----AVDIWSLGCIFAEMVTR 200

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 78
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 79  -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 126
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT     G +   ++ APE 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTFTAHAGAKFPIKWTAPES 181
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 182 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 213

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 52/261 (19%)
Query: 126 GAVWKAKFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH 182
           G +WK +++  ++ VK+  ++D   ++S    +E  +L    H N+L  +GA +   + H
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 183 TEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
               LIT +   GSL + L      +V   Q  + AL  ++G   LH         + +P
Sbjct: 84  PT--LITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH---------TLEP 132
Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
            +      S +V +  D TA I+   +   F+       + G+     ++APE L+    
Sbjct: 133 LIPRHALNSRSVXIDEDXTARISXADVKFSFQ-------SPGRXYAPAWVAPEALQKK-- 183
Query: 300 FSRDAFLR-IDMYACALVLWELASRCSSVSPPPGEYRLPFS----AEVGDHPSLEDMQEA 354
              D   R  D ++ A++LWEL +R            +PF+     E+G   +LE     
Sbjct: 184 -PEDTNRRSADXWSFAVLLWELVTR-----------EVPFADLSNXEIGXKVALEG---- 227
Query: 355 VVHKKLRPTLPETWKQHAGML 375
                LRPT+P     H   L
Sbjct: 228 -----LRPTIPPGISPHVSKL 243

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 12  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E           ++T Y  +GSL DFLK     +    QL  +A  ++ G+ ++   
Sbjct: 72  VSEEP--------IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 121
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 122 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA-RQGAKFPIKW 171
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 172 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 214
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  + E R
Sbjct: 215 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKEPEER 249

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEH 165
           +I + +V   G FG V   + K    + ++V I  ++    +KQ      E   +   +H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLM 223
            NI+R  G   + + +     ++T Y E GSL  FL+ +    T  QL  +   ++ G+ 
Sbjct: 94  PNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 149
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG-KPCGDTHGQ 282
           +L +               HRD  + N+L+ S+L   ++DFGL+ + E   +    T G 
Sbjct: 150 YLSDM-----------GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               R+ +PE    AI + R      D+++  +VLWE+ S
Sbjct: 199 KIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEH 165
           +I + +V   G FG V   + K    + ++V I  ++    +KQ      E   +   +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLM 223
            NI+R  G   + + +     ++T Y E GSL  FL+ +    T  QL  +   ++ G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG-KPCGDTHGQ 282
           +L +               HRD  + N+L+ S+L   ++DFGL+ + E   +    T G 
Sbjct: 133 YLSDM-----------GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               R+ +PE    AI + R      D+++  +VLWE+ S
Sbjct: 182 KIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWEVMS 216

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA-- 174
           +E+   G FG V+KAK + +     I  ++   + ++E+E+  L  ++H NI+ Y G   
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIRRVK-YNNEKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 175 ------EKRGESIHTEFW---LITAYHERGSLCDFLK---CNIVTWEQLC--RIALSMSK 220
                 E   +S+ +  +            + C F++   C+  T EQ    R    + K
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 221 GL-MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
            L + L E+I       +   + HRD K +N+ L       I DFGL       K  G  
Sbjct: 136 VLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKR 192
Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS 326
               GT RYM+PE +      S+D    +D+YA  L+L EL   C +
Sbjct: 193 TRSKGTLRYMSPEQIS-----SQDYGKEVDLYALGLILAELLHVCDT 234

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 287
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 288 -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 335
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HR+  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 390
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 391 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 422

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 85
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 86  -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 133
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT     G +   ++ APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTXTAHAGAKFPIKWTAPES 188
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 189 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 220

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 105/243 (43%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T Y E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEYMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPG-KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL  + E   +    T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFL--MQDKQSWQSEQEIFKLPHMEHDNIL 169
           S++L +    G+FG VW A + K+  VAVK         +++ +E  + K   ++HD ++
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT--LQHDKLV 240
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           + + A    E I+    +IT +  +GSL DFLK +  + + L +        L+    +I
Sbjct: 241 K-LHAVVTKEPIY----IITEFMAKGSLLDFLKSDEGSKQPLPK--------LIDFSAQI 287
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR--- 286
               A   +    HRD ++ N+L+ + L   IADFGLA              +VG +   
Sbjct: 288 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA--------------RVGAKFPI 333
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++ APE    AINF     ++ D+++  ++L E+ +
Sbjct: 334 KWTAPE----AINFGSFT-IKSDVWSFGILLMEIVT 364

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAV--KIFLMQDKQSWQSE--QEIFKLPHMEHDNILR 170
           Q +E   +G +G V+KAK     +    +I L  + +   S   +EI  L  + H NI+ 
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
            I      + IH+E  L   +       +F++ ++       +  L  S+  ++L++ +L
Sbjct: 84  LI------DVIHSERCLTLVF-------EFMEKDLKKVLDENKTGLQDSQIKIYLYQ-LL 129
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
              A  ++  + HRD K  N+L+ SD    +ADFGLA  F  G P      +V T  Y A
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRA 187
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           P+VL G+  +S      +D+++   +  E+ +
Sbjct: 188 PDVLMGSKKYSTS----VDIWSIGCIFAEMIT 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 45/237 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLM----QDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V    +        E VAVK        Q +  WQ E EI +  
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT- 66
Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            + H++I++Y G  E +GE       L+  Y   GSL D+L  + V   QL   A  + +
Sbjct: 67  -LYHEHIVKYKGCCEDQGEK---SVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICE 122
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +LH       A  Y     HR   + NVLL +D    I DFGLA      K   + H
Sbjct: 123 GMAYLH-------AQHY----IHRALAARNVLLDNDRLVKIGDFGLA------KAVPEGH 165
Query: 281 GQVGTRR-------YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                R        + APE L+         +   D+++  + L+EL + C S   P
Sbjct: 166 EYYRVREDGDSPVFWYAPECLKEC-----KFYYASDVWSFGVTLYELLTYCDSNQSP 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 113/258 (43%), Gaps = 54/258 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAVKI    DK    S   Q++F+    +  + H 
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKII---DKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL-SMSKGLM 223
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R     +   + 
Sbjct: 74  NIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           + H++            + HRD K+ N+LL +D+   IADFG +  F  G    DT    
Sbjct: 128 YCHQKF-----------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTF--C 173
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G+  Y APE+ +G     +     +D+++  ++L+ L S             LPF     
Sbjct: 174 GSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF----- 213
Query: 344 DHPSLEDMQEAVVHKKLR 361
           D  +L++++E V+  K R
Sbjct: 214 DGQNLKELRERVLRGKYR 231

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 45/237 (18%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLM----QDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V    +        E VAVK        Q +  WQ E EI +  
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT- 67
Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            + H++I++Y G  E +GE       L+  Y   GSL D+L  + V   QL   A  + +
Sbjct: 68  -LYHEHIVKYKGCCEDQGEK---SVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICE 123
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +LH       A  Y     HR   + NVLL +D    I DFGLA      K   + H
Sbjct: 124 GMAYLH-------AQHY----IHRALAARNVLLDNDRLVKIGDFGLA------KAVPEGH 166
Query: 281 GQVGTRR-------YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                R        + APE L+         +   D+++  + L+EL + C S   P
Sbjct: 167 EYYRVREDGDSPVFWYAPECLKEC-----KFYYASDVWSFGVTLYELLTYCDSNQSP 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNIL 169
           LV+   +G +G V  A  +   E VAVKI  M+      ++ + E  I K+  + H+N++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM--LNHENVV 67
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEE 228
           ++ G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH  
Sbjct: 68  KFYGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K  N+LL       I+DFGLA +F         +   GT  Y
Sbjct: 122 ---------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 289 MAPEVLEGAINFSRDAFLR--IDMYACALVL 317
           +APE+L+      R  F    +D+++C +VL
Sbjct: 173 VAPELLK------RREFHAEPVDVWSCGIVL 197

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 80
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++I  +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 81  -EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 128
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 184 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 80
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++I  +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 81  -EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 128
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 184 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 215

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 61/307 (19%)
Query: 101 PTSPPSPQQGCR--------SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIF---LMQDK 148
           PTS P  Q   +        S++L     QG FG VW   +     VA+K      M  +
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 224
Query: 149 QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW 208
              Q  Q + KL H +   +   +  E          +++  Y  +GSL DFLK     +
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEP--------IYIVGEYMSKGSLLDFLKGETGKY 276
Query: 209 ---EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
               QL  +A  ++ G+ ++            +    HRD ++ N+L+  +L   +ADFG
Sbjct: 277 LRLPQLVDMAAQIASGMAYVE-----------RMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           LA L E  +      G     ++ APE    A  + R   ++ D+++  ++L EL ++  
Sbjct: 326 LARLIEDNEYTA-RQGAKFPIKWTAPE----AALYGRFT-IKSDVWSFGILLTELTTKG- 378
Query: 326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
                    R+P+   V  +  + D  E        P  PE         +L D M +CW
Sbjct: 379 ---------RVPYPGMV--NREVLDQVERGYRMPCPPECPE---------SLHDLMCQCW 418
Query: 386 DHDAEAR 392
             + E R
Sbjct: 419 RKEPEER 425

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 113/258 (43%), Gaps = 54/258 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAVKI    DK    S   Q++F+    +  + H 
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKII---DKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL-SMSKGLM 223
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R     +   + 
Sbjct: 74  NIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           + H++            + HRD K+ N+LL +D+   IADFG +  F  G    DT    
Sbjct: 128 YCHQKF-----------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTF--C 173
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G+  Y APE+ +G     +     +D+++  ++L+ L S             LPF     
Sbjct: 174 GSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF----- 213
Query: 344 DHPSLEDMQEAVVHKKLR 361
           D  +L++++E V+  K R
Sbjct: 214 DGQNLKELRERVLRGKYR 231

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 54/284 (19%)
Query: 117 VEVK-AQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           +EVK  QG FG VW   +     VA+K      M  +   Q  Q + KL H +   +   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLHEE 228
           +  E          +++  Y  +G L DFLK  +  +    QL  +A  ++ G+ ++   
Sbjct: 82  VSEEP--------IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 132 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 181
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE    A  + R   ++ D+++  ++L EL ++           R+P+   V  +  +
Sbjct: 182 TAPE----AALYGRFT-IKSDVWSFGILLTELTTKG----------RVPYPGMV--NREV 224
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            D  E        P  PE+         L D M +CW  D E R
Sbjct: 225 LDQVERGYRMPCPPECPES---------LHDLMCQCWRKDPEER 259

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNIL 169
           LV+   +G +G V  A  +   E VAVKI  M+      ++ + E  I K+  + H+N++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM--LNHENVV 68
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEE 228
           ++ G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH  
Sbjct: 69  KFYGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K  N+LL       I+DFGLA +F         +   GT  Y
Sbjct: 123 ---------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 289 MAPEVLEGAINFSRDAFLR--IDMYACALVL 317
           +APE+L+      R  F    +D+++C +VL
Sbjct: 174 VAPELLK------RREFHAEPVDVWSCGIVL 198

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAV--KIFLMQDKQSWQSE--QEIFKLPHMEHDNILR 170
           Q +E   +G +G V+KAK     +    +I L  + +   S   +EI  L  + H NI+ 
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
            I      + IH+E  L   +       +F++ ++       +  L  S+  ++L++ +L
Sbjct: 84  LI------DVIHSERCLTLVF-------EFMEKDLKKVLDENKTGLQDSQIKIYLYQ-LL 129
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
              A  ++  + HRD K  N+L+ SD    +ADFGLA  F  G P      +V T  Y A
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRA 187
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           P+VL G+  +S      +D+++   +  E+ +
Sbjct: 188 PDVLMGSKKYSTS----VDIWSIGCIFAEMIT 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 110/291 (37%), Gaps = 47/291 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 89  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------- 135
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  + DFG      P +        VGT  +MAPEV+   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSEMVGTPYWMAPEVV--- 188
Query: 298 INFSRDAFL-RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
              +R A+  ++D+++  ++  E+                      G+ P L +     +
Sbjct: 189 ---TRKAYGPKVDIWSLGIMAIEMIE--------------------GEPPYLNENPLRAL 225
Query: 357 HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC 407
           +       PE            D +  C D D E R SA  +++   L + 
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 49/294 (16%)
Query: 121 AQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFK-LPHMEHDNILRYIG-AEKR 177
             G FG V+K   ++   VA+K    +  Q  +  +   + L    H +++  IG  ++R
Sbjct: 48  GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCN-----IVTWEQLCRIALSMSKGLMHLHEEILPN 232
            E I     LI  Y E G+L   L  +      ++WEQ   I +  ++GL +LH      
Sbjct: 108 NEMI-----LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---- 158
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV---GTRRYM 289
                  A+ HRD KS N+LL  +    I DFG++   + G     TH      GT  Y+
Sbjct: 159 -------AIIHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTHLXXVVKGTLGYI 208
Query: 290 APE-VLEGAINFSRDAFLRIDMYACALVLWE-LASRCSSVSPPPGEY--RLPFSAEVGDH 345
            PE  ++G +        + D+Y+  +VL+E L +R + V   P E      ++ E  ++
Sbjct: 209 DPEYFIKGRLT------EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV 399
             LE + +  +  K+R   PE+ ++        DT  +C    +E R S   V+
Sbjct: 263 GQLEQIVDPNLADKIR---PESLRKFG------DTAVKCLALSSEDRPSMGDVL 307

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNIL 169
           LV+   +G +G V  A  +   E VAVKI  M+      ++ + E  I K+  + H+N++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM--LNHENVV 67
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEE 228
           ++ G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH  
Sbjct: 68  KFYGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K  N+LL       I+DFGLA +F         +   GT  Y
Sbjct: 122 ---------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 289 MAPEVLEGAINFSRDAFLR--IDMYACALVL 317
           +APE+L+      R  F    +D+++C +VL
Sbjct: 173 VAPELLK------RREFHAEPVDVWSCGIVL 197

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 85
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++I  +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 86  -EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 133
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 188
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 189 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 220

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 326
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++IT +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 327 -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 374
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HR+  + N L+  +    +ADFGL+ L       GDT+    G +   ++ APE 
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 429
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 430 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 461

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 52/270 (19%)
Query: 102 TSPPSPQQGCRSIQLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQ--SEQEI 157
           TS    Q    + +L +   +G F  V  A+       VAVKI    DK      S Q++
Sbjct: 5   TSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKII---DKTQLNPTSLQKL 61
Query: 158 FK----LPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQL 211
           F+    +  + H NI++        E I TE   +L+  Y   G + D+L  +    E+ 
Sbjct: 62  FREVRIMKILNHPNIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 115
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
            R              +I+      ++  + HRD K+ N+LL  D+   IADFG +  F 
Sbjct: 116 ARAKF----------RQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFT 165
Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
            G    DT    G+  Y APE+ +G     +     +D+++  ++L+ L S         
Sbjct: 166 VGNKL-DTF--CGSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS------- 211
Query: 332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLR 361
               LPF     D  +L++++E V+  K R
Sbjct: 212 ----LPF-----DGQNLKELRERVLRGKYR 232

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHD 166
           I++ +V   G FG V   + K      + V I  ++    DKQ      E   +   +H 
Sbjct: 31  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMH 224
           NI+   G   + + +     +IT Y E GSL  FL+ N    T  QL  +   +  G+ +
Sbjct: 91  NIIHLEGVVTKCKPVM----IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG-DTHGQV 283
           L +            +  HRD  + N+L+ S+L   ++DFG++ + E        T G  
Sbjct: 147 LSDM-----------SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              R+ APE    AI + R      D+++  +V+WE+ S
Sbjct: 196 IPIRWTAPE----AIAY-RKFTSASDVWSYGIVMWEVMS 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 36  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 93
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LKC  ++ + +C     + +GL ++H       
Sbjct: 94  IRAPTIEQMKDVYIVQDLME-TDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS------ 146
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 147 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 202 IMLNSKGYTKS----IDIWSVGCILAEMLS 227

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 89  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------- 135
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  + DFG      P +        VGT  +MAPEV+   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPYWMAPEVV--- 188
Query: 298 INFSRDAFL-RIDMYACALVLWEL 320
              +R A+  ++D+++  ++  E+
Sbjct: 189 ---TRKAYGPKVDIWSLGIMAIEM 209

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILR 170
           QL  +  +G +G V  A  K   E VA+K     DK   + ++ +EI  L H +H+NI+ 
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 171 YIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
               + R +S     E ++I    +   L   +   +++ + +        + +  LH  
Sbjct: 74  IFNIQ-RPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP-----GKPCGDTHGQ- 282
                       V HRD K +N+L+ S+    + DFGLA + +       +P G   G  
Sbjct: 132 -----------NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 283 --VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             V TR Y APEV+  +  +SR     +D+++C  +L EL  R
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSR----AMDVWSCGCILAELFLR 219

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 52  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 109
Query: 176 KRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
            R  +I    + +L+T  H  G+ L   LK   ++ + +C     + +GL ++H      
Sbjct: 110 IRAPTIEQMKDVYLVT--HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---- 163
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAP 291
                   V HRD K +N+LL +     I DFGLA + +P     G     V TR Y AP
Sbjct: 164 -------NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           E++  +  +++     ID+++   +L E+ S
Sbjct: 217 EIMLNSKGYTKS----IDIWSVGCILAEMLS 243

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 89
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 90  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------- 136
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+N+LL  D +  + DFG      P +        VGT  +MAPEV+   
Sbjct: 137 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPYWMAPEVV--- 189
Query: 298 INFSRDAFL-RIDMYACALVLWEL 320
              +R A+  ++D+++  ++  E+
Sbjct: 190 ---TRKAYGPKVDIWSLGIMAIEM 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A+ K+    V + +M  ++  + E    E+  +   +H N++    +   
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           GE    E W++  + + G+L D +    +  EQ+  +  ++ + L +LH +         
Sbjct: 114 GE----ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ--------- 160
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HRD KS+++LL  D    ++DFG         P       VGT  +MAPEV+  +
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKXLVGTPYWMAPEVISRS 216
Query: 298 INFSRDAFLRIDMYACALVLWELA 321
           +  +      +D+++  +++ E+ 
Sbjct: 217 LYAT-----EVDIWSLGIMVIEMV 235

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILR 170
           QL  +  +G +G V  A  K   E VA+K     DK   + ++ +EI  L H +H+NI+ 
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 171 YIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
               + R +S     E ++I    +   L   +   +++ + +        + +  LH  
Sbjct: 74  IFNIQ-RPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP-----GKPCGDTHGQ- 282
                       V HRD K +N+L+ S+    + DFGLA + +       +P G   G  
Sbjct: 132 -----------NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 283 --VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             V TR Y APEV+  +  +SR     +D+++C  +L EL  R
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSR----AMDVWSCGCILAELFLR 219

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG--- 173
           +E+   G FG V+KAK + +     I  ++   + ++E+E+  L  ++H NI+ Y G   
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 174 --------AEKRGESIHTE-FWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSM----S 219
                   + K      T+  ++   + ++G+L  +++      E+L ++ AL +    +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQIT 132
Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           KG+ ++H + L N           RD K +N+ L       I DFGL       K  G  
Sbjct: 133 KGVDYIHSKKLIN-----------RDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKR 178
Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS 326
               GT RYM+PE +      S+D    +D+YA  L+L EL   C +
Sbjct: 179 XRSKGTLRYMSPEQIS-----SQDYGKEVDLYALGLILAELLHVCDT 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILR 170
           QL  +  +G +G V  A  K   E VA+K     DK   + ++ +EI  L H +H+NI+ 
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 171 YIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
               + R +S     E ++I    +   L   +   +++ + +        + +  LH  
Sbjct: 74  IFNIQ-RPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP-----GKPCGDTHGQ- 282
                       V HRD K +N+L+ S+    + DFGLA + +       +P G   G  
Sbjct: 132 -----------NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 283 --VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             V TR Y APEV+  +  +SR     +D+++C  +L EL  R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSR----AMDVWSCGCILAELFLR 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHD 166
           I++ +V   G FG V   + K      + V I  ++    DKQ      E   +   +H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMH 224
           NI+   G   + + +     +IT Y E GSL  FL+ N    T  QL  +   +  G+ +
Sbjct: 70  NIIHLEGVVTKCKPVM----IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG-DTHGQV 283
           L +        SY     HRD  + N+L+ S+L   ++DFG++ + E        T G  
Sbjct: 126 LSDM-------SY----VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              R+ APE    AI + R      D+++  +V+WE+ S
Sbjct: 175 IPIRWTAPE----AIAY-RKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHD 166
           I++ +V   G FG V   + K      + V I  ++    DKQ      E   +   +H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMH 224
           NI+   G   + + +     +IT Y E GSL  FL+ N    T  QL  +   +  G+ +
Sbjct: 76  NIIHLEGVVTKCKPVM----IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG-DTHGQV 283
           L +        SY     HRD  + N+L+ S+L   ++DFG++ + E        T G  
Sbjct: 132 LSDM-------SY----VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              R+ APE    AI + R      D+++  +V+WE+ S
Sbjct: 181 IPIRWTAPE----AIAY-RKFTSASDVWSYGIVMWEVMS 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 39/248 (15%)
Query: 100 HPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQS 153
           +P S  +      + Q+V+   +G FG V  A      + VA+KI     L +     + 
Sbjct: 1   NPKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 60
Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+EI  L  + H +I++     K  + I     ++   +    L D++       EQ  R
Sbjct: 61  EREISYLRLLRHPHIIKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQEAR 115
Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
                        ++I+      ++  + HRD K  N+LL   L   IADFGL+ +   G
Sbjct: 116 ----------RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165
Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                +    G+  Y APEV+ G +     A   +D+++C ++L+ +  R          
Sbjct: 166 NFLKTS---CGSPNYAAPEVISGKLY----AGPEVDVWSCGVILYVMLCR---------- 208
Query: 334 YRLPFSAE 341
            RLPF  E
Sbjct: 209 -RLPFDDE 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 33/188 (17%)
Query: 140 VKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD 199
           + I  M  K+  +S +E+  L +M+H NI++Y  + +   S+    +++  Y E G L  
Sbjct: 57  INISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL----YIVMDYCEGGDLFK 112
Query: 200 FL---KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD 256
            +   K  +   +Q+    + +   L H+H+             + HRD KS N+ L  D
Sbjct: 113 RINAQKGVLFQEDQILDWFVQICLALKHVHDR-----------KILHRDIKSQNIFLTKD 161
Query: 257 LTAAIADFGLALLF----EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYA 312
            T  + DFG+A +     E  + C      +GT  Y++PE+ E     ++      D++A
Sbjct: 162 GTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENKPYNNKS-----DIWA 210
Query: 313 CALVLWEL 320
              VL+EL
Sbjct: 211 LGCVLYEL 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 54/258 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAV+I    DK    S   Q++F+    +  + H 
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVRII---DKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL-SMSKGLM 223
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R     +   + 
Sbjct: 74  NIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           + H++            + HRD K+ N+LL +D+   IADFG +  F  G    DT    
Sbjct: 128 YCHQKF-----------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTF--C 173
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G+  Y APE+ +G     +     +D+++  ++L+ L S             LPF     
Sbjct: 174 GSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF----- 213
Query: 344 DHPSLEDMQEAVVHKKLR 361
           D  +L++++E V+  K R
Sbjct: 214 DGQNLKELRERVLRGKYR 231

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            QG  G V+ A        V I  M  +Q  + E    EI  +   ++ NI+ Y+ +   
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 89
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  Y   GSL D +    +   Q+  +     + L  LH           
Sbjct: 90  GD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--------- 136
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA 297
              V HR+ KS+N+LL  D +  + DFG      P +    T   VGT  +MAPEV+   
Sbjct: 137 --QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV--- 189
Query: 298 INFSRDAFL-RIDMYACALVLWEL 320
              +R A+  ++D+++  ++  E+
Sbjct: 190 ---TRKAYGPKVDIWSLGIMAIEM 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 39/248 (15%)
Query: 100 HPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQS 153
           +P S  +      + Q+V+   +G FG V  A      + VA+KI     L +     + 
Sbjct: 2   NPKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 61
Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+EI  L  + H +I++     K  + I     ++   +    L D++       EQ  R
Sbjct: 62  EREISYLRLLRHPHIIKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQEAR 116
Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
                        ++I+      ++  + HRD K  N+LL   L   IADFGL+ +   G
Sbjct: 117 ----------RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 166
Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                +    G+  Y APEV+ G +     A   +D+++C ++L+ +  R          
Sbjct: 167 NFLKTS---CGSPNYAAPEVISGKLY----AGPEVDVWSCGVILYVMLCR---------- 209
Query: 334 YRLPFSAE 341
            RLPF  E
Sbjct: 210 -RLPFDDE 216

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 116/263 (44%), Gaps = 41/263 (15%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQS----EQEIFKLPHMEHDNI 168
           ++V+    G    V+ A+    N  VA+K   +  ++  ++    E+E+     + H NI
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHE 227
           +  I  ++  +     ++L+  Y E  +L ++++ +  ++ +        +  G+ H H+
Sbjct: 74  VSMIDVDEEDDC----YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K  N+L+ S+ T  I DFG+A            H  +GT +
Sbjct: 130 -----------MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y +PE  +G    + D     D+Y+  +VL+E+      V  P      PF+ E     +
Sbjct: 178 YFSPEQAKGE---ATDECT--DIYSIGIVLYEML-----VGEP------PFNGETAVSIA 221
Query: 348 LEDMQEAV--VHKKLRPTLPETW 368
           ++ +Q++V  V   +R  +P++ 
Sbjct: 222 IKHIQDSVPNVTTDVRKDIPQSL 244

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 20/148 (13%)
Query: 185 FWLITAYHERGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAH 243
            +L+     +G L D+L   +   E+  R I  S+ + +  LH              + H
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN-----------NIVH 223
Query: 244 RDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRD 303
           RD K  N+LL  ++   ++DFG +   EPG+   +  G  G   Y+APE+L+ +++ +  
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG---YLAPEILKCSMDETHP 280
Query: 304 AFLR-IDMYACALVLWELASRCSSVSPP 330
            + + +D++AC ++L+ L +     SPP
Sbjct: 281 GYGKEVDLWACGVILFTLLAG----SPP 304

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 52/257 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQ--SEQEIFK----LPHMEHD 166
           +L++   +G F  V  A+       VA+KI    DK      S Q++F+    +  + H 
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
           NI++        E I TE   +LI  Y   G + D+L  +    E+  R           
Sbjct: 75  NIVKLF------EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-------- 120
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
              +I+      ++  + HRD K+ N+LL +D+   IADFG +  F  G   G      G
Sbjct: 121 --RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCG 175
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
              Y APE+ +G     +     +D+++  ++L+ L S             LPF     D
Sbjct: 176 APPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF-----D 215
Query: 345 HPSLEDMQEAVVHKKLR 361
             +L++++E V+  K R
Sbjct: 216 GQNLKELRERVLRGKYR 232

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  ++    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 219
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ + L  LH +         
Sbjct: 220 GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------- 266
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 267 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELI 319

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 110/257 (42%), Gaps = 52/257 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQ--SEQEIFK----LPHMEHD 166
           +L++   +G F  V  A+       VA+KI    DK      S Q++F+    +  + H 
Sbjct: 15  RLLKTIGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
           NI++        E I TE   +LI  Y   G + D+L  +    E+  R           
Sbjct: 72  NIVKLF------EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-------- 117
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
              +I+      ++  + HRD K+ N+LL +D+   IADFG +  F  G   G      G
Sbjct: 118 --RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCG 172
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           +  Y APE+ +G     +     +D+++  ++L+ L S             LPF     D
Sbjct: 173 SPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF-----D 212
Query: 345 HPSLEDMQEAVVHKKLR 361
             +L++++E V+  K R
Sbjct: 213 GQNLKELRERVLRGKYR 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 94  VPTLEPHPTSPPSPQQGC---RSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIF- 143
           V  L P  T+P   Q        ++ V+V   G FG V+K  +  E       VA+KI  
Sbjct: 17  VEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN 76
Query: 144 -LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL- 201
                K + +   E   +  M+H +++R +G       +     L+T     G L +++ 
Sbjct: 77  ETTGPKANVEFMDEALIMASMDHPHLVRLLGV-----CLSPTIQLVTQLMPHGCLLEYVH 131
Query: 202 --KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA 259
             K NI + + L    + ++KG+M+L E  L            HRD  + NVL+KS    
Sbjct: 132 EHKDNIGS-QLLLNWCVQIAKGMMYLEERRL-----------VHRDLAARNVLVKSPNHV 179
Query: 260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
            I DFGLA L E  +   +  G     ++MA E +       R    + D+++  + +WE
Sbjct: 180 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWE 234
Query: 320 LAS 322
           L +
Sbjct: 235 LMT 237

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 78
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++I  +   G+L D+L+ CN   V+   L  +A  +S  + +L            
Sbjct: 79  -EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----------- 126
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT     G +   ++ APE 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTXTAHAGAKFPIKWTAPES 181
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 182 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  ++    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 38  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 97
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ + L  LH +         
Sbjct: 98  GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------- 144
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 145 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELI 197

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  ++    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 40  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 99
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ + L  LH +         
Sbjct: 100 GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------- 146
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 147 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELI 199

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 52/257 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAVKI    DK    S   Q++F+    +  + H 
Sbjct: 10  RLLKTIGKGNFAKVKLARHILTGKEVAVKII---DKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R           
Sbjct: 67  NIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF-------- 112
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
              +I+      ++  + HRD K+ N+LL +D+   IADFG +  F  G    DT    G
Sbjct: 113 --RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTF--CG 167
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           +  Y APE+ +G     +     +D+++  ++L+ L S             LPF     D
Sbjct: 168 SPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF-----D 207
Query: 345 HPSLEDMQEAVVHKKLR 361
             +L++++E V+  K R
Sbjct: 208 GQNLKELRERVLRGKYR 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 39/233 (16%)
Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
           Q+V+   +G FG V  A      + VA+KI     L +     + E+EI  L  + H +I
Sbjct: 7   QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 66
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
           ++     K  + I     ++   +    L D++       EQ  R             ++
Sbjct: 67  IKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQ 111
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
           I+      ++  + HRD K  N+LL   L   IADFGL+ +   G     +    G+  Y
Sbjct: 112 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 168
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
            APEV+ G +     A   +D+++C ++L+ +  R           RLPF  E
Sbjct: 169 AAPEVISGKLY----AGPEVDVWSCGVILYVMLCR-----------RLPFDDE 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 123 GRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIGAEKRGES 180
           G++G V++  +K  ++ V +  +++      E  +E   +  ++H N+++ +G   R   
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--- 81
Query: 181 IHTEFWLITAYHERGSLCDFLK-CNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
               F++I  +   G+L D+L+ CN   V    L  +A  +S  + +L            
Sbjct: 82  -EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----------- 129
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTR---RYMAPEV 293
           K    HRD  + N L+  +    +ADFGL+ L       GDT     G +   ++ APE 
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTXTAHAGAKFPIKWTAPES 184
Query: 294 LEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
           L  A N FS    ++ D++A  ++LWE+A+    +SP PG
Sbjct: 185 L--AYNKFS----IKSDVWAFGVLLWEIATY--GMSPYPG 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 54/258 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAV+I    DK    S   Q++F+    +  + H 
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVRII---DKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL-SMSKGLM 223
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R     +   + 
Sbjct: 74  NIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           + H++            + HRD K+ N+LL +D+   IADFG +  F  G    +     
Sbjct: 128 YCHQKF-----------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEF---C 173
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G+  Y APE+ +G     +     +D+++  ++L+ L S             LPF     
Sbjct: 174 GSPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF----- 213
Query: 344 DHPSLEDMQEAVVHKKLR 361
           D  +L++++E V+  K R
Sbjct: 214 DGQNLKELRERVLRGKYR 231

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 39/233 (16%)
Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
           Q+V+   +G FG V  A      + VA+KI     L +     + E+EI  L  + H +I
Sbjct: 11  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 70
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
           ++     K  + I     ++   +    L D++       EQ  R             ++
Sbjct: 71  IKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQ 115
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
           I+      ++  + HRD K  N+LL   L   IADFGL+ +   G     +    G+  Y
Sbjct: 116 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 172
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
            APEV+ G +     A   +D+++C ++L+ +  R           RLPF  E
Sbjct: 173 AAPEVISGKLY----AGPEVDVWSCGVILYVMLCR-----------RLPFDDE 210

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  ++    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 29  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 88
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ + L  LH +         
Sbjct: 89  GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------- 135
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELI 188

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 69  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 120
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 121 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 174 PELLK------RREFHAEPVDVWSCGIVL 196

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 112/256 (43%), Gaps = 33/256 (12%)
Query: 79  YWYYRQRKLGSYFNPVPTLEPH-PTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--- 134
           Y++++     +Y +P    +P+      + +     I++  V   G FG V   + K   
Sbjct: 9   YFHFKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPG 68
Query: 135 NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA 190
             +VAV I  ++    +KQ      E   +   +H N++   G   RG+ +     ++  
Sbjct: 69  KRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPV----MIVIE 124
Query: 191 YHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS 248
           + E G+L  FL+ +    T  QL  +   ++ G+ +L +               HRD  +
Sbjct: 125 FMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM-----------GYVHRDLAA 173
Query: 249 NNVLLKSDLTAAIADFGLALLFE--PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFL 306
            N+L+ S+L   ++DFGL+ + E  P      T G++   R+ APE ++      R    
Sbjct: 174 RNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV-RWTAPEAIQ-----YRKFTS 227
Query: 307 RIDMYACALVLWELAS 322
             D+++  +V+WE+ S
Sbjct: 228 ASDVWSYGIVMWEVMS 243

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  ++    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 33  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 92
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ + L  LH +         
Sbjct: 93  GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------- 139
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 140 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELI 192

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 126/297 (42%), Gaps = 49/297 (16%)
Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDNILRY 171
             G +G+V  A  K   E VA+K       + +QSE       +E+  L HM+H+N++  
Sbjct: 33  GSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 172 IGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTW--EQLCRIALSMSKGLMHLHE 227
           +       S+    +F+L+  + +     D  K   + +  E++  +   M KGL ++H 
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        V HRD K  N+ +  D    I DFGLA          +  G V TR 
Sbjct: 145 -----------AGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRW 188
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y APEV+   +++++     +D+++   ++ E+ +  +         +L    +V   P 
Sbjct: 189 YRAPEVILSWMHYNQ----TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244
Query: 348 LEDMQEA--VVHKKLRPTLPETWKQHAGML------ALCDTMEECWDHDAEARLSAS 396
            E +Q+      K    +LP+T ++    L         D +E+  + D + RL+A+
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKR 177
            +G  G V  A  ++    V +  M  ++  + E    E+  +   +H+N++    +   
Sbjct: 83  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 142
Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSY 237
           G+    E W++  + E G+L D +    +  EQ+  + L++ + L  LH +         
Sbjct: 143 GD----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--------- 189
Query: 238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              V HRD KS+++LL  D    ++DFG     +  K        VGT  +MAPE++
Sbjct: 190 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELI 242

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 87/174 (50%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++  A+++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNAMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF 70
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 71  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 122
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 123 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 176 PELLK------RREFHAEPVDVWSCGIVL 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 117 VEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRY 171
           +E   +G +G V+KAK +  +E VA+K   + D        + +EI  L  ++H NI+R 
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCD------FLKCN-IVTWEQLCRIALSMSKGLMH 224
                  + +H++  L   +      CD      F  CN  +  E +      + KGL  
Sbjct: 67  ------HDVLHSDKKLTLVFE----FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
            H              V HRD K  N+L+  +    +ADFGLA  F  G P      +V 
Sbjct: 117 CHSR-----------NVLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVV 163
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
           T  Y  P+VL GA  +S      IDM++   +  ELA+    + P
Sbjct: 164 TLWYRPPDVLFGAKLYSTS----IDMWSAGCIFAELANAARPLFP 204

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 43/239 (17%)
Query: 96  TLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIFL--MQD 147
           T E HP+        C + Q  +V   G FG V+K   K  +      VA+K       +
Sbjct: 38  TTEIHPS--------CVTRQ--KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 87
Query: 148 KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNI 205
           KQ      E   +    H NI+R  G   +    +    +IT Y E G+L  FL  K   
Sbjct: 88  KQRVDFLGEAGIMGQFSHHNIIRLEGVISK----YKPMMIITEYMENGALDKFLREKDGE 143
Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
            +  QL  +   ++ G+ +L                 HRD  + N+L+ S+L   ++DFG
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANM-----------NYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 266 LALLFE--PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           L+ + E  P      + G++   R+ APE    AI++ R      D+++  +V+WE+ +
Sbjct: 193 LSRVLEDDPEATYTTSGGKIPI-RWTAPE----AISY-RKFTSASDVWSFGIVMWEVMT 245

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 126/297 (42%), Gaps = 49/297 (16%)
Query: 121 AQGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDNILRY 171
             G +G+V  A  K   E VA+K       + +QSE       +E+  L HM+H+N++  
Sbjct: 51  GSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 172 IGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTW--EQLCRIALSMSKGLMHLHE 227
           +       S+    +F+L+  + +     D  K   + +  E++  +   M KGL ++H 
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        V HRD K  N+ +  D    I DFGLA          +  G V TR 
Sbjct: 163 -----------AGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRW 206
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y APEV+   +++++     +D+++   ++ E+ +  +         +L    +V   P 
Sbjct: 207 YRAPEVILSWMHYNQ----TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262
Query: 348 LEDMQEA--VVHKKLRPTLPETWKQHAGML------ALCDTMEECWDHDAEARLSAS 396
            E +Q+      K    +LP+T ++    L         D +E+  + D + RL+A+
Sbjct: 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 104/227 (45%), Gaps = 42/227 (18%)
Query: 105 PSPQQGCRSIQLVEVKAQGRFGAV---WKAKFKNENVAVKIF------LMQDKQSWQSEQ 155
           P   QG R +        G +G+V   + A+ + + VAVK        L+  +++++   
Sbjct: 27  PQRLQGLRPV------GSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYR--- 76
Query: 156 EIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+  L H++H+N++  +       SI   +E +L+T       L + +K   ++ E +  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQF 135
Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
           +   + +GL ++H              + HRD K +NV +  D    I DFGLA      
Sbjct: 136 LVYQLLRGLKYIH-----------SAGIIHRDLKPSNVAVNEDSELRILDFGLA-----R 179
Query: 274 KPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           +   +  G V TR Y APE++   +++++     +D+++   ++ EL
Sbjct: 180 QADEEMTGYVATRWYRAPEIMLNWMHYNQT----VDIWSVGCIMAEL 222

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 54/258 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAVKI    DK    S   Q++F+    +  + H 
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKII---DKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL-SMSKGLM 223
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R     +   + 
Sbjct: 74  NIVKLF------EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           + H++            + HRD K+ N+LL +D+   IADFG +  F  G          
Sbjct: 128 YCHQKF-----------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFC 173
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G   Y APE+ +G     +     +D+++  ++L+ L S             LPF     
Sbjct: 174 GAPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF----- 213
Query: 344 DHPSLEDMQEAVVHKKLR 361
           D  +L++++E V+  K R
Sbjct: 214 DGQNLKELRERVLRGKYR 231

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 104/243 (42%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T   E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEXMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GAVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E        T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 49/287 (17%)
Query: 111 CRSIQLVEVKAQGRFGAVWKA--KFKNENVAVK-IF--LMQDKQSWQSEQEIFKLPHME- 164
            R  +LV+   +G +G VWK+  +   E VAVK IF        + ++ +EI  L  +  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
           H+NI+  +   +       + +L+  Y E   L   ++ NI+       +   + K + +
Sbjct: 68  HENIVNLLNVLRADND--RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF-------------- 270
           LH              + HRD K +N+LL ++    +ADFGL+  F              
Sbjct: 125 LHS-----------GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 271 -EPGKPCGDTH----GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
            E  +   D        V TR Y APE+L G+  +++     IDM++   +L E+   C 
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG----IDMWSLGCILGEIL--CG 227
Query: 326 SVSPPPGEYRLPFSAEVG--DHPSLEDMQEAVVHKKLRPTLPETWKQ 370
               P           +G  D PS ED++   +      T+ E+ K+
Sbjct: 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVES--IQSPFAKTMIESLKE 272

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 104/243 (42%), Gaps = 37/243 (15%)
Query: 97  LEPHPTSPPS-------PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ 146
           ++PH    P+        +    +I + +V   G FG V   + K    + ++V I  ++
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 147 ----DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK 202
               +KQ      E   +   +H NI+R  G   + + +     ++T   E GSL  FL+
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM----IVTEXMENGSLDSFLR 138
Query: 203 CNIVTWE--QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
            +   +   QL  +   ++ G+ +L +               HRD  + N+L+ S+L   
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLVCK 187
Query: 261 IADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           ++DFGL+ + E        T G     R+ +PE    AI + R      D+++  +VLWE
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWE 242
Query: 320 LAS 322
           + S
Sbjct: 243 VMS 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 28/239 (11%)
Query: 93  PVPTLEPHPTSPPSPQQGCRSIQLVEVK-AQGRFGAVWKAKFKNENV-----AVKIF-LM 145
           PVP  +P     P       +   +E K  +G+F  V++A    + V      V+IF LM
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 146 QDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI 205
             K      +EI  L  + H N+++Y  +      ++    L  A      +  F K   
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 206 VTWEQLC-RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF 264
           +  E+   +  + +   L H+H              V HRD K  NV + +     + D 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSR-----------RVMHRDIKPANVFITATGVVKLGDL 180
Query: 265 GLALLFEPGKPCGDTHGQVGTRRYMAPE-VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           GL   F         H  VGT  YM+PE + E   NF      + D+++   +L+E+A+
Sbjct: 181 GLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNF------KSDIWSLGCLLYEMAA 231

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQ----DKQSWQSEQEIFKLPHMEH 165
           +I + +V   G FG V   + K    + ++V I  ++    +KQ      E   +   +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV--TWEQLCRIALSMSKGLM 223
            NI+R  G   + + +     ++T   E GSL  FL+ +    T  QL  +   ++ G+ 
Sbjct: 77  PNIIRLEGVVTKSKPVM----IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPG-KPCGDTHGQ 282
           +L +               HRD  + N+L+ S+L   ++DFGL+ + E   +    T G 
Sbjct: 133 YLSDM-----------GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               R+ +PE    AI + R      D+++  +VLWE+ S
Sbjct: 182 KIPIRWTSPE----AIAY-RKFTSASDVWSYGIVLWEVMS 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFK-----LPHME 164
           R ++ +    +G FG+V   ++    +N    + + Q + S   +Q  F+     L  + 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 66
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGL 222
            D I++Y G          E  L+  Y   G L DFL+ +    +  +L   +  + KG+
Sbjct: 67  SDFIVKYRGVSY--GPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-- 280
            +L                 HRD  + N+L++S+    IADFGLA L    K        
Sbjct: 125 EYLGSR-----------RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREP 173
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           GQ     Y APE L   I FSR +    D+++  +VL+EL + C     P  E+
Sbjct: 174 GQSPIFWY-APESLSDNI-FSRQS----DVWSFGVVLYELFTYCDKSCSPSAEF 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 114/258 (44%), Gaps = 56/258 (21%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL 211
           Q E EI  L  ++H NI++     +  E  H   +++    E G L +     IV+ +  
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIF---EVFEDYHN-MYIVMETCEGGELLE----RIVSAQAR 117
Query: 212 CRIALSMSKGLM-HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLA 267
            +   ++S+G +  L ++++   A  +   V H+D K  N+L +     +   I DFGLA
Sbjct: 118 GK---ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV 327
            LF+  +   +     GT  YMAPEV      F RD   + D+++  +V++ L + C   
Sbjct: 175 ELFKSDEHSTNA---AGTALYMAPEV------FKRDVTFKCDIWSAGVVMYFLLTGC--- 222
Query: 328 SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHK------KLRPTLPETWKQHAGMLALCDTM 381
                   LPF+       SLE++Q+   +K      + RP  P+            D +
Sbjct: 223 --------LPFTG-----TSLEEVQQKATYKEPNYAVECRPLTPQA----------VDLL 259
Query: 382 EECWDHDAEARLSASCVV 399
           ++    D E R SA+ V+
Sbjct: 260 KQMLTKDPERRPSAAQVL 277

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN------VAVKIF--LMQDKQSWQSEQEIFKLPHMEH 165
           ++ V+V   G FG V+K  +  E       VA+KI       K + +   E   +  M+H
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGL 222
            +++R +G       +     L+T     G L +++   K NI + + L    + ++KG+
Sbjct: 77  PHLVRLLGV-----CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGS-QLLLNWCVQIAKGM 130
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
           M+L E  L            HRD  + NVL+KS     I DFGLA L E  +   +  G 
Sbjct: 131 MYLEERRL-----------VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               ++MA E +       R    + D+++  + +WEL +
Sbjct: 180 KMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWELMT 214

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 117 VEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           + V  QG FG V KA+    +   A+K     +++      E+  L  + H  ++RY  A
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 175 --EKR-------GESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLM 223
             E+R            +  ++   Y E G+L D +    +  +  +  R+   + + L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA---------LLFE--- 271
           ++H +            + HRD K  N+ +       I DFGLA         L  +   
Sbjct: 131 YIHSQ-----------GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 272 -PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            PG     T   +GT  Y+A EVL+G  +++     +IDMY+  ++ +E+
Sbjct: 180 LPGSSDNLTSA-IGTAMYVATEVLDGTGHYNE----KIDMYSLGIIFFEM 224

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 43/233 (18%)
Query: 106 SPQQGC--RSIQLVEVKAQGRFGAVWKAKFKNE-----NVAVKIF----LMQDKQSWQSE 154
           SPQ G     + L  +  +G FG V++  + N      NVAVK       + +K+ + SE
Sbjct: 16  SPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 75
Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI 214
             I K  +++H +I++ IG  +   +     W+I   +  G L  +L+ N  + + L  +
Sbjct: 76  AVIMK--NLDHPHIVKLIGIIEEEPT-----WIIMELYPYGELGHYLERNKNSLKVLTLV 128
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAV--AHRDFKSNNVLLKSDLTAAIADFGLALLFEP 272
             S+              KA +Y  ++   HRD    N+L+ S     + DFGL+   E 
Sbjct: 129 LYSLQIC-----------KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 177
Query: 273 GKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                D +    TR   ++M+PE    +INF R      D++  A+ +WE+ S
Sbjct: 178 ----EDYYKASVTRLPIKWMSPE----SINFRRFTTAS-DVWMFAVCMWEILS 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 67/271 (24%)
Query: 117 VEVKAQGRFGAVWKAKFKNE--NVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYI 172
           ++   +G FG V++AK K +  N A+K   + +++  + +  +E+  L  +EH  I+RY 
Sbjct: 11  IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 173 GA------EKRGESIHTEFWL------------------------ITAYHERGSLCDFL- 201
            A      EK  E +  E WL                        +  +  + ++     
Sbjct: 71  NAWLETPPEKWQEEM-DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 202 ---KCNIVTWEQLCR---IALSMSK---------GL-MHLHEEILPNKADSYKPAVAHRD 245
              K  +    QLCR   +   M++         G+ +H+  +I       +   + HRD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 246 FKSNNVLLKSDLTAAIADFGLALLFEPGK---------PCGDTH-GQVGTRRYMAPEVLE 295
            K +N+    D    + DFGL    +  +         P   TH GQVGT+ YM+PE + 
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIH 249
Query: 296 GAINFSRDAFLRIDMYACALVLWELASRCSS 326
           G  N+S     ++D+++  L+L+EL    S+
Sbjct: 250 GN-NYSH----KVDIFSLGLILFELLYSFST 275

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 32  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 89
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 90  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 142
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 143 -----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 198 IMLNSKGYTKS----IDIWSVGCILAEMLS 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 115 QLVEVKAQGRFGAVW--KAKFKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
           Q V+    G +G V   K K      A+KI     +     S     E+  L  ++H NI
Sbjct: 24  QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 83
Query: 169 LRY--IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           ++      +KR       ++L+   +  G L D     I+  ++   +  ++      + 
Sbjct: 84  MKLYEFFEDKRN------YYLVMEVYRGGELFD----EIILRQKFSEVDAAV------IM 127
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQV 283
           +++L      +K  + HRD K  N+LL+S   D    I DFGL+  FE G   G    ++
Sbjct: 128 KQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERL 184
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           GT  Y+APEVL    +       + D+++C ++L+ L
Sbjct: 185 GTAYYIAPEVLRKKYD------EKCDVWSCGVILYIL 215

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 32  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 89
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 90  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 142
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 143 -----ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 198 IMLNSKGYTKS----IDIWSVGCILAEMLS 223

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKI----FLMQDKQSWQSEQEIFKLPHME 164
           +++ +V   G FG V     K        VA+K     +  + ++ + SE  I  +   +
Sbjct: 35  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI--MGQFD 92
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGL 222
           H N++   G   +     T   +IT + E GSL  FL+ N    T  QL  +   ++ G+
Sbjct: 93  HPNVIHLEGVVTKS----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 148
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +L +               HRD  + N+L+ S+L   ++DFGL+   E           
Sbjct: 149 KYLADM-----------NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 283 VGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +G +   R+ APE ++      R      D+++  +V+WE+ S
Sbjct: 198 LGGKIPIRWTAPEAIQ-----YRKFTSASDVWSYGIVMWEVMS 235

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 32  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 89
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 90  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 142
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 143 -----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 198 IMLNSKGYTKS----IDIWSVGCILAEMLS 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 36  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 93
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 94  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 146
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 147 -----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 202 IMLNSKGYTKS----IDIWSVGCILAEMLS 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 34  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 91
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 92  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 144
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 145 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 200 IMLNSKGYTKS----IDIWSVGCILAEMLS 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 36  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 93
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 94  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 146
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 147 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 202 IMLNSKGYTKS----IDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 37  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 94
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 95  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 147
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 148 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 203 IMLNSKGYTKS----IDIWSVGCILAEMLS 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEHDNILRYIG 173
             G +GAV  A   +     K+ + +  + +QSE       +E+  L HM H+N++  + 
Sbjct: 34  GSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 174 AEKRGESI--HTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
                E++   T+F+L+  +     L   +K   +  +++  +   M KGL ++H     
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH----- 145
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    + HRD K  N+ +  D    I DFGLA      +   +  G V TR Y AP
Sbjct: 146 ------AAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMXGXVVTRWYRAP 194
Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           EV+   + +++     +D+++   ++ E+ +
Sbjct: 195 EVILNWMRYTQ----TVDIWSVGCIMAEMIT 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 32  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 89
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 90  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 142
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 143 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 198 IMLNSKGYTKS----IDIWSVGCILAEMLS 223

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 131
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 132 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 179
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 180 ----RHTADEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 131
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 132 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 179
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 180 ----RHTADEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 225

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 33/232 (14%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQSE--QEIFKLPHM 163
           R ++ +    +G FG V   ++        E VAVK    +   +  ++  +EI  L ++
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 164 EHDNILRYIG--AEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMS 219
            H+NI++Y G   E  G  I     LI  +   GSL ++L    N +  +Q  + A+ + 
Sbjct: 81  YHENIVKYKGICTEDGGNGIK----LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           KG+ +L                 HRD  + NVL++S+    I DFGL    E  K     
Sbjct: 137 KGMDYLGSR-----------QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 280 HGQVGTRRY-MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                +  +  APE L          ++  D+++  + L EL + C S S P
Sbjct: 186 KDDRDSPVFWYAPECL-----MQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 116 LVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRY 171
           LV+   +G  G V  A  +   E VAVKI  M+         ++EI     + H+N++++
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEIL 230
            G  + G +I    +L   Y   G L D ++ +I   E    R    +  G+++LH    
Sbjct: 70  YGHRREG-NIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---- 121
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     + HRD K  N+LL       I+DFGLA +F         +   GT  Y+A
Sbjct: 122 -------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 291 PEVLEGAINFSRDAFLR--IDMYACALVL 317
           PE+L+      R  F    +D+++C +VL
Sbjct: 175 PELLK------RREFHAEPVDVWSCGIVL 197

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 36  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIG-INDI 93
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 94  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 146
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 147 -----ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 202 IMLNSKGYTKS----IDIWSVGCILAEMLS 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVR----- 77
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIV---TWEQLCRIALSMSKGLMHL------- 225
                      L   ++  G   D +  N+V     E + R+A   S+    L       
Sbjct: 78  -----------LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 226 -HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQV 283
              ++  + A  +   + HRD K  N+LL  D     + DFG A     G+P       +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXI 183
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 184 CSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 33/232 (14%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQSE--QEIFKLPHM 163
           R ++ +    +G FG V   ++        E VAVK    +   +  ++  +EI  L ++
Sbjct: 9   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 68
Query: 164 EHDNILRYIG--AEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMS 219
            H+NI++Y G   E  G  I     LI  +   GSL ++L    N +  +Q  + A+ + 
Sbjct: 69  YHENIVKYKGICTEDGGNGIK----LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 124
Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           KG+ +L                 HRD  + NVL++S+    I DFGL    E  K     
Sbjct: 125 KGMDYLGSR-----------QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 280 HGQVGTRRY-MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                +  +  APE L          ++  D+++  + L EL + C S S P
Sbjct: 174 KDDRDSPVFWYAPECL-----MQSKFYIASDVWSFGVTLHELLTYCDSDSSP 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 131
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 132 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 179
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 180 ----RHTADEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 52  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 109
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 110 IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA----- 163
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 164 ------NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 218 IMLNSKGYTKS----IDIWSVGCILAEMLS 243

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 40  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 97
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 98  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 150
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 151 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 206 IMLNSKGYTKS----IDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 32  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 89
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 90  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 142
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 143 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 198 IMLNSKGYTKS----IDIWSVGCILAEMLS 223

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKI----FLMQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V K  +  E  ++KI     +++DK   QS Q +      +  ++H +I
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           +R +G    G S+     L+T Y   GSL D ++ +   +  + L    + ++KG+ +L 
Sbjct: 96  VRLLGLCP-GSSLQ----LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 150
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             + HR+  + NVLLKS     +ADFG+A L  P              
Sbjct: 151 EH-----------GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++MA E    +I+F +    + D+++  + +WEL +
Sbjct: 200 KWMALE----SIHFGKYTH-QSDVWSYGVTVWELMT 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 37  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 94
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 95  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 147
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 148 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 203 IMLNSKGYTKS----IDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 38  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 95
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 96  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 148
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 149 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 204 IMLNSKGYTKS----IDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 29  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 86
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 87  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 139
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 140 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 195 IMLNSKGYTKS----IDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 36  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 93
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 94  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 146
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 147 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 202 IMLNSKGYTKS----IDIWSVGCILAEMLS 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  L QDK+    E +I 
Sbjct: 43  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNRELQIM 101
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 102 R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 160 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 207 LVRGEP---NVSXICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 250

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 30  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 87
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 88  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 140
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 141 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 196 IMLNSKGYTKS----IDIWSVGCILAEMLS 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 30  GEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 87
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 88  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 140
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 141 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 196 IMLNSKGYTKS----IDIWSVGCILAEMLS 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 96  RTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 153
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 154 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 201
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   ++++    + +D+++   ++ EL +
Sbjct: 202 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYN----MTVDIWSVGCIMAELLT 247

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 117 VEVKAQGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYI 172
           +E    G +  V+K   K   V  A+K   +  ++   S   +EI  +  ++H+NI+R  
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGL-----MHLHE 227
                 + IHTE  L   +       +F+  ++  +    R   +  +GL      +   
Sbjct: 70  ------DVIHTENKLTLVF-------EFMDNDLKKYMD-SRTVGNTPRGLELNLVKYFQW 115
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           ++L   A  ++  + HRD K  N+L+       + DFGLA  F  G P      +V T  
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLW 173
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           Y AP+VL G+  +S      ID+++C  +L E+ +
Sbjct: 174 YRAPDVLMGSRTYSTS----IDIWSCGCILAEMIT 204

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  L QDK+    E +I 
Sbjct: 45  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNRELQIM 103
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 104 R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 161
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 162 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 208
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 209 LVRGEP---NVSYICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 252

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKI----FLMQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V K  +  E  ++KI     +++DK   QS Q +      +  ++H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           +R +G    G S+     L+T Y   GSL D ++ +   +  + L    + ++KG+ +L 
Sbjct: 78  VRLLGLCP-GSSLQ----LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             + HR+  + NVLLKS     +ADFG+A L  P              
Sbjct: 133 EH-----------GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++MA E    +I+F +    + D+++  + +WEL +
Sbjct: 182 KWMALE----SIHFGKYTH-QSDVWSYGVTVWELMT 212

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFK-----LPHMEHDNILRYIGAE 175
            +G F  V+K       V V    +QD++  +SE++ FK     L  ++H NI+R+  + 
Sbjct: 35  GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSW 94
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLK----CNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           +          L+T     G+L  +LK      I      CR  L   KGL  LH     
Sbjct: 95  ESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL---KGLQFLH----- 146
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDL-TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
               +  P + HRD K +N+ +     +  I D GLA L    K        +GT  + A
Sbjct: 147 ----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXA 198
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           PE  E   + S      +D+YA      E A+
Sbjct: 199 PEXYEEKYDES------VDVYAFGXCXLEXAT 224

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 115 QLVEVKAQGRFGAVW--KAKFKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
           Q V+    G +G V   K K      A+KI     +     S     E+  L  ++H NI
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 66
Query: 169 LRY--IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           ++      +KR       ++L+   +  G L D     I+  ++   +  ++      + 
Sbjct: 67  MKLYEFFEDKRN------YYLVMEVYRGGELFD----EIILRQKFSEVDAAV------IM 110
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQV 283
           +++L      +K  + HRD K  N+LL+S   D    I DFGL+  FE G   G    ++
Sbjct: 111 KQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERL 167
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           GT  Y+APEVL    +       + D+++C ++L+ L
Sbjct: 168 GTAYYIAPEVLRKKYD------EKCDVWSCGVILYIL 198

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQSW--QSEQEIFKLPHMEH 165
           G R  QL  +  +G +G V  A    +   VA+K     + Q++  ++ +EI  L    H
Sbjct: 42  GPRYTQLQYI-GEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRH 100
Query: 166 DNIL--RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM 223
           +N++  R I      E++  + +++    E   L   LK   ++ + +C     + +GL 
Sbjct: 101 ENVIGIRDILRASTLEAMR-DVYIVQDLME-TDLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQ 282
           ++H              V HRD K +N+L+ +     I DFGLA + +P     G     
Sbjct: 159 YIH-----------SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           V TR Y APE++  +  +++     ID+++   +L E+ S
Sbjct: 208 VATRWYRAPEIMLNSKGYTKS----IDIWSVGCILAEMLS 243

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  ++QDK+    E +I 
Sbjct: 47  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIM 105
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 106 R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 163
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 164 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 210
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 211 LVRGEP---NVSYICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 254

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 108/258 (41%), Gaps = 54/258 (20%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE--QEIFK----LPHMEHD 166
           +L++   +G F  V  A+     + VAVKI    DK    S   Q++F+       + H 
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKII---DKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 167 NILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL-SMSKGLM 223
           NI++        E I TE   +L+  Y   G + D+L  +    E+  R     +   + 
Sbjct: 74  NIVKLF------EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           + H++            + HRD K+ N+LL +D    IADFG +  F  G          
Sbjct: 128 YCHQKF-----------IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFC 173
Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G   Y APE+ +G     +     +D+++  ++L+ L S             LPF     
Sbjct: 174 GAPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGS-----------LPF----- 213
Query: 344 DHPSLEDMQEAVVHKKLR 361
           D  +L++++E V+  K R
Sbjct: 214 DGQNLKELRERVLRGKYR 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 117 VEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRY 171
           +E   +G +G V+KAK +  +E VA+K   + D        + +EI  L  ++H NI+R 
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCD------FLKCN-IVTWEQLCRIALSMSKGLMH 224
                  + +H++  L   +      CD      F  CN  +  E +      + KGL  
Sbjct: 67  ------HDVLHSDKKLTLVFE----FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
            H              V HRD K  N+L+  +    +A+FGLA  F  G P      +V 
Sbjct: 117 CHSR-----------NVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVV 163
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
           T  Y  P+VL GA  +S      IDM++   +  ELA+    + P
Sbjct: 164 TLWYRPPDVLFGAKLYSTS----IDMWSAGCIFAELANAGRPLFP 204

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 72  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 129
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 130 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDXELKILDFGLA- 177
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 178 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 72  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 129
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 130 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDXELKILDFGLA- 177
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 178 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 223

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  L QDK+    E +I 
Sbjct: 43  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNRELQIM 101
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 102 R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 160 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 250

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 34  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIG-INDI 91
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 92  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA----- 145
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 146 ------NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 200 IMLNSKGYTKS----IDIWSVGCILAEMLS 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 78  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 135
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 136 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDXELKILDFGLA- 183
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 184 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 229

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 13  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 72
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 73  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI 126
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 127 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 176 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 117 VEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR---- 170
            +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R    
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVRLRYF 109
Query: 171 -YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
            Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H  
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 169
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGT 285
                         + HRD K  N+LL  D     + DFG A     G+P       + +
Sbjct: 170 -------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 213
Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           R Y APE++ GA +++      ID+++   VL EL
Sbjct: 214 RYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 244

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  ++QDK+    E +I 
Sbjct: 28  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIM 86
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 87  R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 144
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 145 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 191
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 192 LVRGEP---NVSXICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  ++QDK+    E +I 
Sbjct: 17  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIM 75
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 76  R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 133
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 134 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 180
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 181 LVRGEP---NVSXICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  L QDK+    E +I 
Sbjct: 21  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNRELQIM 79
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 80  R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 137
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 138 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 184
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 185 LVRGEP---NVSXICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVRLRYFF 82
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 142 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 187 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA------LLFEPGKPCGDTHGQVGTRRYM 289
                + HRD K +N+++KSD T  I DFGLA       + EP         +V TR Y 
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP---------EVVTRYYR 192
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           APEV+ G + +  +    +D+++   ++ E+   C  +  P  +Y
Sbjct: 193 APEVILG-MGYKEN----VDLWSVGCIMGEMV--CHKILFPGRDY 230

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R     
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVRLRYFF 83
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 142
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 143 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 187
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 188 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 217

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 113/260 (43%), Gaps = 57/260 (21%)
Query: 81  YYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAV 140
           Y++ RKLGS          +       ++   S + ++V  + +F    K ++ ++N  +
Sbjct: 38  YFKVRKLGS--------GAYGEVLLCKEKNGHSEKAIKVIKKSQFD---KGRYSDDNKNI 86
Query: 141 KIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF 200
           + F        +   EI  L  ++H NI++     +  +     F+L+T ++E G L + 
Sbjct: 87  EKF------HEEIYNEISLLKSLDHPNIIKLFDVFEDKKY----FYLVTEFYEGGELFE- 135
Query: 201 LKCNIVTWEQL--CRIALSMSK---GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
               I+   +   C  A  M +   G+ +LH           K  + HRD K  N+LL++
Sbjct: 136 ---QIINRHKFDECDAANIMKQILSGICYLH-----------KHNIVHRDIKPENILLEN 181
Query: 256 D---LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYA 312
               L   I DFGL+  F       D   ++GT  Y+APEVL+   N       + D+++
Sbjct: 182 KNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPEVLKKKYN------EKCDVWS 232
Query: 313 CALVLWELASRCSSVSPPPG 332
           C ++++ L   C    PP G
Sbjct: 233 CGVIMYILL--CG--YPPFG 248

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVRLRYFF 82
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 142 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 187 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  ++QDK+    E +I 
Sbjct: 21  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIM 79
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 80  R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 137
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 138 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 184
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 185 LVRGEP---NVSXICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  L QDK+    E +I 
Sbjct: 88  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNRELQIM 146
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 147 R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 204
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 205 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 251
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 252 LVRGEP---NVSYICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 295

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA+K     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 34  GEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIG-INDI 91
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 92  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA----- 145
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 146 ------NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 200 IMLNSKGYTKS----IDIWSVGCILAEMLS 225

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 107 PQQGC--RSIQLVEVKAQGRFGAVWKAKFKNE-----NVAVKIF----LMQDKQSWQSEQ 155
           PQ G     + L  +  +G FG V++  + N      NVAVK       + +K+ + SE 
Sbjct: 1   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 60
Query: 156 EIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIA 215
            I K  +++H +I++ IG  +   +     W+I   +  G L  +L+ N  + + L  + 
Sbjct: 61  VIMK--NLDHPHIVKLIGIIEEEPT-----WIIMELYPYGELGHYLERNKNSLKVLTLVL 113
Query: 216 LSMSKGLMHLHEEILPNKADSYKPAV--AHRDFKSNNVLLKSDLTAAIADFGLALLFEPG 273
            S+              KA +Y  ++   HRD    N+L+ S     + DFGL+   E  
Sbjct: 114 YSLQIC-----------KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED- 161
Query: 274 KPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               D +    TR   ++M+PE    +INF R      D++  A+ +WE+ S
Sbjct: 162 ---EDYYKASVTRLPIKWMSPE----SINFRRFTTAS-DVWMFAVCMWEILS 205

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGXVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  ++QDK+    E +I 
Sbjct: 22  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIM 80
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 81  R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 138
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 139 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 185
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 186 LVRGEP---NVSYICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 229

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 106 SPQQGCRSIQLV-----EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIF 158
           +P QG    Q V     +V   G FG V++AK     E VA+K  L QDK+    E +I 
Sbjct: 14  TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-QDKRFKNRELQIM 72
Query: 159 KLPHMEHDNILR-----YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           +   ++H NI+R     Y   EK+ E   ++  ++   T Y          +   V + +
Sbjct: 73  R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 130
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALL 269
           L    L  S   +H                + HRD K  N+LL  D     + DFG A  
Sbjct: 131 LYMYQLFRSLAYIHSF-------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 177
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              G+P       + +R Y APE++ GA +++      ID+++   VL EL
Sbjct: 178 LVRGEP---NVSYICSRYYRAPELIFGATDYTSS----IDVWSAGCVLAEL 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA------LLFEPGKPCGDTHGQVGTRRYM 289
                + HRD K +N+++KSD T  I DFGLA       + EP         +V TR Y 
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP---------EVVTRYYR 192
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           APEV+ G + +  +    +D+++   ++ E+   C  +  P  +Y
Sbjct: 193 APEVILG-MGYKEN----VDIWSVGCIMGEMV--CHKILFPGRDY 230

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 72  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 129
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 130 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 177
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 178 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 66  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 123
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 124 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 171
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 172 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 217

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 43/236 (18%)
Query: 103 SPPSPQQGC--RSIQLVEVKAQGRFGAVWKAKFKNE-----NVAVKIF----LMQDKQSW 151
           S   PQ G     + L  +  +G FG V++  + N      NVAVK       + +K+ +
Sbjct: 1   SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF 60
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL 211
            SE  I K  +++H +I++ IG  +   +     W+I   +  G L  +L+ N  + + L
Sbjct: 61  MSEAVIMK--NLDHPHIVKLIGIIEEEPT-----WIIMELYPYGELGHYLERNKNSLKVL 113
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAV--AHRDFKSNNVLLKSDLTAAIADFGLALL 269
             +  S+              KA +Y  ++   HRD    N+L+ S     + DFGL+  
Sbjct: 114 TLVLYSLQIC-----------KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
Query: 270 FEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            E      D +    TR   ++M+PE    +INF R      D++  A+ +WE+ S
Sbjct: 163 IED----EDYYKASVTRLPIKWMSPE----SINFRRFTTAS-DVWMFAVCMWEILS 209

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 69  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 126
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 127 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 174
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 175 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVRLRYFF 82
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 142 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSR 186
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 187 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 87  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 144
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 145 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 192
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 193 ----RHTDDEMXGXVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 238

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++QDK+    E +I +   ++H NI+R     
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMR--KLDHCNIVRLRYFF 86
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 145
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 146 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 190
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 191 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 121 AQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAE 175
            +G +G V  A + N N   VA++     + Q++  ++ +EI  L    H+NI+  I   
Sbjct: 36  GEGAYGMVCSA-YDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIG-INDI 93
Query: 176 KRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            R  +I    + +++    E   L   LK   ++ + +C     + +GL ++H       
Sbjct: 94  IRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS------ 146
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPE 292
                  V HRD K +N+LL +     I DFGLA + +P     G     V TR Y APE
Sbjct: 147 -----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           ++  +  +++     ID+++   +L E+ S
Sbjct: 202 IMLNSKGYTKS----IDIWSVGCILAEMLS 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 69  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 126
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 127 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDSELKILDFGLA- 174
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 175 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 131
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 132 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 179
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 180 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 90  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 147
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 148 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 195
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 196 ----RHTDDEMXGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 241

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 69  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 126
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 127 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 174
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 175 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 64  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 121
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 122 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 169
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 170 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 64  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 121
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 122 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 169
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 170 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 215

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 120
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 121 DHVQFLIYQILRGLKYIHS------AD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 168
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 169 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 214

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 73  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 130
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 131 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDSELKILDFGLA- 178
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 179 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 72  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 129
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 130 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 177
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 178 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 77  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 134
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 135 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 182
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 183 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 228

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 69  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 126
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 127 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 174
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 175 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 121 AQGRFGAVWKAKFKNENV---AVKI--FLMQDKQSWQSEQEIFKLPHMEHDNILR-YIGA 174
            +G +G V  A  K   +   A KI  + ++D   ++ E EI K   ++H NI+R Y   
Sbjct: 18  GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK--SLDHPNIIRLYETF 75
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           E      +T+ +L+      G L          +E++    +        + +++L   A
Sbjct: 76  ED-----NTDIYLVMELCTGGEL----------FERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
             +K  VAHRD K  N L  +D   +   + DFGLA  F+PGK       +VGT  Y++P
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSP 177
Query: 292 EVLEG 296
           +VLEG
Sbjct: 178 QVLEG 182

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 73  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 130
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 131 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 178
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 179 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 224

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 87  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 144
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 145 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 192
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 193 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 238

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 78  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 135
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 136 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 183
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 184 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 229

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 65  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 122
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 123 DHVQFLIYQILRGLKYIHS------AD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 170
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 171 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 86  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 143
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 144 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 191
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 192 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 79  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 136
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 137 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 184
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 185 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 31/278 (11%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFK-----LPHME 164
           R ++ +    +G FG+V   ++    +N    + + Q + S   +Q  F+     L  + 
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 69
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGL 222
            D I++Y G             L+  Y   G L DFL+ +    +  +L   +  + KG+
Sbjct: 70  SDFIVKYRGVSY--GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 127
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-- 280
            +L                 HRD  + N+L++S+    IADFGLA L    K        
Sbjct: 128 EYLGSR-----------RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
           GQ     Y APE L   I FSR +    D+++  +VL+EL + C     P  E+     +
Sbjct: 177 GQSPIFWY-APESLSDNI-FSRQS----DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGS 230
Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALC 378
           E  D P+L  + E +   +  P  P    +   ++ LC
Sbjct: 231 ER-DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLC 267

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 120
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 121 DHVQFLIYQILRGLKYIHS------AD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 168
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 169 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 214

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 79  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 136
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 137 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 184
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 185 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 79  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 136
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 137 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 184
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 185 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 87  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 144
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 145 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 192
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 193 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 238

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 90  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 147
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 148 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 195
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 196 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 241

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 121 AQGRFGAVWKAKFKNENV---AVKI--FLMQDKQSWQSEQEIFKLPHMEHDNILR-YIGA 174
            +G +G V  A  K   +   A KI  + ++D   ++ E EI K   ++H NI+R Y   
Sbjct: 35  GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK--SLDHPNIIRLYETF 92
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           E      +T+ +L+      G L          +E++    +        + +++L   A
Sbjct: 93  ED-----NTDIYLVMELCTGGEL----------FERVVHKRVFRESDAARIMKDVLSAVA 137
Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
             +K  VAHRD K  N L  +D   +   + DFGLA  F+PGK       +VGT  Y++P
Sbjct: 138 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSP 194
Query: 292 EVLEG 296
           +VLEG
Sbjct: 195 QVLEG 199

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 86  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 143
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 144 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 191
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 192 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFK-----LPHME 164
           R ++ +    +G FG+V   ++    +N    + + Q + S   +Q  F+     L  + 
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 70
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGL 222
            D I++Y G             L+  Y   G L DFL+ +    +  +L   +  + KG+
Sbjct: 71  SDFIVKYRGVSY--GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 128
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-- 280
            +L                 HRD  + N+L++S+    IADFGLA L    K        
Sbjct: 129 EYLGSR-----------RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           GQ     Y APE L   I FSR +    D+++  +VL+EL + C     P  E+
Sbjct: 178 GQSPIFWY-APESLSDNI-FSRQS----DVWSFGVVLYELFTYCDKSCSPSAEF 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 73  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 130
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 131 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 178
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 179 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 224

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFK-----LPHME 164
           R ++ +    +G FG+V   ++    +N    + + Q + S   +Q  F+     L  + 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGL 222
            D I++Y G             L+  Y   G L DFL+ +    +  +L   +  + KG+
Sbjct: 83  SDFIVKYRGVSY--GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-- 280
            +L                 HRD  + N+L++S+    IADFGLA L    K        
Sbjct: 141 EYLGSR-----------RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           GQ     Y APE L   I FSR +    D+++  +VL+EL + C     P  E+
Sbjct: 190 GQSPIFWY-APESLSDNI-FSRQS----DVWSFGVVLYELFTYCDKSCSPSAEF 237

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 73  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 130
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 131 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 178
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 179 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 224

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILR---Y 171
            +G+FG V+ A+ K  +  VA+K+     + ++    Q  +EI    H+ H NILR   Y
Sbjct: 32  GKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNY 91
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEIL 230
               +R        +LI  Y  RG L   L+ +    EQ    I   ++  LM+ H +  
Sbjct: 92  FYDRRR-------IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK-- 142
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     V HRD K  N+LL       IADFG ++      P        GT  Y+ 
Sbjct: 143 ---------KVIHRDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLP 189
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           PE++EG ++       ++D++   ++ +EL      V  PP E
Sbjct: 190 PEMIEGRMHNE-----KVDLWCIGVLCYELL-----VGNPPFE 222

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 116 LVEVKAQGRFGAVWKAKFKNEN---VAVKIFLMQDKQSWQSEQEIFK-----LPHMEHDN 167
           L ++  +G FG+V +   K E+   + V +  M+   S Q E E F      +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 168 ILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCNI-------VTWEQLCRIALSM 218
           ++R +G   E   + I     +I  + + G L  +L  +        +  + L +  + +
Sbjct: 98  VIRLLGVCIEMSSQGIPKPM-VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           + G+     E L N+         HRD  + N +L+ D+T  +ADFGL+     G     
Sbjct: 157 ALGM-----EYLSNRN------FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-- 203
Query: 279 THGQVGTR--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
             G++     +++A E L   +  S+      D++A  + +WE+A+R   ++P PG
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKS-----DVWAFGVTMWEIATR--GMTPYPG 252

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCAKLTD 120
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 121 DHVQFLIYQILRGLKYIHS------AD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 168
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 169 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 214

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMAGFVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 101 HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 155 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 203
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 204 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 255

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMAGFVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 9   RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 68
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 69  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 123 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 171
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 172 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 8   RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 67
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 68  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 122 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 170
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 171 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 222

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 70  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 124 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 173 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 14  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 73
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 74  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 128 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 176
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 177 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 120
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 121 DHVQFLIYQILRGLKYIHS------AD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 168
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 169 ----RHTDDEMAGFVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 70  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 124 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 173 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 16  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 75
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 76  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 130 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 178
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 179 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 15  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 74
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 75  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 129 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 177
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 178 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 13  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 72
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 73  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 127 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 176 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y  RG +   L K +    ++       ++  L + H +     
Sbjct: 82  FHDA----TRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK----- 132
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 133 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYLPPEM 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 183 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 212

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 118 EVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR-----Y 171
           +V   G FG V++AK  +++ VA+K  L QDK+    E +I ++  ++H N++      Y
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVL-QDKRFKNRELQIMRI--VKHPNVVDLKAFFY 102
Query: 172 IGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH-E 227
              +K+ E   ++  E+   T Y  R S                ++  +M   L+ L+  
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVY--RAS------------RHYAKLKQTMPMLLIKLYMY 148
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLK-SDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           ++L + A  +   + HRD K  N+LL        + DFG A +   G+P       + +R
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICSR 205
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA N++ +    ID+++   V+ EL
Sbjct: 206 YYRAPELIFGATNYTTN----IDIWSTGCVMAEL 235

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 88
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 89  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 145
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 146 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEXXSVHN 192
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 193 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 236
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 237 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 285
Query: 398 VVER 401
           +V R
Sbjct: 286 LVSR 289

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ KN    +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDS----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------KVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 17  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 76
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 77  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 130
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 131 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 179
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS    +  D+++  +VL+EL +       PP E+
Sbjct: 180 VKEPGESPIFWY-APESLTES-KFS----VASDVWSFGVVLYELFTYIEKSKSPPAEF 231

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I D+GLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDYGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 38/263 (14%)
Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAK---FKNENVAVKIFLM 145
           SY    PT  P+      P+    ++Q  +    G FG V +A       E+  +K+ + 
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRN---NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 146 QDKQSWQSEQ------EIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLC 198
             K +  +++      E+  + H+ +H+NI+  +GA   G  +     +IT Y   G L 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV----LVITEYCCYGDLL 138
Query: 199 DFL--KCNIVTWEQLCRIALSM--SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK 254
           +FL  K  ++  +    IA S   ++ L+H   ++    A        HRD  + NVLL 
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 255 SDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFLRID 309
           +   A I DFGLA          D++  V G  R    +MAPE +     F     ++ D
Sbjct: 199 NGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTVQSD 248
Query: 310 MYACALVLWELASRCSSVSPPPG 332
           +++  ++LWE+ S    ++P PG
Sbjct: 249 VWSYGILLWEIFSL--GLNPYPG 269

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 87
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 88  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 142 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 191 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 242

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 87
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 88  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 142 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 190
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 191 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 242

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 115 QLVEVKAQGRFGAVWK-------AKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN 167
           QL E   +G F  V +        ++  + +  K    +D Q  + E  I +L  ++H N
Sbjct: 25  QLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRL--LKHPN 82
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I+R   +       +  F L+T     G L +    +IV  E       S      H  +
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTG----GELFE----DIVAREYYSEADAS------HCIQ 128
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVG 284
           +IL      ++  V HRD K  N+LL S L  A   +ADFGLA+  E  +      G  G
Sbjct: 129 QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAG 186
Query: 285 TRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
           T  Y++PEVL       +D + + +D++AC ++L+ L
Sbjct: 187 TPGYLSPEVLR------KDPYGKPVDLWACGVILYIL 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 38/263 (14%)
Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAK---FKNENVAVKIFLM 145
           SY    PT  P+      P+    ++Q  +    G FG V +A       E+  +K+ + 
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRN---NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 146 QDKQSWQSEQ------EIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLC 198
             K +  +++      E+  + H+ +H+NI+  +GA   G  +     +IT Y   G L 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV----LVITEYCCYGDLL 138
Query: 199 DFL--KCNIVTWEQLCRIALSM--SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK 254
           +FL  K  ++  +    IA S   ++ L+H   ++    A        HRD  + NVLL 
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 255 SDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFLRID 309
           +   A I DFGLA          D++  V G  R    +MAPE +     F     ++ D
Sbjct: 199 NGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTVQSD 248
Query: 310 MYACALVLWELASRCSSVSPPPG 332
           +++  ++LWE+ S    ++P PG
Sbjct: 249 VWSYGILLWEIFSL--GLNPYPG 269

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 51  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 108
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 109 HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 165
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 166 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 212
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 213 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 256
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 257 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 305
Query: 398 VVER 401
           +V R
Sbjct: 306 LVSR 309

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 30  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 88
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 89  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 138
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 139 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 189
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           V+ G + +  +    +D+++   ++ E+   C  +  P  +Y
Sbjct: 190 VILG-MGYKEN----VDLWSVGCIMGEMV--CHKILFPGRDY 224

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 24  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 81
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 82  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 138
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 139 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 185
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 186 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 229
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 230 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 278
Query: 398 VVER 401
           +V R
Sbjct: 279 LVSR 282

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 175 EKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y  RG +   L K +    ++       ++  L + H +     
Sbjct: 82  FHDA----TRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK----- 132
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 133 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 183 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 212

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 41  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 99
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 100 QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 149
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 150 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 200
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
           V+ G + +  +    +D+++   ++ E+   C  +  P  +Y
Sbjct: 201 VILG-MGYKEN----VDLWSVGCIMGEMV--CHKILFPGRDY 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 50  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 107
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 108 HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 164
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 165 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 211
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 212 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 255
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 256 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 304
Query: 398 VVER 401
           +V R
Sbjct: 305 LVSR 308

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTP 94
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 27  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 84
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 85  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 142 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 188
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 189 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 232
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 233 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 281
Query: 398 VVER 401
           +V R
Sbjct: 282 LVSR 285

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 42/230 (18%)
Query: 117 VEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           + V  QG FG V KA+    +   A+K     +++      E+  L  + H  ++RY  A
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 175 --EKR-------GESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLM 223
             E+R            +  ++   Y E  +L D +    +  +  +  R+   + + L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA---------LLFE--- 271
           ++H +            + HRD K  N+ +       I DFGLA         L  +   
Sbjct: 131 YIHSQ-----------GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 272 -PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            PG     T   +GT  Y+A EVL+G  +++     +IDMY+  ++ +E+
Sbjct: 180 LPGSSDNLTSA-IGTAMYVATEVLDGTGHYNE----KIDMYSLGIIFFEM 224

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 89
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 90  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 146
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 147 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 193
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 194 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 237
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 238 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 286
Query: 398 VVER 401
           +V R
Sbjct: 287 LVSR 290

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 91  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 148
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 149 HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
             L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 206 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 252
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 253 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 296
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 297 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 345
Query: 398 VVERGMLALCDTMEECWDH 416
           +V R        + E + H
Sbjct: 346 LVSRISAIFSTFIGEHYVH 364

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 86
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 87  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 144 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 190
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 191 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 234
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 235 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 283
Query: 398 VVER 401
           +V R
Sbjct: 284 LVSR 287

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 70  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 124 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK 172
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 173 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 88
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 89  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 145
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 146 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 192
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 193 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 236
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 237 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 285
Query: 398 VVER 401
           +V R
Sbjct: 286 LVSR 289

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 87
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 88  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 144
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 145 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 191
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 192 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 235
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 236 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 284
Query: 398 VVER 401
           +V R
Sbjct: 285 LVSR 288

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKI----FLMQDKQSWQSEQEIFKLPHME 164
           +++ +V   G FG V     K        VA+K     +  + ++ + SE  I  +   +
Sbjct: 9   VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI--MGQFD 66
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGL 222
           H N++   G   +     T   +IT + E GSL  FL+ N    T  QL  +   ++ G+
Sbjct: 67  HPNVIHLEGVVTKS----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 122
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +L +               HR   + N+L+ S+L   ++DFGL+   E           
Sbjct: 123 KYLADM-----------NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 283 VGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +G +   R+ APE ++      R      D+++  +V+WE+ S
Sbjct: 172 LGGKIPIRWTAPEAIQ-----YRKFTSASDVWSYGIVMWEVMS 209

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 89
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 90  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 146
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
            +L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 147 KYLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 193
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 194 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 237
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 238 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 286
Query: 398 VVER 401
           +V R
Sbjct: 287 LVSR 290

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNE-NVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           I L++    G+FG V   K+K + +VAVK+     K+   SE E F+    +  + H  +
Sbjct: 10  ITLLKELGSGQFGVVKLGKWKGQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKL 65
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMHLH 226
           +++ G   +   I    +++T Y   G L ++L+ +    E  QL  +   + +G+  L 
Sbjct: 66  VKFYGVCSKEYPI----YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                           HRD  + N L+  DL   ++DFG+       +        VGT+
Sbjct: 122 SH-----------QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTK 166
Query: 287 ---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              ++ APEV      +S  +    D++A  +++WE+ S
Sbjct: 167 FPVKWSAPEVFH-YFKYSSKS----DVWAFGILMWEVFS 200

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 37  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 94
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 95  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 151
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
             L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 152 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 198
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 199 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 242
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 243 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 291
Query: 398 VVERGMLALCDTMEECWDH 416
           +V R        + E + H
Sbjct: 292 LVSRISAIFSTFIGEHYVH 310

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 89
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 90  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 146
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
             L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 147 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 193
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 194 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 237
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 238 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 286
Query: 398 VVERGMLALCDTMEECWDH 416
           +V R        + E + H
Sbjct: 287 LVSRISAIFSTFIGEHYVH 305

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 20/106 (18%)
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           +  GL HLH+             + +RD K  NVLL  D    I+D GLA+  + G+   
Sbjct: 298 IVSGLEHLHQR-----------NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-- 344
Query: 278 DTHGQVGTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELAS 322
            T G  GT  +MAPE+L G   +FS      +D +A  + L+E+ +
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFS------VDYFALGVTLYEMIA 384

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 74  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 133 QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 182
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 183 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 233
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELA 321
           V+ G + +  +    +D+++   ++ E+ 
Sbjct: 234 VILG-MGYKEN----VDIWSVGCIMGEMV 257

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++Q K     E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQGKAFKNRELQIMR--KLDHCNIVRLRYFF 82
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 142 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 187 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 20/106 (18%)
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           +  GL HLH+             + +RD K  NVLL  D    I+D GLA+  + G+   
Sbjct: 298 IVSGLEHLHQR-----------NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-- 344
Query: 278 DTHGQVGTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELAS 322
            T G  GT  +MAPE+L G   +FS      +D +A  + L+E+ +
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFS------VDYFALGVTLYEMIA 384

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 43  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 102
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 103 FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 153
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 154 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPPEM 203
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 204 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 89
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 90  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 146
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
             L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 147 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 193
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 194 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 237
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 238 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 286
Query: 398 VVERGMLALCDTMEECWDH 416
           +V R        + E + H
Sbjct: 287 LVSRISAIFSTFIGEHYVH 305

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 22/149 (14%)
Query: 184 EFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK    +  E L ++++++ +GL +L E          K  + 
Sbjct: 88  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE----------KHQIM 137
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YMAPE L+G  ++S
Sbjct: 138 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMAPERLQGT-HYS 191
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPP 330
               ++ D+++  L L ELA     + PP
Sbjct: 192 ----VQSDIWSMGLSLVELAVGRYPIPPP 216

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 20/103 (19%)
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL HLH+             + +RD K  NVLL  D    I+D GLA+  + G+    T 
Sbjct: 301 GLEHLHQR-----------NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTK 347
Query: 281 GQVGTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELAS 322
           G  GT  +MAPE+L G   +FS      +D +A  + L+E+ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFS------VDYFALGVTLYEMIA 384

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 87
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 88  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 144
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
             L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 145 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 191
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 192 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 235
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 236 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 284
Query: 398 VVERGMLALCDTMEECWDH 416
           +V R        + E + H
Sbjct: 285 LVSRISAIFSTFIGEHYVH 303

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLH------ 226
           K+GE++     ++ +    G  C F+ C    +   ++L  I   M+ G +H H      
Sbjct: 230 KQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288
Query: 227 ----------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                      EI+      +   V +RD K  N+LL       I+D GLA  F   KP 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 347
Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              H  VGT  YMAPEVL+  + +   A    D ++   +L++L
Sbjct: 348 ---HASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKL 384

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLH------ 226
           K+GE++     ++ +    G  C F+ C    +   ++L  I   M+ G +H H      
Sbjct: 230 KQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288
Query: 227 ----------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                      EI+      +   V +RD K  N+LL       I+D GLA  F   KP 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 347
Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              H  VGT  YMAPEVL+  + +   A    D ++   +L++L
Sbjct: 348 ---HASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKL 384

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 140 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 189
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 243
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPG-EYRLPFSAEV-GD 344
               ++ D+++  L L E+A     + PP   E  L F  +V GD
Sbjct: 244 ----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 284

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 61/319 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 90
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 91  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 147
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHG 281
             L  +              HRD  + N +L    T  +ADFGLA  +++  K     H 
Sbjct: 148 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 194
Query: 282 QVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
           + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP        
Sbjct: 195 KTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP-------- 238
Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASC 397
                 +P +      V   + R  L PE          L + M +CW   AE R S S 
Sbjct: 239 ------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSE 287
Query: 398 VVERGMLALCDTMEECWDH 416
           +V R        + E + H
Sbjct: 288 LVSRISAIFSTFIGEHYVH 306

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 20/106 (18%)
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           +  GL HLH+             + +RD K  NVLL  D    I+D GLA+  + G+   
Sbjct: 298 IVSGLEHLHQR-----------NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-- 344
Query: 278 DTHGQVGTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELAS 322
            T G  GT  +MAPE+L G   +FS      +D +A  + L+E+ +
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFS------VDYFALGVTLYEMIA 384

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG---QVGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +     +V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPEVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLH------ 226
           K+GE++     ++ +    G  C F+ C    +   ++L  I   M+ G +H H      
Sbjct: 230 KQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288
Query: 227 ----------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                      EI+      +   V +RD K  N+LL       I+D GLA  F   KP 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 347
Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              H  VGT  YMAPEVL+  + +   A    D ++   +L++L
Sbjct: 348 ---HASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKL 384

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 121 AQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAEK 176
            +G +  V+K K K  +  VA+K   ++ ++     + +E+  L  ++H NI+       
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL----- 65
Query: 177 RGESIHTE--FWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
             + IHTE    L+  Y ++  L  +L    NI+    +      + +GL + H +    
Sbjct: 66  -HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---- 119
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   V HRD K  N+L+       +ADFGLA       P      +V T  Y  P+
Sbjct: 120 -------KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPD 170
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +L G+ ++S     +IDM+    + +E+A+
Sbjct: 171 ILLGSTDYST----QIDMWGVGCIFYEMAT 196

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 117 VEVKAQGRFGAVWKAKFK-NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNILRYI 172
           +E   +G +G V+KA+    E  A+K I L ++ +   S   +EI  L  ++H NI++  
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
                 + IHT+  L+  +       + L  ++     +C   L        L + +L  
Sbjct: 67  ------DVIHTKKRLVLVF-------EHLDQDLKKLLDVCEGGLESVTAKSFLLQ-LLNG 112
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
            A  +   V HRD K  N+L+  +    IADFGLA  F  G P      +V T  Y AP+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPD 170
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           VL G+  +S      ID+++   +  E+ +
Sbjct: 171 VLMGSKKYSTT----IDIWSVGCIFAEMVN 196

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 46/285 (16%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHD 166
              +V    +G+FG V+ A+ K     +A+K+     L ++    Q  +EI    H+ H 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 167 NILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS-MSKGL 222
           NILR   Y    KR        +L+  +  RG L   L+ +    EQ     +  ++  L
Sbjct: 75  NILRMYNYFHDRKR-------IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            + HE             V HRD K  N+L+       IADFG ++      P       
Sbjct: 128 HYCHER-----------KVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXM 172
Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG--EYRLPFSA 340
            GT  Y+ PE++EG  +       ++D++   ++ +E          P     +R   + 
Sbjct: 173 CGTLDYLPPEMIEGKTHDE-----KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
           ++   P L D  + ++ K LR   P+        L L   ME  W
Sbjct: 228 DLKFPPFLSDGSKDLISKLLRYHPPQR-------LPLKGVMEHPW 265

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTW---EQLCRIALSMSKGLMHLH------ 226
           K+GE++     ++ +    G  C F+ C    +   ++L  I   M+ G +H H      
Sbjct: 229 KQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 287
Query: 227 ----------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                      EI+      +   V +RD K  N+LL       I+D GLA  F   KP 
Sbjct: 288 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 346
Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
              H  VGT  YMAPEVL+  + +   A    D ++   +L++L
Sbjct: 347 ---HASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKL 383

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 117 VEVKAQGRFGAVWKAKFK-NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNILRYI 172
           +E   +G +G V+KA+    E  A+K I L ++ +   S   +EI  L  ++H NI++  
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 173 GAEKRGESIHTEFWLITAY-HERGSLCDFLKCNIVTWEQLC--RIALSMSKGLMHLHEEI 229
                 + IHT+  L+  + H    L   L       E +      L +  G+ + H+  
Sbjct: 67  ------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      V HRD K  N+L+  +    IADFGLA  F  G P      +V T  Y 
Sbjct: 120 ----------RVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYR 167
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           AP+VL G+  +S      ID+++   +  E+ +
Sbjct: 168 APDVLMGSKKYSTT----IDIWSVGCIFAEMVN 196

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAE 175
            +G +G V K + K+    VA+K FL  D      +   +EI  L  + H+N++  +   
Sbjct: 34  GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93
Query: 176 KRGESIHTEFWLITAYHERGSLCDF-LKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           K+ +     ++L+  + +   L D  L  N + ++ + +    +  G+   H        
Sbjct: 94  KKKK----RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH------ 143
Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 + HRD K  N+L+       + DFG A  L  PG+   D   +V TR Y APE+
Sbjct: 144 -----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---EVATRWYRAPEL 195
Query: 294 LEGAINFSRDAFLRIDMYACALVLWEL 320
           L G + + +     +D++A   ++ E+
Sbjct: 196 LVGDVKYGK----AVDVWAIGCLVTEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 37  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 95
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 96  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 145
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 146 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 196
Query: 293 VLEG 296
           V+ G
Sbjct: 197 VILG 200

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 94
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 154
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 208
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPG-EYRLPFSAEV-GD 344
               ++ D+++  L L E+A     + PP   E  L F  +V GD
Sbjct: 209 ----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 35  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 93
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 94  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 143
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 144 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 194
Query: 293 VLEG 296
           V+ G
Sbjct: 195 VILG 198

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 43  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 102
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 103 FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 153
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 154 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 203
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 204 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 94
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 37  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 95
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 96  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 145
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 146 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 196
Query: 293 VLEG 296
           V+ G
Sbjct: 197 VILG 200

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 30  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 88
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 89  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 138
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 139 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 189
Query: 293 VLEG 296
           V+ G
Sbjct: 190 VILG 193

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 78/349 (22%), Positives = 146/349 (41%), Gaps = 55/349 (15%)
Query: 90  YFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ 149
           YF  +   E H T   +P+      +++     G FG V+KA+ K  +V     ++  K 
Sbjct: 19  YFQSMKQYE-HVTRDLNPEDFW---EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS 74
Query: 150 SWQSEQ---EIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI- 205
             + E    EI  L   +H NI++ + A           W++  +   G++ D +   + 
Sbjct: 75  EEELEDYMVEIDILASCDHPNIVKLLDAF----YYENNLWILIEFCAGGAV-DAVMLELE 129
Query: 206 --VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
             +T  Q+  +       L +LH+    NK       + HRD K+ N+L   D    +AD
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHD----NK-------IIHRDLKAGNILFTLDGDIKLAD 178
Query: 264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           FG++   +  +        +GT  +MAPEV+    +  R    + D+++  + L E+A  
Sbjct: 179 FGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-- 234
Query: 324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV-VHKKLRPTL--PETWKQHAGMLALCDT 380
              + PP              H  L  M+  + + K   PTL  P  W  +       D 
Sbjct: 235 --EIEPP--------------HHELNPMRVLLKIAKSEPPTLAQPSRWSSN-----FKDF 273
Query: 381 MEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVE 429
           +++C + + +AR + S +++   + + D+ +   +  AEA+   +  VE
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTV-DSNKPIRELIAEAKAEVTEEVE 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 30  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 88
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 89  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 138
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 139 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 189
Query: 293 VLEG 296
           V+ G
Sbjct: 190 VILG 193

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 74  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 133 QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 182
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 183 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 233
Query: 293 VLEG 296
           V+ G
Sbjct: 234 VILG 237

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 29  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 88  QKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 137
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 188
Query: 293 VLEG 296
           V+ G
Sbjct: 189 VILG 192

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 115 QLVEVKAQGRFGAVWK-------AKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN 167
           QL E   +G F  V +        ++  + +  K    +D Q  + E  I +L  ++H N
Sbjct: 7   QLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRL--LKHPN 64
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I+R   +       +  F L+T     G L +    +IV  E       S      H  +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTG----GELFE----DIVAREYYSEADAS------HCIQ 110
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTH---G 281
           +IL +    +   + HRD K  N+LL S    A   +ADFGLA+  +     GD     G
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----GDQQAWFG 165
Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
             GT  Y++PEVL       +D + + +DM+AC ++L+ L
Sbjct: 166 FAGTPGYLSPEVLR------KDPYGKPVDMWACGVILYIL 199

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 78/192 (40%), Gaps = 37/192 (19%)
Query: 121 AQGRFGAVWKA--KFKNENVAVKIFL---------MQDKQSWQSEQEIFKLPHMEHDNIL 169
             G FG VW A  K KN+ V VK            ++D +  +   EI  L  +EH NI+
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 170 RYIGA-EKRGESIHTEFWLITAYHERG-SLCDFLKCNIVTWEQLCRIA---LSMSKGLMH 224
           + +   E +G      F L+   H  G  L  F+  +    E L       L  + G + 
Sbjct: 93  KVLDIFENQGF-----FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L +             + HRD K  N+++  D T  + DFG A   E GK     +   G
Sbjct: 148 LKD-------------IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCG 191
Query: 285 TRRYMAPEVLEG 296
           T  Y APEVL G
Sbjct: 192 TIEYCAPEVLMG 203

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 46/277 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILR---Y 171
            +G+FG V+ A+ K     +A+K+     L ++    Q  +EI    H+ H NILR   Y
Sbjct: 24  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 83
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS-MSKGLMHLHEEIL 230
               KR        +L+  +  RG L   L+ +    EQ     +  ++  L + HE   
Sbjct: 84  FHDRKR-------IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER-- 134
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     V HRD K  N+L+       IADFG ++      P        GT  Y+ 
Sbjct: 135 ---------KVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLP 181
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG--EYRLPFSAEVGDHPSL 348
           PE++EG  +       ++D++   ++ +E          P     +R   + ++   P L
Sbjct: 182 PEMIEGKTHDE-----KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 236
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECW 385
            D  + ++ K LR   P+        L L   ME  W
Sbjct: 237 SDGSKDLISKLLRYHPPQR-------LPLKGVMEHPW 266

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I  FGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILGFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 78/349 (22%), Positives = 146/349 (41%), Gaps = 55/349 (15%)
Query: 90  YFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ 149
           YF  +   E H T   +P+      +++     G FG V+KA+ K  +V     ++  K 
Sbjct: 19  YFQSMKQYE-HVTRDLNPEDFW---EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS 74
Query: 150 SWQSEQ---EIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI- 205
             + E    EI  L   +H NI++ + A           W++  +   G++ D +   + 
Sbjct: 75  EEELEDYMVEIDILASCDHPNIVKLLDAF----YYENNLWILIEFCAGGAV-DAVMLELE 129
Query: 206 --VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
             +T  Q+  +       L +LH+    NK       + HRD K+ N+L   D    +AD
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHD----NK-------IIHRDLKAGNILFTLDGDIKLAD 178
Query: 264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           FG++   +  +        +GT  +MAPEV+    +  R    + D+++  + L E+A  
Sbjct: 179 FGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-- 234
Query: 324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV-VHKKLRPTL--PETWKQHAGMLALCDT 380
              + PP              H  L  M+  + + K   PTL  P  W  +       D 
Sbjct: 235 --EIEPP--------------HHELNPMRVLLKIAKSEPPTLAQPSRWSSN-----FKDF 273
Query: 381 MEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVE 429
           +++C + + +AR + S +++   + + D+ +   +  AEA+   +  VE
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTV-DSNKPIRELIAEAKAEVTEEVE 321

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 117 VEVKAQGRFGAVWKAKFK-NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNILRYI 172
           +E   +G +G V+KA+    E  A+K I L ++ +   S   +EI  L  ++H NI++  
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
                 + IHT+  L+  +       + L  ++     +C   L        L + +L  
Sbjct: 67  ------DVIHTKKRLVLVF-------EHLDQDLKKLLDVCEGGLESVTAKSFLLQ-LLNG 112
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
            A  +   V HRD K  N+L+  +    IADFGLA  F  G P      ++ T  Y AP+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPD 170
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELAS 322
           VL G+  +S      ID+++   +  E+ +
Sbjct: 171 VLMGSKKYSTT----IDIWSVGCIFAEMVN 196

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +K   +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKXQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDXELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 78  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 127
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 181
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPG-EYRLPFSAEV-GD 344
               ++ D+++  L L E+A     + PP   E  L F  +V GD
Sbjct: 182 ----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 115 QLVEVKAQGRFGAVWKA-------KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN 167
           QL E   +G F  V +        ++  + +  K    +D Q  + E  I +L  ++H N
Sbjct: 7   QLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRL--LKHSN 64
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I+R   +       +  F L+T     G L +    +IV  E       S      H  +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTG----GELFE----DIVAREYYSEADAS------HCIQ 110
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTH---G 281
           +IL      ++  V HRD K  N+LL S    A   +ADFGLA+  +     GD     G
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-----GDQQAWFG 165
Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
             GT  Y++PEVL       ++A+ + +D++AC ++L+ L
Sbjct: 166 FAGTPGYLSPEVLR------KEAYGKPVDIWACGVILYIL 199

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 115 QLVEVKAQGRFGAVWK-------AKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN 167
           QL E   +G F  V +        ++  + +  K    +D Q  + E  I +L  ++H N
Sbjct: 7   QLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRL--LKHPN 64
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I+R   +       +  F L+T     G L +    +IV  E       S      H  +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTG----GELFE----DIVAREYYSEADAS------HCIQ 110
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTH---G 281
           +IL +    +   + HRD K  N+LL S    A   +ADFGLA+  +     GD     G
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----GDQQAWFG 165
Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
             GT  Y++PEVL       +D + + +DM+AC ++L+ L
Sbjct: 166 FAGTPGYLSPEVLR------KDPYGKPVDMWACGVILYIL 199

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLSQVIQMEL-DHERMSYLLYQMLVGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWEL 320
           V+ G + +  +    +D+++  +++ E+
Sbjct: 196 VILG-MGYKEN----VDIWSVGVIMGEM 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 24/136 (17%)
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTH 280
           H  ++IL + A  +   + HR+ K  N+LL S    A   +ADFGLA+     +     H
Sbjct: 132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---H 188
Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWELASRCSSVSPPP----GEYR 335
           G  GT  Y++PEVL+      +D + + +D++AC ++L+ L      V  PP     ++R
Sbjct: 189 GFAGTPGYLSPEVLK------KDPYSKPVDIWACGVILYILL-----VGYPPFWDEDQHR 237
Query: 336 LPFSAEVG--DHPSLE 349
           L    + G  D+PS E
Sbjct: 238 LYAQIKAGAYDYPSPE 253

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 27/161 (16%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL 169
           G   + LVE    G F A+ +     +         QD++  Q E ++ +L    H NIL
Sbjct: 41  GFSYVDLVEGLHDGHFYALKRILCHEQ---------QDREEAQREADMHRL--FNHPNIL 89
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFL-----KCNIVTWEQLCRIALSMSKGLMH 224
           R +    R      E WL+  + +RG+L + +     K N +T +Q+  + L + +GL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           +H       A  Y    AHRD K  N+LL  +    + D G
Sbjct: 150 IH-------AKGY----AHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 14/106 (13%)
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLAL-LFEPGKPCGDT 279
           H   +IL      +   + HRD K  NVLL S   +A   + DFG+A+ L E G   G  
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG-- 191
Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWELASRC 324
            G+VGT  +MAPEV++      R+ + + +D++ C ++L+ L S C
Sbjct: 192 -GRVGTPHFMAPEVVK------REPYGKPVDVWGCGVILFILLSGC 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 78  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 127
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 181
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPG-EYRLPFSAEV-GD 344
               ++ D+++  L L E+A     + PP   E  L F  +V GD
Sbjct: 182 ----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 43/262 (16%)
Query: 83  RQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSI------QLVEVKAQGRFGAVWKAKFKNE 136
           R+R L         +EP   S  +P Q    I      + ++V   G FG V+K  +  E
Sbjct: 14  RKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPE 73
Query: 137 NVAVKI----FLMQDKQSWQSEQEI----FKLPHMEHDNILRYIGAEKRGESIHTEFWLI 188
              VKI      +++  S ++ +EI    + +  +++ ++ R +G       + +   LI
Sbjct: 74  GEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGI-----CLTSTVQLI 128
Query: 189 TAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRD 245
           T     G L D++   K NI + + L    + ++KG+ +L +  L            HRD
Sbjct: 129 TQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYLEDRRL-----------VHRD 176
Query: 246 FKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR--RYMAPEVLEGAINFSRD 303
             + NVL+K+     I DFGLA L   G    + H + G    ++MA E +   I   + 
Sbjct: 177 LAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 234
Query: 304 AFLRIDMYACALVLWELASRCS 325
                D+++  + +WEL +  S
Sbjct: 235 -----DVWSYGVTVWELMTFGS 251

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 122/305 (40%), Gaps = 63/305 (20%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-----KNENVAVK----IFLMQDKQSWQSEQEIFKLPHME 164
           +   EV  +G FG V+         K  + AVK    I  + +   + +E  I K     
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DFS 90
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGL 222
           H N+L  +G   R E       ++  Y + G L +F++   +  T + L    L ++KG+
Sbjct: 91  HPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 147
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKPCGDTH 280
             L  +              HRD  + N +L    T  +ADFGLA  +L    K     H
Sbjct: 148 KFLASK-----------KFVHRDLAARNCMLDEKFTVKVADFGLARDML---DKEFDSVH 193
Query: 281 GQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP 337
            + G +   ++MA E L+     ++    + D+++  ++LWEL +R    +PP       
Sbjct: 194 NKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRG---APP------- 238
Query: 338 FSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                  +P +      V   + R  L PE          L + M +CW   AE R S S
Sbjct: 239 -------YPDVNTFDITVYLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFS 286
Query: 397 CVVER 401
            +V R
Sbjct: 287 ELVSR 291

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 78  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 127
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 181
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPG-EYRLPFSAEV-GD 344
               ++ D+++  L L E+A     + PP   E  L F  +V GD
Sbjct: 182 ----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 78  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 127
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 181
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPG-EYRLPFSAEV-GD 344
               ++ D+++  L L E+A     + PP   E  L F  +V GD
Sbjct: 182 ----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ ++   +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 11  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 70
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 71  HDNIVKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HR+  + N+L++++    I DFGL  +    K    
Sbjct: 125 CKGMEYLGTK-----------RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYK 173
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 174 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTP 94
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKTLEEFQDVYLVMELMD-ANLXQVIQMEL-DHERMSYLLYQMLXGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++Q K     E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQGKAFKNRELQIMR--KLDHCNIVRLRYFF 82
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 142 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSR 186
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 187 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 118 EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----- 170
           +V   G FG V++AK     E VA+K  ++Q K     E +I +   ++H NI+R     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQGKAFKNRELQIMR--KLDHCNIVRLRYFF 82
Query: 171 YIGAEKRGE---SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           Y   EK+ E   ++  ++   T Y          +   V + +L    L  S   +H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA-AIADFGLALLFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+LL  D     + DFG A     G+P       + +R
Sbjct: 142 ------------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSR 186
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            Y APE++ GA +++      ID+++   VL EL
Sbjct: 187 YYRAPELIFGATDYTSS----IDVWSAGCVLAEL 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 80  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 130
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 131 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEM 180
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 181 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 34  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 93
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 94  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 144
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 145 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 194
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 195 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 224

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 37  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 95
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 96  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 145
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 146 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 196
Query: 293 VLEG 296
           V+ G
Sbjct: 197 VILG 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 132 KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY 191
           +F  + +  K    +D Q  + E  I +   ++H NI+R   + +     +  F L+T  
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTG- 89
Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
              G L +    +IV  E       S      H  ++IL + A  +   + HR+ K  N+
Sbjct: 90  ---GELFE----DIVAREFYSEADAS------HCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 252 LLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR- 307
           LL S    A   +ADFGLA+     +     HG  GT  Y++PEVL+      +D + + 
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLK------KDPYSKP 187
Query: 308 IDMYACALVLWELASRCSSVSPPP----GEYRLPFSAEVG--DHPSLE 349
           +D++AC ++L+ L      V  PP     ++RL    + G  D+PS E
Sbjct: 188 VDIWACGVILYILL-----VGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/349 (22%), Positives = 146/349 (41%), Gaps = 55/349 (15%)
Query: 90  YFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ 149
           YF  +   E H T   +P+      +++     G FG V+KA+ K  +V     ++  K 
Sbjct: 19  YFQSMKQYE-HVTRDLNPEDFW---EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS 74
Query: 150 SWQSEQ---EIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI- 205
             + E    EI  L   +H NI++ + A           W++  +   G++ D +   + 
Sbjct: 75  EEELEDYMVEIDILASCDHPNIVKLLDAF----YYENNLWILIEFCAGGAV-DAVMLELE 129
Query: 206 --VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
             +T  Q+  +       L +LH+    NK       + HRD K+ N+L   D    +AD
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHD----NK-------IIHRDLKAGNILFTLDGDIKLAD 178
Query: 264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           FG++   +  +        +GT  +MAPEV+    +  R    + D+++  + L E+A  
Sbjct: 179 FGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-- 234
Query: 324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV-VHKKLRPTL--PETWKQHAGMLALCDT 380
              + PP              H  L  M+  + + K   PTL  P  W  +       D 
Sbjct: 235 --EIEPP--------------HHELNPMRVLLKIAKSEPPTLAQPSRWSSN-----FKDF 273
Query: 381 MEECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSASCVVE 429
           +++C + + +AR + S +++   + + D+ +   +  AEA+   +  VE
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTV-DSNKPIRELIAEAKAEVTEEVE 321

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I D GLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDAGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 132 KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY 191
           +F  + +  K    +D Q  + E  I +   ++H NI+R   + +     +  F L+T  
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTG- 89
Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
              G L +    +IV  E       S      H  ++IL + A  +   + HR+ K  N+
Sbjct: 90  ---GELFE----DIVAREFYSEADAS------HCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 252 LLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR- 307
           LL S    A   +ADFGLA+     +     HG  GT  Y++PEVL+      +D + + 
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLK------KDPYSKP 187
Query: 308 IDMYACALVLWELASRCSSVSPPP----GEYRLPFSAEVG--DHPSLE 349
           +D++AC ++L+ L      V  PP     ++RL    + G  D+PS E
Sbjct: 188 VDIWACGVILYILL-----VGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DF LA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFYLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 78  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 128
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 129 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDTLCGTLDYLPPEM 178
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 179 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 132 KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY 191
           +F  + +  K    +D Q  + E  I +   ++H NI+R   + +     +  F L+T  
Sbjct: 32  EFAAKIINTKKLSARDFQKLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTG- 88
Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
              G L +    +IV  E       S      H  ++IL + A  +   + HR+ K  N+
Sbjct: 89  ---GELFE----DIVAREFYSEADAS------HCIQQILESIAYCHSNGIVHRNLKPENL 135
Query: 252 LLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR- 307
           LL S    A   +ADFGLA+     +     HG  GT  Y++PEVL+      +D + + 
Sbjct: 136 LLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLK------KDPYSKP 186
Query: 308 IDMYACALVLWELASRCSSVSPPP----GEYRLPFSAEVG--DHPSLE 349
           +D++AC ++L+ L      V  PP     ++RL    + G  D+PS E
Sbjct: 187 VDIWACGVILYILL-----VGYPPFWDEDQHRLYAQIKAGAYDYPSPE 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 38  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 96
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 97  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 146
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 147 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMVPFVVTRYYRAPE 197
Query: 293 VLEG 296
           V+ G
Sbjct: 198 VILG 201

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 19  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 78
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 79  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 129
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 130 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEM 179
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 180 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 209

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +LC  ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 80  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 130
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 131 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPPEM 180
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 181 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 78  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 128
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 129 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 178
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 179 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 80  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 130
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 131 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 180
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 181 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 210

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I D GLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDRGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 82  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 132
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 133 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 183 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 212

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 101/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I AY  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +KC  +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKCQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I D GLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDGGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +K   +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKXQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGLA 
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLA- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 30/195 (15%)
Query: 137 NVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAY 191
           NVAVK           + ++ +E+  L  + H NI+  +      +++    + +L+   
Sbjct: 51  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
            +  +LC  +   +   E++  +   M  G+ HLH              + HRD K +N+
Sbjct: 111 MD-ANLCQVIHMEL-DHERMSYLLYQMLCGIKHLH-----------SAGIIHRDLKPSNI 157
Query: 252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMAPEVLEGAINFSRDAFLRID 309
           ++KSD T  I DFGLA        C +      V TR Y APEV+ G + ++ +    +D
Sbjct: 158 VVKSDCTLKILDFGLA-----RTACTNFMMTPYVVTRYYRAPEVILG-MGYAAN----VD 207
Query: 310 MYACALVLWELASRC 324
           +++   ++ EL   C
Sbjct: 208 IWSVGCIMGELVKGC 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLSQVIQMEL-DHERMSYLLYQMLVGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWEL 320
           V+ G + +  +    +D+++  +++ E+
Sbjct: 196 VILG-MGYKEN----VDIWSVGVIMGEM 218

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 22/149 (14%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 78  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 127
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 181
Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPP 330
               ++ D+++  L L E+A     + PP
Sbjct: 182 ----VQSDIWSMGLSLVEMAVGRYPIPPP 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 82  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 132
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 133 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 183 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 212

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 115 QLVEVKAQGRFGAVWK-------AKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN 167
           QL E   +G F  V +        ++    +  K    +D Q  + E  I +L  ++H N
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL--LKHPN 71
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I+R   +       +  F L+T     G L +    +IV  E       S      H  +
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTG----GELFE----DIVAREYYSEADAS------HCIQ 117
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVG 284
           +IL      ++  V HR+ K  N+LL S L  A   +ADFGLA+  E  +      G  G
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAG 175
Query: 285 TRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
           T  Y++PEVL       +D + + +D++AC ++L+ L
Sbjct: 176 TPGYLSPEVLR------KDPYGKPVDLWACGVILYIL 206

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 32/149 (21%)
Query: 155 QEIFKLPHMEHDNILRYIG--AEKRGESIHTEFWLITAYHERGSLCD----FLKCNIVTW 208
           +E+  L  ++H NI++      +KR       ++L+   ++ G L D     +K N V  
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRN------YYLVMECYKGGELFDEIIHRMKFNEVDA 138
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFG 265
             + +  LS   G+ +LH           K  + HRD K  N+LL+S   D    I DFG
Sbjct: 139 AVIIKQVLS---GVTYLH-----------KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           L+ +FE  K   +   ++GT  Y+APEVL
Sbjct: 185 LSAVFENQKKMKE---RLGTAYYIAPEVL 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 16  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 75
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 76  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 126
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 127 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 176
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 177 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 80  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 130
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 131 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEM 180
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 181 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 14  GKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 73
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 74  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 124
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 125 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 174
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 175 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 77  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 127
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 128 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPPEM 177
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 178 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 80  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 130
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 131 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 180
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 181 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 21  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 81  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 131
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE+
Sbjct: 132 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 181
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 182 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 211

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 39/214 (18%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAE 175
            +G +G V+K + ++    VA+K FL  +      +   +EI  L  ++H N++  +   
Sbjct: 12  GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF 71
Query: 176 KRGESIHTEFWLI--TAYHE-----RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
           +R   +H  F     T  HE     RG     +K   +TW+ L  +              
Sbjct: 72  RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS--ITWQTLQAVNFC----------- 118
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                   +K    HRD K  N+L+       + DFG A L     P      +V TR Y
Sbjct: 119 --------HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWY 168
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            +PE+L G   +       +D++A   V  EL S
Sbjct: 169 RSPELLVGDTQYGPP----VDVWAIGCVFAELLS 198

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ +     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 21  GKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 81  FHDA----TRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK----- 131
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S+    IADFG ++      P        GT  Y+ PE+
Sbjct: 132 ------RVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRDTLCGTLDYLPPEM 181
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 182 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGMPPFE 211

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 106 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 153
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 208
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 209 KSAXKSSDLWALGCIIYQLVA 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 72  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 127 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 176 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 205

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 94
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKTLEEFQDVYLVMELMD-ANLXQVIQMEL-DHERMSYLLYQMLXGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 107 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 154
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-----E 209
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 210 KSACKSSDLWALGCIIYQLVA 230

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ +     + + ++   Q        Q  +E+    H+ H NILR  G 
Sbjct: 21  GKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 81  FHDA----TRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK----- 131
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S+    IADFG ++      P        GT  Y+ PE+
Sbjct: 132 ------RVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 181
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 182 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGMPPFE 211

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 29  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 88  QKTLEEFQDVYLVMELMD-ANLXQVIQMEL-DHERMSYLLYQMLXGIKHLHS-------- 137
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 188
Query: 293 VLEG 296
           V+ G
Sbjct: 189 VILG 192

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 101/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                  +T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKNTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 104 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 151
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT-----E 206
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 82  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 132
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE 
Sbjct: 133 ------RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEX 182
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG     R    ++D+++  ++ +E       V  PP E
Sbjct: 183 IEG-----RXHDEKVDLWSLGVLCYEFL-----VGKPPFE 212

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 18/105 (17%)
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++  + HRD K  N+LL  +L   IADFGL+ +   G     +    G+  Y APEV+ G
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVING 181
Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
            +     A   +D+++C +VL+ +              RLPF  E
Sbjct: 182 KLY----AGPEVDVWSCGIVLYVMLVG-----------RLPFDDE 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 83  KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 130
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 185
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 186 KSACKSSDLWALGCIIYQLVA 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 84  KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 131
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 186
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 187 KSACKSSDLWALGCIIYQLVA 207

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 91
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 92  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 147
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 206
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 207 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 235

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 106 KLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 153
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-----E 208
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 209 KSASKSSDLWALGCIIYQLVA 229

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 111 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 158
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 213
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 214 KSACKSSDLWALGCIIYQLVA 234

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 100 HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 154
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 155 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 204 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 233

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 38/238 (15%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIFLMQDKQSWQS-EQEIFKLPHME 164
           R ++ +    +G FG+V   ++        E VAVK      ++  +  E+EI  L  ++
Sbjct: 13  RHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 72
Query: 165 HDNILRYIG----AEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
           HDNI++Y G    A +R         LI  +   GSL ++L+ +   +   +L +    +
Sbjct: 73  HDNIVKYKGVCYSAGRRN------LKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI 126
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
            KG+ +L  +              HRD  + N+L++++    I DFGL  +    K    
Sbjct: 127 CKGMEYLGTK-----------RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 279 TH--GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               G+     Y APE L  +  FS  +    D+++  +VL+EL +       PP E+
Sbjct: 176 VKEPGESPIFWY-APESLTES-KFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 106 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 153
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 208
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 82  KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 129
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 184
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 185 KSACKSSDLWALGCIIYQLVA 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 107 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 154
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 209
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 210 KSACKSSDLWALGCIIYQLVA 230

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLSQVIQMEL-DHERMSYLLYQMLVGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 15  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 75  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 129
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 130 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 179 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 81  KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 128
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 183
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 184 KSACKSSDLWALGCIIYQLVA 204

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A   + NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTP 94
Query: 178 GESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +++    + +L+    +  +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKTLEEFQDVYLVMELMD-ANLXQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 103 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 150
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-----E 205
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 206 KSACKSSDLWALGCIIYQLVA 226

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 69  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 124 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 173 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 77  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 132 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 181 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 210

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 109 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 156
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 211
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 212 KSACKSSDLWALGCIIYQLVA 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 104 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 151
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 206
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 14  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 74  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 129 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 178 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 72  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 127 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 176 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 72  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 127 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 176 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 205

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 106 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 153
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 208
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 78  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 128
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IADFG +       P        GT  Y+ PE+
Sbjct: 129 ------RVIHRDIKPENLLLGSAGELKIADFGWSC----HAPSSRRTTLSGTLDYLPPEM 178
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 179 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 208

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 104 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 151
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 206
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 104 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 151
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 206
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 106 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 153
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 208
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 27  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 84
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 85  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 199
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 200 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 228

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 19  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 78
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 79  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 129
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IA+FG ++      P        GT  Y+ PE+
Sbjct: 130 ------RVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPPEM 179
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 180 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 22/140 (15%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 81  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 130
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+   +   + VGTR YM+PE L+G  ++S
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDEMANEFVGTRSYMSPERLQGT-HYS 184
Query: 302 RDAFLRIDMYACALVLWELA 321
               ++ D+++  L L E+A
Sbjct: 185 ----VQSDIWSMGLSLVEMA 200

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 106 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 153
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 208
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 35/210 (16%)
Query: 103 SPPSPQQGCRSIQLVEVKAQGRFGAV--WKAKFKNENVAVKI----FLMQDKQSWQSEQE 156
           SP  P Q C   ++ E    G FG V  W  +   E VA+K        ++++ W  E +
Sbjct: 6   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ 65
Query: 157 IFKLPHMEHDNIL--RYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-----CNIVTWE 209
           I K   + H N++  R +    +  + +    L   Y E G L  +L      C +   E
Sbjct: 66  IMK--KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK--E 121
Query: 210 QLCRIALS-MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK---SDLTAAIADFG 265
              R  LS +S  L +LHE             + HRD K  N++L+     L   I D G
Sbjct: 122 GPIRTLLSDISSALRYLHEN-----------RIIHRDLKPENIVLQPGPQRLIHKIIDLG 170
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLE 295
            A   + G+ C +    VGT +Y+APE+LE
Sbjct: 171 YAKELDQGELCTEF---VGTLQYLAPELLE 197

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 21  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 78
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 79  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 193
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 194 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 35/210 (16%)
Query: 103 SPPSPQQGCRSIQLVEVKAQGRFGAV--WKAKFKNENVAVKI----FLMQDKQSWQSEQE 156
           SP  P Q C   ++ E    G FG V  W  +   E VA+K        ++++ W  E +
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ 64
Query: 157 IFKLPHMEHDNIL--RYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-----CNIVTWE 209
           I K   + H N++  R +    +  + +    L   Y E G L  +L      C +   E
Sbjct: 65  IMK--KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK--E 120
Query: 210 QLCRIALS-MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK---SDLTAAIADFG 265
              R  LS +S  L +LHE             + HRD K  N++L+     L   I D G
Sbjct: 121 GPIRTLLSDISSALRYLHEN-----------RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLE 295
            A   + G+ C +    VGT +Y+APE+LE
Sbjct: 170 YAKELDQGELCTEF---VGTLQYLAPELLE 196

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 25  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 82
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 83  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 138
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 139 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 197
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 198 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 28  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 85
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 86  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 200
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 201 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 27  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 84
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 85  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 199
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 200 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 88  KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 135
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 190
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 191 KSACKSSDLWALGCIIYQLVA 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 18/121 (14%)
Query: 204 NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
           +++  E L +I L+  K L HL E +           + HRD K +N+LL       + D
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENL----------KIIHRDIKPSNILLDRSGNIKLCD 169
Query: 264 FGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELA 321
           FG++  L +      D     G R YMAPE ++ +   SR  + +R D+++  + L+ELA
Sbjct: 170 FGISGQLVDSIAKTRDA----GCRPYMAPERIDPSA--SRQGYDVRSDVWSLGITLYELA 223
Query: 322 S 322
           +
Sbjct: 224 T 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAYHERGS-LCDFLKCNIVTW 208
           ++ +E+  L HM+H+N++  +       S+    + +L+T  H  G+ L + +K   +T 
Sbjct: 67  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKSQKLTD 124
Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL 268
           + +  +   + +GL ++H       AD     + HRD K +N+ +  D    I DFGL  
Sbjct: 125 DHVQFLIYQILRGLKYIH------SAD-----IIHRDLKPSNLAVNEDSELKILDFGLC- 172
Query: 269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                    +  G V TR Y APE++   +++++     +D+++   ++ EL +
Sbjct: 173 ----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLT 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 121 AQGRFGAVWKAKFKNEN--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 175 EKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                   T  +LI  Y   G++  +  K +    ++       ++  L + H +     
Sbjct: 80  FHDA----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK----- 130
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                  V HRD K  N+LL S     IA+FG ++      P        GT  Y+ PE+
Sbjct: 131 ------RVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPPEM 180
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           +EG ++       ++D+++  ++ +E       V  PP E
Sbjct: 181 IEGRMHDE-----KVDLWSLGVLCYEFL-----VGKPPFE 210

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IIHLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQLCR--IALSMSKGLMHLHEEILPNKADSYKPAV 241
           + +   +Y + G L  +++  I ++++ C       +   L +LH +            +
Sbjct: 103 KLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK-----------GI 150
Query: 242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
            HRD K  N+LL  D+   I DFG A +  P       +  VGT +Y++PE+L       
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT-----E 205
Query: 302 RDAFLRIDMYACALVLWELAS 322
           + A    D++A   ++++L +
Sbjct: 206 KSACKSSDLWALGCIIYQLVA 226

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IITLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 33/212 (15%)
Query: 115 QLVEVKAQGRFGA--VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           +LV+    G FG   + + K  NE VAVK     +K     ++EI     + H NI+R+ 
Sbjct: 22  ELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRF- 80
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
              K      T   ++  Y   G L          +E++C              ++++  
Sbjct: 81  ---KEVILTPTHLAIVMEYASGGEL----------FERICNAGRFSEDEARFFFQQLISG 127
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLT--AAIADFGLALLFEPGKPCGDTHGQ----VGTR 286
            + ++   VAHRD K  N LL         IADFG +            H Q    VGT 
Sbjct: 128 VSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYS-------KASVLHSQPKSAVGTP 180
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLW 318
            Y+APEVL       + A    D+++C + L+
Sbjct: 181 AYIAPEVLLKKEYDGKVA----DVWSCGVTLY 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDN 167
            +G FG V  A+          E V V + +++D  + +      SE E+ K+   +H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKN 102
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    +T++ 
Sbjct: 103 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L      +++G+ +L  +              HRD  + NVL+  +    IADFGLA   
Sbjct: 159 LVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  +++WE+ +     SP 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPY 260
Query: 331 PG 332
           PG
Sbjct: 261 PG 262

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 19  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 76
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 77  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
               A        HRD  + N ++  D T  I DFG+                +   R+M
Sbjct: 133 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +PE L+  +  +       D+++  +VLWE+A+
Sbjct: 193 SPESLKDGVFTTYS-----DVWSFGVVLWEIAT 220

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 56  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 113
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 114 RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 169
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 170 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 228
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 229 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 257

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 28  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 85
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 86  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
               A        HRD  + N ++  D T  I DFG+                +   R+M
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           +PE L+  +  +       D+++  +VLWE+A+
Sbjct: 202 SPESLKDGVFTTYS-----DVWSFGVVLWEIAT 229

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           S++  + HRD K  N+L+ +     + DFG+A  + + G     T   +GT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            G    S DA  R D+Y+   VL+E+
Sbjct: 192 RGD---SVDA--RSDVYSLGCVLYEV 212

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 24/191 (12%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
            ++++V  +G FG V   K KN   A K+F M+    W+  +        E  ++L   G
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVL-VNG 131
Query: 174 AEKRGESIHTEF------WLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLH 226
             K   ++H  F      +L+  Y+  G L   L K      E++ R  L+         
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA--------- 182
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGT 285
            E++      ++    HRD K +N+L+  +    +ADFG  L L E G     +   VGT
Sbjct: 183 -EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVAVGT 239
Query: 286 RRYMAPEVLEG 296
             Y++PE+L+ 
Sbjct: 240 PDYISPEILQA 250

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 117 VEVKAQGRFGAVWKAKF----KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           V+V   G FG V+K  +    +N  + V I ++++  S ++ +EI    ++       Y+
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEIL 230
            +   G  + +   L+T     G L D ++ N   +  + L    + ++KG+ +L +  L
Sbjct: 82  -SRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRL 140
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                       HRD  + NVL+KS     I DFGLA L +  +      G     ++MA
Sbjct: 141 -----------VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            E +       R    + D+++  + +WEL +
Sbjct: 190 LESI-----LRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 452 HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ S+    + DFGL+   E       + G++ 
Sbjct: 507 LESK-----------RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 556 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 585

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 115 QLVEVKAQGRFGAVWK--AKFKNENVAVKI-----FLMQDKQSWQSEQEIFKLPHMEHDN 167
           QL E   +G F  V +   K   +  A KI        +D Q  + E  I +L  ++H N
Sbjct: 34  QLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRL--LKHPN 91
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
           I+R   +       +  F L+T     G L +    +IV  E       S      H   
Sbjct: 92  IVRLHDSISEEGFHYLVFDLVTG----GELFE----DIVAREYYSEADAS------HCIH 137
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVG 284
           +IL +    ++  + HRD K  N+LL S    A   +ADFGLA+  +  +      G  G
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW--FGFAG 195
Query: 285 TRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWEL 320
           T  Y++PEVL       +D + + +D++AC ++L+ L
Sbjct: 196 TPGYLSPEVLR------KDPYGKPVDIWACGVILYIL 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLSQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/290 (20%), Positives = 112/290 (38%), Gaps = 42/290 (14%)
Query: 117 VEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           + V  QG FG V KA+    +   A+K     +++      E+  L  + H  ++RY  A
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 175 --EKR-------GESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLM 223
             E+R            +  ++   Y E  +L D +    +  +  +  R+   + + L 
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA---------LLFE--- 271
           ++H +            + HR+ K  N+ +       I DFGLA         L  +   
Sbjct: 131 YIHSQ-----------GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 272 -PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
            PG     T   +GT  Y+A EVL+G  +++     +ID Y+  ++ +E     S+    
Sbjct: 180 LPGSSDNLTSA-IGTAXYVATEVLDGTGHYNE----KIDXYSLGIIFFEXIYPFSTGXER 234
Query: 331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT 380
               +   S  +   P  +D +  V  K +R  +     +  G   L ++
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNS 284

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 43/245 (17%)
Query: 100 HPTSPPSPQQGCRSI------QLVEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQ 149
           H  S  +P Q    I      + ++V   G FG V+K  +  E   VKI +    +++  
Sbjct: 3   HMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 62
Query: 150 SWQSEQEI----FKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---K 202
           S ++ +EI    + +  +++ ++ R +G       + +   LIT     G L D++   K
Sbjct: 63  SPKANKEILDEAYVMASVDNPHVCRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHK 117
Query: 203 CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA 262
            NI + + L    + ++KG+ +L +  L            HRD  + NVL+K+     I 
Sbjct: 118 DNIGS-QYLLNWCVQIAKGMNYLEDRRL-----------VHRDLAARNVLVKTPQHVKIT 165
Query: 263 DFGLALLFEPGKPCGDTHGQVGTR--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           DFGLA L   G    + H + G    ++MA E +       R    + D+++  + +WEL
Sbjct: 166 DFGLAKLL--GAEEKEYHAEGGKVPIKWMALESI-----LHRIYTHQSDVWSYGVTVWEL 218
Query: 321 ASRCS 325
            +  S
Sbjct: 219 MTFGS 223

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 52/247 (21%)
Query: 109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQ------SEQEIFKLPH 162
           +GC   Q+V  +A G    + K K K E V V + +++D  + +      SE E+ K+  
Sbjct: 91  EGCFG-QVVMAEAVG----IDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------I 205
            +H NI+  +GA  +   +    ++I  Y  +G+L ++L+                    
Sbjct: 145 -KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           +T++ L      +++G+ +L  +              HRD  + NVL+  +    IADFG
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFG 248
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           LA           T       ++MAPE L     F R    + D+++  +++WE+ +   
Sbjct: 249 LARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 326 SVSPPPG 332
             SP PG
Sbjct: 304 --SPYPG 308

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 28/192 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----------DKQSWQSEQEIFKLPHM 163
            +L+ V  +G +G V++ +        KIF M+           K +  ++ E   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGL 222
           +H  I+  I A + G     + +LI  Y   G L   L +  I   +  C     +S  L
Sbjct: 79  KHPFIVDLIYAFQTG----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            HLH++            + +RD K  N++L       + DFGL    E       TH  
Sbjct: 135 GHLHQK-----------GIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTF 181
Query: 283 VGTRRYMAPEVL 294
            GT  YMAPE+L
Sbjct: 182 CGTIEYMAPEIL 193

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 28/192 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----------DKQSWQSEQEIFKLPHM 163
            +L+ V  +G +G V++ +        KIF M+           K +  ++ E   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGL 222
           +H  I+  I A + G     + +LI  Y   G L   L +  I   +  C     +S  L
Sbjct: 79  KHPFIVDLIYAFQTG----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            HLH++            + +RD K  N++L       + DFGL    E       TH  
Sbjct: 135 GHLHQK-----------GIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXF 181
Query: 283 VGTRRYMAPEVL 294
            GT  YMAPE+L
Sbjct: 182 CGTIEYMAPEIL 193

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 136 ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT 189
           E V V + +++D  + +      SE E+ K+   +H NI+  +GA  +   +    ++I 
Sbjct: 53  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPL----YVIV 107
Query: 190 AYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPN 232
            Y  +G+L ++L+                    +T++ L      +++G+ +L  +    
Sbjct: 108 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---- 163
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD  + NVL+  +    IADFGLA           T       ++MAPE
Sbjct: 164 -------KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 216
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            L     F R    + D+++  +++WE+ +     SP PG
Sbjct: 217 AL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPG 249

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 136 ENVAVKIFLMQDKQSWQ------SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT 189
           E V V + +++D  + +      SE E+ K+   +H NI+  +GA  +   +    ++I 
Sbjct: 55  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPL----YVIV 109
Query: 190 AYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPN 232
            Y  +G+L ++L+                    +T++ L      +++G+ +L  +    
Sbjct: 110 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---- 165
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                     HRD  + NVL+  +    IADFGLA           T       ++MAPE
Sbjct: 166 -------KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 218
Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG 332
            L     F R    + D+++  +++WE+ +     SP PG
Sbjct: 219 AL-----FDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPG 251

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 52/247 (21%)
Query: 109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQ------SEQEIFKLPH 162
           +GC   Q+V  +A G    + K K K E V V + +++D  + +      SE E+ K+  
Sbjct: 37  EGCFG-QVVMAEAVG----IDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 90
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------I 205
            +H NI+  +GA  +   +    ++I  Y  +G+L ++L+                    
Sbjct: 91  -KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           +T++ L      +++G+ +L  +              HRD  + NVL+  +    IADFG
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQ-----------KCIHRDLAARNVLVTENNVMKIADFG 194
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           LA           T       ++MAPE L     F R    + D+++  +++WE+ +   
Sbjct: 195 LARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGG 249
Query: 326 SVSPPPG 332
             SP PG
Sbjct: 250 --SPYPG 254

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 137 NVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH--TEFWLITAY 191
           NVAVK           + ++ +E+  L  + H NI+  +      +++    + +L+   
Sbjct: 49  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
            +  +LC  +   +   E++  +   M  G+ HLH              + HRD K +N+
Sbjct: 109 MD-ANLCQVIHMEL-DHERMSYLLYQMLCGIKHLH-----------SAGIIHRDLKPSNI 155
Query: 252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMY 311
           ++KSD T  I DFGLA               V TR Y APEV+ G + +  +    +D++
Sbjct: 156 VVKSDCTLKILDFGLA---RTASTNFMMTPYVVTRYYRAPEVILG-MGYKEN----VDIW 207
Query: 312 ACALVLWELA 321
           +   ++ EL 
Sbjct: 208 SVGCIMGELV 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 21  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 78
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+      E    +A      ++ +  EI
Sbjct: 79  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N  +  D T  I DFG+   ++E         G +   R+
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 193
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 194 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 222

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 91
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+           +A      ++ +  EI
Sbjct: 92  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 206
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 207 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 235

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 48/266 (18%)
Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAK---FKNENVAVKIFLM 145
           SY    PT  P+      P+    ++Q  +    G FG V +A       E+  +K+ + 
Sbjct: 18  SYTFIDPTQLPYNEKWEFPRN---NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 74
Query: 146 QDKQSWQSEQ------EIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLC 198
             K +  +++      E+  + H+ +H+NI+  +GA   G  +     +IT Y   G L 
Sbjct: 75  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV----LVITEYCCYGDLL 130
Query: 199 DFLKCNIVTWEQLCRIALSMSKG-------LMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
           +FL+       +     L    G       L+H   ++    A        HRD  + NV
Sbjct: 131 NFLR-------RKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 183
Query: 252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFL 306
           LL +   A I DFGLA          D++  V G  R    +MAPE +     F     +
Sbjct: 184 LLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTV 233
Query: 307 RIDMYACALVLWELASRCSSVSPPPG 332
           + D+++  ++LWE+ S    ++P PG
Sbjct: 234 QSDVWSYGILLWEIFSL--GLNPYPG 257

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 18/122 (14%)
Query: 202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           K   +  + L +IA+S+ K L HLH ++          +V HRD K +NVL+ +     +
Sbjct: 102 KGQTIPEDILGKIAVSIVKALEHLHSKL----------SVIHRDVKPSNVLINALGQVKM 151
Query: 262 ADFGLALLFEPGKPCGDTHGQV--GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
            DFG++     G    D    +  G + YMAPE +   +N  +   ++ D+++  + + E
Sbjct: 152 CDFGIS-----GYLVDDVAKDIDAGCKPYMAPERINPELN-QKGYSVKSDIWSLGITMIE 205
Query: 320 LA 321
           LA
Sbjct: 206 LA 207

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLSQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 80  CRLLGI-----CLTSTVQLITQLMPFGXLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 134 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 180
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 181 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 48/266 (18%)
Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAK---FKNENVAVKIFLM 145
           SY    PT  P+      P+    ++Q  +    G FG V +A       E+  +K+ + 
Sbjct: 26  SYTFIDPTQLPYNEKWEFPRN---NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 146 QDKQSWQSEQ------EIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLC 198
             K +  +++      E+  + H+ +H+NI+  +GA   G  +     +IT Y   G L 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV----LVITEYCCYGDLL 138
Query: 199 DFLKCNIVTWEQLCRIALSMSKG-------LMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
           +FL+       +     L    G       L+H   ++    A        HRD  + NV
Sbjct: 139 NFLR-------RKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 191
Query: 252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFL 306
           LL +   A I DFGLA          D++  V G  R    +MAPE +     F     +
Sbjct: 192 LLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTV 241
Query: 307 RIDMYACALVLWELASRCSSVSPPPG 332
           + D+++  ++LWE+ S    ++P PG
Sbjct: 242 QSDVWSYGILLWEIFSL--GLNPYPG 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 22/140 (15%)
Query: 184 EFWLITAYHERGSLCDFLKCNIVTWEQ-LCRIALSMSKGLMHLHEEILPNKADSYKPAVA 242
           E  +   + + GSL   LK      EQ L ++++++ KGL +L E          K  + 
Sbjct: 97  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE----------KHKIM 146
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFS 301
           HRD K +N+L+ S     + DFG++     G+      +  VGTR YM+PE L+G  ++S
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT-HYS 200
Query: 302 RDAFLRIDMYACALVLWELA 321
               ++ D+++  L L E+A
Sbjct: 201 ----VQSDIWSMGLSLVEMA 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 53/294 (18%)
Query: 116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD------KQSWQSEQEIFKLPHMEHDNIL 169
           L E   +G FG V+  + + +N  V +   ++      K  +  E  I K     H NI+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK--QYSHPNIV 175
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHE 227
           R IG   + + I+    L+      G    FL+     +  + L ++    + G+ +L  
Sbjct: 176 RLIGVCTQKQPIYIVMELVQG----GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           +              HRD  + N L+       I+DFG++     G        +    +
Sbjct: 232 K-----------CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK 280
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           + APE    A+N+ R +    D+++  ++LWE                  FS     +P+
Sbjct: 281 WTAPE----ALNYGRYSS-ESDVWSFGILLWE-----------------TFSLGASPYPN 318
Query: 348 LEDMQ-EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
           L + Q    V K  R   PE         A+   ME+CW ++   R S S + +
Sbjct: 319 LSNQQTREFVEKGGRLPCPELCPD-----AVFRLMEQCWAYEPGQRPSFSTIYQ 367

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 28/184 (15%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           AQG   A + A  +  NVA+K           + ++ +E+  +  + H NI+  +     
Sbjct: 36  AQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 178 GESIHTEFWLITAYHE--RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            +S+  EF  +    E    +L   ++  +   E++  +   M  G+ HLH         
Sbjct: 95  QKSLE-EFQDVYIVMELMDANLSQVIQMEL-DHERMSYLLYQMLCGIKHLHS-------- 144
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRRYMAPE 292
                + HRD K +N+++KSD T  I DFGLA      +  G +      V TR Y APE
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 293 VLEG 296
           V+ G
Sbjct: 196 VILG 199

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 147 DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL----- 201
           +KQ   SE  + +   ++H NI+RY   ++  +  +T  +++  Y E G L   +     
Sbjct: 48  EKQMLVSEVNLLR--ELKHPNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 103
Query: 202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           +   +  E + R+   ++  L   H      ++D     V HRD K  NV L       +
Sbjct: 104 ERQYLDEEFVLRVMTQLTLALKECHR-----RSDG-GHTVLHRDLKPANVFLDGKQNVKL 157
Query: 262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            DFGLA +         T   VGT  YM+PE +   ++++  +    D+++   +L+EL
Sbjct: 158 GDFGLARILNHDTSFAKTF--VGTPYYMSPEQM-NRMSYNEKS----DIWSLGCLLYEL 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 72  HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ +     + DFGL+   E       + G++ 
Sbjct: 127 LESK-----------RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 176 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 205

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           S++  + HRD K  N+++ +     + DFG+A  + + G     T   +GT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            G    S DA  R D+Y+   VL+E+
Sbjct: 192 RGD---SVDA--RSDVYSLGCVLYEV 212

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 121 AQGRFGAVW----KAKFKNE---NVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            QG FG V+    K   K+E    VA+K       M+++  + +E  + K  +  H  ++
Sbjct: 24  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--VV 81
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           R +G   +G+       L+T    RG L  +L+           +A      ++ +  EI
Sbjct: 82  RLLGVVSQGQPTLVIMELMT----RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 137
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTRRY 288
               A        HRD  + N ++  D T  I DFG+   ++E         G +   R+
Sbjct: 138 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 196
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           M+PE L+  +  +       D+++  +VLWE+A+
Sbjct: 197 MSPESLKDGVFTTYS-----DVWSFGVVLWEIAT 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           S++  + HRD K  N+++ +     + DFG+A  + + G     T   +GT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            G    S DA  R D+Y+   VL+E+
Sbjct: 192 RGD---SVDA--RSDVYSLGCVLYEV 212

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 118 EVKAQGRFGA-VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +V   G  G  V++  F N +VAVK  L +       E ++ +    EH N++RY   EK
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-EHPNVIRYFCTEK 88
Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIAL--SMSKGLMHLHEEILPNKA 234
             +  +    L  A     +L ++++        L  I L    + GL HLH        
Sbjct: 89  DRQFQYIAIELCAA-----TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-------- 135
Query: 235 DSYKPAVAHRDFKSNNVLLK-----SDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                 + HRD K +N+L+        + A I+DFGL      G+        V GT  +
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           +APE+L  + +   +    +D+++   V + + S  S
Sbjct: 193 IAPEML--SEDCKENPTYTVDIFSAGCVFYYVISEGS 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 42/227 (18%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIF-----LMQDKQSWQSEQEIFKLPHMEHDN 167
           +++E    G +G V  A+     + VA+K       ++ + +    E +I K  H +HDN
Sbjct: 58  EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK--HFKHDN 115
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---------VTWEQLCRIALSM 218
           I+  I    R    + EF  +        + D ++ ++         +T E +      +
Sbjct: 116 IIA-IKDILRPTVPYGEFKSVYV------VLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 168
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKPC 276
            +GL ++H              V HRD K +N+L+  +    I DFG+A  L   P +  
Sbjct: 169 LRGLKYMHSA-----------QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 217
Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
                 V TR Y APE++     +++     ID+++   +  E+ +R
Sbjct: 218 YFMTEYVATRWYRAPELMLSLHEYTQ----AIDLWSVGCIFGEMLAR 260

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           S++  + HRD K  N+++ +     + DFG+A  + + G     T   +GT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            G    S DA  R D+Y+   VL+E+
Sbjct: 192 RGD---SVDA--RSDVYSLGCVLYEV 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 95
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 96  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 152 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 201 HHIDXXKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 252
Query: 330 PPG 332
            PG
Sbjct: 253 YPG 255

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           S++  + HRD K  N+++ +     + DFG+A  + + G     T   +GT +Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            G    S DA  R D+Y+   VL+E+
Sbjct: 192 RGD---SVDA--RSDVYSLGCVLYEV 212

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQSWQ-SEQEIFKLPHMEHD 166
           G R + L  +   G  G V+ A   +  + VA+K  ++ D QS + + +EI  +  ++HD
Sbjct: 10  GSRYMDLKPLGCGGN-GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 167 NILRYIGAEKRGESIHTE----------FWLITAYHERGSLCDFLKCNIVTWEQLCRIAL 216
           NI++         S  T+           +++  Y E   L + L+   +  E       
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMY 127
Query: 217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKP 275
            + +GL ++H              V HRD K  N+ + + DL   I DFGLA + +P   
Sbjct: 128 QLLRGLKYIH-----------SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 276 C-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
             G     + T+ Y +P +L    N+++     IDM+A   +  E+ +
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTK----AIDMWAAGCIFAEMLT 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 82  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 135
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 136 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 182
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 183 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V + G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 27  IKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 87  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 140
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 141 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 187
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 188 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V + G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 20  IKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 80  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 134 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 180
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 181 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 49/247 (19%)
Query: 113 SIQLVEVKAQGRFGAVWKAK---FKNENVAVKIFLMQDKQSWQSEQ------EIFKLPHM 163
           ++Q  +    G FG V +A       E+  +K+ +   K +  +++      E+  + H+
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 164 -EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW------------EQ 210
            +H+NI+  +GA   G  +     +IT Y   G L +FL+                  EQ
Sbjct: 107 GQHENIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L       S+ L+H   ++    A        HRD  + NVLL +   A I DFGLA   
Sbjct: 163 LS------SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-- 214
Query: 271 EPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
                  D++  V G  R    +MAPE +     F     ++ D+++  ++LWE+ S   
Sbjct: 215 ---DIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTVQSDVWSYGILLWEIFSL-- 264
Query: 326 SVSPPPG 332
            ++P PG
Sbjct: 265 GLNPYPG 271

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 30  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 89
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 90  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 143
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 144 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 190
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 191 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 45  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 104
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 105 CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 158
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 159 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 205
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 206 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 242

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 104/234 (44%), Gaps = 33/234 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILR 170
           +++ E+  +GRFG V+  ++  E VA+++  ++   + Q    ++E+       H+N++ 
Sbjct: 35  LEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           ++GA      +     +IT      SLC       V  +   +I L ++K    + +EI+
Sbjct: 94  FMGACMSPPHLA----IIT------SLCKGRTLYSVVRD--AKIVLDVNK-TRQIAQEIV 140
Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL---ALLFEPGKPCGDTHGQVGTRR 287
                 +   + H+D KS NV   +     I DFGL   + + + G+       Q G   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 288 YMAPEVL--------EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
           ++APE++        E  + FS+ +    D++A   + +EL +R       P E
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHS----DVFALGTIWYELHAREWPFKTQPAE 249

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 83  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 136
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 137 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 183
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 184 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 80  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 134 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 180
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 181 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 57/295 (19%)
Query: 119 VKAQGRFGAVWKAKFKNE-----NVAVK----IFLMQDKQSWQSEQEIFKLPHMEHDNIL 169
           V  +G FG V+  ++ ++       A+K    I  MQ  +++  E  + +   + H N+L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR--GLNHPNVL 85
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHE 227
             IG     E +     ++  Y   G L  F++      T + L    L +++G+ +L E
Sbjct: 86  ALIGIMLPPEGLPH---VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA---LLFEPGKPCGDTHGQVG 284
           +              HRD  + N +L    T  +ADFGLA   L  E        H ++ 
Sbjct: 143 Q-----------KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
             ++ A E L+    F+  +    D+++  ++LWEL +R +    PP  +  PF      
Sbjct: 192 V-KWTALESLQ-TYRFTTKS----DVWSFGVLLWELLTRGA----PPYRHIDPF------ 235
Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV 399
                D+   +   +  P  PE         +L   M++CW+ D   R +   +V
Sbjct: 236 -----DLTHFLAQGRRLPQ-PEYCPD-----SLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           S++  + HRD K  N+++ +     + DFG+A  + + G     T   +GT +Y++PE  
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 295 EGAINFSRDAFLRIDMYACALVLWEL 320
            G    S DA  R D+Y+   VL+E+
Sbjct: 209 RGD---SVDA--RSDVYSLGCVLYEV 229

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 27  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 87  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 140
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 141 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 187
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 188 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 83  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 136
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 137 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 183
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 184 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 53/294 (18%)
Query: 116 LVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD------KQSWQSEQEIFKLPHMEHDNIL 169
           L E   +G FG V+  + + +N  V +   ++      K  +  E  I K     H NI+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK--QYSHPNIV 175
Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHE 227
           R IG   + + I+    L+      G    FL+     +  + L ++    + G+ +L  
Sbjct: 176 RLIGVCTQKQPIYIVMELVQG----GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           +              HRD  + N L+       I+DFG++     G        +    +
Sbjct: 232 K-----------CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           + APE    A+N+ R +    D+++  ++LWE                  FS     +P+
Sbjct: 281 WTAPE----ALNYGRYSS-ESDVWSFGILLWE-----------------TFSLGASPYPN 318
Query: 348 LEDMQ-EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
           L + Q    V K  R   PE         A+   ME+CW ++   R S S + +
Sbjct: 319 LSNQQTREFVEKGGRLPCPELCPD-----AVFRLMEQCWAYEPGQRPSFSTIYQ 367

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 83  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 136
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 137 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 183
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 184 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 16/121 (13%)
Query: 202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           K   +  + L +IA+S+ K L HLH ++          +V HRD K +NVL+ +     +
Sbjct: 146 KGQTIPEDILGKIAVSIVKALEHLHSKL----------SVIHRDVKPSNVLINALGQVKM 195
Query: 262 ADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            DFG++  L +      D     G + YMAPE +   +N  +   ++ D+++  + + EL
Sbjct: 196 CDFGISGYLVDSVAKTIDA----GCKPYMAPERINPELN-QKGYSVKSDIWSLGITMIEL 250
Query: 321 A 321
           A
Sbjct: 251 A 251

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 82/198 (41%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 114
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 115 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           +      K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 164 S------KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 210
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 211 -ICLSGYPPFSEHRTQVS 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 82/198 (41%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 114
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 115 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           +      K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 164 S------KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 210
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 211 -ICLSGYPPFSEHRTQVS 227

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 82/198 (41%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 120
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 121 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGH 169
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           +      K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 170 S------KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 216
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 217 -ICLSGYPPFSEHRTQVS 233

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 26  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 84
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 85  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 141 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 190 HHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 241
Query: 330 PPG 332
            PG
Sbjct: 242 YPG 244

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 82/198 (41%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 113
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 114 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGH 162
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           +      K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 163 S------KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 209
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 210 -ICLSGYPPFSEHRTQVS 226

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 95
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 96  IINLLGACTQDGPL----YVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 152 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 252
Query: 330 PPG 332
            PG
Sbjct: 253 YPG 255

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 102/243 (41%), Gaps = 31/243 (12%)
Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM---EHDNILRY 171
           ++V     G FG V+KAK K         +++ K   + E  I ++  +   +H  I++ 
Sbjct: 14  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 73
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEE 228
           +GA         + W++  +   G++ D +   +   +T  Q+  +   M + L  LH +
Sbjct: 74  LGAYYHD----GKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K+ NVL+  +    +ADFG++   +  K        +GT  +
Sbjct: 129 -----------RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYW 175
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---RLPFSAEVGDH 345
           MAPEV+            + D+++  + L E+A     + PP  E    R+       D 
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMA----QIEPPHHELNPMRVLLKIAKSDP 231
Query: 346 PSL 348
           P+L
Sbjct: 232 PTL 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 82/198 (41%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 114
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 115 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           +      K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 164 S------KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 210
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 211 -ICLSGYPPFSEHRTQVS 227

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 22  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 80
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 81  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 137 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 186 HHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 237
Query: 330 PPG 332
            PG
Sbjct: 238 YPG 240

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 30  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 88
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 89  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 145 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 194 HHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 245
Query: 330 PPG 332
            PG
Sbjct: 246 YPG 248

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 95
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 96  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 152 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 252
Query: 330 PPG 332
            PG
Sbjct: 253 YPG 255

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 98/242 (40%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 95
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 96  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA   
Sbjct: 152 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  ++LWE+ +     SP 
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SPY 253
Query: 331 PG 332
           PG
Sbjct: 254 PG 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 80  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 134 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 180
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 181 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 74  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 127
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 128 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 174
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +   I   +      D+++  + +WEL +  S
Sbjct: 175 VPIKWMALESILHRIYTHQS-----DVWSYGVTVWELMTFGS 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 102/243 (41%), Gaps = 31/243 (12%)
Query: 115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM---EHDNILRY 171
           ++V     G FG V+KAK K         +++ K   + E  I ++  +   +H  I++ 
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEE 228
           +GA         + W++  +   G++ D +   +   +T  Q+  +   M + L  LH +
Sbjct: 82  LGAYYHD----GKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K+ NVL+  +    +ADFG++   +  K        +GT  +
Sbjct: 137 -----------RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYW 183
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---RLPFSAEVGDH 345
           MAPEV+            + D+++  + L E+A     + PP  E    R+       D 
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMA----QIEPPHHELNPMRVLLKIAKSDP 239
Query: 346 PSL 348
           P+L
Sbjct: 240 PTL 242

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 19  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 79  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LF 270
            ++A  ++ G+ +L+ +              HRD  + N ++  D T  I DFG+   ++
Sbjct: 133 IQMAAEIADGMAYLNAK-----------KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           E         G +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 182 ETAYYRKGGKGLLPV-RWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 227

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 98/242 (40%), Gaps = 53/242 (21%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 136
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 137 IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA   
Sbjct: 193 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                   T       ++MAPE L     F R    + D+++  ++LWE+ +     SP 
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SPY 294
Query: 331 PG 332
           PG
Sbjct: 295 PG 296

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 39/231 (16%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIF---LMQDKQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N +       VAVK      +  ++ +Q E E+  L 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL--LT 72
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIA-- 215
           +++H++I+++ G    G+ +     ++  Y + G L  FL+ +    ++  +   R A  
Sbjct: 73  NLQHEHIVKFYGVCGDGDPL----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 216 -LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK 274
            L +S+ ++H+  +I             HRD  + N L+ ++L   I DFG++       
Sbjct: 129 ELGLSQ-MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----D 182
Query: 275 PCGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
                + +VG       R+M PE +       R      D+++  ++LWE+
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESI-----MYRKFTTESDVWSFGVILWEI 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 66/259 (25%)
Query: 113 SIQLVEVKAQGRFGAVWKAK---FKNENVAVKI---FLMQDKQSWQSEQEIFKLPHM--- 163
           +++  +V   G FG V  A         V++++    L +   S + E  + +L  M   
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 164 -EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-------------------- 202
             H+NI+  +GA     ++    +LI  Y   G L ++L+                    
Sbjct: 106 GSHENIVNLLGAC----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 203 ----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT 258
                N++T+E L   A  ++KG+  L           +K  V HRD  + NVL+     
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLE----------FKSCV-HRDLAARNVLVTHGKV 210
Query: 259 AAIADFGLALLFEPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFLRIDMYAC 313
             I DFGLA          D++  V G  R    +MAPE L     F     ++ D+++ 
Sbjct: 211 VKICDFGLA-----RDIMSDSNYVVRGNARLPVKWMAPESL-----FEGIYTIKSDVWSY 260
Query: 314 ALVLWELASRCSSVSPPPG 332
            ++LWE+ S    V+P PG
Sbjct: 261 GILLWEIFSL--GVNPYPG 277

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/221 (21%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 121 AQGRFGAVWKAKFKN-----ENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEHDNILR 170
            +G FG V+ A+  N     + + V +  ++D     ++ +  E E+  L +++H++I++
Sbjct: 22  GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL--LTNLQHEHIVK 79
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLH 226
           + G    G+ +     ++  Y + G L  FL+ +    ++  E      L+ S+ ++H+ 
Sbjct: 80  FYGVCVEGDPL----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ-MLHIA 134
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           ++I             HRD  + N L+  +L   I DFG++            + +VG  
Sbjct: 135 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS-----RDVYSTDYYRVGGH 189
Query: 287 -----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                R+M PE +       R      D+++  +VLWE+ +
Sbjct: 190 TMLPIRWMPPESI-----MYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 82/198 (41%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 240 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
           +      K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 289 S------KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 335
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 336 -ICLSGYPPFSEHRTQVS 352

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 121 AQGRFGAVWKAKF---------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDN 167
            +G FG V  A+          +   VAVK+       +D     SE E+ K+   +H N
Sbjct: 29  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKN 87
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQ 210
           I+  +GA  +   +    ++I  Y  +G+L ++L+                    ++ + 
Sbjct: 88  IINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-L 269
           L   A  +++G+ +L  +              HRD  + NVL+  D    IADFGLA  +
Sbjct: 144 LVSCAYQVARGMEYLASK-----------KCIHRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP 329
                    T+G++   ++MAPE L     F R    + D+++  ++LWE+ +     SP
Sbjct: 193 HHIDYYKKTTNGRLPV-KWMAPEAL-----FDRIYTHQSDVWSFGVLLWEIFTLGG--SP 244
Query: 330 PPG 332
            PG
Sbjct: 245 YPG 247

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFL------MQDKQSWQSEQEIFKLPHMEHD 166
           I+L     +G+FG V +  + + EN A+ + +        D    +  QE   +   +H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL+    + +   L   A  +S  L +
Sbjct: 452 HIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L  +              HRD  + NVL+ +     + DFGL+   E       + G++ 
Sbjct: 507 LESK-----------RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             ++MAPE    +INF R      D++   + +WE+
Sbjct: 556 I-KWMAPE----SINFRRFTSAS-DVWMFGVCMWEI 585

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 42/227 (18%)
Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIF-----LMQDKQSWQSEQEIFKLPHMEHDN 167
           +++E    G +G V  A+     + VA+K       ++ + +    E +I K  H +HDN
Sbjct: 57  EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK--HFKHDN 114
Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI---------VTWEQLCRIALSM 218
           I+  I    R    + EF  +        + D ++ ++         +T E +      +
Sbjct: 115 IIA-IKDILRPTVPYGEFKSVYV------VLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKPC 276
            +GL ++H              V HRD K +N+L+  +    I DFG+A  L   P +  
Sbjct: 168 LRGLKYMHSA-----------QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 216
Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
                 V TR Y APE++     +++     ID+++   +  E+ +R
Sbjct: 217 YFMTEYVATRWYRAPELMLSLHEYTQA----IDLWSVGCIFGEMLAR 259

>pdb|1LX5|B Chain B, Crystal Structure Of The Bmp7ACTRII EXTRACELLULAR DOMAIN COMPLEX Length = 102

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 27/38 (71%), Gaps = 2/38 (5%)
Query: 1  MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEP 38
          + CYD+  C+EK+   +  + FCCCEG+MCN+ F++ P
Sbjct: 64 INCYDRTDCIEKKDSPE--VYFCCCEGNMCNEKFSYFP 99

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 81/198 (40%), Gaps = 45/198 (22%)
Query: 154 EQEIFKLPHMEHDNILR---YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
           E EI  L  + H  I++   +  AE        +++++    E G L D +  N    E 
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA 253
Query: 211 LCRIAL-SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGL 266
            C++    M   + +LHE             + HRD K  NVLL S   D    I DFG 
Sbjct: 254 TCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFG- 301
Query: 267 ALLFEPGKPCGDT---HGQVGTRRYMAPEVL--EGAINFSRDAFLRIDMYACALVLWELA 321
                  K  G+T       GT  Y+APEVL   G   ++R     +D ++  ++L+   
Sbjct: 302 -----HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILF--- 349
Query: 322 SRCSSVSPPPGEYRLPFS 339
             C S  PP  E+R   S
Sbjct: 350 -ICLSGYPPFSEHRTQVS 366

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQSWQS--EQEIFKLPHM 163
           +I+ V    +G FG V++A+            VAVK+   +     Q+  ++E   +   
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-------CNIV---------- 206
           ++ NI++ +G    G+ +     L+  Y   G L +FL+       C++           
Sbjct: 108 DNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 207 ---------TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL 257
                      EQLC IA  ++ G+ +L E               HRD  + N L+  ++
Sbjct: 164 SSPGPPPLSCAEQLC-IARQVAAGMAYLSER-----------KFVHRDLATRNCLVGENM 211
Query: 258 TAAIADFGLAL-LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALV 316
              IADFGL+  ++       D +  +   R+M PE +     F        D++A  +V
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPI-RWMPPESI-----FYNRYTTESDVWAYGVV 265
Query: 317 LWELAS 322
           LWE+ S
Sbjct: 266 LWEIFS 271

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 19  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 79  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LF 270
            ++A  ++ G+ +L+ +              HRD  + N ++  D T  I DFG+   ++
Sbjct: 133 IQMAAEIADGMAYLNAK-----------KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           E         G +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 182 ETDYYRKGGKGLLPV-RWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/231 (20%), Positives = 94/231 (40%), Gaps = 44/231 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 19  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 79  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
            ++A  ++ G+ +L+ +              HRD  + N ++  D T  I DFG+     
Sbjct: 133 IQMAAEIADGMAYLNAK-----------KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                      +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 18  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 77
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 78  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LF 270
            ++A  ++ G+ +L+ +              HRD  + N ++  D T  I DFG+   ++
Sbjct: 132 IQMAAEIADGMAYLNAK-----------KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 180
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           E         G +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 181 ETDYYRKGGKGLLPV-RWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/231 (20%), Positives = 94/231 (40%), Gaps = 44/231 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 19  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 79  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
            ++A  ++ G+ +L+ +              HRD  + N ++  D T  I DFG+     
Sbjct: 133 IQMAAEIADGMAYLNAK-----------KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                      +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 227

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 44/87 (50%), Gaps = 9/87 (10%)
Query: 241 VAHRDFKSNNVLLKSDL----TAAIADFGLALLFE-PGKPCGDTHGQVGTRRYMAPEVLE 295
           V HRD K  N+L+  +        IAD G A LF  P KP  D    V T  Y APE+L 
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 296 GAINFSRDAFLRIDMYACALVLWELAS 322
           GA ++++     ID++A   +  EL +
Sbjct: 209 GARHYTK----AIDIWAIGCIFAELLT 231

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQS--W-QSEQEIFKLP 161
           G +   L+ V  +G +  V   + K  +       VK  L+ D +   W Q+E+ +F+  
Sbjct: 7   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE-- 64
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSK 220
             +  N    +G     ++  +  + +  Y   G L   ++      E+  R  +  +S 
Sbjct: 65  --QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LHE             + +RD K +NVLL S+    + D+G+    + G   GDT 
Sbjct: 122 ALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTT 167
Query: 281 GQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               GT  Y+APE+L G      D    +D +A  ++++E+ +
Sbjct: 168 SXFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMA 205

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 14/106 (13%)
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLAL-LFEPGKPCGDT 279
           H   +IL      +   + HRD K + VLL S   +A   +  FG+A+ L E G   G  
Sbjct: 136 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-- 193
Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWELASRC 324
            G+VGT  +MAPEV++      R+ + + +D++ C ++L+ L S C
Sbjct: 194 -GRVGTPHFMAPEVVK------REPYGKPVDVWGCGVILFILLSGC 232

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQS--W-QSEQEIFKLP 161
           G +   L+ V  +G +  V   + K  +       VK  L+ D +   W Q+E+ +F+  
Sbjct: 3   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE-- 60
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSK 220
             +  N    +G     ++  +  + +  Y   G L   ++      E+  R  +  +S 
Sbjct: 61  --QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 117
Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LHE             + +RD K +NVLL S+    + D+G+    + G   GDT 
Sbjct: 118 ALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTT 163
Query: 281 GQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
               GT  Y+APE+L G      D    +D +A  ++++E+ +
Sbjct: 164 SXFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMA 201

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 14/106 (13%)
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLAL-LFEPGKPCGDT 279
           H   +IL      +   + HRD K + VLL S   +A   +  FG+A+ L E G   G  
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-- 191
Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLR-IDMYACALVLWELASRC 324
            G+VGT  +MAPEV++      R+ + + +D++ C ++L+ L S C
Sbjct: 192 -GRVGTPHFMAPEVVK------REPYGKPVDVWGCGVILFILLSGC 230

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/231 (20%), Positives = 94/231 (40%), Gaps = 44/231 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 16  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 75
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 76  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
            ++A  ++ G+ +L+ +              HRD  + N ++  D T  I DFG+     
Sbjct: 130 IQMAAEIADGMAYLNAK-----------KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                      +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 179 ETDXXRKGGKGLLPVRWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 224

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 97/231 (41%), Gaps = 34/231 (14%)
Query: 102 TSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENV-----AVKIFLMQDKQS--W-QS 153
           +   S   G +   L+ V  +G +  V   + K  +       VK  L+ D +   W Q+
Sbjct: 42  SGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT 101
Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+ +F+    +  N    +G     ++  +  + +  Y   G L   ++      E+  R
Sbjct: 102 EKHVFE----QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 156
Query: 214 I-ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP 272
             +  +S  L +LHE             + +RD K +NVLL S+    + D+G+    + 
Sbjct: 157 FYSAEISLALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMC---KE 202
Query: 273 GKPCGDTHGQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           G   GDT     GT  Y+APE+L G      D    +D +A  ++++E+ +
Sbjct: 203 GLRPGDTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMA 248

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 152 QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL 211
           Q  QEI  L  ++H N+++ +  E   +      +++     +G + +      ++ +Q 
Sbjct: 82  QVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
                 + KG+ +LH +            + HRD K +N+L+  D    IADFG++  F+
Sbjct: 140 RFYFQDLIKGIEYLHYQ-----------KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 272 PGKPCGDTHGQVGTRRYMAPEVL-EGAINFSRDAFLRIDMYACALVLW 318
                      VGT  +MAPE L E    FS  A   +D++A  + L+
Sbjct: 189 GSDAL--LSNTVGTPAFMAPESLSETRKIFSGKA---LDVWAMGVTLY 231

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSE-QEIFKLPHME-HDNIL 169
           +++  V A+G F  V++A+        A+K  L  +++  ++  QE+  +  +  H NI+
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 170 RYIGAEKRG----ESIHTEFWLITAYHERGSLCDFLKC----NIVTWEQLCRIALSMSKG 221
           ++  A   G    ++   EF L+T    +G L +FLK       ++ + + +I     + 
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA 267
           + H+H +         KP + HRD K  N+LL +  T  + DFG A
Sbjct: 149 VQHMHRQ---------KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 97/231 (41%), Gaps = 34/231 (14%)
Query: 102 TSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQS--W-QS 153
           +   S   G +   L+ V  +G +  V   + K  +       VK  L+ D +   W Q+
Sbjct: 10  SGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 69
Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCR 213
           E+ +F+    +  N    +G     ++  +  + +  Y   G L   ++      E+  R
Sbjct: 70  EKHVFE----QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 124
Query: 214 I-ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP 272
             +  +S  L +LHE             + +RD K +NVLL S+    + D+G+    + 
Sbjct: 125 FYSAEISLALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMC---KE 170
Query: 273 GKPCGDTHGQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           G   GDT     GT  Y+APE+L G      D    +D +A  ++++E+ +
Sbjct: 171 GLRPGDTTSXFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMA 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 81  CRLLGI-----CLTSTVQLIMQLMPFGXLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 134
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 135 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 181
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 182 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 218

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 24  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 84  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 137
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 138 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 184
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 185 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 147 DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL----- 201
           +KQ   SE  + +   ++H NI+RY   ++  +  +T  +++  Y E G L   +     
Sbjct: 48  EKQMLVSEVNLLR--ELKHPNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 103
Query: 202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           +   +  E + R+   ++  L   H      ++D     V HRD K  NV L       +
Sbjct: 104 ERQYLDEEFVLRVMTQLTLALKECHR-----RSDG-GHTVLHRDLKPANVFLDGKQNVKL 157
Query: 262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            DFGLA +             VGT  YM+PE +   ++++  +    D+++   +L+EL
Sbjct: 158 GDFGLARILNHDTSFAKAF--VGTPYYMSPEQM-NRMSYNEKS----DIWSLGCLLYEL 209

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 147 DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL----- 201
           +KQ   SE  + +   ++H NI+RY   ++  +  +T  +++  Y E G L   +     
Sbjct: 48  EKQMLVSEVNLLR--ELKHPNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 103
Query: 202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           +   +  E + R+   ++  L   H      ++D     V HRD K  NV L       +
Sbjct: 104 ERQYLDEEFVLRVMTQLTLALKECH-----RRSDG-GHTVLHRDLKPANVFLDGKQNVKL 157
Query: 262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            DFGLA +    +        VGT  YM+PE +   ++++  +    D+++   +L+EL
Sbjct: 158 GDFGLARILNHDEDFAKEF--VGTPYYMSPEQM-NRMSYNEKS----DIWSLGCLLYEL 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVK-----IFLMQDK-QSWQSEQEIFKLPHME 164
             +L ++  +G FG V+ A+FK  N+  A+K     + LM D  +    E+ +  L   E
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WE 77
Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLM 223
           H  +       +  E++    + +  Y   G L   ++ C+     +    A  +  GL 
Sbjct: 78  HPFLTHMFCTFQTKENL----FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD--THG 281
            LH +            + +RD K +N+LL  D    IADFG+          GD  T+ 
Sbjct: 134 FLHSK-----------GIVYRDLKLDNILLDKDGHIKIADFGMC----KENMLGDAKTNE 178
Query: 282 QVGTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWEL 320
             GT  Y+APE+L G   N S      +D ++  ++L+E+
Sbjct: 179 FCGTPDYIAPEILLGQKYNHS------VDWWSFGVLLYEM 212

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 17  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 76
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + +++G+ +L
Sbjct: 77  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAEGMNYL 130
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 131 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 177
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 178 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD-NI 168
           G  + +L++V   G +G V+  +  + +   K++ M+  +     Q+     H   +  +
Sbjct: 52  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 169 LRYIGAEKRGESIH------TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALS-MSKG 221
           L +I       ++H      T+  LI  Y   G L   L       E   +I +  +   
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L HLH           K  + +RD K  N+LL S+    + DFGL+  F         + 
Sbjct: 172 LEHLH-----------KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYD 219
Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
             GT  YMAP+++ G  +    A   +D ++  ++++EL +  S
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKA---VDWWSLGVLMYELLTGAS 260

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V + G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 27  IKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 87  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 140
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 141 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 187
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 188 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 81  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 134
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 135 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 181
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 182 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 80  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 134 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 180
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 181 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 33/212 (15%)
Query: 115 QLVEVKAQGRFGA--VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           +LV+    G FG   + + K  NE VAVK     +K +   ++EI     + H NI+R+ 
Sbjct: 22  ELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRF- 80
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
              K      T   ++  Y   G L          +E++C              ++++  
Sbjct: 81  ---KEVILTPTHLAIVMEYASGGEL----------FERICNAGRFSEDEARFFFQQLISG 127
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLT--AAIADFGLALLFEPGKPCGDTHGQ----VGTR 286
            +  +   V HRD K  N LL         I DFG +            H Q    VGT 
Sbjct: 128 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTP 180
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLW 318
            Y+APEVL       + A    D+++C + L+
Sbjct: 181 AYIAPEVLLKKEYDGKVA----DVWSCGVTLY 208

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           +  V+    G+FG V    + N++ VA+K      ++   SE++  +    +  + H  +
Sbjct: 10  LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLH 226
           ++  G       I     L+T + E G L D+L+    +   E L  + L + +G+ +L 
Sbjct: 66  VQLYGVCLEQAPIC----LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             V HRD  + N L+  +    ++DFG+       +    T    GT+
Sbjct: 122 E-----------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTK 166
Query: 287 ---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              ++ +PEV     +FSR +  + D+++  +++WE+ S
Sbjct: 167 FPVKWASPEVF----SFSRYS-SKSDVWSFGVLMWEVFS 200

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQDKQSW----QSEQEIFKLPHM 163
           +++ +E   + RFG V+K          +  AV I  ++DK       +   E      +
Sbjct: 27  AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 86
Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-------KCNIVTWEQLCRIAL 216
           +H N++  +G   + + +     +I +Y   G L +FL              ++  + AL
Sbjct: 87  QHPNVVCLLGVVTKDQPLS----MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 142
Query: 217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                 +HL  +I           V H+D  + NVL+   L   I+D GL          
Sbjct: 143 E-PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----A 197
Query: 277 GDTHGQVGTR----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            D +  +G      R+MAPE +     FS D+    D+++  +VLWE+ S
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDS----DIWSYGVVLWEVFS 242

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 82  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 135
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 136 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 182
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 183 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 125/309 (40%), Gaps = 74/309 (23%)
Query: 121 AQGRFGAVWKAKF-------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHD-NI 168
            +G FG V +A             VAVK+        + ++  SE +I  L H+ H  N+
Sbjct: 36  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI--LIHIGHHLNV 93
Query: 169 LRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKC-------------NIVTWEQLCRI 214
           +  +GA  K G  +     +I  + + G+L  +L+              + +T E L   
Sbjct: 94  VNLLGACTKPGGPL----MVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEP 272
           +  ++KG+     E L ++         HRD  + N+LL       I DFGLA  +  +P
Sbjct: 150 SFQVAKGM-----EFLASRK------XIHRDLAARNILLSEKNVVKIXDFGLARDIYKDP 198
Query: 273 GKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
                GD    +   ++MAPE +     F R   ++ D+++  ++LWE+ S  +S     
Sbjct: 199 DYVRKGDARLPL---KWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGAS----- 245
Query: 332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA 391
                P+     D      ++E    +    T PE ++          TM +CW  +   
Sbjct: 246 -----PYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQ----------TMLDCWHGEPSQ 290
Query: 392 RLSASCVVE 400
           R + S +VE
Sbjct: 291 RPTFSELVE 299

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 50/252 (19%)
Query: 112 RSIQLVEVKAQGRFGAVWKAK---FKNENVAVKIFLMQDKQSWQSEQ------EIFKLPH 162
            ++Q  +    G FG V +A       E+  +K+ +   K +  +++      E+  + H
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 163 M-EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS-- 219
           + +H+NI+  +GA   G  +     +IT Y   G L +FL+      E +   +L+    
Sbjct: 91  LGQHENIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKA---EAMLGPSLAPGQD 143
Query: 220 --------------KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
                         + L+H   ++    A        HRD  + NVLL +   A I DFG
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 266 LALLFEPGKPCGDTHGQV-GTRR----YMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           LA          D++  V G  R    +MAPE +     F     ++ D+++  ++LWE+
Sbjct: 204 LAR-----DIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTVQSDVWSYGILLWEI 253
Query: 321 ASRCSSVSPPPG 332
            S    ++P PG
Sbjct: 254 FSL--GLNPYPG 263

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 38/230 (16%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD-----KQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N     + + V +  +++     +Q +Q E E+  + 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM- 99
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------IVTWEQLCRIA 215
            ++H +I+R+ G    G  +     ++  Y   G L  FL+ +      +   E +    
Sbjct: 100 -LQHQHIVRFFGVCTEGRPL----LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
           L + + L+ +  ++             HRD  + N L+   L   I DFG++        
Sbjct: 155 LGLGQ-LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DI 208
Query: 276 CGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
               + +VG R     R+M PE +       R      D+++  +VLWE+
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESI-----LYRKFTTESDVWSFGVVLWEI 253

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 83  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 136
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFGLA L   G    + H + G 
Sbjct: 137 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGK 183
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 184 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 45/91 (49%), Gaps = 16/91 (17%)
Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGK--PCGDTHGQVGTRRYMAPEVLEGAINF 300
           HRD K  N+L+ +D  A + DFG+A      K    G+T   VGT  Y APE       F
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT---VGTLYYXAPE------RF 207
Query: 301 SRD-AFLRIDMYACALVLWELASRCSSVSPP 330
           S   A  R D+YA   VL+E    C + SPP
Sbjct: 208 SESHATYRADIYALTCVLYE----CLTGSPP 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 82  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 135
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFG A L   G    + H + G 
Sbjct: 136 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGK 182
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 183 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 113 SIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQDKQSW----QSEQEIFKLPHM 163
           +++ +E   + RFG V+K          +  AV I  ++DK       +   E      +
Sbjct: 10  AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 69
Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-------KCNIVTWEQLCRIAL 216
           +H N++  +G   + + +     +I +Y   G L +FL              ++  + AL
Sbjct: 70  QHPNVVCLLGVVTKDQPLS----MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 217 SMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
                 +HL  +I           V H+D  + NVL+   L   I+D GL          
Sbjct: 126 E-PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----A 180
Query: 277 GDTHGQVGTR----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
            D +  +G      R+MAPE +     FS D+    D+++  +VLWE+ S
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDS----DIWSYGVVLWEVFS 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 121 AQGRFGAVWKAKFK--NENVAVK-----IFLMQDK-QSWQSEQEIFKLPHMEHDNILRYI 172
            +G FG V+ A+FK  N+  A+K     + LM D  +    E+ +  L   EH  +    
Sbjct: 26  GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHMF 84
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILP 231
              +  E++    + +  Y   G L   ++ C+     +    A  +  GL  LH +   
Sbjct: 85  CTFQTKENL----FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--- 137
Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD--THGQVGTRRYM 289
                    + +RD K +N+LL  D    IADFG+          GD  T+   GT  Y+
Sbjct: 138 --------GIVYRDLKLDNILLDKDGHIKIADFGMC----KENMLGDAKTNXFCGTPDYI 185
Query: 290 APEVLEG-AINFSRDAFLRIDMYACALVLWEL 320
           APE+L G   N S      +D ++  ++L+E+
Sbjct: 186 APEILLGQKYNHS------VDWWSFGVLLYEM 211

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 80  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 133
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFG A L   G    + H + G 
Sbjct: 134 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGK 180
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 181 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 31/211 (14%)
Query: 121 AQGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
            +G FG V + + K      AVK   ++  ++    +E+     +    I+   GA + G
Sbjct: 102 GRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA----EELMACAGLTSPRIVPLYGAVREG 157
Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSY 237
             ++    L+    E GSL   +K      E      L  + +GL +LH           
Sbjct: 158 PWVNIFMELL----EGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR--------- 204
Query: 238 KPAVAHRDFKSNNVLLKSDLT-AAIADFGLALLFEP---GKPCGDTHGQVGTRRYMAPEV 293
              + H D K++NVLL SD + AA+ DFG A+  +P   GK         GT  +MAPEV
Sbjct: 205 --RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRC 324
           + G     R    ++D+++   ++  + + C
Sbjct: 263 VLG-----RSCDAKVDVWSSCCMMLHMLNGC 288

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 121 AQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR-----YIGAE 175
             G  G VWK +F+     + +  M+   + +  + I     M+ D +L+     YI  +
Sbjct: 34  GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRIL----MDLDVVLKSHDCPYI-VQ 88
Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPN 232
             G  I T   +  A    G+  + LK  +   +    L ++ +++ K L +L E     
Sbjct: 89  CFGTFI-TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE----- 142
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--VGTRRYMA 290
                K  V HRD K +N+LL       + DFG++     G+   D       G   YMA
Sbjct: 143 -----KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYMA 192
Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           PE ++       D  +R D+++  + L ELA+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELAT 224

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 38/230 (16%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD-----KQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N     + + V +  +++     +Q +Q E E+  + 
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM- 70
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------IVTWEQLCRIA 215
            ++H +I+R+ G    G  +     ++  Y   G L  FL+ +      +   E +    
Sbjct: 71  -LQHQHIVRFFGVCTEGRPL----LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 125
Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
           L + + L+ +  ++             HRD  + N L+   L   I DFG++        
Sbjct: 126 LGLGQ-LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DI 179
Query: 276 CGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
               + +VG R     R+M PE +       R      D+++  +VLWE+
Sbjct: 180 YSTDYYRVGGRTMLPIRWMPPESI-----LYRKFTTESDVWSFGVVLWEI 224

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 19  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 79  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LF 270
            ++A  ++ G+ +L+ +              HR+  + N ++  D T  I DFG+   ++
Sbjct: 133 IQMAAEIADGMAYLNAK-----------KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           E         G +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 182 ETDYYRKGGKGLLPV-RWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 227

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 38/230 (16%)
Query: 112 RSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD-----KQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N     + + V +  +++     +Q +Q E E+  + 
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM- 76
Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------IVTWEQLCRIA 215
            ++H +I+R+ G    G  +     ++  Y   G L  FL+ +      +   E +    
Sbjct: 77  -LQHQHIVRFFGVCTEGRPL----LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 131
Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
           L + + L+ +  ++             HRD  + N L+   L   I DFG++        
Sbjct: 132 LGLGQ-LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DI 185
Query: 276 CGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
               + +VG R     R+M PE +       R      D+++  +VLWE+
Sbjct: 186 YSTDYYRVGGRTMLPIRWMPPESI-----LYRKFTTESDVWSFGVVLWEI 230

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 27  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LIT     G L D++   K NI + + L    + ++KG+ +L
Sbjct: 87  CRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 140
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFG A L   G    + H + G 
Sbjct: 141 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGK 187
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 188 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           I L+    QG FG V++   ++         VAVK       ++++  + +E  + K   
Sbjct: 20  ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 79
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV-----------TWEQL 211
             H  ++R +G   +G+       ++      G L  +L+               T +++
Sbjct: 80  CHH--VVRLLGVVSKGQPT----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 212 CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LF 270
            ++A  ++ G+ +L+ +              HR+  + N ++  D T  I DFG+   ++
Sbjct: 134 IQMAAEIADGMAYLNAK-----------KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY 182
Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           E         G +   R+MAPE L+  + F+  +    DM++  +VLWE+ S
Sbjct: 183 ETDYYRKGGKGLLPV-RWMAPESLKDGV-FTTSS----DMWSFGVVLWEITS 228

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 26/185 (14%)
Query: 118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIG 173
           +V   G F  V  A+ K     V I  +  K    +    E EI  L  ++H NI+    
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 174 AEKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
             + G  ++    L++     G L D  ++    T     R+   +   + +LH+     
Sbjct: 84  IYESGGHLYLIMQLVSG----GELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD----- 134
Query: 233 KADSYKPAVAHRDFKSNNVL---LKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   + HRD K  N+L   L  D    I+DFGL+ + +PG          GT  Y+
Sbjct: 135 ------LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYV 185
Query: 290 APEVL 294
           APEVL
Sbjct: 186 APEVL 190

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 26/185 (14%)
Query: 118 EVKAQGRFGAVWKAKFKNEN--VAVKIFLMQ--DKQSWQSEQEIFKLPHMEHDNILRYIG 173
           +V   G F  V  A+ K     VA+K    +  + +    E EI  L  ++H NI+    
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 174 AEKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
             + G  ++    L++     G L D  ++    T     R+   +   + +LH+     
Sbjct: 84  IYESGGHLYLIMQLVSG----GELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD----- 134
Query: 233 KADSYKPAVAHRDFKSNNVL---LKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   + HRD K  N+L   L  D    I+DFGL+ + +PG          GT  Y+
Sbjct: 135 ------LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYV 185
Query: 290 APEVL 294
           APEVL
Sbjct: 186 APEVL 190

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 44/246 (17%)
Query: 105 PSPQQGCRSIQLVE-VKAQGRFG-AVWKAKFKNENVAVK--------IFLMQDKQSWQSE 154
           P+ +Q  +++ + E +   G  G  V++  F+   VAVK        I LM+ K   +S+
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI 214
                    +H N++RY  +E     ++    L        +L D ++   V+ E L   
Sbjct: 67  ---------DHPNVIRYYCSETTDRFLYIALELCNL-----NLQDLVESKNVSDENL--- 109
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-------------DLTAAI 261
            L      + L  +I    A  +   + HRD K  N+L+ +             +L   I
Sbjct: 110 KLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 262 ADFGLALLFEPGKPCGDT--HGQVGTRRYMAPEVLEGAINF--SRDAFLRIDMYACALVL 317
           +DFGL    + G+    T  +   GT  + APE+LE + N    R     ID+++   V 
Sbjct: 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 318 WELASR 323
           + + S+
Sbjct: 230 YYILSK 235

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 76  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 131 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 175
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 176 DHXVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 31/211 (14%)
Query: 121 AQGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
            +G FG V + + K      AVK   ++  ++    +E+     +    I+   GA + G
Sbjct: 83  GRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA----EELMACAGLTSPRIVPLYGAVREG 138
Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSY 237
             ++    L+    E GSL   +K      E      L  + +GL +LH           
Sbjct: 139 PWVNIFMELL----EGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR--------- 185
Query: 238 KPAVAHRDFKSNNVLLKSDLT-AAIADFGLALLFEP---GKPCGDTHGQVGTRRYMAPEV 293
              + H D K++NVLL SD + AA+ DFG A+  +P   GK         GT  +MAPEV
Sbjct: 186 --RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEV 243
Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRC 324
           + G     R    ++D+++   ++  + + C
Sbjct: 244 VLG-----RSCDAKVDVWSSCCMMLHMLNGC 269

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 107 PQQGCRSIQLVEVKAQGRFGAV--WKAKFKNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           P+   +  Q++     G FG V   +++      A+K+     +++ KQ   +  E   L
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMS 219
             + H  I+R  G  +  + I    ++I  Y E G L   L+ +      + +  A  + 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQI----FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD- 278
             L +LH +            + +RD K  N+LL  +    I DFG A      K   D 
Sbjct: 117 LALEYLHSK-----------DIIYRDLKPENILLDKNGHIKITDFGFA------KYVPDV 159
Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           T+   GT  Y+APEV+      ++     ID ++  ++++E+ +
Sbjct: 160 TYXLCGTPDYIAPEVVS-----TKPYNKSIDWWSFGILIYEMLA 198

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 16/197 (8%)
Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI 214
           +EI  L H  H NIL       R   +H E     A H+   + + ++ ++       RI
Sbjct: 78  REIRLLNHFHHPNILGL-----RDIFVHFE---EPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK 274
            +S  + + +    IL      ++  V HRD    N+LL  +    I DF LA   E   
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               TH  V  R Y APE++     F++     +DM++   V+ E+ +R +         
Sbjct: 187 DANKTH-YVTHRWYRAPELVMQFKGFTK----LVDMWSAGCVMAEMFNRKALFRGSTFYN 241
Query: 335 RLPFSAEVGDHPSLEDM 351
           +L    EV   P +ED+
Sbjct: 242 QLNKIVEVVGTPKIEDV 258

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/68 (36%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           EI     D ++  + +RD K  N+LL       I+D GLA+    G+      G+VGT  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVG 350
Query: 288 YMAPEVLE 295
           YMAPEV++
Sbjct: 351 YMAPEVVK 358

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 16/197 (8%)
Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI 214
           +EI  L H  H NIL       R   +H E     A H+   + + ++ ++       RI
Sbjct: 78  REIRLLNHFHHPNILGL-----RDIFVHFE---EPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK 274
            +S  + + +    IL      ++  V HRD    N+LL  +    I DF LA   E   
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
               TH  V  R Y APE++     F++     +DM++   V+ E+ +R +         
Sbjct: 187 DANKTH-YVTHRWYRAPELVMQFKGFTK----LVDMWSAGCVMAEMFNRKALFRGSTFYN 241
Query: 335 RLPFSAEVGDHPSLEDM 351
           +L    EV   P +ED+
Sbjct: 242 QLNKIVEVVGTPKIEDV 258

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 115 QLVEVKAQGRFGA--VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           +LV+    G FG   + + K  NE VAVK     +K     ++EI     + H NI+R+ 
Sbjct: 21  ELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRF- 79
Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
              K      T   ++  Y   G L          +E++C              ++++  
Sbjct: 80  ---KEVILTPTHLAIVMEYASGGEL----------FERICNAGRFSEDEARFFFQQLISG 126
Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLT--AAIADFGLALLFEPGKPCGDTHGQ----VGTR 286
            +  +   V HRD K  N LL         I DFG +            H Q    VGT 
Sbjct: 127 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTP 179
Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLW 318
            Y+APEVL       + A    D+++C + L+
Sbjct: 180 AYIAPEVLLKKEYDGKVA----DVWSCGVTLY 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 22/145 (15%)
Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLC 212
           E EI  L  ++H NI+      + G  ++    L++     G L D  ++    T     
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG----GELFDRIVEKGFYTERDAS 119
Query: 213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVL---LKSDLTAAIADFGLALL 269
           R+   +   + +LH+             + HRD K  N+L   L  D    I+DFGL+ +
Sbjct: 120 RLIFQVLDAVKYLHD-----------LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVL 294
            +PG          GT  Y+APEVL
Sbjct: 169 EDPGSVLSTA---CGTPGYVAPEVL 190

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 55/327 (16%)
Query: 106 SPQQGCRSIQLVEVKAQGRFGAVW--KAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM 163
            P+      + +++  +G FG V   K K      A+KI     K+   ++ E+     +
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KKEVIVAKDEVAHT--L 58
Query: 164 EHDNILR-----YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALS 217
             + +L+     ++ A K     H     +  Y   G L   L    V  E   R     
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           +   L +LH E            V +RD K  N++L  D    I DFGL    + G   G
Sbjct: 119 IVSALDYLHSE----------KNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDG 165
Query: 278 DTHGQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL 336
            T     GT  Y+APEVLE       D    +D +   +V++E+   C          RL
Sbjct: 166 ATMKXFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RL 209
Query: 337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
           PF  +  DH   E + E ++ +++R   P T    A  L     +      D + RL   
Sbjct: 210 PFYNQ--DH---EKLFELILMEEIR--FPRTLGPEAKSL-----LSGLLKKDPKQRLGGG 257
Query: 397 CVVERGMLALCDTMEECWDHDAEARLS 423
               + ++         W H  E +LS
Sbjct: 258 SEDAKEIMQHRFFAGIVWQHVYEKKLS 284

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 66  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 121 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 165
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 166 DHXVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 22/145 (15%)
Query: 154 EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLC 212
           E EI  L  ++H NI+      + G  ++    L++     G L D  ++    T     
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG----GELFDRIVEKGFYTERDAS 119
Query: 213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVL---LKSDLTAAIADFGLALL 269
           R+   +   + +LH+             + HRD K  N+L   L  D    I+DFGL+ +
Sbjct: 120 RLIFQVLDAVKYLHD-----------LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVL 294
            +PG          GT  Y+APEVL
Sbjct: 169 EDPGSVLSTA---CGTPGYVAPEVL 190

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIF-LMQDKQSWQSEQEIFK-LPHMEHDNILR- 170
            Q+  +  QG FG V   K K+  ++V I  ++QD +    E +I + L  + H NI++ 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 171 ----YIGAEKRGESIHTEFWLITAYHERGSLC-DFLKCNIVTWEQLCRI---ALSMSKGL 222
               Y   E+    I+    +          C ++ +  +     L ++    L  S G 
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLALLFEPGKPCGDTHG 281
           +HL               V HRD K +NVL+ ++D T  + DFG A    P +P      
Sbjct: 145 LHLPSV-----------NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVA 190
Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            + +R Y APE++ G  +++      +D+++   +  E+
Sbjct: 191 YICSRYYRAPELIFGNQHYT----TAVDIWSVGCIFAEM 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/68 (36%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           EI     D ++  + +RD K  N+LL       I+D GLA+    G+      G+VGT  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVG 350
Query: 288 YMAPEVLE 295
           YMAPEV++
Sbjct: 351 YMAPEVVK 358

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 41/93 (44%), Gaps = 12/93 (12%)
Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           V HRD K  N+ L  DL   I DFGLA   E       T    GT  Y+APEVL      
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLS----- 190
Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
            +     +D+++   +++ L      V  PP E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLL-----VGKPPFE 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 41/93 (44%), Gaps = 12/93 (12%)
Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           V HRD K  N+ L  DL   I DFGLA   E       T    GT  Y+APEVL      
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLS----- 194
Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
            +     +D+++   +++ L      V  PP E
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLL-----VGKPPFE 222

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/318 (22%), Positives = 129/318 (40%), Gaps = 76/318 (23%)
Query: 114 IQLVEVKAQGRFGAVWKAKF-------KNENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           ++L +   +G FG V +A             VAVK+        + ++  SE +I  L H
Sbjct: 31  LKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI--LIH 88
Query: 163 MEHD-NILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKC---------------NI 205
           + H  N++  +GA  K G  +     +I  + + G+L  +L+                + 
Sbjct: 89  IGHHLNVVNLLGACTKPGGPL----MVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF 144
Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           +T E L   +  ++KG+     E L ++         HRD  + N+LL       I DFG
Sbjct: 145 LTLEHLIXYSFQVAKGM-----EFLASRK------XIHRDLAARNILLSEKNVVKICDFG 193
Query: 266 LA--LLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
           LA  +  +P     GD    +   ++MAPE +     F R   ++ D+++  ++LWE+ S
Sbjct: 194 LARDIXKDPDXVRKGDARLPL---KWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFS 245
Query: 323 RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTME 382
             +S          P+     D      ++E    +    T PE ++          TM 
Sbjct: 246 LGAS----------PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ----------TML 285
Query: 383 ECWDHDAEARLSASCVVE 400
           +CW  +   R + S +VE
Sbjct: 286 DCWHGEPSQRPTFSELVE 303

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           ++  V HRD K  N+ L  DL   I DFGLA   E       T    GT  Y+APEVL  
Sbjct: 134 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLS- 190
Query: 297 AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                +     +D+++   +++ L      V  PP E
Sbjct: 191 ----KKGHSFEVDVWSIGCIMYTLL-----VGKPPFE 218

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 18/122 (14%)
Query: 202 KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
           K   +  + L +IA+S+ K L HLH ++          +V HRD K +NVL+ +      
Sbjct: 129 KGQTIPEDILGKIAVSIVKALEHLHSKL----------SVIHRDVKPSNVLINALGQVKX 178
Query: 262 ADFGLALLFEPGKPCGDTHGQV--GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
            DFG++     G    D    +  G + Y APE +   +N  +   ++ D+++  +   E
Sbjct: 179 CDFGIS-----GYLVDDVAKDIDAGCKPYXAPERINPELN-QKGYSVKSDIWSLGITXIE 232
Query: 320 LA 321
           LA
Sbjct: 233 LA 234

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 76  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 131 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 175
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 75/197 (38%), Gaps = 25/197 (12%)
Query: 106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPH-ME 164
           +P         ++V  +G FG V  A+ K E V   + ++Q K   + ++E     H M 
Sbjct: 32  NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE----KHIMS 87
Query: 165 HDNILRYIGAEKRGESIHTEF------WLITAYHERGSLCDFLKCNIVTWEQLCRI-ALS 217
             N+L           +H  F      + +  Y   G L   L+      E   R  A  
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE 147
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           ++  L +LH              + +RD K  N+LL S     + DFGL    E  +   
Sbjct: 148 IASALGYLHSL-----------NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNS 194
Query: 278 DTHGQVGTRRYMAPEVL 294
            T    GT  Y+APEVL
Sbjct: 195 TTSTFCGTPEYLAPEVL 211

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 26/183 (14%)
Query: 121 AQGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
            +G FG V + K K      AVK   ++  +     +E+     +    I+   GA + G
Sbjct: 83  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----EELVACAGLSSPRIVPLYGAVREG 138
Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSY 237
             ++    L+    E GSL   +K      E      L  + +GL +LH           
Sbjct: 139 PWVNIFMELL----EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--------- 185
Query: 238 KPAVAHRDFKSNNVLLKSDLT-AAIADFGLALLFEP---GKPCGDTHGQVGTRRYMAPEV 293
              + H D K++NVLL SD + AA+ DFG AL  +P   GK         GT  +MAPEV
Sbjct: 186 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 294 LEG 296
           + G
Sbjct: 244 VMG 246

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 66  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 121 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 165
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 207

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 26/183 (14%)
Query: 121 AQGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
            +G FG V + K K      AVK   ++  +     +E+     +    I+   GA + G
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----EELVACAGLSSPRIVPLYGAVREG 122
Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSY 237
             ++    L+    E GSL   +K      E      L  + +GL +LH           
Sbjct: 123 PWVNIFMELL----EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--------- 169
Query: 238 KPAVAHRDFKSNNVLLKSDLT-AAIADFGLALLFEP---GKPCGDTHGQVGTRRYMAPEV 293
              + H D K++NVLL SD + AA+ DFG AL  +P   GK         GT  +MAPEV
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 294 LEG 296
           + G
Sbjct: 228 VMG 230

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 10  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 70  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 125 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 169
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 211

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 26/183 (14%)
Query: 121 AQGRFGAVWKAKFKNENV--AVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRG 178
            +G FG V + K K      AVK   ++  +     +E+     +    I+   GA + G
Sbjct: 81  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----EELVACAGLSSPRIVPLYGAVREG 136
Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSY 237
             ++    L+    E GSL   +K      E      L  + +GL +LH           
Sbjct: 137 PWVNIFMELL----EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--------- 183
Query: 238 KPAVAHRDFKSNNVLLKSDLT-AAIADFGLALLFEP---GKPCGDTHGQVGTRRYMAPEV 293
              + H D K++NVLL SD + AA+ DFG AL  +P   GK         GT  +MAPEV
Sbjct: 184 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 294 LEG 296
           + G
Sbjct: 242 VMG 244

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 93/255 (36%), Gaps = 43/255 (16%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E   R     +   L +LH E 
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 267
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 268 ---------KNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEY 315
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 316 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 354
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD 408
           E + E ++ +++R   P T    A  L     +      D + RL       + ++    
Sbjct: 355 EKLFELILMEEIR--FPRTLGPEAKSL-----LSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
Query: 409 TMEECWDHDAEARLS 423
                W H  E +LS
Sbjct: 408 FAGIVWQHVYEKKLS 422

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 43/99 (43%), Gaps = 17/99 (17%)
Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L HLH +            + H D K  N+ L       + DFGL  L E G   G    
Sbjct: 170 LAHLHSQ-----------GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGT-AGAGEV 215
Query: 282 QVGTRRYMAPEVLEGAINFSRDAF---LRIDMYACALVL 317
           Q G  RYMAPE+L+G+   + D F   L I   AC + L
Sbjct: 216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 14/98 (14%)
Query: 237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRYMAPEVLE 295
           ++  V HRD K  N+ L  DL   I DFGLA   E     G+    + GT  Y+APEVL 
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLS 188
Query: 296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
                 +     +D+++   +++ L      V  PP E
Sbjct: 189 -----KKGHSFEVDVWSIGCIMYTLL-----VGKPPFE 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 10  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 70  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 125 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 169
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 211

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 100/239 (41%), Gaps = 44/239 (18%)
Query: 94  VPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQ 152
           VP    H    PS       +  V+    G+FG V    + N++ VA+K      K+   
Sbjct: 15  VPRGSLHMVIDPS------ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----KEGSM 64
Query: 153 SEQEIFK----LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIV 206
           SE +  +    +  + H  +++  G       I     L+  + E G L D+L+    + 
Sbjct: 65  SEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLF 120
Query: 207 TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL 266
             E L  + L + +G+ +L E             V HRD  + N L+  +    ++DFG+
Sbjct: 121 AAETLLGMCLDVCEGMAYLEE-----------ACVIHRDLAARNCLVGENQVIKVSDFGM 169
Query: 267 ALLFEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                  +    T    GT+   ++ +PEV     +FSR +  + D+++  +++WE+ S
Sbjct: 170 TRFVLDDQYTSST----GTKFPVKWASPEVF----SFSRYS-SKSDVWSFGVLMWEVFS 219

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 98  EPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----------D 147
           E H  + PS        +L++V  QG FG V+  K  + + A +++ M+          D
Sbjct: 16  EGHEKADPS------QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 148 KQSWQSEQEIFKLPHMEHDNILR-YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV 206
           +   + E++I  L  + H  I++ +   +  G+      +LI  +   G L   L   ++
Sbjct: 70  RVRTKMERDI--LVEVNHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVM 122
Query: 207 TWEQLCRIALS-MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
             E+  +  L+ ++  L HLH              + +RD K  N+LL  +    + DFG
Sbjct: 123 FTEEDVKFYLAELALALDHLHS-----------LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           L+   E        +   GT  YMAPEV+
Sbjct: 172 LSK--ESIDHEKKAYSFCGTVEYMAPEVV 198

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 93/255 (36%), Gaps = 43/255 (16%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E   R     +   L +LH E 
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 127
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 128 ---------KNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKXFCGTPEY 175
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 176 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 214
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD 408
           E + E ++ +++R   P T    A  L     +      D + RL       + ++    
Sbjct: 215 EKLFELILMEEIR--FPRTLGPEAKSL-----LSGLLKKDPKQRLGGGSEDAKEIMQHRF 267
Query: 409 TMEECWDHDAEARLS 423
                W H  E +LS
Sbjct: 268 FAGIVWQHVYEKKLS 282

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 110 GCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIF----LMQDKQSWQSEQEIFKL 160
           G + ++L+E    G FG V + ++     K  +VAVK      L Q +      +E+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSM 218
             ++H N++R  G       +     ++T     GSL D L+ +        L R A+ +
Sbjct: 66  HSLDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL        P  D
Sbjct: 121 AEGMGYLESK-----------RFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQND 165
Query: 279 THGQVGTRRYM-----APEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            H  +   R +     APE L+    FS  +    D +   + LWE+
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLK-TRTFSHAS----DTWMFGVTLWEM 207

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 14/94 (14%)
Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRYMAPEVLEGAIN 299
           V HRD K  N+ L  DL   I DFGLA   E     G+    + GT  Y+APEVL     
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLS---- 212
Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
             +     +D+++   +++ L      V  PP E
Sbjct: 213 -KKGHSFEVDVWSIGCIMYTLL-----VGKPPFE 240

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 66  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 120 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 169 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 216
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 217 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 261
Query: 396 SCV 398
           + V
Sbjct: 262 AAV 264

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           +  V+    G+FG V    + N++ VA+K      ++   SE++  +    +  + H  +
Sbjct: 9   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKL 64
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLH 226
           ++  G       I     L+  + E G L D+L+    +   E L  + L + +G+ +L 
Sbjct: 65  VQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E            +V HRD  + N L+  +    ++DFG+       +    T    GT+
Sbjct: 121 E-----------ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTK 165
Query: 287 ---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              ++ +PEV     +FSR +  + D+++  +++WE+ S
Sbjct: 166 FPVKWASPEVF----SFSRYS-SKSDVWSFGVLMWEVFS 199

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 14/94 (14%)
Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRYMAPEVLEGAIN 299
           V HRD K  N+ L  DL   I DFGLA   E     G+    + GT  Y+APEVL     
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLS---- 214
Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
             +     +D+++   +++ L      V  PP E
Sbjct: 215 -KKGHSFEVDVWSIGCIMYTLL-----VGKPPFE 242

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 44/246 (17%)
Query: 105 PSPQQGCRSIQLVE-VKAQGRFG-AVWKAKFKNENVAVK--------IFLMQDKQSWQSE 154
           P+ +Q  +++ + E +   G  G  V++  F+   VAVK        I LM+ K   +S+
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI 214
                    +H N++RY  +E     ++    L        +L D ++   V+ E L   
Sbjct: 67  ---------DHPNVIRYYCSETTDRFLYIALELCNL-----NLQDLVESKNVSDENL--- 109
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-------------DLTAAI 261
            L      + L  +I    A  +   + HRD K  N+L+ +             +L   I
Sbjct: 110 KLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 262 ADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINF--SRDAFLRIDMYACALVL 317
           +DFGL    + G+     + +   GT  + APE+LE + N    R     ID+++   V 
Sbjct: 170 SDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 318 WELASR 323
           + + S+
Sbjct: 230 YYILSK 235

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 125/309 (40%), Gaps = 74/309 (23%)
Query: 121 AQGRFGAVWKAKF-------KNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHD-NI 168
            +G FG V +A             VAVK+        + ++  SE +I  L H+ H  N+
Sbjct: 36  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI--LIHIGHHLNV 93
Query: 169 LRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKC-------------NIVTWEQLCRI 214
           +  +GA  K G  +     +I  + + G+L  +L+              + +T E L   
Sbjct: 94  VNLLGACTKPGGPL----MVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEP 272
           +  ++KG+     E L ++         HRD  + N+LL       I DFGLA  +  +P
Sbjct: 150 SFQVAKGM-----EFLASRK------XIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 198
Query: 273 GKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
                GD    +   ++MAPE +     F R   ++ D+++  ++LWE+ S  +S     
Sbjct: 199 DYVRKGDARLPL---KWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGAS----- 245
Query: 332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA 391
                P+     D      ++E    +    T PE ++          TM +CW  +   
Sbjct: 246 -----PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ----------TMLDCWHGEPSQ 290
Query: 392 RLSASCVVE 400
           R + S +VE
Sbjct: 291 RPTFSELVE 299

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 97/243 (39%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 82  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 136 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE  S             
Sbjct: 185 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWEAFSYGQK--------- 229
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            P+    G   +      A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 230 -PYRGMKGSEVT------AMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 277
Query: 396 SCV 398
           + V
Sbjct: 278 AAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 97/243 (39%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 82  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 136 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE  S             
Sbjct: 185 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWEAFSYGQK--------- 229
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            P+    G   +      A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 230 -PYRGMKGSEVT------AMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 277
Query: 396 SCV 398
           + V
Sbjct: 278 AAV 280

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 93/255 (36%), Gaps = 43/255 (16%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E   R     +   L +LH E 
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 270
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 271 ---------KNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEY 318
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 319 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 357
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD 408
           E + E ++ +++R   P T    A  L     +      D + RL       + ++    
Sbjct: 358 EKLFELILMEEIR--FPRTLGPEAKSL-----LSGLLKKDPKQRLGGGSEDAKEIMQHRF 410
Query: 409 TMEECWDHDAEARLS 423
                W H  E +LS
Sbjct: 411 FAGIVWQHVYEKKLS 425

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 30/199 (15%)
Query: 137 NVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGS 196
            V  K  L++  Q  +   EI     +++ +++ + G  +  + +    +++     R S
Sbjct: 73  KVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFV----YVVLEICRRRS 128
Query: 197 LCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
           L +  K      E   R  +  + +G+ +LH              V HRD K  N+ L  
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN-----------RVIHRDLKLGNLFLND 177
Query: 256 DLTAAIADFGLALLFE-PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACA 314
           D+   I DFGLA   E  G+   D     GT  Y+APEVL       +     +D+++  
Sbjct: 178 DMDVKIGDFGLATKIEFDGERKKDL---CGTPNYIAPEVL-----CKKGHSFEVDIWSLG 229
Query: 315 LVLWELASRCSSVSPPPGE 333
            +L+ L      V  PP E
Sbjct: 230 CILYTLL-----VGKPPFE 243

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 93/255 (36%), Gaps = 43/255 (16%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E   R     +   L +LH E 
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 128
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 129 ---------KNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKXFCGTPEY 176
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 177 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 215
Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD 408
           E + E ++ +++R   P T    A  L     +      D + RL       + ++    
Sbjct: 216 EKLFELILMEEIR--FPRTLGPEAKSL-----LSGLLKKDPKQRLGGGSEDAKEIMQHRF 268
Query: 409 TMEECWDHDAEARLS 423
                W H  E +LS
Sbjct: 269 FAGIVWQHVYEKKLS 283

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 74/320 (23%), Positives = 130/320 (40%), Gaps = 78/320 (24%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           ++L +   +G FG V +A             VAVK+        + ++  SE +I  L H
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LIH 77
Query: 163 MEHD-NILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKC----------------- 203
           + H  N++  +GA  K G  +     +IT + + G+L  +L+                  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPL----MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 204 NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
           + +T E L   +  ++KG+     E L ++         HRD  + N+LL       I D
Sbjct: 134 DFLTLEHLICYSFQVAKGM-----EFLASRK------CIHRDLAARNILLSEKNVVKICD 182
Query: 264 FGLA--LLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           FGLA  +  +P     GD    +   ++MAPE +     F R   ++ D+++  ++LWE+
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPL---KWMAPETI-----FDRVYTIQSDVWSFGVLLWEI 234
Query: 321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT 380
            S  +S          P+     D      ++E    +    T PE ++          T
Sbjct: 235 FSLGAS----------PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ----------T 274
Query: 381 MEECWDHDAEARLSASCVVE 400
           M +CW  +   R + S +VE
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 43/94 (45%), Gaps = 14/94 (14%)
Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFE-PGKPCGDTHGQVGTRRYMAPEVLEGAIN 299
           V HRD K  N+ L  D+   I DFGLA   E  G+   D     GT  Y+APEVL     
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL---CGTPNYIAPEVL----- 198
Query: 300 FSRDAFLRIDMYACALVLWELASRCSSVSPPPGE 333
             +     +D+++   +L+ L      V  PP E
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLL-----VGKPPFE 227

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 82  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 135
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFG A L   G    + H + G 
Sbjct: 136 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGK 182
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 183 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 29/199 (14%)
Query: 111 CRSIQLVEVKAQ---GRFGAVWKAK-FKNEN--VAVKIFLMQDKQS---WQSEQEIFKLP 161
           CR+ Q  E  A+   G +G V+KA+  KN    VA+K   +Q  +      + +E+  L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 162 HME---HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIA 215
           H+E   H N++R         +       +   H    L  +L       V  E +  + 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
             + +GL  LH              V HRD K  N+L+ S     +ADFGLA ++     
Sbjct: 127 FQLLRGLDFLHSH-----------RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 276 CGDTHGQVGTRRYMAPEVL 294
                  V T  Y APEVL
Sbjct: 176 LTSV---VVTLWYRAPEVL 191

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 82  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 135
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFG A L   G    + H + G 
Sbjct: 136 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGK 182
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 183 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 98  EPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----------D 147
           E H  + PS        +L++V  QG FG V+  K  + + A +++ M+          D
Sbjct: 17  EGHEKADPS------QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 70
Query: 148 KQSWQSEQEIFKLPHMEHDNILR-YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV 206
           +   + E++I  L  + H  I++ +   +  G+      +LI  +   G L   L   ++
Sbjct: 71  RVRTKMERDI--LVEVNHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVM 123
Query: 207 TWEQLCRIALS-MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
             E+  +  L+ ++  L HLH              + +RD K  N+LL  +    + DFG
Sbjct: 124 FTEEDVKFYLAELALALDHLHS-----------LGIIYRDLKPENILLDEEGHIKLTDFG 172
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           L+   E        +   GT  YMAPEV+
Sbjct: 173 LSK--ESIDHEKKAYSFCGTVEYMAPEVV 199

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 98  EPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQ----------D 147
           E H  + PS        +L++V  QG FG V+  K  + + A +++ M+          D
Sbjct: 16  EGHEKADPS------QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 148 KQSWQSEQEIFKLPHMEHDNILR-YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIV 206
           +   + E++I  L  + H  I++ +   +  G+      +LI  +   G L   L   ++
Sbjct: 70  RVRTKMERDI--LVEVNHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVM 122
Query: 207 TWEQLCRIALS-MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
             E+  +  L+ ++  L HLH              + +RD K  N+LL  +    + DFG
Sbjct: 123 FTEEDVKFYLAELALALDHLHS-----------LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
           L+   E        +   GT  YMAPEV+
Sbjct: 172 LSK--ESIDHEKKAYSFCGTVEYMAPEVV 198

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 66  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 120 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 169 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 216
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 217 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 261
Query: 396 SCV 398
           + V
Sbjct: 262 AAV 264

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 97/243 (39%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 80  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 134 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE  S             
Sbjct: 183 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWEAFSYGQK--------- 227
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            P+    G   +      A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 228 -PYRGMKGSEVT------AMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 275
Query: 396 SCV 398
           + V
Sbjct: 276 AAV 278

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 72  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 126 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 175 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 222
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 223 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 267
Query: 396 SCV 398
           + V
Sbjct: 268 AAV 270

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 117 VEVKAQGRFGAVWKAKFKNENVAVKIFL----MQDKQSWQSEQEI----FKLPHMEHDNI 168
           ++V   G FG V+K  +  E   VKI +    +++  S ++ +EI    + +  +++ ++
Sbjct: 24  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHL 225
            R +G       + +   LI      G L D++   K NI + + L    + ++KG+ +L
Sbjct: 84  CRLLGI-----CLTSTVQLIMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYL 137
Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
            +  L            HRD  + NVL+K+     I DFG A L   G    + H + G 
Sbjct: 138 EDRRL-----------VHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGK 184
Query: 286 R--RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
              ++MA E +       R    + D+++  + +WEL +  S
Sbjct: 185 VPIKWMALESI-----LHRIYTHQSDVWSYGVTVWELMTFGS 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 84/235 (35%), Gaps = 45/235 (19%)
Query: 116 LVEVKAQGRFGA--VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
            V+    G FG   + + K   E VAVK            ++EI     + H NI+R+  
Sbjct: 24  FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF-- 81
Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
             K      T   +I  Y   G L          +E++C              +++L   
Sbjct: 82  --KEVILTPTHLAIIMEYASGGEL----------YERICNAGRFSEDEARFFFQQLLSGV 129
Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLT--AAIADFGLALLFEPGKPCGDTHGQ----VGTRR 287
           +  +   + HRD K  N LL         I DFG +            H Q    VGT  
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTPA 182
Query: 288 YMAPEVL-----EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP--PGEYR 335
           Y+APEVL     +G I          D+++C + L+ +         P  P +YR
Sbjct: 183 YIAPEVLLRQEYDGKIA---------DVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 74/320 (23%), Positives = 130/320 (40%), Gaps = 78/320 (24%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           ++L +   +G FG V +A             VAVK+        + ++  SE +I  L H
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LIH 77
Query: 163 MEHD-NILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKC----------------- 203
           + H  N++  +GA  K G  +     +IT + + G+L  +L+                  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPL----MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 204 NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
           + +T E L   +  ++KG+     E L ++         HRD  + N+LL       I D
Sbjct: 134 DFLTLEHLICYSFQVAKGM-----EFLASRK------CIHRDLAARNILLSEKNVVKICD 182
Query: 264 FGLA--LLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           FGLA  +  +P     GD    +   ++MAPE +     F R   ++ D+++  ++LWE+
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPL---KWMAPETI-----FDRVYTIQSDVWSFGVLLWEI 234
Query: 321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT 380
            S  +S          P+     D      ++E    +    T PE ++          T
Sbjct: 235 FSLGAS----------PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ----------T 274
Query: 381 MEECWDHDAEARLSASCVVE 400
           M +CW  +   R + S +VE
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 48/246 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 424 MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 478 VSMGMKYLEES-----------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 527 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 574
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 575 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 619
Query: 396 SCVVER 401
           + V  R
Sbjct: 620 AAVELR 625

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 74/320 (23%), Positives = 130/320 (40%), Gaps = 78/320 (24%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIF----LMQDKQSWQSEQEIFKLPH 162
           ++L +   +G FG V +A             VAVK+        + ++  SE +I  L H
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LIH 77
Query: 163 MEHD-NILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKC----------------- 203
           + H  N++  +GA  K G  +     +IT + + G+L  +L+                  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPL----MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 204 NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
           + +T E L   +  ++KG+     E L ++         HRD  + N+LL       I D
Sbjct: 134 DFLTLEHLICYSFQVAKGM-----EFLASRK------CIHRDLAARNILLSEKNVVKICD 182
Query: 264 FGLA--LLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           FGLA  +  +P     GD    +   ++MAPE +     F R   ++ D+++  ++LWE+
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPL---KWMAPETI-----FDRVYTIQSDVWSFGVLLWEI 234
Query: 321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT 380
            S  +S          P+     D      ++E    +    T PE ++          T
Sbjct: 235 FSLGAS----------PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ----------T 274
Query: 381 MEECWDHDAEARLSASCVVE 400
           M +CW  +   R + S +VE
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 48/246 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 425 MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 478
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 479 VSMGMKYLEES-----------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 528 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 575
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 576 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 620
Query: 396 SCVVER 401
           + V  R
Sbjct: 621 AAVELR 626

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           +  V+    G+FG V    + N++ VA+K      ++   SE++  +    +  + H  +
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLH 226
           ++  G       I     L+  + E G L D+L+    +   E L  + L + +G+ +L 
Sbjct: 63  VQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             V HRD  + N L+  +    ++DFG+       +    T    GT+
Sbjct: 119 E-----------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTK 163
Query: 287 ---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              ++ +PEV     +FSR +  + D+++  +++WE+ S
Sbjct: 164 FPVKWASPEVF----SFSRYS-SKSDVWSFGVLMWEVFS 197

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 125 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEY 171
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 172 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 210
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 28/198 (14%)
Query: 137 NVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGS 196
            V  K  L++  Q  +   EI     +++ +++ + G  +  + +    +++     R S
Sbjct: 73  KVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFV----YVVLEICRRRS 128
Query: 197 LCDFLKCNIVTWEQLCRIALSMS-KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
           L +  K      E   R  +  + +G+ +LH              V HRD K  N+ L  
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN-----------RVIHRDLKLGNLFLND 177
Query: 256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL 315
           D+   I DFGLA   E       T    GT  Y+APEVL       +     +D+++   
Sbjct: 178 DMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVL-----CKKGHSFEVDIWSLGC 230
Query: 316 VLWELASRCSSVSPPPGE 333
           +L+ L      V  PP E
Sbjct: 231 ILYTLL-----VGKPPFE 243

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 60  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 113
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 114 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 163 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 210
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 211 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 255
Query: 396 SCV 398
           + V
Sbjct: 256 AAV 258

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 125 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKXFCGTPEY 171
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 172 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 210
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 129
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 130 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKXFCGTPEY 176
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 177 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 215
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 216 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 245

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 125 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKXFCGTPEY 171
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 172 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 210
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 48/243 (19%)
Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFW-LITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           +  +++  I+R IG          E W L+    E G L  +L+ N  V  + +  +   
Sbjct: 62  MQQLDNPYIVRMIGI------CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115
Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL--ALLFEPGKP 275
           +S G+ +L E               HRD  + NVLL +   A I+DFGL  AL  +    
Sbjct: 116 VSMGMKYLEE-----------SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
              THG+   + Y APE     IN+ + +  + D+++  +++WE      S    P  YR
Sbjct: 165 KAQTHGKWPVKWY-APE----CINYYKFSS-KSDVWSFGVLMWE----AFSYGQKP--YR 212
Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               +EV           A++ K  R   P    +      + D M  CW +D E R   
Sbjct: 213 GMKGSEV----------TAMLEKGERMGCPAGCPRE-----MYDLMNLCWTYDVENRPGF 257
Query: 396 SCV 398
           + V
Sbjct: 258 AAV 260

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 125 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKXFCGTPEY 171
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 172 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 210
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           +  V+    G+FG V    + N++ VA+K      ++   SE++  +    +  + H  +
Sbjct: 9   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKL 64
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLH 226
           ++  G       I     L+  + E G L D+L+    +   E L  + L + +G+ +L 
Sbjct: 65  VQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             V HRD  + N L+  +    ++DFG+       +    T    GT+
Sbjct: 121 E-----------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTK 165
Query: 287 ---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              ++ +PEV     +FSR +  + D+++  +++WE+ S
Sbjct: 166 FPVKWASPEVF----SFSRYS-SKSDVWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           +  V+    G+FG V    + N++ VA+K      ++   SE++  +    +  + H  +
Sbjct: 12  LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKL 67
Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLH 226
           ++  G       I     L+  + E G L D+L+    +   E L  + L + +G+ +L 
Sbjct: 68  VQLYGVCLEQAPIC----LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 123
Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           E             V HRD  + N L+  +    ++DFG+       +    T    GT+
Sbjct: 124 E-----------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTK 168
Query: 287 ---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
              ++ +PEV     +FSR +  + D+++  +++WE+ S
Sbjct: 169 FPVKWASPEVF----SFSRYS-SKSDVWSFGVLMWEVFS 202

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 20/189 (10%)
Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNIL---- 169
            ++++V  +G FG V   K KN     +I+ M+    W+  +        E  ++L    
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTE---RIYAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 170 -RYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHE 227
            ++I A           +L+  Y+  G L   L K      E + R  +           
Sbjct: 133 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG---------- 182
Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           E++      ++    HRD K +NVLL  +    +ADFG  L          +   VGT  
Sbjct: 183 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA-VGTPD 241
Query: 288 YMAPEVLEG 296
           Y++PE+L+ 
Sbjct: 242 YISPEILQA 250

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/256 (21%), Positives = 105/256 (41%), Gaps = 58/256 (22%)
Query: 112 RSIQLVEVKAQGRFGAVWKA-----KFKNENVAVKIFLMQDKQSWQSEQEIFK----LPH 162
           +++ L +   +G FG V KA     K +     V + ++++  S    +++      L  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------------------ 204
           + H ++++  GA     S      LI  Y + GSL  FL+ +                  
Sbjct: 83  VNHPHVIKLYGAC----SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 205 -------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL 257
                   +T   L   A  +S+G+ +L E            ++ HRD  + N+L+    
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM-----------SLVHRDLAARNILVAEGR 187
Query: 258 TAAIADFGLAL-LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALV 316
              I+DFGL+  ++E       + G++   ++MA E L   I  ++      D+++  ++
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRSQGRIPV-KWMAIESLFDHIYTTQS-----DVWSFGVL 241
Query: 317 LWELASRCSSVSPPPG 332
           LWE+ +     +P PG
Sbjct: 242 LWEIVTLGG--NPYPG 255

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 127
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 128 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEY 174
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 175 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 213
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 214 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 243

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI-ALSMSKGLMHLHEEI 229
           ++ A K     H     +  Y   G L   L    V  E+  R     +   L +LH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-GTRRY 288
                      V +RD K  N++L  D    I DFGL    + G   G T     GT  Y
Sbjct: 125 ----------DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEY 171
Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEVLE       D    +D +   +V++E+   C          RLPF  +  DH   
Sbjct: 172 LAPEVLE-----DNDYGRAVDWWGLGVVMYEMM--CG---------RLPFYNQ--DH--- 210
Query: 349 EDMQEAVVHKKLR--PTL-PETWKQHAGML 375
           E + E ++ +++R   TL PE     AG+L
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	461
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-154
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-144
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-143
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-140
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-139
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-132
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-51
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-26
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-26
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-22
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-15
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-15
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-14
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-12
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-11
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-10
4fao_E	124	Activin receptor type-2B; TGF-beta, CTK, cystine k	5e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-09
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-09
1bte_A	97	Protein (activin receptor type II); serine kinase,	7e-09
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2h62_D	98	ACVR2B protein; TGF-beta superfamily, ligand-recep	3e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-06
2hlr_A	100	Bone morphogenetic protein receptor type-2; three-	1e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-06
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-04

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  439 bits (1132), Expect = e-154
 Identities = 200/299 (66%), Positives = 238/299 (79%), Gaps = 1/299 (0%)

Query: 103 SPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPH 162
              +       +QL+EVKA+GRFG VWKA+  NE VAVKIF +QDKQSWQ+E E++ LP 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGL 222
           M+H+NIL++IGAEKRG S+  + WLITA+HE+GSL DFLK N+V+W +LC IA +M++GL
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGL 134

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ 282
            +LHE+I P   D +KPA++HRD KS NVLLK++LTA IADFGLAL FE GK  GDTHGQ
Sbjct: 135 AYLHEDI-PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           VGTRRYMAPEVLEGAINF RDAFLRIDMYA  LVLWELASRC++   P  EY LPF  E+
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

Query: 343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           G HPSLEDMQE VVHKK RP L + W++HAGM  LC+T+EECWDHDAEARLSA CV ER
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  413 bits (1063), Expect = e-144
 Identities = 117/293 (39%), Positives = 170/293 (58%), Gaps = 7/293 (2%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           R I L+E   +GR+G VW+  ++ ENVAVKIF  +D++SW  E E++    + H+NIL +
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGF 67

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           I ++       T+ WLIT YHE GSL D+L+   +      RI LS++ GL HLH EI  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRYM 289
            +    KPA+AHRD KS N+L+K +    IAD GLA++        D   + +VGT+RYM
Sbjct: 128 TQ---GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 290 APEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APEVL+  I     D++ R+D++A  LVLWE+A R  S      +Y+ PF   V + PS 
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE-DYKPPFYDVVPNDPSF 243

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           EDM++ V   + RP +P  W     + +L   M+ECW  +  ARL+A  + + 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  405 bits (1043), Expect = e-140
 Identities = 121/293 (41%), Positives = 173/293 (59%), Gaps = 7/293 (2%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + IQ+V+   +GR+G VW  K++ E VAVK+F   ++ SW  E EI++   M H+NIL +
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           I A+ +G    T+ +LIT YHE GSL D+LK   +  + + ++A S   GL HLH EI  
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD--THGQVGTRRYM 289
            +    KPA+AHRD KS N+L+K + T  IAD GLA+ F       D   + +VGT+RYM
Sbjct: 157 TQ---GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 290 APEVLEGAINF-SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            PEVL+ ++N     +++  DMY+  L+LWE+A RC S      EY+LP+   V   PS 
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE-EYQLPYHDLVPSDPSY 272

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           EDM+E V  KKLRP+ P  W     +  +   M ECW H+  +RL+A  V + 
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  402 bits (1035), Expect = e-139
 Identities = 122/293 (41%), Positives = 179/293 (61%), Gaps = 7/293 (2%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL +
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 101

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+ 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT--HGQVGTRRYM 289
            +    KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RYM
Sbjct: 162 TQ---GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 290 APEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APEVL+ +IN    ++F R D+YA  LV WE+A RCS       +Y+LP+   V   PS+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQLPYYDLVPSDPSV 277

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A  + + 
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  384 bits (987), Expect = e-132
 Identities = 127/312 (40%), Positives = 190/312 (60%), Gaps = 14/312 (4%)

Query: 102 TSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLP 161
            +   P     +++L+E+  +GR+GAV+K       VAVK+F   ++Q++ +E+ I+++P
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62

Query: 162 HMEHDNILRYIGAEKRG-ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSK 220
            MEHDNI R+I  ++R       E+ L+  Y+  GSL  +L  +   W   CR+A S+++
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTR 122

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF------EPGK 274
           GL +LH E+     D YKPA++HRD  S NVL+K+D T  I+DFGL++         PG+
Sbjct: 123 GLAYLHTELPRG--DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFS--RDAFLRIDMYACALVLWELASRCSSVSP--P 330
                  +VGT RYMAPEVLEGA+N      A  ++DMYA  L+ WE+  RC+ + P   
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

Query: 331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGML-ALCDTMEECWDHDA 389
             EY++ F  EVG+HP+ EDMQ  V  +K RP  PE WK+++  + +L +T+E+CWD DA
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300

Query: 390 EARLSASCVVER 401
           EARL+A    ER
Sbjct: 301 EARLTAQXAEER 312

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (467), Expect = 5e-55
 Identities = 66/287 (22%), Positives = 123/287 (42%), Gaps = 51/287 (17%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILR 170
           +  +    +   G +WK +++  ++ VK+  ++D  + +S    +E  +L    H N+L 
Sbjct: 12  LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHLHE 227
            +GA +   + H    LIT +   GSL + L      +V   Q  + AL M++G+  LH 
Sbjct: 72  VLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH- 128

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                   + +P +      S +V++  D+TA I+   +   F+       + G++    
Sbjct: 129 --------TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPA 173

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           ++APE L+             DM++ A++LWEL +R            +PF+        
Sbjct: 174 WVAPEALQK--KPEDTNRRSADMWSFAVLLWELVTR-----------EVPFA-------D 213

Query: 348 LEDMQ--EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           L +M+    V  + LRPT+P     H     +   M+ C + D   R
Sbjct: 214 LSNMEIGMKVALEGLRPTIPPGISPH-----VSKLMKICMNEDPAKR 255

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  175 bits (446), Expect = 2e-51
 Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 52/288 (18%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILR 170
           + + E    G FG V +A++   +VAVKI + QD  + +     +E+  +  + H NI+ 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI----VTWEQLCRIALSMSKGLMHLH 226
           ++GA  +  +      ++T Y  RGSL   L  +     +   +   +A  ++KG+ +LH
Sbjct: 99  FMGAVTQPPN----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                    +  P + HR+ KS N+L+    T  + DFGL+ L         +    GT 
Sbjct: 155 ---------NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTP 203

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
            +MAPEVL      +     + D+Y+  ++LWELA+            + P+        
Sbjct: 204 EWMAPEVLRDE-PSNE----KSDVYSFGVILWELATL-----------QQPW-------G 240

Query: 347 SLEDMQ--EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           +L   Q   AV  K  R  +P     +  + A+   +E CW ++   R
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNL--NPQVAAI---IEGCWTNEPWKR 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  166 bits (423), Expect = 1e-48
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 59/305 (19%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQS-----EQEIFKLPHMEHD 166
             + L E+   G FG V++A +  + VAVK       +          QE      ++H 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
           NI+   G   +  +      L+  +   G L   L    +  + L   A+ +++G+ +LH
Sbjct: 67  NIIALRGVCLKEPN----LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH 122

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLL--------KSDLTAAIADFGLALLFEPGKPCGD 278
           +E            + HRD KS+N+L+         S+    I DFGLA           
Sbjct: 123 DE--------AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTT 170

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
                G   +MAPEV+  +  FS+      D+++  ++LWEL +             +PF
Sbjct: 171 KMSAAGAYAWMAPEVIRAS-MFSK----GSDVWSYGVLLWELLTG-----------EVPF 214

Query: 339 SAEVGDHPSLEDMQ--EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                    ++ +     V   KL   +P T         L   ME+CW+ D  +R S +
Sbjct: 215 -------RGIDGLAVAYGVAMNKLALPIPSTC--PEPFAKL---MEDCWNPDPHSRPSFT 262

Query: 397 CVVER 401
            ++++
Sbjct: 263 NILDQ 267

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  166 bits (423), Expect = 3e-48
 Identities = 80/294 (27%), Positives = 123/294 (41%), Gaps = 52/294 (17%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
           I++ EV  +G FG V KAK++ ++VA+K    + ++      E+ +L  + H NI++  G
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK-AFIVELRQLSRVNHPNIVKLYG 68

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFL----KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           A            L+  Y E GSL + L         T        L  S+G+ +LH   
Sbjct: 69  ACLN------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH--- 119

Query: 230 LPNKADSYKP-AVAHRDFKSNNVLLKSDLTAA-IADFGLALLFEPGKPCGDTHGQVGTRR 287
                 S +P A+ HRD K  N+LL +  T   I DFG A                G+  
Sbjct: 120 ------SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAA 168

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           +MAPEV EG+ N+S     + D+++  ++LWE+ +R           R PF     +   
Sbjct: 169 WMAPEVFEGS-NYSE----KCDVFSWGIILWEVITR-----------RKPFD----EIGG 208

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                   VH   RP L +       + +L   M  CW  D   R S   +V+ 
Sbjct: 209 PAFRIMWAVHNGTRPPLIKNL--PKPIESL---MTRCWSKDPSQRPSMEEIVKI 257

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  165 bits (419), Expect = 7e-48
 Identities = 63/306 (20%), Positives = 121/306 (39%), Gaps = 61/306 (19%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--------QEIFKLPHM 163
           I+  +   +G FG V K +       VA+K  ++ D +             +E+F + ++
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKG 221
            H NI++  G       +H    ++  +   G L   L  K + + W    R+ L ++ G
Sbjct: 81  NHPNIVKLYGL------MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLL-----KSDLTAAIADFGLALLFEPGKPC 276
           + ++          +  P + HRD +S N+ L      + + A +ADFGL+         
Sbjct: 135 IEYMQ---------NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----- 180

Query: 277 GDTHGQVGTRRYMAPEVLEGA-INFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
               G +G  ++MAPE +     +++     + D Y+ A++L+ + +             
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTE----KADTYSFAMILYTILTG-----------E 225

Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            PF                +  + LRPT+PE       +  +   +E CW  D + R   
Sbjct: 226 GPFD---EYSYGKIKFINMIREEGLRPTIPEDC--PPRLRNV---IELCWSGDPKKRPHF 277

Query: 396 SCVVER 401
           S +V+ 
Sbjct: 278 SYIVKE 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  155 bits (393), Expect = 6e-44
 Identities = 75/288 (26%), Positives = 118/288 (40%), Gaps = 47/288 (16%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNIL 169
            I + +    G FG V+K K+  + VAVK+  +      Q +    E+  L    H NIL
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHE 227
            ++G      S   +  ++T + E  SL   L         ++L  IA   ++G+ +LH 
Sbjct: 84  LFMGY-----STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH- 137

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                       ++ HRD KSNN+ L  D T  I DFGLA                G+  
Sbjct: 138 ----------AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 288 YMAPEVL--EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
           +MAPEV+  + +  +S  +    D+YA  +VL+EL +            +LP+S    + 
Sbjct: 188 WMAPEVIRMQDSNPYSFQS----DVYAFGIVLYELMTG-----------QLPYS----NI 228

Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQ-HAGMLALCDTMEECWDHDAEAR 392
            + + + E V    L P L +        M  L   M EC     + R
Sbjct: 229 NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL---MAECLKKKRDER 273

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  150 bits (382), Expect = 5e-42
 Identities = 56/301 (18%), Positives = 119/301 (39%), Gaps = 52/301 (17%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDNILR 170
           +++ E+  +GRFG V+  ++  E VA+++  ++     Q +   +E+       H+N++ 
Sbjct: 35  LEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEE 228
           ++GA            +IT+  +  +L   +     ++   +  +IA  + KG+ +LH  
Sbjct: 94  FMGACMSPP----HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA---LLFEPGKPCGDTHGQVGT 285
                       + H+D KS NV    +    I DFGL     + + G+       Q G 
Sbjct: 148 ---------AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 286 RRYMAPEVLEGAINFSRDAFL----RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
             ++APE++      + +  L      D++A   + +EL +R             PF   
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR-----------EWPF--- 243

Query: 342 VGDHPSLEDMQ-EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
                +         +   ++P L +          + D +  CW  + E R + + +++
Sbjct: 244 ----KTQPAEAIIWQMGTGMKPNLSQIGMGK----EISDILLFCWAFEQEERPTFTKLMD 295

Query: 401 R 401
            
Sbjct: 296 M 296

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  148 bits (375), Expect = 3e-41
 Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 57/297 (19%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNIL 169
            +   EV  +G FG   K   +   E + +K  +  D+++ ++  +E+  +  +EH N+L
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHE 227
           ++IG   + + ++     IT Y + G+L   +K       W Q    A  ++ G+ +LH 
Sbjct: 71  KFIGVLYKDKRLN----FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE------------PGKP 275
                        + HRD  S+N L++ +    +ADFGLA L                  
Sbjct: 127 M-----------NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
               +  VG   +MAPE++ G  ++      ++D+++  +VL E+  R   V+  P    
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGR-SYDE----KVDVFSFGIVLCEIIGR---VNADP--DY 225

Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           LP + + G            V   L    P           +      C D D E R
Sbjct: 226 LPRTMDFG----------LNVRGFLDRYCPPNC--PPSFFPI---TVRCCDLDPEKR 267

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 2e-29
 Identities = 64/327 (19%), Positives = 104/327 (31%), Gaps = 59/327 (18%)

Query: 80  WYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGC--RSIQLVEVKAQGRFGAVWKAKFKNEN 137
            +  Q +  S+          P   PS  +    +S Q +     G +G V+K + K + 
Sbjct: 23  MHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDG 82

Query: 138 --VAVKI---FLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLITAY 191
              AVK         K   +   E+     + +H   +R   A + G       +L T  
Sbjct: 83  RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG----ILYLQTEL 138

Query: 192 HERGSLCDFLKCNIVTW--EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN 249
               SL    +    +    Q+          L HLH +            + H D K  
Sbjct: 139 CG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ-----------GLVHLDVKPA 186

Query: 250 NVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRID 309
           N+ L       + DFGL +        G    Q G  RYMAPE+L+G+   +       D
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQGSYGTA------AD 237

Query: 310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWK 369
           +++  L + E+A              LP           E  Q+ +    L P       
Sbjct: 238 VFSLGLTILEVACN----------MELPHGG--------EGWQQ-LRQGYLPPEFTAGLS 278

Query: 370 QHAGMLALCDTMEECWDHDAEARLSAS 396
                  L   +    + D + R +A 
Sbjct: 279 S-----ELRSVLVMMLEPDPKLRATAE 300

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (278), Expect = 2e-27
 Identities = 48/247 (19%), Positives = 84/247 (34%), Gaps = 39/247 (15%)

Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQS-EQEIFKLPHMEHD 166
             +    ++   +G F  V   +  ++    A+K  L  ++Q  +  ++E        H 
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKG 221
           NILR +    R      E WL+  + +RG+L + ++        L       + L + +G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP------ 275
           L  +H               AHRD K  N+LL  +    + D G                
Sbjct: 147 LEAIH-----------AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 276 -CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
              D   Q  T  Y APE+     +   D   R D+++   VL+ +              
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDE--RTDVWSLGCVLYAMMF-----------G 242

Query: 335 RLPFSAE 341
             P+   
Sbjct: 243 EGPYDMV 249

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  109 bits (275), Expect = 3e-27
 Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 46/282 (16%)

Query: 122 QGRFGAVWKA--KFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +G F  V+K         VA      +     +  + ++E   L  ++H NI+R+  + +
Sbjct: 36  RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95

Query: 177 RGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
                     L+T     G+L  +L +  ++  + L      + KGL  LH         
Sbjct: 96  STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR------- 148

Query: 236 SYKPAVAHRDFKSNNVLLKSDL-TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
              P + HRD K +N+ +     +  I D GLA L    K        +GT  +MAPE+ 
Sbjct: 149 --TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY 202

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
           E   + S      +D+YA  + + E+A+          EY  P+S    +  +   +   
Sbjct: 203 EEKYDES------VDVYAFGMCMLEMAT---------SEY--PYS----ECQNAAQIYRR 241

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
           V       +  +            + +E C   + + R S  
Sbjct: 242 VTSGVKPASFDKVAIPEVK-----EIIEGCIRQNKDERYSIK 278

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  107 bits (270), Expect = 1e-26
 Identities = 58/286 (20%), Positives = 101/286 (35%), Gaps = 49/286 (17%)

Query: 122 QGRFGAVWKAKFKNEN--VAVK---IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
            G +G   K + K++   +  K      M + +      E+  L  ++H NI+RY     
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTW-----EQLCRIALSMSKGLMHLHEEILP 231
             +  +T  +++  Y E G L   +            E + R+   ++  L   H     
Sbjct: 76  --DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    V HRD K  NV L       + DFGLA +         T   VGT  YM+P
Sbjct: 134 GHT------VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSP 185

Query: 292 EVLEG-AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED 350
           E +   + N       + D+++   +L+EL +              PF+A      S ++
Sbjct: 186 EQMNRMSYNE------KSDIWSLGCLLYELCAL-----------MPPFTAF-----SQKE 223

Query: 351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
           +   +   K R  +P  +        L + +    +     R S  
Sbjct: 224 LAGKIREGKFRR-IPYRYSD-----ELNEIITRMLNLKDYHRPSVE 263

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  107 bits (269), Expect = 2e-26
 Identities = 47/232 (20%), Positives = 88/232 (37%), Gaps = 40/232 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           + + V  QG FG V KA+    +   A+K     +++      E+  L  + H  ++RY 
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 173 GA---------EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--QLCRIALSMSKG 221
            A                 +  ++   Y E G+L D +    +  +  +  R+   + + 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE---------- 271
           L ++H +            + HRD K  N+ +       I DFGLA              
Sbjct: 129 LSYIHSQ-----------GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 272 --PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
                   +    +GT  Y+A EVL+G  +++       DMY+  ++ +E+ 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI----DMYSLGIIFFEMI 225

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  107 bits (269), Expect = 3e-26
 Identities = 59/327 (18%), Positives = 115/327 (35%), Gaps = 55/327 (16%)

Query: 83  RQRKLGSYFNPVPTLEP-HPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN--VA 139
            ++  G    PVP  +P     P        + ++ +   +G+F  V++A    +   VA
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 140 VK----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERG 195
           +K      LM  K      +EI  L  + H N+++Y  +      +     ++    + G
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL----NIVLELADAG 117

Query: 196 SLCDFLKCNIVTW-----EQLCRIALSMSKGLMHLHEE-ILPNKADSYKPAVAHRDFKSN 249
            L   +K             + +  + +   L H+H   ++            HRD K  
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM------------HRDIKPA 165

Query: 250 NVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRID 309
           NV + +     + D GL   F        +   VGT  YM+PE +            + D
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHE-----NGYNFKSD 218

Query: 310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWK 369
           +++   +L+E+A+            + PF  +  +  SL    + +      P   + + 
Sbjct: 219 IWSLGCLLYEMAAL-----------QSPFYGDKMNLYSL---CKKIEQCDYPPLPSDHYS 264

Query: 370 QHAGMLALCDTMEECWDHDAEARLSAS 396
           +      L   +  C + D E R   +
Sbjct: 265 E-----ELRQLVNMCINPDPEKRPDVT 286

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  106 bits (266), Expect = 5e-26
 Identities = 54/305 (17%), Positives = 99/305 (32%), Gaps = 80/305 (26%)

Query: 122 QGRFGAVWKAKFKNEN--VAVK---IFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAE 175
            G FG+V+K   + +    A+K     L        + +E++    + +H +++RY  A 
Sbjct: 21  SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTW-----EQLCRIALSMSKGLMHLHEEIL 230
              + +     +   Y   GSL D +  N          +L  + L + +GL ++H    
Sbjct: 81  AEDDHM----LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSD-------------------LTAAIADFGLALLFE 271
                    ++ H D K +N+ +                      +   I D G      
Sbjct: 135 ---------SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---- 181

Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
                     + G  R++A EVL+        A    D++A AL +   A       P P
Sbjct: 182 --TRISSPQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGA----EPLP 231

Query: 332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA 391
                            +   E  + +   P +P+   Q        + ++     D E 
Sbjct: 232 RNG--------------DQWHE--IRQGRLPRIPQVLSQ-----EFTELLKVMIHPDPER 270

Query: 392 RLSAS 396
           R SA 
Sbjct: 271 RPSAM 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  106 bits (267), Expect = 6e-26
 Identities = 69/307 (22%), Positives = 114/307 (37%), Gaps = 68/307 (22%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKI----FLMQDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V    +   N      VAVK        Q +  W+ E +I +  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR-- 88

Query: 162 HMEHDNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMS 219
            + H++I++Y G   +    S+     L+  Y   GSL D+L  + +   QL   A  + 
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASL----QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC 144

Query: 220 KGLMHLHEE--ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           +G+ +LH +  I             HRD  + NVLL +D    I DFGLA     G    
Sbjct: 145 EGMAYLHAQHYI-------------HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY- 190

Query: 278 DTHGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE 333
               +        + APE     +   +  F    D+++  + L+EL + C S   PP +
Sbjct: 191 -YRVREDGDSPVFWYAPE----CLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTK 243

Query: 334 YRLPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEECW 385
           +        G    L       + + L            P           +   M+ CW
Sbjct: 244 FLELIGIAQGQMTVLR------LTELLERGERLPRPDKCPA---------EVYHLMKNCW 288

Query: 386 DHDAEAR 392
           + +A  R
Sbjct: 289 ETEASFR 295

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  106 bits (267), Expect = 6e-26
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 40/228 (17%)

Query: 122 QGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILRYIG--AEK 176
           +G FG V+K +  +   VAVK    +  Q  + +   E+  +    H N+LR  G     
Sbjct: 40  RGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99

Query: 177 RGESIHTEFWLITAYHERGSLCDFL-----KCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
                 TE  L+  Y   GS+   L         + W +  RIAL  ++GL +LH+    
Sbjct: 100 ------TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-- 151

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH---GQVGTRRY 288
                  P + HRD K+ N+LL  +  A + DFGLA L        DTH      GT  +
Sbjct: 152 ------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIGH 201

Query: 289 MAPE-VLEGAINFSRDAFLRIDMYACALVLWELAS--RCSSVSPPPGE 333
           +APE +  G  +       + D++   ++L EL +  R   ++    +
Sbjct: 202 IAPEYLSTGKSS------EKTDVFGYGVMLLELITGQRAFDLARLAND 243

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  104 bits (262), Expect = 2e-25
 Identities = 61/189 (32%), Positives = 84/189 (44%), Gaps = 34/189 (17%)

Query: 122 QGRFGAVWKAKFKNENVAVK-IFLMQDKQSWQSEQ----EIFKLPHMEHDNILRYIG--A 174
           +G FG V+K    N  VAVK +  M D  + + +Q    EI  +   +H+N++  +G  +
Sbjct: 41  EGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 100

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFL----KCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           +        +  L+  Y   GSL D L        ++W   C+IA   + G+  LHE   
Sbjct: 101 D------GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-- 152

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---VGTRR 287
                       HRD KS N+LL    TA I+DFGLA   E       T      VGT  
Sbjct: 153 ---------HHIHRDIKSANILLDEAFTAKISDFGLARASEKF---AQTVMTSRIVGTTA 200

Query: 288 YMAPEVLEG 296
           YMAPE L G
Sbjct: 201 YMAPEALRG 209

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  104 bits (261), Expect = 2e-25
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 20/186 (10%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
              E   QG  G V+ A      + VA++   +Q +   +    EI  +   ++ NI+ Y
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           + +   G+    E W++  Y   GSL D +    +   Q+  +     + L  LH     
Sbjct: 83  LDSYLVGD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    V HRD KS+N+LL  D +  + DFG      P +    T   VGT  +MAP
Sbjct: 136 --------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAP 185

Query: 292 EVLEGA 297
           EV+   
Sbjct: 186 EVVTRK 191

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  103 bits (260), Expect = 3e-25
 Identities = 52/294 (17%), Positives = 101/294 (34%), Gaps = 70/294 (23%)

Query: 122 QGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA----- 174
            G FG V+KAK + +     +K        + ++E+E+  L  ++H NI+ Y G      
Sbjct: 21  SGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77

Query: 175 -------EKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMH 224
                  +    S     ++   + ++G+L  +++      +       +   ++KG+ +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137

Query: 225 LHEE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           +H + ++            +RD K +N+ L       I DFGL    +     G      
Sbjct: 138 IHSKKLI------------NRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRTRSK 182

Query: 284 GTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
           GT RYM+PE +              +D+YA  L+L EL      V     E         
Sbjct: 183 GTLRYMSPEQISSQDYGK------EVDLYALGLILAELL----HVCDTAFE--------- 223

Query: 343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                                + + + +          +++      E R + S
Sbjct: 224 ---------TSKFFTDLRDGIISDIFDK-----KEKTLLQKLLSKKPEDRPNTS 263

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (256), Expect = 1e-24
 Identities = 69/307 (22%), Positives = 114/307 (37%), Gaps = 66/307 (21%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKI----FLMQDKQSWQSEQEIFKLP 161
           R ++ +    +G FG V   ++  E       VAVK              + E EI +  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR-- 78

Query: 162 HMEHDNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALS 217
           ++ H+NI++Y G   E  G  I     LI  +   GSL ++L  N   +  +Q  + A+ 
Sbjct: 79  NLYHENIVKYKGICTEDGGNGI----KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
           + KG+ +L            +  V HRD  + NVL++S+    I DFGL    E  K   
Sbjct: 135 ICKGMDYLGS----------RQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDK--E 181

Query: 278 DTHGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE 333
               +        + APE     +  S+  F +  D+++  + L EL + C S S P   
Sbjct: 182 YYTVKDDRDSPVFWYAPE----CLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

Query: 334 YRLPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEECW 385
           +        G            +   L+        P  P+          +   M +CW
Sbjct: 236 FLKMIGPTHGQMTVTR------LVNTLKEGKRLPCPPNCPD---------EVYQLMRKCW 280

Query: 386 DHDAEAR 392
           +     R
Sbjct: 281 EFQPSNR 287

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (256), Expect = 2e-24
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 20/183 (10%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
                  +G  G V  A+ K     VAVK+  ++ +Q  +    E+  +   +H N++  
Sbjct: 48  DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
             +   GE    E W++  + + G+L D +    +  EQ+  +  ++ + L +LH +   
Sbjct: 108 YKSYLVGE----ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ--- 160

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    V HRD KS+++LL  D    ++DFG         P   +   VGT  +MAP
Sbjct: 161 --------GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAP 210

Query: 292 EVL 294
           EV+
Sbjct: 211 EVI 213

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  101 bits (254), Expect = 2e-24
 Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 76/306 (24%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI--FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA--- 174
           +G FG V++AK K  + N A+K      ++    +  +E+  L  +EH  I+RY  A   
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 74

Query: 175 -----EKRGESIHTEFWLITAYHERGSLCDFLK----CNIVTWEQLCRIALSMSKGLMHL 225
                + +  S     ++      + +L D++                I L +++ +  L
Sbjct: 75  KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL 134

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA----------LLFEPGKP 275
           H              + HRD K +N+    D    + DFGL            +  P   
Sbjct: 135 HS----KG-------LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 276 CGDTHGQVGTRRYMAPEVLEG-AINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY 334
                GQVGT+ YM+PE + G + +       ++D+++  L+L+EL              
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSH------KVDIFSLGLILFELLY------------ 225

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKLR----PTLPETWKQHAGMLALCDTMEECWDHDAE 390
             PFS +         M+       +R    P L         ++     +++       
Sbjct: 226 --PFSTQ---------MERVRTLTDVRNLKFPPLFTQKYPCEYVM-----VQDMLSPSPM 269

Query: 391 ARLSAS 396
            R  A 
Sbjct: 270 ERPEAI 275

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (253), Expect = 4e-24
 Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 68/308 (22%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFK------NENVAVKIF---LMQDKQSWQSEQEIFKLPH 162
           R ++ ++   +G FG+V   ++        E VAVK       +  + ++ E EI K   
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--S 67

Query: 163 MEHDNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSM 218
           ++HDNI++Y G        ++     LI  Y   GSL D+L+ +   +   +L +    +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNL----KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123

Query: 219 SKGLMHLHEE--ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
            KG+ +L  +  I             HRD  + N+L++++    I DFGL  +    K  
Sbjct: 124 CKGMEYLGTKRYI-------------HRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170

Query: 277 GDTHGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPG 332
                +        + APE    ++  S+  F +  D+++  +VL+EL +       PP 
Sbjct: 171 --FKVKEPGESPIFWYAPE----SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPA 222

Query: 333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEEC 384
           E    F   +G+      M    + + L+           P+          +   M EC
Sbjct: 223 E----FMRMIGNDK-QGQMIVFHLIELLKNNGRLPRPDGCPD---------EIYMIMTEC 268

Query: 385 WDHDAEAR 392
           W+++   R
Sbjct: 269 WNNNVNQR 276

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  101 bits (254), Expect = 4e-24
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 52/232 (22%)

Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKA------------QGRFGAVWKAKFKN- 135
            Y     ++    +S          + LV+++              G FG V+K   ++ 
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 136 ENVAVKIFLMQDKQS---WQSEQEIFKLPHMEHDNILRYIG--AEKRGESIHTEFWLITA 190
             VA+K    +  Q    +++E E   L    H +++  IG   E R E I     LI  
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIET--LSFCRHPHLVSLIGFCDE-RNEMI-----LIYK 115

Query: 191 YHERGSLCDFL-----KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRD 245
           Y E G+L   L         ++WEQ   I +  ++GL +LH             A+ HRD
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-----------RAIIHRD 164

Query: 246 FKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV-----GTRRYMAPE 292
            KS N+LL  +    I DFG++           TH  +     GT  Y+ PE
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTEL---DQTH--LSTVVKGTLGYIDPE 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 7e-24
 Identities = 69/346 (19%), Positives = 130/346 (37%), Gaps = 72/346 (20%)

Query: 78  CYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGC----RSIQLVEVKAQGRFGAVWKAKF 133
            Y ++               +    S    +       R ++ ++   +G FG+V   ++
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRY 62

Query: 134 K------NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGA--EKRGESIH 182
                   E VAVK       +  + ++ E EI K   ++HDNI++Y G        ++ 
Sbjct: 63  DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SLQHDNIVKYKGVCYSAGRRNL- 119

Query: 183 TEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEE--ILPNKADSYK 238
               LI  Y   GSL D+L+ +   +   +L +    + KG+ +L  +  I         
Sbjct: 120 ---KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI--------- 167

Query: 239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPEVLE 295
               HRD  + N+L++++    I DFGL  +    K       +        + APE   
Sbjct: 168 ----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWYAPE--- 218

Query: 296 GAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
            ++  S+  F +  D+++  +VL+EL +       PP E    F   +G+      M   
Sbjct: 219 -SLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDK-QGQMIVF 270

Query: 355 VVHKKLR--------PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            + + L+           P+          +   M ECW+++   R
Sbjct: 271 HLIELLKNNGRLPRPDGCPD---------EIYMIMTECWNNNVNQR 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 62/319 (19%), Positives = 117/319 (36%), Gaps = 66/319 (20%)

Query: 97  LEPHPTSPPSPQQGCRSI--------QLVEVKAQGRFGAVWKAKFKNEN--VAVK-IFL- 144
           +  H         G  ++          ++   +G FG     K   +     +K I + 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS 60

Query: 145 -MQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK- 202
            M  K+  +S +E+  L +M+H NI++Y  + +   S++    ++  Y E G L   +  
Sbjct: 61  RMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY----IVMDYCEGGDLFKRINA 116

Query: 203 --CNIVTWEQLCRIALSMSKGLMHLHEE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTA 259
               +   +Q+    + +   L H+H+  IL            HRD KS N+ L  D T 
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRKIL------------HRDIKSQNIFLTKDGTV 164

Query: 260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
            + DFG+A +             +GT  Y++PE+ E      +    + D++A   VL+E
Sbjct: 165 QLGDFGIARVLNSTVELARA--CIGTPYYLSPEICEN-----KPYNNKSDIWALGCVLYE 217

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAV--VHKKLRPTLPETWKQHAGMLAL 377
           L +            +  F A          M+  V  +     P +   +        L
Sbjct: 218 LCTL-----------KHAFEA--------GSMKNLVLKIISGSFPPVSLHYSY-----DL 253

Query: 378 CDTMEECWDHDAEARLSAS 396
              + + +  +   R S +
Sbjct: 254 RSLVSQLFKRNPRDRPSVN 272

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 31/190 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF-LMQDKQSWQS-EQEIFKLPHMEHDNILR 170
             +E   +G FG V+K       + VA+KI  L + +   +  +QEI  L   +   + +
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           Y G+  +     T+ W+I  Y   GS  D L+   +   Q+  I   + KGL +LH E  
Sbjct: 85  YYGSYLKD----TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE-- 138

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL-ALLFEPGKPCGDTHGQ----VGT 285
                       HRD K+ NVLL       +ADFG+   L        DT  +    VGT
Sbjct: 139 ---------KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-------DTQIKRNTFVGT 182

Query: 286 RRYMAPEVLE 295
             +MAPEV++
Sbjct: 183 PFWMAPEVIK 192

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 57/200 (28%), Positives = 82/200 (41%), Gaps = 37/200 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILR 170
           +L EV   G    V  A      E VA+K   ++  Q+   E  +EI  +    H NI+ 
Sbjct: 18  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ------------LCRIALSM 218
           Y  +         E WL+      GS+ D +K  +   E             + R  L  
Sbjct: 78  YYTSFVVK----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL-- 131

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL-ALLFEPGKPCG 277
            +GL +LH+               HRD K+ N+LL  D +  IADFG+ A L   G    
Sbjct: 132 -EGLEYLHKN-----------GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 278 DTHGQ--VGTRRYMAPEVLE 295
           +   +  VGT  +MAPEV+E
Sbjct: 180 NKVRKTFVGTPCWMAPEVME 199

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 67/324 (20%), Positives = 114/324 (35%), Gaps = 55/324 (16%)

Query: 87  LGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKA-KFKNENVAVKIFLM 145
           +GS  +P    +           G  S    +V   G  G +     F N +VAVK  L 
Sbjct: 1   MGS--SPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP 58

Query: 146 QDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIH--TEFWLITAYHERGSLCDFL- 201
           +      +++E+  L    EH N++RY   EK  +  +   E           +L +++ 
Sbjct: 59  ECFS--FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-------AATLQEYVE 109

Query: 202 -KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-----S 255
            K       +   +    + GL HLH              + HRD K +N+L+       
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHS----LN-------IVHRDLKPHNILISMPNAHG 158

Query: 256 DLTAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACA 314
            + A I+DFGL      G+       G  GT  ++APE+L      +      +D+++  
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY--TVDIFSAG 216

Query: 315 LVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGM 374
            V + + S              PF             Q  ++            K H  +
Sbjct: 217 CVFYYVISEG----------SHPFGKS-------LQRQANILLGACSLDCLHPEK-HEDV 258

Query: 375 LALCDTMEECWDHDAEARLSASCV 398
           +A  + +E+    D + R SA  V
Sbjct: 259 IAR-ELIEKMIAMDPQKRPSAKHV 281

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 48/283 (16%)

Query: 122 QGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRYIGAEKRG 178
           +G +G V+          +A+K    +D +  Q   +EI    H++H NI++Y+G+    
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91

Query: 179 ESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCR-IALSMSKGLMHLHEEILPNKA 234
                   +       GSL   L+     +   EQ        + +GL +LH+       
Sbjct: 92  GF----IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN------ 141

Query: 235 DSYKPAVAHRDFKSNNVLLKSDL-TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEV 293
                 + HRD K +NVL+ +      I+DFG +       PC +T    GT +YMAPE+
Sbjct: 142 -----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEI 194

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQE 353
           ++      R      D+++    + E+A+      PP  E   P +A             
Sbjct: 195 IDKG---PRGYGKAADIWSLGCTIIEMATG----KPPFYELGEPQAAMF----------- 236

Query: 354 AVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
            V   K+ P +PE+    A        + +C++ D + R  A+
Sbjct: 237 KVGMFKVHPEIPESMSAEA-----KAFILKCFEPDPDKRACAN 274

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 69/308 (22%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIF---LMQDKQSWQSEQEIFKLPH 162
           R ++ +    +G FG+V   ++          VAVK         ++ +Q E +I K   
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK--A 80

Query: 163 MEHDNILRYIG--AEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSM 218
           +  D I++Y G       +S+     L+  Y   G L DFL+ +   +   +L   +  +
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSL----RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136

Query: 219 SKGLMHLHEE--ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC 276
            KG+ +L     +             HRD  + N+L++S+    IADFGLA L    K  
Sbjct: 137 CKGMEYLGSRRCV-------------HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

Query: 277 GDTHGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPG 332
                +   +    + APE    +++ +   F  + D+++  +VL+EL + C     P  
Sbjct: 184 --YVVREPGQSPIFWYAPE----SLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSA 235

Query: 333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEEC 384
           E+      E              + + L         P  P           + + M+ C
Sbjct: 236 EFLRMMGCERDVPALSR------LLELLEEGQRLPAPPACPA---------EVHELMKLC 280

Query: 385 WDHDAEAR 392
           W    + R
Sbjct: 281 WAPSPQDR 288

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 49/211 (23%), Positives = 76/211 (36%), Gaps = 26/211 (12%)

Query: 93  PVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVKIFLMQDKQS 150
            V   E         ++    +       +G FG V +   K      AVK   ++    
Sbjct: 39  GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--- 95

Query: 151 WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWE 209
               +E+     +    I+   GA + G  +     +     E GSL   +K    +  +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGAVREGPWV----NIFMELLEGGSLGQLIKQMGCLPED 150

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIADFGLAL 268
           +         +GL +LH              + H D K++NVLL SD   AA+ DFG AL
Sbjct: 151 RALYYLGQALEGLEYLHTR-----------RILHGDVKADNVLLSSDGSRAALCDFGHAL 199

Query: 269 LFEPGKPCGDTHGQ---VGTRRYMAPEVLEG 296
             +P              GT  +MAPEV+ G
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 22/184 (11%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
           ++V     G FG V+KAK K      A K+   + ++  +    EI  L   +H  I++ 
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEI 229
           +GA         + W++  +   G++   +      +T  Q+  +   M + L  LH + 
Sbjct: 82  LGAYYHD----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK- 136

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + HRD K+ NVL+  +    +ADFG++          D+   +GT  +M
Sbjct: 137 ----------RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWM 184

Query: 290 APEV 293
           APEV
Sbjct: 185 APEV 188

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 65/331 (19%), Positives = 127/331 (38%), Gaps = 67/331 (20%)

Query: 81  YYRQRKLG---SYFNPVPTLEPHPTSPPSPQQGC-----RSIQLVEVKAQGRFGAVWKAK 132
           ++     G   +   P P          SP           I +      G++G V++  
Sbjct: 181 HHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240

Query: 133 FKNEN--VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL 187
           +K  +  VAVK      M + + +  E  + K   ++H N+++ +G   R        ++
Sbjct: 241 WKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMK--EIKHPNLVQLLGVCTREPPF----YI 293

Query: 188 ITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR 244
           IT +   G+L D+L+      V+   L  +A  +S  + +L ++              HR
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-----------NFIHR 342

Query: 245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDA 304
           +  + N L+  +    +ADFGL+ L            +    ++ APE    ++ +++ +
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPE----SLAYNKFS 397

Query: 305 FLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV--HKKLRP 362
             + D++A  ++LWE+A+     SP PG               L  + E +   ++  RP
Sbjct: 398 I-KSDVWAFGVLLWEIATYGM--SPYPGI-------------DLSQVYELLEKDYRMERP 441

Query: 363 TL-PETWKQHAGMLALCDTMEECWDHDAEAR 392
              PE          + + M  CW  +   R
Sbjct: 442 EGCPE---------KVYELMRACWQWNPSDR 463

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 55/316 (17%), Positives = 106/316 (33%), Gaps = 52/316 (16%)

Query: 122 QGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           QG    V++   K   +  A+K+F     ++       E E+ K   + H NI++    E
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK--LNHKNIVKLFAIE 76

Query: 176 KRGESIHTEFWLITAYHERGSLCDFL----KCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           +   + H    LI  +   GSL   L        +   +   +   +  G+ HL E    
Sbjct: 77  EETTTRH--KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---- 130

Query: 232 NKADSYKPAVAHRDFKSNNVLLKS----DLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           N        + HR+ K  N++            + DFG A   E  +         GT  
Sbjct: 131 NG-------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEE 180

Query: 288 YMAPEVLEGAINFSRDAF---LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           Y+ P++ E A+            +D+++  +  +  A+         G   LPF    G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT---------G--SLPFRPFEGP 229

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML 404
               +++   ++  K    +    K   G +     M          ++  + V+   +L
Sbjct: 230 R-RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL-ANIL 287

Query: 405 ----ALCDTMEECWDH 416
                 C   ++ +  
Sbjct: 288 EADQEKCWGFDQFFAE 303

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 54/251 (21%), Positives = 103/251 (41%), Gaps = 45/251 (17%)

Query: 110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHM-EH 165
           G   +++  V A+G F  V++A+        A+K  L  +++  ++  QE+  +  +  H
Sbjct: 26  GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85

Query: 166 DNILRYIGA----EKRGESIHTEFWLITAYHERGSLCDFLK----CNIVTWEQLCRIALS 217
            NI+++  A    ++  ++   EF L+T    +G L +FLK       ++ + + +I   
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCG 277
             + + H+H           KP + HRD K  N+LL +  T  + DFG A          
Sbjct: 145 TCRAVQHMH---------RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 278 DTHGQ----------VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV 327
            +  +            T  Y  PE+++   NF      + D++A   +L+ L       
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE--KQDIWALGCILYLLCF----- 248

Query: 328 SPPPGEYRLPF 338
                  + PF
Sbjct: 249 ------RQHPF 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 30/191 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
            ++E   +G +G+V+KA  K   + VA+K   ++     +  +EI  +   +  ++++Y 
Sbjct: 32  DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVVKYY 90

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           G+  +     T+ W++  Y   GS+ D ++     +T +++  I  S  KGL +LH    
Sbjct: 91  GSYFKN----TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM-- 144

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ----VGTR 286
                       HRD K+ N+LL ++  A +ADFG+A          DT  +    +GT 
Sbjct: 145 ---------RKIHRDIKAGNILLNTEGHAKLADFGVA------GQLTDTMAKRNTVIGTP 189

Query: 287 RYMAPEVLEGA 297
            +MAPEV++  
Sbjct: 190 FWMAPEVIQEI 200

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 96.3 bits (239), Expect = 2e-21
 Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 31/211 (14%)

Query: 101 PTSPPSPQQGCRSIQLVEVKAQGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQSE 154
             SP  P Q C   ++ E    G FG V +   +   E VA+K        ++++ W  E
Sbjct: 3   GRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE 62

Query: 155 QEIFKLPHMEHDNI--LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL----KCNIVTW 208
            +I K   + H N+   R +    +  + +    L   Y E G L  +L     C  +  
Sbjct: 63  IQIMKK--LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120

Query: 209 EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFG 265
             +  +   +S  L +LHE             + HRD K  N++L+         I D G
Sbjct: 121 GPIRTLLSDISSALRYLHEN-----------RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169

Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
            A   + G+ C      VGT +Y+APE+LE 
Sbjct: 170 YAKELDQGELC-TE--FVGTLQYLAPELLEQ 197

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 46/248 (18%)

Query: 122 QGRFGAVWKA--KFKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           QG    V++   K   +  A+K+F     ++       E E+ K   + H NI++    E
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK--LNHKNIVKLFAIE 76

Query: 176 KRGESIHTEFWLITAYHERGSLCDFL----KCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           +   + H    LI  +   GSL   L        +   +   +   +  G+ HL E    
Sbjct: 77  EETTTRH--KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---- 130

Query: 232 NKADSYKPAVAHRDFKSNNVLLKS----DLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           N        + HR+ K  N++            + DFG A   E  +         GT  
Sbjct: 131 NG-------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEE 180

Query: 288 YMAPEVLEGAINFSRDAF---LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           Y+ P++ E A+            +D+++  +  +  A+         G   LPF    G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT---------G--SLPFRPFEGP 229

Query: 345 HPSLEDMQ 352
             + E M 
Sbjct: 230 RRNKEVMY 237

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 59/314 (18%), Positives = 117/314 (37%), Gaps = 59/314 (18%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNIL 169
            + +     G  G V+K   K     +A K+  ++ K + +++  +E+  L       I+
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEE 228
            + GA      I     +   + + GSL   LK      E  L ++++++ KGL +L E+
Sbjct: 95  GFYGAFYSDGEI----SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K +N+L+ S     + DFG++          ++   VGTR Y
Sbjct: 151 H----------KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSF--VGTRSY 196

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELA--------------------------S 322
           M+PE L+G  ++S  +    D+++  L L E+A                          +
Sbjct: 197 MSPERLQGT-HYSVQS----DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 323 RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTME 382
                   PG     F  +     ++ ++ + +V++         +          D + 
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL-----EFQDFVN 306

Query: 383 ECWDHDAEARLSAS 396
           +C   +   R    
Sbjct: 307 KCLIKNPAERADLK 320

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 69/350 (19%), Positives = 117/350 (33%), Gaps = 94/350 (26%)

Query: 81  YYRQRKLGSYFNPVPTLEPHPTSPPSPQQGC----RSIQLVEVKAQGRFGAVWKAKFKNE 136
           +    +       +            P+         + L E   +G FG V+  + + +
Sbjct: 84  HLLSTQQP-----LTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRAD 138

Query: 137 N--VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA 190
           N  VAVK          K  +  E  I K     H NI+R IG   + + I    +++  
Sbjct: 139 NTLVAVKSCRETLPPDLKAKFLQEARILK--QYSHPNIVRLIGVCTQKQPI----YIVME 192

Query: 191 YHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS 248
             + G    FL+     +  + L ++    + G+ +L            K  + HRD  +
Sbjct: 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES----------KCCI-HRDLAA 241

Query: 249 NNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR----RYMAPEVLEGAINFSRDA 304
            N L+       I+DFG++         G      G R    ++ APE L     +S   
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEALNYGR-YS--- 293

Query: 305 FLRIDMYACALVLWELASRCSSVSPPPGE------------YRLPFSAEVGDHPSLEDMQ 352
               D+++  ++LWE  S  +  SP P               RLP               
Sbjct: 294 -SESDVWSFGILLWETFSLGA--SPYPNLSNQQTREFVEKGGRLP--------------- 335

Query: 353 EAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                    P L P+         A+   ME+CW ++   R S S + + 
Sbjct: 336 --------CPELCPD---------AVFRLMEQCWAYEPGQRPSFSTIYQE 368

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 31/192 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKL-PHMEHDNILR 170
           +LVE+   G +G V+K +     +  A+K+  +      +  +QEI  L  +  H NI  
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 171 YIGA--EKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHL 225
           Y GA  +K    +  + WL+  +   GS+ D +K    N +  E +  I   + +GL HL
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--- 282
           H+             V HRD K  NVLL  +    + DFG++           T G+   
Sbjct: 146 HQH-----------KVIHRDIKGQNVLLTENAEVKLVDFGVS------AQLDRTVGRRNT 188

Query: 283 -VGTRRYMAPEV 293
            +GT  +MAPEV
Sbjct: 189 FIGTPYWMAPEV 200

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 50/288 (17%)

Query: 122 QGRFGAVWKAKFKN-ENVAVKI--FLMQDKQSWQS-EQEIFKLPHMEH--DNILRYIGAE 175
            G    V++   +  +  A+K       D Q+  S   EI  L  ++   D I+R    E
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
              + I+    ++        L  +LK    +   +      +M + +  +H+       
Sbjct: 79  ITDQYIY----MVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH------ 127

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + H D K  N L+       + DFG+A   +P         QVGT  YM PE +
Sbjct: 128 -----GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 295 EGAINFSRDAFLRI------DMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +   +   +   +       D+++   +L+ +              + PF   +     L
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-----------KTPFQQIINQISKL 230

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                A++        P+  ++        D ++ C   D + R+S  
Sbjct: 231 ----HAIIDPNHEIEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIP 269

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 65/341 (19%), Positives = 122/341 (35%), Gaps = 94/341 (27%)

Query: 81  YYRQRKLG---SYFNPVPTLEPHPTSPPSPQQGC----RSIQLVEVKAQGRFGAVWKAKF 133
           +Y     G       P              + G     + ++L++   +G FG V    +
Sbjct: 155 HYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214

Query: 134 KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY 191
           +   VAVK  +  D   Q++ +E  +     + H N+++ +G     +      +++T Y
Sbjct: 215 RGNKVAVKC-IKNDATAQAFLAEASVMT--QLRHSNLVQLLGVIVEEK---GGLYIVTEY 268

Query: 192 HERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS 248
             +GSL D+L+     ++  + L + +L + + + +L                 HRD  +
Sbjct: 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-----------NFVHRDLAA 317

Query: 249 NNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAF 305
            NVL+  D  A ++DFGL            +  Q   +   ++ APE    A+   +  F
Sbjct: 318 RNVLVSEDNVAKVSDFGLT--------KEASSTQDTGKLPVKWTAPE----ALREKK--F 363

Query: 306 -LRIDMYACALVLWELASRCSSVSPPPGE------------YRLPFSAEVGDHPSLEDMQ 352
             + D+++  ++LWE+ S      P P              Y++                
Sbjct: 364 STKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYKMD--------------- 406

Query: 353 EAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEAR 392
                    P   P          A+ D M+ CW  DA  R
Sbjct: 407 --------APDGCPP---------AVYDVMKNCWHLDAATR 430

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 57/289 (19%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           S++L     QG FG VW   +     VA+K             QE   +  + H+ +++ 
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244

Query: 172 IGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLH 226
                    + +E   +++T Y  +GSL DFLK      +   QL  +A  ++ G+ ++ 
Sbjct: 245 YA-------VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                           HRD ++ N+L+  +L   +ADFGLA L E  +       +    
Sbjct: 298 RM-----------NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI- 345

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++ APE       F+  +    D+++  ++L EL ++     P PG              
Sbjct: 346 KWTAPEAALYGR-FTIKS----DVWSFGILLTELTTKGR--VPYPGM------------- 385

Query: 347 SLEDMQEAVV--HKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEAR 392
              ++ + V   ++   P   PE         +L D M +CW  + E R
Sbjct: 386 VNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 425

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 36/199 (18%), Positives = 70/199 (35%), Gaps = 36/199 (18%)

Query: 115 QLVEVKAQGR--FGAVWKAKFK--NENVAVKIFLMQDKQSWQSE---QEIFKLPHMEHDN 167
           +L+ V  +G      V  A++K   E V V+   ++   +        E+       H N
Sbjct: 28  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW--EQL----CRIALSMSKG 221
           I+ Y            E W++T++   GS  D +  + +    E       +  L   K 
Sbjct: 88  IVPYRATFIAD----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KA 140

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG-LALLFEPGK----PC 276
           L ++H                HR  K++++L+  D    ++       +   G+      
Sbjct: 141 LDYIHHM-----------GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 277 GDTHGQVGTRRYMAPEVLE 295
                 V    +++PEVL+
Sbjct: 190 DFPKYSVKVLPWLSPEVLQ 208

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 52/194 (26%), Positives = 76/194 (39%), Gaps = 44/194 (22%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS---WQS-EQEIFKLPHMEHDNI 168
             +     G FGAV+ A+    +E VA+K      KQS   WQ   +E+  L  + H N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           ++Y G   R        WL+  Y   GS  D L+ +   +   ++  +     +GL +LH
Sbjct: 117 IQYRGCYLRE----HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ---- 282
                         + HRD K+ N+LL       + DFG A                   
Sbjct: 172 SH-----------NMIHRDVKAGNILLSEPGLVKLGDFGSA-------------SIMAPA 207

Query: 283 ---VGTRRYMAPEV 293
              VGT  +MAPEV
Sbjct: 208 NSFVGTPYWMAPEV 221

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.5 bits (227), Expect = 6e-20
 Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 57/289 (19%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           S++L     QG FG VW   +     VA+K             QE   +  + H+ +++ 
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 172 IGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLH 226
                    + +E   +++T Y  +GSL DFLK      +   QL  +A  ++ G+ ++ 
Sbjct: 328 YA-------VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                           HRD ++ N+L+  +L   +ADFGLA L E  +       +    
Sbjct: 381 RM-----------NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI- 428

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           ++ APE       F+  +    D+++  ++L EL ++     P PG              
Sbjct: 429 KWTAPEAALYGR-FTIKS----DVWSFGILLTELTTKGR--VPYPGM------------- 468

Query: 347 SLEDMQEAVV--HKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEAR 392
              ++ + V   ++   P   PE         +L D M +CW  + E R
Sbjct: 469 VNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 508

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 90.6 bits (225), Expect = 8e-20
 Identities = 60/306 (19%), Positives = 105/306 (34%), Gaps = 66/306 (21%)

Query: 122 QGRFGAVWKA-KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES 180
            G  G V     F+   VAVK  L+        E ++      +H N++RY  +E     
Sbjct: 25  YGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE-SDDHPNVIRYYCSETTDRF 83

Query: 181 IH--TEFWLITAYHERGSLCDFL--------KCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           ++   E           +L D +           +        +   ++ G+ HLH    
Sbjct: 84  LYIALELC-------NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS-------------DLTAAIADFGLALLFEPGKPCG 277
             K       + HRD K  N+L+ +             +L   I+DFGL    + G+   
Sbjct: 134 -LK-------IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 278 DT--HGQVGTRRYMAPEVLEGAINFSRDAFLR--IDMYACALVLWELASRCSSVSPPPGE 333
            T  +   GT  + APE+LE + N      L   ID+++   V + + S+          
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG--------- 236

Query: 334 YRLPFSAEVGDHPSLEDMQEAVVHKKLR-PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
            + PF  +          +  ++        +     +     A  D + +  DHD   R
Sbjct: 237 -KHPFGDK-------YSRESNIIRGIFSLDEMKCLHDRSLIAEAT-DLISQMIDHDPLKR 287

Query: 393 LSASCV 398
            +A  V
Sbjct: 288 PTAMKV 293

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 60/300 (20%), Positives = 120/300 (40%), Gaps = 72/300 (24%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIFLMQDKQSWQSEQEIFK----LPH 162
             + ++V   G FG V+K  +  E       VA+K   +++  S ++ +EI      +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMAS 73

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSK 220
           +++ ++ R +G       + +   LIT     G L D+++ +   +  + L    + ++K
Sbjct: 74  VDNPHVCRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +L +          +  V HRD  + NVL+K+     I DFGLA L    +     +
Sbjct: 129 GMNYLED----------RRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---KEY 174

Query: 281 GQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRL 336
              G +   ++MA E    +I      +  + D+++  + +WEL +         G    
Sbjct: 175 HAEGGKVPIKWMALE----SILHRI--YTHQSDVWSYGVTVWELMTF--------GS--K 218

Query: 337 PFSAEVGDHPSLEDMQEAVVHKKL----RPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           P+          + +  + +   L    R   P           +   M +CW  DA++R
Sbjct: 219 PY----------DGIPASEISSILEKGERLPQPPICTI-----DVYMIMRKCWMIDADSR 263

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 51/288 (17%), Positives = 99/288 (34%), Gaps = 50/288 (17%)

Query: 122 QGRFGAVWKAKFKN-ENVAVKI--FLMQDKQSWQS-EQEIFKLPHMEH--DNILRYIGAE 175
            G    V++   +  +  A+K       D Q+  S   EI  L  ++   D I+R    E
Sbjct: 38  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
              + I+    ++        L  +LK    +   +      +M + +  +H+       
Sbjct: 98  ITDQYIY----MVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH------ 146

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + H D K  N L+  D    + DFG+A   +P         QVGT  YM PE +
Sbjct: 147 -----GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 295 EGAINFSRDAFLRI------DMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +   +   +   +       D+++   +L+ +              + PF   +     L
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-----------KTPFQQIINQISKL 249

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                A++        P+  ++        D ++ C   D + R+S  
Sbjct: 250 ----HAIIDPNHEIEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIP 288

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 50/288 (17%)

Query: 122 QGRFGAVWKAKFKN-ENVAVKI--FLMQDKQSWQS-EQEIFKLPHMEH--DNILRYIGAE 175
            G    V++   +  +  A+K       D Q+  S   EI  L  ++   D I+R    E
Sbjct: 66  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
              + I+    ++        L  +LK    +   +      +M + +  +H+       
Sbjct: 126 ITDQYIY----MVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH------ 174

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + H D K  N L+  D    + DFG+A   +P         QVG   YM PE +
Sbjct: 175 -----GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 295 EGAINFSRDAFLRI------DMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +   +   +   +       D+++   +L+ +              + PF   +     L
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-----------KTPFQQIINQISKL 277

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                A++        P+  ++        D ++ C   D + R+S  
Sbjct: 278 ----HAIIDPNHEIEFPDIPEKDL-----QDVLKCCLKRDPKQRISIP 316

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 59/305 (19%), Positives = 108/305 (35%), Gaps = 87/305 (28%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDN 167
             +  V+    G+FG V    + N++ VA+K      M  ++ +  E E+     + H  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMM--KLSHPK 64

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHL 225
           +++  G       I     L+T + E G L D+L+    +   E L  + L + +G+ +L
Sbjct: 65  LVQLYGVCLEQAPI----CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVG 284
            E             V HRD  + N L+  +    ++DFG+           D +    G
Sbjct: 121 EEA-----------CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTG 164

Query: 285 TR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE------- 333
           T+   ++ +PE      +FSR  +  + D+++  +++WE+ S      P           
Sbjct: 165 TKFPVKWASPE----VFSFSR--YSSKSDVWSFGVLMWEVFSE--GKIPYENRSNSEVVE 216

Query: 334 -----YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDH 387
                +RL                        +P L             +   M  CW  
Sbjct: 217 DISTGFRLY-----------------------KPRLAST---------HVYQIMNHCWRE 244

Query: 388 DAEAR 392
             E R
Sbjct: 245 RPEDR 249

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 73/339 (21%), Positives = 130/339 (38%), Gaps = 89/339 (26%)

Query: 81  YYRQRKLG---SYFNPVPTLEPHPTSPPSPQQGCRS-IQLVEVKAQGRFGAVWKAKFKNE 136
           +Y++   G       P  + +P         +  R  ++L +    G+FG VW A +   
Sbjct: 153 HYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212

Query: 137 -NVAVKIF--LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE 193
             VAVK         +++ +E  + K   ++HD +++               ++IT +  
Sbjct: 213 TKVAVKTMKPGSMSVEAFLAEANVMK--TLQHDKLVKLHAV-----VTKEPIYIITEFMA 265

Query: 194 RGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN 250
           +GSL DFLK +        +L   +  +++G+  + +               HRD ++ N
Sbjct: 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-----------NYIHRDLRAAN 314

Query: 251 VLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAF-L 306
           +L+ + L   IADFGLA + E      +   + G +   ++ APE    AINF    F +
Sbjct: 315 ILVSASLVCKIADFGLARVIE----DNEYTAREGAKFPIKWTAPE----AINFGS--FTI 364

Query: 307 RIDMYACALVLWELASRCSSVSPPPGE------------YRLPFSAEVGDHPSLEDMQEA 354
           + D+++  ++L E+ +      P PG             YR+P                 
Sbjct: 365 KSDVWSFGILLMEIVTYGR--IPYPGMSNPEVIRALERGYRMP----------------- 405

Query: 355 VVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEAR 392
                 RP   PE          L + M  CW +  E R
Sbjct: 406 ------RPENCPE---------ELYNIMMRCWKNRPEER 429

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 66/306 (21%), Positives = 123/306 (40%), Gaps = 89/306 (29%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN--VAVKIF---LMQDKQSWQSEQEIFKLPHMEHDN 167
            I +      G++G V++  +K  +  VAVK      M + + +  E  + K   ++H N
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMK--EIKHPN 70

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMH 224
           +++ +G   R        ++IT +   G+L D+L+      V+   L  +A  +S  + +
Sbjct: 71  LVQLLGVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQV 283
           L ++              HRD  + N L+  +    +ADFGL+ L       GDT+    
Sbjct: 127 LEKK-----------NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-----GDTYTAHA 170

Query: 284 GTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE------ 333
           G +   ++ APE    ++ +++  F ++ D++A  ++LWE+A+    +SP PG       
Sbjct: 171 GAKFPIKWTAPE----SLAYNK--FSIKSDVWAFGVLLWEIATY--GMSPYPGIDLSQVY 222

Query: 334 ------YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWD 386
                 YR+                        RP   PE          + + M  CW 
Sbjct: 223 ELLEKDYRME-----------------------RPEGCPE---------KVYELMRACWQ 250

Query: 387 HDAEAR 392
            +   R
Sbjct: 251 WNPSDR 256

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 73/311 (23%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVK----IFLMQDKQSWQSEQEIFKLPHM 163
            +   EV  +G FG V+     + +      AVK    I  + +   + +E  I K    
Sbjct: 26  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK--DF 83

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKG 221
            H N+L  +G   R E       ++  Y + G L +F++      T + L    L ++KG
Sbjct: 84  SHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTH 280
           + +L            K  V HRD  + N +L    T  +ADFGLA  +++      + +
Sbjct: 141 MKYLAS----------KKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD-----KEYY 184

Query: 281 GQVGTR------RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE 333
                       ++MA E    ++   +  F  + D+++  ++LWEL +R     P P  
Sbjct: 185 SVHNKTGAKLPVKWMALE----SLQTQK--FTTKSDVWSFGVLLWELMTR--GAPPYPDV 236

Query: 334 YRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAGMLALCDTMEECWDHDAE 390
                        +  D+   ++  +   +P   P+          L + M +CW   AE
Sbjct: 237 -------------NTFDITVYLLQGRRLLQPEYCPD---------PLYEVMLKCWHPKAE 274

Query: 391 ARLSASCVVER 401
            R S S +V R
Sbjct: 275 MRPSFSELVSR 285

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 60/304 (19%), Positives = 116/304 (38%), Gaps = 89/304 (29%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNIL 169
           + ++L++   +G FG V    ++   VAVK  +  D   Q++ +E  +     + H N++
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMT--QLRHSNLV 77

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLH 226
           + +G     +      +++T Y  +GSL D+L+     ++  + L + +L + + + +L 
Sbjct: 78  QLLGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGT 285
                           HRD  + NVL+  D  A ++DFGL           +    Q   
Sbjct: 135 GN-----------NFVHRDLAARNVLVSEDNVAKVSDFGLT---------KEASSTQDTG 174

Query: 286 R---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE-------- 333
           +   ++ APE    A+   +  F  + D+++  ++LWE+ S      P P          
Sbjct: 175 KLPVKWTAPE----ALREKK--FSTKSDVWSFGILLWEIYSF--GRVPYPRIPLKDVVPR 226

Query: 334 ----YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHD 388
               Y++                         P   P          A+ + M+ CW  D
Sbjct: 227 VEKGYKMD-----------------------APDGCPP---------AVYEVMKNCWHLD 254

Query: 389 AEAR 392
           A  R
Sbjct: 255 AAMR 258

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 85.3 bits (212), Expect = 6e-19
 Identities = 57/303 (18%), Positives = 107/303 (35%), Gaps = 83/303 (27%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIF--LMQDKQSWQSEQEIFKLPHMEHDNI 168
             I L++    G+FG V   K+K + +VAVK+       +  +  E +      + H  +
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMM--KLSHPKL 65

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLH 226
           +++ G   +   I    +++T Y   G L ++L+ +   +   QL  +   + +G+  L 
Sbjct: 66  VKFYGVCSKEYPI----YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                           HRD  + N L+  DL   ++DFG+                VGT+
Sbjct: 122 SH-----------QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTK 166

Query: 287 ---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE--------- 333
              ++ APE      ++ +  +  + D++A  +++WE+ S      P             
Sbjct: 167 FPVKWSAPE----VFHYFK--YSSKSDVWAFGILMWEVFSL--GKMPYDLYTNSEVVLKV 218

Query: 334 ---YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDA 389
              +RL                        RP L  +          +   M  CW    
Sbjct: 219 SQGHRLY-----------------------RPHLASD---------TIYQIMYSCWHELP 246

Query: 390 EAR 392
           E R
Sbjct: 247 EKR 249

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 77/354 (21%), Positives = 122/354 (34%), Gaps = 99/354 (27%)

Query: 79  YWYYRQRKLGSYFN---PVPTLEPHPTSPPSPQQGCR---------SIQLVEVKAQGRFG 126
           + ++   +   YF    P P     P +   P +  R          I + ++   G  G
Sbjct: 4   HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSG 63

Query: 127 AVWKAKFKNEN-----VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
            V   + +        VA+K        + ++ + SE  I      +H NI+R  G   R
Sbjct: 64  EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG--QFDHPNIIRLEGVVTR 121

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
           G        ++T Y E GSL  FL+ +    T  QL  +   +  G+ +L +        
Sbjct: 122 GRLA----MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL------- 170

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPE 292
                  HRD  + NVL+ S+L   ++DFGL+ + E        +   G +   R+ APE
Sbjct: 171 ----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--DAAYTTTGGKIPIRWTAPE 224

Query: 293 VLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPG------------EYRLPFS 339
               AI F    F    D+++  +V+WE+ +      P                YRLP  
Sbjct: 225 ----AIAFRT--FSSASDVWSFGVVMWEVLAYGE--RPYWNMTNRDVISSVEEGYRLP-- 274

Query: 340 AEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEAR 392
                                 P   P          AL   M +CW  D   R
Sbjct: 275 ---------------------APMGCPH---------ALHQLMLDCWHKDRAQR 298

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 68/349 (19%), Positives = 121/349 (34%), Gaps = 88/349 (25%)

Query: 77  LCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCR---------SIQLVEVKAQGRFGA 127
           + Y+++                        P Q             +   +V   G FG 
Sbjct: 1   MSYYHHHHHHDYDIPTTENLY-FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGE 59

Query: 128 VWKAKFKNEN------VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           V+K   K  +      VA+K        + +  +  E  I       H NI+R  G   +
Sbjct: 60  VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG--QFSHHNIIRLEGVISK 117

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKAD 235
            + +     +IT Y E G+L  FL+      +  QL  +   ++ G+ +L          
Sbjct: 118 YKPM----MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM------- 166

Query: 236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPE 292
                  HRD  + N+L+ S+L   ++DFGL+ + E       T+   G +   R+ APE
Sbjct: 167 ----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EATYTTSGGKIPIRWTAPE 220

Query: 293 VLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDM 351
               AI++ +  F    D+++  +V+WE+ +         GE   P+           ++
Sbjct: 221 ----AISYRK--FTSASDVWSFGIVMWEVMTY--------GE--RPY----------WEL 254

Query: 352 QEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
               V K +            P          A+   M +CW  +   R
Sbjct: 255 SNHEVMKAINDGFRLPTPMDCPS---------AIYQLMMQCWQQERARR 294

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 62/314 (19%), Positives = 122/314 (38%), Gaps = 70/314 (22%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVK-----IFLMQDKQSWQSEQEIFKLPH 162
              L  +  +G FG+V +A+ K E+     VAVK     I    D + +  E    K   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK--E 81

Query: 163 MEHDNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCN-------IVTWEQLCR 213
            +H ++ + +G     R +       +I  + + G L  FL  +        +  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 214 IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEP 272
             + ++ G+ +L            +  + HRD  + N +L  D+T  +ADFGL+  ++  
Sbjct: 142 FMVDIACGMEYLSS----------RNFI-HRDLAARNCMLAEDMTVCVADFGLSRKIYS- 189

Query: 273 GKPCGDTHGQVGTR----RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSV 327
               GD + Q        +++A E    ++  +   + +  D++A  + +WE+ +R    
Sbjct: 190 ----GDYYRQGCASKLPVKWLALE----SLADNL--YTVHSDVWAFGVTMWEIMTRGQ-- 237

Query: 328 SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDH 387
           +P  G                 ++   ++    R   P    +      + D M +CW  
Sbjct: 238 TPYAGI-------------ENAEIYNYLIGGN-RLKQPPECME-----EVYDLMYQCWSA 278

Query: 388 DAEARLSASCVVER 401
           D + R S +C+   
Sbjct: 279 DPKQRPSFTCLRME 292

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 55/304 (18%), Positives = 110/304 (36%), Gaps = 85/304 (27%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNE-NVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDN 167
           + +  ++    G+FG V   K++ + +VA+K+     M  +  +  E ++    ++ H+ 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMM--NLSHEK 80

Query: 168 ILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHL 225
           +++  G   +   I    ++IT Y   G L ++L+        +QL  +   + + + +L
Sbjct: 81  LVQLYGVCTKQRPI----FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
             +              HRD  + N L+       ++DFGL+          +    VG+
Sbjct: 137 ESK-----------QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGS 181

Query: 286 R---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE-------- 333
           +   R+  PE     + +S+  F  + D++A  +++WE+ S      P            
Sbjct: 182 KFPVRWSPPE----VLMYSK--FSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEH 233

Query: 334 ----YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHD 388
                RL                        RP L  E          +   M  CW   
Sbjct: 234 IAQGLRLY-----------------------RPHLASE---------KVYTIMYSCWHEK 261

Query: 389 AEAR 392
           A+ R
Sbjct: 262 ADER 265

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 63/308 (20%), Positives = 111/308 (36%), Gaps = 85/308 (27%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVK----IFLMQDKQSWQSEQEIFKLPHM 163
                 V  +G FG V+  ++ ++       A+K    I  MQ  +++  E  + +   +
Sbjct: 22  VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR--GL 79

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKG 221
            H N+L  IG     E +     ++  Y   G L  F++      T + L    L +++G
Sbjct: 80  NHPNVLALIGIMLPPEGL---PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           + +L E          +  V HRD  + N +L    T  +ADFGLA      +       
Sbjct: 137 MEYLAE----------QKFV-HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185

Query: 282 QVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE---- 333
           +   R   ++ A E    ++   R  F  + D+++  ++LWEL +R     P        
Sbjct: 186 R-HARLPVKWTALE----SLQTYR--FTTKSDVWSFGVLLWELLTR--GAPPYRHIDPFD 236

Query: 334 --------YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEEC 384
                    RLP                       +P   P+         +L   M++C
Sbjct: 237 LTHFLAQGRRLP-----------------------QPEYCPD---------SLYQVMQQC 264

Query: 385 WDHDAEAR 392
           W+ D   R
Sbjct: 265 WEADPAVR 272

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 61/296 (20%), Positives = 109/296 (36%), Gaps = 51/296 (17%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEI-FKLPHMEHDNI 168
           ++ +    +G +G+V K   K   + +AVK       +  Q +   ++   +   +   I
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTW------EQLCRIALSMSKGL 222
           +++ GA  R        W+        S   F K            E L +I L+  K L
Sbjct: 84  VQFYGALFREGDC----WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL-ALLFEPGKPCGDTHG 281
            HL E +           + HRD K +N+LL       + DFG+   L +      D   
Sbjct: 139 NHLKENL----------KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--- 185

Query: 282 QVGTRRYMAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
             G R YMAPE ++ + +    D   R D+++  + L+ELA+         G +  P+  
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDV--RSDVWSLGITLYELAT---------GRF--PYPK 231

Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
               +   + +   VV     P L  + ++     +  + +  C   D   R    
Sbjct: 232 ---WNSVFDQLT-QVVKGDP-PQLSNSEEREFSP-SFINFVNLCLTKDESKRPKYK 281

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 58/305 (19%), Positives = 113/305 (37%), Gaps = 73/305 (23%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEI-FKLPHMEHDNI 168
           ++ +    +G +G V K +     + +AVK          Q     ++   +  ++    
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLM 223
           + + GA  R   +    W+     +  SL  F K        +  + L +IA+S+ K L 
Sbjct: 69  VTFYGALFREGDV----WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ- 282
           HLH ++          +V HRD K +NVL+ +     + DFG++             G  
Sbjct: 124 HLHSKL----------SVIHRDVKPSNVLINALGQVKMCDFGIS-------------GYL 160

Query: 283 ---------VGTRRYMAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPG 332
                     G + YMAPE +   +N        + D+++  + + ELA           
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSV--KSDIWSLGITMIELAI---------L 209

Query: 333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEA 391
            +  P+ +     P  + ++  VV +   P LP + +          D   +C   +++ 
Sbjct: 210 RF--PYDSW--GTP-FQQLK-QVVEEPS-PQLPADKFSAEF-----VDFTSQCLKKNSKE 257

Query: 392 RLSAS 396
           R +  
Sbjct: 258 RPTYP 262

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 72/335 (21%), Positives = 122/335 (36%), Gaps = 76/335 (22%)

Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN-----VAVK-- 141
           S  NP                    +   EV  +G FG V+     + +      AVK  
Sbjct: 69  SALNPELVQAVQHVVIGPSSL---IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125

Query: 142 --IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD 199
             I  + +   + +E  I K     H N+L  +G   R E       ++  Y + G L +
Sbjct: 126 NRITDIGEVSQFLTEGIIMK--DFSHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRN 180

Query: 200 FLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL 257
           F++      T + L    L ++KG+  L            K  V HRD  + N +L    
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLAS----------KKFV-HRDLAARNCMLDEKF 229

Query: 258 TAAIADFGLA-LLFEPGKPCGDTHGQVGTR------RYMAPEVLEGAINFSRDAF-LRID 309
           T  +ADFGLA  +++      +              ++MA E    ++   +  F  + D
Sbjct: 230 TVKVADFGLARDMYD-----KEFDSVHNKTGAKLPVKWMALE----SLQTQK--FTTKSD 278

Query: 310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PE 366
           +++  ++LWEL +R     P P               +  D+   ++  +   +P   P+
Sbjct: 279 VWSFGVLLWELMTR--GAPPYPDV-------------NTFDITVYLLQGRRLLQPEYCPD 323

Query: 367 TWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                     L + M +CW   AE R S S +V R
Sbjct: 324 ---------PLYEVMLKCWHPKAEMRPSFSELVSR 349

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 54/295 (18%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEI-FKLPHMEHDNI 168
           ++ +     G  G VWK +F+     +AVK       +        ++   L   +   I
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHE 227
           ++  G       +    ++        +     +      E  L ++ +++ K L +L E
Sbjct: 87  VQCFGTFITNTDV----FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL-ALLFEPGKPCGDTHGQ---V 283
           +            V HRD K +N+LL       + DFG+   L        D   +    
Sbjct: 143 KH----------GVIHRDVKPSNILLDERGQIKLCDFGISGRLV-------DDKAKDRSA 185

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           G   YMAPE ++       D  +R D+++  + L ELA+         G++  P+     
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT---------GQF--PYK---N 231

Query: 344 DHPSLEDMQEAVVHKKLRPTLPE--TWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                E +   V+ ++  P LP    +            +++C   D   R   +
Sbjct: 232 CKTDFEVLT-KVLQEEP-PLLPGHMGFSG-----DFQSFVKDCLTKDHRKRPKYN 279

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 43/328 (13%), Positives = 82/328 (25%), Gaps = 70/328 (21%)

Query: 109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE----QEIFKLPH 162
           QG R ++LVE    G    V+  +     E+ A+K+F M  + S        +  F    
Sbjct: 59  QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118

Query: 163 MEHDNILRYIGAEK--------RGESIHTEFWLITAYHER-------------GSLCDFL 201
           +  ++        +          +S      L     +                L    
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178

Query: 202 KC--------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL 253
                            L  +   + +   +L  +            + H  F  +N+ +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-----------GLVHGHFTPDNLFI 227

Query: 254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
             D    + D      ++ G              Y   E L  +   +      ++ +  
Sbjct: 228 MPDGRLMLGDVSAL--WKVGTR---GPASSVPVTYAPREFLNAS---TATFTHALNAWQL 279

Query: 314 ALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQH-A 372
            L ++ +          P     P        PSL       +       LP+  K    
Sbjct: 280 GLSIYRVWCLF-----LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334

Query: 373 GMLALCDTMEECWDHDAEARLSASCVVE 400
             L          + D   RL     +E
Sbjct: 335 RFL----------NFDRRRRLLPLEAME 352

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 73/310 (23%), Positives = 114/310 (36%), Gaps = 94/310 (30%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIF----LMQDKQSWQSEQEIFKLPHM 163
            + L  +  +G FG V++  + N       VAVK       + +K+ + SE  I K  ++
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK--NL 70

Query: 164 EHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMS 219
           +H +I++ IG       I  E   W+I   +  G L  +L+ N   +    L   +L + 
Sbjct: 71  DHPHIVKLIG-------IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
           K + +L               V HRD    N+L+ S     + DFGL+   E      D 
Sbjct: 124 KAMAYLES----------INCV-HRDIAVRNILVASPECVKLGDFGLSRYIED----EDY 168

Query: 280 HGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE-- 333
           +    TR   ++M+PE    +INF R  F    D++  A+ +WE+ S      P      
Sbjct: 169 YKASVTRLPIKWMSPE----SINFRR--FTTASDVWMFAVCMWEILSFGK--QPFFWLEN 220

Query: 334 ----------YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTME 382
                      RLP                       +P L P           L   M 
Sbjct: 221 KDVIGVLEKGDRLP-----------------------KPDLCPP---------VLYTLMT 248

Query: 383 ECWDHDAEAR 392
            CWD+D   R
Sbjct: 249 RCWDYDPSDR 258

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 89/305 (29%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIF--LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           +++LVE    G+FG VW   +     VAVK          ++ +E  + K   ++H  ++
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMK--QLQHQRLV 71

Query: 170 RYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMH 224
           R          + T+   ++IT Y E GSL DFLK      +T  +L  +A  +++G+  
Sbjct: 72  RLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           + E               HRD ++ N+L+   L+  IADFGLA L E      +   + G
Sbjct: 125 IEER-----------NYIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREG 169

Query: 285 TR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGE------- 333
            +   ++ APE    AIN+    F ++ D+++  ++L E+ +      P PG        
Sbjct: 170 AKFPIKWTAPE----AINYGT--FTIKSDVWSFGILLTEIVTH--GRIPYPGMTNPEVIQ 221

Query: 334 -----YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDH 387
                YR+                        RP   PE          L   M  CW  
Sbjct: 222 NLERGYRMV-----------------------RPDNCPE---------ELYQLMRLCWKE 249

Query: 388 DAEAR 392
             E R
Sbjct: 250 RPEDR 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 62/316 (19%), Positives = 122/316 (38%), Gaps = 75/316 (23%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVK-----IFLMQDKQSWQSEQEIFKLPH 162
            + L ++  +G FG+V +   K E+     VAVK         ++ + + SE    K   
Sbjct: 35  LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK--D 92

Query: 163 MEHDNILRYIGAEKRGESIHTE-FWLITAYHERGSLCDFLKCN-------IVTWEQLCRI 214
             H N++R +G      S       +I  + + G L  +L  +        +  + L + 
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 215 ALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPG 273
            + ++ G+ +L                 HRD  + N +L+ D+T  +ADFGL+  ++   
Sbjct: 153 MVDIALGMEYLSN----RN-------FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS-- 199

Query: 274 KPCGDTHGQVGTR----RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVS 328
              GD + Q        +++A E    ++      +  + D++A  + +WE+A+R    +
Sbjct: 200 ---GDYYRQGRIAKMPVKWIAIE----SLADRV--YTSKSDVWAFGVTMWEIATRGM--T 248

Query: 329 PPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAGMLALCDTMEECW 385
           P PG                 +M + ++H     +P    +          L + M  CW
Sbjct: 249 PYPGV-------------QNHEMYDYLLHGHRLKQPEDCLD---------ELYEIMYSCW 286

Query: 386 DHDAEARLSASCVVER 401
             D   R + S +  +
Sbjct: 287 RTDPLDRPTFSVLRLQ 302

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 74/333 (22%), Positives = 123/333 (36%), Gaps = 88/333 (26%)

Query: 94  VPTLEP--HPTSPPSPQQGCR---------SIQLVEVKAQGRFGAVWKAKFKNEN----- 137
           +P L     P +   P Q            +I + +V   G FG V   + K  +     
Sbjct: 16  LPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75

Query: 138 VAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHE 193
           VA+K        + ++ +  E  I      +H NI+R  G   + + +     ++T Y E
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMG--QFDHPNIIRLEGVVTKSKPV----MIVTEYME 129

Query: 194 RGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
            GSL  FL+ +    T  QL  +   ++ G+ +L +               HRD  + N+
Sbjct: 130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNI 178

Query: 252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAF-LR 307
           L+ S+L   ++DFGL  + E        +   G +   R+ +PE    AI + +  F   
Sbjct: 179 LINSNLVCKVSDFGLGRVLEDDP--EAAYTTRGGKIPIRWTSPE----AIAYRK--FTSA 230

Query: 308 IDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLR------ 361
            D+++  +VLWE+ S         GE   P+           +M    V K +       
Sbjct: 231 SDVWSYGIVLWEVMSY--------GE--RPY----------WEMSNQDVIKAVDEGYRLP 270

Query: 362 --PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                P          AL   M +CW  D   R
Sbjct: 271 PPMDCPA---------ALYQLMLDCWQKDRNNR 294

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 60/307 (19%), Positives = 106/307 (34%), Gaps = 83/307 (27%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSEQEIFK-----LPH 162
            ++L+E    G FG V + ++   +     VAVK  L  D  S     + F      +  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC-LKPDVLSQPEAMDDFIREVNAMHS 77

Query: 163 MEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSM 218
           ++H N++R  G       +       ++T     GSL D L+ +        L R A+ +
Sbjct: 78  LDHRNLIRLYG-------VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           ++G+ +L  +              HRD  + N+LL +     I DFGL            
Sbjct: 131 AEGMGYLESKRF-----------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-- 177

Query: 279 THGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEY 334
              Q   +    + APE    ++      F    D +   + LWE+ +            
Sbjct: 178 YVMQEHRKVPFAWCAPE----SLKTRT--FSHASDTWMFGVTLWEMFTYG---------- 221

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKL--------RPTL-PETWKQHAGMLALCDTMEECW 385
           + P+            +  + +  K+        RP   P+          + + M +CW
Sbjct: 222 QEPW----------IGLNGSQILHKIDKEGERLPRPEDCPQ---------DIYNVMVQCW 262

Query: 386 DHDAEAR 392
            H  E R
Sbjct: 263 AHKPEDR 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 59/305 (19%), Positives = 109/305 (35%), Gaps = 82/305 (26%)

Query: 113 SIQLVEVK-AQGRFGAVWKAKFKNEN----VAVKI----FLMQDKQSWQSEQEIFKLPHM 163
           ++ + +++   G FG+V +  ++       VA+K+        D +    E +I     +
Sbjct: 10  NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH--QL 67

Query: 164 EHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMS 219
           ++  I+R IG       +       L+      G L  FL      +    +  +   +S
Sbjct: 68  DNPYIVRLIG-------VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
            G+ +L E+       ++     HRD  + NVLL +   A I+DFGL+            
Sbjct: 121 MGMKYLEEK-------NF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--Y 167

Query: 280 HGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYR 335
             +   +   ++ APE     INF +  F  R D+++  + +WE  S            +
Sbjct: 168 TARSAGKWPLKWYAPE----CINFRK--FSSRSDVWSYGVTMWEALSYG----------Q 211

Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEECWDH 387
            P+          + M+   V   +         P  P           L   M +CW +
Sbjct: 212 KPY----------KKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWIY 252

Query: 388 DAEAR 392
             E R
Sbjct: 253 KWEDR 257

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 45/271 (16%), Positives = 89/271 (32%), Gaps = 66/271 (24%)

Query: 144 LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTEFWLITAYHERGSLCDFL 201
           L           +I ++      N +  +          I  +         + +L D++
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQ------LCRKENLKDWM 152

Query: 202 KCNIVTWEQLCRIALS----MSKGLMHLHEE-ILPNKADSYKPAVAHRDFKSNNVLLKSD 256
                  ++   + L     +++ +  LH + ++            HRD K +N+    D
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM------------HRDLKPSNIFFTMD 200

Query: 257 LTAAIADFGLA----------LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFL 306
               + DFGL            +  P        GQVGT+ YM+PE + G  N+S     
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSH---- 255

Query: 307 RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLR-PTLP 365
           ++D+++  L+L+EL                 FS +         M+   +   +R    P
Sbjct: 256 KVDIFSLGLILFELLY--------------SFSTQ---------MERVRIITDVRNLKFP 292

Query: 366 ETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
             + Q          +++        R  A+
Sbjct: 293 LLFTQK--YPQEHMMVQDMLSPSPTERPEAT 321

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 63/305 (20%), Positives = 108/305 (35%), Gaps = 84/305 (27%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKI----FLMQDKQSWQSEQEIFKLPHM 163
            I+L     +G+FG V +  + +       VA+K          ++ +  E    +    
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR--QF 73

Query: 164 EHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMS 219
           +H +I++ IG       + TE   W+I      G L  FL+     +    L   A  +S
Sbjct: 74  DHPHIVKLIG-------VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT 279
             L +L  +        +     HRD  + NVL+ S+    + DFGL+   E        
Sbjct: 127 TALAYLESK-------RF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTY 171

Query: 280 HGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYR 335
           +     +   ++MAPE    +INF R  F    D++   + +WE+           G   
Sbjct: 172 YKASKGKLPIKWMAPE----SINFRR--FTSASDVWMFGVCMWEILMH--------GV-- 215

Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEECWDH 387
            PF          + ++   V  ++         P  P           L   M +CW +
Sbjct: 216 KPF----------QGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAY 256

Query: 388 DAEAR 392
           D   R
Sbjct: 257 DPSRR 261

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.2 bits (208), Expect = 2e-17
 Identities = 71/400 (17%), Positives = 125/400 (31%), Gaps = 79/400 (19%)

Query: 16  SKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTPIKTESHPLIIFLYTMLPIFALIIPI 75
             K      C  + C    A   +    P        T +HP           +      
Sbjct: 240 KLKADGLIYCLKEACPNSSASNASGAAAP-TLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298

Query: 76  FLCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVK-AQGRFGAVWKAKFK 134
                  R   + +     P  +P             ++ + +++   G FG+V +  ++
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYR 358

Query: 135 NEN----VAVKI----FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW 186
                  VA+K+        D +    E +I     +++  I+R IG             
Sbjct: 359 MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH--QLDNPYIVRLIGV-----CQAEALM 411

Query: 187 LITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR 244
           L+      G L  FL      +    +  +   +S G+ +L E          K  V HR
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----------KNFV-HR 460

Query: 245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFS 301
           +  + NVLL +   A I+DFGL+              +   +   ++ APE     INF 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPE----CINFR 514

Query: 302 RDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL 360
           +  F  R D+++  + +WE  S            + P+          + M+   V   +
Sbjct: 515 K--FSSRSDVWSYGVTMWEALSYG----------QKPY----------KKMKGPEVMAFI 552

Query: 361 R--------PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                    P  P           L   M +CW +  E R
Sbjct: 553 EQGKRMECPPECPP---------ELYALMSDCWIYKWEDR 583

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 33/259 (12%), Positives = 82/259 (31%), Gaps = 53/259 (20%)

Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN-------VAVK 141
            +   +P ++P        Q G + + +  +  +G F  V++A   + N         +K
Sbjct: 46  EWQCKLPAIKP----KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK 101

Query: 142 IFLMQDKQSWQSE---QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLC 198
           +   +    W+     Q + +L        +++  A            L+   +  G+L 
Sbjct: 102 V--QKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL----FQNGSVLVGELYSYGTLL 155

Query: 199 DFL-KCNIVTWEQL-----CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVL 252
           + +        + +        A+ M   +  +H+             + H D K +N +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-----------EIIHGDIKPDNFI 204

Query: 253 LKSDLTAA-----------IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
           L +                + D G ++  +          +  T  +   E+L       
Sbjct: 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN----- 259

Query: 302 RDAFLRIDMYACALVLWEL 320
           +    +ID +  A  ++ +
Sbjct: 260 KPWNYQIDYFGVAATVYCM 278

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 60/300 (20%), Positives = 119/300 (39%), Gaps = 72/300 (24%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIFLMQDKQSWQSEQEIFK----LPH 162
             + ++V   G FG V+K  +  E       VA+K   +++  S ++ +EI      +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMAS 73

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSK 220
           +++ ++ R +G       + +   LIT     G L D+++ +   +  + L    + ++K
Sbjct: 74  VDNPHVCRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +L +          +  V HRD  + NVL+K+     I DFGLA L    +     +
Sbjct: 129 GMNYLED----------RRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---KEY 174

Query: 281 GQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRL 336
              G +   ++MA E    +I      +  + D+++  + +WEL +              
Sbjct: 175 HAEGGKVPIKWMALE----SILHRI--YTHQSDVWSYGVTVWELMTF------------- 215

Query: 337 PFSAEVGDHPSLEDMQEAVVHKKL----RPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                 G  P  + +  + +   L    R   P           +   M +CW  DA++R
Sbjct: 216 ------GSKP-YDGIPASEISSILEKGERLPQPPICTI-----DVYMIMVKCWMIDADSR 263

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 37/210 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI-----FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
            G +G V   + K  +   A+KI                E  + K   ++H NI++    
Sbjct: 47  SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK--LLDHPNIMKLYDF 104

Query: 175 EKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            +   + +    L+   ++ G L D  +            I   +  G+ +LH+      
Sbjct: 105 FEDKRNYY----LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH----- 155

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                  + HRD K  N+LL+S    A   I DFGL+ +FE  K       ++GT  Y+A
Sbjct: 156 ------NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIA 206

Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           PEVL    +         D+++  ++L+ L
Sbjct: 207 PEVLRKKYDEK------CDVWSIGVILFIL 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 35/327 (10%), Positives = 85/327 (25%), Gaps = 77/327 (23%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS----EQEIFK------ 159
           R++    V  Q    A  +A  +   E+  V +    ++    +    ++E+ +      
Sbjct: 78  RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137

Query: 160 -------------------LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF 200
                              +   +   ++R    E+    +   F          +  + 
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197

Query: 201 LKCNIVTWEQL-----CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS 255
           L  +  T + L      ++ L + + L  LH              + H   +  +++L  
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-----------GLVHTYLRPVDIVLDQ 246

Query: 256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL 315
                +  F   +                     A  +L    +         D +   L
Sbjct: 247 RGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305

Query: 316 VLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQH-AGM 374
            ++ +               LP + +     +     E +   +    +P+  +    G 
Sbjct: 306 AIYWIWCA-----------DLPNTDD-----AALGGSEWIF--RSCKNIPQPVRALLEGF 347

Query: 375 LALCDTMEECWDHDAEARLSASCVVER 401
           L           +  E RL     +E 
Sbjct: 348 LR----------YPKEDRLLPLQAMET 364

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 52/230 (22%), Positives = 80/230 (34%), Gaps = 59/230 (25%)

Query: 99  PHPTSPPSPQQGCRSIQLVEVKA--------------QGRFGAVWKAKFK--NENVAVKI 142
           PH  S    QQ  R  + +   +              +G F  V +   K      A KI
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 143 FL-----MQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSL 197
                   +D Q  + E  I +   ++H NI+R   + +     +    L+      G L
Sbjct: 62  INTKKLSARDFQKLEREARICR--KLQHPNIVRLHDSIQEESFHY----LVFDLVTGGEL 115

Query: 198 CDFLKCNIVTWE--------QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSN 249
            +     IV  E           +  L     + + H              + HR+ K  
Sbjct: 116 FED----IVAREFYSEADASHCIQQILE---SIAYCHSN-----------GIVHRNLKPE 157

Query: 250 NVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           N+LL S    A   +ADFGLA+     +     HG  GT  Y++PEVL+ 
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKK 204

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 34/209 (16%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G FG V   K K   +  AVK+     + Q        +E+  L  ++H NI++     
Sbjct: 36  KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95

Query: 176 KRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
           +     +    L+   +  G L D  +     +     RI   +  G+ ++H+       
Sbjct: 96  EDKGYFY----LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN------ 145

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                 + HRD K  N+LL+S    A   I DFGL+  FE  K       ++GT  Y+AP
Sbjct: 146 -----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAP 197

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWEL 320
           EVL G  +         D+++  ++L+ L
Sbjct: 198 EVLHGTYDEK------CDVWSTGVILYIL 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 43/270 (15%), Positives = 92/270 (34%), Gaps = 69/270 (25%)

Query: 122 QGRFGAVWKAKFKNENVAVKIF----LMQDKQSW--------------QSEQEIFKLPHM 163
           QG+F  +   +  N+  A+K +    L + +                   + E+  +  +
Sbjct: 41  QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 164 EHDNILR-YIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLC-------- 212
           +++  L            I      ++I  Y E  S+  F +   V  +           
Sbjct: 101 KNEYCLTCE-------GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 213 -RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE 271
             I  S+     ++H           +  + HRD K +N+L+  +    ++DFG +    
Sbjct: 154 KCIIKSVLNSFSYIH----------NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP 331
             K      G  GT  +M PE      +++      +D+++  + L+ +           
Sbjct: 204 DKK----IKGSRGTYEFMPPEFFSNESSYNGAK---VDIWSLGICLYVMFYN-------- 248

Query: 332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLR 361
               +PFS +     SL ++   +  K + 
Sbjct: 249 ---VVPFSLK----ISLVELFNNIRTKNIE 271

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 66/306 (21%), Positives = 114/306 (37%), Gaps = 84/306 (27%)

Query: 113 SIQLVEVK-AQGRFGAVWKAKFKNEN----VAVKIFLMQDKQSWQSEQEIFK----LPHM 163
            + L + +   G FG V K  ++ +     VAVKI L  +      + E+      +  +
Sbjct: 17  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQL 75

Query: 164 EHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSK 220
           ++  I+R IG       I     + L+    E G L  +L+ N  V  + +  +   +S 
Sbjct: 76  DNPYIVRMIG-------ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 128

Query: 221 GLMHLHEE--ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           G+ +L E   +             HRD  + NVLL +   A I+DFGL+      +    
Sbjct: 129 GMKYLEESNFV-------------HRDLAARNVLLVTQHYAKISDFGLSKALRADENY-- 173

Query: 279 THGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEY 334
              Q   +   ++ APE     IN+ +  F  + D+++  +++WE  S         G  
Sbjct: 174 YKAQTHGKWPVKWYAPE----CINYYK--FSSKSDVWSFGVLMWEAFSY--------G-- 217

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKLR--------PTLPETWKQHAGMLALCDTMEECWD 386
           + P+            M+ + V   L            P           + D M  CW 
Sbjct: 218 QKPY----------RGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCWT 258

Query: 387 HDAEAR 392
           +D E R
Sbjct: 259 YDVENR 264

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 76/302 (25%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIFLMQDKQSWQSEQEIFK----LPH 162
            ++ ++V   G FG V K  +  E       V +K+  ++DK   QS Q +      +  
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGS 71

Query: 163 MEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSM 218
           ++H +I+R +G       +       L+T Y   GSL D ++ +   +  + L    + +
Sbjct: 72  LDHAHIVRLLG-------LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
           +KG+ +L E  +            HR+  + NVLLKS     +ADFG+A L  P      
Sbjct: 125 AKGMYYLEEHGM-----------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---K 170

Query: 279 THGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEY 334
                  +   ++MA E    +I+F +  +  + D+++  + +WEL +            
Sbjct: 171 QLLYSEAKTPIKWMALE----SIHFGK--YTHQSDVWSYGVTVWELMTFG---------- 214

Query: 335 RLPFSAEVGDHPSLEDMQEAVVHKKL----RPTLPETWKQHAGMLALCDTMEECWDHDAE 390
             P+            ++ A V   L    R   P+          +   M +CW  D  
Sbjct: 215 AEPY----------AGLRLAEVPDLLEKGERLAQPQICTI-----DVYMVMVKCWMIDEN 259

Query: 391 AR 392
            R
Sbjct: 260 IR 261

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.5 bits (197), Expect = 7e-17
 Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 39/190 (20%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFL-----MQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           +G F  V +   K      A KI        +D Q  + E  I +   ++H NI+R   +
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR--KLQHPNIVRLHDS 73

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEI 229
            +     +    L+      G L +     IV  E             + + + + H   
Sbjct: 74  IQEESFHY----LVFDLVTGGELFED----IVAREFYSEADASHCIQQILESIAYCHSN- 124

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTR 286
                      + HR+ K  N+LL S    A   +ADFGLA+     +     HG  GT 
Sbjct: 125 ----------GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTP 171

Query: 287 RYMAPEVLEG 296
            Y++PEVL+ 
Sbjct: 172 GYLSPEVLKK 181

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 63/320 (19%), Positives = 120/320 (37%), Gaps = 83/320 (25%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVK----IFLMQDKQSWQSEQEIFKLP 161
            I +     QG FG V++   K          VA+K       M+++  + +E  + K  
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK-- 83

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------IVTWEQ 210
                +++R +G   +G+       +I     RG L  +L+               +  +
Sbjct: 84  EFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LL 269
           + ++A  ++ G+ +L+              V HRD  + N ++  D T  I DFG+   +
Sbjct: 140 MIQMAGEIADGMAYLNA----------NKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDI 188

Query: 270 FEPGKPCGDTHGQVGTR----RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRC 324
           +E      D + + G      R+M+PE    ++      F    D+++  +VLWE+A+  
Sbjct: 189 YE-----TDYYRKGGKGLLPVRWMSPE----SLKDGV--FTTYSDVWSFGVVLWEIATLA 237

Query: 325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAGMLALCDTM 381
               P  G              S E +   V+   L  +P   P+          L + M
Sbjct: 238 E--QPYQGL-------------SNEQVLRFVMEGGLLDKPDNCPD---------MLFELM 273

Query: 382 EECWDHDAEARLSASCVVER 401
             CW ++ + R S   ++  
Sbjct: 274 RMCWQYNPKMRPSFLEIISS 293

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 7e-17
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 31/186 (16%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI-----FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           +G FG V K K +   +  AVK+        +D  +   E E+ K   ++H NI++    
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK--KLDHPNIMKLFEI 89

Query: 175 EKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
            +   S +    ++   +  G L D  +K    +     RI   +  G+ ++H+      
Sbjct: 90  LEDSSSFY----IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH----- 140

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                  + HRD K  N+LL+S        I DFGL+  F+          ++GT  Y+A
Sbjct: 141 ------NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIA 191

Query: 291 PEVLEG 296
           PEVL G
Sbjct: 192 PEVLRG 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 35/188 (18%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFL---MQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +G FG V K K +   +  AVK+      ++K +    +E+  L  ++H NI++     +
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEILP 231
              S +    ++   +  G L D     I+  ++       RI   +  G+ ++H+    
Sbjct: 92  DSSSFY----IVGELYTGGELFD----EIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140

Query: 232 NKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    + HRD K  N+LL+S   D    I DFGL+  F+      D    +GT  Y
Sbjct: 141 --------NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYY 189

Query: 289 MAPEVLEG 296
           +APEVL G
Sbjct: 190 IAPEVLRG 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 51/188 (27%), Positives = 75/188 (39%), Gaps = 37/188 (19%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFL---MQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +G +G V  A  K      A K      ++D   ++ E EI K   ++H NI+R     +
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK--SLDHPNIIRLYETFE 76

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEILP 231
               I+    L+      G L +     +V           RI   +   + + H+    
Sbjct: 77  DNTDIY----LVMELCTGGELFER----VVHKRVFRESDAARIMKDVLSAVAYCHKL--- 125

Query: 232 NKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    VAHRD K  N L  +   D    + DFGLA  F+PGK        VGT  Y
Sbjct: 126 --------NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYY 174

Query: 289 MAPEVLEG 296
           ++P+VLEG
Sbjct: 175 VSPQVLEG 182

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 40/189 (21%), Positives = 70/189 (37%), Gaps = 34/189 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
            G FG V   + +       +K           +  ++E E+ K   ++H NI++     
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK--SLDHPNIIKIFEVF 89

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEIL 230
           +   +++    ++    E G L + +       + L       +   M   L + H +  
Sbjct: 90  EDYHNMY----IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                     V H+D K  N+L +         I DFGLA LF+  +   +     GT  
Sbjct: 144 ---------HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTAL 191

Query: 288 YMAPEVLEG 296
           YMAPEV + 
Sbjct: 192 YMAPEVFKR 200

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 40/322 (12%), Positives = 85/322 (26%), Gaps = 88/322 (27%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSW----QSEQEIFK---------------- 159
           Q    A  +A  +   E+  V +    ++       Q ++E+ +                
Sbjct: 83  QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142

Query: 160 ---------LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQ 210
                    +   +   ++R    E+    +   F          +  + L  +  T + 
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202

Query: 211 L-----CRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           L      ++ L + + L  LH              + H   +  +++L       +  F 
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHY-----------GLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR------IDMYACALVLWE 319
                      G       +R +  PE+       S     R       D +A  LV++ 
Sbjct: 252 HL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQH-AGMLALC 378
           +               LP         +     E +   +    +P+  +    G L   
Sbjct: 306 IWCA-----------DLPI-----TKDAALGGSEWIF--RSCKNIPQPVRALLEGFL--- 344

Query: 379 DTMEECWDHDAEARLSASCVVE 400
                   +  E RL     +E
Sbjct: 345 -------RYPKEDRLLPLQAME 359

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 65/326 (19%), Positives = 128/326 (39%), Gaps = 88/326 (26%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIF---LMQDKQSWQSEQEIFKLP 161
           R I L     +G FG V+ A+  N +       VAVK      +  ++ +Q E E+    
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT-- 72

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----------------- 204
           +++H++I+++ G    G+ +     ++  Y + G L  FL+ +                 
Sbjct: 73  NLQHEHIVKFYGVCGDGDPL----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128

Query: 205 IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF 264
            +   Q+  IA  ++ G+++L                 HRD  + N L+ ++L   I DF
Sbjct: 129 ELGLSQMLHIASQIASGMVYLAS----QH-------FVHRDLATRNCLVGANLLVKIGDF 177

Query: 265 GLALLFEPGKPCGDTHGQVGTR-----RYMAPEVLEGAINFSRDAF-LRIDMYACALVLW 318
           G++          D + +VG       R+M PE    +I + +  F    D+++  ++LW
Sbjct: 178 GMSRDVY----STDYY-RVGGHTMLPIRWMPPE----SIMYRK--FTTESDVWSFGVILW 226

Query: 319 ELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAGML 375
           E+ +      P                 S  ++ E +   ++  RP + P+         
Sbjct: 227 EIFTYGK--QPWFQL-------------SNTEVIECITQGRVLERPRVCPK--------- 262

Query: 376 ALCDTMEECWDHDAEARLSASCVVER 401
            + D M  CW  + + RL+   + + 
Sbjct: 263 EVYDVMLGCWQREPQQRLNIKEIYKI 288

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 49/237 (20%), Positives = 98/237 (41%), Gaps = 36/237 (15%)

Query: 99  PHPTSPPSPQQGCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW-- 151
                  +     +S+   + + +  +G +G V K + K     VA+K FL  D      
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK 68

Query: 152 -QSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--CNIVTW 208
             + +EI  L  + H+N++  +   K+ +  +    L+  + +  ++ D L+   N + +
Sbjct: 69  KIAMREIKLLKQLRHENLVNLLEVCKKKKRWY----LVFEFVDH-TILDDLELFPNGLDY 123

Query: 209 EQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA 267
           + + +    +  G+   H   I+            HRD K  N+L+       + DFG A
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNII------------HRDIKPENILVSQSGVVKLCDFGFA 171

Query: 268 LLF-EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
                PG+       +V TR Y APE+L G + + +     +D++A   ++ E+   
Sbjct: 172 RTLAAPGEVY--DD-EVATRWYRAPELLVGDVKYGKA----VDVWAIGCLVTEMFMG 221

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 72/350 (20%), Positives = 121/350 (34%), Gaps = 88/350 (25%)

Query: 88  GSYFNPVPTLEPHPTSPPSPQQGCRS-IQLVEVKAQGRFGAVWKAKFKNEN-------VA 139
           GS         P   S        R  I L     +G FG V+ A+  N         VA
Sbjct: 16  GSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVA 75

Query: 140 VKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGS 196
           VK         +Q +Q E E+     ++H +I+R+ G    G  +     ++  Y   G 
Sbjct: 76  VKALKEASESARQDFQREAELLT--MLQHQHIVRFFGVCTEGRPL----LMVFEYMRHGD 129

Query: 197 LCDFLKCN----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA 240
           L  FL+ +                 +   QL  +A  ++ G+++L               
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG----LH------- 178

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTR-----RYMAPEVL 294
             HRD  + N L+   L   I DFG++  ++       D + +VG R     R+M PE +
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-----TDYY-RVGGRTMLPIRWMPPESI 232

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
                F+ ++    D+++  +VLWE+ +      P                 S  +  + 
Sbjct: 233 LYRK-FTTES----DVWSFGVVLWEIFTYGK--QPWYQL-------------SNTEAIDC 272

Query: 355 VVHKKL--RPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           +   +   RP   P           +   M  CW  + + R S   V  R
Sbjct: 273 ITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHAR 313

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 47/313 (15%), Positives = 95/313 (30%), Gaps = 92/313 (29%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN---------VAVKIF---LMQDKQSWQSEQEIFK 159
             +   E   QG F  ++K   +            V +K+         +S+     +  
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALS 217
              + H +++   G    G+       L+  + + GSL  +LK N   +       +A  
Sbjct: 68  --KLSHKHLVLNYGVCVCGDEN----ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA--------IADFGLALL 269
           ++  +  L E             + H +  + N+LL  +            ++D G+++ 
Sbjct: 122 LAAAMHFLEEN-----------TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170

Query: 270 FEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS 326
             P             +    ++ PE +E   N +       D ++    LWE+ S    
Sbjct: 171 VLPKD---------ILQERIPWVPPECIENPKNLNLAT----DKWSFGTTLWEICSG--- 214

Query: 327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL-------RPTLPETWKQHAGMLALCD 379
                           GD P L  +      +          P   E          L +
Sbjct: 215 ----------------GDKP-LSALDSQRKLQFYEDRHQLPAPKAAE----------LAN 247

Query: 380 TMEECWDHDAEAR 392
            +  C D++ + R
Sbjct: 248 LINNCMDYEPDHR 260

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.1 bits (195), Expect = 7e-16
 Identities = 58/253 (22%), Positives = 97/253 (38%), Gaps = 52/253 (20%)

Query: 90  YFNPVPTLEPHPTSPPSPQQG--CRS-IQLVEVKAQGRFGAVWKAKFKNEN-----VAVK 141
           Y   +   E    + PS +     R  I+L     +G+FG V +  + +       VA+K
Sbjct: 367 YAEIID--EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424

Query: 142 I----FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERG 195
                     ++ +  E    +    +H +I++ IG       + TE   W+I      G
Sbjct: 425 TCKNCTSDSVREKFLQEALTMR--QFDHPHIVKLIG-------VITENPVWIIMELCTLG 475

Query: 196 SLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL 253
            L  FL+     +    L   A  +S  L +L            K  V HRD  + NVL+
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLES----------KRFV-HRDIAARNVLV 524

Query: 254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR---RYMAPEVLEGAINFSRDAF-LRID 309
            S+    + DFGL+   E        +     +   ++MAPE    +INF R  F    D
Sbjct: 525 SSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAPE----SINFRR--FTSASD 574

Query: 310 MYACALVLWELAS 322
           ++   + +WE+  
Sbjct: 575 VWMFGVCMWEILM 587

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 76.9 bits (190), Expect = 8e-16
 Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 45/213 (21%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF------------LMQDKQSWQSEQEIFKLPHM-EHD 166
           +G    V +   K   +  AVKI             + + +++   E +I  L  +  H 
Sbjct: 27  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI--LRKVSGHP 84

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKG 221
           NI++     +          L+    ++G L D+    +     L      +I  ++ + 
Sbjct: 85  NIIQLKDTYETNTFFF----LVFDLMKKGELFDY----LTEKVTLSEKETRKIMRALLEV 136

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           +  LH+             + HRD K  N+LL  D+   + DFG +   +PG+   +   
Sbjct: 137 ICALHKL-----------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-- 183

Query: 282 QVGTRRYMAPEVLEGAINFSRDAF-LRIDMYAC 313
             GT  Y+APE++E ++N +   +   +DM++ 
Sbjct: 184 -CGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 48/193 (24%), Positives = 71/193 (36%), Gaps = 44/193 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFL-----MQDKQSWQSEQEIFKLPHMEHDNILRYIGA 174
           +G F  V +       +  A  I        +D Q  + E  I +   ++H NI+R   +
Sbjct: 21  KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR--LLKHPNIVRLHDS 78

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE--------QLCRIALSMSKGLMHLH 226
                  +    LI      G L +     IV  E           +  L     ++H H
Sbjct: 79  ISEEGHHY----LIFDLVTGGELFED----IVAREYYSEADASHCIQQILE---AVLHCH 127

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQV 283
           +             V HR+ K  N+LL S L  A   +ADFGLA+  E  +      G  
Sbjct: 128 QM-----------GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFA 174

Query: 284 GTRRYMAPEVLEG 296
           GT  Y++PEVL  
Sbjct: 175 GTPGYLSPEVLRK 187

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 48/214 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI----------------FLMQDKQSWQSEQEIFKLPHM 163
            G +G V   K K  +   A+K+                 + +  +   +E  + K   +
Sbjct: 46  SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK--SL 103

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCD-FLKCNIVTWEQLCRIALSMSKGL 222
           +H NI++     +  +  +    L+T ++E G L +  +  +         I   +  G+
Sbjct: 104 DHPNIIKLFDVFEDKKYFY----LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDT 279
            +LH+             + HRD K  N+LL++    L   I DFGL+  F         
Sbjct: 160 CYLHKH-----------NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--- 205

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
             ++GT  Y+APEVL+   N         D+++C
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNEK------CDVWSC 233

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK----IFLMQDKQSWQ-SEQEIFKLPHMEHDN 167
           + ++    G +GAV  A        VA+K     F  Q +   + + +E+  L HM H+N
Sbjct: 28  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHEN 85

Query: 168 ILRYIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           ++  +      E++    +F+L+  +     L   +K   +  +++  +   M KGL ++
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H       A      + HRD K  N+ +  D    I DFGLA   +         G V T
Sbjct: 145 HA------AG-----IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVT 188

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           R Y APEV+   + +++     +D+++   ++ E+ + 
Sbjct: 189 RWYRAPEVILNWMRYTQ----TVDIWSVGCIMAEMITG 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 57/222 (25%), Positives = 82/222 (36%), Gaps = 41/222 (18%)

Query: 96  TLEPHPTSPPSPQQGCRSIQLV------EVKAQGRFGAVWKA--KFKNENVAVKI----- 142
            LE  P +           +             G FG VW A  K KN+ V VK      
Sbjct: 2   ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61

Query: 143 ----FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGS 196
                 ++D +  +   EI  L  +EH NI++ +      +    +  F L+   H  G 
Sbjct: 62  VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL------DIFENQGFFQLVMEKHGSGL 115

Query: 197 -LCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK 254
            L  F+  +    E L   I   +   + +L  +            + HRD K  N+++ 
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK-----------DIIHRDIKDENIVIA 164

Query: 255 SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
            D T  + DFG A   E GK    T    GT  Y APEVL G
Sbjct: 165 EDFTIKLIDFGSAAYLERGKLF-YTF--CGTIEYCAPEVLMG 203

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 49/216 (22%), Positives = 68/216 (31%), Gaps = 31/216 (14%)

Query: 93  PVPTLEPHPTSPPSPQQGCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---- 143
             P   P     P      RS           +G F   ++       E  A KI     
Sbjct: 19  GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78

Query: 144 LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFL 201
           L++  Q  +   EI     + H +++ +                +++     R SL +  
Sbjct: 79  LLKPHQREKMSMEISIHRSLAHQHVVGFH------GFFEDNDFVFVVLELCRRRSLLELH 132

Query: 202 KCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA 260
           K      E   R     +  G  +LH              V HRD K  N+ L  DL   
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRN-----------RVIHRDLKLGNLFLNEDLEVK 181

Query: 261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           I DFGLA   E            GT  Y+APEVL  
Sbjct: 182 IGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSK 215

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 39/218 (17%), Positives = 63/218 (28%), Gaps = 46/218 (21%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE------QEIFKLPHMEHDNILRYIG 173
           QG +G V  A         A+KI      +    +       E+  +  + H NI R   
Sbjct: 36  QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
             +  + I     L+      G L D L   I      C + +  ++             
Sbjct: 96  VYEDEQYIC----LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 234 ADSYKPA------------------------------VAHRDFKSNNVLLKSDLTAA--I 261
              +                                 + HRD K  N L  ++ +    +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211

Query: 262 ADFGLALLFEPGKPCGDT--HGQVGTRRYMAPEVLEGA 297
            DFGL+  F             + GT  ++APEVL   
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 53/244 (21%), Positives = 82/244 (33%), Gaps = 57/244 (23%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---------LMQDKQSWQSEQEIFKLPHMEHDNILR 170
            G  G V  A  +   + VA++I            +   +   E EI  L  + H  I++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204

Query: 171 YIGAEKRGESIHTE-FWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMH 224
                        E ++++    E G L D     +V  ++L           M   + +
Sbjct: 205 IK------NFFDAEDYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHG 281
           LHE             + HRD K  NVLL S   D    I DFG + +            
Sbjct: 255 LHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRT 300

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
             GT  Y+APEVL        +    +D ++  ++L+   S         G    PFS  
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYN--RAVDCWSLGVILFICLS---------G--YPPFSEH 347

Query: 342 VGDH 345
               
Sbjct: 348 RTQV 351

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 55/249 (22%), Positives = 98/249 (39%), Gaps = 51/249 (20%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NILR  G  
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY- 77

Query: 176 KRGESIHTE--FWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
                 H     +LI  Y   G++   L K +    ++       ++  L + H +    
Sbjct: 78  -----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---- 128

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   V HRD K  N+LL S     IADFG ++      P        GT  Y+ PE
Sbjct: 129 -------RVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDYLPPE 177

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ 352
           ++EG      D   ++D+++  ++ +E            G  + PF     +  + ++  
Sbjct: 178 MIEGR---MHDE--KVDLWSLGVLCYEFLV---------G--KPPF-----EANTYQETY 216

Query: 353 EAVVHKKLR 361
           + +   +  
Sbjct: 217 KRISRVEFT 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 43/188 (22%), Positives = 70/188 (37%), Gaps = 38/188 (20%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
            G F  V+  K +   +  A+K           S ++E  + K   ++H+NI+       
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK--KIKHENIVTLEDIY- 75

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEILP 231
             ES  T ++L+      G L D     I+            +   +   + +LHE    
Sbjct: 76  --ES-TTHYYLVMQLVSGGELFDR----ILERGVYTEKDASLVIQQVLSAVKYLHEN--- 125

Query: 232 NKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    + HRD K  N+L  +   +    I DFGL+ + + G          GT  Y
Sbjct: 126 --------GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGY 173

Query: 289 MAPEVLEG 296
           +APEVL  
Sbjct: 174 VAPEVLAQ 181

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 73/351 (20%), Positives = 121/351 (34%), Gaps = 82/351 (23%)

Query: 82  YRQRKLGSYFNPVPTLEPHPTSPPSPQQGCRS-IQLVEVKAQGRFGAVWKAKFKNEN--- 137
            R   + + +NP        +S    ++  R  I L+     G FG V++ +        
Sbjct: 40  LRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 99

Query: 138 ----VAVK----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT 189
               VAVK    +   QD+  +  E  I       H NI+R IG   +        +++ 
Sbjct: 100 SPLQVAVKTLPEVCSEQDELDFLMEALIIS--KFNHQNIVRCIGVSLQSLPR----FILL 153

Query: 190 AYHERGSLCDFLKCN--------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV 241
                G L  FL+           +    L  +A  ++ G  +L E    N         
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE----NH-------F 202

Query: 242 AHRDFKSNNVLLK---SDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTR----RYMAPEV 293
            HRD  + N LL        A I DFG+A  ++         + + G      ++M PE 
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----AGYYRKGGCAMLPVKWMPPEA 257

Query: 294 LEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQE 353
               I F+       D ++  ++LWE+ S      P P +             S +++ E
Sbjct: 258 FMEGI-FTSKT----DTWSFGVLLWEIFSLGY--MPYPSK-------------SNQEVLE 297

Query: 354 AVVHKKL--RPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            V        P   P           +   M +CW H  E R + + ++ER
Sbjct: 298 FVTSGGRMDPPKNCPG---------PVYRIMTQCWQHQPEDRPNFAIILER 339

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 46/187 (24%), Positives = 70/187 (37%), Gaps = 37/187 (19%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFL-MQDKQSWQSEQEIFKLPHMEHDNILRYIGA-EKR 177
           +G    V++ K K   +  A+K+     DK+  ++E  +     + H NI++     E  
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL--RLSHPNIIKLKEIFETP 120

Query: 178 GESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEILPN 232
                TE  L+      G L D     IV                + + + +LHE     
Sbjct: 121 -----TEISLVLELVTGGELFDR----IVEKGYYSERDAADAVKQILEAVAYLHEN---- 167

Query: 233 KADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   + HRD K  N+L  +   D    IADFGL+ + E            GT  Y 
Sbjct: 168 -------GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV---CGTPGYC 217

Query: 290 APEVLEG 296
           APE+L G
Sbjct: 218 APEILRG 224

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 70/344 (20%), Positives = 117/344 (34%), Gaps = 82/344 (23%)

Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRS-IQLVEVKAQGRFGAVWKAKFKNEN-------VAV 140
            + NP        +S    ++  R  I L+     G FG V++ +            VAV
Sbjct: 6   HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65

Query: 141 K----IFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGS 196
           K    +   QD+  +  E  I       H NI+R IG   +        +++      G 
Sbjct: 66  KTLPEVCSEQDELDFLMEALIIS--KFNHQNIVRCIGVSLQSLPR----FILMELMAGGD 119

Query: 197 LCDFLKCN--------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS 248
           L  FL+           +    L  +A  ++ G  +L               + HRD  +
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL----------EENHFI-HRDIAA 168

Query: 249 NNVLLK---SDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTR----RYMAPEVLEGAINF 300
            N LL        A I DFG+A  ++         + + G      ++M PE     I F
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYR-----ASYYRKGGCAMLPVKWMPPEAFMEGI-F 222

Query: 301 SRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL 360
           +       D ++  ++LWE+ S      P P +             S +++ E V     
Sbjct: 223 TSKT----DTWSFGVLLWEIFSLGY--MPYPSK-------------SNQEVLEFVTSGGR 263

Query: 361 --RPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
              P   P           +   M +CW H  E R + + ++ER
Sbjct: 264 MDPPKNCPG---------PVYRIMTQCWQHQPEDRPNFAIILER 298

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.1 bits (183), Expect = 7e-15
 Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 33/211 (15%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSW---QSEQEIFKLPHMEHDNILRYIGAEK 176
           +G +G V+K + +   + VA+K FL  +        + +EI  L  ++H N++  +   +
Sbjct: 13  EGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72

Query: 177 RGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHE-EILPNK 233
           R   +H    L+  Y +  ++   L      V    +  I     + +   H+   +   
Sbjct: 73  RKRRLH----LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI--- 124

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF-EPGKPCGDTHGQVGTRRYMAPE 292
                    HRD K  N+L+       + DFG A L   P         +V TR Y +PE
Sbjct: 125 ---------HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DD-EVATRWYRSPE 172

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASR 323
           +L G   +       +D++A   V  EL S 
Sbjct: 173 LLVGDTQYGPP----VDVWAIGCVFAELLSG 199

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 43/210 (20%), Positives = 83/210 (39%), Gaps = 40/210 (19%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---------LMQDKQSWQSEQEIFKLPHM-EHDNIL 169
           +G    V +   +      AVKI             ++    + +E   L  +  H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMH 224
             I + +    +     L+     +G L D+    +     L       I  S+ + +  
Sbjct: 164 TLIDSYESSSFMF----LVFDLMRKGELFDY----LTEKVALSEKETRSIMRSLLEAVSF 215

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           LH              + HRD K  N+LL  ++   ++DFG +   EPG+   +     G
Sbjct: 216 LHAN-----------NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL---CG 261

Query: 285 TRRYMAPEVLEGAINFSRDAF-LRIDMYAC 313
           T  Y+APE+L+ +++ +   +   +D++AC
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWAC 291

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 37/185 (20%), Positives = 71/185 (38%), Gaps = 29/185 (15%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G F  V++A+       VA+K+     + +     + + E+     ++H +IL      
Sbjct: 21  KGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY--- 77

Query: 176 KRGESIHTE--FWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILP 231
                       +L+      G +  +LK      +  +       +  G+++LH     
Sbjct: 78  ---NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--- 131

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    + HRD   +N+LL  ++   IADFGLA   +   P    +   GT  Y++P
Sbjct: 132 --------GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISP 181

Query: 292 EVLEG 296
           E+   
Sbjct: 182 EIATR 186

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 41/191 (21%), Positives = 74/191 (38%), Gaps = 29/191 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFL---MQDKQSWQSEQEIFKLPHMEHDNIL 169
            + E    G FG V +   +    N A K  +     DK++ + E +   +  + H  ++
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT--MSVLRHPTLV 217

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHE 227
               A +    +     +I  +   G L + +  + N ++ ++       + KGL H+HE
Sbjct: 218 NLHDAFEDDNEMV----MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI--ADFGLALLFEPGKPCGDTHGQVGT 285
                          H D K  N++  +  +  +   DFGL    +P +    T    GT
Sbjct: 274 N-----------NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGT 319

Query: 286 RRYMAPEVLEG 296
             + APEV EG
Sbjct: 320 AEFAAPEVAEG 330

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQ-SEQEIFKLPHMEHDNILR- 170
             ++    G  G V+ A     ++ VA+K  ++ D QS + + +EI  +  ++HDNI++ 
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73

Query: 171 ---------YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG 221
                     +  +    +     +++  Y E   L + L+   +  E        + +G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRG 132

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGDTH 280
           L ++H       A+     V HRD K  N+ + + DL   I DFGLA + +P        
Sbjct: 133 LKYIH------SAN-----VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 281 -GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
              + T+ Y +P +L    N+++     IDM+A   +  E+ + 
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKA----IDMWAAGCIFAEMLTG 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 60/250 (24%), Positives = 98/250 (39%), Gaps = 53/250 (21%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILR-YIGA 174
           +G+FG V+ A+ K     +A+K+     L ++    Q  +EI    H+ H NILR Y   
Sbjct: 24  KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY--- 80

Query: 175 EKRGESIHTE--FWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
                  H     +L+  +  RG L   L K      ++       ++  L + HE    
Sbjct: 81  ----NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER--- 133

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    V HRD K  N+L+       IADFG ++      P        GT  Y+ P
Sbjct: 134 --------KVIHRDIKPENLLMGYKGELKIADFGWSVH----APSLRRRTMCGTLDYLPP 181

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDM 351
           E++EG    + D   ++D++   ++ +E            G    PF     D PS  + 
Sbjct: 182 EMIEGK---THDE--KVDLWCAGVLCYEFLV---------G--MPPF-----DSPSHTET 220

Query: 352 QEAVVHKKLR 361
              +V+  L+
Sbjct: 221 HRRIVNVDLK 230

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 40/191 (20%), Positives = 67/191 (35%), Gaps = 43/191 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEK 176
            G FG V +   K        K        DK + ++E  I  +  + H  ++    A +
Sbjct: 61  SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI--MNQLHHPKLINLHDAFE 118

Query: 177 RGESIHTEFWLITAYHERGSLCDFLKCNIVTWE---------QLCRIALSMSKGLMHLHE 227
               +     LI  +   G L D     I   +            R A     GL H+HE
Sbjct: 119 DKYEMV----LILEFLSGGELFDR----IAAEDYKMSEAEVINYMRQACE---GLKHMHE 167

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI--ADFGLALLFEPGKPCGDTHGQVGT 285
                       ++ H D K  N++ ++   +++   DFGLA    P +    T     T
Sbjct: 168 H-----------SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TAT 213

Query: 286 RRYMAPEVLEG 296
             + APE+++ 
Sbjct: 214 AEFAAPEIVDR 224

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 43/184 (23%), Positives = 64/184 (34%), Gaps = 28/184 (15%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G F   ++       E  A KI     L++  Q  +   EI     + H +++ +    
Sbjct: 25  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH--- 81

Query: 176 KRGESIHTE--FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
                       +++     R SL +  K    +T  +       +  G  +LH      
Sbjct: 82  ---GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---- 134

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   V HRD K  N+ L  DL   I DFGLA   E            GT  Y+APE
Sbjct: 135 -------RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE 185

Query: 293 VLEG 296
           VL  
Sbjct: 186 VLSK 189

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 56/237 (23%), Positives = 102/237 (43%), Gaps = 34/237 (14%)

Query: 104 PPSPQQGCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSW--QSEQ 155
                  C  +   + +    QG FG V+KA+ +   + VA+K + +  +K+ +   + +
Sbjct: 6   DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR 65

Query: 156 EIFKLPHMEHDNILRYI----GAEKRGESIHTEFWLITAY--HERGSLCDFLKCNIVTWE 209
           EI  L  ++H+N++  I                 +L+  +  H+   L   +     T  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLS 124

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL 269
           ++ R+   +  GL ++H     NK       + HRD K+ NVL+  D    +ADFGLA  
Sbjct: 125 EIKRVMQMLLNGLYYIHR----NK-------ILHRDMKAANVLITRDGVLKLADFGLARA 173

Query: 270 FEPGKPCGD---THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           F   K       T+ +V T  Y  PE+L G  ++       ID++    ++ E+ +R
Sbjct: 174 FSLAKNSQPNRYTN-RVVTLWYRPPELLLGERDYGP----PIDLWGAGCIMAEMWTR 225

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 33/188 (17%), Positives = 58/188 (30%), Gaps = 38/188 (20%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
           +G FG V +       +    K   ++       ++EI  L    H NIL    + +  E
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME 74

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWE---------QLCRIALSMSKGLMHLHEEIL 230
            +     +I  +     + +     I T                       L  LH    
Sbjct: 75  ELV----MIFEFISGLDIFER----INTSAFELNEREIVSYVHQVCE---ALQFLHSH-- 121

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAA--IADFGLALLFEPGKPCGDTHGQVGTRRY 288
                     + H D +  N++ ++  ++   I +FG A   +PG              Y
Sbjct: 122 ---------NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEY 169

Query: 289 MAPEVLEG 296
            APEV + 
Sbjct: 170 YAPEVHQH 177

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 54/244 (22%), Positives = 80/244 (32%), Gaps = 57/244 (23%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQS-----EQEIFKLPHMEHDNILR 170
            G  G V  A  +   + VA+KI                    E EI  L  + H  I++
Sbjct: 20  SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79

Query: 171 YIGAEKRGESIHTE-FWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMH 224
                        E ++++    E G L D     +V  ++L           M   + +
Sbjct: 80  IK------NFFDAEDYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHG 281
           LHE             + HRD K  NVLL S   D    I DFG + +            
Sbjct: 130 LHEN-----------GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRT 175

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
             GT  Y+APEVL        +    +D ++  ++L+   S         G    PFS  
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYN--RAVDCWSLGVILFICLS---------G--YPPFSEH 222

Query: 342 VGDH 345
               
Sbjct: 223 RTQV 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK----IFLMQDKQSWQ-SEQEIFKLPHMEHDN 167
                   G +G+V  A  K   E VA+K     F  Q +   + + +E+  L HM+H+N
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHEN 84

Query: 168 ILRYIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           ++  +       S+    +F+L+  + +   L   +     + E++  +   M KGL ++
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKF-SEEKIQYLVYQMLKGLKYI 142

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H       A      V HRD K  N+ +  D    I DFGLA   +         G V T
Sbjct: 143 HS------AG-----VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVT 186

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           R Y APEV+   +++++     +D+++   ++ E+ + 
Sbjct: 187 RWYRAPEVILSWMHYNQ----TVDIWSVGCIMAEMLTG 220

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 73/344 (21%), Positives = 124/344 (36%), Gaps = 108/344 (31%)

Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNEN----VAVKI-- 142
              NP PT+ P      +       I+  +V  +G FG V KA+ K +      A+K   
Sbjct: 10  GKNNPDPTIYPV--LDWN------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK 61

Query: 143 --FLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDF 200
                 D + +  E E+       H NI+  +GA +    +    +L   Y   G+L DF
Sbjct: 62  EYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYL----YLAIEYAPHGNLLDF 116

Query: 201 LKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAH 243
           L+ +                  ++ +QL   A  +++G+ +L          S K  + H
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL----------SQKQFI-H 165

Query: 244 RDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR------RYMAPEVLEGA 297
           RD  + N+L+  +  A IADFGL+               V         R+MA E    +
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVRWMAIE----S 212

Query: 298 INFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV 356
           +N+S   +    D+++  ++LWE+ S     +P  G                  M  A +
Sbjct: 213 LNYSV--YTTNSDVWSYGVLLWEIVSLGG--TPYCG------------------MTCAEL 250

Query: 357 HKKLR--------PTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
           ++KL             +          + D M +CW      R
Sbjct: 251 YEKLPQGYRLEKPLNCDD---------EVYDLMRQCWREKPYER 285

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 24/216 (11%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQ-SEQEIFKLPHMEHDNI-- 168
             +    +G +G V  A        VA+K I   + +   Q + +EI  L    H+NI  
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 89

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
           +  I      E +  + +++    E   L   LK   ++ + +C     + +GL ++H  
Sbjct: 90  INDIIRAPTIEQMK-DVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 146

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH-GQVGTRR 287
                A+     V HRD K +N+LL +     I DFGLA + +P           V TR 
Sbjct: 147 -----AN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           Y APE++  +  +++     ID+++   +L E+ S 
Sbjct: 197 YRAPEIMLNSKGYTK----SIDIWSVGCILAEMLSN 228

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 39/195 (20%), Positives = 72/195 (36%), Gaps = 41/195 (21%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI-----FLMQDKQSWQS-EQEIFKLPHMEHDNILRYIG 173
           +G F  V +   +   +  AVKI     F      S +  ++E      ++H +I+  + 
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL---------CRIALSMSKGLMH 224
                  ++    ++  + +   LC      IV                    + + L +
Sbjct: 94  TYSSDGMLY----MVFEFMDGADLCFE----IVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHG 281
            H+             + HRD K + VLL S   +A   +  FG+A+     +      G
Sbjct: 146 CHDN-----------NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGG 192

Query: 282 QVGTRRYMAPEVLEG 296
           +VGT  +MAPEV++ 
Sbjct: 193 RVGTPHFMAPEVVKR 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 45/192 (23%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFL---MQDKQSWQSEQEIFKLPHMEHDNILRYIGA-E 175
            GRFG V K +       +A KI     M+DK+  ++E  +  +  ++H N+++   A E
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISV--MNQLDHANLIQLYDAFE 156

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE---------QLCRIALSMSKGLMHLH 226
            +      +  L+  Y + G L D     I+               +       G+ H+H
Sbjct: 157 SK-----NDIVLVMEYVDGGELFD----RIIDESYNLTELDTILFMKQICE---GIRHMH 204

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI--ADFGLALLFEPGKPCGDTHGQVG 284
           +             + H D K  N+L  +     I   DFGLA  ++P +         G
Sbjct: 205 QM-----------YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FG 250

Query: 285 TRRYMAPEVLEG 296
           T  ++APEV+  
Sbjct: 251 TPEFLAPEVVNY 262

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 63/328 (19%), Positives = 110/328 (33%), Gaps = 85/328 (25%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKI----FLMQDKQSWQSEQEIFKLP 161
           +I+ V    +G FG V++A+            VAVK+         +  +Q E  +    
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA-- 105

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG 221
             ++ NI++ +G    G+ +     L+  Y   G L +FL+            +   ++ 
Sbjct: 106 EFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161

Query: 222 LMHLHEEILPNKADSYKPA--VA------------HRDFKSNNVLLKSDLTAAIADFGLA 267
            +        + A+    A  VA            HRD  + N L+  ++   IADFGL+
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 268 -LLFEPGKPCGDTHGQVGTR-----RYMAPEVLEGAINFSRDAFLRI-----DMYACALV 316
             ++       D + +         R+M PE +          F        D++A  +V
Sbjct: 222 RNIYS-----ADYY-KADGNDAIPIRWMPPESI----------FYNRYTTESDVWAYGVV 265

Query: 317 LWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAG 373
           LWE+ S      P  G              + E++   V    +   P   P        
Sbjct: 266 LWEIFSYGL--QPYYGM-------------AHEEVIYYVRDGNILACPENCPL------- 303

Query: 374 MLALCDTMEECWDHDAEARLSASCVVER 401
              L + M  CW      R S   +   
Sbjct: 304 --ELYNLMRLCWSKLPADRPSFCSIHRI 329

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 41/211 (19%), Positives = 66/211 (31%), Gaps = 40/211 (18%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI---FLMQDKQSWQSEQEIFKLPH-MEHDNILRYIGAE 175
           +G    V        ++  AVKI        +     E E+        H N+L  I   
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY--QCQGHRNVLELIEFF 80

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEIL 230
           +  +  +    L+      GS+      +I             +   ++  L  LH    
Sbjct: 81  EEEDRFY----LVFEKMRGGSILS----HIHKRRHFNELEASVVVQDVASALDFLHN--- 129

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQ----- 282
                     +AHRD K  N+L +         I DF L    +    C           
Sbjct: 130 --------KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
            G+  YMAPEV+E     +     R D+++ 
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQ-------EIFKLPHMEH 165
           Q +     G +G+V  A        VAVK       + +QS         E+  L HM+H
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 166 DNILRYIGAEKRGESIHT--EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM 223
           +N++  +       S+    + +L+T       L + +KC  +T + +  +   + +GL 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           ++H       AD     + HRD K +N+ +  D    I DFGLA             G V
Sbjct: 147 YIH------SAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----GYV 190

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            TR Y APE++   +++++     +D+++   ++ EL + 
Sbjct: 191 ATRWYRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLTG 226

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 60/325 (18%), Positives = 113/325 (34%), Gaps = 87/325 (26%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIF----LMQDKQSWQSEQEIFKLP 161
           +++ +E   + RFG V+K              VA+K          ++ ++ E  +    
Sbjct: 10  AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA-- 67

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----------------- 204
            ++H N++  +G   + + +     +I +Y   G L +FL                    
Sbjct: 68  RLQHPNVVCLLGVVTKDQPL----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 205 IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF 264
            +       +   ++ G+ +L               V H+D  + NVL+   L   I+D 
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSS----------HHVV-HKDLATRNVLVYDKLNVKISDL 172

Query: 265 GLALLFEPGKPCGDT-HGQVGTR---RYMAPEVLEGAINFSRDAF-LRIDMYACALVLWE 319
           GL           D       +    R+MAPE    AI + +  F +  D+++  +VLWE
Sbjct: 173 GLFREVY----AADYYKLLGNSLLPIRWMAPE----AIMYGK--FSIDSDIWSYGVVLWE 222

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAGMLA 376
           + S      P  G              S +D+ E + ++++   P   P           
Sbjct: 223 VFSYGL--QPYCGY-------------SNQDVVEMIRNRQVLPCPDDCPA---------W 258

Query: 377 LCDTMEECWDHDAEARLSASCVVER 401
           +   M ECW+     R     +  R
Sbjct: 259 VYALMIECWNEFPSRRPRFKDIHSR 283

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 69/326 (21%), Positives = 118/326 (36%), Gaps = 85/326 (26%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKI----FLMQDKQSWQSEQEIFKLP 161
            +   +    G FG V +A             VAVK+      + ++++  SE ++    
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN----------------- 204
              H NI+  +GA   G        +IT Y   G L +FL+                   
Sbjct: 84  G-NHMNIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 205 --IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA 262
              +  E L   +  ++KG+  L                 HRD  + N+LL       I 
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS----KN-------CIHRDLAARNILLTHGRITKIC 187

Query: 263 DFGLA-LLFEPGKPCGDTHGQ--VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           DFGLA  +          + +  V   ++MAPE +   + ++ ++    D+++  + LWE
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCV-YTFES----DVWSYGIFLWE 239

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLED---MQEAVVHKKLRPTL-PETWKQHAGML 375
           L S  S  SP PG   +P  ++      +++   M          P   P          
Sbjct: 240 LFSLGS--SPYPG---MPVDSKFYKM--IKEGFRML--------SPEHAPA--------- 275

Query: 376 ALCDTMEECWDHDAEARLSASCVVER 401
            + D M+ CWD D   R +   +V+ 
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIVQL 301

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 36/187 (19%), Positives = 55/187 (29%), Gaps = 34/187 (18%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
            G  G V +   +   +  A+K+  + D    + E +          +I+  +   +   
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKL--LYDSPKARQEVDHHWQ-ASGGPHIVCILDVYENMH 95

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC-------RIALSMSKGLMHLHEEILPN 232
                  +I    E G L       I               I   +   +  LH      
Sbjct: 96  HGKRCLLIIMECMEGGELFS----RIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---- 147

Query: 233 KADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   +AHRD K  N+L  S   D    + DFG A                 T  Y+
Sbjct: 148 -------NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYV 196

Query: 290 APEVLEG 296
           APEVL  
Sbjct: 197 APEVLGP 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 49/250 (19%)

Query: 92  NPVPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDK 148
           + V T+   P   P   Q   S    +V   G FG V++AK     E VA+K +   QDK
Sbjct: 35  SKVTTVVATPGQGPDRPQE-VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDK 91

Query: 149 QSWQSEQEIFKLPHMEHDNI--LRYI---GAEKRGES---IHTEFW------LITAYHER 194
           +    E +I +   ++H NI  LRY      EK+ E    +  ++       +   Y   
Sbjct: 92  RFKNRELQIMR--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149

Query: 195 GSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK 254
                 +   +  + QL R        L ++H              + HRD K  N+LL 
Sbjct: 150 KQTLPVIYVKLYMY-QLFR-------SLAYIH-----------SFGICHRDIKPQNLLLD 190

Query: 255 SDLTAA-IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
            D     + DFG A     G+P  +    + +R Y APE++ GA +++      ID+++ 
Sbjct: 191 PDTAVLKLCDFGSAKQLVRGEP--NVS-YICSRYYRAPELIFGATDYTS----SIDVWSA 243

Query: 314 ALVLWELASR 323
             VL EL   
Sbjct: 244 GCVLAELLLG 253

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 46/229 (20%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQSE-QEIFKLPHMEHDNI-- 168
           Q+  +  QG FG V   K K    +VA+K +   QD +    E Q +  L  + H NI  
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRNRELQIMQDLAVLHHPNIVQ 83

Query: 169 LRYI----GAEKRGE---SIHTEFW------LITAYHERGSLCDFLKCNIVTWEQLCRIA 215
           L+      G   R +   ++  E+           Y+ R      +   +  + QL R  
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF-QLIR-- 140

Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLALLFEPGK 274
                 +  LH   +          V HRD K +NVL+ ++D T  + DFG A    P +
Sbjct: 141 -----SIGCLHLPSV---------NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 275 PCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           P  +    + +R Y APE++ G  +++      +D+++   +  E+   
Sbjct: 187 P--NVA-YICSRYYRAPELIFGNQHYTT----AVDIWSVGCIFAEMMLG 228

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 40/187 (21%), Positives = 63/187 (33%), Gaps = 33/187 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
            G  G V +   K   E  A+K+  +QD    + E E+      +  +I+R +   +   
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWR-ASQCPHIVRIVDVYENLY 128

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC-------RIALSMSKGLMHLHEEILPN 232
           +      ++    + G L       I               I  S+ + + +LH      
Sbjct: 129 AGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---- 180

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   +AHRD K  N+L  S    A   + DFG A                 T  Y+
Sbjct: 181 -------NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYV 230

Query: 290 APEVLEG 296
           APEVL  
Sbjct: 231 APEVLGP 237

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 41/195 (21%), Positives = 65/195 (33%), Gaps = 44/195 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI---------FLMQDKQSWQSEQEIFKLPHMEHDNILR 170
            G+F  V K + K      A K               ++  + E  I  L  ++H N++ 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI--LKEIQHPNVIT 78

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHL 225
                +    +     LI      G L DF    +   E L           +  G+ +L
Sbjct: 79  LHEVYENKTDVI----LILELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYL 130

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKS----DLTAAIADFGLALLFEPGKPCGDTHG 281
           H              +AH D K  N++L           I DFGLA   + G    +   
Sbjct: 131 HSL-----------QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-- 177

Query: 282 QVGTRRYMAPEVLEG 296
             GT  ++APE++  
Sbjct: 178 -FGTPEFVAPEIVNY 191

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 41/195 (21%), Positives = 68/195 (34%), Gaps = 44/195 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---------LMQDKQSWQSEQEIFKLPHMEHDNILR 170
            G+F  V K + K   +  A K               ++  + E  I  L  + H NI+ 
Sbjct: 15  SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI--LREIRHPNIIT 72

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHL 225
                +    +     LI      G L DF    +   E L      +    +  G+ +L
Sbjct: 73  LHDIFENKTDVV----LILELVSGGELFDF----LAEKESLTEDEATQFLKQILDGVHYL 124

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKS----DLTAAIADFGLALLFEPGKPCGDTHG 281
           H +            +AH D K  N++L      +    + DFG+A   E G    +   
Sbjct: 125 HSK-----------RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-- 171

Query: 282 QVGTRRYMAPEVLEG 296
             GT  ++APE++  
Sbjct: 172 -FGTPEFVAPEIVNY 185

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 59/243 (24%), Positives = 97/243 (39%), Gaps = 42/243 (17%)

Query: 98  EPHPTSPPSPQQGCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQ-- 149
           +   +   S      SI   + +    +G +G V+KA     NE VA+K I L  +++  
Sbjct: 17  QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV 76

Query: 150 SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFL-KCNIV 206
              + +E+  L  ++H NI+           IH      LI  Y E   L  ++ K   V
Sbjct: 77  PGTAIREVSLLKELQHRNIIELK------SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV 129

Query: 207 TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA-----I 261
           +   +      +  G+   H                HRD K  N+LL     +      I
Sbjct: 130 SMRVIKSFLYQLINGVNFCH-----------SRRCLHRDLKPQNLLLSVSDASETPVLKI 178

Query: 262 ADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
            DFGLA  F  G P    TH ++ T  Y  PE+L G+ ++S      +D+++ A +  E+
Sbjct: 179 GDFGLARAF--GIPIRQFTH-EIITLWYRPPEILLGSRHYSTS----VDIWSIACIWAEM 231

Query: 321 ASR 323
             +
Sbjct: 232 LMK 234

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 29/222 (13%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQ-SEQEIFKLPHMEHDNILR 170
           QL  +  +G +G V  A  K   E VA+K I           + +EI  L H +H+NI+ 
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIIT 73

Query: 171 YIGAEK-RGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
               ++        E ++I    +   L   +   +++ + +        + +  LH   
Sbjct: 74  IFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG-- 130

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ------- 282
               ++     V HRD K +N+L+ S+    + DFGLA + +                  
Sbjct: 131 ----SN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 283 -VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            V TR Y APEV+  +  +SR     +D+++C  +L EL  R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSR----AMDVWSCGCILAELFLR 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 41/191 (21%), Positives = 68/191 (35%), Gaps = 36/191 (18%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---------LMQDKQSWQSEQEIFKLPHMEHDNILR 170
            G+F  V K + K      A K               ++  + E  I  L  + H N++ 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI--LRQVLHHNVIT 79

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
                +    +     LI      G L DFL +   ++ E+       +  G+ +LH + 
Sbjct: 80  LHDVYENRTDVV----LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK- 134

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAA----IADFGLALLFEPGKPCGDTHGQVGT 285
                      +AH D K  N++L           + DFGLA   E G    +     GT
Sbjct: 135 ----------KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI---FGT 181

Query: 286 RRYMAPEVLEG 296
             ++APE++  
Sbjct: 182 PEFVAPEIVNY 192

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 35/225 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK-NENVAVK-IFLMQDKQSWQSE-----------QEIFKLP 161
            +    + G +GAV          VA+K +F         +            +EI  L 
Sbjct: 25  TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 162 HMEHDNILRYIGAEK-RGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSM 218
           H  H NIL          E    + +L+T       L   +     +++ + +      +
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
             GL  LHE      A      V HRD    N+LL  +    I DF LA          +
Sbjct: 144 LLGLHVLHE------AG-----VVHRDLHPGNILLADNNDITICDFNLAREDTAD---AN 189

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
               V  R Y APE++     F++     +DM++   V+ E+ +R
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTK----LVDMWSAGCVMAEMFNR 230

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 66/321 (20%), Positives = 121/321 (37%), Gaps = 76/321 (23%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKI----FLMQDKQSWQSEQEIFKLP 161
            ++L +   +G FG V +A     +       VAVK+        + ++  SE +I    
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87

Query: 162 HMEHDNILRYIGA-EKRGESIHTEFWLITAYHERGSLCDFLKCN---------------- 204
              H N++  +GA  K G  +     +I  + + G+L  +L+                  
Sbjct: 88  G-HHLNVVNLLGACTKPGGPL----MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 205 -IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
             +T E L   +  ++KG+  L       K         HRD  + N+LL       I D
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLAS----RK-------CIHRDLAARNILLSEKNVVKICD 191

Query: 264 FGLA-LLFEPGKPCGDTHGQ--VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           FGLA  +++          +  +   ++MAPE +   + ++  +    D+++  ++LWE+
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPL---KWMAPETIFDRV-YTIQS----DVWSFGVLLWEI 243

Query: 321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDT 380
            S     SP PG   +    E              + +  R   P+          +  T
Sbjct: 244 FSL--GASPYPG---VKIDEEFCRR----------LKEGTRMRAPDYTTP-----EMYQT 283

Query: 381 MEECWDHDAEARLSASCVVER 401
           M +CW  +   R + S +VE 
Sbjct: 284 MLDCWHGEPSQRPTFSELVEH 304

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 71/366 (19%), Positives = 134/366 (36%), Gaps = 88/366 (24%)

Query: 77  LCYWYYRQRKLGSYFNPVPTLEPHPTSPPSPQQGC---------RSIQLVEVKAQGRFGA 127
           + Y Y ++ K    +  + + E +  +   P Q            ++Q  +    G FG 
Sbjct: 2   VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGK 61

Query: 128 VWKAKFKNEN-------VAVKI----FLMQDKQSWQSEQEIFK-LPHMEHDNILRYIGAE 175
           V +A             VAVK+        +K++  SE +I   L    H+NI+  +GA 
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--HENIVNLLGAC 119

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN---------------IVTWEQLCRIALSMSK 220
             G  +     +IT Y   G L +FL+                   +   L   +  +++
Sbjct: 120 THGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDT 279
           G+  L                 HRD  + NVLL +   A I DFGLA  +          
Sbjct: 176 GMAFLAS----KN-------CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS 339
           + ++   ++MAPE +   + ++  +    D+++  ++LWE+ S     +P PG   +  +
Sbjct: 225 NARL-PVKWMAPESIFDCV-YTVQS----DVWSYGILLWEIFSLGL--NPYPG---ILVN 273

Query: 340 AEVGDHPSLED---MQEAVVHKKLRPTL-PETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           ++      ++D   M         +P   P+          +   M+ CW  +   R + 
Sbjct: 274 SKFYKL--VKDGYQMA--------QPAFAPK---------NIYSIMQACWALEPTHRPTF 314

Query: 396 SCVVER 401
             +   
Sbjct: 315 QQICSF 320

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 39/180 (21%), Positives = 68/180 (37%), Gaps = 31/180 (17%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKI----FLMQDKQSWQSEQEIFKLP 161
           ++ L +   +G FG V KA   +         VAVK+        + +   SE  + K  
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK-- 81

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG 221
            + H ++++  GA  +   +     LI  Y + GSL  FL+ +            S +  
Sbjct: 82  QVNHPHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137

Query: 222 LMHLHEEILPNKADSYKPA--VA------------HRDFKSNNVLLKSDLTAAIADFGLA 267
            +   +E      D    A  ++            HRD  + N+L+       I+DFGL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 42/195 (21%), Positives = 65/195 (33%), Gaps = 44/195 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF---------LMQDKQSWQSEQEIFKLPHMEHDNILR 170
            G+F  V K + K      A K               ++  + E  I  L  + H NI+ 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI--LRQVLHPNIIT 79

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHL 225
                +    +     LI      G L DF    +   E L           +  G+ +L
Sbjct: 80  LHDVYENRTDVV----LILELVSGGELFDF----LAQKESLSEEEATSFIKQILDGVNYL 131

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA----IADFGLALLFEPGKPCGDTHG 281
           H +            +AH D K  N++L           + DFGLA   E G    +   
Sbjct: 132 HTK-----------KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-- 178

Query: 282 QVGTRRYMAPEVLEG 296
             GT  ++APE++  
Sbjct: 179 -FGTPEFVAPEIVNY 192

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 32/218 (14%)

Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVK----IFLMQDKQSWQ-SEQEIFKLPHMEHDN 167
           Q ++    G  G V  A     + NVA+K     F  Q++   + + +E+  +  + H N
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKN 122

Query: 168 I--LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I  L  +   ++      + +L+    +  +LC  ++  +   E++  +   M  G+ HL
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHL 180

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H       A      + HRD K +N+++KSD T  I DFGLA               V T
Sbjct: 181 H------SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVT 226

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           R Y APEV+             +D+++   ++ E+   
Sbjct: 227 RYYRAPEVI-----LGMGYKENVDIWSVGCIMGEMVRH 259

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 48/225 (21%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILR 170
             ++   +G +  V+K K K  +  VA+K   ++ ++     + +E+  L  ++H NI+ 
Sbjct: 5   IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 171 YIGAEKRGESIHTE--FWLITAYHE-------RGSLCDFLKCNIVTW-EQLCRIALSMSK 220
                   + IHTE    L+  Y +                 N+  +  QL R       
Sbjct: 65  LH------DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR------- 111

Query: 221 GLMHLHEE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD- 278
           GL + H + +L            HRD K  N+L+       +ADFGLA       P    
Sbjct: 112 GLAYCHRQKVL------------HRDLKPQNLLINERGELKLADFGLARAK--SIPTKTY 157

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            + +V T  Y  P++L G+ ++S      IDM+    + +E+A+ 
Sbjct: 158 DN-EVVTLWYRPPDILLGSTDYSTQ----IDMWGVGCIFYEMATG 197

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 67/325 (20%), Positives = 121/325 (37%), Gaps = 84/325 (25%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN---------VAVKI----FLMQDKQSWQSEQEIFK 159
            + L +   +G FG V  A+    +         VAVK+       +D     SE E+ K
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141

Query: 160 -LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-------------- 204
            +    H NI+  +GA  +   +    ++I  Y  +G+L ++L+                
Sbjct: 142 MIGK--HKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 205 ---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
               +T++ L      +++G+ +L       K         HRD  + NVL+  +    I
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLAS----QK-------CIHRDLAARNVLVTENNVMKI 244

Query: 262 ADFGLA-LLFEPGKPCGDT-HGQVGTR---RYMAPEVLEGAINFSRDAFLRIDMYACALV 316
           ADFGLA  +        D        R   ++MAPE L   + ++  +    D+++  ++
Sbjct: 245 ADFGLARDINN-----IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQS----DVWSFGVL 294

Query: 317 LWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLA 376
           +WE+ +     SP PG               +E++ + +     R   P           
Sbjct: 295 MWEIFTL--GGSPYPGI-------------PVEELFKLLKEGH-RMDKPANCTN-----E 333

Query: 377 LCDTMEECWDHDAEARLSASCVVER 401
           L   M +CW      R +   +VE 
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVED 358

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 44/185 (23%), Positives = 62/185 (33%), Gaps = 32/185 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
           +G F    K   K  N+  AVKI   + + + Q E    KL    H NI++         
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKL-CEGHPNIVKLHEVFHDQL 79

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIV-----TWEQLCRIALSMSKGLMHLHEEILPNKA 234
                  L+      G L +     I      +  +   I   +   + H+H+       
Sbjct: 80  HTF----LVMELLNGGELFE----RIKKKKHFSETEASYIMRKLVSAVSHMHDV------ 125

Query: 235 DSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                 V HRD K  N+L      +L   I DFG A L  P            T  Y AP
Sbjct: 126 -----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAP 178

Query: 292 EVLEG 296
           E+L  
Sbjct: 179 ELLNQ 183

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 50/245 (20%)

Query: 98  EPHPTSPPSPQQGCRSI----QLVEVKAQGRFGAVWKAKFK-NENVAVK-IFLMQDKQ-- 149
             H  S        + +    Q +E   +G +G V+KAK      VA+K I L  + +  
Sbjct: 3   HHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI 62

Query: 150 SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHE-------RGSLCDF 200
              + +EI  L  + H NI+  I      + IH+E    L+  + E         +    
Sbjct: 63  PSTAIREISLLKELHHPNIVSLI------DVIHSERCLTLVFEFMEKDLKKVLDENKTGL 116

Query: 201 LKCNIVTW-EQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA 259
               I  +  QL R       G+ H H+    ++       + HRD K  N+L+ SD   
Sbjct: 117 QDSQIKIYLYQLLR-------GVAHCHQ----HR-------ILHRDLKPQNLLINSDGAL 158

Query: 260 AIADFGLALLFEPGKPCGD-THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW 318
            +ADFGLA  F  G P    TH +V T  Y AP+VL G+  +S      +D+++   +  
Sbjct: 159 KLADFGLARAF--GIPVRSYTH-EVVTLWYRAPDVLMGSKKYSTS----VDIWSIGCIFA 211

Query: 319 ELASR 323
           E+ + 
Sbjct: 212 EMITG 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 32/218 (14%)

Query: 115 QLVEVKAQGRFGAVWKA--KFKNENVAVK----IFLMQDKQSWQ-SEQEIFKLPHMEHDN 167
           Q ++    G  G V  A       NVA+K     F  Q++   + + +E+  +  + H N
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKN 85

Query: 168 I--LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           I  L  +   ++      + +++    +  +LC  ++  +   E++  +   M  G+ HL
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMEL-DHERMSYLLYQMLCGIKHL 143

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H       A      + HRD K +N+++KSD T  I DFGLA               V T
Sbjct: 144 H------SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVT 189

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           R Y APEV+             +D+++   ++ E+   
Sbjct: 190 RYYRAPEVI-----LGMGYKENVDIWSVGCIMGEMIKG 222

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.4 bits (163), Expect = 3e-12
 Identities = 52/238 (21%), Positives = 87/238 (36%), Gaps = 50/238 (21%)

Query: 110 GCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQS-------EQE 156
           G  +    + V     G +G V+KA+       VA+K + +                E  
Sbjct: 4   GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63

Query: 157 IFK-LPHMEHDNILR----YIGAEKRGESIHTEFWLITAYHER--GSLCDFLKCNIVTWE 209
           + + L   EH N++R       +    E    +  L+  + ++   +  D      +  E
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDRE---IKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL 269
            +  +     +GL  LH     N        + HRD K  N+L+ S  T  +ADFGLA +
Sbjct: 121 TIKDLMRQFLRGLDFLHA----NC-------IVHRDLKPENILVTSGGTVKLADFGLARI 169

Query: 270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR----IDMYACALVLWELASR 323
           +        T   V T  Y APEVL  +              +DM++   +  E+  R
Sbjct: 170 Y--SYQMALTP-VVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRR 215

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 74/345 (21%), Positives = 133/345 (38%), Gaps = 86/345 (24%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN---------VAVKI----FLMQDKQSWQSEQEIFK 159
            + L +   +G FG V  A+    +         VAVK+       +D     SE E+ K
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129

Query: 160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--------------- 204
           +   +H NI+  +GA  +   +    ++I  Y  +G+L ++L+                 
Sbjct: 130 MIG-KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 205 --IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA 262
              ++ + L   A  +++G+ +L       K         HRD  + NVL+  D    IA
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLAS----KK-------CIHRDLAARNVLVTEDNVMKIA 233

Query: 263 DFGLA-LLFEPGKPCGDTHGQ--VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           DFGLA  +         T+G+  V   ++MAPE L   I ++  +    D+++  ++LWE
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPV---KWMAPEALFDRI-YTHQS----DVWSFGVLLWE 285

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL--RPTL-PETWKQHAGMLA 376
           + +     SP PG               +E++ + +       +P+              
Sbjct: 286 IFTLGG--SPYPGV-------------PVEELFKLLKEGHRMDKPSNCTN---------E 321

Query: 377 LCDTMEECWDHDAEARLSASCVVER--GMLALCDTMEECWDHDAE 419
           L   M +CW      R +   +VE    ++AL    E  + H   
Sbjct: 322 LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHH 366

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 44/187 (23%), Positives = 69/187 (36%), Gaps = 36/187 (19%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRG 178
            G +    +   K  N   AVKI    DK      +EI  L    +H NI+        G
Sbjct: 32  VGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG 88

Query: 179 ESIHTEFWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLHEEILPNK 233
           + ++    ++T   + G L D     I+  +         +  +++K + +LH +     
Sbjct: 89  KYVY----VVTELMKGGELLDK----ILRQKFFSEREASAVLFTITKTVEYLHAQ----- 135

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAA----IADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                  V HRD K +N+L   +        I DFG A         G       T  ++
Sbjct: 136 ------GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFV 187

Query: 290 APEVLEG 296
           APEVLE 
Sbjct: 188 APEVLER 194

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 36/190 (18%), Positives = 64/190 (33%), Gaps = 36/190 (18%)

Query: 122 QGRFGAVWKAKFK--NENVAVKI-----FLMQDKQSWQSEQEIFK-LPHMEHDNILRYIG 173
           +G+F  V +   K   +  A K           +     E  + +         ++    
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS--CPRVINLHE 96

Query: 174 A-EKRGESIHTEFWLITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
             E       +E  LI  Y   G +          +V+   + R+   + +G+ +LH+  
Sbjct: 97  VYENT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---IADFGLALLFEPGKPCGDTHGQVGTR 286
                      + H D K  N+LL S        I DFG++          +    +GT 
Sbjct: 151 ----------NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI---MGTP 197

Query: 287 RYMAPEVLEG 296
            Y+APE+L  
Sbjct: 198 EYLAPEILNY 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 46/244 (18%)

Query: 105 PSPQQGCRSIQLVEVK----AQGRFGAVWKAKFK----NENVAVKIFLMQDKQSWQSEQE 156
               +  R   L E +     +G +G V+KAK K    +++ A+K        S  + +E
Sbjct: 10  KLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACRE 68

Query: 157 IFKLPHMEHDNI--LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRI 214
           I  L  ++H N+  L+ +        +    WL+  Y E   L   +K +  +      +
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKV----WLLFDYAEH-DLWHIIKFHRASKANKKPV 123

Query: 215 ALSMS----------KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA---- 260
            L              G+ +LH     N        V HRD K  N+L+  +        
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHA----NW-------VLHRDLKPANILVMGEGPERGRVK 172

Query: 261 IADFGLALLF-EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
           IAD G A LF  P KP  D    V T  Y APE+L GA ++++     ID++A   +  E
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA----IDIWAIGCIFAE 228

Query: 320 LASR 323
           L + 
Sbjct: 229 LLTS 232

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 63/227 (27%)

Query: 122 QGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES 180
            G FG V++AK    + VA+K  L QDK+    E +I +   ++H N++           
Sbjct: 50  NGSFGVVFQAKLVESDEVAIKKVL-QDKRFKNRELQIMR--IVKHPNVVD---------- 96

Query: 181 IHTEFWLITAYHERGSLCDFLKCNIVT---WEQLCRIALSMSK----------------- 220
                 L   ++  G   D +  N+V     E + R +   +K                 
Sbjct: 97  ------LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 221 --GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA--IADFGLALLFEPGKPC 276
              L ++H              + HRD K  N+LL    +    + DFG A +   G+P 
Sbjct: 151 LRSLAYIH-----------SIGICHRDIKPQNLLLDPP-SGVLKLIDFGSAKILIAGEP- 197

Query: 277 GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            +    + +R Y APE++ GA N++      ID+++   V+ EL   
Sbjct: 198 -NVS-YICSRYYRAPELIFGATNYTT----NIDIWSTGCVMAELMQG 238

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 69/327 (21%), Positives = 122/327 (37%), Gaps = 88/327 (26%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN---------VAVKI----FLMQDKQSWQSEQEIFK 159
            + L +   +G FG V  A+    +         VAVK+       +D     SE E+ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95

Query: 160 -LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-------------- 204
            +    H NI+  +GA  +   +    ++I  Y  +G+L ++L+                
Sbjct: 96  MIGK--HKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 205 ---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI 261
               +T++ L      +++G+ +L       K         HRD  + NVL+  +    I
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLAS----QK-------CIHRDLAARNVLVTENNVMKI 198

Query: 262 ADFGLA-LLFEPGKPCGDTHGQ--VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW 318
           ADFGLA  +         T+G+  V   ++MAPE L   + ++  +    D+++  +++W
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPV---KWMAPEALFDRV-YTHQS----DVWSFGVLMW 250

Query: 319 ELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL----RPTLPETWKQHAGM 374
           E+ +     SP PG                  +    + K L    R   P         
Sbjct: 251 EIFTLGG--SPYPG------------------IPVEELFKLLKEGHRMDKPANCTN---- 286

Query: 375 LALCDTMEECWDHDAEARLSASCVVER 401
             L   M +CW      R +   +VE 
Sbjct: 287 -ELYMMMRDCWHAVPSQRPTFKQLVED 312

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 42/190 (22%)

Query: 122 QGRFGAVWKAK--FKNENVAVKI-----FLMQDKQSWQSEQEIFKLPHMEHDNILR-YIG 173
           +G F  V  A+       VA+KI           Q    E  I K+  + H NI++ +  
Sbjct: 25  KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI--LNHPNIVKLF-- 80

Query: 174 AEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQL-----CRIALSMSKGLMHLH 226
                E I TE   +LI  Y   G + D+    +V   ++           +   + + H
Sbjct: 81  -----EVIETEKTLYLIMEYASGGEVFDY----LVAHGRMKEKEARSKFRQIVSAVQYCH 131

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
           ++            + HRD K+ N+LL +D+   IADFG +  F  G          G  
Sbjct: 132 QK-----------RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAP 177

Query: 287 RYMAPEVLEG 296
            Y APE+ +G
Sbjct: 178 PYAAPELFQG 187

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 65.2 bits (160), Expect = 5e-12
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 48/218 (22%)

Query: 122 QGRFGAVWKAKFK-NENVAVK-IFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKR 177
           +G +G V+KA+    E  A+K I L ++ +     + +EI  L  ++H NI++       
Sbjct: 12  EGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY----- 66

Query: 178 GESIHTE--FWLITAYHE-------RGSLCDFLKCNIVTW-EQLCRIALSMSKGLMHLHE 227
            + IHT+    L+  + +                    ++  QL         G+ + H+
Sbjct: 67  -DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAYCHD 118

Query: 228 E-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVGT 285
             +L            HRD K  N+L+  +    IADFGLA  F  G P    TH ++ T
Sbjct: 119 RRVL------------HRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTH-EIVT 163

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             Y AP+VL G+  +S      ID+++   +  E+ + 
Sbjct: 164 LWYRAPDVLMGSKKYSTT----IDIWSVGCIFAEMVNG 197

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 71/336 (21%), Positives = 119/336 (35%), Gaps = 100/336 (29%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-------VAVKI----FLMQDKQSWQSEQEIFKLP 161
           +++  +V   G FG V  A     +       VAVK+        ++++  SE ++    
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK------------------- 202
              H+NI+  +GA      I    +LI  Y   G L ++L+                   
Sbjct: 106 G-SHENIVNLLGACTLSGPI----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 203 -----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL 257
                 N++T+E L   A  ++KG+  L                 HRD  + NVL+    
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF----KS-------CVHRDLAARNVLVTHGK 209

Query: 258 TAAIADFGLA-LLFEPGKPCGDTHGQ--VGTRRYMAPEVLEGAINFSRDAFLRI-----D 309
              I DFGLA  +          + +  V   ++MAPE L          F  I     D
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPV---KWMAPESL----------FEGIYTIKSD 256

Query: 310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED---MQEAVVHKKLRPTL-P 365
           +++  ++LWE+ S     +P PG   +P  A       +++   M         +P    
Sbjct: 257 VWSYGILLWEIFSLGV--NPYPG---IPVDANFYKL--IQNGFKMD--------QPFYAT 301

Query: 366 ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           E          +   M+ CW  D+  R S   +   
Sbjct: 302 E---------EIYIIMQSCWAFDSRKRPSFPNLTSF 328

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 53/223 (23%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKR 177
            G +  V+K   K     VA+K   +  ++     + +EI  +  ++H+NI+R       
Sbjct: 15  NGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY----- 69

Query: 178 GESIHT--------EF------WLITAYHERGSLCDFLKCNIVTW-EQLCRIALSMSKGL 222
            + IHT        EF        + +     +        +  +  QL +       GL
Sbjct: 70  -DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ-------GL 121

Query: 223 MHLHEE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-TH 280
              HE  IL            HRD K  N+L+       + DFGLA  F  G P    + 
Sbjct: 122 AFCHENKIL------------HRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSS 167

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            +V T  Y AP+VL G+  +S      ID+++C  +L E+ + 
Sbjct: 168 -EVVTLWYRAPDVLMGSRTYSTS----IDIWSCGCILAEMITG 205

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 58/225 (25%)

Query: 122 QGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQ-----SEQEIFKLPHMEHDNILRYIG 173
           +G+F  V+KA+ K  N+ VA+K I L    ++       + +EI  L  + H NI+    
Sbjct: 20  EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG--- 76

Query: 174 AEKRGESIHTEFWLITAYHERGSLC---DFLKCNIVTWEQLCRIALSMS----------K 220
                        L+ A+  + ++    DF++ ++    +   + L+ S          +
Sbjct: 77  -------------LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 221 GLMHLHEE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD- 278
           GL +LH+  IL            HRD K NN+LL  +    +ADFGLA  F  G P    
Sbjct: 124 GLEYLHQHWIL------------HRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAY 169

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           TH QV TR Y APE+L GA  +       +DM+A   +L EL  R
Sbjct: 170 TH-QVVTRWYRAPELLFGARMYGVG----VDMWAVGCILAELLLR 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 49/219 (22%)

Query: 122 QGRFGAVWKAKFK--NENVAVK-IFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEK 176
           +G +G V+KAK +  +E VA+K + L  D +     + +EI  L  ++H NI+R      
Sbjct: 12  EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH---- 67

Query: 177 RGESIHTE--FWLITAYHE-------RGSLCDFLKCNIVTW-EQLCRIALSMSKGLMHLH 226
             + +H++    L+  + +            D     + ++  QL +       GL   H
Sbjct: 68  --DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK-------GLGFCH 118

Query: 227 EE-ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-THGQVG 284
              +L            HRD K  N+L+  +    +A+FGLA  F  G P    +  +V 
Sbjct: 119 SRNVL------------HRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSA-EVV 163

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           T  Y  P+VL GA  +S      IDM++   +  ELA+ 
Sbjct: 164 TLWYRPPDVLFGAKLYSTS----IDMWSAGCIFAELANA 198

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 36/264 (13%), Positives = 71/264 (26%), Gaps = 55/264 (20%)

Query: 115 QLVEVKAQGRFGAVWKAK---FKNENVAVKIFLMQDKQSWQSEQEIFK-----LPHMEHD 166
           ++    A G  G ++ A         V +K  +          Q +       L  + H 
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE---AQAMAMAERQFLAEVVHP 139

Query: 167 NILR-YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL 225
           +I++ +   E          +++  Y    SL       +    +     L +   L +L
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL-PVAEAIAYLLEILPALSYL 198

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H              + + D K  N++L  +    + D G                  GT
Sbjct: 199 HSI-----------GLVYNDLKPENIMLTEE-QLKLIDLGAV------SRINSFGYLYGT 240

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
             + APE++           +  D+Y     L  L                  +    D 
Sbjct: 241 PGFQAPEIVRTG------PTVATDIYTVGRTLAALTLD-----------LPTRNGRYVDG 283

Query: 346 -------PSLEDMQEAVVHKKLRP 362
                      D    ++ + + P
Sbjct: 284 LPEDDPVLKTYDSYGRLLRRAIDP 307

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 55/242 (22%), Positives = 92/242 (38%), Gaps = 60/242 (24%)

Query: 110 GCRSI---QLVEVKAQGRFGAVWKA---KFKNENVAVKIFLMQDKQSWQSEQEIF----- 158
            CR+    + V    +G +G V+KA   K     VA+K   +Q      + +E       
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTI 59

Query: 159 -------KLPHMEHDNILR----YIGAEKRGESIHTEFWLITAYHER--GSLCDFLKCNI 205
                   L   EH N++R       +    E   T+  L+  + ++   +  D +    
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRE---TKLTLVFEHVDQDLTTYLDKVPEPG 116

Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           V  E +  +   + +GL  LH     ++       V HRD K  N+L+ S     +ADFG
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS----HR-------VVHRDLKPQNILVTSSGQIKLADFG 165

Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR----IDMYACALVLWELA 321
           LA ++        T   V T  Y APEVL  +              +D+++   +  E+ 
Sbjct: 166 LARIY--SFQMALTS-VVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMF 213

Query: 322 SR 323
            R
Sbjct: 214 RR 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G +G V  A  +   E VAVKI      +   ++ + E  I K+  + H+N++++    
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM--LNHENVVKFY--- 71

Query: 176 KRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCR------IALSMSKGLMHLHE 227
                       +L   Y   G L D ++ +I   E   +      +A     G+++LH 
Sbjct: 72  ---GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLH- 122

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K  N+LL       I+DFGLA +F         +   GT  
Sbjct: 123 ----------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 288 YMAPEVLEG 296
           Y+APE+L+ 
Sbjct: 173 YVAPELLKR 181

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 46/242 (19%), Positives = 81/242 (33%), Gaps = 46/242 (19%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQSEQEIFKLPHMEHDNI--L 169
            L +    G FG V +       +  A+K +   QD +    E +I K   ++H NI  L
Sbjct: 10  SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--QDPRYKNRELDIMK--VLDHVNIIKL 65

Query: 170 RYI--------------GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVT---WEQLC 212
                              +                    +       N++     + L 
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125

Query: 213 RIALSMSKGLMHLHEE--------ILPNKADSY--KPAVAHRDFKSNNVLL-KSDLTAAI 261
           ++  S  +    +           +   +A  +     + HRD K  N+L+   D T  +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF--RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA 321
            DFG A    P +P       + +R Y APE++ GA  ++      ID+++   V  EL 
Sbjct: 184 CDFGSAKKLIPSEP--SVA-YICSRFYRAPELMLGATEYTP----SIDLWSIGCVFGELI 236

Query: 322 SR 323
             
Sbjct: 237 LG 238

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 42/204 (20%), Positives = 77/204 (37%), Gaps = 44/204 (21%)

Query: 122 QGRFGAVWKAK--FKNENVAVKIF----LMQDKQSWQS---------------------- 153
           +G +G V  A     N   A+K+     L++     +                       
Sbjct: 23  KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82

Query: 154 -EQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC 212
             QEI  L  ++H N+++ +  E   +      +++     +G + +      ++ +Q  
Sbjct: 83  VYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 213 RIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP 272
                + KG+ +LH +            + HRD K +N+L+  D    IADFG++  F+ 
Sbjct: 141 FYFQDLIKGIEYLHYQ-----------KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 273 GKPCGDTHGQVGTRRYMAPEVLEG 296
                     VGT  +MAPE L  
Sbjct: 190 SD--ALLSNTVGTPAFMAPESLSE 211

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE 175
           +G +G V  A  +   E VAVKI      +   ++ + E  I K+  + H+N++++    
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM--LNHENVVKFY--- 71

Query: 176 KRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCR------IALSMSKGLMHLHE 227
                       +L   Y   G L D ++ +I   E   +      +A     G+++LH 
Sbjct: 72  ---GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLH- 122

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K  N+LL       I+DFGLA +F         +   GT  
Sbjct: 123 ----------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 288 YMAPEVLEG 296
           Y+APE+L+ 
Sbjct: 173 YVAPELLKR 181

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 45/233 (19%), Positives = 70/233 (30%), Gaps = 46/233 (19%)

Query: 89  SYFNPVPTLEPHPTSPPSPQQGCRSI-------QLVEVKAQGRFGAVWKAK--FKNENVA 139
           S         P P   P+P  G +         +L  +  +G FG V+          VA
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60

Query: 140 VKI---------FLMQDKQSWQSEQEIFKL--PHMEHDNILRYIGAEKRGESIHTE--FW 186
           +K+           + D  +   E  +         H  ++R +      +   T+  F 
Sbjct: 61  IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL------DWFETQEGFM 114

Query: 187 LITAYHERGS-LCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHR 244
           L+         L D++       E   R     +   + H H              V HR
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR-----------GVVHR 163

Query: 245 DFKSNNVLLKSD-LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           D K  N+L+      A + DFG   L              GTR Y  PE +  
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISR 212

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 56/220 (25%), Positives = 80/220 (36%), Gaps = 56/220 (25%)

Query: 101 PTSPPSPQQGCRSI---QLVEVKAQGRFGAVWKAK--FKNENVAVKIF----LMQDKQSW 151
           P +      G   I    L +    G FG V   K       VAVKI     +       
Sbjct: 2   PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG 61

Query: 152 QSEQEIFKLPHMEHDNILR-YIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTW 208
           +  +EI  L    H +I++ Y       + I T    +++  Y   G L D++       
Sbjct: 62  KIRREIQNLKLFRHPHIIKLY-------QVISTPSDIFMVMEYVSGGELFDYI------- 107

Query: 209 EQLCRIALSMSKGLMHLHE------EILPNKADSY--KPAVAHRDFKSNNVLLKSDLTAA 260
                       G +   E      +IL      Y  +  V HRD K  NVLL + + A 
Sbjct: 108 ---------CKNGRLDEKESRRLFQQIL--SGVDYCHRHMVVHRDLKPENVLLDAHMNAK 156

Query: 261 IADFGLALLFEPGKP----CGDTHGQVGTRRYMAPEVLEG 296
           IADFGL+ +   G+     CG  +       Y APEV+ G
Sbjct: 157 IADFGLSNMMSDGEFLRTSCGSPN-------YAAPEVISG 189

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 27/76 (35%), Positives = 36/76 (47%), Gaps = 14/76 (18%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL  LH E            + +RD K  N+LL       I+D GLA+    G+      
Sbjct: 298 GLEDLHRE-----------RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IK 343

Query: 281 GQVGTRRYMAPEVLEG 296
           G+VGT  YMAPEV++ 
Sbjct: 344 GRVGTVGYMAPEVVKN 359

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 36/141 (25%), Positives = 52/141 (36%), Gaps = 32/141 (22%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL H+H              V +RD K  N+LL       I+D GLA  F   K     H
Sbjct: 304 GLEHMHNR-----------FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 348

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
             VGT  YMAPEVL+  + +   A    D ++   +L++L           G    PF  
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLR---------G--HSPFRQ 393

Query: 341 EVGDHPSLEDMQEAVVHKKLR 361
                    ++    +   + 
Sbjct: 394 HKTK--DKHEIDRMTLTMAVE 412

>4fao_E Activin receptor type-2B; TGF-beta, CTK, cystine knot, extracellular domain, signaling protein-signaling protein complex; HET: NAG; 3.36A {Homo sapiens} Length = 124

 Score = 56.4 bits (135), Expect = 5e-10
 Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 2/50 (4%)

Query: 1   MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPLPPPINSTTP 50
             CYD+ +CV         + FCCCEG+ CN+ F   P    P +    P
Sbjct: 66  FNCYDRQECVATEE--NPQVYFCCCEGNFCNERFTHLPEAGGPEVTYEPP 113

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 59.1 bits (144), Expect = 5e-10
 Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 49/194 (25%)

Query: 122 QGRFGAVWKAK--FKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILR-YIGA 174
            G FG V   +       VAVKI     +       + ++EI  L    H +I++ Y   
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY--- 77

Query: 175 EKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCR------IALSMSKGLMHLH 226
               + I T   F+++  Y   G L D++  +    E   R      ++      + + H
Sbjct: 78  ----QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AVDYCH 128

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP----CGDTHGQ 282
                      +  V HRD K  NVLL + + A IADFGL+ +   G+     CG  +  
Sbjct: 129 -----------RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-- 175

Query: 283 VGTRRYMAPEVLEG 296
                Y APEV+ G
Sbjct: 176 -----YAAPEVISG 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 55/250 (22%), Positives = 92/250 (36%), Gaps = 47/250 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK----IFLMQDKQSWQ-SEQEIFKLPHMEHDN 167
            +  +  +G +G V+ A  K   +NVA+K    +F  +D    +   +EI  L  ++ D 
Sbjct: 29  IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDY 86

Query: 168 ILRYIGAEK-RGESIHTEFWLITAYHERGSLCDFLKCNIV-TWEQLCRIALSMSKGLMHL 225
           I+R              E +++    +   L    K  I  T E +  I  ++  G   +
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ--- 282
           HE      +      + HRD K  N LL  D +  + DFGLA      K     +     
Sbjct: 146 HE------SG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 283 -----------------VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
                            V TR Y APE++    N+++     ID+++   +  EL +   
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS----IDIWSTGCIFAELLNMLQ 250

Query: 326 SVSPPPGEYR 335
           S    P    
Sbjct: 251 SHINDPTNRF 260

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 57/241 (23%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK----IFLMQDKQSWQ-SEQEIFKLPHM-EHD 166
           +LV+   +G +G VWK+  +   E VAVK     F  Q+    Q + +EI  L  +  H+
Sbjct: 12  ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHE 69

Query: 167 NILRYIGAEKRGESIHT-----EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG 221
           NI+  +       ++       + +L+  Y E   L   ++ NI+       +   + K 
Sbjct: 70  NIVNLL-------NVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKV 121

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           + +LH              + HRD K +N+LL ++    +ADFGL+  F   +   +   
Sbjct: 122 IKYLHS------GG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 282 Q-------------------VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS 322
                               V TR Y APE+L G+  +++     IDM++   +L E+  
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG----IDMWSLGCILGEILC 226

Query: 323 R 323
            
Sbjct: 227 G 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 50/216 (23%), Positives = 67/216 (31%), Gaps = 44/216 (20%)

Query: 98  EPHPTSPPSPQQGCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQ 152
               T+ P              V+    G FG     + K   E VAVK           
Sbjct: 3   RAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN 62

Query: 153 SEQEIFKLPHMEHDNILRYIGAEKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQ 210
            ++EI     + H NI+R+       E I T     +I  Y   G L + +         
Sbjct: 63  VQREIINHRSLRHPNIVRFK------EVILTPTHLAIIMEYASGGELYERI--------- 107

Query: 211 LCRIALSMSKGLMHLHE------EILPNKADSY--KPAVAHRDFKSNNVLLKSDLTAA-- 260
                   + G     E      ++L     SY     + HRD K  N LL         
Sbjct: 108 -------CNAGRFSEDEARFFFQQLL--SGVSYCHSMQICHRDLKLENTLLDGSPAPRLK 158

Query: 261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           I DFG +               VGT  Y+APEVL  
Sbjct: 159 ICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLR 191

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 29/76 (38%), Positives = 38/76 (50%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL HLH+             + +RD K  NVLL  D    I+D GLA+  + G+    T 
Sbjct: 301 GLEHLHQR-----------NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTK 347

Query: 281 GQVGTRRYMAPEVLEG 296
           G  GT  +MAPE+L G
Sbjct: 348 GYAGTPGFMAPELLLG 363

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 31/129 (24%), Positives = 54/129 (41%), Gaps = 24/129 (18%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFS 301
           HRD K  N+++ +     + DFG+A  + + G     T   +GT +Y++PE   G     
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG----- 193

Query: 302 RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP---SLEDMQEAVVH- 357
                R D+Y+   VL+E+ +         G    PF+   GD P   + + ++E  +  
Sbjct: 194 DSVDARSDVYSLGCVLYEVLT---------G--EPPFT---GDSPVSVAYQHVREDPIPP 239

Query: 358 KKLRPTLPE 366
                 L  
Sbjct: 240 SARHEGLSA 248

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 51/196 (26%), Positives = 77/196 (39%), Gaps = 54/196 (27%)

Query: 122 QGRFGAVWKAK--FKNENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNILR-YIGA 174
           +G FG V  A      + VA+K      L +     + E+EI  L  + H +I++ Y   
Sbjct: 19  EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY--- 75

Query: 175 EKRGESIHTE--FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE----- 227
               + I T     ++  Y   G L D++                + K  M   E     
Sbjct: 76  ----DVITTPTDIVMVIEYAG-GELFDYI----------------VEKKRMTEDEGRRFF 114

Query: 228 -EILPNKADSY--KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP----CGDTH 280
            +I+   A  Y  +  + HRD K  N+LL  +L   IADFGL+ +   G      CG  +
Sbjct: 115 QQII--CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN 172

Query: 281 GQVGTRRYMAPEVLEG 296
                  Y APEV+ G
Sbjct: 173 -------YAAPEVING 181

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 46/225 (20%), Positives = 88/225 (39%), Gaps = 37/225 (16%)

Query: 88  GSYFNPVPTLEPHPTSPPSPQQGCRSIQ---LVEVKAQGRFGAVWKAKFKNEN--VAVKI 142
           G+   P P       + P PQ   +  +     ++  +G F  V  A+    +   A+KI
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62

Query: 143 F----LMQDKQSWQ--SEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGS 196
                ++++ +      E+++  +  ++H   ++     +  E ++       +Y + G 
Sbjct: 63  LEKRHIIKENKVPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLY----FGLSYAKNGE 116

Query: 197 LCDFLKCNIVTWEQLCR-----IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV 251
           L  +++      E   R     I       L +LH +            + HRD K  N+
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-----------GIIHRDLKPENI 161

Query: 252 LLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           LL  D+   I DFG A +  P       +  VGT +Y++PE+L  
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 51/292 (17%), Positives = 90/292 (30%), Gaps = 74/292 (25%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVK-IFLMQDKQSWQSE--QEIFKLPHMEHDNI- 168
           ++  +   G +G V +A  K     VA+K I  + +         +EI  L  + HD++ 
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115

Query: 169 -LRYIGAEKRGESIHTEFWLITAY---------HERGSLCDFLKCNIVTWEQLCRIALSM 218
            +  I   K  E    E +++                 L +     ++    L       
Sbjct: 116 KVLDIVIPKDVEKFD-ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY--NLLV----- 167

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
             G+ ++H       A      + HRD K  N L+  D +  + DFGLA   +  +    
Sbjct: 168 --GVKYVHS------AG-----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 279 THGQ-------------------------VGTRRYMAPEVLEGAINFSRDAFLRIDMYAC 313
                                        V TR Y APE++    N++      ID+++ 
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA----IDVWSI 270

Query: 314 ALVLWELASRCSSVSPP--------PGEYRLPFSAEVGDHPSLEDMQEAVVH 357
             +  EL +                PG    P S +       +        
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 19/80 (23%), Positives = 36/80 (45%), Gaps = 3/80 (3%)

Query: 241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF 300
           + H+D K  N+LL +  T  I+  G+A    P           G+  +  PE+  G   F
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189

Query: 301 SRDAFLRIDMYACALVLWEL 320
           S     ++D+++  + L+ +
Sbjct: 190 SG---FKVDIWSAGVTLYNI 206

>1bte_A Protein (activin receptor type II); serine kinase, ligand binding domain, three-finger transferase; HET: NAG; 1.50A {Mus musculus} SCOP: g.7.1.3 PDB: 2goo_C* 1lx5_B* Length = 97

 Score = 52.0 bits (124), Expect = 7e-09
 Identities = 17/37 (45%), Positives = 25/37 (67%), Gaps = 2/37 (5%)

Query: 2  ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEP 38
           CYD+  C+EK+      + FCCCEG+MCN+ F++ P
Sbjct: 60 NCYDRTDCIEKKDSP--EVYFCCCEGNMCNEKFSYFP 94

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 30/104 (28%), Positives = 41/104 (39%), Gaps = 27/104 (25%)

Query: 243 HRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH----GQV-GTRRYMAPEVLEGA 297
           HRD K  N+L+ +D  A + DFG+A          D      G   GT  YMAPE    +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIA------SATTDEKLTQLGNTVGTLYYMAPERFSES 210

Query: 298 INFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
                    R D+YA   VL+E  +         G    P+  +
Sbjct: 211 ---HATY--RADIYALTCVLYECLT---------G--SPPYQGD 238

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 30/162 (18%), Positives = 53/162 (32%), Gaps = 35/162 (21%)

Query: 211 LCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           +C + +     L +L  +            + HRD K +N+LL       I DF +A + 
Sbjct: 121 ICELVM----ALDYLQNQ-----------RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

Query: 271 EPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP 330
                        GT+ YMAPE+              +D ++  +  +EL          
Sbjct: 166 PRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSF--AVDWWSLGVTAYELLRG------- 213

Query: 331 PGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHA 372
               R P+   +    S +++        +    P  W Q  
Sbjct: 214 ----RRPY--HIRSSTSSKEIVHTFETTVVT--YPSAWSQEM 247

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 47/232 (20%), Positives = 80/232 (34%), Gaps = 61/232 (26%)

Query: 122 QGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
            G F  VW AK    N +VA+KI       +  +E EI          +L+ +      +
Sbjct: 29  WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEI---------KLLQRVNDADNTK 79

Query: 180 SIHTEFWLITAYHE----RG---------------SLCDFLKCNI---VTWEQLCRIALS 217
                   I    +    +G               +L   +K      +    + +I+  
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA------IADFGLALLFE 271
           +  GL ++H              + H D K  NVL++   +        IAD G A  + 
Sbjct: 140 LLLGLDYMHRRC----------GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWY 188

Query: 272 PGKPCGDTHGQVGTRRYMAPEVLEGA-INFSRDAFLRIDMYACALVLWELAS 322
                      + TR Y +PEVL GA            D+++ A +++EL +
Sbjct: 189 DEHYTNS----IQTREYRSPEVLLGAPWGCG------ADIWSTACLIFELIT 230

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 50/225 (22%), Positives = 83/225 (36%), Gaps = 49/225 (21%)

Query: 115 QLVEVKAQGRFGAVWKAK--FKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           ++  +  +G FG V KA    + E VA+KI   +     Q++ E+          +L  +
Sbjct: 57  EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEV---------RLLELM 107

Query: 173 GAEKRGESIHTEFWLITAYHERGSLC-----------DFLKCNI---VTWEQLCRIALSM 218
                    +           R  LC           D L+      V+     + A  M
Sbjct: 108 NKHDTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 219 SKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI--ADFGLALLFEPGKPC 276
              L+ L            + ++ H D K  N+LL +   +AI   DFG +         
Sbjct: 167 CTALLFLATP---------ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQL----- 211

Query: 277 GDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           G    Q + +R Y +PEVL G + +     L IDM++   +L E+
Sbjct: 212 GQRIYQYIQSRFYRSPEVLLG-MPYD----LAIDMWSLGCILVEM 251

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 48/227 (21%), Positives = 72/227 (31%), Gaps = 40/227 (17%)

Query: 88  GSYFNPVPTLEPHPTSPPSPQQGCRSI-QLVEVKAQGRFGAVWKAKFK--NENVAVKIFL 144
           GS+  P   L     +P   ++   S  Q+  +   G FG+V+       N  VA+K   
Sbjct: 18  GSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 77

Query: 145 MQDKQSWQS---------EQEIFKLPHMEHDNILR-YIGAEKRGESIHTE--FWLITAYH 192
                 W           E  + K        ++R         +       F LI    
Sbjct: 78  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL-------DWFERPDSFVLILERP 130

Query: 193 E-RGSLCDFLKCNIVTWEQLCR-IALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN 250
           E    L DF+       E+L R     + + + H H              V HRD K  N
Sbjct: 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-----------GVLHRDIKDEN 179

Query: 251 VLL-KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG 296
           +L+  +     + DFG   L +            GTR Y  PE +  
Sbjct: 180 ILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 36/166 (21%)

Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG 265
           ++ +        +  G+ H H+             + HRD K  N+L+ S+ T  I DFG
Sbjct: 108 LSVDTAINFTNQILDGIKHAHDM-----------RIVHRDIKPQNILIDSNKTLKIFDFG 156

Query: 266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS 325
           +A           T+  +GT +Y +PE  +G            D+Y+  +VL+E+     
Sbjct: 157 IAKALS-ETSLTQTNHVLGTVQYFSPEQAKG-----EATDECTDIYSIGIVLYEMLV--- 207

Query: 326 SVSPPPGEYRLPFSAEVGDHP---SLEDMQEAV--VHKKLRPTLPE 366
                 G    PF+   G+     +++ +Q++V  V   +R  +P+
Sbjct: 208 ------G--EPPFN---GETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 55/220 (25%)

Query: 122 QGRFGAVWKAK--FKNENVAVKIFLMQDKQSW--QSEQEIFKLPHMEHDNILRYIGAEKR 177
           +G FG V KA     +++VA+K+  +++++ +  Q+ +EI          IL ++  + +
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKM--VRNEKRFHRQAAEEI---------RILEHLRKQDK 155

Query: 178 GESIHTEFWLITAYHERGSLC-----------DFLKCNI---VTWEQLCRIALSMSKGLM 223
             +++    L      R  +C           + +K N     +   + + A S+ + L 
Sbjct: 156 DNTMNVIHMLENFTF-RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI--ADFGLALLFEPGKPCGDTHG 281
            LH           K  + H D K  N+LLK    + I   DFG +  +E          
Sbjct: 215 ALH-----------KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YE-----HQRVY 257

Query: 282 Q-VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
             + +R Y APEV+ G   +     + IDM++   +L EL
Sbjct: 258 TYIQSRFYRAPEVILG-ARYG----MPIDMWSLGCILAEL 292

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 28/146 (19%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            +  +H+               HRD K +N+L+  +    +ADFG  L          + 
Sbjct: 187 AIDSVHQL-----------HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSS 234

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
             VGT  Y++PE+L+             D ++  + ++E+           GE   PF A
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY---------GE--TPFYA 283

Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPE 366
           E     SL +    +++ K R   P 
Sbjct: 284 E-----SLVETYGKIMNHKERFQFPT 304

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.4 bits (122), Expect = 2e-07
 Identities = 24/211 (11%), Positives = 49/211 (23%), Gaps = 60/211 (28%)

Query: 104 PPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQE------- 156
           P    Q C  I       +G FG V++    +  VA+KI  ++         +       
Sbjct: 18  PTEKLQRCEKI------GEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 157 -----------IFKLPHMEHDNILRYIGA--------------------EKRGESIH--- 182
                      +        +  +                          K   +     
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 183 ---TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP 239
               + +++  +   G   + ++  + +      I   ++  L                 
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA----------SL 181

Query: 240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
              HRD    NVLLK      +         
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>2h62_D ACVR2B protein; TGF-beta superfamily, ligand-receptor complex, hormone/growth factor complex; 1.85A {Homo sapiens} SCOP: g.7.1.3 PDB: 1nys_A 1nyu_A 2h64_C 1s4y_A Length = 98

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 14/35 (40%), Positives = 19/35 (54%), Gaps = 2/35 (5%)

Query: 2  ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAW 36
           CYD+ +CV         + FCCCEG+ CN+ F  
Sbjct: 65 NCYDRQECVATEE--NPQVYFCCCEGNFCNERFTH 97

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 42/220 (19%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRY 171
           QLV    +G++  V++A     NE V VKI     K+  + ++EI  L ++    NI+  
Sbjct: 39  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGPNIITL 96

Query: 172 I----GAEKRGESIHTEFWLITAYHE-RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH 226
                    R  ++  E    T + +   +L D+     +   ++ +        L + H
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY--EILK-------ALDYCH 147

Query: 227 EEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
                         + HRD K +NV++      L   + D+GLA  + PG+   + + +V
Sbjct: 148 SM-----------GIMHRDVKPHNVMIDHEHRKLR--LIDWGLAEFYHPGQ---EYNVRV 191

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
            +R +  PE+L     +       +DM++   +L  +  R
Sbjct: 192 ASRYFKGPELLVDYQMYDY----SLDMWSLGCMLASMIFR 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 27/76 (35%), Positives = 32/76 (42%), Gaps = 12/76 (15%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LH E            V +RD K  N++L  D    I DFGL    E  K      
Sbjct: 260 ALDYLHSEK----------NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK 307

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APEVLE 
Sbjct: 308 TFCGTPEYLAPEVLED 323

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 44/215 (20%)

Query: 191 YHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN 250
             E     + L  + +T E L   +  ++KG+  L          + +  + HRD  + N
Sbjct: 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL----------ASRKCI-HRDLAARN 223

Query: 251 VLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR----YMAPEVLEGAINFSRDAFL 306
           +LL       I DFGLA            + + G  R    +MAPE +   + ++  +  
Sbjct: 224 ILLSEKNVVKICDFGLARDIY----KDPDYVRKGDARLPLKWMAPETIFDRV-YTIQS-- 276

Query: 307 RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPE 366
             D+++  ++LWE+ S     SP PG   +    E              + +  R   P+
Sbjct: 277 --DVWSFGVLLWEIFSL--GASPYPG---VKIDEEFCRR----------LKEGTRMRAPD 319

Query: 367 TWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
               +     +  TM +CW  +   R + S +VE 
Sbjct: 320 ----YTTP-EMYQTMLDCWHGEPSQRPTFSELVEH 349

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 20/76 (26%), Positives = 30/76 (39%), Gaps = 12/76 (15%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            +  +H                HRD K +N+LL       +ADFG  L          + 
Sbjct: 174 AIDSVHRL-----------GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SL 221

Query: 281 GQVGTRRYMAPEVLEG 296
             VGT  Y++PE+L+ 
Sbjct: 222 VAVGTPDYLSPEILQA 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 25/76 (32%), Positives = 36/76 (47%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LHE             + +RD K +NVLL S+    + D+G+    E  +P   T 
Sbjct: 122 ALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTS 168

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APE+L G
Sbjct: 169 TFCGTPNYIAPEILRG 184

>2hlr_A Bone morphogenetic protein receptor type-2; three-finger toxin, BMP receptor, TGF-beta, transferase; 1.20A {Ovis aries} PDB: 2hlq_A Length = 100

 Score = 45.9 bits (108), Expect = 1e-06
 Identities = 10/40 (25%), Positives = 14/40 (35%), Gaps = 3/40 (7%)

Query: 1  MECYDKPKCVEK---RPESKKNLNFCCCEGDMCNKDFAWE 37
           +     +CV              FCCC  D+CN +F   
Sbjct: 60 PQECHYEECVVTTTPPSIQNGTYRFCCCSTDLCNVNFTEN 99

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 35/170 (20%), Positives = 58/170 (34%), Gaps = 33/170 (19%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
            G  G V +   K   E  A+K+  +QD    + E E+      +  +I+R +   +   
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWR-ASQCPHIVRIVDVYENLY 84

Query: 180 SIHTEFWLITAYHERGSLCDFLKCNIVTWEQLC-------RIALSMSKGLMHLHEEILPN 232
           +      ++    + G L       I               I  S+ + + +LH      
Sbjct: 85  AGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---- 136

Query: 233 KADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLA--LLFEP-GKPC 276
                   +AHRD K  N+L  S   +    + DFG A     E   K C
Sbjct: 137 -------NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC 179

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 25/76 (32%), Positives = 30/76 (39%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LH              V +RD K  N++L  D    I DFGL    E         
Sbjct: 117 ALEYLHSR-----------DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMK 163

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APEVLE 
Sbjct: 164 TFCGTPEYLAPEVLED 179

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 16/78 (20%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA--LLFEPGKPCGD 278
            L HLH+             + +RD K  N+LL S+    + DFGL+   + +  +    
Sbjct: 171 ALEHLHKL-----------GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--- 216

Query: 279 THGQVGTRRYMAPEVLEG 296
            +   GT  YMAP+++ G
Sbjct: 217 AYDFCGTIEYMAPDIVRG 234

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 23/77 (29%), Positives = 33/77 (42%), Gaps = 15/77 (19%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDT 279
           GL  L  +            + +RD K +NV+L S+    IADFG+       G     T
Sbjct: 133 GLFFLQSK-----------GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---T 178

Query: 280 HGQVGTRRYMAPEVLEG 296
               GT  Y+APE++  
Sbjct: 179 KTFCGTPDYIAPEIIAY 195

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 24/77 (31%), Positives = 32/77 (41%), Gaps = 15/77 (19%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDT 279
            L HLH++            + +RD K  N++L       + DFGL       G     T
Sbjct: 133 ALGHLHQK-----------GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---T 178

Query: 280 HGQVGTRRYMAPEVLEG 296
           H   GT  YMAPE+L  
Sbjct: 179 HTFCGTIEYMAPEILMR 195

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 24/76 (31%), Positives = 35/76 (46%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            LM LH++            + +RD K +NVLL  +    +ADFG+    E       T 
Sbjct: 136 ALMFLHDK-----------GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTA 182

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APE+L+ 
Sbjct: 183 TFCGTPDYIAPEILQE 198

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 25/76 (32%), Positives = 36/76 (47%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LHE             + +RD K +NVLL S+    + D+G+    E  +P   T 
Sbjct: 165 ALNYLHER-----------GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTS 211

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APE+L G
Sbjct: 212 TFCGTPNYIAPEILRG 227

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 21/75 (28%), Positives = 29/75 (38%), Gaps = 12/75 (16%)

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHG 281
           L  +H                HRD K +N+LL       +ADFG  +             
Sbjct: 181 LDAIHSM-----------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDT 228

Query: 282 QVGTRRYMAPEVLEG 296
            VGT  Y++PEVL+ 
Sbjct: 229 AVGTPDYISPEVLKS 243

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 23/77 (29%), Positives = 32/77 (41%), Gaps = 15/77 (19%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA-LLFEPGKPCGDT 279
            L HLH              + +RD K  N+LL  +    + DFGL+    +  K     
Sbjct: 138 ALDHLHSL-----------GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---A 183

Query: 280 HGQVGTRRYMAPEVLEG 296
           +   GT  YMAPEV+  
Sbjct: 184 YSFCGTVEYMAPEVVNR 200

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 23/76 (30%), Positives = 33/76 (43%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL  L  +            + +RD K +NV+L S+    IADFG+    E       T 
Sbjct: 454 GLFFLQSK-----------GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTK 500

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APE++  
Sbjct: 501 TFCGTPDYIAPEIIAY 516

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 47.1 bits (113), Expect = 5e-06
 Identities = 24/77 (31%), Positives = 33/77 (42%), Gaps = 18/77 (23%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-T 279
            L +LH +            + +RD K  N+LL  +    I DFG A      K   D T
Sbjct: 118 ALEYLHSK-----------DIIYRDLKPENILLDKNGHIKITDFGFA------KYVPDVT 160

Query: 280 HGQVGTRRYMAPEVLEG 296
           +   GT  Y+APEV+  
Sbjct: 161 YTLCGTPDYIAPEVVST 177

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 24/76 (31%), Positives = 31/76 (40%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
            L +LH              + +RD K  N+LL S     + DFGL    E  +    T 
Sbjct: 151 ALGYLHSL-----------NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTS 197

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APEVL  
Sbjct: 198 TFCGTPEYLAPEVLHK 213

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 47.2 bits (113), Expect = 6e-06
 Identities = 26/76 (34%), Positives = 35/76 (46%), Gaps = 13/76 (17%)

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           GL  LH +            + +RD K +N+LL  D    IADFG+    E       T+
Sbjct: 130 GLQFLHSK-----------GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTN 176

Query: 281 GQVGTRRYMAPEVLEG 296
              GT  Y+APE+L G
Sbjct: 177 TFCGTPDYIAPEILLG 192

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 18/76 (23%), Positives = 27/76 (35%), Gaps = 18/76 (23%)

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD-TH 280
             +LH              + +RD K  N+L+       + DFG A      K     T 
Sbjct: 154 FEYLHSL-----------DLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTW 196

Query: 281 GQVGTRRYMAPEVLEG 296
              GT   +APE++  
Sbjct: 197 TLCGTPEALAPEIILS 212

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 46/232 (19%), Positives = 75/232 (32%), Gaps = 57/232 (24%)

Query: 122 QGRFGAVWKA--KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE 179
            G FG V         +  AVK+     K +  ++ E          +IL+ I  +    
Sbjct: 45  DGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEA---------DILKKIQNDDINN 95

Query: 180 S--IHTEFWLITAYHERGSLC-----------DFLKCNI---VTWEQLCRIALSMSKGLM 223
           +  +         +     +C           + +  N       E +    + + K L 
Sbjct: 96  NNIVK----YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 224 HLH-----------EEIL---PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL 269
           +L            E IL   P    S        D K   +         + DFG A  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT- 210

Query: 270 FEPGKPCGDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           F+      D HG  + TR+Y APEV+   + +     +  DM++   VL EL
Sbjct: 211 FK-----SDYHGSIINTRQYRAPEVILN-LGWD----VSSDMWSFGCVLAEL 252

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.3 bits (95), Expect = 9e-04
 Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 59/231 (25%)

Query: 122 QGRFGAVWKA---KFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG-AEKR 177
           +G FG V +    K    +VAVKI    D+    +  EI          +L ++   +  
Sbjct: 24  EGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI---------QVLEHLNTTDPN 74

Query: 178 GES--IHTEFWLITAYHERGSLC-----------DFLKCNI---VTWEQLCRIALSMSKG 221
                +    W     H  G +C           DF+K N       + + ++A  + K 
Sbjct: 75  STFRCVQMLEWF---EH-HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 222 LMHLH-----------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF 270
           +  LH           E IL  ++D Y  A   +  +    L+  D+   + DFG A  +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSD-YTEAYNPKIKRDERTLINPDIK--VVDFGSA-TY 186

Query: 271 EPGKPCGDTHGQ-VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL 320
           +      + H   V TR Y APEV+   + +S       D+++   +L E 
Sbjct: 187 D-----DEHHSTLVSTRHYRAPEVILA-LGWS----QPCDVWSIGCILIEY 227

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	461
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.87
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.12
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.97
4fao_E	124	Activin receptor type-2B; TGF-beta, CTK, cystine k	97.81
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.78
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.76
1bte_A	97	Protein (activin receptor type II); serine kinase,	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.7
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.42
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.35
2h62_D	98	ACVR2B protein; TGF-beta superfamily, ligand-recep	97.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.27
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.99
2hlr_A	100	Bone morphogenetic protein receptor type-2; three-	96.99
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.79
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.51
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.67
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.31
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.04
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.46
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.57
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.29
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	90.56
1ks6_A	107	Transforming growth factor beta type II receptor;	89.0
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	86.74
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.34
1m9z_A	111	TGF-beta receptor type II; three finger toxin fold	83.71
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.5
3kfd_E	116	TGF-beta receptor type-2; TGF-beta recepto tbrii,	80.42

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.4e-62  Score=472.52  Aligned_cols=292  Identities=41%  Similarity=0.736  Sum_probs=244.7

Q ss_pred             cceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      ++|.+.+.||+|+||+||+|+++|+.||||++..........+.|+..+.+++|||||+++|++...+.....++|||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            57899999999999999999999999999999876666666788999999999999999999998766544567999999


Q ss_pred             ccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccC
Q psy17532        192 HERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFE  271 (461)
Q Consensus       192 ~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~  271 (461)
                      |++|+|.++|+...++++.+.+++.|+|.||+|||++.   ..+.+.++||||||||+||||+.++++||+|||+|+...
T Consensus        83 ~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~---~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI---VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCB---CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhh---hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            99999999999889999999999999999999999762   122345699999999999999999999999999998775


Q ss_pred             CCCCC--CCCCCCcCCCccccccccccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        272 PGKPC--GDTHGQVGTRRYMAPEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       272 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .....  ......+||+.|||||++.+..... ..++.++|||||||+||||+||++|+.... ..+.||.......+..
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~-~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC-CCCCTTTTTSCSSCCH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc-cccccchhcccccchH
Confidence            44321  1233467999999999997642111 245678999999999999999987765433 3467888877777888


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      +.+...+.....+|.+|..+........+.+||.+||+.||++||||.|++++|..+..
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            88888888899999999888776777789999999999999999999999999877653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.4e-59  Score=450.66  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=213.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      .....++++.+.||+|+||+||+|++.       ++.||||+++....  ....+.+|+.++++++|||||+++|++.+.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            345678999999999999999999973       46799999864332  234577899999999999999999999886


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCe
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV  241 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~i  241 (461)
                      ..    ++||||||++|||.++|..                 ..+++.+++.++.|||.||+|||++           +|
T Consensus       102 ~~----~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-----------~i  166 (308)
T 4gt4_A          102 QP----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-----------HV  166 (308)
T ss_dssp             SS----CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-----------TC
T ss_pred             CE----EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CC
Confidence            64    4899999999999999943                 2489999999999999999999999           99


Q ss_pred             ecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       242 vHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      |||||||+||||++++.+||+|||+|+.+.............||+.|||||++.+     ..++.++|||||||+||||+
T Consensus       167 iHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-----~~~s~ksDVwSfGvvl~El~  241 (308)
T 4gt4_A          167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-----GKFSIDSDIWSYGVVLWEVF  241 (308)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-----CCCCccchhhhHHHHHHHHH
Confidence            9999999999999999999999999988765443334556789999999999976     37889999999999999999


Q ss_pred             c-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        322 S-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       322 t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                      | |           ..||.+.     +..++...+..+ .+++.|+.++.     .+.+||.+||+.||++|||+++|++
T Consensus       242 t~g-----------~~Pf~~~-----~~~~~~~~i~~~-~~~~~p~~~~~-----~~~~li~~C~~~dP~~RPs~~ei~~  299 (308)
T 4gt4_A          242 SYG-----------LQPYCGY-----SNQDVVEMIRNR-QVLPCPDDCPA-----WVYALMIECWNEFPSRRPRFKDIHS  299 (308)
T ss_dssp             TTT-----------CCTTTTC-----CHHHHHHHHHTT-CCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hCC-----------CCCCCCC-----CHHHHHHHHHcC-CCCCCcccchH-----HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9 6           6677654     456666666544 44556666554     8999999999999999999999999


Q ss_pred             hcHH
Q psy17532        401 RGML  404 (461)
Q Consensus       401 ~l~~  404 (461)
                      +|..
T Consensus       300 ~L~a  303 (308)
T 4gt4_A          300 RLRA  303 (308)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            8753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-58  Score=447.97  Aligned_cols=265  Identities=28%  Similarity=0.362  Sum_probs=207.0

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      .+....+++++.+.||+|+||+||+|++++ .||||+++....   ....+.+|+.++++++|||||+++|++..+    
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  104 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD----  104 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC----
Confidence            345667889999999999999999999865 599999864332   234567899999999999999999988653    


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       .++||||||++|+|.++|+.  ..+++.+++.|+.|||.||+|||++           +||||||||+||||++++.+|
T Consensus       105 -~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----------~IiHRDlKp~NILl~~~~~~K  172 (307)
T 3omv_A          105 -NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK-----------NIIHRDMKSNNIFLHEGLTVK  172 (307)
T ss_dssp             -SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCSCCCSSSEEEETTEEEE
T ss_pred             -eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccCCccCHHHEEECCCCcEE
Confidence             34899999999999999953  4699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+...............||+.|||||++.+.  ....++.++|||||||+||||+||           +.||..
T Consensus       173 i~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~--~~~~y~~ksDVwS~Gvvl~Elltg-----------~~Pf~~  239 (307)
T 3omv_A          173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ--DNNPFSFQSDVYSYGIVLYELMTG-----------ELPYSH  239 (307)
T ss_dssp             ECCCSSCBC------------CCCCTTSCCHHHHHCC--SSCCCCHHHHHHHHHHHHHHHHHS-----------SCTTTT
T ss_pred             EeeccCceecccCCcceeecccccCCCccCHHHhhcc--CCCCCCcHHHhHhHHHHHHHHHHC-----------CCCCCC
Confidence            9999999877544332334556899999999999753  123588899999999999999999           666654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .    .....+...+..+...|.++....  ..+..+.+||.+||+.||++|||+.+++++++.+.
T Consensus       240 ~----~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          240 I----NNRDQIIFMVGRGYASPDLSKLYK--NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             C----CCHHHHHHHHHTTCCCCCSTTSCT--TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             C----ChHHHHHHHHhcCCCCCCcccccc--cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            3    123333344444433443332221  13348999999999999999999999999987665

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.1e-58  Score=451.55  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=207.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|.+.++||+|+||.||+|++.       ++.||||++...... ...+.+|+.+|++++|||||+++|+|.+...
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45578999999999999999999974       467999999754433 3457899999999999999999999988654


Q ss_pred             cceeeeeeehhccCCChhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHR  244 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHr  244 (461)
                          ++||||||++|+|.++++.                .++++.+++.|+.|||.||+|||+.           +||||
T Consensus       118 ----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-----------~iiHR  182 (329)
T 4aoj_A          118 ----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-----------HFVHR  182 (329)
T ss_dssp             ----EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCS
T ss_pred             ----EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-----------Ceecc
Confidence                4999999999999999853                3589999999999999999999998           99999


Q ss_pred             cCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-C
Q psy17532        245 DFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-R  323 (461)
Q Consensus       245 DLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g  323 (461)
                      ||||+||||++++.+||+|||+|+.+.............||+.|||||++.+     ..++.++|||||||+||||+| |
T Consensus       183 DLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-----~~~~~~sDvwS~Gvvl~Ellt~G  257 (329)
T 4aoj_A          183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-----RKFTTESDVWSFGVVLWEIFTYG  257 (329)
T ss_dssp             CCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-----CCCCccccccchHHHHHHHHcCC
Confidence            9999999999999999999999998765443334445689999999999976     478899999999999999999 7


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       324 ~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                 +.||...     +..++...+..+ .++..|..++.     ++.+||.+||+.||++|||++||+++|.
T Consensus       258 -----------~~Pf~~~-----~~~~~~~~i~~g-~~~~~p~~~~~-----~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          258 -----------KQPWYQL-----SNTEAIDCITQG-RELERPRACPP-----EVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             -----------CCTTCSS-----CHHHHHHHHHHT-CCCCCCTTCCH-----HHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             -----------CCCCCCC-----CHHHHHHHHHcC-CCCCCcccccH-----HHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence                       6677554     445555555443 45666766554     8999999999999999999999999987


Q ss_pred             HHhh
Q psy17532        404 LALC  407 (461)
Q Consensus       404 ~~~~  407 (461)
                      .+..
T Consensus       316 ~l~~  319 (329)
T 4aoj_A          316 ALAQ  319 (329)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            6653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.5e-59  Score=448.74  Aligned_cols=256  Identities=23%  Similarity=0.342  Sum_probs=212.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|.+.+.||+|+||+||+|++.       +..||||+++..... ...+.+|+.+|++++|||||+++|++.+.+.
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            45578999999999999999999873       467999999754432 3456799999999999999999999988654


Q ss_pred             cceeeeeeehhccCCChhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC--------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDF  246 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDL  246 (461)
                          ++||||||++|+|.++|+.              ..+++.+++.++.|||.||+|||++           +||||||
T Consensus        90 ----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-----------~iiHRDl  154 (299)
T 4asz_A           90 ----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-----------HFVHRDL  154 (299)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCC
T ss_pred             ----EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCcc
Confidence                4999999999999999953              2599999999999999999999999           9999999


Q ss_pred             CCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCC
Q psy17532        247 KSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCS  325 (461)
Q Consensus       247 kp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~  325 (461)
                      ||+||||++++.+||+|||+|+...............||+.|||||++.+     ..++.++|||||||++|||+| |  
T Consensus       155 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-----~~~~~k~DVwS~Gvvl~Ellt~G--  227 (299)
T 4asz_A          155 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFTYG--  227 (299)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTT--
T ss_pred             CHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHcCC--
Confidence            99999999999999999999987765433233344579999999999976     478899999999999999999 7  


Q ss_pred             CCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       326 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                               +.||...     +..++...+..+ .++..|..++.     ++.+||.+||+.||++|||++++++.|..+
T Consensus       228 ---------~~Pf~~~-----~~~~~~~~i~~~-~~~~~p~~~~~-----~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          228 ---------KQPWYQL-----SNNEVIECITQG-RVLQRPRTCPQ-----EVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             ---------CCTTTTS-----CHHHHHHHHHHT-CCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCC-----CHHHHHHHHHcC-CCCCCCccchH-----HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     6677654     455666666554 34566665544     899999999999999999999998877655


Q ss_pred             h
Q psy17532        406 L  406 (461)
Q Consensus       406 ~  406 (461)
                      .
T Consensus       288 ~  288 (299)
T 4asz_A          288 A  288 (299)
T ss_dssp             H
T ss_pred             H
Confidence            4

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3e-57  Score=437.18  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=213.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.+.||+|+||+||+|++  +++.||||++....    .......+|+.+|++++|||||++++++.+.+   
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---  105 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE---  105 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC---
Confidence            3456899999999999999999998  47889999997432    22345678999999999999999999998865   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+|||||||++|+|.++++. +.+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+||
T Consensus       106 -~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~-----------~IiHRDlKPeNILl~~~g~vKl  173 (311)
T 4aw0_A          106 -KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-----------GIIHRDLKPENILLNEDMHIQI  173 (311)
T ss_dssp             -EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTSCEEE
T ss_pred             -EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCccCCCCHHHeEEcCCCCEEE
Confidence             45999999999999999954 5799999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|+.+............+||+.|||||++.+     ..|+.++|||||||++|||++|           ..||.+.
T Consensus       174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G-----------~~PF~~~  237 (311)
T 4aw0_A          174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAG-----------LPPFRAG  237 (311)
T ss_dssp             CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-----SCBCHHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             EEcCCceecCCCCCcccccCcccCcccCCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhC-----------CCCCCCC
Confidence            99999998865443344556789999999999976     4678899999999999999999           6777554


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                           +..++...+.....  .+|+.++     .++.+||.+||..||++|||++|++.+.+
T Consensus       238 -----~~~~~~~~i~~~~~--~~p~~~s-----~~~~dli~~lL~~dp~~R~t~~e~~~~~~  287 (311)
T 4aw0_A          238 -----NEGLIFAKIIKLEY--DFPEKFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGP  287 (311)
T ss_dssp             -----SHHHHHHHHHHTCC--CCCTTCC-----HHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred             -----CHHHHHHHHHcCCC--CCCcccC-----HHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence                 55666677766543  4555443     37899999999999999999999765544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-57  Score=443.87  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=212.0

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ..|++.+.||+|+||+||+|++  +|+.||||++..... ......+|+.+|++++|||||++++++.+.+    .+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEEEE
Confidence            5699999999999999999999  478999999975432 2344678999999999999999999998865    45999


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ||||++|+|.+++....+++..+..++.||+.||+|||++           +||||||||+||||+.++.+||+|||+|+
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~-----------~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-----------GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            9999999999999888999999999999999999999999           99999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+....  ......+||+.|||||++.+     ..|+.++|||||||++|||++|           ..||.+.     +.
T Consensus       219 ~~~~~~--~~~~~~~GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G-----------~~PF~~~-----~~  275 (346)
T 4fih_A          219 QVSKEV--PRRKSLVGTPYWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDG-----------EPPYFNE-----PP  275 (346)
T ss_dssp             ECCSSS--CCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS-----CH
T ss_pred             ecCCCC--CcccccccCcCcCCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHC-----------CCCCCCc-----CH
Confidence            876543  23445789999999999976     4788999999999999999999           6666543     44


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+....+... ..+.++. +  ...+.++.+||.+||..||++|||++|+++|.|...
T Consensus       276 ~~~~~~i~~~-~~~~~~~-~--~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          276 LKAMKMIRDN-LPPRLKN-L--HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHHHHHHHHS-SCCCCSC-G--GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHcC-CCCCCCc-c--ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            4444444432 2222221 1  123358999999999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-57  Score=433.40  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=202.5

Q ss_pred             eeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      |++.++||+|+||+||+|++.  +..||||.+....   .....+.+|+.++++++|||||++++++.+.......+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            478889999999999999984  6789999986432   22345678999999999999999999987643323457999


Q ss_pred             ehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~DFGl  266 (461)
                      ||||++|+|.++++. ..+++..+..++.||+.||+|||++         +++||||||||+||||+. ++.+||+|||+
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---------~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---------TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---------SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence            999999999999954 5799999999999999999999998         223999999999999985 79999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      |+.....    .....+||+.|||||++.+      .++.++|||||||++|||+||           +.||...    .
T Consensus       179 a~~~~~~----~~~~~~GTp~YmAPE~~~~------~y~~~~DiwSlGvilyelltg-----------~~Pf~~~----~  233 (290)
T 3fpq_A          179 ATLKRAS----FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATS-----------EYPYSEC----Q  233 (290)
T ss_dssp             GGGCCTT----SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHS-----------SCTTTTC----S
T ss_pred             CEeCCCC----ccCCcccCccccCHHHcCC------CCCcHHHHHHHHHHHHHHHHC-----------CCCCCCC----C
Confidence            9865432    2445689999999999864      578899999999999999999           6666432    1


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ....+...+......+.++..     .+.++.+||.+||+.||++|||++|+++|.|.
T Consensus       234 ~~~~~~~~i~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~  286 (290)
T 3fpq_A          234 NAAQIYRRVTSGVKPASFDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             SHHHHHHHHTTTCCCGGGGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cHHHHHHHHHcCCCCCCCCcc-----CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            334444555443222222222     23479999999999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-57  Score=446.71  Aligned_cols=253  Identities=23%  Similarity=0.407  Sum_probs=206.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ..++|++++.||+|+||+||+|++  +|+.||||++....   .....+.+|+.+|++++|||||++++++.+.+    .
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~----~   97 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG----S   97 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----E
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC----E
Confidence            457899999999999999999998  47899999997543   22345678999999999999999999998865    4


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +|||||||++|+|.++|..   ..+++..+..++.||+.||+|||++           +||||||||+||||+.++.+||
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~-----------~IiHRDlKp~NILl~~~g~vKl  166 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-----------KILHRDIKSQNIFLTKDGTVQL  166 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCEETTCCGGGEEECTTCCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCCHHHEEECCCCCEEE
Confidence            5999999999999999943   3478999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|+.+....  ......+||+.|||||++.+     ..|+.++|||||||++|||++|           +.||.+.
T Consensus       167 ~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~-----~~y~~~~DiwSlGvilyemltG-----------~~PF~~~  228 (350)
T 4b9d_A          167 GDFGIARVLNSTV--ELARACIGTPYYLSPEICEN-----KPYNNKSDIWALGCVLYELCTL-----------KHAFEAG  228 (350)
T ss_dssp             CSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------SCSCCCS
T ss_pred             cccccceeecCCc--ccccccCCCccccCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHC-----------CCCCCCc
Confidence            9999998765321  11234579999999999986     4688899999999999999999           6777654


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           +..++...+..... +.++..++     .++.+||.+||+.||++|||++|+++|.|...
T Consensus       229 -----~~~~~~~~i~~~~~-~~~~~~~s-----~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          229 -----SMKNLVLKIISGSF-PPVSLHYS-----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -----SHHHHHHHHHHTCC-CCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -----CHHHHHHHHHcCCC-CCCCccCC-----HHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                 55666666666543 34444443     38999999999999999999999999987643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-57  Score=446.42  Aligned_cols=260  Identities=24%  Similarity=0.343  Sum_probs=212.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCChh--hhHHHHHHHHcCCCCC-CCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEH-DNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H-~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||+||+|++.+       +.||||.+......  ...+.+|+.+|.+++| ||||+++|+|..
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3456789999999999999999999843       46999999754332  3446789999999865 899999999876


Q ss_pred             CCccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA  240 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~  240 (461)
                      .+.   .++||||||++|+|.++|+.                 ..+++.+++.++.|||+||+|||++           +
T Consensus       140 ~~~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-----------~  205 (353)
T 4ase_A          140 PGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-----------K  205 (353)
T ss_dssp             TTS---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-----------T
T ss_pred             cCC---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-----------C
Confidence            432   34899999999999999953                 2489999999999999999999999           9


Q ss_pred             eecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHH
Q psy17532        241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL  320 (461)
Q Consensus       241 ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el  320 (461)
                      ||||||||+|||+++++.+||+|||+|+.+..+..........||+.|||||++.+     ..++.++|||||||+||||
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-----~~y~~ksDVwS~Gv~l~El  280 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEI  280 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHH
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-----CCCCCcccEeehHHHHHHH
Confidence            99999999999999999999999999998765544334455679999999999976     4788999999999999999


Q ss_pred             Hc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        321 AS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       321 ~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      +| |           ..||.+..    ..+.+. .....+.++..|+.++.     ++.+||.+||+.||++|||+++++
T Consensus       281 ~t~G-----------~~Pf~~~~----~~~~~~-~~i~~g~~~~~p~~~~~-----~~~~li~~c~~~dP~~RPt~~eil  339 (353)
T 4ase_A          281 FSLG-----------ASPYPGVK----IDEEFC-RRLKEGTRMRAPDYTTP-----EMYQTMLDCWHGEPSQRPTFSELV  339 (353)
T ss_dssp             TTTS-----------CCSSTTCC----CSHHHH-HHHHHTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HhCC-----------CCCCCCCC----HHHHHH-HHHHcCCCCCCCccCCH-----HHHHHHHHHcCcChhHCcCHHHHH
Confidence            98 7           56665431    122333 33445566777766554     899999999999999999999999


Q ss_pred             hhcHHHhh
Q psy17532        400 ERGMLALC  407 (461)
Q Consensus       400 ~~l~~~~~  407 (461)
                      ++|..+..
T Consensus       340 ~~L~~llq  347 (353)
T 4ase_A          340 EHLGNLLQ  347 (353)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99977654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.5e-56  Score=434.65  Aligned_cols=256  Identities=22%  Similarity=0.257  Sum_probs=204.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ...+.|++.+.||+|+||.||+|+++  |+.||||++.....    ..+|+.+++.++|||||++++++.+.+    .+|
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~----~~~  126 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGP----WVN  126 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETT----EEE
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECC----EEE
Confidence            34567999999999999999999984  78999999975432    246899999999999999999998865    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~DF  264 (461)
                      ||||||++|+|.++|+. +.+++..+..++.||+.||+|||++           +||||||||+||||+.++ .+||+||
T Consensus       127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~-----------~IiHRDlKp~NILl~~~g~~vKl~DF  195 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR-----------RILHGDVKADNVLLSSDGSRAALCDF  195 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT-----------TEECSCCCGGGEEECTTSCCEEECCC
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecccCHHHEEEeCCCCEEEEeeC
Confidence            99999999999999954 5799999999999999999999999           999999999999999987 6999999


Q ss_pred             CCccccCCCCCC---CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        265 GLALLFEPGKPC---GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       265 Gla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      |+|+.+......   ......+||+.|||||++.+     ..++.++|||||||++|||++|           ..||...
T Consensus       196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyemltG-----------~~Pf~~~  259 (336)
T 4g3f_A          196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-----KPCDAKVDIWSSCCMMLHMLNG-----------CHPWTQY  259 (336)
T ss_dssp             TTCEEC------------CCCCCCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------SCSSTTT
T ss_pred             CCCeEccCCCcccceecCCccccCccccCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHC-----------cCCCCCC
Confidence            999987643221   12234579999999999987     4788999999999999999999           5555443


Q ss_pred             cCCCCCHHHHHHHHhccCCC-CCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLR-PTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                      ..     .++...+...... ..+|..+     +..+.+||.+||+.||++|||+.|+++++.......
T Consensus       260 ~~-----~~~~~~i~~~~~~~~~~~~~~-----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          260 FR-----GPLCLKIASEPPPIREIPPSC-----APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             CC-----SCCHHHHHHSCCGGGGSCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CH-----HHHHHHHHcCCCCchhcCccC-----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            21     1122233332211 1233333     348999999999999999999999999987766543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-56  Score=445.94  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=212.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...|++.+.||+|+||.||+|+++  |+.||||++..... ......+|+.+|+.++|||||++++++.+.+    .+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----~~~i  225 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWV  225 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC----EEEE
Confidence            457999999999999999999994  78999999975443 2344678999999999999999999998865    4699


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      |||||++|+|.++++...+++.++..++.||+.||+|||++           +||||||||+||||+.++.+||+|||+|
T Consensus       226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~-----------~IiHRDiKp~NILl~~~g~vKl~DFGla  294 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-----------GVIHRDIKSDSILLTHDGRVKLSDFGFC  294 (423)
T ss_dssp             EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecccCCHHHEEEcCCCCEEEecCccc
Confidence            99999999999999888999999999999999999999999           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      +.+....  ......+||+.|||||++.+     ..|+.++|||||||++|||++|           ..||.+.     .
T Consensus       295 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G-----------~~PF~~~-----~  351 (423)
T 4fie_A          295 AQVSKEV--PRRKSLVGTPYWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDG-----------EPPYFNE-----P  351 (423)
T ss_dssp             EECCSSC--CCBCCCEECTTTCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS-----C
T ss_pred             eECCCCC--ccccccccCcCcCCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHC-----------CCCCCCc-----C
Confidence            9876543  23455789999999999976     4788999999999999999999           6666543     4


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..+....+... ..+.++. +  ...+.++.+||.+||..||++|||++|+++|.|...
T Consensus       352 ~~~~~~~i~~~-~~~~~~~-~--~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          352 PLKAMKMIRDN-LPPRLKN-L--HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHHHHHHHHHS-CCCCCSC-T--TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHcC-CCCCCcc-c--ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            44444444433 2222221 1  113348999999999999999999999999998654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.7e-56  Score=422.94  Aligned_cols=250  Identities=25%  Similarity=0.387  Sum_probs=195.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||+||+|+.  +++.||||++....    .......+|+.++++++|||||++++++.+.+    
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   86 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD----   86 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence            357899999999999999999998  47899999996532    22345678999999999999999999998865    


Q ss_pred             eeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+|+||||+ +|+|.+++. .+.+++.++..++.||+.||+|||++           +|+||||||+|||++.++.+||+
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~-----------~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-----------KIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCTTTEEECTTCCEEEC
T ss_pred             EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccccCChHHeEECCCCCEEEe
Confidence            459999999 679999884 56799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+......   .....+||+.|||||++.+.    ..++.++|||||||++|||++|           +.||.+. 
T Consensus       155 DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~----~y~~~~~DiwSlGvily~lltg-----------~~PF~~~-  215 (275)
T 3hyh_A          155 DFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYVMLCR-----------RLPFDDE-  215 (275)
T ss_dssp             CSSCC------------------CTTSCHHHHSSS----SCCCTHHHHHHHHHHHHHHHHS-----------SCSSCCS-
T ss_pred             ecCCCeecCCCC---ccCCeeECcccCChhhhcCC----CCCCChhhhHHHHHHHHHHHHC-----------CCCCCCC-
Confidence            999998765432   23456899999999999864    1235789999999999999999           6777543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                          +...+...+....  +.+|..++     .++.+||.+||+.||++|||++|+++|.|..
T Consensus       216 ----~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          216 ----SIPVLFKNISNGV--YTLPKFLS-----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             ----SHHHHHHHHHHTC--CCCCTTSC-----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             ----CHHHHHHHHHcCC--CCCCCCCC-----HHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence                5566666665543  34454433     3789999999999999999999999998864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-56  Score=429.32  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      .++|++++.||+|+||+||+|+.     .++.||||++....   .......+|+.+|++++|||||++++++.+.+   
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG---   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT---
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC---
Confidence            46899999999999999999987     25679999986432   22345678999999999999999999998865   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+|+|||||++|+|.++++. ..+++.++..++.||+.||+|||++           +|+||||||+|||++.++.+||
T Consensus       100 -~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~-----------~IiHRDlKp~NILl~~~g~vKl  167 (304)
T 3ubd_A          100 -KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL-----------GIIYRDLKPENILLDEEGHIKL  167 (304)
T ss_dssp             -EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSSCCGGGEEECTTSCEEE
T ss_pred             -EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCcCCCCCHHHeEEcCCCCEEe
Confidence             45999999999999999954 5799999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|+......  ......+||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+.
T Consensus       168 ~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyemltG-----------~~PF~~~  229 (304)
T 3ubd_A          168 TDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTG-----------TLPFQGK  229 (304)
T ss_dssp             ESSEEEEC-------CCCCSCCCCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             cccccceeccCCC--ccccccccCcccCCHHHhcc-----CCCCCCCcccchHHHHHHHHhC-----------CCCCCCc
Confidence            9999998764433  23445789999999999976     4778899999999999999999           6777654


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLA  405 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~  405 (461)
                           +..++...+....  +.+|..++     .++.+||.+||+.||++|||+     +|+++|.|+.
T Consensus       230 -----~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~  286 (304)
T 3ubd_A          230 -----DRKETMTMILKAK--LGMPQFLS-----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS  286 (304)
T ss_dssp             -----SHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred             -----CHHHHHHHHHcCC--CCCCCcCC-----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence                 5566666666554  34555443     379999999999999999996     5788887653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-53  Score=411.33  Aligned_cols=253  Identities=23%  Similarity=0.385  Sum_probs=188.1

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc------
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI------  181 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~------  181 (461)
                      .+|++++.||+|+||+||+|+++  ++.||||++......  .....+|+.+|++++|||||++++++.+.+..      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            57999999999999999999984  789999999754432  34567899999999999999999998764421      


Q ss_pred             --ceeeeeeehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        182 --HTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       182 --~~~~~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                        ...+|+|||||++|+|.++++..    ...+..+..++.||+.||+|||++           +|+||||||+|||++.
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~-----------~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK-----------GLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECT
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC-----------cCccccCcHHHeEECC
Confidence              22468999999999999999653    245667889999999999999999           9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCC----------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPC----------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS  325 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~  325 (461)
                      ++.+||+|||+|+.+......          ......+||+.|||||++.+     ..|+.++|||||||++|||++   
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyell~---  225 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-----NSYSHKVDIFSLGLILFELLY---  225 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHS---
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-----CCCCCHHHHHHHHHHHHHHcc---
Confidence            999999999999887643221          11234579999999999976     478899999999999999996   


Q ss_pred             CCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       326 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |           |....    ........+..    ..+|..+..  ....+.+||.+||+.||++|||+.|+++|.+.
T Consensus       226 P-----------f~~~~----~~~~~~~~~~~----~~~p~~~~~--~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          226 P-----------FSTQM----ERVRTLTDVRN----LKFPPLFTQ--KYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             C-----------CSSHH----HHHHHHHHHHT----TCCCHHHHH--HCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             C-----------CCCcc----HHHHHHHHHhc----CCCCCCCcc--cCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            2           32110    01111122222    233333322  22357789999999999999999999999764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.4e-52  Score=408.21  Aligned_cols=300  Identities=67%  Similarity=1.109  Sum_probs=258.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .....++|++.+.||+|+||.||+|++.++.||||++..........+.|+.++.+++||||+++++++.........++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            34567899999999999999999999999999999998776667777889999999999999999999988665455679


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||||+++|+|.++++...+++..+..++.|++.||.|||+.. .+....+.++|+||||||+|||++.++.+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~-~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI-PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCE-EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhc-cccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999999998888999999999999999999999751 111122344899999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++.+.............||+.|+|||++.+.......++.++|||||||++|||++|+.||.+.......||.......+
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            98876554333444568999999999998743333455678899999999999999999999888888889988878888


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ....+...+.....++.++..+.....+..+.+||.+||+.||++|||+.++++.|..+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            8899888888888888888888777777889999999999999999999999999987764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=412.00  Aligned_cols=263  Identities=21%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--ccee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTE  184 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~  184 (461)
                      ++|++++.||+|+||+||+|++  +|+.||||++.....   ......+|+.+|+.++|||||++++++.....  ....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999998  478999999964432   22345689999999999999999999865422  1245


Q ss_pred             eeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +|||||||+ |+|.+++. .+.+++..+..++.||+.||.|||++           +||||||||+|||++.++.+||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~-----------~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA-----------QVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------cCcCCCcCccccccCCCCCEEEee
Confidence            799999996 68999985 45799999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCC--CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        264 FGLALLFEPGKP--CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       264 FGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      ||+|+.+.....  .......+||+.|||||++.+.    ..++.++||||+||++|||++|.+           ||.+.
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~----~~~~~~~DiWSlG~il~ell~G~~-----------pF~g~  266 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL----HEYTQAIDLWSVGCIFGEMLARRQ-----------LFPGK  266 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHHTSC-----------SSCCS
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCC----CCCCChhheehhHHHHHHHHHCCC-----------CCCCC
Confidence            999987754321  1234457899999999998764    356789999999999999999954           44332


Q ss_pred             cCCCCCHHHHHHHHhccC----------------------CCCCCCchhcc--chhHHHHHHHHHHHccccHhhhccccc
Q psy17532        342 VGDHPSLEDMQEAVVHKK----------------------LRPTLPETWKQ--HAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~----------------------~~~~~p~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                           +..+....+....                      ..+..+..|..  ...+.++.+||.+||..||++|||++|
T Consensus       267 -----~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  341 (398)
T 4b99_A          267 -----NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA  341 (398)
T ss_dssp             -----SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             -----CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                 2222222221110                      01111111110  112357899999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      +++|.|...
T Consensus       342 ~L~Hp~f~~  350 (398)
T 4b99_A          342 ALRHPFLAK  350 (398)
T ss_dssp             HTTSGGGTT
T ss_pred             HhcCHhhCc
Confidence            999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4e-50  Score=420.22  Aligned_cols=259  Identities=22%  Similarity=0.272  Sum_probs=210.0

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhH-HHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQ-SEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~-~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      ...++|+++++||+|+||.||+|+.  +|+.||||++.....      .... ...++.+++.++|||||++++++.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3467999999999999999999999  478899999964321      1111 123466788899999999999999876


Q ss_pred             ccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .+|||||||+||+|.++|. .+.+++..+..++.||+.||+|||++           +||||||||+||||+.+|+
T Consensus       266 ----~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~-----------gIiHRDLKPeNILld~~G~  330 (689)
T 3v5w_A          266 ----KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-----------FVVYRDLKPANILLDEHGH  330 (689)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCSGGGEEECTTSC
T ss_pred             ----EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCchHHeEEeCCCC
Confidence                4599999999999999995 45799999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+|+.+....    ....+||+.|||||++.++    ..|+.++|||||||++|||++|           ..||
T Consensus       331 vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~----~~y~~~vDiWSLGvilYEmLtG-----------~~PF  391 (689)
T 3v5w_A          331 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRG-----------HSPF  391 (689)
T ss_dssp             EEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTT----CCCCTHHHHHHHHHHHHHHHHS-----------SCTT
T ss_pred             EEecccceeeecCCCC----CCCccCCcCccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhC-----------CCCC
Confidence            9999999998876543    3457899999999999643    3678899999999999999999           6666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHhhhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLALCDTM  410 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~~~~~  410 (461)
                      .+....  ...++...+....  ..+|..++     .++.+||.+||..||++|++     ++|+++|.|+....+.
T Consensus       392 ~~~~~~--~~~~i~~~i~~~~--~~~p~~~S-----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          392 RQHKTK--DKHEIDRMTLTMA--VELPDSFS-----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             CGGGCC--CHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             CCCChH--HHHHHHHhhcCCC--CCCCccCC-----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            543221  3334444444433  34555443     37899999999999999998     6899999988654443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4e-50  Score=398.33  Aligned_cols=271  Identities=20%  Similarity=0.297  Sum_probs=196.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .+.|++.+.||+|+||+||+|+.+     ++.||||.+..... ..+..+|+.+|..+ +|||||++++++.+.+    .
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~----~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKND----H   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT----E
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECC----E
Confidence            357999999999999999999863     46799999865432 34556788888777 7999999999998865    4


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~ki~D  263 (461)
                      +|+||||+++|+|.++++  .+++.++..++.||+.||+|||++           +|+||||||+|||++.+ +.+||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~-----------gIiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQF-----------GIVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeCcCCHHHeEEeCCCCeEEECc
Confidence            599999999999999995  599999999999999999999999           99999999999999877 7999999


Q ss_pred             cCCccccCCCCCC--------------------------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        264 FGLALLFEPGKPC--------------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       264 FGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                      ||+|+........                          ......+||+.|||||++.+.    ..++.++||||+||++
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC----PNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC----SCCCTHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC----CCCCCccchhhhHHHH
Confidence            9999865432210                          112345799999999999764    3577889999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCC-----------------------CCccccCCCCCHHHHHHHHhccCC-CCCC---------
Q psy17532        318 WELASRCSSVSPPPGEYRL-----------------------PFSAEVGDHPSLEDMQEAVVHKKL-RPTL---------  364 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~-----------------------pf~~~~~~~~~~~~~~~~~~~~~~-~~~~---------  364 (461)
                      |||++|..||.+..++...                       .+..............+....... .+.+         
T Consensus       238 ~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  317 (361)
T 4f9c_A          238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT  317 (361)
T ss_dssp             HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred             HHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence            9999996665432211000                       000000000011111111110000 0000         


Q ss_pred             -CchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        365 -PETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       365 -p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                       .+.|  ...++++.+||.+||..||++|||++|+++|.|+-
T Consensus       318 ~~~~~--~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          318 NLEGW--NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             ----C--TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             ccccc--ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence             0011  11335788999999999999999999999998763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-49  Score=382.40  Aligned_cols=284  Identities=39%  Similarity=0.704  Sum_probs=232.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..++|++.+.||+|+||.||+|+++++.||||++..........+.|+.....++||||+++++++.........+++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            45789999999999999999999999999999997766555566777777777899999999999776544345679999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHh--------hcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLH--------EEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ||+++|+|.++++...+++..+..++.|++.||+|||        +.           +|+||||||+|||++.++.+||
T Consensus        86 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-----------~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           86 HYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-----------AIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             CCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-----------EEECSCCCGGGEEECTTSCEEE
T ss_pred             hhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-----------CeecCCCChHhEEEcCCCCEEE
Confidence            9999999999999889999999999999999999999        66           9999999999999999999999


Q ss_pred             EecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        262 ADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       262 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~-~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +|||+++........  .......||+.|+|||++.+...... .++.++|||||||++|||++|..++.. ......||
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~-~~~~~~pf  233 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI-VEDYKPPF  233 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB-CCCCCCTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc-cccccccc
Confidence            999999776543221  11234579999999999976421110 344689999999999999999655432 22336677


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ............+...+.....++.++..+.....+..+.+||.+||+.||++|||+.++++.|..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            7666666677777777777777788887766666778999999999999999999999999998654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-49  Score=418.21  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=210.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .++|++.+.||+|+||.||+|+.  +|+.||||++...... .....+|+.+|+.++|||||++++++.+..    .+||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~i  231 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN----EMVM  231 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS----EEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEE
Confidence            56899999999999999999998  4789999999765433 344578999999999999999999998865    4599


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC--CceEEEe
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD--LTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~--~~~ki~D  263 (461)
                      |||||++|+|.++|..  +.+++.++..++.||+.||+|||++           +|+||||||+|||++.+  +.+||+|
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~-----------~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-----------NYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCChhhccccCCCCCCEEEee
Confidence            9999999999999843  4699999999999999999999999           99999999999999864  8999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+.+....   .....+||+.|||||++.+     ..|+.++|||||||++|||++|           ..||.+.  
T Consensus       301 FG~a~~~~~~~---~~~~~~GT~~y~APEv~~~-----~~y~~~~DiWSlGvilyeml~G-----------~~Pf~~~--  359 (573)
T 3uto_A          301 FGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSG-----------LSPFGGE--  359 (573)
T ss_dssp             CSSCEECCTTS---EEEEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHS-----------CCSSCCS--
T ss_pred             ccceeEccCCC---ceeeeEECccccCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHC-----------CCCCCCc--
Confidence            99999876543   2334589999999999987     4678899999999999999999           6677544  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         ...+....+......... ..+.  ..+.++.+||.+||..||++|||+.|+++|.|...
T Consensus       360 ---~~~~~~~~i~~~~~~~~~-~~~~--~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          360 ---NDDETLRNVKSCDWNMDD-SAFS--GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             ---SHHHHHHHHHTTCCCCCS-GGGT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ---CHHHHHHHHHhCCCCCCc-cccc--CCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence               455666666554433221 1111  13357899999999999999999999999987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-47  Score=376.86  Aligned_cols=294  Identities=41%  Similarity=0.711  Sum_probs=238.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..++|++.+.||+|+||.||+|+++++.||||++..........+.|+.....++||||+++++++.........+++||
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  114 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT  114 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence            34689999999999999999999999999999997666555556677777777799999999999987654335679999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ||+++|+|.++++...+++..+..++.|++.||.|||+....   ...+++|+||||||+|||++.++.+||+|||+++.
T Consensus       115 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~---~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~  191 (337)
T 3mdy_A          115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS---TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK  191 (337)
T ss_dssp             CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCS---TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhh---hccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence            999999999999888899999999999999999999976221   12345899999999999999999999999999987


Q ss_pred             cCCCCCCC--CCCCCcCCCcccccccccccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        270 FEPGKPCG--DTHGQVGTRRYMAPEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       270 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~-~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      +.......  ......||+.|+|||++.+...... ..+.++|||||||++|||++|+.++... .....||........
T Consensus       192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~-~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV-EEYQLPYHDLVPSDP  270 (337)
T ss_dssp             CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC-CCCCCTTTTTSCSSC
T ss_pred             eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc-ccccccHhhhcCCCC
Confidence            65433211  1234579999999999976421110 0112489999999999999997766433 344778887777777


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ....+...+.....++.++..+.....+..+.+||.+||+.||++|||+.+++++|..+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            8888888887888888888877777778899999999999999999999999999987764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=376.04  Aligned_cols=300  Identities=42%  Similarity=0.767  Sum_probs=234.4

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCC-cccee
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE-SIHTE  184 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~-~~~~~  184 (461)
                      .+....++|++.+.||+|+||.||+|+.+++.||||++..........+.|+..+..++||||+++++.+.... .....
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            34566789999999999999999999999999999999877666666678888888899999999998654321 11345


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +++||||+++|+|.++++....++..+..++.||+.||.|||+....  ...++++|+||||||+|||++.++.+||+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~--~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPR--GDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCC--GGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhcc--ccccccceeecccccceEEEcCCCcEEEeec
Confidence            68999999999999999888889999999999999999999976211  1122448999999999999999999999999


Q ss_pred             CCccccCCCCC------CCCCCCCcCCCccccccccccccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCC--CCC
Q psy17532        265 GLALLFEPGKP------CGDTHGQVGTRRYMAPEVLEGAINFS--RDAFLRIDMYACALVLWELASRCSSVSPPP--GEY  334 (461)
Q Consensus       265 Gla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~--~~~~~k~DVwS~Gvil~el~tg~~~~~~~~--~~~  334 (461)
                      |+++.+.....      ........||+.|+|||++.+.....  ..++.++|||||||++|||++|+.|+....  ..+
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987654321      11223457999999999997632111  245568999999999999999976654332  223


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccch-hHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHA-GMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...+....+..+....+...+.....++.++..+.... .+..+.+||.+||+.||++|||++++++.|..+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            33333344556677777777777788888887766533 55689999999999999999999999999988775

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.2e-47  Score=369.97  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=205.6

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ........+|++.+.||+|+||.||+|+++++.||||++......   ...+.+|+.++.+++||||+++++++.+... 
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC-
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc-
Confidence            344566789999999999999999999999999999998654322   2345689999999999999999999987654 


Q ss_pred             ceeeeeeehhccCCChhhhhcCCC----CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC--eecccCCCCcEEEcC
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCNI----VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA--VAHRDFKSNNVLLKS  255 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~--ivHrDLkp~NILl~~  255 (461)
                         +++||||+++|+|.+++....    +++..+..++.|++.||+|||+.           +  |+||||||+|||++.
T Consensus       109 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~~~ivH~Dikp~NIll~~  174 (309)
T 3p86_A          109 ---LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-----------NPPIVHRNLKSPNLLVDK  174 (309)
T ss_dssp             ---CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-----------SSCCCCTTCCGGGEEECT
T ss_pred             ---eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------CCCEECCCCChhhEEEeC
Confidence               489999999999999997643    89999999999999999999998           7  999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      ++.+||+|||+++......  .......||+.|+|||++.+.     .++.++||||||+++|||++|           .
T Consensus       175 ~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg-----------~  236 (309)
T 3p86_A          175 KYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDE-----PSNEKSDVYSFGVILWELATL-----------Q  236 (309)
T ss_dssp             TCCEEECCCC-------------------CCTTSCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHC-----------C
T ss_pred             CCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCC-----CCCchhhHHHHHHHHHHHHhC-----------C
Confidence            9999999999998654332  223446799999999999763     567899999999999999999           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .||...     ...+....+.....+..++..++.     .+.+||.+||+.||++|||+.++++.|..+..
T Consensus       237 ~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          237 QPWGNL-----NPAQVVAAVGFKCKRLEIPRNLNP-----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CTTTTS-----CHHHHHHHHHHSCCCCCCCTTSCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCC-----CHHHHHHHHHhcCCCCCCCccCCH-----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            666543     444555555445555566655443     79999999999999999999999999876654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.3e-47  Score=371.95  Aligned_cols=294  Identities=41%  Similarity=0.736  Sum_probs=233.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      .++|++.+.||+|+||.||+|+++++.||||++..........+.++.....++||||+++++++.........+++|||
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            36899999999999999999999999999999976554444445555555558999999999999876543346699999


Q ss_pred             hccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        191 YHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       191 ~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      |+++|+|.++++...+++..+..++.|++.||.|||.....   .....+|+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~---~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  197 (342)
T 1b6c_B          121 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG---TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  197 (342)
T ss_dssp             CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCS---TTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhh---hcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence            99999999999888899999999999999999999921000   000119999999999999999999999999999876


Q ss_pred             CCCCCCC--CCCCCcCCCccccccccccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        271 EPGKPCG--DTHGQVGTRRYMAPEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       271 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      .......  ......||+.|+|||++.+..... ..++.++||||||+++|||++|+.+ .+.......||.........
T Consensus       198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~-~~~~~~~~~p~~~~~~~~~~  276 (342)
T 1b6c_B          198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPS  276 (342)
T ss_dssp             ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB-TTBCCCCCCTTTTTSCSSCC
T ss_pred             cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc-CCcccccccCccccCcCccc
Confidence            5433211  234457999999999987642111 0223679999999999999999643 33334446788777666667


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      ...+...+.....++.++..+........+.+||.+||+.||++|||+.+++++|..+...
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            7888888878888888888776666777899999999999999999999999999887653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.5e-47  Score=367.02  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=208.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++..... ......+|+.++..++||||+++++++....    .++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~   93 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELW   93 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC----EEE
Confidence            346899999999999999999987  578899999865433 2344568888899999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +||||+++|+|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+
T Consensus        94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  162 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-----------QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (297)
T ss_dssp             EEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-----------CceeCCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999999888899999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++.......  ......||+.|+|||++.+     ..++.++||||||+++|||++|           ..||...     
T Consensus       163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~pf~~~-----  219 (297)
T 3fxz_A          163 CAQITPEQS--KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEG-----------EPPYLNE-----  219 (297)
T ss_dssp             CEECCSTTC--CBCCCCSCGGGCCHHHHHC-----SCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS-----
T ss_pred             ceecCCccc--ccCCccCCcCccChhhhcC-----CCCCcHHHHHHHHHHHHHHHhC-----------CCCCCCC-----
Confidence            987764432  2345679999999999976     3678899999999999999999           5666433     


Q ss_pred             CHHHHHHHH-hccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        347 SLEDMQEAV-VHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       347 ~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ........+ .........+..+     +..+.+||.+||+.||++|||++++++|.+...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          220 NPLRALYLIATNGTPELQNPEKL-----SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             CHHHHHHHHHHHCSCCCSCGGGS-----CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CHHHHHHHHHhCCCCCCCCcccc-----CHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence            222222222 2222222333333     347899999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-46  Score=375.52  Aligned_cols=259  Identities=23%  Similarity=0.344  Sum_probs=210.6

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC---------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEE
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGA  174 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~  174 (461)
                      .....++|++.+.||+|+||.||+|++.         +..||||++.....  ......+|+.++..+ +||||++++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3456789999999999999999999873         23599999875432  233457889999999 89999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      +.+...    +++||||+++|+|.+++...                 .+++..++.++.||+.||+|||+.         
T Consensus       156 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------  222 (370)
T 2psq_A          156 CTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---------  222 (370)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---------
T ss_pred             EccCCC----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---------
Confidence            987654    49999999999999999542                 478999999999999999999999         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +|+||||||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+     ..++.++|||||||++
T Consensus       223 --~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il  295 (370)
T 2psq_A          223 --KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLM  295 (370)
T ss_dssp             --TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-----CCCCHHHHHHHHHHHH
T ss_pred             --CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-----CCCCcHHHHHHHHHHH
Confidence              999999999999999999999999999987765443333445567889999999876     3678899999999999


Q ss_pred             HHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        318 WELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       318 ~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      |||++ |           ..||...     ...++...+.. ..++..+..++     ..+.+||.+||+.||++|||+.
T Consensus       296 ~ellt~g-----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rpt~~  353 (370)
T 2psq_A          296 WEIFTLG-----------GSPYPGI-----PVEELFKLLKE-GHRMDKPANCT-----NELYMMMRDCWHAVPSQRPTFK  353 (370)
T ss_dssp             HHHHTTS-----------CCSSTTC-----CGGGHHHHHHT-TCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHcCC-----------CCCCCCC-----CHHHHHHHHhc-CCCCCCCCCCC-----HHHHHHHHHHcCCChhhCcCHH
Confidence            99999 7           5566543     33344444333 33445555443     3899999999999999999999


Q ss_pred             chhhhcHHHhh
Q psy17532        397 CVVERGMLALC  407 (461)
Q Consensus       397 evl~~l~~~~~  407 (461)
                      +++++|..+..
T Consensus       354 ell~~L~~il~  364 (370)
T 2psq_A          354 QLVEDLDRILT  364 (370)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999987764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=363.37  Aligned_cols=258  Identities=21%  Similarity=0.260  Sum_probs=204.2

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---------------------------hhHHHHHHHH
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---------------------------SWQSEQEIFK  159 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---------------------------~~~~~~ei~~  159 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||++......                           .....+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3467899999999999999999998  4678999998654311                           1345689999


Q ss_pred             cCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCC
Q psy17532        160 LPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKP  239 (461)
Q Consensus       160 l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~  239 (461)
                      +++++||||+++++++.+..  ...+++||||+++|+|.+++....+++..+..++.||+.||+|||+.           
T Consensus        90 l~~l~h~~iv~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------  156 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPN--EDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ-----------  156 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSS--SSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT-----------
T ss_pred             HHhCCCCCCCeEEEEEEcCC--CCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------
Confidence            99999999999999998643  23569999999999999998888899999999999999999999999           


Q ss_pred             CeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHH
Q psy17532        240 AVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE  319 (461)
Q Consensus       240 ~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~e  319 (461)
                      +|+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+...  ..++.++|||||||++||
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRK--IFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCC--CEESHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCC--CCCCchhhhHhHHHHHHH
Confidence            999999999999999999999999999987654321  2234579999999999876310  113567899999999999


Q ss_pred             HHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       320 l~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      |++|           ..||...     ....+...+............     .+..+.+||.+||+.||++|||+.+++
T Consensus       233 l~~g-----------~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~R~s~~e~l  291 (298)
T 2zv2_A          233 FVFG-----------QCPFMDE-----RIMCLHSKIKSQALEFPDQPD-----IAEDLKDLITRMLDKNPESRIVVPEIK  291 (298)
T ss_dssp             HHHS-----------SCSSCCS-----SHHHHHHHHHHCCCCCCSSSC-----CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             HHHC-----------CCCCCCc-----cHHHHHHHHhcccCCCCCccc-----cCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence            9999           5666543     334444444443332222222     234799999999999999999999999


Q ss_pred             hhcHH
Q psy17532        400 ERGML  404 (461)
Q Consensus       400 ~~l~~  404 (461)
                      +|.+.
T Consensus       292 ~hp~~  296 (298)
T 2zv2_A          292 LHPWV  296 (298)
T ss_dssp             TCHHH
T ss_pred             cCccc
Confidence            99875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.9e-47  Score=370.64  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=211.4

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....++|++.+.||+|+||.||+|++  +++.||||++.....   ......+|+.+++.++||||+++++++.+..   
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---   87 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK---   87 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC---
Confidence            34567899999999999999999998  578999999975432   2334568999999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||||+++|+|.+++. .+.+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||
T Consensus        88 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~-----------~ivHrDlkp~NIll~~~~~~kl  155 (328)
T 3fe3_A           88 -TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-----------RIVHRDLKAENLLLDADMNIKI  155 (328)
T ss_dssp             -EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTSCEEE
T ss_pred             -EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeccCCCHHHEEEcCCCCEEE
Confidence             4599999999999999984 46799999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++......   ......||+.|+|||++.+.    ...+.++|||||||++|||++|           ..||...
T Consensus       156 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g-----------~~pf~~~  217 (328)
T 3fe3_A          156 ADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGK----KYDGPEVDVWSLGVILYTLVSG-----------SLPFDGQ  217 (328)
T ss_dssp             CSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTC----CCCSHHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             eeccCceecCCCC---ccccccCCcceeCcccccCC----CcCCchhhhhhhHHHHHHHHhC-----------CCCCCCC
Confidence            9999998765432   23456799999999999764    1224689999999999999999           6677554


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           ...++...+..+...  +|...+     ..+.+||.+||..||++|||++++++|.|...
T Consensus       218 -----~~~~~~~~i~~~~~~--~p~~~s-----~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          218 -----NLKELRERVLRGKYR--IPFYMS-----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             -----SHHHHHHHHHHCCCC--CCTTSC-----HHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             -----CHHHHHHHHHhCCCC--CCCCCC-----HHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence                 556666666665443  333322     37899999999999999999999999988654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.8e-46  Score=366.64  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=209.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+|+.+  ++.||||++....    .......+|+.++..++||||+++++++.+..    
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----   78 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----   78 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS----
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC----
Confidence            4578999999999999999999984  7889999996532    22334567888899999999999999998865    


Q ss_pred             eeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++||||+++|+|.+++. ...+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+||+
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-----------DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCcCCHHHEEECCCCCEEEe
Confidence            4599999999999999985 45699999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||... 
T Consensus       148 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~Pf~~~-  208 (337)
T 1o6l_A          148 DFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ-  208 (337)
T ss_dssp             CCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHS-----------SCSSCCS-
T ss_pred             eccchhhcccCC--CcccccccChhhCChhhhcC-----CCCCchhhcccchhHHHHHhcC-----------CCCCCCC-
Confidence            999998643322  22445689999999999976     3678899999999999999999           6666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~~  407 (461)
                          ....+...+.....  .+|..++     .++.+||.+||+.||++||     +++++++|.+....
T Consensus       209 ----~~~~~~~~i~~~~~--~~p~~~s-----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          209 ----DHERLFELILMEEI--RFPRTLS-----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             ----SHHHHHHHHHHCCC--CCCTTSC-----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ----CHHHHHHHHHcCCC--CCCCCCC-----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence                44555555555433  3444333     3789999999999999999     89999999887543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.3e-46  Score=368.09  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=207.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~  180 (461)
                      ....++|++.+.||+|+||.||+|+.+  ++.||||++....    ........|..++..+ +||||+++++++.+.. 
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence            456789999999999999999999984  6789999997532    1223345566666655 8999999999998865 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+
T Consensus        92 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~g~v  157 (345)
T 1xjd_A           92 ---NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-----------GIVYRDLKLDNILLDKDGHI  157 (345)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSCE
T ss_pred             ---EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeCCCChhhEEECCCCCE
Confidence               45999999999999999964 6799999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||.
T Consensus       158 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~Pf~  219 (345)
T 1xjd_A          158 KIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIG-----------QSPFH  219 (345)
T ss_dssp             EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEeEChhhhhcccCC--CcccCCCCCcccCChhhhcC-----CCCCChhhhHHHHHHHHHHhcC-----------CCCCC
Confidence            999999998654332  22445689999999999976     3678899999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc-chhhhcHHHhhhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS-CVVERGMLALCDT  409 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~l~~~~~~~  409 (461)
                      ..     ...++...+....  +.+|..++     ..+.+||.+||..||++||++. ++++|.+.....+
T Consensus       220 ~~-----~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          220 GQ-----DEEELFHSIRMDN--PFYPRWLE-----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             CS-----SHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             CC-----CHHHHHHHHHhCC--CCCCcccC-----HHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence            43     4455555555443  33444333     3789999999999999999998 9999998765443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=359.61  Aligned_cols=260  Identities=24%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ...++|++.+.||+|+||.||+|++.  ++.||+|.+..... ....+.+|+.++.+++||||+++++++.+..    .+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~   82 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK----RL   82 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC----ee
Confidence            45679999999999999999999984  78899998855433 3445678999999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+++|+|.++++.  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM-----------NIIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSTTSEEECTTSCEEECC
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCCCCCcCeEEECCCCCEEEee
Confidence            899999999999999964  5699999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCC------------CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        264 FGLALLFEPGKPCG------------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       264 FGla~~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      ||+++.........            ......||+.|+|||++.+     ..++.++||||||+++|||++|..++....
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~~~~~~~  226 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-----RSYDEKVDVFSFGIVLCEIIGRVNADPDYL  226 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcC-----CCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence            99998765432211            1114579999999999976     367789999999999999999965543221


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      ..           ...............    .+..++.     .+.++|.+||+.||++|||+.++++.+..+...
T Consensus       227 ~~-----------~~~~~~~~~~~~~~~----~~~~~~~-----~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          227 PR-----------TMDFGLNVRGFLDRY----CPPNCPP-----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             CB-----------CTTSSBCHHHHHHHT----CCTTCCT-----THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hh-----------HHHHhhhhhcccccc----CCCCCCH-----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11           101000011111111    1222222     688999999999999999999999998877654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-45  Score=351.84  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=211.5

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ....++|++.+.||+|+||.||+|+++++.||||++....   .....+.+|+.++.+++||||+++++++.+...  ..
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~   83 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA--PH   83 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS--SS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC--CC
Confidence            4566799999999999999999999999999999997543   223456789999999999999999999987631  24


Q ss_pred             eeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC--eecccCCCCcEEEcCCCce
Q psy17532        185 FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA--VAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~--ivHrDLkp~NILl~~~~~~  259 (461)
                      +++||||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +  |+||||||+|||++.++.+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~~~i~H~dikp~Nil~~~~~~~  152 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-----------EPLIPRHALNSRSVMIDEDMTA  152 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-----------SSCCTTCCCSGGGEEECTTSCE
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-----------CCceecCCCccceEEEcCCcce
Confidence            58999999999999999654   389999999999999999999998           6  9999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      +|+|||++....       .....||+.|+|||++.+...  ..++.++||||||+++|||++|           ..||.
T Consensus       153 ~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~--~~~~~~~Di~slG~il~el~~g-----------~~p~~  212 (271)
T 3kmu_A          153 RISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPE--DTNRRSADMWSFAVLLWELVTR-----------EVPFA  212 (271)
T ss_dssp             EEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGG--GSCHHHHHHHHHHHHHHHHHHC-----------SCTTT
T ss_pred             eEEeccceeeec-------ccCccCCccccChhhhccCCC--CCCCchhhHHHHHHHHHHHHhC-----------CCCcc
Confidence            999999876532       223578999999999976421  1233479999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ........+.....++.++..++.     .+.+++.+||+.||++|||++++++.+..+.
T Consensus       213 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          213 DL-----SNMEIGMKVALEGLRPTIPPGISP-----HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             TS-----CHHHHHHHHHHSCCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cc-----ChHHHHHHHHhcCCCCCCCCCCCH-----HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            43     445555556666666666665543     7999999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=370.81  Aligned_cols=258  Identities=21%  Similarity=0.297  Sum_probs=204.0

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|+||.||+|+.+  ++.||||++....    ........|+.++..+ +||||+++++++.+..
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            3456789999999999999999999984  6889999997532    1223345677777766 7999999999998865


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.
T Consensus        98 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------givHrDlkp~NILl~~~g~  162 (353)
T 3txo_A           98 ----RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK-----------GIIYRDLKLDNVLLDHEGH  162 (353)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSC
T ss_pred             ----EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCcccCCCHHHEEECCCCC
Confidence                45999999999999999954 5799999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+|+......  ......+||+.|+|||++.+.     .++.++|||||||++|||++|           ..||
T Consensus       163 ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~G-----------~~Pf  224 (353)
T 3txo_A          163 CKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEM-----LYGPAVDWWAMGVLLYEMLCG-----------HAPF  224 (353)
T ss_dssp             EEECCCTTCBCSCC-----------CCGGGCCHHHHHHH-----HCTTHHHHHHHHHHHHHHHHS-----------SCSS
T ss_pred             EEEccccceeecccCC--ccccccCCCcCeEChhhcCCC-----CcCCccCCCcchHHHHHHHhC-----------CCCC
Confidence            9999999998643322  234456899999999999763     577899999999999999999           6677


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc------cchhhhcHHHhhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA------SCVVERGMLALCDT  409 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~~~~~~~  409 (461)
                      ...     +..++...+.....  .+|..++     ..+.+||.+||..||++||++      .++++|.++....+
T Consensus       225 ~~~-----~~~~~~~~i~~~~~--~~p~~~~-----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          225 EAE-----NEDDLFEAILNDEV--VYPTWLH-----EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             CCS-----SHHHHHHHHHHCCC--CCCTTSC-----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             CCC-----CHHHHHHHHHcCCC--CCCCCCC-----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence            544     55566666665543  3343333     378999999999999999999      78999998765433

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.8e-46  Score=374.26  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=210.1

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ......++|++.+.||+|+||.||+|++.  ++.||||.+.....  ....+.+|+.++++++||||+++++++..... 
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-  186 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-  186 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC-
Confidence            34556789999999999999999999994  78899999864422  22345689999999999999999999987654 


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         +++||||+++|+|.++++.  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+
T Consensus       187 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivHrDlkp~Nil~~~~~~~  252 (377)
T 3cbl_A          187 ---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK-----------CCIHRDLAARNCLVTEKNVL  252 (377)
T ss_dssp             ---CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCCE
T ss_pred             ---cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcCCcccCHHHEEEcCCCcE
Confidence               4899999999999999964  3599999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+++...............++..|+|||++.+.     .++.++|||||||++|||++ |           ..||
T Consensus       253 kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~t~g-----------~~p~  316 (377)
T 3cbl_A          253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-----RYSSESDVWSFGILLWETFSLG-----------ASPY  316 (377)
T ss_dssp             EECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTS-----------CCSS
T ss_pred             EECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-----CCCchhhHHHHHHHHHHHHhCC-----------CCCC
Confidence            99999999875443211112223467789999998753     56778999999999999999 7           5666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ...+....+. ...+...|..++.     .+.+||.+||+.||++|||+.++++.|..+..
T Consensus       317 ~~~-----~~~~~~~~~~-~~~~~~~~~~~~~-----~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          317 PNL-----SNQQTREFVE-KGGRLPCPELCPD-----AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             TTS-----CHHHHHHHHH-TTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC-----CHHHHHHHHH-cCCCCCCCCCCCH-----HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            543     3344444443 3445555655443     79999999999999999999999999877654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.6e-46  Score=353.73  Aligned_cols=257  Identities=20%  Similarity=0.344  Sum_probs=212.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ....++|++.+.||+|+||.||+|++ +++.||||++...........+|+.++.+++||||+++++++.+...    ++
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~   81 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----IC   81 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----EE
T ss_pred             EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc----eE
Confidence            34567899999999999999999999 56789999998766556677889999999999999999999987653    58


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-----------CVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCcchheEEEcCCCCEEeccc
Confidence            99999999999999954  3489999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++....... .......+|..|+|||++.+     ..++.++||||||+++|||++ |           ..||...  
T Consensus       151 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~~g-----------~~p~~~~--  211 (269)
T 4hcu_A          151 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEG-----------KIPYENR--  211 (269)
T ss_dssp             TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCTTTTC--
T ss_pred             ccccccccccc-ccccCcccccccCCHHHhcC-----CCCCchhhhHHHHHHHHHHhcCC-----------CCCCCCC--
Confidence            99987654321 12334567888999999875     367789999999999999999 7           6666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                         ...+....+... .++..+...+     ..+.+++.+||+.||++|||+.++++++..+..
T Consensus       212 ---~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          212 ---SNSEVVEDISTG-FRLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---CHHHHHHHHHTT-CCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHhcC-ccCCCCCcCC-----HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               444544444333 3334443333     379999999999999999999999999987764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=361.69  Aligned_cols=258  Identities=26%  Similarity=0.361  Sum_probs=206.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....+|++.+.||+|+||.||+|++.     +..||||++.....  ....+.+|+.++..++||||+++++++.+.. 
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  123 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-  123 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence            345678999999999999999999983     23499999975422  2345678999999999999999999998755 


Q ss_pred             cceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                         .+++||||+++|+|.++++.  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.
T Consensus       124 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~~~~  189 (325)
T 3kul_A          124 ---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL-----------GYVHRDLAARNVLVDSNLV  189 (325)
T ss_dssp             ---CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCC
T ss_pred             ---ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeCCCCCcceEEECCCCC
Confidence               34899999999999999954  4699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      +||+|||+++........ .......+|+.|+|||++.+.     .++.++||||||+++|||++ |           ..
T Consensus       190 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~~g-----------~~  253 (325)
T 3kul_A          190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-----TFSSASDVWSFGVVMWEVLAYG-----------ER  253 (325)
T ss_dssp             EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTS-----------CC
T ss_pred             EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-----CCCcHHHHHHHHHHHHHHHcCC-----------CC
Confidence            999999999887543221 122334567889999999753     56788999999999999999 7           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ||...     ...++...+... .+...+..++     ..+.+||.+||..||++|||+.++++.|..+..
T Consensus       254 p~~~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          254 PYWNM-----TNRDVISSVEEG-YRLPAPMGCP-----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             TTTTS-----CHHHHHHHHHTT-CCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcccC-----CHHHHHHHHHcC-CCCCCCCCcC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            66543     444555444433 3444444433     389999999999999999999999999987764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.3e-46  Score=354.45  Aligned_cols=251  Identities=26%  Similarity=0.419  Sum_probs=198.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChh-----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ-----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~-----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ...++|++.+.||+|+||.||+|++.++.||||++......     .....+|+.++..++||||+++++++.+...   
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN---   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc---
Confidence            35678999999999999999999999999999998643221     2345678888999999999999999987653   


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC---eecccCCCCcEEEcC-----
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA---VAHRDFKSNNVLLKS-----  255 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~---ivHrDLkp~NILl~~-----  255 (461)
                       +++||||+++|+|.++++...+++..+..++.|++.||.|||++           +   |+||||||+|||++.     
T Consensus        81 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~-----------~~~~i~H~dikp~Nil~~~~~~~~  148 (271)
T 3dtc_A           81 -LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE-----------AIVPIIHRDLKSSNILILQKVENG  148 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHS-----------SSSCCCCSCCSGGGEEESSCCSSS
T ss_pred             -eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CCCceeecCCchHHEEEecccccc
Confidence             48999999999999999888999999999999999999999998           6   999999999999986     


Q ss_pred             ---CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q psy17532        256 ---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG  332 (461)
Q Consensus       256 ---~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~  332 (461)
                         ++.+||+|||+++......    .....||+.|+|||++.+     ..++.++||||||+++|||++|         
T Consensus       149 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g---------  210 (271)
T 3dtc_A          149 DLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRA-----SMFSKGSDVWSYGVLLWELLTG---------  210 (271)
T ss_dssp             CCSSCCEEECCCCC-----------------CCGGGSCHHHHHH-----CCCSHHHHHHHHHHHHHHHHHC---------
T ss_pred             cccCcceEEccCCccccccccc----ccCCCCccceeCHHHhcc-----CCCCchhhHHHHHHHHHHHHhC---------
Confidence               6789999999998765432    224578999999999876     3577889999999999999999         


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                        ..||...     ........+........++..++     ..+.++|.+||+.||++|||+.+++++|..
T Consensus       211 --~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          211 --EVPFRGI-----DGLAVAYGVAMNKLALPIPSTCP-----EPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             --CCTTTTS-----CHHHHHHHHHTSCCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             --CCCCCCC-----CHHHHHHhhhcCCCCCCCCcccC-----HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence              5666543     33444444555555555555444     379999999999999999999999999853

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-46  Score=366.10  Aligned_cols=257  Identities=24%  Similarity=0.319  Sum_probs=201.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++......  .....+|+.++..++||||+++++++.+..    ..+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~   81 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN----IQY   81 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS----EEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----eEE
Confidence            468999999999999999999984  788999998654322  234568888899999999999999998765    458


Q ss_pred             eeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.+++... .+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-----------GITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccccchHHEEEeCCCCEEEEEee
Confidence            999999999999999754 699999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.+.............||+.|+|||++.+.    ..++.++|||||||++|||++|           ..||.....  
T Consensus       151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g-----------~~pf~~~~~--  213 (323)
T 3tki_A          151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRR----EFHAEPVDVWSCGIVLTAMLAG-----------ELPWDQPSD--  213 (323)
T ss_dssp             TCEECEETTEECCBCSCCSCGGGSCHHHHHCS----SBCHHHHHHHHHHHHHHHHHHS-----------SCSCSSSCT--
T ss_pred             ccceeccCCcccccCCCccCcCccCcHHhccC----CCCCCcccHHHHHHHHHHHHhC-----------CCCCCCCch--
Confidence            99876433222233456899999999999763    2235679999999999999999           555543311  


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ....... .............     .+..+.+||.+||..||++|||+.|++++.|...
T Consensus       214 -~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          214 -SCQEYSD-WKEKKTYLNPWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             -TSHHHHH-HHTTCTTSTTGGG-----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -HHHHHHH-HhcccccCCcccc-----CCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence             1111111 1111111111111     2347889999999999999999999999988653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-46  Score=365.04  Aligned_cols=255  Identities=20%  Similarity=0.272  Sum_probs=211.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||+|.+...........+|+.++..++||||+++++++.+..    .+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME----ELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT----EEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC----EEEEE
Confidence            468999999999999999999984  678999999766655566778999999999999999999998765    45999


Q ss_pred             ehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC--CCceEEEec
Q psy17532        189 TAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS--DLTAAIADF  264 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~--~~~~ki~DF  264 (461)
                      |||+++|+|.+++...  .+++..+..++.|++.||.|||+.           +|+||||||+|||++.  ++.+||+||
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------givH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-----------NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence            9999999999999653  599999999999999999999999           9999999999999997  789999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.+..+.   ......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...   
T Consensus       149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g-----------~~pf~~~---  206 (321)
T 1tki_A          149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHD-----VVSTATDMWSLGTLVYVLLSG-----------INPFLAE---  206 (321)
T ss_dssp             TTCEECCTTC---EEEEEESCGGGSCHHHHTTC-----EECHHHHHHHHHHHHHHHHHS-----------SCTTCCS---
T ss_pred             CCCeECCCCC---ccccccCChhhcCcHHhcCC-----CCCchhhHHHHHHHHHHHHhC-----------CCCCcCC---
Confidence            9998876443   12345789999999999763     467889999999999999999           6666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                        ...+....+........ +..+.  ..+.++.+||.+||..||++|||+.|+++|.+....
T Consensus       207 --~~~~~~~~i~~~~~~~~-~~~~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          207 --TNQQIIENIMNAEYTFD-EEAFK--EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --SHHHHHHHHHHTCCCCC-HHHHT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --CHHHHHHHHHcCCCCCC-hhhhc--cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence              44555555555443221 11111  133589999999999999999999999999987543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-45  Score=365.57  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=207.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh-------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ-------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .+.|++.+.||+|+||.||+|+..  ++.||||++......       .....+|+.++..++||||+++++++.+..  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--   88 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT--   88 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence            457999999999999999999984  788999999754321       245678999999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC---
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL---  257 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~---  257 (461)
                        .+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++   
T Consensus        89 --~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------givHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           89 --DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK-----------KIAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             --EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESCTTSSS
T ss_pred             --EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEEeCCCCCc
Confidence              45999999999999999954 4699999999999999999999999           999999999999998877   


Q ss_pred             -ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 -TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 -~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                       .+||+|||+++.+....   ......||+.|+|||++.+     ..++.++|||||||++|||++|           ..
T Consensus       156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~~ll~g-----------~~  216 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSG-----------AS  216 (361)
T ss_dssp             CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------CC
T ss_pred             cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcC-----CCCCccccHHHHHHHHHHHHhC-----------CC
Confidence             79999999998876543   2344679999999999876     3677899999999999999999           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||.+.     ...+....+.....  .++..+. ...+..+.+||.+||..||++|||+.++++|.|..
T Consensus       217 Pf~~~-----~~~~~~~~i~~~~~--~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          217 PFLGD-----TKQETLANITAVSY--DFDEEFF-SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             SSCCS-----SHHHHHHHHHTTCC--CCCHHHH-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             CCCCC-----CHHHHHHHHHhcCC--CCCchhc-cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            66543     44455555544432  2222111 11334789999999999999999999999998864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-45  Score=358.14  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||++....    .......+|+.++..++||||+++++++.+..   
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~---   79 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ---   79 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS---
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC---
Confidence            4567999999999999999999998  47889999997532    12234457888889999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||
T Consensus        80 -~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~g~~kL  147 (318)
T 1fot_A           80 -QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK-----------DIIYRDLKPENILLDKNGHIKI  147 (318)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCCGGGEEECTTSCEEE
T ss_pred             -EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCChheEEEcCCCCEEE
Confidence             45999999999999999954 5699999999999999999999998           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++.....     .....||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...
T Consensus       148 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~pf~~~  206 (318)
T 1fot_A          148 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAG-----------YTPFYDS  206 (318)
T ss_dssp             CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHS-----------SCTTCCS
T ss_pred             eecCcceecCCc-----cccccCCccccCHhHhcC-----CCCCcccchhhhHHHHHHHHhC-----------CCCCCCC
Confidence            999999876432     334679999999999876     3677899999999999999999           6666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~~  407 (461)
                           ........+.....  .+|..++     .++.+||.+||..||++||     +++++++|.+....
T Consensus       207 -----~~~~~~~~i~~~~~--~~p~~~~-----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          207 -----NTMKTYEKILNAEL--RFPPFFN-----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             -----SHHHHHHHHHHCCC--CCCTTSC-----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             -----CHHHHHHHHHhCCC--CCCCCCC-----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence                 44455555555433  3444333     3789999999999999999     89999999987543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-45  Score=377.97  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=212.7

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .......++|++.+.||+|+||.||+|+++ +..||||++.........+.+|+.++++++|||||++++++.. .    
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~----  255 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E----  255 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S----
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C----
Confidence            334566789999999999999999999995 6789999998766556677899999999999999999999863 2    


Q ss_pred             eeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        184 EFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      .+++||||+++|+|.++++..   .+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+|
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivHrDlkp~Nill~~~~~~k  324 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-----------NYIHRDLRAANILVSASLVCK  324 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSSCSGGGEEECTTCCEE
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCCCCCHHHEEECCCCcEE
Confidence            348999999999999999643   689999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~  339 (461)
                      |+|||+++....... .......+|..|+|||++.+     ..++.++|||||||++|||++ |           ..||.
T Consensus       325 l~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~t~g-----------~~P~~  387 (454)
T 1qcf_A          325 IADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYG-----------RIPYP  387 (454)
T ss_dssp             ECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCSST
T ss_pred             EeeCCCceEcCCCce-eccCCCcccccccCHHHhcc-----CCCCcHHHHHhHHHHHHHHHhCC-----------CCCCC
Confidence            999999987654221 12233457889999999975     367789999999999999999 7           66775


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ...++...+.. ..+...|..++     ..+.+||.+||+.||++|||+.++++.|..+.
T Consensus       388 ~~-----~~~~~~~~i~~-~~~~~~~~~~~-----~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          388 GM-----SNPEVIRALER-GYRMPRPENCP-----EELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             TC-----CHHHHHHHHHH-TCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CC-----CHHHHHHHHHc-CCCCCCCCCCC-----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            43     44455554443 34455555444     38999999999999999999999999886554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-45  Score=377.17  Aligned_cols=253  Identities=24%  Similarity=0.426  Sum_probs=207.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ....++|++.+.||+|+||.||+|+++++.||||+++... ....+.+|+.++++++||||+++++++.....   .+++
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~i  264 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYI  264 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS---CEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC---ceEE
Confidence            4566899999999999999999999999999999997543 44566789999999999999999999876542   3589


Q ss_pred             eehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        188 ITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||+++|+|.++++..   .+++..++.++.||+.||+|||++           +|+||||||+|||++.++.+||+||
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-----------NFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCCHhhEEECCCCCEEEeeC
Confidence            99999999999999642   379999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++.....     .....++..|+|||++.+     ..++.++|||||||++|||++ |           ..||...  
T Consensus       334 G~a~~~~~~-----~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g-----------~~P~~~~--  390 (450)
T 1k9a_A          334 GLTKEASST-----QDTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFG-----------RVPYPRI--  390 (450)
T ss_dssp             TTCEECC-----------CCCTTTSCHHHHHS-----SCCCHHHHHHHHHHHHHHHHTTT-----------CCSSTTS--
T ss_pred             CCccccccc-----ccCCCCCcceeCHHHhcC-----CCCCcHHHHHHHHHHHHHHHhCC-----------CCCCCCC--
Confidence            999865422     122367889999999976     367889999999999999998 7           5666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                         ...+....+. .+.++..|..++.     .+.+||.+||+.||++|||+.++++.|..+..
T Consensus       391 ---~~~~~~~~i~-~~~~~~~p~~~~~-----~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          391 ---PLKDVVPRVE-KGYKMDAPDGCPP-----AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ---CTTTHHHHHH-TTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHH-cCCCCCCCCcCCH-----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence               2223333333 3445556655443     89999999999999999999999999877664

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=367.29  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=212.8

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECC---------CcEEEEEEecCChh--hhHHHHHHHHcCCC-CCCCeeEEEE
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKN---------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHM-EHDNILRYIG  173 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l-~H~nIv~l~g  173 (461)
                      ......++|++.+.||+|+||.||+|++.+         ..||||++......  .....+|+.++.++ +||||+++++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            345566899999999999999999999732         46999999754332  24456888888888 9999999999


Q ss_pred             EEecCCccceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCC
Q psy17532        174 AEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADS  236 (461)
Q Consensus       174 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~  236 (461)
                      ++.....    +++||||+++|+|.+++...                 .+++..++.++.||+.||.|||+.        
T Consensus       143 ~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------  210 (382)
T 3tt0_A          143 ACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--------  210 (382)
T ss_dssp             EECSSSS----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--------
T ss_pred             eeccCCc----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--------
Confidence            9987654    48999999999999999542                 489999999999999999999999        


Q ss_pred             CCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHH
Q psy17532        237 YKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALV  316 (461)
Q Consensus       237 ~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvi  316 (461)
                         +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+     ..++.++|||||||+
T Consensus       211 ---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~i  282 (382)
T 3tt0_A          211 ---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVL  282 (382)
T ss_dssp             ---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-----CCCCHHHHHHHHHHH
T ss_pred             ---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-----CCCCchhHHHHHHHH
Confidence               999999999999999999999999999987765443333445567899999999976     367789999999999


Q ss_pred             HHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc
Q psy17532        317 LWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA  395 (461)
Q Consensus       317 l~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  395 (461)
                      +|||++ |           ..||...     ...++...+.. ..++..+..++     ..+.+||.+||+.||++|||+
T Consensus       283 l~ellt~g-----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~  340 (382)
T 3tt0_A          283 LWEIFTLG-----------GSPYPGV-----PVEELFKLLKE-GHRMDKPSNCT-----NELYMMMRDCWHAVPSQRPTF  340 (382)
T ss_dssp             HHHHHTTS-----------CCSSTTC-----CHHHHHHHHHT-TCCCCCCSSCC-----HHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHhCC-----------CCCCCCC-----CHHHHHHHHHc-CCCCCCCccCC-----HHHHHHHHHHcCCChhhCcCH
Confidence            999999 7           5666543     44455544433 33444454433     389999999999999999999


Q ss_pred             cchhhhcHHHhhh
Q psy17532        396 SCVVERGMLALCD  408 (461)
Q Consensus       396 ~evl~~l~~~~~~  408 (461)
                      .+++++|..+...
T Consensus       341 ~ell~~L~~~~~~  353 (382)
T 3tt0_A          341 KQLVEDLDRIVAL  353 (382)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999887753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-45  Score=370.22  Aligned_cols=265  Identities=18%  Similarity=0.275  Sum_probs=205.1

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.++||+|+||.||+|+.+  ++.||||++.....    .......|..++.++ +|||||++++++.+..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            3456789999999999999999999984  67899999975421    122345667666665 8999999999998765


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.
T Consensus       127 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------givHrDLKp~NILl~~~g~  191 (396)
T 4dc2_A          127 ----RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-----------GIIYRDLKLDNVLLDSEGH  191 (396)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSC
T ss_pred             ----EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEeccCCHHHEEECCCCC
Confidence                45999999999999999854 5799999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+|+......  ......+||+.|+|||++.+     ..++.++|||||||++|||++|..||......     
T Consensus       192 ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~DiwslGvllyell~G~~Pf~~~~~~-----  259 (396)
T 4dc2_A          192 IKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-----  259 (396)
T ss_dssp             EEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------
T ss_pred             EEEeecceeeecccCC--CccccccCCcccCCchhhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCcccccc-----
Confidence            9999999998643222  23445789999999999976     36788999999999999999995544321110     


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc------cchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA------SCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~~~~~  407 (461)
                        ..........+...+....  ..+|..++     .++.+||.+||+.||++||++      +++++|.++...
T Consensus       260 --~~~~~~~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          260 --DNPDQNTEDYLFQVILEKQ--IRIPRSLS-----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             -------CCHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             --cccchhhHHHHHHHHhccc--cCCCCcCC-----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence              0011112333444444433  34454443     378999999999999999996      689999887544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=373.36  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=207.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      ....++|++.+.||+|+||.||+|++.       ++.||||++....  .......+|+.++.+++||||+++++++.+.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            345678999999999999999999963       3579999986432  2233567889999999999999999999876


Q ss_pred             CccceeeeeeehhccCCChhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCc
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC--------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN  250 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~N  250 (461)
                      ...    ++||||+++|+|.++++.        ..+++..++.++.||+.||+|||++           +|+||||||+|
T Consensus       147 ~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlkp~N  211 (367)
T 3l9p_A          147 LPR----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-----------HFIHRDIAARN  211 (367)
T ss_dssp             SSC----EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGG
T ss_pred             CCC----EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCChhh
Confidence            543    899999999999999953        2489999999999999999999999           99999999999


Q ss_pred             EEEcCCC---ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCC
Q psy17532        251 VLLKSDL---TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSS  326 (461)
Q Consensus       251 ILl~~~~---~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~  326 (461)
                      ||++.++   .+||+|||+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++ |   
T Consensus       212 Ill~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~ellt~g---  283 (367)
T 3l9p_A          212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-----GIFTSKTDTWSFGVLLWEIFSLG---  283 (367)
T ss_dssp             EEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS---
T ss_pred             EEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-----CCCCcHHHHHHHHHHHHHHHhCC---
Confidence            9999554   599999999986543322223344568999999999876     367789999999999999998 7   


Q ss_pred             CCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                              ..||...     ...++...+.... ++..+..++     ..+.+||.+||+.||++|||+.+++++++.+.
T Consensus       284 --------~~pf~~~-----~~~~~~~~i~~~~-~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          284 --------YMPYPSK-----SNQEVLEFVTSGG-RMDPPKNCP-----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             --------CCSSTTC-----CHHHHHHHHHTTC-CCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCC-----CHHHHHHHHHcCC-CCCCCccCC-----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                    6666543     4455555554433 334444433     37999999999999999999999999998776


Q ss_pred             h
Q psy17532        407 C  407 (461)
Q Consensus       407 ~  407 (461)
                      .
T Consensus       345 ~  345 (367)
T 3l9p_A          345 Q  345 (367)
T ss_dssp             H
T ss_pred             h
Confidence            5

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-46  Score=369.64  Aligned_cols=261  Identities=24%  Similarity=0.325  Sum_probs=207.8

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh--hhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      .....++|++.+.||+|+||.||+|++.       ++.||||++......  .....+|+.++.++ +||||+++++++.
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3456789999999999999999999852       367999999754332  23467889988888 8999999999987


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcCCC---------------------------------------------------
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKCNI---------------------------------------------------  205 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------  205 (461)
                      ....   .+++||||+++|+|.++++...                                                   
T Consensus        97 ~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           97 KPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             STTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             cCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            7542   3589999999999999995432                                                   


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        206 ----------------VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       206 ----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                                      +++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-----------~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  242 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-----------KCIHRDLAARNILLSEKNVVKICDFGLARD  242 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCChhhEEEcCCCcEEEEeccceee
Confidence                            88999999999999999999999           999999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      +.............||+.|+|||++.+     ..++.++||||||+++|||++ |           ..||....    ..
T Consensus       243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g-----------~~p~~~~~----~~  302 (359)
T 3vhe_A          243 IYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLG-----------ASPYPGVK----ID  302 (359)
T ss_dssp             TTSCTTCEEC--CEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTS-----------CCSSTTCC----CS
T ss_pred             ecccccchhccccCCCceeEChhhhcC-----CCCCchhhhhhHHHHHHHHHhcC-----------CCCCCccc----hh
Confidence            654433233445678999999999875     367789999999999999998 8           55664431    11


Q ss_pred             HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       349 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .... ...........+..++     ..+.++|.+||+.||++|||+.+++++|..+..
T Consensus       303 ~~~~-~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          303 EEFC-RRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHH-HHHHHTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH-HHHHcCCCCCCCCCCC-----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2222 2233333444554433     379999999999999999999999999987764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.7e-46  Score=375.06  Aligned_cols=263  Identities=19%  Similarity=0.205  Sum_probs=210.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.+.||+|+||.||+|+.+  ++.||||++....    .......+|+.++..++|||||++++++.+..   
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---  142 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR---  142 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence            34678999999999999999999994  6789999996422    12223457788888999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                       .+++||||+++|+|.++++...+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus       143 -~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~-----------givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          143 -YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM-----------GFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             -EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEEC
T ss_pred             -EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeccCCHHHeeECCCCCEEEe
Confidence             459999999999999999888899999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+....... ......+||+.|+|||++.+... ...++.++|||||||++|||++|           ..||... 
T Consensus       211 DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~-~~~~~~~~DiwSlGvilyell~G-----------~~Pf~~~-  276 (410)
T 3v8s_A          211 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVG-----------DTPFYAD-  276 (410)
T ss_dssp             CCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTT-TCEEETHHHHHHHHHHHHHHHHS-----------SCTTCCS-
T ss_pred             ccceeEeeccCCc-ccccCCcCCccccCHHHhhccCC-CcCCCCcceEecchHHHHHHHhC-----------CCCCCCC-
Confidence            9999987654321 12345689999999999975310 11267899999999999999999           6666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~~~  407 (461)
                          +.......+........+|..   ...+.++.+||.+||..+|++  ||+++|+++|.++...
T Consensus       277 ----~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          277 ----SLVGTYSKIMNHKNSLTFPDD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             ----SHHHHHHHHHTHHHHCCCCTT---CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ----ChhhHHHHHHhccccccCCCc---ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                445555555543322233321   112347999999999999988  9999999999987543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.2e-45  Score=352.60  Aligned_cols=260  Identities=20%  Similarity=0.335  Sum_probs=210.4

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .......++|++.+.||+|+||.||+|.+.+ ..||||++...........+|+.++.+++||||+++++++.+..    
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   92 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR----   92 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC----
Confidence            3445677899999999999999999999964 57999999876655566788999999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      .+++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dikp~Nili~~~~~~kl  161 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-----------QFLHRDLAARNCLVNDQGVVKV  161 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSSCSGGGEEECTTSCEEE
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC-----------CccCCCCccceEEEcCCCCEEE
Confidence            35899999999999999965  5699999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++....... .......+|+.|+|||++.+.     .++.++||||||+++|||++ |           ..||..
T Consensus       162 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~~l~t~g-----------~~p~~~  224 (283)
T 3gen_A          162 SDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS-----KFSSKSDIWAFGVLMWEIYSLG-----------KMPYER  224 (283)
T ss_dssp             CSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTT-----------CCTTTT
T ss_pred             cccccccccccccc-ccccCCccCcccCCHHHhccC-----CCCchhhHHHHHHHHHHHHhCC-----------CCCccc
Confidence            99999987654321 123344578889999998753     57789999999999999998 7           666654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .     ...+....+.. ..+...+...+     ..+.+++.+||+.||++|||+.++++++..+..
T Consensus       225 ~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          225 F-----TNSETAEHIAQ-GLRLYRPHLAS-----EKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             S-----CHHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c-----ChhHHHHHHhc-ccCCCCCCcCC-----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            3     33444444433 33334443333     379999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7e-45  Score=356.17  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=206.0

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .|+..+.||+|+||.||+|+.  +|+.||||++...... .....+|+.++.+++||||+++++++....    .+++||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE----ELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----EEEEEE
Confidence            478888999999999999998  4789999999754433 334568999999999999999999998765    459999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ||+++|+|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||+++.
T Consensus       122 e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  190 (321)
T 2c30_A          122 EFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ-----------GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  190 (321)
T ss_dssp             CCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence            999999999999888899999999999999999999999           999999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHH
Q psy17532        270 FEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE  349 (461)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~  349 (461)
                      ......  ......||+.|+|||++.+     ..++.++||||||+++|||++|           ..||...     ...
T Consensus       191 ~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g-----------~~pf~~~-----~~~  247 (321)
T 2c30_A          191 ISKDVP--KRKSLVGTPYWMAPEVISR-----SLYATEVDIWSLGIMVIEMVDG-----------EPPYFSD-----SPV  247 (321)
T ss_dssp             CCSSSC--CBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS-----CHH
T ss_pred             cccCcc--ccccccCCccccCHhhhcC-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-----CHH
Confidence            754322  2344679999999999976     3677899999999999999999           5566433     233


Q ss_pred             HHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       350 ~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      +....+.... .+.+...   ...+..+.++|.+||+.||++|||+.++++|.+...
T Consensus       248 ~~~~~~~~~~-~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          248 QAMKRLRDSP-PPKLKNS---HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             HHHHHHHHSS-CCCCTTG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             HHHHHHhcCC-CCCcCcc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            3333333321 2222211   113347999999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.8e-46  Score=377.36  Aligned_cols=267  Identities=20%  Similarity=0.209  Sum_probs=212.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.++||+|+||.||+|+++  ++.||||++.....    ......+|+.++..++||||+++++++.+..   
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~---  147 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN---  147 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS---
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC---
Confidence            34678999999999999999999995  57899999964221    1223567777888899999999999998865   


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       .+++||||+++|+|.+++..  ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+|
T Consensus       148 -~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-----------giiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          148 -NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL-----------HYVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             -EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEE
T ss_pred             -EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEecccCHHHeeEcCCCCEE
Confidence             45999999999999999965  5799999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+....... ......+||+.|+|||++.+.......++.++|||||||++|||++|           ..||..
T Consensus       216 L~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG-----------~~Pf~~  283 (437)
T 4aw2_A          216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG-----------ETPFYA  283 (437)
T ss_dssp             ECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS-----------SCTTCC
T ss_pred             EcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC-----------CCCCCC
Confidence            999999987654332 12334689999999999863111124577899999999999999999           666654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhh--hccccchhhhcHHHhhhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEA--RLSASCVVERGMLALCDT  409 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~~~~~~  409 (461)
                      .     +..+....+.....+..+|..+..  .+.++.+||++||..+|++  ||+++|+++|.+.....+
T Consensus       284 ~-----~~~~~~~~i~~~~~~~~~p~~~~~--~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          284 E-----SLVETYGKIMNHKERFQFPTQVTD--VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             S-----SHHHHHHHHHTHHHHCCCCSSCCC--SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             C-----ChhHHHHhhhhccccccCCccccc--CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            3     445555555443323344433211  2347899999999999988  999999999998865433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.7e-45  Score=363.28  Aligned_cols=254  Identities=20%  Similarity=0.308  Sum_probs=207.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|..+  ++.||||++.....   ......+|+.++..++||||+++++++.+..    .+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~  103 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES----FH  103 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----EE
Confidence            457999999999999999999984  78899999975432   2234568999999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC---CceEE
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD---LTAAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~---~~~ki  261 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.+   +.+||
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-----------GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeccCchHHEEEecCCCCCCEEE
Confidence            999999999999998854 5689999999999999999999999           99999999999999865   45999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++......   ......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...
T Consensus       173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g-----------~~Pf~~~  233 (362)
T 2bdw_A          173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVG-----------YPPFWDE  233 (362)
T ss_dssp             CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             eecCcceEecCCc---ccccCCCCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHHC-----------CCCCCCC
Confidence            9999998776432   2334679999999999876     3677899999999999999999           6666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           ....+...+.........+ .|.  ..+.++.+||.+||..||++|||+.++++|.|...
T Consensus       234 -----~~~~~~~~i~~~~~~~~~~-~~~--~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          234 -----DQHRLYAQIKAGAYDYPSP-EWD--TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             -----SHHHHHHHHHHTCCCCCTT-GGG--GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             -----CHHHHHHHHHhCCCCCCcc-ccc--CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                 4455555555554433222 222  13358999999999999999999999999988653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-45  Score=356.02  Aligned_cols=273  Identities=25%  Similarity=0.354  Sum_probs=204.2

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|+||.||+|++      +++.||||++...... .....+|+.++.+++||||+++++++....
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345668999999999999999999995      4678999998755433 245678999999999999999999986543


Q ss_pred             ccceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      .  ..+++||||+++|+|.+++...  .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus        85 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dikp~Nil~~~~~  151 (295)
T 3ugc_A           85 R--RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK-----------RYIHRDLATRNILVENEN  151 (295)
T ss_dssp             H--TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEEEETT
T ss_pred             C--CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC-----------CcccCCCCHhhEEEcCCC
Confidence            1  2458999999999999999643  499999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      .+||+|||+++........ .......++..|+|||++.+.     .++.++||||||+++|||++|..|+..+....  
T Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--  224 (295)
T 3ugc_A          152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-----KFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--  224 (295)
T ss_dssp             EEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--
T ss_pred             eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-----CCChHHHHHHHHHHHHHHHhcccccCCChHHH--
Confidence            9999999999877543321 122334577889999998763     67789999999999999999965543221100  


Q ss_pred             CCccccCCCCCH----HHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        337 PFSAEVGDHPSL----EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       337 pf~~~~~~~~~~----~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                        ....+..+..    ...... .....+...+..++     ..+.+||.+||+.||++|||+.++++.+..+..
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          225 --MRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCP-----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             --HHHHCTTCCTHHHHHHHHHH-HHTTCCCCCCTTCC-----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HhhhcCccccchhHHHHHHH-HhccCcCCCCcCcC-----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence              0000111111    112222 22333444555444     389999999999999999999999999987764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.5e-45  Score=361.02  Aligned_cols=251  Identities=20%  Similarity=0.270  Sum_probs=209.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||++....    .......+|+.++..++||||+++++++.+..   
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---  114 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS---  114 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC---
Confidence            3467999999999999999999998  47889999996532    12234567899999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||
T Consensus       115 -~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~g~~kL  182 (350)
T 1rdq_E          115 -NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-----------DLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEE
T ss_pred             -EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccccCccceEEECCCCCEEE
Confidence             45999999999999999954 5799999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++.....     .....||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...
T Consensus       183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~Pf~~~  241 (350)
T 1rdq_E          183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAG-----------YPPFFAD  241 (350)
T ss_dssp             CCCTTCEECSSC-----BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             cccccceeccCC-----cccccCCccccCHHHhcC-----CCCCCcCCEecccHhHhHHhhC-----------CCCCCCC
Confidence            999999876532     334679999999999976     3677899999999999999999           6666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~~  407 (461)
                           ...++...+.....  .+|..++     ..+.+||.+||+.||++||+     ++++++|.+....
T Consensus       242 -----~~~~~~~~i~~~~~--~~p~~~~-----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          242 -----QPIQIYEKIVSGKV--RFPSHFS-----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -----SHHHHHHHHHHCCC--CCCTTCC-----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -----CHHHHHHHHHcCCC--CCCCCCC-----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence                 44555566655533  3444443     37999999999999999998     8999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=373.15  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=208.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|..  +++.||+|++.....   .....++|+.+++.++||||+++++++.+..    .+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~   85 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG----HH   85 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS----EE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC----EE
Confidence            46899999999999999999988  578899999975442   2334578999999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc---CCCceEE
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK---SDLTAAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~---~~~~~ki  261 (461)
                      ++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++   .++.+||
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~-----------givHrDlKp~NIll~~~~~~~~vkL  154 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM-----------GVVHRNLKPENLLLASKLKGAAVKL  154 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEEeccCCCCcEEE
Confidence            99999999999999884 45699999999999999999999999           999999999999998   4578999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...
T Consensus       155 ~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~-----~~~~~~~DIwSlGvilyell~G-----------~~Pf~~~  216 (444)
T 3soa_A          155 ADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRK-----DPYGKPVDLWACGVILYILLVG-----------YPPFWDE  216 (444)
T ss_dssp             CCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCSCCCS
T ss_pred             ccCceeEEecCCC--ceeecccCCcccCCHHHhcC-----CCCCCccccHHHHHHHHHHHhC-----------CCCCCCc
Confidence            9999998775433  22345689999999999976     3678899999999999999999           5666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                           ...++...+..+......+ .|.  ..+.++.+||.+||+.||++|||+.++++|.+....
T Consensus       217 -----~~~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          217 -----DQHRLYQQIKAGAYDFPSP-EWD--TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             -----SHHHHHHHHHHTCCCCCTT-TTT--TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             -----cHHHHHHHHHhCCCCCCcc-ccc--cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                 4455566665554433322 121  133489999999999999999999999999986543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3e-45  Score=358.48  Aligned_cols=269  Identities=25%  Similarity=0.331  Sum_probs=207.4

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ....++|++.+.||+|+||.||+|+++ ++.||||++..... ......+|+.++..++||||+++++++....    .+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~  110 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EM  110 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT----CC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC----eE
Confidence            445678999999999999999999984 78899998865433 3345678999999999999999999988765    34


Q ss_pred             eeeehhccCCChhhhhcCC-----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLKCN-----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+|
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-----------AIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCSTTEEECTTCCEE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-----------CeecCCCCHHHEEECCCCCEE
Confidence            8999999999999999643     489999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++...............||+.|+|||++.+.     .++.++||||||+++|||++|+.||.......      
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~g~~p~~~~~~~~------  248 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-----RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE------  248 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-----BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS------
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCC-----CCCcccchHhHHHHHHHHHhCCCcccccCcHH------
Confidence            9999999875433222223345689999999998763     67789999999999999999966554322110      


Q ss_pred             ccCCCCCHHHH-HHHHhccC----CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDM-QEAVVHKK----LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~-~~~~~~~~----~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                          ....... ........    ..+.+.... ....+..+.+++.+||+.||++|||+.++++++..+..
T Consensus       249 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          249 ----MVNLAEWAVESHNNGQLEQIVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             ----CCCHHHHTHHHHTTTCCCSSSSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHhhhccccccHHHhcChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence                0011111 11111111    111111111 12345689999999999999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-45  Score=363.88  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=198.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ...++|++.+.||+|+||.||+++.  +++.||||++...........+|+.+++.++||||+++++++.+..    .++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC----EEE
Confidence            4567899999999999999999999  4788999999866555566778999999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc--eEEEe
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT--AAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~--~ki~D  263 (461)
                      +||||+++|+|.+++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.  +||+|
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-----------~ivH~Dlkp~Nill~~~~~~~~kl~D  161 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM-----------QICHRDLKLENTLLDGSPAPRLKICD  161 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEEcCCCCceEEEee
Confidence            9999999999999984 45799999999999999999999999           9999999999999987765  99999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||+++......   ......||+.|+|||++.+.     .++ .++|||||||++|||++|           ..||....
T Consensus       162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~Pf~~~~  222 (361)
T 3uc3_A          162 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQ-----EYDGKIADVWSCGVTLYVMLVG-----------AYPFEDPE  222 (361)
T ss_dssp             CCCC------------------CTTSCHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHS-----------SCSCC---
T ss_pred             cCccccccccC---CCCCCcCCCCcCChhhhcCC-----CCCCCeeeeehhHHHHHHHHhC-----------CCCCCCCc
Confidence            99997543222   23345799999999998763     343 348999999999999999           55554332


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .. .........+.......+....     .+..+.+||.+||..||++|||+.++++|.+....
T Consensus       223 ~~-~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          223 EP-RDYRKTIQRILSVKYSIPDDIR-----ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -C-CCHHHHHHHHHTTCCCCCTTSC-----CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             cH-HHHHHHHHHHhcCCCCCCCcCC-----CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            11 1334444444443332222112     23478999999999999999999999999988553

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.3e-45  Score=356.87  Aligned_cols=267  Identities=23%  Similarity=0.276  Sum_probs=199.7

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...+.-.++|++.+.||+|+||.||+|+. +++.||||++......   .....+|+.++.+++||||+++++++.+.. 
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   92 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-   92 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-
Confidence            34455678999999999999999999998 5788999998644322   234568999999999999999999998765 


Q ss_pred             cceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                         .+++||||+++ +|.+++...  .+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.
T Consensus        93 ---~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivH~Dikp~NIl~~~~~~  157 (311)
T 3niz_A           93 ---CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-----------RILHRDLKPQNLLINSDGA  157 (311)
T ss_dssp             ---CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCC
T ss_pred             ---EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCchHhEEECCCCC
Confidence               45899999985 888888543  489999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......  .......||+.|+|||++.+.    ..++.++|||||||++|||++|..||           
T Consensus       158 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf-----------  220 (311)
T 3niz_A          158 LKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGS----KKYSTSVDIWSIGCIFAEMITGKPLF-----------  220 (311)
T ss_dssp             EEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSSCSC-----------
T ss_pred             EEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCC----CCCCchHHhHHHHHHHHHHHhCCCCC-----------
Confidence            9999999998765332  223345789999999998763    45778999999999999999995444           


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCC------------------chhc--cchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLP------------------ETWK--QHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p------------------~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      ....... ....+...... ......+                  ..+.  ....+.++.+||.+||+.||++|||++|+
T Consensus       221 ~~~~~~~-~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  298 (311)
T 3niz_A          221 PGVTDDD-QLPKIFSILGT-PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA  298 (311)
T ss_dssp             CCSSTTT-HHHHHHHHHCC-CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCChHH-HHHHHHHHHCC-CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            3321110 11111111100 0000000                  0000  01123478899999999999999999999


Q ss_pred             hhhcHHHh
Q psy17532        399 VERGMLAL  406 (461)
Q Consensus       399 l~~l~~~~  406 (461)
                      ++|.+...
T Consensus       299 l~hp~f~~  306 (311)
T 3niz_A          299 MNHPYFKD  306 (311)
T ss_dssp             HTSGGGTT
T ss_pred             hcCccccc
Confidence            99987643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=362.27  Aligned_cols=260  Identities=19%  Similarity=0.294  Sum_probs=209.2

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....++|++.+.||+|+||.||+|+..  ++.||||++....    .......+|+.++..++|||||++++++.+.. 
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-   88 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-   88 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence            3456789999999999999999999984  6779999986432    12234567899999999999999999998865 


Q ss_pred             cceeeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+++||||+++|+|.+++... .+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+
T Consensus        89 ---~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------givHrDlkp~NIll~~~g~v  154 (384)
T 4fr4_A           89 ---DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ-----------RIIHRDMKPDNILLDEHGHV  154 (384)
T ss_dssp             ---EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCE
T ss_pred             ---EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceeccCcHHHeEECCCCCE
Confidence               459999999999999999654 699999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++.+....   ......||+.|+|||++.+.  ....++.++|||||||++|||++|           ..||.
T Consensus       155 kL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~--~~~~~~~~~DiwSlG~il~elltG-----------~~Pf~  218 (384)
T 4fr4_A          155 HITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSR--KGAGYSFAVDWWSLGVTAYELLRG-----------RRPYH  218 (384)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCC--SSCCBCTTHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEeccceeeeccCCC---ceeccCCCccccCCeeeccC--CCCCCCccceeechHHHHHHHHhC-----------CCCCC
Confidence            999999998775432   24456899999999998652  123577899999999999999999           55554


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-ccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-ASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~l~~~~  406 (461)
                      ....  .....+...+...  ...+|..++.     .+.+||.+||+.||++||+ ++++++|.+.-.
T Consensus       219 ~~~~--~~~~~~~~~~~~~--~~~~p~~~s~-----~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          219 IRSS--TSSKEIVHTFETT--VVTYPSAWSQ-----EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             CCTT--SCHHHHHHHHHHC--CCCCCTTSCH-----HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             CCCC--ccHHHHHHHHhhc--ccCCCCcCCH-----HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            3211  1334444433332  2344444443     7999999999999999998 788888877643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-44  Score=349.10  Aligned_cols=257  Identities=24%  Similarity=0.318  Sum_probs=198.0

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++.+.||+|+||.||+|+.  +++.||||++......   .....+|+.++.+++||||+++++++.+..    .++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   77 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK----KLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC----EEE
Confidence            5799999999999999999999  4688999999754332   244568999999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++ +|.+++.  ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+||
T Consensus        78 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-----------~ivH~dikp~Nil~~~~~~~kl~Df  145 (292)
T 3o0g_A           78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-----------NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCCCCEEEeec
Confidence            99999986 6666553  45799999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++......  .......||+.|+|||++.+.    ..++.++|||||||++|||++|+.|+          |...   
T Consensus       146 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~~~~p~----------~~~~---  206 (292)
T 3o0g_A          146 GLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPL----------FPGN---  206 (292)
T ss_dssp             TTCEECCSCC--SCCCSCCSCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHTTTSCCS----------CCCS---
T ss_pred             ccceecCCcc--ccccCCccccCCcChHHHcCC----CCcCchHHHHHHHHHHHHHHHcCCCC----------cCCC---
Confidence            9998765432  223446789999999998763    34678999999999999999995443          2111   


Q ss_pred             CCCHHHHHHHHhccCCCC------------------CCCchh----ccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        345 HPSLEDMQEAVVHKKLRP------------------TLPETW----KQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~------------------~~p~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                        ...+....+......+                  ..+...    .....+..+.+||.+||+.||++|||++|+++|.
T Consensus       207 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  284 (292)
T 3o0g_A          207 --DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             --SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --CHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence              2222222221100000                  000000    0011335789999999999999999999999998


Q ss_pred             HHH
Q psy17532        403 MLA  405 (461)
Q Consensus       403 ~~~  405 (461)
                      +..
T Consensus       285 ~f~  287 (292)
T 3o0g_A          285 YFS  287 (292)
T ss_dssp             GGT
T ss_pred             ccc
Confidence            753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=362.82  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=209.3

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      ....++|++.+.||+|+||.||+|++.+       +.||||++......  .....+|+.++.+++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            4456899999999999999999999854       67999998754322  34467899999999999999999999876


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-------------------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-------------------------NIVTWEQLCRIALSMSKGLMHLHEEILPNK  233 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  233 (461)
                      ..    +++||||+++|+|.+++..                         ..+++..++.++.||+.||.|||+.     
T Consensus       123 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----  193 (343)
T 1luf_A          123 KP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-----  193 (343)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred             Cc----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Confidence            53    4899999999999999954                         4689999999999999999999999     


Q ss_pred             cCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHH
Q psy17532        234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC  313 (461)
Q Consensus       234 ~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~  313 (461)
                            +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+.     .++.++|||||
T Consensus       194 ------~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~sl  262 (343)
T 1luf_A          194 ------KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-----RYTTESDVWAY  262 (343)
T ss_dssp             ------TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-----CCCHHHHHHHH
T ss_pred             ------CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-----CcCcccccHHH
Confidence                  9999999999999999999999999999876543322233445788999999998753     57789999999


Q ss_pred             HHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        314 ALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       314 Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      |+++|||++ |           ..||...     ...++...+.... .+..+..++     ..+.+||.+||+.||++|
T Consensus       263 G~il~el~t~g-----------~~p~~~~-----~~~~~~~~~~~~~-~~~~~~~~~-----~~l~~li~~~l~~~p~~R  320 (343)
T 1luf_A          263 GVVLWEIFSYG-----------LQPYYGM-----AHEEVIYYVRDGN-ILACPENCP-----LELYNLMRLCWSKLPADR  320 (343)
T ss_dssp             HHHHHHHHTTT-----------CCTTTTS-----CHHHHHHHHHTTC-CCCCCTTCC-----HHHHHHHHHHTCSSGGGS
T ss_pred             HHHHHHHHhcC-----------CCcCCCC-----ChHHHHHHHhCCC-cCCCCCCCC-----HHHHHHHHHHcccCcccC
Confidence            999999999 7           5666543     4455555554433 334444443     379999999999999999


Q ss_pred             ccccchhhhcHHHhh
Q psy17532        393 LSASCVVERGMLALC  407 (461)
Q Consensus       393 ps~~evl~~l~~~~~  407 (461)
                      ||+.++++++..+..
T Consensus       321 ps~~~~~~~L~~~~~  335 (343)
T 1luf_A          321 PSFCSIHRILQRMCE  335 (343)
T ss_dssp             CCHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHHHHh
Confidence            999999999876653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.5e-45  Score=347.63  Aligned_cols=256  Identities=21%  Similarity=0.336  Sum_probs=209.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ....++|++.+.||+|+||.||+|++++ ..||||++...........+|+.++.+++||||+++++++.+..    .++
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~   79 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY----PIY   79 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----SEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC----ceE
Confidence            3456789999999999999999999865 47999999876655566788999999999999999999997765    358


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dikp~Nil~~~~~~~~l~Df  148 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-----------QFIHRDLAARNCLVDRDLCVKVSDF  148 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-----------TEEESSCSGGGEEECTTCCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCcCcceEEECCCCCEEEccC
Confidence            99999999999999954  3599999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~  343 (461)
                      |+++....... .......+|+.|+|||++.+.     .++.++||||||+++|||++ |           ..||...  
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g-----------~~p~~~~--  209 (268)
T 3sxs_A          149 GMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYF-----KYSSKSDVWAFGILMWEVFSLG-----------KMPYDLY--  209 (268)
T ss_dssp             TCEEECCTTCE-EECCSCCCCGGGCCHHHHHHS-----EEETTHHHHHHHHHHHHHHTTT-----------CCTTTTS--
T ss_pred             ccceecchhhh-hcccCCCcCcccCCHHHHhcc-----CCchhhhhHHHHHHHHHHHcCC-----------CCCcccc--
Confidence            99987654432 123345567889999998763     56678999999999999999 7           5666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         ...+....+... .....+...+     ..+.+++.+||+.||++|||+.++++++..+.
T Consensus       210 ---~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          210 ---TNSEVVLKVSQG-HRLYRPHLAS-----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             ---CHHHHHHHHHTT-CCCCCCTTSC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             ---ChHHHHHHHHcC-CCCCCCCcCh-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence               334444443332 2333333332     37999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-45  Score=366.73  Aligned_cols=260  Identities=27%  Similarity=0.398  Sum_probs=197.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....+|++.+.||+|+||.||+|++.     +..||||++.....  ....+.+|+.++.+++||||+++++++.....
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            345578999999999999999999874     56799999875432  23456789999999999999999999987653


Q ss_pred             cceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          +++||||+++|+|.++++..  .+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.
T Consensus       121 ----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~  185 (373)
T 2qol_A          121 ----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-----------GYVHRDLAARNILINSNLV  185 (373)
T ss_dssp             ----CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTCC
T ss_pred             ----eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeCCCCCcceEEEcCCCC
Confidence                48999999999999999653  699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      +||+|||+++........ .......++..|+|||++.+     ..++.++||||||+++|||++ |           ..
T Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~ellt~g-----------~~  249 (373)
T 2qol_A          186 CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-----RKFTSASDVWSYGIVLWEVMSYG-----------ER  249 (373)
T ss_dssp             EEECCC----------------------CTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTC------------C
T ss_pred             EEECcCccccccccCCccceeccCCCcCCCccChhhhcc-----CCcCchhcHHHHHHHHHHHHhCC-----------CC
Confidence            999999999877543211 11223346788999999875     367789999999999999998 7           56


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                      ||...     ...++...+... .+...+..++     ..+.+||.+||+.||++||++.++++.|..+....
T Consensus       250 P~~~~-----~~~~~~~~i~~~-~~~~~~~~~~-----~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          250 PYWEM-----SNQDVIKAVDEG-YRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTTTC-----CHHHHHHHHHTT-EECCCCTTCB-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CCCCC-----CHHHHHHHHHcC-CCCCCCcccc-----HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            66543     344444444332 3333343333     37999999999999999999999999998876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.5e-45  Score=354.27  Aligned_cols=261  Identities=22%  Similarity=0.314  Sum_probs=209.9

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEE
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAE  175 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~  175 (461)
                      +......++|++.+.||+|+||.||+|+..       ++.||||++.....  ......+|+.++..++||||+++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            344556789999999999999999999872       36799999865432  224457899999999999999999999


Q ss_pred             ecCCccceeeeeeehhccCCChhhhhcCC-------------------------CCCHHHHHHHHHHHHHHHHHHhhccc
Q psy17532        176 KRGESIHTEFWLITAYHERGSLCDFLKCN-------------------------IVTWEQLCRIALSMSKGLMHLHEEIL  230 (461)
Q Consensus       176 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~  230 (461)
                      .+...    +++||||+++|+|.+++...                         .+++..+..++.||+.||.|||+.  
T Consensus        96 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--  169 (314)
T 2ivs_A           96 SQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--  169 (314)
T ss_dssp             CSSSS----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             ecCCc----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence            87654    48999999999999999532                         378999999999999999999999  


Q ss_pred             CCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccch
Q psy17532        231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDM  310 (461)
Q Consensus       231 ~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DV  310 (461)
                               +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+.     .++.++||
T Consensus       170 ---------~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di  235 (314)
T 2ivs_A          170 ---------KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-----IYTTQSDV  235 (314)
T ss_dssp             ---------TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-----EECHHHHH
T ss_pred             ---------CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-----CcCchhhH
Confidence                     9999999999999999999999999999877554332334445678899999998763     56788999


Q ss_pred             HHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccH
Q psy17532        311 YACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDA  389 (461)
Q Consensus       311 wS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP  389 (461)
                      ||||+++|||++ |           ..||...     ....+...+.. ...+..+..++     ..+.+++.+||+.||
T Consensus       236 ~slG~il~el~t~g-----------~~p~~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~li~~~l~~dp  293 (314)
T 2ivs_A          236 WSFGVLLWEIVTLG-----------GNPYPGI-----PPERLFNLLKT-GHRMERPDNCS-----EEMYRLMLQCWKQEP  293 (314)
T ss_dssp             HHHHHHHHHHHTTS-----------CCSSTTC-----CGGGHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSG
T ss_pred             HHHHHHHHHHHhCC-----------CCCCCCC-----CHHHHHHHhhc-CCcCCCCccCC-----HHHHHHHHHHccCCh
Confidence            999999999999 7           5565443     22334433333 23344444333     389999999999999


Q ss_pred             hhhccccchhhhcHHHhh
Q psy17532        390 EARLSASCVVERGMLALC  407 (461)
Q Consensus       390 ~~Rps~~evl~~l~~~~~  407 (461)
                      ++|||+.++++++..+..
T Consensus       294 ~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          294 DKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GGSCCHHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHHh
Confidence            999999999999987664

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-44  Score=347.68  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=205.8

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh--------hHHHHHHHHcCCCCCCCeeEEEEEE
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS--------WQSEQEIFKLPHMEHDNILRYIGAE  175 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--------~~~~~ei~~l~~l~H~nIv~l~g~~  175 (461)
                      .+....++|++.+.||+|+||.||+|++  +++.||||++.......        ....+|+.++.+++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            3445668999999999999999999998  57889999986433211        3457899999999999999999998


Q ss_pred             ecCCccceeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC--eecccCCCCcE
Q psy17532        176 KRGESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA--VAHRDFKSNNV  251 (461)
Q Consensus       176 ~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~--ivHrDLkp~NI  251 (461)
                      .+..      ++||||+++|+|.+++.  ...+++..+..++.|++.||+|||+.           +  |+||||||+||
T Consensus        93 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-----------~~~ivH~dikp~Ni  155 (287)
T 4f0f_A           93 HNPP------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ-----------NPPIVHRDLRSPNI  155 (287)
T ss_dssp             TTTT------EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS-----------SSCCBCSCCSGGGE
T ss_pred             cCCC------eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC-----------CCCeecCCCCcceE
Confidence            7644      69999999999999884  34699999999999999999999998           7  99999999999


Q ss_pred             EEcCCCc-----eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCC
Q psy17532        252 LLKSDLT-----AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS  326 (461)
Q Consensus       252 Ll~~~~~-----~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~  326 (461)
                      |++.++.     +||+|||+++....     ......||+.|+|||++.+.   ...++.++||||||+++|||++|   
T Consensus       156 l~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~---~~~~~~~~Di~slG~~l~~l~~g---  224 (287)
T 4f0f_A          156 FLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAE---EESYTEKADTYSFAMILYTILTG---  224 (287)
T ss_dssp             EESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCS---SCEECHHHHHHHHHHHHHHHHHS---
T ss_pred             EEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccC---CCCcCchhhHHHHHHHHHHHHcC---
Confidence            9988776     99999999975432     23346789999999998532   13567789999999999999999   


Q ss_pred             CCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                              ..||....   .........+.....++.++..++.     .+.++|.+||+.||++|||+.++++.+..
T Consensus       225 --------~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          225 --------EGPFDEYS---YGKIKFINMIREEGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --------SCTTTTCC---CCHHHHHHHHHHSCCCCCCCTTSCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --------CCCCcccc---ccHHHHHHHHhccCCCCCCCcccCH-----HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                    55654331   1223334445555666666665543     89999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.4e-45  Score=358.52  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCC-----hhhhHHHHHHHHcCCCCCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|+.     .++.||||++....     .......+|+.++..++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            34567999999999999999999997     46789999986532     122334678888999999999999999987


Q ss_pred             CCccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ..    .+++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++.+
T Consensus        93 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           93 GG----KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK-----------GIIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             SS----CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCTTTEEECTT
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEcccCCHHHeEECCC
Confidence            65    4599999999999999995 45689999999999999999999999           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+++......  .......||+.|+|||++.+     ..++.++||||||+++|||++|           ..
T Consensus       158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g-----------~~  219 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMR-----SGHNRAVDWWSLGALMYDMLTG-----------AP  219 (327)
T ss_dssp             SCEEECCCSCC------------CTTSSCCTTSCHHHHTT-----SCCCTHHHHHHHHHHHHHHHHS-----------SC
T ss_pred             CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcC-----CCCCCcccchhHHHHHHHHHHC-----------CC
Confidence            999999999997654322  12344679999999999876     3567899999999999999999           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      ||...     ........+....  ..+|..++     ..+.+||.+||..||++||     ++.++++|.+...
T Consensus       220 pf~~~-----~~~~~~~~i~~~~--~~~p~~~~-----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          220 PFTGE-----NRKKTIDKILKCK--LNLPPYLT-----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             SCCCS-----SHHHHHHHHHHTC--CCCCTTSC-----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             CCCCC-----CHHHHHHHHHhCC--CCCCCCCC-----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            66543     3444555554433  23444333     3789999999999999999     6779999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.2e-45  Score=360.44  Aligned_cols=255  Identities=20%  Similarity=0.262  Sum_probs=207.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~  180 (461)
                      ....++|++.+.||+|+||.||+|+.+  ++.||||++....    ........|..++..+ +||||+++++++.+.. 
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-   94 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-   94 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS-
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC-
Confidence            456789999999999999999999995  5779999997532    2223445778888777 8999999999998765 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+
T Consensus        95 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------givHrDlkp~NIll~~~g~v  160 (353)
T 2i0e_A           95 ---RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-----------GIIYRDLKLDNVMLDSEGHI  160 (353)
T ss_dssp             ---EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSCE
T ss_pred             ---EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEeccCCHHHEEEcCCCcE
Confidence               45999999999999999964 6799999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||.
T Consensus       161 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G-----------~~Pf~  222 (353)
T 2i0e_A          161 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAG-----------QAPFE  222 (353)
T ss_dssp             EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTT-----CCBSTHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEEeCCcccccccCC--cccccccCCccccChhhhcC-----CCcCCcccccchHHHHHHHHcC-----------CCCCC
Confidence            999999998643322  23445689999999999976     3677899999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~~  407 (461)
                      ..     ...++...+.....  .+|..++     .++.+||.+||..||++||+     +.++++|.++...
T Consensus       223 ~~-----~~~~~~~~i~~~~~--~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          223 GE-----DEDELFQSIMEHNV--AYPKSMS-----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             CS-----SHHHHHHHHHHCCC--CCCTTSC-----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             CC-----CHHHHHHHHHhCCC--CCCCCCC-----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            43     45566666655433  3444433     37899999999999999995     5899999887543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-45  Score=362.38  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+|++  +++.||||++....    ......++|+.+++.++||||+++++++.+..    
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----   82 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT----   82 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----
Confidence            457899999999999999999998  57889999986432    12235678999999999999999999998865    


Q ss_pred             eeeeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++||||+ +|+|.+++ ....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH-----------KIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH-----------TCCCCCCSTTTEEECTTCCEEEC
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCchhhEEEcCCCCEEEE
Confidence            459999999 68999988 456799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++....+.   ......||+.|+|||++.+..    ..+.++|||||||++|||++|..|           |....
T Consensus       151 DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~P-----------f~~~~  212 (336)
T 3h4j_B          151 DFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKL----YAGPEVDVWSCGIVLYVMLVGRLP-----------FDDEF  212 (336)
T ss_dssp             CSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSG----GGCHHHHHHHHHHHHHHHHHSSCS-----------SBCSS
T ss_pred             EeccceeccCCc---ccccccCCcCcCCHHHHcCCC----CCCCccchhHHHHHHHHHHhCCCC-----------CCCcc
Confidence            999998765443   234467999999999997642    225789999999999999999544           43321


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     .+...+.  .....+|..++     ..+.+||.+||..||++|||++|+++|.|...
T Consensus       213 ~~-----~~~~~i~--~~~~~~p~~~s-----~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          213 IP-----NLFKKVN--SCVYVMPDFLS-----PGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ST-----TCBCCCC--SSCCCCCTTSC-----HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HH-----HHHHHHH--cCCCCCcccCC-----HHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            10     0000010  11122333332     37899999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-44  Score=360.35  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=201.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHH-cCCCCCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFK-LPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~-l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|+||.||+|+.+  ++.||||++.....    .......|..+ ++.++||||+++++++.+..
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            3456789999999999999999999994  67799999975432    12223455555 57789999999999998865


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++           +|+||||||+|||++.++.
T Consensus       113 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------givHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          113 ----KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL-----------NIVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTSC
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCCHHHEEECCCCC
Confidence                45999999999999999954 5699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||
T Consensus       178 ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G-----------~~Pf  239 (373)
T 2r5t_A          178 IVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYG-----------LPPF  239 (373)
T ss_dssp             EEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------SCTT
T ss_pred             EEEeeCccccccccCC--CccccccCCccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHcC-----------CCCC
Confidence            9999999998643322  23445689999999999976     3678899999999999999999           6666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc----chhhhcHHHh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS----CVVERGMLAL  406 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----evl~~l~~~~  406 (461)
                      ...     ...++...+.....  .++..++     ..+.+||.+||..||++||++.    ++++|.++..
T Consensus       240 ~~~-----~~~~~~~~i~~~~~--~~~~~~~-----~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          240 YSR-----NTAEMYDNILNKPL--QLKPNIT-----NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             CCS-----BHHHHHHHHHHSCC--CCCSSSC-----HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             CCC-----CHHHHHHHHHhccc--CCCCCCC-----HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            543     44555666655432  2333333     3789999999999999999984    6777776543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-45  Score=356.06  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=205.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .+.|++.+.||+|+||.||+|+..  ++.||||++.....       .....++|+.++..++||||+++++++.+..  
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence            357999999999999999999984  78899999875432       2345678999999999999999999998755  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC---
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL---  257 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~---  257 (461)
                        .+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++   
T Consensus        88 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           88 --DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-----------QIAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             --EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESCSSSSS
T ss_pred             --EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC-----------CeEcCCCCHHHEEEecCCCCC
Confidence              45999999999999999954 4699999999999999999999999           999999999999999887   


Q ss_pred             -ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 -TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 -~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                       .+||+|||+++......   ......||+.|+|||++.+     ..++.++|||||||++|||++|           ..
T Consensus       155 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g-----------~~  215 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSG-----------AS  215 (326)
T ss_dssp             CCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------CC
T ss_pred             CCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecC-----CCCCcHHHHHHHHHHHHHHHHC-----------cC
Confidence             89999999998875433   2334579999999999875     3677899999999999999999           56


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...     ...+....+.....  .++.... ...+..+.+||.+||..||++|||+.++++|.+..
T Consensus       216 pf~~~-----~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          216 PFLGD-----TKQETLANVSAVNY--EFEDEYF-SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             SSCCS-----SHHHHHHHHHHTCC--CCCHHHH-TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             CCCCC-----CHHHHHHHHHhcCC--CcCcccc-ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence            66443     33444444433322  2222111 11334789999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=362.27  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=205.8

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|++       .+..||||++....  .......+|+.++.++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            44568999999999999999999997       23569999986432  2234567889999999 89999999999987


Q ss_pred             CCccceeeeeeehhccCCChhhhhcCC------------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKCN------------------------IVTWEQLCRIALSMSKGLMHLHEEILPNK  233 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  233 (461)
                      .+.    +++||||+++|+|.+++...                        .+++..+..++.||+.||.|||+.     
T Consensus       121 ~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----  191 (344)
T 1rjb_A          121 SGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-----  191 (344)
T ss_dssp             SSS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred             CCc----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-----
Confidence            654    48999999999999999543                        278999999999999999999999     


Q ss_pred             cCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHH
Q psy17532        234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC  313 (461)
Q Consensus       234 ~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~  313 (461)
                            +|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+     ..++.++|||||
T Consensus       192 ------~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~sl  260 (344)
T 1rjb_A          192 ------SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDVWSY  260 (344)
T ss_dssp             ------TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHH
T ss_pred             ------CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-----CCCChhHhHHHH
Confidence                  999999999999999999999999999987654432222334567889999999875     367789999999


Q ss_pred             HHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        314 ALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       314 Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      |+++|||+| |           ..||....     ..............+..+..++     ..+.+||.+||+.||++|
T Consensus       261 G~il~el~t~g-----------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~R  319 (344)
T 1rjb_A          261 GILLWEIFSLG-----------VNPYPGIP-----VDANFYKLIQNGFKMDQPFYAT-----EEIYIIMQSCWAFDSRKR  319 (344)
T ss_dssp             HHHHHHHTTTS-----------CCSSTTCC-----CSHHHHHHHHTTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGS
T ss_pred             HHHHHHHHcCC-----------CCCcccCC-----cHHHHHHHHhcCCCCCCCCCCC-----HHHHHHHHHHcCCCchhC
Confidence            999999998 7           55664431     1122233334444455554433     389999999999999999


Q ss_pred             ccccchhhhcHHHhh
Q psy17532        393 LSASCVVERGMLALC  407 (461)
Q Consensus       393 ps~~evl~~l~~~~~  407 (461)
                      ||+.++++++..+..
T Consensus       320 ps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          320 PSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCHHHHHHHHHHHC-
T ss_pred             cCHHHHHHHHHHHHH
Confidence            999999999977654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-45  Score=355.69  Aligned_cols=260  Identities=24%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      .....++|++.+.||+|+||.||+|++       .++.||||++.....  ......+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            445668999999999999999999986       246799999975432  234457889989999 9999999999998


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcCC-------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKCN-------------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      +...    .++||||+++|+|.+++...                   .+++..+..++.|++.||.|||+.         
T Consensus        98 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---------  164 (313)
T 1t46_A           98 IGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---------  164 (313)
T ss_dssp             SSSS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---------
T ss_pred             cCCC----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---------
Confidence            7654    48999999999999999543                   389999999999999999999999         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+     ..++.++||||||+++
T Consensus       165 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il  237 (313)
T 1t46_A          165 --NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGIFL  237 (313)
T ss_dssp             --TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHH
T ss_pred             --CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-----CCCChHHHHHHHHHHH
Confidence              999999999999999999999999999987765443223344567889999999875     3677899999999999


Q ss_pred             HHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        318 WELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       318 ~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      |||++ |           ..||....     .............+...+..++     ..+.++|.+||+.||++|||+.
T Consensus       238 ~ellt~g-----------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~  296 (313)
T 1t46_A          238 WELFSLG-----------SSPYPGMP-----VDSKFYKMIKEGFRMLSPEHAP-----AEMYDIMKTCWDADPLKRPTFK  296 (313)
T ss_dssp             HHHHTTT-----------CCSSTTCC-----SSHHHHHHHHHTCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHhCC-----------CCCCCccc-----chhHHHHHhccCCCCCCcccCC-----HHHHHHHHHHcCCCchhCcCHH
Confidence            99999 7           55554431     1122222233333444444333     3799999999999999999999


Q ss_pred             chhhhcHHHhh
Q psy17532        397 CVVERGMLALC  407 (461)
Q Consensus       397 evl~~l~~~~~  407 (461)
                      ++++++..+..
T Consensus       297 ell~~L~~~~~  307 (313)
T 1t46_A          297 QIVQLIEKQIS  307 (313)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999877664

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.5e-45  Score=371.95  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=201.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ....++|++.+.||+|+||.||+|+.  .++.||||++....    .......+|+.++..++||||+++++++.+.+  
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--  221 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--  221 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT--
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--
Confidence            34567899999999999999999998  47889999997431    12234457888999999999999999998865  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        .+++||||+++|+|.+++. ...+++..+..++.||+.||+|||+ .           +|+||||||+|||++.++.+
T Consensus       222 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----------giiHrDlkp~NIll~~~~~~  288 (446)
T 4ejn_A          222 --RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK-----------NVVYRDLKLENLMLDKDGHI  288 (446)
T ss_dssp             --EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT-----------CCCCCCCCGGGEEECSSSCE
T ss_pred             --EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC-----------CEEECCCCHHHEEECCCCCE
Confidence              4599999999999999985 4569999999999999999999998 7           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+|+......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||.
T Consensus       289 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g-----------~~Pf~  350 (446)
T 4ejn_A          289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCG-----------RLPFY  350 (446)
T ss_dssp             EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEccCCCceeccCCC--cccccccCCccccCHhhcCC-----CCCCCccchhhhHHHHHHHhhC-----------CCCCC
Confidence            999999998644322  22345689999999999976     3678899999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      ..     ....+...+.....  .+|..++     ..+.+||.+||+.||++||     +++++++|.++..
T Consensus       351 ~~-----~~~~~~~~i~~~~~--~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          351 NQ-----DHEKLFELILMEEI--RFPRTLG-----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             CS-----SHHHHHHHHHHCCC--CCCTTSC-----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CC-----CHHHHHHHHHhCCC--CCCccCC-----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            43     44555555555443  3444333     3789999999999999999     9999999987643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-44  Score=357.91  Aligned_cols=263  Identities=19%  Similarity=0.277  Sum_probs=205.0

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      ...++|++.+.||+|+||.||+|+.+  ++.||||++.....    ......+|+.++.++ +||||+++++++.+..  
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--   83 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--   83 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC--
Confidence            35678999999999999999999984  67899999975421    122345677777766 8999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+|
T Consensus        84 --~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~g~~k  150 (345)
T 3a8x_A           84 --RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-----------GIIYRDLKLDNVLLDSEGHIK  150 (345)
T ss_dssp             --EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSCEE
T ss_pred             --EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCCHHHEEECCCCCEE
Confidence              45999999999999999954 5799999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++......  .......||+.|+|||++.+     ..++.++|||||||++|||++|..||......       
T Consensus       151 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------  216 (345)
T 3a8x_A          151 LTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-------  216 (345)
T ss_dssp             ECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------
T ss_pred             EEeccccccccCCC--CcccccCCCccccCccccCC-----CCCChHHhHHHHHHHHHHHHhCCCCcCCcccc-------
Confidence            99999998643322  22445689999999999976     36778999999999999999995554321100       


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc------cchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA------SCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~~~~~  407 (461)
                      ..........+...+....  ..+|..++     ..+.+||.+||+.||++||++      .++++|.+....
T Consensus       217 ~~~~~~~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          217 DNPDQNTEDYLFQVILEKQ--IRIPRSLS-----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             ------CHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             cccccccHHHHHHHHHcCC--CCCCCCCC-----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            0000112333444444433  33454433     378999999999999999997      689999887543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-45  Score=379.06  Aligned_cols=257  Identities=23%  Similarity=0.365  Sum_probs=211.6

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ......+|++.+.||+|+||.||+|+++  +..||||++.........+.+|+.++++++|||||++++++.....    
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----  290 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----  290 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc----
Confidence            3456678999999999999999999995  6789999997665555667889999999999999999999987654    


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +++||||+++|+|.++++.   ..+++..++.++.||+.||+|||++           +|+||||||+|||++.++.+||
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivHrDlkp~NIll~~~~~~kl  359 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-----------NFIHRNLAARNCLVGENHLVKV  359 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCChhhEEECCCCcEEE
Confidence            4899999999999999953   4589999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++....... .......++..|+|||++.+.     .++.++|||||||++|||++ |           ..||..
T Consensus       360 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwSlG~~l~el~t~g-----------~~p~~~  422 (495)
T 1opk_A          360 ADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYG-----------MSPYPG  422 (495)
T ss_dssp             CCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTS-----------CCSSTT
T ss_pred             eecccceeccCCce-eecCCCcCCcceeCHhHHhcC-----CCCcHHhHHhHHHHHHHHHhCC-----------CCCCCC
Confidence            99999987654321 223345577899999998753     56789999999999999999 6           556654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .     ...++.+.+ ....+...|..++     ..+.+||.+||+.||++|||+.++++.|..+.
T Consensus       423 ~-----~~~~~~~~~-~~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          423 I-----DLSQVYELL-EKDYRMERPEGCP-----EKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             C-----CGGGHHHHH-HTTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             C-----CHHHHHHHH-HcCCCCCCCCCCC-----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            3     233344333 3344555555544     38999999999999999999999999876543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.1e-45  Score=362.30  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      .+.|++.+.||+|+||.||+|+.  +++.||||++.....      ......+|+.++..++||||+++++++.+..   
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG---   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence            36799999999999999999998  478899999864321      2345678999999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                       .+++||||+++|+|.+++..     ..+++..+..++.||+.||.|||++           +|+||||||+|||++.++
T Consensus       100 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivHrDlkp~NIl~~~~~  167 (351)
T 3c0i_A          100 -MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-----------NIIHRDVKPHCVLLASKE  167 (351)
T ss_dssp             -EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECSSS
T ss_pred             -EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceeccCChHHeEEecCC
Confidence             45999999999999988742     2489999999999999999999999           999999999999998765


Q ss_pred             c---eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        258 T---AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       258 ~---~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      .   +||+|||+++......  .......||+.|+|||++.+.     .++.++|||||||++|||++|           
T Consensus       168 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g-----------  229 (351)
T 3c0i_A          168 NSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKRE-----PYGKPVDVWGCGVILFILLSG-----------  229 (351)
T ss_dssp             TTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTC-----CBCTHHHHHHHHHHHHHHHHS-----------
T ss_pred             CCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCC-----CCCchHhhHHHHHHHHHHHHC-----------
Confidence            4   9999999998876433  123446799999999999763     577899999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..||...      ...+...+....... .+..|..  .+..+.+||.+||..||++|||+.++++|.+....
T Consensus       230 ~~pf~~~------~~~~~~~i~~~~~~~-~~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          230 CLPFYGT------KERLFEGIIKGKYKM-NPRQWSH--ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             SCSSCSS------HHHHHHHHHHTCCCC-CHHHHTT--SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCCCCCc------HHHHHHHHHcCCCCC-Ccccccc--CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            6666542      234444444443321 1222221  33589999999999999999999999999987653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-44  Score=348.61  Aligned_cols=256  Identities=22%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             cceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.+.||+|+||.||+|+.. ++.||||++......   .....+|+.++++++||||+++++++.+..    .+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK----RLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS----CEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC----eEEE
Confidence            57999999999999999999984 788999999654332   244568999999999999999999998765    4599


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||||+++ +|.+++..  ..+++..+..++.|++.||+|||++           +|+||||||+|||++.++.+||+|||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-----------RVLHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEEcCCCCEEEeECc
Confidence            9999985 99998854  5699999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++......  .......||+.|+|||++.+.    ..++.++|||||||++|||++|.           .||...    
T Consensus       146 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~-----------~pf~~~----  204 (288)
T 1ob3_A          146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGS----KKYSTTIDIWSVGCIFAEMVNGT-----------PLFPGV----  204 (288)
T ss_dssp             HHHHHCC-----------CCCTTCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSS-----------CSCCCS----
T ss_pred             cccccCccc--cccccccccccccCchheeCC----CCCCcHHHHHHHHHHHHHHHhCC-----------CCCCCC----
Confidence            998765322  123345789999999998753    35778999999999999999994           444332    


Q ss_pred             CCHHHHHHHHhcc----------------CCCCCCC----chhc--cchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        346 PSLEDMQEAVVHK----------------KLRPTLP----ETWK--QHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       346 ~~~~~~~~~~~~~----------------~~~~~~p----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                       ...+....+...                ...+.++    ..+.  ....+..+.+||.+||+.||++|||++++++|.+
T Consensus       205 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          205 -SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             -SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             -CHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence             111211111110                0000000    0000  0113457899999999999999999999999987


Q ss_pred             HH
Q psy17532        404 LA  405 (461)
Q Consensus       404 ~~  405 (461)
                      ..
T Consensus       284 f~  285 (288)
T 1ob3_A          284 FK  285 (288)
T ss_dssp             GG
T ss_pred             hh
Confidence            53

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9e-45  Score=371.87  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=205.5

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ......++|++.+.||+|+||.||+|++++ ..||||++.........+.+|+.++++++||||+++++++.+ .    .
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~----~  252 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E----P  252 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S----S
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C----c
Confidence            345567889999999999999999999965 569999997655555567889999999999999999999865 2    3


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +++||||+++|+|.++++.   ..+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+||
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~ivHrDlkp~Nill~~~~~~kl  321 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-----------NYVHRDLRAANILVGENLVCKV  321 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECGGGCEEE
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCChhhEEECCCCCEEE
Confidence            4899999999999999963   4599999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++....... .......+|..|+|||++.+     ..++.++||||||+++|||++ |           ..||..
T Consensus       322 ~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g-----------~~P~~~  384 (452)
T 1fmk_A          322 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKG-----------RVPYPG  384 (452)
T ss_dssp             CCCCTTC---------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTT-----------CCSSTT
T ss_pred             CCCccceecCCCce-ecccCCcccccccCHhHHhc-----CCCCccccHHhHHHHHHHHHhCC-----------CCCCCC
Confidence            99999987654321 22334457889999999875     367789999999999999999 7           667754


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .     ...++...+. ...+...|..++     ..+.+||.+||+.||++|||++++++.|..+.
T Consensus       385 ~-----~~~~~~~~i~-~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          385 M-----VNREVLDQVE-RGYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             C-----CHHHHHHHHH-TTCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             C-----CHHHHHHHHH-cCCCCCCCCCCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            3     4445555443 334455555444     37999999999999999999999999876544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=353.11  Aligned_cols=268  Identities=19%  Similarity=0.267  Sum_probs=205.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..++|++.+.||+|+||.||+|++.  ++.||||++.....  ......+|+.++.+++||||+++++++.....  ..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--RHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--CCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC--ceE
Confidence            3568999999999999999999995  78899999975332  22345688999999999999999999876552  256


Q ss_pred             eeeehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE----cCCC
Q psy17532        186 WLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL----KSDL  257 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl----~~~~  257 (461)
                      ++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.           +|+||||||+|||+    +.++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-----------GIVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEEECTTSCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCCCHHHEEEeccCCCCc
Confidence            8999999999999999653    289999999999999999999999           99999999999999    7888


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccc---ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN---FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      .+||+|||+++.......   .....||..|+|||++.....   ....++.++|||||||++|||++|           
T Consensus       154 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g-----------  219 (319)
T 4euu_A          154 VYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG-----------  219 (319)
T ss_dssp             EEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS-----------
T ss_pred             eEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC-----------
Confidence            999999999988765432   334579999999999863110   124677899999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCC-----------------CCCchh-ccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRP-----------------TLPETW-KQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~p~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      ..||.......... +....+..+....                 .++... ........+.+++.+||+.||++|||++
T Consensus       220 ~~pf~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (319)
T 4euu_A          220 SLPFRPFEGPRRNK-EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (319)
T ss_dssp             SCSEECTTCGGGCH-HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             CCCCCCCCccchhH-HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence            55554322222222 2233333222110                 111100 0123456889999999999999999999


Q ss_pred             chhhhcHHH
Q psy17532        397 CVVERGMLA  405 (461)
Q Consensus       397 evl~~l~~~  405 (461)
                      |+++|+...
T Consensus       299 ell~h~~d~  307 (319)
T 4euu_A          299 QFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHH
T ss_pred             HhhhccHHH
Confidence            999998643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-44  Score=355.36  Aligned_cols=263  Identities=23%  Similarity=0.343  Sum_probs=211.6

Q ss_pred             CCCCCccCCcceeEEeEeecCCceEEEEEEEC---------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeE
Q psy17532        103 SPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILR  170 (461)
Q Consensus       103 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~  170 (461)
                      ..+......++|++.+.||+|+||.||+|++.         +..||||++.....  ......+|+.++.++ +||||++
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            34455667789999999999999999999973         45699999875432  233456788888888 8999999


Q ss_pred             EEEEEecCCccceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCC
Q psy17532        171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNK  233 (461)
Q Consensus       171 l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  233 (461)
                      +++++.....    +++||||+++|+|.+++...                 .+++..++.++.||+.||.|||+.     
T Consensus       106 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----  176 (334)
T 2pvf_A          106 LLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-----  176 (334)
T ss_dssp             EEEEECSSSC----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred             EEEEEccCCc----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-----
Confidence            9999987653    48999999999999999643                 389999999999999999999999     


Q ss_pred             cCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHH
Q psy17532        234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC  313 (461)
Q Consensus       234 ~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~  313 (461)
                            +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+.     .++.++|||||
T Consensus       177 ------~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~sl  245 (334)
T 2pvf_A          177 ------KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSF  245 (334)
T ss_dssp             ------TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-----EECHHHHHHHH
T ss_pred             ------CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-----CcChHHHHHHH
Confidence                  9999999999999999999999999999877654332233445678899999998753     56788999999


Q ss_pred             HHHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        314 ALVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       314 Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      |+++|||++ |           ..||...     ...++...+... .++..+..++     ..+.++|.+||+.||++|
T Consensus       246 G~il~ellt~g-----------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~dp~~R  303 (334)
T 2pvf_A          246 GVLMWEIFTLG-----------GSPYPGI-----PVEELFKLLKEG-HRMDKPANCT-----NELYMMMRDCWHAVPSQR  303 (334)
T ss_dssp             HHHHHHHHTTS-----------CCSSTTC-----CHHHHHHHHHHT-CCCCCCTTCC-----HHHHHHHHHHTCSSGGGS
T ss_pred             HHHHHHHHhCC-----------CCCcCcC-----CHHHHHHHHhcC-CCCCCCccCC-----HHHHHHHHHHccCChhhC
Confidence            999999999 7           5666543     444544444333 2334444333     379999999999999999


Q ss_pred             ccccchhhhcHHHhh
Q psy17532        393 LSASCVVERGMLALC  407 (461)
Q Consensus       393 ps~~evl~~l~~~~~  407 (461)
                      ||+.+++++|..+..
T Consensus       304 ps~~ell~~L~~l~~  318 (334)
T 2pvf_A          304 PTFKQLVEDLDRILT  318 (334)
T ss_dssp             CCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999987764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7e-45  Score=355.46  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=187.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++.....  ......+|+.++++++||||+++++++.+.+    .++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN----KLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT----EEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC----eEE
Confidence            468999999999999999999884  78899999975432  2345678999999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        187 LITAYHERGSLCDFLKC-------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                      +||||++ |+|.+++..       ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-----------~ivH~Dlkp~NIl~~~~~~~  147 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-----------KILHRDLKPQNLLINKRGQL  147 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCE
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCChHHeEEcCCCCE
Confidence            9999998 599999843       3589999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++......  .......||+.|+|||++.+.    ..++.++|||||||++|||++|.           .||.
T Consensus       148 kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~-----------~pf~  210 (317)
T 2pmi_A          148 KLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGS----RTYSTSIDIWSCGCILAEMITGK-----------PLFP  210 (317)
T ss_dssp             EECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSS-----------CSCC
T ss_pred             EECcCccceecCCCc--ccCCCCcccccccCchHhhCC----CCCCcHHHHHHHHHHHHHHHhCC-----------CCCC
Confidence            999999998765332  123345789999999998753    35778999999999999999994           4443


Q ss_pred             cccCCCCCHHHHHHHHhcc----------------CCCCCCC----chh-------ccchhHHHHHHHHHHHccccHhhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHK----------------KLRPTLP----ETW-------KQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~p----~~~-------~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      ..     ...+....+...                ...+.++    ...       .....+..+.+||.+||+.||++|
T Consensus       211 ~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  285 (317)
T 2pmi_A          211 GT-----NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR  285 (317)
T ss_dssp             CS-----SHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGS
T ss_pred             CC-----ChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccC
Confidence            32     122222221110                0000000    000       001133579999999999999999


Q ss_pred             ccccchhhhcHHHhh
Q psy17532        393 LSASCVVERGMLALC  407 (461)
Q Consensus       393 ps~~evl~~l~~~~~  407 (461)
                      ||+.++++|.+....
T Consensus       286 pt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          286 LSAKQALHHPWFAEY  300 (317)
T ss_dssp             CCHHHHTTSGGGGGG
T ss_pred             CCHHHHhCChhhhcc
Confidence            999999999886553

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8e-45  Score=357.06  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      .....++|++.+.||+|+||.||+|...+       ..||||.+.....  ......+|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34566889999999999999999999842       3699999875432  234456889999999 8999999999998


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCe
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKC---------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV  241 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~i  241 (461)
                      ....    +++||||+++|+|.+++..               ..+++..+..++.|++.||.|||+.           +|
T Consensus       121 ~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i  185 (333)
T 2i1m_A          121 HGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-----------NC  185 (333)
T ss_dssp             SSSS----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-----------TE
T ss_pred             cCCc----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-----------Cc
Confidence            7654    4899999999999999852               3579999999999999999999999           99


Q ss_pred             ecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       242 vHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      +||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+     ..++.++||||||+++|||+
T Consensus       186 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~  260 (333)
T 2i1m_A          186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEIF  260 (333)
T ss_dssp             ECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHT
T ss_pred             ccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-----CCCChHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999987654432222344567889999999875     36778999999999999999


Q ss_pred             c-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        322 S-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       322 t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                      + |           ..||....     .................+...+     ..+.+||.+||+.||++|||+.++++
T Consensus       261 t~g-----------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          261 SLG-----------LNPYPGIL-----VNSKFYKLVKDGYQMAQPAFAP-----KNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             TTS-----------CCSSTTCC-----SSHHHHHHHHHTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCC-----------CCCCcccc-----hhHHHHHHHhcCCCCCCCCCCC-----HHHHHHHHHHhccChhhCcCHHHHHH
Confidence            9 6           55664431     1122222333333444443332     37999999999999999999999999


Q ss_pred             hcHHHhh
Q psy17532        401 RGMLALC  407 (461)
Q Consensus       401 ~l~~~~~  407 (461)
                      +|..+..
T Consensus       320 ~L~~~~~  326 (333)
T 2i1m_A          320 FLQEQAQ  326 (333)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9876654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-44  Score=351.48  Aligned_cols=264  Identities=18%  Similarity=0.272  Sum_probs=200.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ....++|++.+.||+|+||.||+|++  +++.||||++......    .....+|+.++.+++||||+++++++......
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            34457899999999999999999997  5788999999754322    23456899999999999999999998776544


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ....++||||+++|+|.++++ ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+|
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN-----------GIIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEEETTSCEE
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCCcCCCCHHHEEEcCCCCEE
Confidence            445689999999999999995 45699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      |+|||+++.+...... .......||+.|+|||++.+.     .++.++||||||+++|||++|           ..||.
T Consensus       157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g-----------~~pf~  220 (311)
T 3ork_A          157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-----SVDARSDVYSLGCVLYEVLTG-----------EPPFT  220 (311)
T ss_dssp             ECCCSCC------------------CCTTCCHHHHHTC-----CCCHHHHHHHHHHHHHHHHHS-----------SCSCC
T ss_pred             EeeccCcccccccccccccccccCcCcccCCHHHhcCC-----CCCchHhHHHHHHHHHHHHhC-----------CCCCC
Confidence            9999999876543221 223345789999999999763     677889999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ...............   +........+..+.+||.+||+.||++||++.+++.+.+...
T Consensus       221 ~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          221 GD-----SPVSVAYQHVREDPI---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CS-----SHHHHHHHHHHCCCC---CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CC-----ChHHHHHHHhcCCCC---CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            43     333333333333221   111111123457999999999999999999998888776544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.4e-45  Score=356.84  Aligned_cols=256  Identities=22%  Similarity=0.333  Sum_probs=200.2

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCc----EEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NEN----VAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~----vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|++.+.||+|+||.||+|++.  ++.    ||+|.+....  .....+.+|+.++++++||||+++++++.... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            45678999999999999999999983  333    5778764332  22345678999999999999999999998753 


Q ss_pred             cceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .++|+||+++|+|.+++..  ..+++..++.++.||+.||.|||+.           +|+||||||+|||++.++.
T Consensus        91 ----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivH~Dikp~NIll~~~~~  155 (327)
T 3poz_A           91 ----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-----------RLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEEEETTE
T ss_pred             ----eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-----------CeeCCCCChheEEECCCCC
Confidence                4799999999999999954  4699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~p  337 (461)
                      +||+|||+++...............+|..|+|||++.+     ..++.++|||||||++|||++ |           ..|
T Consensus       156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g-----------~~p  219 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFG-----------SKP  219 (327)
T ss_dssp             EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCT
T ss_pred             EEEccCcceeEccCCcccccccCCCccccccChHHhcc-----CCCCchhhhhhhHHHHHHHHhcC-----------CCC
Confidence            99999999988765443333444567889999999976     367789999999999999999 8           556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |...     ...++...+. ...+...+..++     ..+.+++.+||+.||++|||+.++++++..+..
T Consensus       220 ~~~~-----~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          220 YDGI-----PASEISSILE-KGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTTC-----CGGGHHHHHH-TTCCCCCCTTBC-----HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ccCC-----CHHHHHHHHH-cCCCCCCCccCC-----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            6443     2233333333 333334444333     379999999999999999999999999887764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.4e-45  Score=355.78  Aligned_cols=264  Identities=22%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECCC-----cEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEec
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKNE-----NVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKR  177 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~-----~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~  177 (461)
                      ......++|++.+.||+|+||.||+|++...     .||||++...   ........+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3445567899999999999999999998432     6999998653   2334456789999999999999999999877


Q ss_pred             CCccc--eeeeeeehhccCCChhhhhcCC-------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        178 GESIH--TEFWLITAYHERGSLCDFLKCN-------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       178 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      .....  ...++||||+++|+|.+++...       .+++..+..++.|++.||+|||+.           +|+||||||
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-----------~ivH~Dikp  165 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-----------NFIHRDLAA  165 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSG
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-----------CcccCCCCc
Confidence            54321  1238999999999999998432       489999999999999999999999           999999999


Q ss_pred             CcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCC
Q psy17532        249 NNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSV  327 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~  327 (461)
                      +|||++.++.+||+|||+++...............+++.|+|||++.+     ..++.++||||||+++|||++ |    
T Consensus       166 ~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g----  236 (323)
T 3qup_A          166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-----NLYTVHSDVWAFGVTMWEIMTRG----  236 (323)
T ss_dssp             GGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS----
T ss_pred             ceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-----CCCCCccchhhHHHHHHHHHhCC----
Confidence            999999999999999999987755443233334567889999999876     367789999999999999999 7    


Q ss_pred             CCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        328 SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       328 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                             ..||...     ...+....+.... ....+..++     ..+.+|+.+||+.||++|||+.++++.+..+..
T Consensus       237 -------~~p~~~~-----~~~~~~~~~~~~~-~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          237 -------QTPYAGI-----ENAEIYNYLIGGN-RLKQPPECM-----EEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             -------CCTTTTC-----CGGGHHHHHHTTC-CCCCCTTCC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCcccc-----ChHHHHHHHhcCC-CCCCCCccC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                   5566543     2334444443332 233343333     379999999999999999999999999988775

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-44  Score=349.91  Aligned_cols=257  Identities=21%  Similarity=0.357  Sum_probs=195.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+|+.  .++.||||.+.....    ....+.+|+.++.+++||||+++++++....    
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----   84 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD----   84 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS----
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC----
Confidence            346899999999999999999998  478899999864332    2234578999999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~Dlkp~Nil~~~~~~~kl~  153 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM-----------RIVHRDIKPQNILIDSNKTLKIF  153 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECCCCCEEEE
Confidence            45999999999999999954 5699999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++....... .......||+.|+|||++.+.     .++.++||||||+++|||++|           ..||... 
T Consensus       154 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g-----------~~pf~~~-  215 (294)
T 4eqm_A          154 DFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGE-----ATDECTDIYSIGIVLYEMLVG-----------EPPFNGE-  215 (294)
T ss_dssp             CCSSSTTC--------------CCSSCCHHHHHTC-----CCCTTHHHHHHHHHHHHHHHS-----------SCSSCSS-
T ss_pred             eCCCccccccccc-cccCccccCccccCHhHhcCC-----CCCchHhHHHHHHHHHHHHhC-----------CCCCCCC-
Confidence            9999987654321 223345799999999999763     567889999999999999999           6666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-cccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-SASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~~~  405 (461)
                          .............. +..+.... ...+..+.++|.+||+.||++|| +++++.+.+..+
T Consensus       216 ----~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          216 ----TAVSIAIKHIQDSV-PNVTTDVR-KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             ----CHHHHHHHHHSSCC-CCHHHHSC-TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             ----ChHHHHHHHhhccC-CCcchhcc-cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence                22232222222211 11111111 11234799999999999999999 666666665443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-44  Score=354.18  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc-----
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI-----  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~-----  181 (461)
                      .++|++.+.||+|+||.||+|++  +++.||||++.....  ......+|+.++++++||||+++++++.+....     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            36799999999999999999999  478899999975432  334567899999999999999999998664320     


Q ss_pred             ------------------------------------------------ceeeeeeehhccCCChhhhhcCC----CCCHH
Q psy17532        182 ------------------------------------------------HTEFWLITAYHERGSLCDFLKCN----IVTWE  209 (461)
Q Consensus       182 ------------------------------------------------~~~~~lv~e~~~~gsL~~~l~~~----~l~~~  209 (461)
                                                                      ...+++||||+++|+|.+++...    ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                            11368999999999999999653    35677


Q ss_pred             HHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCC----------CCC
Q psy17532        210 QLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPC----------GDT  279 (461)
Q Consensus       210 ~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~----------~~~  279 (461)
                      .+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|||+++........          ...
T Consensus       165 ~~~~i~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK-----------GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             HHHHHHHHHHHHHHHHHhC-----------CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            7899999999999999999           9999999999999999999999999999887654211          122


Q ss_pred             CCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccC
Q psy17532        280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK  359 (461)
Q Consensus       280 ~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~  359 (461)
                      ....||+.|+|||++.+     ..++.++||||||+++|||++|           ..|+..       ..........  
T Consensus       234 ~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~-----------~~~~~~-------~~~~~~~~~~--  288 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHG-----NNYSHKVDIFSLGLILFELLYS-----------FSTQME-------RVRIITDVRN--  288 (332)
T ss_dssp             CSCC-CGGGSCHHHHHC-----CCCCTHHHHHHHHHHHHHHHSC-----------CCCHHH-------HHHHHHHHHT--
T ss_pred             cccCCCcCccChHHhcC-----CCCcchhhHHHHHHHHHHHHHc-----------CCChhH-------HHHHHHHhhc--
Confidence            34579999999999976     3678899999999999999998           333321       1112222222  


Q ss_pred             CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        360 LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       360 ~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                        ..++..+..  ....+.+||.+||+.||++|||+.++++|.+.
T Consensus       289 --~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          289 --LKFPLLFTQ--KYPQEHMMVQDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             --TCCCHHHHH--HCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             --cCCCccccc--CChhHHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence              122322221  22467899999999999999999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-44  Score=369.67  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=209.6

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....++|.+.+.||+|+||.||+|++  +|+.||||++.....    ......+|+.+++.++||||+++++++.+.. 
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-   89 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-   89 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence            344567899999999999999999998  478999999975322    1234578999999999999999999998765 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+
T Consensus        90 ---~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------givHrDLkp~NIll~~~~~v  155 (476)
T 2y94_A           90 ---DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH-----------MVVHRDLKPENVLLDAHMNA  155 (476)
T ss_dssp             ---EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT-----------TEECSCCSGGGEEECTTCCE
T ss_pred             ---EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCCcccccHHHEEEecCCCe
Confidence               45999999999999999964 4699999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++....+.   ......||+.|+|||++.+.    ...+.++|||||||++|||++|           ..||.
T Consensus       156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~elltG-----------~~Pf~  217 (476)
T 2y94_A          156 KIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGR----LYAGPEVDIWSSGVILYALLCG-----------TLPFD  217 (476)
T ss_dssp             EECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTC----CBCSHHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEEeccchhhccccc---cccccCCCcCeEChhhccCC----CCCCCcceehhhHHHHHHHhhC-----------CCCCC
Confidence            999999998875443   23346799999999999764    1235689999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ....+...+..+..  ..|...+     ..+.+||.+||..||++|||+.++++|.+...
T Consensus       218 ~~-----~~~~~~~~i~~~~~--~~p~~~s-----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          218 DD-----HVPTLFKKICDGIF--YTPQYLN-----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CS-----SSHHHHHHHHTTCC--CCCTTCC-----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CC-----CHHHHHHHHhcCCc--CCCccCC-----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            43     33445555544432  2333322     37899999999999999999999999988754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=350.44  Aligned_cols=255  Identities=30%  Similarity=0.437  Sum_probs=197.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ...++|++.+.||+|+||.||+|+++++.||||.+... .....+.+|+.++++++||||+++++++.+.      .++|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~lv   77 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLNP------VCLV   77 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT------TEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC------cEEE
Confidence            45678999999999999999999999999999998643 2344567899999999999999999987642      3899


Q ss_pred             ehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc-eEEEe
Q psy17532        189 TAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT-AAIAD  263 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~-~ki~D  263 (461)
                      |||+++|+|.+++...    .+++..++.++.|+++||+|||+..        ..+|+||||||+|||++.++. +||+|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--------~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ--------PKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS--------SSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC--------CCCeecCCCChhHEEEeCCCCEEEEcc
Confidence            9999999999999654    3789999999999999999999820        118999999999999998886 79999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++......     .....||..|+|||++.+     ..++.++||||||+++|||++|           ..||.....
T Consensus       150 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g-----------~~p~~~~~~  208 (307)
T 2eva_A          150 FGTACDIQTH-----MTNNKGSAAWMAPEVFEG-----SNYSEKCDVFSWGIILWEVITR-----------RKPFDEIGG  208 (307)
T ss_dssp             CCC-----------------CCTTSSCHHHHTC-----CCCCTHHHHHHHHHHHHHHHHT-----------CCTTTTTCS
T ss_pred             cccccccccc-----cccCCCCCceEChhhhCC-----CCCCcHHHHHHHHHHHHHHHHC-----------CCCchhhCc
Confidence            9999765432     223468999999999976     3677899999999999999999           555543211


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                         ........+ ....++..+..++     ..+.++|.+||+.||++|||++++++++..+...
T Consensus       209 ---~~~~~~~~~-~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          209 ---PAFRIMWAV-HNGTRPPLIKNLP-----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             ---SHHHHHHHH-HTTCCCCCBTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             ---cHHHHHHHH-hcCCCCCcccccC-----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence               112222222 2233444444433     3789999999999999999999999999877653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-44  Score=342.94  Aligned_cols=256  Identities=20%  Similarity=0.354  Sum_probs=209.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...++|++.+.||+|+||.||+|++ +++.||||++...........+|+.++..++||||+++++++.+...    +++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   80 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICL   80 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----CEE
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC----eEE
Confidence            4557899999999999999999999 56789999998765555667889999999999999999999987653    489


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~Nili~~~~~~kl~dfg  149 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-----------CVIHRDLAARNCLVGENQVIKVSDFG  149 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCchheEEECCCCCEEEcccc
Confidence            9999999999999964  4589999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +++....... .......++..|+|||++.+     ..++.++||||||+++|||++ |           ..||...   
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g-----------~~p~~~~---  209 (267)
T 3t9t_A          150 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEG-----------KIPYENR---  209 (267)
T ss_dssp             GGGGBCCHHH-HSTTSTTCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCTTTTC---
T ss_pred             cccccccccc-cccccccccccccChhhhcC-----CCccchhchhhhHHHHHHHhccC-----------CCCCCCC---
Confidence            9987643211 12234567889999999875     356788999999999999999 6           5666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                        ...+....+... .+...+...+     ..+.+++.+||+.||++|||+.++++++..+..
T Consensus       210 --~~~~~~~~i~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          210 --SNSEVVEDISTG-FRLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --CHHHHHHHHHTT-CCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CHHHHHHHHhcC-CcCCCCccCc-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              344444444333 3333343332     379999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.6e-44  Score=356.03  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=201.0

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..|++.+.||+|+||.||+|+.  +++.||||++......    .....+|+.++.+++||||+++++++....    ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~  129 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----TA  129 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----eE
Confidence            5699999999999999999997  5788999999754321    234568999999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+. |+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~~kL~D  197 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-----------NMIHRDVKAGNILLSEPGLVKLGD  197 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCSGGGEEEETTTEEEECC
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCCHHHEEECCCCCEEEee
Confidence            99999997 68888874  45799999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++....      .....||+.|+|||++.+.  ....++.++|||||||++|||++|           ..||...  
T Consensus       198 fG~a~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~ell~g-----------~~p~~~~--  256 (348)
T 1u5q_A          198 FGSASIMAP------ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER-----------KPPLFNM--  256 (348)
T ss_dssp             CTTCBSSSS------BCCCCSCGGGCCHHHHHTT--SSCCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS--
T ss_pred             ccCceecCC------CCcccCCcceeCHhhhccc--cCCCCCcHHHHHHHHHHHHHHHhC-----------CCCCCCC--
Confidence            999987643      2335799999999998532  124677899999999999999999           5555433  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         ........+.........+..++     ..+.+||.+||+.||++|||+++++++.+...
T Consensus       257 ---~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          257 ---NAMSALYHIAQNESPALQSGHWS-----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             ---CHHHHHHHHHHSCCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ---ChHHHHHHHHhcCCCCCCCCCCC-----HHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence               22233333333332222233333     37899999999999999999999999988654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7e-44  Score=343.48  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ...+.|++.+.||+|+||.||+|.+.  +..||+|.+....   .......+|+.+++.++||||+++++++........
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            34567899999999999999999984  5679999986533   223345689999999999999999999876443345


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC--eecccCCCCcEEEc-CCCce
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA--VAHRDFKSNNVLLK-SDLTA  259 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~--ivHrDLkp~NILl~-~~~~~  259 (461)
                      .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +  |+||||||+|||++ .++.+
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~~~i~H~dikp~Nil~~~~~~~~  171 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-----------TPPIIHRDLKCDNIFITGPTGSV  171 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-----------SSCCCCSCCCGGGEEESSTTSCE
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-----------CCCEEECCCCHHHEEEECCCCCE
Confidence            67999999999999999965 6799999999999999999999998           6  99999999999998 78999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||++......    ......||+.|+|||++.+      .++.++||||||+++|||++|           ..||.
T Consensus       172 kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g-----------~~pf~  230 (290)
T 1t4h_A          172 KIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATS-----------EYPYS  230 (290)
T ss_dssp             EECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHS-----------SCTTT
T ss_pred             EEeeCCCccccccc----ccccccCCcCcCCHHHHhc------cCCCcchHHHHHHHHHHHHhC-----------CCCCC
Confidence            99999999765432    2334578999999998864      467899999999999999999           55654


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ..    .........+........++..     .+..+.+||.+||+.||++|||+.++++|.+.
T Consensus       231 ~~----~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          231 EC----QNAAQIYRRVTSGVKPASFDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             TC----SSHHHHHHHHTTTCCCGGGGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             Cc----CcHHHHHHHHhccCCccccCCC-----CCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence            32    1333444444333222222222     22479999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.9e-45  Score=356.26  Aligned_cols=256  Identities=22%  Similarity=0.331  Sum_probs=201.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCc----EEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NEN----VAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~----vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|++.+.||+|+||.||+|++.  ++.    ||+|.+.....  ......+|+.++.+++||||+++++++...  
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--   87 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS--   87 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS--
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence            44578999999999999999999984  444    77787753321  123445788888999999999999998643  


Q ss_pred             cceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                         ..++||||+++|+|.+++...  .+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.
T Consensus        88 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dikp~Nil~~~~~~  153 (325)
T 3kex_A           88 ---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH-----------GMVHRNLAARNVLLKSPSQ  153 (325)
T ss_dssp             ---SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSSTTEEESSSSC
T ss_pred             ---ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC-----------CCCCCccchheEEECCCCe
Confidence               358999999999999999653  689999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~p  337 (461)
                      +||+|||+++...............||..|+|||++.+.     .++.++||||||+++|||++ |           ..|
T Consensus       154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~g-----------~~p  217 (325)
T 3kex_A          154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-----KYTHQSDVWSYGVTVWELMTFG-----------AEP  217 (325)
T ss_dssp             EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTS-----------CCT
T ss_pred             EEECCCCcccccCcccccccccCCCCcccccChHHhccC-----CCChhhHhHHhHHHHHHHHhCC-----------CCC
Confidence            999999999987655433334456788899999999763     67789999999999999999 8           556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |...     ...++...+.. ..+...+..++.     .+.++|.+||..||++|||+.++++++..+..
T Consensus       218 ~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          218 YAGL-----RLAEVPDLLEK-GERLAQPQICTI-----DVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTTS-----CTTHHHHHHHT-TCBCCCCTTBCT-----TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             cccc-----CHHHHHHHHHc-CCCCCCCCcCcH-----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            6543     22233333332 233444444433     68899999999999999999999999977654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-44  Score=346.62  Aligned_cols=268  Identities=27%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             CCCCCccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        103 SPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       103 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .........++|++.+.||+|+||.||+|++.+ .||||++.....   ....+.+|+.++++++||||++++++.... 
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   92 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-   92 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC-
Confidence            344456677899999999999999999998765 599999865432   224457899999999999999999976443 


Q ss_pred             ccceeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                          .+++||||+++|+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus        93 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-----------~i~H~Dlkp~Nil~~~~~  157 (289)
T 3og7_A           93 ----QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK-----------SIIHRDLKSNNIFLHEDN  157 (289)
T ss_dssp             ----SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEEETTT
T ss_pred             ----ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccccCccceEEECCCC
Confidence                3489999999999999995  34699999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++...............||+.|+|||++...  ....++.++||||||+++|||++|           ..|
T Consensus       158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g-----------~~p  224 (289)
T 3og7_A          158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ--DSNPYSFQSDVYAFGIVLYELMTG-----------QLP  224 (289)
T ss_dssp             EEEECCCC------------------CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHS-----------SCT
T ss_pred             CEEEccceeccccccccccccccccCCCccccCchhhccc--CCCCCCcccchHHHHHHHHHHHHC-----------CCC
Confidence            9999999999866533222233445789999999998632  124567789999999999999999           566


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      |...    .....+...+......+.++...  ...+..+.+||.+||+.||++|||+.++++.+..+.
T Consensus       225 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          225 YSNI----NNRDQIIEMVGRGSLSPDLSKVR--SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             TSSC----CCHHHHHHHHHHTSCCCCTTSSC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cccc----chHHHHHHHhcccccCcchhhcc--ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            6432    13344444444444433332211  113348999999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=367.15  Aligned_cols=265  Identities=21%  Similarity=0.188  Sum_probs=206.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||++.....    ......+|..++..++||||+++++++.+..   
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~---  134 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN---  134 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS---
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC---
Confidence            3457899999999999999999998  478899999964321    1223457777888899999999999998865   


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       .+|+||||+++|+|.+++..  ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+|
T Consensus       135 -~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------giiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          135 -YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL-----------GYVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEE
T ss_pred             -EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecccCHHHeeecCCCCEE
Confidence             45999999999999999964  4799999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccc--cccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAI--NFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      |+|||+++....... ......+||+.|+|||++.+..  .....++.++|||||||++|||++|           ..||
T Consensus       203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG-----------~~Pf  270 (412)
T 2vd5_A          203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG-----------QTPF  270 (412)
T ss_dssp             ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS-----------SCTT
T ss_pred             EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC-----------CCCC
Confidence            999999987754332 1233468999999999986310  0013577899999999999999999           6666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhh---ccccchhhhcHHHhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR---LSASCVVERGMLALCD  408 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~l~~~~~~  408 (461)
                      ...     +..+....+........+|...  ...+.++.+||++||. +|++|   |+++++++|.++....
T Consensus       271 ~~~-----~~~~~~~~i~~~~~~~~~p~~~--~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          271 YAD-----STAETYGKIVHYKEHLSLPLVD--EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             CCS-----SHHHHHHHHHTHHHHCCCC------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             CCC-----CHHHHHHHHHhcccCcCCCccc--cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            543     4445444544322112222110  1123489999999999 99998   5899999999875543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-45  Score=365.65  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=191.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+|.+  +++.||||++....   .......+|+.++..+. ||||+++++++...+.  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~   84 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND--R   84 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS--S
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC--C
Confidence            346899999999999999999998  47889999985432   22334567888888886 9999999999976542  3


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||++ |+|.++++.+.+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG-----------GLLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEeCCCCHHHeEEcCCCCEEecC
Confidence            5699999998 5999999888899999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCC-------------------CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCC
Q psy17532        264 FGLALLFEPGKP-------------------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC  324 (461)
Q Consensus       264 FGla~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~  324 (461)
                      ||+|+.+.....                   ........||+.|+|||++.+.    ..++.++|||||||++|||++|.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~  228 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS----TKYTKGIDMWSLGCILGEILCGK  228 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC----CCCCChhhHHHHHHHHHHHHhCC
Confidence            999987643110                   0112345799999999998763    46788999999999999999995


Q ss_pred             CCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCC-----------------------------CCCCCchhc------
Q psy17532        325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKL-----------------------------RPTLPETWK------  369 (461)
Q Consensus       325 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~p~~~~------  369 (461)
                      +||.           +.     ...+....+.....                             .......++      
T Consensus       229 ~pf~-----------~~-----~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (388)
T 3oz6_A          229 PIFP-----------GS-----STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL  292 (388)
T ss_dssp             CSCC-----------CS-----SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHH
T ss_pred             CCCC-----------CC-----CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhc
Confidence            5543           22     11111111110000                             000000000      


Q ss_pred             -----cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        370 -----QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       370 -----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           ....+..+.+||.+||..||++|||++|+++|.+...
T Consensus       293 ~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI  334 (388)
T ss_dssp             HHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred             ccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence                 0023357899999999999999999999999987543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.7e-44  Score=351.45  Aligned_cols=261  Identities=21%  Similarity=0.341  Sum_probs=210.0

Q ss_pred             CCCCccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEE
Q psy17532        104 PPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGA  174 (461)
Q Consensus       104 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~  174 (461)
                      ........++|++.+.||+|+||.||+|++.       ++.||||.+.....  ......+|+.+++.++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3445666789999999999999999999874       46799999865432  22345689999999999999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeec
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKC-----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAH  243 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivH  243 (461)
                      +.+...    .++||||+++|+|.+++..           ..+++..+..++.|++.||.|||++           +|+|
T Consensus        97 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H  161 (322)
T 1p4o_A           97 VSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-----------KFVH  161 (322)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBC
T ss_pred             EccCCc----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-----------CCcc
Confidence            987653    4899999999999999953           4578999999999999999999999           9999


Q ss_pred             ccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-
Q psy17532        244 RDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-  322 (461)
Q Consensus       244 rDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-  322 (461)
                      |||||+|||++.++.+||+|||+++...............+|+.|+|||++.+.     .++.++||||||+++|||++ 
T Consensus       162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~  236 (322)
T 1p4o_A          162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-----VFTTYSDVWSFGVVLWEIATL  236 (322)
T ss_dssp             SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHHT
T ss_pred             CCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-----CCCchhhHHHHHHHHHHHHhc
Confidence            999999999999999999999999876543322223345678899999998763     57788999999999999999 


Q ss_pred             CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        323 RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       323 g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                      |           ..||...     ...+....+..... +..+..++     ..+.+||.+||+.||++|||+.++++++
T Consensus       237 g-----------~~p~~~~-----~~~~~~~~~~~~~~-~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~e~l~~L  294 (322)
T 1p4o_A          237 A-----------EQPYQGL-----SNEQVLRFVMEGGL-LDKPDNCP-----DMLFELMRMCWQYNPKMRPSFLEIISSI  294 (322)
T ss_dssp             S-----------CCTTTTS-----CHHHHHHHHHTTCC-CCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C-----------CCccccC-----CHHHHHHHHHcCCc-CCCCCCCC-----HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            6           5666543     44555555544432 23333333     3799999999999999999999999998


Q ss_pred             HHHh
Q psy17532        403 MLAL  406 (461)
Q Consensus       403 ~~~~  406 (461)
                      ....
T Consensus       295 ~~~~  298 (322)
T 1p4o_A          295 KEEM  298 (322)
T ss_dssp             GGGS
T ss_pred             HHhh
Confidence            6554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=358.73  Aligned_cols=255  Identities=20%  Similarity=0.278  Sum_probs=205.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+.|++.+.||+|+||.||+|..  +++.||+|++..... ......+|+.++..++||||+++++++.+..    .++
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~  124 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY----EMV  124 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS----EEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC----EEE
Confidence            356899999999999999999998  478899999875533 3345678999999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC--CCceEEE
Q psy17532        187 LITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS--DLTAAIA  262 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~--~~~~ki~  262 (461)
                      +||||+++|+|.+++...  .+++..+..++.||+.||+|||+.           +|+||||||+|||++.  ++.+||+
T Consensus       125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------givHrDlkp~NIll~~~~~~~vkL~  193 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-----------SIVHLDIKPENIMCETKKASSVKII  193 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeecccchHHeEEecCCCCceEEE
Confidence            999999999999999643  689999999999999999999999           9999999999999974  4789999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++.......   .....||+.|+|||++.+     ..++.++|||||||++|||++|           ..||... 
T Consensus       194 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg-----------~~Pf~~~-  253 (387)
T 1kob_A          194 DFGLATKLNPDEI---VKVTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSG-----------LSPFAGE-  253 (387)
T ss_dssp             CCTTCEECCTTSC---EEEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHS-----------CCSSCCS-
T ss_pred             ecccceecCCCcc---eeeeccCCCccCchhccC-----CCCCCcccEeeHhHHHHHHHhC-----------CCCCCCC-
Confidence            9999988754321   233478999999999976     3577889999999999999999           5666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ...+....+........ +..+.  ..+.++.+||.+||..||++|||+.++++|.+...
T Consensus       254 ----~~~~~~~~i~~~~~~~~-~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (387)
T 1kob_A          254 ----DDLETLQNVKRCDWEFD-EDAFS--SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  310 (387)
T ss_dssp             ----SHHHHHHHHHHCCCCCC-SSTTT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             ----CHHHHHHHHHhCCCCCC-ccccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence                33344444443332211 11111  12347999999999999999999999999987543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-44  Score=357.27  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=202.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      -.++|++.+.||+|+||.||+|+.+  ++.||||++......   ..+|+.++.++ +||||+++++++.+..    .++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGK----YVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSS----EEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCC----EEE
Confidence            3468999999999999999999984  678999999754332   33566666666 7999999999998765    459


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC----CceEE
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD----LTAAI  261 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~----~~~ki  261 (461)
                      +||||+++|+|.+++. ...+++..+..++.||+.||+|||+.           +|+||||||+|||+.++    +.+||
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-----------GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            9999999999999985 45699999999999999999999999           99999999999998543    35999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++......  .......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||...
T Consensus       162 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g-----------~~Pf~~~  223 (342)
T 2qr7_A          162 CDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQ-----GYDAACDIWSLGVLLYTMLTG-----------YTPFANG  223 (342)
T ss_dssp             CCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHH-----HHHHHHHHHHHHHHHHHHHHS-----------SCSSCSS
T ss_pred             EECCCcccCcCCC--CceeccCCCccccCHHHhcCC-----CCCCccCeeeHhHHHHHHhcC-----------CCCCCCC
Confidence            9999998765433  223446789999999998763     466789999999999999999           5555432


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ......++...+..+...... ..|.  ..+..+.+||.+||..||++|||+.++++|.|...
T Consensus       224 --~~~~~~~~~~~i~~~~~~~~~-~~~~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          224 --PDDTPEEILARIGSGKFSLSG-GYWN--SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             --TTSCHHHHHHHHHHCCCCCCS-TTTT--TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             --CcCCHHHHHHHHccCCcccCc-cccc--cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence              112455666666555433221 1111  12348999999999999999999999999999854

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.5e-44  Score=342.29  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      +...++|++.+.||+|+||.||+|+..  ++.||||++......    .....+|+.++..++||||+++++++.+..  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   82 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--   82 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC--
Confidence            456789999999999999999999984  567999998643221    234567899999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        ..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus        83 --~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~i~H~dlkp~Nili~~~~~~~  149 (279)
T 3fdn_A           83 --RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-----------RVIHRDIKPENLLLGSAGELK  149 (279)
T ss_dssp             --EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT-----------TCEECCCCGGGEEECTTSCEE
T ss_pred             --EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecccCChHhEEEcCCCCEE
Confidence              45999999999999999854 5699999999999999999999998           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++.......    .....||..|+|||++.+.     .++.++||||||+++|||++|           ..||..
T Consensus       150 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~  209 (279)
T 3fdn_A          150 IADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGR-----MHDEKVDLWSLGVLCYEFLVG-----------KPPFEA  209 (279)
T ss_dssp             ECSCCEESCC------------CCCCTTCCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHS-----------SCTTCC
T ss_pred             EEeccccccCCccc----ccccCCCCCccCHhHhccC-----CCCccchhHhHHHHHHHHHHC-----------CCCCCC
Confidence            99999986654322    2345789999999998763     567889999999999999999           566654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .     ...+....+....  ..+|..++     ..+.+||.+||+.||++|||+.++++|.+....
T Consensus       210 ~-----~~~~~~~~~~~~~--~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          210 N-----TYQETYKRISRVE--FTFPDFVT-----EGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             S-----SHHHHHHHHHHTC--CCCCTTSC-----HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             C-----cHHHHHHHHHhCC--CCCCCcCC-----HHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence            3     3444444443322  23343333     378999999999999999999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=348.25  Aligned_cols=267  Identities=23%  Similarity=0.380  Sum_probs=201.9

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc-
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI-  181 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~-  181 (461)
                      ......+.|++.+.||+|+||.||+|++  +++.||||++...........+|+.++.++ +||||+++++++...... 
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3445668899999999999999999999  578999999987665566677888888887 899999999998764321 


Q ss_pred             -ceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        182 -HTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       182 -~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                       ...+++||||+++|+|.+++..   ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-----------KVIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCSGGGEEECTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCcHHHEEEcCCC
Confidence             2357999999999999999964   4689999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||++.......  .......||..|+|||++.+.......++.++||||||+++|||++|           ..|
T Consensus       167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g-----------~~p  233 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-----------APP  233 (326)
T ss_dssp             CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS-----------SCT
T ss_pred             CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC-----------CCC
Confidence            99999999998765322  12334578999999999864322234677899999999999999999           555


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      |...     ........+.........+..+     +..+.+||.+||..||++|||+.++++|.+...
T Consensus       234 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          234 LCDM-----HPMRALFLIPRNPAPRLKSKKW-----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             TTTS-----CHHHHHHHHHHSCCCCCSCSCS-----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             CCCC-----cHHHHHHHhhcCccccCCcccc-----CHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            5432     2222223332322222222222     248999999999999999999999999987644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.2e-44  Score=355.89  Aligned_cols=258  Identities=22%  Similarity=0.243  Sum_probs=196.9

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC-----CCCeeEEEEEEec
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME-----HDNILRYIGAEKR  177 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-----H~nIv~l~g~~~~  177 (461)
                      .......++|++.+.||+|+||.||+|++  +++.||||++............|+.++..++     ||||+++++++..
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            34445567999999999999999999999  5788999999754444444556666666554     9999999999987


Q ss_pred             CCccceeeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                      ..    .+++||||+ +|+|.+++...   .+++..+..++.||+.||+|||+.           +|+||||||+|||++
T Consensus       108 ~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~  171 (360)
T 3llt_A          108 YD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM-----------SLTHTDLKPENILLD  171 (360)
T ss_dssp             TT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEES
T ss_pred             CC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCCcccEEEc
Confidence            65    459999999 88999999644   499999999999999999999999           999999999999997


Q ss_pred             C-------------------------CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccc
Q psy17532        255 S-------------------------DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRID  309 (461)
Q Consensus       255 ~-------------------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~D  309 (461)
                      .                         ++.+||+|||+++.....     .....||+.|+|||++.+.     .++.++|
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~D  241 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNL-----GWDVSSD  241 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTC-----CCCTTHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCC-----CCCCccc
Confidence            5                         789999999999865432     2345789999999999763     6788999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccC------------------------CCCCCC
Q psy17532        310 MYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK------------------------LRPTLP  365 (461)
Q Consensus       310 VwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~p  365 (461)
                      ||||||++|||++|..           ||...     ...+....+....                        .....|
T Consensus       242 iwslG~il~ell~g~~-----------pf~~~-----~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p  305 (360)
T 3llt_A          242 MWSFGCVLAELYTGSL-----------LFRTH-----EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWP  305 (360)
T ss_dssp             HHHHHHHHHHHHHSSC-----------SCCCS-----SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTT
T ss_pred             hHHHHHHHHHHHHCCC-----------CCCCC-----cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCc
Confidence            9999999999999954           44322     1111111111100                        000011


Q ss_pred             chhcc---------------chhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        366 ETWKQ---------------HAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       366 ~~~~~---------------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .....               ......+.+||.+||+.||++|||++|+++|.|.
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          306 ENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             TTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             ccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCccc
Confidence            10000               0011468899999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-44  Score=345.98  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...+.|++.+.||+|+||.||+|+..  +..||+|++.....  .....++|+.++++++||||+++++++.+..    .
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~   94 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH----N   94 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----E
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC----e
Confidence            34578999999999999999999984  67899999875432  2345678999999999999999999998755    4


Q ss_pred             eeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCC
Q psy17532        185 FWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSD  256 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~  256 (461)
                      +++||||+++|+|.+++.     ...+++..+..++.|++.||+|||+.           +|+||||||+|||+   +.+
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~dikp~NIl~~~~~~~  163 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-----------HVVHKDLKPENILFQDTSPH  163 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCSGGGEEESSSSTT
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEECCCCHHHEEEecCCCC
Confidence            599999999999999883     35699999999999999999999999           99999999999999   456


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+++......   ......||+.|+|||++.+      .++.++||||||+++|||++|           ..
T Consensus       164 ~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~il~~ll~g-----------~~  223 (285)
T 3is5_A          164 SPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKR------DVTFKCDIWSAGVVMYFLLTG-----------CL  223 (285)
T ss_dssp             CCEEECCCCCCCC-------------CTTGGGCCHHHHTT------CCCHHHHHHHHHHHHHHHHHS-----------SC
T ss_pred             CCEEEEeeecceecCCcc---cCcCcccccCcCChHHhcc------CCCcccCeehHHHHHHHHHhC-----------CC
Confidence            889999999998765432   2334578999999999853      567889999999999999999           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...     ...+...............  .  ...+..+.+||.+||+.||++|||+.|+++|.+..
T Consensus       224 pf~~~-----~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          224 PFTGT-----SLEEVQQKATYKEPNYAVE--C--RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             SSCCS-----SHHHHHHHHHHCCCCCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             CCCCC-----CHHHHHhhhccCCcccccc--c--CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            66543     3444444443332221111  1  11234788999999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.5e-44  Score=345.20  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|+||.||+|++.     +..||||.+.....  ......+|+..+.+++||||+++++++.+. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   88 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-   88 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC-
Confidence            4456689999999999999999999984     23599998764332  233456889999999999999999998542 


Q ss_pred             ccceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                          ..++||||+++|+|.+++...  .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus        89 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~  153 (281)
T 1mp8_A           89 ----PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-----------RFVHRDIAARNVLVSSND  153 (281)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEEEETT
T ss_pred             ----ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecccccHHHEEECCCC
Confidence                348999999999999999643  589999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      .+||+|||+++....... .......+|+.|+|||++.+     ..++.++||||||+++|||++ |           ..
T Consensus       154 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~ell~~g-----------~~  216 (281)
T 1mp8_A          154 CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHG-----------VK  216 (281)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTS-----------CC
T ss_pred             CEEECccccccccCcccc-cccccCCCcccccChhhccc-----CCCCCccCchHHHHHHHHHHhcC-----------CC
Confidence            999999999987654332 12233457789999999875     367788999999999999997 7           55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ||...     ...+....+... .+..++..++     ..+.++|.+||+.||++|||+.++++++..+..
T Consensus       217 pf~~~-----~~~~~~~~i~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          217 PFQGV-----KNNDVIGRIENG-ERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             TTTTC-----CGGGHHHHHHTT-CCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcC-----CHHHHHHHHHcC-CCCCCCCCCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            66443     223334444333 2333444333     379999999999999999999999999887654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9e-44  Score=344.46  Aligned_cols=272  Identities=24%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      .....+.|++.+.||+|+||.||+|++      .++.||||++.....  ......+|+.++..++||||+++++++...
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            345567899999999999999999995      467899999864432  234567899999999999999999999875


Q ss_pred             CccceeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ..  ..+++||||+++|+|.+++.  ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.+
T Consensus        96 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dikp~Nil~~~~  162 (302)
T 4e5w_A           96 GG--NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR-----------QYVHRDLAARNVLVESE  162 (302)
T ss_dssp             ----CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEEET
T ss_pred             CC--ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC-----------CcccCCCchheEEEcCC
Confidence            32  24689999999999999993  34699999999999999999999999           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC--
Q psy17532        257 LTAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE--  333 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~--  333 (461)
                      +.+||+|||+++........ .......||..|+|||++.+.     .++.++||||||+++|||++|+.|+..+...  
T Consensus       163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  237 (302)
T 4e5w_A          163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-----KFYIASDVWSFGVTLHELLTYCDSDSSPMALFL  237 (302)
T ss_dssp             TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred             CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-----CCCcchhHHHHHHHHHHHHHccCCCcchhhHHh
Confidence            99999999999887654321 123345688899999998763     5567899999999999999996543211000  


Q ss_pred             -CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        334 -YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       334 -~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ...|+...    .........+ ....+...+..++     ..+.+||.+||+.||++|||+.++++.+..+.
T Consensus       238 ~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          238 KMIGPTHGQ----MTVTRLVNTL-KEGKRLPCPPNCP-----DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHCSCCGG----GHHHHHHHHH-HTTCCCCCCTTCC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCcccc----cCHHHHHHHH-hccCCCCCCCCCC-----HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence             00011111    1122222222 3333444444443     38999999999999999999999999987653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=357.17  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             eeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      +...+.||+|+||.||+|+.  +++.||||++..... ......+|+.++.+++||||+++++++.+..    .+++|||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~E  166 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DIVLVME  166 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEEEEe
Confidence            34467899999999999998  478899999976543 3345678999999999999999999998765    4599999


Q ss_pred             hccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE--cCCCceEEEecCC
Q psy17532        191 YHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL--KSDLTAAIADFGL  266 (461)
Q Consensus       191 ~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl--~~~~~~ki~DFGl  266 (461)
                      |+++|+|.+++..  ..+++..+..++.||+.||+|||+.           +|+||||||+|||+  +.++.+||+|||+
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~~~~kl~DFG~  235 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM-----------YILHLDLKPENILCVNRDAKQIKIIDFGL  235 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence            9999999998854  3599999999999999999999999           99999999999999  5678999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      ++......   ......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||...     
T Consensus       236 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg-----------~~pf~~~-----  291 (373)
T 2x4f_A          236 ARRYKPRE---KLKVNFGTPEFLAPEVVNY-----DFVSFPTDMWSVGVIAYMLLSG-----------LSPFLGD-----  291 (373)
T ss_dssp             CEECCTTC---BCCCCCSSCTTCCHHHHTT-----CBCCHHHHHHHHHHHHHHHHHS-----------SCTTCCS-----
T ss_pred             ceecCCcc---ccccccCCCcEeChhhccC-----CCCCcHHhHHHHHHHHHHHHhC-----------CCCCCCC-----
Confidence            98875443   2334579999999999865     3667889999999999999999           5666543     


Q ss_pred             CHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...+....+........ +..+.  ..+.++.+||.+||..||++|||+.++++|.+....
T Consensus       292 ~~~~~~~~i~~~~~~~~-~~~~~--~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          292 NDAETLNNILACRWDLE-DEEFQ--DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SHHHHHHHHHHTCCCSC-SGGGT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHhccCCCC-hhhhc--cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            33444444444332211 11111  133589999999999999999999999999887554

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.5e-44  Score=341.61  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=209.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .....++|++.+.||+|+||.||+|+.++ ..||||.+...........+|+.++..++||||+++++++...     ..
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~   82 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PI   82 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SC
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-----Cc
Confidence            44556799999999999999999999864 5799999976655556677899999999999999999998643     24


Q ss_pred             eeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ++||||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-----------NYIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHhhEEEcCCCCEEEC
Confidence            8999999999999999654   699999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~  341 (461)
                      |||+++....... .......++..|+|||++.+.     .++.++||||||+++|||++ |           ..||...
T Consensus       152 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g-----------~~p~~~~  214 (279)
T 1qpc_A          152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSFGILLTEIVTHG-----------RIPYPGM  214 (279)
T ss_dssp             CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTT-----------CCSSTTC
T ss_pred             CCcccccccCccc-ccccCCCCccCccChhhhccC-----CCCchhhhHHHHHHHHHHHhCC-----------CCCCccc
Confidence            9999987754321 223345678899999998753     56678999999999999999 7           5666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                           ...+....+.. ..+...+..++     ..+.+++.+||+.||++|||+.++++.+..+..
T Consensus       215 -----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          215 -----TNPEVIQNLER-GYRMVRPDNCP-----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             -----CHHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CHHHHHHHHhc-ccCCCCccccc-----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                 33444444433 23334444333     489999999999999999999999998877654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=356.88  Aligned_cols=255  Identities=22%  Similarity=0.248  Sum_probs=189.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..+.|++.+.||+|+||.||+|+..  ++.||||++.... ......+|+.++.+++||||+++++++.+..    .+++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT----EISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSS----EEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCC----eEEE
Confidence            3467999999999999999999995  5779999987543 2334567888899999999999999998765    4589


Q ss_pred             eehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCceEEEe
Q psy17532        188 ITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~~ki~D  263 (461)
                      ||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.   ++.+||+|
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN-----------GIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEecCCCcccEEEecCCCCCCEEEcc
Confidence            9999999999999854 4589999999999999999999999           9999999999999975   88999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++......   ......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||.... 
T Consensus       195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g-----------~~pf~~~~-  254 (349)
T 2w4o_A          195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC-----AYGPEVDMWSVGIITYILLCG-----------FEPFYDER-  254 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHS-----------SCTTCCTT-
T ss_pred             CccccccCccc---ccccccCCCCccCHHHhcCC-----CCCcccchHHHHHHHHHHHhC-----------CCCCCCCc-
Confidence            99998765432   23345789999999999763     677899999999999999999           55554321 


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         ....+...+........ +..+.  ..+..+.+||.+||..||++|||+.++++|.+...
T Consensus       255 ---~~~~~~~~i~~~~~~~~-~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          255 ---GDQFMFRRILNCEYYFI-SPWWD--EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             ---CHHHHHHHHHTTCCCCC-TTTTT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ---ccHHHHHHHHhCCCccC-Cchhh--hCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence               22333444444332211 11111  13347999999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.2e-44  Score=361.96  Aligned_cols=261  Identities=18%  Similarity=0.195  Sum_probs=193.6

Q ss_pred             cCCcceeEE-eEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHc-CCCCCCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLV-EVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKL-PHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~-~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l-~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...++|.+. ++||+|+||.||+|.+.  ++.||||++...    ....+|+.++ ...+||||+++++++.........
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            345678877 79999999999999984  778999998632    2344556554 345899999999988652222345


Q ss_pred             eeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCc
Q psy17532        185 FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLT  258 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~  258 (461)
                      +++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.           +|+||||||+|||++.   ++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlkp~Nill~~~~~~~~  202 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-----------NIAHRDVKPENLLYTSKRPNAI  202 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSSSTTCC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCcCcceEEEecCCCCcc
Confidence            79999999999999999653   499999999999999999999999           9999999999999998   789


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......   ......||+.|+|||++.+     ..++.++|||||||++|||++|..||.          
T Consensus       203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~----------  264 (400)
T 1nxk_A          203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGYPPFY----------  264 (400)
T ss_dssp             EEECCCTTCEECC--------------CTTCCGGGSCC-----CCSSSHHHHHHHHHHHHHHHHSSCSCC----------
T ss_pred             EEEEecccccccCCCC---ccccCCCCCCccCHhhcCC-----CCCCCcccHHHHHHHHHHHHhCCCCCC----------
Confidence            9999999998765432   2345678999999999865     367889999999999999999955543          


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ........ ..+...+.........+ .|.  ..+.++.+||.+||..||++|||+.++++|.|....
T Consensus       265 -~~~~~~~~-~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          265 -SNHGLAIS-PGMKTRIRMGQYEFPNP-EWS--EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             -CCTTCSSC-CSHHHHHHHTCCCCCTT-TTT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -CCcccccc-HHHHHHHHcCcccCCCc-ccc--cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence             32111111 11223333333322221 111  133479999999999999999999999999987653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-44  Score=354.99  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=203.2

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC------hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD------KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~------~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||++....      .......+|+.++.+++||||+++++++.+.. 
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-  101 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-  101 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC-
Confidence            3457899999999999999999998  46789999986432      22345678999999999999999999998765 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-----------------------------------------CCCCHHHHHHHHHHHH
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-----------------------------------------NIVTWEQLCRIALSMS  219 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-----------------------------------------~~l~~~~~~~i~~~ia  219 (461)
                         .+++||||+++|+|.+++..                                         ..+++..+..++.||+
T Consensus       102 ---~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A          102 ---YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             ---EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             ---eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence               45999999999999999851                                         1235677889999999


Q ss_pred             HHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC--ceEEEecCCccccCCCCC--CCCCCCCcCCCccccccccc
Q psy17532        220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL--TAAIADFGLALLFEPGKP--CGDTHGQVGTRRYMAPEVLE  295 (461)
Q Consensus       220 ~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~--~~ki~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~  295 (461)
                      .||+|||+.           +|+||||||+|||++.++  .+||+|||+++.+.....  ........||+.|+|||++.
T Consensus       179 ~~l~~LH~~-----------~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          179 SALHYLHNQ-----------GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             HHHHHHHHT-----------TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHC-----------CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence            999999999           999999999999998766  899999999986543211  11234567999999999986


Q ss_pred             ccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHH
Q psy17532        296 GAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGML  375 (461)
Q Consensus       296 ~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  375 (461)
                      +.   ...++.++||||||+++|||++|           ..||...     ...+....+.........+. +  ...+.
T Consensus       248 ~~---~~~~~~~~DiwslG~il~el~~g-----------~~pf~~~-----~~~~~~~~~~~~~~~~~~~~-~--~~~~~  305 (345)
T 3hko_A          248 TT---NESYGPKCDAWSAGVLLHLLLMG-----------AVPFPGV-----NDADTISQVLNKKLCFENPN-Y--NVLSP  305 (345)
T ss_dssp             CS---SSCCCTHHHHHHHHHHHHHHHHS-----------SCSSCCS-----SHHHHHHHHHHCCCCTTSGG-G--GGSCH
T ss_pred             cC---CCCCCcHHHHHHHHHHHHHHHHC-----------CCCCCCC-----ChHHHHHHHHhcccccCCcc-c--ccCCH
Confidence            52   24677899999999999999999           6666543     34445555555444333222 1  11334


Q ss_pred             HHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        376 ALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       376 ~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+.+||.+||+.||++|||+.++++|.+...
T Consensus       306 ~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          306 LARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            8999999999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.6e-44  Score=366.38  Aligned_cols=282  Identities=21%  Similarity=0.231  Sum_probs=205.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc-ce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI-HT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~-~~  183 (461)
                      ..++|++.+.||+|+||.||+|+..  ++.||||++.....   ......+|+.++..++||||+++++++...... ..
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4578999999999999999999984  67899999964322   234456899999999999999999998765321 13


Q ss_pred             eeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+|+||||+. |+|.++++.. .+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-----------givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES-----------GIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCCCCCCCHHHeEECCCCCEEEc
Confidence            5699999987 5999999654 599999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCC--------------------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc
Q psy17532        263 DFGLALLFEPGKPC--------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS  322 (461)
Q Consensus       263 DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t  322 (461)
                      |||+|+........                    ......+||+.|+|||++...    ..++.++|||||||++|||++
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ----ENYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC----CCCCcccccchHHHHHHHHHh
Confidence            99999877543211                    112456899999999987543    467889999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCccccCC----------------------------CCCH--------HHHHHHHhccCCCCCCCc
Q psy17532        323 RCSSVSPPPGEYRLPFSAEVGD----------------------------HPSL--------EDMQEAVVHKKLRPTLPE  366 (461)
Q Consensus       323 g~~~~~~~~~~~~~pf~~~~~~----------------------------~~~~--------~~~~~~~~~~~~~~~~p~  366 (461)
                      |..||.........+|.+....                            .+..        ......+.........+.
T Consensus       248 g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (432)
T 3n9x_A          248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINL  327 (432)
T ss_dssp             TCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             cccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCH
Confidence            8777655443334444332100                            0000        011111111111111110


Q ss_pred             hhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        367 TWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       367 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...-...+..+.+||.+||..||++|||++|+++|.+....
T Consensus       328 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            00001134578999999999999999999999999987553

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-44  Score=368.19  Aligned_cols=280  Identities=17%  Similarity=0.222  Sum_probs=191.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-cce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~  183 (461)
                      ..++|++.+.||+|+||.||+|++  +++.||||++.....   ......+|+.++..++|||||++++++..... ...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            457899999999999999999988  478899999864322   23445689999999999999999999865431 124


Q ss_pred             eeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+|+||||+. |+|.++++.. .+++..+..++.||+.||+|||+.           +|+||||||+||||+.++.+||+
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA-----------GILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcCCCCCChhhEEECCCCCEeec
Confidence            5799999985 6999998654 599999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCC-------------------------CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        263 DFGLALLFEPGKPC-------------------------GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       263 DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                      |||+|+........                         ......+||+.|+|||++...    ..++.++|||||||++
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~DiwSlG~il  274 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ----ENYTEAIDVWSIGCIF  274 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC----CCCCTHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC----CCCCcHhHHHHHHHHH
Confidence            99999876532210                         112345789999999987543    4678899999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCC---------------CHHHHHHHHh-----------------------c--
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHP---------------SLEDMQEAVV-----------------------H--  357 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~---------------~~~~~~~~~~-----------------------~--  357 (461)
                      |||++|..++.........+|.+......               ...+....+.                       .  
T Consensus       275 ~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~  354 (458)
T 3rp9_A          275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF  354 (458)
T ss_dssp             HHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS
T ss_pred             HHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc
Confidence            99999644433322222333332210000               0000000000                       0  


Q ss_pred             -cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        358 -KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       358 -~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ......+...++  ..+..+.+||.+||..||++|||++|+++|.+....
T Consensus       355 ~~~~~~~~~~~~~--~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          355 PKREGTDLAERFP--ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             CCCCCCCGGGGST--TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCCCCHHHHCC--CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence             000001111111  124578999999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-44  Score=360.71  Aligned_cols=270  Identities=14%  Similarity=0.188  Sum_probs=200.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChhhh------------HHHHHHHHcCCCCCCCeeE
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQSW------------QSEQEIFKLPHMEHDNILR  170 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~------------~~~~ei~~l~~l~H~nIv~  170 (461)
                      ..++|++.+.||+|+||.||+|.+.       ++.||||++........            ....|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            4568999999999999999999984       36799999875542211            1124556678899999999


Q ss_pred             EEEEEecCCccceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       171 l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      +++++..........++||||+ +|+|.+++..  ..+++..++.++.||+.||+|||+.           +|+||||||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-----------~iiHrDlkp  180 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH-----------EYVHGDIKA  180 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCG
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEEecCCH
Confidence            9999877543334579999999 9999999954  5699999999999999999999999           999999999


Q ss_pred             CcEEEc--CCCceEEEecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        249 NNVLLK--SDLTAAIADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       249 ~NILl~--~~~~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      +|||++  .++.+||+|||+++.+......     .......||+.|+|||++.+.     .++.++|||||||++|||+
T Consensus       181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~  255 (364)
T 3op5_A          181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-----APSRRGDLEILGYCMIQWL  255 (364)
T ss_dssp             GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHH
T ss_pred             HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-----CCCchhhHHHHHHHHHHHH
Confidence            999999  8899999999999876543211     112345699999999999763     5788999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        322 SRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       322 tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      +|           ..||....... .................+...+.....+.++.++|..||..||++||++.++++.
T Consensus       256 ~g-----------~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          256 TG-----------HLPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HS-----------CCTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hC-----------CCCccccccCH-HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            99           66665432111 1111011100000000000001111123489999999999999999999999999


Q ss_pred             cHHHhhh
Q psy17532        402 GMLALCD  408 (461)
Q Consensus       402 l~~~~~~  408 (461)
                      +..+...
T Consensus       324 l~~~~~~  330 (364)
T 3op5_A          324 LLQGLKA  330 (364)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=375.47  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=211.1

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ......++|++.+.||+|+||.||+|++++ ..||||++.........+.+|+.+|++++|+||+++++++.+ .    .
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~----~  335 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E----P  335 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S----S
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c----c
Confidence            345567889999999999999999999965 579999998655555567889999999999999999999865 2    3


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      +++||||+++|+|.++++.   ..+++..++.++.||+.||+|||++           +|+||||||+|||++.++.+||
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~ivHrDlkp~NIll~~~~~~kl  404 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-----------NYVHRDLRAANILVGENLVCKV  404 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECGGGCEEE
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCCHhhEEEcCCCcEEE
Confidence            4899999999999999964   4599999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~  340 (461)
                      +|||+++.+.... ........++..|+|||++.+     ..++.++|||||||++|||++ |           ..||..
T Consensus       405 ~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~t~g-----------~~P~~~  467 (535)
T 2h8h_A          405 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKG-----------RVPYPG  467 (535)
T ss_dssp             CCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTT-----------CCSSTT
T ss_pred             cccccceecCCCc-eecccCCcCcccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCC-----------CCCCCC
Confidence            9999998765321 112233457889999999875     367789999999999999999 6           667754


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .     ...++...+. ...+...+..++     ..+.+||.+||+.||++|||+.++++.|..+.
T Consensus       468 ~-----~~~~~~~~i~-~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          468 M-----VNREVLDQVE-RGYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             C-----CHHHHHHHHH-TTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C-----CHHHHHHHHH-cCCCCCCCCCCC-----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            4     4445555543 334455555444     37999999999999999999999999876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=353.95  Aligned_cols=261  Identities=19%  Similarity=0.281  Sum_probs=197.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCC--CCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEH--DNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H--~nIv~l~g~~~~~~~~~  182 (461)
                      ...+.|++.+.||+|+||.||+|.. +++.||||++......   .....+|+.++..++|  +||+++++++.+..   
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~---   82 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---   82 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC---
Confidence            3457899999999999999999988 4678999998754322   2345678888888876  99999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||| +.+|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++ ++.+||
T Consensus        83 -~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           83 -YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-----------GIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             -EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEEE-TTEEEE
T ss_pred             -EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCcceEEEE-CCcEEE
Confidence             4599999 567899999954 5699999999999999999999999           999999999999997 678999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCccccccccccccc------ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN------FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      +|||+++.+.............||+.|+|||++.+...      ....++.++|||||||++|||++|           .
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g-----------~  217 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-----------K  217 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS-----------S
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC-----------C
Confidence            99999987765433223345679999999999864110      013567889999999999999999           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .||....    .................++...+     ..+.+||.+||+.||++|||+.++++|.+...
T Consensus       218 ~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          218 TPFQQII----NQISKLHAIIDPNHEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CTTTTCC----SHHHHHHHHHCTTSCCCCCCCSC-----HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             Ccchhhh----hHHHHHHHHhcCCcccCCcccCC-----HHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            5554321    12222333334444444444333     37899999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=349.16  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=189.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---hhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||+||+|+..  ++.||||++......   ......|+..+.++ +|+||+++++++.+..    .
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~----~  131 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG----I  131 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----E
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC----E
Confidence            368999999999999999999994  788999998643222   22333444444443 8999999999998765    4


Q ss_pred             eeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +++||||+ +|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dikp~NIll~~~~~~kl~  199 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ-----------GLVHLDVKPANIFLGPRGRCKLG  199 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCCCCHHHEEECCCCCEEEc
Confidence            59999999 6799998843  4699999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++......   ......||+.|+|||++.+      .++.++|||||||++|||++|..+          |+..  
T Consensus       200 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~el~~g~~~----------~~~~--  258 (311)
T 3p1a_A          200 DFGLLVELGTAG---AGEVQEGDPRYMAPELLQG------SYGTAADVFSLGLTILEVACNMEL----------PHGG--  258 (311)
T ss_dssp             CCTTCEECC---------CCCCCGGGCCGGGGGT------CCSTHHHHHHHHHHHHHHHHTCCC----------CSSH--
T ss_pred             cceeeeecccCC---CCcccCCCccccCHhHhcC------CCCchhhHHHHHHHHHHHHhCCCC----------CCCc--
Confidence            999998765432   2334569999999998864      467899999999999999999422          2221  


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                             .....+......+.++.     ..+..+.+||.+||+.||++|||+++++++.+.
T Consensus       259 -------~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (311)
T 3p1a_A          259 -------EGWQQLRQGYLPPEFTA-----GLSSELRSVLVMMLEPDPKLRATAEALLALPVL  308 (311)
T ss_dssp             -------HHHHHHTTTCCCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             -------cHHHHHhccCCCccccc-----CCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence                   11222222222111111     133489999999999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-43  Score=339.99  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=206.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|...  ++.||||++.....   .....++|+.++.+++||||+++++++....    ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   80 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES----FH   80 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC----EE
Confidence            468999999999999999999984  78899999965432   2234568899999999999999999998765    44


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc---eEE
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT---AAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~---~ki  261 (461)
                      ++||||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.   +||
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dikp~Nil~~~~~~~~~~kl  149 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-----------GIVHRNLKPENLLLASKAKGAAVKL  149 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcCcCCCCHHHEEEecCCCCCcEEE
Confidence            89999999999988874 45699999999999999999999999           9999999999999987655   999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++.......   ......||+.|+|||++.+.     .++.++||||||+++|||++|           ..||...
T Consensus       150 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g-----------~~pf~~~  210 (284)
T 3kk8_A          150 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKD-----PYSKPVDIWACGVILYILLVG-----------YPPFWDE  210 (284)
T ss_dssp             CCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTC-----CBCTHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             eeceeeEEcccCc---cccCCCCCcCCcCchhhcCC-----CCCcccchHHHHHHHHHHHHC-----------CCCCCCC
Confidence            9999998765432   23346799999999998763     677899999999999999999           5666443


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                           ........+.........+. +.  ..+..+.+||.+||+.||++|||+.++++|.+....
T Consensus       211 -----~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          211 -----DQHRLYAQIKAGAYDYPSPE-WD--TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             -----SHHHHHHHHHHTCCCCCTTT-TT--TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             -----chhHHHHHHHhccccCCchh-hc--ccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence                 44455555544443332221 11  123479999999999999999999999999887543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-43  Score=366.93  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=208.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecC---ChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQ---DKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      -.++|++.+.||+|+||.||+|+..  ++.||||++...   ........+|+.++.+++||||+++++++.+..    .
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~   95 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----S   95 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----E
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC----E
Confidence            4578999999999999999999984  788999998642   223345678999999999999999999998765    4


Q ss_pred             eeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc---CCCceE
Q psy17532        185 FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK---SDLTAA  260 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~---~~~~~k  260 (461)
                      +++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++   .++.+|
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-----------NIVHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeccCchHHEEEecCCCCCCEE
Confidence            599999999999999884 46799999999999999999999999           999999999999995   456799


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++......   ......||+.|+|||++.+      .++.++|||||||++|+|++|           ..||..
T Consensus       165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g-----------~~pf~~  224 (486)
T 3mwu_A          165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG------TYDEKCDVWSAGVILYILLSG-----------TPPFYG  224 (486)
T ss_dssp             ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS------CCCHHHHHHHHHHHHHHHHHS-----------SCSSCC
T ss_pred             EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC------CCCchhhHHHHHHHHHHHHhC-----------CCCCCC
Confidence            99999998765432   2334579999999999865      467889999999999999999           666654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .     ...++...+.........+. |.  ..+..+.+||.+||..||++|||+.++++|.|....
T Consensus       225 ~-----~~~~~~~~i~~~~~~~~~~~-~~--~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          225 K-----NEYDILKRVETGKYAFDLPQ-WR--TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             S-----SHHHHHHHHHHTCCCSCSGG-GG--GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             C-----CHHHHHHHHHhCCCCCCCcc-cC--CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            3     44556666666554444332 22  134589999999999999999999999999987653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.9e-44  Score=351.51  Aligned_cols=259  Identities=22%  Similarity=0.264  Sum_probs=183.9

Q ss_pred             cceeEE---eEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLV---EVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~---~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++|++.   +.||+|+||.||+|++.  ++.||||++....  .....+|+.++..+. ||||+++++++.+..    ..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHEVFHDQL----HT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EE
Confidence            456664   78999999999999994  7889999997543  334567888888886 999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC---ceEE
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL---TAAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~---~~ki  261 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++   .+||
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV-----------GVVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEEEC----CEEEE
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCeecCCCHHHEEEecCCCcccEEE
Confidence            899999999999999954 4699999999999999999999999           999999999999998765   8999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++......  .......||+.|+|||++.+     ..++.++||||||+++|||++|..||......        
T Consensus       151 ~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------  215 (325)
T 3kn6_A          151 IDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQ-----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRS--------  215 (325)
T ss_dssp             CCCTTCEECCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------------
T ss_pred             eccccceecCCCC--CcccccCCCcCccCHHHhcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCccc--------
Confidence            9999998765433  22334578999999999876     36778999999999999999995444322110        


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       .......++...+........ .+.|..  .+.++.+||.+||..||++|||++++++|.|...
T Consensus       216 -~~~~~~~~~~~~i~~~~~~~~-~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          216 -LTCTSAVEIMKKIKKGDFSFE-GEAWKN--VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             ---CCCHHHHHHHHTTTCCCCC-SHHHHT--SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             -cccccHHHHHHHHHcCCCCCC-cccccC--CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence             011233445555544433221 122211  3358999999999999999999999999988654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.5e-44  Score=348.70  Aligned_cols=274  Identities=24%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...+.|++.+.||+|+||.||++.+      +++.||||++.....  ......+|+.++.+++||||+++++++.+...
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            3344569999999999999999976      467799999975432  23445789999999999999999999987542


Q ss_pred             cceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        ..+++||||+++|+|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus       108 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~-----------~ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A          108 --ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ-----------HYIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             --TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCCEE
T ss_pred             --ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCCCCchheEEEcCCCCEE
Confidence              3568999999999999999888899999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      |+|||+++........ .......+|..|+|||++.+.     .++.++||||||+++|||++|+.||........ .+.
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~  248 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-----KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELI  248 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHH
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCC-----CCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhh
Confidence            9999999887654321 123345688899999999763     566789999999999999999544321100000 000


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...........+ ............+..++     ..+.+||.+||+.||++|||+.++++.|..+..
T Consensus       249 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          249 GIAQGQMTVLRL-TELLERGERLPRPDKCP-----AEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             CSCCHHHHHHHH-HHHHHTTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccchhHHHH-HHHHhcccCCCCCcccc-----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            000000001111 12223334444554443     389999999999999999999999999877664

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.7e-44  Score=359.49  Aligned_cols=283  Identities=19%  Similarity=0.244  Sum_probs=202.0

Q ss_pred             CccCCcceeEEeEeecC--CceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQG--RFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G--~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|  +||.||+|+..  ++.||||++.....   ......+|+.+++.++|||||++++++.+..
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            33456799999999999  99999999994  78899999975432   2234567999999999999999999998865


Q ss_pred             ccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                          .+++||||+++|+|.+++..   ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.+
T Consensus       100 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivHrDlkp~NIll~~~  164 (389)
T 3gni_B          100 ----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-----------GYVHRSVKASHILISVD  164 (389)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTT
T ss_pred             ----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEcCC
Confidence                45999999999999999954   5699999999999999999999999           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCC-----CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKP-----CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      +.+||+|||++........     ........||+.|+|||++.+.   ...++.++|||||||++|||++|..||....
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT---SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCEEEcccccceeeccccccccccccccccccccccccCHHHHhcc---CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999999865432211     0112334789999999999763   1357789999999999999999966664322


Q ss_pred             CCCC--------CCCccccCCCCC------------HHHHHHHHhccCCCC---CCCchhccchhHHHHHHHHHHHcccc
Q psy17532        332 GEYR--------LPFSAEVGDHPS------------LEDMQEAVVHKKLRP---TLPETWKQHAGMLALCDTMEECWDHD  388 (461)
Q Consensus       332 ~~~~--------~pf~~~~~~~~~------------~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~l~~li~~cl~~d  388 (461)
                      ....        .|........+.            .............++   ..+........+..+.+||.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  321 (389)
T 3gni_B          242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN  321 (389)
T ss_dssp             STTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred             HHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence            1100        000000000000            000000000000000   00000000112347999999999999


Q ss_pred             HhhhccccchhhhcHHHhh
Q psy17532        389 AEARLSASCVVERGMLALC  407 (461)
Q Consensus       389 P~~Rps~~evl~~l~~~~~  407 (461)
                      |++|||+.++++|.+....
T Consensus       322 P~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          322 PDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             TTTSCCHHHHTTSGGGGGC
T ss_pred             cccCCCHHHHhcCHHHHHH
Confidence            9999999999999887543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=341.41  Aligned_cols=252  Identities=20%  Similarity=0.323  Sum_probs=181.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++......    .....+|+.++.+++||||+++++++.+..    
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   84 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN----   84 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS----
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC----
Confidence            456899999999999999999997  5788999999643221    234568899999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ..++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~Nili~~~~~~kl  153 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH-----------GILHRDLTLSNLLLTRNMNIKI  153 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSSCCGGGEEECTTCCEEE
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHEEEcCCCCEEE
Confidence            45899999999999999965  4689999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++........  ......||+.|+|||++.+.     .++.++||||||+++|||++|..           ||...
T Consensus       154 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~-----------p~~~~  215 (278)
T 3cok_A          154 ADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRS-----AHGLESDVWSLGCMFYTLLIGRP-----------PFDTD  215 (278)
T ss_dssp             CCCTTCEECC-----------------------------------CTHHHHHHHHHHHHHHSSC-----------SSCCC
T ss_pred             EeecceeeccCCCC--cceeccCCCCcCCcchhcCC-----CCCchhhHHHHHHHHHHHHhCCC-----------CCCCh
Confidence            99999987653321  22345789999999998763     56788999999999999999954           44332


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ......+....  ...|..+     +..+.+||.+||+.||++|||++++++|.+...
T Consensus       216 ~~-----~~~~~~~~~~~--~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          216 TV-----KNTLNKVVLAD--YEMPSFL-----SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             SC-----C-----CCSSC--CCCCTTS-----CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             hH-----HHHHHHHhhcc--cCCcccc-----CHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence            11     11111111111  1223322     237899999999999999999999999987543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-43  Score=342.29  Aligned_cols=254  Identities=26%  Similarity=0.353  Sum_probs=208.6

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..+.|++.+.||+|+||.||+|+.  .++.||||++....  .......+|+.++..++||||+++++++....    .+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   95 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT----KL   95 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----eE
Confidence            346799999999999999999998  47889999997543  22345678899999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        186 WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++||||+++|+|.+++..+.+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE-----------KKIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCccCCCChheEEECCCCCEEEeecc
Confidence            9999999999999999988999999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++.......  .......||..|+|||++.+.     .++.++||||||+++|||++|           ..||...    
T Consensus       165 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~~----  222 (303)
T 3a7i_A          165 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELARG-----------EPPHSEL----  222 (303)
T ss_dssp             TCEECBTTB--CCBCCCCSCGGGCCHHHHTTC-----CBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS----
T ss_pred             cceecCccc--cccCccCCCcCccCHHHHhcC-----CCCchhhhHHHHHHHHHHccC-----------CCCCCCc----
Confidence            998765432  123445789999999999763     567899999999999999999           5555432    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ........+.. ...+.++..++     ..+.+||.+||+.||++|||+.+++++.+....
T Consensus       223 -~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          223 -HPMKVLFLIPK-NNPPTLEGNYS-----KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -CHHHHHHHHHH-SCCCCCCSSCC-----HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -CHHHHHHHhhc-CCCCCCccccC-----HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence             22333333322 22333443333     379999999999999999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-43  Score=338.90  Aligned_cols=253  Identities=23%  Similarity=0.282  Sum_probs=205.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC-hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD-KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+.|++.+.||+|+||.||+|+..  +..||+|.+.... .......+|+.++.+++||||+++++++.+..    .+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~l   83 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT----DIYL   83 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----eEEE
Confidence            467999999999999999999995  5679999986543 23345678899999999999999999998765    4599


Q ss_pred             eehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCCCceEEEe
Q psy17532        188 ITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~~~~ki~D  263 (461)
                      ||||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||+   +.++.+||+|
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL-----------NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            999999999999884 45689999999999999999999999           99999999999999   7889999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||++.......   ......||+.|+|||++.+      .++.++||||||+++|||++|           ..||...  
T Consensus       153 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g-----------~~p~~~~--  210 (277)
T 3f3z_A          153 FGLAARFKPGK---MMRTKVGTPYYVSPQVLEG------LYGPECDEWSAGVMMYVLLCG-----------YPPFSAP--  210 (277)
T ss_dssp             CTTCEECCTTS---CBCCCCSCTTTCCHHHHTT------CBCTTHHHHHHHHHHHHHHHS-----------SCSSCCS--
T ss_pred             cccceeccCcc---chhccCCCCCccChHHhcc------cCCchhhehhHHHHHHHHHHC-----------CCCCCCC--
Confidence            99998766443   2334579999999999864      367889999999999999999           6666543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         ...+....+......  ++.... ...+..+.+||.+||+.||++|||+.++++|.+...
T Consensus       211 ---~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          211 ---TDSEVMLKIREGTFT--FPEKDW-LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             ---SHHHHHHHHHHCCCC--CCHHHH-TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             ---CHHHHHHHHHhCCCC--CCchhh-hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence               344444454444322  222100 113348999999999999999999999999988654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.6e-44  Score=341.53  Aligned_cols=254  Identities=23%  Similarity=0.406  Sum_probs=200.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .....++|++.+.||+|+||.||+|+++++.||||++.... ......+|+.++.+++||||+++++++....   ..++
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~   91 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK---GGLY   91 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---CceE
Confidence            34567899999999999999999999999999999986543 3445678999999999999999999876543   2458


Q ss_pred             eeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +||||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~~l~D  160 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-----------NFVHRDLAARNVLVSEDNVAKVSD  160 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC-----------CccccCCCcceEEEeCCCcEEEee
Confidence            999999999999999643   389999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCcccc
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||+++.....     .....++..|+|||++.+     ..++.++||||||+++|||++ |           ..||... 
T Consensus       161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~t~g-----------~~p~~~~-  218 (278)
T 1byg_A          161 FGLTKEASST-----QDTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFG-----------RVPYPRI-  218 (278)
T ss_dssp             CCC-----------------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCSCTTS-
T ss_pred             cccccccccc-----ccCCCccccccCHHHhCC-----CCCCchhcHHHHHHHHHHHHhCC-----------CCCCCCC-
Confidence            9999765432     223457889999999865     367788999999999999998 7           5555433 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                          ...+....+.. ..++..+..++     ..+.++|.+||+.||++|||+.++++.|..+..
T Consensus       219 ----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          219 ----PLKDVVPRVEK-GYKMDAPDGCP-----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ----CGGGHHHHHTT-TCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHhc-CCCCCCcccCC-----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                23334444332 33344444433     389999999999999999999999999987765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-44  Score=351.10  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=206.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCChh--hhHHHHHHHHcCCC-CCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHM-EHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l-~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|++       .++.||||++......  .....+|+.++.++ +||||+++++++..
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            45568999999999999999999985       2467999999754332  23456888888888 79999999999876


Q ss_pred             CCccceeeeeeehhccCCChhhhhcCCC-----------------CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKCNI-----------------VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA  240 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~  240 (461)
                      .+.   .+++||||+++|+|.+++....                 +++..+..++.|++.||.|||+.           +
T Consensus       103 ~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~  168 (316)
T 2xir_A          103 PGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-----------K  168 (316)
T ss_dssp             TTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-----------T
T ss_pred             CCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-----------C
Confidence            542   3589999999999999996432                 78999999999999999999999           9


Q ss_pred             eecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHH
Q psy17532        241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL  320 (461)
Q Consensus       241 ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el  320 (461)
                      |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+     ..++.++||||||+++|||
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l  243 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEI  243 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHH
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-----ccccchhHHHHHHHHHHHH
Confidence            99999999999999999999999999987654433223334567889999999875     3677899999999999999


Q ss_pred             Hc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchh
Q psy17532        321 AS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV  399 (461)
Q Consensus       321 ~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  399 (461)
                      ++ |           ..||....    ........+. ...+...+..++     ..+.++|.+||+.||++|||+.+++
T Consensus       244 ~t~g-----------~~p~~~~~----~~~~~~~~~~-~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~ell  302 (316)
T 2xir_A          244 FSLG-----------ASPYPGVK----IDEEFCRRLK-EGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFSELV  302 (316)
T ss_dssp             HTTS-----------CCSSTTCC----CSHHHHHHHH-HTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HhCC-----------CCCCcccc----hhHHHHHHhc-cCccCCCCCCCC-----HHHHHHHHHHcCCChhhCcCHHHHH
Confidence            98 7           55664431    1122222222 233334444333     3799999999999999999999999


Q ss_pred             hhcHHHhh
Q psy17532        400 ERGMLALC  407 (461)
Q Consensus       400 ~~l~~~~~  407 (461)
                      +++..+..
T Consensus       303 ~~L~~~~~  310 (316)
T 2xir_A          303 EHLGNLLQ  310 (316)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99987764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-43  Score=346.27  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=206.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|.+.+.||+|+||.||+++..  ++.||+|++....    .......+|+.++..++||||+++++++.+..    
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  114 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----  114 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----
Confidence            4578999999999999999999984  6789999986542    22344567899999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-----------RVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCEecCCCchhEEEcCCCCEEEe
Confidence            45999999999999999854 5799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++.......  ......||..|+|||++.+     ..++.++||||||+++|||++|           ..||... 
T Consensus       184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g-----------~~pf~~~-  244 (335)
T 2owb_A          184 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVG-----------KPPFETS-  244 (335)
T ss_dssp             CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHT-----SCBCTHHHHHHHHHHHHHHHHS-----------SCTTCCS-
T ss_pred             eccCceecccCcc--cccccCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHHC-----------cCCCCCC-
Confidence            9999987653321  2334578999999999876     3567899999999999999999           5666443 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ...+....+....  ..++..++     ..+.+||.+||+.||++|||+.+++++.+...
T Consensus       245 ----~~~~~~~~~~~~~--~~~~~~~~-----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          245 ----CLKETYLRIKKNE--YSIPKHIN-----PVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             ----SHHHHHHHHHHTC--CCCCTTSC-----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             ----CHHHHHHHHhcCC--CCCCccCC-----HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                3334444443332  23343333     37899999999999999999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.2e-44  Score=359.29  Aligned_cols=260  Identities=18%  Similarity=0.276  Sum_probs=199.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCCh---hhhHHHHHHHHcCCCC--CCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDK---QSWQSEQEIFKLPHME--HDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~--H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..+.|++.+.||+|+||.||+|... ++.||||++.....   ......+|+.++.+++  ||||+++++++....    
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~----  129 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----  129 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC----
Confidence            4467999999999999999999884 67899999975432   2234568888888885  599999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+++||| +.+|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++ ++.+||+
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~-----------~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-----------GIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT-----------TCCCCCCCGGGEEES-SSCEEEC
T ss_pred             EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCHHHEEEE-CCeEEEE
Confidence            3599999 567899999854 4689999999999999999999998           999999999999995 5799999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCccccccccccccc------ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN------FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      |||+++.+.............||+.|+|||++.+...      ....++.++|||||||++|||++|           ..
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G-----------~~  265 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-----------KT  265 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS-----------SC
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC-----------CC
Confidence            9999987754432223345679999999999865211      013577899999999999999999           55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ||....    ........+........++...+     ..+.+||.+||+.||++|||+.++++|.+...
T Consensus       266 Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          266 PFQQII----NQISKLHAIIDPNHEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             TTTTCC----CHHHHHHHHHCTTSCCCCCCCSC-----HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             cchhhh----HHHHHHHHHhCccccCCCCccch-----HHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence            554321    12223334444444444444332     37899999999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.1e-44  Score=343.24  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=212.7

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      .......++|++.+.||+|+||.||+|.+.  +..||||.+...........+|+.++..++||||+++++++.+..   
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP---   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC---
Confidence            345567789999999999999999999995  678999999876666667788999999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        183 TEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                       .+++||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+
T Consensus        83 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~i~H~dikp~Nil~~~~~~~  150 (288)
T 3kfa_A           83 -PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-----------NFIHRDLAARNCLVGENHLV  150 (288)
T ss_dssp             -SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH-----------TCCCSCCSGGGEEECGGGCE
T ss_pred             -CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC-----------CccCCCCCcceEEEcCCCCE
Confidence             35899999999999999953   4589999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      ||+|||++........ .......+|+.|+|||++.+.     .++.++||||||+++|||++ |           ..||
T Consensus       151 ~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~ll~~g-----------~~p~  213 (288)
T 3kfa_A          151 KVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYG-----------MSPY  213 (288)
T ss_dssp             EECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTS-----------CCSS
T ss_pred             EEccCccceeccCCcc-ccccCCccccCcCChhhhccC-----CCCchhhHHHHHHHHHHHHhCC-----------CCCC
Confidence            9999999987654321 223334578899999998763     67789999999999999999 7           5555


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ........+. ...+...+..++     ..+.+|+.+||+.||++|||+.++++.+..+..
T Consensus       214 ~~~-----~~~~~~~~~~-~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          214 PGI-----DLSQVYELLE-KDYRMERPEGCP-----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             TTC-----CGGGHHHHHH-TTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC-----CHHHHHHHHh-ccCCCCCCCCCC-----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            443     2233333332 333444444443     379999999999999999999999999876654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=350.18  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=192.8

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhh--hHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQS--WQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~--~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||||++.......  ....+|+.++..++||||+++++++.+..    .+++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK----SLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS----CEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC----EEEE
Confidence            57999999999999999999984  7889999986443221  12346888899999999999999998765    3589


Q ss_pred             eehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||||++ |+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-----------KVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccCCCcCHHHEEECCCCCEEEccCc
Confidence            999998 599998853  4589999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++......  .......||..|+|||++.+.    ..++.++|||||||++|||++|.           .||...    
T Consensus       146 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~-----------~pf~~~----  204 (324)
T 3mtl_A          146 LARAKSIPT--KTYDNEVVTLWYRPPDILLGS----TDYSTQIDMWGVGCIFYEMATGR-----------PLFPGS----  204 (324)
T ss_dssp             EEECC--------------CGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSS-----------CSCCCS----
T ss_pred             ccccccCCc--cccccccCcccccChhhhcCC----CCCCcHHHHHHHHHHHHHHHhCC-----------CCCCCC----
Confidence            998654332  123345789999999998763    35778999999999999999994           455432    


Q ss_pred             CCHHHHHHHHhcc---CCCCCCCchhc--------------------cchhHHHHHHHHHHHccccHhhhccccchhhhc
Q psy17532        346 PSLEDMQEAVVHK---KLRPTLPETWK--------------------QHAGMLALCDTMEECWDHDAEARLSASCVVERG  402 (461)
Q Consensus       346 ~~~~~~~~~~~~~---~~~~~~p~~~~--------------------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l  402 (461)
                       ...+....+...   ......+....                    ....+..+.+||.+||+.||++|||++|+++|.
T Consensus       205 -~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          205 -TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             -SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             -CHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence             222222222111   00001110000                    011235789999999999999999999999999


Q ss_pred             HHHhh
Q psy17532        403 MLALC  407 (461)
Q Consensus       403 ~~~~~  407 (461)
                      +....
T Consensus       284 ~f~~~  288 (324)
T 3mtl_A          284 FFLSL  288 (324)
T ss_dssp             GGGGG
T ss_pred             hhhhc
Confidence            87654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-44  Score=353.59  Aligned_cols=268  Identities=26%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ....++|++.+.||+|+||.||+|+. +++.||||++.....  ......+|+.++..++||||+++++++.....    
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  101 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----  101 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC----
T ss_pred             HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc----
Confidence            34567899999999999999999987 478899999865432  22356789999999999999999999987654    


Q ss_pred             eeeeehhccCCChhhhhcCC-----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        185 FWLITAYHERGSLCDFLKCN-----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                      .++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.        +.++|+||||||+|||++.++.+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH--------CDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHS--------SSSCEECCCCSGGGEEECTTCCE
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeCCCchhhEEECCCCCE
Confidence            48999999999999999643     389999999999999999999987        24589999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++....... .......||+.|+|||++.+.     .++.++||||||+++|||++|..|           |.
T Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p-----------f~  236 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRA-----------FD  236 (326)
T ss_dssp             EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHS-----EECHHHHHHHHHHHHHHHHHCCCS-----------BC
T ss_pred             EeccCccccccCcccc-cccccccCCcCccCHHHhccC-----CCCccccchhHHHHHHHHHhCCCc-----------cc
Confidence            9999999987654332 223345699999999998663     567889999999999999999544           43


Q ss_pred             ccc---CCCCCHHHHHHHHhccC-----CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        340 AEV---GDHPSLEDMQEAVVHKK-----LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       340 ~~~---~~~~~~~~~~~~~~~~~-----~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ...   .......+.........     ........+ ....+..+.+++.+||+.||++|||+.+++++|...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC-CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ccccccccchhHHHHHHHHhhchhhhhhcChhhcccc-CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            110   00001111111111110     011111111 123456899999999999999999999999998653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.7e-43  Score=337.79  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=205.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||.||+|+..  ++.||+|++....    .......+|+.+++.++||||+++++++.+.+    
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   88 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----   88 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC----
Confidence            4578999999999999999999995  6789999986542    22334567899999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-----------RVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCChHhEEEcCCCCEEEE
Confidence            45899999999999999854 5699999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++.......  ......||+.|+|||++.+     ..++.++||||||+++|||++|           ..||... 
T Consensus       158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g-----------~~p~~~~-  218 (294)
T 2rku_A          158 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVG-----------KPPFETS-  218 (294)
T ss_dssp             CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTT-----SCBCTHHHHHHHHHHHHHHHHS-----------SCTTCCS-
T ss_pred             eccCceecccCcc--ccccccCCCCcCCcchhcc-----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC-
Confidence            9999987653321  2334578999999999876     3567899999999999999999           5666443 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ...+....+....  ..++..++     ..+.++|.+||+.||++|||+++++++.+...
T Consensus       219 ----~~~~~~~~~~~~~--~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          219 ----CLKETYLRIKKNE--YSIPKHIN-----PVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             ----SHHHHHHHHHTTC--CCCCTTSC-----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             ----CHHHHHHHHhhcc--CCCccccC-----HHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence                3334333333332  23343333     37899999999999999999999999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=346.05  Aligned_cols=261  Identities=22%  Similarity=0.260  Sum_probs=194.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh------hhhHHHHHHHHcCCC---CCCCeeEEEEEEecC
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK------QSWQSEQEIFKLPHM---EHDNILRYIGAEKRG  178 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~------~~~~~~~ei~~l~~l---~H~nIv~l~g~~~~~  178 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++.....      ......+|+.++..+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999996  578899999864321      122344566555544   599999999998765


Q ss_pred             Ccc-ceeeeeeehhccCCChhhhhcCCC---CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        179 ESI-HTEFWLITAYHERGSLCDFLKCNI---VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       179 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                      ... ...+++||||+. |+|.+++....   +++..+..++.|++.||+|||+.           +|+||||||+|||++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-----------CIVHRDLKPENILVT  154 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCTTTEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEEc
Confidence            421 234689999997 59999996543   89999999999999999999999           999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        255 SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      .++.+||+|||+++......   ......||+.|+|||++.+.     .++.++|||||||++|||++|           
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g-----------  215 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQS-----TYATPVDMWSVGCIFAEMFRR-----------  215 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTS-----CCCSTHHHHHHHHHHHHTTTS-----------
T ss_pred             CCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCC-----CCCchHHHHHHHHHHHHHHhC-----------
Confidence            99999999999998765432   23446789999999999763     678899999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCC---CCCCCch-----------------hccchhHHHHHHHHHHHccccHhhhcc
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKL---RPTLPET-----------------WKQHAGMLALCDTMEECWDHDAEARLS  394 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rps  394 (461)
                      ..||...     ...+....+.....   ....+..                 ......+..+.+||.+||+.||++|||
T Consensus       216 ~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  290 (308)
T 3g33_A          216 KPLFCGN-----SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS  290 (308)
T ss_dssp             SCSCCCS-----SHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCCCCCC-----CHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC
Confidence            4455432     22222222211100   0000000                 000123457899999999999999999


Q ss_pred             ccchhhhcHHHh
Q psy17532        395 ASCVVERGMLAL  406 (461)
Q Consensus       395 ~~evl~~l~~~~  406 (461)
                      +.++++|.+...
T Consensus       291 ~~e~l~h~~~~~  302 (308)
T 3g33_A          291 AFRALQHSYLHK  302 (308)
T ss_dssp             HHHHHTSTTC--
T ss_pred             HHHHhcCccccC
Confidence            999999987544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.8e-44  Score=366.18  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|++.+.||+|+||.||+|..  +++.||||++....   .......+|+.+++.++||||+++++++......  .
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            357899999999999999999988  47889999997532   2234456899999999999999999999765421  2


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~-----------~iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCChHhEEEeCCCCEEEE
Confidence            457999999986 57777754 489999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+......   ......||+.|+|||++.+     ..++.++|||||||++|||++|..|           |.+. 
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~p-----------F~g~-  266 (464)
T 3ttj_A          207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKIL-----------FPGR-  266 (464)
T ss_dssp             CCCCC-----CC---CC----CCCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCS-----------SCCS-
T ss_pred             EEEeeeecCCCc---ccCCCcccccccCHHHHcC-----CCCCHHHHHHHHHHHHHHHHhCCCC-----------CCCC-
Confidence            999998765432   2345689999999999976     3678899999999999999999544           4332 


Q ss_pred             CCCCCHHHHHHHHhc----------------------c-CC--CCCCCchhcc----------chhHHHHHHHHHHHccc
Q psy17532        343 GDHPSLEDMQEAVVH----------------------K-KL--RPTLPETWKQ----------HAGMLALCDTMEECWDH  387 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~----------------------~-~~--~~~~p~~~~~----------~~~~~~l~~li~~cl~~  387 (461)
                          ...+....+..                      . ..  ...++..++.          ...+..+.+||.+||..
T Consensus       267 ----~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~  342 (464)
T 3ttj_A          267 ----DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  342 (464)
T ss_dssp             ----SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             ----CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence                11111111110                      0 00  0000111110          01245789999999999


Q ss_pred             cHhhhccccchhhhcHHHh
Q psy17532        388 DAEARLSASCVVERGMLAL  406 (461)
Q Consensus       388 dP~~Rps~~evl~~l~~~~  406 (461)
                      ||++|||++|+++|.+...
T Consensus       343 dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          343 DPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             STTTSCCHHHHHTSTTTGG
T ss_pred             ChhhCCCHHHHhcChhhhh
Confidence            9999999999999998753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=340.81  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=206.8

Q ss_pred             cCCcceeEEe-EeecCCceEEEEEEE----CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        109 QGCRSIQLVE-VKAQGRFGAVWKAKF----KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       109 ~~~~~~~~~~-~lg~G~fg~Vy~~~~----~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...++|.+.+ .||+|+||.||+|.+    ++..||||++.....  ......+|+.++.+++||||+++++++...   
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC---
Confidence            4456788887 999999999999986    356799999976432  234557899999999999999999998442   


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        .+++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+
T Consensus        83 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nili~~~~~~  149 (287)
T 1u59_A           83 --ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-----------NFVHRDLAARNVLLVNRHYA  149 (287)
T ss_dssp             --SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEEETTEE
T ss_pred             --CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC-----------CEeeCCCchheEEEcCCCCE
Confidence              35899999999999999953  4599999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLP  337 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~p  337 (461)
                      ||+|||+++........ .......+|+.|+|||++.+.     .++.++||||||+++|||++ |           ..|
T Consensus       150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g-----------~~p  213 (287)
T 1u59_A          150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGVTMWEALSYG-----------QKP  213 (287)
T ss_dssp             EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTS-----------CCT
T ss_pred             EECcccceeeeccCcceeeccccccccccccCHHHhccC-----CCCchhhHHHHHHHHHHHHcCC-----------CCC
Confidence            99999999877543321 122334578999999998653     56788999999999999998 8           566


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                      |...     ...++...+.. ..++.++..++     ..+.++|.+||+.||++||++.+++++++.+....
T Consensus       214 ~~~~-----~~~~~~~~i~~-~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          214 YKKM-----KGPEVMAFIEQ-GKRMECPPECP-----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TTTC-----CTHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cccC-----CHHHHHHHHhc-CCcCCCCCCcC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            6543     22334444333 33445554443     38999999999999999999999999998877543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-43  Score=378.91  Aligned_cols=255  Identities=20%  Similarity=0.267  Sum_probs=209.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESI  181 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~  181 (461)
                      ....+|++.++||+|+||.||+|+..  ++.||||++....    ........|..++..+ +||||+++++++.+..  
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--  415 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--  415 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS--
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC--
Confidence            34678999999999999999999984  5779999997432    2233445677777776 7999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+||||+.++.+|
T Consensus       416 --~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------gIiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          416 --RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-----------GIIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------SEECCCCCSTTEEECSSSCEE
T ss_pred             --EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEeccCChhhEEEcCCCcEE
Confidence              45999999999999999964 6799999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           ..||..
T Consensus       483 L~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DvwSlGvilyelltG-----------~~Pf~~  544 (674)
T 3pfq_A          483 IADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAG-----------QAPFEG  544 (674)
T ss_dssp             ECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTC-----CCBSTHHHHHHHHHHHHHHHHS-----------SCSSCC
T ss_pred             EeecceeeccccCC--cccccccCCCcccCHhhhcC-----CCCCccceEechHHHHHHHHcC-----------CCCCCC
Confidence            99999998644322  23445689999999999976     3678899999999999999999           667765


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHHhhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLALCD  408 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~~~~  408 (461)
                      .     ...++...+.....  .+|..++     .++.+||.+||+.||++||++     +++++|.++....
T Consensus       545 ~-----~~~~~~~~i~~~~~--~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          545 E-----DEDELFQSIMEHNV--AYPKSMS-----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             S-----SHHHHHHHHHSSCC--CCCTTSC-----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             C-----CHHHHHHHHHhCCC--CCCccCC-----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            4     55666666666543  4454433     389999999999999999998     8999998875443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-43  Score=338.01  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=206.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....++|++.+.||+|+||.||+|+..  ++.||||++.....    ......+|+.++..++||||+++++++.+.. 
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   87 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-   87 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-
Confidence            3455689999999999999999999984  56799999864321    1234568899999999999999999998755 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+
T Consensus        88 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~  153 (284)
T 2vgo_A           88 ---RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER-----------KVIHRDIKPENLLMGYKGEL  153 (284)
T ss_dssp             ---EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCSGGGEEECTTCCE
T ss_pred             ---EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCCHHHEEEcCCCCE
Confidence               45999999999999999853 5699999999999999999999998           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||++.......    .....|+..|+|||++.+.     .++.++||||||+++|||++|           ..||.
T Consensus       154 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~pf~  213 (284)
T 2vgo_A          154 KIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGK-----THDEKVDLWCAGVLCYEFLVG-----------MPPFD  213 (284)
T ss_dssp             EECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTC-----CBCTTHHHHHHHHHHHHHHHS-----------SCTTC
T ss_pred             EEecccccccCcccc----cccccCCCCcCCHHHhccC-----CCCcccchhhHHHHHHHHHHC-----------CCCCC
Confidence            999999997654322    2345789999999998763     567899999999999999999           55664


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..     ...+....+....  ..++..++     ..+.++|.+||+.||++|||+.++++|.+....
T Consensus       214 ~~-----~~~~~~~~~~~~~--~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          214 SP-----SHTETHRRIVNVD--LKFPPFLS-----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             CS-----SHHHHHHHHHTTC--CCCCTTSC-----HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             CC-----CHhHHHHHHhccc--cCCCCcCC-----HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            33     3334444443332  23443333     378999999999999999999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-43  Score=366.48  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=204.4

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .+.|++.+.||+|+||.||+|+.+  +..||||++....   .......+|+.+++.++||||+++++++.+..    .+
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~  111 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR----NY  111 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----EE
Confidence            457999999999999999999994  6789999986542   22345678999999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCceEE
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~~ki  261 (461)
                      ++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||++.   ++.+||
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~Dlkp~Nil~~~~~~~~~~kl  180 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH-----------NIVHRDLKPENLLLESKEKDALIKI  180 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceeccCChhhEEEeCCCCCCcEEE
Confidence            99999999999999884 45799999999999999999999999           9999999999999976   456999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+++......   ......||+.|+|||++.+      .++.++|||||||++|||++|           ..||...
T Consensus       181 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~------~~~~~~DiwslG~il~~ll~g-----------~~pf~~~  240 (494)
T 3lij_A          181 VDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK------KYDEKCDVWSIGVILFILLAG-----------YPPFGGQ  240 (494)
T ss_dssp             CCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT------CBCTHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             EECCCCeECCCCc---cccccCCCcCeeCHHHHcc------cCCCchhHHHHHHHHHHHHhC-----------CCCCCCC
Confidence            9999998765432   2344679999999999853      577899999999999999999           6666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           ...++...+.........+ .|..  .+..+.+||.+||+.||++|||+.++++|.|...
T Consensus       241 -----~~~~~~~~i~~~~~~~~~~-~~~~--~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          241 -----TDQEILRKVEKGKYTFDSP-EWKN--VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             -----SHHHHHHHHHHTCCCCCSG-GGTT--SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             -----CHHHHHHHHHhCCCCCCch-hccc--CCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence                 4556666665555443322 2222  3347999999999999999999999999998754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.8e-44  Score=350.27  Aligned_cols=262  Identities=22%  Similarity=0.276  Sum_probs=192.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .....++|++.+.||+|+||.||+|+.  +++.||||++......   .....+|+.++.+++||||+++++++.+..  
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  106 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--  106 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT--
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--
Confidence            345678999999999999999999987  5788999998654322   233468999999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc-----C
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-----S  255 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~-----~  255 (461)
                        .+++||||++ |+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++     .
T Consensus       107 --~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----------~ivH~Dlkp~NIll~~~~~~~  172 (329)
T 3gbz_A          107 --RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR-----------RCLHRDLKPQNLLLSVSDASE  172 (329)
T ss_dssp             --EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEEEC-----
T ss_pred             --EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEECCCCCHHHEEEecCCCCc
Confidence              4599999998 599999854 4699999999999999999999999           999999999999994     5


Q ss_pred             CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      ++.+||+|||+++......  .......||..|+|||++.+.    ..++.++|||||||++|||++|.           
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~-----------  235 (329)
T 3gbz_A          173 TPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGS----RHYSTSVDIWSIACIWAEMLMKT-----------  235 (329)
T ss_dssp             CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSS-----------
T ss_pred             cceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCC----CCCCcHHHHHHHHHHHHHHHHCC-----------
Confidence            5669999999998765332  223345789999999999763    35778999999999999999994           


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCC----------------CCCch-------hccchhHHHHHHHHHHHccccHhhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRP----------------TLPET-------WKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~----------------~~p~~-------~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      .||...     ...+....+......+                .++..       ......+.++.+||.+||+.||++|
T Consensus       236 ~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  310 (329)
T 3gbz_A          236 PLFPGD-----SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR  310 (329)
T ss_dssp             CSSCCS-----SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGS
T ss_pred             CCcCCC-----CHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhC
Confidence            455332     1222222211110000                00000       0001133578999999999999999


Q ss_pred             ccccchhhhcHHHh
Q psy17532        393 LSASCVVERGMLAL  406 (461)
Q Consensus       393 ps~~evl~~l~~~~  406 (461)
                      ||++|+++|.++..
T Consensus       311 ~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          311 ISAKNALEHPYFSH  324 (329)
T ss_dssp             CCHHHHHTSGGGSS
T ss_pred             CCHHHHhCCcccCC
Confidence            99999999987643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.7e-44  Score=368.21  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=210.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      -.++|++.+.||+|+||.||+|+.  +++.||||++....    .......+|+.++.+++||||+++++++.+..    
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----   99 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG----   99 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----
Confidence            346899999999999999999998  47889999986442    23345678999999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCCCce
Q psy17532        184 EFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTA  259 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~~~~  259 (461)
                      .+++||||+.+|+|.+++. ...+++..+..++.||+.||.|||++           +|+||||||+|||+   +.++.+
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~Dlkp~Nil~~~~~~~~~~  168 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN-----------KIVHRDLKPENLLLESKSKDANI  168 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCCHHHEEEecCCCCCcE
Confidence            4599999999999999884 45799999999999999999999999           99999999999999   467899


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++.+....   ......||+.|+|||++.+      .++.++|||||||++|||++|           ..||.
T Consensus       169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g-----------~~pf~  228 (484)
T 3nyv_A          169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG------TYDEKCDVWSTGVILYILLSG-----------CPPFN  228 (484)
T ss_dssp             EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT------CCCTHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEEeeeeeEEccccc---ccccCCCCccccCceeecC------CCCCcceeHHHHHHHHHHHHC-----------CCCCC
Confidence            999999998775433   2233579999999999865      467899999999999999999           66665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..     ...++...+.........+. |.  ..+..+.+||.+||..||++|||+.++++|.|....
T Consensus       229 ~~-----~~~~~~~~i~~~~~~~~~~~-~~--~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          229 GA-----NEYDILKKVEKGKYTFELPQ-WK--KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             CS-----SHHHHHHHHHHCCCCCCSGG-GG--GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             CC-----CHHHHHHHHHcCCCCCCCcc-cc--cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            43     44556666666655444332 22  134589999999999999999999999999987653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=347.86  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=200.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....+|++.+.||+|+||.||+|++..      ..||||++.....  ......+|+.++.+++||||+++++++....
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3456789999999999999999998742      2499999875432  2334568999999999999999999997755


Q ss_pred             ccceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                          .+++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus       120 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dikp~NIl~~~~~  184 (333)
T 1mqb_A          120 ----PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM-----------NYVHRDLAARNILVNSNL  184 (333)
T ss_dssp             ----SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTC
T ss_pred             ----CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCCChheEEECCCC
Confidence                45899999999999999954  4699999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYR  335 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~  335 (461)
                      .+||+|||+++........ .......+|..|+|||++.+     ..++.++||||||+++|||++ |           .
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g-----------~  248 (333)
T 1mqb_A          185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-----RKFTSASDVWSFGIVMWEVMTYG-----------E  248 (333)
T ss_dssp             CEEECCCCC-----------------CCCGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTS-----------C
T ss_pred             cEEECCCCcchhhccccccccccCCCCccccccCchhccc-----CCCCchhhhHHHHHHHHHHHcCC-----------C
Confidence            9999999999876543211 12223456789999999875     367788999999999999999 7           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      .||...     ...++...+... .+...+..++     ..+.++|.+||+.||++||++.++++++..+...
T Consensus       249 ~pf~~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          249 RPYWEL-----SNHEVMKAINDG-FRLPTPMDCP-----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             CTTTTC-----CHHHHHHHHHTT-CCCCCCTTCB-----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCcccC-----CHHHHHHHHHCC-CcCCCcccCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            666543     344444444433 3334444333     3799999999999999999999999999877643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-43  Score=338.68  Aligned_cols=256  Identities=23%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++.....  ......+|+.++..++||||+++++++.+..    ..+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   81 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN----IQY   81 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC----EEE
Confidence            368999999999999999999984  78899999865432  2345578898999999999999999998765    458


Q ss_pred             eeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.+++... .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-----------GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCChHHEEEccCCCEEEeeCC
Confidence            999999999999999754 699999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      ++................||..|+|||++.+.    ...+.++||||||+++|||++|           ..||...... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g-----------~~p~~~~~~~-  214 (276)
T 2yex_A          151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRR----EFHAEPVDVWSCGIVLTAMLAG-----------ELPWDQPSDS-  214 (276)
T ss_dssp             TCEECEETTEECCBCCCCSCGGGCCGGGGTCS----SBCHHHHHHHHHHHHHHHHHHS-----------SCCCSCSCTT-
T ss_pred             CccccCCCcchhcccCCccccCccChHHHhcC----CCCCCcchHHHHHHHHHHHHhC-----------CCCCCCCchH-
Confidence            99876433221223446789999999998763    1235679999999999999999           5555433111 


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                        .... ...............     .+..+.+||.+||+.||++|||++++++|.+..
T Consensus       215 --~~~~-~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (276)
T 2yex_A          215 --CQEY-SDWKEKKTYLNPWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (276)
T ss_dssp             --SHHH-HHHHTTCTTSTTGGG-----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             --HHHH-HHhhhcccccCchhh-----cCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence              1111 111111111111111     234789999999999999999999999997643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-43  Score=365.22  Aligned_cols=255  Identities=23%  Similarity=0.330  Sum_probs=206.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--------------hhhHHHHHHHHcCCCCCCCeeEEEE
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--------------QSWQSEQEIFKLPHMEHDNILRYIG  173 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--------------~~~~~~~ei~~l~~l~H~nIv~l~g  173 (461)
                      ..++|++.+.||+|+||.||+|+..  ++.||||++.....              ......+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999984  67899999865331              1234568999999999999999999


Q ss_pred             EEecCCccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEE
Q psy17532        174 AEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVL  252 (461)
Q Consensus       174 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NIL  252 (461)
                      ++.+..    .+++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||
T Consensus       114 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          114 VFEDKK----YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH-----------NIVHRDIKPENIL  178 (504)
T ss_dssp             EEECSS----EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEE
T ss_pred             EEEcCC----EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeEeCCCcHHHEE
Confidence            998765    4599999999999999884 45799999999999999999999999           9999999999999


Q ss_pred             EcCCC---ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q psy17532        253 LKSDL---TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSP  329 (461)
Q Consensus       253 l~~~~---~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~  329 (461)
                      ++.++   .+||+|||+++......   ......||+.|+|||++.+      .++.++|||||||++|+|++|      
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g------  243 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK------KYNEKCDVWSCGVIMYILLCG------  243 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT------CBCTHHHHHHHHHHHHHHHHS------
T ss_pred             EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc------CCCchHHHHHHHHHHHHHHhC------
Confidence            99775   69999999998776442   2344679999999999864      577899999999999999999      


Q ss_pred             CCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        330 PPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       330 ~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                           ..||...     ...++...+.........+ .|..  .+..+.+||.+||..||++|||+.++++|.|....
T Consensus       244 -----~~pf~~~-----~~~~~~~~i~~~~~~~~~~-~~~~--~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          244 -----YPPFGGQ-----NDQDIIKKVEKGKYYFDFN-DWKN--ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             -----SCSSCCS-----SHHHHHHHHHHCCCCCCHH-HHTT--SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             -----CCCCCCC-----CHHHHHHHHHcCCCCCCcc-ccCC--CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence                 6666543     4556666666554432221 1221  33489999999999999999999999999987553

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=356.50  Aligned_cols=261  Identities=22%  Similarity=0.330  Sum_probs=203.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCC-----hhhhHHHHHHHHcCCC-CCCCeeEEEEEEe
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQD-----KQSWQSEQEIFKLPHM-EHDNILRYIGAEK  176 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~  176 (461)
                      .....+|++.+.||+|+||.||+|+.     .++.||||++....     .......+|+.++..+ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            34567999999999999999999998     57889999985422     1223345677777788 7999999999998


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                      ...    .+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.
T Consensus       130 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          130 TET----KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL-----------GIIYRDIKLENILLDS  194 (355)
T ss_dssp             ETT----EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECT
T ss_pred             eCc----eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEECC
Confidence            765    45899999999999999954 5699999999999999999999999           9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      ++.+||+|||+++.+..... .......||+.|+|||++.+.   ...++.++|||||||++|||++|           .
T Consensus       195 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~ell~g-----------~  259 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTG-----------A  259 (355)
T ss_dssp             TSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHS-----------S
T ss_pred             CCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHHC-----------C
Confidence            99999999999987643221 123345799999999999753   13467889999999999999999           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                      .||..... ......+...+...  .+.++..++     ..+.+||.+||..||++||     ++.++++|++...
T Consensus       260 ~pf~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          260 SPFTVDGE-KNSQAEISRRILKS--EPPYPQEMS-----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CTTSCTTS-CCCHHHHHHHHHHC--CCCCCTTSC-----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCCccCCc-cchHHHHHHHHhcc--CCCCCcccC-----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            55543211 12334444444332  233444333     3789999999999999999     8999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-44  Score=344.14  Aligned_cols=251  Identities=19%  Similarity=0.277  Sum_probs=198.9

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECC---------CcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKN---------ENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      ...++|++.+.||+|+||.||+|+...         ..||+|++..... ......+|+.++.+++||||+++++++.+.
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            345789999999999999999998842         4599999865432 234567889999999999999999999876


Q ss_pred             CccceeeeeeehhccCCChhhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ..    .++||||+++|+|.+++....  +++..+..++.|++.||.|||+.           +|+||||||+|||++.+
T Consensus        85 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           85 DE----NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN-----------TLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             TC----CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEEEEC
T ss_pred             CC----CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC-----------CeECCCcCcceEEEecC
Confidence            54    489999999999999996543  99999999999999999999999           99999999999999988


Q ss_pred             Cc--------eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q psy17532        257 LT--------AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVS  328 (461)
Q Consensus       257 ~~--------~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~  328 (461)
                      +.        +||+|||++......      ....||..|+|||++.+.    ..++.++||||||+++|||++|+    
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~----  215 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENP----KNLNLATDKWSFGTTLWEICSGG----  215 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG----GGCCHHHHHHHHHHHHHHHHTTT----
T ss_pred             CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCC----CCCCchhHHHHHHHHHHHHHcCC----
Confidence            87        999999999754321      224578899999999763    35678899999999999999974    


Q ss_pred             CCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        329 PPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       329 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                            ..||...     ...........   ...++...+.     .+.+||.+||+.||++|||+.++++++..+..
T Consensus       216 ------~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~-----~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          216 ------DKPLSAL-----DSQRKLQFYED---RHQLPAPKAA-----ELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             ------CCTTTTS-----CHHHHHHHHHT---TCCCCCCSSC-----TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ------CCCcccc-----chHHHHHHhhc---cCCCCCCCCH-----HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                  3333322     22222222221   2223333222     68899999999999999999999999876654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-43  Score=365.69  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=208.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++.++||+|+||.||+|+.  +++.||||++.....    ......+|+.++.+++||||+++++++.+..   
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~---  258 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT---  258 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC---
Confidence            3457899999999999999999998  478899999965322    1234567888899999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                       .+++||||+++|+|.+++..     ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++
T Consensus       259 -~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-----------gIvHrDLKP~NILl~~~g  326 (543)
T 3c4z_A          259 -DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-----------NIIYRDLKPENVLLDDDG  326 (543)
T ss_dssp             -EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTS
T ss_pred             -EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-----------CCcccCCChHHEEEeCCC
Confidence             45999999999999999853     3599999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++.+.....  ......||+.|+|||++.+     ..++.++|||||||++|||++|           ..|
T Consensus       327 ~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiwSlGvilyelltG-----------~~P  388 (543)
T 3c4z_A          327 NVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLG-----EEYDFSVDYFALGVTLYEMIAA-----------RGP  388 (543)
T ss_dssp             CEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCS
T ss_pred             CEEEeecceeeeccCCCc--ccccccCCccccChhhhcC-----CCCChHHhcCcchHHHHHHHhC-----------CCC
Confidence            999999999988765432  2334589999999999976     3678899999999999999999           555


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccc-----cchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA-----SCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~~~~~  407 (461)
                      |.... .......+...+....  ..+|..++     ..+.+||.+||..||++||++     +++++|.++...
T Consensus       389 F~~~~-~~~~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          389 FRARG-EKVENKELKQRVLEQA--VTYPDKFS-----PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             SCCTT-CCCCHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             CCCCc-cchhHHHHHHHHhhcc--cCCCcccC-----HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            54431 1123455555555443  23444333     378999999999999999964     678888876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=351.00  Aligned_cols=244  Identities=25%  Similarity=0.314  Sum_probs=197.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++.....         ......+|+.++.+++||||+++++++.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46899999999999999999987  578899999975432         1223457899999999999999999998765


Q ss_pred             ccceeeeeeehhccCC-ChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        180 SIHTEFWLITAYHERG-SLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~g-sL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                          .+++||||+.+| +|.+++... .+++..+..++.||+.||.|||+.           +|+||||||+|||++.++
T Consensus       103 ----~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A          103 ----FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK-----------DIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             ----EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTS
T ss_pred             ----EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEEeccCHHHEEEcCCC
Confidence                458999999877 999999654 699999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++.......   .....||+.|+|||++.+.    ...+.++||||||+++|||++|           ..|
T Consensus       168 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g-----------~~p  229 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGN----PYRGPELEMWSLGVTLYTLVFE-----------ENP  229 (335)
T ss_dssp             CEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTC----CBCSHHHHHHHHHHHHHHHHHS-----------SCS
T ss_pred             cEEEeecccceECCCCCc---eeccCCCccccChhhhcCC----CCCCCcccchhHHHHHHHHHhC-----------CCc
Confidence            999999999988765432   2345789999999999764    2236789999999999999999           455


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      |...       .+    ....  ....+..+     +..+.+||.+||+.||++|||+.++++|.+..
T Consensus       230 f~~~-------~~----~~~~--~~~~~~~~-----~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~  279 (335)
T 3dls_A          230 FCEL-------EE----TVEA--AIHPPYLV-----SKELMSLVSGLLQPVPERRTTLEKLVTDPWVT  279 (335)
T ss_dssp             CSSG-------GG----GTTT--CCCCSSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred             hhhH-------HH----HHhh--ccCCCccc-----CHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence            5332       00    0111  11122222     23799999999999999999999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-43  Score=368.54  Aligned_cols=256  Identities=23%  Similarity=0.265  Sum_probs=207.6

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.++||+|+||.||+|+.  +++.||||++....    .......+|+.++..++|||||++++++.+..    
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----  257 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----  257 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC----
Confidence            457899999999999999999998  47899999996432    12234567888899999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        184 EFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      .+++||||+++|+|.+++...   .+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+|
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~-----------gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-----------RIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeccCCchheEEEeCCCCeE
Confidence            459999999999999998543   399999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++.+....   ......||+.|+|||++.+.     .++.++|||||||++|||++|           ..||..
T Consensus       327 L~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~-----~~~~~~DiwSLGvilyeLltG-----------~~PF~~  387 (576)
T 2acx_A          327 ISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE-----RYTFSPDWWALGCLLYEMIAG-----------QSPFQQ  387 (576)
T ss_dssp             ECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTC-----EESSHHHHHHHHHHHHHHHHS-----------SCSSSC
T ss_pred             EEecccceecccCc---cccccCCCccccCHHHHcCC-----CCCccchHHHHHHHHHHHHhC-----------CCCCcc
Confidence            99999998876443   22345899999999999763     577899999999999999999           555544


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLALC  407 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~~  407 (461)
                      ... ......+...+...  ...++..++     ..+.+||.+||..||++||     +++|+++|.+....
T Consensus       388 ~~~-~~~~~~i~~~i~~~--~~~~p~~~s-----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          388 RKK-KIKREEVERLVKEV--PEEYSERFS-----PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             SSS-CCCHHHHHHHHHHC--CCCCCTTSC-----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             ccc-chhHHHHHHHhhcc--cccCCccCC-----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            311 11334444444332  223444333     3899999999999999999     78999999987653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=348.08  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCc----EEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NEN----VAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~----vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ...++|++.+.||+|+||.||+|++.  ++.    ||+|.+....  .......+|+.++..++||||+++++++.... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            44678999999999999999999983  444    4777664332  23345678999999999999999999998753 


Q ss_pred             cceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          .++|+||+++|+|.+++..  ..+++..++.++.|++.||.|||+.           +|+||||||+|||++.++.
T Consensus        91 ----~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           91 ----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-----------RLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             ----EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEEEETTE
T ss_pred             ----ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-----------CCcCCCCCHHHEEEcCCCC
Confidence                4799999999999999954  4699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~p  337 (461)
                      +||+|||+++...............+|+.|+|||++.+     ..++.++||||||+++|||++ |           ..|
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g-----------~~p  219 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFG-----------SKP  219 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCT
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcC-----CCCChHHHHHHHHHHHHHHHHCC-----------CCC
Confidence            99999999987754433233344567889999999976     367789999999999999999 8           556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |...     ...++...+. ...+...+..++     ..+.+||.+||+.||++|||+.++++.+..+..
T Consensus       220 ~~~~-----~~~~~~~~~~-~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          220 YDGI-----PASEISSILE-KGERLPQPPICT-----IDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTTC-----CGGGHHHHHH-TTCCCCCCTTBC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCC-----CHHHHHHHHH-cCCCCCCCccCC-----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            6443     2233333333 333344444433     379999999999999999999999999987764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.9e-44  Score=352.02  Aligned_cols=260  Identities=18%  Similarity=0.139  Sum_probs=203.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++..... .....+|+.++..+ +||||+++++++....    ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK----YNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT----EEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC----ccEE
Confidence            46899999999999999999997  578899999875432 23456788888888 9999999999998865    4589


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc-----eE
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT-----AA  260 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~-----~k  260 (461)
                      ||||+ +|+|.+++.  ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.     +|
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~iiHrDlkp~Nill~~~~~~~~~~~k  150 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK-----------NLIYRDVKPENFLIGRPGNKTQQVIH  150 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeccCCCHHHeeeccCCCCCCceEE
Confidence            99999 899999996  46799999999999999999999999           9999999999999998887     99


Q ss_pred             EEecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       261 i~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      |+|||+++.+......     .......||+.|+|||++.+     ..++.++|||||||++|||++|           .
T Consensus       151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g-----------~  214 (330)
T 2izr_A          151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-----KEQSRRDDLEALGHMFMYFLRG-----------S  214 (330)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------S
T ss_pred             EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-----CCCCchhHHHHHHHHHHHHhcC-----------C
Confidence            9999999876543221     11345689999999999976     3677899999999999999999           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      .||....  .....+....+.......  +........+ ++.+++..||+.||++||+++++++.+..+...
T Consensus       215 ~Pf~~~~--~~~~~~~~~~i~~~~~~~--~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          215 LPWQGLK--ADTLKERYQKIGDTKRAT--PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             CTTTTCC--CSSHHHHHHHHHHHHHHS--CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCccccc--cccHHHHHHHHHhhhccC--CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            5665431  113333333332221111  1111111123 799999999999999999999999988766543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-43  Score=344.94  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=197.3

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEe
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEK  176 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~  176 (461)
                      .......++|++.+.||+|+||.||+|+..     +..||||++.....   ......+|+.++.+++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344456789999999999999999999873     23699999865432   2234568899999999999999999987


Q ss_pred             cCCcc-ceeeeeeehhccCCChhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCC
Q psy17532        177 RGESI-HTEFWLITAYHERGSLCDFLK-------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKS  248 (461)
Q Consensus       177 ~~~~~-~~~~~lv~e~~~~gsL~~~l~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp  248 (461)
                      ..... ....++||||+++|+|.+++.       ...+++..++.++.|++.||.|||+.           +|+||||||
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dikp  175 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-----------NFLHRDLAA  175 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-----------TCCCCCCSG
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCc
Confidence            65422 124589999999999999982       24589999999999999999999998           999999999


Q ss_pred             CcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCC
Q psy17532        249 NNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSV  327 (461)
Q Consensus       249 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~  327 (461)
                      +|||++.++.+||+|||+++...............+++.|+|||++.+     ..++.++||||||+++|||++ |    
T Consensus       176 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g----  246 (313)
T 3brb_A          176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-----RVYTSKSDVWAFGVTMWEIATRG----  246 (313)
T ss_dssp             GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-----SCCCHHHHHHHHHHHHHHHHTTS----
T ss_pred             ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-----CCccchhhhHHHHHHHHHHHhcC----
Confidence            999999999999999999987755432223334567889999999876     367789999999999999999 6    


Q ss_pred             CCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        328 SPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       328 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                             ..||...     ....+...+... .++..+..++     ..+.++|.+||..||++|||+.+++++|..+..
T Consensus       247 -------~~p~~~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          247 -------MTPYPGV-----QNHEMYDYLLHG-HRLKQPEDCL-----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             -------CCSSTTC-----CGGGHHHHHHTT-CCCCCBTTCC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCccC-----CHHHHHHHHHcC-CCCCCCcccc-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                   5555443     223334443332 2344444433     379999999999999999999999999987764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-43  Score=339.38  Aligned_cols=257  Identities=23%  Similarity=0.308  Sum_probs=200.9

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .....++|++.+.||+|+||.||+|++.+     ..||||.+.....  ......+|+.++..++||||+++++++.+..
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   86 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP   86 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence            34566899999999999999999999742     2499999875432  2345578898899999999999999986542


Q ss_pred             ccceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                           .++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus        87 -----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~  150 (281)
T 3cc6_A           87 -----TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-----------NCVHRDIAVRNILVASPE  150 (281)
T ss_dssp             -----CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCSGGGEEEEETT
T ss_pred             -----CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCccceEEECCCC
Confidence                 3899999999999999954  4599999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      .+||+|||+++....... .......+|..|+|||++.+     ..++.++||||||+++|||++ |           ..
T Consensus       151 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~llt~g-----------~~  213 (281)
T 3cc6_A          151 CVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINF-----RRFTTASDVWMFAVCMWEILSFG-----------KQ  213 (281)
T ss_dssp             EEEECCCCGGGCC----------CCCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTT-----------CC
T ss_pred             cEEeCccCCCcccccccc-cccccCCCCcceeCchhhcc-----CCCCchhccHHHHHHHHHHHhCC-----------CC
Confidence            999999999987654322 12334567889999999865     367788999999999999998 8           55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ||...     ...+....+... .+...+..++     ..+.++|.+||+.||++|||+.+++++|..+..
T Consensus       214 p~~~~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          214 PFFWL-----ENKDVIGVLEKG-DRLPKPDLCP-----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             TTTTS-----CGGGHHHHHHHT-CCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcccC-----ChHHHHHHHhcC-CCCCCCCCCC-----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            55432     222333333322 2333443333     379999999999999999999999999877654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-43  Score=345.54  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=206.5

Q ss_pred             CCCCCccCCcceeEEeEeecCCceEEEEEEEC--CCc--EEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEE
Q psy17532        103 SPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NEN--VAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAE  175 (461)
Q Consensus       103 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~--vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~  175 (461)
                      ....+....++|++.+.||+|+||.||+|+..  +..  ||||.+....  .......+|+.++.++ +||||+++++++
T Consensus        16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             CcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            34455667789999999999999999999983  443  5999886432  2334567899999999 999999999999


Q ss_pred             ecCCccceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCC
Q psy17532        176 KRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK  238 (461)
Q Consensus       176 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~  238 (461)
                      .+..    .+++||||+++|+|.+++...                 .+++..+..++.||+.||.|||+.          
T Consensus        96 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------  161 (327)
T 1fvr_A           96 EHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----------  161 (327)
T ss_dssp             EETT----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----------
T ss_pred             eeCC----ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----------
Confidence            8765    459999999999999999643                 589999999999999999999999          


Q ss_pred             CCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHH
Q psy17532        239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW  318 (461)
Q Consensus       239 ~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~  318 (461)
                       +|+||||||+|||++.++.+||+|||+++......   ......++..|+|||++.+.     .++.++||||||+++|
T Consensus       162 -~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~  232 (327)
T 1fvr_A          162 -QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-----VYTTNSDVWSYGVLLW  232 (327)
T ss_dssp             -TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC-----EECHHHHHHHHHHHHH
T ss_pred             -CccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccc-----cCCchhcchHHHHHHH
Confidence             99999999999999999999999999997543221   22334578899999998653     5678899999999999


Q ss_pred             HHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        319 ELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       319 el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                      ||++ |           ..||...     ...++...+.. ..+...+..++     ..+.+||.+||+.||++|||+.+
T Consensus       233 ellt~g-----------~~pf~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~e  290 (327)
T 1fvr_A          233 EIVSLG-----------GTPYCGM-----TCAELYEKLPQ-GYRLEKPLNCD-----DEVYDLMRQCWREKPYERPSFAQ  290 (327)
T ss_dssp             HHHTTS-----------CCTTTTC-----CHHHHHHHGGG-TCCCCCCTTBC-----HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHcCC-----------CCCCCCC-----cHHHHHHHhhc-CCCCCCCCCCC-----HHHHHHHHHHccCChhhCcCHHH
Confidence            9998 8           5666543     44444444433 33344444333     37999999999999999999999


Q ss_pred             hhhhcHHHhhh
Q psy17532        398 VVERGMLALCD  408 (461)
Q Consensus       398 vl~~l~~~~~~  408 (461)
                      +++++..+...
T Consensus       291 ll~~L~~~~~~  301 (327)
T 1fvr_A          291 ILVSLNRMLEE  301 (327)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHHHh
Confidence            99999877653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=344.34  Aligned_cols=259  Identities=21%  Similarity=0.291  Sum_probs=194.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++......   .....+|+.++.+++||||+++++++.+..    .+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~   77 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR----RL   77 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC----eE
Confidence            357999999999999999999994  788999998654332   233467899999999999999999998765    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ++||||+++++|.++++ ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~kl~Df  146 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-----------NCIHRDVKPENILITKHSVIKLCDF  146 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CCcCCCCChhhEEEcCCCCEEEeeC
Confidence            89999999999999886 45699999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+++.......  ......||..|+|||++.+.    ..++.++||||||+++|||++|.           .||...   
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~-----------~p~~~~---  206 (311)
T 4agu_A          147 GFARLLTGPSD--YYDDEVATRWYRSPELLVGD----TQYGPPVDVWAIGCVFAELLSGV-----------PLWPGK---  206 (311)
T ss_dssp             TTCEECC--------------GGGCCHHHHHTC----SCCCTHHHHHHHHHHHHHHHHSS-----------CSCCCS---
T ss_pred             CCchhccCccc--ccCCCcCCccccChHHHhcC----CCCCcchhhHHHHHHHHHHHhCC-----------CCCCCC---
Confidence            99987654321  23345789999999998753    35678999999999999999994           455332   


Q ss_pred             CCCHHHHHHHHhc-------------------cCCCCCCCchh-----ccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        345 HPSLEDMQEAVVH-------------------KKLRPTLPETW-----KQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       345 ~~~~~~~~~~~~~-------------------~~~~~~~p~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                        ...+....+..                   .......+...     .....+..+.+||.+||+.||++|||++++++
T Consensus       207 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          207 --SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             --SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             --CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              11111111100                   00000111000     00123347899999999999999999999999


Q ss_pred             hcHHHh
Q psy17532        401 RGMLAL  406 (461)
Q Consensus       401 ~l~~~~  406 (461)
                      |.+...
T Consensus       285 hp~f~~  290 (311)
T 4agu_A          285 HPYFEN  290 (311)
T ss_dssp             SGGGTT
T ss_pred             ChHHHh
Confidence            987654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-43  Score=345.87  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=205.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .+.|++.+.||+|+||.||+|+..  ++.||||++.....       ......+|+.++.+++||||+++++++.+..  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence            467999999999999999999984  78899999975432       1344678999999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC---
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL---  257 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~---  257 (461)
                        .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++   
T Consensus        89 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~-----------~ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           89 --DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK-----------KIAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             --EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESCTTSSS
T ss_pred             --EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCChHHEEEecCCCCc
Confidence              45999999999999999964 4689999999999999999999999           999999999999999887   


Q ss_pred             -ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 -TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 -~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                       .+||+|||+++......   ......||+.|+|||++.+     ..++.++||||||+++|||++|           ..
T Consensus       156 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g-----------~~  216 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSG-----------AS  216 (321)
T ss_dssp             CCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------CC
T ss_pred             CCEEEccCccceecCccc---cccccCCCCCccCcccccC-----CCCCCccccHHHHHHHHHHHHC-----------CC
Confidence             79999999998776543   2334579999999999876     3677899999999999999999           56


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...     ...+....+.....  .++.... ...+..+.+||.+||..||++|||+.++++|.+..
T Consensus       217 pf~~~-----~~~~~~~~i~~~~~--~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          217 PFLGD-----TKQETLANITSVSY--DFDEEFF-SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             SSCCS-----SHHHHHHHHHTTCC--CCCHHHH-TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             CCCCC-----CHHHHHHHHHhccc--ccChhhh-cccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            66543     33444444433322  2222111 11334789999999999999999999999998753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-43  Score=351.96  Aligned_cols=260  Identities=20%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-------
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES-------  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-------  180 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++.....   ...+|+.+++.++||||+++++++.....       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            456899999999999999999998  578999999864432   22468888999999999999999865331       


Q ss_pred             ---------------------------cceeeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhc
Q psy17532        181 ---------------------------IHTEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEE  228 (461)
Q Consensus       181 ---------------------------~~~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~  228 (461)
                                                 ....+++||||++ |+|.+++.     ...+++..+..++.||+.||+|||+.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  160 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL  160 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence                                       1123689999998 58887774     35799999999999999999999998


Q ss_pred             ccCCCcCCCCCCeecccCCCCcEEEc-CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCc
Q psy17532        229 ILPNKADSYKPAVAHRDFKSNNVLLK-SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLR  307 (461)
Q Consensus       229 ~~~~~~~~~~~~ivHrDLkp~NILl~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k  307 (461)
                                 +|+||||||+|||++ .++.+||+|||+|+.+....   ......||..|+|||++.+.    ..++.+
T Consensus       161 -----------gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~----~~~~~~  222 (383)
T 3eb0_A          161 -----------GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGA----TEYTPS  222 (383)
T ss_dssp             -----------TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTC----SSCCTH
T ss_pred             -----------cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCC----CCCCcc
Confidence                       999999999999998 68899999999998765443   23345789999999998763    357889


Q ss_pred             cchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhc--------------cC-CCCCCC----chh
Q psy17532        308 IDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVH--------------KK-LRPTLP----ETW  368 (461)
Q Consensus       308 ~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~--------------~~-~~~~~p----~~~  368 (461)
                      +|||||||++|||++|           +.||.+.     ...+....+..              .. ....++    ..|
T Consensus       223 ~DiwslG~il~ell~g-----------~~pf~~~-----~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  286 (383)
T 3eb0_A          223 IDLWSIGCVFGELILG-----------KPLFSGE-----TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW  286 (383)
T ss_dssp             HHHHHHHHHHHHHHHS-----------SCSSCCS-----SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH
T ss_pred             hhhhhHHHHHHHHHhC-----------CCCCCCC-----ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH
Confidence            9999999999999999           4555432     11121111111              00 000011    111


Q ss_pred             c---cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        369 K---QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       369 ~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .   ....+..+.+||.+||..||++|||+.|+++|.+.-..
T Consensus       287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence            1   01133478999999999999999999999999987543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.8e-44  Score=362.93  Aligned_cols=255  Identities=22%  Similarity=0.283  Sum_probs=191.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .++|.+.+.||+|+||.||+|...  ++.||||++.....         ......+|+.++.+++||||+++++++... 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            568999999999999999999984  67899999875321         112356899999999999999999997543 


Q ss_pred             ccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC--
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD--  256 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~--  256 (461)
                          .+++||||+++|+|.+++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++.+  
T Consensus       213 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          213 ----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             ----EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEESSSSS
T ss_pred             ----ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCChHhEEEecCCC
Confidence                3589999999999999885 45699999999999999999999999           99999999999999754  


Q ss_pred             -CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        257 -LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       257 -~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                       +.+||+|||+++......   ......||+.|+|||++.+.  ....++.++|||||||++|||++|           .
T Consensus       278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~~lltg-----------~  341 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSG-----------Y  341 (419)
T ss_dssp             SCCEEECCSSTTTSCC--------------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHS-----------S
T ss_pred             cceEEEeecccceecCCCc---cccccCCCCCccCceeeecC--CCCCCCchhhhHhHHHHHHHHHHC-----------C
Confidence             459999999998765432   23346799999999998642  113567789999999999999999           4


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .||......    ..+...+.... ....+..+..  .+..+.+||.+||+.||++|||++++++|.|.
T Consensus       342 ~pf~~~~~~----~~~~~~i~~~~-~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  403 (419)
T 3i6u_A          342 PPFSEHRTQ----VSLKDQITSGK-YNFIPEVWAE--VSEKALDLVKKLLVVDPKARFTTEEALRHPWL  403 (419)
T ss_dssp             CSSCCCSSS----CCHHHHHHTTC-CCCCHHHHTT--SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCCCCCcch----HHHHHHHhcCC-CCCCchhhcc--cCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence            555432111    11222222222 1222332222  33479999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.9e-43  Score=340.84  Aligned_cols=259  Identities=21%  Similarity=0.364  Sum_probs=195.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....+|++.+.||+|+||.||+|+.  +++.||||++....    .......+|+.++.+++||||+++++++...+   
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---  105 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN---  105 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT---
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence            3567899999999999999999997  57889999987432    22344568999999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        183 TEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                       .+++||||+++|+|.+++.     ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus       106 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~i~H~dl~p~NIl~~~~~  173 (310)
T 2wqm_A          106 -ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-----------RVMHRDIKPANVFITATG  173 (310)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTS
T ss_pred             -cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-----------CeeCCCCcHHHEEEcCCC
Confidence             4589999999999999985     35689999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++......  .......|+..|+|||++.+     ..++.++||||||+++|||++|           ..|
T Consensus       174 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g-----------~~p  235 (310)
T 2wqm_A          174 VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAAL-----------QSP  235 (310)
T ss_dssp             CEEECCC--------------------CCSSCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------SCT
T ss_pred             CEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCC-----CCCCchhhHHHHHHHHHHHHhC-----------CCC
Confidence            99999999998765432  12334578999999999876     3567889999999999999999           555


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      |...   ..........+......+..+..+     +..+.+||.+||+.||++|||+.++++.+..+...
T Consensus       236 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          236 FYGD---KMNLYSLCKKIEQCDYPPLPSDHY-----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             TC------CCHHHHHHHHHTTCSCCCCTTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Cccc---chhHHHHHHHhhcccCCCCccccc-----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            5432   113334444444433332222222     34799999999999999999999999999887753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-43  Score=338.36  Aligned_cols=246  Identities=21%  Similarity=0.303  Sum_probs=196.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++....   .......+|+..+..+ +||||+++++++.+..    .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----~   85 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----H   85 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT----E
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----e
Confidence            468999999999999999999994  7899999987542   2334456788777777 9999999999998765    4


Q ss_pred             eeeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC----
Q psy17532        185 FWLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS----  255 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~----  255 (461)
                      +++||||+++|+|.+++..     ..+++..+..++.||+.||.|||++           +|+||||||+|||++.    
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~Dikp~NIl~~~~~~~  154 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-----------SLVHMDIKPSNIFISRTSIP  154 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEC-----
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeecCCCHHHEEEcCCCCC
Confidence            5899999999999999954     5689999999999999999999999           9999999999999984    


Q ss_pred             ---------------CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHH
Q psy17532        256 ---------------DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL  320 (461)
Q Consensus       256 ---------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el  320 (461)
                                     ...+||+|||++.......      ...||..|+|||++.+.    ..++.++||||||+++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l  224 (289)
T 1x8b_A          155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN----YTHLPKADIFALALTVVCA  224 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC----CCCCchhhHHHHHHHHHHH
Confidence                           4479999999998765432      24589999999998763    2445689999999999999


Q ss_pred             HcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       321 ~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                      ++|.+           ++...        .....+.. ...+.++..++     ..+.+||.+||+.||++|||+.++++
T Consensus       225 ~~~~~-----------~~~~~--------~~~~~~~~-~~~~~~~~~~~-----~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          225 AGAEP-----------LPRNG--------DQWHEIRQ-GRLPRIPQVLS-----QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             TTCCC-----------CCSSS--------HHHHHHHT-TCCCCCSSCCC-----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCC-----------CCcch--------hHHHHHHc-CCCCCCCcccC-----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            99842           22211        11222222 23344554443     37999999999999999999999999


Q ss_pred             hcHHHh
Q psy17532        401 RGMLAL  406 (461)
Q Consensus       401 ~l~~~~  406 (461)
                      |.+...
T Consensus       280 h~~~~~  285 (289)
T 1x8b_A          280 HSVLLS  285 (289)
T ss_dssp             CTTC--
T ss_pred             ChHhhh
Confidence            987543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.6e-44  Score=349.85  Aligned_cols=258  Identities=23%  Similarity=0.352  Sum_probs=202.6

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE-------CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF-------KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      ....++|++.+.||+|+||.||+|++       .++.||||.+....  .......+|+.++.+++||||+++++++...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            45568999999999999999999984       35679999986432  2334556789899999999999999999876


Q ss_pred             CccceeeeeeehhccCCChhhhhcCC--------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCc
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKCN--------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNN  250 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~N  250 (461)
                      ..    .++||||+++|+|.+++...        .+++..++.++.|++.||.|||+.           +|+||||||+|
T Consensus       106 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-----------~i~H~dlkp~N  170 (327)
T 2yfx_A          106 LP----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-----------HFIHRDIAARN  170 (327)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGG
T ss_pred             CC----cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-----------CeecCcCCHhH
Confidence            54    48999999999999999543        489999999999999999999999           99999999999


Q ss_pred             EEEcC---CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCC
Q psy17532        251 VLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSS  326 (461)
Q Consensus       251 ILl~~---~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~  326 (461)
                      ||++.   +..+||+|||+++...............||+.|+|||++.+.     .++.++||||||+++|||++ |   
T Consensus       171 Ili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g---  242 (327)
T 2yfx_A          171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-----IFTSKTDTWSFGVLLWEIFSLG---  242 (327)
T ss_dssp             EEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTS---
T ss_pred             EEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-----CCCchhhHHHHHHHHHHHHcCC---
Confidence            99994   456999999999765443322233345678999999998753     67789999999999999998 6   


Q ss_pred             CCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                              ..||...     ...+....+.... ++..+..++     ..+.+||.+||+.||++|||+.+++++++.+.
T Consensus       243 --------~~p~~~~-----~~~~~~~~~~~~~-~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          243 --------YMPYPSK-----SNQEVLEFVTSGG-RMDPPKNCP-----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             --------CCSSTTC-----CHHHHHHHHHTTC-CCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCc-----CHHHHHHHHhcCC-CCCCCCCCC-----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                    5666543     3444444444332 333444333     37999999999999999999999999998776


Q ss_pred             h
Q psy17532        407 C  407 (461)
Q Consensus       407 ~  407 (461)
                      .
T Consensus       304 ~  304 (327)
T 2yfx_A          304 Q  304 (327)
T ss_dssp             H
T ss_pred             c
Confidence            5

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=354.68  Aligned_cols=258  Identities=26%  Similarity=0.363  Sum_probs=192.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--C---CcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--N---ENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~---~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ...|++.+.||+|+||.||+|++.  +   ..||||.+....  .....+.+|+.++++++||||+++++++....   .
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---~  164 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---G  164 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---S
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---C
Confidence            346788999999999999999973  2   358999886432  23345678999999999999999999876543   2


Q ss_pred             eeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      ..++||||+++|+|.++++.  ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlkp~NIll~~~~~~kL  233 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-----------KFVHRDLAARNCMLDEKFTVKV  233 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTCCEEE
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEecCccchheEEECCCCCEEE
Confidence            34899999999999999964  3589999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        262 ADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       262 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      +|||+++.+......  .......+|+.|+|||++.+     ..++.++||||||+++|||++|+          ..||.
T Consensus       234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~il~ellt~~----------~~p~~  298 (373)
T 3c1x_A          234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRG----------APPYP  298 (373)
T ss_dssp             CCC---------------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS----------CCSCT
T ss_pred             eeccccccccccccccccccCCCCCcccccChHHhcC-----CCCCcHHHHHHHHHHHHHHHhCc----------CCCCC
Confidence            999999876443211  11234467889999999876     36778999999999999999953          44554


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      ...     ..+....+.. ..++..|..++     ..+.++|.+||+.||++|||+.+++++|..+...
T Consensus       299 ~~~-----~~~~~~~~~~-~~~~~~p~~~~-----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          299 DVN-----TFDITVYLLQ-GRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             TSC-----SSCHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCC-----HHHHHHHHHc-CCCCCCCCCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            331     1122223322 22334444433     3799999999999999999999999999887654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-43  Score=342.66  Aligned_cols=261  Identities=19%  Similarity=0.168  Sum_probs=203.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++.... ......+|+..+..+ +|+||+++++++....    ..+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----~~~   82 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL----HNV   82 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT----EEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc----eeE
Confidence            456899999999999999999996  57899999986443 233456777777777 7999999999987755    458


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc-----e
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT-----A  259 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~-----~  259 (461)
                      +||||+ +|+|.+++..  ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.     +
T Consensus        83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-----------SLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEeccCCCCCCCeE
Confidence            999999 8999999963  4699999999999999999999998           9999999999999987765     9


Q ss_pred             EEEecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      ||+|||+++........     .......||+.|+|||++.+     ..++.++||||||+++|||++|           
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g-----------  214 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRG-----------  214 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcC-----CCCChHHHHHHHHHHHHHHHcC-----------
Confidence            99999999877543221     12345679999999999876     3577899999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..||.....  .........+......+..+....  ..+..+.+|+.+||+.||++|||++++++.+..+..
T Consensus       215 ~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          215 SLPWQGLKA--ATNKQKYERIGEKKQSTPLRELCA--GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             SCTTSSCCS--CCHHHHHHHHHHHHHHSCHHHHTT--TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCcchhhc--cccHHHHHHHHhhccCccHHHHHh--hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            555544211  122333333322221122111111  123489999999999999999999999999887764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4e-44  Score=342.93  Aligned_cols=252  Identities=21%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||+|.+.....   ......+|+.++++++||||+++++++....  ...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--GTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--CceE
Confidence            56899999999999999999998  478899999975432   2334568899999999999999999876533  2356


Q ss_pred             eeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC-----eecccCCCCcEEEcC
Q psy17532        186 WLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA-----VAHRDFKSNNVLLKS  255 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~-----ivHrDLkp~NILl~~  255 (461)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.           +     |+||||||+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~~~~~~ivH~dl~p~NIl~~~  151 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-----------SDGGHTVLHRDLKPANVFLDG  151 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-----------C------CCCCCSGGGEEECS
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-----------cCCCCeeEEeccchhhEEEcC
Confidence            999999999999999953     3499999999999999999999998           6     999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      ++.+||+|||+++.......  ......||..|+|||++.+.     .++.++||||||+++|||++|           .
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~  213 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRM-----SYNEKSDIWSLGCLLYELCAL-----------M  213 (279)
T ss_dssp             SSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC------CCHHHHHHHHHHHHHHHHHS-----------S
T ss_pred             CCCEEEecCchheeeccccc--cccccCCCccccChHHhccC-----CCCchhhHHHHHHHHHHHHHC-----------C
Confidence            99999999999987653221  11234689999999998763     567889999999999999999           5


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .||...     ...++...+.... .+.++..++     ..+.++|.+||+.||++|||+.+++++++.
T Consensus       214 ~p~~~~-----~~~~~~~~i~~~~-~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          214 PPFTAF-----SQKELAGKIREGK-FRRIPYRYS-----DELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CSSCCS-----SHHHHHHHHHHTC-CCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCccc-----CHHHHHHHHhhcc-cccCCcccC-----HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            666543     3344444444433 334444433     389999999999999999999999999754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=372.09  Aligned_cols=255  Identities=21%  Similarity=0.320  Sum_probs=201.0

Q ss_pred             CCcceeEEe-EeecCCceEEEEEEEC----CCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVE-VKAQGRFGAVWKAKFK----NENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~-~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++.+.+ .||+|+||.||+|.++    +..||||++....  .....+.+|+.+|.+++|||||++++++...    
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----  408 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE----  408 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS----
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC----
Confidence            345666666 8999999999999873    3569999987542  2345567899999999999999999998763    


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       .+++||||+++|+|.+++..  ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.+|
T Consensus       409 -~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~iiHrDlkp~NILl~~~~~vk  476 (613)
T 2ozo_A          409 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-----------NFVHRNLAARNVLLVNRHYAK  476 (613)
T ss_dssp             -SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEEEETTEEE
T ss_pred             -CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEcCcCCHHHEEEcCCCcEE
Confidence             35899999999999999953  4599999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       261 i~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      |+|||+++.+...... .......+|+.|+|||++.+     ..++.++|||||||++|||++ |           ..||
T Consensus       477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G-----------~~Pf  540 (613)
T 2ozo_A          477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYG-----------QKPY  540 (613)
T ss_dssp             ECCCSTTTTCC--------------CCTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCTT
T ss_pred             EeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-----CCCCcHHHHHHHHHHHHHHHHCC-----------CCCC
Confidence            9999999877543321 12223456789999999875     367889999999999999998 8           6666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ...++...+.. ..+...|..++.     .+.+||.+||+.||++||++.++++.|..+..
T Consensus       541 ~~~-----~~~~~~~~i~~-~~~~~~p~~~~~-----~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          541 KKM-----KGPEVMAFIEQ-GKRMECPPECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             TTC-----CSHHHHHHHHT-TCCCCCCTTCCH-----HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCC-----CHHHHHHHHHc-CCCCCCCCcCCH-----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            543     23344444433 345555655443     89999999999999999999999998876654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-43  Score=346.66  Aligned_cols=275  Identities=24%  Similarity=0.334  Sum_probs=208.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ....++|++.+.||+|+||.||+|++      .++.||||++...... .....+|+.++.+++||||+++++++.... 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   97 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG-   97 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC-
Confidence            45668999999999999999999995      4677999999765433 334678999999999999999999987543 


Q ss_pred             cceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                       ...+++||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~Dikp~NIl~~~~~~  165 (327)
T 3lxl_A           98 -RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR-----------RCVHRDLAARNILVESEAH  165 (327)
T ss_dssp             -SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEEETTE
T ss_pred             -CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCCCCChhhEEECCCCC
Confidence             2356899999999999999964  4699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      +||+|||+++........ .......||..|+|||++.+.     .++.++||||||+++|||++|+.||..........
T Consensus       166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~  240 (327)
T 3lxl_A          166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-----IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM  240 (327)
T ss_dssp             EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred             EEEcccccceecccCCccceeeccCCccccccCHHHhccC-----CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence            999999999877544321 123345688899999998763     55678999999999999999955443211100000


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      + ......+....+...+ ....+...+..++     ..+.+||.+||+.||++|||+.+++++|..+..
T Consensus       241 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          241 M-GCERDVPALSRLLELL-EEGQRLPAPPACP-----AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             C-C----CCHHHHHHHHH-HTTCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             c-ccccccccHHHHHHHh-hcccCCCCCCccc-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0 0001111222232222 3333444444443     389999999999999999999999999876654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=353.24  Aligned_cols=257  Identities=22%  Similarity=0.307  Sum_probs=195.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++.....   ......+|+.+++.++||||+++++++......  ..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999998  478899999854322   223456899999999999999999998765422  23


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||+ +++|.++++...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-----------GIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCcCHHHEEEcCCCCEEEEe
Confidence            569999999 78999999888899999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....     .....||..|+|||++.+.    ..++.++|||||||++|||++|..           ||.+.  
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~-----------pf~~~--  229 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNW----MRYTQTVDIWSVGCIMAEMITGKT-----------LFKGS--  229 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTT----TCCCTTHHHHHHHHHHHHHHHSSC-----------SSCCS--
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCC----CCCChhhhHHHHHHHHHHHHhCCC-----------CCCCC--
Confidence            9999876432     3346789999999998763    367789999999999999999954           44332  


Q ss_pred             CCCCHHHHHHHHhc--------------------------cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        344 DHPSLEDMQEAVVH--------------------------KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       344 ~~~~~~~~~~~~~~--------------------------~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                         ...+....+..                          ......+...++  ..+..+.+|+.+||..||++|||+++
T Consensus       230 ---~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~mL~~dP~~R~t~~e  304 (367)
T 1cm8_A          230 ---DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT--NASPLAVNLLEKMLVLDAEQRVTAGE  304 (367)
T ss_dssp             ---SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT--TCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ---CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCC--CCCHHHHHHHHHHccCChhHCCCHHH
Confidence               11111111110                          000011111111  12357899999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      +++|.+...
T Consensus       305 ~l~hp~f~~  313 (367)
T 1cm8_A          305 ALAHPYFES  313 (367)
T ss_dssp             HHHSGGGTT
T ss_pred             HhcChHHHh
Confidence            999988654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.3e-43  Score=341.39  Aligned_cols=257  Identities=29%  Similarity=0.418  Sum_probs=198.6

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCC-----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ...+.||+|+||.||+|+.+++.||||++....     .......+|+.++..++||||+++++++.+...    .++||
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~  109 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD----LCLVY  109 (307)
T ss_dssp             TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEE
T ss_pred             ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc----eEEEE
Confidence            345899999999999999999999999986432     223456789999999999999999999987653    48999


Q ss_pred             hhccCCChhhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        190 AYHERGSLCDFLK----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       190 e~~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ||+++|+|.+++.    ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~i~H~dlkp~Nili~~~~~~kl~Dfg  178 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-----------HHIHRDIKSANILLDEAFTAKISDFG  178 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999999999985    34599999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++...............||+.|+|||++.+      .++.++||||||+++|||++|..||.           ......
T Consensus       179 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~-----------~~~~~~  241 (307)
T 2nru_A          179 LARASEKFAQTVMTSRIVGTTAYMAPEALRG------EITPKSDIYSFGVVLLEIITGLPAVD-----------EHREPQ  241 (307)
T ss_dssp             TCEECCSCSSCEECSSCCSCGGGCCHHHHTT------EECTHHHHHHHHHHHHHHHHCCCSBC-----------TTBSSS
T ss_pred             cccccccccccccccccCCCcCcCChHHhcC------CCCccchhHHHHHHHHHHHHCCCCcc-----------cCcchH
Confidence            9987654332222344579999999998865      35678999999999999999955443           221111


Q ss_pred             CCHHHHHHHHhccC------CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKK------LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ....+...+....      ....++..  ....+..+.+++.+||+.||++|||+.+++++|..+.
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          242 -LLLDIKEEIEDEEKTIEDYIDKKMNDA--DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             -BTTHHHHHHHTTSCCHHHHSCSSCSCC--CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             -HHHHHHHHhhhhhhhhhhhcccccccc--chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             1112222111110      01111111  1224468999999999999999999999999987654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-43  Score=349.39  Aligned_cols=271  Identities=23%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...++|++.+.||+|+||.||+|++.  ++.||+|++.....  ......+|+.++..++||||+++++++.+..    .
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  105 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----E  105 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT----E
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC----E
Confidence            34578999999999999999999995  78899999875432  2345578999999999999999999998765    4


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++||||+++|+|.++++. ..+++..+..++.|++.||.|||+..          +|+||||||+|||++.++.+||+|
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----------~i~H~dlkp~Nil~~~~~~~kl~D  175 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH----------KIMHRDVKPSNILVNSRGEIKLCD  175 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH----------CCCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC----------CEEcCCccHHHEEECCCCCEEEEE
Confidence            5999999999999999964 46999999999999999999999831          799999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||+++.....    ......||+.|+|||++.+     ..++.++||||||+++|||++|..||.......         
T Consensus       176 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  246 (360)
T 3eqc_A          176 FGVSGQLIDS----MANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  246 (360)
T ss_dssp             CCCCHHHHHH----C----CCCCTTCCHHHHTT-----CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred             CCCCcccccc----cccCCCCCCCeECHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence            9999765322    1234578999999999976     367789999999999999999976664321100         


Q ss_pred             -----CCC------------CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        335 -----RLP------------FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       335 -----~~p------------f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                           ..+            |...........+....+..... +..+.    ...+..+.+||.+||+.||++|||+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e  321 (360)
T 3eqc_A          247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQ  321 (360)
T ss_dssp             ---------------------------CCCHHHHHHHHHHSCC-CCCCT----TTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC-CCCCc----ccccHHHHHHHHHHhhcChhhCCCHHH
Confidence                 000            00000001112222233332221 22221    112347999999999999999999999


Q ss_pred             hhhhcHHHhh
Q psy17532        398 VVERGMLALC  407 (461)
Q Consensus       398 vl~~l~~~~~  407 (461)
                      +++|.+....
T Consensus       322 ll~hp~~~~~  331 (360)
T 3eqc_A          322 LMVHAFIKRS  331 (360)
T ss_dssp             HHTSHHHHHH
T ss_pred             HhhChHhhcc
Confidence            9999987664

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=339.87  Aligned_cols=256  Identities=18%  Similarity=0.300  Sum_probs=202.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC-----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .++|++.+.||+|+||.||+|..  +++.||||++....     .......+|+.++..++||||+++++++....  ..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~   81 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--KQ   81 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--CC
Confidence            46899999999999999999998  46789999996432     22345678999999999999999999986433  23


Q ss_pred             eeeeeehhccCCChhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        184 EFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      .+++||||+++| |.+++.   ...+++..+..++.|++.||.|||++           +|+||||||+|||++.++.+|
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-----------~i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-----------GIVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCCEE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCCcccEEEcCCCcEE
Confidence            569999999876 777663   45699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++................||..|+|||++.+.   ....+.++||||||+++|||++|           ..||..
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~l~~g-----------~~p~~~  215 (305)
T 2wtk_C          150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL---DTFSGFKVDIWSAGVTLYNITTG-----------LYPFEG  215 (305)
T ss_dssp             ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC---SCEESHHHHHHHHHHHHHHHHHS-----------SCSCCC
T ss_pred             eeccccccccCccccccccccCCCCCCCcChhhccCc---ccCCcchhhHHHHHHHHHHHHhC-----------CCCCCC
Confidence            9999999876543322223345789999999998753   12235689999999999999999           566654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .     ...+....+....  ..++..++     ..+.+||.+||+.||++|||+.++++|.+...
T Consensus       216 ~-----~~~~~~~~i~~~~--~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          216 D-----NIYKLFENIGKGS--YAIPGDCG-----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             S-----SHHHHHHHHHHCC--CCCCSSSC-----HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             c-----hHHHHHHHHhcCC--CCCCCccC-----HHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            3     3444444444432  23343333     37899999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.2e-43  Score=334.67  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=198.4

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .....++|++.+.||+|+||.||+|+..  ++.||||++.....    ......+|+..++.++||||+++++++.... 
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   84 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-   84 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-
Confidence            3445678999999999999999999984  78999999865322    1234568899999999999999999998755 


Q ss_pred             cceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+++||||+++++|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+
T Consensus        85 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~  150 (276)
T 2h6d_A           85 ---DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-----------MVVHRDLKPENVLLDAHMNA  150 (276)
T ss_dssp             ---EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH-----------CSSCCCCCGGGEEECTTSCE
T ss_pred             ---eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCccCCCChhhEEECCCCCE
Confidence               4599999999999999995 45699999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||++.......   ......||+.|+|||++.+.    ...+.++||||||+++|||++|           ..||.
T Consensus       151 ~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g-----------~~p~~  212 (276)
T 2h6d_A          151 KIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGR----LYAGPEVDIWSCGVILYALLCG-----------TLPFD  212 (276)
T ss_dssp             EECCCCGGGCCCC----------------CCTGGGTTS----CCCHHHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEeecccccccCCCc---ceecccCCccccCHHHHcCC----CCCCccchHHHHHHHHHHHHhC-----------CCCCC
Confidence            999999998765432   12345789999999998763    1234689999999999999999           56664


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ........+....  ..+|...+     ..+.++|.+||+.||++|||+.++++|.+...
T Consensus       213 ~~-----~~~~~~~~~~~~~--~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          213 DE-----HVPTLFKKIRGGV--FYIPEYLN-----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             CS-----SHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CC-----cHHHHHHHhhcCc--ccCchhcC-----HHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence            43     3444444444332  22333332     37899999999999999999999999987644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.2e-43  Score=334.73  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=200.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCC---------
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGE---------  179 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~---------  179 (461)
                      ..+|++.+.||+|+||.||+|++.  ++.||||++....   ...++|+.++.+++||||+++++++....         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            468999999999999999999994  7899999997543   34567888889999999999999875411         


Q ss_pred             ---ccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        180 ---SIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       180 ---~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                         .....+++||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~  155 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-----------KLINRDLKPSNIFL  155 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeccCCHHHEEE
Confidence               112356999999999999999953   4699999999999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      +.++.+||+|||+++......   ......||+.|+|||++.+     ..++.++||||||+++|||++|          
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~----------  217 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISS-----QDYGKEVDLYALGLILAELLHV----------  217 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHC-----SCCCTHHHHHHHHHHHHHHHSC----------
T ss_pred             cCCCCEEECcchhheeccccc---cccccCCcccccChhhhcc-----CCCcchhhhHHHHHHHHHHHhc----------
Confidence            999999999999998776543   2334578999999999876     3677899999999999999999          


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ..||...       ...........    ++..++     ..+.++|.+||+.||++|||+.+++++++.+..
T Consensus       218 -~~~~~~~-------~~~~~~~~~~~----~~~~~~-----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          218 -CDTAFET-------SKFFTDLRDGI----ISDIFD-----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -CSSHHHH-------HHHHHHHHTTC----CCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -CCcchhH-------HHHHHHhhccc----ccccCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence             4444321       22222222222    222222     378899999999999999999999999987664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5e-43  Score=344.24  Aligned_cols=264  Identities=21%  Similarity=0.291  Sum_probs=198.8

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      .....++|++.+.||+|+||.||+|+..  ++.||||++......   .....+|+.++.+++||||+++++++.+..  
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   97 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--   97 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--
Confidence            3456789999999999999999999995  788999998654332   233467899999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+++||||+++++|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus        98 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----------~ivH~dlkp~Nil~~~~~~~k  164 (331)
T 4aaa_A           98 --RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH-----------NIIHRDIKPENILVSQSGVVK  164 (331)
T ss_dssp             --EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTSCEE
T ss_pred             --EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEccCcChheEEEcCCCcEE
Confidence              4599999999999998864 45699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++......  .......||..|+|||++.+.    ..++.++||||||+++|||++|.           .||..
T Consensus       165 l~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~-----------~pf~~  227 (331)
T 4aaa_A          165 LCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGD----VKYGKAVDVWAIGCLVTEMFMGE-----------PLFPG  227 (331)
T ss_dssp             ECCCTTC--------------CCCCCTTCCHHHHTTC----TTCCTHHHHHHHHHHHHHHHHSS-----------CSCCC
T ss_pred             EEeCCCceeecCCc--cccCCCcCCccccCcccccCC----CCcchHHHHHHHHHHHHHHHhCC-----------CCCCC
Confidence            99999998765432  123345789999999998763    35678899999999999999994           45533


Q ss_pred             ccCCCCCHHHHHHHHhc--------------------cCCCCCCCch----hccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        341 EVGDHPSLEDMQEAVVH--------------------KKLRPTLPET----WKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~p~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      .     ...+....+..                    ....+.+...    ......+..+.+||.+||+.||++|||++
T Consensus       228 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  302 (331)
T 4aaa_A          228 D-----SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA  302 (331)
T ss_dssp             S-----SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred             C-----CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence            2     11111111100                    0000111000    00012345899999999999999999999


Q ss_pred             chhhhcHHHhh
Q psy17532        397 CVVERGMLALC  407 (461)
Q Consensus       397 evl~~l~~~~~  407 (461)
                      |+++|.+....
T Consensus       303 ell~hp~f~~~  313 (331)
T 4aaa_A          303 ELLHHDFFQMD  313 (331)
T ss_dssp             GGGGSHHHHGG
T ss_pred             HHhcCchhccC
Confidence            99999987553

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.5e-43  Score=345.70  Aligned_cols=265  Identities=23%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc---
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI---  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~---  181 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++......   .....+|+.++..++||||+++++++......   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            457999999999999999999998  4788999988544322   23456899999999999999999998775321   


Q ss_pred             -ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        182 -HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       182 -~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                       ...+++||||+++ +|.+.+..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN-----------KILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeCCCCCHHHEEEcCCCC
Confidence             2356999999985 78877754  4699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +||+|||+++.+......  .......||+.|+|||++.+.    ..++.++|||||||++|||++|..           
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~-----------  227 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE----RDYGPPIDLWGAGCIMAEMWTRSP-----------  227 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSSC-----------
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCC----CCCCcHhHHHHHHHHHHHHHhCCC-----------
Confidence            999999999876533211  223446789999999998753    356789999999999999999954           


Q ss_pred             CCccccCCCCCHHHHHHHHhc--cCCCCCCCchhc-----------------------cchhHHHHHHHHHHHccccHhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVH--KKLRPTLPETWK-----------------------QHAGMLALCDTMEECWDHDAEA  391 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~-----------------------~~~~~~~l~~li~~cl~~dP~~  391 (461)
                      ||...     ........+..  ....+.....+.                       ....+..+.+||.+||+.||++
T Consensus       228 pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  302 (351)
T 3mi9_A          228 IMQGN-----TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ  302 (351)
T ss_dssp             SCCCS-----SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGG
T ss_pred             CCCCC-----ChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhh
Confidence            44332     22222222211  111111111100                       0001346889999999999999


Q ss_pred             hccccchhhhcHHHh
Q psy17532        392 RLSASCVVERGMLAL  406 (461)
Q Consensus       392 Rps~~evl~~l~~~~  406 (461)
                      |||++|+++|.+...
T Consensus       303 R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          303 RIDSDDALNHDFFWS  317 (351)
T ss_dssp             SCCHHHHHTSGGGGS
T ss_pred             CCCHHHHhCCCCcCC
Confidence            999999999987643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.9e-43  Score=338.57  Aligned_cols=258  Identities=22%  Similarity=0.304  Sum_probs=203.9

Q ss_pred             CccCCcceeEEe-EeecCCceEEEEEEEC----CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        107 PQQGCRSIQLVE-VKAQGRFGAVWKAKFK----NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       107 ~~~~~~~~~~~~-~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      .....++|++.+ .||+|+||.||+|.+.    ++.||||++.....   ......+|+.++..++||||+++++++...
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   90 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE   90 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCC
Confidence            345567899998 9999999999999762    46799999865432   234567899999999999999999998432


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                           .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++
T Consensus        91 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           91 -----SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-----------NFVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             -----SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEEETT
T ss_pred             -----CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC-----------CeEcCCCCcceEEEeCCC
Confidence                 35899999999999999964 4599999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYR  335 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~  335 (461)
                      .+||+|||+++......... ......++..|+|||++.+.     .++.++||||||+++|||++ |           .
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g-----------~  218 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-----KFSSKSDVWSFGVLMWEAFSYG-----------Q  218 (291)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTT-----------C
T ss_pred             cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-----CCChhhhHHHHHHHHHHHHhcC-----------C
Confidence            99999999998775443211 12234567899999998753     46678999999999999999 8           6


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .||...     ...++...+.. ..++..+..++     ..+.++|.+||+.||++|||+.++++.+..+..
T Consensus       219 ~p~~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          219 KPYRGM-----KGSEVTAMLEK-GERMGCPAGCP-----REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             CSSTTC-----CHHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCC-----CHHHHHHHHHc-CCCCCCCCCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            666543     33444444433 33444554433     389999999999999999999999999877664

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.6e-43  Score=336.22  Aligned_cols=261  Identities=20%  Similarity=0.321  Sum_probs=188.7

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh--hHH-HHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS--WQS-EQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~-~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....++|++.+.||+|+||.||+|+.  +++.||||++.......  ... ..+...++.++||||+++++++.+..   
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~---   79 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG---   79 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC---
Confidence            34567999999999999999999998  57889999986543222  122 23444578889999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        183 TEFWLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                       ..++||||++ |+|.+++.     ...+++..+..++.|++.||.|||++.          +|+||||||+|||++.++
T Consensus        80 -~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----------~i~H~dlkp~Nil~~~~~  147 (290)
T 3fme_A           80 -DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL----------SVIHRDVKPSNVLINALG  147 (290)
T ss_dssp             -SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS----------CCCCCCCSGGGCEECTTC
T ss_pred             -CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC----------CeecCCCCHHHEEECCCC
Confidence             3589999997 58888774     357999999999999999999999852          899999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+++......   ......||+.|+|||++.... ....++.++||||||+++|||++|           ..|
T Consensus       148 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g-----------~~p  212 (290)
T 3fme_A          148 QVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPEL-NQKGYSVKSDIWSLGITMIELAIL-----------RFP  212 (290)
T ss_dssp             CEEBCCC------------------CCCCCCSCHHHHSCCT-TC--CCHHHHHHHHHHHHHHHHHT-----------SCS
T ss_pred             CEEEeecCCcccccccc---cccccCCCccccChhhcChhh-cCcCCCcHHHHHHHHHHHHHHHHC-----------CCC
Confidence            99999999998765432   223347899999999974221 124677899999999999999999           555


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |...   . ..................+..+     +..+.+||.+||+.||++|||+.++++|.+....
T Consensus       213 ~~~~---~-~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          213 YDSW---G-TPFQQLKQVVEEPSPQLPADKF-----SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             SCCC---S-CHHHHHHHHHHSCCCCCCTTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccc---C-chHHHHHHHhccCCCCcccccC-----CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            5432   1 2222222222322222222222     3479999999999999999999999999987653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=353.15  Aligned_cols=264  Identities=15%  Similarity=0.149  Sum_probs=194.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCChh------------hhHHHHHHHHcCCCCCCCeeEEE
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDKQ------------SWQSEQEIFKLPHMEHDNILRYI  172 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~------------~~~~~~ei~~l~~l~H~nIv~l~  172 (461)
                      ..++|++.+.||+|+||.||+|+..     +..||||++......            .....+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            4578999999999999999999994     467999998754321            11234677778899999999999


Q ss_pred             EEEecCCccceeeeeeehhccCCChhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcE
Q psy17532        173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       173 g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                      +++.........+++||||+ +|+|.+++... .+++..++.++.||+.||+|||+.           +|+||||||+||
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dlkp~NI  182 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-----------EYVHGDIKAANL  182 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeCCCcCHHHE
Confidence            99877432234679999999 89999999643 799999999999999999999999           999999999999


Q ss_pred             EEcCCC--ceEEEecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCC
Q psy17532        252 LLKSDL--TAAIADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC  324 (461)
Q Consensus       252 Ll~~~~--~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~  324 (461)
                      |++.++  .+||+|||+++.+......     .......||..|+|||++.+.     .++.++|||||||++|||++| 
T Consensus       183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~g-  256 (345)
T 2v62_A          183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-----ALSRRSDVEILGYCMLRWLCG-  256 (345)
T ss_dssp             EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-----CCCHHHHHHHHHHHHHHHHHS-
T ss_pred             EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhC-
Confidence            999887  9999999999876533211     112345799999999998763     677899999999999999999 


Q ss_pred             CCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhc----cchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWK----QHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       325 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                                ..||.....   .........  ......++....    ....+..+.++|.+||..||++|||+.++++
T Consensus       257 ----------~~pf~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          257 ----------KLPWEQNLK---DPVAVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             ----------SCTTGGGTT---CHHHHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----------CCCcccccc---ccHHHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                      666644321   111111111  111112222111    0123458999999999999999999999999


Q ss_pred             hcHHHh
Q psy17532        401 RGMLAL  406 (461)
Q Consensus       401 ~l~~~~  406 (461)
                      .|..+.
T Consensus       322 ~L~~~~  327 (345)
T 2v62_A          322 ILNPHG  327 (345)
T ss_dssp             HHCTTC
T ss_pred             HHhccC
Confidence            886544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.3e-43  Score=340.39  Aligned_cols=251  Identities=21%  Similarity=0.283  Sum_probs=203.1

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++..... .....++|+.++..++||||+++++++.+..    .+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   83 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT----HYYL   83 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC----EEEE
Confidence            46899999999999999999998  478899999975432 2334578899999999999999999998765    4599


Q ss_pred             eehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCCCceEEEe
Q psy17532        188 ITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~~~~ki~D  263 (461)
                      ||||+++|+|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||+   +.++.+||+|
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN-----------GIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCCHHHEEEecCCCCCCEEEcc
Confidence            999999999999884 45689999999999999999999999           99999999999999   7789999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....    ......||+.|+|||++.+     ..++.++||||||+++|||++|           ..||...  
T Consensus       153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g-----------~~pf~~~--  210 (304)
T 2jam_A          153 FGLSKMEQNG----IMSTACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVITYILLCG-----------YPPFYEE--  210 (304)
T ss_dssp             CSTTCCCCCB----TTHHHHSCCCBCCTTTBSS-----CSCCHHHHHHHHHHHHHHHHHS-----------SCTTTTS--
T ss_pred             CCcceecCCC----ccccccCCCCccChHHhcc-----CCCCchhhHHHHHHHHHHHHHC-----------CCCCCCC--
Confidence            9999764432    1233468999999999876     3677899999999999999999           5566443  


Q ss_pred             CCCCHHHHHHHHhccCCCCC--CCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPT--LPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         ....+...+........  .+..     .+..+.+||.+||..||++|||+.++++|.+...
T Consensus       211 ---~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          211 ---TESKLFEKIKEGYYEFESPFWDD-----ISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             ---CHHHHHHHHHHCCCCCCTTTTTT-----SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             ---CHHHHHHHHHcCCCCCCcccccc-----CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence               34445555544433221  1122     2347999999999999999999999999988654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5e-43  Score=349.11  Aligned_cols=256  Identities=23%  Similarity=0.398  Sum_probs=205.1

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh---------hhHHHHHHHHcCCC-CCCCeeEEEEEEecCC
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ---------SWQSEQEIFKLPHM-EHDNILRYIGAEKRGE  179 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---------~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~  179 (461)
                      .+|++.+.||+|+||.||+|+..  |+.||||++......         .....+|+.++.++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            57999999999999999999984  789999998754311         22345788888888 8999999999998754


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                          ..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.
T Consensus       174 ----~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          174 ----FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN-----------NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTCC
T ss_pred             ----EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEECCCCC
Confidence                45999999999999999954 4699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      +||+|||++..+....   ......||+.|+|||++.+... ....++.++|||||||++|||++|           ..|
T Consensus       239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g-----------~~p  304 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG-----------SPP  304 (365)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS-----------SCS
T ss_pred             EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC-----------CCC
Confidence            9999999998876543   2344679999999999865321 123577899999999999999999           566


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |...     ........+.........+ .|.  ..+..+.+||.+||+.||++|||+.++++|.+.
T Consensus       305 f~~~-----~~~~~~~~i~~~~~~~~~~-~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          305 FWHR-----RQILMLRMIMEGQYQFSSP-EWD--DRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             SCCS-----SHHHHHHHHHHTCCCCCHH-HHS--SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCCC-----CHHHHHHHHHhCCCCCCCc-ccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            6443     3344444444443332221 121  133479999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=355.47  Aligned_cols=272  Identities=19%  Similarity=0.266  Sum_probs=207.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..+.|++.+.||+|+||.||+|++.  ++.||||++.....  ......+|+.++.+++||||+++++++.....  ..+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT--RHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT--CCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC--Cee
Confidence            3568999999999999999999995  78899999975332  22345678989999999999999999887552  255


Q ss_pred             eeeehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE----cCCC
Q psy17532        186 WLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL----KSDL  257 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl----~~~~  257 (461)
                      ++||||+++|+|.++++..    .+++..+..++.||+.||+|||+.           +|+||||||+|||+    +.++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dlkp~NIll~~~~~~~~  153 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-----------GIVHRNIKPGNIMRVIGEDGQS  153 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEEEECTTSCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEECCcCHHHEEEeecCCCce
Confidence            8999999999999999653    299999999999999999999999           99999999999999    7788


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINF---SRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      .+||+|||+++......   ......||..|+|||++.+....   ...++.++|||||||++|||++|           
T Consensus       154 ~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg-----------  219 (396)
T 4eut_A          154 VYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG-----------  219 (396)
T ss_dssp             EEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS-----------
T ss_pred             eEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC-----------
Confidence            89999999998775433   23345799999999998642110   02456789999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCC-----------------CCCchhc-cchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRP-----------------TLPETWK-QHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~p~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      ..||.......... +....+..+....                 .++.... .......+.+++.+||+.||++|||+.
T Consensus       220 ~~Pf~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          220 SLPFRPFEGPRRNK-EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             SCSEECTTCTTTCH-HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             CCCCCCCCcccchH-HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence            55554433222233 3333333322111                 0111000 122456889999999999999999999


Q ss_pred             chhhhcHHHhhhh
Q psy17532        397 CVVERGMLALCDT  409 (461)
Q Consensus       397 evl~~l~~~~~~~  409 (461)
                      ++++.+..+....
T Consensus       299 e~l~~l~~il~~~  311 (396)
T 4eut_A          299 QFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHHHHTCE
T ss_pred             HHHHHHHHHhhce
Confidence            9999998876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.7e-43  Score=335.61  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=201.4

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ++|++.+.||+|+||.||+|+..  ++.||||.+.....       .....++|+.++.+++||||+++++++.+..   
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT---   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC---
Confidence            57999999999999999999994  78999999875432       2345678999999999999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC----
Q psy17532        183 TEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL----  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~----  257 (461)
                       .+++||||+++++|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++    
T Consensus        82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           82 -DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK-----------RIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEESCSSSSSC
T ss_pred             -eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCCCCChHHEEEecCCCCCC
Confidence             4599999999999999995 45699999999999999999999999           999999999999998877    


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||++........   .....||+.|+|||++.+     ..++.++||||||+++|||++|           ..|
T Consensus       150 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g-----------~~p  210 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSG-----------ASP  210 (283)
T ss_dssp             CEEECCCTTCEECC-----------CCCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------SCT
T ss_pred             ceEEEecccceeccCCCc---ccccCCCcCccCcceecC-----CCCCcchhhhhHHHHHHHHHHC-----------CCC
Confidence            899999999987654321   234568999999999875     3677899999999999999999           556


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |...     ...+....+.....  ..+.... ...+..+.+|+.+||..||++|||+.++++|.+....
T Consensus       211 ~~~~-----~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          211 FLGE-----TKQETLTNISAVNY--DFDEEYF-SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             TCCS-----SHHHHHHHHHTTCC--CCCHHHH-TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CCCc-----chHHHHHHhHhccc--CCcchhc-ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            6443     33333333333222  1221111 1133478999999999999999999999999876553

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-43  Score=337.31  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=202.1

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CC---cEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NE---NVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      -.|++.+.||+|+||.||+|++.  +.   .||+|.+.....  ......+|+.+++.++||||+++++++.+.+.   .
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~   97 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG---L   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---C
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC---C
Confidence            35677899999999999999972  22   699999865333  23445688999999999999999999976543   2


Q ss_pred             eeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .++||||+.+|+|.+++..  ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ-----------KFVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECTTCCEEEC
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCcceEEEcCCCcEEeC
Confidence            3799999999999999965  5689999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCC--CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        263 DFGLALLFEPGKP--CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       263 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |||+++.......  ........+|..|+|||.+.+     ..++.++||||||+++|||++|+.|          ||..
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~~----------~~~~  231 (298)
T 3pls_A          167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-----YRFTTKSDVWSFGVLLWELLTRGAP----------PYRH  231 (298)
T ss_dssp             CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHTSCC----------TTTT
T ss_pred             cCCCcccccCCcccccccCcCCCCCccccChhhhcc-----CCCChhhchhhHHHHHHHHhhCCCC----------CCcc
Confidence            9999986644321  122334568899999999976     3677899999999999999997432          3322


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      .     ...++...+... .....+..++     ..+.+++.+||+.||++|||+.++++.+..+...
T Consensus       232 ~-----~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          232 I-----DPFDLTHFLAQG-RRLPQPEYCP-----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             S-----CGGGHHHHHHTT-CCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----CHHHHHHHhhcC-CCCCCCccch-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            2     223333333332 2333444333     3799999999999999999999999999887653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.4e-43  Score=349.29  Aligned_cols=264  Identities=21%  Similarity=0.289  Sum_probs=202.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-cceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~  185 (461)
                      ..+|++.+.||+|+||.||+|+.  +++.||||++......  .....+|+.++.+++||||+++++++..... ....+
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            35899999999999999999998  4678999998743322  2445689999999999999999999876532 12356


Q ss_pred             eeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        186 WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++||||+. |+|.++++...+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|||
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-----------NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCChHhEEECCCCCEEEEeCc
Confidence            89999997 5999999888899999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        266 LALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       266 la~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      +++......... ......||+.|+|||++.+.    ..++.++|||||||++|||++|..|           |...   
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~p-----------f~~~---  235 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNS----KGYTKSIDIWSVGCILAEMLSNRPI-----------FPGK---  235 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB----CSCSTHHHHHHHHHHHHHHHHSSCS-----------SCCS---
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCC----CCCCcchhHHHHHHHHHHHHHCCCC-----------CCCC---
Confidence            998765432211 13445899999999987653    3577899999999999999999544           4332   


Q ss_pred             CCCHHHHHHHHh------------------------ccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        345 HPSLEDMQEAVV------------------------HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       345 ~~~~~~~~~~~~------------------------~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                        ...+....+.                        ........+..-.....+..+.+||.+||+.||++|||+.++++
T Consensus       236 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          236 --HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             --SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              1111111111                        00000111100000112347899999999999999999999999


Q ss_pred             hcHHHh
Q psy17532        401 RGMLAL  406 (461)
Q Consensus       401 ~l~~~~  406 (461)
                      |.+...
T Consensus       314 hp~~~~  319 (364)
T 3qyz_A          314 HPYLEQ  319 (364)
T ss_dssp             SGGGTT
T ss_pred             Ccchhh
Confidence            998654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8e-43  Score=339.57  Aligned_cols=257  Identities=21%  Similarity=0.269  Sum_probs=192.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ....++|++.+.||+|+||.||+|+.  +++.||||++......    .....+|+.++.+++||||+++++++....  
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--  107 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--  107 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--
Confidence            34567899999999999999999998  4778999998644322    244568999999999999999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        .+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus       108 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          108 --QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA-----------GATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             --EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTSCEE
T ss_pred             --eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------cCCcCCCChHHEEEcCCCCEE
Confidence              45899999999999999964 5699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||++........ .......||..|+|||++.+.     .++.++||||||+++|||++|           ..||..
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~pf~~  237 (309)
T 2h34_A          175 LVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSES-----HATYRADIYALTCVLYECLTG-----------SPPYQG  237 (309)
T ss_dssp             ECSCCC-----------------CCGGGCCGGGTCC---------CCCHHHHHHHHHHHHHHS-----------SCSSCS
T ss_pred             EecCccCcccccccc-ccccccCCCcCccCHHHHcCC-----CCCchHhHHHHHHHHHHHHHC-----------CCCCCC
Confidence            999999987654321 123345789999999998763     567889999999999999999           666654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCC-CCCchhccchhHHHHHHHHHHHccccHhhhc-cccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRP-TLPETWKQHAGMLALCDTMEECWDHDAEARL-SASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~~~~  406 (461)
                      .     ....+...+......+ ..+..+     +..+.++|.+||+.||++|| +++++++.+....
T Consensus       238 ~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          238 D-----QLSVMGAHINQAIPRPSTVRPGI-----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             C-----HHHHHHHHHHSCCCCGGGTSTTC-----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             c-----hHHHHHHHhccCCCCccccCCCC-----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            3     2222222222211111 112222     23789999999999999999 8999888876544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-42  Score=335.24  Aligned_cols=262  Identities=21%  Similarity=0.323  Sum_probs=207.1

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----------hhhHHHHHHHHcCCCC-CCCeeEEEEE
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----------QSWQSEQEIFKLPHME-HDNILRYIGA  174 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----------~~~~~~~ei~~l~~l~-H~nIv~l~g~  174 (461)
                      ..-.++|++.+.||+|+||.||+|+.  +++.||||++.....          ......+|+.++.++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34467999999999999999999999  467899999975431          1223457888888885 9999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      +....    .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||+
T Consensus        93 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~  157 (298)
T 1phk_A           93 YETNT----FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL-----------NIVHRDLKPENILL  157 (298)
T ss_dssp             EECSS----EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEE
T ss_pred             eccCC----eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCcceEEE
Confidence            98754    45999999999999999964 4699999999999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPG  332 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~  332 (461)
                      +.++.+||+|||++.......   ......||..|+|||++.+... ....++.++||||||+++|||++|         
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g---------  225 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG---------  225 (298)
T ss_dssp             CTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS---------
T ss_pred             cCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC---------
Confidence            999999999999998776443   2334578999999999863211 123567899999999999999999         


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ..||...     ........+.........+. +.  ..+..+.+||.+||+.||++|||+.++++|.+...
T Consensus       226 --~~p~~~~-----~~~~~~~~~~~~~~~~~~~~-~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (298)
T 1phk_A          226 --SPPFWHR-----KQMLMLRMIMSGNYQFGSPE-WD--DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  289 (298)
T ss_dssp             --SCSSCCS-----SHHHHHHHHHHTCCCCCTTT-GG--GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             --CCCCcCc-----cHHHHHHHHhcCCcccCccc-cc--ccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence              5666433     33444455544443332221 11  13347999999999999999999999999987543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.2e-43  Score=373.05  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             CcceeEE-eEeecCCceEEEEEEEC----CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        111 CRSIQLV-EVKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       111 ~~~~~~~-~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...+.+. +.||+|+||.||+|.+.    ++.||||+++.....   ...+.+|+.++.+++|||||++++++...    
T Consensus       367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  442 (635)
T 4fl3_A          367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE----  442 (635)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred             chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            3445554 48999999999999762    467999999754322   34567899999999999999999998653    


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+++||||+++|+|.++++. ..+++..+..++.||+.||+|||+.           +|+||||||+||||+.++.+||
T Consensus       443 -~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~-----------~iiHrDLkp~NILl~~~~~~kL  510 (635)
T 4fl3_A          443 -SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-----------NFVHRDLAARNVLLVTQHYAKI  510 (635)
T ss_dssp             -SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEEEETTEEEE
T ss_pred             -CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeCCCCChHhEEEeCCCCEEE
Confidence             24899999999999999964 4699999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCc
Q psy17532        262 ADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       262 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~  339 (461)
                      +|||+++.+...... .......+|+.|+|||++.+     ..++.++|||||||++|||++ |           ..||.
T Consensus       511 ~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G-----------~~Pf~  574 (635)
T 4fl3_A          511 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYG-----------QKPYR  574 (635)
T ss_dssp             CCTTHHHHTTC-------------CGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTT-----------CCSST
T ss_pred             EEcCCccccccCccccccccCCCCceeeeChhhhcC-----CCCCcHHHHHHHHHHHHHHHhCC-----------CCCCC
Confidence            999999887654321 12333457889999999965     367889999999999999998 8           66775


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..     ...++...+.. ..+...|..++     .++.+||.+||+.||++|||+.++++.|..+.
T Consensus       575 ~~-----~~~~~~~~i~~-~~~~~~p~~~~-----~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          575 GM-----KGSEVTAMLEK-GERMGCPAGCP-----REMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             TC-----CHHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CC-----CHHHHHHHHHc-CCCCCCCCCCC-----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            54     44455444443 34555565544     38999999999999999999999999987654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-43  Score=348.76  Aligned_cols=259  Identities=28%  Similarity=0.330  Sum_probs=194.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..++|++.+.||+|+||.||+|+..  ++.||||++......      .....+|+.++..++||||+++++++.+... 
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc-
Confidence            4578999999999999999999984  788999998643221      2345688999999999999999999987653 


Q ss_pred             ceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         +++||||+++ +|.+++...  .+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+
T Consensus        87 ---~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           87 ---ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-----------WILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             ---CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTCCE
T ss_pred             ---eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC-----------CEECCCCCHHHEEEcCCCCE
Confidence               4899999986 899988654  589999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++.+....  .......||+.|+|||++.+.    ..++.++|||||||++|||++|.           .||.
T Consensus       152 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~-----------~~~~  214 (346)
T 1ua2_A          152 KLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGA----RMYGVGVDMWAVGCILAELLLRV-----------PFLP  214 (346)
T ss_dssp             EECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTC----SCCCHHHHHHHHHHHHHHHHHSS-----------CSSC
T ss_pred             EEEecccceeccCCc--ccCCcccccccccCchHhhCC----CCCCchhhhHhHHHHHHHHHHCC-----------CCCC
Confidence            999999998765432  223446789999999998653    34678899999999999999994           4443


Q ss_pred             cccCCCCCHHHHHHHHhccCCC---------------------CCCCchhccchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLR---------------------PTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      ..     ...+....+......                     +..+........+..+.+||.+||..||++|||+.|+
T Consensus       215 ~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  289 (346)
T 1ua2_A          215 GD-----SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  289 (346)
T ss_dssp             CS-----SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             CC-----CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            32     222222222111000                     0001000001233589999999999999999999999


Q ss_pred             hhhcHHHh
Q psy17532        399 VERGMLAL  406 (461)
Q Consensus       399 l~~l~~~~  406 (461)
                      ++|.+...
T Consensus       290 l~h~~f~~  297 (346)
T 1ua2_A          290 LKMKYFSN  297 (346)
T ss_dssp             HTSGGGTS
T ss_pred             hcChhhhc
Confidence            99998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-43  Score=345.45  Aligned_cols=277  Identities=22%  Similarity=0.234  Sum_probs=197.0

Q ss_pred             CcceeEE-eEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCC-CCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLV-EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPH-MEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~-l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .+.|++. +.||+|+||.||+|+.  +++.||||++...... .....+|+.++.+ ++||||+++++++.+.+    .+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~----~~   86 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED----RF   86 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC----EE
Confidence            3578885 7899999999999997  5788999999754332 3455678888777 47999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc---eEE
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT---AAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~---~ki  261 (461)
                      ++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.   +||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~dlkp~Nil~~~~~~~~~~kl  155 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK-----------GIAHRDLKPENILCEHPNQVSPVKI  155 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CceeCCCCHHHEEEccCCCcCceEE
Confidence            999999999999999954 5699999999999999999999999           9999999999999998765   999


Q ss_pred             EecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        262 ADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       262 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +|||+++........     .......||+.|+|||++.+.......++.++|||||||++|||++|..||....... .
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~  234 (316)
T 2ac3_A          156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-C  234 (316)
T ss_dssp             CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC-S
T ss_pred             EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc-c
Confidence            999999766432211     1122346999999999986421111246788999999999999999966664332211 0


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .|............+...+.....  .++.... ...+..+.+||.+||+.||++|||+.++++|.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          235 GWDRGEACPACQNMLFESIQEGKY--EFPDKDW-AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             CC----CCHHHHHHHHHHHHHCCC--CCCHHHH-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             cccccccchhHHHHHHHHHhccCc--ccCchhc-ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence            011000000001223334433332  2222110 113347999999999999999999999999987543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.4e-43  Score=345.48  Aligned_cols=258  Identities=18%  Similarity=0.287  Sum_probs=204.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhh------------------hHHHHHHHHcCCCCCCCeeE
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQS------------------WQSEQEIFKLPHMEHDNILR  170 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~------------------~~~~~ei~~l~~l~H~nIv~  170 (461)
                      ...++|++.+.||+|+||.||+|+.+++.||||.+.......                  ....+|+.++.+++||||++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            345799999999999999999999999999999986432211                  56678999999999999999


Q ss_pred             EEEEEecCCccceeeeeeehhccCCChhhh------hcC---CCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCC
Q psy17532        171 YIGAEKRGESIHTEFWLITAYHERGSLCDF------LKC---NIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPA  240 (461)
Q Consensus       171 l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~---~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~  240 (461)
                      +++++.+.+    .+++||||+++|+|.++      +..   ..+++..+..++.|++.||.|||+ .           +
T Consensus       108 ~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----------~  172 (348)
T 2pml_X          108 CEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-----------N  172 (348)
T ss_dssp             CSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-----------C
T ss_pred             EEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-----------C
Confidence            999998765    45999999999999999      643   569999999999999999999998 7           9


Q ss_pred             eecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCC-ccchHHHHHHHHH
Q psy17532        241 VAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFL-RIDMYACALVLWE  319 (461)
Q Consensus       241 ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~-k~DVwS~Gvil~e  319 (461)
                      |+||||||+|||++.++.+||+|||++......    ......||..|+|||++.+.    ..++. ++||||||+++||
T Consensus       173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~----~~~~~~~~Di~slG~il~~  244 (348)
T 2pml_X          173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE----SSYNGAKVDIWSLGICLYV  244 (348)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC----CCEEHHHHHHHHHHHHHHH
T ss_pred             EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC----CCCCcchhhHHHHHHHHHH
Confidence            999999999999999999999999999876443    23345789999999999763    13434 8999999999999


Q ss_pred             HHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchh--------------ccchhHHHHHHHHHHHc
Q psy17532        320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETW--------------KQHAGMLALCDTMEECW  385 (461)
Q Consensus       320 l~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--------------~~~~~~~~l~~li~~cl  385 (461)
                      |++|           ..||....    ...+....+......  ++...              .....+..+.+||.+||
T Consensus       245 l~~g-----------~~pf~~~~----~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  307 (348)
T 2pml_X          245 MFYN-----------VVPFSLKI----SLVELFNNIRTKNIE--YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL  307 (348)
T ss_dssp             HHHS-----------SCSSCCSS----CSHHHHHHHTSCCCC--CCCSSSSSTTTTCC--------CCCHHHHHHHHHHC
T ss_pred             HHhC-----------CCCCCCCC----cHHHHHHHHhccCcC--CccchhhhhccccccccccchhhcCHHHHHHHHHHc
Confidence            9999           45554321    113334444333221  12100              00123358999999999


Q ss_pred             cccHhhhccccchhhhcHHHh
Q psy17532        386 DHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       386 ~~dP~~Rps~~evl~~l~~~~  406 (461)
                      +.||++|||+.++++|.+...
T Consensus       308 ~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          308 RKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             CSSGGGSCCHHHHHTSGGGTT
T ss_pred             cCChhhCCCHHHHhcCccccC
Confidence            999999999999999987543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=337.83  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ...+.|++.+.||+|+||.||+|+..  ++.||||.+.... ......+|+.++..++||||+++++++....    .++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT----DLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC----EEE
Confidence            44578999999999999999999985  7889999987543 2345678899999999999999999998755    459


Q ss_pred             eeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++|+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM-----------RKIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CCcCCCcCHHHEEECCCCCEEEeec
Confidence            9999999999999985  56799999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++.......  .......||..|+|||++.+.     .++.++||||||+++|||++|           ..||...   
T Consensus       170 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g-----------~~p~~~~---  228 (314)
T 3com_A          170 GVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEI-----GYNCVADIWSLGITAIEMAEG-----------KPPYADI---  228 (314)
T ss_dssp             TTCEECBTTB--SCBCCCCSCGGGCCHHHHSSS-----CBCTTHHHHHHHHHHHHHHHS-----------SCTTTTS---
T ss_pred             ccchhhhhhc--cccCccCCCCCccChhhcCCC-----CCCccccHHHHHHHHHHHHhC-----------CCCCCCC---
Confidence            9998765432  223345789999999998763     577899999999999999999           5566432   


Q ss_pred             CCCHHHHHHHHhcc-CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHK-KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ........+... ......+..+     +..+.+||.+||+.||++|||+.++++|.+...
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          229 --HPMRAIFMIPTNPPPTFRKPELW-----SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             --CHHHHHHHHHHSCCCCCSSGGGS-----CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             --ChHHHHHHHhcCCCcccCCcccC-----CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence              222222222111 1111222333     247999999999999999999999999987654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=342.10  Aligned_cols=272  Identities=25%  Similarity=0.361  Sum_probs=205.5

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE------CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF------KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ....++|++.+.||+|+||.||+|++      +++.||||++..... .....++|+.++.+++||||+++++++.....
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            44567899999999999999999995      467899999875433 23456789999999999999999999876441


Q ss_pred             cceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                        ..+++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.
T Consensus       117 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dikp~NIli~~~~~  183 (326)
T 2w1i_A          117 --RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK-----------RYIHRDLATRNILVENENR  183 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEEEETTE
T ss_pred             --CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeccCCCcceEEEcCCCc
Confidence              245899999999999999964  3599999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      +||+|||+++......... ......++..|+|||++.+.     .++.++||||||+++|||++|..|+......    
T Consensus       184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~tg~~~~~~~~~~----  254 (326)
T 2w1i_A          184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-----KFSVASDVWSFGVVLYELFTYIEKSKSPPAE----  254 (326)
T ss_dssp             EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----
T ss_pred             EEEecCcchhhccccccccccccCCCCceeEECchhhcCC-----CCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----
Confidence            9999999998876443211 12334677889999998763     4667899999999999999995443211000    


Q ss_pred             CccccCCCCC----HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPS----LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~----~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |....+....    ...+.+. .....+...+..++     ..+.+||.+||+.||++|||+.++++.+..+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          255 FMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCP-----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHCTTCCTHHHHHHHHHH-HHTTCCCCCCTTCC-----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhccccchhhhHHHHHHH-hhcCCCCCCCCccc-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0000011111    1111222 22333344444433     389999999999999999999999999877654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-42  Score=352.14  Aligned_cols=258  Identities=22%  Similarity=0.289  Sum_probs=194.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~~  186 (461)
                      ..+|++.+.||+|+||.||+|++  +++.||||++.....   ...+|+.+++.++|||||++++++.....  ....++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            45799999999999999999999  478899999864322   23468888999999999999998864321  122357


Q ss_pred             eeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-CceE
Q psy17532        187 LITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAA  260 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-~~~k  260 (461)
                      +||||+++ +|.+++.     ...+++..+..++.||+.||+|||+.           +|+||||||+|||++.+ +.+|
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-----------GICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-----------TEECSCCSGGGEEEETTTTEEE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccccCCChhhEEEeCCCCeEE
Confidence            99999986 6766653     35799999999999999999999998           99999999999999965 6789


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+++.+.....   .....||+.|+|||++.+.    ..++.++|||||||++|||++|           +.||.+
T Consensus       198 l~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~G-----------~~pf~~  259 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGA----TDYTSSIDVWSAGCVLAELLLG-----------QPIFPG  259 (420)
T ss_dssp             ECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHS-----------SCSSCC
T ss_pred             eccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCC----CCCCchhhhHHHHHHHHHHHhC-----------CCCCCC
Confidence            999999987654432   3345789999999998753    3677899999999999999999           555543


Q ss_pred             ccCCCCCHHHHHHHHhc--------------cC-CCCCCCc----hhcc---chhHHHHHHHHHHHccccHhhhccccch
Q psy17532        341 EVGDHPSLEDMQEAVVH--------------KK-LRPTLPE----TWKQ---HAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~--------------~~-~~~~~p~----~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      .     ...+....+..              .. ....+|.    .|..   ...+.++.+||.+||..||++|||+.|+
T Consensus       260 ~-----~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~  334 (420)
T 1j1b_A          260 D-----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  334 (420)
T ss_dssp             S-----SHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             C-----CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence            2     11111111110              00 0111111    1110   1123579999999999999999999999


Q ss_pred             hhhcHHHh
Q psy17532        399 VERGMLAL  406 (461)
Q Consensus       399 l~~l~~~~  406 (461)
                      ++|.++..
T Consensus       335 l~hp~f~~  342 (420)
T 1j1b_A          335 CAHSFFDE  342 (420)
T ss_dssp             HTSGGGGG
T ss_pred             hCCHhhcc
Confidence            99998744

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=344.94  Aligned_cols=265  Identities=21%  Similarity=0.243  Sum_probs=201.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ...++|++.+.||+|+||.||+++.  +++.||||++..... ......+|+.++..++||||+++++++..........
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4567899999999999999999997  578899999865443 3344578899999999999999999987543334567


Q ss_pred             eeeehhccCCChhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLKC-----NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~dlkp~NIl~~~~~~~k  174 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-----------GYAHRDLKPTNILLGDEGQPV  174 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEEcCCCCEE
Confidence            999999999999999853     5699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCC-------CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPCG-------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      |+|||+++.........       ......||+.|+|||++.+..  ...++.++||||||+++|||++|          
T Consensus       175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g----------  242 (317)
T 2buj_A          175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS--HCVIDERTDVWSLGCVLYAMMFG----------  242 (317)
T ss_dssp             ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS--EEEECTHHHHHHHHHHHHHHHHS----------
T ss_pred             EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC--CcCCCchhhHHHHHHHHHHHHhC----------
Confidence            99999987653211000       001235789999999986531  12357899999999999999999          


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ..||...........   ..+ ........+..+     +..+.+||.+||+.||++|||+.++++++..+.
T Consensus       243 -~~p~~~~~~~~~~~~---~~~-~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          243 -EGPYDMVFQKGDSVA---LAV-QNQLSIPQSPRH-----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             -SCTTHHHHHTTSCHH---HHH-HCC--CCCCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             -CCChhhhhcccchhh---HHh-hccCCCCccccC-----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence             566643211111211   111 122222222222     247999999999999999999999999986544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7e-43  Score=355.40  Aligned_cols=192  Identities=25%  Similarity=0.304  Sum_probs=160.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCC------CCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPH------MEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~------l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...+|++.+.||+|+||.||+|+..  ++.||||++...........+|+.++..      .+|+||+++++++....  
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~--  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN--  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--
Confidence            4567999999999999999999984  6789999997654433444555554433      37889999999998765  


Q ss_pred             ceeeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        182 HTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                        .+++||||+. |+|.+++...   .+++..+..++.||+.||+|||+.           +|+||||||+|||++.++.
T Consensus       173 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlKp~NILl~~~~~  238 (429)
T 3kvw_A          173 --HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-----------RIIHCDLKPENILLKQQGR  238 (429)
T ss_dssp             --EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH-----------TEECSCCSGGGEEESSTTS
T ss_pred             --eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEEccCCC
Confidence              4599999996 6999998543   489999999999999999999999           9999999999999999887


Q ss_pred             --eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q psy17532        259 --AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV  327 (461)
Q Consensus       259 --~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~  327 (461)
                        +||+|||+|+.....     .....||+.|+|||++.+.     .++.++|||||||++|||++|.+||
T Consensus       239 ~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltG~~pf  299 (429)
T 3kvw_A          239 SGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGA-----RYGMPIDMWSLGCILAELLTGYPLL  299 (429)
T ss_dssp             CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTB-----CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cceEEeecccceecCCc-----ccccCCCCCccChHHHhCC-----CCCchHHHHhHHHHHHHHHhCCCCC
Confidence              999999999765432     3345789999999999763     6788999999999999999995544

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.4e-43  Score=342.06  Aligned_cols=271  Identities=21%  Similarity=0.241  Sum_probs=198.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++.....  ....+|+.++.+++ ||||+++++++.+...  ...+
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~--~~~~  109 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLADIVKDPVS--RTPA  109 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH--HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT--CCEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch--HHHHHHHHHHHHcCCCCCEEEeeeeeccCCC--CceE
Confidence            357899999999999999999987  578899999875433  45667888888886 9999999999987432  3458


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~DFG  265 (461)
                      +||||+++++|.++++.  +++..+..++.|++.||+|||+.           +|+||||||+|||++.++ .+||+|||
T Consensus       110 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSM-----------GIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             EEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            99999999999999864  89999999999999999999999           999999999999999776 89999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.......   .....||..|+|||++.+.    ..++.++|||||||++|||++|..||..............  ..
T Consensus       177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~--~~  247 (330)
T 3nsz_A          177 LAEFYHPGQE---YNVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA--KV  247 (330)
T ss_dssp             TCEECCTTCC---CCSCCSCGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH--HH
T ss_pred             CceEcCCCCc---cccccccccccChhhhcCC----CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH--Hh
Confidence            9987665432   3345789999999998653    3577899999999999999999544421110000000000  00


Q ss_pred             CCHHHHHHHHhccCCC--------------CCCC---chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        346 PSLEDMQEAVVHKKLR--------------PTLP---ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~--------------~~~p---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .........+......              ....   ........+..+.+||.+||+.||++|||++++++|.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence            0000000001000000              0000   00000113458999999999999999999999999987643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.6e-43  Score=337.48  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC---CC--cEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEec
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK---NE--NVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKR  177 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---~~--~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~  177 (461)
                      .....++|++.+.||+|+||.||+|++.   ++  .||||++....    .......+|+.++.+++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            3456679999999999999999999873   22  58999886432    223455788999999999999999999876


Q ss_pred             CCccceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                      ..     .++||||+++|+|.+++..  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.
T Consensus        93 ~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dikp~Nili~~  156 (291)
T 1u46_A           93 PP-----MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-----------RFIHRDLAARNLLLAT  156 (291)
T ss_dssp             SS-----CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEEEE
T ss_pred             CC-----ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCchheEEEcC
Confidence            53     4899999999999999954  4699999999999999999999999           9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCC
Q psy17532        256 DLTAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGE  333 (461)
Q Consensus       256 ~~~~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~  333 (461)
                      ++.+||+|||+++........ .......+|..|+|||++.+.     .++.++||||||+++|||++ |          
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g----------  221 (291)
T 1u46_A          157 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-----TFSHASDTWMFGVTLWEMFTYG----------  221 (291)
T ss_dssp             TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTS----------
T ss_pred             CCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-----CCCchhhHHHHHHHHHHHHhCC----------
Confidence            999999999999887543321 122334678899999998753     56678999999999999999 8          


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ..||...     ...+....+.........+..++     ..+.++|.+||+.||++|||+.++++.+..+.
T Consensus       222 -~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          222 -QEPWIGL-----NGSQILHKIDKEGERLPRPEDCP-----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             -CCTTTTC-----CHHHHHHHHHTSCCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -CCCcccC-----CHHHHHHHHHccCCCCCCCcCcC-----HHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence             6666543     44555555555544444444433     38999999999999999999999999887654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.7e-43  Score=337.40  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=199.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....|++.+.||+|+||.||+|++..     ..||||.+.....  ......+|+.++++++||||+++++++...+.  
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG--  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS--
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC--
Confidence            34579999999999999999999732     2489998864332  23445688999999999999999998765432  


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       ..++||||+++|+|.++++.  ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus       101 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-----------~i~H~dikp~Nil~~~~~~~k  168 (298)
T 3f66_A          101 -SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-----------KFVHRDLAARNCMLDEKFTVK  168 (298)
T ss_dssp             -CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECTTCCEE
T ss_pred             -ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCCCCchheEEECCCCCEE
Confidence             45899999999999999954  4589999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       261 i~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      |+|||+++........  .......+|+.|+|||++.+     ..++.++||||||+++|||++|+          ..||
T Consensus       169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~~----------~~~~  233 (298)
T 3f66_A          169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRG----------APPY  233 (298)
T ss_dssp             ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS----------CCSS
T ss_pred             ECcccccccccccchhccccccCCCCCccccChHHhcC-----CCCChHHHHHHHHHHHHHHHhCC----------CCCC
Confidence            9999999876543211  12334567889999999876     36778999999999999999964          3344


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ...+....+.. ..+...+..++     ..+.+++.+||+.||++|||+.++++.+..+..
T Consensus       234 ~~~-----~~~~~~~~~~~-~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          234 PDV-----NTFDITVYLLQ-GRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             TTS-----CTTTHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccC-----CHHHHHHHHhc-CCCCCCCccCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            332     11122222222 22333344333     379999999999999999999999999987765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-42  Score=345.50  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=190.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--c
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--H  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~  182 (461)
                      ..++|++.+.||+|+||.||+|..  .++.||||++.....   ......+|+.+++.++||||+++++++......  .
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            357899999999999999999988  478899999975322   223456889999999999999999998765421  2


Q ss_pred             eeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ..+++||||+++ +|.+++.. .+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~-----------~ivH~Dlkp~NIl~~~~~~~kl~  169 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKIL  169 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             cceEEEEEcCCC-CHHHHHhh-ccCHHHHHHHHHHHHHHHHHHHHC-----------CeecccCCHHHEEEcCCCCEEEE
Confidence            356999999975 89888863 589999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++......   ......||+.|+|||++.+.     .++.++|||||||++|||++|..           ||.+. 
T Consensus       170 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~-----------pf~~~-  229 (371)
T 2xrw_A          170 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIKGGV-----------LFPGT-  229 (371)
T ss_dssp             CCCC-------------------CTTCCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHSSC-----------SSCCS-
T ss_pred             Eeeccccccccc---ccCCceecCCccCHHHhcCC-----CCCchHhHHHHHHHHHHHHhCCC-----------CCCCC-
Confidence            999998765332   23345789999999999763     67789999999999999999954           44332 


Q ss_pred             CCCCCHHHHHHHHhccCC--------------------CCCC--------------Cchh-ccchhHHHHHHHHHHHccc
Q psy17532        343 GDHPSLEDMQEAVVHKKL--------------------RPTL--------------PETW-KQHAGMLALCDTMEECWDH  387 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~--------------------~~~~--------------p~~~-~~~~~~~~l~~li~~cl~~  387 (461)
                          ...+....+.....                    ++.+              |... .....+..+.+||.+||..
T Consensus       230 ----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  305 (371)
T 2xrw_A          230 ----DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  305 (371)
T ss_dssp             ----SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             ----CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC
Confidence                11111111111000                    0000              0000 0011246789999999999


Q ss_pred             cHhhhccccchhhhcHHHh
Q psy17532        388 DAEARLSASCVVERGMLAL  406 (461)
Q Consensus       388 dP~~Rps~~evl~~l~~~~  406 (461)
                      ||++|||++++++|.+...
T Consensus       306 dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          306 DASKRISVDEALQHPYINV  324 (371)
T ss_dssp             SGGGSCCHHHHHHSHHHHT
T ss_pred             ChhhCCCHHHHhCCcchhh
Confidence            9999999999999998643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-42  Score=349.54  Aligned_cols=259  Identities=20%  Similarity=0.282  Sum_probs=194.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~~  186 (461)
                      ...+|++.+.||+|+||.||+|+. .+..||+|++.....   ...+|+.+++.++||||+++++++.....  ....++
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            456899999999999999999999 455699998864332   22368888999999999999999865432  122368


Q ss_pred             eeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc-CCCceE
Q psy17532        187 LITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-SDLTAA  260 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~-~~~~~k  260 (461)
                      +||||++++ +.+.+.     ...+++..+..++.||+.||+|||+.           +|+||||||+|||++ .++.+|
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----------~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-----------GICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEETTTTEEE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CccCCCCCHHHEEEcCCCCcEE
Confidence            999999874 444332     45799999999999999999999999           999999999999999 799999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+....+..   .....||+.|+|||++.+.    ..++.++|||||||++|||++|           ..||.+
T Consensus       183 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g-----------~~pf~~  244 (394)
T 4e7w_A          183 LIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGA----TNYTTNIDIWSTGCVMAELMQG-----------QPLFPG  244 (394)
T ss_dssp             ECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHS-----------SCSSCC
T ss_pred             EeeCCCcccccCCCC---CcccccCcCccCHHHHcCC----CCCCcHHHHHHHHHHHHHHHhC-----------CCCCCC
Confidence            999999988754432   3345789999999998763    3578899999999999999999           455543


Q ss_pred             ccCCCCCHHHHHHHHhc---------------cCCCCCCCc----hhc---cchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        341 EVGDHPSLEDMQEAVVH---------------KKLRPTLPE----TWK---QHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~---------------~~~~~~~p~----~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      .     ...+....+..               ......++.    .+.   ....+.++.+||.+||..||++|||+.++
T Consensus       245 ~-----~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (394)
T 4e7w_A          245 E-----SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA  319 (394)
T ss_dssp             S-----SHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             C-----CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence            3     11111111110               000011110    010   01133589999999999999999999999


Q ss_pred             hhhcHHHh
Q psy17532        399 VERGMLAL  406 (461)
Q Consensus       399 l~~l~~~~  406 (461)
                      ++|.+.-.
T Consensus       320 l~hp~f~~  327 (394)
T 4e7w_A          320 LCHPFFDE  327 (394)
T ss_dssp             HTSGGGST
T ss_pred             hcChhhhh
Confidence            99998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-43  Score=349.77  Aligned_cols=257  Identities=22%  Similarity=0.322  Sum_probs=182.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      .++|++.+.||+|+||.||+|..  +++.||||++.....   ......+|+.+++.++||||+++++++......  ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999987  478899999864322   233456899999999999999999998764321  23


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++|+||+ +++|.++++...+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------givH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-----------DIIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             CCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeCCCCHhhEEECCCCCEEEee
Confidence            568999999 68999999888899999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....     .....||..|+|||++.+.    ..++.++|||||||++|||++|..           ||.+.  
T Consensus       176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~-----------pf~~~--  233 (367)
T 2fst_X          176 FGLARHTADE-----MTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGRT-----------LFPGT--  233 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTC----CSCCTTHHHHHHHHHHHHHHHSSC-----------SCCCS--
T ss_pred             cccccccccc-----CCCcCcCcCccChHHHcCC----cCCCchhhHHHHHHHHHHHHhCCC-----------CCCCC--
Confidence            9999875432     2345789999999998763    367789999999999999999954           44332  


Q ss_pred             CCCCHHHHHHHHhc------------------------cCCCCCC--CchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        344 DHPSLEDMQEAVVH------------------------KKLRPTL--PETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       344 ~~~~~~~~~~~~~~------------------------~~~~~~~--p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                         ...+....+..                        -...+..  ...++  ..+..+.+||.+||..||++|||+.+
T Consensus       234 ---~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dLl~~mL~~dP~~R~t~~e  308 (367)
T 2fst_X          234 ---DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI--GANPLAVDLLEKMLVLDSDKRITAAQ  308 (367)
T ss_dssp             ---SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTT--TCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ---CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCC--CCCHHHHHHHHHhCCCCcccCcCHHH
Confidence               11111111110                        0000110  01111  12357899999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      +++|.+...
T Consensus       309 ~L~hp~~~~  317 (367)
T 2fst_X          309 ALAHAYFAQ  317 (367)
T ss_dssp             HHTSGGGTT
T ss_pred             HhcChhhhh
Confidence            999988654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-43  Score=339.40  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=184.8

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ....++|++.+.||+|+||.||+|..  +++.||||++....  .......+|+.++.+++||||+++++++...+    
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   86 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----   86 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS----
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC----
Confidence            44567999999999999999999987  57889999886432  22334568899999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc
Q psy17532        184 EFWLITAYHERGSLCDFLK---------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK  254 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~  254 (461)
                      ..++||||+++|+|.+++.         ...+++..+..++.|++.||.|||+.           +|+||||||+|||++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~~  155 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-----------GQIHRDVKAGNILLG  155 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCSGGGEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CCCCCCCChhhEEEc
Confidence            3589999999999999985         34589999999999999999999999           999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCC---CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC
Q psy17532        255 SDLTAAIADFGLALLFEPGKPC---GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPP  331 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~  331 (461)
                      .++.+||+|||++.........   .......||+.|+|||++.+.    ..++.++||||||+++|||++|.       
T Consensus       156 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~-------  224 (303)
T 2vwi_A          156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV----RGYDFKADIWSFGITAIELATGA-------  224 (303)
T ss_dssp             TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH----HCCCTHHHHHHHHHHHHHHHHSS-------
T ss_pred             CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc----cCCCchhhHHHHHHHHHHHHhCC-------
Confidence            9999999999999876543211   112345789999999998653    35678899999999999999994       


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhc----cchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        332 GEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWK----QHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       332 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          .||...     ............. .+.......    ....+..+.+||.+||+.||++|||+.++++|.+...
T Consensus       225 ----~pf~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          225 ----APYHKY-----PPMKVLMLTLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             ----CTTTTS-----CGGGHHHHHHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             ----CCCccC-----chhhHHHHHhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence                455432     1111111111111 111111000    0112347899999999999999999999999987543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-42  Score=334.59  Aligned_cols=258  Identities=22%  Similarity=0.364  Sum_probs=195.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--------
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--------  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--------  180 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++...........+|+.++.+++||||+++++++.+...        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            35799999999999999999998  57889999997655445566789999999999999999998865421        


Q ss_pred             -cceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        181 -IHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       181 -~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                       ....+++||||+++|+|.+++...  .+++..+..++.|++.||+|||++           +|+||||||+|||++.++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ-----------GIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTS
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC-----------CeecccCCHHhEEEcCCC
Confidence             134679999999999999999633  478899999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCC------------CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCC
Q psy17532        258 TAAIADFGLALLFEPGKP------------CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS  325 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~  325 (461)
                      .+||+|||+++.......            ........||..|+|||++.+.    ..++.++||||||+++|||+++  
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~p--  227 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT----GHYNEKIDMYSLGIIFFEMIYP--  227 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC----SCCCTHHHHHHHHHHHHHHHSC--
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC----CCCcchhhHHHHHHHHHHHHhc--
Confidence            999999999987643211            0112345689999999998753    3577899999999999999983  


Q ss_pred             CCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       326 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                       |           ...    .........+...  ...+|..+.. ..+..+.++|.+||+.||++|||+.++++|.+.
T Consensus       228 -~-----------~~~----~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          228 -F-----------STG----MERVNILKKLRSV--SIEFPPDFDD-NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             -C-----------SSH----HHHHHHHHHHHST--TCCCCTTCCT-TTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             -c-----------CCc----hhHHHHHHhcccc--ccccCccccc-cchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence             1           100    0112222222222  2223332221 233478999999999999999999999999865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-42  Score=340.08  Aligned_cols=253  Identities=20%  Similarity=0.273  Sum_probs=196.9

Q ss_pred             cceeEE-eEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCcccee
Q psy17532        112 RSIQLV-EVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       112 ~~~~~~-~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      +.|.+. +.||+|+||.||+|+..  ++.||||++.....   ......+|+.++..+ +||||+++++++.+..    .
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~----~  103 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS----E  103 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----E
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC----e
Confidence            456666 89999999999999984  78999999865322   234456788887777 5799999999998765    4


Q ss_pred             eeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCc
Q psy17532        185 FWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLT  258 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~  258 (461)
                      +++||||+++|+|.+++..   ..+++..+..++.|++.||+|||+.           +|+||||||+|||++.   ++.
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~-----------givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-----------NIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEESCBTTBCC
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCcCChHHEEEecCCCCCc
Confidence            5999999999999999854   4699999999999999999999999           9999999999999998   789


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......   ......||+.|+|||++.+     ..++.++||||||+++|||++|           ..||
T Consensus       173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g-----------~~pf  233 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNY-----DPITTATDMWNIGIIAYMLLTH-----------TSPF  233 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------SCSS
T ss_pred             EEEeeCccccccCCcc---ccccccCCcCccCCeeecC-----CCCCchhhHHHHHHHHHHHHhC-----------CCCC
Confidence            9999999998775432   2334579999999999875     3677899999999999999999           5666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ...     ...+....+......... ..+.  ..+..+.+||.+||+.||++|||++++++|.+...
T Consensus       234 ~~~-----~~~~~~~~i~~~~~~~~~-~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          234 VGE-----DNQETYLNISQVNVDYSE-ETFS--SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             CCS-----SHHHHHHHHHHTCCCCCT-TTTT--TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             CCC-----CchHHHHHHHhcccccCc-hhhc--ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence            443     333333333332221111 1111  12347899999999999999999999999987644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.2e-44  Score=356.72  Aligned_cols=253  Identities=14%  Similarity=0.089  Sum_probs=188.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHH---HHcCCCCCCCeeEEE-------E
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEI---FKLPHMEHDNILRYI-------G  173 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei---~~l~~l~H~nIv~l~-------g  173 (461)
                      ..++|++.+.||+|+||.||+|++  +++.||||++....    .......+|+   ..+++++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999997  48899999996432    2334556788   677888999999998       5


Q ss_pred             EEecCCcc--------c-----eeeeeeehhccCCChhhhhcC-CCC-------CHHHHHHHHHHHHHHHHHHhhcccCC
Q psy17532        174 AEKRGESI--------H-----TEFWLITAYHERGSLCDFLKC-NIV-------TWEQLCRIALSMSKGLMHLHEEILPN  232 (461)
Q Consensus       174 ~~~~~~~~--------~-----~~~~lv~e~~~~gsL~~~l~~-~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~  232 (461)
                      ++.+.+..        .     ...++||||+ +|+|.+++.. ..+       ++..+..++.||+.||+|||+.    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----  225 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----  225 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----
Confidence            55543210        0     0258999999 6899999953 223       3578888999999999999999    


Q ss_pred             CcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccc------ccccCCCCC
Q psy17532        233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGA------INFSRDAFL  306 (461)
Q Consensus       233 ~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~~~  306 (461)
                             +|+||||||+|||++.++.+||+|||+|+....     ......| +.|+|||++.+.      ......++.
T Consensus       226 -------~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  292 (377)
T 3byv_A          226 -------GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF  292 (377)
T ss_dssp             -------TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred             -------CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence                   999999999999999999999999999986432     2234567 999999999763      000015778


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHcc
Q psy17532        307 RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWD  386 (461)
Q Consensus       307 k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~  386 (461)
                      ++|||||||++|||++|.           .||.......     ....+..      .+..     .+..+.+||.+||+
T Consensus       293 ~~DvwSlG~il~elltg~-----------~Pf~~~~~~~-----~~~~~~~------~~~~-----~~~~~~~li~~~L~  345 (377)
T 3byv_A          293 SFDAWALGLVIYWIWCAD-----------LPITKDAALG-----GSEWIFR------SCKN-----IPQPVRALLEGFLR  345 (377)
T ss_dssp             HHHHHHHHHHHHHHHHSS-----------CCC------C-----CSGGGGS------SCCC-----CCHHHHHHHHHHTC
T ss_pred             hhhHHHHHHHHHHHHHCC-----------CCCccccccc-----chhhhhh------hccC-----CCHHHHHHHHHHcC
Confidence            999999999999999994           4553321110     0001110      0111     22378999999999


Q ss_pred             ccHhhhccccchhhhcHHHhh
Q psy17532        387 HDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       387 ~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .||++|||+.++++|.+....
T Consensus       346 ~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          346 YPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             SSGGGCCCHHHHHTSHHHHHH
T ss_pred             CCchhCCCHHHHhhChHHHHH
Confidence            999999999999999876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=335.19  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=199.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ...+....+||+|+||.||+|+.  +++.||||.+..... ......+|+.++..++||||+++++++....    .+++
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l   96 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG----FIKI   96 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----cEEE
Confidence            34445556999999999999998  467899999875543 2345678899999999999999999998765    4589


Q ss_pred             eehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CCceEEE
Q psy17532        188 ITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~~~ki~  262 (461)
                      ||||+++|+|.+++...    .+++..+..++.|++.||.|||+.           +|+||||||+|||++. ++.+||+
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dl~p~Nil~~~~~~~~kl~  165 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-----------QIVHRDIKGDNVLINTYSGVLKIS  165 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEETTTCCEEEC
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-----------CEEccCCChhhEEEECCCCCEEEe
Confidence            99999999999999643    467888999999999999999999           9999999999999998 8999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++.......  ......||..|+|||++.+..   ..++.++||||||+++|||++|           ..||....
T Consensus       166 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g-----------~~pf~~~~  229 (295)
T 2clq_A          166 DFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGP---RGYGKAADIWSLGCTIIEMATG-----------KPPFYELG  229 (295)
T ss_dssp             CTTTCEESCC-------CCCCCCGGGCCHHHHHHGG---GGCSHHHHHHHHHHHHHHHHHT-----------SCTTGGGS
T ss_pred             ecccccccCCCCC--cccccCCCccccChhhhcCCC---CCCCcHHHHHHHHHHHHHHHHC-----------CCCccCCC
Confidence            9999987654321  233457899999999987531   2367789999999999999999           56664321


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          ...............+.++..++     ..+.+||.+||+.||++|||+.++++|.+...
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~  284 (295)
T 2clq_A          230 ----EPQAAMFKVGMFKVHPEIPESMS-----AEAKAFILKCFEPDPDKRACANDLLVDEFLKV  284 (295)
T ss_dssp             ----SHHHHHHHHHHHCCCCCCCTTSC-----HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred             ----chhHHHHhhccccccccccccCC-----HHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence                11111222222233445554443     37899999999999999999999999986543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-43  Score=353.83  Aligned_cols=263  Identities=13%  Similarity=0.091  Sum_probs=181.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh----hhhHHHHH---HHHcCCCCCCCeeEEE-------E
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK----QSWQSEQE---IFKLPHMEHDNILRYI-------G  173 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~----~~~~~~~e---i~~l~~l~H~nIv~l~-------g  173 (461)
                      ....|++.+.||+|+||.||+|++  +++.||||++.....    ......+|   +..|.. +||||++++       +
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence            345699999999999999999998  467899999986543    12233455   455666 899988866       3


Q ss_pred             EEecCCcc-------------ceeeeeeehhccCCChhhhhcC--CCCCHHHH------HHHHHHHHHHHHHHhhcccCC
Q psy17532        174 AEKRGESI-------------HTEFWLITAYHERGSLCDFLKC--NIVTWEQL------CRIALSMSKGLMHLHEEILPN  232 (461)
Q Consensus       174 ~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~  232 (461)
                      ++......             ...+++||||++ |+|.+++..  ..+.+..+      ..++.||+.||+|||++    
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----  213 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK----  213 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC----
Confidence            43332210             134799999999 899999964  23555555      67889999999999999    


Q ss_pred             CcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHH
Q psy17532        233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYA  312 (461)
Q Consensus       233 ~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS  312 (461)
                             +|+||||||+|||++.++.+||+|||+|+.....     .....+|+.|+|||++.+.   ...++.++||||
T Consensus       214 -------~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwS  278 (371)
T 3q60_A          214 -------GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNAS---TATFTHALNAWQ  278 (371)
T ss_dssp             -------TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCS---EEECCHHHHHHH
T ss_pred             -------CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCC---CCCcCccccHHH
Confidence                   9999999999999999999999999999876432     1134677999999999652   135778999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        313 CALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       313 ~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      |||++|||++|..||.........-+...     .      ..........++. +  ...+..+.+||.+||+.||++|
T Consensus       279 lG~il~elltg~~Pf~~~~~~~~~~~~~~-----~------~~~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dP~~R  344 (371)
T 3q60_A          279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRP-----S------LRVPGTDSLAFGS-C--TPLPDFVKTLIGRFLNFDRRRR  344 (371)
T ss_dssp             HHHHHHHHHHSSCSTTBCCTTCTTCCCBC-----C------TTSCCCCSCCCTT-S--SCCCHHHHHHHHHHTCSSTTTC
T ss_pred             HHHHHHHHHhCCCCCCCcCcccccchhhh-----h------hhhccccccchhh-c--cCCCHHHHHHHHHHcCCChhhC
Confidence            99999999999666544322111111100     0      0000011111111 0  1123489999999999999999


Q ss_pred             ccccchhhhcHHHhh
Q psy17532        393 LSASCVVERGMLALC  407 (461)
Q Consensus       393 ps~~evl~~l~~~~~  407 (461)
                      ||+.++++|.+....
T Consensus       345 pt~~e~l~hp~f~~~  359 (371)
T 3q60_A          345 LLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCHHHHTTSHHHHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999887654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=336.93  Aligned_cols=264  Identities=22%  Similarity=0.307  Sum_probs=194.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-------
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGES-------  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-------  180 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++...... .....+|+.++++++||||+++++++.....       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999995  788999998765433 3445789999999999999999998854321       


Q ss_pred             ---cceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc-CC
Q psy17532        181 ---IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-SD  256 (461)
Q Consensus       181 ---~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~-~~  256 (461)
                         ....+++||||++ |+|.+++..+.+++..+..++.|++.||+|||+.           +|+||||||+|||++ .+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA-----------NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCSGGGEEEETTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC-----------CEecCCCCHHHEEEcCCC
Confidence               1245689999998 6999999988999999999999999999999999           999999999999997 56


Q ss_pred             CceEEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                      +.+||+|||+++........ .......+|..|+|||++.+.    ..++.++||||||+++|||++|           .
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~el~~g-----------~  222 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP----NNYTKAIDMWAAGCIFAEMLTG-----------K  222 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT----TCCCHHHHHHHHHHHHHHHHHS-----------S
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCc----ccCCchhhhHhHHHHHHHHHhC-----------C
Confidence            79999999999876532211 123345678999999988653    3577889999999999999999           4


Q ss_pred             CCCccccCCCCCHHHHHHHHhccC-----------------------CCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKK-----------------------LRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      .||...     ...+....+....                       ..+..+..-.....+..+.+||.+||+.||++|
T Consensus       223 ~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  297 (320)
T 2i6l_A          223 TLFAGA-----HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR  297 (320)
T ss_dssp             CSSCCS-----SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred             CCCCCC-----CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence            555432     1111111111110                       000110000001134589999999999999999


Q ss_pred             ccccchhhhcHHHh
Q psy17532        393 LSASCVVERGMLAL  406 (461)
Q Consensus       393 ps~~evl~~l~~~~  406 (461)
                      ||++++++|.+...
T Consensus       298 pt~~ell~hp~~~~  311 (320)
T 2i6l_A          298 LTAEEALSHPYMSI  311 (320)
T ss_dssp             CCHHHHHTSHHHHT
T ss_pred             CCHHHHhCCccccc
Confidence            99999999988654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-42  Score=342.53  Aligned_cols=281  Identities=22%  Similarity=0.271  Sum_probs=200.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCc-ccee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGES-IHTE  184 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~  184 (461)
                      ..++|++.+.||+|+||.||+|++.  ++.||||++......  .....+|+.++.+++||||+++++++..... ....
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999985  788999998643322  2345688999999999999999998765421 1235


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      .++||||+. |+|.+++....+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-----------~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-----------NVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeEEcCCCcEEEEec
Confidence            699999997 5999999888899999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCC--------CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC--
Q psy17532        265 GLALLFEPGKPCG--------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY--  334 (461)
Q Consensus       265 Gla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~--  334 (461)
                      |+++.........        ......||+.|+|||++.+.    ..++.++|||||||++|||++|..||.+.....  
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  232 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS----AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL  232 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSC----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccC----CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9998765332110        12235789999999988653    367788999999999999999965553321000  


Q ss_pred             -------CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        335 -------RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       335 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                             ..|...............+........+..+........+..+.+||.+||+.||++|||+.++++|.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                   000000000000001111111110000000000000123357899999999999999999999999987654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-42  Score=344.99  Aligned_cols=265  Identities=19%  Similarity=0.219  Sum_probs=189.5

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc---cc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES---IH  182 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~---~~  182 (461)
                      ....++|++.+.||+|+||.||+|++.  ++.||||++...........+++..+..++||||+++++++.....   ..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            345678999999999999999999984  7889999987655444455667777778899999999999865332   12


Q ss_pred             eeeeeeehhccCCChhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHh--hcccCCCcCCCCCCeecccCCCCcEEEcC
Q psy17532        183 TEFWLITAYHERGSLCDFL-----KCNIVTWEQLCRIALSMSKGLMHLH--EEILPNKADSYKPAVAHRDFKSNNVLLKS  255 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l-----~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~~~~~~~~ivHrDLkp~NILl~~  255 (461)
                      ..+++||||+++ +|.+.+     ....+++..+..++.|++.||.|||  +.           +|+||||||+|||++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-----------~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-----------NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-----------CCBCSCCCGGGEEEET
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-----------CeecCcCCHHHEEEeC
Confidence            236899999986 555443     2456899999999999999999999  77           9999999999999997


Q ss_pred             -CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        256 -DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       256 -~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                       ++.+||+|||+++......   ......||+.|+|||++.+.    ..++.++|||||||++|||++|           
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~ell~g-----------  228 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGN----QHYTTAVDIWSVGCIFAEMMLG-----------  228 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHS-----------
T ss_pred             CCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCC----CCCCcHHHHHHHHHHHHHHHhC-----------
Confidence             8999999999998776443   23345789999999998653    3577899999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCC---------------------CCC--chhc--cchhHHHHHHHHHHHccccH
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRP---------------------TLP--ETWK--QHAGMLALCDTMEECWDHDA  389 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~p--~~~~--~~~~~~~l~~li~~cl~~dP  389 (461)
                      ..||...     ........+......+                     ..+  ..+.  ....+..+.+||.+||+.||
T Consensus       229 ~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  303 (360)
T 3e3p_A          229 EPIFRGD-----NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP  303 (360)
T ss_dssp             SCSSCCS-----SHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred             CCCcCCC-----ChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence            4555432     2222222221100000                     000  0000  01134689999999999999


Q ss_pred             hhhccccchhhhcHHHhh
Q psy17532        390 EARLSASCVVERGMLALC  407 (461)
Q Consensus       390 ~~Rps~~evl~~l~~~~~  407 (461)
                      ++|||+.|+++|.+....
T Consensus       304 ~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          304 EERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             GGSCCHHHHTTSGGGGGG
T ss_pred             cccCCHHHHhcCcccccc
Confidence            999999999999987654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-42  Score=330.99  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||.||+|+.  +++.||||++....   .......+|+.++++++||||+++++++.+..    .+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   96 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----SF   96 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC----eE
Confidence            46899999999999999999998  47889999986432   22345678899999999999999999998754    45


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC---CceEE
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD---LTAAI  261 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~---~~~ki  261 (461)
                      ++||||+++++|.+++. ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.+   +.+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-----------NIVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCChhhEEEecCCCcccEEE
Confidence            99999999999999874 45799999999999999999999999           99999999999999764   47999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||++.......   ......||..|+|||++.+      .++.++||||||+++|||++|           ..||...
T Consensus       166 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g-----------~~p~~~~  225 (287)
T 2wei_A          166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG------TYDEKCDVWSAGVILYILLSG-----------TPPFYGK  225 (287)
T ss_dssp             CSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT------CCCTHHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             eccCcceeecCCC---ccccccCcccccChHHhcC------CCCCchhhHhHHHHHHHHHhC-----------CCCCCCC
Confidence            9999998765432   2233468899999999865      467889999999999999999           5666543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                           ...++...+.........+. +  ...+..+.++|.+||..||++|||+.+++++.+...
T Consensus       226 -----~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          226 -----NEYDILKRVETGKYAFDLPQ-W--RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             -----SHHHHHHHHHHCCCCCCSGG-G--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             -----CHHHHHHHHHcCCCCCCchh-h--hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence                 34455555555544333332 1  112347999999999999999999999999987654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.7e-43  Score=340.13  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+.|++.+.||+|+||.||+|++.  ++.||+|++..... ......+|+.++..++||||+++++++....    .++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   92 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG----KLW   92 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-----CEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC----eEE
Confidence            4568999999999999999999995  78899999865432 2345567888899999999999999998765    459


Q ss_pred             eeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +||||+++|+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+||+||
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~kl~Df  161 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK-----------RIIHRDLKAGNVLMTLEGDIRLADF  161 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC-----------CcccCCCCHHHEEECCCCCEEEEEC
Confidence            9999999999999985  35699999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |++.......  .......||..|+|||++.........++.++||||||+++|||++|           ..||...   
T Consensus       162 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g-----------~~p~~~~---  225 (302)
T 2j7t_A          162 GVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-----------EPPHHEL---  225 (302)
T ss_dssp             HHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS-----------SCTTTTS---
T ss_pred             CCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC-----------CCCCccC---
Confidence            9975432110  11223578999999999853221224677899999999999999999           5555433   


Q ss_pred             CCCHHHHHHHHhccCCC-CCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLR-PTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ........+...... ...+..+     +..+.++|.+||+.||++|||+.++++|.+...
T Consensus       226 --~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          226 --NPMRVLLKIAKSDPPTLLTPSKW-----SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             --CHHHHHHHHHHSCCCCCSSGGGS-----CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             --CHHHHHHHHhccCCcccCCcccc-----CHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence              223333333332211 1122333     347999999999999999999999999986543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.1e-43  Score=343.42  Aligned_cols=255  Identities=23%  Similarity=0.285  Sum_probs=195.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCC
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGE  179 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~  179 (461)
                      .++|++.+.||+|+||.||+|+..  ++.||||++.....         ......+|+.++.+++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            468999999999999999999984  67899999864321         1223567899999999999999999987543


Q ss_pred             ccceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                           +++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.
T Consensus        89 -----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           89 -----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN-----------GIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             -----EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESSSSS
T ss_pred             -----eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeccCCCHHHEEEecCCC
Confidence                 5899999999999998854 4699999999999999999999999           9999999999999987654


Q ss_pred             ---eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCC
Q psy17532        259 ---AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR  335 (461)
Q Consensus       259 ---~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~  335 (461)
                         +||+|||+++......   ......||+.|+|||++.+.  ....++.++||||||+++|||++|           .
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~~l~~g-----------~  216 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSG-----------Y  216 (322)
T ss_dssp             SCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHT--TTTTCTTHHHHHHHHHHHHHHHHS-----------S
T ss_pred             CCeEEEccCccceeccccc---ccccccCCcCccCchhhccC--CCCCCCchhhHHHHHHHHHHHHhC-----------C
Confidence               9999999998764321   12234689999999997431  124677899999999999999999           4


Q ss_pred             CCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       336 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .||.......    .+...+..... ...+..+..  .+..+.+||.+||..||++|||+.++++|.+.
T Consensus       217 ~pf~~~~~~~----~~~~~~~~~~~-~~~~~~~~~--~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          217 PPFSEHRTQV----SLKDQITSGKY-NFIPEVWAE--VSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             CSSCSTTCSS----CHHHHHHHTCC-CCCHHHHTT--SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             CCCcccchHH----HHHHHHHhCcc-ccCchhhhh--cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence            5554332111    12222222221 122222211  33479999999999999999999999999865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=344.15  Aligned_cols=250  Identities=13%  Similarity=0.123  Sum_probs=190.6

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEE-------ECCCcEEEEEEecCChhhhHHHHHHHH---cCCCCCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAK-------FKNENVAVKIFLMQDKQSWQSEQEIFK---LPHMEHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~-------~~~~~vAvK~~~~~~~~~~~~~~ei~~---l~~l~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|.       ..++.||||++.......  ...|+.+   +....|+||+++++++..
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHH--HHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhH--HHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            4556889999999999999999994       257889999997654433  3344444   444459999999999987


Q ss_pred             CCccceeeeeeehhccCCChhhhhc------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcE
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLK------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNV  251 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NI  251 (461)
                      .+.    .++||||+++|+|.+++.      ...+++..+..++.||+.||+|||+.           +|+||||||+||
T Consensus       139 ~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-----------~ivHrDiKp~NI  203 (365)
T 3e7e_A          139 QNG----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-----------EIIHGDIKPDNF  203 (365)
T ss_dssp             SSC----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCSGGGE
T ss_pred             CCC----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-----------CeecCCCCHHHE
Confidence            654    489999999999999995      45699999999999999999999998           999999999999


Q ss_pred             EEcC-----------CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHH
Q psy17532        252 LLKS-----------DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWEL  320 (461)
Q Consensus       252 Ll~~-----------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el  320 (461)
                      |++.           ++.+||+|||+|+.+.............||..|+|||++.+.     .++.++|||||||++|||
T Consensus       204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el  278 (365)
T 3e7e_A          204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-----PWNYQIDYFGVAATVYCM  278 (365)
T ss_dssp             EECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-----CBSTHHHHHHHHHHHHHH
T ss_pred             EecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-----CCCccccHHHHHHHHHHH
Confidence            9998           899999999999765422222234456799999999999763     578899999999999999


Q ss_pred             HcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-cccchh
Q psy17532        321 ASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-SASCVV  399 (461)
Q Consensus       321 ~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl  399 (461)
                      ++|           +.||.......            ......++..    ...+.+.+++..|++.+|.+|+ +++++.
T Consensus       279 ltg-----------~~pf~~~~~~~------------~~~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          279 LFG-----------TYMKVKNEGGE------------CKPEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             HHS-----------SCCCEEEETTE------------EEECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             HhC-----------CCccccCCCCc------------eeechhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            999           44543321110            0000111111    1234788999999999999996 455555


Q ss_pred             hhcHHHh
Q psy17532        400 ERGMLAL  406 (461)
Q Consensus       400 ~~l~~~~  406 (461)
                      +.+....
T Consensus       332 ~~l~~~l  338 (365)
T 3e7e_A          332 QKLKKVF  338 (365)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            5555444

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-42  Score=349.14  Aligned_cols=262  Identities=19%  Similarity=0.239  Sum_probs=194.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC--------CCCeeEEEEEEecCCc
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME--------HDNILRYIGAEKRGES  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~--------H~nIv~l~g~~~~~~~  180 (461)
                      .++|++.+.||+|+||.||+|+.  .++.||||++...........+|+.++..++        |+||+++++++.....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            47899999999999999999988  4678999999765444455667888777764        8889999999874332


Q ss_pred             cceeeeeeehhccCCChhhhhc-C--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK-C--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~-~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      ....+++||||+ +|+|.+++. .  ..+++..+..++.||+.||.|||++.          +|+||||||+|||++.++
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~----------givHrDikp~NIll~~~~  184 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC----------RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT----------CEECCCCSGGGEEECCCH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC----------CEecCCCCHHHeeEeccc
Confidence            244679999999 557777663 2  45999999999999999999999852          799999999999999775


Q ss_pred             -------------------------------------------------ceEEEecCCccccCCCCCCCCCCCCcCCCcc
Q psy17532        258 -------------------------------------------------TAAIADFGLALLFEPGKPCGDTHGQVGTRRY  288 (461)
Q Consensus       258 -------------------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y  288 (461)
                                                                       .+||+|||+++.....     .....||..|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence                                                             7999999999876532     2345789999


Q ss_pred             cccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH-HHHHHHHhc--c-------
Q psy17532        289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL-EDMQEAVVH--K-------  358 (461)
Q Consensus       289 ~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~-~~~~~~~~~--~-------  358 (461)
                      +|||++.+.     .++.++|||||||++|||++|..||.+...           ..... ......+..  +       
T Consensus       260 ~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~p~~~~  323 (397)
T 1wak_A          260 RSLEVLIGS-----GYNTPADIWSTACMAFELATGDYLFEPHSG-----------EEYTRDEDHIALIIELLGKVPRKLI  323 (397)
T ss_dssp             CCHHHHHTS-----CCCTHHHHHHHHHHHHHHHHSSCSCCCCCC-----------SSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred             cCChhhcCC-----CCCcHHHHHHHHHHHHHHhhCCCCCCCCcc-----------cccCchHHHHHHHHHhcCCCChHHh
Confidence            999999763     577899999999999999999555543221           11111 111111100  0       


Q ss_pred             ---CCC----------CCCCc------------hh-ccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        359 ---KLR----------PTLPE------------TW-KQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       359 ---~~~----------~~~p~------------~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                         ...          ..+..            .+ .....+..+.+||.+||+.||++|||++|+++|.+.
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence               000          00000            00 012234578999999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.4e-43  Score=336.32  Aligned_cols=262  Identities=18%  Similarity=0.160  Sum_probs=195.3

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      .++|++.+.||+|+||.||+|+.  .++.||||++..... .....+|+.++..++|+|++..++.+....   ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEG---DYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET---TEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCC---CceEEE
Confidence            46899999999999999999997  578899998764432 234567788888888888887777664432   245899


Q ss_pred             ehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCCCceEEEe
Q psy17532        189 TAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTAAIAD  263 (461)
Q Consensus       189 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~~~~ki~D  263 (461)
                      |||+ +|+|.+++.  ...+++..+..++.|++.||.|||+.           +|+||||||+|||+   +.++.+||+|
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-----------NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeecCCCCHHHeeeeccCCCCeEEEec
Confidence            9999 899999996  55799999999999999999999999           99999999999999   7889999999


Q ss_pred             cCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        264 FGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       264 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      ||+++........     .......||+.|+|||++.+.     .++.++|||||||++|||++|..           ||
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~-----------pf  215 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-----EQSRRDDLESLGYVLMYFNLGSL-----------PW  215 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSC-----------TT
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCC-----CCCchhHHHHHHHHHHHHhcCCC-----------CC
Confidence            9999876544321     123356799999999999763     57789999999999999999954           44


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      .......  .......+.........+...  ...+..+.+||.+||+.||++|||++++++.+..+...
T Consensus       216 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          216 QGLKAAT--KRQKYERISEKKMSTPIEVLC--KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             SSCCCSS--SSSHHHHHHHHHHHSCHHHHT--TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccchhh--hhhhhhhhhcccccchhhhhh--ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            4321111  111111111111111111000  11234799999999999999999999999998877653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-42  Score=334.90  Aligned_cols=263  Identities=18%  Similarity=0.165  Sum_probs=199.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++..... .....+|+.++..++|+|++..++.+....   ...++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---~~~~l   82 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEG---DYNVM   82 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEET---TEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCC---CceEE
Confidence            346899999999999999999997  578899999865433 235677888888999888777776664432   24589


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCCCceEEE
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~~~~ki~  262 (461)
                      ||||+ +|+|.+++.  ...+++..+..++.|++.||.|||++           +|+||||||+|||+   +.++.+||+
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-----------NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeCCCCHHHeEEecCCCCCeEEEe
Confidence            99999 899999996  45799999999999999999999999           99999999999999   488999999


Q ss_pred             ecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        263 DFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       263 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      |||+++........     .......||+.|+|||++.+.     .++.++||||||+++|||++|.           .|
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~-----------~p  214 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-----EQSRRDDLESLGYVLMYFNLGS-----------LP  214 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSS-----------CT
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCC-----CCCcchhhHHHHHHHHHHHhCC-----------CC
Confidence            99999876554321     123456799999999999763     5778999999999999999995           44


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                      |......  ........+.........+...  ...+..+.+++.+||+.||++|||+.++++.+..+...
T Consensus       215 f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          215 WQGLKAA--TKRQKYERISEKKMSTPIEVLC--KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             TSSCCCS--SSSSHHHHHHHHHHHSCHHHHT--TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCcCch--hhhhhhhhhcccccCCchHHHH--hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            4432111  1111111111111111111000  11224799999999999999999999999998877653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=338.52  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=185.1

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-hhHHHHHHHHcCCCC-CCCeeEEEEEEecCC----
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHME-HDNILRYIGAEKRGE----  179 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~----  179 (461)
                      .....+|++.+.||+|+||.||+|++  +++.||||++...... .....+|+.++.++. ||||+++++++....    
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34456899999999999999999998  6789999998654433 334567888888885 999999999985322    


Q ss_pred             ccceeeeeeehhccCCChhhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCC--eecccCCCCcEEE
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLK----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPA--VAHRDFKSNNVLL  253 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~--ivHrDLkp~NILl  253 (461)
                      .....+++||||+. |+|.+++.    ...+++..+..++.||+.||.|||+.           +  |+||||||+|||+
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------~~~ivH~Dikp~NIl~  171 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-----------KPPIIHRDLKVENLLL  171 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-----------SSCCBCCCCCGGGCEE
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CCCEEEccCCcccEEE
Confidence            12345799999996 79999884    35699999999999999999999998           7  9999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCC----------CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCG----------DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      +.++.+||+|||+++.........          ......||+.|+|||++...  ....++.++||||||+++|||++|
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~Dv~slG~il~el~~g  249 (337)
T 3ll6_A          172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY--SNFPIGEKQDIWALGCILYLLCFR  249 (337)
T ss_dssp             CTTSCEEBCCCTTCBCCSSCC-------------------------------CC--TTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred             CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc--ccCCCChHHhHHHHHHHHHHHHhC
Confidence            999999999999998765432211          11134689999999998421  124677899999999999999999


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       324 ~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                 ..||....     ...    +.........+...+     ..+.+||.+||+.||++|||+.++++++.
T Consensus       250 -----------~~p~~~~~-----~~~----~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          250 -----------QHPFEDGA-----KLR----IVNGKYSIPPHDTQY-----TVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----------SCCC---------------------CCCCTTCCSS-----GGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             -----------CCCCcchh-----HHH----hhcCcccCCcccccc-----hHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                       45553321     111    111222222222222     25889999999999999999999999998


Q ss_pred             HHhhh
Q psy17532        404 LALCD  408 (461)
Q Consensus       404 ~~~~~  408 (461)
                      .+...
T Consensus       305 ~~~~~  309 (337)
T 3ll6_A          305 EIAAA  309 (337)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            87753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-42  Score=342.27  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=192.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChh------------hhHHHHHHHHcCCCCCCCeeEEEEEEe
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ------------SWQSEQEIFKLPHMEHDNILRYIGAEK  176 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~------------~~~~~~ei~~l~~l~H~nIv~l~g~~~  176 (461)
                      ..++|++.+.||+|+||.||+|.. +++.||||++......            .....+|+.++.+++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            356899999999999999999987 5788999998542211            144578999999999999999999986


Q ss_pred             cCC-ccceeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        177 RGE-SIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       177 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ... .....+++||||++ |+|.+++...  .+++..+..++.||+.||.|||+.           +|+||||||+|||+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA-----------GVVHRDLHPGNILL  167 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEE
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-----------cCEecCCChHHEEE
Confidence            533 22345799999998 6898888544  589999999999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      +.++.+||+|||+++......   ......||..|+|||++.+.    ..++.++|||||||++|||++|.         
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~---------  231 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQF----KGFTKLVDMWSAGCVMAEMFNRK---------  231 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTC----TTCCTHHHHHHHHHHHHHHHHSS---------
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCC----CCCCcHhHHHhHHHHHHHHHhCC---------
Confidence            999999999999997654332   23345789999999998753    35778999999999999999994         


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhc-----------------------cCCCCCCCchhc--cchhHHHHHHHHHHHcccc
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVH-----------------------KKLRPTLPETWK--QHAGMLALCDTMEECWDHD  388 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~p~~~~--~~~~~~~l~~li~~cl~~d  388 (461)
                        .||...     ...+....+..                       ..........+.  ....+..+.+||.+||+.|
T Consensus       232 --~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  304 (362)
T 3pg1_A          232 --ALFRGS-----TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN  304 (362)
T ss_dssp             --CSCCCS-----SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred             --CCCCCC-----CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence              444332     11222211111                       111100011111  0112357899999999999


Q ss_pred             HhhhccccchhhhcHHHh
Q psy17532        389 AEARLSASCVVERGMLAL  406 (461)
Q Consensus       389 P~~Rps~~evl~~l~~~~  406 (461)
                      |++|||+.++++|.+.-.
T Consensus       305 P~~Rpt~~ell~hp~f~~  322 (362)
T 3pg1_A          305 PQRRISTEQALRHPYFES  322 (362)
T ss_dssp             GGGSCCHHHHHTSGGGTT
T ss_pred             hhhCCCHHHHHcCchhhh
Confidence            999999999999988654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=339.40  Aligned_cols=262  Identities=21%  Similarity=0.311  Sum_probs=200.1

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .....++|++.+.||+|+||.||+|++++ .||||++.....   ....+.+|+.++.+++||||+++++++.+..    
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  102 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP----  102 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS----
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC----
Confidence            34566889999999999999999999876 599999864322   2234567899999999999999999998765    


Q ss_pred             eeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                      .+++||||+++|+|.+++...  .+++..+..++.|++.||+|||+.           +|+||||||+|||++ ++.+||
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------~i~H~dlkp~NIl~~-~~~~~l  170 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK-----------GILHKDLKSKNVFYD-NGKVVI  170 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCSTTEEEC---CCEE
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccccCCChhhEEEe-CCCEEE
Confidence            358999999999999999754  489999999999999999999999           999999999999998 679999


Q ss_pred             EecCCccccCCCCC---CCCCCCCcCCCccccccccccccc----ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        262 ADFGLALLFEPGKP---CGDTHGQVGTRRYMAPEVLEGAIN----FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       262 ~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      +|||+++.......   ........||..|+|||++.+...    ....++.++||||||+++|||++|           
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g-----------  239 (319)
T 2y4i_B          171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR-----------  239 (319)
T ss_dssp             CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS-----------
T ss_pred             eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC-----------
Confidence            99999876532211   112334568999999999875211    113467889999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCC-chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLP-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..||...     ........+.... .+... ..++     ..+.++|.+||+.||++|||+.++++.+..+..
T Consensus       240 ~~p~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          240 EWPFKTQ-----PAEAIIWQMGTGM-KPNLSQIGMG-----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             SCSSSSC-----CHHHHHHHHHTTC-CCCCCCSSCC-----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             CCCCCCC-----CHHHHHHHhccCC-CCCCCcCCCC-----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            6666543     3444444443332 22222 2222     368999999999999999999999998866553

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-41  Score=335.73  Aligned_cols=261  Identities=19%  Similarity=0.233  Sum_probs=174.7

Q ss_pred             cCCcceeEEe-EeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        109 QGCRSIQLVE-VKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       109 ~~~~~~~~~~-~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ...++|++.+ +||+|+||.||+|+..  ++.||||++...........   ..+..++||||+++++++.........+
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~---~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD---HHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHH---HHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHH---HHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4457899954 6999999999999995  78999999865432222111   2234568999999999987643323457


Q ss_pred             eeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCce
Q psy17532        186 WLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTA  259 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~~  259 (461)
                      ++||||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +|+||||||+|||++.   ++.+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-----------~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-----------NIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEESCSSTTCCE
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCCCCHHHEEEEecCCCceE
Confidence            9999999999999999653   599999999999999999999999           9999999999999986   4569


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++......    .....||+.|+|||++.+.     .++.++||||||+++|||++|.           .||.
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~-----------~pf~  230 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPE-----KYDKSCDMWSLGVIMYILLCGF-----------PPFY  230 (336)
T ss_dssp             EECCCTTCEEC--------------------------C-----HHHHHHHHHHHHHHHHHHHHSS-----------CCC-
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCC-----CCCchhhHHHHHHHHHHHHHCC-----------CCCC
Confidence            999999998765322    3345789999999998653     5667899999999999999995           4443


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ....... .......+.........+ .+  ...+..+.+||.+||+.||++|||+.++++|.+....
T Consensus       231 ~~~~~~~-~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          231 SNTGQAI-SPGMKRRIRLGQYGFPNP-EW--SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---------------------CCCTT-TS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             Cccchhh-hhhHHHhhhccccccCch-hh--ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            3211110 011111111111111111 11  1133479999999999999999999999999987654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.9e-42  Score=343.46  Aligned_cols=256  Identities=22%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      .++|.+.+.||+|+||.||+|+.  +++.||||++......   .....+|+.+++.++||||+++++++......  ..
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46899999999999999999998  4788999999753222   33456889999999999999999999876532  12


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||+. |+|.+++.. .+++..+..++.|++.||+|||+.           +|+||||||+|||++.++.+||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSA-----------GVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTCCEEECS
T ss_pred             eEEEEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC-----------CCcCCCcCHHHeEECCCCCEEEEe
Confidence            3489999998 699988854 499999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....     .....||+.|+|||++.+.    ..++.++|||||||++|||++|.           .||...  
T Consensus       188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~-----------~pf~~~--  245 (371)
T 4exu_A          188 FGLARHADAE-----MTGYVVTRWYRAPEVILSW----MHYNQTVDIWSVGCIMAEMLTGK-----------TLFKGK--  245 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCC----SCCCTTHHHHHHHHHHHHHHHSS-----------CSCCCS--
T ss_pred             cCcccccccC-----cCCcccCccccCHHHhcCC----CCCCcHHhHHHHHHHHHHHHhCC-----------CCCCCC--
Confidence            9999865432     3345789999999998763    36778999999999999999994           454332  


Q ss_pred             CCCCHHHHHHHHhc--------------------------cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        344 DHPSLEDMQEAVVH--------------------------KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       344 ~~~~~~~~~~~~~~--------------------------~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                         ...+....+..                          ...+..+...+  ...+..+.+||.+||+.||++|||+.+
T Consensus       246 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e  320 (371)
T 4exu_A          246 ---DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF--PRASPQAADLLEKMLELDVDKRLTAAQ  320 (371)
T ss_dssp             ---SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHS--TTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             ---ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhc--cccChHHHHHHHHHCCCChhhcCCHHH
Confidence               11111111111                          00000000000  112458999999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      +++|.+...
T Consensus       321 ll~hp~f~~  329 (371)
T 4exu_A          321 ALTHPFFEP  329 (371)
T ss_dssp             HHTSGGGTT
T ss_pred             HhcCccccc
Confidence            999998643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.4e-42  Score=337.32  Aligned_cols=256  Identities=20%  Similarity=0.260  Sum_probs=195.5

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE---CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCC------CeeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF---KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD------NILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~------nIv~l~g~~~~~~  179 (461)
                      ...++|++.+.||+|+||.||+|..   +++.||||++...........+|+.++..++|+      +|+++++++....
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            3456899999999999999999987   467899999976544445556777776666554      5999999998765


Q ss_pred             ccceeeeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-  255 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-  255 (461)
                          .+++||||+ +|+|.+++...   .+++..+..++.|++.||+|||+.           +|+||||||+|||++. 
T Consensus        91 ----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           91 ----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-----------KLTHTDLKPENILFVQS  154 (339)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESCC
T ss_pred             ----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC-----------CCcCCCCCHHHEEEecc
Confidence                459999999 88999999543   589999999999999999999999           9999999999999987 


Q ss_pred             ------------------CCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        256 ------------------DLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       256 ------------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                                        ++.+||+|||+++.....     .....||+.|+|||++.+     ..++.++||||||+++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il  224 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILA-----LGWSQPCDVWSIGCIL  224 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTT-----SCCCTHHHHHHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhC-----CCCCcchhhHHHHHHH
Confidence                              668999999999875432     234578999999999976     3678899999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhc--cC-----------------------------------C
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVH--KK-----------------------------------L  360 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~--~~-----------------------------------~  360 (461)
                      |||++|..|           |...     ...+....+..  ..                                   .
T Consensus       225 ~el~~g~~p-----------f~~~-----~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
T 1z57_A          225 IEYYLGFTV-----------FPTH-----DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC  288 (339)
T ss_dssp             HHHHHSSCS-----------CCCS-----CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred             HHHHhCCCC-----------CCCC-----ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC
Confidence            999999544           4322     11111111100  00                                   0


Q ss_pred             CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       361 ~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+...........+..+.+||.+||+.||++|||+.|+++|.+...
T Consensus       289 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            0000000011223568999999999999999999999999987644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.5e-42  Score=333.97  Aligned_cols=263  Identities=18%  Similarity=0.267  Sum_probs=197.5

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCC--CCCeeEEEEEEecCCc
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDK---QSWQSEQEIFKLPHME--HDNILRYIGAEKRGES  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~--H~nIv~l~g~~~~~~~  180 (461)
                      .....++|++.+.||+|+||.||+|+. +++.||||++.....   ......+|+.++.+++  |+||+++++++.... 
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-  101 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-  101 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS-
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC-
Confidence            344567899999999999999999998 467899999965432   2334567888888886  599999999998765 


Q ss_pred             cceeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+++||| +.+|+|.+++.. ..+++..+..++.|++.||.|||+.           +|+||||||+|||+++ +.+
T Consensus       102 ---~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivH~dlkp~NIl~~~-~~~  165 (313)
T 3cek_A          102 ---YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-----------GIVHSDLKPANFLIVD-GML  165 (313)
T ss_dssp             ---EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEEET-TEE
T ss_pred             ---EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceecCCCcccEEEEC-CeE
Confidence               4589999 567899999954 5689999999999999999999999           9999999999999964 899


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCccccccccccccc------ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN------FSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      ||+|||+++...............||+.|+|||++.+...      ....++.++||||||+++|||++|          
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g----------  235 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG----------  235 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS----------
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC----------
Confidence            9999999987654432222334578999999999865211      013567889999999999999999          


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ..||....    .................++...+     ..+.++|.+||+.||++|||+.+++++.+...
T Consensus       236 -~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          236 -KTPFQQII----NQISKLHAIIDPNHEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             -SCTTTTCC----SHHHHHHHHHCTTSCCCCCCCSC-----HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             -CCchhhHH----HHHHHHHHHHhcccccCCcccch-----HHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence             55554321    11222233344444444444332     37899999999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=346.12  Aligned_cols=259  Identities=14%  Similarity=0.165  Sum_probs=198.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC----------CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeE----------
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK----------NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR----------  170 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~----------  170 (461)
                      .++|++.+.||+|+||.||+|+..          ++.||||++...    ....+|+.++.+++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            479999999999999999999984          578999998754    24567888888889999988          


Q ss_pred             -----EEEEEecCCccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCee
Q psy17532        171 -----YIGAEKRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVA  242 (461)
Q Consensus       171 -----l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~iv  242 (461)
                           +++++....   ..+++||||+ +|+|.+++..   ..+++..+..++.||+.||.|||++           +|+
T Consensus       117 ~~i~~~~~~~~~~~---~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~iv  181 (352)
T 2jii_A          117 LAIPTCMGFGVHQD---KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN-----------EYV  181 (352)
T ss_dssp             CSCCCCCEEEEETT---TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-----------TCB
T ss_pred             cCccchhhccccCC---cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC-----------Ccc
Confidence                 566665522   2569999999 9999999964   5699999999999999999999999           999


Q ss_pred             cccCCCCcEEEcCCC--ceEEEecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHH
Q psy17532        243 HRDFKSNNVLLKSDL--TAAIADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACAL  315 (461)
Q Consensus       243 HrDLkp~NILl~~~~--~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gv  315 (461)
                      ||||||+|||++.++  .+||+|||+++.+......     .......||+.|+|||++.+.     .++.++||||||+
T Consensus       182 H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~  256 (352)
T 2jii_A          182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-----GPSRRSDLQSLGY  256 (352)
T ss_dssp             CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-----CCCHHHHHHHHHH
T ss_pred             CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-----CCCchhhHHHHHH
Confidence            999999999999998  9999999999876543211     112345799999999999763     6778999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHh--ccCCCCCCCchh-ccchhHHHHHHHHHHHccccHhhh
Q psy17532        316 VLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVV--HKKLRPTLPETW-KQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       316 il~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~p~~~-~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                      ++|||++|           ..||.....   ....+.....  .... ..++..+ .....+..+.+||.+||+.||++|
T Consensus       257 il~el~~g-----------~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  321 (352)
T 2jii_A          257 CMLKWLYG-----------FLPWTNCLP---NTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEK  321 (352)
T ss_dssp             HHHHHHHS-----------CCTTGGGTT---CHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCC
T ss_pred             HHHHHHhC-----------CCCcccCCc---CHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhC
Confidence            99999999           666655421   2222222211  1111 1111111 001123589999999999999999


Q ss_pred             ccccchhhhcHHHhhh
Q psy17532        393 LSASCVVERGMLALCD  408 (461)
Q Consensus       393 ps~~evl~~l~~~~~~  408 (461)
                      ||++++++.|..+...
T Consensus       322 ps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          322 PPYAMLRNNLEALLQD  337 (352)
T ss_dssp             CCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHh
Confidence            9999999998877653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-41  Score=362.47  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-----CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-----NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ..++|++.+.||+|+||.||+|++.     +..||||.+......  ...+.+|+.++.+++||||+++++++.++    
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN----  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            4567999999999999999999984     235899987643322  24456889999999999999999998543    


Q ss_pred             eeeeeeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       ..++||||+++|+|.++++..  .+++..+..++.|++.||.|||+.           +|+||||||+|||++.++.+|
T Consensus       464 -~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------givHrDikp~NILl~~~~~vk  531 (656)
T 2j0j_A          464 -PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-----------RFVHRDIAARNVLVSSNDCVK  531 (656)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEEEETTEEE
T ss_pred             -ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccccccchHhEEEeCCCCEE
Confidence             348999999999999999643  589999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~  339 (461)
                      |+|||+++....... .......+|+.|+|||++.+     ..++.++||||||+++|||++ |           ..||.
T Consensus       532 L~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ellt~g-----------~~Pf~  594 (656)
T 2j0j_A          532 LGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHG-----------VKPFQ  594 (656)
T ss_dssp             ECCCCCCCSCCC-----------CCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCTTT
T ss_pred             EEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcC-----CCCCchhhHHHHHHHHHHHHHcC-----------CCCCC
Confidence            999999987754332 22333467889999999865     367789999999999999997 7           56665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..     ...+....+... .++.++..++     ..+.+||.+||+.||++|||+.++++.|..+..
T Consensus       595 ~~-----~~~~~~~~i~~~-~~~~~~~~~~-----~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          595 GV-----KNNDVIGRIENG-ERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             TC-----CHHHHHHHHHHT-CCCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-----CHHHHHHHHHcC-CCCCCCcccc-----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            43     334444444433 3344554443     389999999999999999999999999877653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=337.12  Aligned_cols=256  Identities=22%  Similarity=0.340  Sum_probs=195.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      .++|.+.+.||+|+||.||+|+.  +|+.||||++......   .....+|+.++..++||||+++++++......  ..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36899999999999999999998  4788999998653221   23456889999999999999999998776432  12


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||+. |+|.+++.. .+++..+..++.||+.||.|||+.           +|+||||||+|||++.++.+||+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~-----------~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSA-----------GVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSSCCGGGEEECTTCCEEECS
T ss_pred             eEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEeECCCCcEEEee
Confidence            4589999998 699998864 499999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....     .....||+.|+|||++.+.    ..++.++||||||+++|||++|           ..||...  
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~----~~~~~~~Di~slG~il~el~~g-----------~~pf~~~--  227 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSW----MHYNQTVDIWSVGCIMAEMLTG-----------KTLFKGK--  227 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCC----SCCCTTHHHHHHHHHHHHHHHS-----------SCSSBSS--
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCc----CCCCchhhHHHHHHHHHHHHhC-----------CCCCCCC--
Confidence            9999865432     2345789999999998753    3567889999999999999999           4555432  


Q ss_pred             CCCCHHHHHHHHhc--------------------------cCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        344 DHPSLEDMQEAVVH--------------------------KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       344 ~~~~~~~~~~~~~~--------------------------~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                         ...+....+..                          ...+..+...++  ..+..+.+||.+||+.||++|||+++
T Consensus       228 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~e  302 (353)
T 3coi_A          228 ---DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP--RASPQAADLLEKMLELDVDKRLTAAQ  302 (353)
T ss_dssp             ---CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCT--TSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             ---CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcC--CcCHHHHHHHHHHcCCCcccCCCHHH
Confidence               11111111110                          011111111111  13458999999999999999999999


Q ss_pred             hhhhcHHHh
Q psy17532        398 VVERGMLAL  406 (461)
Q Consensus       398 vl~~l~~~~  406 (461)
                      +++|.+...
T Consensus       303 ~l~hp~f~~  311 (353)
T 3coi_A          303 ALTHPFFEP  311 (353)
T ss_dssp             HHTSGGGTT
T ss_pred             HhcCcchhh
Confidence            999988643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=350.36  Aligned_cols=266  Identities=22%  Similarity=0.270  Sum_probs=183.1

Q ss_pred             ceeE-EeEeecCCceEEEEEEEC----CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQL-VEVKAQGRFGAVWKAKFK----NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~-~~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .|++ .++||+|+||.||+|++.    ++.||||++..... .....+|+.++..++||||+++++++.....  ..+++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHAD--RKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT--TEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC--CeEEE
Confidence            4555 458999999999999974    57899999864432 3356689999999999999999999865332  35699


Q ss_pred             eehhccCCChhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE----
Q psy17532        188 ITAYHERGSLCDFLKC----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL----  253 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl----  253 (461)
                      ||||+. |+|.+++..          ..+++..+..++.||+.||+|||+.           +|+||||||+|||+    
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----------~ivH~Dlkp~NIll~~~~  165 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-----------WVLHRDLKPANILVMGEG  165 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECCSS
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeCCCcCHHHeEEecCC
Confidence            999997 488888742          1489999999999999999999999           99999999999999    


Q ss_pred             cCCCceEEEecCCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q psy17532        254 KSDLTAAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG  332 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~  332 (461)
                      +.++.+||+|||+|+.+..... ........||+.|+|||++.+.    ..++.++|||||||++|||++|..||.....
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTC----CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC----CcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            6779999999999987654321 1223446799999999998763    3577899999999999999999777654332


Q ss_pred             CC--CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhcc--------------------------------chhHHHHH
Q psy17532        333 EY--RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQ--------------------------------HAGMLALC  378 (461)
Q Consensus       333 ~~--~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--------------------------------~~~~~~l~  378 (461)
                      ..  ..++        ..+. ...+....-. +....|..                                ...+..+.
T Consensus       242 ~~~~~~~~--------~~~~-l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (405)
T 3rgf_A          242 DIKTSNPY--------HHDQ-LDRIFNVMGF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF  311 (405)
T ss_dssp             -----CCC--------CHHH-HHHHHHHHCC-CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHH
T ss_pred             cccccccc--------hHHH-HHHHHHhhCC-CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHH
Confidence            11  0111        1111 1111110000 00000000                                00134788


Q ss_pred             HHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        379 DTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       379 ~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      +||.+||..||++|||++|+++|.|+...
T Consensus       312 ~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          312 HLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             HHHHHHccCCcccCCCHHHHhcChhhccC
Confidence            99999999999999999999999987653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-41  Score=339.94  Aligned_cols=197  Identities=26%  Similarity=0.288  Sum_probs=160.1

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CC-----CeeEEEEEEecCC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HD-----NILRYIGAEKRGE  179 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~-----nIv~l~g~~~~~~  179 (461)
                      ....++|++.+.||+|+||.||+|+..  ++.||||++............|+.++..++ |+     +|+++++++....
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            334679999999999999999999984  678999999755433344456666655553 44     5999999998765


Q ss_pred             ccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc--
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK--  254 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~--  254 (461)
                          .+++||||++ |+|.+++..   ..+++..+..++.|++.||.|||++         ..+|+||||||+|||++  
T Consensus       130 ----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---------~~~ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          130 ----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP---------ELSIIHCDLKPENILLCNP  195 (382)
T ss_dssp             ----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST---------TTCEECCCCSGGGEEESST
T ss_pred             ----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC---------CCCEEcCCCCcccEEEecC
Confidence                4599999996 599999954   3589999999999999999999953         22899999999999995  


Q ss_pred             CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q psy17532        255 SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVS  328 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~  328 (461)
                      .++.+||+|||+++.....     .....||+.|+|||++.+.     .++.++|||||||++|||++|..||.
T Consensus       196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGM-----PYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCC-----CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            4788999999999876532     2346789999999999763     67889999999999999999955543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-41  Score=330.63  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=179.8

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh--hhHHHHHHH-HcCCCCCCCeeEEEEEEecCCccc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ--SWQSEQEIF-KLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~ei~-~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....++|++.+.||+|+||.||+|..+  ++.||||++......  ......|+. .++.++||||+++++++...+   
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~---   94 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG---   94 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS---
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC---
Confidence            345689999999999999999999995  788999999754322  223344554 677889999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc------CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        183 TEFWLITAYHERGSLCDFLK------CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                       ..++||||+++ +|.+++.      ...+++..+..++.|++.||.|||+..          +|+||||||+|||++.+
T Consensus        95 -~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----------~ivH~dlkp~NIll~~~  162 (327)
T 3aln_A           95 -DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL----------KIIHRDIKPSNILLDRS  162 (327)
T ss_dssp             -EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH----------SCCCSCCCGGGEEEETT
T ss_pred             -ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC----------CEeECCCCHHHEEEcCC
Confidence             45899999985 8888875      567999999999999999999999853          89999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+++......   ......||..|+|||++.+.. ....++.++||||||+++|||++|..           
T Consensus       163 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~-----------  227 (327)
T 3aln_A          163 GNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSA-SRQGYDVRSDVWSLGITLYELATGRF-----------  227 (327)
T ss_dssp             TEEEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCC-----------
T ss_pred             CCEEEccCCCceeccccc---ccccCCCCccccCceeecccc-CcCCCCchhhHHHHHHHHHHHHHCCC-----------
Confidence            999999999998765432   122347899999999985321 12357789999999999999999954           


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ||.....   . .+....+. ....+.++.... ...+..+.+||.+||+.||++|||+.+++++.+....
T Consensus       228 pf~~~~~---~-~~~~~~~~-~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          228 PYPKWNS---V-FDQLTQVV-KGDPPQLSNSEE-REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CSSCC-----------CCCC-CSCCCCCCCCSS-CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCcch---H-HHHHHHHh-cCCCCCCCCccc-ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            4432210   0 00000111 111122221100 1133489999999999999999999999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-41  Score=332.09  Aligned_cols=259  Identities=23%  Similarity=0.278  Sum_probs=194.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCChh---hhHHHHHHHHcCC---CCCCCeeEEEEEEecCC-
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDKQ---SWQSEQEIFKLPH---MEHDNILRYIGAEKRGE-  179 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~---~~~~~~ei~~l~~---l~H~nIv~l~g~~~~~~-  179 (461)
                      ..++|++.+.||+|+||.||+|+..   ++.||||++......   .....+|+.++..   ++||||+++++++.... 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3478999999999999999999983   578999998643221   2233455555444   48999999999986321 


Q ss_pred             ccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      .....+++||||++ |+|.+++..   ..+++..+..++.|++.||.|||+.           +|+||||||+|||++.+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------gi~H~dlkp~Nili~~~  156 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-----------RVVHRDLKPQNILVTSS  156 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTT
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CceeccCCHHHeEEcCC
Confidence            12346799999998 699999854   3489999999999999999999999           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+++......   ......||..|+|||++.+.     .++.++||||||+++|||++|.           .
T Consensus       157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~-----------~  217 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS-----SYATPVDLWSVGCIFAEMFRRK-----------P  217 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSS-----------C
T ss_pred             CCEEEecCcccccccCCC---CccccccccceeCHHHHhcC-----CCCcchhHHHHHHHHHHHHcCC-----------C
Confidence            999999999998764322   23345789999999998763     5778999999999999999994           4


Q ss_pred             CCccccCCCCCHHHHHHHHhccCC----------------------CCCCCchhccchhHHHHHHHHHHHccccHhhhcc
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKL----------------------RPTLPETWKQHAGMLALCDTMEECWDHDAEARLS  394 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps  394 (461)
                      ||...     ........+.....                      ...+.. + ....+..+.+||.+||+.||++|||
T Consensus       218 pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~li~~~L~~dP~~Rpt  290 (326)
T 1blx_A          218 LFRGS-----SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK-F-VTDIDELGKDLLLKCLTFNPAKRIS  290 (326)
T ss_dssp             SCCCS-----SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG-T-CCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred             CCCCC-----CHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhh-c-cccCCHHHHHHHHHHcCCCcccCCC
Confidence            44332     12222222211000                      000000 0 0113457899999999999999999


Q ss_pred             ccchhhhcHHHh
Q psy17532        395 ASCVVERGMLAL  406 (461)
Q Consensus       395 ~~evl~~l~~~~  406 (461)
                      +.++++|.+...
T Consensus       291 ~~e~l~hp~~~~  302 (326)
T 1blx_A          291 AYSALSHPYFQD  302 (326)
T ss_dssp             HHHHHTSGGGTT
T ss_pred             HHHHhcCccccc
Confidence            999999987644

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.5e-42  Score=334.03  Aligned_cols=245  Identities=19%  Similarity=0.256  Sum_probs=195.2

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh-------hhHHHHHHHHcCCCC--CCCeeEEEEEEec
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ-------SWQSEQEIFKLPHME--HDNILRYIGAEKR  177 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-------~~~~~~ei~~l~~l~--H~nIv~l~g~~~~  177 (461)
                      ...++|++.+.||+|+||.||+|+.  +++.||||++......       .....+|+.++.+++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999998  5788999999754321       123346777777775  6999999999987


Q ss_pred             CCccceeeeeeehhccC-CChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc-
Q psy17532        178 GESIHTEFWLITAYHER-GSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-  254 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~-gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~-  254 (461)
                      ..    .+++||||+.+ ++|.+++. ...+++..+..++.|++.||+|||+.           +|+||||||+|||++ 
T Consensus       120 ~~----~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          120 PD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-----------GVLHRDIKDENILIDL  184 (320)
T ss_dssp             SS----EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEET
T ss_pred             CC----cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcEeCCCCHHHEEEeC
Confidence            65    45899999976 89999985 45799999999999999999999999           999999999999999 


Q ss_pred             CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC
Q psy17532        255 SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY  334 (461)
Q Consensus       255 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~  334 (461)
                      +++.+||+|||+++......    .....||+.|+|||++.+.    ...+.++||||||+++|||++|           
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~el~~g-----------  245 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYH----RYHGRSAAVWSLGILLYDMVCG-----------  245 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHS----CBCHHHHHHHHHHHHHHHHHHS-----------
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccC----CCCCccchHHhHHHHHHHHHHC-----------
Confidence            78999999999998775432    2345789999999998753    2235678999999999999999           


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ..||...       ...    ....  ..++..+     +..+.+||.+||+.||++|||+++++++.+..
T Consensus       246 ~~pf~~~-------~~~----~~~~--~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          246 DIPFEHD-------EEI----IRGQ--VFFRQRV-----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             SCSCCSH-------HHH----HHCC--CCCSSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             CCCCCCh-------hhh----hccc--ccccccC-----CHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence            5666432       111    1111  1222222     23789999999999999999999999998653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=345.41  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=188.7

Q ss_pred             ccCCcceeEEeEeecCCceE-EEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGA-VWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .....+|++.++||+|+||+ ||++..+++.||||++......  ...+|+.++..+ +|||||++++++.+..    .+
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~--~~~~E~~~l~~l~~HpnIv~l~~~~~~~~----~~   93 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--FADREVQLLRESDEHPNVIRYFCTEKDRQ----FQ   93 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE--ECHHHHHHHHHSCCCTTBCCEEEEEEETT----EE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH--HHHHHHHHHHhccCCCCcCeEEEEEecCC----EE
Confidence            34556799999999999998 5666678999999998654332  345678878787 8999999999998765    45


Q ss_pred             eeeehhccCCChhhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-----CCc
Q psy17532        186 WLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-----DLT  258 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-----~~~  258 (461)
                      ++||||+. |+|.+++....  +....+..++.||+.||.|||+.           +|+||||||+|||++.     ...
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDlKp~NIll~~~~~~~~~~  161 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL-----------NIVHRDLKPHNILISMPNAHGKIK  161 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT-----------TCCCCCCSTTSEEECCCBTTTBCC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC-----------cCEeCCCCHHHEEEecCCCCCcee
Confidence            99999997 59999996543  45556789999999999999999           9999999999999953     346


Q ss_pred             eEEEecCCccccCCCCC-CCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKP-CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      +||+|||+|+.+..... ........||+.|+|||++.+.  ....++.++|||||||++|||++ |           ..
T Consensus       162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~t~~~DiwSlG~il~ellt~g-----------~~  228 (432)
T 3p23_A          162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED--CKENPTYTVDIFSAGCVFYYVISEG-----------SH  228 (432)
T ss_dssp             EEECCTTEEECC------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTS-----------CB
T ss_pred             EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc--cccCCCcHHHHHHHHHHHHHHHcCC-----------CC
Confidence            88999999987754321 1223456799999999999752  12356678999999999999999 6           55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ||...     ..... .............   .....+..+.+||.+||+.||++|||+.++++|.+..
T Consensus       229 pf~~~-----~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~  288 (432)
T 3p23_A          229 PFGKS-----LQRQA-NILLGACSLDCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW  288 (432)
T ss_dssp             TTBST-----TTHHH-HHHTTCCCCTTSC---TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred             Ccchh-----hHHHH-HHHhccCCccccC---ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence            66432     11111 1221111111111   1122345688999999999999999999999998763

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.7e-42  Score=341.24  Aligned_cols=262  Identities=22%  Similarity=0.259  Sum_probs=197.5

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC-----------CCCeeEEEEEE
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME-----------HDNILRYIGAE  175 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-----------H~nIv~l~g~~  175 (461)
                      ....+|++.+.||+|+||.||+|+.  +++.||||++...........+|+.++.+++           |+||+++++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            3457899999999999999999997  5788999999765444455667777777665           89999999998


Q ss_pred             ecCCccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEE
Q psy17532        176 KRGESIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVL  252 (461)
Q Consensus       176 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NIL  252 (461)
                      .........+++||||+ +|+|.+++..   ..+++..+..++.||+.||+|||++.          +|+||||||+|||
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~----------~ivH~Dikp~NIl  164 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC----------GIIHTDIKPENVL  164 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT----------CEECSCCSGGGEE
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC----------CEEecCCChHHeE
Confidence            76543334679999999 8899999854   45999999999999999999999842          8999999999999


Q ss_pred             Ec------CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCC
Q psy17532        253 LK------SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS  326 (461)
Q Consensus       253 l~------~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~  326 (461)
                      ++      ..+.+||+|||+++.....     .....||+.|+|||++.+.     .++.++|||||||++|||++|..|
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA-----PWGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC-----CCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC-----CCCchHhHHHHHHHHHHHHhCCCC
Confidence            95      3458999999999876532     2335789999999999763     577899999999999999999555


Q ss_pred             CCCCCCCCCCCCccccCCCC-CHHHHHHHHhcc-CC---------------------------------------CCCCC
Q psy17532        327 VSPPPGEYRLPFSAEVGDHP-SLEDMQEAVVHK-KL---------------------------------------RPTLP  365 (461)
Q Consensus       327 ~~~~~~~~~~pf~~~~~~~~-~~~~~~~~~~~~-~~---------------------------------------~~~~p  365 (461)
                      |.....           ... ........+... +.                                       ...++
T Consensus       235 f~~~~~-----------~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
T 1q8y_A          235 FEPDEG-----------HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS  303 (373)
T ss_dssp             C--------------------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred             CCCCcc-----------cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC
Confidence            432221           100 011111111100 00                                       00111


Q ss_pred             chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        366 ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       366 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                           ...+..+.+||.+||+.||++|||++++++|.+....
T Consensus       304 -----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          304 -----KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             -----HHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             -----cchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence                 1244689999999999999999999999999986553

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-41  Score=343.56  Aligned_cols=257  Identities=23%  Similarity=0.334  Sum_probs=184.2

Q ss_pred             cceeEEeEeecCCceEEEE-EEECCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWK-AKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~-~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      +.|...++||+|+||+||. +..+|+.||||++.....  ....+|+.++.++ +|||||++++++.+..    .+++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESDDHPNVIRYYCSETTDR----FLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH--HHHHHHHHHHHHHTTSTTBCCEEEEEECSS----EEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCC----eEEEEE
Confidence            4456678999999999965 455789999999875432  2345777777765 8999999999988765    459999


Q ss_pred             hhccCCChhhhhcCCCC--------CHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC-----
Q psy17532        190 AYHERGSLCDFLKCNIV--------TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-----  256 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l--------~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~-----  256 (461)
                      ||+. |+|.+++.....        ++..+..++.||+.||+|||+.           +|+||||||+|||++.+     
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------~ivHrDLkp~NILl~~~~~~~~  156 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-----------KIIHRDLKPQNILVSTSSRFTA  156 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEECCHHHHS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-----------CccccCCChHhEEEecCccccc
Confidence            9996 699999965432        2234577999999999999999           99999999999999754     


Q ss_pred             --------CceEEEecCCccccCCCCCCC--CCCCCcCCCccccccccccccc--ccCCCCCccchHHHHHHHHHHHc-C
Q psy17532        257 --------LTAAIADFGLALLFEPGKPCG--DTHGQVGTRRYMAPEVLEGAIN--FSRDAFLRIDMYACALVLWELAS-R  323 (461)
Q Consensus       257 --------~~~ki~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~k~DVwS~Gvil~el~t-g  323 (461)
                              +.+||+|||+++.........  ......||+.|+|||++.+...  ....++.++|||||||++|||++ |
T Consensus       157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g  236 (434)
T 2rio_A          157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG  236 (434)
T ss_dssp             CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence                    489999999998876543211  1234579999999999975211  12467889999999999999999 7


Q ss_pred             CCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       324 ~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                                 ..||....    . ..  ..+..................+.++.+||.+||+.||++|||+.++++|.+
T Consensus       237 -----------~~Pf~~~~----~-~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          237 -----------KHPFGDKY----S-RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             -----------CCTTCSTT----T-HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             -----------CCCCCCch----h-hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence                       55654321    1 11  122222222111111112234568999999999999999999999999987


Q ss_pred             H
Q psy17532        404 L  404 (461)
Q Consensus       404 ~  404 (461)
                      .
T Consensus       299 f  299 (434)
T 2rio_A          299 F  299 (434)
T ss_dssp             G
T ss_pred             c
Confidence            6

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-41  Score=332.76  Aligned_cols=257  Identities=19%  Similarity=0.211  Sum_probs=194.4

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--C-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCC------eeEEEEEEecCC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--N-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN------ILRYIGAEKRGE  179 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n------Iv~l~g~~~~~~  179 (461)
                      ...++|++.+.||+|+||.||+|+..  + +.||||++...........+|+.++..++|+|      ++.+++++....
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            34578999999999999999999984  3 57999999765444455567777777776555      999999988755


Q ss_pred             ccceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---
Q psy17532        180 SIHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---  253 (461)
Q Consensus       180 ~~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---  253 (461)
                          .+++||||+ +|+|.+++..   ..+++..+..++.||+.||+|||+.           +|+||||||+|||+   
T Consensus        96 ----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-----------~ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           96 ----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN-----------QLTHTDLKPENILFVNS  159 (355)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCCGGGEEESCC
T ss_pred             ----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CcccCCCCHHHEEEecc
Confidence                459999999 5678777743   3599999999999999999999998           99999999999999   


Q ss_pred             ----------------cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        254 ----------------KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       254 ----------------~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                                      +.++.+||+|||+++.....     .....||+.|+|||++.+     ..++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il  229 (355)
T 2eu9_A          160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILE-----LGWAQPCDVWSIGCIL  229 (355)
T ss_dssp             CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeec-----CCCCCccchHHHHHHH
Confidence                            66889999999999875432     234579999999999976     3677899999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhc--cC-----------------------------------C
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVH--KK-----------------------------------L  360 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~--~~-----------------------------------~  360 (461)
                      |||++|..|           |...     ...+....+..  +.                                   .
T Consensus       230 ~el~~g~~p-----------f~~~-----~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (355)
T 2eu9_A          230 FEYYRGFTL-----------FQTH-----ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC  293 (355)
T ss_dssp             HHHHHSSCS-----------CCCS-----SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred             HHHHhCCCC-----------CCCC-----CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC
Confidence            999999544           4322     11111111100  00                                   0


Q ss_pred             CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        361 RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       361 ~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .+...........+..+.+||.+||+.||++|||+.++++|.+....
T Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             CcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence            00000001112234588999999999999999999999999876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-41  Score=348.20  Aligned_cols=260  Identities=19%  Similarity=0.196  Sum_probs=196.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCC-CeeEEEEEEecCCccceeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD-NILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~-nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .++|++.+.||+|+||.||+|++  .++.||||++...... .+...|+.++..++|. +|..+..++....    ..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~E~~il~~L~~~~~i~~i~~~~~~~~----~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGVEGD----YNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-CCHHHHHHHHHHTTTSTTCCCEEEEEEETT----EEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC----EEEE
Confidence            46899999999999999999997  4789999988654332 2455677777788764 4555555554433    4589


Q ss_pred             eehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE---cCCCceEEE
Q psy17532        188 ITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL---KSDLTAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl---~~~~~~ki~  262 (461)
                      ||||+ +|+|.+++.  ...+++..++.++.||+.||+|||+.           +|+||||||+||||   +.++.+||+
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----------gIvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-----------SFLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEeecccCcceEEEecCCCCCeEEEE
Confidence            99999 899999996  56799999999999999999999999           99999999999999   688999999


Q ss_pred             ecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        263 DFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       263 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      |||+++.+......     .......||..|+|||++.+.     .++.++|||||||+||||++|           ..|
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDvwSlGvil~elltG-----------~~P  212 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-----EQSRRDDLESLGYVLMYFLRG-----------SLP  212 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHS-----------SCT
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCC-----CCChHHHHHHHHHHHHHHHhC-----------CCC
Confidence            99999877544321     123356799999999999763     677899999999999999999           555


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      |.....  ....+....+........+...+  ...+.++.+||..||+.||++||++.++++.+..+..
T Consensus       213 f~~~~~--~~~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          213 WQGLKA--GTKKQKYEKISEKKVATSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             TSSCCC--SSHHHHHHHHHHHHHHSCHHHHH--TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             Cccccc--hhHHHHHHHHhhccccccHHHHh--cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            544311  12222233322221111111110  1123479999999999999999999999998877754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=325.89  Aligned_cols=262  Identities=20%  Similarity=0.291  Sum_probs=182.9

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhh--hHH-HHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQS--WQS-EQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~-~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ....++|++.+.||+|+||.||+|++  +++.||||++.......  ... ..+...+..++||||+++++++....   
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~---   97 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT---   97 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC---
Confidence            34567899999999999999999999  47899999997553322  122 23334567789999999999998765   


Q ss_pred             eeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        183 TEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                       .+++||||+ ++.+..+..  ...+++..+..++.|++.||.|||+ .           +|+||||||+|||++.++.+
T Consensus        98 -~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----------~i~H~dlkp~Nil~~~~~~~  164 (318)
T 2dyl_A           98 -DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-----------GVIHRDVKPSNILLDERGQI  164 (318)
T ss_dssp             -EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH-----------CCCCCCCCGGGEEECTTSCE
T ss_pred             -cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC-----------CEEeCCCCHHHEEECCCCCE
Confidence             459999999 445555543  4579999999999999999999998 5           89999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+++......   ......||+.|+|||++.+.......++.++||||||+++|||++|           ..||.
T Consensus       165 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g-----------~~pf~  230 (318)
T 2dyl_A          165 KLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG-----------QFPYK  230 (318)
T ss_dssp             EECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS-----------SCTTT
T ss_pred             EEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC-----------CCCCC
Confidence            999999997765432   1234578999999999864322234677899999999999999999           55664


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..    ....+....+.... .+.++..   ...+..+.+||.+||+.||++|||+.++++|.+....
T Consensus       231 ~~----~~~~~~~~~~~~~~-~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          231 NC----KTDFEVLTKVLQEE-PPLLPGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             TC----CSHHHHHHHHHHSC-CCCCCSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CC----CccHHHHHHHhccC-CCCCCcc---CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            32    12233333333322 2223221   1123479999999999999999999999999876543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=333.54  Aligned_cols=245  Identities=19%  Similarity=0.291  Sum_probs=188.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-------hhhHHHHHHHHcCCC----CCCCeeEEEEEE
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-------QSWQSEQEIFKLPHM----EHDNILRYIGAE  175 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l----~H~nIv~l~g~~  175 (461)
                      .-.++|++.+.||+|+||.||+|+.  +++.||||++.....       ......+|+.++.++    +|+||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999988  577899999865432       112234577766666    899999999998


Q ss_pred             ecCCccceeeeeeehh-ccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        176 KRGESIHTEFWLITAY-HERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       176 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ...+    .+++|||| +.+++|.+++. ...+++..+..++.||+.||.|||+.           +|+||||||+|||+
T Consensus       108 ~~~~----~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          108 ETQE----GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR-----------GVVHRDIKDENILI  172 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH-----------TEECCCCSGGGEEE
T ss_pred             ecCC----eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecCCChhhEEE
Confidence            7755    34899999 78999999995 45699999999999999999999999           99999999999999


Q ss_pred             c-CCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCC
Q psy17532        254 K-SDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPG  332 (461)
Q Consensus       254 ~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~  332 (461)
                      + .++.+||+|||+++......    .....||..|+|||++.+.    ...+.++||||||+++|||++|         
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g---------  235 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH----QYHALPATVWSLGILLYDMVCG---------  235 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS----CBCHHHHHHHHHHHHHHHHHHS---------
T ss_pred             eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecC----CCCCccchHHHHHHHHHHHHHC---------
Confidence            9 88999999999998775432    3345689999999998753    1223579999999999999999         


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        333 EYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       333 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                        ..||...       .+.    ...  ...++..++     ..+.+||.+||+.||++|||+.++++|.+..
T Consensus       236 --~~pf~~~-------~~~----~~~--~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          236 --DIPFERD-------QEI----LEA--ELHFPAHVS-----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             --SCSCCSH-------HHH----HHT--CCCCCTTSC-----HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             --CCCCCCh-------HHH----hhh--ccCCcccCC-----HHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence              5666432       111    111  122333332     3789999999999999999999999997653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6e-39  Score=310.66  Aligned_cols=241  Identities=15%  Similarity=0.145  Sum_probs=178.4

Q ss_pred             cCCcceeEE-eEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHc-CCCCCCCeeEEEEEEecCCcccee
Q psy17532        109 QGCRSIQLV-EVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKL-PHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       109 ~~~~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l-~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ...++|.+. +.||+|+||.||+|..  +++.||||++...    ....+|+.++ ..++||||+++++++.........
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            445678887 7899999999999998  4788999998642    2344566555 456899999999998762222345


Q ss_pred             eeeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCc
Q psy17532        185 FWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLT  258 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~  258 (461)
                      +++||||+++|+|.+++...   .+++..+..++.|++.||.|||+.           +|+||||||+|||++.   ++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------~i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-----------NIAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESSSSTTCC
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCCCCHHHEEEecCCCCCc
Confidence            79999999999999999643   599999999999999999999999           9999999999999998   789


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||++.....                             ..++.++|||||||++|||++|..||...........
T Consensus       159 ~kl~Dfg~a~~~~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  209 (299)
T 3m2w_A          159 LKLTDFGFAKETTG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG  209 (299)
T ss_dssp             EEECCCTTCEECTT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC
T ss_pred             EEEecccccccccc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH
Confidence            99999999865321                             1345678999999999999999555432211100000


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                                  +...+..  ....++... ....+..+.+||.+||+.||++|||+.++++|.+.....
T Consensus       210 ------------~~~~~~~--~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          210 ------------MKTRIRM--GQYEFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ------------SCCSSCT--TCCSSCHHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ------------HHHHHhh--ccccCCchh-cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                        0000000  001111100 011335899999999999999999999999999876653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-39  Score=347.96  Aligned_cols=240  Identities=16%  Similarity=0.160  Sum_probs=186.6

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE---CCCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc-e
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF---KNENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH-T  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~-~  183 (461)
                      ..++|++.+.||+|+||.||+|.+   +++.||||++.....  ....+.+|+.++.+++||||+++++++....... .
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            347899999999999999999998   368899998864332  2334578999999999999999999988755321 1


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ..|+||||+++|+|.+++.. .+++..++.++.||+.||.|||++           +|+||||||+|||++.+ .+||+|
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~-----------giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSI-----------GLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             EEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECSS-CEEECC
T ss_pred             eeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC-----------CCeecccChHHeEEeCC-cEEEEe
Confidence            25899999999999998866 799999999999999999999999           99999999999999986 899999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++.....      ....||+.|+|||++.+.      .+.++|||||||++|||++|.++           |.....
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~------~~~~sDi~slG~~l~~l~~g~~~-----------~~~~~~  281 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG------PTVATDIYTVGRTLAALTLDLPT-----------RNGRYV  281 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC------SCHHHHHHHHHHHHHHHHSCCCE-----------ETTEEC
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC------CCCceehhhhHHHHHHHHhCCCC-----------Cccccc
Confidence            9999876532      345799999999998652      36789999999999999999443           332110


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .                  .++...+....+..+.+||.+||+.||++||++.+++.+.+
T Consensus       282 ~------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          282 D------------------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             S------------------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             c------------------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence            0                  00110011112247889999999999999997766665543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.3e-40  Score=322.84  Aligned_cols=250  Identities=16%  Similarity=0.185  Sum_probs=187.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChh---------hhHHHHHHHHcCCCC---------CCCeeEE
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ---------SWQSEQEIFKLPHME---------HDNILRY  171 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~~~ei~~l~~l~---------H~nIv~l  171 (461)
                      ..++|++.+.||+|+||.||+|+++++.||||++......         .....+|+.+++.++         |||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            4578999999999999999999999999999999754321         134456776666554         8888888


Q ss_pred             EEEEecCCc--------------------------cceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q psy17532        172 IGAEKRGES--------------------------IHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHL  225 (461)
Q Consensus       172 ~g~~~~~~~--------------------------~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yL  225 (461)
                      .+++.....                          ....+++||||+++|++.+.+....+++..+..++.||+.||+||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence            887542100                          023569999999999888877777899999999999999999999


Q ss_pred             h-hcccCCCcCCCCCCeecccCCCCcEEEcCCC--------------------ceEEEecCCccccCCCCCCCCCCCCcC
Q psy17532        226 H-EEILPNKADSYKPAVAHRDFKSNNVLLKSDL--------------------TAAIADFGLALLFEPGKPCGDTHGQVG  284 (461)
Q Consensus       226 H-~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~g  284 (461)
                      | +.           +|+||||||+|||++.++                    .+||+|||+|+.....       ...|
T Consensus       178 H~~~-----------~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~g  239 (336)
T 2vuw_A          178 EASL-----------RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVF  239 (336)
T ss_dssp             HHHH-----------CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEEC
T ss_pred             HHhC-----------CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEE
Confidence            9 88           999999999999999887                    8999999999876532       2479


Q ss_pred             CCcccccccccccccccCCCCCccchHHHHHH-HHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccC-CCC
Q psy17532        285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALV-LWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKK-LRP  362 (461)
Q Consensus       285 t~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvi-l~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  362 (461)
                      |+.|||||++.+.     . +.++||||||++ .+++++|           ..||....    ........+.... ...
T Consensus       240 t~~y~aPE~~~g~-----~-~~~~Diwsl~~~~~~~~~~g-----------~~p~~~~~----~~~~~~~~~~~~~~~~~  298 (336)
T 2vuw_A          240 CDVSMDEDLFTGD-----G-DYQFDIYRLMKKENNNRWGE-----------YHPYSNVL----WLHYLTDKMLKQMTFKT  298 (336)
T ss_dssp             CCCTTCSGGGCCC-----S-SHHHHHHHHHHHHHTTCTTS-----------CCTHHHHH----HHHHHHHHHHHTCCCSS
T ss_pred             eecccChhhhcCC-----C-ccceehhhhhCCCCcccccc-----------cCCCcchh----hhhHHHHhhhhhhccCc
Confidence            9999999999863     2 678999998777 7778888           55664310    0011222322211 111


Q ss_pred             CCCchhccchhHHHHHHHHHHHccccHhhhccccchh-hhcHH
Q psy17532        363 TLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV-ERGML  404 (461)
Q Consensus       363 ~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl-~~l~~  404 (461)
                      ..+... ....+.++.+||++||+.|     |++|++ +|.+.
T Consensus       299 ~~~~~~-~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f  335 (336)
T 2vuw_A          299 KCNTPA-MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF  335 (336)
T ss_dssp             CCCSHH-HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred             ccchhh-hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCc
Confidence            111111 1225568999999999987     999999 88763

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-40  Score=347.49  Aligned_cols=282  Identities=20%  Similarity=0.219  Sum_probs=197.0

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--  180 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--  180 (461)
                      +....++|++.+.||+|+||.||+|.+  +++.||||++....  .......+|+.++.+++||||+++++++.....  
T Consensus         9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A            9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            334557899999999999999999998  47889999986432  223445679999999999999999998765211  


Q ss_pred             cceeeeeeehhccCCChhhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKCN----IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      .....++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.           +|+||||||+|||++.+
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~-----------gIVHrDLKP~NILl~~~  157 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN-----------RIIHRDLKPENIVLQPG  157 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT-----------TBCCCCCCSTTEEEECC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCccCCCCHHHeEeecC
Confidence            123568999999999999999643    489999999999999999999999           99999999999999976


Q ss_pred             Cc---eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC
Q psy17532        257 LT---AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE  333 (461)
Q Consensus       257 ~~---~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~  333 (461)
                      +.   +||+|||+++......   ......||..|+|||++.+     ..++.++||||||+++|||++|..||.+....
T Consensus       158 g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~  229 (676)
T 3qa8_A          158 PQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQ-----KKYTVTVDYWSFGTLAFECITGFRPFLPNWQP  229 (676)
T ss_dssp             SSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCC-----SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred             CCceeEEEccccccccccccc---ccccccCCcccCChHHhcc-----CCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence            54   9999999998876543   2334679999999999876     36778999999999999999997666432110


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhccC----CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhhh
Q psy17532        334 YRLPFSAEVGDHPSLEDMQEAVVHKK----LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCDT  409 (461)
Q Consensus       334 ~~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~  409 (461)
                      .  .+...................+.    .....+.... ...+..+.+||.+||..||++|||+.++++|.++.....
T Consensus       230 ~--~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~-~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          230 V--QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLS-GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             H--HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCC-GGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             h--hhhhhhhcccchhhhhhhhhccccccccccCCchhhc-hhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            0  00000000000000000000000    0011111111 224568999999999999999999999999888765544


Q ss_pred             h
Q psy17532        410 M  410 (461)
Q Consensus       410 ~  410 (461)
                      +
T Consensus       307 i  307 (676)
T 3qa8_A          307 I  307 (676)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-39  Score=312.40  Aligned_cols=230  Identities=14%  Similarity=0.070  Sum_probs=175.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||.||+|++.  ++.||||++......    ...+.+|+..+.+++||||+++++++.+.+    .
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~  105 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA----G  105 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----E
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC----c
Confidence            367999999999999999999995  788999998754332    245568888899999999999999998765    4


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|+||||+++|+|.++++.+. ...++..++.|++.||+|||++           +|+||||||+|||++.++.+||+++
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~-----------givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRA-----------GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHC-----------CCccCCCCcccEEEcCCCCEEEEec
Confidence            599999999999999997654 5667899999999999999999           9999999999999999999999844


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |                      |++|            ++.++|||||||++|||++|..||..............   
T Consensus       174 ~----------------------~~~~------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~---  216 (286)
T 3uqc_A          174 A----------------------TMPD------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---  216 (286)
T ss_dssp             C----------------------CCTT------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---
T ss_pred             c----------------------ccCC------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---
Confidence            3                      2222            34678999999999999999555543221100000000   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                                .....  +..+... ....+..+.+||.+||+.||++| |+.++++.|..+..
T Consensus       217 ----------~~~~~--~~~~~~~-~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          217 ----------DTAGQ--PIEPADI-DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             ----------CTTSC--BCCHHHH-CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             ----------HhccC--CCChhhc-ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence                      00000  0000000 01123479999999999999999 99999999877664

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-39  Score=328.49  Aligned_cols=254  Identities=14%  Similarity=0.140  Sum_probs=180.7

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh----hhhHHHHHHHHcCCCCC-CCe-------------
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK----QSWQSEQEIFKLPHMEH-DNI-------------  168 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~----~~~~~~~ei~~l~~l~H-~nI-------------  168 (461)
                      ...+.|...++||+|+||.||+|++.  ++.||||++.....    ....+++|+.++..++| .|+             
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            44567899999999999999999985  88999999873322    23455688888888876 221             


Q ss_pred             --eE------EEEEEecCC-ccceeeeeeehhccCCChhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcccC
Q psy17532        169 --LR------YIGAEKRGE-SIHTEFWLITAYHERGSLCDFLK--------CNIVTWEQLCRIALSMSKGLMHLHEEILP  231 (461)
Q Consensus       169 --v~------l~g~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  231 (461)
                        +.      ++.++.... .....++++|+++ +|+|.++++        ...+++..++.++.||+.||+|||+.   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence              11      111111111 0112346777765 579999984        33478889999999999999999999   


Q ss_pred             CCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccc-----cccCCCCC
Q psy17532        232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAI-----NFSRDAFL  306 (461)
Q Consensus       232 ~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~~~  306 (461)
                              +|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.+..     .....++.
T Consensus       231 --------~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          231 --------GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             --------TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             --------CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence                    9999999999999999999999999999875432     334567 9999999984221     01235678


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHcc
Q psy17532        307 RIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWD  386 (461)
Q Consensus       307 k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~  386 (461)
                      ++|||||||++|||++|.           .||......     .....+...  ...+         +..+.+||.+||+
T Consensus       297 ~~DvwSlGvil~elltg~-----------~Pf~~~~~~-----~~~~~~~~~--~~~~---------~~~~~~li~~~l~  349 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCAD-----------LPNTDDAAL-----GGSEWIFRS--CKNI---------PQPVRALLEGFLR  349 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSS-----------CCCCTTGGG-----SCSGGGGSS--CCCC---------CHHHHHHHHHHTC
T ss_pred             hhhHHHHHHHHHHHHHCC-----------CCCCCcchh-----hhHHHHHhh--cccC---------CHHHHHHHHHHcc
Confidence            999999999999999994           444332111     000111110  1112         2379999999999


Q ss_pred             ccHhhhccccchhhhcHHHhh
Q psy17532        387 HDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       387 ~dP~~Rps~~evl~~l~~~~~  407 (461)
                      .||++|||+.+++++.+....
T Consensus       350 ~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          350 YPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             SSGGGSCCHHHHTTSHHHHHH
T ss_pred             CChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999776544

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.3e-32  Score=288.48  Aligned_cols=178  Identities=16%  Similarity=0.151  Sum_probs=124.9

Q ss_pred             eecCCceEEEEEEE--CCCcEEEEEEecCC-----------hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceee
Q psy17532        120 KAQGRFGAVWKAKF--KNENVAVKIFLMQD-----------KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       120 lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~-----------~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ++.|++|.+..++.  -|+.+|||.+....           ....++.+|+.+|+++ .|+||+++++++.+..    .+
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~----~~  317 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ----SG  317 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS----EE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC----EE
Confidence            45677776665544  58999999996532           1123456899999999 7999999999998865    55


Q ss_pred             eeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      ||||||++||+|.++|.. ++++..   +|+.||+.||+|+|++           |||||||||+||||+.++.+||+||
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~-----------GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ-----------GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT-----------TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC-----------CceeccCchHhEEECCCCCEEEeec
Confidence            999999999999999965 457654   5889999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      |+|+......  ......+||+.|||||++.+      .+..++|+||+|++++++.++
T Consensus       384 GlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g------~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          384 GSIVTTPQDC--SWPTNLVQSFFVFVNELFAE------NKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             TTEESCC-----CCSHHHHHHHHHHHHHHC-----------------------CCCCTT
T ss_pred             ccCeeCCCCC--ccccCceechhhccHHHhCC------CCCCcccccccccchhhhccc
Confidence            9998775433  23445689999999999976      344678999999999888766

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5.7e-29  Score=259.38  Aligned_cols=182  Identities=15%  Similarity=0.124  Sum_probs=137.6

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCChh---------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQ---------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~---------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ...++||+|+||.||+|+..++.+|+|........         ...+.+|+.++.+++||||+++..++.....    .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~----~  414 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN----K  414 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT----T
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc----c
Confidence            34578999999999999989999999987542211         1234789999999999999944444444332    3


Q ss_pred             eeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        186 WLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      ++||||+++|+|.++++.       +..++.|++.||.|||++           +|+||||||+|||++.  .+||+|||
T Consensus       415 ~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~-----------gIiHrDiKp~NILl~~--~~kL~DFG  474 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKN-----------DVIHNDLTTSNFIFDK--DLYIIDFG  474 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHT-----------TEECTTCCTTSEEESS--SEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHC-----------cCccCCCCHHHEEECC--eEEEEECc
Confidence            899999999999999976       668999999999999999           9999999999999999  99999999


Q ss_pred             CccccCCCCCCC-----CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        266 LALLFEPGKPCG-----DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       266 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                      +|+.........     ......||+.|||||++.+..   ..|+..+|+||..+-..+-+.+
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~---~~Y~~~~d~ws~vl~~l~~v~~  534 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL---EGYKSVYDRWEIILELMKDVER  534 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH---HHHHHHCTTHHHHHHHHHHHHT
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH---HHHHHHHhHHHHHHHHHHHHHh
Confidence            999875432100     012457999999999997621   2455677999999888887766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=9.3e-25  Score=209.15  Aligned_cols=142  Identities=15%  Similarity=0.135  Sum_probs=111.4

Q ss_pred             eeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCCh-------------------hhhHHHHHHHHcCCCCCCCeeEEEE
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDK-------------------QSWQSEQEIFKLPHMEHDNILRYIG  173 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-------------------~~~~~~~ei~~l~~l~H~nIv~l~g  173 (461)
                      |++.+.||+|+||.||+|++ +++.||||.+.....                   ......+|+.++.+++|   +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence            44559999999999999999 478899999864321                   12345688888888874   44444


Q ss_pred             EEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       174 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ++..     ...++||||+++|+|.+ +..     .....++.|++.||.|||+.           +|+||||||+|||+
T Consensus       169 ~~~~-----~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~-----------giiHrDlkp~NILl  226 (282)
T 1zar_A          169 VYAW-----EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHR-----------GIVHGDLSQYNVLV  226 (282)
T ss_dssp             EEEE-----ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHT-----------TEECSCCSTTSEEE
T ss_pred             EEec-----cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHC-----------CCEeCCCCHHHEEE
Confidence            4432     23489999999999999 532     23457999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccc
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEG  296 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  296 (461)
                      + ++.+||+|||+|+..               ..++|||++..
T Consensus       227 ~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEV---------------GEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence            9 999999999999642               34789998864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.1e-21  Score=182.24  Aligned_cols=135  Identities=16%  Similarity=0.192  Sum_probs=103.4

Q ss_pred             ceeEEeEeecCCceEEEEEEE--CCCc--EEEEEEecCChh-------------------------hhHHHHHHHHcCCC
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF--KNEN--VAVKIFLMQDKQ-------------------------SWQSEQEIFKLPHM  163 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~-------------------------~~~~~~ei~~l~~l  163 (461)
                      -|++.+.||+|+||.||+|..  +|+.  ||||++......                         ....++|+..+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998  7888  999987533111                         01356788888888


Q ss_pred             CCCCe--eEEEEEEecCCccceeeeeeehhccC-C----ChhhhhcCCCCCHHHHHHHHHHHHHHHHHHh-hcccCCCcC
Q psy17532        164 EHDNI--LRYIGAEKRGESIHTEFWLITAYHER-G----SLCDFLKCNIVTWEQLCRIALSMSKGLMHLH-EEILPNKAD  235 (461)
Q Consensus       164 ~H~nI--v~l~g~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~~  235 (461)
                      +|+||  ...++.  .      ..+|||||+.+ |    +|.++...  .++..+..++.|++.||.||| +.       
T Consensus       128 ~~~~i~~p~~~~~--~------~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~-------  190 (258)
T 1zth_A          128 KEAGVSVPQPYTY--M------KNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEA-------  190 (258)
T ss_dssp             HHTTCCCCCEEEE--E------TTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTS-------
T ss_pred             HhCCCCCCeEEEc--C------CCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHC-------
Confidence            77653  344432  1      23899999942 4    56665432  234567889999999999999 88       


Q ss_pred             CCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        236 SYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       236 ~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                          +|+||||||+|||++.  .++|+|||+|...
T Consensus       191 ----givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ----ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ----CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             ----CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence                9999999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=8.9e-18  Score=165.57  Aligned_cols=133  Identities=13%  Similarity=0.176  Sum_probs=96.3

Q ss_pred             ceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChh-----------------hh------HHHHHHHHcCCCCCCCe
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ-----------------SW------QSEQEIFKLPHMEHDNI  168 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~-----------------~~------~~~~ei~~l~~l~H~nI  168 (461)
                      -|++...||+|+||.||+|.. +|+.||||+++.....                 .+      ..++|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            378999999999999999997 6889999987532100                 00      01234444555533332


Q ss_pred             --eEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccC
Q psy17532        169 --LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDF  246 (461)
Q Consensus       169 --v~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDL  246 (461)
                        ...++.  .      ..+|||||+++++|..+...     .....++.|++.+|.|||+.           |||||||
T Consensus       176 ~vp~p~~~--~------~~~LVME~i~G~~L~~l~~~-----~~~~~l~~qll~~l~~lH~~-----------gIVHrDL  231 (397)
T 4gyi_A          176 PVPEPIAQ--S------RHTIVMSLVDALPMRQVSSV-----PDPASLYADLIALILRLAKH-----------GLIHGDF  231 (397)
T ss_dssp             SCCCEEEE--E------TTEEEEECCSCEEGGGCCCC-----SCHHHHHHHHHHHHHHHHHT-----------TEECSCC
T ss_pred             CCCeeeec--c------CceEEEEecCCccHhhhccc-----HHHHHHHHHHHHHHHHHHHC-----------CCcCCCC
Confidence              122222  1      12799999999988776532     23457889999999999998           9999999


Q ss_pred             CCCcEEEcCCC----------ceEEEecCCccc
Q psy17532        247 KSNNVLLKSDL----------TAAIADFGLALL  269 (461)
Q Consensus       247 kp~NILl~~~~----------~~ki~DFGla~~  269 (461)
                      ||.|||+++++          .+.|+||+-+..
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            99999998876          388999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=2.1e-12  Score=121.56  Aligned_cols=150  Identities=13%  Similarity=0.073  Sum_probs=108.8

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCC-hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD-KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~-~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ...|++...++.|+++.||+....++.+++|+..... ......++|+..+..+ .+.++.++++++.+.+    ..|+|
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~----~~~lv   88 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG----WSNLL   88 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT----EEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC----ceEEE
Confidence            4568888999999999999999888999999986421 1122455667666655 3677888888877654    34899


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCc----------------------------------
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA----------------------------------  234 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~----------------------------------  234 (461)
                      |||++|.+|.+.+.    +......++.+++++|..||+.-.....                                  
T Consensus        89 ~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           89 MSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             EECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            99999999987642    1223457888999999999982100000                                  


Q ss_pred             --------------CCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        235 --------------DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       235 --------------~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                                    ....+.++|+|+++.|||++++..+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          0122579999999999999876667799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=4.2e-11  Score=111.98  Aligned_cols=146  Identities=14%  Similarity=0.074  Sum_probs=98.5

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCC--eeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN--ILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n--Iv~l~g~~~~~~~~~~~~~  186 (461)
                      ....+.+..+.+.|..+.||+.... |+.++||+....  .....+.|+..+..+.+.+  +.+++++...++    ..+
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~----~~~   91 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG----RDW   91 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----CEE
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC----CCE
Confidence            3445666555556677999999774 577999987543  2233456666666664334  556888776643    348


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCC---------------------------------
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK---------------------------------  233 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~---------------------------------  233 (461)
                      +||||++|.+|.  ...  .+   ...++.++++.|..||+......                                 
T Consensus        92 ~v~e~i~G~~l~--~~~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEEECCSSEETT--TSC--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEEecCCcccC--cCc--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            999999998884  221  22   23677888999999997520000                                 


Q ss_pred             --------------cCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        234 --------------ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       234 --------------~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                                    .....+.++|+|++|.|||++++..+.|+|||.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          01123359999999999999887667899999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1e-10  Score=115.23  Aligned_cols=152  Identities=13%  Similarity=0.111  Sum_probs=107.1

Q ss_pred             EEeEeecCCceEEEEEEECCCcEEEEEEe--cCC--hhhhHHHHHHHHcCCCC--CCCeeEEEEEEecCCccceeeeeee
Q psy17532        116 LVEVKAQGRFGAVWKAKFKNENVAVKIFL--MQD--KQSWQSEQEIFKLPHME--HDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~--~~~--~~~~~~~~ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      ..+.++.|.++.||+....+..+++|+..  ...  ......++|..++..+.  +..+.++++++.+... .+..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-IGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-TSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-cCCeEEEE
Confidence            45778999999999999888889999765  322  11234456776666654  4568888888876532 13458999


Q ss_pred             hhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCc-----------------------------------
Q psy17532        190 AYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA-----------------------------------  234 (461)
Q Consensus       190 e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~-----------------------------------  234 (461)
                      ||+++..+.+..- ..++..+...++.++++.|+.||+.......                                   
T Consensus       121 e~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          121 EFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             ECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             EecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            9999988754321 2377888899999999999999984211110                                   


Q ss_pred             ----------CCC--CCCeecccCCCCcEEEcCCCc--eEEEecCCccc
Q psy17532        235 ----------DSY--KPAVAHRDFKSNNVLLKSDLT--AAIADFGLALL  269 (461)
Q Consensus       235 ----------~~~--~~~ivHrDLkp~NILl~~~~~--~ki~DFGla~~  269 (461)
                                ...  .+.++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                      001  368999999999999997653  68999998854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.87  E-value=6e-10  Score=107.14  Aligned_cols=148  Identities=18%  Similarity=0.186  Sum_probs=99.8

Q ss_pred             eEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCC-CCC--CeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        118 EVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM-EHD--NILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-~H~--nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      +.++.|.+..||+..   ..+++|+.... ......++|...+..+ .+.  .+.+.+......... ...|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~-~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN---RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY-QMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST---TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC-SCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC---CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC-CcceEEEcccCC
Confidence            458999999999864   67899986432 2234456677666554 222  234455544332211 123788999999


Q ss_pred             CChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCC------------------------------------------
Q psy17532        195 GSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN------------------------------------------  232 (461)
Q Consensus       195 gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~------------------------------------------  232 (461)
                      .+|.+... ..++..+...++.++++.|+.||+....+                                          
T Consensus       101 ~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          101 VPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             EECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             eECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            88875332 24778888999999999999999731100                                          


Q ss_pred             -----CcCCCCCCeecccCCCCcEEEcC--CCceEEEecCCccccC
Q psy17532        233 -----KADSYKPAVAHRDFKSNNVLLKS--DLTAAIADFGLALLFE  271 (461)
Q Consensus       233 -----~~~~~~~~ivHrDLkp~NILl~~--~~~~ki~DFGla~~~~  271 (461)
                           ......+.++|+|+++.|||++.  ...+.|+||+.+....
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~  225 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD  225 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence                 00123467999999999999998  5567899999987643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=2e-06  Score=82.52  Aligned_cols=145  Identities=19%  Similarity=0.186  Sum_probs=98.5

Q ss_pred             EeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCC---CeeEEEEEEecCCccceeeeeeehhcc
Q psy17532        117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHD---NILRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      .+.++.|....||+.   +..++||+.. ........+.|...|..+.+.   .+.+.+.+.....   +..++||||++
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~---g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD---GNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT---SCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC---CceEEEEeccC
Confidence            456788999999988   7889999853 222234556777777666532   3456666654222   23379999999


Q ss_pred             CCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccC-----CCc----------------------------------
Q psy17532        194 RGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP-----NKA----------------------------------  234 (461)
Q Consensus       194 ~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-----~~~----------------------------------  234 (461)
                      |..|.+..- ..++..+...++.++++.|+.||+....     +..                                  
T Consensus        97 G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           97 GQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             SEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             CeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            988876321 2356777788888888888888875210     000                                  


Q ss_pred             ----------CCCCCCeecccCCCCcEEEcC---CCc-eEEEecCCccc
Q psy17532        235 ----------DSYKPAVAHRDFKSNNVLLKS---DLT-AAIADFGLALL  269 (461)
Q Consensus       235 ----------~~~~~~ivHrDLkp~NILl~~---~~~-~ki~DFGla~~  269 (461)
                                ....+.++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                      014567899999999999997   344 58999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=2e-06  Score=84.24  Aligned_cols=154  Identities=12%  Similarity=0.121  Sum_probs=98.2

Q ss_pred             eeEEeEe-ecCCceEEEEEEEC--------CCcEEEEEEecCC---h-hhhHHHHHHHHcCCCC-C--CCeeEEEEEEec
Q psy17532        114 IQLVEVK-AQGRFGAVWKAKFK--------NENVAVKIFLMQD---K-QSWQSEQEIFKLPHME-H--DNILRYIGAEKR  177 (461)
Q Consensus       114 ~~~~~~l-g~G~fg~Vy~~~~~--------~~~vAvK~~~~~~---~-~~~~~~~ei~~l~~l~-H--~nIv~l~g~~~~  177 (461)
                      ....+.| +.|....+|+....        ++.+++|+.....   . .....++|...+..+. +  -.+.++++++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4456778 88999999998765        6778898764322   0 1233456666655552 2  346677777655


Q ss_pred             CCccceeeeeeehhccCCChhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcccC-------------C-----
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKC-------NIVTWEQLCRIALSMSKGLMHLHEEILP-------------N-----  232 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~-------------~-----  232 (461)
                      ... ....++||||++|..+.+.+..       ..++..+...++.++++.|+-||+....             .     
T Consensus       102 ~~~-~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~  180 (357)
T 3ats_A          102 GDV-LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHR  180 (357)
T ss_dssp             STT-TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHH
T ss_pred             CCc-cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHH
Confidence            431 1234799999998877654310       1245555566677777777777753110             0     


Q ss_pred             --------------------------------CcCC---CCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        233 --------------------------------KADS---YKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       233 --------------------------------~~~~---~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                                                      ....   ..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          181 HFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             HHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             HHHHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence                                            0000   15689999999999999965557899998774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.12  E-value=1.3e-05  Score=75.02  Aligned_cols=141  Identities=16%  Similarity=0.115  Sum_probs=91.2

Q ss_pred             EeecCCce-EEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        119 VKAQGRFG-AVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       119 ~lg~G~fg-~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      .+..|..| .||+....  +..+.||+-....  .....+|...|..+. +--+-++++++.+.+    ..++|||++++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~----~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD----DAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETT----EEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECC----eEEEEEEeeCC
Confidence            34445555 68987663  5679999865432  223445555544432 333567777777654    34899999999


Q ss_pred             CChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCC-----------------------------------------
Q psy17532        195 GSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK-----------------------------------------  233 (461)
Q Consensus       195 gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-----------------------------------------  233 (461)
                      .++.+....   .......+..+++..|.-||+.-....                                         
T Consensus       105 ~~~~~~~~~---~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          105 KTAFQVLEE---YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EEHHHHHHH---CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccccC---CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            888776532   123344567778888888886421100                                         


Q ss_pred             ------cCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        234 ------ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       234 ------~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                            .....+.++|+|+.+.|||++.++.+-|.||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                  11223458999999999999988777899998774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.97  E-value=1.5e-05  Score=79.28  Aligned_cols=74  Identities=11%  Similarity=-0.014  Sum_probs=43.4

Q ss_pred             EEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh--------hhhHHHHHHHHcCCCC---CCCeeEEEEEEecCCccc
Q psy17532        116 LVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK--------QSWQSEQEIFKLPHME---HDNILRYIGAEKRGESIH  182 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--------~~~~~~~ei~~l~~l~---H~nIv~l~g~~~~~~~~~  182 (461)
                      ..+.+|.|.++.||++..  .++.++||.......        .......|...+..+.   ...+.+++.+..  ..  
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~--~~--  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EM--  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TT--
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC--Cc--
Confidence            356889999999999965  467899997643211        1122344555544432   223445665432  21  


Q ss_pred             eeeeeeehhccCC
Q psy17532        183 TEFWLITAYHERG  195 (461)
Q Consensus       183 ~~~~lv~e~~~~g  195 (461)
                        .++||||+++.
T Consensus       110 --~~lvmE~l~g~  120 (397)
T 2olc_A          110 --AVTVMEDLSHL  120 (397)
T ss_dssp             --TEEEECCCTTS
T ss_pred             --cEEEEEeCCCc
Confidence              27999999764

>4fao_E Activin receptor type-2B; TGF-beta, CTK, cystine knot, extracellular domain, signaling protein-signaling protein complex; HET: NAG; 3.36A {Homo sapiens}

Probab=97.81  E-value=6.6e-06  Score=66.03  Aligned_cols=39  Identities=38%  Similarity=1.078  Sum_probs=31.5

Q ss_pred             CCCCCCccccccccccCCCceEEecCCCCCCCCCCCCCCCC
Q psy17532          1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPAPL   41 (461)
Q Consensus         1 ~~~~~~~~c~~~~~~~~~~~~~c~~~~~~C~~~~~~~~~~~   41 (461)
                      ++|+|..+||.++  .+.+.++|||.+|+||.++.|.|.+.
T Consensus        66 ~~C~~~~eCv~t~--~~~~~~fCCC~gdlCN~nfs~~p~~~  104 (124)
T 4fao_E           66 FNCYDRQECVATE--ENPQVYFCCCEGNFCNERFTHLPEAG  104 (124)
T ss_dssp             GGGTTCCSEEECC--SSCSEEEEEECSTTTTSSEEECC---
T ss_pred             CCCCCCCeeeccC--CCCCcEEEecCCCccCCceeecCCCC
Confidence            5899999999755  34679999999999999999987643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.78  E-value=4.9e-05  Score=73.43  Aligned_cols=31  Identities=23%  Similarity=0.426  Sum_probs=27.3

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      .+.++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3489999999999999888889999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.76  E-value=6.8e-05  Score=71.41  Aligned_cols=133  Identities=14%  Similarity=0.115  Sum_probs=77.6

Q ss_pred             EeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCe-eEEEEEEecCCccceeeeeeehhc-cC
Q psy17532        117 VEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNI-LRYIGAEKRGESIHTEFWLITAYH-ER  194 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~lv~e~~-~~  194 (461)
                      .+.|+.|....+|+.    ..+++|+...........+.|...+..+...++ .++++...+.+      ++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~------~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPATG------VMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTC------CEEEECCTTC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECCCC------EEEEeecCCC
Confidence            578889999999999    778899875432222223455554443321112 35555433222      6899999 54


Q ss_pred             CChhhhhcCCCCCHHHH---HHHHHHHHHHHHHHhhcccCCC--------------------------------------
Q psy17532        195 GSLCDFLKCNIVTWEQL---CRIALSMSKGLMHLHEEILPNK--------------------------------------  233 (461)
Q Consensus       195 gsL~~~l~~~~l~~~~~---~~i~~~ia~gL~yLH~~~~~~~--------------------------------------  233 (461)
                      .+|..         ...   -.+..++++.|+-||+......                                      
T Consensus        93 ~~l~~---------~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  163 (301)
T 3dxq_A           93 QTMSP---------EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR  163 (301)
T ss_dssp             EECCH---------HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred             ccCCH---------hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence            33321         111   1245556666666665321000                                      


Q ss_pred             ----cCCCCCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        234 ----ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       234 ----~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                          .....+.++|+|+.+.||| ..++.+.|+||..+..
T Consensus       164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                0123456899999999999 5566789999987743

>1bte_A Protein (activin receptor type II); serine kinase, ligand binding domain, three-finger transferase; HET: NAG; 1.50A {Mus musculus} SCOP: g.7.1.3 PDB: 2goo_C* 1lx5_B*

Probab=97.76  E-value=9.9e-06  Score=62.42  Aligned_cols=37  Identities=46%  Similarity=1.324  Sum_probs=32.7

Q ss_pred             CCCCCCccccccccccCCCceEEecCCCCCCCCCCCCCC
Q psy17532          1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPA   39 (461)
Q Consensus         1 ~~~~~~~~c~~~~~~~~~~~~~c~~~~~~C~~~~~~~~~   39 (461)
                      ++|+|+.+||.++  .+++.++|||.||+||.++.|.|.
T Consensus        59 ~~C~d~~eCv~t~--~~~~~~fCCC~gd~CN~nft~~p~   95 (97)
T 1bte_A           59 INCYDRTDCIEKK--DSPEVYFCCCEGNMCNEKFSYFPE   95 (97)
T ss_dssp             CCCSCSSSEEECS--SSCSSEEEEECSTTGGGSEEECCC
T ss_pred             CCCCCcceeecCC--CCCCEEEEECCCCccccCcccCCC
Confidence            5899999999876  567999999999999999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=6.7e-05  Score=75.14  Aligned_cols=80  Identities=13%  Similarity=0.133  Sum_probs=46.4

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCc--CCCcccccccccccccccCCCCCccchHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV--GTRRYMAPEVLEGAINFSRDAFLRIDMYACAL  315 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gv  315 (461)
                      .+.++|+|+++.|||++.++ ++|+||+.+..-.....   .....  -...|.+|+......  ........++.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  304 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQE--NDRKEYKQWILRTIE  304 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSS--CCSHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccc--cchHHHHHHHHHHHH
Confidence            45899999999999999876 99999998865332110   00000  012355655442100  000011234557788


Q ss_pred             HHHHHHcC
Q psy17532        316 VLWELASR  323 (461)
Q Consensus       316 il~el~tg  323 (461)
                      .+|+.+++
T Consensus       305 ~~~~~y~~  312 (420)
T 2pyw_A          305 QTWNLFNK  312 (420)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88887765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.70  E-value=0.00027  Score=67.70  Aligned_cols=77  Identities=16%  Similarity=0.089  Sum_probs=54.9

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCC---CCCeeEEEEEEecCCccceeeeeeehh
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHME---HDNILRYIGAEKRGESIHTEFWLITAY  191 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~~~lv~e~  191 (461)
                      .-.+.|+.|.+..+|+....+..++||+.....  ...++.|...|..+.   ...+.+.+++....+    ..++||||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~--~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g----~~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSY--RSMFRAEADQLALLAKTNSINVPLVYGIGNSQG----HSFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG--HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----EEEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCccc--HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----ceEEEEEe
Confidence            345778999999999999888889999876432  233455665555542   356777777766543    35899999


Q ss_pred             ccCCCh
Q psy17532        192 HERGSL  197 (461)
Q Consensus       192 ~~~gsL  197 (461)
                      +++..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.42  E-value=0.00042  Score=65.40  Aligned_cols=77  Identities=9%  Similarity=0.094  Sum_probs=49.8

Q ss_pred             ceeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCChh-hhHHHHHHHHcCCCC---CCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDKQ-SWQSEQEIFKLPHME---HDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+.-.+.+|.|..+.||+.+. +|+.|.||+....... ...++.|...|..+.   ---+.+.+++.  ..      ++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~------~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DR------TL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TT------EE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--Cc------eE
Confidence            456678899999999999998 5789999976433221 223456665544442   12344555542  11      78


Q ss_pred             eehhccCCCh
Q psy17532        188 ITAYHERGSL  197 (461)
Q Consensus       188 v~e~~~~gsL  197 (461)
                      ||||++.+..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999887654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.35  E-value=0.00059  Score=68.94  Aligned_cols=73  Identities=12%  Similarity=0.043  Sum_probs=45.2

Q ss_pred             EeEeecCCceEEEEEEECC--CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCe-eEEEEEEecCCccceeeeeeehhcc
Q psy17532        117 VEVKAQGRFGAVWKAKFKN--ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNI-LRYIGAEKRGESIHTEFWLITAYHE  193 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~lv~e~~~  193 (461)
                      .+.|+.|-...+|+....+  ..+++|+...........+.|..++..+...++ .++++.+.  +      .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~------G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N------GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T------EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C------eEEEEeeC
Confidence            4577888899999999876  788899874332222223566666555543333 46777662  1      35999998


Q ss_pred             CCCh
Q psy17532        194 RGSL  197 (461)
Q Consensus       194 ~gsL  197 (461)
                      +.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.35  E-value=0.00053  Score=66.07  Aligned_cols=32  Identities=31%  Similarity=0.476  Sum_probs=27.5

Q ss_pred             CCCeecccCCCCcEEEcCC----CceEEEecCCccc
Q psy17532        238 KPAVAHRDFKSNNVLLKSD----LTAAIADFGLALL  269 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~----~~~ki~DFGla~~  269 (461)
                      .+.++|+|+.+.|||++.+    +.+.|.||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4589999999999999874    6789999998754

>2h62_D ACVR2B protein; TGF-beta superfamily, ligand-receptor complex, hormone/growth factor complex; 1.85A {Homo sapiens} SCOP: g.7.1.3 PDB: 1nys_A 1nyu_A 2h64_C 1s4y_A

Probab=97.32  E-value=8.9e-05  Score=57.03  Aligned_cols=33  Identities=42%  Similarity=1.251  Sum_probs=29.4

Q ss_pred             CCCCCccccccccccCCCceEEecCCCCCCCCCCC
Q psy17532          2 ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAW   36 (461)
Q Consensus         2 ~~~~~~~c~~~~~~~~~~~~~c~~~~~~C~~~~~~   36 (461)
                      +|+|+.+||.++  .+++.++|||.||+||.++.|
T Consensus        65 ~C~d~~eCv~t~--~~~~~~fCCC~gd~CN~nft~   97 (98)
T 2h62_D           65 NCYDRQECVATE--ENPQVYFCCCEGNFCNERFTH   97 (98)
T ss_dssp             GGTTCSSEECCC--SSCSSEEEEESSTTTTSSEEC
T ss_pred             CCCCcceeeccC--CCCCEEEEECCCCccccceec
Confidence            799889999875  578899999999999999876

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.27  E-value=0.00027  Score=69.34  Aligned_cols=73  Identities=12%  Similarity=0.114  Sum_probs=40.7

Q ss_pred             EeEeecCCceEEEEEEECC----------CcEEEEEEecCChhhhHHHHHHHHcCCCCCCC-eeEEEEEEecCCccceee
Q psy17532        117 VEVKAQGRFGAVWKAKFKN----------ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN-ILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~  185 (461)
                      .+.++.|....+|+....+          +.+++|+...........+.|...+..+...+ +.++++..  .+      
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~------  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG------  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC------
Confidence            4567788889999998754          67888876433222222345555554443222 34666544  11      


Q ss_pred             eeeehhccCCCh
Q psy17532        186 WLITAYHERGSL  197 (461)
Q Consensus       186 ~lv~e~~~~gsL  197 (461)
                      ++||||++|..+
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999987544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.25  E-value=0.0005  Score=65.81  Aligned_cols=145  Identities=14%  Similarity=0.118  Sum_probs=75.9

Q ss_pred             eEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCC-----CCCCeeEEEEEEecCCc---cceeee
Q psy17532        115 QLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHM-----EHDNILRYIGAEKRGES---IHTEFW  186 (461)
Q Consensus       115 ~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l-----~H~nIv~l~g~~~~~~~---~~~~~~  186 (461)
                      .-.+.|+.|....+|+....+..+++|+..... .......|...+..+     .-|.++..   . ++..   ..+..+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~-~g~~~~~~~g~~~   99 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPR---K-DGELLGELSGRPA   99 (322)
T ss_dssp             EEEEEECC---EEEEEEEESSCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCB---T-TCCSCEEETTEEE
T ss_pred             eEeeccCCCcccceEEEEeCCccEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCC---C-CCCEEEEECCEEE
Confidence            445678888889999998877789999886421 112223344433333     23333321   0 1100   012347


Q ss_pred             eeehhccCCChhhh--------------hc----C--CC----CC---HHHHHH------------HHHHHHHHHHHHhh
Q psy17532        187 LITAYHERGSLCDF--------------LK----C--NI----VT---WEQLCR------------IALSMSKGLMHLHE  227 (461)
Q Consensus       187 lv~e~~~~gsL~~~--------------l~----~--~~----l~---~~~~~~------------i~~~ia~gL~yLH~  227 (461)
                      ++++|++|..+...              ++    .  ..    ..   |.....            +...+...++++.+
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            89999987654210              00    0  00    11   211100            00113444555554


Q ss_pred             cccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       228 ~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ...    ......++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       180 ~~~----~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWP----KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HCC----CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCc----ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            311    1224589999999999999987666899998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0013  Score=65.99  Aligned_cols=72  Identities=8%  Similarity=0.120  Sum_probs=43.9

Q ss_pred             EeEeecCCceEEEEEEEC---------CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCC-eeEEEEEEecCCccceeee
Q psy17532        117 VEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDN-ILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~~  186 (461)
                      .+.|+.|....||+....         ++.+.+|+...... ......|..++..+...+ ..++++.+.+        .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~li~E~~~l~~L~~~g~~P~l~~~~~~--------g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG--------G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT--------E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--------C
Confidence            457788888999999874         46788998743111 022234655555442222 3566765532        3


Q ss_pred             eeehhccCCCh
Q psy17532        187 LITAYHERGSL  197 (461)
Q Consensus       187 lv~e~~~~gsL  197 (461)
                      +|+||+++.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            88999976444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.99  E-value=0.001  Score=63.73  Aligned_cols=30  Identities=23%  Similarity=0.247  Sum_probs=25.6

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            45789999999999999 4 889999987743

>2hlr_A Bone morphogenetic protein receptor type-2; three-finger toxin, BMP receptor, TGF-beta, transferase; 1.20A {Ovis aries} PDB: 2hlq_A

Probab=96.99  E-value=0.00023  Score=54.66  Aligned_cols=33  Identities=36%  Similarity=0.964  Sum_probs=23.9

Q ss_pred             CCCCCccccccccc---cCCCceEEecCCCCCCCCCC
Q psy17532          2 ECYDKPKCVEKRPE---SKKNLNFCCCEGDMCNKDFA   35 (461)
Q Consensus         2 ~~~~~~~c~~~~~~---~~~~~~~c~~~~~~C~~~~~   35 (461)
                      +|++ .+||.+.++   .+++.++|||.+|+||.++.
T Consensus        62 ~C~~-~eCv~t~~~~~~~n~~~~FCCC~gd~CN~nft   97 (100)
T 2hlr_A           62 ECHY-EECVVTTTPPSIQNGTYRFCCCSTDLCNVNFT   97 (100)
T ss_dssp             TSBS-SSCBCC----------CCEEEESSTTGGGSCB
T ss_pred             CCCC-CcccccCCCcccCCCCEEEEECCCCccccccc
Confidence            7997 899998654   68888999999999999885

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.79  E-value=0.0027  Score=62.39  Aligned_cols=140  Identities=12%  Similarity=0.089  Sum_probs=74.8

Q ss_pred             eEeecCCceEEEEEEEC---------CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeeee
Q psy17532        118 EVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       118 ~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      +.+..|-...+|+....         ++.+.+|+............+|..+++.+. +.-..++++.+.+        .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------cc
Confidence            45666888888998873         367888875322112233346666655442 2223556666543        28


Q ss_pred             eehhccCCChhhh-h----------------cCC------CC--CHHHHHHHHHHHH-------------------HHHH
Q psy17532        188 ITAYHERGSLCDF-L----------------KCN------IV--TWEQLCRIALSMS-------------------KGLM  223 (461)
Q Consensus       188 v~e~~~~gsL~~~-l----------------~~~------~l--~~~~~~~i~~~ia-------------------~gL~  223 (461)
                      ||||++|..|..- +                +.-      ..  -+.++.++..++.                   ..+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999987554311 1                000      11  1334444443322                   1233


Q ss_pred             HHhhcccCCCcCCCCCCeecccCCCCcEEEcCC----CceEEEecCCcc
Q psy17532        224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD----LTAAIADFGLAL  268 (461)
Q Consensus       224 yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~----~~~ki~DFGla~  268 (461)
                      .|.+....   ......++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       208 ~L~~~L~~---~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLES---TPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHT---SCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhh---cCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            33332110   1224479999999999999876    688999998763

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.51  E-value=0.0042  Score=61.94  Aligned_cols=143  Identities=13%  Similarity=0.206  Sum_probs=81.4

Q ss_pred             EeEeecCCceEEEEEEEC---------CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeee
Q psy17532        117 VEVKAQGRFGAVWKAKFK---------NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .+.+..|-...+|+....         ++.+++|+...........++|..++..+. +.-..++++.+.  +      +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~------~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E------G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T------E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C------C
Confidence            456667888899999886         578899886433222223455666555442 222345555332  2      6


Q ss_pred             eeehhccCCChhh--h------------h---cC------------C--CCCHHHHHHHHHH------------------
Q psy17532        187 LITAYHERGSLCD--F------------L---KC------------N--IVTWEQLCRIALS------------------  217 (461)
Q Consensus       187 lv~e~~~~gsL~~--~------------l---~~------------~--~l~~~~~~~i~~~------------------  217 (461)
                      +||||++|..|..  +            |   +.            .  +..+.++.++..+                  
T Consensus       147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~  226 (424)
T 3mes_A          147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS  226 (424)
T ss_dssp             EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred             EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence            8999999865421  0            0   00            0  0113333333322                  


Q ss_pred             -HHHHHHHHhhcccCCC-------------cCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        218 -MSKGLMHLHEEILPNK-------------ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       218 -ia~gL~yLH~~~~~~~-------------~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                       +...+.+|.+......             .......++|+|+.+.||| +.++.+.|+||..|.
T Consensus       227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence             2233445544321100             1122457899999999999 778899999998763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.79  E-value=0.03  Score=50.00  Aligned_cols=98  Identities=12%  Similarity=0.043  Sum_probs=62.1

Q ss_pred             CChhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCC
Q psy17532        195 GSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEP  272 (461)
Q Consensus       195 gsL~~~l--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~  272 (461)
                      -+|.+.|  ...++++++++.++.|.+.+|.-+-...          .-..+=+-|..|++..+|.|.+.+ +.+.    
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~----------~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR----------QPRHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT----------CCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc----------cCCceecCCcceEEecCCceeccc-cccc----
Confidence            3788888  4678999999999999999987662210          001233457899999999988764 2111    


Q ss_pred             CCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcC
Q psy17532        273 GKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR  323 (461)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg  323 (461)
                                .....+.|||...      ...+.+.=|||||+++|.-+--
T Consensus        98 ----------~~~~~~~~pe~~~------~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY------SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             -------------------CCSS------SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ----------ccccCCCChhhcc------ccchHHHHHHHHHHHHHHHhhc
Confidence                      1123466888763      1334556799999999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.31  E-value=0.064  Score=51.61  Aligned_cols=32  Identities=28%  Similarity=0.451  Sum_probs=28.1

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALL  269 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~  269 (461)
                      ...++|+|+.+.|||++.++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45799999999999999888899999987754

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.04  E-value=0.026  Score=36.32  Aligned_cols=27  Identities=15%  Similarity=0.155  Sum_probs=12.6

Q ss_pred             eehhhHHHHHHHHHHHHHHHhhhhhcc
Q psy17532         60 IFLYTMLPIFALIIPIFLCYWYYRQRK   86 (461)
Q Consensus        60 ~~~~~~~~~~~l~~~~~~~~~~~~~r~   86 (461)
                      |+..++++++++++++++.++++|+|+
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            445555545544444444444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.46  E-value=0.04  Score=35.36  Aligned_cols=27  Identities=22%  Similarity=0.219  Sum_probs=12.2

Q ss_pred             eehhhHHHHHHHHHHHHHHHhhhhhcc
Q psy17532         60 IFLYTMLPIFALIIPIFLCYWYYRQRK   86 (461)
Q Consensus        60 ~~~~~~~~~~~l~~~~~~~~~~~~~r~   86 (461)
                      |+..++++++++++++++.++++|+|+
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence            444455445444444444444444443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.57  E-value=0.11  Score=51.34  Aligned_cols=29  Identities=24%  Similarity=0.429  Sum_probs=24.1

Q ss_pred             CeecccCCCCcEEE------cCCCceEEEecCCcc
Q psy17532        240 AVAHRDFKSNNVLL------KSDLTAAIADFGLAL  268 (461)
Q Consensus       240 ~ivHrDLkp~NILl------~~~~~~ki~DFGla~  268 (461)
                      .++|+|+.+.|||+      +++..+.++||-.|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      445779999998764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.29  E-value=0.12  Score=33.14  Aligned_cols=11  Identities=9%  Similarity=0.205  Sum_probs=4.4

Q ss_pred             HHHHHhhhhhc
Q psy17532         75 IFLCYWYYRQR   85 (461)
Q Consensus        75 ~~~~~~~~~~r   85 (461)
                      +++++|++|||
T Consensus        29 l~~~~~~RRR~   39 (44)
T 2jwa_A           29 VVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHC
T ss_pred             HHHHhheehhh
Confidence            33344444443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=90.56  E-value=0.18  Score=31.30  Aligned_cols=18  Identities=6%  Similarity=0.102  Sum_probs=7.4

Q ss_pred             HHHHHHHHHHHHHhhhhh
Q psy17532         67 PIFALIIPIFLCYWYYRQ   84 (461)
Q Consensus        67 ~~~~l~~~~~~~~~~~~~   84 (461)
                      +++.+++++.++++++||
T Consensus        20 ~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           20 LLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHeec
Confidence            333333344444444444

>1ks6_A Transforming growth factor beta type II receptor; three finger toxin fold, hormone/growth factor complex; NMR {Gallus gallus} SCOP: g.7.1.3

Probab=89.00  E-value=0.3  Score=37.26  Aligned_cols=33  Identities=24%  Similarity=0.636  Sum_probs=28.6

Q ss_pred             CCCccccccc-cccCCCceEEecCCCCCCCCCCC
Q psy17532          4 YDKPKCVEKR-PESKKNLNFCCCEGDMCNKDFAW   36 (461)
Q Consensus         4 ~~~~~c~~~~-~~~~~~~~~c~~~~~~C~~~~~~   36 (461)
                      +++++|+++. +...+..+.|.|.++.||+.+..
T Consensus        71 ~nss~C~M~e~~~~g~~~~iCSC~~eECND~L~F  104 (107)
T 1ks6_A           71 SSSEQCVMKEKKDDGGLMFMCSCTGEECNDVLIF  104 (107)
T ss_dssp             SSSSSCBCEEECCSSSEEEEEEESSSSTTTBCBC
T ss_pred             CCCCeeEEeeccCCCCcEEEEecCcccccceEee
Confidence            4678999995 47899999999999999999854

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=86.74  E-value=0.45  Score=30.01  Aligned_cols=8  Identities=13%  Similarity=0.492  Sum_probs=3.1

Q ss_pred             HHHhhhhh
Q psy17532         77 LCYWYYRQ   84 (461)
Q Consensus        77 ~~~~~~~~   84 (461)
                      ++++++||
T Consensus        32 ~~~~~~rR   39 (41)
T 2k9y_A           32 VGFFIHRR   39 (41)
T ss_dssp             HHHSSSSS
T ss_pred             HheeEeee
Confidence            33333343

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.34  E-value=0.66  Score=41.13  Aligned_cols=92  Identities=10%  Similarity=0.034  Sum_probs=65.2

Q ss_pred             HHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCc
Q psy17532        155 QEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKA  234 (461)
Q Consensus       155 ~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~  234 (461)
                      .|+..| ...||+.+.. .+-.+.+      -++..|-...+...|-.-..++...+++++.+|+.-..++++.      
T Consensus        35 ~el~LL-~~~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~r------  100 (215)
T 4ann_A           35 HLMYLL-EQHSPYFIDA-ELTELRD------SFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRTR------  100 (215)
T ss_dssp             GGGGGG-GSCCTTBCCE-EEEECSS------EEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGSS------
T ss_pred             HHHHHH-hccCCcccce-EEEEccc------EEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcCc------
Confidence            345444 3478988865 3433333      2444444444555555545688899999999999877777655      


Q ss_pred             CCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       235 ~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                             +|--|.|+||+++.++.++|.-.|+.
T Consensus       101 -------~tf~L~P~NL~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          101 -------YTFVLAPDELFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             -------EECCCSGGGEEECTTSCEEESCCEET
T ss_pred             -------eEEEEecceEEEcCCCCEEEEEccCc
Confidence                   78889999999999999999877764

>1m9z_A TGF-beta receptor type II; three finger toxin fold, hormone-growth factor complex; 1.05A {Homo sapiens} SCOP: g.7.1.3 PDB: 1plo_A 1ktz_B 2pjy_B

Probab=83.71  E-value=0.39  Score=36.90  Aligned_cols=35  Identities=23%  Similarity=0.681  Sum_probs=29.5

Q ss_pred             CCCcccccccc-ccCCCceEEecCCCCCCCCCCCCC
Q psy17532          4 YDKPKCVEKRP-ESKKNLNFCCCEGDMCNKDFAWEP   38 (461)
Q Consensus         4 ~~~~~c~~~~~-~~~~~~~~c~~~~~~C~~~~~~~~   38 (461)
                      +++++|+++.. ...+..+.|.|.++.||+.+....
T Consensus        68 ~nss~CiMke~~~~g~~~~~CSC~~eECND~LiF~~  103 (111)
T 1m9z_A           68 AASPTCIMKEKKKPGETFFMCSCSSDECNDNIIFSE  103 (111)
T ss_dssp             TTCSSEECEEECCTTSEEEEEEECSTTGGGEEECCS
T ss_pred             CCCCeeEEeeccCCCCcEEEEecCcccccceEEEcC
Confidence            46789999954 789999999999999999986543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.50  E-value=1.3  Score=39.29  Aligned_cols=84  Identities=14%  Similarity=0.133  Sum_probs=56.3

Q ss_pred             CCCCCeeEEEEEEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHH-HHhhcccCCCcCCCCCCe
Q psy17532        163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLM-HLHEEILPNKADSYKPAV  241 (461)
Q Consensus       163 l~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~~~~~~~~~i  241 (461)
                      ..||+.-.  .+-.+.+    .  +...|-...+...|-.-..++...+++++.+|+.-.. ++++.             
T Consensus        47 ~~~~~f~~--~I~~~eD----~--~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~~~r-------------  105 (219)
T 4ano_A           47 EVDPCIVR--DIDVSED----E--VKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHSARR-------------  105 (219)
T ss_dssp             GSCSSSEE--EEEECSS----E--EEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCCSSS-------------
T ss_pred             ccCCCCCe--EEEEeCC----E--EEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhhhCc-------------
Confidence            36888722  2223332    2  3333433333344433345888999999999888766 66644             


Q ss_pred             ecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        242 AHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       242 vHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      +|--|.|+||+++.++.++|.-.|+-
T Consensus       106 ~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          106 LIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EECCCCGGGEEECTTCCEEESCCEET
T ss_pred             eeEEEeCceEEEeCCCcEEEEEcCCc
Confidence            78889999999999999999887764

>3kfd_E TGF-beta receptor type-2; TGF-beta recepto tbrii, TBRI, growth factor, serine/threonine-PROT kinase, cytokine-cytokine receptor complex; 3.00A {Homo sapiens}

Probab=80.42  E-value=0.47  Score=36.73  Aligned_cols=34  Identities=26%  Similarity=0.736  Sum_probs=28.7

Q ss_pred             CCCcccccccc-ccCCCceEEecCCCCCCCCCCCC
Q psy17532          4 YDKPKCVEKRP-ESKKNLNFCCCEGDMCNKDFAWE   37 (461)
Q Consensus         4 ~~~~~c~~~~~-~~~~~~~~c~~~~~~C~~~~~~~   37 (461)
                      +++++|++++. ...+..+.|.|.++-||+.+...
T Consensus        79 ~nss~C~Mke~~~~gg~~~iCSC~~eECND~L~F~  113 (116)
T 3kfd_E           79 AASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFS  113 (116)
T ss_dssp             TTBSSEECCCEEETTEEEEEEEECSTTGGGSEESC
T ss_pred             CCCCeeEEEeccCCCCcEEEEecCchhcCceEecc
Confidence            46789999954 68889999999999999988654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	461
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-70
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-36
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-34
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-34
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-31
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-31
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-31
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-29
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-29
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-29
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-28
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-27
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-27
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-22
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-22
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-21
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-21
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-18
d1btea_	96	g.7.1.3 (A:) Type II activin receptor {Mouse (Mus	9e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-09
d2h62d1	91	g.7.1.3 (D:8-98) Type II activin receptor {Mouse (	2e-07

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (565), Expect = 8e-70
 Identities = 122/293 (41%), Positives = 179/293 (61%), Gaps = 7/293 (2%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           R+I L E   +GRFG VW+ K++ E VAVKIF  ++++SW  E EI++   + H+NIL +
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           I A+ +     T+ WL++ YHE GSL D+L    VT E + ++ALS + GL HLH EI+ 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV- 121

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD--THGQVGTRRYM 289
                 KPA+AHRD KS N+L+K + T  IAD GLA+  +      D   + +VGT+RYM
Sbjct: 122 --GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 290 APEVLEGAINFSR-DAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           APEVL+ +IN    ++F R D+YA  LV WE+A RC S+     +Y+LP+   V   PS+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSV 238

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           E+M++ V  +KLRP +P  W+    +  +   M ECW  +  ARL+A  + + 
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-44
 Identities = 72/294 (24%), Positives = 115/294 (39%), Gaps = 41/294 (13%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            I + +    G FG V+K K+  + VAVK+        +Q    + E+  L    H NIL
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHE 227
            ++G          +  ++T + E  SL   L          +L  IA   ++G+ +LH 
Sbjct: 68  LFMGYS-----TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH- 121

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                       ++ HRD KSNN+ L  DLT  I DFGLA +              G+  
Sbjct: 122 ----------AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           +MAPEV+            + D+YA  +VL+EL +            +LP+S    +  +
Sbjct: 172 WMAPEVIRMQDKNPYSF--QSDVYAFGIVLYELMTG-----------QLPYS----NINN 214

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            + +   V    L P L +         A+   M EC     + R     ++  
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCP--KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 7e-39
 Identities = 60/296 (20%), Positives = 112/296 (37%), Gaps = 46/296 (15%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFK-----LPHMEHD 166
           R ++      +G F  V+K       V V    +QD++  +SE++ FK     L  ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHL 225
           NI+R+  + +          L+T     G+L  +L +  ++  + L      + KGL  L
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           H            P + HRD K +N+ +     +  I D GLA L             +G
Sbjct: 129 HTR---------TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIG 175

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           T  +MAPE+ E   +        +D+YA  + + E+A+              P+S    +
Sbjct: 176 TPEFMAPEMYEEKYDE------SVDVYAFGMCMLEMATS-----------EYPYS----E 214

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
             +   +   V       +  +          + + +E C   + + R S   ++ 
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAIP-----EVKEIIEGCIRQNKDERYSIKDLLN 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 4e-38
 Identities = 61/293 (20%), Positives = 119/293 (40%), Gaps = 49/293 (16%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           + ++L++   +G FG V    ++   VAVK  +  D  +     E   +  + H N+++ 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEE 228
           +G     +      +++T Y  +GSL D+L+    +++  + L + +L + + + +L   
Sbjct: 66  LGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                         HRD  + NVL+  D  A ++DFGL                    ++
Sbjct: 121 ---------GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKW 166

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE L       +    + D+++  ++LWE+ S            R+P+         L
Sbjct: 167 TAPEALRE-----KKFSTKSDVWSFGILLWEIYSFG----------RVPYPRI-----PL 206

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           +D+   V  K  +   P+         A+ + M+ CW  DA  R S   + E+
Sbjct: 207 KDVVPRVE-KGYKMDAPDGCPP-----AVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 5e-37
 Identities = 65/317 (20%), Positives = 119/317 (37%), Gaps = 38/317 (11%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILR 170
           + +     G  G V+K   K     +A K+  ++ K + +++  +E+  L       I+ 
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           + GA         E  +   + + GSL   L K   +  + L ++++++ KGL +L E  
Sbjct: 69  FYGAFYSDG----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-- 122

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                   K  + HRD K +N+L+ S     + DFG++            +  VGTR YM
Sbjct: 123 --------KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM 170

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPP-PGEYRLPFSAEVGDHPSL 348
           +PE L+G         ++ D+++  L L E+A     + PP   E  L F  +V    + 
Sbjct: 171 SPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD 408
              +     + L     ++    A    L   + E          S             D
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF---------QD 276

Query: 409 TMEECWDHDAEARLSAS 425
            + +C   +   R    
Sbjct: 277 FVNKCLIKNPAERADLK 293

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 9e-36
 Identities = 50/293 (17%), Positives = 110/293 (37%), Gaps = 45/293 (15%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILR 170
           + +  ++    G+FG V   K++ +  VA+K+         +  +E   + ++ H+ +++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEE 228
             G   +        ++IT Y   G L ++L+   +    +QL  +   + + + +L   
Sbjct: 64  LYGVCTKQR----PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 117

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                         HRD  + N L+       ++DFGL+      +      G     R+
Sbjct: 118 ---------SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRW 167

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
             PEVL            + D++A  +++WE+ S            ++P+     +  + 
Sbjct: 168 SPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLG----------KMPY-----ERFTN 207

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            +  E +  + LR   P    +      +   M  CW   A+ R +   ++  
Sbjct: 208 SETAEHIA-QGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSN 254

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-35
 Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 47/292 (16%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           ++LVE    G+FG VW   +     VAVK              E   +  ++H  ++R  
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEI 229
                        ++IT Y E GSL DFLK      +T  +L  +A  +++G+  + E  
Sbjct: 75  AV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                        HRD ++ N+L+   L+  IADFGLA L E  +            ++ 
Sbjct: 128 ---------RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWT 177

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APE +           ++ D+++  ++L E+ +            R+P+           
Sbjct: 178 APEAINY-----GTFTIKSDVWSFGILLTEIVTHG----------RIPYPGMT------N 216

Query: 350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                 + +  R   P+   +      L   M  CW    E R +   +   
Sbjct: 217 PEVIQNLERGYRMVRPDNCPE-----ELYQLMRLCWKERPEDRPTFDYLRSV 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-35
 Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 54/293 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
           ++     +G+FG V+ A+ K     +A+K+     L +     Q  +E+    H+ H NI
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHE 227
           LR  G       +    +LI  Y   G++   L K +    ++       ++  L + H 
Sbjct: 69  LRLYGYFHDATRV----YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
           +            V HRD K  N+LL S     IADFG ++     +         GT  
Sbjct: 125 K-----------RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLD 169

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y+ PE++EG     R    ++D+++  ++ +E               + PF A      +
Sbjct: 170 YLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVG-----------KPPFEAN-----T 208

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
            ++  + +   ++  T P+   + A      D +     H+   R     V+E
Sbjct: 209 YQETYKRI--SRVEFTFPDFVTEGA-----RDLISRLLKHNPSQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (324), Expect = 2e-34
 Identities = 58/286 (20%), Positives = 103/286 (36%), Gaps = 51/286 (17%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNILRYIGAE 175
            G FGAV+ A+    +E VA+K      KQS +  Q+I K    L  + H N ++Y G  
Sbjct: 25  HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84

Query: 176 KRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILPNKA 234
            R  +     WL+  Y    +          +   ++  +     +GL +LH        
Sbjct: 85  LREHTA----WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH------ 134

Query: 235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVL 294
                 + HRD K+ N+LL       + DFG A            +  VGT  +MAPEV+
Sbjct: 135 -----NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVI 183

Query: 295 EGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEA 354
                   D   ++D+++  +   ELA R           + P         +       
Sbjct: 184 LAMDEGQYDG--KVDVWSLGITCIELAER-----------KPPLFNM-----NAMSALYH 225

Query: 355 VVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
           +   +        W +        + ++ C     + R ++  +++
Sbjct: 226 IAQNESPALQSGHWSE-----YFRNFVDSCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 55/287 (19%), Positives = 111/287 (38%), Gaps = 42/287 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
           +++     G FG V+KA+ K  +   A K+   + ++  +    EI  L   +H NI++ 
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           + A     ++    W++  +   G++   +      +T  Q+  +       L +LH+  
Sbjct: 75  LDAFYYENNL----WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN- 129

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + HRD K+ N+L   D    +ADFG++          D+   +GT  +M
Sbjct: 130 ----------KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWM 177

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APEV+    +  R    + D+++  + L E+A               P          + 
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAE-----------IEPPHHEL----NPMR 222

Query: 350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
            + +    +      P  W          D +++C + + +AR + S
Sbjct: 223 VLLKIAKSEPPTLAQPSRWSS-----NFKDFLKKCLEKNVDARWTTS 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 44/291 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILR 170
            LV+   +G +G V  A  +   E VAVKI  M+         ++EI     + H+N+++
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMHLHEEI 229
           + G  + G       +L   Y   G L D ++ +I +      R    +  G+++LH   
Sbjct: 68  FYGHRREGNIQ----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + HRD K  N+LL       I+DFGLA +F         +   GT  Y+
Sbjct: 122 ---------IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APE+L+     +      +D+++C +VL  + +                           
Sbjct: 173 APELLKRREFHAE----PVDVWSCGIVLTAMLAGEL------------------PWDQPS 210

Query: 350 DMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
           D  +     K + T    WK+     A    + +    +  AR++   + +
Sbjct: 211 DSCQEYSDWKEKKTYLNPWKKIDS--APLALLHKILVENPSARITIPDIKK 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 8e-34
 Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 45/291 (15%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           +  V+    G+FG V    + N + VA+K             +E   +  + H  +++  
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
           G             L+  + E G L D+L  +  +   E L  + L + +G+ +L E   
Sbjct: 67  GVCLEQA----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMA 290
                     V HRD  + N L+  +    ++DFG+       +    + G     ++ +
Sbjct: 120 --------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 170

Query: 291 PEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLED 350
           PEV             + D+++  +++WE+ S        P E R           S  +
Sbjct: 171 PEVFSF-----SRYSSKSDVWSFGVLMWEVFSEG----KIPYENR-----------SNSE 210

Query: 351 MQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           + E +     R   P     H     +   M  CW    E R + S ++ +
Sbjct: 211 VVEDIS-TGFRLYKPRLASTH-----VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 8e-34
 Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 47/296 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           +++     G +G   K + K   + +  K      M + +      E+  L  ++H NI+
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI-----VTWEQLCRIALSMSKGLMH 224
           RY       +  +T  +++  Y E G L   +         +  E + R+   ++  L  
Sbjct: 67  RYYDRII--DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
            H              V HRD K  NV L       + DFGLA +             VG
Sbjct: 125 CHRRSDGG------HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVG 176

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           T  YM+PE +            + D+++   +L+EL +              PF+A    
Sbjct: 177 TPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCAL-----------MPPFTAF--- 217

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
             S +++   +   K    +P  +        L + +    +     R S   ++E
Sbjct: 218 --SQKELAGKIREGK-FRRIPYRYSD-----ELNEIITRMLNLKDYHRPSVEEILE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 8e-34
 Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 47/293 (16%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           S++L     QG FG VW   +     VA+K             QE   +  + H+ +++ 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLK---CNIVTWEQLCRIALSMSKGLMHLHEE 228
                         +++T Y  +GSL DFLK      +   QL  +A  ++ G+ ++   
Sbjct: 78  YAV-----VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    +    HRD ++ N+L+  +L   +ADFGLA L E  +      G     ++
Sbjct: 131 ---------RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKW 180

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE             ++ D+++  ++L EL ++           R+P+          
Sbjct: 181 TAPEAALY-----GRFTIKSDVWSFGILLTELTTKG----------RVPY-----PGMVN 220

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            ++ + V  +  R   P    +     +L D M +CW  + E R +   +   
Sbjct: 221 REVLDQVE-RGYRMPCPPECPE-----SLHDLMCQCWRKEPEERPTFEYLQAF 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 62/285 (21%), Positives = 104/285 (36%), Gaps = 45/285 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
              E   QG  G V+ A      + VA++   +Q +   +    EI  +   ++ NI+ Y
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILP 231
           + +   G+    E W++  Y   GSL D +    +   Q+  +     + L  LH     
Sbjct: 83  LDSYLVGD----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135

Query: 232 NKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                    V HRD KS+N+LL  D +  + DFG      P +        VGT  +MAP
Sbjct: 136 --------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDM 351
           EV+       +    ++D+++  ++  E+                P+     +   L  +
Sbjct: 186 EVVTR-----KAYGPKVDIWSLGIMAIEMIEG-----------EPPYL----NENPLRAL 225

Query: 352 QEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
                +       PE            D +  C D D E R SA 
Sbjct: 226 YLIATNGTPELQNPEKLSA-----IFRDFLNRCLDMDVEKRGSAK 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-33
 Identities = 59/289 (20%), Positives = 104/289 (35%), Gaps = 51/289 (17%)

Query: 122 QGRFGAVWKAKFKNEN----VAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILRYIGA 174
            G FG V K  ++ +     VAVKI   +       ++   E   +  +++  I+R IG 
Sbjct: 17  SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 76

Query: 175 EKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNK 233
                     + L+    E G L  +L +   V  + +  +   +S G+ +L        
Sbjct: 77  -----CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE------- 124

Query: 234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYMAPE 292
               +    HRD  + NVLL +   A I+DFGL+      +             ++ APE
Sbjct: 125 ----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQ 352
            +            + D+++  +++WE  S            + P+    G         
Sbjct: 181 CINY-----YKFSSKSDVWSFGVLMWEAFSYG----------QKPYRGMKGSE------V 219

Query: 353 EAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
            A++ K  R   P    +      + D M  CW +D E R   + V  R
Sbjct: 220 TAMLEKGERMGCPAGCPR-----EMYDLMNLCWTYDVENRPGFAAVELR 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 59/317 (18%), Positives = 110/317 (34%), Gaps = 60/317 (18%)

Query: 113 SIQLVEVK-AQGRFGAVWKAKFKNEN----VAVKIFLMQDKQSWQSE--QEIFKLPHMEH 165
           ++ + +++   G FG+V +  ++       VA+K+     +++   E  +E   +  +++
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLM 223
             I+R IG  +          L+      G L  FL  K   +    +  +   +S G+ 
Sbjct: 69  PYIVRLIGVCQ-----AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           +L            +    HRD  + NVLL +   A I+DFGL+                
Sbjct: 124 YLE-----------EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 284 -GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
               ++ APE +       R    R D+++  + +WE  S            + P+    
Sbjct: 173 KWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYG----------QKPYKKM- 216

Query: 343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERG 402
                  ++   +   K R   P           L   M +CW +  E R     V +R 
Sbjct: 217 ----KGPEVMAFIEQGK-RMECPPECPP-----ELYALMSDCWIYKWEDRPDFLTVEQR- 265

Query: 403 MLALCDTMEECWDHDAE 419
                  M  C+   A 
Sbjct: 266 -------MRACYYSLAS 275

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 4e-32
 Identities = 62/322 (19%), Positives = 109/322 (33%), Gaps = 74/322 (22%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIFLMQDKQSWQSE--QEIFKLPHME 164
           ++  +V   G FG V  A     +       VAVK+   +   S +     E+  +  + 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 165 -HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK--------------------- 202
            H+NI+  +GA      I    +LI  Y   G L ++L+                     
Sbjct: 99  SHENIVNLLGACTLSGPI----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 203 ---CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA 259
               N++T+E L   A  ++KG+  L              +  HRD  + NVL+      
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF-----------KSCVHRDLAARNVLVTHGKVV 203

Query: 260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
            I DFGLA                   ++MAPE L           ++ D+++  ++LWE
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDVWSYGILLWE 258

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCD 379
           + S              P+         ++     ++    +   P    +      +  
Sbjct: 259 IFSLG----------VNPYPGI-----PVDANFYKLIQNGFKMDQPFYATE-----EIYI 298

Query: 380 TMEECWDHDAEARLSASCVVER 401
            M+ CW  D+  R S   +   
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 59/302 (19%), Positives = 105/302 (34%), Gaps = 53/302 (17%)

Query: 112 RSIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIF----LMQDKQSWQSEQEIFKLPH 162
           + ++L+E    G FG V + ++   +     VAVK      L Q +      +E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 163 MEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSK 220
           ++H N++R  G       +     ++T     GSL D L           L R A+ +++
Sbjct: 68  LDHRNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 221 GLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH 280
           G+ +L                 HRD  + N+LL +     I DFGL              
Sbjct: 123 GMGYLES-----------KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171

Query: 281 GQV-GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS 339
                   + APE L+      R      D +   + LWE+ +            + P+ 
Sbjct: 172 EHRKVPFAWCAPESLKT-----RTFSHASDTWMFGVTLWEMFTY----------GQEPWI 216

Query: 340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVV 399
                  +   +   +  +  R   PE   Q      + + M +CW H  E R +   + 
Sbjct: 217 GL-----NGSQILHKIDKEGERLPRPEDCPQ-----DIYNVMVQCWAHKPEDRPTFVALR 266

Query: 400 ER 401
           + 
Sbjct: 267 DF 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (299), Expect = 4e-31
 Identities = 63/301 (20%), Positives = 108/301 (35%), Gaps = 53/301 (17%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSE--QEIFKLPHMEH 165
            +++ +V   G FG V     K        VA+K       +  + +   E   +   +H
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI--VTWEQLCRIALSMSKGLM 223
            N++   G   +         +IT + E GSL  FL+ N    T  QL  +   ++ G+ 
Sbjct: 87  PNVIHLEGVVTKST----PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH--- 280
           +L                 HRD  + N+L+ S+L   ++DFGL+   E            
Sbjct: 143 YLA-----------DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
           G     R+ APE ++      R      D+++  +V+WE+ S              P+  
Sbjct: 192 GGKIPIRWTAPEAIQY-----RKFTSASDVWSYGIVMWEVMSYG----------ERPYWD 236

Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
                 + +D+  A+  +  R   P          AL   M +CW  D   R     +V 
Sbjct: 237 M-----TNQDVINAIE-QDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 401 R 401
            
Sbjct: 286 T 286

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 7e-31
 Identities = 66/299 (22%), Positives = 110/299 (36%), Gaps = 51/299 (17%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSE--QEIFKLPHMEHD 166
           +   EV  +G FG V+     + +      AVK           S+   E   +    H 
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMH 224
           N+L  +G   R E       ++  Y + G L +F++      T + L    L ++KG+  
Sbjct: 89  NVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTH--GQ 282
           L                 HRD  + N +L    T  +ADFGLA      +     +  G 
Sbjct: 146 LA-----------SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 283 VGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV 342
               ++MA E L+     +     + D+++  ++LWEL +R             P+    
Sbjct: 195 KLPVKWMALESLQTQKFTT-----KSDVWSFGVLLWELMTRG----------APPYPDV- 238

Query: 343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
               +  D+   ++  + R   PE          L + M +CW   AE R S S +V R
Sbjct: 239 ----NTFDITVYLLQGR-RLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 55/289 (19%), Positives = 104/289 (35%), Gaps = 50/289 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFK----LPHMEHDNI 168
           +  ++  +G F  V  A+    +   A+KI   +          + +    +  ++H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHE 227
           ++     +  E +    +   +Y + G L  ++ K               +   L +LH 
Sbjct: 71  VKLYFTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K  N+LL  D+   I DFG A +  P       +  VGT +
Sbjct: 127 -----------KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y++PE+L       + A    D++A   ++++L +              PF A      +
Sbjct: 176 YVSPELLTE-----KSACKSSDLWALGCIIYQLVAG-----------LPPFRAG-----N 214

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
              + + ++  KL    PE +   A      D +E+    DA  RL   
Sbjct: 215 EYLIFQKII--KLEYDFPEKFFPKA-----RDLVEKLLVLDATKRLGCE 256

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 4e-30
 Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 50/303 (16%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN----VAVKIF----LMQDKQSWQSEQEIF-KLPHME 164
           I+  +V  +G FG V KA+ K +      A+K         D + +  E E+  KL H  
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-- 69

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKG--- 221
           H NI+  +GA +         +L   Y   G+L DFL+ + V          + +     
Sbjct: 70  HPNIINLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 222 ---LMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGD 278
              L+H   ++        +    HRD  + N+L+  +  A IADFGL+   E       
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---K 182

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
                   R+MA E L  ++  +       D+++  ++LWE+ S              P+
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTT-----NSDVWSYGVLLWEIVSL----------GGTPY 227

Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV 398
                   +  ++ E +  +  R   P           + D M +CW      R S + +
Sbjct: 228 CGM-----TCAELYEKLP-QGYRLEKPLNCDD-----EVYDLMRQCWREKPYERPSFAQI 276

Query: 399 VER 401
           +  
Sbjct: 277 LVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 9e-30
 Identities = 63/312 (20%), Positives = 116/312 (37%), Gaps = 54/312 (17%)

Query: 113 SIQLVEVKAQGRFGAVWKAKFKNEN------VAVKIFLMQDKQSWQSE--QEIFKLPHME 164
            +   +V   G FG V+K   K  +      VA+K       +  + +   E   +    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGL 222
           H NI+R  G   + +       +IT Y E G+L  FL  K    +  QL  +   ++ G+
Sbjct: 68  HHNIIRLEGVISKYK----PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 223 MHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDT-HG 281
            +L                 HRD  + N+L+ S+L   ++DFGL+ + E       T  G
Sbjct: 124 KYLAN-----------MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 282 QVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE 341
                R+ APE +      S       D+++  +V+WE+ +                  E
Sbjct: 173 GKIPIRWTAPEAISYRKFTS-----ASDVWSFGIVMWEVMTY-----------GERPYWE 216

Query: 342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
           + +H  ++      ++   R   P          A+   M +CW  +   R   + +V  
Sbjct: 217 LSNHEVMK-----AINDGFRLPTPMDC-----PSAIYQLMMQCWQQERARRPKFADIVSI 266

Query: 402 --GMLALCDTME 411
              ++   D+++
Sbjct: 267 LDKLIRAPDSLK 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (287), Expect = 1e-29
 Identities = 55/293 (18%), Positives = 119/293 (40%), Gaps = 44/293 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQ-EIFKLPHMEHDNILRY 171
           +  E+  +G    V +   K   +  AVKI  +    S+ +E+ +  +   ++  +ILR 
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 172 IGAEKRGESIHTEF------WLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLMH 224
           +        +   +      +L+    ++G L D+L   + ++ ++  +I  ++ + +  
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           LH+             + HRD K  N+LL  D+   + DFG +   +PG+         G
Sbjct: 126 LHKL-----------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 171

Query: 285 TRRYMAPEVLEGAINFSRDAF-LRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           T  Y+APE++E ++N +   +   +DM++  ++++ L +              PF     
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-----------SPPF----- 215

Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
            H     M   ++    +   PE W  ++    + D +        + R +A 
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPE-WDDYSD--TVKDLVSRFLVVQPQKRYTAE 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  115 bits (288), Expect = 3e-29
 Identities = 53/291 (18%), Positives = 95/291 (32%), Gaps = 53/291 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
            ++E    G FG V +   K        K        DK + ++E  I     + H  ++
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN--QLHHPKLI 89

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHE 227
               A +    +     LI  +   G L D +      ++  ++        +GL H+HE
Sbjct: 90  NLHDAFEDKYEM----VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLL--KSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
                       ++ H D K  N++   K   +  I DFGLA    P +          T
Sbjct: 146 H-----------SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTAT 191

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
             + APE+++             DM+A  ++ + L S              PF+ E    
Sbjct: 192 AEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSG-----------LSPFAGE---- 231

Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
              +D++     K+      E            D ++     +   RL+  
Sbjct: 232 ---DDLETLQNVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVH 278

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (285), Expect = 4e-29
 Identities = 62/322 (19%), Positives = 108/322 (33%), Gaps = 75/322 (23%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQSWQSE--QEIFKLPHME 164
           I+ V    +G FG V++A+            VAVK+   +     Q++  +E   +   +
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK---------------------- 202
           + NI++ +G    G+       L+  Y   G L +FL+                      
Sbjct: 75  NPNIVKLLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 203 ---CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA 259
                 ++  +   IA  ++ G+ +L E               HRD  + N L+  ++  
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE-----------RKFVHRDLATRNCLVGENMVV 179

Query: 260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWE 319
            IADFGL+                   R+M PE +     ++       D++A  +VLWE
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTT----ESDVWAYGVVLWE 234

Query: 320 LASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCD 379
           + S              P+        + E++   V         PE        L L +
Sbjct: 235 IFSYG----------LQPYYGM-----AHEEVIYYVRDGN-ILACPENC-----PLELYN 273

Query: 380 TMEECWDHDAEARLSASCVVER 401
            M  CW      R S   +   
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRI 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  114 bits (287), Expect = 4e-29
 Identities = 52/289 (17%), Positives = 97/289 (33%), Gaps = 49/289 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-EQEIFKLPHMEHDNILRY 171
            + E    G FG V +   +    N A K  +   +   ++  +EI  +  + H  ++  
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
             A +       E  +I  +   G L + +  + N ++ ++       + KGL H+HE  
Sbjct: 89  HDAFEDDN----EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 143

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDL--TAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        H D K  N++  +       + DFGL    +P +         GT  
Sbjct: 144 ----------NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAE 190

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           + APEV EG     +      DM++  ++ + L S              PF  E      
Sbjct: 191 FAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSG-----------LSPFGGE------ 228

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
             D +     K     + ++           D + +    D   R++  
Sbjct: 229 -NDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIH 275

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 65/317 (20%), Positives = 106/317 (33%), Gaps = 69/317 (21%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQSWQSE--QEIFKLPHME 164
           +   +    G FG V +A             VAVK+       + +     E+  L ++ 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 165 -HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN------------------- 204
            H NI+  +GA   G        +IT Y   G L +FL+                     
Sbjct: 85  NHMNIVNLLGACTIGG----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 205 IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF 264
            +  E L   +  ++KG+  L  +              HRD  + N+LL       I DF
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASK-----------NCIHRDLAARNILLTHGRITKICDF 189

Query: 265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC 324
           GLA   +               ++MAPE +   +          D+++  + LWEL S  
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-----ESDVWSYGIFLWELFSLG 244

Query: 325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEEC 384
           SS  P                  ++     ++ +  R   PE          + D M+ C
Sbjct: 245 SSPYP---------------GMPVDSKFYKMIKEGFRMLSPEHAPA-----EMYDIMKTC 284

Query: 385 WDHDAEARLSASCVVER 401
           WD D   R +   +V+ 
Sbjct: 285 WDADPLKRPTFKQIVQL 301

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 61/313 (19%), Positives = 118/313 (37%), Gaps = 45/313 (14%)

Query: 111 CRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQ---DKQSWQSEQEIFKLPH 162
           C  +   + +    QG FG V+KA+ +   + VA+K  LM+   +     + +EI  L  
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65

Query: 163 MEHDNILRYIGAEKRGESIHTE----FWLITAYHERGSLCDFLKCNI-VTWEQLCRIALS 217
           ++H+N++  I   +   S +       +L+  + E           +  T  ++ R+   
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 218 MSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGK--P 275
           +  GL ++H              + HRD K+ NVL+  D    +ADFGLA  F   K   
Sbjct: 126 LLNGLYYIHR-----------NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
                 +V T  Y  PE+L G  ++       ID++    ++ E+ +R        G   
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGP----PIDLWGAGCIMAEMWTRS---PIMQGNTE 227

Query: 336 L------------PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEE 383
                               +  + E  ++  + K  +  + +  K +       D +++
Sbjct: 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287

Query: 384 CWDHDAEARLSAS 396
               D   R+ + 
Sbjct: 288 LLVLDPAQRIDSD 300

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 48/288 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
            + E   +G FG V +       +    K   ++       ++EI  L    H NIL   
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEIL 230
            + +  E    E  +I  +     + + +  +   +   ++      + + L  LH    
Sbjct: 68  ESFESME----ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--- 120

Query: 231 PNKADSYKPAVAHRDFKSNNVLL--KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                     + H D +  N++   +   T  I +FG A   +PG              Y
Sbjct: 121 --------HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEY 169

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APEV +             DM++   +++ L S              PF AE     + 
Sbjct: 170 YAPEVHQH-----DVVSTATDMWSLGTLVYVLLSG-----------INPFLAE-----TN 208

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
           + + E +++ +      E +K+ +  +   D ++     + ++R++AS
Sbjct: 209 QQIIENIMNAEYTFD-EEAFKEIS--IEAMDFVDRLLVKERKSRMTAS 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 57/297 (19%), Positives = 110/297 (37%), Gaps = 52/297 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFKNEN------VAVKIFLMQDKQSWQSE--QEIFKLPHMEHD 166
           + ++V   G FG V+K  +  E       VA+K            E   E + +  +++ 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMH 224
           ++ R +G       + +   LIT     G L D++    + +  + L    + ++KG+ +
Sbjct: 72  HVCRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L               + HRD  + NVL+K+     I DFGLA L    +      G   
Sbjct: 127 LE-----------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
             ++MA E +       R    + D+++  + +WEL +              P+      
Sbjct: 176 PIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTF----------GSKPYDGI--- 217

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                ++   ++ K  R   P         + +   M +CW  DA++R     ++  
Sbjct: 218 --PASEISS-ILEKGERLPQPPIC-----TIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (278), Expect = 4e-28
 Identities = 61/290 (21%), Positives = 105/290 (36%), Gaps = 50/290 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS--EQEIFKLPHMEHDNILR 170
              +V   G F  V  A+ K   + VA+K    +  +  +   E EI  L  ++H NI+ 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEI 229
                + G  +    +LI      G L D + +    T     R+   +   + +LH+  
Sbjct: 72  LDDIYESGGHL----YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTR 286
                      + HRD K  N+L  S   D    I+DFGL+ + +PG          GT 
Sbjct: 128 -----------IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTP 173

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
            Y+APEVL       +     +D ++  ++ + L                PF  E     
Sbjct: 174 GYVAPEVLAQ-----KPYSKAVDCWSIGVIAYILLCG-----------YPPFYDE----- 212

Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
           +   + E ++  +     P  W   +   +  D +    + D E R +  
Sbjct: 213 NDAKLFEQILKAEYEFDSPY-WDDISD--SAKDFIRHLMEKDPEKRFTCE 259

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 28/295 (9%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE--QEIFKLPHMEHDNILR 170
             +    +G +G V  A        VA+K     + Q++     +EI  L    H+NI+ 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEIL 230
                +       +   +  +     L   LK   ++ + +C     + +GL ++H    
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-- 128

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQ-VGTRRYM 289
                     V HRD K +N+LL +     I DFGLA + +P         + V TR Y 
Sbjct: 129 ---------NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APE++  +  +++     ID+++   +L E+ S            +L     +   PS E
Sbjct: 180 APEIMLNSKGYTK----SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 350 DMQEAVVHKKLRPTLPETWKQHAGMLALC--------DTMEECWDHDAEARLSAS 396
           D+   +  K     L    K       L         D +++    +   R+   
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 58/297 (19%), Positives = 101/297 (34%), Gaps = 52/297 (17%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-----VAVKIFLMQDKQSWQSE--QEIFKLPHMEHD 166
           I+L     +G+FG V +  + +       VA+K        S + +  QE   +   +H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMH 224
           +I++ IG            W+I      G L  FL  +   +    L   A  +S  L +
Sbjct: 69  HIVKLIGVITENP-----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           L                 HRD  + NVL+ S+    + DFGL+   E       + G   
Sbjct: 124 LES-----------KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KL 171

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
             ++MAPE +       R      D++   + +WE+         P              
Sbjct: 172 PIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHG---VKPF------------Q 211

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
                D+   + + + R  +P           L   M +CW +D   R   + +  +
Sbjct: 212 GVKNNDVIGRIENGE-RLPMPPNCPP-----TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 61/293 (20%), Positives = 115/293 (39%), Gaps = 47/293 (16%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN--VAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRY 171
           I +      G++G V++  +K  +  VAVK       +  +  +E   +  ++H N+++ 
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 172 IGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEE 228
           +G   R       F++IT +   G+L D+L+      V+   L  +A  +S  + +L   
Sbjct: 79  LGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                    K    HRD  + N L+  +    +ADFGL+ L           G     ++
Sbjct: 133 ---------KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKW 182

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
            APE L           ++ D++A  ++LWE+A+              P+         L
Sbjct: 183 TAPESLAY-----NKFSIKSDVWAFGVLLWEIATYG----------MSPYPGI-----DL 222

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             + E ++ K  R   PE   +      + + M  CW  +   R S + + + 
Sbjct: 223 SQVYE-LLEKDYRMERPEGCPE-----KVYELMRACWQWNPSDRPSFAEIHQA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  108 bits (270), Expect = 3e-27
 Identities = 52/289 (17%), Positives = 101/289 (34%), Gaps = 43/289 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQS-EQEIFKLPHMEHDNI 168
           +L E+   G    V  A+    + +VAVK+    L +D   +    +E      + H  I
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHE 227
           +      +         +++  Y +  +L D +     +T ++   +     + L   H+
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL-LFEPGKPCGDTHGQVGTR 286
                        + HRD K  N+++ +     + DFG+A  + + G     T   +GT 
Sbjct: 130 -----------NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 287 RYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP 346
           +Y++PE   G          R D+Y+   VL+E+ +              PF+ +     
Sbjct: 179 QYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTG-----------EPPFTGD----- 217

Query: 347 SLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
           S   +    V +   P         A    L   + +    + E R   
Sbjct: 218 SPVSVAYQHVREDPIPPSARHEGLSA---DLDAVVLKALAKNPENRYQT 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 60/290 (20%), Positives = 109/290 (37%), Gaps = 55/290 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLM------QDKQSWQSEQEIFKLPHMEHD 166
            L ++  +G FG V+ A+FK  N+  A+K           D +    E+ +  L   EH 
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHP 63

Query: 167 NILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHL 225
            +       +  E++    + +  Y   G L   ++ C+     +    A  +  GL  L
Sbjct: 64  FLTHMFCTFQTKENL----FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 226 HEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGT 285
           H              + +RD K +N+LL  D    IADFG+      G    +T    GT
Sbjct: 120 H-----------SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGT 166

Query: 286 RRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH 345
             Y+APE+L G     +     +D ++  ++L+E+              + PF  +    
Sbjct: 167 PDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIG-----------QSPFHGQ---- 206

Query: 346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
              ++ +     +   P  P   ++ A      D + + +  + E RL  
Sbjct: 207 ---DEEELFHSIRMDNPFYPRWLEKEA-----KDLLVKLFVREPEKRLGV 248

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 58/290 (20%), Positives = 97/290 (33%), Gaps = 53/290 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE-------QEIFKLPHMEH 165
            +  +  +G FG V+  +     +  A+K    +  +  Q E         +  +   + 
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMH 224
             I+    A    + +      I      G L   L  + V  E  +   A  +  GL H
Sbjct: 67  PFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           +H              V +RD K  N+LL       I+D GLA  F   K     H  VG
Sbjct: 123 MHN-----------RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
           T  YMAPEVL+  + +        D ++   +L++L                PF      
Sbjct: 168 THGYMAPEVLQKGVAYDS----SADWFSLGCMLFKLLRG-----------HSPFR----Q 208

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS 394
           H + +  +   +   +   LP+++            +E     D   RL 
Sbjct: 209 HKTKDKHEIDRMTLTMAVELPDSFSPEL-----RSLLEGLLQRDVNRRLG 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 49/289 (16%), Positives = 94/289 (32%), Gaps = 45/289 (15%)

Query: 116 LVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIG 173
             +V   G  G V +   K   E  A+K+  +QD    + E E+      +  +I+R + 
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWR-ASQCPHIVRIVD 72

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEIL 230
             +   +      ++    + G L   ++       T  +   I  S+ + + +LH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130

Query: 231 PNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                     +AHRD K  N+L  S   +    + DFG A                 T  
Sbjct: 131 ---------NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPY 178

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y+APEVL              DM++  ++++ L                PF +       
Sbjct: 179 YVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCG-----------YPPFYSN-HGLAI 221

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
              M+  +   +     PE  +       +   +      +   R++ +
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSE---EVKMLIRNLLKTEPTQRMTIT 267

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 57/301 (18%), Positives = 106/301 (35%), Gaps = 43/301 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           QLV    +G++  V++A     NE V VKI     K+  + E +I +       NI+   
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG-GPNIITLA 96

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN 232
              K   S      L+  +          +   +T   +      + K L + H      
Sbjct: 97  DIVKDPVSRT--PALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH------ 146

Query: 233 KADSYKPAVAHRDFKSNNVLLKSD-LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP 291
                   + HRD K +NV++  +     + D+GLA  + PG+     + +V +R +  P
Sbjct: 147 -----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 198

Query: 292 EVLEGAINFSRDAFLRIDMYACALVLWELASRCS----------------SVSPPPGEYR 335
           E+L     +       +DM++   +L  +  R                   V      Y 
Sbjct: 199 ELLVDYQMYDY----SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
                 +   P   D+      K+    +    +      AL D +++   +D ++RL+A
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL-DFLDKLLRYDHQSRLTA 313

Query: 396 S 396
            
Sbjct: 314 R 314

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 5e-25
 Identities = 67/325 (20%), Positives = 121/325 (37%), Gaps = 74/325 (22%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN---------VAVKIF----LMQDKQSWQSEQEIFKL 160
           + L +   +G FG V  A+    +         VAVK+       +D     SE E+ K+
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 161 PHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---------------- 204
              +H NI+  +GA  +   +    ++I  Y  +G+L ++L+                  
Sbjct: 75  -IGKHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 205 -IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD 263
             ++ + L   A  +++G+ +L                 HRD  + NVL+  D    IAD
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-----------KKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
           FGLA           T       ++MAPE L       R    + D+++  ++LWE+ + 
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTL 233

Query: 324 CSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEE 383
                        P+         +E++ + ++ +  R   P           L   M +
Sbjct: 234 G----------GSPYPGV-----PVEELFK-LLKEGHRMDKPSNCTN-----ELYMMMRD 272

Query: 384 CWDHDAEARLSASCVVER--GMLAL 406
           CW      R +   +VE    ++AL
Sbjct: 273 CWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 2e-24
 Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 39/297 (13%)

Query: 114 IQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQSWQSE--QEIFKLPHME 164
           I +     QG FG V++   K          VA+K          + E   E   +    
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMH 224
             +++R +G   +G+       +I     RG L  +L+           +A      ++ 
Sbjct: 82  CHHVVRLLGVVSQGQ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVG 284
           +  EI    A        HRD  + N ++  D T  I DFG+                + 
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 285 TRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD 344
             R+M+PE L+  +  +       D+++  +VLWE+A+              P+      
Sbjct: 198 PVRWMSPESLKDGVFTTYS-----DVWSFGVVLWEIATLA----------EQPYQGL--- 239

Query: 345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER 401
             S E +   V+   L    P+          L + M  CW ++ + R S   ++  
Sbjct: 240 --SNEQVLRFVMEGGLLD-KPDNCPD-----MLFELMRMCWQYNPKMRPSFLEIISS 288

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-24
 Identities = 61/310 (19%), Positives = 106/310 (34%), Gaps = 48/310 (15%)

Query: 111 CRSI---QLVEVKAQGRFGAVWKAKFK---NENVAVKIF---LMQDKQSWQSEQEIF--- 158
           CR+    + V    +G +G V+KA+        VA+K       ++     + +E+    
Sbjct: 3   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 159 KLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN---IVTWEQLCRIA 215
            L   EH N++R         +       +   H    L  +L       V  E +  + 
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
             + +GL  LH              V HRD K  N+L+ S     +ADFGLA ++     
Sbjct: 123 FQLLRGLDFLHSH-----------RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 171

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE-- 333
                  V T  Y APEVL  + +++      +D+++   +  E+  R        G   
Sbjct: 172 L---TSVVVTLWYRAPEVLLQS-SYAT----PVDLWSVGCIFAEMFRRK---PLFRGSSD 220

Query: 334 -------YRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWD 386
                    +       D P    +     H K    + +       +    D + +C  
Sbjct: 221 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLT 278

Query: 387 HDAEARLSAS 396
            +   R+SA 
Sbjct: 279 FNPAKRISAY 288

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 97.6 bits (242), Expect = 2e-23
 Identities = 48/293 (16%), Positives = 83/293 (28%), Gaps = 52/293 (17%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF-LMQDKQSWQSEQEIFK-LPHMEHDNILR 170
           ++     +G FG +++      N+ VA+K      D    + E   +K L        + 
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEI 229
           Y G E           L+              C    + + +   A  M   +  +HE  
Sbjct: 68  YFGQEGL------HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-- 119

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAA-----IADFGLALLFEPGK-----PCGDT 279
                     ++ +RD K +N L+    +       + DFG+   +         P  + 
Sbjct: 120 ---------KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 280 HGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS 339
               GT RYM+     G     R+   R D+ A   V               G       
Sbjct: 171 KNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLR---------GSLPWQGL 216

Query: 340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR 392
                  + +   E +  KK    L E              M    +   +A 
Sbjct: 217 ----KAATNKQKYERIGEKKQSTPLRELCAGFPEEFY--KYMHYARNLAFDAT 263

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 3e-23
 Identities = 74/293 (25%), Positives = 118/293 (40%), Gaps = 43/293 (14%)

Query: 122 QGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSE------QEIFKLPHMEHDNILRYIG 173
           +G+F  V+KA+ K  N+ VA+K   +  +   +        +EI  L  + H NI+  + 
Sbjct: 8   EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67

Query: 174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWE-QLCRIALSMSKGLMHLHEEILPN 232
           A     +I     L+  + E          ++V     +    L   +GL +LH+     
Sbjct: 68  AFGHKSNI----SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120

Query: 233 KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPE 292
                   + HRD K NN+LL  +    +ADFGLA  F  G P      QV TR Y APE
Sbjct: 121 --------ILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPE 170

Query: 293 VLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------YRLPFSAEVG 343
           +L GA  +       +DM+A   +L EL  R   V   PG+         +    +    
Sbjct: 171 LLFGARMYGV----GVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEE 223

Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
             P +  + + V  K             AG   L D ++  +  +  AR++A+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL-DLIQGLFLFNPCARITAT 275

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 96.9 bits (240), Expect = 3e-23
 Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 38/296 (12%)

Query: 115 QLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNILR 170
             +E   +G +G V+KA+    E  A+K   ++ +          EI  L  ++H NI++
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 171 YIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEI 229
                           L+  + ++        C   +         L +  G+ + H+  
Sbjct: 65  LYDVIHT----KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-- 118

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      V HRD K  N+L+  +    IADFGLA  F  G P      ++ T  Y 
Sbjct: 119 ---------RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYR 167

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------YRLPFSA 340
           AP+VL G+  +S      ID+++   +  E+ +        PG          +R+  + 
Sbjct: 168 APDVLMGSKKYST----TIDIWSVGCIFAEMVNGT---PLFPGVSEADQLMRIFRILGTP 220

Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
              + P++ ++ +   +  +   LP          +  D + +    D   R++A 
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.5 bits (239), Expect = 6e-23
 Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 30/293 (10%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           Q VE   +G +G V+KA+ K   E VA+K        +     + +EI  L  + H NI+
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           + +        ++  F  +  + +     D      +    +      + +GL   H   
Sbjct: 65  KLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      V HRD K  N+L+ ++    +ADFGLA  F  G P      +V T  Y 
Sbjct: 123 -----------VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 169

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLE 349
           APE+L G   +S      +D+++   +  E+ +R +         +L         P   
Sbjct: 170 APEILLGCKYYST----AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 350 DMQEAVVHKKLRPTLPETWKQHAGML------ALCDTMEECWDHDAEARLSAS 396
                      +P+ P+  +Q    +           + +   +D   R+SA 
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-22
 Identities = 57/315 (18%), Positives = 107/315 (33%), Gaps = 66/315 (20%)

Query: 114 IQLVEVKAQGRFGAVWKAKFKNEN-------VAVKIF---LMQDKQSWQSEQEIFKLPHM 163
           ++L +   +G FG V +A     +       VAVK+        +      +    +   
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLK-----------------CNIV 206
            H N++  +GA            +I  + + G+L  +L+                  + +
Sbjct: 75  HHLNVVNLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 207 TWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL 266
           T E L   +  ++KG+  L                 HRD  + N+LL       I DFGL
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS-----------RKCIHRDLAARNILLSEKNVVKICDFGL 180

Query: 267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSS 326
           A                   ++MAPE +       R   ++ D+++  ++LWE+ S    
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLG-- 233

Query: 327 VSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWD 386
                     P+         +++     + +  R   P+          +  TM +CW 
Sbjct: 234 --------ASPYPGV-----KIDEEFCRRLKEGTRMRAPDYTTP-----EMYQTMLDCWH 275

Query: 387 HDAEARLSASCVVER 401
            +   R + S +VE 
Sbjct: 276 GEPSQRPTFSELVEH 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.2 bits (236), Expect = 1e-22
 Identities = 58/298 (19%), Positives = 101/298 (33%), Gaps = 60/298 (20%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQS-------EQEIFKLPHMEH 165
              E    G+F  V K + K      A K    +  +S +        E+E+  L  ++H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 166 DNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMH 224
            N++      +    +     LI      G L DFL +   +T E+       +  G+ +
Sbjct: 73  PNVITLHEVYENKTDV----ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128

Query: 225 LHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA----IADFGLALLFEPGKPCGDTH 280
           LH              +AH D K  N++L           I DFGLA   + G       
Sbjct: 129 LHS-----------LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FK 174

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
              GT  ++APE++           L  DM++  ++ + L S                  
Sbjct: 175 NIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLS------------------ 211

Query: 341 EVGDHPSLEDMQEAVVHK--KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
             G  P L D ++  +     +     + +  +   LA  D +      D + R++  
Sbjct: 212 --GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK-DFIRRLLVKDPKKRMTIQ 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.6 bits (232), Expect = 4e-22
 Identities = 47/296 (15%), Positives = 83/296 (28%), Gaps = 66/296 (22%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFL---------MQDKQSWQSEQEIFKLPHM 163
           Q+  +   G FG+V+       N  VA+K            + +      E  + K    
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 164 EHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKG 221
               ++R +   +R +S    F LI    E          +   +  E        + + 
Sbjct: 67  GFSGVIRLLDWFERPDS----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 222 LMHLHEEILPNKADSYKPAVAHRDFKSNNVLL-KSDLTAAIADFGLALLFEPGKPCGDTH 280
           + H H              V HRD K  N+L+  +     + DFG   L +         
Sbjct: 123 VRHCHNC-----------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYT 167

Query: 281 GQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA 340
              GTR Y  PE +       R       +++  ++L+++                    
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGR----SAAVWSLGILLYDMVC------------------ 205

Query: 341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
             GD P   D +        R  +                +  C       R +  
Sbjct: 206 --GDIPFEHDEEIIRGQVFFRQRVSS---------ECQHLIRWCLALRPSDRPTFE 250

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.7 bits (232), Expect = 1e-21
 Identities = 60/288 (20%), Positives = 98/288 (34%), Gaps = 52/288 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
             +++  +G FG V   + K      A+KI     ++   +   +  E   L +  H  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHE 227
                A +     H     +  Y   G L   L +  + T E+       +   L +LH 
Sbjct: 68  TALKYAFQT----HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        V +RD K  N++L  D    I DFGL                 GT  
Sbjct: 124 -----------RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 170

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y+APEVLE       D    +D +   +V++E+              RLPF  +      
Sbjct: 171 YLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ-----D 209

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
            E + E ++ +++R   P T    A        +      D + RL  
Sbjct: 210 HERLFELILMEEIR--FPRTLSPEA-----KSLLAGLLKKDPKQRLGG 250

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.7 bits (232), Expect = 1e-21
 Identities = 67/343 (19%), Positives = 114/343 (33%), Gaps = 58/343 (16%)

Query: 94  VPTLEPHPTSPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSW 151
           V T+   P   P   Q   S    +V   G FG V++AK     E VA+K  ++QDK+  
Sbjct: 3   VTTVVATPGQGPDRPQE-VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFK 60

Query: 152 QSEQEIFKLPHMEHDNILRYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCN----I 205
             E +I +   ++H NI+R          +       L+  Y            +     
Sbjct: 61  NRELQIMR--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118

Query: 206 VTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD-LTAAIADF 264
           +    +      + + L ++H              + HRD K  N+LL  D     + DF
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHS-----------FGICHRDIKPQNLLLDPDTAVLKLCDF 167

Query: 265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRC 324
           G A     G+P       + +R Y APE++ GA +++      ID+++   VL EL    
Sbjct: 168 GSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTS----SIDVWSAGCVLAELLLG- 219

Query: 325 SSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQ--HAGMLALCDTME 382
                     +  F  +     S  D    ++     PT  +  +   +           
Sbjct: 220 ----------QPIFPGD-----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA 264

Query: 383 ECWDHDAEARLSASCVVERGMLALCDTMEECWDHDAEARLSAS 425
             W      R     +                ++   ARL+  
Sbjct: 265 HPWTKVFRPRTPPEAI---------ALCSRLLEYTPTARLTPL 298

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 92.6 bits (229), Expect = 1e-21
 Identities = 46/297 (15%), Positives = 86/297 (28%), Gaps = 46/297 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYI 172
           +L      G FG ++        E VA+K+  ++ K   Q   E      M+    +  I
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGIPTI 68

Query: 173 GAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEEILP 231
                  +      ++           F  C+   + + +  +A  M   + ++H +   
Sbjct: 69  RW---CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--- 122

Query: 232 NKADSYKPAVAHRDFKSNNVLLKS---DLTAAIADFGLALLFEPGK-----PCGDTHGQV 283
                      HRD K +N L+          I DFGLA  +   +     P  +     
Sbjct: 123 --------NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           GT RY +     G      +   R D+ +   VL                          
Sbjct: 175 GTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLK------------ 217

Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE 400
              +     E +  KK+   +    K +         +  C     + +   S + +
Sbjct: 218 -AATKRQKYERISEKKMSTPIEVLCKGYPS--EFATYLNFCRSLRFDDKPDYSYLRQ 271

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 2e-21
 Identities = 59/318 (18%), Positives = 125/318 (39%), Gaps = 49/318 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           + ++    G +GAV  A        VA+K        +  + ++ +E+  L HM H+N++
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 170 RYIGAEKRGESIH--TEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
             +      E++   T+F+L+  +         +K   +  +++  +   M KGL ++H 
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFMGTDLG-KLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K  N+ +  D    I DFGLA      +   +  G V TR 
Sbjct: 140 -----------AGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRW 183

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y APEV+   + +++     +D+++   ++ E+ +            +  F         
Sbjct: 184 YRAPEVILNWMRYTQ----TVDIWSVGCIMAEMITG-----------KTLFKGS------ 222

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC 407
            + + +     K+  T P  + Q        + M+   + +   +   + ++        
Sbjct: 223 -DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE---KKDFASILTNASPLAV 278

Query: 408 DTMEECWDHDAEARLSAS 425
           + +E+    DAE R++A 
Sbjct: 279 NLLEKMLVLDAEQRVTAG 296

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.5 bits (229), Expect = 2e-21
 Identities = 54/287 (18%), Positives = 96/287 (33%), Gaps = 53/287 (18%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQEIFKLPHMEHDNI 168
           Q++     G FG V   + +      A+K+     +++ KQ   +  E   L  + H  I
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66

Query: 169 LRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEE 228
           +R  G  +  + I      I        L    +            A  +   L +LH  
Sbjct: 67  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLHS- 122

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + +RD K  N+LL  +    I DFG A           T+   GT  Y
Sbjct: 123 ----------KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDY 167

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL 348
           +APEV+       +     ID ++  ++++E+ +              PF        + 
Sbjct: 168 IAPEVVST-----KPYNKSIDWWSFGILIYEMLAG-----------YTPF-----YDSNT 206

Query: 349 EDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSA 395
               E +++ +LR   P  + +      + D +      D   RL  
Sbjct: 207 MKTYEKILNAELR--FPPFFNE-----DVKDLLSRLITRDLSQRLGN 246

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.2 bits (225), Expect = 4e-21
 Identities = 68/295 (23%), Positives = 110/295 (37%), Gaps = 34/295 (11%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQ---EIFKLPHMEHDNIL 169
           + +E   +G +G V+KAK +  +E VA+K   + D           EI  L  ++H NI+
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN-IVTWEQLCRIALSMSKGLMHLHEE 228
           R             +  L+  + ++     F  CN  +  E +      + KGL   H  
Sbjct: 65  RLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       V HRD K  N+L+  +    +A+FGLA  F  G P      +V T  Y
Sbjct: 119 ---------SRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWY 167

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY-------RLPFSAE 341
             P+VL GA  +S      IDM++   +  ELA+    + P            RL  +  
Sbjct: 168 RPPDVLFGAKLYST----SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223

Query: 342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
               PS+  + +   +     T               D ++     +   R+SA 
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.8 bits (216), Expect = 1e-19
 Identities = 57/334 (17%), Positives = 101/334 (30%), Gaps = 49/334 (14%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEI-----------FKLP 161
            LV     G F  VW AK    N +VA+KI       +  +E EI            K  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 162 HMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCN--IVTWEQLCRIALSMS 219
            M  ++IL+ +              ++        L    K     +    + +I+  + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 220 KGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DLTAAIADFGLALLFEPGKPCGD 278
            GL ++H           +  + H D K  NVL++  D    +    +A L         
Sbjct: 136 LGLDYMH----------RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 279 THGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF 338
               + TR Y +PEVL G            D+++ A +++EL +               F
Sbjct: 186 YTNSIQTREYRSPEVLLG-----APWGCGADIWSTACLIFELITG-----------DFLF 229

Query: 339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV 398
             + G   + +D   A + + L        +         ++     +           V
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289

Query: 399 VERGML-------ALCDTMEECWDHDAEARLSAS 425
           +             + D +      D   R  A 
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 86.4 bits (213), Expect = 3e-19
 Identities = 50/298 (16%), Positives = 99/298 (33%), Gaps = 58/298 (19%)

Query: 106 SPQQGCRSI---QLVEVKAQGRFGAVWKAKFK--NENVAVKIF----LMQDKQSWQSEQE 156
           +P Q    +     ++    G FG V   K K    + A+KI     +++ KQ   +  E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 157 IFKLPHMEHDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIA 215
              L  +    +++   + K     ++  +++  Y   G +   L +    +       A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKD----NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147

Query: 216 LSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKP 275
             +     +LH              + +RD K  N+L+       + DFG A      + 
Sbjct: 148 AQIVLTFEYLHSL-----------DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RV 191

Query: 276 CGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYR 335
            G T    GT   +APE++       +     +D +A  ++++E+A+             
Sbjct: 192 KGRTWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAG-----------Y 235

Query: 336 LPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL 393
            PF A+       + +Q        +   P  +          D +      D   R 
Sbjct: 236 PPFFAD-------QPIQIYEKIVSGKVRFPSHFSSDL-----KDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 1e-18
 Identities = 59/293 (20%), Positives = 109/293 (37%), Gaps = 48/293 (16%)

Query: 115 QLVEVKAQGRFGAVWKAKFK-----NENVAVKIF-----LMQDKQSWQSEQEIFKLPHME 164
           +L++V   G +G V+  +        +  A+K+      + + K +  +  E   L H+ 
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 165 HDNILRYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNI-VTWEQLCRIALSMSKGLM 223
               L  +    + E   T+  LI  Y   G L   L      T  ++      +   L 
Sbjct: 87  QSPFLVTLHYAFQTE---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 224 HLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQV 283
           HLH+             + +RD K  N+LL S+    + DFGL+  F         +   
Sbjct: 144 HLHK-----------LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFC 191

Query: 284 GTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG 343
           GT  YMAP+++ G           +D ++  ++++EL +              PF+ + G
Sbjct: 192 GTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTG-----------ASPFTVD-G 236

Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS 396
           +  S  ++   ++  K  P  P+     A      D ++     D + RL   
Sbjct: 237 EKNSQAEISRRIL--KSEPPYPQEMSALA-----KDLIQRLLMKDPKKRLGCG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.6 bits (208), Expect = 1e-18
 Identities = 58/299 (19%), Positives = 119/299 (39%), Gaps = 40/299 (13%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           Q +     G +G+V  A        VAVK           + ++ +E+  L HM+H+N++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEE 228
             +       S+     +    H  G+  + + KC  +T + +  +   + +GL ++H  
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139

Query: 229 ILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRY 288
                       + HRD K +N+ +  D    I DFGLA   +      +  G V TR Y
Sbjct: 140 ----------ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWY 184

Query: 289 MAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE-----YRLPFSAEVG 343
            APE++   +++++     +D+++   ++ EL +     +  PG       +L       
Sbjct: 185 RAPEIMLNWMHYNQ----TVDIWSVGCIMAELLTGR---TLFPGTDHIDQLKLILRLVGT 237

Query: 344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGML------ALCDTMEECWDHDAEARLSAS 396
               L     +   +    +L +  K +   +         D +E+    D++ R++A+
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.7 bits (203), Expect = 6e-18
 Identities = 56/324 (17%), Positives = 102/324 (31%), Gaps = 50/324 (15%)

Query: 115 QLVEVKAQGRFGAVWKAKFK--NENVAVKIF---LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           Q ++    G  G V  A     + NVA+K           + ++ +E+  +  + H NI+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 170 RYIGA--EKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHE 227
             +     ++      + +L+    +               E++  +   M  G+ HLH 
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHS 137

Query: 228 EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRR 287
                        + HRD K +N+++KSD T  I DFGLA               V TR 
Sbjct: 138 -----------AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183

Query: 288 YMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS 347
           Y APEV+ G           +D+++   ++ E+              ++ F         
Sbjct: 184 YRAPEVILGMGYKE-----NVDIWSVGCIMGEMVRH-----------KILFPGR-----D 222

Query: 348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML--- 404
             D    V+ +   P      K    +    +   +            S           
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282

Query: 405 ---ALCDTMEECWDHDAEARLSAS 425
                 D + +    D   R+S  
Sbjct: 283 KASQARDLLSKMLVIDPAKRISVD 306

>d1btea_ g.7.1.3 (A:) Type II activin receptor {Mouse (Mus musculus) [TaxId: 10090]} Length = 96

class: Small proteins
fold: Snake toxin-like
superfamily: Snake toxin-like
family: Extracellular domain of cell surface receptors
domain: Type II activin receptor
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 53.3 bits (128), Expect = 9e-10
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 1  MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEP 38
          + CYD+  C+EK+      + FCCCEG+MCN+ F++ P
Sbjct: 58 INCYDRTDCIEKKD--SPEVYFCCCEGNMCNEKFSYFP 93

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.2 bits (127), Expect = 7e-09
 Identities = 28/214 (13%), Positives = 51/214 (23%), Gaps = 47/214 (21%)

Query: 122 QGRFGAVWKAK-FKNENVAVKIF-----------LMQDKQSWQSEQEIFKLPHMEHDNIL 169
           +G+  AV+     K     VK               +D           +    E   + 
Sbjct: 10  EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69

Query: 170 RYIGAEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEI 229
           +  G             ++    +        +   V  E    +   + + +   +   
Sbjct: 70  KLQGLAVPKVYAWEGNAVLMELIDAK------ELYRVRVENPDEVLDMILEEVAKFYH-- 121

Query: 230 LPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYM 289
                      + H D    NVL+ S+    I DF  +               V      
Sbjct: 122 ---------RGIVHGDLSQYNVLV-SEEGIWIIDFPQS---------------VEVGEEG 156

Query: 290 APEVLEGAINFSRDAFLRIDMYACALVLWELASR 323
             E+LE  +      F R   Y     +     R
Sbjct: 157 WREILERDVRNIITYFSR--TYRTEKDINSAIDR 188

>d2h62d1 g.7.1.3 (D:8-98) Type II activin receptor {Mouse (Mus musculus), isoform IIB [TaxId: 10090]} Length = 91

class: Small proteins
fold: Snake toxin-like
superfamily: Snake toxin-like
family: Extracellular domain of cell surface receptors
domain: Type II activin receptor
species: Mouse (Mus musculus), isoform IIB [TaxId: 10090]

 Score = 46.8 bits (111), Expect = 2e-07
 Identities = 14/33 (42%), Positives = 20/33 (60%), Gaps = 2/33 (6%)

Query: 2  ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDF 34
           CYD+ +CV      +  + FCCCEG+ CN+ F
Sbjct: 58 NCYDRQECVATEENPQ--VYFCCCEGNFCNERF 88

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	461
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.41
d1btea_	96	Type II activin receptor {Mouse (Mus musculus) [Ta	97.36
d2h62d1	91	Type II activin receptor {Mouse (Mus musculus), is	96.53
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.35
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.7

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=433.81  Aligned_cols=293  Identities=41%  Similarity=0.731  Sum_probs=243.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeeeh
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLITA  190 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~e  190 (461)
                      .++|.+.+.||+|+||.||+|+++|+.||||++..........+.|+..+..++|||||+++|++.+.+.....+++|||
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            36899999999999999999999999999999977666666667888888899999999999999876655557899999


Q ss_pred             hccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcccc
Q psy17532        191 YHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLF  270 (461)
Q Consensus       191 ~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~  270 (461)
                      ||++|+|.++|+...+++..+++++.|+|.||+|||+..   ....+.++|+||||||+||||+.++.+||+|||+++..
T Consensus        82 y~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~---~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI---VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCB---CSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhh---hhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999889999999999999999999999752   12233459999999999999999999999999999887


Q ss_pred             CCCCCC--CCCCCCcCCCccccccccccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        271 EPGKPC--GDTHGQVGTRRYMAPEVLEGAINFS-RDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       271 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      ......  .......||+.|||||++.+..... ..++.++|||||||+||||+||..|+..... ...|+.......+.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~-~~~~~~~~~~~~~~  237 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVPSDPS  237 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC-CCCTTTTTSCSSCC
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc-cccchhhcccccch
Confidence            543321  1234568999999999987642111 1256789999999999999999877654333 35677766667778


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...+...+.....+|.++..+........+.+||.+||+.||++|||+.||+++|..+..
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            888888888889999999888777777889999999999999999999999999877654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=426.24  Aligned_cols=264  Identities=28%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ....++|++.+.||+|+||+||+|++++ .||||++....   .....+.+|+.++.+++|||||+++|++..+     .
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-----~   77 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-----Q   77 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc-----E
Confidence            3456789999999999999999998765 59999986432   2334567899999999999999999987543     3


Q ss_pred             eeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        185 FWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      +++|||||++|+|.+++.  ...+++..++.++.|||+||+|||++           +||||||||+|||++.++.+||+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-----------~ivHrDlKp~NiLl~~~~~~Kl~  146 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-----------SIIHRDLKSNNIFLHEDLTVKIG  146 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEEETTSSEEEC
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC-----------CEeccccCHHHEEEcCCCCEEEc
Confidence            589999999999999994  34699999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+...............||+.|||||++.+.  ....++.++|||||||++|||+||           +.||.+. 
T Consensus       147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~~sDiwS~Gv~l~el~tg-----------~~Pf~~~-  212 (276)
T d1uwha_         147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ--DKNPYSFQSDVYAFGIVLYELMTG-----------QLPYSNI-  212 (276)
T ss_dssp             CCCCSCC------------CCCCGGGCCHHHHTTC--SSCCCCHHHHHHHHHHHHHHHHHS-----------SCTTTTC-
T ss_pred             cccceeeccccCCcccccccccCcccCCHHHHhcc--cCCCCCchhhhhhhHHHHHHHHHC-----------CCCCCCC-
Confidence            99999887654333344556899999999998753  123578899999999999999999           6666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                         .....+...+..+...+.++...  ...+.++.+||.+||+.||++|||+++++++|+.+..
T Consensus       213 ---~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         213 ---NNRDQIIFMVGRGYLSPDLSKVR--SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ---CCHHHHHHHHHHTSCCCCGGGSC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---ChHHHHHHHHhcCCCCCcchhcc--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               12334444444443333322111  1133489999999999999999999999999877653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=420.35  Aligned_cols=254  Identities=20%  Similarity=0.355  Sum_probs=202.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .++|++.+.||+|+||.||+|++. ++.||||++.........+.+|+.++++++|||||+++|++...+.    +++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~lv~   79 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVF   79 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc----eEEEE
Confidence            458999999999999999999995 5679999998766666677899999999999999999999987654    48999


Q ss_pred             hhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++|+|.+++..  ..+++..++.++.|||.||+|||++           +|+||||||+|||+++++.+||+|||+|
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~-----------~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-----------CVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc-----------ceeecccchhheeecCCCCeEecccchh
Confidence            99999999999854  4589999999999999999999999           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      +....... .......||+.|||||++.+.     .++.++|||||||++|||+|++          ..||...     .
T Consensus       149 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvil~el~t~~----------~~~~~~~-----~  207 (263)
T d1sm2a_         149 RFVLDDQY-TSSTGTKFPVKWASPEVFSFS-----RYSSKSDVWSFGVLMWEVFSEG----------KIPYENR-----S  207 (263)
T ss_dssp             -----------------CTTSCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHTTS----------CCTTCSC-----C
T ss_pred             eeccCCCc-eeecceecCcccCChHHhcCC-----CCCchhhhcchHHHHHHHHHCC----------CCCCCCC-----C
Confidence            87754432 223346789999999999763     6788999999999999999974          3334322     4


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..++...+.. ..++..|..++     .++.+||.+||+.||++|||+++++++|..+.
T Consensus       208 ~~~~~~~i~~-~~~~~~p~~~~-----~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         208 NSEVVEDIST-GFRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HHHHHHHHHH-TCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHh-cCCCCCccccC-----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            4555555544 34555565544     38999999999999999999999999988765

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=416.31  Aligned_cols=250  Identities=23%  Similarity=0.352  Sum_probs=211.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++.+.||+|+||+||+|+++  ++.||||++....    .......+|+.++++++|||||++++++.+.+    
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----   79 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----   79 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC----
Confidence            3578999999999999999999984  6789999986432    22344578999999999999999999998865    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+||+
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~-----------~ivHrDiKp~Nill~~~~~~kl~  148 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-----------RVIHRDIKPENLLLGSAGELKIA  148 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeeeeeccccceecCCCCEeec
Confidence            45999999999999999954 5799999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+......    .....||+.|||||++.+     ..++.++|||||||++|||++|           +.||... 
T Consensus       149 DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~G-----------~~Pf~~~-  207 (263)
T d2j4za1         149 DFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVG-----------KPPFEAN-  207 (263)
T ss_dssp             CCCSCSCCCCCC----CEETTEEGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHS-----------SCTTCCS-
T ss_pred             ccceeeecCCCc----ccccCCCCcccCHHHHcC-----CCCCchhhhhhHhHHHHHHhcC-----------CCCCCCC-
Confidence            999998765432    334679999999999986     3678899999999999999999           6677543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          +..++...+....  +.+|+.++     +++.+||.+||+.||++|||++|+++|.|...
T Consensus       208 ----~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         208 ----TYQETYKRISRVE--FTFPDFVT-----EGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----SHHHHHHHHHTTC--CCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----CHHHHHHHHHcCC--CCCCccCC-----HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                4556666655443  34554443     37999999999999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.9e-56  Score=424.50  Aligned_cols=261  Identities=23%  Similarity=0.365  Sum_probs=215.2

Q ss_pred             CCCCCccCCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        103 SPPSPQQGCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       103 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      .........++|++.+.||+|+||+||+|+++  ++.||||++........++.+|+.+|++++|||||+++|++.+.+.
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            34445567789999999999999999999994  6789999987666666677899999999999999999999987654


Q ss_pred             cceeeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        181 IHTEFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                          +++|||||++|+|.+++..   ..+++..+..++.|||.||+|||++           +|+||||||+||||+.++
T Consensus        88 ----~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-----------~iiHrDlKp~NILl~~~~  152 (287)
T d1opja_          88 ----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-----------NFIHRDLAARNCLVGENH  152 (287)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECGGG
T ss_pred             ----eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC-----------CcccCccccCeEEECCCC
Confidence                4899999999999999853   4689999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+|+....... .......||+.|||||++.+.     .++.++|||||||++|||++|+.|          |
T Consensus       153 ~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-----~~~~k~DiwS~Gv~l~ell~~~~p----------~  216 (287)
T d1opja_         153 LVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYGMS----------P  216 (287)
T ss_dssp             CEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTSCC----------S
T ss_pred             cEEEccccceeecCCCCc-eeeccccccccccChHHHcCC-----CCCchhhhhhHHHHHHHHHhCCCC----------C
Confidence            999999999988764432 223344688999999998763     678899999999999999998432          2


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      |...     ....+.+. .....++.+|..++.     .+.+||.+||+.||++|||++++++.|..+
T Consensus       217 ~~~~-----~~~~~~~~-i~~~~~~~~~~~~~~-----~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         217 YPGI-----DLSQVYEL-LEKDYRMERPEGCPE-----KVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             STTC-----CHHHHHHH-HHTTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCcc-----hHHHHHHH-HhcCCCCCCCccchH-----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2221     33444443 344566677766554     899999999999999999999998877544

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-56  Score=420.15  Aligned_cols=255  Identities=24%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.+.||+|+||+||+|+++  ++.||||++.....  ......+|+.++++++|||||++++++.+.+    .+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~----~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN----IQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT----EEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc----eeE
Confidence            458999999999999999999984  78899999875432  2234578999999999999999999998865    459


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +||||+++|+|.+++.. ..+++..+..++.||+.||+|||++           +|+||||||+|||+++++.+||+|||
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~-----------~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-----------GITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-----------CCccCcccHHHEEECCCCCEEEccch
Confidence            99999999999999964 4699999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +|+.+............+||+.|||||++.+.    ..++.++|||||||++|||++|           +.||.....  
T Consensus       149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~~~~~~DiwSlGvilyeml~G-----------~~pf~~~~~--  211 (271)
T d1nvra_         149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRR----EFHAEPVDVWSCGIVLTAMLAG-----------ELPWDQPSD--  211 (271)
T ss_dssp             TCEECEETTEECCBCCCCSCGGGSCTHHHHCS----SBCHHHHHHHHHHHHHHHHHHS-----------SCSCSSSST--
T ss_pred             hheeeccCCccccccceeeCcCccCHhHhcCC----CCCCCceeeeHhHHHHHHHHhC-----------CCCCCCCCh--
Confidence            99887544322334557899999999999764    1234679999999999999999           555543211  


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                       .. ...............+..     .+.++.+||.+||+.||++|||++|+++|.|.
T Consensus       212 -~~-~~~~~~~~~~~~~~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         212 -SC-QEYSDWKEKKTYLNPWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             -TS-HHHHHHHTTCTTSTTGGG-----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             -HH-HHHHHHhcCCCCCCcccc-----CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence             11 111222222211111122     23478899999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=418.72  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=197.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .++|++.+.||+|+||+||+|+.+  |+.||||.+.....   ....+.+|+.++++++|||||++++++.+..  ...+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------CE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--CCEE
Confidence            468999999999999999999984  78899999965432   2334578999999999999999999987543  2346


Q ss_pred             eeeehhccCCChhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        186 WLITAYHERGSLCDFLK-----CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      |+|||||++|+|.+++.     ...+++..+..++.||+.||.|||+..      ....+|+||||||+||||+.++.+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~------~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS------DGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHC------C---------CCGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhc------CCCCCEEeCcCchhhcCcCCCCcEE
Confidence            89999999999999984     356999999999999999999999871      0011499999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+.+.....  ......||+.|||||++.+     ..++.++|||||||++|||+||           +.||..
T Consensus       155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~-----~~~~~~~DIwSlGvilyel~tg-----------~~Pf~~  216 (269)
T d2java1         155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCAL-----------MPPFTA  216 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------SCSCCC
T ss_pred             EeeccceeecccCCC--ccccCCCCcccCCHHHHcC-----CCCChHHHHHhhCHHHHHHhhC-----------CCCCCC
Confidence            999999998765432  2345689999999999976     3678899999999999999999           667654


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      .     +..++...+..... +.+|..++     +++.+||.+||+.||++|||++|+++|.|
T Consensus       217 ~-----~~~~~~~~i~~~~~-~~~~~~~s-----~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         217 F-----SQKELAGKIREGKF-RRIPYRYS-----DELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             S-----SHHHHHHHHHHTCC-CCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             C-----CHHHHHHHHHcCCC-CCCCcccC-----HHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence            3     45566666655543 34555444     37999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=421.86  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=210.1

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ++|++.+.||+|+||+||+|+.  +|+.||||++..... ......+|+.++++++|||||++++++.+.+    .+|+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC----EEEEE
Confidence            4799999999999999999997  488999999975433 3345678999999999999999999998866    45999


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ||||++|+|.+++..+.+++.++..++.||+.||+|||++           +|+||||||+|||++.++.+||+|||+|+
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----------~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-----------QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC-----------CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            9999999999999888899999999999999999999999           99999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCH
Q psy17532        269 LFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSL  348 (461)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~  348 (461)
                      .+.....  ......||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+.     ..
T Consensus       165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG-----------~~Pf~~~-----~~  221 (293)
T d1yhwa1         165 QITPEQS--KRSTMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEG-----------EPPYLNE-----NP  221 (293)
T ss_dssp             ECCSTTC--CBCCCCSCGGGCCHHHHSS-----SCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS-----CH
T ss_pred             eeccccc--cccccccCCCccChhhhcC-----CCCCchhceehHhHHHHHHhhC-----------CCCCCCC-----CH
Confidence            8765432  3445689999999999976     3678899999999999999999           6666543     23


Q ss_pred             HHHHHHHh-ccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        349 EDMQEAVV-HKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       349 ~~~~~~~~-~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+....+. ........+..+     +..+.+||.+||+.||++|||++|+++|.|...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~-----s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         222 LRALYLIATNGTPELQNPEKL-----SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHHCSCCCSSGGGS-----CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHhCCCCCCCCcccC-----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            33333333 333333334333     348999999999999999999999999987643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-55  Score=412.64  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             ceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC---hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD---KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      -|++.+.||+|+||+||+|+++  ++.||||.+....   .....+.+|+.+|++++|||||++++++.+.......+++
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            4578889999999999999984  6789999986542   2233467899999999999999999998764333456799


Q ss_pred             eehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc-CCCceEEEecC
Q psy17532        188 ITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK-SDLTAAIADFG  265 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~-~~~~~ki~DFG  265 (461)
                      ||||+++|+|.+++.. ..+++..+..++.||+.||+|||++         +++|+||||||+|||++ .++.+||+|||
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---------~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---------TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---------SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---------CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            9999999999999954 5799999999999999999999998         22399999999999997 47899999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +|+.....    ......||+.|||||++.+      .++.++|||||||++|||++|           +.||...    
T Consensus       161 la~~~~~~----~~~~~~GT~~Y~aPE~~~~------~~~~~~DIwSlGvilyel~~g-----------~~Pf~~~----  215 (270)
T d1t4ha_         161 LATLKRAS----FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATS-----------EYPYSEC----  215 (270)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHS-----------SCTTTTC----
T ss_pred             cceeccCC----ccCCcccCccccCHHHhCC------CCCCcCchhhHHHHHHHHHHC-----------CCCCCCc----
Confidence            99865432    2345689999999999864      578899999999999999999           6666432    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .....+...+......+.++..     .++++.+||.+||+.||++|||++|+++|.|.
T Consensus       216 ~~~~~~~~~i~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         216 QNAAQIYRRVTSGVKPASFDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             SSHHHHHHHHTTTCCCGGGGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccHHHHHHHHHcCCCCcccCcc-----CCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence            2344455555443222222222     23478999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=415.75  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=211.2

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      .....++|++.+.||+|+||.||+|+++ ++.||||++.........+.+|+.++.+++|||||+++|++.++     .+
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~   82 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-----PI   82 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SC
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ce
Confidence            3445679999999999999999999996 46799999987665566778999999999999999999987653     34


Q ss_pred             eeeehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        186 WLITAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      ++||||+++|+|.+++...   .+++..++.++.||++||.|||++           +|+||||||+||||++++.+||+
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~-----------~ivHrDiKp~NIll~~~~~~Kl~  151 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-----------NYIHRDLRAANILVSDTLSCKIA  151 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CcccCccchhheeeecccceeec
Confidence            8999999999999988542   599999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+.+..... .......||+.|||||++.+.     .++.++|||||||++|||+||+          ..||... 
T Consensus       152 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-----~~~~~sDvwS~Gvvl~ellt~~----------~~~~~~~-  214 (272)
T d1qpca_         152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSFGILLTEIVTHG----------RIPYPGM-  214 (272)
T ss_dssp             CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTT----------CCSSTTC-
T ss_pred             cccceEEccCCcc-ccccccCCcccccChHHHhCC-----CCCchhhhhhhHHHHHHHHhCC----------CCCCCCC-
Confidence            9999998765432 233456789999999999763     6778999999999999999974          2333322 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                          ...++...+. ...++..|..++.     ++.+||.+||+.||++|||++++++.|...
T Consensus       215 ----~~~~~~~~i~-~~~~~~~p~~~~~-----~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         215 ----TNPEVIQNLE-RGYRMVRPDNCPE-----ELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ----CHHHHHHHHH-TTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHH-hcCCCCCcccChH-----HHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                3444444443 3455666665543     799999999999999999999999877543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-55  Score=410.23  Aligned_cols=251  Identities=20%  Similarity=0.354  Sum_probs=213.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLIT  189 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv~  189 (461)
                      .++|++.+.||+|+||+||+|+++ ++.||||+++........+.+|+.++++++|||||+++|++.+.+    .+++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~----~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR----PIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS----SEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----ceEEEE
Confidence            368899999999999999999995 558999999877666677889999999999999999999998765    459999


Q ss_pred             hhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        190 AYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       190 e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      ||+++|+|.+++.  ...+++..+.+++.|+|+||+|||+.           +|+||||||+|||+++++.+||+|||+|
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-----------~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-----------QFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-----------TBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc-----------CcccccccceeEEEcCCCcEEECcchhh
Confidence            9999999999974  44689999999999999999999999           9999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCC
Q psy17532        268 LLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPS  347 (461)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~  347 (461)
                      +.+..... .......||+.|+|||++.+     ..++.++|||||||++|||+|++          +.||...     +
T Consensus       148 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-----~~~~~ksDiwS~G~~l~el~t~g----------~~Pf~~~-----~  206 (258)
T d1k2pa_         148 RYVLDDEY-TSSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLG----------KMPYERF-----T  206 (258)
T ss_dssp             CBCSSSSC-CCCCCSCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS----------CCTTTTS-----C
T ss_pred             eeccCCCc-eeecccCCCCCcCCcHHhcC-----CCCCcceeecccchhhHhHHhcC----------CCCCCCC-----C
Confidence            87765432 23445679999999999976     36788999999999999999832          6677654     5


Q ss_pred             HHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcH
Q psy17532        348 LEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGM  403 (461)
Q Consensus       348 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~  403 (461)
                      ..++...+.. ..++..|...+     +++.+||.+||+.||++|||+++++++|.
T Consensus       207 ~~~~~~~i~~-~~~~~~p~~~~-----~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         207 NSETAEHIAQ-GLRLYRPHLAS-----EKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             HHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHh-CCCCCCccccc-----HHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            5666666654 45666666544     38999999999999999999999999873

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=418.47  Aligned_cols=255  Identities=21%  Similarity=0.317  Sum_probs=207.4

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC-hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD-KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~-~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      +.|++.+.||+|+||+||+|++  +++.||||++.... .....+.+|+.+|++++|||||++++++.+.+    .+++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----eEEEE
Confidence            4689999999999999999998  46789999997543 33355678999999999999999999998865    45899


Q ss_pred             ehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        189 TAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       189 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||||++|+|.+++.  ...+++..+..++.||+.||.|||++           +|+||||||+|||++.++.+||+|||+
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~-----------~ivHrDiKp~NIll~~~~~~Kl~DFG~  156 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN-----------KIIHRDLKAGNILFTLDGDIKLADFGV  156 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CEEEeecChhheeECCCCCEEEEechh
Confidence            99999999999974  35699999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      |+......  .......||+.|||||++.+.......++.++|||||||++|||++|           ..||.+.     
T Consensus       157 a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg-----------~~Pf~~~-----  218 (288)
T d2jfla1         157 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI-----------EPPHHEL-----  218 (288)
T ss_dssp             CEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS-----------SCTTTTS-----
T ss_pred             hhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC-----------CCCCCCC-----
Confidence            97654221  12234679999999999865433345788999999999999999999           5666543     


Q ss_pred             CHHHHHHHHhccCC-CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        347 SLEDMQEAVVHKKL-RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       347 ~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ...+....+..... ....+..+     +.++.+||.+||+.||++|||++|+++|.|.
T Consensus       219 ~~~~~~~~i~~~~~~~~~~~~~~-----s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         219 NPMRVLLKIAKSEPPTLAQPSRW-----SSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             CGGGHHHHHHHSCCCCCSSGGGS-----CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             CHHHHHHHHHcCCCCCCCccccC-----CHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            23334444444322 22223333     3489999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=414.26  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=205.9

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||+||+|++.  ++.||||++....    .......+|+.++++++|||||++++++.+.+    .
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~   82 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE----K   82 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS----E
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC----E
Confidence            368999999999999999999984  7889999996432    22344678999999999999999999998865    4


Q ss_pred             eeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +|+||||+++|+|.+++. .+.+++..+..++.|++.||+|||+.           +|+||||||+|||+++++.+||+|
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~-----------~iiHrDiKp~NIll~~~~~vkl~D  151 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-----------GIIHRDLKPENILLNEDMHIQITD  151 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc-----------cEEcCcCCccccccCCCceEEecc
Confidence            599999999999999885 46799999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+.+.............||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+.  
T Consensus       152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~g-----------~~Pf~~~--  213 (288)
T d1uu3a_         152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAG-----------LPPFRAG--  213 (288)
T ss_dssp             CTTCEECC----------CCCCGGGCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHS-----------SCSSCCS--
T ss_pred             cccceecccCCcccccccccCCccccCceeecc-----CCCCcccceehhhHHHHHHhhC-----------CCCCCCc--
Confidence            999998765433333445689999999999976     3678899999999999999999           6777543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                         +..++...+....  ..+|..++     +++.+||.+||+.||++|||++|++++.+.
T Consensus       214 ---~~~~~~~~i~~~~--~~~p~~~s-----~~~~~li~~~L~~dP~~R~t~~e~~~~~~i  264 (288)
T d1uu3a_         214 ---NEYLIFQKIIKLE--YDFPEKFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPL  264 (288)
T ss_dssp             ---SHHHHHHHHHTTC--CCCCTTCC-----HHHHHHHHTTSCSSGGGSTTSGGGTCHHHH
T ss_pred             ---CHHHHHHHHHcCC--CCCCccCC-----HHHHHHHHHHccCCHhHCcCHHHHcCCHHH
Confidence               4555556665543  34554433     378999999999999999999998776543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-55  Score=425.38  Aligned_cols=254  Identities=23%  Similarity=0.345  Sum_probs=206.8

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~  178 (461)
                      ...++|++.+.||+|+||+||+|++.+       ..||||.+....  .....+.+|+.++.++ +|||||+++|++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            455789999999999999999999843       259999885432  2334567888888887 899999999999887


Q ss_pred             CccceeeeeeehhccCCChhhhhcCC------------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCc
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKCN------------------------IVTWEQLCRIALSMSKGLMHLHEEILPNKA  234 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~  234 (461)
                      +.    +++|||||++|+|.++|+..                        .+++..++.++.||+.||+|||++      
T Consensus       114 ~~----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~------  183 (325)
T d1rjba_         114 GP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK------  183 (325)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT------
T ss_pred             Ce----EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC------
Confidence            64    49999999999999999542                        488999999999999999999999      


Q ss_pred             CCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHH
Q psy17532        235 DSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACA  314 (461)
Q Consensus       235 ~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~G  314 (461)
                           +||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+     ..++.++||||||
T Consensus       184 -----~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwS~G  253 (325)
T d1rjba_         184 -----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDVWSYG  253 (325)
T ss_dssp             -----TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHH
T ss_pred             -----CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-----CCCCcceeccchh
Confidence                 999999999999999999999999999987765443223345678999999999876     3678899999999


Q ss_pred             HHHHHHHc-CCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc
Q psy17532        315 LVLWELAS-RCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       315 vil~el~t-g~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      |++|||+| |           ..||.+.     ........+.....++..|..++.     ++.+||.+||+.||++||
T Consensus       254 vil~emlt~g-----------~~Pf~~~-----~~~~~~~~~~~~~~~~~~p~~~~~-----~l~~li~~cl~~dP~~RP  312 (325)
T d1rjba_         254 ILLWEIFSLG-----------VNPYPGI-----PVDANFYKLIQNGFKMDQPFYATE-----EIYIIMQSCWAFDSRKRP  312 (325)
T ss_dssp             HHHHHHTTTS-----------CCSSTTC-----CCSHHHHHHHHTTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHhCC-----------CCCCCCC-----CHHHHHHHHHhcCCCCCCCCcCCH-----HHHHHHHHHcCCChhHCc
Confidence            99999998 7           5666543     122333445556667777766554     899999999999999999


Q ss_pred             cccchhhhcH
Q psy17532        394 SASCVVERGM  403 (461)
Q Consensus       394 s~~evl~~l~  403 (461)
                      |++||+++|.
T Consensus       313 t~~ei~~~L~  322 (325)
T d1rjba_         313 SFPNLTSFLG  322 (325)
T ss_dssp             CHHHHHHHHH
T ss_pred             CHHHHHHHHh
Confidence            9999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-54  Score=415.65  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..|+.++.||+|+||+||+|+.  +++.||||++......    .....+|+.+|++++|||||++++++.+.+    .+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~   90 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----TA   90 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC----EE
Confidence            3599999999999999999998  4678999999754322    234578999999999999999999998865    45


Q ss_pred             eeeehhccCCChhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        186 WLITAYHERGSLCDFL-KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      |+|||||++|+|..++ ....+++..+..++.||+.||.|||++           +|+||||||+|||++.++.+||+||
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~-----------~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-----------NMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEeccCCCcceEEECCCCCEEEeec
Confidence            9999999999998766 456799999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+|+....      .....||+.|||||++.+.  ....++.++|||||||++|||++|           ..||.+.   
T Consensus       160 G~a~~~~~------~~~~~GT~~Y~APE~~~~~--~~~~y~~~~DiwSlGvilyel~~g-----------~~Pf~~~---  217 (309)
T d1u5ra_         160 GSASIMAP------ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAER-----------KPPLFNM---  217 (309)
T ss_dssp             TTCBSSSS------BCCCCSCGGGCCHHHHTTT--TSCCBCTHHHHHHHHHHHHHHHHS-----------SCTTTTS---
T ss_pred             ccccccCC------CCccccCccccCHHHHhcc--CCCCcCchhhhhhHHHHHHHHHHC-----------CCCCCCC---
Confidence            99987543      2346799999999998653  124578899999999999999999           6666543   


Q ss_pred             CCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        345 HPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                        ...+....+.........+..++     +.+.+||.+||+.||++|||++|+++|.+...
T Consensus       218 --~~~~~~~~i~~~~~~~~~~~~~s-----~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         218 --NAMSALYHIAQNESPALQSGHWS-----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             --CHHHHHHHHHHSCCCCCSCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             --CHHHHHHHHHhCCCCCCCCCCCC-----HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence              33444445544443333333333     48999999999999999999999999987654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-54  Score=415.03  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=198.1

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CC---cEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NE---NVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ..++|++.++||+|+||+||+|+++  ++   .||||.+.....  ....+.+|+.+|++++|||||+++|++...+.  
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~--  101 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP--  101 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS--
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE--
Confidence            4568999999999999999999984  22   488888754322  23456789999999999999999999987654  


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                        +++|||||++|+|.+++..  ..+++.+++.++.|||+||+|||++           +|+||||||+||||+.++++|
T Consensus       102 --~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-----------~iiHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_         102 --VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM-----------NYVHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             --CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTCCEE
T ss_pred             --EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC-----------CCccCccccceEEECCCCcEE
Confidence              4999999999999998864  3689999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCC---CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPCG---DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      |+|||+|+.+.......   ......||+.|||||++.+     ..++.++|||||||++|||+| |           ..
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~el~t~g-----------~~  232 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-----RKFTSASDVWSYGIVMWEVMSYG-----------ER  232 (299)
T ss_dssp             ECCC-----------------------CGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTS-----------CC
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-----CCCCcccccccchHHHHHHHhCC-----------CC
Confidence            99999998876543211   1223467999999999876     367889999999999999998 6           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ||...     ...++...+.. +.+++.|..++     ..+.+||.+||+.||++|||+.++++.|..+..
T Consensus       233 Pf~~~-----~~~~~~~~i~~-~~~~~~~~~~~-----~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         233 PYWDM-----TNQDVINAIEQ-DYRLPPPMDCP-----SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             TTTTC-----CHHHHHHHHHT-TCCCCCCTTCC-----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCC-----CHHHHHHHHHc-CCCCCCCccch-----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            66544     44555555543 44555555544     389999999999999999999999999876653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-54  Score=409.21  Aligned_cols=253  Identities=21%  Similarity=0.328  Sum_probs=207.1

Q ss_pred             CCcceeEEeE-eecCCceEEEEEEEC----CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        110 GCRSIQLVEV-KAQGRFGAVWKAKFK----NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       110 ~~~~~~~~~~-lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ..++|.+.+. ||+|+||.||+|.++    +..||||+++....  ....+.+|+.+|++++|||||+++|++.++    
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----   81 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE----   81 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC----
Confidence            4567888885 999999999999874    34699999975432  234567899999999999999999998653    


Q ss_pred             eeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                       .+++|||||++|+|.+++..  ..+++..+..++.|||.||+|||++           +|+||||||+|||++.++.+|
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~-----------~iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-----------NFVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEEETTEEE
T ss_pred             -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC-----------CeecCcCchhheeeccCCcee
Confidence             34899999999999999843  4699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCC
Q psy17532        261 IADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPF  338 (461)
Q Consensus       261 i~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf  338 (461)
                      |+|||+|+.+...... .......||+.|||||++.+.     .++.++|||||||++|||+| |           ..||
T Consensus       150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwS~Gv~l~E~lt~G-----------~~Pf  213 (285)
T d1u59a_         150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGVTMWEALSYG-----------QKPY  213 (285)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTS-----------CCTT
T ss_pred             eccchhhhcccccccccccccccccCccccChHHHhCC-----CCCccchhhcchHHHHHHHhCC-----------CCCC
Confidence            9999999987654322 223345789999999999763     67789999999999999998 7           6666


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ...     ...++...+. .+.++.+|..++.     ++.+||.+||+.||++|||+.+++++|...
T Consensus       214 ~~~-----~~~~~~~~i~-~~~~~~~p~~~~~-----~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         214 KKM-----KGPEVMAFIE-QGKRMECPPECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TTC-----CTHHHHHHHH-TTCCCCCCTTCCH-----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-----CHHHHHHHHH-cCCCCCCCCcCCH-----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            543     3344444443 3455666766553     899999999999999999999998887544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=408.80  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC------CcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN------ENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ..+.|++.++||+|+||.||+|++++      ..||||++.....  ....+.+|+.++++++|||||+++|++.+... 
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~-   83 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-   83 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc-
Confidence            34579999999999999999999843      3599999865432  23346789999999999999999999987654 


Q ss_pred             ceeeeeeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         +++||||+.+|+|.+++..  ..+++.+++.++.||+.||+|||+.           +|+||||||+||||+.++.+
T Consensus        84 ---~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~-----------~iiHrDlKp~NILl~~~~~~  149 (283)
T d1mqba_          84 ---MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM-----------NYVHRDLAARNILVNSNLVC  149 (283)
T ss_dssp             ---EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTCCE
T ss_pred             ---eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc-----------ccccCccccceEEECCCCeE
Confidence               4899999999999998843  4699999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      ||+|||+|+.+...... .......||+.|||||++.+     ..++.++|||||||++|||++|+.|          ||
T Consensus       150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~sDI~S~Gvil~el~t~~~~----------~~  214 (283)
T d1mqba_         150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-----RKFTSASDVWSFGIVMWEVMTYGER----------PY  214 (283)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTSCC----------TT
T ss_pred             EEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-----CCCCCcccccccHHHHHHHHhCCCC----------cc
Confidence            99999999887554321 12334578999999999976     3778899999999999999997422          22


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ...     ...++...+ ..+.++..|..++.     .+.+||.+||+.||++|||+.++++.|..+..
T Consensus       215 ~~~-----~~~~~~~~i-~~~~~~~~~~~~~~-----~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         215 WEL-----SNHEVMKAI-NDGFRLPTPMDCPS-----AIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             TTC-----CHHHHHHHH-HTTCCCCCCTTCBH-----HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ccC-----CHHHHHHHH-hccCCCCCchhhHH-----HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            221     344555444 34456666665543     79999999999999999999999998876553

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-54  Score=416.67  Aligned_cols=269  Identities=23%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEF  185 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~  185 (461)
                      ..++|++.+.||+|+||+||+|++.  |+.||||++.....  ...+..+|+.+|++++|||||++++++.+..    .+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~   79 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----EI   79 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS----EE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EE
Confidence            4578999999999999999999984  78899999875432  2345678999999999999999999998865    46


Q ss_pred             eeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        186 WLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       186 ~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      ++||||+++|+|.+++. ...+++..+..++.|++.||.|||+ +           +|+||||||+||||+.++.+||+|
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~-----------~IiHRDiKP~NILl~~~~~vkl~D  148 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-----------KIMHRDVKPSNILVNSRGEIKLCD  148 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH-----------CCCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC-----------CEEccccCHHHeeECCCCCEEEee
Confidence            99999999999999995 4579999999999999999999997 5           899999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||+|+.+....    ....+||+.|||||++.+     ..++.++|||||||++|||++|+.||.+.....         
T Consensus       149 FGla~~~~~~~----~~~~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  219 (322)
T d1s9ja_         149 FGVSGQLIDSM----ANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  219 (322)
T ss_dssp             CCCCHHHHHHT----C---CCSSCCCCHHHHHC-----SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred             CCCccccCCCc----cccccCCccccCchHHcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            99998764322    334689999999999987     368899999999999999999977775432110         


Q ss_pred             -----CCC-C-----------ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        335 -----RLP-F-----------SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       335 -----~~p-f-----------~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                           ..| .           ...........+....... ...+.++.    ...+.++.+||.+||..||++|||++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e  294 (322)
T d1s9ja_         220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQ  294 (322)
T ss_dssp             --------------------------CCCCHHHHHHHHHT-SCCCCCCB----TTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCcc----ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence                 000 0           0000000011111122111 11122222    123357899999999999999999999


Q ss_pred             hhhhcHHHhh
Q psy17532        398 VVERGMLALC  407 (461)
Q Consensus       398 vl~~l~~~~~  407 (461)
                      +++|.+....
T Consensus       295 ~L~Hpf~~~~  304 (322)
T d1s9ja_         295 LMVHAFIKRS  304 (322)
T ss_dssp             HHTSHHHHHH
T ss_pred             HhhCHhhCcC
Confidence            9999887654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-53  Score=411.91  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=194.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh--hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK--QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .+.|++.+.||+|+||+||+|+++  ++.||||++.....  .....++|+.+|++++|||||++++++.+.+    .+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~   83 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG----HLY   83 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEE
Confidence            356999999999999999999984  78899999975432  2234568999999999999999999998865    459


Q ss_pred             eeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc---CCCceEEE
Q psy17532        187 LITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK---SDLTAAIA  262 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~---~~~~~ki~  262 (461)
                      +|||||++|+|.+++. .+.+++..+..++.||+.||+|||++           +|+||||||+|||+.   .++.+||+
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~-----------~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-----------GIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc-----------eeeeEEecccceeecccCCCceEEEe
Confidence            9999999999999995 45799999999999999999999999           999999999999995   47899999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+......   .....+||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+. 
T Consensus       153 DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g-----------~~Pf~~~-  212 (307)
T d1a06a_         153 DFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVIAYILLCG-----------YPPFYDE-  212 (307)
T ss_dssp             CC---------------------CTTSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHS-----------SCSCCCS-
T ss_pred             ccceeEEccCCC---eeeeeeeCccccCcHHHcC-----CCCCcHHHhhhhhHHHHHHHhC-----------CCCCCCC-
Confidence            999998765443   2344679999999999976     3678899999999999999999           6677543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                          ...++...+.........+. +  ...++++.+||.+||+.||++|||++|+++|.+..
T Consensus       213 ----~~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         213 ----NDAKLFEQILKAEYEFDSPY-W--DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             ----SHHHHHHHHHTTCCCCCTTT-T--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             ----CHHHHHHHHhccCCCCCCcc-c--cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence                45556666666554333221 1  11234799999999999999999999999998753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=404.62  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             ceeEE-eEeecCCceEEEEEEEC----CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        113 SIQLV-EVKAQGRFGAVWKAKFK----NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       113 ~~~~~-~~lg~G~fg~Vy~~~~~----~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .+.+. +.||+|+||+||+|.+.    ++.||||++.....   ....+.+|+.+|++++|||||+++|++.++     .
T Consensus         7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-----~   81 (277)
T d1xbba_           7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----S   81 (277)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-----S
T ss_pred             hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-----C
Confidence            34444 46999999999999873    25699999864322   234567899999999999999999998653     2


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++||||+++|+|.++++. ..+++..++.++.|||.||+|||++           +|+||||||+|||++.++.+||+|
T Consensus        82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~-----------~iiHrDlKp~Nill~~~~~~kl~D  150 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-----------NFVHRDLAARNVLLVTQHYAKISD  150 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC-----------CcccCCCcchhhcccccCcccccc
Confidence            4899999999999999964 5699999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCCCCccc
Q psy17532        264 FGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       264 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~pf~~~  341 (461)
                      ||+|+.+...... .......||+.|||||++.+.     .++.++|||||||++|||+| |           +.||.+.
T Consensus       151 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDiwS~Gv~l~ellt~g-----------~~Pf~~~  214 (277)
T d1xbba_         151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-----KFSSKSDVWSFGVLMWEAFSYG-----------QKPYRGM  214 (277)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTT-----------CCSSTTC
T ss_pred             hhhhhhccccccccccccccCCCceecCchhhcCC-----CCCchhhhccchhhhhHHhhCC-----------CCCCCCC
Confidence            9999887654322 123345789999999999763     56789999999999999998 6           6677654


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                           ...++...+. .+.++.+|..++.     ++.+||.+||+.||++|||++++++.|..
T Consensus       215 -----~~~~~~~~i~-~~~~~~~p~~~~~-----~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         215 -----KGSEVTAMLE-KGERMGCPAGCPR-----EMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -----CHHHHHHHHH-TTCCCCCCTTCCH-----HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CHHHHHHHHH-cCCCCCCCcccCH-----HHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                 4455555444 3456667766554     89999999999999999999999876644

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=401.12  Aligned_cols=253  Identities=24%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeeee
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ...++|++.+.||+|+||.||+|+++|+.||||+++... ....+.+|+.++++++|||||+++|++.+..   ..+++|
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---~~~~lv   79 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK---GGLYIV   79 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC---CcEEEE
Confidence            456789999999999999999999999999999986543 3455678999999999999999999986543   235899


Q ss_pred             ehhccCCChhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        189 TAYHERGSLCDFLKCN---IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      |||+++|+|.++|...   .+++..+++++.||+.||.|||+.           +|+||||||+|||++.++.+||+|||
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~-----------~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-----------NFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC-----------ceeccccchHhheecCCCCEeecccc
Confidence            9999999999999543   489999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      +++.....     .....+|..|+|||++.+     ..++.++|||||||++|||+|++          +.||...    
T Consensus       149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~-----~~~t~~sDIwSfG~il~el~t~~----------~~p~~~~----  204 (262)
T d1byga_         149 LTKEASST-----QDTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFG----------RVPYPRI----  204 (262)
T ss_dssp             C-----------------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS----------CCSCTTS----
T ss_pred             cceecCCC-----CccccccccCCChHHHhC-----CCCChHHHHHhHHHHHHHHHHCC----------CCCCCCC----
Confidence            99876432     233467899999999976     36788999999999999999953          4555443    


Q ss_pred             CCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        346 PSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                       ...++...+. .+.++.+|..++.     ++.+||.+||+.||++|||+.+++++|..++.
T Consensus       205 -~~~~~~~~i~-~~~~~~~~~~~~~-----~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         205 -PLKDVVPRVE-KGYKMDAPDGCPP-----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -CGGGHHHHHT-TTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CHHHHHHHHH-cCCCCCCCccCCH-----HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence             4445555543 4466777766554     89999999999999999999999999987764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-53  Score=409.24  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=211.0

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEECC-------CcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecC
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFKN-------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRG  178 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~  178 (461)
                      ....++|++.+.||+|+||+||+|++++       +.||||++......  ...+.+|+.++++++||||+++++++...
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            3456789999999999999999999853       57999998654332  34567899999999999999999999876


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-------------------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-------------------------NIVTWEQLCRIALSMSKGLMHLHEEILPNK  233 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~  233 (461)
                      ..    .+++|||+++|+|.+++..                         ..+++..++.++.|++.||+|||+.     
T Consensus        89 ~~----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-----  159 (301)
T d1lufa_          89 KP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-----  159 (301)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-----
T ss_pred             Cc----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-----
Confidence            54    4899999999999999842                         1378999999999999999999999     


Q ss_pred             cCCCCCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHH
Q psy17532        234 ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYAC  313 (461)
Q Consensus       234 ~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~  313 (461)
                            +||||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+     ..++.++|||||
T Consensus       160 ------~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~t~ksDVwS~  228 (301)
T d1lufa_         160 ------KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-----NRYTTESDVWAY  228 (301)
T ss_dssp             ------TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-----CCCCHHHHHHHH
T ss_pred             ------CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-----CCCChhhhhccc
Confidence                  999999999999999999999999999987755443334445678999999999976     478889999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc
Q psy17532        314 ALVLWELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL  393 (461)
Q Consensus       314 Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp  393 (461)
                      ||++|||++|.          ..||...     ...++...+..+. ++.+|..++.     ++.+||.+||+.||++||
T Consensus       229 Gvvl~ell~~~----------~~p~~~~-----~~~e~~~~v~~~~-~~~~p~~~~~-----~~~~li~~cl~~~P~~RP  287 (301)
T d1lufa_         229 GVVLWEIFSYG----------LQPYYGM-----AHEEVIYYVRDGN-ILACPENCPL-----ELYNLMRLCWSKLPADRP  287 (301)
T ss_dssp             HHHHHHHHTTT----------CCTTTTS-----CHHHHHHHHHTTC-CCCCCTTCCH-----HHHHHHHHHTCSSGGGSC
T ss_pred             hhhHHHHHccC----------CCCCCCC-----CHHHHHHHHHcCC-CCCCCccchH-----HHHHHHHHHcCCChhHCc
Confidence            99999999994          3355443     5556666665544 5566655543     799999999999999999


Q ss_pred             cccchhhhcHHH
Q psy17532        394 SASCVVERGMLA  405 (461)
Q Consensus       394 s~~evl~~l~~~  405 (461)
                      ||.||++.|.++
T Consensus       288 t~~ev~~~L~~i  299 (301)
T d1lufa_         288 SFCSIHRILQRM  299 (301)
T ss_dssp             CHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHh
Confidence            999999988665

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=403.23  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             CCCccCCcceeEEeEeecCCceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        105 PSPQQGCRSIQLVEVKAQGRFGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       105 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .++....++|++.+.||+|+||.||+|++++ +.||||++.........+.+|+.++.+++|||||+++|++.+.     
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-----   84 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----   84 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-----
Confidence            3445667899999999999999999999954 5799999976665566778999999999999999999998543     


Q ss_pred             eeeeeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceE
Q psy17532        184 EFWLITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAA  260 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~k  260 (461)
                      .+++||||+++|+|.+++..   ..+++.+++.++.||+.||+|||++           +|+||||||+||||++++++|
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-----------~ivH~DlKp~NIll~~~~~~k  153 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-----------NYVHRDLRAANILVGENLVCK  153 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECGGGCEE
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh-----------heecccccceEEEECCCCcEE
Confidence            34899999999999998853   4699999999999999999999999           999999999999999999999


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+.+..... .......||+.|+|||++.+     ..++.++|||||||++|||++|+.          .|+..
T Consensus       154 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~S~Giil~el~t~~~----------p~~~~  217 (285)
T d1fmka3         154 VADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGR----------VPYPG  217 (285)
T ss_dssp             ECCCCTTC---------------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTC----------CSSTT
T ss_pred             EcccchhhhccCCCc-eeeccccccccccChHHHhC-----CCCCcHHhhhcchHHHHHHHhCCC----------CCCCC
Confidence            999999987754432 22334578999999999976     367889999999999999999853          23332


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      .     ...++...+.. ..++.++..++     +++.+||.+||+.||++|||+++|++.|..
T Consensus       218 ~-----~~~~~~~~i~~-~~~~~~~~~~~-----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         218 M-----VNREVLDQVER-GYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             C-----CHHHHHHHHHT-TCCCCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             C-----CHHHHHHHHHh-cCCCCCCcccC-----HHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            2     44555555544 44555666554     389999999999999999999999876543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.9e-52  Score=409.64  Aligned_cols=255  Identities=21%  Similarity=0.302  Sum_probs=210.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChh-hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQ-SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++.+.||+|+||.||+|+..  |+.||||++...... .....+|+.+|++++|||||++++++.+.+    .+|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN----EMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT----EEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEE
Confidence            4578999999999999999999984  788999999755433 344578999999999999999999998865    459


Q ss_pred             eeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC--CCceEEE
Q psy17532        187 LITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS--DLTAAIA  262 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~--~~~~ki~  262 (461)
                      +|||||++|+|.+++.  .+.+++..+..++.||+.||.|||++           +||||||||+|||++.  ++.+||+
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-----------~iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-----------NYVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-----------CCeeeeechhHeeeccCCCCeEEEe
Confidence            9999999999999984  34699999999999999999999999           9999999999999964  6889999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+.+....   ......||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+. 
T Consensus       169 DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~-----~~~~~~~DiwSlGvilyell~G-----------~~Pf~~~-  228 (350)
T d1koaa2         169 DFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSG-----------LSPFGGE-  228 (350)
T ss_dssp             CCTTCEECCTTS---CEEEECSCTTTCCHHHHHT-----CCBCHHHHHHHHHHHHHHHHHS-----------SCSSCCS-
T ss_pred             ecchheeccccc---ccceecCcccccCHHHHcC-----CCCChhHhhhhhhHHHHHHHhC-----------CCCCCCC-
Confidence            999998876543   2334679999999999976     3677899999999999999999           6677544 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                          +..++...+.......... .+.  ..++++.+||.+||..||++|||++|+++|.|...
T Consensus       229 ----~~~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         229 ----NDDETLRNVKSCDWNMDDS-AFS--GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             ----SHHHHHHHHHHTCCCSCCG-GGG--GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ----CHHHHHHHHHhCCCCCCcc-ccc--CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                4556666665554332211 111  13357899999999999999999999999987543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=407.24  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=213.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      ...++|++++.||+|+||.||+|+.  +++.||||++....    .......+|+.+|++++|||||++++++.+..   
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---   78 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD---   78 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS---
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc---
Confidence            3467899999999999999999998  47899999997432    22344578999999999999999999999866   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .+|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||++           +|+||||||+|||++.+|.+||
T Consensus        79 -~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~-----------~iiHRDlKP~NILl~~~g~vkl  146 (337)
T d1o6la_          79 -RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-----------DVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSCEEE
T ss_pred             -ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc-----------CccccccCHHHeEecCCCCEEE
Confidence             45999999999999999954 5799999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|+......  ......+||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+.
T Consensus       147 ~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~-----~~y~~~~DiwSlGvilyeml~G-----------~~pf~~~  208 (337)
T d1o6la_         147 TDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCG-----------RLPFYNQ  208 (337)
T ss_dssp             CCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHS-----------SCSSCCS
T ss_pred             eecccccccccCC--cccccceeCHHHhhhhhccC-----CCCChhhcccchhhHHHHHHHC-----------CCCCCCc
Confidence            9999998765433  23445789999999999987     4778899999999999999999           6677654


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLAL  406 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~  406 (461)
                           +..++...+....  +.+|..++     .++.+||.+||+.||++|++     ++++++|.++..
T Consensus       209 -----~~~~~~~~i~~~~--~~~p~~~s-----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         209 -----DHERLFELILMEE--IRFPRTLS-----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             -----SHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             -----CHHHHHHHHhcCC--CCCCccCC-----HHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence                 5566666665554  34555444     37899999999999999995     789999988654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=407.48  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=199.1

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCCh--hhhHHHHHHHHcCCC-CCCCeeEEEEEEecC
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDK--QSWQSEQEIFKLPHM-EHDNILRYIGAEKRG  178 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~--~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~  178 (461)
                      ...++|++.+.||+|+||.||+|++.       ++.||||++.....  ....+.+|+..+.++ +|+|||.+++++...
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            44578999999999999999999973       24699999864332  223344555555555 799999999998765


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCe
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV  241 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~i  241 (461)
                      +.   .+++|||||++|+|.++++.                 ..+++.+++.++.||+.||.|||++           +|
T Consensus        90 ~~---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-----------~i  155 (299)
T d1ywna1          90 GG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-----------KC  155 (299)
T ss_dssp             TS---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-----------TC
T ss_pred             CC---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-----------CC
Confidence            42   45899999999999999843                 2488999999999999999999999           99


Q ss_pred             ecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       242 vHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      +||||||+||||++++.+||+|||+|+...............||+.|||||++.+     ..++.++|||||||++|||+
T Consensus       156 vHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDiwS~Gvil~ell  230 (299)
T d1ywna1         156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIF  230 (299)
T ss_dssp             CCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-----CCCCcccceeehHHHHHHHH
Confidence            9999999999999999999999999988765544344556689999999999976     36788999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        322 SRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       322 tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      ||.          ..||....    ..+.+ ......+.++.+|+.++.     ++.+||.+||+.||++|||++|+++|
T Consensus       231 t~~----------~~p~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~-----~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         231 SLG----------ASPYPGVK----IDEEF-CRRLKEGTRMRAPDYTTP-----EMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TTS----------CCSSTTCC----CSHHH-HHHHHHTCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hCC----------CCCCCCCC----HHHHH-HHHHhcCCCCCCCccCCH-----HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            984          34554331    12222 333444556667665543     79999999999999999999999999


Q ss_pred             cHHHhh
Q psy17532        402 GMLALC  407 (461)
Q Consensus       402 l~~~~~  407 (461)
                      |..++.
T Consensus       291 L~~ilq  296 (299)
T d1ywna1         291 LGNLLQ  296 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            987653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=401.32  Aligned_cols=251  Identities=22%  Similarity=0.286  Sum_probs=206.9

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh-------hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccc
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK-------QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIH  182 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~  182 (461)
                      +.|++.+.||+|+||+||+|+++  |+.||||++.....       ....+++|+.+|++++|||||++++++.+..   
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---   86 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT---   86 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence            46999999999999999999984  78999999964321       1345678999999999999999999998865   


Q ss_pred             eeeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC----
Q psy17532        183 TEFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL----  257 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~----  257 (461)
                       .+|+|||||++|+|.+++.. +.+++..+..++.|++.||+|||+.           +|+||||||+|||++.++    
T Consensus        87 -~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~-----------~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          87 -DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-----------QIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESCSSSSSC
T ss_pred             -EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc-----------ceeecccccceEEEecCCCccc
Confidence             45999999999999999954 5799999999999999999999999           999999999999998876    


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+|+....+.   ......||+.|||||++.+     ..++.++|||||||++|||++|           ..|
T Consensus       155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g-----------~~P  215 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSG-----------ASP  215 (293)
T ss_dssp             CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCS
T ss_pred             ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcC-----CCCCCcccchhhhHHHHHHHcC-----------CCC
Confidence            59999999998876543   2344678999999999976     3678899999999999999999           667


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |.+.     +..+....+......  ++.... ...+..+.+||.+||+.||++|||++|+++|.+.
T Consensus       216 f~~~-----~~~~~~~~i~~~~~~--~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         216 FLGD-----TKQETLANVSAVNYE--FEDEYF-SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             SCCS-----SHHHHHHHHHTTCCC--CCHHHH-TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             CCCC-----CHHHHHHHHHhcCCC--CCchhc-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            7544     445555555544332  222111 1133478999999999999999999999999765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.4e-52  Score=408.01  Aligned_cols=254  Identities=20%  Similarity=0.276  Sum_probs=208.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..+.|++.+.||+|+||.||+|+.  +|+.||||++..... .....++|+.+|++++|||||++++++.+..    .+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~~  102 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY----EMV  102 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS----EEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEE
Confidence            346799999999999999999998  478899999876543 3345578999999999999999999998765    459


Q ss_pred             eeehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEc--CCCceEEE
Q psy17532        187 LITAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLK--SDLTAAIA  262 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~--~~~~~ki~  262 (461)
                      +|||||++|+|.+++..  ..+++.++..++.||+.||.|||++           +|+||||||+||||+  .++.+||+
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-----------~iiHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-----------SIVHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------CeeecccccccccccccCCCeEEEe
Confidence            99999999999998754  3599999999999999999999999           999999999999998  57899999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+.+....   ......||+.|||||++.+     ..++.++|||||||++|||++|           ..||.+. 
T Consensus       172 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG-----------~~Pf~~~-  231 (352)
T d1koba_         172 DFGLATKLNPDE---IVKVTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSG-----------LSPFAGE-  231 (352)
T ss_dssp             CCTTCEECCTTS---CEEEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHS-----------CCSSCCS-
T ss_pred             ecccceecCCCC---ceeeccCcccccCHHHHcC-----CCCCCccchHHHHHHHHHHHhC-----------CCCCCCC-
Confidence            999999876543   2334578999999999976     3678899999999999999999           6677543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                          ...+....+......... ..+.  ..+.++.+||.+||+.||++|||++|+++|.|..
T Consensus       232 ----~~~~~~~~i~~~~~~~~~-~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~  287 (352)
T d1koba_         232 ----DDLETLQNVKRCDWEFDE-DAFS--SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  287 (352)
T ss_dssp             ----SHHHHHHHHHHCCCCCCS-STTT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             ----CHHHHHHHHHhCCCCCCc-cccc--CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence                445555555554432221 1111  1234789999999999999999999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=405.81  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=203.7

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CC----cEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NE----NVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~----~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+|+++++||+|+||+||+|++.  |+    .||||.+....  .....+.+|+.++++++|||||+++|++.++.    
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST----   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence            57999999999999999999984  33    58999886432  23345678999999999999999999998753    


Q ss_pred             eeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEE
Q psy17532        184 EFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAI  261 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki  261 (461)
                       .++++||+.+|+|.+++.  ...+++..++.++.|||.||+|||++           +|+||||||+|||++.++.+||
T Consensus        85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-----------~iiHrDlKp~NIll~~~~~~kl  152 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-----------RLVHRDLAARNVLVKTPQHVKI  152 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEEEETTEEEE
T ss_pred             -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc-----------CcccCcchhhcceeCCCCCeEe
Confidence             378999999999999885  44699999999999999999999999           9999999999999999999999


Q ss_pred             EecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc
Q psy17532        262 ADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE  341 (461)
Q Consensus       262 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~  341 (461)
                      +|||+|+.+.............||+.|||||++.++     .++.++|||||||++|||+|++          ..||...
T Consensus       153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDvwS~Gvil~el~t~g----------~~p~~~~  217 (317)
T d1xkka_         153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-----IYTHQSDVWSYGVTVWELMTFG----------SKPYDGI  217 (317)
T ss_dssp             CCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTS----------CCTTTTS
T ss_pred             eccccceecccccccccccccccCccccChHHHhcC-----CCChhhhhhhHHHHHHHHHHCC----------CCCCCCC
Confidence            999999987655443344456789999999999763     6788999999999999999943          5566543


Q ss_pred             cCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        342 VGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                           ...++...+ ..+.++..|..++.     .+.+||.+||+.||++|||+.++++++..+..
T Consensus       218 -----~~~~~~~~i-~~~~~~~~p~~~~~-----~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         218 -----PASEISSIL-EKGERLPQPPICTI-----DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -----CGGGHHHHH-HHTCCCCCCTTBCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CHHHHHHHH-HcCCCCCCCcccCH-----HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                 334444444 34455666665543     79999999999999999999999999877654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=396.12  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESI  181 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~  181 (461)
                      ...++|++.+.||+|+||.||+|++..     ..||||.+......  ...+.+|+.++++++|||||+++|++.++   
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---   80 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---   80 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence            345789999999999999999999842     34788877543222  34467899999999999999999998643   


Q ss_pred             ceeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 HTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 ~~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                        .+++||||+++|+|.+++.  ...+++..++.++.||+.||.|||++           +|+||||||+|||++.++.+
T Consensus        81 --~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-----------~iiHrDlKp~NIll~~~~~~  147 (273)
T d1mp8a_          81 --PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-----------RFVHRDIAARNVLVSSNDCV  147 (273)
T ss_dssp             --SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEEEETTEE
T ss_pred             --eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc-----------CeeccccchhheeecCCCcE
Confidence              3589999999999999874  34689999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+|+.+..... .......||+.|+|||++.+     ..++.++|||||||++|||++++          ..||.
T Consensus       148 Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~-----~~~~~~~DiwSlGvil~e~lt~g----------~~P~~  211 (273)
T d1mp8a_         148 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHG----------VKPFQ  211 (273)
T ss_dssp             EECC--------------------CCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTS----------CCTTT
T ss_pred             EEccchhheeccCCcc-eeccceecCcccchhhHhcc-----CCCCCccccccchHHHHHHHhcC----------CCCCC
Confidence            9999999987654332 23344578999999999976     36778999999999999999832          55665


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~  407 (461)
                      ..     ...++...+..+ .++.+|..++.     .+.+||.+||+.||++|||+.+++++|..+..
T Consensus       212 ~~-----~~~~~~~~i~~~-~~~~~~~~~~~-----~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         212 GV-----KNNDVIGRIENG-ERLPMPPNCPP-----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             TC-----CGGGHHHHHHTT-CCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-----CHHHHHHHHHcC-CCCCCCCCCCH-----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            43     334555555443 44556655543     89999999999999999999999999876653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-51  Score=400.53  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=209.4

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccce
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~  183 (461)
                      ..++|++++.||+|+||+||+|+++  |+.||||++....    .......+|+.+++.++|||||++++++.+.+    
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----   77 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ----   77 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS----
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC----
Confidence            3578999999999999999999984  7899999996432    22344568999999999999999999998865    


Q ss_pred             eeeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEE
Q psy17532        184 EFWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIA  262 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~  262 (461)
                      .+|+|||||++|+|..++.. ..+++..+..++.||+.||+|||++           +|+||||||+||||+.++.+||+
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-----------~iiHrDiKp~NILl~~~g~vkL~  146 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK-----------DIIYRDLKPENILLDKNGHIKIT  146 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCCGGGEEECTTSCEEEC
T ss_pred             eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC-----------cEEccccCchheeEcCCCCEEEe
Confidence            45999999999999998854 5689999999999999999999999           99999999999999999999999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+|+.....     .....||+.|||||++.+     ..++.++|||||||++|||++|           +.||.+. 
T Consensus       147 DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~-----~~y~~~~DiwSlGvilyemltG-----------~~Pf~~~-  204 (316)
T d1fota_         147 DFGFAKYVPDV-----TYTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAG-----------YTPFYDS-  204 (316)
T ss_dssp             CCSSCEECSSC-----BCCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHS-----------SCTTCCS-
T ss_pred             cCccceEeccc-----cccccCcccccCHHHHcC-----CCCCchhhccccchhHHHHHhC-----------CCCCCCc-
Confidence            99999887532     334689999999999976     3678899999999999999999           6777544 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLAL  406 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~  406 (461)
                          +..++...+.....  .+|..++     .++.+++.+||..||++|+     |++++++|.+...
T Consensus       205 ----~~~~~~~~i~~~~~--~~p~~~s-----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         205 ----NTMKTYEKILNAEL--RFPPFFN-----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             ----SHHHHHHHHHHCCC--CCCTTSC-----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             ----CHHHHHHHHHcCCC--CCCCCCC-----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence                55566666655543  3444333     3789999999999999996     8999999988644

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=397.66  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=201.8

Q ss_pred             CCcceeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..++|++.+.||+|+||.||+|++++     ..||||++....    .....+.+|+.+|++++|||||+++|++.+.  
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--   83 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--   83 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--
Confidence            45789999999999999999999732     258999886432    2234567899999999999999999999764  


Q ss_pred             cceeeeeeehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                         .+++||||+++|+|.+++.  ...+++..++.++.|||.||.|||++           +|+||||||+|||++.++.
T Consensus        84 ---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-----------~iiHrDikp~NIll~~~~~  149 (273)
T d1u46a_          84 ---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-----------RFIHRDLAARNLLLATRDL  149 (273)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEEEETTE
T ss_pred             ---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC-----------CEeeeeecHHHhccccccc
Confidence               2489999999999999874  34699999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCC-CCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCG-DTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELAS-RCSSVSPPPGEYRL  336 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~t-g~~~~~~~~~~~~~  336 (461)
                      +||+|||+++.+....... ......||..|+|||++.+.     .++.++|||||||++|||+| |           ..
T Consensus       150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~S~Gvil~emlt~G-----------~~  213 (273)
T d1u46a_         150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-----TFSHASDTWMFGVTLWEMFTYG-----------QE  213 (273)
T ss_dssp             EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTS-----------CC
T ss_pred             eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC-----CCCcchhhhhhHHHHHHHHhCC-----------CC
Confidence            9999999999876543222 23345678899999999763     56788999999999999998 6           66


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ||.+.     +..+....+.....+++.+..++.     .+.+||.+||+.||++|||+++|++.|.+
T Consensus       214 Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~-----~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         214 PWIGL-----NGSQILHKIDKEGERLPRPEDCPQ-----DIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             TTTTC-----CHHHHHHHHHTSCCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCc-----CHHHHHHHHHhCCCCCCCcccccH-----HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            77654     666777777777777777766554     79999999999999999999999887654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=400.77  Aligned_cols=258  Identities=25%  Similarity=0.362  Sum_probs=209.4

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEECC--C--cEEEEEEecCC--hhhhHHHHHHHHcCCC-CCCCeeEEEEEEecC
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFKN--E--NVAVKIFLMQD--KQSWQSEQEIFKLPHM-EHDNILRYIGAEKRG  178 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~--~vAvK~~~~~~--~~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~  178 (461)
                      .+..+.++|++.++||+|+||.||+|++++  .  .||||.+....  .....+.+|+.+|.++ +|||||+++|++.+.
T Consensus         4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            345567899999999999999999999843  3  47888875332  2334567899999998 799999999999886


Q ss_pred             CccceeeeeeehhccCCChhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCe
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLKC-----------------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAV  241 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~i  241 (461)
                      +    .+++||||+++|+|.++|+.                 ..+++..+..++.|||.||.|||+.           +|
T Consensus        84 ~----~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-----------~i  148 (309)
T d1fvra_          84 G----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-----------QF  148 (309)
T ss_dssp             T----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-----------TE
T ss_pred             C----eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-----------Cc
Confidence            5    45999999999999999853                 3589999999999999999999999           99


Q ss_pred             ecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHH
Q psy17532        242 AHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELA  321 (461)
Q Consensus       242 vHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~  321 (461)
                      +||||||+|||++.++.+||+|||+|+......   ......||..|+|||.+.+     ..++.++|||||||++|||+
T Consensus       149 iHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSfGvil~ell  220 (309)
T d1fvra_         149 IHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIV  220 (309)
T ss_dssp             ECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHH-----CEECHHHHHHHHHHHHHHHH
T ss_pred             cccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhcc-----CCCCccceeehhHHHHHHHH
Confidence            999999999999999999999999998655332   2334578999999999976     36788999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        322 SRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       322 tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      +|+          ..||...     +..++...+.. +.++.+|..++.     ++.+||.+||+.||++|||+++++++
T Consensus       221 ~~~----------~~p~~~~-----~~~~~~~~i~~-~~~~~~~~~~~~-----~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         221 SLG----------GTPYCGM-----TCAELYEKLPQ-GYRLEKPLNCDD-----EVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TTS----------CCTTTTC-----CHHHHHHHGGG-TCCCCCCTTBCH-----HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcC----------CCCCCCC-----CHHHHHHHHHh-cCCCCCCccCCH-----HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            984          3455443     55666666544 456666665543     89999999999999999999999999


Q ss_pred             cHHHhh
Q psy17532        402 GMLALC  407 (461)
Q Consensus       402 l~~~~~  407 (461)
                      |..+..
T Consensus       280 L~~i~~  285 (309)
T d1fvra_         280 LNRMLE  285 (309)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            877653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-51  Score=392.85  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=211.4

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----------hhHHHHHHHHcCCCC-CCCeeEEEEEEecC
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----------SWQSEQEIFKLPHME-HDNILRYIGAEKRG  178 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----------~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~  178 (461)
                      ++|++.+.||+|+||+||+|+.  +++.||||++......          .....+|+.++++++ |||||++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999998  5789999999754321          123467999999996 99999999999886


Q ss_pred             CccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC
Q psy17532        179 ESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL  257 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~  257 (461)
                      +    .+|||||||++|+|.++++ ...+++.++..++.||+.||+|||++           +|+||||||+|||++.++
T Consensus        83 ~----~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~-----------~ivHrDlkp~Nill~~~~  147 (277)
T d1phka_          83 T----FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL-----------NIVHRDLKPENILLDDDM  147 (277)
T ss_dssp             S----EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEECTTC
T ss_pred             c----ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-----------CCcccccccceEEEcCCC
Confidence            5    4599999999999999994 45799999999999999999999999           999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCccccccccccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAIN-FSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      .+||+|||+++.+....   ......||..|+|||++.+... ....++.++||||+||++|||++|           +.
T Consensus       148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g-----------~~  213 (277)
T d1phka_         148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-----------SP  213 (277)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS-----------SC
T ss_pred             CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC-----------CC
Confidence            99999999999876543   2344679999999999975432 124578899999999999999999           67


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      ||.+.     ........+..+......+. +  ...++++.+||.+||+.||++|||++|+++|.|.
T Consensus       214 Pf~~~-----~~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         214 PFWHR-----KQMLMLRMIMSGNYQFGSPE-W--DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             SSCCS-----SHHHHHHHHHHTCCCCCTTT-G--GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             CCCCC-----CHHHHHHHHHhCCCCCCCcc-c--ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence            77654     45555666666554433322 1  1133589999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=398.03  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=206.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCC----hhhhHHHHHHHHcC-CCCCCCeeEEEEEEecCCcccee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD----KQSWQSEQEIFKLP-HMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~----~~~~~~~~ei~~l~-~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      ++|++.+.||+|+||+||+|++  +++.||||++....    ........|+.++. .++|||||++++++.+++    .
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~----~   77 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----N   77 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS----E
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC----c
Confidence            5799999999999999999999  57889999996432    12223345555544 689999999999999876    4


Q ss_pred             eeeeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +|+||||+++|+|.++++. ..+++.++..++.||+.||+|||++           +|+||||||+|||+++++.+||+|
T Consensus        78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~-----------~iiHrDikp~NiL~~~~~~~kl~D  146 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-----------GIVYRDLKLDNILLDKDGHIKIAD  146 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             eeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CeeeccCcccceeecCCCceeccc
Confidence            5999999999999999954 5699999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+......  .......||+.|+|||++.+     ..++.++|||||||++|||++|           +.||.+.  
T Consensus       147 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG-----------~~PF~~~--  206 (320)
T d1xjda_         147 FGMCKENMLGD--AKTNTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIG-----------QSPFHGQ--  206 (320)
T ss_dssp             CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCSSCCS--
T ss_pred             cchhhhccccc--ccccccCCCCCcCCHHHHcC-----CCCCchhhhhhhhHHHHHHHhC-----------CCCCCCC--
Confidence            99998765433  23344689999999999987     3678899999999999999999           6777654  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc-chhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS-CVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~l~~~~  406 (461)
                         +..++...+....  +.+|..++     .++.+||.+||..||++|||+. ++++|.+...
T Consensus       207 ---~~~~~~~~i~~~~--~~~p~~~s-----~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         207 ---DEEELFHSIRMDN--PFYPRWLE-----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             ---SHHHHHHHHHHCC--CCCCTTSC-----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ---CHHHHHHHHHcCC--CCCCccCC-----HHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence               5566666665443  45555443     3799999999999999999995 8999987644

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-51  Score=404.95  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=204.3

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----h---hHHHHHHHHcCCCCCCCeeEEEEEEecCCc
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----S---WQSEQEIFKLPHMEHDNILRYIGAEKRGES  180 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~---~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~  180 (461)
                      ..++|++.++||+|+||.||+|++  +|+.||||++......    .   .....++.+++.++|||||++++++.+.+ 
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~-   80 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-   80 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC-
Confidence            357899999999999999999998  4788999998643211    1   11234577888999999999999998865 


Q ss_pred             cceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        181 IHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                         .+|+|||||++|+|.+++. ...+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+
T Consensus        81 ---~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~-----------~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          81 ---KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-----------FVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECSSSCE
T ss_pred             ---EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC-----------CccceeeccceeEEcCCCcE
Confidence               4599999999999999995 45689999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCc
Q psy17532        260 AIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFS  339 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~  339 (461)
                      ||+|||+|+.+....    .....||+.|||||++.++    ..++.++|||||||++|||+||           +.||.
T Consensus       147 Kl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~----~~~~~~~DiwSlGvilyemltG-----------~~Pf~  207 (364)
T d1omwa3         147 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRG-----------HSPFR  207 (364)
T ss_dssp             EECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTT----CCCCTHHHHHHHHHHHHHHHHS-----------SCSSC
T ss_pred             EEeeeceeeecCCCc----ccccccccccchhHHhhcC----CCCCcccchhHHHHHHHHHHhC-----------CCCCC
Confidence            999999998776543    3456899999999998653    4678899999999999999999           55664


Q ss_pred             cccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHHhh
Q psy17532        340 AEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLALC  407 (461)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~~  407 (461)
                      ....  .....+.....  ...+.+|..++     .++.+||.+||+.||++|||     |+++++|.++...
T Consensus       208 ~~~~--~~~~~~~~~~~--~~~~~~~~~~s-----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         208 QHKT--KDKHEIDRMTL--TMAVELPDSFS-----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             SSCS--SCHHHHHHHSS--SCCCCCCSSSC-----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CCCH--HHHHHHHHhcc--cCCCCCCCCCC-----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            4311  12222222222  22334444433     37999999999999999999     6899999987543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=395.89  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=208.7

Q ss_pred             CccCCcceeEEeEeecCCceEEEEEEECC---------CcEEEEEEecCChh--hhHHHHHHHHcCCC-CCCCeeEEEEE
Q psy17532        107 PQQGCRSIQLVEVKAQGRFGAVWKAKFKN---------ENVAVKIFLMQDKQ--SWQSEQEIFKLPHM-EHDNILRYIGA  174 (461)
Q Consensus       107 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~--~~~~~~ei~~l~~l-~H~nIv~l~g~  174 (461)
                      .....++|++.+.||+|+||.||+|+..+         ..||||++......  .....+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            34566899999999999999999998732         36999998654432  23445677666666 89999999999


Q ss_pred             EecCCccceeeeeeehhccCCChhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCC
Q psy17532        175 EKRGESIHTEFWLITAYHERGSLCDFLKCN-----------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSY  237 (461)
Q Consensus       175 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~  237 (461)
                      +.+...    +++||||+++|+|.+++...                 .+++..++.++.||+.||+|||+.         
T Consensus        88 ~~~~~~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---------  154 (299)
T d1fgka_          88 CTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---------  154 (299)
T ss_dssp             ECSSSS----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---------
T ss_pred             cccCCe----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---------
Confidence            988654    48999999999999999532                 489999999999999999999999         


Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHH
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVL  317 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil  317 (461)
                        +||||||||+|||++.++.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++
T Consensus       155 --~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-----~~y~~k~DiwS~Gvvl  227 (299)
T d1fgka_         155 --KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLL  227 (299)
T ss_dssp             --TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-----CCCCHHHHHHHHHHHH
T ss_pred             --CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-----CCCCchhhhHHhHHHH
Confidence              999999999999999999999999999998766554444556789999999999976     4788999999999999


Q ss_pred             HHHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccc
Q psy17532        318 WELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASC  397 (461)
Q Consensus       318 ~el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  397 (461)
                      |||++++          ..||...     ...++...+. .+.++..|..++.     ++.+||.+||+.||++|||+.|
T Consensus       228 ~ell~~g----------~~p~~~~-----~~~~~~~~i~-~~~~~~~p~~~~~-----~l~~li~~cl~~dP~~Rps~~e  286 (299)
T d1fgka_         228 WEIFTLG----------GSPYPGV-----PVEELFKLLK-EGHRMDKPSNCTN-----ELYMMMRDCWHAVPSQRPTFKQ  286 (299)
T ss_dssp             HHHHTTS----------CCSSTTC-----CHHHHHHHHH-TTCCCCCCSSCCH-----HHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHhccCC----------CCCCCCC-----CHHHHHHHHH-cCCCCCCCccchH-----HHHHHHHHHccCCHhHCcCHHH
Confidence            9999853          5566543     4455555544 4566677765543     7999999999999999999999


Q ss_pred             hhhhcHHHhh
Q psy17532        398 VVERGMLALC  407 (461)
Q Consensus       398 vl~~l~~~~~  407 (461)
                      |++.|..+..
T Consensus       287 il~~L~~i~a  296 (299)
T d1fgka_         287 LVEDLDRIVA  296 (299)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHhh
Confidence            9999977754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-51  Score=400.74  Aligned_cols=249  Identities=21%  Similarity=0.279  Sum_probs=209.7

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCC----hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQD----KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++++.||+|+||.||+|+++  |+.||||++....    .......+|+.+|+.++|||||++++++.+..    .
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~  115 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----N  115 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----E
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc----c
Confidence            468999999999999999999984  7899999986432    22334578999999999999999999998865    4


Q ss_pred             eeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +++||||+.+|+|.+++. .+.+++..+..++.||+.||.|||++           +||||||||+|||++.++.+||+|
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-----------~iiHRDIKP~NILl~~~g~ikL~D  184 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-----------DLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTSCEEECC
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEecCcCCHHHcccCCCCCEEeee
Confidence            589999999999999984 45799999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+.+...     .....||+.|||||++.+     ..++.++|||||||++|||+||           ..||.+.  
T Consensus       185 FG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyemltG-----------~~Pf~~~--  241 (350)
T d1rdqe_         185 FGFAKRVKGR-----TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAG-----------YPPFFAD--  241 (350)
T ss_dssp             CTTCEECSSC-----BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHS-----------SCSSCCS--
T ss_pred             ceeeeecccc-----cccccCccccCCHHHHcC-----CCCCccccccchhHHHHHHHhC-----------CCCCCCc--
Confidence            9999887532     334689999999999976     4678899999999999999999           6677543  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-----cccchhhhcHHHhh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-----SASCVVERGMLALC  407 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~~~  407 (461)
                         +...+...+.....  .+|..++     .++.+||.+||..||++|+     |++++++|.++...
T Consensus       242 ---~~~~~~~~i~~~~~--~~p~~~s-----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         242 ---QPIQIYEKIVSGKV--RFPSHFS-----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             ---SHHHHHHHHHHCCC--CCCTTCC-----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             ---CHHHHHHHHhcCCC--CCCccCC-----HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence               45555666655543  3444433     3789999999999999995     89999999886543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.1e-51  Score=389.10  Aligned_cols=260  Identities=19%  Similarity=0.258  Sum_probs=201.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh----hhHHHHHHHHcCCCCCCCeeEEEEEEecCCcccee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ----SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~----~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~  184 (461)
                      .++|++.+.||+|+||.||+|++  +++.||||++......    ...+.+|+.+++.++|||||++++++.........
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999998  4789999999754322    23457899999999999999999998876554456


Q ss_pred             eeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        185 FWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +|+||||+++|+|.+++. .+.+++.++..++.||+.||+|||++           +|+||||||+|||++.++..+|+|
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-----------~iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN-----------GIIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEETTSCEEECC
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC-----------CccCccccCcccccCccccceeeh
Confidence            799999999999999884 45799999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        264 FGLALLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       264 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      ||.++........ .......||+.|||||++.+     ..++.++|||||||++|||+||           +.||... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG-----------~~Pf~~~-  217 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTG-----------EPPFTGD-  217 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------SCSCCCS-
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcC-----CCCCcceecccchHHHHHHHhC-----------CCCCCCc-
Confidence            9999776443221 23445679999999999976     3678899999999999999999           6666543 


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhc-cccchhhhcHHH
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARL-SASCVVERGMLA  405 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~~~  405 (461)
                          +..+...........+..   ......++++.+||.+||+.||++|| |++++++.+..+
T Consensus       218 ----~~~~~~~~~~~~~~~~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         218 ----SPVSVAYQHVREDPIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ----SHHHHHHHHHHCCCCCGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHHhcCCCCCc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                444444444444332211   11112345899999999999999999 778887776654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=398.86  Aligned_cols=255  Identities=19%  Similarity=0.258  Sum_probs=211.7

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      -.++|++.+.||+|+||+||+|+++  ++.||||++...........+|+.+|+.++|||||++++++.+.+    .+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME----ELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT----EEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEE
Confidence            3578999999999999999999984  778999999877666666789999999999999999999998865    4599


Q ss_pred             eehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC--CceEEEe
Q psy17532        188 ITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD--LTAAIAD  263 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~--~~~ki~D  263 (461)
                      |||||++|+|.+++...  .+++.++..++.||+.||+|||+.           +|+||||||+|||++.+  ..+||+|
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~-----------~iiHrDlKp~NIll~~~~~~~ikl~D  147 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-----------NIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-----------CCCcccccccceeecCCCceEEEEcc
Confidence            99999999999999643  689999999999999999999999           99999999999999854  5899999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+++......   ......||+.|+|||.+.+.     .++.++|||||||++|||++|           ..||...  
T Consensus       148 FG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~-----~~~~~~DiWSlGvily~ll~G-----------~~Pf~~~--  206 (321)
T d1tkia_         148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD-----VVSTATDMWSLGTLVYVLLSG-----------INPFLAE--  206 (321)
T ss_dssp             CTTCEECCTTC---EEEEEESCGGGSCHHHHTTC-----EECHHHHHHHHHHHHHHHHHS-----------SCTTCCS--
T ss_pred             cchhhccccCC---cccccccccccccchhccCC-----CCCchhhcccHHHHHHHHHhC-----------CCCCCCC--
Confidence            99998765432   23345789999999998763     677899999999999999999           6677554  


Q ss_pred             CCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        344 DHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                         +..++...+......  ++.... ...+.++.+||.+||..||++|||++|+++|.|...
T Consensus       207 ---~~~~~~~~i~~~~~~--~~~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         207 ---TNQQIIENIMNAEYT--FDEEAF-KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---SHHHHHHHHHHTCCC--CCHHHH-TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---CHHHHHHHHHhCCCC--CChhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence               455666666655433  222111 113347899999999999999999999999988643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=395.46  Aligned_cols=259  Identities=21%  Similarity=0.319  Sum_probs=213.1

Q ss_pred             CCccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEe
Q psy17532        106 SPQQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEK  176 (461)
Q Consensus       106 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~  176 (461)
                      ......++|++.+.||+|+||.||+|+++       ++.||||++......  ...+.+|+.++++++|||||+++|++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34566789999999999999999999874       367999998754322  234578999999999999999999998


Q ss_pred             cCCccceeeeeeehhccCCChhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeeccc
Q psy17532        177 RGESIHTEFWLITAYHERGSLCDFLKC-----------NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRD  245 (461)
Q Consensus       177 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrD  245 (461)
                      ....    .++||||+++|+|.+++..           ..+++..+..++.|+|+||.|||++           +|+|||
T Consensus        94 ~~~~----~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-----------~ivHrD  158 (308)
T d1p4oa_          94 QGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-----------KFVHRD  158 (308)
T ss_dssp             SSSS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCBCSC
T ss_pred             cCCc----eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-----------Ceeece
Confidence            7654    4899999999999999842           2478999999999999999999999           999999


Q ss_pred             CCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCC
Q psy17532        246 FKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCS  325 (461)
Q Consensus       246 Lkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~  325 (461)
                      |||+|||++.++++||+|||+|+.+.............||+.|+|||.+.+.     .++.++||||||+++|||+||+ 
T Consensus       159 lk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-----~~~~~~Dv~S~G~il~El~t~~-  232 (308)
T d1p4oa_         159 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-----VFTTYSDVWSFGVVLWEIATLA-  232 (308)
T ss_dssp             CSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHHTS-
T ss_pred             EcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-----CCCcccccccHHHHHHHHHhCC-
Confidence            9999999999999999999999877554433334456789999999999763     6778899999999999999985 


Q ss_pred             CCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        326 SVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       326 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                               ..||...     +..+....+..+. ++..|..++     ..+.+||.+||+.||++|||+.+++++|...
T Consensus       233 ---------~~p~~~~-----~~~~~~~~i~~~~-~~~~p~~~~-----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         233 ---------EQPYQGL-----SNEQVLRFVMEGG-LLDKPDNCP-----DMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---------CCTTTTS-----CHHHHHHHHHTTC-CCCCCTTCC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---------CCCCCCC-----CHHHHHHHHHhCC-CCCCcccch-----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                     4555443     5566666665543 455565544     3899999999999999999999999987544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=394.61  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=211.2

Q ss_pred             ccCCcceeEEeEeecCCceEEEEEEEC-------CCcEEEEEEecCChh--hhHHHHHHHHcCCC-CCCCeeEEEEEEec
Q psy17532        108 QQGCRSIQLVEVKAQGRFGAVWKAKFK-------NENVAVKIFLMQDKQ--SWQSEQEIFKLPHM-EHDNILRYIGAEKR  177 (461)
Q Consensus       108 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l-~H~nIv~l~g~~~~  177 (461)
                      ....++|++.+.||+|+||.||+|++.       ++.||||++......  ...+.+|+.+++++ +|||||+++|++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            356689999999999999999999873       246999999754432  23456788888888 79999999999988


Q ss_pred             CCccceeeeeeehhccCCChhhhhcCC-------------------CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLKCN-------------------IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYK  238 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~  238 (461)
                      ...    +++|||||++|+|.++++..                   .+++..+..++.||+.||+|||++          
T Consensus        99 ~~~----~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----------  164 (311)
T d1t46a_          99 GGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----------  164 (311)
T ss_dssp             SSS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----------
T ss_pred             CCE----EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----------
Confidence            654    49999999999999998532                   489999999999999999999999          


Q ss_pred             CCeecccCCCCcEEEcCCCceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHH
Q psy17532        239 PAVAHRDFKSNNVLLKSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLW  318 (461)
Q Consensus       239 ~~ivHrDLkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~  318 (461)
                       +||||||||+|||++.++.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|
T Consensus       165 -~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwS~G~~l~  238 (311)
T d1t46a_         165 -NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGIFLW  238 (311)
T ss_dssp             -TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHH
T ss_pred             -CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-----CCCCCcccccchHHHHH
Confidence             999999999999999999999999999998765544444556789999999999976     36788999999999999


Q ss_pred             HHHcCCCCCCCCCCCCCCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccch
Q psy17532        319 ELASRCSSVSPPPGEYRLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCV  398 (461)
Q Consensus       319 el~tg~~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  398 (461)
                      ||+|++          ..||...     ........+...+.++..|..++.     .+.+||.+||+.||++|||++++
T Consensus       239 ellt~g----------~p~~~~~-----~~~~~~~~~i~~~~~~~~~~~~~~-----~l~~Li~~cl~~dP~~RPs~~~i  298 (311)
T d1t46a_         239 ELFSLG----------SSPYPGM-----PVDSKFYKMIKEGFRMLSPEHAPA-----EMYDIMKTCWDADPLKRPTFKQI  298 (311)
T ss_dssp             HHHTTT----------CCSSTTC-----CSSHHHHHHHHHTCCCCCCTTSCH-----HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhCC----------CCCCCCC-----CHHHHHHHHHhcCCCCCCcccccH-----HHHHHHHHHcCCChhHCcCHHHH
Confidence            999964          3333322     112223344455667777765544     89999999999999999999999


Q ss_pred             hhhcHHHh
Q psy17532        399 VERGMLAL  406 (461)
Q Consensus       399 l~~l~~~~  406 (461)
                      ++.|....
T Consensus       299 l~~L~~~i  306 (311)
T d1t46a_         299 VQLIEKQI  306 (311)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhh
Confidence            99887654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=391.90  Aligned_cols=255  Identities=26%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             eeEEeEeecCCceEEEEEEECC-----CcEEEEEEecCC--hhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        114 IQLVEVKAQGRFGAVWKAKFKN-----ENVAVKIFLMQD--KQSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~~~-----~~vAvK~~~~~~--~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      +.+.++||+|+||+||+|++..     ..||||++....  .....+.+|+.+|++++|||||+++|++...+   ..++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---~~~~  105 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPL  105 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT---TEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC---CceE
Confidence            3457899999999999999832     248999986432  22345678999999999999999999987643   2458


Q ss_pred             eeehhccCCChhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        187 LITAYHERGSLCDFLKCN--IVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      +|||||++|+|.+++...  .+++..++.++.|+|.||.|||+.           +|+||||||+|||+++++.+||+||
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~-----------~iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-----------KFVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc-----------CcccCCccHHhEeECCCCCEEEecc
Confidence            999999999999998644  477889999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        265 GLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       265 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |+++.+......  .......||..|+|||.+.+     ..++.++||||||+++|||+||+           .||....
T Consensus       175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~SfGivl~El~t~~-----------~p~~~~~  238 (311)
T d1r0pa_         175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRG-----------APPYPDV  238 (311)
T ss_dssp             GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTS-----------CCSCC--
T ss_pred             cchhhccccccccceecccccccccccChHHHhc-----CCCCChhHhhhhHHHHHHHHHCC-----------CCCCCCC
Confidence            999887654322  12334578999999999876     36788999999999999999984           3333221


Q ss_pred             CCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHhhh
Q psy17532        343 GDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLALCD  408 (461)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~  408 (461)
                          +..++...+.. +.++..|..++.     .+.+||.+||+.||++|||+.||+++|..+...
T Consensus       239 ----~~~~~~~~i~~-g~~~~~p~~~~~-----~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         239 ----NTFDITVYLLQ-GRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             --------CHHHHHT-TCCCCCCTTCCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CHHHHHHHHHc-CCCCCCcccCcH-----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                11222333333 345666655443     799999999999999999999999999887654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-51  Score=397.46  Aligned_cols=258  Identities=17%  Similarity=0.187  Sum_probs=198.3

Q ss_pred             CcceeEEe-EeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCC-CCCCCeeEEEEEEecCCccceeee
Q psy17532        111 CRSIQLVE-VKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPH-MEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       111 ~~~~~~~~-~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~-l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      .++|++.. +||+|+||+||+|++  +++.||||++...    ....+|+.++.+ .+|||||++++++.+.......+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            56898875 699999999999998  4788999998642    345567776544 489999999999876433345679


Q ss_pred             eeehhccCCChhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCceE
Q psy17532        187 LITAYHERGSLCDFLKC---NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAA  260 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~~k  260 (461)
                      +|||||++|+|.+++..   ..+++.++..++.||+.||+|||+.           +|+||||||+|||++.   ++.+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-----------~iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-----------NIAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEESCSSTTCCEE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc-----------CCcccccccccccccccccccccc
Confidence            99999999999999964   3599999999999999999999999           9999999999999986   46799


Q ss_pred             EEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcc
Q psy17532        261 IADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSA  340 (461)
Q Consensus       261 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~  340 (461)
                      |+|||+|+......   ......||+.|||||++.+.     .++.++|||||||++|||+||           +.||.+
T Consensus       155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~y~~~~DiwSlGvily~lltg-----------~~Pf~~  215 (335)
T d2ozaa1         155 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE-----KYDKSCDMWSLGVIMYILLCG-----------YPPFYS  215 (335)
T ss_dssp             ECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGG-----GGSHHHHHHHHHHHHHHHTTS-----------SCSCEE
T ss_pred             ccccceeeeccCCC---ccccccCCcccCCcHHHcCC-----CCCHHHHHHhhchhHHHHhhC-----------CCCCCC
Confidence            99999998876543   23456899999999999763     677899999999999999999           555544


Q ss_pred             ccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        341 EVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ..... ....+...+.....  .+|... ....++++.+||.+||+.||++|||+.|+++|.|...
T Consensus       216 ~~~~~-~~~~~~~~i~~~~~--~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         216 NHGLA-ISPGMKTRIRMGQY--EFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             TTCC---------CCCSCSS--SCCTTH-HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCHHH-HHHHHHHHHhcCCC--CCCCcc-cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            31111 11112222222221  122111 0123458999999999999999999999999988654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=391.54  Aligned_cols=253  Identities=27%  Similarity=0.316  Sum_probs=193.9

Q ss_pred             EEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh------hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        116 LVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ------SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       116 ~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~------~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+++||+|+||+||+|++  +|+.||||++......      .....+|+.++++++|||||++++++.+.+.    +++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~----~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN----ISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----CEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc----eee
Confidence            468999999999999998  4788999998643221      2345789999999999999999999988764    499


Q ss_pred             eehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      ||||+.+|++..+.. ...+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+||+|||+
T Consensus        78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~-----------~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-----------WILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc-----------ceecccCCcceEEecCCCccccccCcc
Confidence            999999987777765 34689999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      |+......  ......+||+.|||||++.+.    ..++.++|||||||++|||++|.           .||...     
T Consensus       147 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~~g~-----------~pf~~~-----  204 (299)
T d1ua2a_         147 AKSFGSPN--RAYTHQVVTRWYRAPELLFGA----RMYGVGVDMWAVGCILAELLLRV-----------PFLPGD-----  204 (299)
T ss_dssp             GSTTTSCC--CCCCCSCCCCTTCCHHHHTTC----SCCCHHHHHHHHHHHHHHHHHSS-----------CSSCCS-----
T ss_pred             ccccCCCc--ccccceecChhhccHHHHccC----CCCChhhhhhhcchHHHHHHhCc-----------CCCCCC-----
Confidence            98765443  223446899999999998753    45678999999999999999994           444332     


Q ss_pred             CHHHHHHHHhcc---------------------CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        347 SLEDMQEAVVHK---------------------KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       347 ~~~~~~~~~~~~---------------------~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      +..+....+...                     ...+..+........++++.+||.+||..||++||||+|+++|.+..
T Consensus       205 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence            222222222110                     00000110000012345799999999999999999999999998753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=381.41  Aligned_cols=241  Identities=20%  Similarity=0.268  Sum_probs=193.8

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh-------hhhHHHHHHHHcCCCC--CCCeeEEEEEEecCCc
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK-------QSWQSEQEIFKLPHME--HDNILRYIGAEKRGES  180 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-------~~~~~~~ei~~l~~l~--H~nIv~l~g~~~~~~~  180 (461)
                      ++|++.+.||+|+||+||+|+.  +++.||||++.....       ...+..+|+.++++++  |||||++++++.+.+ 
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~-   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD-   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence            5799999999999999999998  478999999864321       1122457888887775  999999999998865 


Q ss_pred             cceeeeeeehhccC-CChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-CC
Q psy17532        181 IHTEFWLITAYHER-GSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-DL  257 (461)
Q Consensus       181 ~~~~~~lv~e~~~~-gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-~~  257 (461)
                         .+++||||+.+ +++.+++. ...+++..+..++.||+.||+|||++           +|+||||||+|||++. ++
T Consensus        83 ---~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~-----------~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          83 ---SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-----------GVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             ---EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCSGGGEEEETTTT
T ss_pred             ---eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCccccCcccceEEecCCC
Confidence               45999999976 57888874 56799999999999999999999999           9999999999999985 47


Q ss_pred             ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        258 TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       258 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      .+||+|||+|+.....    ......||+.|||||++.+.    ..++.++|||||||++|||++|           +.|
T Consensus       149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~----~~~~~~~DiwSlGvilyell~g-----------~~P  209 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYH----RYHGRSAAVWSLGILLYDMVCG-----------DIP  209 (273)
T ss_dssp             EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHS----CBCHHHHHHHHHHHHHHHHHHS-----------SCS
T ss_pred             eEEECccccceecccc----cccccccCCCcCCHHHHcCC----CCCCcccccccceeeehhHhhC-----------CCC
Confidence            9999999999876433    23456899999999999764    2234678999999999999999           666


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      |...       .+    +....  ..++..++     .++.+||.+||+.||++|||++|+++|.|.
T Consensus       210 f~~~-------~~----i~~~~--~~~~~~~s-----~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         210 FEHD-------EE----IIRGQ--VFFRQRVS-----SECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             CCSH-------HH----HHHCC--CCCSSCCC-----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCc-------hH----Hhhcc--cCCCCCCC-----HHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            6532       12    22221  22333333     379999999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=381.03  Aligned_cols=255  Identities=23%  Similarity=0.337  Sum_probs=195.9

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++++.||+|+||+||+|++.  ++.||||++.....   ......+|+.++++++|||||++++++.+..    .+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~----~~~   77 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN----KLY   77 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc----cee
Confidence            58999999999999999999984  78999999864332   2345678999999999999999999998865    459


Q ss_pred             eeehhccCCChhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        187 LITAYHERGSLCDFL---KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       187 lv~e~~~~gsL~~~l---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      +||||+.+ ++.+++   ....+++..+..++.||+.||+|||++           +||||||||+|||++.++.+||+|
T Consensus        78 iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~-----------~IiHrDiKpeNIl~~~~~~~kl~D  145 (298)
T d1gz8a_          78 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-----------RVLHRDLKPQNLLINTEGAIKLAD  145 (298)
T ss_dssp             EEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             EEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC-----------CEEccccCchheeecccCcceecc
Confidence            99999976 455544   234699999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccC
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVG  343 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~  343 (461)
                      ||+|+......  .......||+.|+|||++...    ..++.++|||||||++|||++|+           .||...  
T Consensus       146 FG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~----~~~~~~~DiwSlGvily~m~~G~-----------~Pf~~~--  206 (298)
T d1gz8a_         146 FGLARAFGVPV--RTYTHEVVTLWYRAPEILLGC----KYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGD--  206 (298)
T ss_dssp             TTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHSS-----------CSCCCS--
T ss_pred             CCcceeccCCc--ccceeecccceeeehhhhccc----cCCCccccccccchhhhHHhhCC-----------CCCCCC--
Confidence            99998775433  234456899999999988764    34568899999999999999994           455332  


Q ss_pred             CCCCHHHHHHHHhc----------------cCCCCCCCchhc------cchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        344 DHPSLEDMQEAVVH----------------KKLRPTLPETWK------QHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       344 ~~~~~~~~~~~~~~----------------~~~~~~~p~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                         +..+....+..                ......++....      ....+.++.+||.+||..||++|||++|+++|
T Consensus       207 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         207 ---SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             ---SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---CHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               11111111110                000111111000      01233578999999999999999999999999


Q ss_pred             cHH
Q psy17532        402 GML  404 (461)
Q Consensus       402 l~~  404 (461)
                      .+.
T Consensus       284 ~ff  286 (298)
T d1gz8a_         284 PFF  286 (298)
T ss_dssp             GGG
T ss_pred             Hhh
Confidence            875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.7e-49  Score=375.34  Aligned_cols=256  Identities=21%  Similarity=0.251  Sum_probs=196.5

Q ss_pred             cceeEEeEeecCCceEEEEEEEC-CCcEEEEEEecCChh---hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK-NENVAVKIFLMQDKQ---SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~---~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      ++|++++.||+|+||+||+|+++ ++.||||++......   ...+.+|+.+|++++|||||++++++.+.+.    +++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR----LVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC----EEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc----eeE
Confidence            68999999999999999999984 688999999654322   3456789999999999999999999988764    489


Q ss_pred             eehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCC
Q psy17532        188 ITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGL  266 (461)
Q Consensus       188 v~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGl  266 (461)
                      +|||+.++.+..+.+ .+.+++..+..++.||+.||+|||+.           +||||||||+|||++.++.+||+|||+
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-----------RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC-----------cEEecCCCCceeeEcCCCCEEeccccc
Confidence            999998877777765 45699999999999999999999999           999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCCC
Q psy17532        267 ALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDHP  346 (461)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~~  346 (461)
                      |.......  .......|++.|+|||.+.+.    ..++.++|||||||++|||++|+           .||.+.     
T Consensus       147 a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~----~~~~~~~DiwslGv~l~el~~G~-----------~pf~~~-----  204 (286)
T d1ob3a_         147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGS----KKYSTTIDIWSVGCIFAEMVNGT-----------PLFPGV-----  204 (286)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTC----CSCCTHHHHHHHHHHHHHHHHSS-----------CSCCCS-----
T ss_pred             ceecccCc--cccceecccchhhhHHHHhCC----CCCCcceeehhcCcHHHHHHHCC-----------CCCCCC-----
Confidence            98875433  223445789999999998764    45678999999999999999995           444332     


Q ss_pred             CHHHHHHHHhcc----------------C------CCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHH
Q psy17532        347 SLEDMQEAVVHK----------------K------LRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGML  404 (461)
Q Consensus       347 ~~~~~~~~~~~~----------------~------~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~  404 (461)
                      +..+....+...                .      .....+........+..+.+||++||..||++|||++|+++|.+.
T Consensus       205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            111211111100                0      000000000011133578999999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=376.29  Aligned_cols=258  Identities=23%  Similarity=0.258  Sum_probs=194.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC---CCcEEEEEEecCCh---hhhHHHHHHHHcC---CCCCCCeeEEEEEEecCCc-
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK---NENVAVKIFLMQDK---QSWQSEQEIFKLP---HMEHDNILRYIGAEKRGES-  180 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vAvK~~~~~~~---~~~~~~~ei~~l~---~l~H~nIv~l~g~~~~~~~-  180 (461)
                      .++|++++.||+|+||+||+|++.   ++.||||++.....   ......+|+.+++   .++||||+++++++..... 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            368999999999999999999983   45699999864322   2223445665544   4589999999999864321 


Q ss_pred             cceeeeeeehhccCCChhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCc
Q psy17532        181 IHTEFWLITAYHERGSLCDFL--KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLT  258 (461)
Q Consensus       181 ~~~~~~lv~e~~~~gsL~~~l--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~  258 (461)
                      ....++++|||+.+|++....  ....+++..+..++.|++.||+|||++           +|+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-----------~ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-----------RVVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------CEEecCCCccEEEEcCCCC
Confidence            234679999999987765444  345689999999999999999999999           9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        259 AAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       259 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      +||+|||+++......   ......||+.|||||++.+     ..++.++|||||||++|||++|.           .||
T Consensus       155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~-----~~y~~~~DiwSlG~il~ell~g~-----------~pf  215 (305)
T d1blxa_         155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRK-----------PLF  215 (305)
T ss_dssp             EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSS-----------CSC
T ss_pred             eeecchhhhhhhcccc---cCCCcccChhhcCcchhcC-----CCCChhehhhchHHHHHHHHHCC-----------CCC
Confidence            9999999998654332   2445689999999999976     47889999999999999999994           455


Q ss_pred             ccccCCCCCHHHHHHHHhcc----------------------CCCCCCCchhccchhHHHHHHHHHHHccccHhhhcccc
Q psy17532        339 SAEVGDHPSLEDMQEAVVHK----------------------KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSAS  396 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  396 (461)
                      ...     +..+....+...                      ...... ..+. ...++.+.+||.+||..||++|||++
T Consensus       216 ~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~s~~~~dli~~mL~~dP~~R~sa~  288 (305)
T d1blxa_         216 RGS-----SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI-EKFV-TDIDELGKDLLLKCLTFNPAKRISAY  288 (305)
T ss_dssp             CCS-----SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCG-GGTC-CSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCC-----CHHHHHHHHHHhhCCCchhcccccccchhhhhccccccch-hhcc-ccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            432     222222221110                      000000 0000 11335789999999999999999999


Q ss_pred             chhhhcHHH
Q psy17532        397 CVVERGMLA  405 (461)
Q Consensus       397 evl~~l~~~  405 (461)
                      |+++|.+..
T Consensus       289 e~L~Hpff~  297 (305)
T d1blxa_         289 SALSHPYFQ  297 (305)
T ss_dssp             HHHTSGGGT
T ss_pred             HHhcChhhc
Confidence            999998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-48  Score=378.15  Aligned_cols=276  Identities=20%  Similarity=0.262  Sum_probs=198.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChh--hhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQ--SWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~--~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l  187 (461)
                      .+|++++.||+|+||+||+|+.  +++.||||++......  .....+|+.+|++++||||+++++++..........++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4699999999999999999998  4889999999654322  23456899999999999999999999776544334455


Q ss_pred             eehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecCCc
Q psy17532        188 ITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLA  267 (461)
Q Consensus       188 v~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla  267 (461)
                      +++|+.+|+|.+++..+.+++..+..++.|++.||+|||++           +||||||||+|||++.++.+||+|||+|
T Consensus        88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~-----------~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-----------NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            66677899999999888999999999999999999999999           9999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCC---------CCCC
Q psy17532        268 LLFEPGKPC-GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGE---------YRLP  337 (461)
Q Consensus       268 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~---------~~~p  337 (461)
                      +........ .......||+.|+|||++...    ..++.++||||+||++|||++|..||......         ...|
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNS----KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTB----CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             eeccCCCccceeeccccccceechHHHhhcC----CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            876543221 224456799999999998654    35678899999999999999995444321100         0000


Q ss_pred             CccccCCCCCHHHHHHHHhccCCCCCCC--chhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        338 FSAEVGDHPSLEDMQEAVVHKKLRPTLP--ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      ........... ...............+  ..++  ..+.++.+|+.+||+.||++|||++|+++|.+..
T Consensus       233 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         233 SQEDLNCIINL-KARNYLLSLPHKNKVPWNRLFP--NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  299 (345)
T ss_dssp             CHHHHHTCCCH-HHHHHHHTSCCCCCCCHHHHCT--TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             Chhhhhhhhhh-hhhcccccCCccCCCCHHHhCC--CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            00000000000 0000000000000111  1111  1234788999999999999999999999998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=377.04  Aligned_cols=258  Identities=22%  Similarity=0.258  Sum_probs=193.5

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cceeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHTEFWL  187 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~~l  187 (461)
                      .+|+..++||+|+||+||+|++  +++.||||++.....   ...+|+.+|++++|||||++++++.....  ....+++
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            3799999999999999999999  478899999975432   23468888999999999999999865432  1234689


Q ss_pred             eehhccCCChhhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEE
Q psy17532        188 ITAYHERGSLCDFL----KCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIA  262 (461)
Q Consensus       188 v~e~~~~gsL~~~l----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~  262 (461)
                      |||||++|.+..+.    ....+++..+..++.||+.||+|||++           +|+||||||+|||++.++ .+||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-----------~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-----------GICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCCGGGEEECTTTCCEEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-----------CCcccCCCcceEEEecCCCceeEe
Confidence            99999875433332    244699999999999999999999998           999999999999999775 89999


Q ss_pred             ecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCcccc
Q psy17532        263 DFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEV  342 (461)
Q Consensus       263 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~  342 (461)
                      |||+++.+.....   .....||..|+|||.+.+.    ..++.++|||||||++|||++|.           .||... 
T Consensus       166 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DIwSlG~il~el~~g~-----------~pf~~~-  226 (350)
T d1q5ka_         166 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGA----TDYTSSIDVWSAGCVLAELLLGQ-----------PIFPGD-  226 (350)
T ss_dssp             CCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHTS-----------CSSCCS-
T ss_pred             cccchhhccCCcc---cccccccccccChHHhhcc----cCCCcceeecccceEEEehhhCC-----------CCCCCC-
Confidence            9999988765432   3346799999999988753    46788999999999999999994           455332 


Q ss_pred             CCCCCHHHHHHHHh---------------ccCCCCCCCc----hh---ccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        343 GDHPSLEDMQEAVV---------------HKKLRPTLPE----TW---KQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       343 ~~~~~~~~~~~~~~---------------~~~~~~~~p~----~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                          ...+....+.               .......++.    .+   .....+.++.+||.+||..||++|||+.|+++
T Consensus       227 ----~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         227 ----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             ----SHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1111111111               0000111110    00   01123457899999999999999999999999


Q ss_pred             hcHHHh
Q psy17532        401 RGMLAL  406 (461)
Q Consensus       401 ~l~~~~  406 (461)
                      |.++-.
T Consensus       303 Hp~f~~  308 (350)
T d1q5ka_         303 HSFFDE  308 (350)
T ss_dssp             SGGGGG
T ss_pred             CHhhcc
Confidence            987643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=376.23  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=196.2

Q ss_pred             CCcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc---
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI---  181 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~---  181 (461)
                      ..++|++++.||+|+||+||+|++  +|+.||||++.....   ......+|+.+|++++||||+++++++......   
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            358999999999999999999998  478999999854322   234456899999999999999999998664321   


Q ss_pred             -ceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCce
Q psy17532        182 -HTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTA  259 (461)
Q Consensus       182 -~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~  259 (461)
                       ...+++||||+.++.+..+.. ...++...+..++.|++.||.|||+.           +|+||||||+|||++.++.+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~-----------~ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN-----------KILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTSCE
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC-----------CEEecCcCchheeecCCCcE
Confidence             235689999998877665553 34689999999999999999999999           99999999999999999999


Q ss_pred             EEEecCCccccCCCCCC--CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q psy17532        260 AIADFGLALLFEPGKPC--GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLP  337 (461)
Q Consensus       260 ki~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~p  337 (461)
                      ||+|||+++.+......  .......||+.|+|||++.+.    ..++.++|||||||++|||++|..||.+        
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~----~~~~~k~DiwSlGvil~el~~g~~pf~~--------  224 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE----RDYGPPIDLWGAGCIMAEMWTRSPIMQG--------  224 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHSSCSCCC--------
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCC----CCCCcHHHcccCCceeeeHhhCCCCCCC--------
Confidence            99999999877643321  223345799999999998763    4678899999999999999999555532        


Q ss_pred             CccccCCCCCHHHHHHHHhc-------------------------cCCCCCCCchhccchhHHHHHHHHHHHccccHhhh
Q psy17532        338 FSAEVGDHPSLEDMQEAVVH-------------------------KKLRPTLPETWKQHAGMLALCDTMEECWDHDAEAR  392 (461)
Q Consensus       338 f~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  392 (461)
                         .     ........+..                         ......+++.+........+.+||.+||..||++|
T Consensus       225 ---~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R  296 (318)
T d3blha1         225 ---N-----TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR  296 (318)
T ss_dssp             ---S-----SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTS
T ss_pred             ---C-----CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHC
Confidence               1     11111111100                         00011111111111223567899999999999999


Q ss_pred             ccccchhhhcHHH
Q psy17532        393 LSASCVVERGMLA  405 (461)
Q Consensus       393 ps~~evl~~l~~~  405 (461)
                      ||++|+++|.++.
T Consensus       297 ~sa~elL~Hpff~  309 (318)
T d3blha1         297 IDSDDALNHDFFW  309 (318)
T ss_dssp             CCHHHHHHSGGGS
T ss_pred             cCHHHHHcChhhc
Confidence            9999999998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=377.77  Aligned_cols=273  Identities=20%  Similarity=0.242  Sum_probs=195.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc--ce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI--HT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~--~~  183 (461)
                      .++|++++.||+|+||+||+|+++  |+.||||++.....   ......+|+.+|+.++|||||++++++...+..  ..
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999984  78899999864322   233456899999999999999999999776532  34


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+++||||+ +++|..+++...+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-----------GIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC-----------CCcccccCcchhhccccccccccc
Confidence            579999999 56888888888999999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||+|+.....     .....||+.|+|||++.+.    ..++.++||||+||++|||++|..||.+.....         
T Consensus       165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  235 (346)
T d1cm8a_         165 FGLARQADSE-----MTGYVVTRWYRAPEVILNW----MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  235 (346)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTT----TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             ccceeccCCc-----cccccccccccCHHHHcCC----CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence            9999876532     3446799999999998763    356789999999999999999955443221000         


Q ss_pred             -CCCCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        335 -RLPFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       335 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                       ..|..........................+....  ...+..+.+||.+||..||++|||++|+++|.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhc--cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence             0000000000000000000000000111111111  112347889999999999999999999999987643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.6e-47  Score=370.44  Aligned_cols=272  Identities=22%  Similarity=0.247  Sum_probs=197.9

Q ss_pred             CCcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccceeee
Q psy17532        110 GCRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       110 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ..++|++++.||+|+||+||+|+..  ++.||||+++....  .+..+|+.+|..++ ||||+++++++.....  ..++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~--~~~~  108 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLADIVKDPVS--RTPA  108 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH--HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT--CSEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH--HHHHHHHHHHHhccCCCCCcEEEEEEEecCC--Ccee
Confidence            3468999999999999999999984  78899999875443  35567888888884 9999999999876432  3468


Q ss_pred             eeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCC-ceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDL-TAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~-~~ki~DFG  265 (461)
                      +||||+.+|+|..+.+  .+++..+..++.||+.||+|||++           +|+||||||+|||++.++ .+||+|||
T Consensus       109 ~v~e~~~~~~L~~~~~--~l~e~~i~~i~~qil~aL~~LH~~-----------gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSM-----------GIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EEEECCCSCBGGGTTT--SCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             EEEeecCCCcHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhc-----------ccccccccccceEEcCCCCeeeecccc
Confidence            9999999999988754  599999999999999999999999           999999999999998755 69999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccc-cCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAE-VGD  344 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~-~~~  344 (461)
                      +|+......   ......||+.|+|||.+.+.    ..++.++||||+||++|||++|+.||.............. ...
T Consensus       176 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g  248 (328)
T d3bqca1         176 LAEFYHPGQ---EYNVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  248 (328)
T ss_dssp             GCEECCTTC---CCCSCCSCGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred             cceeccCCC---cccccccCccccCcccccCC----CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence            998876543   23456789999999998764    3567899999999999999999555432211100000000 000


Q ss_pred             CCCHHHHHHHH-----------hccCCCCC---CCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        345 HPSLEDMQEAV-----------VHKKLRPT---LPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       345 ~~~~~~~~~~~-----------~~~~~~~~---~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      .+.........           .....+..   ..........+.++.+||++||..||++|||++|+++|.++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            00000000000           00000000   000001112345789999999999999999999999998864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=360.87  Aligned_cols=255  Identities=24%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCccceeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESIHTEFW  186 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~  186 (461)
                      ++|++++.||+|+||+||+|++  +++.||||+++....   ...+..+|+.+++.++|||||++++++.+..    .++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~~~   77 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK----KLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc----cee
Confidence            5799999999999999999998  467899999965432   2345678999999999999999999998866    458


Q ss_pred             eeehhccCCChhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEecC
Q psy17532        187 LITAYHERGSLCDFLKC-NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADFG  265 (461)
Q Consensus       187 lv~e~~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFG  265 (461)
                      +|+|++.+++|..++.. +.+++..+..++.|++.||+|||++           +|+||||||+|||++.++.+||+|||
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~-----------~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-----------NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC-----------CEeeecccCcccccccCCceeeeecc
Confidence            99999999999888754 4689999999999999999999999           99999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCCC
Q psy17532        266 LALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGDH  345 (461)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~~  345 (461)
                      .|+.......  ......++..|+|||++.+.    ..++.++|||||||++|||++|+.||....              
T Consensus       147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~----~~~~~~~DiwSlG~il~ell~g~~p~~~~~--------------  206 (292)
T d1unla_         147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGN--------------  206 (292)
T ss_dssp             TCEECCSCCS--CCCSCCSCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--------------
T ss_pred             hhhcccCCCc--cceeeccccchhhhhHhccC----CCCCchhhccccchHHHHHhhCCCCCCCCC--------------
Confidence            9988765432  23345678899999998764    346789999999999999999954432111              


Q ss_pred             CCHHHHHHHHhccCC------------------------CCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        346 PSLEDMQEAVVHKKL------------------------RPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       346 ~~~~~~~~~~~~~~~------------------------~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                       ...+....+.....                        ........  ...+..+.+||.+||+.||++||||+|+++|
T Consensus       207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         207 -DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVV--PKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             -SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhcc--ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11221111111000                        00000000  1123578899999999999999999999999


Q ss_pred             cHH
Q psy17532        402 GML  404 (461)
Q Consensus       402 l~~  404 (461)
                      .|.
T Consensus       284 p~f  286 (292)
T d1unla_         284 PYF  286 (292)
T ss_dssp             GGG
T ss_pred             hhh
Confidence            875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=369.43  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=203.3

Q ss_pred             cCCcceeEEeEeecCCceEEEEEEE-----CCCcEEEEEEecCC-----hhhhHHHHHHHHcCCCCC-CCeeEEEEEEec
Q psy17532        109 QGCRSIQLVEVKAQGRFGAVWKAKF-----KNENVAVKIFLMQD-----KQSWQSEQEIFKLPHMEH-DNILRYIGAEKR  177 (461)
Q Consensus       109 ~~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~ei~~l~~l~H-~nIv~l~g~~~~  177 (461)
                      ...++|++++.||+|+||+||+|+.     +|+.||||++....     .......+|+.++++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3568899999999999999999987     36789999985321     223345678888999966 899999999988


Q ss_pred             CCccceeeeeeehhccCCChhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCC
Q psy17532        178 GESIHTEFWLITAYHERGSLCDFLK-CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSD  256 (461)
Q Consensus       178 ~~~~~~~~~lv~e~~~~gsL~~~l~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~  256 (461)
                      ..    .++++|||+.+|+|.+++. .+.+.+..+..++.||+.||+|||+.           +|+||||||+|||++.+
T Consensus       101 ~~----~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~-----------~ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_         101 ET----KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL-----------GIIYRDIKLENILLDSN  165 (322)
T ss_dssp             TT----EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTT
T ss_pred             CC----ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC-----------CEEeccCCccceeecCC
Confidence            76    4589999999999999985 44688899999999999999999999           99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        257 LTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       257 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +.+||+|||+|+.+..... .......|++.|+|||.+.+.   ...++.++|||||||+||||++|           ..
T Consensus       166 ~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~---~~~~~~ksDIWSlG~iLyelltG-----------~~  230 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTG-----------AS  230 (322)
T ss_dssp             SCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHS-----------SC
T ss_pred             CCEEEeeccchhhhccccc-ccccccccccccchhHHhhcC---CcCCCchhhhHHHHHHHHHHHhC-----------CC
Confidence            9999999999987654322 223446799999999999763   12466789999999999999999           55


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhcc-----ccchhhhcHHH
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLS-----ASCVVERGMLA  405 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~  405 (461)
                      ||..... ......+.......  .+.+|..++     .++.+||.+||++||++|||     ++|+++|.+..
T Consensus       231 PF~~~~~-~~~~~~i~~~~~~~--~~~~~~~~s-----~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~  296 (322)
T d1vzoa_         231 PFTVDGE-KNSQAEISRRILKS--EPPYPQEMS-----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  296 (322)
T ss_dssp             TTSCTTS-CCCHHHHHHHHHHC--CCCCCTTSC-----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             CCCCCCH-HHHHHHHHHhcccC--CCCCcccCC-----HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence            5544322 12344444433332  234444433     38999999999999999995     78899998753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-46  Score=358.63  Aligned_cols=257  Identities=19%  Similarity=0.177  Sum_probs=187.0

Q ss_pred             cceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCChhhhHHHHHHHHcCCCCCCCeeEEEEEE-ecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDKQSWQSEQEIFKLPHMEHDNILRYIGAE-KRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H~nIv~l~g~~-~~~~~~~~~~~lv  188 (461)
                      ++|++.+.||+|+||.||+|++.  ++.||||++..... ......|+.+++.++|+|++..++.+ .+..    .+++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~----~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD----YNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT----EEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCC----EEEEE
Confidence            46999999999999999999984  78999999875433 23456788888888877766555544 4433    45899


Q ss_pred             ehhccCCChhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC---CCceEEEe
Q psy17532        189 TAYHERGSLCDFLK--CNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS---DLTAAIAD  263 (461)
Q Consensus       189 ~e~~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~---~~~~ki~D  263 (461)
                      |||+. |+|.+.+.  ...+++..+..++.|++.||+|||++           +|+||||||+|||++.   +..+||+|
T Consensus        82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-----------~iiHrDiKp~NIl~~~~~~~~~vkl~D  149 (299)
T d1ckia_          82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-----------NFIHRDVKPDNFLMGLGKKGNLVYIID  149 (299)
T ss_dssp             EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-----------TEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC-----------CeeeccCCHhhccccccCCCceeeeec
Confidence            99995 57776653  45799999999999999999999999           9999999999999864   56799999


Q ss_pred             cCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCC
Q psy17532        264 FGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPF  338 (461)
Q Consensus       264 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf  338 (461)
                      ||+|+.+......     .......||+.|||||++.+     ..++.++|||||||++|||++|           ..||
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~el~tg-----------~~P~  213 (299)
T d1ckia_         150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLG-----------SLPW  213 (299)
T ss_dssp             CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-----BCCCHHHHHHHHHHHHHHHHHS-----------SCTT
T ss_pred             cCcceeccccccccceeccccCCcCCCccccCHHHHhC-----CCCCChhhEEecCHHHHHHHhC-----------CCcc
Confidence            9999987644321     12345679999999999976     3678899999999999999999           5555


Q ss_pred             ccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHH
Q psy17532        339 SAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLA  405 (461)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~  405 (461)
                      .......... . .............+...  ...+.++.+||.+||+.||++||+++++.+.|..+
T Consensus       214 ~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~--~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         214 QGLKAATKRQ-K-YERISEKKMSTPIEVLC--KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             CCCC---------HHHHHHHHHHSCHHHHT--TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             cccchHHHHH-H-HHHhhcccCCCChhHhc--cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            4332111111 1 11111111111111110  11234799999999999999999998887665544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=366.96  Aligned_cols=260  Identities=21%  Similarity=0.273  Sum_probs=196.6

Q ss_pred             CcceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCcc-cee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGESI-HTE  184 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~~-~~~  184 (461)
                      .++|++++.||+|+||+||+|+.  +|+.||||++.....   ......+|+.+|++++|||||++++++...... ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            35799999999999999999998  478999999865432   223456899999999999999999998654321 123


Q ss_pred             eeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEec
Q psy17532        185 FWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIADF  264 (461)
Q Consensus       185 ~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DF  264 (461)
                      .+++++|+.+|+|.+++..+.+++..+..++.||+.||+|||++           +|+||||||+|||++.++.+|++||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~-----------giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-----------DIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC-----------CCcccccCCcccccccccccccccc
Confidence            46677888899999999888999999999999999999999999           9999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCCCCccccCC
Q psy17532        265 GLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRLPFSAEVGD  344 (461)
Q Consensus       265 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~pf~~~~~~  344 (461)
                      |+|.....     ......||..|+|||++.+.    ..++.++|||||||++|||++|..|           |.+.   
T Consensus       166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~----~~~~~~~DiwSlGv~l~~ll~g~~p-----------F~~~---  222 (348)
T d2gfsa1         166 GLARHTDD-----EMTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGRTL-----------FPGT---  222 (348)
T ss_dssp             ----CCTG-----GGSSSCHHHHTSCHHHHTTC----SCCCTTHHHHHHHHHHHHHHHSSCS-----------CCCS---
T ss_pred             chhcccCc-----ccccccccccccCchhhcCC----ccCCcccchhhhhHHHHHHHhCCCC-----------CCCC---
Confidence            99976542     23456789999999987663    3457899999999999999999544           4322   


Q ss_pred             CCCHHHHHHHHhcc------------------------CCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhh
Q psy17532        345 HPSLEDMQEAVVHK------------------------KLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVE  400 (461)
Q Consensus       345 ~~~~~~~~~~~~~~------------------------~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  400 (461)
                        +.......+...                        ...+..+-.-.....+..+.+||.+||..||++|||++|+++
T Consensus       223 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         223 --DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             --SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence              111111111110                        000010000000113457899999999999999999999999


Q ss_pred             hcHHHh
Q psy17532        401 RGMLAL  406 (461)
Q Consensus       401 ~l~~~~  406 (461)
                      |.|...
T Consensus       301 Hp~f~~  306 (348)
T d2gfsa1         301 HAYFAQ  306 (348)
T ss_dssp             SGGGTT
T ss_pred             CHhhCC
Confidence            998654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=363.31  Aligned_cols=272  Identities=21%  Similarity=0.260  Sum_probs=188.5

Q ss_pred             CcceeEEeEeecCCceEEEEEEEC--CCcEEEEEEecCCh---hhhHHHHHHHHcCCCCCCCeeEEEEEEecCCc--cce
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFK--NENVAVKIFLMQDK---QSWQSEQEIFKLPHMEHDNILRYIGAEKRGES--IHT  183 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~ei~~l~~l~H~nIv~l~g~~~~~~~--~~~  183 (461)
                      .++|+++++||+|+||+||+|++.  |+.||||++.....   ...+..+|+.++++++|||||++++++.....  ...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999984  78999999975432   22345689999999999999999999976543  235


Q ss_pred             eeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcCCCceEEEe
Q psy17532        184 EFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKSDLTAAIAD  263 (461)
Q Consensus       184 ~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~~~~~ki~D  263 (461)
                      .+|+||||+.++ +.+.+. ..+++..+..++.||+.||+|||+.           ||+||||||+|||++.++.+|++|
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~-----------giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSA-----------GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT-----------TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             eeEEEEeccchH-HHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhc-----------ccccccCCccccccccccceeeec
Confidence            779999999765 555543 4589999999999999999999999           999999999999999999999999


Q ss_pred             cCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCC---------
Q psy17532        264 FGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEY---------  334 (461)
Q Consensus       264 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~---------  334 (461)
                      ||+++......   ......||+.|+|||++.+     ..++.++||||+||++|||++|..||.+.....         
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~-----~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~  234 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcC-----CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            99998765433   2344578999999999976     367889999999999999999955543221000         


Q ss_pred             CCCCccccCCCCCHHHHHHHHhccCC-CCCC-----------C-chhccchhHHHHHHHHHHHccccHhhhccccchhhh
Q psy17532        335 RLPFSAEVGDHPSLEDMQEAVVHKKL-RPTL-----------P-ETWKQHAGMLALCDTMEECWDHDAEARLSASCVVER  401 (461)
Q Consensus       335 ~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~-----------p-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  401 (461)
                      ..|.......  .... ......... ....           + ........+.++.+||.+||..||++||||+|+++|
T Consensus       235 ~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         235 GTPCPEFMKK--LQPT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCCCHHHHTT--SCHH-HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCHHHHHH--hhhh-HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000000  0000 000011100 0000           0 000011245678999999999999999999999999


Q ss_pred             cHHHh
Q psy17532        402 GMLAL  406 (461)
Q Consensus       402 l~~~~  406 (461)
                      .|...
T Consensus       312 pw~~~  316 (355)
T d2b1pa1         312 PYINV  316 (355)
T ss_dssp             TTTGG
T ss_pred             cccCC
Confidence            98754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-45  Score=351.90  Aligned_cols=258  Identities=19%  Similarity=0.178  Sum_probs=193.7

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCCC-CCeeEEEEEEecCCccceeeeee
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHMEH-DNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ++|++.+.||+|+||+||+|++  +|+.||||++..... .....+|+..+..++| +||+.+++++....    ..++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL----HNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT----EEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC----ccEEE
Confidence            5799999999999999999998  478899998865432 2334556666666754 89999999987765    45899


Q ss_pred             ehhccCCChhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEEcC-----CCceEE
Q psy17532        189 TAYHERGSLCDFLKC--NIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLLKS-----DLTAAI  261 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl~~-----~~~~ki  261 (461)
                      |||+ +|+|.+++..  ..++...+..++.|++.||+|||++           +|+||||||+|||++.     ++.+||
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~-----------giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-----------SLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT-----------TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC-----------CceeccCCccceeecCcccccCCceEE
Confidence            9998 6799998853  4699999999999999999999999           9999999999999974     578999


Q ss_pred             EecCCccccCCCCCC-----CCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCCCCCC
Q psy17532        262 ADFGLALLFEPGKPC-----GDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSVSPPPGEYRL  336 (461)
Q Consensus       262 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~~~~~~~~~~  336 (461)
                      +|||+|+........     .......||+.|||||++.+     ..++.++|||||||++|||++|           ..
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg-----------~~  211 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRG-----------SL  211 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHS-----------SC
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-----CCCChHHHHHHhhHHHHHHHhC-----------CC
Confidence            999999886543211     12345679999999999976     4688899999999999999999           56


Q ss_pred             CCccccCCCCCHHHHHHHHhccCCCCCCCchhccchhHHHHHHHHHHHccccHhhhccccchhhhcHHHh
Q psy17532        337 PFSAEVGDHPSLEDMQEAVVHKKLRPTLPETWKQHAGMLALCDTMEECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       337 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      ||......  ........+.........++...  ..++++.+++..||..+|++||+++.+.+.+..+.
T Consensus       212 Pf~~~~~~--~~~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         212 PWQGLKAA--TNKQKYERIGEKKQSTPLRELCA--GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             TTSSCCSC--CHHHHHHHHHHHHHHSCHHHHTT--TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCCccch--hHHHHHHHHHhccCCCChHHhcC--CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            66433211  22222222222111111111111  12247999999999999999999887766655443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-41  Score=333.17  Aligned_cols=271  Identities=21%  Similarity=0.248  Sum_probs=184.3

Q ss_pred             cceeEEeEeecCCceEEEEEEE--CCCcEEEEEEecCChhhhHHHHHHHHcCCCC-----------CCCeeEEEEEEecC
Q psy17532        112 RSIQLVEVKAQGRFGAVWKAKF--KNENVAVKIFLMQDKQSWQSEQEIFKLPHME-----------HDNILRYIGAEKRG  178 (461)
Q Consensus       112 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-----------H~nIv~l~g~~~~~  178 (461)
                      .+|+++++||+|+||+||+|+.  +|+.||||++...........+|+.+++.++           |+|||++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            3599999999999999999998  4788999999765544445566777665553           68899999988654


Q ss_pred             CccceeeeeeehhccCCChhhh-h---cCCCCCHHHHHHHHHHHHHHHHHHhh-cccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        179 ESIHTEFWLITAYHERGSLCDF-L---KCNIVTWEQLCRIALSMSKGLMHLHE-EILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       179 ~~~~~~~~lv~e~~~~gsL~~~-l---~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      ...  ..+++++++..+..... .   ....+++..+..++.||+.||+|||+ .           +|+||||||+||||
T Consensus        93 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~-----------~IvHrDlKp~NIll  159 (362)
T d1q8ya_          93 GPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-----------GIIHTDIKPENVLM  159 (362)
T ss_dssp             ETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-----------CEECSCCSGGGEEE
T ss_pred             ccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc-----------CcccccCChhHeee
Confidence            322  33556665554433222 2   33468999999999999999999998 5           89999999999999


Q ss_pred             cCCC------ceEEEecCCccccCCCCCCCCCCCCcCCCcccccccccccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q psy17532        254 KSDL------TAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAPEVLEGAINFSRDAFLRIDMYACALVLWELASRCSSV  327 (461)
Q Consensus       254 ~~~~------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~k~DVwS~Gvil~el~tg~~~~  327 (461)
                      +.++      .+||+|||.|.....     ......||+.|+|||++.+     ..++.++||||+||+++||++|+.||
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLG-----APWGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHT-----CCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             eccCcccccceeeEeeccccccccc-----ccccccccccccChhhccc-----cCCCccccccchHHHHHHHHHCCCCC
Confidence            8765      389999999986543     2344679999999999876     36788999999999999999996665


Q ss_pred             CCCCCCCCCCCc-------cccCCCCCHHHHHH-----HHhc-cCCCCCCCc------------hh-ccchhHHHHHHHH
Q psy17532        328 SPPPGEYRLPFS-------AEVGDHPSLEDMQE-----AVVH-KKLRPTLPE------------TW-KQHAGMLALCDTM  381 (461)
Q Consensus       328 ~~~~~~~~~pf~-------~~~~~~~~~~~~~~-----~~~~-~~~~~~~p~------------~~-~~~~~~~~l~~li  381 (461)
                      .+........-.       ...+. ........     .... ......+..            .. .....+..+.+|+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  308 (362)
T d1q8ya_         230 EPDEGHSYTKDDDHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL  308 (362)
T ss_dssp             ---------CHHHHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred             CCCccccccchhHHHHHHHHHhCC-CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHH
Confidence            432211000000       00000 00000000     0000 000000000            00 0012456899999


Q ss_pred             HHHccccHhhhccccchhhhcHHHh
Q psy17532        382 EECWDHDAEARLSASCVVERGMLAL  406 (461)
Q Consensus       382 ~~cl~~dP~~Rps~~evl~~l~~~~  406 (461)
                      .+||..||++||||+|+++|.++..
T Consensus       309 ~~mL~~dP~~Rpta~e~L~Hp~f~~  333 (362)
T d1q8ya_         309 SPMLQLDPRKRADAGGLVNHPWLKD  333 (362)
T ss_dssp             GGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred             HHHCCCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999987653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=9e-26  Score=201.46  Aligned_cols=164  Identities=15%  Similarity=0.134  Sum_probs=117.9

Q ss_pred             eeEEeEeecCCceEEEEEEE-CCCcEEEEEEecCCh-------------------hhhHHHHHHHHcCCCCCCCeeEEEE
Q psy17532        114 IQLVEVKAQGRFGAVWKAKF-KNENVAVKIFLMQDK-------------------QSWQSEQEIFKLPHMEHDNILRYIG  173 (461)
Q Consensus       114 ~~~~~~lg~G~fg~Vy~~~~-~~~~vAvK~~~~~~~-------------------~~~~~~~ei~~l~~l~H~nIv~l~g  173 (461)
                      +.+.+.||+|+||.||+|+. +|+.||||++.....                   .....++|...+.++.|.|++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35789999999999999997 678999998743210                   0112245777788889999999887


Q ss_pred             EEecCCccceeeeeeehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCCcCCCCCCeecccCCCCcEEE
Q psy17532        174 AEKRGESIHTEFWLITAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNKADSYKPAVAHRDFKSNNVLL  253 (461)
Q Consensus       174 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~~~~~ivHrDLkp~NILl  253 (461)
                      +...        +++|||++++.+.+      ++......++.|++.||.|||+.           +|+||||||+|||+
T Consensus        82 ~~~~--------~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~-----------giiHrDiKP~NILv  136 (191)
T d1zara2          82 WEGN--------AVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHR-----------GIVHGDLSQYNVLV  136 (191)
T ss_dssp             EETT--------EEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHT-----------TEECSCCSTTSEEE
T ss_pred             ecCC--------EEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhC-----------CEEEccCChhheee
Confidence            6321        79999999866544      33445668999999999999999           99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCCCCCCCCcCCCccccc--ccccccccccCCCCCccchHHHHH
Q psy17532        254 KSDLTAAIADFGLALLFEPGKPCGDTHGQVGTRRYMAP--EVLEGAINFSRDAFLRIDMYACAL  315 (461)
Q Consensus       254 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aP--E~l~~~~~~~~~~~~k~DVwS~Gv  315 (461)
                      +++ .++|+|||+|+......          ...|...  +.+.  .++.+.|+.++|+||..-
T Consensus       137 ~~~-~~~liDFG~a~~~~~~~----------~~~~l~rd~~~~~--~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVGEEG----------WREILERDVRNII--TYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             ETT-EEEECCCTTCEETTSTT----------HHHHHHHHHHHHH--HHHHHHHCCCCCHHHHHH
T ss_pred             eCC-CEEEEECCCcccCCCCC----------cHHHHHHHHHHHH--HHHcCCCCCcccHHHHHH
Confidence            965 58999999997654221          0111111  1111  123456778899999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=7.4e-07  Score=80.91  Aligned_cols=150  Identities=13%  Similarity=0.085  Sum_probs=96.0

Q ss_pred             CcceeEEeEeecCCceEEEEEEECCCcEEEEEEecCCh-hhhHHHHHHHHcCCC-CCCCeeEEEEEEecCCccceeeeee
Q psy17532        111 CRSIQLVEVKAQGRFGAVWKAKFKNENVAVKIFLMQDK-QSWQSEQEIFKLPHM-EHDNILRYIGAEKRGESIHTEFWLI  188 (461)
Q Consensus       111 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vAvK~~~~~~~-~~~~~~~ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lv  188 (461)
                      ...|+..+..+.++.+.||+...+++.+.||+...... .....++|...+..+ .+--+-+++.+..+++    ..++|
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~----~~~lv   88 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG----WSNLL   88 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT----EEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC----ceEEE
Confidence            34666666655566678999988888899998764332 222345555543333 2323456666665544    33899


Q ss_pred             ehhccCCChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCCC-----------------------------------
Q psy17532        189 TAYHERGSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPNK-----------------------------------  233 (461)
Q Consensus       189 ~e~~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-----------------------------------  233 (461)
                      |+++++.++.+.....    .....++.++++.|+.||+......                                   
T Consensus        89 ~~~l~G~~~~~~~~~~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             EECCSSEEHHHHTTTC----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             EEeccccccccccccc----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            9999998876654321    1233456677777888886421110                                   


Q ss_pred             -------------cCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        234 -------------ADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       234 -------------~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                                   .....+.++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                         01123358999999999999987767799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.94  E-value=2.9e-05  Score=69.55  Aligned_cols=137  Identities=15%  Similarity=0.098  Sum_probs=79.7

Q ss_pred             EeecCC-ceEEEEEEECC-CcEEEEEEecCChhhhHHHHHHHHcCCC--CCCCeeEEEEEEecCCccceeeeeeehhccC
Q psy17532        119 VKAQGR-FGAVWKAKFKN-ENVAVKIFLMQDKQSWQSEQEIFKLPHM--EHDNILRYIGAEKRGESIHTEFWLITAYHER  194 (461)
Q Consensus       119 ~lg~G~-fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~ei~~l~~l--~H~nIv~l~g~~~~~~~~~~~~~lv~e~~~~  194 (461)
                      .+..|. -+.||+...++ ..+.+|.........  ...|...+..+  ..-.+.+++++..+.+    ..++||+|+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~--l~~E~~~l~~L~~~gvpvP~v~~~~~~~~----~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNE--LQDEAARLSWLATTGVPCAAVLDVVTEAG----RDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSC--HHHHHHHHHHHHTTTCCBCCEEEEEECSS----CEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhH--HHHHHHHHHHHHhcCCCCCceeeeccccc----ceEEEEEeeec
Confidence            344444 46899998864 457888765443332  23344433333  2333566777766654    34899999988


Q ss_pred             CChhhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcccCC------------------------------------------
Q psy17532        195 GSLCDFLKCNIVTWEQLCRIALSMSKGLMHLHEEILPN------------------------------------------  232 (461)
Q Consensus       195 gsL~~~l~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~------------------------------------------  232 (461)
                      -++.+..    ...   ...+.++++.|+-||+.....                                          
T Consensus        91 ~~~~~~~----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          91 QDLLSSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             EETTTSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccccccc----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            6654421    111   122334444555555321000                                          


Q ss_pred             -----CcCCCCCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        233 -----KADSYKPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       233 -----~~~~~~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                           ......+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 011223458999999999999987777899998763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.41  E-value=0.00018  Score=68.97  Aligned_cols=74  Identities=8%  Similarity=-0.050  Sum_probs=43.4

Q ss_pred             EeEeecCCceEEEEEEE--CCCcEEEEEEecCC--------hhhhHHHHHHHHcCCC---CCCCeeEEEEEEecCCccce
Q psy17532        117 VEVKAQGRFGAVWKAKF--KNENVAVKIFLMQD--------KQSWQSEQEIFKLPHM---EHDNILRYIGAEKRGESIHT  183 (461)
Q Consensus       117 ~~~lg~G~fg~Vy~~~~--~~~~vAvK~~~~~~--------~~~~~~~~ei~~l~~l---~H~nIv~l~g~~~~~~~~~~  183 (461)
                      .+.||.|....||+...  .++.|+||.-....        ....+...|...|..+   -...+.+++.+..+..    
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~----  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMA----  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTT----
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCC----
Confidence            45689999999999976  35689999753210        0111223344443322   2245667776643322    


Q ss_pred             eeeeeehhccCCC
Q psy17532        184 EFWLITAYHERGS  196 (461)
Q Consensus       184 ~~~lv~e~~~~gs  196 (461)
                        ++|||++++..
T Consensus       107 --~lvmE~L~~~~  117 (392)
T d2pula1         107 --VTVMEDLSHLK  117 (392)
T ss_dssp             --EEEECCCTTSE
T ss_pred             --EEEEeccCCcc
Confidence              79999997644

>d1btea_ g.7.1.3 (A:) Type II activin receptor {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Snake toxin-like
superfamily: Snake toxin-like
family: Extracellular domain of cell surface receptors
domain: Type II activin receptor
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.36  E-value=2.9e-05  Score=57.45  Aligned_cols=37  Identities=46%  Similarity=1.314  Sum_probs=30.9

Q ss_pred             CCCCCCccccccccccCCCceEEecCCCCCCCCCCCCCC
Q psy17532          1 MECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFAWEPA   39 (461)
Q Consensus         1 ~~~~~~~~c~~~~~~~~~~~~~c~~~~~~C~~~~~~~~~   39 (461)
                      ++|.|.++||.+.++  .+..+|||.||+||.++.|.|.
T Consensus        58 ~~cc~~~~Cv~~~~~--~~~~FCCC~gd~CN~nfs~~P~   94 (96)
T d1btea_          58 INCYDRTDCIEKKDS--PEVYFCCCEGNMCNEKFSYFPE   94 (96)
T ss_dssp             CCCSCSSSEEECSSS--CSSEEEEECSTTGGGSEEECCC
T ss_pred             CCcccccccccCCCC--CceEEEeCCCCccccccccCCC
Confidence            479999999987643  3589999999999999998663

>d2h62d1 g.7.1.3 (D:8-98) Type II activin receptor {Mouse (Mus musculus), isoform IIB [TaxId: 10090]}

class: Small proteins
fold: Snake toxin-like
superfamily: Snake toxin-like
family: Extracellular domain of cell surface receptors
domain: Type II activin receptor
species: Mouse (Mus musculus), isoform IIB [TaxId: 10090]

Probab=96.53  E-value=0.00047  Score=50.10  Aligned_cols=32  Identities=44%  Similarity=1.298  Sum_probs=26.8

Q ss_pred             CCCCCccccccccccCCCceEEecCCCCCCCCCC
Q psy17532          2 ECYDKPKCVEKRPESKKNLNFCCCEGDMCNKDFA   35 (461)
Q Consensus         2 ~~~~~~~c~~~~~~~~~~~~~c~~~~~~C~~~~~   35 (461)
                      +|+|.++||.+.  ..+...+|||.||+||.++.
T Consensus        58 ~c~~~~eCv~~~--~~~~~~FCCC~gd~CN~nfs   89 (91)
T d2h62d1          58 NCYDRQECVATE--ENPQVYFCCCEGNFCNERFT   89 (91)
T ss_dssp             GGTTCSSEECCC--SSCSSEEEEESSTTTTSSEE
T ss_pred             CcccccccCccC--CCCceEEEeCCCCcccccee
Confidence            688889999864  34568999999999999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.43  E-value=0.0027  Score=58.71  Aligned_cols=29  Identities=21%  Similarity=0.256  Sum_probs=23.8

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ..++||+|+.+.|||++++  ..+.||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            4579999999999999754  4588998774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.35  E-value=0.005  Score=58.47  Aligned_cols=75  Identities=8%  Similarity=0.129  Sum_probs=46.6

Q ss_pred             ceeEEeEeecCCceEEEEEEECC---------CcEEEEEEecCChhhhHHHHHHHHcCCCC-CCCeeEEEEEEecCCccc
Q psy17532        113 SIQLVEVKAQGRFGAVWKAKFKN---------ENVAVKIFLMQDKQSWQSEQEIFKLPHME-HDNILRYIGAEKRGESIH  182 (461)
Q Consensus       113 ~~~~~~~lg~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~ei~~l~~l~-H~nIv~l~g~~~~~~~~~  182 (461)
                      ++++ +.|+.|-.-.+|+.....         +.|.+++.- ........++|..+++.+. +.-..++++++.+     
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG-----  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence            4444 567778889999998742         346666654 2223334556766665553 3223477777643     


Q ss_pred             eeeeeeehhccCCCh
Q psy17532        183 TEFWLITAYHERGSL  197 (461)
Q Consensus       183 ~~~~lv~e~~~~gsL  197 (461)
                         .+|+||+++-.|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               589999987444

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.70  E-value=0.005  Score=56.33  Aligned_cols=31  Identities=29%  Similarity=0.413  Sum_probs=27.4

Q ss_pred             CCCeecccCCCCcEEEcCCCceEEEecCCcc
Q psy17532        238 KPAVAHRDFKSNNVLLKSDLTAAIADFGLAL  268 (461)
Q Consensus       238 ~~~ivHrDLkp~NILl~~~~~~ki~DFGla~  268 (461)
                      ..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999998877899999773